data_2kd7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kd7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.507 HG21 ' HE2' ' A' ' 146' ' ' LYS . 19.2 p . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.347 -0.612 . . . . 74.030000000000001 109.347 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 149' ' ' ILE . 40.1 mm -67.16 129.17 31.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.446 -0.343 . . . . 75.120000000000005 110.388 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.8 m -63.11 116.47 5.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 71.230000000000004 110.356 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -86.61 15.7 5.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 74.420000000000002 110.907 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -62.54 -35.23 78.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.774 -0.648 . . . . 73.019999999999996 111.848 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.36 15.9 38.55 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.551 -0.833 . . . . 62.530000000000001 113.106 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m0 -84.06 141.99 30.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.933 0.366 . . . . 75.230000000000004 110.842 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.458 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.7 pt-20 -136.73 157.36 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.966 0.412 . . . . 64.439999999999998 110.373 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.24 122.44 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.747 -0.661 . . . . 73.129999999999995 109.94 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 60' ' ' ASP . 71.4 mt -84.75 -39.95 17.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.056 0.455 . . . . 70.129999999999995 110.572 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -154.59 142.06 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 70.319999999999993 110.091 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 18' ' ' GLN . 32.5 p90 -139.97 145.58 38.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 109.38 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 m -88.24 -33.88 17.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.86 0.362 . . . . 71.319999999999993 111.282 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 t -148.88 151.15 34.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 111.158 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG2' ' CE2' ' A' ' 15' ' ' PHE . 1.5 pp0? -167.81 142.71 3.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.894 -0.78 . . . . 73.010000000000005 108.894 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -109.82 94.2 4.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.138 0.494 . . . . 65.430000000000007 110.776 -174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.58 8.01 41.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 74.140000000000001 111.048 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -120.01 -46.33 2.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.116 0.484 . . . . 75.319999999999993 110.26 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.209 0 CA-C-N 115.963 -0.562 . . . . 62.140000000000001 112.647 -179.77 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.6 t30 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.233 -0.654 . . . . 72.129999999999995 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.05 6.6 88.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.993 -0.622 . . . . 62.539999999999999 112.175 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.8 mt -80.15 148.59 30.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 72.310000000000002 110.565 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.536 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.31 -25.71 65.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 73.329999999999998 111.191 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -76.39 -23.21 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.796 -0.362 . . . . 74.010000000000005 111.254 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 71.1 m -63.08 -27.73 69.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.03 0.443 . . . . 73.230000000000004 110.234 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.27 -30.92 70.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 74.349999999999994 110.469 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.692 HG23 HG12 ' A' ' 59' ' ' ILE . 46.9 pt -115.23 13.1 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 75.420000000000002 111.054 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.4 t70 -77.32 -33.02 55.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 74.0 109.226 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.401 ' HA2' ' OE1' ' A' ' 142' ' ' GLU . . . 84.2 55.1 2.83 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.519 -0.764 . . . . 73.219999999999999 112.623 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.51 129.62 16.51 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.815 -0.439 . . . . 74.010000000000005 109.815 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.589 HG21 HD23 ' A' ' 73' ' ' LEU . 11.1 p -70.21 -19.79 63.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.38 0.511 . . . . 70.329999999999998 112.38 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.52 -13.29 40.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.733 0.301 . . . . 73.209999999999994 110.893 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -105.36 151.72 23.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.789 -0.448 . . . . 71.439999999999998 109.789 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -151.93 162.37 41.18 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.575 -0.45 . . . . 75.0 111.04 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.536 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.6 t90 -98.79 137.59 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 74.439999999999998 109.271 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.3 t-80 -131.67 139.16 49.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.588 -0.523 . . . . 75.049999999999997 109.588 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 151.5 46.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 63.039999999999999 109.973 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -61.87 129.32 40.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.318 -0.253 . . . . 73.439999999999998 110.318 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -134.71 -32.99 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.073 -0.251 . . . . 75.439999999999998 111.068 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -81.27 102.6 10.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.727 -0.471 . . . . 73.5 109.727 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.62 -11.64 53.72 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.921 -0.657 . . . . 72.209999999999994 111.54 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.45 149.42 7.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.733 -0.746 . . . . 74.430000000000007 112.291 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.5 m -86.16 173.44 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 65.310000000000002 111.3 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.583 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 24.1 m-20 -98.2 166.51 13.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.966 -0.561 . . . . 71.019999999999996 109.787 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 56.9 Cg_endo -71.92 122.76 8.76 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.1 1.867 . . . . 62.299999999999997 112.973 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 16.8 mt -67.96 154.49 93.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 75.420000000000002 110.139 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 86.6 Cg_endo -81.17 167.21 72.63 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.669 -1.388 . . . . 74.439999999999998 113.019 1.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.0 m-85 -104.99 119.43 38.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 70.120000000000005 110.491 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.19 125.51 54.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.911 0.386 . . . . 64.310000000000002 110.705 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.4 mt -118.62 117.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.446 . . . . 74.530000000000001 110.049 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.915 HG22 ' HG3' ' A' ' 125' ' ' ARG . 54.7 t -106.23 122.34 59.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.34 -0.391 . . . . 72.540000000000006 110.936 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.692 HG12 HG23 ' A' ' 34' ' ' ILE . 4.6 mp -112.38 139.39 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 75.319999999999993 110.609 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.512 ' HB2' HD13 ' A' ' 13' ' ' LEU . 58.0 t0 -103.26 121.19 42.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.333 -0.618 . . . . 73.140000000000001 109.333 174.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.1 mtm -88.34 -3.14 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.284 -0.416 . . . . 73.329999999999998 110.725 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 65.57 13.44 8.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.712 -0.676 . . . . 74.140000000000001 111.991 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.42 ' OE1' HD11 ' A' ' 149' ' ' ILE . 4.8 pt20 -165.35 153.8 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.359 -0.608 . . . . 74.099999999999994 109.359 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -82.7 123.81 29.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.942 -0.392 . . . . 74.530000000000001 109.942 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.431 ' CD1' HG22 ' A' ' 5' ' ' ILE . 85.4 mt -126.44 139.14 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.167 -0.47 . . . . 74.540000000000006 110.374 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -82.1 101.46 10.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.734 -0.839 . . . . 75.129999999999995 108.734 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.7 mm -70.55 134.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 73.319999999999993 110.811 -174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 -42.57 1.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.067 -0.515 . . . . 71.019999999999996 110.699 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.616 ' HG2' ' HD3' ' A' ' 146' ' ' LYS . 11.8 tt0 -147.95 138.73 23.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 73.540000000000006 111.444 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.9 143.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.028 -0.73 . . . . 75.150000000000006 109.028 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.858 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 17.8 tt0 -120.75 133.72 55.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.175 -0.306 . . . . 75.420000000000002 110.175 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 48.1 mt -117.26 121.45 41.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.311 -0.625 . . . . 74.109999999999999 109.311 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 38' ' ' THR . 34.5 tp -102.4 101.27 18.82 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.829 -0.434 . . . . 73.409999999999997 109.829 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.6 Cg_endo . . . . . 0 N--CA 1.45 -1.062 0 C-N-CA 122.89 2.393 . . . . 73.140000000000001 111.397 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 112.289 0.477 . . . . 73.219999999999999 112.289 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.27 40.48 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.949 2.433 . . . . 74.109999999999999 112.099 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -94.55 122.1 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 75.319999999999993 109.824 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -99.89 -50.35 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 74.0 110.938 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 41.7 t -132.85 139.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 75.5 110.923 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.29 140.14 49.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.259 -0.428 . . . . 74.230000000000004 110.268 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 46.9 mt-10 -120.12 130.45 54.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 110.785 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.82 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.123 -0.49 . . . . 75.349999999999994 110.546 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.47 150.54 49.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.363 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 121' ' ' ALA . . . -138.73 155.74 47.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.367 -0.379 . . . . 74.129999999999995 110.088 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.1 t -149.3 147.42 28.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.072 0.463 . . . . 71.450000000000003 111.743 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.05 -28.21 17.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 70.349999999999994 110.601 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -123.38 4.09 9.09 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.891 0.33 . . . . 74.129999999999995 111.891 -173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 77.24 -20.83 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.522 0.729 . . . . 74.120000000000005 111.265 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.1 -54.27 8.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.024 0.44 . . . . 74.129999999999995 110.351 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -90.14 103.82 16.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.882 -0.599 . . . . 74.150000000000006 110.911 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -94.53 137.16 34.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.178 0.513 . . . . 74.329999999999998 110.573 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -122.01 125.12 26.75 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.668 -0.696 . . . . 72.510000000000005 109.938 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.7 108.63 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.608 2.205 . . . . 71.420000000000002 111.283 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 116' ' ' VAL . 18.2 pt -81.28 -13.46 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.0 -0.546 . . . . 63.240000000000002 111.163 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.46 135.18 1.85 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.326 -0.94 . . . . 71.219999999999999 112.792 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 60.8 ttt180 -111.69 121.29 44.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.486 -0.561 . . . . 72.150000000000006 109.486 172.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -140.0 165.9 26.09 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.768 -0.373 . . . . 73.230000000000004 111.01 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -81.39 147.74 27.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.002 -0.618 . . . . 63.140000000000001 111.678 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.58 123.32 40.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.932 -0.396 . . . . 74.349999999999994 109.932 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.608 ' HB ' HD21 ' A' ' 112' ' ' LEU . 10.3 m -102.13 106.78 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.302 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -65.69 110.29 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 71.340000000000003 110.429 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -152.38 177.98 10.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 75.310000000000002 109.752 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.9 -9.56 36.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.251 0.548 . . . . 74.049999999999997 110.356 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.51 157.65 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 70.530000000000001 110.641 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . . . -70.26 144.47 51.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.045 0.45 . . . . 71.450000000000003 111.703 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.608 HD21 ' HB ' ' A' ' 106' ' ' THR . 20.4 mt -99.55 113.85 26.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.525 -0.761 . . . . 75.230000000000004 110.146 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 50.4 mt-10 -85.15 115.78 23.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.848 0.356 . . . . 74.329999999999998 110.593 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.55 105.36 14.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 110.779 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -75.86 118.55 18.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.959 -0.756 . . . . 72.010000000000005 108.959 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 100' ' ' ILE . 29.4 m -120.67 -172.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.324 0.491 . . . . 71.409999999999997 112.324 -171.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -66.53 125.89 27.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.16 -0.927 . . . . 74.409999999999997 110.719 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.7 m -74.87 108.06 7.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.035 0.445 . . . . 75.25 110.217 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.74 152.2 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.964 -0.562 . . . . 74.409999999999997 109.943 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.59 ' HG3' HD12 ' A' ' 150' ' ' ILE . 1.1 ttmp? -73.36 138.91 45.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.554 -0.536 . . . . 75.030000000000001 109.554 175.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.469 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . . . -156.27 134.43 11.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.51 -0.313 . . . . 73.109999999999999 110.88 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -95.57 -29.82 14.14 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.799 -0.815 . . . . 74.209999999999994 108.799 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.9 145.08 41.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.1 -0.954 . . . . 75.109999999999999 109.499 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.71 137.18 51.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.657 -0.497 . . . . 74.450000000000003 109.657 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.915 ' HG3' HG22 ' A' ' 58' ' ' VAL . 4.4 ttm180 -122.13 130.21 53.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 75.099999999999994 111.159 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.2 tp -97.48 118.16 33.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 75.420000000000002 109.016 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.6 m -109.97 122.83 48.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.5 . . . . 74.510000000000005 111.1 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.1 mm -101.46 94.0 3.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 75.129999999999995 108.714 173.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 59.0 Cg_endo -71.48 151.67 59.41 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.86 2.373 . . . . 70.439999999999998 113.308 -173.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.779 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 12.6 p-10 -89.72 4.79 48.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.589 0.709 . . . . 71.109999999999999 109.535 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.16 -34.39 15.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.075 -0.966 . . . . 72.209999999999994 111.39 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.18 -3.45 76.0 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.616 -0.802 . . . . 65.120000000000005 113.529 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.07 8.18 45.26 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.488 -0.863 . . . . 73.25 111.335 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -69.05 133.73 48.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.309 -0.446 . . . . 74.299999999999997 111.608 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 m -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.965 -0.561 . . . . 73.049999999999997 109.728 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 38.5 p -84.4 16.27 3.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.971 0.415 . . . . 73.239999999999995 111.36 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.83 119.48 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.546 -0.538 . . . . 75.340000000000003 109.546 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -144.27 130.91 20.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.59 -0.277 . . . . 73.400000000000006 110.613 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.64 105.61 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.051 0.453 . . . . 73.420000000000002 110.884 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.63 133.14 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.838 -0.43 . . . . 73.340000000000003 109.838 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.27 -62.54 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.223 0.327 . . . . 75.120000000000005 110.724 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.401 ' OE1' ' HA2' ' A' ' 36' ' ' GLY . 15.1 pt-20 -154.13 161.32 41.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.457 0.646 . . . . 72.319999999999993 111.59 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -119.43 135.94 54.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.832 -1.076 . . . . 75.420000000000002 108.19 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.8 t70 -129.23 161.6 29.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.016 -0.364 . . . . 73.420000000000002 110.016 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.4 t -135.35 133.56 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.403 . . . . 73.319999999999993 110.267 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.858 ' HE3' ' HB2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -108.86 125.6 52.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.848 -0.797 . . . . 75.049999999999997 108.848 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.21 -168.25 30.96 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.407 -0.902 . . . . 74.420000000000002 112.449 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.7 m -112.35 132.29 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.465 -0.198 . . . . 74.310000000000002 110.465 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.446 HD12 HD13 ' A' ' 5' ' ' ILE . 40.3 mm -73.36 123.58 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 70.230000000000004 110.757 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.59 HD12 ' HG3' ' A' ' 120' ' ' LYS . 48.0 mt . . . . . 0 C--N 1.326 -0.451 0 N-CA-C 109.558 -0.534 . . . . 73.310000000000002 109.558 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.831 0.348 . . . . 71.140000000000001 110.539 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 149' ' ' ILE . 30.0 mm -94.69 132.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.467 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -70.77 123.43 21.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.592 -0.522 . . . . 75.530000000000001 109.592 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -98.59 16.41 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 71.510000000000005 111.468 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -77.44 -5.15 48.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.911 0.386 . . . . 75.430000000000007 111.497 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.89 -0.09 24.28 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.652 -0.785 . . . . 34.420000000000002 112.357 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -82.86 153.9 24.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.645 0.26 . . . . 73.439999999999998 110.654 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.02 155.4 48.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 110.663 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.33 119.7 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.516 -0.766 . . . . 75.010000000000005 109.948 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 60' ' ' ASP . 84.9 mt -84.18 -42.04 16.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.942 -0.572 . . . . 74.409999999999997 110.53 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.8 t -149.21 143.73 26.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 75.310000000000002 110.131 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -148.88 149.52 31.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 74.510000000000005 109.687 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 m -92.57 -44.3 8.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.844 0.313 . . . . 74.219999999999999 111.844 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -138.49 149.48 45.45 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.73 -0.388 . . . . 63.350000000000001 111.137 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -161.93 142.86 10.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.799 -0.637 . . . . 75.319999999999993 109.441 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.689 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 tp10 -115.84 93.6 4.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.295 -0.412 . . . . 75.319999999999993 110.541 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.91 -14.31 26.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 70.340000000000003 111.204 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -98.81 -51.84 3.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.406 -0.361 . . . . 75.209999999999994 111.308 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 121.065 -0.588 . . . . 73.310000000000002 113.38 -175.827 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 110.446 -0.205 . . . . 65.319999999999993 110.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.7 -7.78 63.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.242 -0.504 . . . . 75.239999999999995 112.638 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.688 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.8 mt -73.67 142.95 46.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.741 0.305 . . . . 75.230000000000004 110.768 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.41 -27.21 68.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 50.119999999999997 111.309 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -19.35 61.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 75.129999999999995 110.562 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 1.071 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 69.5 m -72.84 -18.42 61.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 73.219999999999999 111.032 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 HD22 ' A' ' 126' ' ' LEU . 32.6 tp -64.88 -24.32 67.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.546 0.689 . . . . 75.120000000000005 109.925 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 pt -122.6 19.65 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.339 -0.846 . . . . 70.129999999999995 109.775 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 1.071 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 22.0 t70 -64.68 -41.57 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.325 -0.852 . . . . 71.409999999999997 111.458 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 38.19 5.25 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.471 -0.871 . . . . 73.519999999999996 112.077 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -151.28 128.8 11.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.194 -0.298 . . . . 63.039999999999999 110.194 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.4 p -75.58 -2.9 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.142 0.423 . . . . 73.219999999999999 112.142 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.37 -22.34 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.109 -0.236 . . . . 74.420000000000002 110.95 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p -88.55 165.69 14.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.875 -0.417 . . . . 71.540000000000006 109.875 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.543 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 31.8 p90 -164.97 165.82 19.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.421 . . . . 74.219999999999999 111.442 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.567 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 36.3 t90 -106.4 141.92 36.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.198 -0.91 . . . . 72.329999999999998 109.018 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.4 t-80 -139.62 143.21 37.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.509 -0.552 . . . . 65.040000000000006 109.509 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 136.65 50.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.583 -0.525 . . . . 75.129999999999995 109.583 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.689 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 3.5 ttpm? -62.87 122.04 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.578 0.228 . . . . 71.420000000000002 110.396 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -117.34 -29.13 5.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.524 -0.307 . . . . 75.140000000000001 110.686 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.9 110.98 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 75.049999999999997 110.251 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.31 -5.95 65.62 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.898 -0.668 . . . . 51.229999999999997 111.982 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.84 143.17 5.51 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 71.030000000000001 112.459 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 19.0 m -93.71 144.7 25.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.813 0.34 . . . . 72.010000000000005 110.761 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.9 m-20 -76.76 148.02 78.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.083 -0.508 . . . . 51.299999999999997 109.965 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 9.6 Cg_exo -72.39 144.25 40.57 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.81 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 161.88 77.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 71.219999999999999 110.342 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.1 Cg_exo -79.77 168.96 71.96 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.082 -1.216 . . . . 74.319999999999993 112.577 -1.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.737 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 25.2 m-85 -107.92 128.74 54.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.688 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.8 133.14 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 64.409999999999997 110.172 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.57 HD11 HD21 ' A' ' 126' ' ' LEU . 51.0 mt -132.17 111.43 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.868 -0.419 . . . . 72.219999999999999 109.868 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' HH2' ' A' ' 97' ' ' TRP . 57.8 t -106.42 121.38 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 74.439999999999998 111.096 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 57' ' ' ILE . 5.1 mp -116.1 136.19 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.33 . . . . 74.310000000000002 110.837 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.421 ' HB2' HD13 ' A' ' 13' ' ' LEU . 37.0 t0 -96.45 117.5 31.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.149 -0.685 . . . . 73.450000000000003 109.149 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.75 -3.28 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 74.510000000000005 110.517 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.1 mmtp 73.05 -13.9 0.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 112.401 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -147.53 177.14 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.9 0.381 . . . . 72.340000000000003 110.953 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 121.51 30.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.609 . . . . 60.32 110.209 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 5' ' ' ILE . 67.7 mt -129.18 134.81 63.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.891 0.377 . . . . 75.239999999999995 110.259 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -81.77 105.76 13.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.194 -0.669 . . . . 71.219999999999999 109.194 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 118' ' ' SER . 10.2 mm -80.18 117.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.231 -0.285 . . . . 74.329999999999998 110.231 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.19 -41.92 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 71.310000000000002 110.665 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -144.59 138.84 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.004 -0.544 . . . . 71.040000000000006 110.865 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -110.2 133.94 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.387 -0.598 . . . . 72.420000000000002 109.387 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -114.42 127.93 56.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.033 0.444 . . . . 71.120000000000005 110.834 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.0 mt -109.35 125.95 52.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.876 -0.602 . . . . 73.049999999999997 109.709 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -112.27 96.44 35.23 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.164 -0.68 . . . . 73.430000000000007 109.164 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 56.6 Cg_endo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.443 2.095 . . . . 72.519999999999996 111.589 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.43 HD22 HD13 ' A' ' 83' ' ' ILE . 21.8 t-20 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 73.319999999999993 110.823 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -92.55 19.47 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.127 2.551 . . . . 73.120000000000005 112.813 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 HD22 ' A' ' 81' ' ' ASN . 58.7 mt -79.59 129.89 36.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 70.430000000000007 109.772 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.93 -38.05 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.856 -0.611 . . . . 73.109999999999999 110.419 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.97 137.96 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 75.310000000000002 111.206 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.38 141.66 45.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.142 -0.481 . . . . 72.239999999999995 110.507 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -118.32 132.79 56.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 109.937 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.71 133.34 55.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.441 -0.345 . . . . 75.349999999999994 110.466 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.98 146.76 50.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.788 0.328 . . . . 74.230000000000004 111.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.39 146.41 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 75.409999999999997 110.162 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.4 t -140.17 157.46 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.226 0.536 . . . . 73.150000000000006 111.516 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.8 mt-10 -116.14 -32.23 5.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 74.329999999999998 110.668 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -114.82 5.13 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 74.310000000000002 112.161 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 71.92 -1.91 2.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.119 0.568 . . . . 74.049999999999997 111.752 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 -51.69 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 72.340000000000003 110.195 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -89.94 112.72 24.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.796 -0.638 . . . . 72.519999999999996 110.538 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.409 ' HH2' HG11 ' A' ' 58' ' ' VAL . 97.9 m95 -104.81 108.04 19.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.07 -0.514 . . . . 75.140000000000001 109.935 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.7 m -89.28 120.05 69.73 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.287 -0.415 . . . . 71.019999999999996 110.314 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.82 110.9 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.396 2.064 . . . . 74.430000000000007 110.83 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -86.38 -10.12 11.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.124 -0.489 . . . . 70.230000000000004 110.81 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.91 128.7 0.98 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.083 -1.056 . . . . 64.540000000000006 113.322 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.27 117.2 33.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.387 -0.968 . . . . 73.109999999999999 108.387 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.58 175.28 9.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.124 0.488 . . . . 74.409999999999997 111.47 -171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.79 15.79 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.35 -0.841 . . . . 71.450000000000003 111.745 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.585 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 51.4 t80 -97.01 148.01 23.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 73.120000000000005 110.106 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -142.71 112.06 6.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.398 -0.364 . . . . 72.030000000000001 110.444 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -72.54 114.42 10.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 110.556 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 74' ' ' PRO . 13.2 pt20 -154.07 179.8 8.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.622 -0.717 . . . . 74.340000000000003 109.43 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.88 -5.39 51.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 75.040000000000006 110.283 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.97 36.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 74.109999999999999 110.208 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.65 140.33 58.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.045 0.45 . . . . 72.430000000000007 110.886 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.81 104.75 16.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.719 -0.673 . . . . 71.400000000000006 110.248 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -79.97 109.04 14.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.004 0.431 . . . . 73.319999999999993 110.752 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.12 104.59 14.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.069 -0.514 . . . . 73.439999999999998 110.404 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -70.86 106.75 3.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.994 -0.743 . . . . 75.450000000000003 108.994 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 27.4 m -106.08 174.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.903 0.382 . . . . 73.239999999999995 111.445 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HD3' ' HB ' ' A' ' 119' ' ' ILE . 7.5 tmtm? -64.04 122.51 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 75.140000000000001 110.086 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 25.1 m -66.53 114.82 5.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.93 -0.577 . . . . 72.230000000000004 109.92 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 12.8 tt -144.19 145.07 22.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.861 0.363 . . . . 70.5 110.958 -174.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -94.29 115.21 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.97 -0.752 . . . . 75.209999999999994 108.97 175.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.503 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.3 175.22 10.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 52.539999999999999 111.303 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -118.39 -34.19 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 110.362 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -107.52 146.21 32.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.932 -0.577 . . . . 75.099999999999994 110.25 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.16 137.91 53.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.945 -0.571 . . . . 75.439999999999998 109.827 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 28.3 ttp180 -123.52 122.54 38.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.499 -0.319 . . . . 73.409999999999997 110.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.57 HD21 HD11 ' A' ' 57' ' ' ILE . 37.2 tp -84.69 113.03 21.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.515 -0.92 . . . . 73.109999999999999 108.515 169.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 22.8 m -103.48 118.37 36.58 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.574 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.737 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.3 mm -102.51 96.76 7.78 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.712 -0.847 . . . . 74.109999999999999 108.712 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 72.8 Cg_endo -76.44 175.98 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.391 2.061 . . . . 64.340000000000003 112.595 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.95 13.25 29.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.729 0.776 . . . . 71.209999999999994 109.141 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.93 144.76 25.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.677 -1.147 . . . . 71.310000000000002 111.093 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.96 57.86 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.992 -0.623 . . . . 70.400000000000006 113.38 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 115.97 22.55 4.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.274 -0.965 . . . . 74.25 112.655 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -68.15 155.01 40.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 72.420000000000002 110.821 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.7 m -129.39 -176.89 4.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.019999999999996 110.197 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 40.3 p -85.23 22.58 1.44 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 72.409999999999997 111.605 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.1 123.55 68.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.574 -0.528 . . . . 71.540000000000006 109.574 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.14 138.88 30.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.469 -0.332 . . . . 71.230000000000004 110.216 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.75 105.24 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 73.140000000000001 111.026 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 42.3 mt -129.45 132.57 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.437 -0.579 . . . . 74.439999999999998 109.437 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 31.6 mmt180 -67.36 -67.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.465 -0.568 . . . . 74.230000000000004 109.465 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.45 152.81 47.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 73.349999999999994 111.494 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -112.76 116.09 29.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.456 -1.312 . . . . 74.129999999999995 107.456 166.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.83 161.39 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.753 -0.462 . . . . 65.439999999999998 109.753 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -131.51 125.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.282 -0.417 . . . . 72.219999999999999 110.262 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -102.31 105.06 15.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.417 0.627 . . . . 74.430000000000007 109.354 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.5 -148.93 4.86 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.181 -0.918 . . . . 63.219999999999999 111.524 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.8 m -132.71 129.25 38.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.809 0.337 . . . . 72.230000000000004 110.878 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.575 HD13 HG23 ' A' ' 5' ' ' ILE . 31.6 mm -71.71 119.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.616 . . . . 75.129999999999995 110.567 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.5 HD11 ' HG2' ' A' ' 120' ' ' LYS . 46.2 mt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 75.5 109.757 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.904 0.383 . . . . 74.049999999999997 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 65' ' ' ILE . 21.2 mm -72.08 137.2 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.969 -0.56 . . . . 74.120000000000005 111.337 -172.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -70.87 111.21 6.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.941 -0.572 . . . . 72.349999999999994 110.538 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -87.04 3.46 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.72 -0.673 . . . . 73.230000000000004 111.803 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -66.88 -26.59 66.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.942 0.401 . . . . 73.310000000000002 110.779 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.84 -5.6 68.27 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.557 -0.83 . . . . 75.510000000000005 112.082 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -81.81 158.43 24.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.606 0.241 . . . . 75.040000000000006 110.643 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.37 158.26 43.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.913 0.387 . . . . 72.209999999999994 110.199 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.22 125.78 45.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 74.019999999999996 109.62 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 60' ' ' ASP . 87.7 mt -94.75 -41.12 9.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.321 -0.399 . . . . 74.299999999999997 110.715 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.0 t -142.48 140.92 32.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 73.409999999999997 110.613 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.43 136.32 19.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.829 -0.623 . . . . 75.340000000000003 109.655 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -87.84 -33.4 18.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 74.510000000000005 111.156 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -146.6 146.61 30.49 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.93 0.395 . . . . 74.340000000000003 110.955 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -162.01 140.47 9.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 74.450000000000003 108.839 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 7.8 tp10 -109.78 81.84 1.5 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.336 0.589 . . . . 72.129999999999995 111.331 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.43 -4.26 53.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.449 -0.796 . . . . 75.439999999999998 110.467 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -100.27 -53.54 3.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.74 -0.664 . . . . 65.049999999999997 111.092 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 121.3 -0.476 . . . . 75.400000000000006 112.412 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.675 -0.491 . . . . 72.239999999999995 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 5.87 88.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 62.310000000000002 112.832 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.582 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.2 mt -77.57 139.38 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.384 -0.228 . . . . 61.329999999999998 110.384 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.14 -21.27 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.030000000000001 111.529 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -22.28 46.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 74.129999999999995 110.901 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.869 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 86.3 m -69.63 -18.29 63.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.058 -0.519 . . . . 74.310000000000002 110.642 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.92 -27.46 69.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 75.519999999999996 110.176 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 59' ' ' ILE . 34.2 pt -120.32 18.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 73.540000000000006 110.208 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.869 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -63.92 -45.75 87.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 73.549999999999997 110.222 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.08 24.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.631 -0.795 . . . . 74.230000000000004 112.708 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.49 131.73 54.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 74.409999999999997 111.134 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.7 p -71.55 -10.26 59.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.713 -0.676 . . . . 73.230000000000004 111.079 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.91 -21.67 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.329999999999998 111.058 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 17.1 p -89.76 169.77 11.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.091 -0.337 . . . . 74.349999999999994 110.091 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.515 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.2 p90 -163.62 157.9 19.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 74.430000000000007 111.284 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.51 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 34.8 t90 -103.83 142.41 34.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.283 -0.871 . . . . 74.5 108.98 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 19' ' ' GLU . 38.4 t-80 -138.72 144.53 39.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.532 -0.544 . . . . 74.200000000000003 109.532 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 144.39 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.027 -0.36 . . . . 71.420000000000002 110.027 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 49' ' ' GLY . 29.2 ttpt -72.61 126.47 29.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.487 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -125.15 -24.84 3.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.39 -0.368 . . . . 74.430000000000007 110.772 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -71.19 112.56 7.43 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.087 0.47 . . . . 75.239999999999995 110.461 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.16 12.99 56.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.957 -0.639 . . . . 73.519999999999996 111.763 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.506 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . 107.97 143.02 10.48 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.091 -0.804 . . . . 74.129999999999995 111.091 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.4 m -85.78 166.79 15.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.71 0.29 . . . . 75.329999999999998 110.72 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 22.7 m-20 -91.13 148.9 38.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.421 -0.354 . . . . 73.299999999999997 110.518 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 12.0 Cg_exo -71.23 151.48 60.68 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.053 2.502 . . . . 73.349999999999994 112.531 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 15.5 mt -93.85 159.65 34.13 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.634 -0.712 . . . . 70.209999999999994 110.391 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.3 Cg_endo -81.73 161.54 79.41 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 123.481 -1.466 . . . . 73.040000000000006 112.845 2.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.791 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.1 m-85 -91.13 123.1 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.566 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.73 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 0.7 OUTLIER -109.49 123.36 49.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.447 -0.797 . . . . 74.310000000000002 110.361 -178.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 126' ' ' LEU . 61.8 mt -127.77 110.76 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.812 -0.44 . . . . 72.540000000000006 109.812 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.455 HG11 ' CH2' ' A' ' 97' ' ' TRP . 59.5 t -104.81 122.11 57.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.873 -0.603 . . . . 74.010000000000005 110.69 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 34' ' ' ILE . 57.5 mt -119.77 136.31 57.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.591 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.544 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.7 t0 -101.73 123.8 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 72.040000000000006 110.339 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 68.5 mtm -90.52 -3.1 57.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 61.140000000000001 110.783 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 71.79 0.2 3.42 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.365 0.666 . . . . 75.439999999999998 112.688 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -163.81 170.95 16.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.431 -0.211 . . . . 73.299999999999997 110.431 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 121' ' ' ALA . 1.9 m120 -79.47 127.16 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 54.210000000000001 110.206 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.464 ' CD1' HG22 ' A' ' 5' ' ' ILE . 75.0 mt -133.42 135.46 56.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.753 -0.462 . . . . 75.129999999999995 109.753 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 150' ' ' ILE . 51.5 tp60 -80.11 104.09 10.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.009 -0.737 . . . . 75.310000000000002 109.009 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.6 mm -74.41 108.12 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.637 -0.256 . . . . 72.040000000000006 110.564 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.26 -50.79 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 73.340000000000003 110.895 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -142.23 140.08 32.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.025 0.441 . . . . 75.219999999999999 111.09 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.0 129.09 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 75.530000000000001 109.445 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -111.47 129.43 56.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.068 0.461 . . . . 73.439999999999998 110.971 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 114' ' ' TYR . 54.3 mt -116.77 129.36 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.804 -0.634 . . . . 73.230000000000004 110.241 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.4 tp -106.92 104.94 53.88 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.285 -0.416 . . . . 74.099999999999994 110.231 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.634 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.51 2.806 . . . . 73.030000000000001 111.477 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.555 HD22 ' HE2' ' A' ' 105' ' ' PHE . 64.5 t30 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.52 -0.548 . . . . 62.140000000000001 109.52 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.51 40.91 1.02 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.191 2.594 . . . . 73.010000000000005 113.636 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mt -83.48 130.73 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.879 -0.415 . . . . 65.129999999999995 109.879 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -109.99 -56.18 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.87 -0.605 . . . . 71.129999999999995 110.578 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.465 HG21 ' HA3' ' A' ' 132' ' ' GLY . 92.6 t -118.83 137.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.549 . . . . 61.140000000000001 110.622 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -127.4 134.56 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.615 . . . . 71.109999999999999 110.273 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.91 125.87 53.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.223 0.535 . . . . 75.099999999999994 110.614 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -104.87 129.45 53.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.807 -0.633 . . . . 74.230000000000004 109.967 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.33 151.21 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 74.030000000000001 110.779 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.01 150.25 51.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.901 -0.591 . . . . 73.349999999999994 109.86 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -149.63 161.11 42.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.101 0.477 . . . . 75.530000000000001 111.047 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.772 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 32.7 mt-10 -120.29 -7.14 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.0 -0.546 . . . . 73.230000000000004 110.603 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -122.14 -9.81 8.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.641 -0.254 . . . . 74.430000000000007 111.036 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 73.58 6.46 5.02 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.907 0.755 . . . . 72.340000000000003 110.331 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.4 t -113.84 -50.71 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.686 -0.688 . . . . 70.319999999999993 110.301 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -98.4 104.78 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.734 -0.666 . . . . 70.319999999999993 109.863 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.455 ' CH2' HG11 ' A' ' 58' ' ' VAL . 99.0 m95 -91.71 131.14 37.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.053 -0.521 . . . . 72.400000000000006 110.529 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 m -110.67 122.82 37.21 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 116.006 -0.543 . . . . 62.5 109.91 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 125.71 15.94 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.427 2.085 . . . . 72.409999999999997 111.723 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 116' ' ' VAL . 28.7 pt -100.4 -17.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 75.219999999999999 110.57 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.65 133.23 1.82 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.891 -1.147 . . . . 65.420000000000002 113.025 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -114.99 114.96 26.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.86 -0.793 . . . . 74.510000000000005 108.86 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.406 ' HE2' HG11 ' A' ' 116' ' ' VAL . 56.9 m-85 -138.69 -174.25 3.78 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.402 -0.519 . . . . 64.120000000000005 111.124 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.61 146.04 16.33 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.944 -0.646 . . . . 71.329999999999998 112.043 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.555 ' HE2' HD22 ' A' ' 81' ' ' ASN . 42.8 t80 -99.1 148.69 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 74.409999999999997 110.057 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -139.61 127.49 22.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.298 -0.41 . . . . 72.329999999999998 110.193 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -80.87 100.3 8.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.185 0.517 . . . . 74.109999999999999 110.187 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -140.73 172.98 11.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.716 -0.675 . . . . 72.420000000000002 109.996 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.98 -3.92 58.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 75.329999999999998 110.603 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.42 34.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.935 -0.575 . . . . 63.210000000000001 110.452 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 131.17 45.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.124 0.488 . . . . 75.540000000000006 110.708 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.37 114.29 21.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.641 -0.709 . . . . 74.409999999999997 110.637 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.41 108.56 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 74.230000000000004 110.711 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 72' ' ' LEU . 96.1 m-85 -100.89 104.33 15.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 75.129999999999995 110.523 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -74.3 99.78 3.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.611 -0.722 . . . . 74.430000000000007 109.28 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 100' ' ' ILE . 26.9 m -100.47 175.22 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 74.540000000000006 111.814 -173.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.607 ' HZ1' ' HB3' ' A' ' 117' ' ' LYS . 4.7 ttpm? -70.89 113.15 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 74.319999999999993 109.295 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.76 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 49.7 m -68.98 118.01 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 70.129999999999995 111.258 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -146.7 150.41 14.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 72.329999999999998 110.028 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG3' HD13 ' A' ' 150' ' ' ILE . 27.0 ttpp -83.88 133.12 34.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.904 -0.406 . . . . 74.239999999999995 109.904 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.772 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -154.64 171.82 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.416 -0.357 . . . . 73.140000000000001 110.433 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -114.61 -35.01 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.372 0.606 . . . . 74.019999999999996 109.82 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -108.08 145.01 34.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.754 . . . . 73.310000000000002 109.902 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -128.87 139.33 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.39 -0.596 . . . . 75.409999999999997 109.39 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.73 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 31.5 ttp180 -127.29 124.56 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.103 0.477 . . . . 74.319999999999993 111.804 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.571 HD21 HD13 ' A' ' 57' ' ' ILE . 41.2 tp -87.4 112.34 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.704 -0.851 . . . . 75.109999999999999 108.704 171.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -107.59 117.09 33.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.952 0.406 . . . . 72.439999999999998 110.81 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.791 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -101.27 95.25 4.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.596 -0.89 . . . . 72.329999999999998 108.596 172.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.61 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -74.36 172.87 15.23 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.384 2.056 . . . . 71.120000000000005 112.529 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.26 25.9 4.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.889 0.852 . . . . 70.099999999999994 109.133 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -113.57 142.83 45.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.432 -1.258 . . . . 74.010000000000005 110.096 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.465 ' HA3' HG21 ' A' ' 85' ' ' VAL . . . 100.29 -18.11 55.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.83 -0.7 . . . . 75.420000000000002 113.044 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 112.95 17.09 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.33 -0.938 . . . . 72.439999999999998 112.248 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.7 127.73 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 74.420000000000002 110.663 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.3 m -93.84 -179.73 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.29 -0.414 . . . . 72.420000000000002 110.069 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 2.0 p -81.3 31.49 0.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.07 0.462 . . . . 65.340000000000003 111.954 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.28 130.77 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.626 -0.509 . . . . 72.140000000000001 109.626 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.28 31.11 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.974 -0.38 . . . . 74.230000000000004 109.974 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.6 105.93 4.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.138 0.494 . . . . 75.040000000000006 111.521 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.3 mt -129.89 132.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.415 -0.587 . . . . 74.200000000000003 109.415 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 74' ' ' PRO . 58.6 mtp180 -72.54 -52.16 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.321 -0.152 . . . . 72.219999999999999 110.914 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.39 160.46 34.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.723 -0.791 . . . . 74.129999999999995 112.097 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -118.91 127.92 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.691 -1.14 . . . . 73.530000000000001 108.602 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.19 145.68 47.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.871 -0.418 . . . . 75.340000000000003 109.871 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.39 124.39 72.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.047 0.451 . . . . 65.0 110.21 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -103.31 103.67 13.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.814 -0.63 . . . . 75.540000000000006 109.341 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.54 -168.23 15.25 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.721 -0.752 . . . . 42.229999999999997 112.166 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.5 m -118.2 134.08 55.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.59 0.233 . . . . 62.5 110.708 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 38.0 mm -71.67 133.04 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 65.140000000000001 111.326 -177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.478 HD13 ' HG3' ' A' ' 120' ' ' LYS . 56.6 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.616 -0.72 . . . . 74.040000000000006 109.132 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.912 0.387 . . . . 54.140000000000001 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.52 HG23 ' CD1' ' A' ' 65' ' ' ILE . 39.0 mm -88.59 136.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.912 -0.585 . . . . 74.239999999999995 110.24 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 m -69.37 120.35 15.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.98 0.419 . . . . 72.239999999999995 110.007 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -88.15 5.96 38.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 73.430000000000007 111.016 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 88.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.887 -0.597 . . . . 74.349999999999994 110.406 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.67 -13.66 3.67 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.513 -0.767 . . . . 64.109999999999999 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -69.5 142.26 53.76 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.725 -0.472 . . . . 75.040000000000006 109.725 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.485 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 21.8 pt-20 -127.89 158.76 36.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.186 0.517 . . . . 61.399999999999999 111.109 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 114.67 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 72.400000000000006 110.023 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 60' ' ' ASP . 81.7 mt -81.35 -48.74 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.036 -0.529 . . . . 74.239999999999995 110.229 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -147.19 142.16 26.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 62.420000000000002 110.371 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.18 146.88 34.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.686 -0.688 . . . . 75.340000000000003 109.196 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -86.0 -37.49 18.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.858 0.361 . . . . 72.420000000000002 111.176 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.7 t -153.89 149.8 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.014 0.435 . . . . 75.230000000000004 111.109 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 24.8 pt20 -159.01 146.4 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.069 -1.086 . . . . 75.230000000000004 108.069 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -99.31 94.73 6.62 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 75.400000000000006 110.407 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.74 -0.83 23.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.665 -0.698 . . . . 74.049999999999997 110.853 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 m -114.26 -37.94 4.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.139 -0.482 . . . . 54.119999999999997 110.94 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-N 116.012 -0.54 . . . . 64.239999999999995 112.891 -178.806 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.4 t30 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.247 -0.649 . . . . 74.299999999999997 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.33 -1.16 76.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.975 -0.631 . . . . 63.200000000000003 111.808 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 63.8 mt -77.08 150.31 35.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.273 -0.269 . . . . 72.150000000000006 110.273 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.47 -29.95 69.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 71.140000000000001 110.108 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -67.62 -22.69 65.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 74.319999999999993 111.374 177.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.8 m -68.86 -25.2 64.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.971 0.415 . . . . 73.129999999999995 110.293 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.22 -27.87 69.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.694 -0.684 . . . . 61.32 110.361 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 59' ' ' ILE . 31.3 pt -119.31 14.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 73.25 110.434 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.8 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.0 t70 -65.15 -40.7 94.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 71.409999999999997 110.548 -176.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.6 25.76 13.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 72.540000000000006 111.882 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -131.8 122.35 25.64 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.652 -0.499 . . . . 74.230000000000004 109.652 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 p -75.07 -7.79 54.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.906 -0.588 . . . . 75.540000000000006 111.791 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -85.65 -24.2 27.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 72.439999999999998 110.38 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.0 p -96.95 155.8 16.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.292 -0.413 . . . . 73.519999999999996 110.454 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 40.9 p90 -149.07 168.91 21.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.855 0.36 . . . . 72.329999999999998 111.153 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.6 t90 -104.85 138.4 41.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 72.209999999999994 109.083 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -133.88 136.96 44.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.411 -0.588 . . . . 74.340000000000003 109.411 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.43 58.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.672 -0.492 . . . . 75.040000000000006 109.672 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' SER . 53.6 tttm -64.87 120.17 12.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 72.219999999999999 110.369 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -111.19 -30.91 7.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.844 -0.617 . . . . 74.519999999999996 110.845 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -73.11 129.21 37.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.996 -0.372 . . . . 75.219999999999999 109.996 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.06 -12.27 62.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.946 -0.645 . . . . 53.299999999999997 111.974 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.23 140.96 5.9 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.599 -0.601 . . . . 33.409999999999997 111.599 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 9.8 p -81.94 145.79 30.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.662 0.268 . . . . 72.140000000000001 110.812 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 4.3 m-20 -72.72 156.02 90.35 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.096 -0.502 . . . . 74.120000000000005 110.339 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.32 148.79 49.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.526 2.151 . . . . 74.129999999999995 113.01 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -82.46 158.69 65.77 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 75.319999999999993 109.866 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.91 159.31 91.24 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.497 -1.46 . . . . 62.25 112.678 0.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.657 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.8 m-85 -91.3 117.89 30.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.092 -0.503 . . . . 74.349999999999994 110.196 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.689 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.2 t70 -108.16 126.7 53.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.528 -0.76 . . . . 65.019999999999996 110.572 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.568 HD13 HD22 ' A' ' 126' ' ' LEU . 57.9 mt -130.64 114.96 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 74.510000000000005 110.242 175.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.13 115.82 49.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 110.984 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 34' ' ' ILE . 49.4 mm -112.16 142.79 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.493 . . . . 73.239999999999995 110.822 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 13' ' ' LEU . 59.0 t0 -108.77 121.6 45.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.912 -0.585 . . . . 71.109999999999999 109.508 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.511 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 68.3 mtm -85.15 -9.65 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.409999999999997 111.155 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 71.6 mmtt 68.33 16.04 9.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.148 -0.478 . . . . 73.400000000000006 112.215 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.511 ' HG2' ' O ' ' A' ' 61' ' ' MET . 8.3 pt20 -169.17 159.51 9.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.61 0.243 . . . . 75.319999999999993 110.936 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.78 126.0 33.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.481 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.52 ' CD1' HG23 ' A' ' 5' ' ' ILE . 71.8 mt -135.95 140.45 44.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.064 -0.517 . . . . 70.420000000000002 110.304 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.628 ' HB2' HD13 ' A' ' 150' ' ' ILE . 53.0 tp60 -82.86 101.81 11.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.188 -0.671 . . . . 75.430000000000007 109.188 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.5 mm -66.8 122.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.551 -0.295 . . . . 70.25 110.328 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.46 -33.09 4.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.738 0.304 . . . . 72.140000000000001 111.429 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.68 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 10.3 tt0 -159.41 145.41 16.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.571 -0.286 . . . . 73.209999999999994 110.384 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -114.18 137.24 48.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.49 -0.559 . . . . 75.420000000000002 109.49 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 16.7 tt0 -112.9 132.6 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.832 -0.347 . . . . 74.109999999999999 110.185 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' A' ' 114' ' ' TYR . 44.5 mt -120.4 116.82 26.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.384 . . . . 75.299999999999997 110.146 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.4 tp -101.91 103.91 32.26 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.348 -0.612 . . . . 75.209999999999994 109.348 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 15.3 Cg_exo . . . . . 0 CA--C 1.53 0.282 0 C-N-CA 123.438 2.759 . . . . 63.25 112.835 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 61.3 t30 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 121.167 0.508 . . . . 61.240000000000002 110.255 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 81' ' ' ASN . 4.1 Cg_exo -74.47 60.5 5.01 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.164 2.576 . . . . 64.409999999999997 113.474 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -92.17 125.54 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.825 -0.435 . . . . 64.409999999999997 109.825 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -93.4 -53.05 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.027 -0.533 . . . . 73.120000000000005 110.003 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.73 137.45 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 65.420000000000002 110.836 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 m -121.68 135.22 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.73 . . . . 72.409999999999997 109.542 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 54.6 mt-10 -119.05 125.48 49.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.03 0.443 . . . . 74.319999999999993 110.646 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -104.81 131.08 52.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 71.040000000000006 110.424 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.57 149.81 49.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.224 -0.444 . . . . 74.25 110.145 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.83 48.49 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.13 -0.486 . . . . 74.5 110.48 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 t -149.86 152.49 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.949 0.404 . . . . 63.299999999999997 110.199 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.652 ' HB3' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.23 7.32 10.22 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.418 0.628 . . . . 75.329999999999998 109.804 175.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.4 -15.06 7.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.342 -0.845 . . . . 73.329999999999998 109.904 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.45 7.22 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.355 -0.839 . . . . 75.430000000000007 110.103 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.69 -59.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.477 -0.783 . . . . 75.230000000000004 110.512 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -88.78 104.05 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 74.349999999999994 110.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.96 116.05 28.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.901 0.381 . . . . 74.239999999999995 110.608 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.5 m -94.83 125.08 52.51 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.972 -0.558 . . . . 74.150000000000006 110.444 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 111.47 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.665 2.243 . . . . 72.409999999999997 111.51 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.1 pt -89.93 -9.88 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.321 -0.4 . . . . 71.510000000000005 111.404 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.35 128.7 0.98 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.259 -1.448 . . . . 44.340000000000003 114.287 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 7.5 ttm180 -98.75 126.17 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.84 -0.8 . . . . 74.430000000000007 108.84 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.426 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.7 m-85 -141.82 169.24 17.96 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.26 -0.576 . . . . 72.299999999999997 111.394 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.32 139.26 15.94 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.649 . . . . 74.109999999999999 111.765 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -95.33 148.23 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.109 0.48 . . . . 75.010000000000005 110.701 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.483 ' O ' HD11 ' A' ' 112' ' ' LEU . 85.6 m -132.3 114.25 14.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.0 -0.546 . . . . 72.209999999999994 110.062 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -75.48 97.4 3.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.44 . . . . 71.230000000000004 110.102 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 12.6 pt20 -136.27 -179.97 5.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.88 -0.6 . . . . 74.450000000000003 110.423 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.46 9.82 42.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 65.129999999999995 110.247 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.66 151.14 39.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.692 -0.686 . . . . 72.310000000000002 109.973 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -75.95 128.17 34.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.161 0.505 . . . . 75.25 111.605 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 106' ' ' THR . 26.7 mt -82.75 117.88 22.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.485 -0.78 . . . . 75.400000000000006 110.388 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.68 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 43.4 mt-10 -92.87 111.76 23.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.923 0.392 . . . . 71.209999999999994 110.811 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.459 ' CE2' HD13 ' A' ' 72' ' ' LEU . 85.0 m-85 -105.15 107.41 18.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.071 0.462 . . . . 75.549999999999997 110.516 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -76.96 95.07 4.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.587 -0.733 . . . . 71.239999999999995 109.36 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.426 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.3 m -97.58 179.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.512 -0.767 . . . . 54.43 111.817 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -65.75 134.94 54.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.739 . . . . 65.040000000000006 110.816 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 45.9 p -79.1 123.32 27.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.366 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.3 tt -157.84 148.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 110.757 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.37 122.76 28.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.693 -0.484 . . . . 75.329999999999998 109.693 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.652 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . . . -144.72 175.39 10.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.351 -0.386 . . . . 74.219999999999999 111.002 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -127.79 -32.51 2.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.377 0.608 . . . . 73.329999999999998 109.631 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.51 145.6 31.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.59 -0.732 . . . . 73.129999999999995 109.424 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.432 HG23 ' HB ' ' A' ' 59' ' ' ILE . 11.4 tt -131.47 135.16 59.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.015 0.436 . . . . 73.340000000000003 109.872 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.689 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 54.5 ttp180 -121.76 118.48 29.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.045 0.45 . . . . 73.129999999999995 111.04 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 57' ' ' ILE . 57.5 tp -87.43 119.71 27.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 74.430000000000007 109.063 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 45.5 m -116.42 120.51 39.04 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.933 0.397 . . . . 62.420000000000002 111.123 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.0 mm -98.76 95.96 3.54 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.311 -0.996 . . . . 72.409999999999997 108.311 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.99 163.33 39.63 Favored 'Trans proline' 0 CA--C 1.52 -0.179 0 C-N-CA 123.056 2.504 . . . . 74.230000000000004 113.575 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.57 71.49 0.79 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.559 -0.904 . . . . 73.400000000000006 108.559 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -149.42 -39.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.027 -0.988 . . . . 61.43 110.901 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.57 -6.18 83.66 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.384 -0.912 . . . . 54.020000000000003 113.705 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.78 26.94 7.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.974 -1.107 . . . . 74.540000000000006 111.917 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -72.69 137.02 45.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.601 0.239 . . . . 72.099999999999994 110.447 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -94.68 173.0 7.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.252 -0.431 . . . . 74.450000000000003 110.171 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 p -81.33 10.89 4.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.422 0.527 . . . . 71.450000000000003 112.422 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.417 . . . . 73.420000000000002 110.089 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.55 125.02 48.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.911 -0.586 . . . . 74.0 110.055 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -142.57 109.08 5.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.281 0.562 . . . . 75.109999999999999 111.558 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.93 132.67 69.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.144 -0.687 . . . . 75.200000000000003 109.144 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.699 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 94.1 mtt180 -67.16 -62.48 1.41 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.082 0.468 . . . . 73.230000000000004 110.212 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.48 148.75 34.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 73.439999999999998 111.614 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.42 126.74 54.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.405 -1.332 . . . . 73.439999999999998 107.405 170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.73 157.95 29.84 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.729 -0.471 . . . . 75.010000000000005 109.729 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.12 124.19 63.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.199 0.523 . . . . 71.010000000000005 110.471 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 80.2 mttt -102.18 112.17 24.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.441 -0.799 . . . . 75.230000000000004 108.862 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.99 -175.01 32.56 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.3 -0.952 . . . . 71.299999999999997 112.685 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 m -104.94 127.91 52.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.589 0.233 . . . . 74.310000000000002 110.795 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.428 HD12 HD12 ' A' ' 5' ' ' ILE . 36.0 mm -65.99 128.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 110.722 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 66' ' ' GLN . 60.4 mt . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.349999999999994 111.272 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.966 -0.383 . . . . 74.329999999999998 109.966 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.542 HG23 ' CD1' ' A' ' 65' ' ' ILE . 44.4 mm -81.76 148.24 5.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.62 -0.264 . . . . 75.530000000000001 110.559 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -66.24 107.08 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.903 0.382 . . . . 74.319999999999993 110.301 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 111.147 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -71.06 -10.26 59.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.026 -0.534 . . . . 74.450000000000003 111.624 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.28 9.32 38.84 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.859 -0.686 . . . . 72.519999999999996 111.967 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -90.9 161.94 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.014 -0.365 . . . . 73.010000000000005 110.014 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.4 pt-20 -141.37 159.81 41.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 72.409999999999997 110.731 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.02 116.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.608 -0.724 . . . . 73.430000000000007 110.132 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.84 -43.62 19.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.921 -0.581 . . . . 73.299999999999997 110.711 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 t -142.45 140.71 32.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 64.299999999999997 110.371 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.02 146.14 29.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.471 -0.786 . . . . 72.329999999999998 109.13 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -85.51 -33.95 21.67 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.723 -0.391 . . . . 73.209999999999994 110.952 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -155.6 152.34 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.05 0.452 . . . . 75.0 110.885 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -163.19 145.99 10.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.153 -1.054 . . . . 72.219999999999999 108.153 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.52 98.21 10.36 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.44 0.638 . . . . 73.420000000000002 110.189 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 8.4 29.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.874 . . . . 73.120000000000005 111.425 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 m -136.52 -43.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.908 -0.317 . . . . 74.420000000000002 111.346 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 121.078 -0.582 . . . . 73.219999999999999 112.769 -179.549 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.0 t30 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.916 -0.401 . . . . 75.340000000000003 109.916 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.16 3.49 72.74 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.846 -0.901 . . . . 73.329999999999998 110.846 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 51.3 mt -84.42 159.15 20.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.177 -0.512 . . . . 74.109999999999999 110.299 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.39 -28.83 68.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 73.129999999999995 110.909 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -75.45 -20.8 58.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 75.120000000000005 111.37 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 64.5 m -69.76 -23.76 63.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 72.049999999999997 110.532 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.73 -21.2 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.698 -0.683 . . . . 74.430000000000007 110.543 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 59' ' ' ILE . 30.4 pt -127.65 24.12 2.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 74.540000000000006 110.41 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.7 t70 -75.22 -38.8 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.117 -0.492 . . . . 70.099999999999994 111.533 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 40.68 3.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.265 -0.734 . . . . 63.119999999999997 111.265 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 8.9 t0 -153.64 126.21 8.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.728 -0.471 . . . . 73.409999999999997 109.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -73.23 -14.38 61.32 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.871 0.693 . . . . 71.129999999999995 112.871 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -93.53 -13.06 28.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 74.430000000000007 110.638 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 41.2 p -97.22 137.1 36.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.204 -0.665 . . . . 74.109999999999999 109.204 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.939 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 4.0 p90 -145.07 171.57 14.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.959 0.409 . . . . 75.329999999999998 111.111 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.525 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 41.5 t90 -105.19 125.46 51.0 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 70.219999999999999 109.256 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -124.47 137.49 54.43 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.425 -0.954 . . . . 74.0 108.425 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 144.88 56.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.625 -0.509 . . . . 75.219999999999999 109.625 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -65.59 112.58 3.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.838 0.351 . . . . 60.310000000000002 110.324 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -103.08 -25.08 13.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 110.364 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.51 121.64 15.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 75.530000000000001 110.318 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.89 -3.62 83.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.924 -0.655 . . . . 71.430000000000007 113.002 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.26 148.5 8.55 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.727 -0.749 . . . . 64.230000000000004 111.884 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 24.9 p -82.86 148.61 27.62 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.986 0.422 . . . . 75.109999999999999 111.338 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.79 158.98 86.8 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.637 . . . . 73.150000000000006 110.642 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.43 136.75 29.32 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.181 1.921 . . . . 71.420000000000002 112.413 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 16.5 mt -77.99 161.5 70.77 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 75.040000000000006 110.157 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.824 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 3.6 Cg_exo -81.9 162.23 78.16 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 124.115 -1.202 . . . . 74.109999999999999 112.585 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.9 m-85 -97.21 133.6 41.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 73.439999999999998 109.742 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.68 117.63 18.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.676 0.274 . . . . 74.030000000000001 110.518 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.45 119.39 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 74.230000000000004 110.819 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -107.01 119.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 110.389 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' HG23 ' A' ' 124' ' ' ILE . 75.2 mt -118.06 139.82 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.407 -0.36 . . . . 65.150000000000006 111.232 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -108.27 121.85 45.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.052 -0.522 . . . . 73.439999999999998 109.629 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.5 mtm -86.01 -8.29 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 70.5 111.068 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 73.3 -11.93 0.86 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.244 0.618 . . . . 73.310000000000002 112.591 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -144.14 167.26 22.82 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.132 -0.321 . . . . 75.519999999999996 110.132 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.29 128.78 34.97 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 110.092 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 5' ' ' ILE . 67.7 mt -135.19 137.98 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.451 -0.34 . . . . 74.439999999999998 110.283 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -82.31 103.28 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.233 -0.654 . . . . 74.439999999999998 109.233 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 118' ' ' SER . 26.5 mm -70.11 125.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.469 -0.332 . . . . 73.400000000000006 110.119 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.34 -48.54 2.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 71.310000000000002 110.813 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.42 ' NE2' ' HE2' ' A' ' 146' ' ' LYS . 23.7 tt0 -147.59 146.42 29.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 74.510000000000005 109.977 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.15 131.96 70.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.16 -0.473 . . . . 72.349999999999994 110.049 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -109.84 135.66 50.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.074 0.464 . . . . 70.409999999999997 111.048 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.541 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 57.1 mt -114.28 118.27 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.062 -0.718 . . . . 75.420000000000002 109.062 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 tp -103.37 99.75 16.02 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.413 -0.358 . . . . 75.219999999999999 110.345 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 12.3 Cg_exo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.734 2.289 . . . . 74.25 111.067 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 . . . . . 0 C--O 1.231 0.102 0 N-CA-C 109.51 -0.552 . . . . 72.109999999999999 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 27.3 Cg_endo -92.81 62.08 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.406 2.737 . . . . 72.219999999999999 113.689 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.61 HD13 ' HB1' ' A' ' 138' ' ' ALA . 54.1 mt -96.64 131.8 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.136 -0.69 . . . . 74.5 109.136 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -108.67 -46.98 3.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.765 0.316 . . . . 72.430000000000007 111.079 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.414 HG11 ' HE ' ' A' ' 102' ' ' ARG . 47.2 t -124.33 139.06 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.565 -0.289 . . . . 74.340000000000003 110.971 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 105' ' ' PHE . 6.7 m -132.03 144.71 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 71.540000000000006 110.668 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 34.2 mt-10 -120.1 135.99 54.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 111.207 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -118.2 130.52 56.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.947 -0.569 . . . . 72.510000000000005 110.618 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.37 148.91 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.474 -0.33 . . . . 63.43 110.628 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.58 148.28 51.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.35 -0.386 . . . . 72.430000000000007 110.382 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -150.3 161.24 42.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 73.439999999999998 111.268 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.36 -20.56 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 63.130000000000003 110.773 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -118.1 -5.09 10.96 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.311 0.486 . . . . 75.439999999999998 112.311 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.0 t30 69.85 12.47 7.94 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.595 0.712 . . . . 71.040000000000006 110.382 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.7 -53.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 72.239999999999995 109.773 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -95.61 98.99 10.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 75.430000000000007 109.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.405 ' CH2' ' HB2' ' A' ' 125' ' ' ARG . 98.2 m95 -88.69 123.46 33.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 73.310000000000002 110.899 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 121.91 57.2 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.073 -0.512 . . . . 72.109999999999999 110.009 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 109.38 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.396 2.064 . . . . 75.109999999999999 111.942 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.598 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -80.62 -12.65 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 64.409999999999997 110.205 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.1 145.94 4.37 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.625 -0.798 . . . . 54.200000000000003 113.02 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.414 ' HE ' HG11 ' A' ' 85' ' ' VAL . 70.9 ttt180 -115.91 120.54 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.818 -0.808 . . . . 74.150000000000006 108.818 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HE2' HG11 ' A' ' 116' ' ' VAL . 89.4 m-85 -133.22 178.94 6.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.099 0.476 . . . . 75.349999999999994 111.151 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.39 143.89 16.99 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.71 -0.677 . . . . 64.310000000000002 111.791 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' A' ' 86' ' ' VAL . 40.3 t80 -94.75 125.61 39.52 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.786 -0.45 . . . . 74.030000000000001 109.786 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.524 ' HB ' HD22 ' A' ' 112' ' ' LEU . 19.7 m -113.76 104.35 12.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 109.94 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.45 92.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.008 0.432 . . . . 74.129999999999995 110.024 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -121.02 -173.59 2.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.778 -0.646 . . . . 72.239999999999995 110.816 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.16 -18.91 27.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.715 -0.675 . . . . 73.409999999999997 110.819 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.3 -175.09 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 74.439999999999998 111.014 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.27 147.99 26.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.979 0.419 . . . . 70.200000000000003 110.442 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.524 HD22 ' HB ' ' A' ' 106' ' ' THR . 21.2 mt -98.33 104.24 16.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.022 -0.535 . . . . 75.150000000000006 110.145 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -81.32 116.09 21.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 72.109999999999999 110.571 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.42 105.48 14.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.826 0.346 . . . . 75.239999999999995 110.848 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -73.03 102.33 3.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.896 -0.779 . . . . 72.340000000000003 108.896 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -107.71 175.93 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.206 0.527 . . . . 74.200000000000003 112.122 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.595 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 52.8 tttp -59.61 116.85 4.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.237 -0.892 . . . . 75.340000000000003 110.434 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.3 m -70.94 115.8 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 110.373 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.5 tt -156.54 147.93 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.286 -0.415 . . . . 75.430000000000007 110.229 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.734 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.4 ttpt -83.62 133.96 34.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.0 -0.37 . . . . 74.439999999999998 110.0 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.98 169.63 21.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.309 -0.405 . . . . 71.099999999999994 110.565 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -117.22 -32.97 4.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.199 0.523 . . . . 74.319999999999993 109.835 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.84 145.39 32.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.653 . . . . 71.030000000000001 109.646 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.519 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.0 tt -133.29 137.8 52.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.482 -0.562 . . . . 74.299999999999997 109.482 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.405 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 23.9 ttp180 -125.71 128.56 47.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.899 0.38 . . . . 72.530000000000001 111.099 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.9 tp -104.31 115.34 30.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.55 -0.75 . . . . 73.340000000000003 109.642 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 41.4 m -107.17 123.72 48.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.111 0.481 . . . . 64.019999999999996 110.746 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.4 mm -105.97 92.46 6.46 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.44 -0.8 . . . . 74.230000000000004 108.973 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.824 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.3 Cg_endo -69.61 -178.62 2.37 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.816 2.344 . . . . 75.349999999999994 113.303 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 36.8 t70 -129.24 65.06 1.47 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.618 -1.253 . . . . 73.120000000000005 107.618 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.7 -46.58 2.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.094 -0.957 . . . . 75.129999999999995 112.506 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.13 36.65 4.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.183 -1.008 . . . . 73.239999999999995 113.754 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.66 18.5 32.42 Favored Glycine 0 CA--C 1.51 -0.258 0 C-N-CA 120.241 -0.98 . . . . 75.299999999999997 112.187 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.91 166.69 10.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 71.420000000000002 111.361 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.0 m -129.9 167.54 18.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.164 -0.471 . . . . 71.409999999999997 110.181 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 32.2 p -84.89 -24.42 28.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.111 0.481 . . . . 54.009999999999998 110.32 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.479 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 57.8 t -82.3 122.35 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 75.439999999999998 109.761 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.61 ' HB1' HD13 ' A' ' 83' ' ' ILE . . . -141.86 139.66 32.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.431 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.54 105.05 4.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.272 0.558 . . . . 72.430000000000007 111.253 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.06 132.48 71.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.737 -0.838 . . . . 73.519999999999996 108.737 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.939 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.7 mtm180 -69.98 -65.02 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.886 -0.326 . . . . 74.239999999999995 110.331 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -139.58 146.58 40.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.606 0.717 . . . . 75.200000000000003 112.331 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -108.2 121.95 45.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.514 -1.291 . . . . 73.319999999999993 107.514 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.8 154.75 37.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.919 0.39 . . . . 73.340000000000003 110.794 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.49 129.94 56.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 64.409999999999997 110.438 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HE2' ' NE2' ' A' ' 69' ' ' GLN . 44.5 mttm -96.02 129.08 43.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.069 -0.715 . . . . 73.439999999999998 109.069 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.53 -176.68 39.01 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.203 -0.999 . . . . 72.120000000000005 112.457 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.8 m -108.4 133.49 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.86 -0.422 . . . . 74.239999999999995 109.86 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.412 HD12 HG21 ' A' ' 5' ' ' ILE . 42.4 mm -75.24 125.02 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.075 0.464 . . . . 75.299999999999997 110.575 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.734 HD12 ' HG3' ' A' ' 120' ' ' LYS . 60.8 mt . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 115.884 -0.598 . . . . 75.310000000000002 110.464 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.616 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 39.9 p . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.744 0.307 . . . . 72.099999999999994 110.306 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.614 HG21 HD12 ' A' ' 149' ' ' ILE . 43.4 mm -86.05 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.347 -0.388 . . . . 74.0 111.152 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -67.38 118.81 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 73.040000000000006 109.76 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -97.2 9.86 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 75.439999999999998 110.726 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 m -65.5 -27.34 68.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.832 -0.622 . . . . 72.239999999999995 111.681 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.5 20.35 34.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 75.400000000000006 112.731 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.431 ' HB2' HD12 ' A' ' 34' ' ' ILE . 36.1 m0 -94.17 150.55 20.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.821 -0.437 . . . . 71.099999999999994 109.821 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.7 pt-20 -133.61 156.59 47.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 71.219999999999999 110.279 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 116.14 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.736 -0.665 . . . . 73.049999999999997 109.76 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 60' ' ' ASP . 80.6 mt -78.76 -42.79 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 74.25 110.494 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 m -152.34 133.9 14.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.1 -0.5 . . . . 74.099999999999994 110.329 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -131.52 137.52 48.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 109.736 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.1 m -78.58 -33.42 47.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.809 0.338 . . . . 75.450000000000003 110.807 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 t -157.53 145.8 19.19 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.794 0.33 . . . . 72.25 110.979 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.27 137.67 5.2 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.963 -0.754 . . . . 74.010000000000005 108.963 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.74 133.56 33.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.136 0.493 . . . . 73.200000000000003 110.23 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.32 -27.91 0.94 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.842 -0.617 . . . . 62.340000000000003 110.852 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -101.97 -31.24 10.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.278 -0.419 . . . . 72.340000000000003 111.09 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.535 0 C-N-CA 120.959 -0.639 . . . . 45.020000000000003 111.509 177.358 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.7 t30 . . . . . 0 CA--C 1.518 -0.268 0 N-CA-C 110.334 -0.247 . . . . 74.239999999999995 110.334 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.49 82.12 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 112.539 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 73.4 mt -72.26 147.01 46.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 73.409999999999997 110.391 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.2 -22.68 64.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.403 -0.362 . . . . 75.120000000000005 111.14 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -79.11 -22.46 45.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 75.540000000000006 110.946 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 66.7 m -65.38 -26.25 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 41.140000000000001 110.102 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 142' ' ' GLU . 22.7 tp -61.84 -26.14 67.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.343 -0.844 . . . . 75.209999999999994 110.543 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 59' ' ' ILE . 28.3 pt -116.16 12.52 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.396 . . . . 75.219999999999999 110.755 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 38.8 t70 -77.72 -29.53 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.116 0.484 . . . . 75.400000000000006 110.105 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.93 31.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.888 -0.672 . . . . 73.329999999999998 113.268 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 14.5 t0 -115.8 128.46 55.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.345 -0.613 . . . . 73.0 109.345 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.603 ' HB ' ' NH2' ' A' ' 141' ' ' ARG . 10.5 p -77.37 -5.65 50.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.916 0.71 . . . . 75.310000000000002 112.916 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.8 pt-20 -103.02 -5.34 23.48 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.324 -0.55 . . . . 75.510000000000005 111.013 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 9.3 p -105.73 161.78 14.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.837 -0.431 . . . . 73.219999999999999 109.837 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.612 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 48.1 p90 -157.33 162.32 39.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.99 0.424 . . . . 74.340000000000003 111.095 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 35.4 t90 -92.72 134.17 35.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.877 -0.786 . . . . 73.329999999999998 108.877 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -132.24 138.01 47.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.04 -0.726 . . . . 75.109999999999999 109.04 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.99 138.94 58.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.706 -0.479 . . . . 75.340000000000003 109.706 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 50' ' ' SER . 31.1 ttpt -67.54 120.1 13.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.61 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -111.51 -22.92 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.167 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -71.89 107.42 4.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 71.400000000000006 110.169 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.94 -0.99 56.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.721 -0.752 . . . . 43.119999999999997 112.258 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.16 133.63 5.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.819 -0.705 . . . . 60.539999999999999 112.215 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.8 m -72.69 143.71 47.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.82 0.343 . . . . 71.040000000000006 110.375 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.01 151.68 88.45 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 110.235 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.65 144.99 25.59 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.684 2.256 . . . . 71.040000000000006 111.599 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 130' ' ' ASP . 15.1 mt -75.31 158.18 84.03 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.18 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.9 Cg_endo -83.49 167.14 63.69 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.696 -1.377 . . . . 74.129999999999995 113.536 2.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -106.85 122.26 46.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 72.239999999999995 109.983 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.84 125.19 51.19 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.095 0.474 . . . . 73.439999999999998 110.524 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 62.8 mt -115.07 112.65 40.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.054 -0.521 . . . . 75.0 110.151 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.97 117.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 110.743 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 34' ' ' ILE . 66.3 mt -117.87 137.05 53.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.255 -0.43 . . . . 72.209999999999994 110.723 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' HB2' HD13 ' A' ' 13' ' ' LEU . 56.9 t0 -103.59 120.63 41.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.682 -0.488 . . . . 70.239999999999995 109.682 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.413 ' SD ' HD12 ' A' ' 65' ' ' ILE . 65.2 mtm -84.66 -7.43 59.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 110.814 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.8 mmtt 65.9 13.64 9.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.769 -0.65 . . . . 74.319999999999993 112.183 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' OE1' HD11 ' A' ' 149' ' ' ILE . 6.0 pt20 -164.57 164.93 21.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 74.150000000000006 110.542 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.98 122.79 31.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.399 . . . . 63.43 110.366 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.543 HD11 HG23 ' A' ' 5' ' ' ILE . 74.0 mt -130.65 137.82 55.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.292 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HB2' HD12 ' A' ' 150' ' ' ILE . 56.0 tp60 -83.29 102.93 12.3 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.063 -0.717 . . . . 75.349999999999994 109.063 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.3 mm -74.14 125.79 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.665 0.269 . . . . 74.25 110.525 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.62 -39.71 2.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.161 0.505 . . . . 71.239999999999995 110.831 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 26.7 tt0 -148.89 142.93 25.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.092 -0.504 . . . . 53.399999999999999 110.821 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.07 136.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.519 -0.549 . . . . 73.400000000000006 109.519 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.47 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 39.9 mt-10 -118.73 133.57 55.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.147 0.499 . . . . 71.519999999999996 111.247 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.52 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 72.2 mt -114.53 126.79 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.549 -0.75 . . . . 75.409999999999997 109.162 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.486 ' HG ' ' HD3' ' A' ' 141' ' ' ARG . 24.3 tp -106.24 97.14 15.06 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.727 -0.472 . . . . 73.310000000000002 109.727 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 6.3 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 123.088 2.526 . . . . 72.439999999999998 111.073 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.799 0.666 . . . . 71.540000000000006 112.799 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.82 25.71 0.41 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.861 2.374 . . . . 71.230000000000004 112.671 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.49 120.75 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.616 -0.513 . . . . 73.319999999999993 109.616 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.52 -50.82 3.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.111 0.482 . . . . 73.400000000000006 110.749 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 102' ' ' ARG . 57.4 t -120.41 137.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 65.140000000000001 110.583 -175.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.36 129.71 65.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.556 -0.747 . . . . 71.010000000000005 109.688 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.57 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 97.2 mt-10 -112.65 125.75 54.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 61.020000000000003 110.128 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -102.84 129.75 49.62 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.679 -0.691 . . . . 74.099999999999994 110.269 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 125' ' ' ARG . . . -125.32 151.07 46.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.144 -0.48 . . . . 61.420000000000002 110.428 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.21 39.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 74.099999999999994 109.96 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 t -148.87 151.15 34.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.198 0.523 . . . . 75.430000000000007 110.762 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 -32.87 10.48 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.794 -0.639 . . . . 71.230000000000004 110.61 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -109.69 -5.59 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.429 -0.351 . . . . 74.219999999999999 110.878 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 78.19 -9.61 1.48 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.991 0.917 . . . . 73.239999999999995 111.083 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.8 t -90.91 -49.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 110.819 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -93.43 102.77 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.105 -0.498 . . . . 72.400000000000006 109.85 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.98 118.07 30.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 75.329999999999998 111.044 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 m -99.46 120.82 56.82 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.469 -0.787 . . . . 75.340000000000003 110.51 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.96 112.53 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.359 2.039 . . . . 63.229999999999997 111.111 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 14.1 pt -87.33 -9.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.466 -0.334 . . . . 74.510000000000005 111.025 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.63 137.35 2.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.763 -1.208 . . . . 51.43 113.848 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 16.2 ttt180 -107.02 114.57 28.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.045 -0.724 . . . . 75.150000000000006 109.045 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.588 ' HE2' HG12 ' A' ' 116' ' ' VAL . 92.2 m-85 -125.98 169.92 12.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.84 0.352 . . . . 74.349999999999994 111.128 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -91.59 139.77 14.9 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.467 -0.653 . . . . 72.439999999999998 111.467 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -93.37 125.48 38.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 72.239999999999995 110.483 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.56 ' HB ' HD22 ' A' ' 112' ' ' LEU . 90.2 m -103.08 115.23 30.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 64.349999999999994 110.579 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -72.59 102.56 3.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 73.299999999999997 110.534 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -143.91 -176.92 5.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 110.446 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.5 -7.97 22.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.05 0.453 . . . . 73.129999999999995 110.033 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.2 170.27 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.861 -0.608 . . . . 73.230000000000004 111.042 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.63 143.45 38.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.124 0.487 . . . . 74.310000000000002 111.613 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.56 HD22 ' HB ' ' A' ' 106' ' ' THR . 46.4 mt -103.28 106.77 17.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 75.310000000000002 110.285 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.47 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 43.0 mt-10 -87.12 112.78 22.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.807 0.337 . . . . 75.420000000000002 110.735 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.23 106.66 17.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.155 -0.475 . . . . 62.030000000000001 110.55 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -72.13 102.61 3.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.061 -0.718 . . . . 61.119999999999997 109.061 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.588 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.1 m -103.18 179.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 72.219999999999999 112.159 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 6.5 tmtm? -66.04 124.19 21.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 74.239999999999995 110.421 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 21.2 p -70.49 127.37 32.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 75.310000000000002 110.68 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -163.45 150.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.42 -0.355 . . . . 65.310000000000002 110.481 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.689 ' HG3' HD11 ' A' ' 150' ' ' ILE . 5.9 ttpm? -85.69 128.07 34.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.285 -0.635 . . . . 70.530000000000001 109.285 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.19 160.82 43.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.861 0.362 . . . . 74.209999999999994 111.239 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -117.42 -26.12 6.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.67 -0.695 . . . . 74.319999999999993 109.642 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.16 146.45 42.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 74.420000000000002 109.859 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -131.1 143.25 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.628 -0.508 . . . . 72.239999999999995 109.628 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.5 ttp180 -131.38 124.75 30.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 73.430000000000007 111.227 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.424 HD21 HD12 ' A' ' 57' ' ' ILE . 37.6 tp -90.16 113.0 24.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.553 -0.749 . . . . 72.340000000000003 109.401 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.6 m -107.18 115.83 30.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.19 0.519 . . . . 74.120000000000005 111.179 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.06 98.05 14.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.104 -0.702 . . . . 72.150000000000006 109.104 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.7 Cg_endo -71.09 170.45 18.1 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.361 2.041 . . . . 75.310000000000002 112.39 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.445 ' HA ' HD11 ' A' ' 53' ' ' LEU . 34.7 t70 -91.21 -4.09 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.109 0.957 . . . . 70.310000000000002 109.099 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.21 140.96 31.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 75.420000000000002 110.677 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.78 -13.28 35.1 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.633 -0.794 . . . . 73.129999999999995 111.93 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 110.68 18.29 8.56 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.712 . . . . 63.310000000000002 112.335 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.56 150.4 43.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 71.439999999999998 110.854 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -127.75 -176.76 3.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.972 -0.558 . . . . 71.319999999999993 110.388 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 39.0 p -84.53 -2.4 57.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.028 0.442 . . . . 74.349999999999994 111.649 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -93.7 96.28 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.149 0.499 . . . . 72.519999999999996 110.038 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.45 129.54 50.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.847 -0.615 . . . . 65.019999999999996 110.159 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -150.07 110.64 4.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 73.530000000000001 110.791 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.5 mt -128.67 133.0 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 64.219999999999999 109.301 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.1 mtp180 -61.76 -61.16 2.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.952 0.406 . . . . 74.409999999999997 110.268 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.462 ' HA ' HD11 ' A' ' 33' ' ' LEU . 15.3 pt-20 -154.82 158.79 39.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.503 0.668 . . . . 70.510000000000005 111.338 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -115.15 134.6 55.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.657 -1.238 . . . . 62.439999999999998 107.657 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.616 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.1 t70 -131.09 167.16 19.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.721 -0.391 . . . . 71.239999999999995 110.014 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.7 t -138.6 128.43 32.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.73 0.3 . . . . 73.340000000000003 110.847 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.5 mttp -97.97 125.27 42.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.391 -0.596 . . . . 74.310000000000002 109.391 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.62 -158.71 14.99 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.798 -0.715 . . . . 60.32 111.404 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.0 m -131.1 130.23 42.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.849 0.324 . . . . 71.209999999999994 110.583 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 5' ' ' ILE . 34.7 mm -68.41 116.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 71.150000000000006 109.902 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.689 HD11 ' HG3' ' A' ' 120' ' ' LYS . 42.6 mt . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 121.239 0.543 . . . . 71.030000000000001 110.17 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 12.8 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.602 -0.888 . . . . 63.039999999999999 108.602 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 145' ' ' VAL . 36.5 mm -65.7 129.1 29.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.978 0.418 . . . . 73.329999999999998 110.752 -173.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 m -67.19 111.69 4.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.947 -0.569 . . . . 71.519999999999996 109.807 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 9.1 mtmp? -85.06 20.37 1.91 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.432 -0.804 . . . . 73.030000000000001 111.467 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -59.13 -42.48 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.899 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.13 7.68 52.46 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 63.229999999999997 113.053 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 34' ' ' ILE . 21.3 m0 -73.08 154.29 40.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.706 0.288 . . . . 70.099999999999994 110.457 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 24.5 pt-20 -148.87 161.27 42.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.262 0.553 . . . . 73.319999999999993 111.183 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.89 120.11 47.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.88 . . . . 71.329999999999998 110.066 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 60' ' ' ASP . 86.3 mt -85.75 -47.72 9.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.001 -0.545 . . . . 75.549999999999997 110.758 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 t -138.76 142.3 38.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.01 -0.541 . . . . 72.420000000000002 109.934 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -146.91 148.92 32.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.072 -0.513 . . . . 73.129999999999995 109.651 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.5 m -86.16 -42.02 14.21 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.852 0.358 . . . . 72.219999999999999 110.973 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -150.9 153.47 35.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.325 -0.398 . . . . 74.5 110.746 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.28 146.0 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.286 -0.635 . . . . 74.439999999999998 109.286 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -102.57 110.81 22.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.932 0.396 . . . . 63.130000000000003 110.417 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.65 13.11 11.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.049 -0.523 . . . . 72.019999999999996 111.187 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 m -134.21 -49.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.513 -0.312 . . . . 64.299999999999997 111.393 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.905 -0.664 . . . . 73.030000000000001 112.201 179.632 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.659 -0.497 . . . . 74.010000000000005 109.659 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.79 -8.43 70.83 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.274 -0.73 . . . . 73.340000000000003 111.274 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 43.2 mt -72.47 153.58 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.14 -0.53 . . . . 75.519999999999996 110.07 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.625 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.22 -28.99 69.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 71.120000000000005 110.787 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.97 -24.82 60.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 71.310000000000002 110.993 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 77.4 m -67.33 -21.56 65.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.386 -0.37 . . . . 73.519999999999996 110.404 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 51.3 tp -64.93 -14.41 59.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.837 -0.62 . . . . 72.430000000000007 110.687 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 10' ' ' TRP . 27.8 pt -131.58 14.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.271 -0.422 . . . . 73.310000000000002 110.531 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.9 t70 -65.85 -33.67 76.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.291 -0.413 . . . . 73.329999999999998 111.279 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' HA2' ' HZ2' ' A' ' 7' ' ' LYS . . . 99.84 5.49 55.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.53 -0.843 . . . . 72.030000000000001 113.408 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.67 140.22 50.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.0 0.4 . . . . 65.439999999999998 109.93 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 26.6 p -80.66 -7.39 59.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.895 0.332 . . . . 71.310000000000002 111.895 -174.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.69 -8.16 44.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.593 -0.276 . . . . 73.209999999999994 110.303 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.6 p -107.49 138.52 43.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 74.420000000000002 110.018 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.841 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 10.9 p90 -141.09 169.85 16.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.45 -0.341 . . . . 63.210000000000001 110.567 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.625 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.0 t90 -104.65 133.04 50.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.826 -0.805 . . . . 72.109999999999999 108.826 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.074 -0.713 . . . . 75.439999999999998 109.074 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 145.21 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.31 -0.626 . . . . 64.439999999999998 109.31 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -55.85 125.24 20.48 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.339 0.399 . . . . 72.120000000000005 109.995 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -124.78 -30.22 3.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.844 -0.342 . . . . 65.109999999999999 110.79 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -77.65 107.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.785 -0.45 . . . . 74.030000000000001 109.785 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.94 11.55 52.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.636 -0.792 . . . . 73.129999999999995 111.899 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.27 20.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.955 -0.64 . . . . 65.450000000000003 111.893 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.0 m -127.7 165.76 19.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 72.409999999999997 110.896 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB3' ' HE1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -89.21 152.79 48.35 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.129999999999995 109.375 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 38.5 Cg_endo -68.09 139.07 45.51 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.158 1.905 . . . . 72.340000000000003 113.222 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.44 158.02 87.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 73.540000000000006 109.951 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.4 161.8 76.61 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.525 -1.448 . . . . 73.049999999999997 113.061 0.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.53 ' HE1' ' HB3' ' A' ' 51' ' ' ASP . 25.8 m-85 -97.79 129.02 44.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.62 . . . . 72.310000000000002 109.598 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.472 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.1 t0 -127.33 118.44 24.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.748 0.308 . . . . 72.209999999999994 110.309 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.427 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 56.9 mt -116.55 122.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 74.400000000000006 111.339 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.1 t -105.45 118.19 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.83 -0.623 . . . . 73.340000000000003 110.514 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HB ' HG23 ' A' ' 124' ' ' ILE . 71.1 mt -115.56 139.07 43.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 75.310000000000002 111.049 -175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.49 ' HB2' HD12 ' A' ' 13' ' ' LEU . 63.8 t0 -105.63 122.13 45.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.169 -0.468 . . . . 63.43 110.001 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.2 mtm -88.45 -5.31 58.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 74.519999999999996 110.672 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 67.11 8.51 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.902 0.704 . . . . 74.219999999999999 112.902 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -168.2 174.8 6.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.589 0.233 . . . . 71.329999999999998 110.642 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 52.3 m-80 -83.06 122.04 27.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.214 -0.448 . . . . 63.299999999999997 110.243 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.524 HD12 HG22 ' A' ' 5' ' ' ILE . 68.2 mt -131.11 133.3 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.063 0.458 . . . . 74.299999999999997 110.022 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.402 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.7 tp60 -79.79 106.47 11.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.573 -0.739 . . . . 75.140000000000001 109.168 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 118' ' ' SER . 15.9 mm -76.79 102.92 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.136 -0.32 . . . . 64.140000000000001 110.136 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.3 -39.62 8.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 74.019999999999996 110.281 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -152.14 142.29 22.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.686 . . . . 70.230000000000004 110.207 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -114.28 134.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.91 -0.404 . . . . 72.420000000000002 109.91 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 49.5 mt-10 -110.75 129.72 55.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.988 0.423 . . . . 70.239999999999995 110.999 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 mt -109.78 120.82 43.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.418 -0.586 . . . . 75.409999999999997 109.418 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -102.99 103.62 34.96 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.912 -0.586 . . . . 74.109999999999999 109.751 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.536 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 8.4 Cg_exo . . . . . 0 N--CA 1.464 -0.234 0 C-N-CA 122.947 2.432 . . . . 75.310000000000002 111.339 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.939 0.399 . . . . 71.299999999999997 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 18.6 Cg_endo -93.37 23.63 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.527 2.818 . . . . 73.439999999999998 112.979 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.66 125.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 75.530000000000001 110.075 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -107.28 -46.21 3.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 74.0 111.145 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.551 HG11 ' HE ' ' A' ' 102' ' ' ARG . 34.2 t -129.34 139.87 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.572 -0.285 . . . . 74.120000000000005 110.82 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.11 144.99 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.343 -0.389 . . . . 74.400000000000006 110.15 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.5 mt-10 -119.06 131.13 55.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.93 0.395 . . . . 74.0 110.595 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.89 136.03 51.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.113 -0.494 . . . . 75.530000000000001 110.772 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.24 152.52 49.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.507 -0.315 . . . . 64.310000000000002 110.851 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.23 51.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.327 -0.397 . . . . 75.409999999999997 110.264 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -149.95 153.81 37.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.196 0.522 . . . . 63.009999999999998 111.076 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 52.3 mt-10 -97.54 -24.82 15.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 72.040000000000006 110.937 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.82 -1.4 8.4 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.859 -0.336 . . . . 62.219999999999999 111.489 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.17 1.81 3.8 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.205 0.526 . . . . 74.239999999999995 111.396 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -96.8 -58.45 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.477 0.656 . . . . 73.219999999999999 110.068 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.79 106.39 18.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.096 -0.956 . . . . 64.430000000000007 109.824 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -97.31 125.15 41.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.157 0.503 . . . . 70.430000000000007 111.409 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -109.02 123.78 35.97 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.73 -0.668 . . . . 75.329999999999998 110.135 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.31 120.76 8.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.412 2.075 . . . . 75.239999999999995 111.578 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.556 HD11 HG22 ' A' ' 116' ' ' VAL . 15.1 pt -86.41 -16.03 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.152 -0.477 . . . . 73.450000000000003 110.65 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.56 143.84 3.85 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.492 -0.861 . . . . 64.040000000000006 112.899 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HE ' HG11 ' A' ' 85' ' ' VAL . 73.7 ttt180 -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.216 -0.661 . . . . 75.349999999999994 109.216 173.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.464 ' HE2' HG13 ' A' ' 116' ' ' VAL . 97.1 m-85 -137.56 174.11 10.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 71.230000000000004 111.449 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.32 138.56 14.26 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.756 -0.656 . . . . 71.329999999999998 112.21 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -93.17 148.45 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 74.109999999999999 110.09 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.478 ' O ' HD13 ' A' ' 112' ' ' LEU . 33.7 m -144.83 110.14 5.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.072 -0.513 . . . . 74.140000000000001 109.908 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -70.03 97.09 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.326 0.584 . . . . 75.519999999999996 109.931 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.536 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 11.1 pt20 -130.8 -179.69 5.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.449 -0.796 . . . . 74.530000000000001 110.713 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.74 -24.41 41.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.557 . . . . 74.340000000000003 110.949 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.39 151.87 20.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 71.319999999999993 110.988 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.12 129.98 41.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 60.299999999999997 110.542 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -80.56 104.9 11.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.703 . . . . 73.439999999999998 110.501 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -85.26 108.73 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.104 0.478 . . . . 73.340000000000003 110.51 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -101.34 106.82 18.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.834 -0.621 . . . . 74.349999999999994 110.679 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -72.3 104.92 3.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 74.329999999999998 109.623 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.556 HG22 HD11 ' A' ' 100' ' ' ILE . 31.6 m -111.13 -176.54 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.068 0.461 . . . . 75.540000000000006 111.776 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.91 117.07 7.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.475 -0.784 . . . . 74.239999999999995 110.109 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 22.0 m -70.39 113.68 7.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 110.718 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.12 144.94 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 75.540000000000006 110.464 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.58 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -86.26 126.03 34.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 72.109999999999999 109.42 175.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -151.43 166.72 30.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.636 -0.256 . . . . 73.349999999999994 111.029 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -107.16 -30.48 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.362 0.601 . . . . 75.200000000000003 109.867 173.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -109.21 145.41 35.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.752 -0.658 . . . . 73.230000000000004 110.481 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.0 tt -133.21 138.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 73.450000000000003 109.432 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 13.0 ttp180 -127.83 130.77 49.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 75.099999999999994 111.249 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.14 114.89 29.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.381 -0.827 . . . . 75.5 109.601 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.7 m -109.11 125.23 51.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.202 0.525 . . . . 73.530000000000001 111.104 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 38.6 mm -103.96 95.96 8.63 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.056 -0.72 . . . . 73.140000000000001 109.056 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -75.92 157.38 38.95 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.821 2.347 . . . . 73.409999999999997 113.087 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.23 63.52 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 60.210000000000001 108.58 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.27 122.53 2.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 61.020000000000003 110.227 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.85 -1.9 21.39 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.834 -0.698 . . . . 52.32 112.314 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.17 21.5 7.67 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.905 -0.664 . . . . 64.0 112.691 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -79.31 146.19 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 74.319999999999993 111.737 -175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.561 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.6 m -113.47 174.43 5.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.486 -0.779 . . . . 71.120000000000005 109.608 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 18.8 p -79.16 -14.36 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 74.400000000000006 111.716 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.38 104.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.969 0.414 . . . . 74.109999999999999 110.219 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.26 130.84 55.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.028 -0.533 . . . . 75.329999999999998 110.24 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.84 105.16 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.102 0.477 . . . . 71.530000000000001 111.289 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.34 133.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.803 -0.814 . . . . 73.129999999999995 108.803 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.841 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 71.1 mtm180 -74.25 -57.63 3.82 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.517 -0.473 . . . . 73.430000000000007 111.278 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.13 148.43 28.27 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.551 -0.86 . . . . 64.430000000000007 112.239 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.416 HD13 HD22 ' A' ' 72' ' ' LEU . 7.8 tt -105.85 120.93 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.551 -1.204 . . . . 72.129999999999995 108.31 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.45 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.6 t70 -117.81 162.03 18.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.361 -0.607 . . . . 73.120000000000005 109.361 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 5' ' ' ILE . 59.9 t -126.08 123.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.197 0.522 . . . . 75.299999999999997 110.422 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.43 ' HG3' HG21 ' A' ' 4' ' ' THR . 47.0 mttt -99.67 76.03 1.96 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.558 0.694 . . . . 75.150000000000006 109.389 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -124.05 -146.19 6.91 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.911 -1.04 . . . . 71.420000000000002 111.785 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.4 m -135.86 134.0 38.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.803 0.335 . . . . 62.119999999999997 110.704 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.509 HD11 HG23 ' A' ' 5' ' ' ILE . 40.4 mm -72.0 130.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 71.540000000000006 110.94 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 66' ' ' GLN . 20.5 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.069 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 108.604 -0.887 . . . . 75.209999999999994 108.604 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.488 HG22 HD12 ' A' ' 65' ' ' ILE . 47.3 mm -60.81 128.49 22.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.701 0.286 . . . . 74.209999999999994 111.13 -173.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -67.5 119.43 12.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.105 0.478 . . . . 75.340000000000003 109.841 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -95.44 4.33 53.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.731 -0.668 . . . . 73.200000000000003 110.647 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -73.43 93.4 1.96 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.736 . . . . 74.430000000000007 109.442 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.34 -16.2 4.39 Favored Glycine 0 C--N 1.316 -0.583 0 CA-C-N 115.28 -0.873 . . . . 74.239999999999995 111.476 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -68.92 150.64 47.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.752 -0.462 . . . . 73.040000000000006 109.752 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.493 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.3 pt-20 -132.37 157.71 43.81 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.319 0.581 . . . . 74.239999999999995 110.924 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.74 110.04 25.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 71.150000000000006 109.645 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.443 HD13 HG12 ' A' ' 58' ' ' VAL . 81.6 mt -72.43 -48.95 37.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.801 -0.636 . . . . 75.340000000000003 110.612 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -149.94 142.85 24.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.666 -0.697 . . . . 62.229999999999997 110.527 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.532 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 38.2 p90 -138.77 148.54 43.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 74.340000000000003 109.837 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m -88.26 -37.91 15.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.739 0.304 . . . . 63.399999999999999 111.029 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 145.88 31.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.148 0.499 . . . . 63.0 110.859 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.532 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -154.94 151.75 28.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 63.210000000000001 108.781 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -124.56 92.35 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.153 0.501 . . . . 73.430000000000007 111.064 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.59 -18.74 21.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.736 -0.666 . . . . 73.209999999999994 111.239 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 m -91.72 -40.37 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 65.230000000000004 110.863 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.639 0 C-N-CA 120.898 -0.668 . . . . 72.219999999999999 112.934 -178.884 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.129 -0.323 . . . . 71.5 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 -5.95 66.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.378 -0.439 . . . . 61.109999999999999 112.119 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 77.1 mt -75.15 148.45 39.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.566 -0.317 . . . . 75.340000000000003 110.321 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.74 63.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.402 -0.363 . . . . 74.310000000000002 111.264 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.75 -25.68 44.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.506 -0.315 . . . . 74.140000000000001 110.888 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.816 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.9 m -64.84 -25.79 68.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 70.510000000000005 110.455 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 143' ' ' LEU . 34.4 tp -64.24 -22.22 66.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 74.420000000000002 110.827 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 59' ' ' ILE . 40.1 pt -125.79 15.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 74.430000000000007 110.363 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.816 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 4.6 t70 -75.38 -37.3 60.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 70.209999999999994 110.528 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.92 23.93 7.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.472 -0.871 . . . . 64.430000000000007 112.299 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.3 109.58 7.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.273 -0.64 . . . . 73.099999999999994 109.273 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.7 p -68.7 -21.16 64.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.214 -0.448 . . . . 72.140000000000001 111.923 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HA ' HH21 ' A' ' 141' ' ' ARG . 61.4 mm-40 -72.56 -26.88 61.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.925 -0.31 . . . . 64.239999999999995 110.422 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -89.3 152.09 21.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.755 -0.831 . . . . 72.109999999999999 108.755 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 47.2 p90 -148.93 174.96 11.7 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.307 -0.557 . . . . 73.329999999999998 111.333 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -107.82 135.67 48.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.559 -0.746 . . . . 75.209999999999994 109.046 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.5 t-80 -135.14 145.01 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.687 -0.486 . . . . 75.349999999999994 109.687 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.53 146.6 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 109.944 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 50' ' ' SER . 75.7 tttt -60.29 133.6 56.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.401 . . . . 74.430000000000007 110.787 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -139.7 -26.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 73.299999999999997 111.553 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -62.42 -42.02 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 64.25 110.255 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.77 32.09 6.21 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 75.109999999999999 111.91 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.37 148.41 13.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 73.340000000000003 111.83 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.46 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -81.94 156.63 24.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.2 0.524 . . . . 73.319999999999993 111.114 -178.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -91.39 162.36 32.14 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 75.439999999999998 110.587 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.35 139.18 31.46 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.736 2.291 . . . . 75.409999999999997 112.791 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.3 mt -80.03 159.88 69.81 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.540000000000006 110.157 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.734 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.4 Cg_endo -79.66 161.28 86.78 Favored 'Cis proline' 0 C--N 1.343 0.273 0 C-N-CA 123.622 -1.408 . . . . 62.409999999999997 112.975 0.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -95.75 108.81 21.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.99 -0.55 . . . . 74.430000000000007 110.112 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -108.72 116.91 32.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.955 0.407 . . . . 74.349999999999994 110.634 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 126' ' ' LEU . 60.9 mt -109.81 108.61 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.96 -0.564 . . . . 74.129999999999995 109.636 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' A' ' 125' ' ' ARG . 48.1 t -97.94 116.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.133 -0.485 . . . . 74.200000000000003 110.512 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.576 HD13 HG23 ' A' ' 34' ' ' ILE . 68.5 mt -115.52 137.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.726 -0.67 . . . . 73.230000000000004 110.615 -175.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -101.84 122.21 43.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 109.697 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.4 mtm -87.33 -8.5 56.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 74.200000000000003 110.611 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.493 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.2 mmtt 67.97 7.55 5.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.719 . . . . 73.239999999999995 112.26 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 5.7 pt20 -161.26 163.03 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.43 -0.211 . . . . 74.109999999999999 110.43 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 43.9 m-80 -83.97 126.17 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.85 -0.426 . . . . 74.019999999999996 109.85 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 5' ' ' ILE . 61.3 mt -132.01 136.88 55.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.033 0.444 . . . . 72.340000000000003 110.701 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -84.38 101.74 12.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.826 -0.805 . . . . 74.230000000000004 108.826 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.2 mm -71.56 127.33 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.327 -0.397 . . . . 73.420000000000002 110.306 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.26 -46.1 2.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 72.319999999999993 110.875 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -144.51 144.91 31.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.687 0.28 . . . . 75.109999999999999 110.847 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.89 132.27 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.232 -0.655 . . . . 74.140000000000001 109.232 173.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.668 ' HG2' ' HB3' ' A' ' 111' ' ' ALA . 26.8 tt0 -115.08 127.97 55.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.933 0.397 . . . . 74.310000000000002 110.367 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 114' ' ' TYR . 57.2 mt -115.72 117.75 31.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.954 -0.566 . . . . 75.409999999999997 110.16 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.6 tp -110.08 100.16 42.5 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.404 -0.362 . . . . 73.340000000000003 110.439 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 105' ' ' PHE . 29.5 Cg_endo . . . . . 0 N--CA 1.452 -0.957 0 C-N-CA 122.84 2.36 . . . . 54.299999999999997 110.465 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.102 0.477 . . . . 71.420000000000002 111.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 1.1 Cg_endo -82.55 59.53 6.92 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.283 2.655 . . . . 71.230000000000004 113.225 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.4 mt -98.41 119.37 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.078 0.466 . . . . 75.450000000000003 109.821 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 25.7 mmmt -97.52 -56.41 2.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.716 -0.675 . . . . 74.450000000000003 111.4 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -121.89 139.65 48.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.319 -0.4 . . . . 65.299999999999997 110.347 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.61 133.41 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.888 0.375 . . . . 72.200000000000003 110.02 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 20.7 tt0 -121.5 128.72 52.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.911 -0.586 . . . . 72.450000000000003 110.095 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -112.07 129.38 56.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.071 -0.513 . . . . 74.040000000000006 109.961 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.76 151.72 41.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.464 -0.334 . . . . 74.439999999999998 110.273 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.34 149.49 45.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.185 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -147.12 148.0 31.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.271 -0.422 . . . . 64.030000000000001 110.232 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -87.04 -32.55 19.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.714 0.292 . . . . 62.32 110.992 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -132.63 16.11 4.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.573 -0.285 . . . . 73.099999999999994 111.632 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.2 t30 59.49 58.5 2.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.727 0.775 . . . . 73.129999999999995 110.308 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.26 -71.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.162 -0.926 . . . . 73.430000000000007 108.917 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -90.46 118.67 30.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.781 -0.645 . . . . 72.530000000000001 109.666 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.97 107.78 19.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.083 0.468 . . . . 75.430000000000007 110.744 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.8 m -93.84 125.99 51.11 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.802 -0.635 . . . . 63.409999999999997 110.212 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.66 104.01 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.543 2.162 . . . . 75.129999999999995 111.662 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.0 -23.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.105 -0.498 . . . . 74.510000000000005 110.901 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -169.69 128.33 1.64 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.209 -0.996 . . . . 62.350000000000001 113.004 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 2.4 tmt_? -124.29 115.0 20.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 74.140000000000001 108.649 171.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -141.4 -177.11 4.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.078 -0.51 . . . . 73.409999999999997 110.91 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.31 143.76 16.81 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.804 -0.634 . . . . 74.519999999999996 111.754 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.448 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 53.3 t80 -96.68 120.97 37.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 72.040000000000006 110.772 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 112' ' ' LEU . 23.0 m -97.75 109.64 22.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 71.040000000000006 110.145 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.38 98.57 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 74.329999999999998 110.468 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -139.55 174.36 10.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 65.109999999999999 109.737 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.31 5.34 50.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.192 0.52 . . . . 70.099999999999994 110.707 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.65 152.63 24.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.596 -0.729 . . . . 73.019999999999996 109.672 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.668 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . . . -73.93 124.96 27.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.03 0.443 . . . . 73.239999999999995 111.316 -175.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 106' ' ' THR . 35.9 mt -77.49 124.35 27.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.729 . . . . 74.340000000000003 110.594 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -95.11 109.55 21.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 74.310000000000002 110.681 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 91.8 m-85 -102.47 109.57 21.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.508 . . . . 74.5 110.474 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -81.13 90.19 6.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.602 . . . . 73.219999999999999 109.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 101' ' ' GLY . 26.8 m -87.62 -177.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.211 -0.904 . . . . 71.25 111.45 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -72.87 128.74 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.585 -0.734 . . . . 74.150000000000006 110.863 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 4.5 m -68.53 114.68 7.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 61.119999999999997 110.201 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 tt -153.53 148.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 75.430000000000007 110.532 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.435 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -88.53 126.26 35.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.767 -0.457 . . . . 73.409999999999997 109.767 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.61 165.22 29.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.442 -0.344 . . . . 75.230000000000004 110.831 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 37.1 ttt180 -115.39 -26.35 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.519 0.676 . . . . 74.340000000000003 109.744 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -116.07 146.33 42.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 74.140000000000001 109.653 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -132.83 140.48 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.962 -0.384 . . . . 74.219999999999999 109.962 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' A' ' 58' ' ' VAL . 5.6 ttm180 -126.38 132.09 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.816 0.341 . . . . 72.299999999999997 111.166 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 57' ' ' ILE . 56.2 tp -98.2 118.18 34.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.088 -0.708 . . . . 73.540000000000006 109.088 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 95.5 m -115.38 125.05 52.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.158 0.504 . . . . 73.409999999999997 111.321 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 39.7 mm -105.1 90.21 3.55 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.431 -0.951 . . . . 74.140000000000001 108.431 171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.734 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 83.6 Cg_endo -86.87 150.49 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.734 2.29 . . . . 75.030000000000001 113.138 -174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -81.77 61.52 5.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.893 0.854 . . . . 64.540000000000006 108.782 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -104.32 -42.67 5.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.877 -1.056 . . . . 75.540000000000006 112.23 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.61 29.67 4.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.82 -1.181 . . . . 75.219999999999999 113.992 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.23 25.18 9.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.181 -1.009 . . . . 74.409999999999997 112.963 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.3 131.32 43.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 63.25 111.358 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 m -93.65 174.68 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 74.349999999999994 110.188 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 3.3 p -85.88 19.07 2.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.007 0.432 . . . . 73.209999999999994 111.926 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.438 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t -125.92 124.36 66.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.843 -0.429 . . . . 74.109999999999999 109.843 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.79 135.94 26.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.538 -0.301 . . . . 71.549999999999997 110.417 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . . . -137.12 105.99 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 74.340000000000003 111.514 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.6 mt -122.31 133.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.114 -0.699 . . . . 75.329999999999998 109.114 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.699 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 67.5 mtp180 -82.59 -45.84 14.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.092 0.473 . . . . 73.219999999999999 110.305 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.89 129.37 13.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.757 -0.656 . . . . 74.409999999999997 110.953 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.413 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 8.9 tt -109.56 118.36 36.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.625 -0.88 . . . . 75.510000000000005 108.625 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 149.98 42.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.007 0.432 . . . . 75.200000000000003 110.86 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.25 135.03 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.983 -0.553 . . . . 75.230000000000004 110.341 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -111.66 120.33 41.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.004 -0.739 . . . . 74.299999999999997 109.004 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.35 -159.9 16.2 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 62.219999999999999 111.847 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.0 m -120.84 130.82 54.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.588 0.232 . . . . 71.230000000000004 110.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 5' ' ' ILE . 33.6 mm -74.78 127.54 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 72.420000000000002 110.143 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.8 mt . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 109.747 -0.464 . . . . 64.319999999999993 109.747 179.116 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.615 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 71.4 p . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 120.989 0.423 . . . . 74.409999999999997 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 65' ' ' ILE . 48.0 mm -88.36 136.48 23.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.698 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -64.26 109.41 1.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 71.450000000000003 109.958 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.51 -1.01 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 75.140000000000001 111.51 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -70.24 91.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.415 0.626 . . . . 60.039999999999999 109.835 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.75 -17.99 2.8 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.279 -0.873 . . . . 75.340000000000003 111.735 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -68.02 155.49 39.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 74.329999999999998 109.698 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -140.08 153.17 46.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.338 -0.545 . . . . 73.5 111.145 175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.31 107.97 19.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.283 -0.871 . . . . 73.549999999999997 109.478 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.483 HD13 HG12 ' A' ' 58' ' ' VAL . 83.5 mt -73.61 -47.12 42.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.725 -0.67 . . . . 72.109999999999999 110.437 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -143.28 139.38 30.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 53.100000000000001 110.167 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.62 140.17 36.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.465 -0.568 . . . . 74.420000000000002 109.465 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -84.61 -28.67 26.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 110.991 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 t -162.19 149.7 14.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.877 0.37 . . . . 72.329999999999998 110.887 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -165.85 137.5 3.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.53 -0.759 . . . . 75.409999999999997 109.107 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.49 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 9.8 tp10 -105.17 95.0 5.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 111.434 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . . . -92.58 -31.48 15.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 72.439999999999998 110.572 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -79.66 -42.21 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 74.129999999999995 110.867 -173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.642 0 C-N-CA 120.947 -0.644 . . . . 73.439999999999998 112.7 -177.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 CA--C 1.515 -0.383 0 N-CA-C 110.017 -0.364 . . . . 74.510000000000005 110.017 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.38 -8.04 79.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.088 -0.577 . . . . 74.510000000000005 112.759 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.672 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.6 mt -73.27 144.65 46.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.322 -0.251 . . . . 74.230000000000004 110.322 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.7 -23.63 66.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.02 0.438 . . . . 65.340000000000003 110.923 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -75.4 -23.87 57.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.519999999999996 110.988 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.759 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 57.8 m -67.15 -25.38 66.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 61.100000000000001 110.417 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.37 -26.75 66.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.724 . . . . 75.109999999999999 110.522 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.563 HG23 HD13 ' A' ' 59' ' ' ILE . 31.9 pt -121.27 12.19 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 73.409999999999997 110.723 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.759 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t70 -71.08 -36.66 72.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 72.319999999999993 109.719 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.94 52.97 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.499 -0.858 . . . . 64.430000000000007 113.42 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.627 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 8.3 t0 -149.3 135.16 18.82 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.842 -0.429 . . . . 74.230000000000004 109.842 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.6 p -81.55 10.77 5.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.604 -0.725 . . . . 75.420000000000002 112.64 -172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.627 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 13.0 pt-20 -118.45 -7.7 10.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.525 -0.47 . . . . 73.409999999999997 111.315 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p -96.71 166.9 11.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.504 -0.554 . . . . 74.319999999999993 109.504 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 50.6 p90 -161.82 165.28 28.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.269 0.557 . . . . 72.120000000000005 112.25 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.522 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 32.1 t90 -109.65 139.41 44.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.763 -1.108 . . . . 75.219999999999999 108.966 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.68 142.4 43.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.06 151.81 45.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.316 -0.402 . . . . 71.340000000000003 110.221 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -62.51 125.76 25.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.039 -0.356 . . . . 72.450000000000003 110.039 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.49 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 68.7 p-90 -126.22 -34.02 2.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 74.439999999999998 110.616 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -75.61 108.6 8.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.622 -0.511 . . . . 73.049999999999997 109.622 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.43 -20.54 46.4 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.769 -0.729 . . . . 45.109999999999999 111.462 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.6 167.8 11.34 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.677 -0.773 . . . . 53.530000000000001 112.001 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 54.8 m -115.03 149.77 36.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 75.25 110.503 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.56 152.5 66.99 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 73.420000000000002 110.076 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.02 142.8 35.16 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.216 1.944 . . . . 74.430000000000007 112.738 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.14 156.69 87.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 75.150000000000006 110.002 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.59 170.24 65.41 Favored 'Cis proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.627 -1.406 . . . . 70.219999999999999 113.437 2.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -110.37 129.94 55.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.651 -0.704 . . . . 70.209999999999994 110.035 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 15.8 m-20 -118.43 130.05 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.882 0.372 . . . . 75.109999999999999 110.505 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.403 HD13 HD21 ' A' ' 126' ' ' LEU . 60.6 mt -121.25 108.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 73.129999999999995 109.681 173.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.483 HG12 HD13 ' A' ' 13' ' ' LEU . 40.8 t -95.93 119.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.907 -0.588 . . . . 74.319999999999993 110.23 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.563 HD13 HG23 ' A' ' 34' ' ' ILE . 61.3 mt -119.28 133.03 67.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.279 -0.419 . . . . 74.299999999999997 110.94 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.7 t0 -100.05 120.88 40.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 74.120000000000005 109.633 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.415 ' HE2' HD13 ' A' ' 67' ' ' ILE . 70.5 mtm -86.78 -4.88 59.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 111.01 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.51 0.07 3.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.181 0.808 . . . . 75.329999999999998 113.181 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -159.94 173.75 15.44 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.298 -0.251 . . . . 75.239999999999995 110.734 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -82.67 122.75 28.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 74.140000000000001 109.906 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 5' ' ' ILE . 64.9 mt -132.59 135.31 57.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 75.230000000000004 110.322 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 118' ' ' SER . 57.2 tp60 -83.16 104.31 13.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.046 -0.724 . . . . 73.129999999999995 109.046 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.1 mm -73.6 121.75 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.414 -0.357 . . . . 73.25 110.288 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.2 -36.33 4.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.053 0.454 . . . . 73.329999999999998 110.748 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 20.6 tt0 -153.44 143.25 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.884 -0.598 . . . . 72.209999999999994 110.813 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -114.7 138.43 44.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.355 -0.609 . . . . 74.540000000000006 109.355 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.4 mt-10 -117.31 133.62 55.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 73.530000000000001 111.3 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.34 122.78 45.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.793 -0.639 . . . . 74.450000000000003 109.687 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 tp -106.25 106.48 57.36 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.239 -0.437 . . . . 71.549999999999997 110.043 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 C-N-CA 122.724 2.283 . . . . 61.549999999999997 111.127 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 83' ' ' ILE . 9.2 m120 . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.346 -0.613 . . . . 71.409999999999997 109.346 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.786 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 2.8 Cg_exo -77.89 31.05 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.369 2.713 . . . . 71.140000000000001 112.24 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 105' ' ' PHE . 30.8 mt -95.1 112.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 75.109999999999999 109.4 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -100.56 -44.76 5.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.005 -0.543 . . . . 74.329999999999998 110.643 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.502 HG11 ' HE ' ' A' ' 102' ' ' ARG . 58.6 t -127.32 138.39 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.865 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 m -128.5 140.74 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.230000000000004 110.364 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -118.12 129.17 55.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.145 -0.48 . . . . 71.040000000000006 110.654 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -112.04 130.18 55.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 74.540000000000006 110.234 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.05 148.46 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.803 0.335 . . . . 72.409999999999997 111.031 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 148.39 52.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 73.219999999999999 109.979 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 154.94 38.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.118 0.485 . . . . 74.439999999999998 111.458 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.62 -9.64 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.279 -0.637 . . . . 73.219999999999999 109.279 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.55 -36.17 8.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 53.219999999999999 111.606 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.32 15.15 3.58 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.574 1.178 . . . . 73.409999999999997 108.031 -167.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -122.28 -62.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.019 -1.446 . . . . 75.450000000000003 109.485 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -89.49 104.85 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.886 -0.597 . . . . 74.519999999999996 109.435 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -93.86 117.6 30.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 73.329999999999998 111.309 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.6 m -94.18 125.29 53.05 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.641 . . . . 73.319999999999993 110.256 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.29 113.92 3.84 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.403 2.069 . . . . 74.140000000000001 111.943 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.577 HD11 HG22 ' A' ' 116' ' ' VAL . 20.9 pt -83.87 -12.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 73.040000000000006 110.75 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.07 146.54 4.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.25 -0.976 . . . . 74.239999999999995 113.035 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HE ' HG11 ' A' ' 85' ' ' VAL . 69.3 ttt180 -125.99 118.56 25.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.801 -0.815 . . . . 75.239999999999995 108.801 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -136.82 -176.14 4.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.019 0.438 . . . . 73.310000000000002 111.051 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.48 148.54 18.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.569 -0.742 . . . . 61.509999999999998 112.134 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.413 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 42.6 t80 -95.81 119.91 35.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 74.319999999999993 110.276 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -103.54 110.18 22.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.228 -0.442 . . . . 54.219999999999999 110.749 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.39 100.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 73.299999999999997 110.572 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -139.94 -179.34 5.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 70.200000000000003 110.375 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.53 -11.06 35.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.99 0.424 . . . . 72.109999999999999 110.975 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.166 -0.47 . . . . 74.349999999999994 111.009 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 130.67 43.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.49 . . . . 75.129999999999995 110.916 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 58.8 mt -83.32 109.46 17.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 64.5 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.26 112.46 21.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 74.109999999999999 110.94 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.0 104.13 14.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 74.239999999999995 110.016 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -77.57 91.25 3.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.356 -0.838 . . . . 74.219999999999999 109.355 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.577 HG22 HD11 ' A' ' 100' ' ' ILE . 31.2 m -96.28 -178.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 72.010000000000005 112.392 -170.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -65.73 126.49 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.136 -0.938 . . . . 75.540000000000006 110.649 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 63.9 m -71.49 123.99 23.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 110.45 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.059 -0.518 . . . . 75.439999999999998 110.286 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.691 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -93.83 113.61 25.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.178 -0.675 . . . . 74.25 109.178 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.06 173.61 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.676 0.274 . . . . 74.329999999999998 111.041 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -115.93 -32.36 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.32 0.581 . . . . 74.510000000000005 110.512 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.35 145.75 31.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.97 -0.559 . . . . 63.409999999999997 110.203 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.7 tt -135.13 138.02 49.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.021 -0.536 . . . . 64.420000000000002 109.69 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.431 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.3 ttp180 -124.7 125.9 44.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.017 0.437 . . . . 71.010000000000005 111.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 57' ' ' ILE . 47.0 tp -93.28 112.79 24.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.491 -0.777 . . . . 75.430000000000007 108.979 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.3 m -111.81 123.09 49.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.39 0.614 . . . . 71.150000000000006 111.151 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.98 100.49 11.53 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.649 -0.871 . . . . 71.099999999999994 108.649 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.6 164.88 24.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.718 2.279 . . . . 74.519999999999996 112.98 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.69 14.71 24.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.153 0.977 . . . . 73.329999999999998 108.855 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -125.08 134.58 52.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.905 -1.043 . . . . 74.109999999999999 110.389 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.78 -9.92 14.21 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.941 -0.647 . . . . 65.450000000000003 112.445 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.72 23.54 6.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.147 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -79.96 144.79 33.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.771 0.32 . . . . 64.430000000000007 110.789 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 24.5 m -117.47 177.28 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.169 -0.469 . . . . 74.209999999999994 110.458 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 32.4 p -79.13 -3.12 43.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 54.119999999999997 111.814 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.786 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 87.4 t -95.23 121.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.373 -0.376 . . . . 75.409999999999997 110.081 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.32 128.65 17.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 74.439999999999998 110.428 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.96 106.22 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.411 . . . . 53.310000000000002 110.674 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.51 132.95 67.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.001 -0.74 . . . . 62.219999999999999 109.001 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 92.9 mtt180 -70.98 -59.41 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.724 -0.39 . . . . 73.310000000000002 110.884 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.1 157.63 40.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.759 0.79 . . . . 73.010000000000005 112.097 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.85 133.28 56.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.454 -1.248 . . . . 75.209999999999994 107.736 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.615 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -130.77 170.3 14.55 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.579 -0.448 . . . . 74.409999999999997 109.844 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.1 t -141.38 128.11 20.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.937 -0.394 . . . . 74.0 109.937 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.2 mttm -97.91 124.41 42.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.433 -0.951 . . . . 75.299999999999997 108.433 172.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.64 -167.13 26.85 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.282 -0.961 . . . . 55.130000000000003 112.052 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 m -119.17 126.76 52.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.767 0.317 . . . . 74.439999999999998 110.501 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 5' ' ' ILE . 41.4 mm -70.66 127.15 32.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.036 -0.529 . . . . 75.340000000000003 110.005 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 120' ' ' LYS . 47.4 mt . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.373 . . . . 65.329999999999998 110.212 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.644 0.259 . . . . 75.219999999999999 110.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 HD13 ' A' ' 65' ' ' ILE . 51.1 mm -86.2 132.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.538 -0.301 . . . . 75.230000000000004 110.578 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -72.81 120.23 18.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.627 . . . . 61.409999999999997 109.306 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HZ1' ' CD ' ' A' ' 142' ' ' GLU . 47.3 mtmt -82.24 29.49 0.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 74.310000000000002 111.017 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -79.01 95.96 5.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.661 -0.699 . . . . 73.019999999999996 110.222 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.86 -9.02 9.16 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 72.120000000000005 112.265 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.442 ' HB3' HD13 ' A' ' 34' ' ' ILE . 21.2 m0 -69.67 134.34 48.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.983 -0.377 . . . . 74.129999999999995 109.983 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 62' ' ' LYS . 13.5 pt-20 -132.41 160.92 34.96 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.764 -0.374 . . . . 74.209999999999994 110.567 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -95.71 125.39 48.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.224 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 60' ' ' ASP . 77.7 mt -90.5 -44.54 9.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.132 0.492 . . . . 75.099999999999994 110.303 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -142.2 137.22 30.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.752 -0.658 . . . . 72.340000000000003 110.316 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.57 144.33 34.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.411 . . . . 74.019999999999996 110.138 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.8 m -80.15 -51.31 9.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 110.858 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.4 t -142.7 150.17 39.79 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.269 -0.423 . . . . 64.420000000000002 110.98 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -164.94 142.82 6.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.471 -0.937 . . . . 74.230000000000004 108.471 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -103.27 107.94 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.7 -0.4 . . . . 73.099999999999994 111.029 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.34 -5.88 12.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 72.420000000000002 111.332 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -111.74 -40.03 4.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.401 -0.363 . . . . 73.140000000000001 110.837 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 121.002 -0.618 . . . . 61.100000000000001 112.038 177.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.549 ' HB2' ' CE1' ' A' ' 41' ' ' PHE . 21.8 p-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.885 0.374 . . . . 73.409999999999997 110.055 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.19 -10.8 60.09 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.481 -0.648 . . . . 70.209999999999994 111.481 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.6 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 89.7 mt -74.49 147.11 42.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.617 -0.291 . . . . 74.450000000000003 110.273 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.497 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.64 -24.06 64.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.995 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -72.56 -26.91 61.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.755 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.992 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.3 m -70.57 -17.78 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 71.510000000000005 110.867 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.14 -20.58 66.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.544 0.687 . . . . 71.150000000000006 110.067 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 10' ' ' TRP . 40.2 pt -131.24 18.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.759 -0.655 . . . . 73.219999999999999 110.267 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.992 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -71.57 -30.44 65.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.026 -0.534 . . . . 74.349999999999994 110.651 -172.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.53 33.97 5.44 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.842 -0.694 . . . . 73.150000000000006 112.33 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 39' ' ' GLU . 8.8 t0 -153.32 124.4 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.695 -0.484 . . . . 73.329999999999998 109.695 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 p -77.53 -3.45 40.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.298 0.481 . . . . 73.120000000000005 112.298 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 16.9 mm-40 -83.34 -24.02 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.751 0.31 . . . . 61.509999999999998 110.208 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.4 p -93.93 165.06 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.958 -0.386 . . . . 72.549999999999997 109.958 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 52.8 p90 -163.92 172.01 14.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.296 . . . . 73.109999999999999 110.91 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.497 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 42.8 t90 -112.28 134.02 54.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.554 -0.748 . . . . 74.019999999999996 109.292 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.6 137.01 45.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.118 -0.697 . . . . 75.219999999999999 109.118 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 144.65 56.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.957 -0.386 . . . . 75.109999999999999 109.957 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.43 137.14 57.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.913 -0.585 . . . . 74.420000000000002 110.11 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -138.35 -13.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 75.510000000000005 110.9 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.59 101.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.127 0.489 . . . . 73.519999999999996 110.65 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.82 90.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.896 -0.669 . . . . 75.409999999999997 112.256 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.99 177.21 14.82 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.818 -0.706 . . . . 72.409999999999997 111.599 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 t -125.0 175.12 7.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.093 0.473 . . . . 72.439999999999998 110.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.629 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 17.0 m-20 -97.97 146.49 31.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 72.120000000000005 110.116 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.31 145.85 61.1 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.764 2.31 . . . . 74.319999999999993 112.835 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 21.0 mt -80.61 159.51 69.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.697 -0.683 . . . . 75.549999999999997 109.968 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.4 Cg_endo -78.42 158.61 92.91 Favored 'Cis proline' 0 C--N 1.344 0.307 0 C-N-CA 123.631 -1.404 . . . . 72.409999999999997 113.125 1.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.699 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.0 m-30 -91.08 129.93 37.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 74.230000000000004 109.974 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -121.07 124.96 46.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.202 -0.454 . . . . 62.420000000000002 109.955 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.39 117.15 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.92 0.391 . . . . 73.510000000000005 110.4 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.35 116.68 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 74.319999999999993 110.842 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.481 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.4 mp -107.82 136.69 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 74.430000000000007 110.517 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.498 ' HB2' HD11 ' A' ' 13' ' ' LEU . 39.8 t0 -104.47 122.75 46.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 63.240000000000002 109.791 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -90.12 -4.34 57.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 72.239999999999995 110.881 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 11' ' ' GLU . 33.4 mmtp 71.74 -6.99 1.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.456 0.702 . . . . 75.530000000000001 112.601 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -152.77 168.18 26.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.189 -0.3 . . . . 73.030000000000001 110.189 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.538 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 47.2 m-80 -85.58 125.43 33.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 74.120000000000005 110.344 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 5' ' ' ILE . 62.0 mt -130.34 136.75 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.973 -0.558 . . . . 73.329999999999998 109.881 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.5 tp60 -83.19 100.53 10.63 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.901 -0.777 . . . . 74.310000000000002 108.901 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -66.89 130.92 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.378 -0.374 . . . . 73.530000000000001 110.318 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.71 -46.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.934 0.397 . . . . 73.5 110.943 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 19.3 tt0 -138.79 149.42 44.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.631 -0.507 . . . . 65.140000000000001 109.631 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.89 127.57 73.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.82 -0.437 . . . . 72.209999999999994 109.82 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 1.9 mp0 -108.66 131.79 54.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.333 0.587 . . . . 72.349999999999994 111.048 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.577 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 60.1 mt -111.66 119.27 38.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.51 -0.922 . . . . 74.109999999999999 108.51 174.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 27.0 tp -102.32 96.45 7.17 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.256 -0.646 . . . . 75.519999999999996 109.256 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.1 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 C-N-CA 123.259 2.64 . . . . 61.350000000000001 112.154 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 138' ' ' ALA . 65.4 t30 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 121.194 0.521 . . . . 71.0 111.543 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.445 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 4.4 Cg_exo -75.79 55.6 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.343 2.696 . . . . 73.219999999999999 113.672 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.7 mt -99.51 115.61 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.089 -0.708 . . . . 71.239999999999995 109.089 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -100.44 -48.36 4.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.829 0.347 . . . . 73.540000000000006 110.832 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.16 139.82 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.099999999999994 110.466 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -130.08 143.32 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.984 0.421 . . . . 74.230000000000004 110.885 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 38.1 mt-10 -125.31 130.5 52.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.071 -0.513 . . . . 71.150000000000006 110.849 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -113.22 132.48 55.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.484 . . . . 74.310000000000002 110.554 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.14 154.69 50.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.393 -0.367 . . . . 43.310000000000002 110.503 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.29 156.78 47.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 73.219999999999999 109.921 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 t -149.65 143.82 25.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 75.540000000000006 110.555 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -93.37 -41.75 9.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.004 -0.544 . . . . 74.25 110.781 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -109.2 3.56 21.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.833 -0.621 . . . . 64.510000000000005 110.992 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 23.7 t-20 75.53 -9.64 1.38 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.559 0.744 . . . . 74.510000000000005 111.055 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.08 -42.98 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 62.329999999999998 110.815 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.68 106.76 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 75.310000000000002 110.043 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.4 m95 -99.58 120.41 39.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 73.319999999999993 110.572 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.3 m -113.36 126.14 28.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.265 -0.425 . . . . 64.329999999999998 110.586 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.75 113.7 2.86 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.445 2.097 . . . . 71.25 111.126 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.589 HD13 HG22 ' A' ' 116' ' ' VAL . 12.8 pt -82.17 -11.52 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 75.319999999999993 110.771 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.92 142.97 3.54 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.496 -0.859 . . . . 72.319999999999993 112.546 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.494 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 34.3 ttt180 -119.0 125.13 48.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.433 -0.58 . . . . 75.530000000000001 109.433 175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -140.28 -176.17 4.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.048 0.451 . . . . 71.219999999999999 110.718 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.81 155.55 20.08 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.435 -0.666 . . . . 74.549999999999997 111.435 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.487 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 52.1 t80 -103.27 135.33 45.12 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.189 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.447 ' O ' HD11 ' A' ' 112' ' ' LEU . 34.3 m -116.04 116.55 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.483 -0.562 . . . . 72.0 109.483 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.68 93.6 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.273 0.559 . . . . 73.239999999999995 110.282 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -131.54 177.15 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.325 -0.852 . . . . 72.420000000000002 108.867 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.28 -8.74 35.08 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.49 -0.484 . . . . 73.129999999999995 110.252 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.62 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.808 -0.633 . . . . 54.329999999999998 110.223 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.31 128.48 35.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.11 0.481 . . . . 75.310000000000002 111.773 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 41.6 mt -84.96 125.68 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 73.219999999999999 110.06 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -98.0 115.32 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.969 0.414 . . . . 54.420000000000002 110.789 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.83 107.27 17.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.154 -0.475 . . . . 71.239999999999995 110.257 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.06 92.1 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.746 -0.661 . . . . 74.310000000000002 109.49 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 100' ' ' ILE . 28.9 m -98.56 176.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.796 . . . . 73.150000000000006 111.937 -171.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.89 134.23 52.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.379 -0.828 . . . . 74.109999999999999 110.594 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.719 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 19.2 m -77.28 117.72 19.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.071 -0.513 . . . . 74.099999999999994 110.7 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.62 143.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.982 -0.554 . . . . 75.329999999999998 110.802 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.538 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.522 -0.547 . . . . 74.030000000000001 109.522 173.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.58 159.72 44.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.944 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 39.9 ttt180 -107.53 -27.47 10.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.45 0.643 . . . . 72.530000000000001 109.728 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 94' ' ' ASN . 71.8 m-85 -114.17 146.26 40.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 110.071 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.481 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.3 tt -133.62 140.3 46.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.452 -0.573 . . . . 72.209999999999994 109.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 49.6 ttp180 -127.97 124.54 37.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 74.340000000000003 111.394 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.3 tp -95.24 120.28 35.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.315 -0.857 . . . . 75.239999999999995 109.428 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -114.84 122.23 45.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 74.010000000000005 110.804 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.6 mm -102.24 97.19 8.13 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.87 -0.789 . . . . 72.140000000000001 108.87 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -73.48 -173.48 1.33 Allowed 'Trans proline' 0 CA--C 1.522 -0.123 0 C-N-CA 122.938 2.425 . . . . 74.430000000000007 113.058 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.527 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 16.2 t0 -129.26 75.36 1.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 65.519999999999996 108.4 166.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.53 -50.94 2.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.273 -0.876 . . . . 71.310000000000002 112.094 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.4 28.77 7.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.24 -0.981 . . . . 74.519999999999996 113.916 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 106.55 26.06 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.858 -1.163 . . . . 64.109999999999999 113.007 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 6.5 m-20 -70.81 132.12 44.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.725 0.298 . . . . 63.240000000000002 110.281 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 m -109.54 179.37 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.5 -0.318 . . . . 74.219999999999999 111.045 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 p -90.02 16.05 9.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.368 0.604 . . . . 65.209999999999994 111.544 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 78.2 t -110.43 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.014 -0.539 . . . . 72.129999999999995 109.65 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . . . -135.38 130.97 35.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.498 -0.319 . . . . 75.549999999999997 110.566 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.3 106.11 5.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.085 0.469 . . . . 71.450000000000003 110.879 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.8 mt -129.46 135.79 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.817 -0.629 . . . . 72.239999999999995 109.432 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 57.5 mtt180 -66.95 -71.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 75.420000000000002 110.096 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.478 ' CD ' ' HZ1' ' A' ' 7' ' ' LYS . 16.7 mt-10 -145.42 162.42 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.544 0.688 . . . . 75.120000000000005 111.98 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.88 124.7 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.507 -1.224 . . . . 75.319999999999993 108.18 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -126.35 162.17 26.14 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.637 -0.505 . . . . 72.319999999999993 109.637 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.1 t -136.03 134.93 50.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.876 0.37 . . . . 73.349999999999994 111.382 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 65.0 mttp -95.76 131.86 41.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.453 -0.573 . . . . 75.420000000000002 109.453 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.22 -169.65 37.96 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.194 -1.003 . . . . 74.349999999999994 112.474 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.2 m -118.81 132.86 56.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.35 -0.241 . . . . 72.340000000000003 110.35 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.82 121.37 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 71.099999999999994 110.11 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 66' ' ' GLN . 73.5 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 120.979 0.418 . . . . 74.329999999999998 110.457 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 109.298 -0.63 . . . . 72.340000000000003 109.298 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 65' ' ' ILE . 39.7 mm -71.43 136.45 25.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 73.540000000000006 111.067 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.1 m -73.15 109.08 6.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 73.5 109.826 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -85.94 26.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 74.200000000000003 111.383 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -6.09 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 65.200000000000003 111.463 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.2 2.87 10.59 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.608 -0.806 . . . . 74.319999999999993 112.399 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -81.46 134.9 35.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.427 -0.212 . . . . 75.140000000000001 110.427 -175.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.3 155.72 45.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.734 -0.386 . . . . 74.400000000000006 110.497 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.6 t -90.05 108.27 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.825 -0.625 . . . . 75.299999999999997 109.981 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.6 mt -74.77 -49.24 21.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.017 -0.538 . . . . 75.439999999999998 110.477 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -143.42 134.18 25.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.726 . . . . 73.400000000000006 110.015 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 54.3 p90 -135.33 148.91 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.706 -0.479 . . . . 73.340000000000003 109.706 175.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.2 m -86.62 -44.61 11.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 73.319999999999993 110.388 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -143.8 144.37 31.76 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.187 0.517 . . . . 74.340000000000003 111.077 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.457 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -149.92 148.29 28.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.184 -1.043 . . . . 74.310000000000002 108.184 175.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 8.5 tp10 -119.4 89.1 3.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.354 0.597 . . . . 52.509999999999998 110.963 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . . . -100.38 -21.77 15.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.546 -0.752 . . . . 74.439999999999998 110.088 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -83.71 -44.46 14.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.673 -0.694 . . . . 65.400000000000006 110.93 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.731 0 C-N-CA 120.911 -0.661 . . . . 73.230000000000004 112.35 178.398 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.513 -0.449 0 N-CA-C 109.78 -0.452 . . . . 75.510000000000005 109.78 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.31 3.06 90.25 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.709 -0.556 . . . . 74.340000000000003 111.709 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 80.6 mt -84.31 144.49 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.273 -0.269 . . . . 75.040000000000006 110.273 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.95 -24.51 66.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 74.519999999999996 110.409 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.74 -25.26 61.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 74.540000000000006 111.037 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.83 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 61.2 m -71.58 -18.67 62.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 75.540000000000006 110.387 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.23 -15.04 61.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.818 -0.628 . . . . 71.329999999999998 110.273 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.23 22.24 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.824 -0.625 . . . . 73.319999999999993 109.593 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.83 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 13.6 t70 -72.54 -58.7 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 64.430000000000007 110.402 -175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.57 39.25 0.79 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.023 -0.608 . . . . 74.409999999999997 112.203 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -148.16 122.58 9.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.866 0.365 . . . . 64.230000000000004 110.265 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -74.9 7.14 3.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.101 0.778 . . . . 75.329999999999998 113.101 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -106.7 -19.72 13.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.035 -0.266 . . . . 75.439999999999998 111.051 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -88.65 168.93 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.03 -0.359 . . . . 73.409999999999997 110.03 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 141' ' ' ARG . 56.2 p90 -161.6 163.62 29.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.036 0.446 . . . . 74.519999999999996 111.586 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 32.5 t90 -107.02 143.02 35.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.294 -0.866 . . . . 73.310000000000002 109.072 172.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -138.96 145.72 40.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.126 -0.694 . . . . 71.340000000000003 109.126 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.1 149.73 39.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.118 -0.327 . . . . 75.530000000000001 110.118 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 50' ' ' SER . 63.1 tttm -61.06 119.37 8.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.428 -0.351 . . . . 73.310000000000002 110.619 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.458 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 69.8 p-90 -118.29 -27.13 6.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 70.349999999999994 110.307 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.32 127.25 32.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.729 -0.471 . . . . 75.450000000000003 109.729 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.22 89.97 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.725 -0.75 . . . . 73.439999999999998 111.828 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.57 148.5 9.0 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.491 -0.643 . . . . 74.420000000000002 111.491 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 20.6 m -78.85 150.19 32.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.117 -0.327 . . . . 44.200000000000003 110.117 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 2.0 t70 -80.42 145.48 59.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 75.420000000000002 110.021 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 20.3 Cg_endo -62.25 129.98 28.84 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.632 2.221 . . . . 71.409999999999997 113.327 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.2 158.69 66.5 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 74.239999999999995 110.125 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.979 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.3 Cg_exo -76.5 161.58 93.48 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 124.284 -1.132 . . . . 75.25 113.295 0.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.1 m-85 -96.11 138.46 33.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 71.409999999999997 109.579 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.469 ' OD2' ' HD3' ' A' ' 125' ' ' ARG . 6.2 t70 -132.67 123.69 26.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.221 -0.288 . . . . 62.219999999999999 110.221 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.39 124.18 66.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.695 0.283 . . . . 72.209999999999994 110.624 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.922 HG21 ' HG3' ' A' ' 125' ' ' ARG . 45.5 t -113.23 120.16 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.34 -0.391 . . . . 63.219999999999999 111.096 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.99 139.36 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.103 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.644 ' HB2' HD11 ' A' ' 13' ' ' LEU . 51.0 t0 -106.0 126.81 52.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.625 -0.509 . . . . 72.439999999999998 109.625 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.0 mtm -90.62 -6.97 53.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 74.230000000000004 110.664 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.436 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 31.5 mmtp 68.48 5.27 4.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.602 0.761 . . . . 74.310000000000002 112.415 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 27.4 pt20 -157.94 174.16 15.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.492 -0.188 . . . . 72.150000000000006 110.492 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -88.6 124.11 33.73 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.679 -0.489 . . . . 71.329999999999998 109.679 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.443 HD12 ' SD ' ' A' ' 61' ' ' MET . 70.9 mt -132.84 133.7 58.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.012 0.435 . . . . 73.019999999999996 110.256 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.431 ' HB2' HD13 ' A' ' 150' ' ' ILE . 52.6 tp60 -82.76 105.41 13.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.684 -0.858 . . . . 71.219999999999999 108.684 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.1 mm -75.44 124.74 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.82 0.343 . . . . 74.010000000000005 110.483 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.81 -43.88 2.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.03 -0.532 . . . . 70.129999999999995 110.784 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -148.47 140.3 23.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.242 -0.436 . . . . 71.430000000000007 111.039 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.31 139.45 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.297 -0.631 . . . . 74.349999999999994 109.297 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 42.0 mt-10 -123.29 131.37 53.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.104 0.478 . . . . 74.099999999999994 111.101 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 65.2 mt -113.36 124.72 53.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 74.0 109.893 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -103.58 104.14 40.22 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.651 -0.5 . . . . 73.349999999999994 109.651 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 11.9 Cg_exo . . . . . 0 N--CA 1.465 -0.2 0 C-N-CA 122.811 2.341 . . . . 74.099999999999994 112.129 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.517 ' HB2' ' ND2' ' A' ' 107' ' ' ASN . 2.7 m120 . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 112.227 0.454 . . . . 71.450000000000003 112.227 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.543 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 85.1 Cg_endo -85.89 30.52 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.813 2.342 . . . . 74.430000000000007 112.306 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -77.76 127.85 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 63.32 109.795 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -98.96 -55.2 2.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 75.109999999999999 111.126 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 48.0 t -128.82 138.03 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 72.329999999999998 110.739 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.59 133.59 68.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.237 -0.438 . . . . 74.109999999999999 110.169 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.2 mt-10 -115.02 126.67 55.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.982 0.42 . . . . 63.520000000000003 110.975 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -107.56 134.06 51.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.773 -0.649 . . . . 74.109999999999999 110.248 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.66 151.54 51.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.33 -0.395 . . . . 72.319999999999993 110.398 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.084 -0.339 . . . . 72.530000000000001 110.084 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -147.58 145.35 28.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.031 0.443 . . . . 62.520000000000003 111.5 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -81.52 -43.25 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.8 -0.636 . . . . 72.329999999999998 109.842 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 1.0 OUTLIER -109.72 -1.97 17.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.268 -0.878 . . . . 70.310000000000002 112.394 -170.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.3 t-20 76.27 -7.96 1.73 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.972 0.509 . . . . 73.230000000000004 111.079 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -94.69 -51.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.231 0.539 . . . . 73.540000000000006 109.804 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -92.64 105.71 17.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.43 -0.805 . . . . 73.140000000000001 110.328 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 96.6 m95 -97.63 121.75 39.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.853 0.359 . . . . 73.349999999999994 111.504 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 35.5 m -97.36 128.95 33.13 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 64.430000000000007 110.046 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 6.0 Cg_exo -75.22 108.69 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.463 2.109 . . . . 74.340000000000003 110.315 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 19.8 pt -82.37 -19.1 10.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.377 -0.374 . . . . 73.150000000000006 111.206 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.19 131.06 1.41 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.037 -1.078 . . . . 41.25 113.002 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 61.4 ttt180 -112.91 115.21 28.08 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.917 -0.401 . . . . 70.319999999999993 109.917 172.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -137.4 176.99 8.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.723 0.297 . . . . 72.230000000000004 110.853 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -95.61 157.59 21.85 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.902 -0.666 . . . . 74.340000000000003 112.057 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -94.14 148.29 22.33 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.719 -0.475 . . . . 73.439999999999998 109.719 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.661 ' HB ' HD23 ' A' ' 112' ' ' LEU . 18.4 m -131.21 115.93 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.501 -0.318 . . . . 73.109999999999999 110.644 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 81' ' ' ASN . 48.7 t-20 -69.67 96.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.165 0.507 . . . . 73.140000000000001 110.09 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -136.94 174.01 11.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.704 . . . . 73.219999999999999 109.284 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.55 -8.38 44.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.232 0.539 . . . . 73.349999999999994 110.752 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.42 158.78 16.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 64.109999999999999 110.618 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.18 138.21 58.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.269 -0.423 . . . . 73.219999999999999 110.945 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.661 HD23 ' HB ' ' A' ' 106' ' ' THR . 39.7 mt -90.95 110.76 22.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 75.420000000000002 110.461 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.43 120.19 26.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.198 0.523 . . . . 64.049999999999997 110.271 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.29 107.5 17.27 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.394 -0.821 . . . . 70.239999999999995 110.007 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -80.02 98.66 7.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.209 -0.663 . . . . 74.310000000000002 109.209 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 30.8 m -100.78 -178.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.911 -0.586 . . . . 74.209999999999994 111.801 -171.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.03 129.59 40.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 74.310000000000002 110.776 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.8 m -75.65 106.81 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 73.109999999999999 110.033 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.18 148.3 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.374 -0.375 . . . . 74.349999999999994 110.244 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.782 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 4.5 ttpm? -84.82 135.84 33.93 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.891 -0.411 . . . . 75.430000000000007 109.891 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.22 40.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.571 -0.286 . . . . 74.420000000000002 110.982 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 41.0 ttt180 -108.73 -33.3 7.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 74.200000000000003 109.462 171.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -109.3 145.51 35.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.655 -0.702 . . . . 74.340000000000003 109.891 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.8 139.1 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.407 -0.59 . . . . 75.019999999999996 109.407 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.922 ' HG3' HG21 ' A' ' 58' ' ' VAL . 1.6 ttm180 -125.12 139.44 53.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.915 0.388 . . . . 74.230000000000004 111.021 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 tp -115.11 120.51 40.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.671 -0.695 . . . . 71.319999999999993 109.458 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 42.1 m -115.55 128.55 56.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.883 0.373 . . . . 74.140000000000001 110.798 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 35.1 mm -108.35 88.77 5.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.171 -0.677 . . . . 65.219999999999999 109.171 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.979 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.8 Cg_endo -87.95 131.42 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.957 2.438 . . . . 74.439999999999998 113.708 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 20.3 t0 -80.1 65.0 5.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.044 0.926 . . . . 75.109999999999999 109.246 172.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.09 -19.14 11.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.687 -1.142 . . . . 74.340000000000003 110.02 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -131.49 29.04 3.5 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.611 -0.804 . . . . 25.300000000000001 112.792 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.69 24.91 16.59 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 120.506 -0.854 . . . . 74.040000000000006 113.321 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 3.2 m-20 -70.25 130.85 43.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.968 0.413 . . . . 74.0 111.193 -176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.543 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.3 m -92.49 157.26 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 70.219999999999999 110.363 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 10.0 p -67.89 -20.98 65.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.032 0.444 . . . . 73.209999999999994 111.908 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.451 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 t -80.47 93.57 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.205 0.526 . . . . 72.310000000000002 110.679 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -114.39 136.05 53.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.313 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -152.02 108.36 3.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.86 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.61 136.22 60.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 75.340000000000003 108.823 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 66.7 mtt180 -74.62 -53.52 9.2 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.852 -0.339 . . . . 65.439999999999998 111.32 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.28 135.56 15.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 75.209999999999994 111.07 -173.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.75 121.14 43.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.371 -0.603 . . . . 71.409999999999997 109.371 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.7 158.26 35.25 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.922 0.391 . . . . 61.310000000000002 110.55 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.56 136.54 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.104 -0.498 . . . . 74.040000000000006 110.379 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -101.7 125.42 48.35 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.207 -0.664 . . . . 73.010000000000005 109.207 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.1 -168.32 30.96 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.395 -0.907 . . . . 73.230000000000004 112.549 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.6 m -115.7 131.25 56.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.582 0.229 . . . . 74.409999999999997 110.948 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.95 118.07 22.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 75.019999999999996 110.374 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.689 HD12 ' HG3' ' A' ' 120' ' ' LYS . 39.7 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.229 0.538 . . . . 73.099999999999994 110.607 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.932 0.396 . . . . 73.510000000000005 111.099 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.626 HG22 HD11 ' A' ' 65' ' ' ILE . 47.8 mm -85.29 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 110.115 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -66.92 118.72 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 110.381 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 144' ' ' ASP . 48.1 mtmt -92.2 25.79 2.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.095 0.474 . . . . 74.230000000000004 110.621 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -52.93 61.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.4 -0.818 . . . . 75.209999999999994 112.23 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.44 6.53 68.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.532 -0.842 . . . . 74.209999999999994 113.304 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -70.54 134.15 47.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.799 0.299 . . . . 73.319999999999993 110.403 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 6.8 pt-20 -130.71 161.83 30.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.983 0.421 . . . . 74.400000000000006 110.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.92 113.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.791 -0.64 . . . . 73.209999999999994 110.118 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.66 HD11 ' HB2' ' A' ' 60' ' ' ASP . 79.4 mt -83.36 -47.89 10.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.996 -0.547 . . . . 75.310000000000002 110.478 -178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -137.36 140.41 41.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.815 -0.629 . . . . 64.420000000000002 110.164 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -150.37 148.52 28.9 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.588 -0.523 . . . . 73.099999999999994 109.588 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -90.73 -36.49 14.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 72.099999999999994 111.065 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -155.22 154.46 32.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 73.540000000000006 111.243 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 10.1 pt20 -165.63 135.81 3.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.192 -0.913 . . . . 71.519999999999996 108.81 174.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.98 94.79 10.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.33 0.586 . . . . 74.030000000000001 110.546 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.49 -3.18 34.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.654 -0.703 . . . . 73.120000000000005 111.49 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -111.39 -51.58 2.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.823 0.344 . . . . 75.230000000000004 110.131 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 121.146 -0.549 . . . . 73.310000000000002 112.14 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 C--O 1.224 -0.288 0 CA-C-O 120.636 0.255 . . . . 63.350000000000001 110.447 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.86 -5.26 83.05 Favored Glycine 0 C--N 1.322 -0.234 0 C-N-CA 120.601 -0.809 . . . . 73.230000000000004 112.438 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.476 HD12 ' HE3' ' A' ' 31' ' ' LYS . 82.2 mt -73.95 150.99 40.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.142 -0.318 . . . . 75.109999999999999 110.142 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.94 -22.25 66.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 63.240000000000002 110.953 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HE3' HD12 ' A' ' 29' ' ' LEU . 16.8 pttp -75.08 -24.17 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 72.430000000000007 110.816 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.937 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.0 m -76.51 -10.71 59.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.941 -0.572 . . . . 63.409999999999997 111.087 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.77 -15.3 62.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.616 0.722 . . . . 75.150000000000006 109.417 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 59' ' ' ILE . 28.4 pt -132.01 21.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 72.129999999999995 109.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.937 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 1.7 t70 -68.22 -48.54 64.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 64.439999999999998 109.931 -174.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.74 31.12 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.809 -0.71 . . . . 74.5 114.077 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.584 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 9.7 t70 -153.27 153.95 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.981 0.89 . . . . 74.140000000000001 111.336 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -72.53 -18.36 61.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.272 0.471 . . . . 74.019999999999996 112.272 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.584 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.7 pt-20 -98.12 3.43 49.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.404 -0.518 . . . . 63.240000000000002 111.189 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -102.27 157.05 17.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.915 -0.772 . . . . 72.329999999999998 108.915 168.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 51.2 p90 -166.98 158.07 12.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 71.209999999999994 111.2 -175.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.582 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.7 t90 -102.35 134.91 44.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.402 -0.817 . . . . 73.519999999999996 109.051 172.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -134.78 136.16 42.37 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.469 -0.567 . . . . 73.209999999999994 109.469 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.18 139.79 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.945 -0.391 . . . . 54.119999999999997 109.945 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' SER . 36.9 ttpt -62.56 118.84 8.14 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.717 -0.475 . . . . 75.150000000000006 109.717 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -112.36 -29.38 7.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.594 -0.275 . . . . 75.409999999999997 110.622 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -74.25 125.47 28.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.978 0.418 . . . . 73.319999999999993 110.17 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.05 -3.09 84.46 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 73.25 112.145 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.85 132.61 7.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.874 -0.679 . . . . 74.439999999999998 111.9 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 49.7 m -78.91 149.57 32.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 74.239999999999995 111.341 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.13 157.69 89.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 74.409999999999997 110.326 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.0 146.56 41.82 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.326 2.018 . . . . 71.319999999999993 112.123 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.49 156.95 88.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.833 -0.621 . . . . 73.530000000000001 109.707 173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 84.0 Cg_endo -82.78 156.46 76.07 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.779 -1.342 . . . . 73.209999999999994 113.62 0.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.21 117.89 30.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.539 -0.755 . . . . 73.0 109.234 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 18.5 t70 -117.42 125.62 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.305 -0.258 . . . . 64.439999999999998 110.305 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 61.4 mt -122.83 115.58 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.831 0.348 . . . . 72.420000000000002 110.94 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.14 116.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.957 -0.565 . . . . 75.239999999999995 110.306 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 34' ' ' ILE . 81.8 mt -115.96 136.75 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.236 -0.438 . . . . 73.310000000000002 110.844 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.66 ' HB2' HD11 ' A' ' 13' ' ' LEU . 53.5 t0 -101.54 120.28 40.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.47 -0.567 . . . . 64.409999999999997 109.47 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm -85.97 -5.94 59.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 73.129999999999995 110.819 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 73.2 mmtt 67.6 7.34 5.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.809 -0.632 . . . . 74.099999999999994 112.159 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -163.93 155.96 16.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.707 0.289 . . . . 71.310000000000002 110.459 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.54 128.74 36.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.601 . . . . 72.310000000000002 109.838 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.626 HD11 HG22 ' A' ' 5' ' ' ILE . 58.5 mt -133.46 135.88 55.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.857 0.36 . . . . 75.150000000000006 110.165 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 118' ' ' SER . 58.5 tp60 -81.51 102.68 10.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.875 -0.787 . . . . 73.329999999999998 108.875 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 118' ' ' SER . 21.4 mm -72.93 118.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.473 -0.33 . . . . 73.439999999999998 110.285 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.12 -41.97 3.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.351 -0.386 . . . . 74.409999999999997 110.843 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -148.64 144.22 27.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.301 -0.409 . . . . 71.510000000000005 110.277 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.02 129.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.961 -0.385 . . . . 71.319999999999993 109.961 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -105.89 131.17 53.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.935 0.398 . . . . 74.510000000000005 110.468 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 38.4 mt -112.6 118.57 35.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.848 -0.615 . . . . 74.510000000000005 109.449 174.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.486 ' HG ' ' HD2' ' A' ' 141' ' ' ARG . 24.2 tp -102.36 101.52 20.1 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 115.82 -0.627 . . . . 75.219999999999999 109.328 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 17.0 Cg_exo . . . . . 0 N--CA 1.462 -0.324 0 C-N-CA 122.5 2.133 . . . . 64.329999999999998 111.111 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.666 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 49.9 t-20 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.311 0.577 . . . . 73.049999999999997 110.133 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.639 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 89.6 Cg_endo -90.88 28.14 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.305 2.67 . . . . 74.019999999999996 113.731 -177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 80.1 mt -82.51 117.46 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 75.329999999999998 110.512 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -92.05 -57.53 2.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.618 -0.719 . . . . 74.219999999999999 110.902 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.66 138.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.574 . . . . 61.439999999999998 111.09 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.41 138.67 54.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 110.146 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.448 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 89.9 mt-10 -119.81 127.68 53.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 110.617 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -106.3 132.85 51.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.761 -0.654 . . . . 73.219999999999999 109.978 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.7 150.31 52.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.588 -0.278 . . . . 74.150000000000006 110.408 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.36 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.766 0.317 . . . . 72.340000000000003 111.169 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 t -150.53 149.11 29.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.303 -0.628 . . . . 74.099999999999994 109.303 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.689 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -90.65 -33.88 15.65 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 122.163 -0.335 . . . . 72.239999999999995 111.755 -177.006 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.6 20.22 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.602 -0.439 . . . . 73.010000000000005 111.222 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 65.79 47.4 2.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.426 0.632 . . . . 61.039999999999999 110.518 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.54 -74.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.042 -0.526 . . . . 74.530000000000001 109.894 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -83.29 105.82 14.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.475 . . . . 74.239999999999995 110.327 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -91.06 108.32 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.274 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.0 m -94.56 123.67 57.52 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.874 -0.603 . . . . 64.519999999999996 110.181 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.48 102.55 0.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.412 2.075 . . . . 73.310000000000002 111.27 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -75.79 -15.64 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 75.519999999999996 111.112 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.6 136.57 2.28 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.809 -1.186 . . . . 72.420000000000002 113.509 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.448 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 40.3 ttt180 -119.67 114.62 22.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.514 -0.921 . . . . 74.230000000000004 108.514 169.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -135.87 179.62 6.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 73.540000000000006 110.755 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.49 135.17 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.319999999999993 112.12 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -94.29 148.08 22.57 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.792 -0.448 . . . . 73.030000000000001 109.792 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.45 ' O ' HD11 ' A' ' 112' ' ' LEU . 47.0 m -142.11 120.36 12.26 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.71 -0.478 . . . . 71.120000000000005 109.71 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 12.0 t30 -77.09 91.66 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.51 0.671 . . . . 75.340000000000003 110.935 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -118.26 -171.89 2.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.002 -0.999 . . . . 74.439999999999998 109.217 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -95.83 -26.05 15.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.935 0.397 . . . . 71.150000000000006 110.63 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.79 155.32 21.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 60.420000000000002 110.624 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.86 141.15 51.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 74.25 111.013 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 106' ' ' THR . 16.0 mt -98.2 106.45 18.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 75.439999999999998 110.083 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -80.3 116.7 20.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 110.569 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.92 112.62 25.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.667 -0.697 . . . . 75.239999999999995 110.578 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -77.22 93.25 3.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.377 -0.601 . . . . 74.530000000000001 109.377 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -96.79 177.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 75.329999999999998 111.495 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -67.59 132.87 48.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.321 -0.854 . . . . 75.010000000000005 110.459 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 41.8 m -74.92 122.25 23.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 75.329999999999998 110.51 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.5 tt -152.84 143.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.896 -0.593 . . . . 75.140000000000001 110.538 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -88.89 112.61 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.168 -0.678 . . . . 73.319999999999993 109.168 174.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.95 161.96 36.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.449 -0.341 . . . . 72.030000000000001 111.082 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.689 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 34.7 ttt180 -109.89 -31.85 7.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 73.219999999999999 110.159 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.05 145.92 30.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.705 -0.679 . . . . 74.219999999999999 109.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.412 HG21 ' HB ' ' A' ' 59' ' ' ILE . 14.7 tt -129.56 140.05 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.546 -0.539 . . . . 73.329999999999998 109.546 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.447 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 57.5 ttp180 -130.29 127.02 38.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 75.430000000000007 111.127 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.18 115.94 31.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.646 -0.707 . . . . 72.010000000000005 109.236 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 34.7 m -112.04 120.52 42.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.031 0.444 . . . . 75.409999999999997 110.91 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.7 96.06 8.4 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.175 -0.676 . . . . 73.430000000000007 109.175 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.767 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 98.0 Cg_endo -79.73 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.513 2.142 . . . . 73.200000000000003 112.617 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -123.69 67.73 1.02 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.912 0.863 . . . . 61.240000000000002 108.867 170.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.8 18.07 3.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.66 -1.154 . . . . 73.109999999999999 110.1 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.84 2.1 0.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.168 -1.015 . . . . 61.049999999999997 113.729 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.75 27.64 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.32 -0.943 . . . . 42.509999999999998 112.045 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.04 156.52 17.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.965 0.412 . . . . 73.340000000000003 110.958 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.639 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 22.4 m -123.43 -179.41 4.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.068 -0.515 . . . . 75.510000000000005 110.199 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 6.6 p -85.06 5.0 31.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.219 0.533 . . . . 74.209999999999994 111.993 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 46.6 t -103.05 128.56 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.48 131.92 19.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.7 -0.227 . . . . 74.099999999999994 110.653 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.36 105.34 4.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 70.140000000000001 111.145 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.95 133.31 67.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.363 -0.606 . . . . 65.439999999999998 109.363 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 66.9 mtt180 -64.76 -71.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.345 0.593 . . . . 73.329999999999998 109.89 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -140.09 144.51 36.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 64.25 111.7 -172.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -107.48 119.61 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.825 -1.176 . . . . 73.299999999999997 107.825 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 7' ' ' LYS . 2.3 m-20 -123.7 141.77 51.7 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.936 0.398 . . . . 72.319999999999993 110.557 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.11 133.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.241 -0.436 . . . . 74.219999999999999 110.678 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -107.49 105.24 15.05 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.75 -0.833 . . . . 74.200000000000003 108.75 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.03 -150.05 5.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.68 . . . . 73.340000000000003 111.966 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 m -132.83 133.85 43.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.503 0.192 . . . . 74.25 110.589 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.58 130.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 75.540000000000006 110.988 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.544 HD12 ' HG2' ' A' ' 120' ' ' LYS . 34.3 mt . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.796 -0.638 . . . . 74.219999999999999 109.749 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.981 0.42 . . . . 70.409999999999997 110.317 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.775 HG23 HD11 ' A' ' 149' ' ' ILE . 42.1 mm -70.9 137.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.781 -0.645 . . . . 75.340000000000003 111.83 -174.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -69.08 108.16 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.564 . . . . 74.040000000000006 110.174 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -87.01 10.34 16.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.168 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -72.06 -7.5 49.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 53.109999999999999 111.654 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -120.19 4.59 12.44 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.263 -0.97 . . . . 74.25 113.076 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.505 ' HB2' HD11 ' A' ' 34' ' ' ILE . 34.8 m0 -80.3 156.81 26.61 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.635 0.255 . . . . 74.230000000000004 110.601 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.559 ' CD ' ' HE3' ' A' ' 62' ' ' LYS . 3.2 pm0 -141.89 153.02 44.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.143 0.497 . . . . 71.510000000000005 111.046 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.99 128.64 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.322 -0.399 . . . . 73.430000000000007 110.186 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 58' ' ' VAL . 57.4 mt -89.42 -49.81 6.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.243 0.544 . . . . 61.140000000000001 110.097 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.2 p -150.7 143.84 24.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.681 -0.69 . . . . 74.239999999999995 110.587 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.77 147.7 41.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.501 -0.772 . . . . 75.319999999999993 109.087 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -85.47 -33.31 21.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.903 0.382 . . . . 74.209999999999994 110.81 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -156.27 155.02 31.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.871 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -168.03 143.05 3.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.602 -0.888 . . . . 71.540000000000006 108.602 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -94.18 115.42 27.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.083 0.468 . . . . 70.430000000000007 110.124 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.36 3.74 6.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 53.119999999999997 110.899 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.6 m -121.74 -42.13 2.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.155 -0.475 . . . . 70.400000000000006 110.923 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 C-N-CA 120.809 -0.71 . . . . 71.140000000000001 112.395 179.083 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 109.407 -0.59 . . . . 74.349999999999994 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.16 -7.88 58.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.015 -0.612 . . . . 74.430000000000007 111.944 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 90.1 mt -75.79 151.87 37.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 74.120000000000005 110.472 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.1 -25.27 65.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.009 0.433 . . . . 70.409999999999997 110.765 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.85 -20.47 61.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.672 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 60.4 m -73.01 -18.0 61.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.042 0.449 . . . . 61.310000000000002 110.742 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 tp -66.93 -17.5 64.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.737 -0.665 . . . . 74.430000000000007 110.219 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 10' ' ' TRP . 29.7 pt -128.39 22.39 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 73.200000000000003 110.45 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 26.5 t70 -70.49 -40.74 73.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 75.239999999999995 112.161 -171.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.32 23.08 9.87 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.651 -0.785 . . . . 73.349999999999994 112.061 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -138.18 128.83 26.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.49 -0.559 . . . . 74.030000000000001 109.49 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 p -76.83 0.56 20.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.029 0.751 . . . . 74.099999999999994 113.029 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.11 -7.44 15.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.572 -0.451 . . . . 72.129999999999995 111.57 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 p -92.42 149.2 21.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.081 -0.711 . . . . 73.530000000000001 109.081 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.561 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 49.7 p90 -153.05 166.72 31.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.946 0.403 . . . . 74.400000000000006 111.468 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.476 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 44.8 t90 -108.03 138.9 43.48 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.189 -0.914 . . . . 73.200000000000003 109.385 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -136.31 142.62 43.9 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.036 -0.727 . . . . 72.120000000000005 109.036 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.61 56.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.636 -0.505 . . . . 74.239999999999995 109.636 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -64.17 115.22 4.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.135 -0.32 . . . . 75.010000000000005 110.135 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -109.24 -28.94 8.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.311 -0.404 . . . . 75.209999999999994 110.805 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -76.54 113.78 14.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 73.420000000000002 110.236 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.87 -8.51 54.32 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.229 -0.748 . . . . 61.140000000000001 111.229 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.53 161.2 11.01 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.545 -0.622 . . . . 74.239999999999995 111.545 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 4.6 p -98.34 148.39 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.738 0.304 . . . . 73.519999999999996 110.51 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 21.2 m-20 -84.57 149.12 53.71 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.263 -0.426 . . . . 73.200000000000003 110.682 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 22.4 Cg_exo -66.24 128.79 20.15 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.872 2.382 . . . . 73.450000000000003 112.822 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.9 mt -73.09 162.33 75.05 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.391 -0.822 . . . . 74.109999999999999 110.207 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 92.4 Cg_endo -78.33 163.56 86.65 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.843 -1.315 . . . . 75.019999999999996 113.249 1.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.5 m-85 -100.19 112.89 25.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 73.310000000000002 110.649 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.78 131.62 44.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.421 -0.354 . . . . 75.400000000000006 110.254 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.406 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 60.6 mt -124.76 108.51 20.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.579 -0.526 . . . . 74.140000000000001 109.579 172.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG13 HD12 ' A' ' 13' ' ' LEU . 49.5 t -102.25 114.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.951 -0.568 . . . . 75.299999999999997 110.388 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.05 139.6 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.87 -0.604 . . . . 73.109999999999999 109.898 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.545 ' HB3' ' OE1' ' A' ' 11' ' ' GLU . 19.5 t0 -102.66 138.52 39.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.693 -0.484 . . . . 64.239999999999995 109.693 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.465 ' SD ' HD13 ' A' ' 65' ' ' ILE . 68.6 mtm -91.83 -3.15 56.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 75.310000000000002 110.07 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HE3' ' CD ' ' A' ' 11' ' ' GLU . 24.0 mmtp 67.6 4.09 3.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.482 -0.781 . . . . 72.340000000000003 112.467 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -165.3 172.12 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.602 0.239 . . . . 73.129999999999995 110.754 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.41 127.18 31.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.259 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.607 HD12 HG22 ' A' ' 5' ' ' ILE . 74.6 mt -136.68 135.16 48.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.143 0.497 . . . . 71.109999999999999 110.363 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -82.82 109.39 16.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.009 -0.738 . . . . 75.400000000000006 109.009 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 118' ' ' SER . 27.4 mm -79.33 129.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.92 -0.312 . . . . 73.430000000000007 110.325 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.59 -39.28 2.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 63.229999999999997 110.968 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 15.8 tt0 -150.96 143.94 24.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 110.996 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.06 131.68 67.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.243 -0.435 . . . . 70.530000000000001 109.836 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.8 mt-10 -110.07 135.85 50.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 110.677 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD13 ' HE2' ' A' ' 114' ' ' TYR . 69.2 mt -119.01 120.3 36.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.733 -0.667 . . . . 72.430000000000007 109.557 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 31.2 tp -104.25 104.02 41.91 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 116.052 -0.522 . . . . 75.519999999999996 109.907 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.7 Cg_exo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 123.222 2.615 . . . . 64.310000000000002 112.267 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 120.99 0.424 . . . . 73.010000000000005 111.423 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 75.4 Cg_endo -77.99 59.9 7.11 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.07 2.514 . . . . 65.129999999999995 113.755 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mt -99.0 119.36 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.041 -0.726 . . . . 74.409999999999997 109.041 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -102.64 -49.64 3.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.342 -0.39 . . . . 73.420000000000002 111.822 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.66 138.0 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.51 -0.314 . . . . 74.420000000000002 111.133 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.82 129.2 63.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.276 -0.42 . . . . 63.439999999999998 110.268 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.9 mt-10 -111.87 132.97 54.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.041 -0.527 . . . . 74.030000000000001 110.302 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.62 129.42 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.868 -0.605 . . . . 75.219999999999999 110.023 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.15 141.79 49.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.831 0.348 . . . . 72.219999999999999 110.943 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.03 46.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.062 -0.517 . . . . 72.150000000000006 110.387 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -149.96 158.89 44.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 111.267 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.3 mt-10 -106.64 -25.08 11.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.985 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -114.42 0.68 14.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.48 -0.327 . . . . 74.120000000000005 111.647 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 74.42 0.7 3.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.555 0.534 . . . . 74.319999999999993 110.516 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.9 -54.47 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 64.329999999999998 110.669 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -88.12 96.59 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.681 . . . . 74.319999999999993 110.278 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -90.38 121.11 32.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 73.109999999999999 110.743 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.0 m -98.47 121.81 55.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.711 -0.677 . . . . 70.340000000000003 109.814 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.42 113.61 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.288 1.992 . . . . 74.340000000000003 111.423 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.552 HD13 HG22 ' A' ' 116' ' ' VAL . 21.9 pt -88.78 -15.71 8.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 65.109999999999999 110.631 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.41 150.62 7.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.318 -0.944 . . . . 50.140000000000001 113.181 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 31.9 ttt180 -129.02 114.69 16.72 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.135 -1.061 . . . . 73.109999999999999 108.135 173.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HE2' HG12 ' A' ' 116' ' ' VAL . 98.0 m-85 -127.28 171.98 11.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 73.239999999999995 111.657 -170.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.09 131.05 10.44 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.481 -0.782 . . . . 71.209999999999994 111.198 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.46 136.87 34.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.994 0.426 . . . . 74.329999999999998 110.265 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.553 ' HB ' HD23 ' A' ' 112' ' ' LEU . 18.0 m -118.52 111.1 18.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.845 -0.616 . . . . 73.409999999999997 109.861 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.45 104.24 3.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.989 0.424 . . . . 73.310000000000002 110.567 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.7 -176.79 5.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 71.430000000000007 109.91 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -103.13 0.66 32.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 75.030000000000001 110.687 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.06 163.15 12.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 75.299999999999997 110.631 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.27 35.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 73.120000000000005 111.329 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.553 HD23 ' HB ' ' A' ' 106' ' ' THR . 33.3 mt -89.07 113.97 25.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.791 -0.64 . . . . 73.450000000000003 110.626 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.18 113.83 26.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 74.310000000000002 110.243 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.418 ' HE2' HD13 ' A' ' 72' ' ' LEU . 79.8 m-85 -106.48 101.87 11.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.95 -0.568 . . . . 75.329999999999998 109.931 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.2 106.42 5.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.536 -0.756 . . . . 75.219999999999999 108.967 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.579 HG12 ' HE2' ' A' ' 103' ' ' PHE . 28.3 m -107.88 178.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.25 0.548 . . . . 73.349999999999994 111.995 -170.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.2 134.48 52.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 74.340000000000003 110.295 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 16.7 m -82.77 130.13 35.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 70.219999999999999 110.979 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.0 tt -160.65 147.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.925 -0.579 . . . . 74.400000000000006 110.123 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.02 121.15 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.424 -0.584 . . . . 75.310000000000002 109.424 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.0 176.95 9.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.424 -0.353 . . . . 61.140000000000001 110.787 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HG2' ' OD1' ' A' ' 60' ' ' ASP . 22.8 ttt180 -119.74 -34.86 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 110.341 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -105.36 146.07 29.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 75.310000000000002 109.932 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.06 133.55 60.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.035 0.445 . . . . 72.140000000000001 110.105 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.404 ' HD3' HG23 ' A' ' 58' ' ' VAL . 12.4 ttp180 -124.37 129.09 50.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.401 . . . . 70.120000000000005 111.198 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.57 119.0 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.525 -0.761 . . . . 75.439999999999998 109.212 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 60.0 m -112.82 126.97 56.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.999 0.428 . . . . 70.439999999999998 110.938 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.7 mm -104.08 89.83 2.69 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.677 -0.692 . . . . 72.25 109.261 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.719 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 88.4 Cg_endo -81.34 134.0 8.81 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.808 2.339 . . . . 75.200000000000003 113.507 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.71 65.8 7.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.822 0.82 . . . . 75.530000000000001 108.999 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.63 -13.61 2.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.185 -0.916 . . . . 64.239999999999995 111.253 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -127.02 15.62 6.49 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.148 -1.025 . . . . 75.109999999999999 113.441 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.69 18.69 13.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.495 -0.86 . . . . 64.150000000000006 112.66 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -72.87 126.87 30.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.076 0.465 . . . . 74.319999999999993 110.927 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.589 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 19.8 m -99.69 171.96 7.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.032 -0.531 . . . . 75.109999999999999 110.232 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 3.1 p -82.31 6.9 15.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.087 0.403 . . . . 74.219999999999999 112.087 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 60.6 t -106.73 102.29 13.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.563 -0.532 . . . . 75.519999999999996 109.563 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -127.69 124.86 38.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.035 -0.53 . . . . 65.209999999999994 110.18 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.13 107.06 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 60.329999999999998 111.179 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.9 132.76 70.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.112 -0.699 . . . . 74.129999999999995 109.112 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.561 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 75.2 mtt180 -63.85 -71.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.118 0.485 . . . . 74.329999999999998 110.062 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -140.01 155.03 47.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.581 0.705 . . . . 62.219999999999999 112.439 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.54 119.98 37.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.232 -1.349 . . . . 75.25 107.84 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.24 151.85 36.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.941 -0.392 . . . . 74.340000000000003 109.941 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.42 131.39 73.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.678 -0.409 . . . . 64.140000000000001 110.741 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 45.1 mttp -98.16 127.21 43.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.122 -0.696 . . . . 75.319999999999993 109.122 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.29 -146.06 5.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.685 -0.769 . . . . 65.430000000000007 111.811 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.4 m -139.89 130.34 25.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.459 -0.2 . . . . 72.519999999999996 110.459 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.775 HD11 HG23 ' A' ' 5' ' ' ILE . 28.6 mm -72.27 120.9 21.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.466 . . . . 73.329999999999998 110.079 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 75.040000000000006 110.024 -179.36 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.601 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 7.0 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 120.717 0.294 . . . . 72.010000000000005 110.919 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.59 HG23 ' CD1' ' A' ' 65' ' ' ILE . 42.8 mm -71.64 136.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.064 -0.516 . . . . 72.129999999999995 110.706 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -67.28 115.79 7.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.175 -0.466 . . . . 73.450000000000003 110.302 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.99 3.26 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 74.099999999999994 111.213 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p -69.03 98.09 0.94 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.61 0.719 . . . . 61.329999999999998 110.62 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.64 -14.72 6.06 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.012 -0.995 . . . . 60.43 112.11 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -66.45 145.88 55.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.3 -0.259 . . . . 73.0 110.3 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.3 pt-20 -132.45 159.41 39.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.998 0.428 . . . . 74.019999999999996 110.664 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -100.72 112.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.527 -0.761 . . . . 75.450000000000003 109.578 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.0 mt -72.57 -46.7 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.527 . . . . 73.310000000000002 110.512 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -152.05 142.44 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.844 -0.616 . . . . 73.540000000000006 110.717 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.86 149.45 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.936 -0.575 . . . . 74.400000000000006 109.829 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.5 m -82.16 -49.81 9.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.354 . . . . 71.510000000000005 111.173 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.5 t -146.39 157.21 43.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 75.319999999999993 110.783 -173.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -163.31 144.6 9.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.845 -0.798 . . . . 64.409999999999997 108.845 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -96.78 101.21 12.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.001 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.16 5.3 34.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 64.549999999999997 111.928 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -136.99 -45.48 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.706 -0.398 . . . . 73.420000000000002 111.176 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 121.116 -0.564 . . . . 65.310000000000002 113.077 -177.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t30 . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.7 -0.482 . . . . 74.140000000000001 109.7 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.04 6.02 46.16 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.921 -0.871 . . . . 52.109999999999999 110.921 -173.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.534 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 66.8 mt -80.32 154.88 27.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.198 -0.501 . . . . 74.420000000000002 110.697 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -69.23 -26.97 65.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.042 -0.526 . . . . 63.130000000000003 110.875 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 110.787 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.4 m -70.47 -22.59 62.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.329999999999998 110.32 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' A' ' 142' ' ' GLU . 25.4 tp -64.0 -19.45 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.554 -0.748 . . . . 74.109999999999999 110.824 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 59' ' ' ILE . 35.9 pt -131.46 18.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 72.540000000000006 110.436 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.8 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -68.77 -38.47 80.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 71.329999999999998 110.909 -173.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.47 19.77 13.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 74.200000000000003 111.98 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.4 121.16 25.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.699 0.285 . . . . 72.200000000000003 110.246 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 p -70.72 -20.26 62.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.333 -0.394 . . . . 73.230000000000004 111.624 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -74.27 -27.13 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.658 -0.246 . . . . 74.319999999999993 111.314 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -89.81 160.67 16.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.839 -0.43 . . . . 61.25 109.839 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.3 p90 -156.18 171.04 20.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 71.510000000000005 111.043 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 49.9 t90 -106.78 134.86 49.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.616 -0.72 . . . . 74.430000000000007 109.474 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -133.06 142.39 48.74 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.129 -0.693 . . . . 74.319999999999993 109.129 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.53 143.67 49.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.797 -0.446 . . . . 63.509999999999998 109.797 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.9 126.01 25.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.256 0.348 . . . . 75.239999999999995 110.231 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -128.02 -25.44 3.03 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.789 -0.364 . . . . 75.010000000000005 111.235 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.49 107.43 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.976 0.417 . . . . 71.340000000000003 110.542 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.74 80.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.933 -0.651 . . . . 64.239999999999995 112.391 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.18 171.68 12.86 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.967 -0.635 . . . . 74.109999999999999 111.581 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 136' ' ' THR . 40.9 m -116.4 175.42 5.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.729 0.3 . . . . 73.329999999999998 111.104 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.589 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 7.2 m-20 -97.99 166.3 13.72 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.133 -0.485 . . . . 74.549999999999997 110.845 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 39.4 Cg_endo -67.88 134.49 32.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.633 2.222 . . . . 64.019999999999996 113.207 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.69 154.39 61.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.557 -0.747 . . . . 73.510000000000005 109.51 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.855 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -76.05 165.54 85.19 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 123.608 -1.413 . . . . 71.230000000000004 112.928 1.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.2 m-85 -99.54 115.4 29.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.872 -0.604 . . . . 74.329999999999998 110.101 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -106.11 129.14 54.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 74.530000000000001 110.847 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -121.7 108.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.959 -0.564 . . . . 75.109999999999999 109.596 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.91 114.13 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 116.047 -0.524 . . . . 74.420000000000002 110.459 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.497 HD13 HG22 ' A' ' 34' ' ' ILE . 71.1 mt -115.29 137.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.861 -0.609 . . . . 71.340000000000003 110.929 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -106.29 121.81 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.847 -0.615 . . . . 74.109999999999999 109.877 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.97 -5.85 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 71.230000000000004 111.043 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 66.61 11.38 8.1 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.148 0.795 . . . . 73.219999999999999 113.148 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -165.5 172.86 11.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.252 -0.277 . . . . 71.540000000000006 110.252 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -85.24 128.65 34.76 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.056 -0.52 . . . . 74.099999999999994 109.654 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CD1' HG23 ' A' ' 5' ' ' ILE . 67.6 mt -134.28 134.39 55.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.949 0.404 . . . . 72.049999999999997 110.17 176.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HB2' HD12 ' A' ' 150' ' ' ILE . 56.2 tp60 -80.8 101.61 9.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.536 -0.756 . . . . 75.519999999999996 109.001 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 118' ' ' SER . 23.8 mm -71.18 123.59 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 73.109999999999999 110.344 -176.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.47 -46.28 2.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 74.510000000000005 110.201 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.559 ' HB3' ' HB3' ' A' ' 146' ' ' LYS . 34.3 tt0 -137.9 141.58 40.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.764 -0.653 . . . . 75.120000000000005 110.42 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -108.93 128.28 64.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.055 -0.72 . . . . 74.510000000000005 109.055 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -110.06 123.45 49.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.248 0.546 . . . . 64.319999999999993 110.76 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.9 mt -109.33 124.53 51.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 75.109999999999999 109.841 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.4 106.97 48.79 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.862 -0.792 . . . . 75.040000000000006 108.862 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.461 -0.431 0 C-N-CA 122.386 2.058 . . . . 74.400000000000006 111.837 177.874 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.832 0.348 . . . . 73.230000000000004 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 93.2 Cg_endo -87.63 37.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.738 2.292 . . . . 74.140000000000001 112.259 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -87.38 134.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 75.030000000000001 110.533 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 24.1 mmmt -111.13 -57.77 2.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.577 -0.738 . . . . 72.329999999999998 110.658 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.466 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 95.2 t -121.19 138.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 74.049999999999997 110.945 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.29 138.34 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.885 -0.598 . . . . 72.310000000000002 109.651 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.0 mt-10 -118.04 135.11 54.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.317 -0.402 . . . . 74.319999999999993 111.152 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -117.02 129.87 56.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 73.319999999999993 110.142 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 97' ' ' TRP . . . -128.49 143.97 51.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.328 -0.397 . . . . 72.129999999999995 110.652 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 149.97 49.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.368 -0.378 . . . . 62.009999999999998 110.34 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.3 t -150.09 150.92 32.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.186 0.517 . . . . 72.310000000000002 111.625 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.17 -30.85 12.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.337 -0.847 . . . . 73.519999999999996 109.837 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 3.4 p-10 -105.73 -12.17 16.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 64.409999999999997 112.126 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.8 t30 71.22 5.14 5.35 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.617 0.722 . . . . 75.120000000000005 110.758 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.569 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 98.7 t -100.82 -58.32 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.93 -0.577 . . . . 73.219999999999999 110.103 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -102.43 118.96 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 70.530000000000001 110.127 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 94.5 m95 -95.86 124.42 39.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 111.154 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 m -90.44 122.63 67.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.143 -0.48 . . . . 72.310000000000002 110.109 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.54 110.2 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.42 2.08 . . . . 64.450000000000003 111.507 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.619 HD11 HG21 ' A' ' 116' ' ' VAL . 13.7 pt -80.81 -19.49 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.577 -0.283 . . . . 73.450000000000003 110.983 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 136.92 2.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.302 -0.951 . . . . 70.510000000000005 113.558 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.3 ttm180 -102.72 125.6 49.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.436 -0.579 . . . . 75.409999999999997 109.436 169.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.552 ' HE2' HG12 ' A' ' 116' ' ' VAL . 77.8 m-85 -138.56 -176.23 4.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.269 -0.572 . . . . 75.140000000000001 111.289 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -99.15 147.54 18.47 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.855 -0.611 . . . . 65.140000000000001 112.248 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.412 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 40.8 t80 -96.47 148.29 22.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 73.230000000000004 110.119 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.418 ' HB ' HD22 ' A' ' 112' ' ' LEU . 26.5 m -133.38 117.83 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.893 -0.41 . . . . 74.329999999999998 109.893 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -77.21 106.44 8.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.408 0.623 . . . . 72.540000000000006 110.533 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -144.47 177.66 8.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.256 -0.883 . . . . 74.030000000000001 110.222 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -97.86 8.67 44.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.31 -0.404 . . . . 64.099999999999994 110.801 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.73 158.05 30.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 74.420000000000002 109.848 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.47 142.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 73.299999999999997 111.539 -175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.418 HD22 ' HB ' ' A' ' 106' ' ' THR . 63.1 mt -92.26 121.85 34.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.569 -0.742 . . . . 71.109999999999999 111.0 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.82 109.8 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 71.530000000000001 111.29 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 95.5 m-85 -104.55 110.11 22.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 75.219999999999999 110.649 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -86.5 100.51 12.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.789 -0.641 . . . . 73.219999999999999 109.709 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.619 HG21 HD11 ' A' ' 100' ' ' ILE . 26.7 m -106.06 179.4 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.95 -0.568 . . . . 73.450000000000003 111.412 -174.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.62 139.19 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 75.5 110.468 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 23.9 m -80.67 121.43 25.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.297 -0.411 . . . . 72.530000000000001 110.861 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -155.14 149.94 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 110.326 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.776 ' HG3' HD11 ' A' ' 150' ' ' ILE . 2.7 ttpm? -89.78 132.53 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.097 -0.334 . . . . 74.519999999999996 110.097 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.08 166.09 33.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.522 -0.308 . . . . 65.239999999999995 111.091 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' A' ' 123' ' ' TYR . 24.9 ttm180 -111.27 -33.53 6.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.171 0.51 . . . . 73.400000000000006 110.2 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.463 ' CE1' ' HD2' ' A' ' 122' ' ' ARG . 70.7 m-85 -105.21 145.16 31.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.914 -0.585 . . . . 73.540000000000006 110.213 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.419 HG23 ' HB ' ' A' ' 59' ' ' ILE . 10.5 tt -136.31 129.34 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.079 -0.509 . . . . 72.120000000000005 110.065 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 125' ' ' ARG . 13.5 ttp180 -113.4 121.19 43.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 72.319999999999993 110.659 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.0 tp -91.55 113.72 26.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.202 -0.666 . . . . 74.409999999999997 109.202 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -109.99 119.94 40.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.997 0.427 . . . . 74.239999999999995 110.934 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.9 mm -100.77 96.28 5.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.058 -0.719 . . . . 72.25 109.058 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.855 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 89.5 Cg_endo -75.68 -179.85 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 75.340000000000003 112.786 -176.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -110.01 -9.05 14.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.166 0.984 . . . . 72.140000000000001 108.398 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.44 -46.14 91.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.659 -1.61 . . . . 75.310000000000002 112.11 -173.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.466 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -82.01 6.82 65.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.716 -0.754 . . . . 74.340000000000003 113.713 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.94 25.41 9.69 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.169 -1.015 . . . . 71.219999999999999 112.071 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -78.78 -175.92 4.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 74.120000000000005 111.133 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.1 m -139.24 174.5 10.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.998 -0.546 . . . . 73.230000000000004 109.628 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 1.2 p -79.96 -0.73 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.952 0.406 . . . . 74.239999999999995 112.035 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.68 124.09 62.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.799 -0.445 . . . . 65.140000000000001 109.799 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.47 142.99 30.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.659 -0.246 . . . . 73.140000000000001 110.655 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.7 109.48 5.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 74.25 111.118 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.8 mt -127.49 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 65.040000000000006 109.102 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.495 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 1.5 tpt180 -74.44 -68.82 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.606 -0.516 . . . . 74.519999999999996 109.606 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.469 ' HA ' HD11 ' A' ' 33' ' ' LEU . 17.7 pt-20 -148.87 160.99 42.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.208 0.527 . . . . 71.420000000000002 110.734 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.34 121.75 44.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.382 -0.826 . . . . 75.019999999999996 108.958 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.601 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.4 t70 -117.1 162.33 18.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.869 -0.419 . . . . 71.310000000000002 109.869 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 5' ' ' ILE . 95.3 t -127.89 124.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 110.296 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . 48.3 tttm -101.45 101.61 12.25 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.264 -0.643 . . . . 75.450000000000003 109.264 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.09 -161.64 10.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.727 -0.749 . . . . 75.099999999999994 112.089 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -118.05 133.64 55.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.652 0.263 . . . . 75.219999999999999 110.554 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 5' ' ' ILE . 38.4 mm -71.54 124.46 28.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.081 -0.509 . . . . 75.329999999999998 111.419 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.776 HD11 ' HG3' ' A' ' 120' ' ' LYS . 29.0 mt . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.162 0.506 . . . . 72.310000000000002 110.109 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 120.734 0.302 . . . . 74.329999999999998 110.992 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.494 HD11 HD13 ' A' ' 149' ' ' ILE . 37.6 mm -66.65 131.91 32.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.134 -0.485 . . . . 73.109999999999999 110.327 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -64.78 111.73 2.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.376 -0.375 . . . . 75.439999999999998 110.829 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 36.0 mtmm -87.52 16.25 5.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 75.030000000000001 110.567 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -65.48 -16.36 63.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.493 -0.776 . . . . 64.209999999999994 112.16 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.1 23.25 4.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.497 -0.859 . . . . 72.319999999999993 112.874 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.411 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 33.3 m0 -84.35 156.79 21.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.992 0.396 . . . . 74.319999999999993 110.853 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 22.2 pt-20 -135.4 159.54 41.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.81 0.338 . . . . 71.209999999999994 110.768 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.54 130.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.972 -0.558 . . . . 64.319999999999993 109.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.5 -36.86 9.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.166 0.508 . . . . 74.230000000000004 110.78 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.3 t -144.94 139.36 27.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 75.219999999999999 110.66 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -151.1 134.84 16.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 74.540000000000006 109.526 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -85.37 -38.9 18.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 71.439999999999998 111.278 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -149.13 152.51 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.993 0.425 . . . . 75.230000000000004 110.959 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.0 pt20 -163.91 139.53 6.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.425 -0.807 . . . . 71.439999999999998 108.919 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -93.74 98.06 10.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.133 0.492 . . . . 74.400000000000006 111.065 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.48 -12.01 18.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.864 -0.607 . . . . 73.540000000000006 110.95 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -101.04 -47.77 4.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.02 -0.536 . . . . 75.239999999999995 110.955 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.909 -0.587 . . . . 73.420000000000002 112.411 -178.92 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.2 t30 . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 109.732 -0.469 . . . . 74.299999999999997 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 2.96 72.73 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.611 -0.595 . . . . 65.450000000000003 111.611 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 82.0 mt -82.13 157.44 24.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.584 -0.308 . . . . 64.319999999999993 110.272 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.83 -28.74 68.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.773 0.321 . . . . 72.420000000000002 110.973 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HE3' HD11 ' A' ' 29' ' ' LEU . 21.3 pttp -69.41 -23.02 63.65 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.742 0.306 . . . . 75.420000000000002 111.044 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.79 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.7 m -66.99 -24.24 66.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.015 0.436 . . . . 71.409999999999997 110.408 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.0 tp -65.92 -25.54 67.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 73.230000000000004 110.371 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.635 HG22 HG22 ' A' ' 59' ' ' ILE . 2.5 pp -119.48 13.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.207 0.527 . . . . 74.140000000000001 110.336 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.79 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.2 t70 -65.27 -42.25 93.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.287 -0.869 . . . . 74.109999999999999 110.174 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.9 55.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.824 -0.703 . . . . 65.219999999999999 111.682 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -117.12 124.44 49.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.368 -0.416 . . . . 73.140000000000001 109.986 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -72.65 -15.13 61.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.285 -0.416 . . . . 72.109999999999999 111.755 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.31 -24.33 50.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 75.439999999999998 110.718 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -100.23 160.16 14.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.4 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.69 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 48.3 p90 -156.15 165.0 37.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.848 -0.427 . . . . 75.299999999999997 109.848 174.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.529 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 39.2 t90 -98.12 129.27 44.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.379 -0.6 . . . . 74.5 109.379 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 49.4 t-80 -131.13 137.07 48.87 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.231 -0.655 . . . . 72.200000000000003 109.231 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.12 144.63 54.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.556 -0.535 . . . . 73.409999999999997 109.556 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 50' ' ' SER . 64.8 tttp -60.4 126.09 26.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.358 . . . . 71.310000000000002 110.339 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -124.52 -32.14 3.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 74.099999999999994 110.064 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.45 108.99 13.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 61.130000000000003 109.383 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.41 -12.33 54.61 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.712 -0.676 . . . . 70.319999999999993 111.635 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 144.34 5.82 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.93 -0.652 . . . . 75.510000000000005 111.547 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 11.0 p -86.63 167.64 14.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.941 0.4 . . . . 74.129999999999995 111.505 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -100.54 146.9 32.83 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 75.239999999999995 109.715 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.96 141.54 44.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.691 2.261 . . . . 71.349999999999994 112.63 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.5 mt -75.85 164.63 59.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 75.420000000000002 110.569 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 88.1 Cg_endo -83.69 161.75 71.04 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 123.766 -1.348 . . . . 71.219999999999999 113.239 1.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -100.06 111.46 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 73.5 109.923 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -104.42 125.69 50.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.082 -0.34 . . . . 70.310000000000002 110.082 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.44 121.36 66.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.134 -0.321 . . . . 74.209999999999994 110.134 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -112.31 117.85 56.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.334 -0.394 . . . . 74.439999999999998 110.616 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.635 HG22 HG22 ' A' ' 34' ' ' ILE . 4.7 mp -117.05 140.62 38.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.19 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 19.8 t70 -103.04 134.2 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.594 -0.275 . . . . 74.239999999999995 110.264 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.515 ' HE2' HD13 ' A' ' 67' ' ' ILE . 64.8 mtm -96.64 3.92 52.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 75.310000000000002 111.092 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.7 mmtp 70.89 -30.06 0.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.617 0.969 . . . . 73.219999999999999 113.617 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -133.71 172.44 12.76 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.236 -0.29 . . . . 74.239999999999995 111.051 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.08 129.82 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 73.209999999999994 110.399 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.455 ' CD1' HG23 ' A' ' 5' ' ' ILE . 69.6 mt -139.07 139.91 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.018 0.437 . . . . 72.120000000000005 110.333 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -83.31 105.08 13.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.927 -0.768 . . . . 73.299999999999997 108.927 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.71 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.8 mm -72.93 106.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.235 -0.283 . . . . 74.299999999999997 110.235 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.03 -43.9 6.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.052 0.453 . . . . 70.150000000000006 110.843 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.6 tt0 -145.42 140.88 27.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.991 -0.549 . . . . 75.439999999999998 110.787 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.21 130.73 61.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.531 -0.544 . . . . 64.409999999999997 109.531 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -113.47 129.76 56.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.957 0.408 . . . . 73.519999999999996 110.521 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 70.4 mt -117.14 120.49 38.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 109.92 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.73 103.56 15.07 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.023 -0.732 . . . . 74.219999999999999 109.023 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 15.3 Cg_exo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 123.038 2.492 . . . . 74.109999999999999 112.645 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.908 0.385 . . . . 74.239999999999995 110.49 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.93 29.77 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.145 2.563 . . . . 72.430000000000007 114.171 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 105' ' ' PHE . 73.2 mt -79.0 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.568 -0.53 . . . . 62.109999999999999 109.568 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -114.84 -46.03 2.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 111.453 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.697 HG11 ' HE ' ' A' ' 102' ' ' ARG . 62.0 t -127.13 138.35 55.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.469 -0.332 . . . . 75.530000000000001 110.898 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.22 137.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.186 -0.461 . . . . 72.549999999999997 110.52 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 40.2 mt-10 -116.6 140.45 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.402 -0.363 . . . . 74.510000000000005 110.907 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -120.4 132.67 55.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 73.219999999999999 110.669 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.51 147.71 50.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 74.239999999999995 110.267 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.32 150.03 52.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 71.030000000000001 110.495 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.5 t -150.26 150.7 31.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 71.030000000000001 110.878 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.629 ' HG3' ' HA ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -101.31 -31.35 11.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.957 0.408 . . . . 74.299999999999997 110.129 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 8.9 p-10 -105.22 -4.33 21.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 71.239999999999995 111.518 -174.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 24.5 t-20 76.31 -16.16 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.797 0.685 . . . . 71.310000000000002 111.337 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 95.2 t -89.32 -58.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.97 0.414 . . . . 72.540000000000006 110.627 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.89 111.48 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.466 . . . . 71.209999999999994 110.454 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -96.6 132.39 42.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.993 0.425 . . . . 74.400000000000006 110.921 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.3 m -105.09 124.76 35.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 75.310000000000002 110.505 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.72 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.468 2.112 . . . . 74.299999999999997 111.572 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 116' ' ' VAL . 21.6 pt -93.1 -6.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.332 -0.395 . . . . 63.200000000000003 111.059 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.61 147.82 4.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.538 -0.839 . . . . 72.430000000000007 113.044 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.697 ' HE ' HG11 ' A' ' 85' ' ' VAL . 77.9 ttt180 -113.06 119.65 38.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.214 -0.661 . . . . 74.25 109.214 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.573 ' HE2' HG13 ' A' ' 116' ' ' VAL . 84.5 m-85 -130.36 177.17 7.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.82 0.343 . . . . 74.540000000000006 110.911 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.8 149.81 19.41 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.043 -0.599 . . . . 72.25 111.774 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.414 ' HB3' HG22 ' A' ' 83' ' ' ILE . 51.6 t80 -105.06 121.62 44.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.985 0.421 . . . . 75.400000000000006 110.081 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 112' ' ' LEU . 24.2 m -113.35 107.69 16.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.972 -0.558 . . . . 70.5 109.962 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -68.83 94.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.38 0.61 . . . . 74.0 110.072 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -113.93 -166.17 1.07 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.087 -0.96 . . . . 75.329999999999998 109.55 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.97 -14.22 20.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.973 0.416 . . . . 61.310000000000002 110.697 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.21 169.42 8.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 74.420000000000002 110.653 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -75.52 137.52 40.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 75.200000000000003 110.948 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 106' ' ' THR . 34.8 mt -87.46 111.29 21.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.622 -0.717 . . . . 70.120000000000005 110.533 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.82 108.93 19.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.933 0.397 . . . . 72.510000000000005 110.47 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.33 113.48 25.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 72.420000000000002 110.799 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -80.2 92.05 5.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.248 -0.649 . . . . 75.219999999999999 109.248 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.573 HG13 ' HE2' ' A' ' 103' ' ' PHE . 27.3 m -96.67 177.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 62.020000000000003 111.669 -172.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.77 118.74 13.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 70.200000000000003 109.662 177.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 14.4 m -75.6 118.75 18.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.001 -0.545 . . . . 74.409999999999997 110.847 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -147.76 153.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.466 . . . . 72.299999999999997 110.731 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.551 ' HG2' HD11 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -81.8 125.81 31.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 64.150000000000006 109.698 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . . . -152.41 175.42 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 72.200000000000003 111.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -128.51 -32.82 2.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.844 -0.616 . . . . 74.519999999999996 109.927 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -106.35 146.38 30.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.626 . . . . 73.420000000000002 109.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.55 135.21 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 110.267 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -121.49 124.06 43.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.93 0.395 . . . . 71.430000000000007 110.93 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.21 116.9 31.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 75.439999999999998 109.091 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.0 m -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.19 0.519 . . . . 75.329999999999998 110.966 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.9 mm -106.52 95.68 12.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 71.219999999999999 109.196 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 57.0 Cg_endo -71.87 173.96 11.93 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.354 2.036 . . . . 75.129999999999995 112.552 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.486 ' HA ' HD11 ' A' ' 53' ' ' LEU . 16.7 t70 -91.01 -6.1 54.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.146 0.974 . . . . 64.430000000000007 108.893 175.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.28 143.35 26.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.695 -1.139 . . . . 74.510000000000005 110.532 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.21 -11.52 58.54 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.721 -0.752 . . . . 73.409999999999997 112.315 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.94 12.12 14.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.876 -0.678 . . . . 64.049999999999997 112.733 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -67.78 124.84 24.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 73.0 110.936 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -95.35 178.15 5.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 110.02 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.8 p -79.08 1.57 23.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 74.209999999999994 112.127 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.12 101.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.871 -0.418 . . . . 53.200000000000003 109.871 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -119.87 130.52 54.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.269 -0.423 . . . . 75.540000000000006 110.114 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -147.07 111.92 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.159 0.505 . . . . 74.430000000000007 111.486 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.94 132.86 56.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.394 -0.595 . . . . 74.519999999999996 109.394 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.69 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmt180 -61.39 -63.79 1.16 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.669 0.271 . . . . 75.099999999999994 110.417 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.6 155.51 30.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.471 0.653 . . . . 64.129999999999995 111.346 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -106.51 123.92 48.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.849 -1.069 . . . . 74.450000000000003 108.313 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.8 152.07 37.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.554 -0.535 . . . . 70.319999999999993 109.554 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.03 130.96 74.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.928 0.394 . . . . 71.409999999999997 111.603 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 39.0 mttp -101.97 107.06 18.08 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.944 -0.761 . . . . 74.329999999999998 108.944 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.11 177.76 31.36 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.238 -0.982 . . . . 63.43 112.143 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.8 m -106.85 127.31 53.3 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.241 -0.281 . . . . 75.109999999999999 110.241 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.494 HD13 HD11 ' A' ' 5' ' ' ILE . 35.8 mm -69.81 130.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.96 -0.564 . . . . 74.120000000000005 110.526 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.551 HD11 ' HG2' ' A' ' 120' ' ' LYS . 16.3 mt . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 109.596 -0.52 . . . . 74.420000000000002 109.596 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.769 0.318 . . . . 70.430000000000007 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 HG22 HD11 ' A' ' 65' ' ' ILE . 37.7 mm -83.5 138.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 110.284 -0.265 . . . . 74.140000000000001 110.284 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -85.21 130.9 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 61.439999999999998 109.755 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -108.97 13.66 24.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 75.430000000000007 110.725 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -71.25 -10.0 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.627 -0.715 . . . . 71.420000000000002 111.192 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.88 9.11 21.37 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 52.43 112.163 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -89.39 159.34 17.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.701 0.286 . . . . 74.129999999999995 110.541 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.482 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 9.2 pt-20 -142.42 161.88 36.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.857 0.36 . . . . 70.239999999999995 110.147 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.0 117.89 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 73.140000000000001 110.185 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.53 -43.88 18.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 73.319999999999993 110.681 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -148.85 141.7 24.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 110.204 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -141.93 142.69 33.03 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.018 -0.734 . . . . 73.310000000000002 109.018 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -85.53 -29.32 24.3 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.83 -0.348 . . . . 75.430000000000007 110.996 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 t -154.49 149.29 26.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 70.140000000000001 111.0 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -168.06 140.28 3.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.904 -0.776 . . . . 61.450000000000003 108.904 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.27 116.92 31.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.015 0.436 . . . . 73.230000000000004 110.573 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.11 -16.37 12.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.01 -0.541 . . . . 75.140000000000001 111.251 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 m -113.4 -40.0 3.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.368 -0.378 . . . . 71.129999999999995 111.169 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 CA-C-N 116.083 -0.508 . . . . 43.520000000000003 112.835 -178.95 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.274 -0.269 . . . . 73.329999999999998 110.274 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.87 -1.75 38.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.015 -0.612 . . . . 43.219999999999999 111.706 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 62.5 mt -80.46 156.77 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 73.519999999999996 110.641 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.93 -31.05 71.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.484 -0.326 . . . . 73.430000000000007 111.252 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -76.09 -16.44 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.479 -0.328 . . . . 72.310000000000002 111.751 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 60.8 m -71.38 -23.65 61.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 74.430000000000007 109.831 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 35.4 tp -72.82 -8.99 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.579 -0.737 . . . . 73.310000000000002 110.701 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -130.56 25.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 73.420000000000002 110.406 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.17 -46.94 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.514 -0.312 . . . . 74.409999999999997 111.627 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.32 6.99 25.13 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.485 -0.864 . . . . 73.409999999999997 112.167 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 39' ' ' GLU . 32.8 t70 -117.48 120.84 39.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.912 -0.403 . . . . 75.549999999999997 109.912 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 p -72.99 -8.79 57.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.507 0.558 . . . . 73.510000000000005 112.507 -173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 47.4 mt-10 -85.21 -26.79 26.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 73.439999999999998 110.292 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -96.84 137.29 36.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.978 -0.556 . . . . 74.430000000000007 109.879 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 23.2 p90 -139.17 175.69 9.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.832 0.348 . . . . 63.030000000000001 110.908 -174.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 45.9 t90 -105.44 134.31 48.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 74.200000000000003 109.597 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -132.37 143.81 50.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.211 -0.663 . . . . 74.0 109.211 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.03 148.57 49.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.545 -0.298 . . . . 74.310000000000002 110.236 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 50' ' ' SER . 78.2 tttt -66.4 116.36 7.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.093 -0.503 . . . . 74.549999999999997 110.018 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -123.13 -27.2 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.887 -0.325 . . . . 74.230000000000004 111.264 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -78.57 107.54 11.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.034 0.445 . . . . 71.549999999999997 110.032 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.14 2.19 51.43 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 52.240000000000002 111.976 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.17 146.15 8.86 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.831 -0.7 . . . . 63.450000000000003 111.937 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.581 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 12.1 p -89.63 151.87 21.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 64.340000000000003 110.889 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.07 158.92 69.36 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 110.978 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.29 153.01 61.8 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.766 2.311 . . . . 63.409999999999997 112.924 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.52 158.04 41.2 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 72.430000000000007 110.132 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.03 167.56 64.85 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.567 -1.43 . . . . 70.409999999999997 112.767 2.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.638 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 26.4 m-85 -101.67 108.98 20.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.075 -0.512 . . . . 73.329999999999998 110.275 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.22 126.62 53.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 73.340000000000003 110.436 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.544 HD11 HD21 ' A' ' 126' ' ' LEU . 55.4 mt -120.31 117.75 54.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 62.229999999999997 109.78 176.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.82 114.55 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.268 -0.423 . . . . 63.439999999999998 110.592 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.4 134.91 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.089 -0.505 . . . . 74.049999999999997 110.091 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -99.17 120.22 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.181 -0.463 . . . . 65.340000000000003 109.755 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.6 mtm -86.84 -5.68 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.596 . . . . 70.5 110.9 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.9 mmtt 68.45 5.96 5.1 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.312 0.856 . . . . 72.540000000000006 113.312 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.35 174.22 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.706 0.289 . . . . 64.239999999999995 111.122 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.8 121.7 27.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 72.040000000000006 110.198 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 5' ' ' ILE . 61.6 mt -132.33 134.52 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 120.995 0.426 . . . . 74.010000000000005 110.517 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HB2' HD12 ' A' ' 150' ' ' ILE . 55.9 tp60 -84.28 105.13 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.608 -0.724 . . . . 75.349999999999994 109.296 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.2 mm -74.35 117.27 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 73.219999999999999 110.427 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.53 -47.99 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.282 -0.417 . . . . 75.430000000000007 110.995 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.578 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 6.1 tt0 -141.79 152.77 44.03 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.84 -0.344 . . . . 64.310000000000002 110.605 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.38 123.07 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.772 -0.649 . . . . 63.119999999999997 109.517 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -103.75 122.71 45.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.968 -0.56 . . . . 74.530000000000001 110.642 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 114' ' ' TYR . 55.2 mt -113.58 123.39 49.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 74.209999999999994 110.337 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.9 tp -102.25 101.16 17.85 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.381 -0.6 . . . . 74.450000000000003 109.381 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.464 -0.227 0 C-N-CA 123.214 2.609 . . . . 74.019999999999996 112.905 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 83' ' ' ILE . 6.6 m-20 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 112.338 0.496 . . . . 74.540000000000006 112.338 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.572 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 5.2 Cg_exo -75.39 36.96 0.47 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.299 2.666 . . . . 75.219999999999999 111.936 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 81' ' ' ASN . 35.8 mt -96.65 125.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.651 . . . . 73.299999999999997 109.553 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.89 -54.0 2.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 74.420000000000002 110.765 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.19 137.3 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.562 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.42 134.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 74.030000000000001 110.261 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.7 mt-10 -116.63 132.51 56.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.022 -0.536 . . . . 72.549999999999997 110.596 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -112.08 129.74 56.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.673 -0.694 . . . . 74.25 109.944 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.28 153.62 42.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.702 -0.227 . . . . 75.219999999999999 110.435 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.82 43.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.377 -0.374 . . . . 71.510000000000005 110.369 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 146.35 27.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 71.340000000000003 110.607 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.86 -42.26 34.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.89 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.06 9.52 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.004 0.372 . . . . 74.230000000000004 112.004 -173.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.6 t30 64.96 30.06 12.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.784 0.802 . . . . 74.420000000000002 110.261 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.78 -52.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.434 -0.803 . . . . 73.340000000000003 109.456 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -103.04 107.13 17.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.25 -0.648 . . . . 61.409999999999997 109.25 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -94.36 130.65 40.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.154 0.502 . . . . 72.109999999999999 111.116 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 m -122.29 122.63 27.41 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.803 -0.635 . . . . 74.420000000000002 110.36 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.81 128.9 27.05 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.515 2.144 . . . . 72.430000000000007 111.129 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.56 -10.94 8.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.985 -0.286 . . . . 75.340000000000003 110.8 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 153.21 7.53 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.095 -1.05 . . . . 54.420000000000002 113.599 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.2 ttt180 -130.77 115.05 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.832 -0.803 . . . . 74.430000000000007 108.832 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.43 -177.82 4.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.689 0.281 . . . . 73.439999999999998 110.828 -174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.96 14.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.957 -0.639 . . . . 65.519999999999996 112.024 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.409 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 49.8 t80 -93.27 114.6 27.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 73.120000000000005 110.069 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -99.17 106.98 19.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 110.025 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -68.17 111.7 4.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.147 0.499 . . . . 74.230000000000004 110.638 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.27 -176.26 5.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.399 -0.819 . . . . 71.409999999999997 108.922 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.74 -10.48 19.91 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.617 -0.433 . . . . 75.540000000000006 110.545 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.48 20.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 61.100000000000001 110.389 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.1 133.0 45.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 62.420000000000002 111.588 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.3 mt -89.65 122.84 33.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.266 -0.879 . . . . 73.530000000000001 110.213 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.578 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 33.0 mt-10 -98.05 108.36 21.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.266 -0.425 . . . . 75.340000000000003 110.591 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.468 ' CE2' HD11 ' A' ' 72' ' ' LEU . 91.2 m-85 -101.85 104.57 15.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.116 -0.493 . . . . 71.120000000000005 110.993 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.64 93.32 2.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.672 -0.694 . . . . 75.25 110.055 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.14 178.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.854 -0.612 . . . . 62.100000000000001 111.913 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.684 ' HB3' ' HZ3' ' A' ' 117' ' ' LYS . 5.3 ttpm? -75.4 112.8 12.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.205 -0.907 . . . . 74.120000000000005 110.094 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 20.0 p -56.72 120.53 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 111.222 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.8 tt -160.57 148.9 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.454 -0.339 . . . . 74.519999999999996 110.238 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.491 ' HG3' HD11 ' A' ' 150' ' ' ILE . 39.6 ttpt -89.86 135.76 33.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 75.140000000000001 110.169 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.86 175.15 13.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.557 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -121.74 -34.49 3.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 74.109999999999999 110.02 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -108.92 145.4 35.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.238 -0.653 . . . . 75.430000000000007 109.238 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.6 tt -131.71 139.23 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.986 -0.375 . . . . 75.120000000000005 109.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 60.7 ttp180 -124.31 118.2 26.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.966 0.412 . . . . 75.329999999999998 111.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 57' ' ' ILE . 43.4 tp -85.61 114.58 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.903 -0.777 . . . . 64.329999999999998 108.903 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -112.1 117.66 33.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.299 0.571 . . . . 65.310000000000002 111.347 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.638 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.1 mm -100.2 98.15 7.27 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.456 -0.793 . . . . 75.409999999999997 108.948 172.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.03 168.86 20.69 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.457 2.105 . . . . 54.439999999999998 112.305 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 7.73 45.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 65.329999999999998 109.881 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.48 138.26 48.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 70.540000000000006 110.157 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.05 -10.84 24.79 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.988 -0.625 . . . . 53.149999999999999 111.699 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 109.1 18.88 8.88 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.051 -0.595 . . . . 72.409999999999997 112.386 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -76.73 135.64 39.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 74.319999999999993 110.759 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 45.9 m -106.88 -173.94 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 74.530000000000001 110.281 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 14.4 p -84.55 2.3 41.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 71.409999999999997 112.131 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.572 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 48.7 t -105.57 124.53 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.452 -0.34 . . . . 62.219999999999999 110.386 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.21 140.93 29.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.22 -0.445 . . . . 75.310000000000002 110.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.6 113.68 4.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.939 0.4 . . . . 74.349999999999994 111.06 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 19.3 mt -126.18 132.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.073 -0.714 . . . . 75.540000000000006 109.073 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 97.4 mtt180 -65.58 -61.83 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 73.219999999999999 110.481 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.74 138.92 23.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.24 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.02 116.41 29.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.323 -0.621 . . . . 74.010000000000005 109.323 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -114.62 150.57 34.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.993 0.425 . . . . 70.140000000000001 110.149 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.37 124.03 72.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.183 -0.673 . . . . 61.509999999999998 109.183 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.33 102.87 12.33 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.366 0.603 . . . . 74.430000000000007 109.86 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.87 -156.9 7.34 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.405 -0.816 . . . . 75.140000000000001 111.574 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.1 m -119.1 131.85 55.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.705 0.288 . . . . 62.030000000000001 110.936 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.483 HD12 HG23 ' A' ' 5' ' ' ILE . 37.5 mm -74.56 123.01 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.097 -0.501 . . . . 75.25 110.29 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 66' ' ' GLN . 51.1 mt . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.683 -0.488 . . . . 74.230000000000004 109.683 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.787 HG21 ' HG2' ' A' ' 146' ' ' LYS . 46.3 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.978 -0.379 . . . . 62.32 109.978 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.555 HG23 HD11 ' A' ' 149' ' ' ILE . 38.9 mm -74.78 138.71 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 111.189 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 122.82 17.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.312 -0.625 . . . . 62.329999999999998 109.312 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -101.64 6.45 42.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.679 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -72.54 84.45 1.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 71.430000000000007 110.239 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.81 -9.76 2.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.635 -0.711 . . . . 73.219999999999999 112.38 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -70.49 155.81 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 73.319999999999993 110.461 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.5 pt-20 -138.96 155.87 47.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.079 0.466 . . . . 75.219999999999999 110.015 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.55 113.48 31.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.821 -0.627 . . . . 74.140000000000001 110.005 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' HB2' ' A' ' 60' ' ' ASP . 93.2 mt -79.67 -36.46 37.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.83 -0.623 . . . . 74.299999999999997 110.591 -177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.3 t -147.91 141.24 25.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 72.329999999999998 110.721 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.466 ' HE2' ' HG2' ' A' ' 18' ' ' GLN . 35.4 p90 -155.72 136.11 13.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.765 -0.652 . . . . 75.329999999999998 109.633 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -85.25 -44.91 12.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.204 -0.453 . . . . 62.420000000000002 111.786 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -134.34 147.51 50.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.022 0.439 . . . . 72.530000000000001 111.001 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.466 ' HG2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -161.57 148.47 14.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.732 -0.667 . . . . 74.230000000000004 109.407 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.67 112.22 20.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.897 -0.409 . . . . 63.420000000000002 109.897 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.65 1.31 17.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.652 0.612 . . . . 71.430000000000007 112.652 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -143.83 -29.79 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.384 -0.526 . . . . 63.310000000000002 112.331 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.218 0 C-N-CA 120.93 -0.652 . . . . 64.200000000000003 112.866 -179.291 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.3 t30 . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.112 -0.329 . . . . 74.219999999999999 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.0 2.49 20.34 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.298 -0.721 . . . . 64.219999999999999 111.298 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.7 mt -74.67 150.74 39.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.532 -0.334 . . . . 73.340000000000003 110.74 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.99 -23.21 67.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.09 0.471 . . . . 71.420000000000002 111.214 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 -17.28 57.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 74.230000000000004 111.341 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.621 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 63.4 m -73.55 -17.61 61.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.176 0.512 . . . . 72.209999999999994 110.046 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -71.97 -14.36 61.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.37 -0.832 . . . . 74.109999999999999 110.7 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -130.66 21.59 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 74.420000000000002 109.911 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.621 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 18.1 t70 -72.39 -45.68 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.646 -0.707 . . . . 74.439999999999998 111.167 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.68 -1.47 21.71 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.478 -0.868 . . . . 61.32 112.655 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -131.16 118.36 20.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.126 -0.324 . . . . 70.230000000000004 110.126 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 p -72.22 2.07 6.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.953 -0.567 . . . . 70.049999999999997 111.683 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.24 -35.78 80.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.631 -0.877 . . . . 75.129999999999995 108.631 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.1 p -95.42 165.73 12.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.834 -1.076 . . . . 70.049999999999997 110.141 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 32.6 p90 -155.63 167.84 29.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.491 -0.322 . . . . 74.409999999999997 110.674 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.54 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.9 t90 -101.22 133.23 46.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.268 -0.642 . . . . 72.439999999999998 109.268 172.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.62 144.19 49.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.332 -0.618 . . . . 75.209999999999994 109.332 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.16 146.93 52.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.282 -0.417 . . . . 74.549999999999997 110.435 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 50' ' ' SER . 82.8 tttt -63.12 116.61 5.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.978 -0.556 . . . . 72.209999999999994 110.197 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -120.4 -27.93 5.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.523 -0.471 . . . . 75.299999999999997 110.663 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.88 110.72 11.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 73.530000000000001 110.2 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 10.11 59.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.804 -0.712 . . . . 54.350000000000001 112.06 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.08 154.6 16.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.841 -0.695 . . . . 74.010000000000005 112.156 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 52.0 m -102.86 159.61 15.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 55.020000000000003 111.286 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.75 156.6 52.75 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.846 -0.615 . . . . 73.450000000000003 110.35 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.68 153.56 43.53 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.534 2.156 . . . . 74.420000000000002 113.194 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 130' ' ' ASP . 11.9 mt -92.16 159.79 36.76 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 75.120000000000005 110.118 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.795 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 77.5 Cg_endo -80.52 162.45 82.71 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.578 -1.426 . . . . 74.319999999999993 112.875 -1.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 28.6 m-85 -93.98 132.31 38.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 73.019999999999996 111.199 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 3.4 t70 -111.49 125.45 53.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 75.409999999999997 110.219 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 59' ' ' ILE . 52.5 mt -131.43 111.26 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 109.909 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.37 122.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.062 -0.517 . . . . 74.129999999999995 110.562 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 57' ' ' ILE . 4.9 mp -116.25 136.13 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.638 -0.255 . . . . 75.140000000000001 110.694 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HB2' HD13 ' A' ' 13' ' ' LEU . 57.3 t0 -99.12 119.73 38.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.721 -0.844 . . . . 75.140000000000001 108.721 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.6 mtm -85.6 -5.62 59.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.356 -0.384 . . . . 73.099999999999994 111.111 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 66.27 12.02 8.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 112.026 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -165.88 147.56 7.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 63.420000000000002 109.746 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.7 128.43 35.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.899 -0.592 . . . . 73.239999999999995 110.042 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.551 ' CD1' HG22 ' A' ' 5' ' ' ILE . 71.7 mt -132.38 139.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 110.258 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 118' ' ' SER . 55.8 tp60 -83.37 102.95 12.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.869 -0.789 . . . . 70.319999999999993 108.869 176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -72.28 129.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.376 . . . . 74.349999999999994 110.833 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.89 -32.85 3.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 72.409999999999997 111.079 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -163.29 147.68 11.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.881 -0.599 . . . . 74.129999999999995 111.177 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.2 t -119.84 133.87 65.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.162 -0.472 . . . . 74.510000000000005 109.871 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.678 ' HG3' ' HD2' ' A' ' 146' ' ' LYS . 26.0 mt-10 -110.76 127.61 55.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.126 0.489 . . . . 73.219999999999999 110.602 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.96 121.3 43.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.664 -0.698 . . . . 63.329999999999998 109.622 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.7 tp -111.13 95.88 27.42 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.325 -0.398 . . . . 72.150000000000006 109.963 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 65.0 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 C-N-CA 122.458 2.105 . . . . 71.430000000000007 111.657 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.778 ' HB3' HD21 ' A' ' 107' ' ' ASN . 21.2 t-20 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.884 0.374 . . . . 74.120000000000005 110.319 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.03 27.4 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.181 2.588 . . . . 74.319999999999993 112.659 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.68 121.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.496 . . . . 73.129999999999995 110.457 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -105.89 -37.24 6.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.623 -0.717 . . . . 75.010000000000005 111.197 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG22 ' HA3' ' A' ' 132' ' ' GLY . 91.1 t -134.53 138.48 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.569 0.223 . . . . 72.200000000000003 111.097 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 m -132.13 139.73 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 73.230000000000004 110.418 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.56 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 67.9 mt-10 -121.06 134.53 55.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.394 -0.366 . . . . 74.310000000000002 110.791 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -116.22 131.03 57.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 73.040000000000006 110.8 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.75 153.33 49.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 110.369 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.16 155.53 46.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.243 -0.435 . . . . 75.319999999999993 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.4 t -150.02 147.33 27.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.063 0.459 . . . . 74.120000000000005 110.781 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.17 -33.74 16.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 74.319999999999993 110.841 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -122.97 -2.69 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.893 0.331 . . . . 75.140000000000001 111.893 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 63.85 34.62 11.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.657 0.741 . . . . 72.150000000000006 109.587 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.2 t -110.39 -54.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.859 -0.609 . . . . 75.329999999999998 109.366 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.65 135.15 54.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.669 -0.863 . . . . 72.340000000000003 108.669 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -105.83 119.22 38.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.364 0.602 . . . . 75.010000000000005 110.687 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.2 m -95.29 125.03 51.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.233 -0.894 . . . . 72.340000000000003 110.875 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.0 111.98 3.3 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.627 2.218 . . . . 72.129999999999995 111.76 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.591 HD13 HG22 ' A' ' 116' ' ' VAL . 21.2 pt -86.24 -18.87 8.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 73.430000000000007 110.948 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.88 139.96 2.78 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.288 -0.958 . . . . 72.450000000000003 113.074 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 30.2 ttt180 -119.59 126.55 51.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.401 -0.592 . . . . 72.409999999999997 109.401 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.36 -175.91 4.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 74.430000000000007 110.84 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.96 143.97 16.42 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.839 -0.696 . . . . 55.149999999999999 111.788 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.529 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 33.4 t80 -91.19 136.38 33.13 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.744 -0.465 . . . . 74.219999999999999 109.744 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.515 ' HB ' HD22 ' A' ' 112' ' ' LEU . 27.1 m -112.78 123.22 49.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.519 -0.31 . . . . 74.140000000000001 110.763 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.778 HD21 ' HB3' ' A' ' 81' ' ' ASN . 24.9 t-20 -67.05 93.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.035 0.445 . . . . 72.219999999999999 109.852 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -144.54 169.27 18.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.895 -0.593 . . . . 75.439999999999998 109.417 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -104.9 18.59 22.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.538 0.685 . . . . 71.329999999999998 110.196 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.54 153.57 31.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.446 -0.797 . . . . 53.229999999999997 109.74 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.54 124.47 22.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.067 0.461 . . . . 70.430000000000007 111.262 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.515 HD22 ' HB ' ' A' ' 106' ' ' THR . 75.0 mt -80.74 117.79 21.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 74.420000000000002 110.439 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -95.86 119.81 35.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.266 -0.424 . . . . 73.530000000000001 110.392 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.57 105.17 13.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 109.905 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -82.59 90.77 6.84 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.282 -0.636 . . . . 73.340000000000003 109.282 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.591 HG22 HD13 ' A' ' 100' ' ' ILE . 30.5 m -86.86 179.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.323 -0.853 . . . . 74.25 110.581 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 100' ' ' ILE . 47.8 pttt -81.44 148.2 29.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.078 0.466 . . . . 72.329999999999998 110.226 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 37.4 p -79.01 127.62 32.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.747 -0.66 . . . . 73.120000000000005 111.511 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.8 tt -161.49 150.57 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.635 -0.711 . . . . 71.319999999999993 109.388 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HG3' HD11 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -79.38 140.69 37.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.157 -0.683 . . . . 73.329999999999998 109.157 177.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.75 144.19 17.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.569 0.223 . . . . 65.420000000000002 110.848 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.76 -22.61 13.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.804 -0.813 . . . . 75.25 108.804 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -115.65 145.42 42.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.846 . . . . 75.319999999999993 109.673 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.0 tt -136.34 141.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.957 -0.386 . . . . 74.400000000000006 109.957 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.552 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 59.9 ttp180 -126.78 125.71 42.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.033 0.444 . . . . 75.219999999999999 111.435 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 57' ' ' ILE . 57.9 tp -95.62 124.32 39.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.554 -0.748 . . . . 71.409999999999997 109.045 172.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 76.4 m -119.47 123.16 43.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.991 0.424 . . . . 72.209999999999994 110.663 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.0 mm -105.56 94.01 7.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.354 -0.61 . . . . 73.040000000000006 109.354 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.795 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 68.0 Cg_endo -87.76 136.94 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.033 2.489 . . . . 75.010000000000005 113.006 -175.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HB2' HD11 ' A' ' 53' ' ' LEU . 25.3 t0 -81.48 66.36 7.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.433 -0.951 . . . . 74.310000000000002 108.433 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -124.93 -12.54 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.835 -1.075 . . . . 74.340000000000003 111.703 -173.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.472 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . -139.83 22.62 2.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.659 -1.258 . . . . 63.119999999999997 114.001 -173.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.8 26.06 7.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.162 -1.018 . . . . 55.450000000000003 112.611 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -82.11 178.45 8.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.887 0.375 . . . . 75.439999999999998 110.827 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 m -146.79 178.96 7.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.882 -0.414 . . . . 64.549999999999997 109.882 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 p -84.68 16.08 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 73.319999999999993 111.667 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.8 127.92 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.52 . . . . 72.040000000000006 109.879 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.95 143.45 30.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.313 -0.403 . . . . 75.120000000000005 110.18 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.16 106.09 3.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.836 0.35 . . . . 73.219999999999999 111.33 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 9.3 mt -126.23 140.5 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.73 -0.841 . . . . 70.209999999999994 108.73 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.502 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 69.6 mtt180 -75.91 -63.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.025 0.44 . . . . 72.329999999999998 110.159 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.97 133.52 22.02 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.666 -0.697 . . . . 73.0 110.863 -170.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 143' ' ' LEU . 9.2 tt -107.47 120.63 42.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 72.530000000000001 109.418 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.88 124.26 44.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 74.430000000000007 110.562 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.21 142.07 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 74.25 109.867 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.787 ' HG2' HG21 ' A' ' 4' ' ' THR . 26.6 mtpt -119.16 124.27 46.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.438 . . . . 73.319999999999993 109.816 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.56 -166.83 32.44 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.649 -0.786 . . . . 64.140000000000001 112.152 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.8 m -107.3 130.15 54.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.573 0.225 . . . . 62.039999999999999 110.592 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.555 HD11 HG23 ' A' ' 5' ' ' ILE . 40.7 mm -72.0 125.05 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.411 . . . . 75.239999999999995 110.938 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.497 HD11 ' HG3' ' A' ' 120' ' ' LYS . 44.6 mt . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 109.169 -0.678 . . . . 70.439999999999998 109.169 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.458 HG21 ' HG3' ' A' ' 146' ' ' LYS . 22.6 p . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 110.304 -0.258 . . . . 72.409999999999997 110.304 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG23 HD12 ' A' ' 65' ' ' ILE . 44.1 mm -63.79 147.76 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 73.040000000000006 111.213 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -72.95 112.79 9.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.575 -0.528 . . . . 72.219999999999999 109.575 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -89.56 -8.54 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.433 . . . . 74.540000000000006 111.057 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -73.17 97.67 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.742 0.782 . . . . 75.010000000000005 109.31 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.12 -11.91 4.14 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.627 -1.17 . . . . 65.129999999999995 111.25 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.515 ' HE3' HG23 ' A' ' 59' ' ' ILE . 30.6 m0 -74.98 161.29 29.61 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.58 -0.526 . . . . 71.120000000000005 109.58 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.482 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 8.9 pt-20 -138.57 158.69 43.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.34 -0.544 . . . . 74.049999999999997 110.585 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.97 119.54 45.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 64.129999999999995 109.709 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.58 -39.0 28.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.014 0.435 . . . . 75.010000000000005 110.448 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.6 t -157.04 141.1 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 74.349999999999994 109.703 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 18' ' ' GLN . 51.7 p90 -136.02 146.2 46.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.002 -0.545 . . . . 75.519999999999996 109.532 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -86.27 -40.98 14.98 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.797 -0.361 . . . . 74.430000000000007 110.737 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 5.9 t -147.81 148.17 30.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.153 0.501 . . . . 75.209999999999994 111.111 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.54 HE22 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.87 145.1 1.85 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.249 -0.887 . . . . 64.510000000000005 108.947 172.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 9.5 tp10 -105.44 102.31 11.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.198 -0.456 . . . . 63.119999999999997 110.67 -173.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HB3' HE22 ' A' ' 18' ' ' GLN . . . -100.43 -30.14 12.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 72.120000000000005 110.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -83.21 -33.69 26.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 71.239999999999995 110.556 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.402 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 120.771 -0.728 . . . . 74.439999999999998 113.129 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 t30 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.274 -0.269 . . . . 75.030000000000001 110.274 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.86 -4.52 60.98 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.403 -0.427 . . . . 71.019999999999996 112.757 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.9 mt -73.79 144.69 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.004 -0.369 . . . . 75.120000000000005 110.004 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.47 -22.83 64.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.573 0.701 . . . . 63.140000000000001 110.064 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.657 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 13.9 ptmt -74.97 -23.44 58.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.999 -1.0 . . . . 73.439999999999998 111.335 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 79.1 m -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.949 0.404 . . . . 74.340000000000003 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -67.15 -15.02 63.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 110.581 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 59' ' ' ILE . 27.5 pt -133.69 26.5 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 75.120000000000005 110.827 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.29 -46.63 19.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.052 0.453 . . . . 72.310000000000002 111.305 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.12 6.03 7.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.53 -0.843 . . . . 75.209999999999994 112.672 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.632 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 7.4 t70 -125.35 127.29 46.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.185 0.492 . . . . 63.200000000000003 110.518 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 p -76.34 -5.55 47.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.956 0.724 . . . . 73.439999999999998 112.956 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.632 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 7.9 pt-20 -91.42 -21.34 21.01 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.111 -0.636 . . . . 73.219999999999999 110.46 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -90.94 136.76 32.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.258 -0.645 . . . . 75.010000000000005 109.258 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.711 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 51.2 p90 -137.76 170.73 15.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.438 0.637 . . . . 75.530000000000001 112.412 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.457 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 30.3 t90 -106.43 139.81 40.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.629 -1.169 . . . . 75.420000000000002 109.375 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -135.52 139.18 43.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.323 -0.621 . . . . 72.129999999999995 109.323 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 146.33 53.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.433 . . . . 62.439999999999998 110.113 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 35.1 ttpt -65.61 131.13 45.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.381 -0.372 . . . . 74.530000000000001 110.164 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.423 ' NE1' ' HG2' ' A' ' 19' ' ' GLU . 64.5 p-90 -130.32 -33.89 1.66 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 73.430000000000007 111.517 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.402 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 7.6 tt0 -67.71 -41.64 83.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 75.310000000000002 110.767 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.85 26.17 25.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.532 -0.842 . . . . 71.349999999999994 111.448 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.27 165.47 40.35 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.1 -0.8 . . . . 73.299999999999997 111.1 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 38.3 m -100.82 145.72 28.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 117.189 0.495 . . . . 70.140000000000001 110.452 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 18.3 m-20 -79.11 161.37 68.43 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 110.621 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 60.1 Cg_endo -73.37 132.78 18.19 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.405 2.07 . . . . 72.430000000000007 112.734 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.11 158.27 88.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.822 -0.626 . . . . 72.25 110.198 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.704 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.7 Cg_exo -76.3 159.98 95.96 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.002 -1.249 . . . . 74.420000000000002 112.692 0.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.714 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.0 m-85 -95.74 101.75 13.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 74.219999999999999 110.13 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.516 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 7.2 m-20 -98.71 117.96 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.059 -0.518 . . . . 75.120000000000005 110.51 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 52.7 mt -111.71 116.79 53.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.266 -0.425 . . . . 75.230000000000004 109.922 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.78 115.44 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.515 HG23 ' HE3' ' A' ' 10' ' ' TRP . 5.0 mp -111.08 136.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 74.450000000000003 110.576 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -104.06 119.54 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.401 -0.592 . . . . 62.420000000000002 109.401 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 73.430000000000007 110.895 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 31.2 mmtp 72.0 -11.67 0.75 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.514 0.726 . . . . 70.450000000000003 112.643 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -145.13 170.5 16.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.617 0.246 . . . . 70.25 110.58 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 64' ' ' ASN . 2.2 m120 -85.95 124.36 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 64.319999999999993 110.74 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.559 HD12 HG23 ' A' ' 5' ' ' ILE . 78.1 mt -130.17 136.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 72.230000000000004 110.065 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.9 tp60 -80.02 100.71 8.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.099 -0.704 . . . . 71.25 109.099 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 118' ' ' SER . 31.7 mm -69.36 118.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.909 -0.404 . . . . 71.430000000000007 109.909 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.6 -39.38 5.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.233 0.539 . . . . 72.109999999999999 110.914 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.684 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 51.3 tt0 -159.24 148.68 18.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.611 -0.722 . . . . 75.310000000000002 110.563 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.16 115.85 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.369 . . . . 72.010000000000005 110.817 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.578 ' OE2' ' HA ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -97.79 128.1 44.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.707 -0.679 . . . . 75.299999999999997 110.689 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.527 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 45.9 mt -109.34 118.17 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.463 -0.569 . . . . 65.099999999999994 109.463 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -103.74 99.07 14.58 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.588 -0.523 . . . . 73.129999999999995 109.588 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 5.4 Cg_exo . . . . . 0 N--CA 1.456 -0.704 0 C-N-CA 122.869 2.379 . . . . 74.239999999999995 111.795 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.698 0.285 . . . . 74.540000000000006 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 2.3 Cg_endo -82.95 32.12 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.35 2.7 . . . . 73.109999999999999 111.73 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.43 118.86 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.818 -0.628 . . . . 74.25 110.186 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -100.57 -50.12 3.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.675 . . . . 74.299999999999997 110.904 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.434 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 60.9 t -127.36 141.68 45.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.042 -0.526 . . . . 71.129999999999995 110.599 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.36 129.82 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 109.743 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.406 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.6 mt-10 -109.79 125.41 52.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.132 -0.486 . . . . 71.409999999999997 110.493 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -107.68 129.66 55.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.081 -0.509 . . . . 74.299999999999997 110.426 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.58 145.33 49.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.279 -0.418 . . . . 63.409999999999997 110.76 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.02 48.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.027 -0.533 . . . . 75.129999999999995 109.846 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t -149.86 154.62 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.345 0.593 . . . . 72.329999999999998 111.344 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.64 -32.79 9.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.432 -0.804 . . . . 71.310000000000002 109.985 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 26.8 t0 -106.81 -12.32 15.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 74.409999999999997 111.252 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 15.8 t-20 76.25 -21.5 0.31 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.413 0.625 . . . . 75.209999999999994 111.114 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 93' ' ' ASP . 78.3 t -75.72 -50.96 21.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 110.319 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.1 113.41 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.225 -0.898 . . . . 63.310000000000002 109.913 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -94.08 142.19 27.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.014 -0.539 . . . . 73.530000000000001 110.946 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.4 m -115.1 124.55 30.09 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.786 -0.643 . . . . 73.230000000000004 109.967 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.52 116.17 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.567 2.178 . . . . 74.349999999999994 112.143 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.527 HD11 HG22 ' A' ' 116' ' ' VAL . 15.7 pt -86.78 -13.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.395 -0.366 . . . . 74.049999999999997 110.571 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.69 130.76 1.15 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.333 -0.937 . . . . 43.420000000000002 113.177 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 38.4 ttt180 -106.71 114.56 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.713 -0.847 . . . . 73.530000000000001 108.713 171.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.55 ' HE2' HG13 ' A' ' 116' ' ' VAL . 96.4 m-85 -125.79 172.3 9.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.404 -0.362 . . . . 74.0 110.682 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.53 151.3 22.41 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.027 -0.829 . . . . 53.409999999999997 111.027 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -100.86 131.96 46.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.96 -0.385 . . . . 65.150000000000006 109.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.506 ' HB ' HD23 ' A' ' 112' ' ' LEU . 21.1 m -105.8 124.74 50.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 110.433 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -70.69 94.87 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.095 0.474 . . . . 73.310000000000002 110.312 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -146.09 176.84 9.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.988 -0.745 . . . . 71.219999999999999 108.988 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.46 -7.81 17.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.033 0.444 . . . . 73.200000000000003 110.983 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.72 159.26 16.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 71.519999999999996 110.47 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.27 130.0 41.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 73.129999999999995 111.616 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' A' ' 106' ' ' THR . 36.0 mt -87.28 116.38 25.33 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 74.510000000000005 110.33 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.578 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 40.9 mt-10 -83.16 121.14 26.68 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.283 0.364 . . . . 62.219999999999999 110.846 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.484 ' HE2' HD11 ' A' ' 72' ' ' LEU . 49.9 m-85 -122.29 104.96 9.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 74.120000000000005 110.711 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.36 97.0 5.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.592 -0.731 . . . . 74.109999999999999 109.414 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.55 HG13 ' HE2' ' A' ' 103' ' ' PHE . 27.1 m -98.13 -178.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.443 -0.798 . . . . 75.420000000000002 111.792 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 45.8 tttp -61.04 125.69 24.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 71.450000000000003 111.088 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 9.6 p -73.05 120.02 18.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 75.239999999999995 110.029 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.413 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 10.6 tt -150.9 141.01 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.972 0.415 . . . . 74.420000000000002 111.406 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -82.9 115.02 21.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.277 -0.638 . . . . 74.010000000000005 109.277 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.8 175.0 10.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.292 . . . . 75.230000000000004 110.983 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -121.04 -32.5 3.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.6 . . . . 74.430000000000007 110.015 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.97 145.98 33.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 73.310000000000002 110.298 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.448 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -134.17 136.68 53.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.134 -0.484 . . . . 65.25 109.953 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.1 ttp180 -123.86 122.2 37.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.993 0.425 . . . . 74.019999999999996 111.095 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 tp -93.79 111.45 23.15 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.974 -0.75 . . . . 75.219999999999999 108.974 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 61.0 m -105.91 120.59 42.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.071 0.462 . . . . 75.019999999999996 111.061 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -98.31 96.23 3.5 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.566 -0.901 . . . . 75.450000000000003 108.566 171.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.704 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -68.71 171.72 12.79 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.68 2.254 . . . . 70.349999999999994 113.057 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.34 -2.43 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.251 1.024 . . . . 74.019999999999996 108.407 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.45 -31.84 65.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.138 -1.392 . . . . 74.040000000000006 112.439 -170.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -94.2 0.11 66.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.187 -1.006 . . . . 74.299999999999997 113.621 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.88 20.71 11.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.108 -1.044 . . . . 74.239999999999995 111.668 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -72.55 142.6 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.45 . . . . 72.340000000000003 111.031 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 17.4 m -100.06 172.24 7.32 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.924 -0.58 . . . . 60.310000000000002 109.867 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 16.2 p -83.19 22.05 1.03 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 62.509999999999998 112.128 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.23 129.42 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.506 -0.553 . . . . 65.219999999999999 109.506 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.17 135.11 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.507 -0.315 . . . . 71.109999999999999 110.939 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -134.47 106.04 6.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 75.519999999999996 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mt -124.07 133.64 68.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.426 -0.583 . . . . 72.109999999999999 109.426 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 72.3 mtt180 -66.03 -71.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.274 0.359 . . . . 74.409999999999997 110.27 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.7 153.73 44.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.431 0.634 . . . . 73.230000000000004 111.705 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 tt -106.68 111.31 23.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.541 -1.281 . . . . 73.140000000000001 107.541 168.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -112.11 123.34 50.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.766 -0.457 . . . . 71.120000000000005 109.766 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.05 128.35 52.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.916 0.389 . . . . 64.209999999999994 111.978 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.684 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 54.1 mtpt -94.51 130.6 40.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.377 -0.601 . . . . 63.039999999999999 109.377 171.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.15 -167.35 35.42 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.186 -1.007 . . . . 44.299999999999997 112.265 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.2 m -123.06 129.49 51.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.479 0.18 . . . . 75.329999999999998 110.548 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.53 HD11 HG21 ' A' ' 5' ' ' ILE . 41.6 mm -69.36 116.36 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.163 -0.471 . . . . 73.450000000000003 109.981 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 66' ' ' GLN . 62.0 mt . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 120.974 0.416 . . . . 72.099999999999994 109.97 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.613 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 35.3 p . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.68 0.276 . . . . 75.420000000000002 110.446 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.8 HG21 HD13 ' A' ' 149' ' ' ILE . 47.5 mm -88.65 134.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.837 0.351 . . . . 71.129999999999995 111.317 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -66.64 118.35 10.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.12 -0.491 . . . . 64.340000000000003 110.07 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -98.47 19.61 14.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.505 . . . . 72.319999999999993 111.217 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.5 m -58.7 -42.18 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.498 0.555 . . . . 73.109999999999999 112.498 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.13 8.05 62.69 Favored Glycine 0 C--O 1.235 0.186 0 C-N-CA 120.541 -0.838 . . . . 41.009999999999998 112.946 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -75.39 138.38 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.29 . . . . 74.409999999999997 110.236 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.4 pt-20 -130.3 152.91 49.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.074 -0.343 . . . . 71.409999999999997 110.074 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.28 115.23 32.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.907 -0.588 . . . . 74.109999999999999 109.829 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' HE2' ' A' ' 123' ' ' TYR . 84.8 mt -77.24 -48.97 16.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 74.340000000000003 110.062 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 t -143.26 142.99 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.562 -0.745 . . . . 74.030000000000001 110.138 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.571 -0.74 . . . . 75.340000000000003 109.257 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.2 m -77.12 -40.91 44.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.055 0.455 . . . . 72.310000000000002 110.37 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -150.98 150.34 30.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.219 -0.446 . . . . 72.129999999999995 110.864 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.19 140.51 7.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.502 -0.925 . . . . 72.349999999999994 108.502 173.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.12 95.94 9.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.423 0.63 . . . . 71.120000000000005 110.632 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.83 2.58 20.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.259 -0.882 . . . . 74.430000000000007 110.786 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 m -112.56 -43.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.887 -0.597 . . . . 72.430000000000007 110.629 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 CA-C-N 116.012 -0.54 . . . . 64.430000000000007 113.372 -176.662 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 110.004 -0.369 . . . . 74.049999999999997 110.004 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.5 83.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.014 -0.612 . . . . 74.239999999999995 111.971 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.75 154.33 21.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.58 0.229 . . . . 74.430000000000007 110.488 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.96 -22.54 65.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.878 0.371 . . . . 72.530000000000001 111.448 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -77.83 -22.69 49.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.504 -0.317 . . . . 74.319999999999993 111.315 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 40.3 m -68.56 -24.33 64.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 74.530000000000001 109.911 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.564 HD11 ' HA ' ' A' ' 142' ' ' GLU . 24.9 tp -65.12 -24.49 67.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.39 -0.823 . . . . 71.540000000000006 110.776 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.557 HG22 HG12 ' A' ' 59' ' ' ILE . 35.9 pt -120.86 14.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.379 . . . . 74.209999999999994 111.16 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.86 -33.03 73.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.05 0.452 . . . . 74.420000000000002 110.197 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.0 36.29 6.41 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.708 -0.678 . . . . 51.439999999999998 112.023 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -139.05 128.93 24.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.988 -0.375 . . . . 63.109999999999999 109.988 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' CD2' ' A' ' 73' ' ' LEU . 2.5 p -70.36 -11.72 61.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.626 0.602 . . . . 72.340000000000003 112.626 -174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -89.06 -27.11 21.02 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.84 0.352 . . . . 64.219999999999999 111.049 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.2 p -87.78 146.1 25.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.739 -0.384 . . . . 74.439999999999998 109.974 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.649 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 42.6 p90 -146.5 166.09 27.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.217 0.532 . . . . 75.019999999999996 111.772 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -108.24 139.89 42.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.948 -1.023 . . . . 74.420000000000002 109.547 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -133.01 147.11 52.26 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.234 -0.654 . . . . 72.219999999999999 109.234 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.11 145.92 41.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.992 -0.373 . . . . 73.430000000000007 109.992 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 51' ' ' ASP . 37.7 ttpt -66.15 118.14 9.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 75.400000000000006 110.355 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -118.96 -30.9 4.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.425 -0.352 . . . . 75.420000000000002 110.896 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -78.72 107.67 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 74.510000000000005 110.249 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.12 -0.6 47.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.891 -0.671 . . . . 75.299999999999997 111.684 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 143.0 7.46 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.795 -0.717 . . . . 71.329999999999998 112.144 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -95.98 151.79 19.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.822 0.344 . . . . 72.340000000000003 111.053 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 30.5 m-20 -82.39 150.32 63.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.921 -0.582 . . . . 54.43 110.661 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.81 145.02 44.97 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.746 2.297 . . . . 72.549999999999997 112.269 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.8 mt -70.6 162.13 72.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 73.109999999999999 110.529 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 95.2 Cg_endo -83.15 170.02 56.16 Favored 'Cis proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.487 -1.464 . . . . 73.299999999999997 112.831 1.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.4 m-85 -108.17 111.02 22.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.406 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -110.79 130.95 55.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 74.329999999999998 110.622 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 57.4 mt -121.72 114.41 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.479 -0.563 . . . . 73.519999999999996 109.479 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -102.36 115.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.921 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 34' ' ' ILE . 4.9 mp -110.1 133.35 55.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.122 -0.49 . . . . 74.120000000000005 110.535 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -97.79 113.74 25.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.675 . . . . 73.420000000000002 109.179 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.2 mtm -81.98 -5.36 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 65.230000000000004 110.82 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 32.5 mmtp 73.41 -35.63 0.32 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.74 0.816 . . . . 74.129999999999995 112.965 174.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -123.9 166.73 15.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.005 0.431 . . . . 74.329999999999998 110.975 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.58 123.19 25.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.139 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.562 HD12 HG23 ' A' ' 5' ' ' ILE . 66.6 mt -131.68 136.87 56.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.614 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HB2' HD13 ' A' ' 150' ' ' ILE . 52.7 tp60 -86.48 108.56 18.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.858 -0.793 . . . . 74.109999999999999 108.858 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 118' ' ' SER . 28.1 mm -75.33 130.56 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.441 -0.207 . . . . 73.530000000000001 110.441 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -42.27 2.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.075 0.464 . . . . 73.420000000000002 111.331 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.8 tt0 -153.39 145.84 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 73.510000000000005 110.296 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -110.39 134.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.02 -0.363 . . . . 75.219999999999999 110.02 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -113.02 126.96 56.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.139 0.495 . . . . 70.420000000000002 110.899 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.617 HD13 ' HE2' ' A' ' 114' ' ' TYR . 61.3 mt -110.71 123.38 49.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.725 -0.67 . . . . 74.200000000000003 109.499 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.519 ' CD2' HG22 ' A' ' 38' ' ' THR . 22.4 tp -103.93 104.76 44.97 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.905 -0.405 . . . . 73.400000000000006 109.905 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 C-N-CA 122.815 2.343 . . . . 74.519999999999996 111.955 178.062 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.612 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 41.1 t-20 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.21 0.528 . . . . 72.129999999999995 110.756 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 9.3 Cg_endo -91.22 21.64 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.912 3.075 . . . . 72.140000000000001 112.796 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.06 122.92 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 75.239999999999995 110.169 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -100.08 -50.24 4.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 73.400000000000006 110.855 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 60.2 t -126.97 138.41 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 73.25 110.928 -173.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.91 137.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.069 -0.514 . . . . 72.129999999999995 110.128 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.13 135.53 54.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.039 0.447 . . . . 64.549999999999997 110.662 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.11 129.76 55.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.938 -0.574 . . . . 74.140000000000001 110.118 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.9 143.44 50.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 64.439999999999998 110.671 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.59 151.35 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 110.254 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 t -146.26 152.88 39.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 62.299999999999997 110.949 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -29.41 9.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.716 -0.674 . . . . 74.519999999999996 110.89 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -111.19 -0.03 16.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 74.109999999999999 111.11 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.1 t30 68.7 21.09 7.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.92 0.866 . . . . 75.219999999999999 109.614 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.76 -59.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.434 -0.803 . . . . 73.030000000000001 110.275 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -89.12 110.86 21.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 74.109999999999999 109.769 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -99.12 107.59 20.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.937 0.398 . . . . 75.519999999999996 110.312 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.8 m -88.46 123.89 67.25 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.967 -0.561 . . . . 73.120000000000005 110.378 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.13 107.33 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.243 1.962 . . . . 63.219999999999999 111.012 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 13.8 pt -80.21 -11.84 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 110.641 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.21 128.56 1.0 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.453 -0.88 . . . . 61.140000000000001 112.862 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -100.62 123.58 45.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.92 -0.771 . . . . 75.239999999999995 108.92 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.52 -177.73 4.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.741 0.305 . . . . 75.409999999999997 110.482 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -96.72 175.26 31.24 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.753 -0.737 . . . . 62.020000000000003 111.264 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -131.7 141.96 49.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.135 0.467 . . . . 75.420000000000002 110.095 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 m -136.69 119.42 16.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.931 -0.577 . . . . 74.099999999999994 110.058 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 63.9 t30 -69.62 95.93 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.725 -0.472 . . . . 71.219999999999999 109.725 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -125.8 -167.98 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 72.040000000000006 110.843 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.09 -33.47 14.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.916 -0.584 . . . . 55.310000000000002 111.186 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.87 168.62 10.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.887 -0.597 . . . . 63.310000000000002 111.56 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.8 144.81 47.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.091 0.472 . . . . 74.030000000000001 111.146 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.6 mt -101.18 104.54 15.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.637 -0.711 . . . . 72.010000000000005 110.01 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.29 115.82 24.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.476 . . . . 73.010000000000005 110.688 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.617 ' HE2' HD13 ' A' ' 72' ' ' LEU . 42.1 m-85 -113.34 108.17 16.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.117 0.484 . . . . 74.140000000000001 110.534 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -72.86 112.78 9.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.477 -0.783 . . . . 74.319999999999993 109.495 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -112.06 178.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.086 -0.507 . . . . 73.430000000000007 111.653 -172.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.73 128.19 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 73.349999999999994 110.481 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.8 p -77.02 106.44 8.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 110.175 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.85 146.73 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.915 -0.584 . . . . 74.129999999999995 110.487 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -88.29 131.44 34.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 110.506 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.96 176.65 11.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 63.439999999999998 110.339 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -125.38 -30.66 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 73.209999999999994 110.158 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.462 ' HE2' HD13 ' A' ' 13' ' ' LEU . 93.5 m-85 -106.78 146.02 31.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.056 -0.52 . . . . 74.129999999999995 110.14 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.0 tt -135.99 135.66 50.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.934 0.397 . . . . 74.140000000000001 110.157 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 33.6 ttp180 -122.88 120.06 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.34 -0.391 . . . . 74.230000000000004 110.679 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.421 HD23 HD13 ' A' ' 57' ' ' ILE . 41.3 tp -84.48 113.73 21.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.769 -0.826 . . . . 74.510000000000005 108.769 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.5 m -107.77 116.92 32.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.349 0.595 . . . . 62.219999999999999 111.278 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.722 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.9 mm -100.59 91.34 1.77 Allowed Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.002 -1.11 . . . . 74.439999999999998 108.002 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 174.45 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.243 1.962 . . . . 53.210000000000001 112.521 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.34 36.91 0.89 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.613 -0.884 . . . . 62.210000000000001 108.613 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -113.52 146.37 39.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.571 -1.195 . . . . 72.140000000000001 110.752 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.98 9.9 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.144 -0.55 . . . . 71.549999999999997 113.522 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 116.37 25.28 3.52 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.285 -0.959 . . . . 44.039999999999999 112.263 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.93 145.0 56.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 71.209999999999994 110.383 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 15.4 m -118.74 176.87 5.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.068 -0.515 . . . . 70.519999999999996 110.541 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 34.1 p -78.16 10.14 3.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.243 -0.435 . . . . 73.150000000000006 111.879 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.407 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 44.8 t -109.4 119.29 58.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.654 -0.499 . . . . 73.409999999999997 109.654 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.59 135.74 33.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.612 -0.267 . . . . 72.530000000000001 110.535 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.87 107.55 3.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 75.540000000000006 110.887 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.9 mt -133.43 136.97 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.478 -0.564 . . . . 71.409999999999997 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 36.3 mmt180 -63.77 -72.4 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.849 0.357 . . . . 75.239999999999995 110.071 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.564 ' HA ' HD11 ' A' ' 33' ' ' LEU . 12.8 pt-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.917 -0.713 . . . . 74.340000000000003 111.812 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.39 130.56 56.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.715 -1.13 . . . . 74.420000000000002 108.147 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.613 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -128.16 164.4 22.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.696 -0.483 . . . . 71.319999999999993 109.696 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -133.28 128.02 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 71.099999999999994 110.277 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 50.7 mttm -93.13 134.66 35.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.172 -0.677 . . . . 73.200000000000003 109.172 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.39 8.56 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.87 -0.681 . . . . 72.439999999999998 111.453 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -136.31 133.61 37.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.484 0.183 . . . . 74.409999999999997 110.562 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.8 HD13 HG21 ' A' ' 5' ' ' ILE . 31.2 mm -73.55 115.83 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.525 -0.546 . . . . 75.430000000000007 109.525 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.415 HD13 ' HB2' ' A' ' 66' ' ' GLN . 56.1 mt . . . . . 0 C--N 1.315 -0.904 0 N-CA-C 109.709 -0.478 . . . . 74.239999999999995 109.709 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.808 0.337 . . . . 71.120000000000005 110.35 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.502 HG22 ' CD1' ' A' ' 65' ' ' ILE . 44.5 mm -82.74 130.53 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.786 0.327 . . . . 73.549999999999997 110.85 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.3 t -65.6 125.05 23.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 110.171 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -96.83 21.8 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 110.586 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 t -54.73 -46.04 74.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.576 -0.738 . . . . 74.430000000000007 112.069 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.29 18.29 36.12 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.239 -0.981 . . . . 61.409999999999997 113.643 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -77.41 144.07 38.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.063 0.432 . . . . 74.150000000000006 110.669 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 23.5 pt-20 -139.85 162.7 34.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.432 . . . . 71.099999999999994 110.666 176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.33 127.48 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.869 -0.605 . . . . 74.349999999999994 110.133 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 mt -90.99 -45.82 8.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.245 0.545 . . . . 75.040000000000006 110.096 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 m -137.0 140.43 42.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 75.209999999999994 110.283 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -149.55 142.42 24.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 72.030000000000001 110.071 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 m -81.8 -51.95 7.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 71.230000000000004 111.256 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -142.17 151.51 42.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.409 . . . . 74.400000000000006 110.8 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.519 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 9.6 pt20 -163.34 137.11 5.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.448 -0.796 . . . . 74.430000000000007 108.972 174.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.8 tp10 -89.48 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.208 0.528 . . . . 73.439999999999998 110.875 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.68 -8.59 22.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.53 -0.759 . . . . 70.219999999999999 111.097 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -106.52 -52.64 2.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 74.030000000000001 110.81 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.657 0 CA-C-N 116.074 -0.512 . . . . 65.340000000000003 112.55 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 t30 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.078 -0.342 . . . . 63.140000000000001 110.078 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.6 -1.98 79.68 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.606 -0.598 . . . . 73.540000000000006 111.606 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 60.4 mt -84.32 155.84 22.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.192 -0.299 . . . . 73.109999999999999 110.192 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.81 -28.34 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.21 0.529 . . . . 71.25 111.098 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -79.58 -14.28 58.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.549 . . . . 75.420000000000002 111.545 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 71.1 m -73.11 -19.29 61.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.063 0.459 . . . . 74.140000000000001 109.822 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.62 -13.05 62.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.482 -0.781 . . . . 73.299999999999997 110.7 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.625 HG22 HD13 ' A' ' 59' ' ' ILE . 34.6 pt -137.59 21.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.803 -0.635 . . . . 74.200000000000003 110.306 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.681 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 12.3 t70 -67.76 -41.58 83.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 73.420000000000002 110.793 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.26 -2.26 11.47 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.869 -0.892 . . . . 61.200000000000003 110.869 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -125.04 115.08 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 75.239999999999995 109.951 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -75.93 2.61 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.929 -0.578 . . . . 73.040000000000006 112.482 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.34 -27.62 21.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.955 0.407 . . . . 65.299999999999997 110.049 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -89.07 137.42 32.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.017 -0.735 . . . . 73.140000000000001 109.017 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.647 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 41.8 p90 -130.11 173.2 10.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.057 0.456 . . . . 70.109999999999999 111.431 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.58 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.7 t90 -107.4 128.6 54.62 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 71.209999999999994 108.793 172.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -129.67 132.9 46.81 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.467 -0.568 . . . . 72.430000000000007 109.467 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.69 136.25 58.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.974 -0.75 . . . . 61.240000000000002 108.974 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.3 132.96 55.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.174 0.296 . . . . 75.129999999999995 110.385 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -124.09 -22.1 4.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.149 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -69.47 108.18 3.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.197 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.96 11.91 72.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 73.319999999999993 112.055 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.16 176.14 18.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 72.319999999999993 111.972 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -123.76 149.28 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.925 0.393 . . . . 73.120000000000005 110.856 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 2.6 t70 -75.66 142.93 74.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.974 -0.557 . . . . 75.299999999999997 109.712 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 30.8 Cg_endo -63.59 146.1 92.3 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.566 2.177 . . . . 73.140000000000001 113.193 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 9.7 mt -77.58 163.53 63.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.661 -0.7 . . . . 74.400000000000006 110.034 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.692 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.8 Cg_endo -81.28 163.95 77.96 Favored 'Cis proline' 0 N--CA 1.461 -0.401 0 C-N-CA 124.101 -1.208 . . . . 65.329999999999998 112.92 1.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.3 m-85 -99.28 122.86 43.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.82 -0.627 . . . . 71.519999999999996 110.318 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 9.9 t0 -110.22 126.67 54.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.695 . . . . 75.530000000000001 109.817 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.7 mt -130.25 108.92 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.769 0.319 . . . . 73.310000000000002 110.372 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.84 118.46 47.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.023 -0.535 . . . . 71.519999999999996 110.566 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 34' ' ' ILE . 82.8 mt -117.35 134.08 62.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.122 -0.49 . . . . 73.109999999999999 111.124 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -100.66 122.7 43.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.521 -0.548 . . . . 75.5 109.521 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.413 ' SD ' HD13 ' A' ' 65' ' ' ILE . 71.3 mtm -88.21 -6.21 57.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 64.209999999999994 110.766 -177.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.531 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.5 mmtt 67.26 11.53 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.752 -0.658 . . . . 70.450000000000003 112.197 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -163.46 159.84 22.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.228 -0.286 . . . . 74.219999999999999 110.228 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 58.7 m-80 -81.5 130.45 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.615 -0.513 . . . . 74.030000000000001 109.615 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.502 ' CD1' HG22 ' A' ' 5' ' ' ILE . 65.4 mt -135.55 136.01 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.078 0.466 . . . . 72.439999999999998 110.422 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -82.34 99.91 9.65 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 73.409999999999997 108.635 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 118' ' ' SER . 34.5 mm -69.79 113.55 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.091 -0.504 . . . . 75.349999999999994 110.174 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 -32.6 7.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.896 0.379 . . . . 65.140000000000001 111.161 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.673 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 7.0 tt0 -154.2 147.42 24.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.283 -0.417 . . . . 73.049999999999997 110.78 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.87 134.15 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.111 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 44.3 mt-10 -115.56 138.63 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.162 0.506 . . . . 74.329999999999998 110.927 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.408 HD12 ' HE2' ' A' ' 114' ' ' TYR . 92.7 mt -124.28 118.71 27.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.739 -0.664 . . . . 75.420000000000002 109.755 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -103.33 99.75 15.9 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 109.094 -0.706 . . . . 75.340000000000003 109.094 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.62 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 55.5 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.526 . . . . 75.109999999999999 112.656 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.2 t30 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.182 0.515 . . . . 72.349999999999994 109.732 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.49 46.07 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.945 3.096 . . . . 74.319999999999993 113.906 -170.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.4 111.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.171 -0.677 . . . . 75.150000000000006 109.171 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.02 -48.05 8.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 72.329999999999998 110.91 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.689 HG11 ' HE ' ' A' ' 102' ' ' ARG . 12.0 t -130.95 143.15 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 110.713 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.88 142.01 45.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.144 -0.48 . . . . 74.400000000000006 110.238 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -112.68 130.18 56.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.983 -0.553 . . . . 75.25 110.497 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.81 129.1 55.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 73.519999999999996 110.312 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.33 148.55 52.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.316 -0.402 . . . . 65.109999999999999 110.476 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.36 153.63 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.42 -0.354 . . . . 71.25 110.479 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 t -145.39 142.38 29.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 70.450000000000003 110.136 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.689 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -77.32 -45.66 25.46 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.925 -0.58 . . . . 73.230000000000004 111.279 -176.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.61 23.85 5.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.372 -0.376 . . . . 71.519999999999996 111.048 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.1 t30 65.63 29.55 10.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.93 0.871 . . . . 73.510000000000005 110.089 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.17 -64.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.34 -0.845 . . . . 71.519999999999996 109.741 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -96.41 105.1 17.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 64.200000000000003 110.792 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -89.33 114.63 26.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.291 -0.413 . . . . 71.319999999999993 110.148 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 60.8 m -117.38 130.4 24.68 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.955 -0.566 . . . . 72.319999999999993 110.87 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 8.1 Cg_exo -70.88 106.99 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.865 2.376 . . . . 61.520000000000003 111.336 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.583 HD13 HG22 ' A' ' 116' ' ' VAL . 11.8 pt -76.04 -11.1 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.777 -0.647 . . . . 72.430000000000007 111.057 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.77 149.0 5.8 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.339 -0.934 . . . . 65.310000000000002 113.101 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.689 ' HE ' HG11 ' A' ' 85' ' ' VAL . 78.1 ttt180 -124.21 118.4 26.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.705 -0.85 . . . . 75.439999999999998 108.705 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' HE2' HG11 ' A' ' 116' ' ' VAL . 96.0 m-85 -133.32 163.17 29.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.897 0.38 . . . . 73.430000000000007 111.364 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.65 141.4 25.5 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.663 -0.699 . . . . 75.310000000000002 111.595 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.62 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 48.0 t80 -100.54 138.38 37.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.954 0.407 . . . . 71.109999999999999 110.368 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.487 ' O ' HD13 ' A' ' 112' ' ' LEU . 32.6 m -131.3 112.73 13.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 73.219999999999999 110.184 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.66 103.07 2.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.291 0.567 . . . . 74.519999999999996 110.942 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -130.83 -174.34 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.317 -0.856 . . . . 73.109999999999999 109.425 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -90.56 -15.38 30.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.78 0.324 . . . . 72.430000000000007 110.98 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 150.77 22.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.344 -0.389 . . . . 64.530000000000001 110.839 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.06 127.51 32.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.115 0.483 . . . . 74.019999999999996 111.125 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -79.63 105.34 10.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.657 -0.701 . . . . 72.340000000000003 110.349 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.782 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 42.6 mt-10 -88.64 111.71 22.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.181 0.515 . . . . 74.329999999999998 111.187 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TYR . . . . . 0.408 ' HE2' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -108.57 111.46 23.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.652 -0.703 . . . . 73.140000000000001 110.35 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -74.25 102.59 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.686 . . . . 72.319999999999993 109.636 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.583 HG22 HD13 ' A' ' 100' ' ' ILE . 31.5 m -102.08 -179.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 73.420000000000002 111.583 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -72.28 125.21 26.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.562 -0.745 . . . . 74.340000000000003 110.07 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.739 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 32.5 p -70.2 127.18 31.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.951 -0.568 . . . . 74.439999999999998 111.295 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.89 148.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.29 -0.414 . . . . 72.299999999999997 110.329 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -85.52 116.28 23.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 71.430000000000007 109.526 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . . . -141.81 156.43 45.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.959 -0.564 . . . . 73.439999999999998 110.828 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.92 -26.99 8.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.505 0.669 . . . . 74.239999999999995 109.388 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -111.4 145.4 38.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.459 -0.792 . . . . 75.0 109.319 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.08 139.63 49.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.693 -0.484 . . . . 73.120000000000005 109.693 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.6 ttp180 -125.02 123.43 39.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.055 0.455 . . . . 74.329999999999998 111.126 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 57' ' ' ILE . 41.3 tp -91.02 115.55 28.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.411 -0.813 . . . . 74.329999999999998 108.92 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.7 m -109.63 116.17 31.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.949 0.404 . . . . 55.43 110.865 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 40.2 mm -100.75 97.54 6.91 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.784 -0.821 . . . . 71.430000000000007 108.784 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 52.2 Cg_endo -69.96 170.28 17.19 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.432 2.088 . . . . 74.129999999999995 112.611 -176.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.98 -16.42 26.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.974 0.893 . . . . 74.340000000000003 108.754 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.55 148.03 22.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.285 -1.325 . . . . 71.409999999999997 110.895 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.97 -12.96 49.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.949 -0.86 . . . . 52.329999999999998 110.949 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.76 24.83 7.53 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.093 -0.575 . . . . 72.299999999999997 111.689 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -75.61 127.58 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 74.430000000000007 110.748 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.2 m -95.88 164.43 12.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 109.996 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 17.4 p -68.98 -6.18 26.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.26 0.467 . . . . 72.439999999999998 112.26 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 42.3 t -85.04 95.58 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.828 -0.434 . . . . 74.310000000000002 109.828 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.61 121.95 36.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.106 -0.497 . . . . 65.049999999999997 110.503 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.25 108.75 6.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 74.409999999999997 111.097 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 21.0 mt -121.96 132.65 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.592 -0.892 . . . . 71.420000000000002 108.592 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 77.1 mtt-85 -69.96 -70.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.936 -0.305 . . . . 75.230000000000004 110.613 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -148.07 141.14 24.94 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.157 -0.617 . . . . 62.109999999999999 111.322 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 143' ' ' LEU . 7.9 tt -100.27 132.0 45.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.154 -0.93 . . . . 74.540000000000006 109.229 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.21 155.94 41.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.961 0.41 . . . . 74.329999999999998 110.387 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.6 t -126.74 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.127 -0.488 . . . . 64.209999999999994 110.542 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.593 ' HD2' ' NE2' ' A' ' 69' ' ' GLN . 46.3 mttp -104.69 115.45 30.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.191 -0.67 . . . . 74.329999999999998 109.191 171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.02 -169.14 24.95 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.762 -0.733 . . . . 75.439999999999998 112.096 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.1 m -113.32 130.73 56.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.425 -0.213 . . . . 70.5 110.425 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 5' ' ' ILE . 34.3 mm -76.11 120.63 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.063 0.459 . . . . 75.510000000000005 110.966 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.522 HD11 ' HG2' ' A' ' 120' ' ' LYS . 37.0 mt . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.698 -0.683 . . . . 72.430000000000007 109.456 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.702 -0.481 . . . . 75.400000000000006 109.702 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.07 -124.98 7.57 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.855 -0.898 . . . . 71.230000000000004 110.855 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -74.29 -29.83 61.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 73.409999999999997 110.505 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.507 HG21 ' HE2' ' A' ' 146' ' ' LYS . 19.2 p -76.41 130.03 37.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.347 -0.612 . . . . 74.030000000000001 109.347 174.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 149' ' ' ILE . 40.1 mm -67.16 129.17 31.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.446 -0.343 . . . . 75.120000000000005 110.388 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.8 m -63.11 116.47 5.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 71.230000000000004 110.356 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -86.61 15.7 5.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 74.420000000000002 110.907 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -62.54 -35.23 78.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.774 -0.648 . . . . 73.019999999999996 111.848 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.36 15.9 38.55 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.551 -0.833 . . . . 62.530000000000001 113.106 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.2 m0 -84.06 141.99 30.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.933 0.366 . . . . 75.230000000000004 110.842 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.458 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.7 pt-20 -136.73 157.36 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.966 0.412 . . . . 64.439999999999998 110.373 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.24 122.44 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.747 -0.661 . . . . 73.129999999999995 109.94 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.512 HD13 ' HB2' ' A' ' 60' ' ' ASP . 71.4 mt -84.75 -39.95 17.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.056 0.455 . . . . 70.129999999999995 110.572 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -154.59 142.06 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 70.319999999999993 110.091 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 18' ' ' GLN . 32.5 p90 -139.97 145.58 38.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 109.38 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 m -88.24 -33.88 17.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.86 0.362 . . . . 71.319999999999993 111.282 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 t -148.88 151.15 34.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 111.158 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.481 ' HG2' ' CE2' ' A' ' 15' ' ' PHE . 1.5 pp0? -167.81 142.71 3.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.894 -0.78 . . . . 73.010000000000005 108.894 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -109.82 94.2 4.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.138 0.494 . . . . 65.430000000000007 110.776 -174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.58 8.01 41.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 74.140000000000001 111.048 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -120.01 -46.33 2.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.116 0.484 . . . . 75.319999999999993 110.26 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.16 -29.2 72.21 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.963 -0.562 . . . . 62.140000000000001 112.647 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.43 16.04 18.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 74.420000000000002 110.303 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 -100.67 2.63 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.703 -0.681 . . . . 62.240000000000002 111.773 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.2 128.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.105 -0.331 . . . . 73.5 110.105 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.78 5.4 62.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.853 -0.689 . . . . 61.509999999999998 112.031 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -140.24 150.89 44.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.233 -0.654 . . . . 72.129999999999995 109.233 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.05 6.6 88.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.993 -0.622 . . . . 62.539999999999999 112.175 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.8 mt -80.15 148.59 30.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 72.310000000000002 110.565 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.536 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.31 -25.71 65.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 73.329999999999998 111.191 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -76.39 -23.21 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.796 -0.362 . . . . 74.010000000000005 111.254 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 71.1 m -63.08 -27.73 69.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.03 0.443 . . . . 73.230000000000004 110.234 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.27 -30.92 70.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 74.349999999999994 110.469 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.692 HG23 HG12 ' A' ' 59' ' ' ILE . 46.9 pt -115.23 13.1 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 75.420000000000002 111.054 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.4 t70 -77.32 -33.02 55.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 74.0 109.226 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' HA2' ' OE1' ' A' ' 142' ' ' GLU . . . 84.2 55.1 2.83 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.519 -0.764 . . . . 73.219999999999999 112.623 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.51 129.62 16.51 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.815 -0.439 . . . . 74.010000000000005 109.815 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.589 HG21 HD23 ' A' ' 73' ' ' LEU . 11.1 p -70.21 -19.79 63.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.38 0.511 . . . . 70.329999999999998 112.38 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.52 -13.29 40.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.733 0.301 . . . . 73.209999999999994 110.893 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -105.36 151.72 23.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.789 -0.448 . . . . 71.439999999999998 109.789 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -151.93 162.37 41.18 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.575 -0.45 . . . . 75.0 111.04 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.536 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.6 t90 -98.79 137.59 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 74.439999999999998 109.271 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.492 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.3 t-80 -131.67 139.16 49.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.588 -0.523 . . . . 75.049999999999997 109.588 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 151.5 46.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 63.039999999999999 109.973 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -61.87 129.32 40.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.318 -0.253 . . . . 73.439999999999998 110.318 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -134.71 -32.99 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.073 -0.251 . . . . 75.439999999999998 111.068 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -81.27 102.6 10.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.727 -0.471 . . . . 73.5 109.727 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.62 -11.64 53.72 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.921 -0.657 . . . . 72.209999999999994 111.54 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.45 149.42 7.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.733 -0.746 . . . . 74.430000000000007 112.291 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.5 m -86.16 173.44 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 65.310000000000002 111.3 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.583 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 24.1 m-20 -98.2 166.51 13.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.966 -0.561 . . . . 71.019999999999996 109.787 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 56.9 Cg_endo -71.92 122.76 8.76 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.1 1.867 . . . . 62.299999999999997 112.973 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 16.8 mt -67.96 154.49 93.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 75.420000000000002 110.139 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 86.6 Cg_endo -81.17 167.21 72.63 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.669 -1.388 . . . . 74.439999999999998 113.019 1.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.0 m-85 -104.99 119.43 38.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 70.120000000000005 110.491 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.19 125.51 54.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.911 0.386 . . . . 64.310000000000002 110.705 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.4 mt -118.62 117.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.446 . . . . 74.530000000000001 110.049 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.915 HG22 ' HG3' ' A' ' 125' ' ' ARG . 54.7 t -106.23 122.34 59.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.34 -0.391 . . . . 72.540000000000006 110.936 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.692 HG12 HG23 ' A' ' 34' ' ' ILE . 4.6 mp -112.38 139.39 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 75.319999999999993 110.609 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.512 ' HB2' HD13 ' A' ' 13' ' ' LEU . 58.0 t0 -103.26 121.19 42.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.333 -0.618 . . . . 73.140000000000001 109.333 174.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.1 mtm -88.34 -3.14 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.284 -0.416 . . . . 73.329999999999998 110.725 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.458 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 65.57 13.44 8.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.712 -0.676 . . . . 74.140000000000001 111.991 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.42 ' OE1' HD11 ' A' ' 149' ' ' ILE . 4.8 pt20 -165.35 153.8 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.359 -0.608 . . . . 74.099999999999994 109.359 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -82.7 123.81 29.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.942 -0.392 . . . . 74.530000000000001 109.942 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.431 ' CD1' HG22 ' A' ' 5' ' ' ILE . 85.4 mt -126.44 139.14 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.167 -0.47 . . . . 74.540000000000006 110.374 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -82.1 101.46 10.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.734 -0.839 . . . . 75.129999999999995 108.734 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.7 mm -70.55 134.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 73.319999999999993 110.811 -174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 -42.57 1.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.067 -0.515 . . . . 71.019999999999996 110.699 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.616 ' HG2' ' HD3' ' A' ' 146' ' ' LYS . 11.8 tt0 -147.95 138.73 23.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 73.540000000000006 111.444 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.9 143.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.028 -0.73 . . . . 75.150000000000006 109.028 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.858 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 17.8 tt0 -120.75 133.72 55.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.175 -0.306 . . . . 75.420000000000002 110.175 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 48.1 mt -117.26 121.45 41.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.311 -0.625 . . . . 74.109999999999999 109.311 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 38' ' ' THR . 34.5 tp -102.4 101.27 18.82 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.829 -0.434 . . . . 73.409999999999997 109.829 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.6 Cg_endo -80.8 -177.75 3.95 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.89 2.393 . . . . 73.140000000000001 111.397 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -96.09 -66.0 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.222 -0.444 . . . . 74.120000000000005 109.839 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.91 -60.06 2.17 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.089 -0.577 . . . . 65.310000000000002 112.148 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -60.46 98.22 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.89 -0.655 . . . . 72.239999999999995 111.143 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.63 15.37 81.61 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.029 -0.605 . . . . 65.549999999999997 112.653 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -119.63 143.43 47.7 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.816 -0.226 . . . . 72.530000000000001 110.625 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -83.56 -56.45 3.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.418 -0.356 . . . . 70.409999999999997 110.33 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 54.17 80.63 0.29 Allowed Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.595 -0.73 . . . . 73.219999999999999 112.289 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.27 40.48 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.949 2.433 . . . . 74.109999999999999 112.099 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -94.55 122.1 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 75.319999999999993 109.824 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -99.89 -50.35 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 74.0 110.938 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 41.7 t -132.85 139.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 75.5 110.923 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.29 140.14 49.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.259 -0.428 . . . . 74.230000000000004 110.268 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 46.9 mt-10 -120.12 130.45 54.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.138 -0.483 . . . . 74.420000000000002 110.785 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.82 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.123 -0.49 . . . . 75.349999999999994 110.546 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.47 150.54 49.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.363 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.469 ' HB1' ' CB ' ' A' ' 121' ' ' ALA . . . -138.73 155.74 47.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.367 -0.379 . . . . 74.129999999999995 110.088 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.1 t -149.3 147.42 28.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.072 0.463 . . . . 71.450000000000003 111.743 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.05 -28.21 17.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 70.349999999999994 110.601 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -123.38 4.09 9.09 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.891 0.33 . . . . 74.129999999999995 111.891 -173.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 77.24 -20.83 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.522 0.729 . . . . 74.120000000000005 111.265 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.1 -54.27 8.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.024 0.44 . . . . 74.129999999999995 110.351 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -90.14 103.82 16.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.882 -0.599 . . . . 74.150000000000006 110.911 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -94.53 137.16 34.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.178 0.513 . . . . 74.329999999999998 110.573 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -122.01 125.12 26.75 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.668 -0.696 . . . . 72.510000000000005 109.938 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.7 108.63 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.608 2.205 . . . . 71.420000000000002 111.283 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 116' ' ' VAL . 18.2 pt -81.28 -13.46 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.0 -0.546 . . . . 63.240000000000002 111.163 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.46 135.18 1.85 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.326 -0.94 . . . . 71.219999999999999 112.792 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 60.8 ttt180 -111.69 121.29 44.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.486 -0.561 . . . . 72.150000000000006 109.486 172.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -140.0 165.9 26.09 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.768 -0.373 . . . . 73.230000000000004 111.01 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -81.39 147.74 27.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.002 -0.618 . . . . 63.140000000000001 111.678 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.58 123.32 40.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.932 -0.396 . . . . 74.349999999999994 109.932 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.608 ' HB ' HD21 ' A' ' 112' ' ' LEU . 10.3 m -102.13 106.78 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.302 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -65.69 110.29 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 71.340000000000003 110.429 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -152.38 177.98 10.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 75.310000000000002 109.752 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.9 -9.56 36.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.251 0.548 . . . . 74.049999999999997 110.356 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.51 157.65 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 70.530000000000001 110.641 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . . . -70.26 144.47 51.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.045 0.45 . . . . 71.450000000000003 111.703 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.608 HD21 ' HB ' ' A' ' 106' ' ' THR . 20.4 mt -99.55 113.85 26.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.525 -0.761 . . . . 75.230000000000004 110.146 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.415 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 50.4 mt-10 -85.15 115.78 23.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.848 0.356 . . . . 74.329999999999998 110.593 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.55 105.36 14.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 64.209999999999994 110.779 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -75.86 118.55 18.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.959 -0.756 . . . . 72.010000000000005 108.959 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 100' ' ' ILE . 29.4 m -120.67 -172.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.324 0.491 . . . . 71.409999999999997 112.324 -171.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -66.53 125.89 27.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.16 -0.927 . . . . 74.409999999999997 110.719 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.7 m -74.87 108.06 7.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.035 0.445 . . . . 75.25 110.217 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.74 152.2 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.964 -0.562 . . . . 74.409999999999997 109.943 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.59 ' HG3' HD12 ' A' ' 150' ' ' ILE . 1.1 ttmp? -73.36 138.91 45.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.554 -0.536 . . . . 75.030000000000001 109.554 175.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.469 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . . . -156.27 134.43 11.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.51 -0.313 . . . . 73.109999999999999 110.88 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -95.57 -29.82 14.14 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.799 -0.815 . . . . 74.209999999999994 108.799 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.9 145.08 41.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.1 -0.954 . . . . 75.109999999999999 109.499 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.71 137.18 51.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.657 -0.497 . . . . 74.450000000000003 109.657 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.915 ' HG3' HG22 ' A' ' 58' ' ' VAL . 4.4 ttm180 -122.13 130.21 53.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 75.099999999999994 111.159 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.2 tp -97.48 118.16 33.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 75.420000000000002 109.016 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.6 m -109.97 122.83 48.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.5 . . . . 74.510000000000005 111.1 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.1 mm -101.46 94.0 3.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 75.129999999999995 108.714 173.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 59.0 Cg_endo -71.48 151.67 59.41 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.86 2.373 . . . . 70.439999999999998 113.308 -173.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.779 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 12.6 p-10 -89.72 4.79 48.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.589 0.709 . . . . 71.109999999999999 109.535 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.16 -34.39 15.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.075 -0.966 . . . . 72.209999999999994 111.39 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.18 -3.45 76.0 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.616 -0.802 . . . . 65.120000000000005 113.529 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.07 8.18 45.26 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.488 -0.863 . . . . 73.25 111.335 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -69.05 133.73 48.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.309 -0.446 . . . . 74.299999999999997 111.608 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 m -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.965 -0.561 . . . . 73.049999999999997 109.728 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 38.5 p -84.4 16.27 3.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.971 0.415 . . . . 73.239999999999995 111.36 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.83 119.48 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.546 -0.538 . . . . 75.340000000000003 109.546 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -144.27 130.91 20.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.59 -0.277 . . . . 73.400000000000006 110.613 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.64 105.61 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.051 0.453 . . . . 73.420000000000002 110.884 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.63 133.14 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.838 -0.43 . . . . 73.340000000000003 109.838 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.27 -62.54 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.223 0.327 . . . . 75.120000000000005 110.724 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.401 ' OE1' ' HA2' ' A' ' 36' ' ' GLY . 15.1 pt-20 -154.13 161.32 41.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.457 0.646 . . . . 72.319999999999993 111.59 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -119.43 135.94 54.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.832 -1.076 . . . . 75.420000000000002 108.19 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.8 t70 -129.23 161.6 29.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.016 -0.364 . . . . 73.420000000000002 110.016 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 45.4 t -135.35 133.56 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.403 . . . . 73.319999999999993 110.267 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.858 ' HE3' ' HB2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -108.86 125.6 52.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.848 -0.797 . . . . 75.049999999999997 108.848 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.21 -168.25 30.96 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.407 -0.902 . . . . 74.420000000000002 112.449 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.7 m -112.35 132.29 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.465 -0.198 . . . . 74.310000000000002 110.465 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.446 HD12 HD13 ' A' ' 5' ' ' ILE . 40.3 mm -73.36 123.58 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 70.230000000000004 110.757 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.59 HD12 ' HG3' ' A' ' 120' ' ' LYS . 48.0 mt -107.26 144.94 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.558 -0.534 . . . . 73.310000000000002 109.558 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -120.28 134.93 55.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.042 0.448 . . . . 74.230000000000004 111.257 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.88 11.61 27.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.639 0.733 . . . . 75.230000000000004 109.262 173.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.98 102.69 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.069 -0.969 . . . . 71.439999999999998 111.38 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -103.58 98.4 8.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.465 -0.939 . . . . 71.540000000000006 108.465 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -62.18 -32.75 73.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.711 0.634 . . . . 72.200000000000003 112.711 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -86.17 7.97 22.88 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.018 -0.273 . . . . 74.510000000000005 111.524 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -140.62 16.22 2.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.902 0.382 . . . . 75.209999999999994 110.802 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -149.95 74.43 1.21 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 74.310000000000002 109.774 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.598 -0.728 . . . . 75.25 109.712 -179.531 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.649 -0.5 . . . . 75.319999999999993 109.649 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.42 -139.61 9.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 64.239999999999995 112.641 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.407 HG21 ' HE3' ' A' ' 146' ' ' LYS . 4.2 t -134.53 -26.75 1.39 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.517 0.192 . . . . 74.310000000000002 111.517 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.29 149.7 40.57 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.739 -0.384 . . . . 71.140000000000001 110.539 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.575 HG23 HD13 ' A' ' 149' ' ' ILE . 30.0 mm -94.69 132.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.249 -0.432 . . . . 70.209999999999994 110.467 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -70.77 123.43 21.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.592 -0.522 . . . . 75.530000000000001 109.592 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -98.59 16.41 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 71.510000000000005 111.468 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -77.44 -5.15 48.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.911 0.386 . . . . 75.430000000000007 111.497 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.89 -0.09 24.28 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.652 -0.785 . . . . 34.420000000000002 112.357 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -82.86 153.9 24.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.645 0.26 . . . . 73.439999999999998 110.654 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.02 155.4 48.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 110.663 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.33 119.7 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.516 -0.766 . . . . 75.010000000000005 109.948 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD23 ' HE1' ' A' ' 158' ' ' HIS . 84.9 mt -84.18 -42.04 16.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.942 -0.572 . . . . 74.409999999999997 110.53 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.8 t -149.21 143.73 26.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 75.310000000000002 110.131 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -148.88 149.52 31.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 74.510000000000005 109.687 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 m -92.57 -44.3 8.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.844 0.313 . . . . 74.219999999999999 111.844 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -138.49 149.48 45.45 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.73 -0.388 . . . . 63.350000000000001 111.137 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -161.93 142.86 10.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.799 -0.637 . . . . 75.319999999999993 109.441 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.689 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 tp10 -115.84 93.6 4.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.295 -0.412 . . . . 75.319999999999993 110.541 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.91 -14.31 26.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 70.340000000000003 111.204 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -98.81 -51.84 3.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.406 -0.361 . . . . 75.209999999999994 111.308 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.01 -30.76 67.42 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.065 -0.588 . . . . 73.310000000000002 113.38 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -95.03 -25.59 16.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.966 0.383 . . . . 72.519999999999996 111.847 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.28 178.11 18.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.318 -0.944 . . . . 72.439999999999998 113.048 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 115.26 11.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.946 0.403 . . . . 54.030000000000001 110.876 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.77 -5.94 69.82 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.79 -0.719 . . . . 74.239999999999995 112.095 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -117.42 128.19 54.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.446 -0.205 . . . . 65.319999999999993 110.446 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.7 -7.78 63.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.242 -0.504 . . . . 75.239999999999995 112.638 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.688 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.8 mt -73.67 142.95 46.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.741 0.305 . . . . 75.230000000000004 110.768 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.41 -27.21 68.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 50.119999999999997 111.309 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -19.35 61.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 75.129999999999995 110.562 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 1.071 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 69.5 m -72.84 -18.42 61.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 73.219999999999999 111.032 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 HD22 ' A' ' 126' ' ' LEU . 32.6 tp -64.88 -24.32 67.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.546 0.689 . . . . 75.120000000000005 109.925 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.8 pt -122.6 19.65 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.339 -0.846 . . . . 70.129999999999995 109.775 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 1.071 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 22.0 t70 -64.68 -41.57 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.325 -0.852 . . . . 71.409999999999997 111.458 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 38.19 5.25 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.471 -0.871 . . . . 73.519999999999996 112.077 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -151.28 128.8 11.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.194 -0.298 . . . . 63.039999999999999 110.194 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.4 p -75.58 -2.9 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.142 0.423 . . . . 73.219999999999999 112.142 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.37 -22.34 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.109 -0.236 . . . . 74.420000000000002 110.95 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p -88.55 165.69 14.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.875 -0.417 . . . . 71.540000000000006 109.875 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.543 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 31.8 p90 -164.97 165.82 19.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.421 . . . . 74.219999999999999 111.442 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.567 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 36.3 t90 -106.4 141.92 36.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.198 -0.91 . . . . 72.329999999999998 109.018 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.4 t-80 -139.62 143.21 37.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.509 -0.552 . . . . 65.040000000000006 109.509 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 136.65 50.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.583 -0.525 . . . . 75.129999999999995 109.583 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.689 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 3.5 ttpm? -62.87 122.04 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.578 0.228 . . . . 71.420000000000002 110.396 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -117.34 -29.13 5.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.524 -0.307 . . . . 75.140000000000001 110.686 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.9 110.98 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 75.049999999999997 110.251 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.31 -5.95 65.62 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.898 -0.668 . . . . 51.229999999999997 111.982 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.84 143.17 5.51 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 71.030000000000001 112.459 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 19.0 m -93.71 144.7 25.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.813 0.34 . . . . 72.010000000000005 110.761 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.9 m-20 -76.76 148.02 78.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.083 -0.508 . . . . 51.299999999999997 109.965 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 9.6 Cg_exo -72.39 144.25 40.57 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.695 2.263 . . . . 73.239999999999995 112.81 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 161.88 77.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 71.219999999999999 110.342 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.1 Cg_exo -79.77 168.96 71.96 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.082 -1.216 . . . . 74.319999999999993 112.577 -1.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.737 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 25.2 m-85 -107.92 128.74 54.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.688 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.8 133.14 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 64.409999999999997 110.172 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.57 HD11 HD21 ' A' ' 126' ' ' LEU . 51.0 mt -132.17 111.43 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.868 -0.419 . . . . 72.219999999999999 109.868 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.409 HG11 ' HH2' ' A' ' 97' ' ' TRP . 57.8 t -106.42 121.38 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 74.439999999999998 111.096 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 57' ' ' ILE . 5.1 mp -116.1 136.19 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.33 . . . . 74.310000000000002 110.837 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.421 ' HB2' HD13 ' A' ' 13' ' ' LEU . 37.0 t0 -96.45 117.5 31.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.149 -0.685 . . . . 73.450000000000003 109.149 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.75 -3.28 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 74.510000000000005 110.517 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.1 mmtp 73.05 -13.9 0.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.625 0.77 . . . . 75.409999999999997 112.401 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -147.53 177.14 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.9 0.381 . . . . 72.340000000000003 110.953 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 121.51 30.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.609 . . . . 60.32 110.209 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 5' ' ' ILE . 67.7 mt -129.18 134.81 63.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.891 0.377 . . . . 75.239999999999995 110.259 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -81.77 105.76 13.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.194 -0.669 . . . . 71.219999999999999 109.194 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.646 ' O ' ' HA ' ' A' ' 118' ' ' SER . 10.2 mm -80.18 117.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.231 -0.285 . . . . 74.329999999999998 110.231 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.19 -41.92 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 71.310000000000002 110.665 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -144.59 138.84 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.004 -0.544 . . . . 71.040000000000006 110.865 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -110.2 133.94 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.387 -0.598 . . . . 72.420000000000002 109.387 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -114.42 127.93 56.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.033 0.444 . . . . 71.120000000000005 110.834 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.0 mt -109.35 125.95 52.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.876 -0.602 . . . . 73.049999999999997 109.709 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -112.27 96.44 35.23 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.164 -0.68 . . . . 73.430000000000007 109.164 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 56.6 Cg_endo -73.19 173.33 13.87 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.443 2.095 . . . . 72.519999999999996 111.589 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.434 ' HB3' ' OG ' ' A' ' 79' ' ' SER . 1.3 mtm180 -63.65 -42.35 98.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.577 -0.449 . . . . 75.109999999999999 110.412 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.36 -86.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.981 -0.554 . . . . 71.549999999999997 113.002 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 48.7 mtm-85 -76.47 117.92 18.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.872 0.367 . . . . 75.349999999999994 111.041 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' C ' ' HG ' ' A' ' 79' ' ' SER . . . 76.94 52.42 5.79 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.89 -0.595 . . . . 60.509999999999998 112.416 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.463 ' HG ' ' C ' ' A' ' 78' ' ' GLY . 22.1 m -153.73 150.73 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 73.129999999999995 111.434 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -109.32 103.9 12.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 74.140000000000001 109.261 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.43 HD22 HD13 ' A' ' 83' ' ' ILE . 21.8 t-20 -108.67 105.64 57.31 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.995 -0.548 . . . . 73.319999999999993 110.823 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -92.55 19.47 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.127 2.551 . . . . 73.120000000000005 112.813 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 HD22 ' A' ' 81' ' ' ASN . 58.7 mt -79.59 129.89 36.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 70.430000000000007 109.772 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.93 -38.05 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.856 -0.611 . . . . 73.109999999999999 110.419 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.97 137.96 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 75.310000000000002 111.206 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.38 141.66 45.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.142 -0.481 . . . . 72.239999999999995 110.507 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -118.32 132.79 56.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 109.937 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.71 133.34 55.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.441 -0.345 . . . . 75.349999999999994 110.466 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.98 146.76 50.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.788 0.328 . . . . 74.230000000000004 111.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.39 146.41 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 75.409999999999997 110.162 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.4 t -140.17 157.46 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.226 0.536 . . . . 73.150000000000006 111.516 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.8 mt-10 -116.14 -32.23 5.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 74.329999999999998 110.668 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -114.82 5.13 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 74.310000000000002 112.161 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 71.92 -1.91 2.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.119 0.568 . . . . 74.049999999999997 111.752 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 -51.69 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 72.340000000000003 110.195 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -89.94 112.72 24.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.796 -0.638 . . . . 72.519999999999996 110.538 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.409 ' HH2' HG11 ' A' ' 58' ' ' VAL . 97.9 m95 -104.81 108.04 19.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.07 -0.514 . . . . 75.140000000000001 109.935 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 80.7 m -89.28 120.05 69.73 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.287 -0.415 . . . . 71.019999999999996 110.314 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.82 110.9 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.396 2.064 . . . . 74.430000000000007 110.83 174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -86.38 -10.12 11.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.124 -0.489 . . . . 70.230000000000004 110.81 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.91 128.7 0.98 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.083 -1.056 . . . . 64.540000000000006 113.322 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.27 117.2 33.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.387 -0.968 . . . . 73.109999999999999 108.387 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.58 175.28 9.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.124 0.488 . . . . 74.409999999999997 111.47 -171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.79 15.79 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.35 -0.841 . . . . 71.450000000000003 111.745 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.585 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 51.4 t80 -97.01 148.01 23.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 73.120000000000005 110.106 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -142.71 112.06 6.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.398 -0.364 . . . . 72.030000000000001 110.444 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -72.54 114.42 10.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 110.556 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 74' ' ' PRO . 13.2 pt20 -154.07 179.8 8.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.622 -0.717 . . . . 74.340000000000003 109.43 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.88 -5.39 51.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 75.040000000000006 110.283 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.97 36.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 74.109999999999999 110.208 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.65 140.33 58.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.045 0.45 . . . . 72.430000000000007 110.886 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 32.8 mt -94.81 104.75 16.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.719 -0.673 . . . . 71.400000000000006 110.248 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -79.97 109.04 14.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.004 0.431 . . . . 73.319999999999993 110.752 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.12 104.59 14.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.069 -0.514 . . . . 73.439999999999998 110.404 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -70.86 106.75 3.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.994 -0.743 . . . . 75.450000000000003 108.994 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 27.4 m -106.08 174.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.903 0.382 . . . . 73.239999999999995 111.445 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.422 ' HD3' ' HB ' ' A' ' 119' ' ' ILE . 7.5 tmtm? -64.04 122.51 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 75.140000000000001 110.086 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 25.1 m -66.53 114.82 5.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.93 -0.577 . . . . 72.230000000000004 109.92 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 12.8 tt -144.19 145.07 22.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.861 0.363 . . . . 70.5 110.958 -174.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -94.29 115.21 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.97 -0.752 . . . . 75.209999999999994 108.97 175.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.503 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.3 175.22 10.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 52.539999999999999 111.303 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -118.39 -34.19 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 74.239999999999995 110.362 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -107.52 146.21 32.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.932 -0.577 . . . . 75.099999999999994 110.25 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.16 137.91 53.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.945 -0.571 . . . . 75.439999999999998 109.827 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 28.3 ttp180 -123.52 122.54 38.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.499 -0.319 . . . . 73.409999999999997 110.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.57 HD21 HD11 ' A' ' 57' ' ' ILE . 37.2 tp -84.69 113.03 21.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.515 -0.92 . . . . 73.109999999999999 108.515 169.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 22.8 m -103.48 118.37 36.58 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 110.574 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.737 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.3 mm -102.51 96.76 7.78 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.712 -0.847 . . . . 74.109999999999999 108.712 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 72.8 Cg_endo -76.44 175.98 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.391 2.061 . . . . 64.340000000000003 112.595 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.95 13.25 29.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.729 0.776 . . . . 71.209999999999994 109.141 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.93 144.76 25.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.677 -1.147 . . . . 71.310000000000002 111.093 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.96 57.86 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.992 -0.623 . . . . 70.400000000000006 113.38 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 115.97 22.55 4.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.274 -0.965 . . . . 74.25 112.655 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -68.15 155.01 40.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 72.420000000000002 110.821 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 50.7 m -129.39 -176.89 4.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.019999999999996 110.197 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 40.3 p -85.23 22.58 1.44 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 72.409999999999997 111.605 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.1 123.55 68.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.574 -0.528 . . . . 71.540000000000006 109.574 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.14 138.88 30.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.469 -0.332 . . . . 71.230000000000004 110.216 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.75 105.24 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 73.140000000000001 111.026 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 42.3 mt -129.45 132.57 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.437 -0.579 . . . . 74.439999999999998 109.437 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 31.6 mmt180 -67.36 -67.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.465 -0.568 . . . . 74.230000000000004 109.465 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.45 152.81 47.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 73.349999999999994 111.494 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -112.76 116.09 29.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.456 -1.312 . . . . 74.129999999999995 107.456 166.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.83 161.39 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.753 -0.462 . . . . 65.439999999999998 109.753 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -131.51 125.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.282 -0.417 . . . . 72.219999999999999 110.262 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 3' ' ' THR . 47.0 mttp -102.31 105.06 15.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.417 0.627 . . . . 74.430000000000007 109.354 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.5 -148.93 4.86 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.181 -0.918 . . . . 63.219999999999999 111.524 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.8 m -132.71 129.25 38.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.809 0.337 . . . . 72.230000000000004 110.878 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.575 HD13 HG23 ' A' ' 5' ' ' ILE . 31.6 mm -71.71 119.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.616 . . . . 75.129999999999995 110.567 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.5 HD11 ' HG2' ' A' ' 120' ' ' LYS . 46.2 mt -106.61 134.49 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 75.5 109.757 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -117.64 143.85 45.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.909 -0.587 . . . . 75.239999999999995 109.964 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 155' ' ' HIS . 3.7 mp -130.69 -167.09 1.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.313 -0.625 . . . . 64.430000000000007 109.313 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -78.3 -163.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.929 0.395 . . . . 52.329999999999998 111.636 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -49.4 139.99 10.98 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.508 -0.769 . . . . 74.209999999999994 112.417 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 152' ' ' LEU . 39.2 m80 -134.4 146.68 50.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.824 -0.625 . . . . 72.129999999999995 110.102 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -85.67 173.56 10.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 64.340000000000003 111.019 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -51.28 160.29 0.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.516 -0.765 . . . . 74.099999999999994 112.784 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.451 ' HE1' HD23 ' A' ' 13' ' ' LEU . 46.8 t60 -55.97 119.25 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 65.129999999999995 111.049 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 72.219999999999999 110.009 177.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.229 -0.286 . . . . 75.010000000000005 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.72 -162.94 36.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.819 -0.705 . . . . 62.43 112.154 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' HG2' ' A' ' 146' ' ' LYS . 13.0 t -109.51 10.31 25.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.264 0.554 . . . . 74.430000000000007 110.403 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 127.61 33.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.713 -0.676 . . . . 74.049999999999997 110.177 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' CD1' ' A' ' 65' ' ' ILE . 21.2 mm -72.08 137.2 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.969 -0.56 . . . . 74.120000000000005 111.337 -172.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -70.87 111.21 6.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.941 -0.572 . . . . 72.349999999999994 110.538 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -87.04 3.46 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.72 -0.673 . . . . 73.230000000000004 111.803 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -66.88 -26.59 66.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.942 0.401 . . . . 73.310000000000002 110.779 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.84 -5.6 68.27 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.557 -0.83 . . . . 75.510000000000005 112.082 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -81.81 158.43 24.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.606 0.241 . . . . 75.040000000000006 110.643 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -142.37 158.26 43.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.913 0.387 . . . . 72.209999999999994 110.199 173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.22 125.78 45.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 74.019999999999996 109.62 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.544 HD11 ' HB2' ' A' ' 60' ' ' ASP . 87.7 mt -94.75 -41.12 9.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.321 -0.399 . . . . 74.299999999999997 110.715 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.0 t -142.48 140.92 32.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 73.409999999999997 110.613 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.43 136.32 19.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.829 -0.623 . . . . 75.340000000000003 109.655 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -87.84 -33.4 18.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 74.510000000000005 111.156 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -146.6 146.61 30.49 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.93 0.395 . . . . 74.340000000000003 110.955 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -162.01 140.47 9.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 74.450000000000003 108.839 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 43' ' ' HIS . 7.8 tp10 -109.78 81.84 1.5 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.336 0.589 . . . . 72.129999999999995 111.331 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.43 -4.26 53.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.449 -0.796 . . . . 75.439999999999998 110.467 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -100.27 -53.54 3.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.74 -0.664 . . . . 65.049999999999997 111.092 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -73.02 -34.85 58.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.3 -0.476 . . . . 75.400000000000006 112.412 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.44 -57.83 2.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.989 0.423 . . . . 74.439999999999998 110.327 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.88 171.98 12.51 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.678 -0.772 . . . . 73.230000000000004 111.944 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.21 119.92 11.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.939 0.4 . . . . 71.109999999999999 110.946 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.89 -10.35 57.15 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.047 -0.597 . . . . 71.409999999999997 112.266 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -121.02 138.33 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.675 -0.491 . . . . 72.239999999999995 109.675 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 5.87 88.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 62.310000000000002 112.832 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.582 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.2 mt -77.57 139.38 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.384 -0.228 . . . . 61.329999999999998 110.384 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.14 -21.27 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.030000000000001 111.529 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -22.28 46.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 74.129999999999995 110.901 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.869 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 86.3 m -69.63 -18.29 63.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.058 -0.519 . . . . 74.310000000000002 110.642 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.92 -27.46 69.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 75.519999999999996 110.176 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG22 HD11 ' A' ' 59' ' ' ILE . 34.2 pt -120.32 18.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 73.540000000000006 110.208 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.869 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -63.92 -45.75 87.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 73.549999999999997 110.222 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.08 24.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.631 -0.795 . . . . 74.230000000000004 112.708 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.49 131.73 54.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 74.409999999999997 111.134 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.7 p -71.55 -10.26 59.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.713 -0.676 . . . . 73.230000000000004 111.079 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.91 -21.67 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.329999999999998 111.058 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 17.1 p -89.76 169.77 11.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.091 -0.337 . . . . 74.349999999999994 110.091 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.515 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.2 p90 -163.62 157.9 19.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 74.430000000000007 111.284 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.51 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 34.8 t90 -103.83 142.41 34.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.283 -0.871 . . . . 74.5 108.98 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 19' ' ' GLU . 38.4 t-80 -138.72 144.53 39.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.532 -0.544 . . . . 74.200000000000003 109.532 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 144.39 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.027 -0.36 . . . . 71.420000000000002 110.027 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HE3' ' O ' ' A' ' 49' ' ' GLY . 29.2 ttpt -72.61 126.47 29.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.487 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -125.15 -24.84 3.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.39 -0.368 . . . . 74.430000000000007 110.772 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -71.19 112.56 7.43 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.087 0.47 . . . . 75.239999999999995 110.461 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.16 12.99 56.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.957 -0.639 . . . . 73.519999999999996 111.763 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.506 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . 107.97 143.02 10.48 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.091 -0.804 . . . . 74.129999999999995 111.091 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.4 m -85.78 166.79 15.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.71 0.29 . . . . 75.329999999999998 110.72 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 22.7 m-20 -91.13 148.9 38.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.421 -0.354 . . . . 73.299999999999997 110.518 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 12.0 Cg_exo -71.23 151.48 60.68 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.053 2.502 . . . . 73.349999999999994 112.531 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 15.5 mt -93.85 159.65 34.13 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.634 -0.712 . . . . 70.209999999999994 110.391 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.61 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.3 Cg_endo -81.73 161.54 79.41 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 123.481 -1.466 . . . . 73.040000000000006 112.845 2.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.791 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.1 m-85 -91.13 123.1 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.566 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.73 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 0.7 OUTLIER -109.49 123.36 49.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.447 -0.797 . . . . 74.310000000000002 110.361 -178.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 126' ' ' LEU . 61.8 mt -127.77 110.76 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.812 -0.44 . . . . 72.540000000000006 109.812 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.455 HG11 ' CH2' ' A' ' 97' ' ' TRP . 59.5 t -104.81 122.11 57.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.873 -0.603 . . . . 74.010000000000005 110.69 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 34' ' ' ILE . 57.5 mt -119.77 136.31 57.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.02 -0.537 . . . . 73.540000000000006 110.591 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.544 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.7 t0 -101.73 123.8 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 72.040000000000006 110.339 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 68.5 mtm -90.52 -3.1 57.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 61.140000000000001 110.783 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 71.79 0.2 3.42 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.365 0.666 . . . . 75.439999999999998 112.688 173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -163.81 170.95 16.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.431 -0.211 . . . . 73.299999999999997 110.431 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 121' ' ' ALA . 1.9 m120 -79.47 127.16 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 54.210000000000001 110.206 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.464 ' CD1' HG22 ' A' ' 5' ' ' ILE . 75.0 mt -133.42 135.46 56.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.753 -0.462 . . . . 75.129999999999995 109.753 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 150' ' ' ILE . 51.5 tp60 -80.11 104.09 10.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.009 -0.737 . . . . 75.310000000000002 109.009 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.76 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.6 mm -74.41 108.12 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.637 -0.256 . . . . 72.040000000000006 110.564 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.26 -50.79 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 73.340000000000003 110.895 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -142.23 140.08 32.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.025 0.441 . . . . 75.219999999999999 111.09 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.0 129.09 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 75.530000000000001 109.445 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -111.47 129.43 56.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.068 0.461 . . . . 73.439999999999998 110.971 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD12 ' CE2' ' A' ' 114' ' ' TYR . 54.3 mt -116.77 129.36 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.804 -0.634 . . . . 73.230000000000004 110.241 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.4 tp -106.92 104.94 53.88 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.285 -0.416 . . . . 74.099999999999994 110.231 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 Cg_exo -75.81 176.98 9.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.51 2.806 . . . . 73.030000000000001 111.477 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.752 ' HD2' ' HB3' ' A' ' 139' ' ' ALA . 48.1 mtp180 -71.96 -23.18 61.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.533 0.206 . . . . 73.109999999999999 111.413 -176.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.56 ' HA2' ' C ' ' A' ' 108' ' ' GLN . . . 88.9 -60.72 3.83 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.704 -0.76 . . . . 61.119999999999997 112.758 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -75.69 167.34 22.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.15 0.5 . . . . 74.319999999999993 111.147 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.59 69.57 0.93 Allowed Glycine 0 C--N 1.321 -0.289 0 CA-C-N 114.928 -1.033 . . . . 51.119999999999997 113.019 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -100.06 167.16 10.65 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.25 -0.648 . . . . 75.450000000000003 109.25 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -68.31 101.34 1.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.963 0.411 . . . . 53.299999999999997 110.266 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.555 HD22 ' HE2' ' A' ' 105' ' ' PHE . 64.5 t30 -144.31 72.97 16.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.734 -0.666 . . . . 62.140000000000001 109.52 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.51 40.91 1.02 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.191 2.594 . . . . 73.010000000000005 113.636 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mt -83.48 130.73 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.879 -0.415 . . . . 65.129999999999995 109.879 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -109.99 -56.18 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.87 -0.605 . . . . 71.129999999999995 110.578 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.465 HG21 ' HA3' ' A' ' 132' ' ' GLY . 92.6 t -118.83 137.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.549 . . . . 61.140000000000001 110.622 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -127.4 134.56 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.615 . . . . 71.109999999999999 110.273 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.91 125.87 53.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.223 0.535 . . . . 75.099999999999994 110.614 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -104.87 129.45 53.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.807 -0.633 . . . . 74.230000000000004 109.967 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.33 151.21 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 74.030000000000001 110.779 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.01 150.25 51.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.901 -0.591 . . . . 73.349999999999994 109.86 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -149.63 161.11 42.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.101 0.477 . . . . 75.530000000000001 111.047 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.772 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 32.7 mt-10 -120.29 -7.14 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.0 -0.546 . . . . 73.230000000000004 110.603 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -122.14 -9.81 8.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.641 -0.254 . . . . 74.430000000000007 111.036 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 73.58 6.46 5.02 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.907 0.755 . . . . 72.340000000000003 110.331 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.4 t -113.84 -50.71 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.686 -0.688 . . . . 70.319999999999993 110.301 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -98.4 104.78 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.734 -0.666 . . . . 70.319999999999993 109.863 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.455 ' CH2' HG11 ' A' ' 58' ' ' VAL . 99.0 m95 -91.71 131.14 37.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.053 -0.521 . . . . 72.400000000000006 110.529 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 m -110.67 122.82 37.21 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 116.006 -0.543 . . . . 62.5 109.91 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 125.71 15.94 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.427 2.085 . . . . 72.409999999999997 111.723 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 116' ' ' VAL . 28.7 pt -100.4 -17.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 75.219999999999999 110.57 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.65 133.23 1.82 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.891 -1.147 . . . . 65.420000000000002 113.025 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -114.99 114.96 26.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.86 -0.793 . . . . 74.510000000000005 108.86 172.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.406 ' HE2' HG11 ' A' ' 116' ' ' VAL . 56.9 m-85 -138.69 -174.25 3.78 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.402 -0.519 . . . . 64.120000000000005 111.124 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.61 146.04 16.33 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.944 -0.646 . . . . 71.329999999999998 112.043 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.555 ' HE2' HD22 ' A' ' 81' ' ' ASN . 42.8 t80 -99.1 148.69 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 74.409999999999997 110.057 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -139.61 127.49 22.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.298 -0.41 . . . . 72.329999999999998 110.193 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -80.87 100.3 8.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.185 0.517 . . . . 74.109999999999999 110.187 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.56 ' C ' ' HA2' ' A' ' 76' ' ' GLY . 11.9 pt20 -140.73 172.98 11.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.716 -0.675 . . . . 72.420000000000002 109.996 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.98 -3.92 58.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 75.329999999999998 110.603 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.42 34.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.935 -0.575 . . . . 63.210000000000001 110.452 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 131.17 45.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.124 0.488 . . . . 75.540000000000006 110.708 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.37 114.29 21.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.641 -0.709 . . . . 74.409999999999997 110.637 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.41 108.56 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 74.230000000000004 110.711 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.445 ' CE2' HD12 ' A' ' 72' ' ' LEU . 96.1 m-85 -100.89 104.33 15.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 75.129999999999995 110.523 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -74.3 99.78 3.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.611 -0.722 . . . . 74.430000000000007 109.28 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.463 HG22 HD11 ' A' ' 100' ' ' ILE . 26.9 m -100.47 175.22 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 74.540000000000006 111.814 -173.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.607 ' HZ1' ' HB3' ' A' ' 117' ' ' LYS . 4.7 ttpm? -70.89 113.15 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 74.319999999999993 109.295 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.76 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 49.7 m -68.98 118.01 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 70.129999999999995 111.258 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -146.7 150.41 14.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 72.329999999999998 110.028 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.478 ' HG3' HD13 ' A' ' 150' ' ' ILE . 27.0 ttpp -83.88 133.12 34.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.904 -0.406 . . . . 74.239999999999995 109.904 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.772 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -154.64 171.82 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.416 -0.357 . . . . 73.140000000000001 110.433 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -114.61 -35.01 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.372 0.606 . . . . 74.019999999999996 109.82 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -108.08 145.01 34.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.754 . . . . 73.310000000000002 109.902 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -128.87 139.33 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.39 -0.596 . . . . 75.409999999999997 109.39 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.73 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 31.5 ttp180 -127.29 124.56 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.103 0.477 . . . . 74.319999999999993 111.804 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.571 HD21 HD13 ' A' ' 57' ' ' ILE . 41.2 tp -87.4 112.34 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.704 -0.851 . . . . 75.109999999999999 108.704 171.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -107.59 117.09 33.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.952 0.406 . . . . 72.439999999999998 110.81 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.791 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -101.27 95.25 4.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.596 -0.89 . . . . 72.329999999999998 108.596 172.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.61 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -74.36 172.87 15.23 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.384 2.056 . . . . 71.120000000000005 112.529 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.26 25.9 4.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.889 0.852 . . . . 70.099999999999994 109.133 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -113.57 142.83 45.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.432 -1.258 . . . . 74.010000000000005 110.096 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.465 ' HA3' HG21 ' A' ' 85' ' ' VAL . . . 100.29 -18.11 55.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.83 -0.7 . . . . 75.420000000000002 113.044 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 112.95 17.09 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.33 -0.938 . . . . 72.439999999999998 112.248 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.7 127.73 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 74.420000000000002 110.663 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.3 m -93.84 -179.73 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.29 -0.414 . . . . 72.420000000000002 110.069 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 2.0 p -81.3 31.49 0.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.07 0.462 . . . . 65.340000000000003 111.954 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.28 130.77 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.626 -0.509 . . . . 72.140000000000001 109.626 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.28 31.11 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.974 -0.38 . . . . 74.230000000000004 109.974 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.752 ' HB3' ' HD2' ' A' ' 75' ' ' ARG . . . -144.6 105.93 4.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.138 0.494 . . . . 75.040000000000006 111.521 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.3 mt -129.89 132.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.415 -0.587 . . . . 74.200000000000003 109.415 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 74' ' ' PRO . 58.6 mtp180 -72.54 -52.16 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.321 -0.152 . . . . 72.219999999999999 110.914 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.39 160.46 34.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.723 -0.791 . . . . 74.129999999999995 112.097 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -118.91 127.92 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.691 -1.14 . . . . 73.530000000000001 108.602 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.19 145.68 47.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.871 -0.418 . . . . 75.340000000000003 109.871 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.39 124.39 72.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.047 0.451 . . . . 65.0 110.21 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.65 ' HG2' HG22 ' A' ' 3' ' ' THR . 16.1 ttmt -103.31 103.67 13.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.814 -0.63 . . . . 75.540000000000006 109.341 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.54 -168.23 15.25 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.721 -0.752 . . . . 42.229999999999997 112.166 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.5 m -118.2 134.08 55.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.59 0.233 . . . . 62.5 110.708 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.462 HG21 ' HG ' ' A' ' 152' ' ' LEU . 38.0 mm -71.67 133.04 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 65.140000000000001 111.326 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.478 HD13 ' HG3' ' A' ' 120' ' ' LYS . 56.6 mt -126.15 150.24 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.616 -0.72 . . . . 74.040000000000006 109.132 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 61.21 53.15 3.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.57 -0.9 . . . . 71.420000000000002 108.57 -171.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.47 HD11 ' H ' ' A' ' 152' ' ' LEU . 4.7 mp -66.81 141.47 57.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 72.209999999999994 111.38 -171.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 65.63 22.12 11.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.09 -0.959 . . . . 73.230000000000004 111.821 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -81.88 -17.52 46.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.921 -0.77 . . . . 73.230000000000004 108.921 170.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -74.28 141.5 45.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.969 -1.014 . . . . 75.129999999999995 111.021 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -130.08 137.66 50.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.117 -0.697 . . . . 73.140000000000001 109.117 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -77.72 -25.85 49.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 73.150000000000006 111.521 -170.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -75.73 98.88 4.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.987 0.422 . . . . 74.439999999999998 110.395 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 110.213 179.07 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.911 0.386 . . . . 71.0 110.437 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.39 -88.5 0.42 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.844 -0.694 . . . . 63.539999999999999 112.217 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t 46.32 27.89 0.64 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.954 0.902 . . . . 75.010000000000005 112.168 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -69.15 136.39 52.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.047 -0.979 . . . . 54.140000000000001 110.726 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.52 HG23 ' CD1' ' A' ' 65' ' ' ILE . 39.0 mm -88.59 136.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.912 -0.585 . . . . 74.239999999999995 110.24 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 m -69.37 120.35 15.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.98 0.419 . . . . 72.239999999999995 110.007 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -88.15 5.96 38.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 73.430000000000007 111.016 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 88.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.887 -0.597 . . . . 74.349999999999994 110.406 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.67 -13.66 3.67 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.513 -0.767 . . . . 64.109999999999999 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -69.5 142.26 53.76 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.725 -0.472 . . . . 75.040000000000006 109.725 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.485 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 21.8 pt-20 -127.89 158.76 36.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.186 0.517 . . . . 61.399999999999999 111.109 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 114.67 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 72.400000000000006 110.023 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 60' ' ' ASP . 81.7 mt -81.35 -48.74 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.036 -0.529 . . . . 74.239999999999995 110.229 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -147.19 142.16 26.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 62.420000000000002 110.371 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.18 146.88 34.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.686 -0.688 . . . . 75.340000000000003 109.196 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -86.0 -37.49 18.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.858 0.361 . . . . 72.420000000000002 111.176 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.4 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.7 t -153.89 149.8 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.014 0.435 . . . . 75.230000000000004 111.109 -178.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 24.8 pt20 -159.01 146.4 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.069 -1.086 . . . . 75.230000000000004 108.069 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -99.31 94.73 6.62 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 75.400000000000006 110.407 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.74 -0.83 23.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.665 -0.698 . . . . 74.049999999999997 110.853 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 m -114.26 -37.94 4.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.139 -0.482 . . . . 54.119999999999997 110.94 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.41 55.9 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.012 -0.54 . . . . 64.239999999999995 112.891 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -113.22 14.87 19.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 73.230000000000004 110.898 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.57 -176.82 51.31 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.912 -0.586 . . . . 74.420000000000002 112.949 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.74 139.29 30.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.024 -0.361 . . . . 74.109999999999999 110.024 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' H ' HD11 ' A' ' 29' ' ' LEU . . . 102.24 -2.71 50.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.99 -0.624 . . . . 61.450000000000003 111.586 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -154.1 131.97 11.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.247 -0.649 . . . . 74.299999999999997 109.247 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.33 -1.16 76.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.975 -0.631 . . . . 63.200000000000003 111.808 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.624 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 63.8 mt -77.08 150.31 35.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.273 -0.269 . . . . 72.150000000000006 110.273 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.47 -29.95 69.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 71.140000000000001 110.108 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -67.62 -22.69 65.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 74.319999999999993 111.374 177.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.8 m -68.86 -25.2 64.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.971 0.415 . . . . 73.129999999999995 110.293 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.22 -27.87 69.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.694 -0.684 . . . . 61.32 110.361 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 59' ' ' ILE . 31.3 pt -119.31 14.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 73.25 110.434 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.8 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.0 t70 -65.15 -40.7 94.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 71.409999999999997 110.548 -176.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.6 25.76 13.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 72.540000000000006 111.882 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -131.8 122.35 25.64 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.652 -0.499 . . . . 74.230000000000004 109.652 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 p -75.07 -7.79 54.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.906 -0.588 . . . . 75.540000000000006 111.791 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -85.65 -24.2 27.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 72.439999999999998 110.38 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.0 p -96.95 155.8 16.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.292 -0.413 . . . . 73.519999999999996 110.454 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 40.9 p90 -149.07 168.91 21.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.855 0.36 . . . . 72.329999999999998 111.153 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.6 t90 -104.85 138.4 41.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 72.209999999999994 109.083 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -133.88 136.96 44.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.411 -0.588 . . . . 74.340000000000003 109.411 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.43 58.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.672 -0.492 . . . . 75.040000000000006 109.672 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 50' ' ' SER . 53.6 tttm -64.87 120.17 12.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 72.219999999999999 110.369 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -111.19 -30.91 7.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.844 -0.617 . . . . 74.519999999999996 110.845 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -73.11 129.21 37.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.996 -0.372 . . . . 75.219999999999999 109.996 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.06 -12.27 62.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.946 -0.645 . . . . 53.299999999999997 111.974 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.23 140.96 5.9 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.599 -0.601 . . . . 33.409999999999997 111.599 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 9.8 p -81.94 145.79 30.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.662 0.268 . . . . 72.140000000000001 110.812 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 4.3 m-20 -72.72 156.02 90.35 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.096 -0.502 . . . . 74.120000000000005 110.339 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.32 148.79 49.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.526 2.151 . . . . 74.129999999999995 113.01 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -82.46 158.69 65.77 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 75.319999999999993 109.866 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.91 159.31 91.24 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.497 -1.46 . . . . 62.25 112.678 0.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.657 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.8 m-85 -91.3 117.89 30.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.092 -0.503 . . . . 74.349999999999994 110.196 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.689 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.2 t70 -108.16 126.7 53.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.528 -0.76 . . . . 65.019999999999996 110.572 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.568 HD13 HD22 ' A' ' 126' ' ' LEU . 57.9 mt -130.64 114.96 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 74.510000000000005 110.242 175.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.13 115.82 49.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.948 -0.569 . . . . 72.209999999999994 110.984 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.521 HD12 HD12 ' A' ' 34' ' ' ILE . 49.4 mm -112.16 142.79 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.493 . . . . 73.239999999999995 110.822 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.434 ' HB2' HD11 ' A' ' 13' ' ' LEU . 59.0 t0 -108.77 121.6 45.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.912 -0.585 . . . . 71.109999999999999 109.508 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.511 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 68.3 mtm -85.15 -9.65 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.409999999999997 111.155 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.485 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 71.6 mmtt 68.33 16.04 9.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.148 -0.478 . . . . 73.400000000000006 112.215 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.611 ' HB2' HD13 ' A' ' 152' ' ' LEU . 8.3 pt20 -169.17 159.51 9.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.61 0.243 . . . . 75.319999999999993 110.936 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.78 126.0 33.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.465 . . . . 73.430000000000007 110.481 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.52 ' CD1' HG23 ' A' ' 5' ' ' ILE . 71.8 mt -135.95 140.45 44.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.064 -0.517 . . . . 70.420000000000002 110.304 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.628 ' HB2' HD13 ' A' ' 150' ' ' ILE . 53.0 tp60 -82.86 101.81 11.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.188 -0.671 . . . . 75.430000000000007 109.188 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.706 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.5 mm -66.8 122.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.551 -0.295 . . . . 70.25 110.328 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.46 -33.09 4.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.738 0.304 . . . . 72.140000000000001 111.429 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.68 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 10.3 tt0 -159.41 145.41 16.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.571 -0.286 . . . . 73.209999999999994 110.384 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -114.18 137.24 48.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.49 -0.559 . . . . 75.420000000000002 109.49 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 16.7 tt0 -112.9 132.6 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.832 -0.347 . . . . 74.109999999999999 110.185 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' A' ' 114' ' ' TYR . 44.5 mt -120.4 116.82 26.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.384 . . . . 75.299999999999997 110.146 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.4 tp -101.91 103.91 32.26 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.348 -0.612 . . . . 75.209999999999994 109.348 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 15.3 Cg_exo -68.47 171.27 13.28 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.438 2.759 . . . . 63.25 112.835 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.511 ' HD2' ' CB ' ' A' ' 139' ' ' ALA . 35.2 ttt180 -60.64 -45.81 92.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.068 -0.515 . . . . 75.219999999999999 110.96 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.41 172.25 12.47 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.868 -0.682 . . . . 70.439999999999998 111.802 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -70.18 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.006 0.373 . . . . 75.109999999999999 112.006 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.5 45.74 3.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 73.409999999999997 112.12 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.9 t -172.45 158.28 4.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.856 -0.794 . . . . 75.340000000000003 108.856 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.57 -69.56 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.195 -0.298 . . . . 74.329999999999998 110.195 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 61.3 t30 52.75 60.2 13.03 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 123.985 0.803 . . . . 61.240000000000002 110.255 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 81' ' ' ASN . 4.1 Cg_exo -74.47 60.5 5.01 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.164 2.576 . . . . 64.409999999999997 113.474 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -92.17 125.54 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.825 -0.435 . . . . 64.409999999999997 109.825 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -93.4 -53.05 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.027 -0.533 . . . . 73.120000000000005 110.003 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.73 137.45 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 65.420000000000002 110.836 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 m -121.68 135.22 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.73 . . . . 72.409999999999997 109.542 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 54.6 mt-10 -119.05 125.48 49.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.03 0.443 . . . . 74.319999999999993 110.646 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -104.81 131.08 52.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 71.040000000000006 110.424 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.57 149.81 49.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.224 -0.444 . . . . 74.25 110.145 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.83 48.49 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.13 -0.486 . . . . 74.5 110.48 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 t -149.86 152.49 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.949 0.404 . . . . 63.299999999999997 110.199 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.652 ' HB3' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.23 7.32 10.22 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.418 0.628 . . . . 75.329999999999998 109.804 175.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.4 -15.06 7.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.342 -0.845 . . . . 73.329999999999998 109.904 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.45 7.22 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.355 -0.839 . . . . 75.430000000000007 110.103 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.69 -59.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.477 -0.783 . . . . 75.230000000000004 110.512 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -88.78 104.05 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 74.349999999999994 110.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -91.96 116.05 28.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.901 0.381 . . . . 74.239999999999995 110.608 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.5 m -94.83 125.08 52.51 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.972 -0.558 . . . . 74.150000000000006 110.444 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 111.47 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.665 2.243 . . . . 72.409999999999997 111.51 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 20.1 pt -89.93 -9.88 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.321 -0.4 . . . . 71.510000000000005 111.404 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.35 128.7 0.98 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.259 -1.448 . . . . 44.340000000000003 114.287 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 7.5 ttm180 -98.75 126.17 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.84 -0.8 . . . . 74.430000000000007 108.84 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.426 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.7 m-85 -141.82 169.24 17.96 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.26 -0.576 . . . . 72.299999999999997 111.394 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.32 139.26 15.94 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.649 . . . . 74.109999999999999 111.765 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -95.33 148.23 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.109 0.48 . . . . 75.010000000000005 110.701 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.483 ' O ' HD11 ' A' ' 112' ' ' LEU . 85.6 m -132.3 114.25 14.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.0 -0.546 . . . . 72.209999999999994 110.062 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -75.48 97.4 3.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.44 . . . . 71.230000000000004 110.102 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 12.6 pt20 -136.27 -179.97 5.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.88 -0.6 . . . . 74.450000000000003 110.423 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.46 9.82 42.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 65.129999999999995 110.247 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.66 151.14 39.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.692 -0.686 . . . . 72.310000000000002 109.973 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.51 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -75.95 128.17 34.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.161 0.505 . . . . 75.25 111.605 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.483 HD11 ' O ' ' A' ' 106' ' ' THR . 26.7 mt -82.75 117.88 22.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.485 -0.78 . . . . 75.400000000000006 110.388 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.68 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 43.4 mt-10 -92.87 111.76 23.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.923 0.392 . . . . 71.209999999999994 110.811 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.459 ' CE2' HD13 ' A' ' 72' ' ' LEU . 85.0 m-85 -105.15 107.41 18.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.071 0.462 . . . . 75.549999999999997 110.516 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -76.96 95.07 4.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.587 -0.733 . . . . 71.239999999999995 109.36 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.426 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.3 m -97.58 179.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.512 -0.767 . . . . 54.43 111.817 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -65.75 134.94 54.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.739 . . . . 65.040000000000006 110.816 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 45.9 p -79.1 123.32 27.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.805 -0.634 . . . . 72.409999999999997 110.366 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.3 tt -157.84 148.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 110.757 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.37 122.76 28.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.693 -0.484 . . . . 75.329999999999998 109.693 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.652 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . . . -144.72 175.39 10.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.351 -0.386 . . . . 74.219999999999999 111.002 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -127.79 -32.51 2.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.377 0.608 . . . . 73.329999999999998 109.631 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.51 145.6 31.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.59 -0.732 . . . . 73.129999999999995 109.424 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.432 HG23 ' HB ' ' A' ' 59' ' ' ILE . 11.4 tt -131.47 135.16 59.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.015 0.436 . . . . 73.340000000000003 109.872 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.689 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 54.5 ttp180 -121.76 118.48 29.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.045 0.45 . . . . 73.129999999999995 111.04 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.568 HD22 HD13 ' A' ' 57' ' ' ILE . 57.5 tp -87.43 119.71 27.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 74.430000000000007 109.063 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 45.5 m -116.42 120.51 39.04 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.933 0.397 . . . . 62.420000000000002 111.123 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.657 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.0 mm -98.76 95.96 3.54 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.311 -0.996 . . . . 72.409999999999997 108.311 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.99 163.33 39.63 Favored 'Trans proline' 0 CA--C 1.52 -0.179 0 C-N-CA 123.056 2.504 . . . . 74.230000000000004 113.575 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.57 71.49 0.79 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.559 -0.904 . . . . 73.400000000000006 108.559 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -149.42 -39.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.027 -0.988 . . . . 61.43 110.901 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.57 -6.18 83.66 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.384 -0.912 . . . . 54.020000000000003 113.705 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.78 26.94 7.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.974 -1.107 . . . . 74.540000000000006 111.917 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -72.69 137.02 45.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.601 0.239 . . . . 72.099999999999994 110.447 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -94.68 173.0 7.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.252 -0.431 . . . . 74.450000000000003 110.171 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 p -81.33 10.89 4.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.422 0.527 . . . . 71.450000000000003 112.422 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.417 . . . . 73.420000000000002 110.089 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.55 125.02 48.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.911 -0.586 . . . . 74.0 110.055 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.511 ' CB ' ' HD2' ' A' ' 75' ' ' ARG . . . -142.57 109.08 5.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.281 0.562 . . . . 75.109999999999999 111.558 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.93 132.67 69.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.144 -0.687 . . . . 75.200000000000003 109.144 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.699 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 94.1 mtt180 -67.16 -62.48 1.41 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.082 0.468 . . . . 73.230000000000004 110.212 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.48 148.75 34.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 73.439999999999998 111.614 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.42 126.74 54.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.405 -1.332 . . . . 73.439999999999998 107.405 170.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.73 157.95 29.84 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.729 -0.471 . . . . 75.010000000000005 109.729 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.12 124.19 63.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.199 0.523 . . . . 71.010000000000005 110.471 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.5 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 80.2 mttt -102.18 112.17 24.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.441 -0.799 . . . . 75.230000000000004 108.862 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.99 -175.01 32.56 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.3 -0.952 . . . . 71.299999999999997 112.685 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 m -104.94 127.91 52.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.589 0.233 . . . . 74.310000000000002 110.795 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.63 HG21 HD12 ' A' ' 152' ' ' LEU . 36.0 mm -65.99 128.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 110.722 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 66' ' ' GLN . 60.4 mt -120.69 140.94 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.349999999999994 111.272 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 64.62 21.15 12.36 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.656 -0.702 . . . . 75.349999999999994 112.128 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.63 HD12 HG21 ' A' ' 149' ' ' ILE . 86.7 mt -121.72 131.77 54.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.118 0.485 . . . . 75.540000000000006 110.47 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -130.97 -174.67 3.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 65.409999999999997 109.602 -174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -84.75 -2.33 57.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 72.549999999999997 109.104 168.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.5 m170 -95.38 -170.57 2.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.956 -1.02 . . . . 65.0 108.61 170.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.454 ' HB2' ' O ' ' A' ' 159' ' ' HIS . 7.7 p80 -133.88 71.11 1.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.46 0.647 . . . . 73.439999999999998 112.011 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -89.51 -19.97 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 70.5 110.265 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -134.0 30.92 3.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 72.140000000000001 110.461 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 8.1 m170 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.16 -0.927 . . . . 74.430000000000007 109.486 176.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.944 0.402 . . . . 73.349999999999994 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.33 -95.43 0.56 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.044 -1.223 . . . . 51.340000000000003 110.044 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.8 m -97.64 -22.39 16.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.618 -1.253 . . . . 73.230000000000004 107.618 166.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -84.77 160.55 20.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.467 -1.242 . . . . 74.329999999999998 109.966 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.542 HG23 ' CD1' ' A' ' 65' ' ' ILE . 44.4 mm -81.76 148.24 5.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.62 -0.264 . . . . 75.530000000000001 110.559 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -66.24 107.08 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.903 0.382 . . . . 74.319999999999993 110.301 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 37.8 mtmt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 111.147 -175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -71.06 -10.26 59.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.026 -0.534 . . . . 74.450000000000003 111.624 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.28 9.32 38.84 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.859 -0.686 . . . . 72.519999999999996 111.967 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -90.9 161.94 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.014 -0.365 . . . . 73.010000000000005 110.014 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.4 pt-20 -141.37 159.81 41.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 72.409999999999997 110.731 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.02 116.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.608 -0.724 . . . . 73.430000000000007 110.132 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.84 -43.62 19.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.921 -0.581 . . . . 73.299999999999997 110.711 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 t -142.45 140.71 32.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 64.299999999999997 110.371 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.02 146.14 29.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.471 -0.786 . . . . 72.329999999999998 109.13 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -85.51 -33.95 21.67 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.723 -0.391 . . . . 73.209999999999994 110.952 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -155.6 152.34 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.05 0.452 . . . . 75.0 110.885 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -163.19 145.99 10.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.153 -1.054 . . . . 72.219999999999999 108.153 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 7.4 tp10 -95.52 98.21 10.36 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.44 0.638 . . . . 73.420000000000002 110.189 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 8.4 29.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.874 . . . . 73.120000000000005 111.425 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 m -136.52 -43.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.908 -0.317 . . . . 74.420000000000002 111.346 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.32 -31.49 71.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.078 -0.582 . . . . 73.219999999999999 112.769 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 62.1 mm-40 -93.03 6.57 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 75.450000000000003 110.835 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.4 -116.62 5.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.845 -0.693 . . . . 51.509999999999998 111.612 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.49 138.07 15.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.711 -0.477 . . . . 50.409999999999997 109.711 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 3.37 90.36 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.674 -0.774 . . . . 62.030000000000001 112.939 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -147.81 149.63 32.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.401 . . . . 75.340000000000003 109.916 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.16 3.49 72.74 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.846 -0.901 . . . . 73.329999999999998 110.846 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 51.3 mt -84.42 159.15 20.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.177 -0.512 . . . . 74.109999999999999 110.299 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.39 -28.83 68.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 73.129999999999995 110.909 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -75.45 -20.8 58.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 75.120000000000005 111.37 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 64.5 m -69.76 -23.76 63.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 72.049999999999997 110.532 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.73 -21.2 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.698 -0.683 . . . . 74.430000000000007 110.543 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.41 HG22 HD13 ' A' ' 59' ' ' ILE . 30.4 pt -127.65 24.12 2.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 74.540000000000006 110.41 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.7 t70 -75.22 -38.8 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.117 -0.492 . . . . 70.099999999999994 111.533 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 40.68 3.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.265 -0.734 . . . . 63.119999999999997 111.265 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 8.9 t0 -153.64 126.21 8.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.728 -0.471 . . . . 73.409999999999997 109.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -73.23 -14.38 61.32 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.871 0.693 . . . . 71.129999999999995 112.871 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -93.53 -13.06 28.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 74.430000000000007 110.638 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 41.2 p -97.22 137.1 36.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.204 -0.665 . . . . 74.109999999999999 109.204 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.939 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 4.0 p90 -145.07 171.57 14.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.959 0.409 . . . . 75.329999999999998 111.111 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.525 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 41.5 t90 -105.19 125.46 51.0 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 70.219999999999999 109.256 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -124.47 137.49 54.43 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.425 -0.954 . . . . 74.0 108.425 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 144.88 56.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.625 -0.509 . . . . 75.219999999999999 109.625 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -65.59 112.58 3.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.838 0.351 . . . . 60.310000000000002 110.324 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -103.08 -25.08 13.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.097 -0.501 . . . . 74.310000000000002 110.364 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.51 121.64 15.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 75.530000000000001 110.318 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.89 -3.62 83.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.924 -0.655 . . . . 71.430000000000007 113.002 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.26 148.5 8.55 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.727 -0.749 . . . . 64.230000000000004 111.884 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.58 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 24.9 p -82.86 148.61 27.62 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.986 0.422 . . . . 75.109999999999999 111.338 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.79 158.98 86.8 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.637 . . . . 73.150000000000006 110.642 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.43 136.75 29.32 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.181 1.921 . . . . 71.420000000000002 112.413 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 16.5 mt -77.99 161.5 70.77 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 75.040000000000006 110.157 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.824 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 3.6 Cg_exo -81.9 162.23 78.16 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 124.115 -1.202 . . . . 74.109999999999999 112.585 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.9 m-85 -97.21 133.6 41.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 73.439999999999998 109.742 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -131.68 117.63 18.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.676 0.274 . . . . 74.030000000000001 110.518 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.45 119.39 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 74.230000000000004 110.819 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -107.01 119.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 110.389 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.519 ' HB ' HG23 ' A' ' 124' ' ' ILE . 75.2 mt -118.06 139.82 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.407 -0.36 . . . . 65.150000000000006 111.232 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -108.27 121.85 45.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.052 -0.522 . . . . 73.439999999999998 109.629 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.5 mtm -86.01 -8.29 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 70.5 111.068 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 73.3 -11.93 0.86 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.244 0.618 . . . . 73.310000000000002 112.591 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -144.14 167.26 22.82 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.132 -0.321 . . . . 75.519999999999996 110.132 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.29 128.78 34.97 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.816 0.341 . . . . 73.319999999999993 110.092 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.542 ' CD1' HG23 ' A' ' 5' ' ' ILE . 67.7 mt -135.19 137.98 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.451 -0.34 . . . . 74.439999999999998 110.283 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -82.31 103.28 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.233 -0.654 . . . . 74.439999999999998 109.233 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 118' ' ' SER . 26.5 mm -70.11 125.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.469 -0.332 . . . . 73.400000000000006 110.119 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.34 -48.54 2.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 71.310000000000002 110.813 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.42 ' NE2' ' HE2' ' A' ' 146' ' ' LYS . 23.7 tt0 -147.59 146.42 29.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 74.510000000000005 109.977 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.15 131.96 70.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.16 -0.473 . . . . 72.349999999999994 110.049 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -109.84 135.66 50.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.074 0.464 . . . . 70.409999999999997 111.048 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.541 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 57.1 mt -114.28 118.27 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.062 -0.718 . . . . 75.420000000000002 109.062 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 tp -103.37 99.75 16.02 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.413 -0.358 . . . . 75.219999999999999 110.345 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.541 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 12.3 Cg_exo -69.62 171.72 13.81 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.734 2.289 . . . . 74.25 111.067 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -77.6 -23.52 49.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.697 -0.401 . . . . 74.540000000000006 110.577 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 109' ' ' ASP . . . 135.14 170.6 12.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.018 -0.611 . . . . 70.420000000000002 111.797 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.426 ' HG2' ' HA ' ' A' ' 108' ' ' GLN . 75.3 mtp180 -77.6 -18.15 57.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 73.109999999999999 110.067 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 29.02 5.99 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.675 -0.693 . . . . 64.200000000000003 111.86 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -145.25 144.04 30.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.6 -0.518 . . . . 74.109999999999999 109.6 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -74.57 122.46 23.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 74.209999999999994 110.543 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -164.63 84.86 1.16 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 72.109999999999999 109.51 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 27.3 Cg_endo -92.81 62.08 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.406 2.737 . . . . 72.219999999999999 113.689 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.61 HD13 ' HB1' ' A' ' 138' ' ' ALA . 54.1 mt -96.64 131.8 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.136 -0.69 . . . . 74.5 109.136 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -108.67 -46.98 3.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.765 0.316 . . . . 72.430000000000007 111.079 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG11 ' HE ' ' A' ' 102' ' ' ARG . 47.2 t -124.33 139.06 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.565 -0.289 . . . . 74.340000000000003 110.971 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 105' ' ' PHE . 6.7 m -132.03 144.71 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 71.540000000000006 110.668 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 34.2 mt-10 -120.1 135.99 54.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 111.207 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -118.2 130.52 56.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.947 -0.569 . . . . 72.510000000000005 110.618 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.37 148.91 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.474 -0.33 . . . . 63.43 110.628 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.58 148.28 51.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.35 -0.386 . . . . 72.430000000000007 110.382 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -150.3 161.24 42.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 73.439999999999998 111.268 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.36 -20.56 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 63.130000000000003 110.773 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -118.1 -5.09 10.96 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.311 0.486 . . . . 75.439999999999998 112.311 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.0 t30 69.85 12.47 7.94 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.595 0.712 . . . . 71.040000000000006 110.382 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.7 -53.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 72.239999999999995 109.773 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -95.61 98.99 10.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 75.430000000000007 109.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.405 ' CH2' ' HB2' ' A' ' 125' ' ' ARG . 98.2 m95 -88.69 123.46 33.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 73.310000000000002 110.899 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 121.91 57.2 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.073 -0.512 . . . . 72.109999999999999 110.009 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 109.38 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.396 2.064 . . . . 75.109999999999999 111.942 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.598 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -80.62 -12.65 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 64.409999999999997 110.205 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.1 145.94 4.37 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.625 -0.798 . . . . 54.200000000000003 113.02 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.414 ' HE ' HG11 ' A' ' 85' ' ' VAL . 70.9 ttt180 -115.91 120.54 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.818 -0.808 . . . . 74.150000000000006 108.818 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.401 ' HE2' HG11 ' A' ' 116' ' ' VAL . 89.4 m-85 -133.22 178.94 6.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.099 0.476 . . . . 75.349999999999994 111.151 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.39 143.89 16.99 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.71 -0.677 . . . . 64.310000000000002 111.791 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.408 ' HB2' HG13 ' A' ' 86' ' ' VAL . 40.3 t80 -94.75 125.61 39.52 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.786 -0.45 . . . . 74.030000000000001 109.786 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.524 ' HB ' HD22 ' A' ' 112' ' ' LEU . 19.7 m -113.76 104.35 12.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 109.94 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.45 92.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.008 0.432 . . . . 74.129999999999995 110.024 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.426 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 20.7 pt20 -121.02 -173.59 2.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.778 -0.646 . . . . 72.239999999999995 110.816 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.423 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 32.1 t70 -88.16 -18.91 27.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.715 -0.675 . . . . 73.409999999999997 110.819 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.3 -175.09 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 74.439999999999998 111.014 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.27 147.99 26.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.979 0.419 . . . . 70.200000000000003 110.442 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.524 HD22 ' HB ' ' A' ' 106' ' ' THR . 21.2 mt -98.33 104.24 16.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.022 -0.535 . . . . 75.150000000000006 110.145 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -81.32 116.09 21.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 72.109999999999999 110.571 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.42 105.48 14.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.826 0.346 . . . . 75.239999999999995 110.848 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -73.03 102.33 3.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.896 -0.779 . . . . 72.340000000000003 108.896 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.598 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -107.71 175.93 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.206 0.527 . . . . 74.200000000000003 112.122 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.595 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 52.8 tttp -59.61 116.85 4.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.237 -0.892 . . . . 75.340000000000003 110.434 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.3 m -70.94 115.8 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 71.040000000000006 110.373 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.5 tt -156.54 147.93 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.286 -0.415 . . . . 75.430000000000007 110.229 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.734 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.4 ttpt -83.62 133.96 34.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.0 -0.37 . . . . 74.439999999999998 110.0 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.98 169.63 21.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.309 -0.405 . . . . 71.099999999999994 110.565 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -117.22 -32.97 4.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.199 0.523 . . . . 74.319999999999993 109.835 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.84 145.39 32.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.653 . . . . 71.030000000000001 109.646 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.519 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.0 tt -133.29 137.8 52.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.482 -0.562 . . . . 74.299999999999997 109.482 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.405 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 23.9 ttp180 -125.71 128.56 47.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.899 0.38 . . . . 72.530000000000001 111.099 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.9 tp -104.31 115.34 30.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.55 -0.75 . . . . 73.340000000000003 109.642 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 41.4 m -107.17 123.72 48.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.111 0.481 . . . . 64.019999999999996 110.746 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.4 mm -105.97 92.46 6.46 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.44 -0.8 . . . . 74.230000000000004 108.973 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.824 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.3 Cg_endo -69.61 -178.62 2.37 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.816 2.344 . . . . 75.349999999999994 113.303 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 36.8 t70 -129.24 65.06 1.47 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.618 -1.253 . . . . 73.120000000000005 107.618 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.7 -46.58 2.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.094 -0.957 . . . . 75.129999999999995 112.506 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.13 36.65 4.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.183 -1.008 . . . . 73.239999999999995 113.754 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.66 18.5 32.42 Favored Glycine 0 CA--C 1.51 -0.258 0 C-N-CA 120.241 -0.98 . . . . 75.299999999999997 112.187 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.91 166.69 10.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 71.420000000000002 111.361 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.0 m -129.9 167.54 18.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.164 -0.471 . . . . 71.409999999999997 110.181 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 32.2 p -84.89 -24.42 28.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.111 0.481 . . . . 54.009999999999998 110.32 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.479 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 57.8 t -82.3 122.35 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 75.439999999999998 109.761 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.61 ' HB1' HD13 ' A' ' 83' ' ' ILE . . . -141.86 139.66 32.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.431 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.54 105.05 4.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.272 0.558 . . . . 72.430000000000007 111.253 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.06 132.48 71.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.737 -0.838 . . . . 73.519999999999996 108.737 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.939 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.7 mtm180 -69.98 -65.02 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.886 -0.326 . . . . 74.239999999999995 110.331 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -139.58 146.58 40.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.606 0.717 . . . . 75.200000000000003 112.331 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -108.2 121.95 45.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.514 -1.291 . . . . 73.319999999999993 107.514 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.8 154.75 37.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.919 0.39 . . . . 73.340000000000003 110.794 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.49 129.94 56.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 64.409999999999997 110.438 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.42 ' HE2' ' NE2' ' A' ' 69' ' ' GLN . 44.5 mttm -96.02 129.08 43.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.069 -0.715 . . . . 73.439999999999998 109.069 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.53 -176.68 39.01 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.203 -0.999 . . . . 72.120000000000005 112.457 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.8 m -108.4 133.49 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.86 -0.422 . . . . 74.239999999999995 109.86 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.412 HD12 HG21 ' A' ' 5' ' ' ILE . 42.4 mm -75.24 125.02 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.075 0.464 . . . . 75.299999999999997 110.575 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.734 HD12 ' HG3' ' A' ' 120' ' ' LYS . 60.8 mt -115.87 135.07 57.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.884 -0.598 . . . . 75.310000000000002 110.464 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -114.82 111.41 21.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.498 -0.774 . . . . 72.340000000000003 109.599 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.82 158.34 36.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.836 -0.62 . . . . 72.519999999999996 110.628 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.408 ' HB2' ' CD2' ' A' ' 155' ' ' HIS . 2.5 pm0 -63.36 148.94 47.02 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.972 -0.558 . . . . 71.219999999999999 110.991 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -127.17 84.83 2.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.64 0.733 . . . . 74.319999999999993 110.262 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.408 ' CD2' ' HB2' ' A' ' 153' ' ' GLU . 33.4 m-70 -101.54 -178.96 3.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.51 -0.768 . . . . 63.520000000000003 109.903 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.0 m170 73.66 116.44 0.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.141 0.901 . . . . 74.319999999999993 110.794 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -81.15 131.72 35.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.212 -0.662 . . . . 74.310000000000002 109.212 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.417 ' O ' ' HB2' ' A' ' 159' ' ' HIS . 58.5 t60 -127.73 76.49 1.68 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.975 -0.29 . . . . 73.420000000000002 111.168 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' 158' ' ' HIS . 8.8 t-80 . . . . . 0 C--O 1.235 0.326 0 CA-C-N 115.553 -0.749 . . . . 71.519999999999996 109.485 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.716 0.294 . . . . 74.120000000000005 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 4' ' ' THR . . . 69.28 -139.02 31.57 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.753 -0.736 . . . . 72.230000000000004 111.471 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m 72.87 -13.81 0.64 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.869 0.468 . . . . 70.299999999999997 111.729 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.616 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 39.9 p -73.37 147.85 43.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.333 -0.394 . . . . 72.099999999999994 110.306 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.614 HG21 HD12 ' A' ' 149' ' ' ILE . 43.4 mm -86.05 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.347 -0.388 . . . . 74.0 111.152 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -67.38 118.81 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 73.040000000000006 109.76 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -97.2 9.86 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 75.439999999999998 110.726 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 m -65.5 -27.34 68.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.832 -0.622 . . . . 72.239999999999995 111.681 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.5 20.35 34.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 75.400000000000006 112.731 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.431 ' HB2' HD12 ' A' ' 34' ' ' ILE . 36.1 m0 -94.17 150.55 20.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.821 -0.437 . . . . 71.099999999999994 109.821 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.7 pt-20 -133.61 156.59 47.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 71.219999999999999 110.279 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 116.14 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.736 -0.665 . . . . 73.049999999999997 109.76 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 60' ' ' ASP . 80.6 mt -78.76 -42.79 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 74.25 110.494 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 m -152.34 133.9 14.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.1 -0.5 . . . . 74.099999999999994 110.329 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -131.52 137.52 48.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 109.736 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.1 m -78.58 -33.42 47.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.809 0.338 . . . . 75.450000000000003 110.807 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 t -157.53 145.8 19.19 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.794 0.33 . . . . 72.25 110.979 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.27 137.67 5.2 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.963 -0.754 . . . . 74.010000000000005 108.963 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.74 133.56 33.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.136 0.493 . . . . 73.200000000000003 110.23 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.32 -27.91 0.94 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.842 -0.617 . . . . 62.340000000000003 110.852 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -101.97 -31.24 10.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.278 -0.419 . . . . 72.340000000000003 111.09 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -33.37 72.19 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.959 -0.639 . . . . 45.020000000000003 111.509 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.87 -48.9 7.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 74.310000000000002 110.011 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.55 -58.75 0.48 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.49 -0.862 . . . . 55.039999999999999 113.582 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.35 91.26 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.416 0.895 . . . . 75.450000000000003 113.416 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.2 18.09 64.55 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.151 0.82 . . . . 74.430000000000007 115.151 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -125.47 146.34 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 117.405 0.603 . . . . 74.239999999999995 110.334 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.49 82.12 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 116.146 -0.479 . . . . 71.340000000000003 112.539 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 73.4 mt -72.26 147.01 46.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 73.409999999999997 110.391 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.45 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.2 -22.68 64.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.403 -0.362 . . . . 75.120000000000005 111.14 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -79.11 -22.46 45.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 75.540000000000006 110.946 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 66.7 m -65.38 -26.25 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 41.140000000000001 110.102 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 142' ' ' GLU . 22.7 tp -61.84 -26.14 67.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.343 -0.844 . . . . 75.209999999999994 110.543 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG22 HD11 ' A' ' 59' ' ' ILE . 28.3 pt -116.16 12.52 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.396 . . . . 75.219999999999999 110.755 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 38.8 t70 -77.72 -29.53 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.116 0.484 . . . . 75.400000000000006 110.105 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.93 31.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.888 -0.672 . . . . 73.329999999999998 113.268 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.54 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 14.5 t0 -115.8 128.46 55.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.345 -0.613 . . . . 73.0 109.345 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.603 ' HB ' ' NH2' ' A' ' 141' ' ' ARG . 10.5 p -77.37 -5.65 50.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.916 0.71 . . . . 75.310000000000002 112.916 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.8 pt-20 -103.02 -5.34 23.48 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.324 -0.55 . . . . 75.510000000000005 111.013 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.446 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 9.3 p -105.73 161.78 14.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.837 -0.431 . . . . 73.219999999999999 109.837 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.612 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 48.1 p90 -157.33 162.32 39.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.99 0.424 . . . . 74.340000000000003 111.095 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.453 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 35.4 t90 -92.72 134.17 35.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.877 -0.786 . . . . 73.329999999999998 108.877 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -132.24 138.01 47.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.04 -0.726 . . . . 75.109999999999999 109.04 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.99 138.94 58.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.706 -0.479 . . . . 75.340000000000003 109.706 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 50' ' ' SER . 31.1 ttpt -67.54 120.1 13.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.61 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -111.51 -22.92 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 72.430000000000007 110.167 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -71.89 107.42 4.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 71.400000000000006 110.169 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.94 -0.99 56.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.721 -0.752 . . . . 43.119999999999997 112.258 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.16 133.63 5.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.819 -0.705 . . . . 60.539999999999999 112.215 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.8 m -72.69 143.71 47.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.82 0.343 . . . . 71.040000000000006 110.375 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -74.01 151.68 88.45 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 110.235 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.65 144.99 25.59 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.684 2.256 . . . . 71.040000000000006 111.599 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 130' ' ' ASP . 15.1 mt -75.31 158.18 84.03 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.18 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.607 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.9 Cg_endo -83.49 167.14 63.69 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.696 -1.377 . . . . 74.129999999999995 113.536 2.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -106.85 122.26 46.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 72.239999999999995 109.983 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.84 125.19 51.19 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.095 0.474 . . . . 73.439999999999998 110.524 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 62.8 mt -115.07 112.65 40.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.054 -0.521 . . . . 75.0 110.151 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.97 117.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.153 -0.476 . . . . 73.109999999999999 110.743 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 34' ' ' ILE . 66.3 mt -117.87 137.05 53.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.255 -0.43 . . . . 72.209999999999994 110.723 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' HB2' HD13 ' A' ' 13' ' ' LEU . 56.9 t0 -103.59 120.63 41.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.682 -0.488 . . . . 70.239999999999995 109.682 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.413 ' SD ' HD12 ' A' ' 65' ' ' ILE . 65.2 mtm -84.66 -7.43 59.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 110.814 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.8 mmtt 65.9 13.64 9.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.769 -0.65 . . . . 74.319999999999993 112.183 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' OE1' HD11 ' A' ' 149' ' ' ILE . 6.0 pt20 -164.57 164.93 21.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 74.150000000000006 110.542 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.98 122.79 31.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.399 . . . . 63.43 110.366 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.543 HD11 HG23 ' A' ' 5' ' ' ILE . 74.0 mt -130.65 137.82 55.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.292 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.475 ' HB2' HD12 ' A' ' 150' ' ' ILE . 56.0 tp60 -83.29 102.93 12.3 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.063 -0.717 . . . . 75.349999999999994 109.063 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.3 mm -74.14 125.79 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.665 0.269 . . . . 74.25 110.525 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.62 -39.71 2.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.161 0.505 . . . . 71.239999999999995 110.831 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 26.7 tt0 -148.89 142.93 25.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.092 -0.504 . . . . 53.399999999999999 110.821 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.07 136.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.519 -0.549 . . . . 73.400000000000006 109.519 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.47 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 39.9 mt-10 -118.73 133.57 55.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.147 0.499 . . . . 71.519999999999996 111.247 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 72.2 mt -114.53 126.79 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.549 -0.75 . . . . 75.409999999999997 109.162 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.486 ' HG ' ' HD3' ' A' ' 141' ' ' ARG . 24.3 tp -106.24 97.14 15.06 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.727 -0.472 . . . . 73.310000000000002 109.727 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 6.3 Cg_exo -72.91 153.49 52.91 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.088 2.526 . . . . 72.439999999999998 111.073 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.669 ' HA ' ' HD2' ' A' ' 141' ' ' ARG . 12.3 ptm180 -69.06 -48.78 61.9 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.03 -0.268 . . . . 73.549999999999997 111.337 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.59 2.22 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.234 -0.508 . . . . 55.32 112.659 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.82 107.68 0.64 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.317 0.647 . . . . 72.310000000000002 111.138 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.19 81.4 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.264 -0.493 . . . . 74.219999999999999 111.953 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -129.18 123.95 33.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.6 0.238 . . . . 71.430000000000007 111.116 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -88.1 -39.49 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.566 -0.531 . . . . 75.299999999999997 109.566 171.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 46.13 84.42 0.19 Allowed Pre-proline 0 N--CA 1.467 0.416 0 O-C-N 124.283 0.989 . . . . 71.540000000000006 112.799 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.82 25.71 0.41 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.861 2.374 . . . . 71.230000000000004 112.671 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.49 120.75 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.616 -0.513 . . . . 73.319999999999993 109.616 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.52 -50.82 3.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.111 0.482 . . . . 73.400000000000006 110.749 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 102' ' ' ARG . 57.4 t -120.41 137.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 65.140000000000001 110.583 -175.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.36 129.71 65.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.556 -0.747 . . . . 71.010000000000005 109.688 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.57 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 97.2 mt-10 -112.65 125.75 54.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 61.020000000000003 110.128 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -102.84 129.75 49.62 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.679 -0.691 . . . . 74.099999999999994 110.269 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 125' ' ' ARG . . . -125.32 151.07 46.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.144 -0.48 . . . . 61.420000000000002 110.428 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.21 39.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 74.099999999999994 109.96 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 t -148.87 151.15 34.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.198 0.523 . . . . 75.430000000000007 110.762 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 -32.87 10.48 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.794 -0.639 . . . . 71.230000000000004 110.61 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -109.69 -5.59 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.429 -0.351 . . . . 74.219999999999999 110.878 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 78.19 -9.61 1.48 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.991 0.917 . . . . 73.239999999999995 111.083 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.8 t -90.91 -49.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 110.819 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -93.43 102.77 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.105 -0.498 . . . . 72.400000000000006 109.85 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.98 118.07 30.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 75.329999999999998 111.044 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 m -99.46 120.82 56.82 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.469 -0.787 . . . . 75.340000000000003 110.51 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.96 112.53 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.359 2.039 . . . . 63.229999999999997 111.111 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 117' ' ' LYS . 14.1 pt -87.33 -9.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.466 -0.334 . . . . 74.510000000000005 111.025 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.63 137.35 2.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.763 -1.208 . . . . 51.43 113.848 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 16.2 ttt180 -107.02 114.57 28.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.045 -0.724 . . . . 75.150000000000006 109.045 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.588 ' HE2' HG12 ' A' ' 116' ' ' VAL . 92.2 m-85 -125.98 169.92 12.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.84 0.352 . . . . 74.349999999999994 111.128 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -91.59 139.77 14.9 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.467 -0.653 . . . . 72.439999999999998 111.467 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -93.37 125.48 38.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 72.239999999999995 110.483 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.56 ' HB ' HD22 ' A' ' 112' ' ' LEU . 90.2 m -103.08 115.23 30.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 64.349999999999994 110.579 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -72.59 102.56 3.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 73.299999999999997 110.534 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -143.91 -176.92 5.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 74.019999999999996 110.446 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.5 -7.97 22.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.05 0.453 . . . . 73.129999999999995 110.033 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.2 170.27 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.861 -0.608 . . . . 73.230000000000004 111.042 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.63 143.45 38.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.124 0.487 . . . . 74.310000000000002 111.613 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.56 HD22 ' HB ' ' A' ' 106' ' ' THR . 46.4 mt -103.28 106.77 17.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 75.310000000000002 110.285 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 43.0 mt-10 -87.12 112.78 22.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.807 0.337 . . . . 75.420000000000002 110.735 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.23 106.66 17.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.155 -0.475 . . . . 62.030000000000001 110.55 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -72.13 102.61 3.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.061 -0.718 . . . . 61.119999999999997 109.061 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.588 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.1 m -103.18 179.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 72.219999999999999 112.159 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 6.5 tmtm? -66.04 124.19 21.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 74.239999999999995 110.421 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 21.2 p -70.49 127.37 32.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 75.310000000000002 110.68 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -163.45 150.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.42 -0.355 . . . . 65.310000000000002 110.481 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.689 ' HG3' HD11 ' A' ' 150' ' ' ILE . 5.9 ttpm? -85.69 128.07 34.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.285 -0.635 . . . . 70.530000000000001 109.285 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.19 160.82 43.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.861 0.362 . . . . 74.209999999999994 111.239 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -117.42 -26.12 6.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.67 -0.695 . . . . 74.319999999999993 109.642 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.16 146.45 42.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 74.420000000000002 109.859 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -131.1 143.25 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.628 -0.508 . . . . 72.239999999999995 109.628 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.5 ttp180 -131.38 124.75 30.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 73.430000000000007 111.227 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.424 HD21 HD12 ' A' ' 57' ' ' ILE . 37.6 tp -90.16 113.0 24.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.553 -0.749 . . . . 72.340000000000003 109.401 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.6 m -107.18 115.83 30.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.19 0.519 . . . . 74.120000000000005 111.179 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 31.7 mm -105.06 98.05 14.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.104 -0.702 . . . . 72.150000000000006 109.104 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.607 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.7 Cg_endo -71.09 170.45 18.1 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.361 2.041 . . . . 75.310000000000002 112.39 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.445 ' HA ' HD11 ' A' ' 53' ' ' LEU . 34.7 t70 -91.21 -4.09 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.109 0.957 . . . . 70.310000000000002 109.099 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.21 140.96 31.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 75.420000000000002 110.677 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.78 -13.28 35.1 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.633 -0.794 . . . . 73.129999999999995 111.93 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 110.68 18.29 8.56 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.712 . . . . 63.310000000000002 112.335 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.56 150.4 43.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 71.439999999999998 110.854 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 48.9 m -127.75 -176.76 3.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.972 -0.558 . . . . 71.319999999999993 110.388 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 39.0 p -84.53 -2.4 57.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.028 0.442 . . . . 74.349999999999994 111.649 -175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -93.7 96.28 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.149 0.499 . . . . 72.519999999999996 110.038 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.45 129.54 50.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.847 -0.615 . . . . 65.019999999999996 110.159 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -150.07 110.64 4.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 73.530000000000001 110.791 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.5 mt -128.67 133.0 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 64.219999999999999 109.301 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.669 ' HD2' ' HA ' ' A' ' 75' ' ' ARG . 74.1 mtp180 -61.76 -61.16 2.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.952 0.406 . . . . 74.409999999999997 110.268 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.462 ' HA ' HD11 ' A' ' 33' ' ' LEU . 15.3 pt-20 -154.82 158.79 39.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.503 0.668 . . . . 70.510000000000005 111.338 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -115.15 134.6 55.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.657 -1.238 . . . . 62.439999999999998 107.657 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.616 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.1 t70 -131.09 167.16 19.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.721 -0.391 . . . . 71.239999999999995 110.014 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.7 t -138.6 128.43 32.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.73 0.3 . . . . 73.340000000000003 110.847 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.5 mttp -97.97 125.27 42.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.391 -0.596 . . . . 74.310000000000002 109.391 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.62 -158.71 14.99 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.798 -0.715 . . . . 60.32 111.404 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.0 m -131.1 130.23 42.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.849 0.324 . . . . 71.209999999999994 110.583 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 5' ' ' ILE . 34.7 mm -68.41 116.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 71.150000000000006 109.902 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.689 HD11 ' HG3' ' A' ' 120' ' ' LYS . 42.6 mt -98.06 130.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.239 0.543 . . . . 71.030000000000001 110.17 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.83 111.97 20.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.648 0.737 . . . . 75.319999999999993 111.703 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.02 130.28 56.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.493 -0.776 . . . . 74.239999999999995 109.397 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 138.77 37.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.981 0.419 . . . . 71.209999999999994 109.998 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -107.46 43.06 1.22 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.388 0.613 . . . . 71.530000000000001 109.905 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -88.9 146.62 24.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 74.140000000000001 110.435 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -152.81 122.87 7.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.256 -0.646 . . . . 71.329999999999998 109.256 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -150.33 146.65 26.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.205 -0.452 . . . . 74.129999999999995 110.149 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -66.05 129.5 40.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.452 -0.34 . . . . 63.0 110.811 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.108 -0.497 . . . . 71.439999999999998 109.713 177.544 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.228 -0.286 . . . . 70.109999999999999 110.228 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.69 -128.58 3.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 72.329999999999998 111.49 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.9 t -163.82 132.87 3.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 74.129999999999995 111.007 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 12.8 p -98.81 137.63 37.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.602 -0.888 . . . . 63.039999999999999 108.602 170.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.549 HG12 ' O ' ' A' ' 145' ' ' VAL . 36.5 mm -65.7 129.1 29.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.978 0.418 . . . . 73.329999999999998 110.752 -173.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 m -67.19 111.69 4.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.947 -0.569 . . . . 71.519999999999996 109.807 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 9.1 mtmp? -85.06 20.37 1.91 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.432 -0.804 . . . . 73.030000000000001 111.467 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -59.13 -42.48 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.899 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.13 7.68 52.46 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 63.229999999999997 113.053 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HB3' HD13 ' A' ' 34' ' ' ILE . 21.3 m0 -73.08 154.29 40.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.706 0.288 . . . . 70.099999999999994 110.457 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 24.5 pt-20 -148.87 161.27 42.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.262 0.553 . . . . 73.319999999999993 111.183 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.89 120.11 47.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.88 . . . . 71.329999999999998 110.066 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 60' ' ' ASP . 86.3 mt -85.75 -47.72 9.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.001 -0.545 . . . . 75.549999999999997 110.758 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 t -138.76 142.3 38.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.01 -0.541 . . . . 72.420000000000002 109.934 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -146.91 148.92 32.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.072 -0.513 . . . . 73.129999999999995 109.651 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.5 m -86.16 -42.02 14.21 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.852 0.358 . . . . 72.219999999999999 110.973 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -150.9 153.47 35.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.325 -0.398 . . . . 74.5 110.746 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.28 146.0 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.286 -0.635 . . . . 74.439999999999998 109.286 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.424 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 10.0 tp10 -102.57 110.81 22.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.932 0.396 . . . . 63.130000000000003 110.417 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.65 13.11 11.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.049 -0.523 . . . . 72.019999999999996 111.187 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 m -134.21 -49.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.513 -0.312 . . . . 64.299999999999997 111.393 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -46.19 79.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.905 -0.664 . . . . 73.030000000000001 112.201 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.485 ' HG2' ' HE1' ' A' ' 46' ' ' TRP . 6.4 mm-40 -91.26 0.64 57.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.069 0.461 . . . . 75.319999999999993 110.033 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 -174.6 42.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.694 -0.685 . . . . 73.439999999999998 112.035 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.06 135.01 42.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.89 -0.411 . . . . 64.219999999999999 109.89 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.82 -1.55 58.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.645 -0.788 . . . . 73.219999999999999 111.512 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -153.36 138.53 17.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.659 -0.497 . . . . 74.010000000000005 109.659 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.79 -8.43 70.83 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.274 -0.73 . . . . 73.340000000000003 111.274 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 43.2 mt -72.47 153.58 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.14 -0.53 . . . . 75.519999999999996 110.07 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.625 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.22 -28.99 69.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 71.120000000000005 110.787 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.97 -24.82 60.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 71.310000000000002 110.993 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 77.4 m -67.33 -21.56 65.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.386 -0.37 . . . . 73.519999999999996 110.404 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 51.3 tp -64.93 -14.41 59.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.837 -0.62 . . . . 72.430000000000007 110.687 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 10' ' ' TRP . 27.8 pt -131.58 14.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.271 -0.422 . . . . 73.310000000000002 110.531 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.9 t70 -65.85 -33.67 76.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.291 -0.413 . . . . 73.329999999999998 111.279 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' HA2' ' HZ2' ' A' ' 7' ' ' LYS . . . 99.84 5.49 55.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.53 -0.843 . . . . 72.030000000000001 113.408 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.67 140.22 50.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.0 0.4 . . . . 65.439999999999998 109.93 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 26.6 p -80.66 -7.39 59.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.895 0.332 . . . . 71.310000000000002 111.895 -174.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.69 -8.16 44.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.593 -0.276 . . . . 73.209999999999994 110.303 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.6 p -107.49 138.52 43.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 74.420000000000002 110.018 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.841 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 10.9 p90 -141.09 169.85 16.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.45 -0.341 . . . . 63.210000000000001 110.567 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.625 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.0 t90 -104.65 133.04 50.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.826 -0.805 . . . . 72.109999999999999 108.826 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.074 -0.713 . . . . 75.439999999999998 109.074 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 145.21 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.31 -0.626 . . . . 64.439999999999998 109.31 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -55.85 125.24 20.48 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.339 0.399 . . . . 72.120000000000005 109.995 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.485 ' HE1' ' HG2' ' A' ' 23' ' ' GLU . 68.2 p-90 -124.78 -30.22 3.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.844 -0.342 . . . . 65.109999999999999 110.79 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -77.65 107.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.785 -0.45 . . . . 74.030000000000001 109.785 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.94 11.55 52.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.636 -0.792 . . . . 73.129999999999995 111.899 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.27 20.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.955 -0.64 . . . . 65.450000000000003 111.893 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.0 m -127.7 165.76 19.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 72.409999999999997 110.896 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB3' ' HE1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -89.21 152.79 48.35 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.129999999999995 109.375 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 38.5 Cg_endo -68.09 139.07 45.51 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.158 1.905 . . . . 72.340000000000003 113.222 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.44 158.02 87.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 73.540000000000006 109.951 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -82.4 161.8 76.61 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.525 -1.448 . . . . 73.049999999999997 113.061 0.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.53 ' HE1' ' HB3' ' A' ' 51' ' ' ASP . 25.8 m-85 -97.79 129.02 44.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.62 . . . . 72.310000000000002 109.598 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.472 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.1 t0 -127.33 118.44 24.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.748 0.308 . . . . 72.209999999999994 110.309 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.427 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 56.9 mt -116.55 122.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 74.400000000000006 111.339 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.1 t -105.45 118.19 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.83 -0.623 . . . . 73.340000000000003 110.514 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HB ' HG23 ' A' ' 124' ' ' ILE . 71.1 mt -115.56 139.07 43.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 75.310000000000002 111.049 -175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.49 ' HB2' HD12 ' A' ' 13' ' ' LEU . 63.8 t0 -105.63 122.13 45.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.169 -0.468 . . . . 63.43 110.001 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.2 mtm -88.45 -5.31 58.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 74.519999999999996 110.672 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 67.11 8.51 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.902 0.704 . . . . 74.219999999999999 112.902 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -168.2 174.8 6.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.589 0.233 . . . . 71.329999999999998 110.642 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 52.3 m-80 -83.06 122.04 27.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.214 -0.448 . . . . 63.299999999999997 110.243 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.524 HD12 HG22 ' A' ' 5' ' ' ILE . 68.2 mt -131.11 133.3 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.063 0.458 . . . . 74.299999999999997 110.022 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.402 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.7 tp60 -79.79 106.47 11.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.573 -0.739 . . . . 75.140000000000001 109.168 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 118' ' ' SER . 15.9 mm -76.79 102.92 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.136 -0.32 . . . . 64.140000000000001 110.136 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.3 -39.62 8.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 74.019999999999996 110.281 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -152.14 142.29 22.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.686 . . . . 70.230000000000004 110.207 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -114.28 134.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.91 -0.404 . . . . 72.420000000000002 109.91 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 49.5 mt-10 -110.75 129.72 55.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.988 0.423 . . . . 70.239999999999995 110.999 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.458 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 mt -109.78 120.82 43.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.418 -0.586 . . . . 75.409999999999997 109.418 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -102.99 103.62 34.96 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.912 -0.586 . . . . 74.109999999999999 109.751 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.536 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 8.4 Cg_exo -70.91 -168.92 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.947 2.432 . . . . 75.310000000000002 111.339 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.565 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 33.6 mtp180 -86.56 0.85 53.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.369 . . . . 72.540000000000006 110.879 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 109' ' ' ASP . . . 96.97 -123.69 7.86 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.592 -0.813 . . . . 74.510000000000005 111.985 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -121.66 128.56 52.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 72.430000000000007 109.77 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.02 57.18 1.09 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.783 -0.722 . . . . 74.540000000000006 111.919 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.378 -0.23 . . . . 73.030000000000001 110.378 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -74.91 90.77 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.781 -0.451 . . . . 74.109999999999999 109.781 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -133.09 92.59 24.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.181 -0.463 . . . . 71.299999999999997 110.315 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.561 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 18.6 Cg_endo -93.37 23.63 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.527 2.818 . . . . 73.439999999999998 112.979 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.66 125.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 75.530000000000001 110.075 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -107.28 -46.21 3.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 74.0 111.145 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.551 HG11 ' HE ' ' A' ' 102' ' ' ARG . 34.2 t -129.34 139.87 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.572 -0.285 . . . . 74.120000000000005 110.82 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.11 144.99 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.343 -0.389 . . . . 74.400000000000006 110.15 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.5 mt-10 -119.06 131.13 55.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.93 0.395 . . . . 74.0 110.595 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.89 136.03 51.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.113 -0.494 . . . . 75.530000000000001 110.772 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.24 152.52 49.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.507 -0.315 . . . . 64.310000000000002 110.851 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.23 51.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.327 -0.397 . . . . 75.409999999999997 110.264 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -149.95 153.81 37.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.196 0.522 . . . . 63.009999999999998 111.076 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 52.3 mt-10 -97.54 -24.82 15.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 72.040000000000006 110.937 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.82 -1.4 8.4 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.859 -0.336 . . . . 62.219999999999999 111.489 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.17 1.81 3.8 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.205 0.526 . . . . 74.239999999999995 111.396 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -96.8 -58.45 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.477 0.656 . . . . 73.219999999999999 110.068 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.79 106.39 18.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.096 -0.956 . . . . 64.430000000000007 109.824 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -97.31 125.15 41.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.157 0.503 . . . . 70.430000000000007 111.409 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -109.02 123.78 35.97 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.73 -0.668 . . . . 75.329999999999998 110.135 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.31 120.76 8.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.412 2.075 . . . . 75.239999999999995 111.578 176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.556 HD11 HG22 ' A' ' 116' ' ' VAL . 15.1 pt -86.41 -16.03 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.152 -0.477 . . . . 73.450000000000003 110.65 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.56 143.84 3.85 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.492 -0.861 . . . . 64.040000000000006 112.899 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HE ' HG11 ' A' ' 85' ' ' VAL . 73.7 ttt180 -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.216 -0.661 . . . . 75.349999999999994 109.216 173.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.464 ' HE2' HG13 ' A' ' 116' ' ' VAL . 97.1 m-85 -137.56 174.11 10.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 71.230000000000004 111.449 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.32 138.56 14.26 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.756 -0.656 . . . . 71.329999999999998 112.21 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -93.17 148.45 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 74.109999999999999 110.09 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.478 ' O ' HD13 ' A' ' 112' ' ' LEU . 33.7 m -144.83 110.14 5.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.072 -0.513 . . . . 74.140000000000001 109.908 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -70.03 97.09 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.326 0.584 . . . . 75.519999999999996 109.931 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.536 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 11.1 pt20 -130.8 -179.69 5.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.449 -0.796 . . . . 74.530000000000001 110.713 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.408 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 5.2 p-10 -79.74 -24.41 41.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.557 . . . . 74.340000000000003 110.949 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.39 151.87 20.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 71.319999999999993 110.988 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.12 129.98 41.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 60.299999999999997 110.542 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.478 HD13 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -80.56 104.9 11.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.703 . . . . 73.439999999999998 110.501 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -85.26 108.73 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.104 0.478 . . . . 73.340000000000003 110.51 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -101.34 106.82 18.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.834 -0.621 . . . . 74.349999999999994 110.679 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -72.3 104.92 3.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 74.329999999999998 109.623 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.556 HG22 HD11 ' A' ' 100' ' ' ILE . 31.6 m -111.13 -176.54 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.068 0.461 . . . . 75.540000000000006 111.776 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.91 117.07 7.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.475 -0.784 . . . . 74.239999999999995 110.109 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 22.0 m -70.39 113.68 7.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 72.109999999999999 110.718 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.12 144.94 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 75.540000000000006 110.464 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.58 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -86.26 126.03 34.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 72.109999999999999 109.42 175.566 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -151.43 166.72 30.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.636 -0.256 . . . . 73.349999999999994 111.029 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -107.16 -30.48 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.362 0.601 . . . . 75.200000000000003 109.867 173.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -109.21 145.41 35.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.752 -0.658 . . . . 73.230000000000004 110.481 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.0 tt -133.21 138.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 73.450000000000003 109.432 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 13.0 ttp180 -127.83 130.77 49.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 75.099999999999994 111.249 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.14 114.89 29.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.381 -0.827 . . . . 75.5 109.601 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.7 m -109.11 125.23 51.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.202 0.525 . . . . 73.530000000000001 111.104 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 38.6 mm -103.96 95.96 8.63 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.056 -0.72 . . . . 73.140000000000001 109.056 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -75.92 157.38 38.95 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.821 2.347 . . . . 73.409999999999997 113.087 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.23 63.52 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 60.210000000000001 108.58 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.27 122.53 2.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 61.020000000000003 110.227 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.85 -1.9 21.39 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.834 -0.698 . . . . 52.32 112.314 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.17 21.5 7.67 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.905 -0.664 . . . . 64.0 112.691 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -79.31 146.19 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 74.319999999999993 111.737 -175.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.561 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.6 m -113.47 174.43 5.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.486 -0.779 . . . . 71.120000000000005 109.608 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 18.8 p -79.16 -14.36 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 74.400000000000006 111.716 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.38 104.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.969 0.414 . . . . 74.109999999999999 110.219 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.26 130.84 55.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.028 -0.533 . . . . 75.329999999999998 110.24 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.565 ' HB1' ' HD2' ' A' ' 75' ' ' ARG . . . -141.84 105.16 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.102 0.477 . . . . 71.530000000000001 111.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.34 133.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.803 -0.814 . . . . 73.129999999999995 108.803 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.841 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 71.1 mtm180 -74.25 -57.63 3.82 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.517 -0.473 . . . . 73.430000000000007 111.278 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.13 148.43 28.27 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.551 -0.86 . . . . 64.430000000000007 112.239 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.416 HD13 HD22 ' A' ' 72' ' ' LEU . 7.8 tt -105.85 120.93 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.551 -1.204 . . . . 72.129999999999995 108.31 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.45 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.6 t70 -117.81 162.03 18.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.361 -0.607 . . . . 73.120000000000005 109.361 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 5' ' ' ILE . 59.9 t -126.08 123.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.197 0.522 . . . . 75.299999999999997 110.422 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.43 ' HG3' HG21 ' A' ' 4' ' ' THR . 47.0 mttt -99.67 76.03 1.96 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.558 0.694 . . . . 75.150000000000006 109.389 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -124.05 -146.19 6.91 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.911 -1.04 . . . . 71.420000000000002 111.785 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.4 m -135.86 134.0 38.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.803 0.335 . . . . 62.119999999999997 110.704 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.509 HD11 HG23 ' A' ' 5' ' ' ILE . 40.4 mm -72.0 130.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 71.540000000000006 110.94 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.438 HG21 ' HG ' ' A' ' 152' ' ' LEU . 20.5 mt -126.64 139.2 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.069 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.31 100.93 8.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.619 0.723 . . . . 72.230000000000004 110.656 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.438 ' HG ' HG21 ' A' ' 150' ' ' ILE . 92.8 mt -117.36 26.67 9.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.717 -0.674 . . . . 74.400000000000006 110.084 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.05 92.63 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 64.239999999999995 109.676 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -94.12 -7.18 43.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.19 -0.914 . . . . 64.340000000000003 110.205 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -141.29 163.48 32.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 75.400000000000006 109.967 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.54 146.57 27.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.978 0.418 . . . . 75.409999999999997 110.543 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -77.88 100.88 6.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 64.040000000000006 110.208 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -85.2 157.28 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 71.030000000000001 110.951 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.3 p80 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.134 -0.484 . . . . 71.319999999999993 110.116 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.22 -0.289 . . . . 64.140000000000001 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.44 144.92 43.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.853 -0.689 . . . . 64.239999999999995 112.544 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.2 m -82.41 112.9 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.46 0.648 . . . . 75.319999999999993 111.512 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -84.88 132.0 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 75.209999999999994 108.604 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.488 HG22 HD12 ' A' ' 65' ' ' ILE . 47.3 mm -60.81 128.49 22.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.701 0.286 . . . . 74.209999999999994 111.13 -173.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -67.5 119.43 12.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.105 0.478 . . . . 75.340000000000003 109.841 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -95.44 4.33 53.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.731 -0.668 . . . . 73.200000000000003 110.647 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -73.43 93.4 1.96 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.736 . . . . 74.430000000000007 109.442 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.34 -16.2 4.39 Favored Glycine 0 C--N 1.316 -0.583 0 CA-C-N 115.28 -0.873 . . . . 74.239999999999995 111.476 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -68.92 150.64 47.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.752 -0.462 . . . . 73.040000000000006 109.752 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.493 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.3 pt-20 -132.37 157.71 43.81 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.319 0.581 . . . . 74.239999999999995 110.924 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.74 110.04 25.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 71.150000000000006 109.645 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.443 HD13 HG12 ' A' ' 58' ' ' VAL . 81.6 mt -72.43 -48.95 37.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.801 -0.636 . . . . 75.340000000000003 110.612 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -149.94 142.85 24.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.666 -0.697 . . . . 62.229999999999997 110.527 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.532 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 38.2 p90 -138.77 148.54 43.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 74.340000000000003 109.837 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m -88.26 -37.91 15.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.739 0.304 . . . . 63.399999999999999 111.029 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 145.88 31.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.148 0.499 . . . . 63.0 110.859 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.532 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -154.94 151.75 28.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 63.210000000000001 108.781 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -124.56 92.35 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.153 0.501 . . . . 73.430000000000007 111.064 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.59 -18.74 21.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.736 -0.666 . . . . 73.209999999999994 111.239 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 m -91.72 -40.37 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 65.230000000000004 110.863 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.17 9.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.898 -0.668 . . . . 72.219999999999999 112.934 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -82.9 -14.0 55.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 75.109999999999999 111.303 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 162.23 29.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.829 -0.701 . . . . 64.140000000000001 112.433 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.2 122.52 16.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.71 0.29 . . . . 70.219999999999999 110.926 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.64 -1.54 61.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.815 -0.707 . . . . 55.310000000000002 112.455 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -133.81 151.85 51.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.129 -0.323 . . . . 71.5 110.129 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 -5.95 66.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.378 -0.439 . . . . 61.109999999999999 112.119 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 77.1 mt -75.15 148.45 39.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.566 -0.317 . . . . 75.340000000000003 110.321 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.74 63.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.402 -0.363 . . . . 74.310000000000002 111.264 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.75 -25.68 44.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.506 -0.315 . . . . 74.140000000000001 110.888 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.816 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.9 m -64.84 -25.79 68.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 70.510000000000005 110.455 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 143' ' ' LEU . 34.4 tp -64.24 -22.22 66.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 74.420000000000002 110.827 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.576 HG23 HD13 ' A' ' 59' ' ' ILE . 40.1 pt -125.79 15.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 74.430000000000007 110.363 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.816 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 4.6 t70 -75.38 -37.3 60.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 70.209999999999994 110.528 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.92 23.93 7.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.472 -0.871 . . . . 64.430000000000007 112.299 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.3 109.58 7.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.273 -0.64 . . . . 73.099999999999994 109.273 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.7 p -68.7 -21.16 64.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.214 -0.448 . . . . 72.140000000000001 111.923 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HA ' HH21 ' A' ' 141' ' ' ARG . 61.4 mm-40 -72.56 -26.88 61.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.925 -0.31 . . . . 64.239999999999995 110.422 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -89.3 152.09 21.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.755 -0.831 . . . . 72.109999999999999 108.755 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.699 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 47.2 p90 -148.93 174.96 11.7 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.307 -0.557 . . . . 73.329999999999998 111.333 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -107.82 135.67 48.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.559 -0.746 . . . . 75.209999999999994 109.046 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.5 t-80 -135.14 145.01 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.687 -0.486 . . . . 75.349999999999994 109.687 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.53 146.6 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.952 -0.567 . . . . 73.120000000000005 109.944 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 50' ' ' SER . 75.7 tttt -60.29 133.6 56.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.401 . . . . 74.430000000000007 110.787 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -139.7 -26.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 73.299999999999997 111.553 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -62.42 -42.02 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 64.25 110.255 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.77 32.09 6.21 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 75.109999999999999 111.91 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.37 148.41 13.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 73.340000000000003 111.83 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.46 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -81.94 156.63 24.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.2 0.524 . . . . 73.319999999999993 111.114 -178.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -91.39 162.36 32.14 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 75.439999999999998 110.587 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.35 139.18 31.46 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.736 2.291 . . . . 75.409999999999997 112.791 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.3 mt -80.03 159.88 69.81 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 74.540000000000006 110.157 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.734 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.4 Cg_endo -79.66 161.28 86.78 Favored 'Cis proline' 0 C--N 1.343 0.273 0 C-N-CA 123.622 -1.408 . . . . 62.409999999999997 112.975 0.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.539 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -95.75 108.81 21.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.99 -0.55 . . . . 74.430000000000007 110.112 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -108.72 116.91 32.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.955 0.407 . . . . 74.349999999999994 110.634 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.455 HD13 HD22 ' A' ' 126' ' ' LEU . 60.9 mt -109.81 108.61 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.96 -0.564 . . . . 74.129999999999995 109.636 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' A' ' 125' ' ' ARG . 48.1 t -97.94 116.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.133 -0.485 . . . . 74.200000000000003 110.512 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.576 HD13 HG23 ' A' ' 34' ' ' ILE . 68.5 mt -115.52 137.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.726 -0.67 . . . . 73.230000000000004 110.615 -175.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -101.84 122.21 43.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 74.129999999999995 109.697 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.4 mtm -87.33 -8.5 56.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 74.200000000000003 110.611 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.493 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.2 mmtt 67.97 7.55 5.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.719 . . . . 73.239999999999995 112.26 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 5.7 pt20 -161.26 163.03 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.43 -0.211 . . . . 74.109999999999999 110.43 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.402 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 43.9 m-80 -83.97 126.17 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.85 -0.426 . . . . 74.019999999999996 109.85 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 5' ' ' ILE . 61.3 mt -132.01 136.88 55.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.033 0.444 . . . . 72.340000000000003 110.701 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -84.38 101.74 12.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.826 -0.805 . . . . 74.230000000000004 108.826 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.637 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.2 mm -71.56 127.33 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.327 -0.397 . . . . 73.420000000000002 110.306 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.26 -46.1 2.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 72.319999999999993 110.875 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -144.51 144.91 31.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.687 0.28 . . . . 75.109999999999999 110.847 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.89 132.27 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.232 -0.655 . . . . 74.140000000000001 109.232 173.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.668 ' HG2' ' HB3' ' A' ' 111' ' ' ALA . 26.8 tt0 -115.08 127.97 55.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.933 0.397 . . . . 74.310000000000002 110.367 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.43 HD11 ' CE2' ' A' ' 114' ' ' TYR . 57.2 mt -115.72 117.75 31.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.954 -0.566 . . . . 75.409999999999997 110.16 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.6 tp -110.08 100.16 42.5 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.404 -0.362 . . . . 73.340000000000003 110.439 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.425 ' HG3' ' CZ ' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -86.81 -175.59 1.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.84 2.36 . . . . 54.299999999999997 110.465 174.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.477 ' HA ' ' HD2' ' A' ' 141' ' ' ARG . 20.6 ptt180 -90.29 -29.94 17.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.956 -0.698 . . . . 74.25 110.055 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.487 ' HA2' ' OD1' ' A' ' 107' ' ' ASN . . . 68.65 -91.28 0.26 Allowed Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.936 -0.574 . . . . 62.25 114.04 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -76.29 128.73 35.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.356 0.598 . . . . 73.109999999999999 110.783 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.97 17.99 33.34 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.511 -0.768 . . . . 51.399999999999999 111.917 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 p -159.03 140.87 13.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.451 -0.203 . . . . 74.25 110.451 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -66.93 -50.79 61.26 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.219 -0.193 . . . . 74.099999999999994 110.573 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 t30 45.02 78.12 0.41 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.975 0.797 . . . . 71.420000000000002 111.487 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 1.1 Cg_endo -82.55 59.53 6.92 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.283 2.655 . . . . 71.230000000000004 113.225 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.4 mt -98.41 119.37 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.078 0.466 . . . . 75.450000000000003 109.821 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 25.7 mmmt -97.52 -56.41 2.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.716 -0.675 . . . . 74.450000000000003 111.4 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -121.89 139.65 48.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.319 -0.4 . . . . 65.299999999999997 110.347 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.61 133.41 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.888 0.375 . . . . 72.200000000000003 110.02 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.481 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 20.7 tt0 -121.5 128.72 52.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.911 -0.586 . . . . 72.450000000000003 110.095 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -112.07 129.38 56.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.071 -0.513 . . . . 74.040000000000006 109.961 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.76 151.72 41.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.464 -0.334 . . . . 74.439999999999998 110.273 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.34 149.49 45.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 110.185 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -147.12 148.0 31.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.271 -0.422 . . . . 64.030000000000001 110.232 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -87.04 -32.55 19.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.714 0.292 . . . . 62.32 110.992 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -132.63 16.11 4.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.573 -0.285 . . . . 73.099999999999994 111.632 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.2 t30 59.49 58.5 2.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.727 0.775 . . . . 73.129999999999995 110.308 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.26 -71.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.162 -0.926 . . . . 73.430000000000007 108.917 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -90.46 118.67 30.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.781 -0.645 . . . . 72.530000000000001 109.666 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.97 107.78 19.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.083 0.468 . . . . 75.430000000000007 110.744 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.8 m -93.84 125.99 51.11 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.802 -0.635 . . . . 63.409999999999997 110.212 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.66 104.01 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.543 2.162 . . . . 75.129999999999995 111.662 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.0 -23.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.105 -0.498 . . . . 74.510000000000005 110.901 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.4 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -169.69 128.33 1.64 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.209 -0.996 . . . . 62.350000000000001 113.004 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 2.4 tmt_? -124.29 115.0 20.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 74.140000000000001 108.649 171.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -141.4 -177.11 4.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.078 -0.51 . . . . 73.409999999999997 110.91 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.31 143.76 16.81 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.804 -0.634 . . . . 74.519999999999996 111.754 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.448 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 53.3 t80 -96.68 120.97 37.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 72.040000000000006 110.772 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 112' ' ' LEU . 23.0 m -97.75 109.64 22.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 71.040000000000006 110.145 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.487 ' OD1' ' HA2' ' A' ' 76' ' ' GLY . 61.5 t30 -70.38 98.57 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 74.329999999999998 110.468 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -139.55 174.36 10.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 65.109999999999999 109.737 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.31 5.34 50.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.192 0.52 . . . . 70.099999999999994 110.707 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.65 152.63 24.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.596 -0.729 . . . . 73.019999999999996 109.672 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.668 ' HB3' ' HG2' ' A' ' 71' ' ' GLU . . . -73.93 124.96 27.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.03 0.443 . . . . 73.239999999999995 111.316 -175.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 106' ' ' THR . 35.9 mt -77.49 124.35 27.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.729 . . . . 74.340000000000003 110.594 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -95.11 109.55 21.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 74.310000000000002 110.681 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 91.8 m-85 -102.47 109.57 21.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.508 . . . . 74.5 110.474 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -81.13 90.19 6.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.602 . . . . 73.219999999999999 109.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.4 HG12 ' HA3' ' A' ' 101' ' ' GLY . 26.8 m -87.62 -177.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.211 -0.904 . . . . 71.25 111.45 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -72.87 128.74 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.585 -0.734 . . . . 74.150000000000006 110.863 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.637 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 4.5 m -68.53 114.68 7.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 61.119999999999997 110.201 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 tt -153.53 148.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 75.430000000000007 110.532 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.435 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -88.53 126.26 35.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.767 -0.457 . . . . 73.409999999999997 109.767 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.61 165.22 29.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.442 -0.344 . . . . 75.230000000000004 110.831 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 37.1 ttt180 -115.39 -26.35 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.519 0.676 . . . . 74.340000000000003 109.744 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -116.07 146.33 42.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 74.140000000000001 109.653 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -132.83 140.48 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.962 -0.384 . . . . 74.219999999999999 109.962 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' A' ' 58' ' ' VAL . 5.6 ttm180 -126.38 132.09 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.816 0.341 . . . . 72.299999999999997 111.166 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 57' ' ' ILE . 56.2 tp -98.2 118.18 34.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.088 -0.708 . . . . 73.540000000000006 109.088 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 95.5 m -115.38 125.05 52.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.158 0.504 . . . . 73.409999999999997 111.321 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 39.7 mm -105.1 90.21 3.55 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.431 -0.951 . . . . 74.140000000000001 108.431 171.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.734 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 83.6 Cg_endo -86.87 150.49 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.734 2.29 . . . . 75.030000000000001 113.138 -174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -81.77 61.52 5.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.893 0.854 . . . . 64.540000000000006 108.782 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -104.32 -42.67 5.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.877 -1.056 . . . . 75.540000000000006 112.23 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.61 29.67 4.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.82 -1.181 . . . . 75.219999999999999 113.992 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.23 25.18 9.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.181 -1.009 . . . . 74.409999999999997 112.963 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.3 131.32 43.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 63.25 111.358 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 m -93.65 174.68 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 74.349999999999994 110.188 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.46 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 3.3 p -85.88 19.07 2.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.007 0.432 . . . . 73.209999999999994 111.926 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.438 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t -125.92 124.36 66.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.843 -0.429 . . . . 74.109999999999999 109.843 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.79 135.94 26.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.538 -0.301 . . . . 71.549999999999997 110.417 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' A' ' 43' ' ' HIS . . . -137.12 105.99 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 74.340000000000003 111.514 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.6 mt -122.31 133.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.114 -0.699 . . . . 75.329999999999998 109.114 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.699 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 67.5 mtp180 -82.59 -45.84 14.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.092 0.473 . . . . 73.219999999999999 110.305 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.89 129.37 13.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.757 -0.656 . . . . 74.409999999999997 110.953 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.413 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 8.9 tt -109.56 118.36 36.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.625 -0.88 . . . . 75.510000000000005 108.625 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 149.98 42.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.007 0.432 . . . . 75.200000000000003 110.86 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.25 135.03 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.983 -0.553 . . . . 75.230000000000004 110.341 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -111.66 120.33 41.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.004 -0.739 . . . . 74.299999999999997 109.004 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.35 -159.9 16.2 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 62.219999999999999 111.847 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.0 m -120.84 130.82 54.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.588 0.232 . . . . 71.230000000000004 110.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.488 HD13 HG23 ' A' ' 5' ' ' ILE . 33.6 mm -74.78 127.54 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 72.420000000000002 110.143 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.07 149.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.747 -0.464 . . . . 64.319999999999993 109.747 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.77 60.06 2.32 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.273 0.558 . . . . 73.230000000000004 109.622 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.23 128.42 36.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.969 -1.014 . . . . 64.219999999999999 110.962 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -72.11 145.02 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.274 -0.421 . . . . 72.150000000000006 110.492 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 12.0 m170 61.92 34.52 16.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.88 -0.6 . . . . 75.230000000000004 110.186 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -54.76 114.02 1.55 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.054 -0.521 . . . . 65.409999999999997 111.225 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -56.34 138.39 50.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 75.310000000000002 110.651 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -151.89 113.9 4.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.966 0.412 . . . . 75.049999999999997 110.412 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -127.17 179.06 5.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.002 -0.544 . . . . 75.109999999999999 110.207 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.503 -0.317 . . . . 73.310000000000002 110.791 -179.857 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.766 0.317 . . . . 63.310000000000002 110.354 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.14 -101.91 2.72 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.764 -0.731 . . . . 74.239999999999995 112.708 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -81.82 -11.01 59.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.349999999999994 110.824 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.615 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 71.4 p -70.98 156.3 39.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.502 -0.772 . . . . 74.409999999999997 110.907 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.538 HG23 HD11 ' A' ' 65' ' ' ILE . 48.0 mm -88.36 136.48 23.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.698 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -64.26 109.41 1.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 71.450000000000003 109.958 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.51 -1.01 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 75.140000000000001 111.51 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -70.24 91.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.415 0.626 . . . . 60.039999999999999 109.835 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.75 -17.99 2.8 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.279 -0.873 . . . . 75.340000000000003 111.735 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -68.02 155.49 39.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 74.329999999999998 109.698 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -140.08 153.17 46.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.338 -0.545 . . . . 73.5 111.145 175.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.31 107.97 19.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.283 -0.871 . . . . 73.549999999999997 109.478 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.483 HD13 HG12 ' A' ' 58' ' ' VAL . 83.5 mt -73.61 -47.12 42.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.725 -0.67 . . . . 72.109999999999999 110.437 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -143.28 139.38 30.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 53.100000000000001 110.167 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.62 140.17 36.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.465 -0.568 . . . . 74.420000000000002 109.465 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -84.61 -28.67 26.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.848 0.356 . . . . 75.329999999999998 110.991 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 t -162.19 149.7 14.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.877 0.37 . . . . 72.329999999999998 110.887 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -165.85 137.5 3.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.53 -0.759 . . . . 75.409999999999997 109.107 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.49 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 9.8 tp10 -105.17 95.0 5.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.011 0.434 . . . . 64.140000000000001 111.434 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . . . -92.58 -31.48 15.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 72.439999999999998 110.572 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -79.66 -42.21 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 74.129999999999995 110.867 -173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.38 -47.54 22.01 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.947 -0.644 . . . . 73.439999999999998 112.7 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.41 -39.32 59.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.828 0.314 . . . . 73.340000000000003 111.166 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.37 -122.77 5.49 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.921 -1.133 . . . . 61.439999999999998 113.879 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.89 97.73 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.381 0.512 . . . . 75.219999999999999 112.381 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.8 9.34 86.97 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.95 -0.643 . . . . 72.329999999999998 113.209 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -112.66 141.47 46.4 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.017 -0.364 . . . . 74.510000000000005 110.017 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.38 -8.04 79.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.088 -0.577 . . . . 74.510000000000005 112.759 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.672 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.6 mt -73.27 144.65 46.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.322 -0.251 . . . . 74.230000000000004 110.322 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.7 -23.63 66.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.02 0.438 . . . . 65.340000000000003 110.923 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -75.4 -23.87 57.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 72.519999999999996 110.988 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.759 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 57.8 m -67.15 -25.38 66.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 61.100000000000001 110.417 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.37 -26.75 66.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.724 . . . . 75.109999999999999 110.522 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.563 HG23 HD13 ' A' ' 59' ' ' ILE . 31.9 pt -121.27 12.19 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 73.409999999999997 110.723 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.759 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t70 -71.08 -36.66 72.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 72.319999999999993 109.719 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.94 52.97 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.499 -0.858 . . . . 64.430000000000007 113.42 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.627 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 8.3 t0 -149.3 135.16 18.82 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.842 -0.429 . . . . 74.230000000000004 109.842 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.6 p -81.55 10.77 5.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.604 -0.725 . . . . 75.420000000000002 112.64 -172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.627 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 13.0 pt-20 -118.45 -7.7 10.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.525 -0.47 . . . . 73.409999999999997 111.315 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p -96.71 166.9 11.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.504 -0.554 . . . . 74.319999999999993 109.504 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.513 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 50.6 p90 -161.82 165.28 28.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.269 0.557 . . . . 72.120000000000005 112.25 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.522 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 32.1 t90 -109.65 139.41 44.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.763 -1.108 . . . . 75.219999999999999 108.966 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.68 142.4 43.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.343 -0.614 . . . . 74.510000000000005 109.343 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.06 151.81 45.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.316 -0.402 . . . . 71.340000000000003 110.221 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -62.51 125.76 25.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.039 -0.356 . . . . 72.450000000000003 110.039 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.49 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 68.7 p-90 -126.22 -34.02 2.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 74.439999999999998 110.616 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -75.61 108.6 8.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.622 -0.511 . . . . 73.049999999999997 109.622 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.43 -20.54 46.4 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.769 -0.729 . . . . 45.109999999999999 111.462 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.6 167.8 11.34 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.677 -0.773 . . . . 53.530000000000001 112.001 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.483 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 54.8 m -115.03 149.77 36.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 75.25 110.503 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.56 152.5 66.99 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 73.420000000000002 110.076 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.02 142.8 35.16 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.216 1.944 . . . . 74.430000000000007 112.738 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.14 156.69 87.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 75.150000000000006 110.002 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.59 170.24 65.41 Favored 'Cis proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.627 -1.406 . . . . 70.219999999999999 113.437 2.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -110.37 129.94 55.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.651 -0.704 . . . . 70.209999999999994 110.035 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 15.8 m-20 -118.43 130.05 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.882 0.372 . . . . 75.109999999999999 110.505 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.403 HD13 HD21 ' A' ' 126' ' ' LEU . 60.6 mt -121.25 108.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 73.129999999999995 109.681 173.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.483 HG12 HD13 ' A' ' 13' ' ' LEU . 40.8 t -95.93 119.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.907 -0.588 . . . . 74.319999999999993 110.23 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.563 HD13 HG23 ' A' ' 34' ' ' ILE . 61.3 mt -119.28 133.03 67.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.279 -0.419 . . . . 74.299999999999997 110.94 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.7 t0 -100.05 120.88 40.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 74.120000000000005 109.633 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.415 ' HE2' HD13 ' A' ' 67' ' ' ILE . 70.5 mtm -86.78 -4.88 59.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 72.230000000000004 111.01 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.51 0.07 3.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.181 0.808 . . . . 75.329999999999998 113.181 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -159.94 173.75 15.44 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.298 -0.251 . . . . 75.239999999999995 110.734 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -82.67 122.75 28.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 74.140000000000001 109.906 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.538 HD11 HG23 ' A' ' 5' ' ' ILE . 64.9 mt -132.59 135.31 57.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 75.230000000000004 110.322 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 118' ' ' SER . 57.2 tp60 -83.16 104.31 13.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.046 -0.724 . . . . 73.129999999999995 109.046 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.1 mm -73.6 121.75 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.414 -0.357 . . . . 73.25 110.288 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.2 -36.33 4.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.053 0.454 . . . . 73.329999999999998 110.748 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.425 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 20.6 tt0 -153.44 143.25 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.884 -0.598 . . . . 72.209999999999994 110.813 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -114.7 138.43 44.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.355 -0.609 . . . . 74.540000000000006 109.355 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.4 mt-10 -117.31 133.62 55.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 73.530000000000001 111.3 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.34 122.78 45.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.793 -0.639 . . . . 74.450000000000003 109.687 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 tp -106.25 106.48 57.36 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.239 -0.437 . . . . 71.549999999999997 110.043 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.95 177.92 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.724 2.283 . . . . 61.549999999999997 111.127 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -87.56 -5.98 58.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.637 -0.425 . . . . 73.310000000000002 110.847 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.78 168.51 11.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.677 -0.773 . . . . 75.140000000000001 112.17 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -89.66 133.6 34.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.626 -0.509 . . . . 63.109999999999999 109.626 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.21 10.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.758 -0.734 . . . . 70.439999999999998 111.597 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.5 m -69.48 160.96 30.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.119 -0.326 . . . . 73.239999999999995 110.119 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -80.43 98.38 7.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.222 0.534 . . . . 74.430000000000007 110.631 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.4 ' C ' ' H ' ' A' ' 83' ' ' ILE . 9.2 m120 -115.4 88.86 19.98 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.443 -0.799 . . . . 71.409999999999997 109.346 173.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.786 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 2.8 Cg_exo -77.89 31.05 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.369 2.713 . . . . 71.140000000000001 112.24 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 105' ' ' PHE . 30.8 mt -95.1 112.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 75.109999999999999 109.4 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -100.56 -44.76 5.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.005 -0.543 . . . . 74.329999999999998 110.643 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.502 HG11 ' HE ' ' A' ' 102' ' ' ARG . 58.6 t -127.32 138.39 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.865 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 m -128.5 140.74 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.230000000000004 110.364 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -118.12 129.17 55.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.145 -0.48 . . . . 71.040000000000006 110.654 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -112.04 130.18 55.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 74.540000000000006 110.234 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.05 148.46 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.803 0.335 . . . . 72.409999999999997 111.031 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 148.39 52.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 73.219999999999999 109.979 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 154.94 38.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.118 0.485 . . . . 74.439999999999998 111.458 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -105.62 -9.64 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.279 -0.637 . . . . 73.219999999999999 109.279 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.55 -36.17 8.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 53.219999999999999 111.606 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.32 15.15 3.58 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.574 1.178 . . . . 73.409999999999997 108.031 -167.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -122.28 -62.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.019 -1.446 . . . . 75.450000000000003 109.485 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -89.49 104.85 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.886 -0.597 . . . . 74.519999999999996 109.435 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -93.86 117.6 30.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 73.329999999999998 111.309 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.6 m -94.18 125.29 53.05 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.641 . . . . 73.319999999999993 110.256 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.29 113.92 3.84 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.403 2.069 . . . . 74.140000000000001 111.943 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.577 HD11 HG22 ' A' ' 116' ' ' VAL . 20.9 pt -83.87 -12.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 73.040000000000006 110.75 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.07 146.54 4.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.25 -0.976 . . . . 74.239999999999995 113.035 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.502 ' HE ' HG11 ' A' ' 85' ' ' VAL . 69.3 ttt180 -125.99 118.56 25.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.801 -0.815 . . . . 75.239999999999995 108.801 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -136.82 -176.14 4.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.019 0.438 . . . . 73.310000000000002 111.051 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.48 148.54 18.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.569 -0.742 . . . . 61.509999999999998 112.134 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.413 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 42.6 t80 -95.81 119.91 35.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 74.319999999999993 110.276 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.1 m -103.54 110.18 22.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.228 -0.442 . . . . 54.219999999999999 110.749 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.39 100.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 73.299999999999997 110.572 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -139.94 -179.34 5.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 70.200000000000003 110.375 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.53 -11.06 35.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.99 0.424 . . . . 72.109999999999999 110.975 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.166 -0.47 . . . . 74.349999999999994 111.009 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 130.67 43.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.49 . . . . 75.129999999999995 110.916 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 58.8 mt -83.32 109.46 17.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 64.5 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.26 112.46 21.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 74.109999999999999 110.94 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.0 104.13 14.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 74.239999999999995 110.016 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -77.57 91.25 3.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.356 -0.838 . . . . 74.219999999999999 109.355 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.577 HG22 HD11 ' A' ' 100' ' ' ILE . 31.2 m -96.28 -178.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 72.010000000000005 112.392 -170.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -65.73 126.49 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.136 -0.938 . . . . 75.540000000000006 110.649 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 63.9 m -71.49 123.99 23.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.074 -0.512 . . . . 74.230000000000004 110.45 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.059 -0.518 . . . . 75.439999999999998 110.286 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.691 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -93.83 113.61 25.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.178 -0.675 . . . . 74.25 109.178 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.06 173.61 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.676 0.274 . . . . 74.329999999999998 111.041 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -115.93 -32.36 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.32 0.581 . . . . 74.510000000000005 110.512 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.35 145.75 31.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.97 -0.559 . . . . 63.409999999999997 110.203 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.7 tt -135.13 138.02 49.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.021 -0.536 . . . . 64.420000000000002 109.69 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.431 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.3 ttp180 -124.7 125.9 44.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.017 0.437 . . . . 71.010000000000005 111.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.403 HD21 HD13 ' A' ' 57' ' ' ILE . 47.0 tp -93.28 112.79 24.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.491 -0.777 . . . . 75.430000000000007 108.979 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.3 m -111.81 123.09 49.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.39 0.614 . . . . 71.150000000000006 111.151 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.98 100.49 11.53 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.649 -0.871 . . . . 71.099999999999994 108.649 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.6 164.88 24.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.718 2.279 . . . . 74.519999999999996 112.98 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.69 14.71 24.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.153 0.977 . . . . 73.329999999999998 108.855 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -125.08 134.58 52.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.905 -1.043 . . . . 74.109999999999999 110.389 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.78 -9.92 14.21 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.941 -0.647 . . . . 65.450000000000003 112.445 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.72 23.54 6.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.147 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -79.96 144.79 33.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.771 0.32 . . . . 64.430000000000007 110.789 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 24.5 m -117.47 177.28 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.169 -0.469 . . . . 74.209999999999994 110.458 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 32.4 p -79.13 -3.12 43.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 54.119999999999997 111.814 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.786 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 87.4 t -95.23 121.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.373 -0.376 . . . . 75.409999999999997 110.081 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.32 128.65 17.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 74.439999999999998 110.428 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.96 106.22 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.411 . . . . 53.310000000000002 110.674 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.51 132.95 67.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.001 -0.74 . . . . 62.219999999999999 109.001 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.513 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 92.9 mtt180 -70.98 -59.41 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.724 -0.39 . . . . 73.310000000000002 110.884 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.1 157.63 40.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.759 0.79 . . . . 73.010000000000005 112.097 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.85 133.28 56.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.454 -1.248 . . . . 75.209999999999994 107.736 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.615 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -130.77 170.3 14.55 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.579 -0.448 . . . . 74.409999999999997 109.844 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.1 t -141.38 128.11 20.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.937 -0.394 . . . . 74.0 109.937 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.2 mttm -97.91 124.41 42.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.433 -0.951 . . . . 75.299999999999997 108.433 172.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.64 -167.13 26.85 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.282 -0.961 . . . . 55.130000000000003 112.052 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 m -119.17 126.76 52.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.767 0.317 . . . . 74.439999999999998 110.501 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 5' ' ' ILE . 41.4 mm -70.66 127.15 32.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.036 -0.529 . . . . 75.340000000000003 110.005 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 120' ' ' LYS . 47.4 mt -119.62 139.43 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.373 . . . . 65.329999999999998 110.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.22 113.17 17.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.154 0.502 . . . . 74.150000000000006 110.242 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.47 86.73 3.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.454 0.645 . . . . 62.450000000000003 110.01 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.63 26.89 3.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.439 -0.801 . . . . 74.099999999999994 111.09 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -78.12 -6.23 54.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 74.349999999999994 109.568 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -80.78 115.86 20.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.418 -0.81 . . . . 74.010000000000005 109.744 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -117.77 124.08 47.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 75.349999999999994 110.036 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -127.77 79.18 1.88 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.604 0.716 . . . . 74.230000000000004 111.006 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -140.83 134.25 29.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.114 -0.948 . . . . 74.120000000000005 109.33 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 116.407 -0.36 . . . . 70.209999999999994 110.866 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.031 0.443 . . . . 74.129999999999995 110.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.06 -168.98 30.76 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.606 -0.598 . . . . 73.109999999999999 111.606 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.9 m -75.12 -43.62 51.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.948 0.404 . . . . 72.439999999999998 110.682 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -92.19 151.88 20.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.474 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.585 HG22 HD13 ' A' ' 65' ' ' ILE . 51.1 mm -86.2 132.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.538 -0.301 . . . . 75.230000000000004 110.578 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -72.81 120.23 18.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.627 . . . . 61.409999999999997 109.306 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HZ1' ' CD ' ' A' ' 142' ' ' GLU . 47.3 mtmt -82.24 29.49 0.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 74.310000000000002 111.017 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -79.01 95.96 5.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.661 -0.699 . . . . 73.019999999999996 110.222 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.86 -9.02 9.16 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 72.120000000000005 112.265 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.442 ' HB3' HD13 ' A' ' 34' ' ' ILE . 21.2 m0 -69.67 134.34 48.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.983 -0.377 . . . . 74.129999999999995 109.983 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 62' ' ' LYS . 13.5 pt-20 -132.41 160.92 34.96 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.764 -0.374 . . . . 74.209999999999994 110.567 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -95.71 125.39 48.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.224 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.498 HD11 ' HB2' ' A' ' 60' ' ' ASP . 77.7 mt -90.5 -44.54 9.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.132 0.492 . . . . 75.099999999999994 110.303 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -142.2 137.22 30.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.752 -0.658 . . . . 72.340000000000003 110.316 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.57 144.33 34.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.411 . . . . 74.019999999999996 110.138 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.8 m -80.15 -51.31 9.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 110.858 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.629 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.4 t -142.7 150.17 39.79 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.269 -0.423 . . . . 64.420000000000002 110.98 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -164.94 142.82 6.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.471 -0.937 . . . . 74.230000000000004 108.471 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.619 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 9.1 tp10 -103.27 107.94 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.7 -0.4 . . . . 73.099999999999994 111.029 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.34 -5.88 12.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 72.420000000000002 111.332 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -111.74 -40.03 4.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.401 -0.363 . . . . 73.140000000000001 110.837 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.65 -45.3 23.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.002 -0.618 . . . . 61.100000000000001 112.038 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.619 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 41.3 mm-40 -84.51 -52.61 6.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.591 -0.522 . . . . 75.530000000000001 109.591 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.11 -170.78 23.39 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.773 -0.727 . . . . 64.129999999999995 112.305 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.48 120.27 28.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.845 0.355 . . . . 75.310000000000002 110.271 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -11.02 58.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.11 -0.567 . . . . 63.25 112.416 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.549 ' HB2' ' CE1' ' A' ' 41' ' ' PHE . 21.8 p-10 -134.67 127.96 32.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.885 0.374 . . . . 73.409999999999997 110.055 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.19 -10.8 60.09 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.481 -0.648 . . . . 70.209999999999994 111.481 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.6 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 89.7 mt -74.49 147.11 42.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.617 -0.291 . . . . 74.450000000000003 110.273 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.497 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.64 -24.06 64.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.044 0.449 . . . . 72.329999999999998 110.995 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -72.56 -26.91 61.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.755 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.992 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.3 m -70.57 -17.78 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 71.510000000000005 110.867 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.14 -20.58 66.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.544 0.687 . . . . 71.150000000000006 110.067 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 10' ' ' TRP . 40.2 pt -131.24 18.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.759 -0.655 . . . . 73.219999999999999 110.267 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.992 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -71.57 -30.44 65.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.026 -0.534 . . . . 74.349999999999994 110.651 -172.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.53 33.97 5.44 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.842 -0.694 . . . . 73.150000000000006 112.33 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 39' ' ' GLU . 8.8 t0 -153.32 124.4 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.695 -0.484 . . . . 73.329999999999998 109.695 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 p -77.53 -3.45 40.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.298 0.481 . . . . 73.120000000000005 112.298 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 16.9 mm-40 -83.34 -24.02 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.751 0.31 . . . . 61.509999999999998 110.208 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.631 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.4 p -93.93 165.06 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.958 -0.386 . . . . 72.549999999999997 109.958 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 52.8 p90 -163.92 172.01 14.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.296 . . . . 73.109999999999999 110.91 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.497 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 42.8 t90 -112.28 134.02 54.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.554 -0.748 . . . . 74.019999999999996 109.292 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.6 137.01 45.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.118 -0.697 . . . . 75.219999999999999 109.118 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 144.65 56.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.957 -0.386 . . . . 75.109999999999999 109.957 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.43 137.14 57.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.913 -0.585 . . . . 74.420000000000002 110.11 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -138.35 -13.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 75.510000000000005 110.9 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.59 101.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.127 0.489 . . . . 73.519999999999996 110.65 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.82 90.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.896 -0.669 . . . . 75.409999999999997 112.256 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.99 177.21 14.82 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.818 -0.706 . . . . 72.409999999999997 111.599 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 t -125.0 175.12 7.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.093 0.473 . . . . 72.439999999999998 110.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.629 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 17.0 m-20 -97.97 146.49 31.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 72.120000000000005 110.116 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.31 145.85 61.1 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.764 2.31 . . . . 74.319999999999993 112.835 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 21.0 mt -80.61 159.51 69.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.697 -0.683 . . . . 75.549999999999997 109.968 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.4 Cg_endo -78.42 158.61 92.91 Favored 'Cis proline' 0 C--N 1.344 0.307 0 C-N-CA 123.631 -1.404 . . . . 72.409999999999997 113.125 1.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.699 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.0 m-30 -91.08 129.93 37.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 74.230000000000004 109.974 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -121.07 124.96 46.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.202 -0.454 . . . . 62.420000000000002 109.955 -178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.39 117.15 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.92 0.391 . . . . 73.510000000000005 110.4 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.35 116.68 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 74.319999999999993 110.842 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.481 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.4 mp -107.82 136.69 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 74.430000000000007 110.517 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.498 ' HB2' HD11 ' A' ' 13' ' ' LEU . 39.8 t0 -104.47 122.75 46.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 63.240000000000002 109.791 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -90.12 -4.34 57.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 72.239999999999995 110.881 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 11' ' ' GLU . 33.4 mmtp 71.74 -6.99 1.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.456 0.702 . . . . 75.530000000000001 112.601 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -152.77 168.18 26.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.189 -0.3 . . . . 73.030000000000001 110.189 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.538 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 47.2 m-80 -85.58 125.43 33.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 74.120000000000005 110.344 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.585 HD13 HG22 ' A' ' 5' ' ' ILE . 62.0 mt -130.34 136.75 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.973 -0.558 . . . . 73.329999999999998 109.881 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.451 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.5 tp60 -83.19 100.53 10.63 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.901 -0.777 . . . . 74.310000000000002 108.901 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.719 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -66.89 130.92 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.378 -0.374 . . . . 73.530000000000001 110.318 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.71 -46.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.934 0.397 . . . . 73.5 110.943 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 19.3 tt0 -138.79 149.42 44.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.631 -0.507 . . . . 65.140000000000001 109.631 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.89 127.57 73.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.82 -0.437 . . . . 72.209999999999994 109.82 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 1.9 mp0 -108.66 131.79 54.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.333 0.587 . . . . 72.349999999999994 111.048 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.577 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 60.1 mt -111.66 119.27 38.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.51 -0.922 . . . . 74.109999999999999 108.51 174.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 27.0 tp -102.32 96.45 7.17 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.256 -0.646 . . . . 75.519999999999996 109.256 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.1 Cg_endo -83.81 -169.73 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.259 2.64 . . . . 61.350000000000001 112.154 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -99.28 -53.23 3.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 73.430000000000007 109.957 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.89 -178.23 7.61 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.907 -0.588 . . . . 54.399999999999999 112.759 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.29 -87.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.102 0.779 . . . . 75.030000000000001 113.102 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.45 48.53 3.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.123 -0.56 . . . . 62.329999999999998 112.276 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 p -168.06 148.45 4.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.527 -0.546 . . . . 53.140000000000001 109.527 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -86.56 -54.78 4.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.986 -0.376 . . . . 54.299999999999997 109.986 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 138' ' ' ALA . 65.4 t30 48.17 75.3 0.68 Allowed Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.868 0.73 . . . . 71.0 111.543 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.445 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 4.4 Cg_exo -75.79 55.6 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.343 2.696 . . . . 73.219999999999999 113.672 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.7 mt -99.51 115.61 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.089 -0.708 . . . . 71.239999999999995 109.089 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -100.44 -48.36 4.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.829 0.347 . . . . 73.540000000000006 110.832 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.16 139.82 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.099999999999994 110.466 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 m -130.08 143.32 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.984 0.421 . . . . 74.230000000000004 110.885 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.494 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 38.1 mt-10 -125.31 130.5 52.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.071 -0.513 . . . . 71.150000000000006 110.849 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -113.22 132.48 55.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.484 . . . . 74.310000000000002 110.554 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.14 154.69 50.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.393 -0.367 . . . . 43.310000000000002 110.503 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.29 156.78 47.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 73.219999999999999 109.921 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 t -149.65 143.82 25.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 75.540000000000006 110.555 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.42 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -93.37 -41.75 9.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.004 -0.544 . . . . 74.25 110.781 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -109.2 3.56 21.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.833 -0.621 . . . . 64.510000000000005 110.992 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 23.7 t-20 75.53 -9.64 1.38 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.559 0.744 . . . . 74.510000000000005 111.055 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.08 -42.98 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 62.329999999999998 110.815 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.68 106.76 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 75.310000000000002 110.043 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.4 m95 -99.58 120.41 39.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 73.319999999999993 110.572 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.3 m -113.36 126.14 28.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.265 -0.425 . . . . 64.329999999999998 110.586 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.75 113.7 2.86 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.445 2.097 . . . . 71.25 111.126 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.589 HD13 HG22 ' A' ' 116' ' ' VAL . 12.8 pt -82.17 -11.52 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 75.319999999999993 110.771 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.92 142.97 3.54 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.496 -0.859 . . . . 72.319999999999993 112.546 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.494 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 34.3 ttt180 -119.0 125.13 48.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.433 -0.58 . . . . 75.530000000000001 109.433 175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -140.28 -176.17 4.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.048 0.451 . . . . 71.219999999999999 110.718 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.81 155.55 20.08 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.435 -0.666 . . . . 74.549999999999997 111.435 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.487 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 52.1 t80 -103.27 135.33 45.12 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.898 0.38 . . . . 74.219999999999999 110.189 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.447 ' O ' HD11 ' A' ' 112' ' ' LEU . 34.3 m -116.04 116.55 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.483 -0.562 . . . . 72.0 109.483 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.68 93.6 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.273 0.559 . . . . 73.239999999999995 110.282 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -131.54 177.15 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.325 -0.852 . . . . 72.420000000000002 108.867 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.28 -8.74 35.08 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.49 -0.484 . . . . 73.129999999999995 110.252 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.62 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.808 -0.633 . . . . 54.329999999999998 110.223 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.31 128.48 35.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.11 0.481 . . . . 75.310000000000002 111.773 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 41.6 mt -84.96 125.68 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 73.219999999999999 110.06 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -98.0 115.32 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.969 0.414 . . . . 54.420000000000002 110.789 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.83 107.27 17.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.154 -0.475 . . . . 71.239999999999995 110.257 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.06 92.1 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.746 -0.661 . . . . 74.310000000000002 109.49 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 100' ' ' ILE . 28.9 m -98.56 176.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.796 . . . . 73.150000000000006 111.937 -171.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.89 134.23 52.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.379 -0.828 . . . . 74.109999999999999 110.594 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.719 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 19.2 m -77.28 117.72 19.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.071 -0.513 . . . . 74.099999999999994 110.7 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.62 143.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.982 -0.554 . . . . 75.329999999999998 110.802 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.538 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.522 -0.547 . . . . 74.030000000000001 109.522 173.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.58 159.72 44.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.211 -0.45 . . . . 75.239999999999995 110.944 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 39.9 ttt180 -107.53 -27.47 10.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.45 0.643 . . . . 72.530000000000001 109.728 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.433 ' CE2' ' HB2' ' A' ' 94' ' ' ASN . 71.8 m-85 -114.17 146.26 40.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.691 -0.686 . . . . 74.239999999999995 110.071 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.481 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.3 tt -133.62 140.3 46.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.452 -0.573 . . . . 72.209999999999994 109.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 49.6 ttp180 -127.97 124.54 37.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 74.340000000000003 111.394 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.3 tp -95.24 120.28 35.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.315 -0.857 . . . . 75.239999999999995 109.428 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -114.84 122.23 45.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 74.010000000000005 110.804 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.6 mm -102.24 97.19 8.13 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.87 -0.789 . . . . 72.140000000000001 108.87 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -73.48 -173.48 1.33 Allowed 'Trans proline' 0 CA--C 1.522 -0.123 0 C-N-CA 122.938 2.425 . . . . 74.430000000000007 113.058 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.527 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 16.2 t0 -129.26 75.36 1.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 65.519999999999996 108.4 166.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.53 -50.94 2.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.273 -0.876 . . . . 71.310000000000002 112.094 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.4 28.77 7.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.24 -0.981 . . . . 74.519999999999996 113.916 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 106.55 26.06 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.858 -1.163 . . . . 64.109999999999999 113.007 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.527 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 6.5 m-20 -70.81 132.12 44.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.725 0.298 . . . . 63.240000000000002 110.281 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 m -109.54 179.37 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.5 -0.318 . . . . 74.219999999999999 111.045 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 p -90.02 16.05 9.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.368 0.604 . . . . 65.209999999999994 111.544 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 78.2 t -110.43 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.014 -0.539 . . . . 72.129999999999995 109.65 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . . . -135.38 130.97 35.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.498 -0.319 . . . . 75.549999999999997 110.566 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.3 106.11 5.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.085 0.469 . . . . 71.450000000000003 110.879 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.8 mt -129.46 135.79 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.817 -0.629 . . . . 72.239999999999995 109.432 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 57.5 mtt180 -66.95 -71.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 75.420000000000002 110.096 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.478 ' CD ' ' HZ1' ' A' ' 7' ' ' LYS . 16.7 mt-10 -145.42 162.42 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.544 0.688 . . . . 75.120000000000005 111.98 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.88 124.7 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.507 -1.224 . . . . 75.319999999999993 108.18 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -126.35 162.17 26.14 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.637 -0.505 . . . . 72.319999999999993 109.637 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.1 t -136.03 134.93 50.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.876 0.37 . . . . 73.349999999999994 111.382 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 65.0 mttp -95.76 131.86 41.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.453 -0.573 . . . . 75.420000000000002 109.453 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.22 -169.65 37.96 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.194 -1.003 . . . . 74.349999999999994 112.474 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.2 m -118.81 132.86 56.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.35 -0.241 . . . . 72.340000000000003 110.35 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.82 121.37 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 71.099999999999994 110.11 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.451 HD11 ' HB2' ' A' ' 66' ' ' GLN . 73.5 mt -106.01 140.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.979 0.418 . . . . 74.329999999999998 110.457 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.07 136.85 54.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.04 -0.527 . . . . 61.329999999999998 110.182 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.66 12.89 27.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.256 0.55 . . . . 73.239999999999995 109.928 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.97 -177.65 6.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.403 -0.817 . . . . 73.099999999999994 110.688 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -68.35 145.27 54.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.137 0.494 . . . . 74.409999999999997 111.786 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -121.46 107.24 12.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 72.5 109.838 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -110.16 -28.22 8.76 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.844 -0.428 . . . . 74.510000000000005 109.844 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -69.89 93.74 0.78 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 74.310000000000002 109.992 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -158.94 86.49 0.84 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 64.319999999999993 110.288 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.687 -0.688 . . . . 75.219999999999999 109.721 176.258 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.871 -0.418 . . . . 62.539999999999999 109.871 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.42 140.11 12.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.771 -0.728 . . . . 73.239999999999995 112.249 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 m -81.95 -24.65 35.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.157 0.503 . . . . 72.450000000000003 109.807 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -77.4 136.75 38.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.298 -0.63 . . . . 72.340000000000003 109.298 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 65' ' ' ILE . 39.7 mm -71.43 136.45 25.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 73.540000000000006 111.067 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.1 m -73.15 109.08 6.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 73.5 109.826 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -85.94 26.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 74.200000000000003 111.383 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -6.09 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 65.200000000000003 111.463 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.2 2.87 10.59 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.608 -0.806 . . . . 74.319999999999993 112.399 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -81.46 134.9 35.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.427 -0.212 . . . . 75.140000000000001 110.427 -175.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.3 155.72 45.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.734 -0.386 . . . . 74.400000000000006 110.497 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.6 t -90.05 108.27 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.825 -0.625 . . . . 75.299999999999997 109.981 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.644 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.6 mt -74.77 -49.24 21.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.017 -0.538 . . . . 75.439999999999998 110.477 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -143.42 134.18 25.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.726 . . . . 73.400000000000006 110.015 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.457 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 54.3 p90 -135.33 148.91 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.706 -0.479 . . . . 73.340000000000003 109.706 175.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.2 m -86.62 -44.61 11.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 73.319999999999993 110.388 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -143.8 144.37 31.76 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.187 0.517 . . . . 74.340000000000003 111.077 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.457 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -149.92 148.29 28.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.184 -1.043 . . . . 74.310000000000002 108.184 175.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 8.5 tp10 -119.4 89.1 3.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.354 0.597 . . . . 52.509999999999998 110.963 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB3' ' CD2' ' A' ' 29' ' ' LEU . . . -100.38 -21.77 15.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.546 -0.752 . . . . 74.439999999999998 110.088 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -83.71 -44.46 14.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.673 -0.694 . . . . 65.400000000000006 110.93 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -37.23 40.05 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.911 -0.661 . . . . 73.230000000000004 112.35 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' HG3' ' A' ' 19' ' ' GLU . 28.6 mm-40 -79.98 -28.49 39.53 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.645 0.239 . . . . 70.510000000000005 111.645 -177.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.19 -83.33 0.36 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.414 -0.898 . . . . 74.120000000000005 112.585 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.77 141.84 8.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.537 0.208 . . . . 71.140000000000001 111.001 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.51 -3.38 17.47 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 116.168 -0.469 . . . . 71.200000000000003 113.564 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.78 -0.452 . . . . 75.510000000000005 109.78 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.31 3.06 90.25 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.709 -0.556 . . . . 74.340000000000003 111.709 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 80.6 mt -84.31 144.49 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.273 -0.269 . . . . 75.040000000000006 110.273 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.95 -24.51 66.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 74.519999999999996 110.409 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.74 -25.26 61.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 74.540000000000006 111.037 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.83 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 61.2 m -71.58 -18.67 62.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 75.540000000000006 110.387 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.23 -15.04 61.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.818 -0.628 . . . . 71.329999999999998 110.273 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.23 22.24 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.824 -0.625 . . . . 73.319999999999993 109.593 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.83 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 13.6 t70 -72.54 -58.7 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 64.430000000000007 110.402 -175.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.57 39.25 0.79 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.023 -0.608 . . . . 74.409999999999997 112.203 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -148.16 122.58 9.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.866 0.365 . . . . 64.230000000000004 110.265 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -74.9 7.14 3.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.101 0.778 . . . . 75.329999999999998 113.101 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -106.7 -19.72 13.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.035 -0.266 . . . . 75.439999999999998 111.051 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -88.65 168.93 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.03 -0.359 . . . . 73.409999999999997 110.03 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 141' ' ' ARG . 56.2 p90 -161.6 163.62 29.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.036 0.446 . . . . 74.519999999999996 111.586 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 32.5 t90 -107.02 143.02 35.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.294 -0.866 . . . . 73.310000000000002 109.072 172.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -138.96 145.72 40.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.126 -0.694 . . . . 71.340000000000003 109.126 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.1 149.73 39.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.118 -0.327 . . . . 75.530000000000001 110.118 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 50' ' ' SER . 63.1 tttm -61.06 119.37 8.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.428 -0.351 . . . . 73.310000000000002 110.619 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.458 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 69.8 p-90 -118.29 -27.13 6.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 70.349999999999994 110.307 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.32 127.25 32.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.729 -0.471 . . . . 75.450000000000003 109.729 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.22 89.97 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.725 -0.75 . . . . 73.439999999999998 111.828 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.57 148.5 9.0 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.491 -0.643 . . . . 74.420000000000002 111.491 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 20.6 m -78.85 150.19 32.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.117 -0.327 . . . . 44.200000000000003 110.117 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 2.0 t70 -80.42 145.48 59.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 75.420000000000002 110.021 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 20.3 Cg_endo -62.25 129.98 28.84 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.632 2.221 . . . . 71.409999999999997 113.327 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.2 158.69 66.5 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 74.239999999999995 110.125 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.979 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.3 Cg_exo -76.5 161.58 93.48 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 124.284 -1.132 . . . . 75.25 113.295 0.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.1 m-85 -96.11 138.46 33.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 71.409999999999997 109.579 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.469 ' OD2' ' HD3' ' A' ' 125' ' ' ARG . 6.2 t70 -132.67 123.69 26.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.221 -0.288 . . . . 62.219999999999999 110.221 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.39 124.18 66.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.695 0.283 . . . . 72.209999999999994 110.624 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.922 HG21 ' HG3' ' A' ' 125' ' ' ARG . 45.5 t -113.23 120.16 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.34 -0.391 . . . . 63.219999999999999 111.096 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -112.99 139.36 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 75.519999999999996 110.103 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.644 ' HB2' HD11 ' A' ' 13' ' ' LEU . 51.0 t0 -106.0 126.81 52.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.625 -0.509 . . . . 72.439999999999998 109.625 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.0 mtm -90.62 -6.97 53.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 74.230000000000004 110.664 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.436 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 31.5 mmtp 68.48 5.27 4.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.602 0.761 . . . . 74.310000000000002 112.415 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 27.4 pt20 -157.94 174.16 15.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.492 -0.188 . . . . 72.150000000000006 110.492 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -88.6 124.11 33.73 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.679 -0.489 . . . . 71.329999999999998 109.679 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.443 HD12 ' SD ' ' A' ' 61' ' ' MET . 70.9 mt -132.84 133.7 58.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.012 0.435 . . . . 73.019999999999996 110.256 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.431 ' HB2' HD13 ' A' ' 150' ' ' ILE . 52.6 tp60 -82.76 105.41 13.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.684 -0.858 . . . . 71.219999999999999 108.684 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.1 mm -75.44 124.74 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.82 0.343 . . . . 74.010000000000005 110.483 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.81 -43.88 2.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.03 -0.532 . . . . 70.129999999999995 110.784 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -148.47 140.3 23.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.242 -0.436 . . . . 71.430000000000007 111.039 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.31 139.45 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.297 -0.631 . . . . 74.349999999999994 109.297 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 42.0 mt-10 -123.29 131.37 53.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.104 0.478 . . . . 74.099999999999994 111.101 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.406 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 65.2 mt -113.36 124.72 53.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 74.0 109.893 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -103.58 104.14 40.22 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.651 -0.5 . . . . 73.349999999999994 109.651 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 11.9 Cg_exo -69.27 -172.42 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.811 2.341 . . . . 74.099999999999994 112.129 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -79.26 -24.56 42.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.164 -0.68 . . . . 73.319999999999993 109.164 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 91.02 -149.76 20.11 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.553 -0.749 . . . . 65.109999999999999 113.42 172.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 126.41 30.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.397 0.618 . . . . 72.430000000000007 109.98 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.16 38.19 4.13 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 110.594 -1.002 . . . . 72.420000000000002 110.594 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.6 t -144.95 151.3 38.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.301 -0.45 . . . . 73.510000000000005 110.222 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -77.34 -65.7 0.92 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.337 -0.616 . . . . 74.340000000000003 109.337 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.517 ' HB2' ' ND2' ' A' ' 107' ' ' ASN . 2.7 m120 48.24 67.72 4.22 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.925 -0.58 . . . . 71.450000000000003 112.227 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.543 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 85.1 Cg_endo -85.89 30.52 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.813 2.342 . . . . 74.430000000000007 112.306 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -77.76 127.85 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 63.32 109.795 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -98.96 -55.2 2.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 75.109999999999999 111.126 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 48.0 t -128.82 138.03 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 72.329999999999998 110.739 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.59 133.59 68.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.237 -0.438 . . . . 74.109999999999999 110.169 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.2 mt-10 -115.02 126.67 55.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.982 0.42 . . . . 63.520000000000003 110.975 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -107.56 134.06 51.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.773 -0.649 . . . . 74.109999999999999 110.248 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.66 151.54 51.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.33 -0.395 . . . . 72.319999999999993 110.398 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.084 -0.339 . . . . 72.530000000000001 110.084 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -147.58 145.35 28.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.031 0.443 . . . . 62.520000000000003 111.5 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -81.52 -43.25 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.8 -0.636 . . . . 72.329999999999998 109.842 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 1.0 OUTLIER -109.72 -1.97 17.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.268 -0.878 . . . . 70.310000000000002 112.394 -170.247 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.3 t-20 76.27 -7.96 1.73 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.972 0.509 . . . . 73.230000000000004 111.079 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -94.69 -51.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.231 0.539 . . . . 73.540000000000006 109.804 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -92.64 105.71 17.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.43 -0.805 . . . . 73.140000000000001 110.328 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.506 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 96.6 m95 -97.63 121.75 39.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.853 0.359 . . . . 73.349999999999994 111.504 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 35.5 m -97.36 128.95 33.13 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 64.430000000000007 110.046 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 6.0 Cg_exo -75.22 108.69 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.463 2.109 . . . . 74.340000000000003 110.315 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 19.8 pt -82.37 -19.1 10.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.377 -0.374 . . . . 73.150000000000006 111.206 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.19 131.06 1.41 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.037 -1.078 . . . . 41.25 113.002 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 61.4 ttt180 -112.91 115.21 28.08 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.917 -0.401 . . . . 70.319999999999993 109.917 172.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -137.4 176.99 8.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.723 0.297 . . . . 72.230000000000004 110.853 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -95.61 157.59 21.85 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.902 -0.666 . . . . 74.340000000000003 112.057 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -94.14 148.29 22.33 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.719 -0.475 . . . . 73.439999999999998 109.719 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.661 ' HB ' HD23 ' A' ' 112' ' ' LEU . 18.4 m -131.21 115.93 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.501 -0.318 . . . . 73.109999999999999 110.644 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 81' ' ' ASN . 48.7 t-20 -69.67 96.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.165 0.507 . . . . 73.140000000000001 110.09 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.409 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 12.4 pt20 -136.94 174.01 11.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.704 . . . . 73.219999999999999 109.284 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.55 -8.38 44.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.232 0.539 . . . . 73.349999999999994 110.752 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.42 158.78 16.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 64.109999999999999 110.618 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.18 138.21 58.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.269 -0.423 . . . . 73.219999999999999 110.945 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.661 HD23 ' HB ' ' A' ' 106' ' ' THR . 39.7 mt -90.95 110.76 22.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 75.420000000000002 110.461 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.43 120.19 26.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.198 0.523 . . . . 64.049999999999997 110.271 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.29 107.5 17.27 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.394 -0.821 . . . . 70.239999999999995 110.007 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -80.02 98.66 7.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.209 -0.663 . . . . 74.310000000000002 109.209 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 30.8 m -100.78 -178.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.911 -0.586 . . . . 74.209999999999994 111.801 -171.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.03 129.59 40.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 74.310000000000002 110.776 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.8 m -75.65 106.81 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 73.109999999999999 110.033 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.18 148.3 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.374 -0.375 . . . . 74.349999999999994 110.244 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.782 ' HZ2' ' HB3' ' A' ' 120' ' ' LYS . 4.5 ttpm? -84.82 135.84 33.93 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.891 -0.411 . . . . 75.430000000000007 109.891 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.22 40.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.571 -0.286 . . . . 74.420000000000002 110.982 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 41.0 ttt180 -108.73 -33.3 7.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 74.200000000000003 109.462 171.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -109.3 145.51 35.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.655 -0.702 . . . . 74.340000000000003 109.891 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -130.8 139.1 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.407 -0.59 . . . . 75.019999999999996 109.407 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.922 ' HG3' HG21 ' A' ' 58' ' ' VAL . 1.6 ttm180 -125.12 139.44 53.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.915 0.388 . . . . 74.230000000000004 111.021 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 tp -115.11 120.51 40.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.671 -0.695 . . . . 71.319999999999993 109.458 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 42.1 m -115.55 128.55 56.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.883 0.373 . . . . 74.140000000000001 110.798 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 35.1 mm -108.35 88.77 5.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.171 -0.677 . . . . 65.219999999999999 109.171 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.979 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.8 Cg_endo -87.95 131.42 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.957 2.438 . . . . 74.439999999999998 113.708 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 20.3 t0 -80.1 65.0 5.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.044 0.926 . . . . 75.109999999999999 109.246 172.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.09 -19.14 11.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.687 -1.142 . . . . 74.340000000000003 110.02 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -131.49 29.04 3.5 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.611 -0.804 . . . . 25.300000000000001 112.792 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.69 24.91 16.59 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 120.506 -0.854 . . . . 74.040000000000006 113.321 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 3.2 m-20 -70.25 130.85 43.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.968 0.413 . . . . 74.0 111.193 -176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.543 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.3 m -92.49 157.26 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 70.219999999999999 110.363 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 10.0 p -67.89 -20.98 65.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.032 0.444 . . . . 73.209999999999994 111.908 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.451 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 t -80.47 93.57 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.205 0.526 . . . . 72.310000000000002 110.679 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -114.39 136.05 53.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.076 -0.511 . . . . 72.420000000000002 110.313 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -152.02 108.36 3.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.86 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.61 136.22 60.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 75.340000000000003 108.823 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 41' ' ' PHE . 66.7 mtt180 -74.62 -53.52 9.2 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.852 -0.339 . . . . 65.439999999999998 111.32 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.28 135.56 15.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 75.209999999999994 111.07 -173.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.75 121.14 43.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.371 -0.603 . . . . 71.409999999999997 109.371 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.7 158.26 35.25 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.922 0.391 . . . . 61.310000000000002 110.55 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.56 136.54 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.104 -0.498 . . . . 74.040000000000006 110.379 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -101.7 125.42 48.35 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.207 -0.664 . . . . 73.010000000000005 109.207 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.1 -168.32 30.96 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.395 -0.907 . . . . 73.230000000000004 112.549 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.6 m -115.7 131.25 56.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.582 0.229 . . . . 74.409999999999997 110.948 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 mm -76.95 118.07 22.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 75.019999999999996 110.374 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.689 HD12 ' HG3' ' A' ' 120' ' ' LYS . 39.7 mt -109.29 132.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.229 0.538 . . . . 73.099999999999994 110.607 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.76 101.29 8.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.841 -0.618 . . . . 73.349999999999994 110.323 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.91 92.78 8.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.286 -0.415 . . . . 75.439999999999998 109.911 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -70.9 105.66 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.508 0.67 . . . . 72.030000000000001 111.391 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -143.02 -173.18 3.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.871 -1.059 . . . . 75.129999999999995 108.284 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -83.48 73.11 10.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.611 0.719 . . . . 72.239999999999995 110.445 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.92 124.47 12.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.554 -1.203 . . . . 70.329999999999998 108.792 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -65.63 97.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.57 0.544 . . . . 71.439999999999998 110.149 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -120.94 151.77 39.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 74.219999999999999 110.693 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 72.099999999999994 110.464 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.626 0.25 . . . . 73.140000000000001 110.527 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.24 143.28 10.05 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.491 -0.862 . . . . 74.239999999999995 112.282 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.8 t -92.59 -15.71 26.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 73.040000000000006 110.684 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 p -95.41 161.16 14.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.969 -0.56 . . . . 73.510000000000005 111.099 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.626 HG22 HD11 ' A' ' 65' ' ' ILE . 47.8 mm -85.29 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 110.115 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -66.92 118.72 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 74.329999999999998 110.381 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 144' ' ' ASP . 48.1 mtmt -92.2 25.79 2.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.095 0.474 . . . . 74.230000000000004 110.621 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -52.93 61.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.4 -0.818 . . . . 75.209999999999994 112.23 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.44 6.53 68.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.532 -0.842 . . . . 74.209999999999994 113.304 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -70.54 134.15 47.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.799 0.299 . . . . 73.319999999999993 110.403 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 6.8 pt-20 -130.71 161.83 30.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.983 0.421 . . . . 74.400000000000006 110.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.92 113.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.791 -0.64 . . . . 73.209999999999994 110.118 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.66 HD11 ' HB2' ' A' ' 60' ' ' ASP . 79.4 mt -83.36 -47.89 10.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.996 -0.547 . . . . 75.310000000000002 110.478 -178.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -137.36 140.41 41.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.815 -0.629 . . . . 64.420000000000002 110.164 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -150.37 148.52 28.9 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.588 -0.523 . . . . 73.099999999999994 109.588 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -90.73 -36.49 14.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 72.099999999999994 111.065 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -155.22 154.46 32.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 73.540000000000006 111.243 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 10.1 pt20 -165.63 135.81 3.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.192 -0.913 . . . . 71.519999999999996 108.81 174.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 9.0 tp10 -88.98 94.79 10.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.33 0.586 . . . . 74.030000000000001 110.546 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.49 -3.18 34.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.654 -0.703 . . . . 73.120000000000005 111.49 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -111.39 -51.58 2.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.823 0.344 . . . . 75.230000000000004 110.131 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.41 92.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.146 -0.549 . . . . 73.310000000000002 112.14 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 61.2 mm-40 -96.79 -58.43 2.04 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.888 -0.412 . . . . 70.200000000000003 109.888 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.16 -177.24 16.6 Favored Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.449 -0.881 . . . . 65.450000000000003 112.998 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.15 117.38 10.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 75.129999999999995 110.355 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.72 -5.95 54.48 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.888 -0.672 . . . . 74.140000000000001 112.343 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -137.6 128.52 27.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.636 0.255 . . . . 63.350000000000001 110.447 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.86 -5.26 83.05 Favored Glycine 0 C--N 1.322 -0.234 0 C-N-CA 120.601 -0.809 . . . . 73.230000000000004 112.438 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.476 HD12 ' HE3' ' A' ' 31' ' ' LYS . 82.2 mt -73.95 150.99 40.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.142 -0.318 . . . . 75.109999999999999 110.142 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.94 -22.25 66.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 63.240000000000002 110.953 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HE3' HD12 ' A' ' 29' ' ' LEU . 16.8 pttp -75.08 -24.17 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 72.430000000000007 110.816 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.937 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.0 m -76.51 -10.71 59.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.941 -0.572 . . . . 63.409999999999997 111.087 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.77 -15.3 62.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.616 0.722 . . . . 75.150000000000006 109.417 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.426 HG23 HD11 ' A' ' 59' ' ' ILE . 28.4 pt -132.01 21.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 72.129999999999995 109.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.937 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 1.7 t70 -68.22 -48.54 64.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 64.439999999999998 109.931 -174.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.74 31.12 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.809 -0.71 . . . . 74.5 114.077 171.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.584 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 9.7 t70 -153.27 153.95 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.981 0.89 . . . . 74.140000000000001 111.336 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -72.53 -18.36 61.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.272 0.471 . . . . 74.019999999999996 112.272 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.584 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.7 pt-20 -98.12 3.43 49.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.404 -0.518 . . . . 63.240000000000002 111.189 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -102.27 157.05 17.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.915 -0.772 . . . . 72.329999999999998 108.915 168.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 51.2 p90 -166.98 158.07 12.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 71.209999999999994 111.2 -175.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.582 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.7 t90 -102.35 134.91 44.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.402 -0.817 . . . . 73.519999999999996 109.051 172.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -134.78 136.16 42.37 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.469 -0.567 . . . . 73.209999999999994 109.469 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.18 139.79 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.945 -0.391 . . . . 54.119999999999997 109.945 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' SER . 36.9 ttpt -62.56 118.84 8.14 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.717 -0.475 . . . . 75.150000000000006 109.717 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -112.36 -29.38 7.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.594 -0.275 . . . . 75.409999999999997 110.622 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -74.25 125.47 28.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.978 0.418 . . . . 73.319999999999993 110.17 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.05 -3.09 84.46 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 73.25 112.145 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.85 132.61 7.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.874 -0.679 . . . . 74.439999999999998 111.9 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 49.7 m -78.91 149.57 32.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 74.239999999999995 111.341 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.13 157.69 89.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 74.409999999999997 110.326 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.0 146.56 41.82 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.326 2.018 . . . . 71.319999999999993 112.123 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.49 156.95 88.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.833 -0.621 . . . . 73.530000000000001 109.707 173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.767 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 84.0 Cg_endo -82.78 156.46 76.07 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.779 -1.342 . . . . 73.209999999999994 113.62 0.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.21 117.89 30.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.539 -0.755 . . . . 73.0 109.234 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 18.5 t70 -117.42 125.62 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.305 -0.258 . . . . 64.439999999999998 110.305 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 61.4 mt -122.83 115.58 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.831 0.348 . . . . 72.420000000000002 110.94 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.14 116.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.957 -0.565 . . . . 75.239999999999995 110.306 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 34' ' ' ILE . 81.8 mt -115.96 136.75 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.236 -0.438 . . . . 73.310000000000002 110.844 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.66 ' HB2' HD11 ' A' ' 13' ' ' LEU . 53.5 t0 -101.54 120.28 40.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.47 -0.567 . . . . 64.409999999999997 109.47 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm -85.97 -5.94 59.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 73.129999999999995 110.819 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 73.2 mmtt 67.6 7.34 5.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.809 -0.632 . . . . 74.099999999999994 112.159 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.78 ' HA ' HD22 ' A' ' 152' ' ' LEU . 24.1 pt20 -163.93 155.96 16.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.707 0.289 . . . . 71.310000000000002 110.459 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 152' ' ' LEU . 79.5 m-20 -74.54 128.74 36.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.601 . . . . 72.310000000000002 109.838 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.626 HD11 HG22 ' A' ' 5' ' ' ILE . 58.5 mt -133.46 135.88 55.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.857 0.36 . . . . 75.150000000000006 110.165 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 118' ' ' SER . 58.5 tp60 -81.51 102.68 10.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.875 -0.787 . . . . 73.329999999999998 108.875 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 118' ' ' SER . 21.4 mm -72.93 118.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.473 -0.33 . . . . 73.439999999999998 110.285 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.12 -41.97 3.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.351 -0.386 . . . . 74.409999999999997 110.843 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -148.64 144.22 27.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.301 -0.409 . . . . 71.510000000000005 110.277 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.02 129.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.961 -0.385 . . . . 71.319999999999993 109.961 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -105.89 131.17 53.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.935 0.398 . . . . 74.510000000000005 110.468 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 38.4 mt -112.6 118.57 35.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.848 -0.615 . . . . 74.510000000000005 109.449 174.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.486 ' HG ' ' HD2' ' A' ' 141' ' ' ARG . 24.2 tp -102.36 101.52 20.1 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 115.82 -0.627 . . . . 75.219999999999999 109.328 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 17.0 Cg_exo -65.25 166.59 18.64 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.5 2.133 . . . . 64.329999999999998 111.111 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.809 ' HA ' ' HG3' ' A' ' 141' ' ' ARG . 76.8 ttt180 -72.01 -13.69 61.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 70.530000000000001 111.13 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.95 -174.53 27.8 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.713 -0.756 . . . . 51.329999999999998 111.449 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -89.49 139.28 30.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.962 0.411 . . . . 73.140000000000001 110.04 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.71 -35.19 2.36 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.285 -1.126 . . . . 74.109999999999999 110.285 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.5 m -113.13 111.83 22.78 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.064 -0.717 . . . . 72.439999999999998 109.064 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.1 OUTLIER -60.51 131.46 50.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.403 0.62 . . . . 75.239999999999995 110.952 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.666 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 49.9 t-20 -124.88 102.7 31.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.597 -0.729 . . . . 73.049999999999997 110.133 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.639 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 89.6 Cg_endo -90.88 28.14 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.305 2.67 . . . . 74.019999999999996 113.731 -177.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 80.1 mt -82.51 117.46 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 75.329999999999998 110.512 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -92.05 -57.53 2.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.618 -0.719 . . . . 74.219999999999999 110.902 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.66 138.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.574 . . . . 61.439999999999998 111.09 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.41 138.67 54.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 110.146 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.448 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 89.9 mt-10 -119.81 127.68 53.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 110.617 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -106.3 132.85 51.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.761 -0.654 . . . . 73.219999999999999 109.978 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.7 150.31 52.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.588 -0.278 . . . . 74.150000000000006 110.408 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.36 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.766 0.317 . . . . 72.340000000000003 111.169 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 t -150.53 149.11 29.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.303 -0.628 . . . . 74.099999999999994 109.303 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.689 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -90.65 -33.88 15.65 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 122.163 -0.335 . . . . 72.239999999999995 111.755 -177.006 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.6 20.22 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.602 -0.439 . . . . 73.010000000000005 111.222 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 65.79 47.4 2.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.426 0.632 . . . . 61.039999999999999 110.518 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.54 -74.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.042 -0.526 . . . . 74.530000000000001 109.894 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -83.29 105.82 14.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.475 . . . . 74.239999999999995 110.327 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -91.06 108.32 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.274 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.0 m -94.56 123.67 57.52 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.874 -0.603 . . . . 64.519999999999996 110.181 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.48 102.55 0.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.412 2.075 . . . . 73.310000000000002 111.27 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.4 pt -75.79 -15.64 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 75.519999999999996 111.112 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.6 136.57 2.28 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.809 -1.186 . . . . 72.420000000000002 113.509 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.448 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 40.3 ttt180 -119.67 114.62 22.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.514 -0.921 . . . . 74.230000000000004 108.514 169.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -135.87 179.62 6.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 73.540000000000006 110.755 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.49 135.17 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.319999999999993 112.12 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -94.29 148.08 22.57 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.792 -0.448 . . . . 73.030000000000001 109.792 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.45 ' O ' HD11 ' A' ' 112' ' ' LEU . 47.0 m -142.11 120.36 12.26 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.71 -0.478 . . . . 71.120000000000005 109.71 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 12.0 t30 -77.09 91.66 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.51 0.671 . . . . 75.340000000000003 110.935 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -118.26 -171.89 2.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.002 -0.999 . . . . 74.439999999999998 109.217 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -95.83 -26.05 15.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.935 0.397 . . . . 71.150000000000006 110.63 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.79 155.32 21.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 60.420000000000002 110.624 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.86 141.15 51.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 74.25 111.013 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 106' ' ' THR . 16.0 mt -98.2 106.45 18.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 75.439999999999998 110.083 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -80.3 116.7 20.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 110.569 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.92 112.62 25.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.667 -0.697 . . . . 75.239999999999995 110.578 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -77.22 93.25 3.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.377 -0.601 . . . . 74.530000000000001 109.377 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.5 m -96.79 177.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 75.329999999999998 111.495 -173.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -67.59 132.87 48.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.321 -0.854 . . . . 75.010000000000005 110.459 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 41.8 m -74.92 122.25 23.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 75.329999999999998 110.51 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.5 tt -152.84 143.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.896 -0.593 . . . . 75.140000000000001 110.538 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -88.89 112.61 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.168 -0.678 . . . . 73.319999999999993 109.168 174.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.95 161.96 36.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.449 -0.341 . . . . 72.030000000000001 111.082 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.689 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 34.7 ttt180 -109.89 -31.85 7.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 73.219999999999999 110.159 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.05 145.92 30.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.705 -0.679 . . . . 74.219999999999999 109.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.412 HG21 ' HB ' ' A' ' 59' ' ' ILE . 14.7 tt -129.56 140.05 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.546 -0.539 . . . . 73.329999999999998 109.546 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.447 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 57.5 ttp180 -130.29 127.02 38.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 75.430000000000007 111.127 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.18 115.94 31.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.646 -0.707 . . . . 72.010000000000005 109.236 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 34.7 m -112.04 120.52 42.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.031 0.444 . . . . 75.409999999999997 110.91 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.7 96.06 8.4 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.175 -0.676 . . . . 73.430000000000007 109.175 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.767 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 98.0 Cg_endo -79.73 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.513 2.142 . . . . 73.200000000000003 112.617 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -123.69 67.73 1.02 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.912 0.863 . . . . 61.240000000000002 108.867 170.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.8 18.07 3.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.66 -1.154 . . . . 73.109999999999999 110.1 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.84 2.1 0.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.168 -1.015 . . . . 61.049999999999997 113.729 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.75 27.64 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.32 -0.943 . . . . 42.509999999999998 112.045 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.04 156.52 17.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.965 0.412 . . . . 73.340000000000003 110.958 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.639 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 22.4 m -123.43 -179.41 4.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.068 -0.515 . . . . 75.510000000000005 110.199 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.451 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 6.6 p -85.06 5.0 31.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.219 0.533 . . . . 74.209999999999994 111.993 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 46.6 t -103.05 128.56 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.48 131.92 19.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.7 -0.227 . . . . 74.099999999999994 110.653 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.36 105.34 4.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 70.140000000000001 111.145 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.95 133.31 67.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.363 -0.606 . . . . 65.439999999999998 109.363 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.809 ' HG3' ' HA ' ' A' ' 75' ' ' ARG . 66.9 mtt180 -64.76 -71.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.345 0.593 . . . . 73.329999999999998 109.89 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -140.09 144.51 36.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 64.25 111.7 -172.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -107.48 119.61 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.825 -1.176 . . . . 73.299999999999997 107.825 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 7' ' ' LYS . 2.3 m-20 -123.7 141.77 51.7 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.936 0.398 . . . . 72.319999999999993 110.557 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.11 133.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.241 -0.436 . . . . 74.219999999999999 110.678 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -107.49 105.24 15.05 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.75 -0.833 . . . . 74.200000000000003 108.75 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.03 -150.05 5.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.68 . . . . 73.340000000000003 111.966 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 m -132.83 133.85 43.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.503 0.192 . . . . 74.25 110.589 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.58 130.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 75.540000000000006 110.988 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.544 HD12 ' HG2' ' A' ' 120' ' ' LYS . 34.3 mt -123.9 150.83 28.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.796 -0.638 . . . . 74.219999999999999 109.749 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.7 168.39 18.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.34 0.59 . . . . 62.43 111.008 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.78 HD22 ' HA ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -154.41 156.13 36.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.011 -0.995 . . . . 73.420000000000002 109.87 175.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.81 11.32 25.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.128 -0.487 . . . . 70.319999999999993 111.174 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -91.11 94.07 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 73.030000000000001 109.439 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -111.41 127.57 55.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.009 0.433 . . . . 71.230000000000004 111.125 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -112.44 107.1 15.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.831 -0.622 . . . . 75.129999999999995 109.995 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -105.67 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.169 -0.468 . . . . 74.409999999999997 111.357 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -121.8 100.6 7.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.65 -0.704 . . . . 73.310000000000002 109.603 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.3 m170 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.525 -0.307 . . . . 73.540000000000006 110.582 -178.288 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.79 0.329 . . . . 63.32 110.353 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.98 157.27 16.81 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.618 -0.593 . . . . 64.230000000000004 111.618 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -77.86 -29.36 50.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.325 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -102.37 135.61 43.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.126 -0.488 . . . . 70.409999999999997 110.317 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.775 HG23 HD11 ' A' ' 149' ' ' ILE . 42.1 mm -70.9 137.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.781 -0.645 . . . . 75.340000000000003 111.83 -174.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -69.08 108.16 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.564 . . . . 74.040000000000006 110.174 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -87.01 10.34 16.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.168 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -72.06 -7.5 49.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 53.109999999999999 111.654 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -120.19 4.59 12.44 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.263 -0.97 . . . . 74.25 113.076 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.505 ' HB2' HD11 ' A' ' 34' ' ' ILE . 34.8 m0 -80.3 156.81 26.61 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.635 0.255 . . . . 74.230000000000004 110.601 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.559 ' CD ' ' HE3' ' A' ' 62' ' ' LYS . 3.2 pm0 -141.89 153.02 44.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.143 0.497 . . . . 71.510000000000005 111.046 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.99 128.64 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.322 -0.399 . . . . 73.430000000000007 110.186 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 58' ' ' VAL . 57.4 mt -89.42 -49.81 6.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.243 0.544 . . . . 61.140000000000001 110.097 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.2 p -150.7 143.84 24.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.681 -0.69 . . . . 74.239999999999995 110.587 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.77 147.7 41.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.501 -0.772 . . . . 75.319999999999993 109.087 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -85.47 -33.31 21.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.903 0.382 . . . . 74.209999999999994 110.81 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -156.27 155.02 31.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 110.871 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -168.03 143.05 3.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.602 -0.888 . . . . 71.540000000000006 108.602 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -94.18 115.42 27.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.083 0.468 . . . . 70.430000000000007 110.124 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.36 3.74 6.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 53.119999999999997 110.899 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.6 m -121.74 -42.13 2.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.155 -0.475 . . . . 70.400000000000006 110.923 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.49 -47.78 15.43 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.809 -0.71 . . . . 71.140000000000001 112.395 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.95 -2.72 57.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 64.409999999999997 111.237 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.27 -165.26 31.31 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.859 -0.686 . . . . 74.409999999999997 112.332 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.25 126.08 50.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.962 0.41 . . . . 73.140000000000001 110.566 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.53 55.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.827 -0.701 . . . . 72.209999999999994 111.728 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -135.57 123.97 23.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.407 -0.59 . . . . 74.349999999999994 109.407 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.16 -7.88 58.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.015 -0.612 . . . . 74.430000000000007 111.944 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 90.1 mt -75.79 151.87 37.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 74.120000000000005 110.472 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.1 -25.27 65.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.009 0.433 . . . . 70.409999999999997 110.765 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.85 -20.47 61.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.672 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 60.4 m -73.01 -18.0 61.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.042 0.449 . . . . 61.310000000000002 110.742 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 tp -66.93 -17.5 64.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.737 -0.665 . . . . 74.430000000000007 110.219 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 10' ' ' TRP . 29.7 pt -128.39 22.39 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 73.200000000000003 110.45 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.636 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 26.5 t70 -70.49 -40.74 73.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 75.239999999999995 112.161 -171.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.32 23.08 9.87 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.651 -0.785 . . . . 73.349999999999994 112.061 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -138.18 128.83 26.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.49 -0.559 . . . . 74.030000000000001 109.49 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 p -76.83 0.56 20.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.029 0.751 . . . . 74.099999999999994 113.029 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.11 -7.44 15.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.572 -0.451 . . . . 72.129999999999995 111.57 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 p -92.42 149.2 21.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.081 -0.711 . . . . 73.530000000000001 109.081 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.561 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 49.7 p90 -153.05 166.72 31.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.946 0.403 . . . . 74.400000000000006 111.468 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.476 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 44.8 t90 -108.03 138.9 43.48 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.189 -0.914 . . . . 73.200000000000003 109.385 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -136.31 142.62 43.9 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.036 -0.727 . . . . 72.120000000000005 109.036 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.61 56.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.636 -0.505 . . . . 74.239999999999995 109.636 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -64.17 115.22 4.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.135 -0.32 . . . . 75.010000000000005 110.135 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -109.24 -28.94 8.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.311 -0.404 . . . . 75.209999999999994 110.805 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -76.54 113.78 14.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 73.420000000000002 110.236 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.87 -8.51 54.32 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.229 -0.748 . . . . 61.140000000000001 111.229 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.53 161.2 11.01 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.545 -0.622 . . . . 74.239999999999995 111.545 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.417 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 4.6 p -98.34 148.39 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.738 0.304 . . . . 73.519999999999996 110.51 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 21.2 m-20 -84.57 149.12 53.71 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.263 -0.426 . . . . 73.200000000000003 110.682 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 22.4 Cg_exo -66.24 128.79 20.15 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.872 2.382 . . . . 73.450000000000003 112.822 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.9 mt -73.09 162.33 75.05 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.391 -0.822 . . . . 74.109999999999999 110.207 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.719 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 92.4 Cg_endo -78.33 163.56 86.65 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.843 -1.315 . . . . 75.019999999999996 113.249 1.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.5 m-85 -100.19 112.89 25.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 73.310000000000002 110.649 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.78 131.62 44.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.421 -0.354 . . . . 75.400000000000006 110.254 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.406 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 60.6 mt -124.76 108.51 20.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.579 -0.526 . . . . 74.140000000000001 109.579 172.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG13 HD12 ' A' ' 13' ' ' LEU . 49.5 t -102.25 114.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.951 -0.568 . . . . 75.299999999999997 110.388 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.05 139.6 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.87 -0.604 . . . . 73.109999999999999 109.898 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.545 ' HB3' ' OE1' ' A' ' 11' ' ' GLU . 19.5 t0 -102.66 138.52 39.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.693 -0.484 . . . . 64.239999999999995 109.693 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.465 ' SD ' HD13 ' A' ' 65' ' ' ILE . 68.6 mtm -91.83 -3.15 56.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 75.310000000000002 110.07 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HE3' ' CD ' ' A' ' 11' ' ' GLU . 24.0 mmtp 67.6 4.09 3.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.482 -0.781 . . . . 72.340000000000003 112.467 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -165.3 172.12 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.602 0.239 . . . . 73.129999999999995 110.754 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.41 127.18 31.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.213 -0.449 . . . . 75.420000000000002 110.259 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.607 HD12 HG22 ' A' ' 5' ' ' ILE . 74.6 mt -136.68 135.16 48.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.143 0.497 . . . . 71.109999999999999 110.363 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -82.82 109.39 16.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.009 -0.738 . . . . 75.400000000000006 109.009 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 118' ' ' SER . 27.4 mm -79.33 129.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.92 -0.312 . . . . 73.430000000000007 110.325 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.59 -39.28 2.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 63.229999999999997 110.968 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 15.8 tt0 -150.96 143.94 24.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 110.996 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.06 131.68 67.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.243 -0.435 . . . . 70.530000000000001 109.836 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.8 mt-10 -110.07 135.85 50.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 110.677 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD13 ' HE2' ' A' ' 114' ' ' TYR . 69.2 mt -119.01 120.3 36.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.733 -0.667 . . . . 72.430000000000007 109.557 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 31.2 tp -104.25 104.02 41.91 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 116.052 -0.522 . . . . 75.519999999999996 109.907 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.7 Cg_exo -76.33 178.17 7.86 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.222 2.615 . . . . 64.310000000000002 112.267 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -115.38 27.34 9.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.483 -0.326 . . . . 74.430000000000007 110.767 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.79 99.79 0.06 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.914 -0.585 . . . . 64.299999999999997 114.355 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.486 ' HB2' ' H ' ' A' ' 78' ' ' GLY . 16.3 mmm180 -105.21 -83.97 0.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.82 -1.178 . . . . 75.420000000000002 107.82 170.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' ' HB2' ' A' ' 77' ' ' ARG . . . -123.42 25.52 6.26 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 108.881 -1.688 . . . . 75.329999999999998 108.881 167.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.62 150.69 37.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.926 -1.137 . . . . 74.129999999999995 111.469 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.94 -47.69 10.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.224 -0.658 . . . . 71.450000000000003 109.224 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 t30 43.59 73.86 0.88 Allowed Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 124.238 0.961 . . . . 73.010000000000005 111.423 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.589 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 75.4 Cg_endo -77.99 59.9 7.11 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.07 2.514 . . . . 65.129999999999995 113.755 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mt -99.0 119.36 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.041 -0.726 . . . . 74.409999999999997 109.041 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -102.64 -49.64 3.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.342 -0.39 . . . . 73.420000000000002 111.822 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.66 138.0 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.51 -0.314 . . . . 74.420000000000002 111.133 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.82 129.2 63.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.276 -0.42 . . . . 63.439999999999998 110.268 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.9 mt-10 -111.87 132.97 54.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.041 -0.527 . . . . 74.030000000000001 110.302 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.62 129.42 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.868 -0.605 . . . . 75.219999999999999 110.023 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.15 141.79 49.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.831 0.348 . . . . 72.219999999999999 110.943 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.03 46.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.062 -0.517 . . . . 72.150000000000006 110.387 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -149.96 158.89 44.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.845 0.355 . . . . 74.209999999999994 111.267 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.3 mt-10 -106.64 -25.08 11.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 110.985 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 p30 -114.42 0.68 14.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.48 -0.327 . . . . 74.120000000000005 111.647 -175.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 74.42 0.7 3.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.555 0.534 . . . . 74.319999999999993 110.516 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.9 -54.47 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 64.329999999999998 110.669 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -88.12 96.59 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.681 . . . . 74.319999999999993 110.278 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -90.38 121.11 32.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 73.109999999999999 110.743 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.0 m -98.47 121.81 55.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.711 -0.677 . . . . 70.340000000000003 109.814 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.42 113.61 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.288 1.992 . . . . 74.340000000000003 111.423 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.552 HD13 HG22 ' A' ' 116' ' ' VAL . 21.9 pt -88.78 -15.71 8.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 65.109999999999999 110.631 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.41 150.62 7.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.318 -0.944 . . . . 50.140000000000001 113.181 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.471 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 31.9 ttt180 -129.02 114.69 16.72 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.135 -1.061 . . . . 73.109999999999999 108.135 173.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.579 ' HE2' HG12 ' A' ' 116' ' ' VAL . 98.0 m-85 -127.28 171.98 11.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 73.239999999999995 111.657 -170.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.09 131.05 10.44 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.481 -0.782 . . . . 71.209999999999994 111.198 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.46 136.87 34.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.994 0.426 . . . . 74.329999999999998 110.265 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.553 ' HB ' HD23 ' A' ' 112' ' ' LEU . 18.0 m -118.52 111.1 18.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.845 -0.616 . . . . 73.409999999999997 109.861 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.45 104.24 3.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.989 0.424 . . . . 73.310000000000002 110.567 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.7 -176.79 5.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 71.430000000000007 109.91 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -103.13 0.66 32.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 75.030000000000001 110.687 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.06 163.15 12.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 75.299999999999997 110.631 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.27 35.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 73.120000000000005 111.329 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.553 HD23 ' HB ' ' A' ' 106' ' ' THR . 33.3 mt -89.07 113.97 25.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.791 -0.64 . . . . 73.450000000000003 110.626 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -92.18 113.83 26.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 74.310000000000002 110.243 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.418 ' HE2' HD13 ' A' ' 72' ' ' LEU . 79.8 m-85 -106.48 101.87 11.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.95 -0.568 . . . . 75.329999999999998 109.931 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.2 106.42 5.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.536 -0.756 . . . . 75.219999999999999 108.967 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.579 HG12 ' HE2' ' A' ' 103' ' ' PHE . 28.3 m -107.88 178.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.25 0.548 . . . . 73.349999999999994 111.995 -170.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.2 134.48 52.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 74.340000000000003 110.295 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 16.7 m -82.77 130.13 35.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 70.219999999999999 110.979 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.0 tt -160.65 147.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.925 -0.579 . . . . 74.400000000000006 110.123 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.02 121.15 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.424 -0.584 . . . . 75.310000000000002 109.424 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.0 176.95 9.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.424 -0.353 . . . . 61.140000000000001 110.787 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HG2' ' OD1' ' A' ' 60' ' ' ASP . 22.8 ttt180 -119.74 -34.86 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 74.420000000000002 110.341 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -105.36 146.07 29.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 75.310000000000002 109.932 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.06 133.55 60.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.035 0.445 . . . . 72.140000000000001 110.105 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.404 ' HD3' HG23 ' A' ' 58' ' ' VAL . 12.4 ttp180 -124.37 129.09 50.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.401 . . . . 70.120000000000005 111.198 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.57 119.0 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.525 -0.761 . . . . 75.439999999999998 109.212 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 60.0 m -112.82 126.97 56.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.999 0.428 . . . . 70.439999999999998 110.938 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.7 mm -104.08 89.83 2.69 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.677 -0.692 . . . . 72.25 109.261 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.719 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 88.4 Cg_endo -81.34 134.0 8.81 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.808 2.339 . . . . 75.200000000000003 113.507 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.71 65.8 7.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.822 0.82 . . . . 75.530000000000001 108.999 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.63 -13.61 2.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.185 -0.916 . . . . 64.239999999999995 111.253 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -127.02 15.62 6.49 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.148 -1.025 . . . . 75.109999999999999 113.441 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.69 18.69 13.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.495 -0.86 . . . . 64.150000000000006 112.66 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -72.87 126.87 30.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.076 0.465 . . . . 74.319999999999993 110.927 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.589 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 19.8 m -99.69 171.96 7.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.032 -0.531 . . . . 75.109999999999999 110.232 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.417 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 3.1 p -82.31 6.9 15.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.087 0.403 . . . . 74.219999999999999 112.087 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.411 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 60.6 t -106.73 102.29 13.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.563 -0.532 . . . . 75.519999999999996 109.563 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -127.69 124.86 38.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.035 -0.53 . . . . 65.209999999999994 110.18 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.13 107.06 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 60.329999999999998 111.179 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.9 132.76 70.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.112 -0.699 . . . . 74.129999999999995 109.112 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.561 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 75.2 mtt180 -63.85 -71.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.118 0.485 . . . . 74.329999999999998 110.062 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -140.01 155.03 47.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.581 0.705 . . . . 62.219999999999999 112.439 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.54 119.98 37.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.232 -1.349 . . . . 75.25 107.84 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.24 151.85 36.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.941 -0.392 . . . . 74.340000000000003 109.941 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.42 131.39 73.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.678 -0.409 . . . . 64.140000000000001 110.741 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 45.1 mttp -98.16 127.21 43.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.122 -0.696 . . . . 75.319999999999993 109.122 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.29 -146.06 5.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.685 -0.769 . . . . 65.430000000000007 111.811 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.4 m -139.89 130.34 25.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.459 -0.2 . . . . 72.519999999999996 110.459 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.775 HD11 HG23 ' A' ' 5' ' ' ILE . 28.6 mm -72.27 120.9 21.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.466 . . . . 73.329999999999998 110.079 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.4 mt -106.44 150.17 9.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 75.040000000000006 110.024 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -116.35 141.6 47.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.296 -1.001 . . . . 72.150000000000006 108.296 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.26 129.23 39.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.189 0.519 . . . . 72.299999999999997 111.398 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -78.17 -6.19 54.05 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.743 0.782 . . . . 52.399999999999999 110.375 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -101.77 86.5 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.843 -1.071 . . . . 65.099999999999994 110.092 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -144.39 100.24 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.979 0.419 . . . . 73.519999999999996 111.197 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -153.59 91.23 1.46 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 75.319999999999993 109.469 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.53 140.24 57.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.193 -0.458 . . . . 73.230000000000004 109.815 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -99.97 -19.69 16.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.092 -0.504 . . . . 74.099999999999994 110.417 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.4 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.835 -0.62 . . . . 73.540000000000006 110.213 177.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 109.385 -0.598 . . . . 64.239999999999995 109.385 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.56 -18.58 4.82 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.401 -0.904 . . . . 74.099999999999994 113.313 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.3 t -80.04 -11.83 59.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.013 0.435 . . . . 75.450000000000003 110.866 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.601 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 7.0 p -74.69 161.21 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.516 . . . . 72.010000000000005 110.919 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.59 HG23 ' CD1' ' A' ' 65' ' ' ILE . 42.8 mm -71.64 136.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.064 -0.516 . . . . 72.129999999999995 110.706 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -67.28 115.79 7.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.175 -0.466 . . . . 73.450000000000003 110.302 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.99 3.26 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 74.099999999999994 111.213 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p -69.03 98.09 0.94 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.61 0.719 . . . . 61.329999999999998 110.62 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.64 -14.72 6.06 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.012 -0.995 . . . . 60.43 112.11 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -66.45 145.88 55.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.3 -0.259 . . . . 73.0 110.3 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.3 pt-20 -132.45 159.41 39.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.998 0.428 . . . . 74.019999999999996 110.664 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -100.72 112.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.527 -0.761 . . . . 75.450000000000003 109.578 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.0 mt -72.57 -46.7 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.527 . . . . 73.310000000000002 110.512 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -152.05 142.44 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.844 -0.616 . . . . 73.540000000000006 110.717 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.86 149.45 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.936 -0.575 . . . . 74.400000000000006 109.829 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.5 m -82.16 -49.81 9.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.354 . . . . 71.510000000000005 111.173 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.5 t -146.39 157.21 43.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 75.319999999999993 110.783 -173.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -163.31 144.6 9.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.845 -0.798 . . . . 64.409999999999997 108.845 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -96.78 101.21 12.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.001 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.16 5.3 34.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 64.549999999999997 111.928 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -136.99 -45.48 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.706 -0.398 . . . . 73.420000000000002 111.176 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -41.45 99.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.116 -0.564 . . . . 65.310000000000002 113.077 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -86.51 -49.45 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.878 0.37 . . . . 75.530000000000001 110.868 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.08 163.37 28.04 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.43 -0.89 . . . . 74.540000000000006 111.845 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.85 2.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.998 0.428 . . . . 74.299999999999997 110.228 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.445 ' HA2' HD11 ' A' ' 29' ' ' LEU . . . 101.52 3.99 52.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.61 -0.805 . . . . 63.310000000000002 112.487 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -125.99 134.07 51.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.7 -0.482 . . . . 74.140000000000001 109.7 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.04 6.02 46.16 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.921 -0.871 . . . . 52.109999999999999 110.921 -173.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.534 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 66.8 mt -80.32 154.88 27.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.198 -0.501 . . . . 74.420000000000002 110.697 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -69.23 -26.97 65.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.042 -0.526 . . . . 63.130000000000003 110.875 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 75.340000000000003 110.787 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.4 m -70.47 -22.59 62.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.329999999999998 110.32 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' A' ' 142' ' ' GLU . 25.4 tp -64.0 -19.45 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.554 -0.748 . . . . 74.109999999999999 110.824 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 59' ' ' ILE . 35.9 pt -131.46 18.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 72.540000000000006 110.436 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.8 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -68.77 -38.47 80.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 71.329999999999998 110.909 -173.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.47 19.77 13.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 74.200000000000003 111.98 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.4 121.16 25.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.699 0.285 . . . . 72.200000000000003 110.246 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 p -70.72 -20.26 62.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.333 -0.394 . . . . 73.230000000000004 111.624 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -74.27 -27.13 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.658 -0.246 . . . . 74.319999999999993 111.314 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -89.81 160.67 16.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.839 -0.43 . . . . 61.25 109.839 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.495 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.3 p90 -156.18 171.04 20.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 71.510000000000005 111.043 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 49.9 t90 -106.78 134.86 49.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.616 -0.72 . . . . 74.430000000000007 109.474 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -133.06 142.39 48.74 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.129 -0.693 . . . . 74.319999999999993 109.129 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.53 143.67 49.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.797 -0.446 . . . . 63.509999999999998 109.797 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.9 126.01 25.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.256 0.348 . . . . 75.239999999999995 110.231 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -128.02 -25.44 3.03 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.789 -0.364 . . . . 75.010000000000005 111.235 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.49 107.43 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.976 0.417 . . . . 71.340000000000003 110.542 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.74 80.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.933 -0.651 . . . . 64.239999999999995 112.391 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.18 171.68 12.86 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.967 -0.635 . . . . 74.109999999999999 111.581 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.403 ' CB ' ' HB ' ' A' ' 136' ' ' THR . 40.9 m -116.4 175.42 5.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.729 0.3 . . . . 73.329999999999998 111.104 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.589 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 7.2 m-20 -97.99 166.3 13.72 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.133 -0.485 . . . . 74.549999999999997 110.845 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 39.4 Cg_endo -67.88 134.49 32.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.633 2.222 . . . . 64.019999999999996 113.207 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.69 154.39 61.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.557 -0.747 . . . . 73.510000000000005 109.51 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.855 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -76.05 165.54 85.19 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 123.608 -1.413 . . . . 71.230000000000004 112.928 1.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.512 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.2 m-85 -99.54 115.4 29.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.872 -0.604 . . . . 74.329999999999998 110.101 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -106.11 129.14 54.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 74.530000000000001 110.847 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.6 mt -121.7 108.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.959 -0.564 . . . . 75.109999999999999 109.596 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.91 114.13 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 116.047 -0.524 . . . . 74.420000000000002 110.459 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.497 HD13 HG22 ' A' ' 34' ' ' ILE . 71.1 mt -115.29 137.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.861 -0.609 . . . . 71.340000000000003 110.929 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -106.29 121.81 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.847 -0.615 . . . . 74.109999999999999 109.877 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.97 -5.85 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 71.230000000000004 111.043 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.504 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 66.61 11.38 8.1 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.148 0.795 . . . . 73.219999999999999 113.148 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -165.5 172.86 11.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.252 -0.277 . . . . 71.540000000000006 110.252 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.906 HD22 ' HB3' ' A' ' 153' ' ' GLU . 39.0 m-80 -85.24 128.65 34.76 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.056 -0.52 . . . . 74.099999999999994 109.654 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.59 ' CD1' HG23 ' A' ' 5' ' ' ILE . 67.6 mt -134.28 134.39 55.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.949 0.404 . . . . 72.049999999999997 110.17 176.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.51 ' HB2' HD12 ' A' ' 150' ' ' ILE . 56.2 tp60 -80.8 101.61 9.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.536 -0.756 . . . . 75.519999999999996 109.001 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 118' ' ' SER . 23.8 mm -71.18 123.59 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 73.109999999999999 110.344 -176.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.47 -46.28 2.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 74.510000000000005 110.201 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.559 ' HB3' ' HB3' ' A' ' 146' ' ' LYS . 34.3 tt0 -137.9 141.58 40.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.764 -0.653 . . . . 75.120000000000005 110.42 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -108.93 128.28 64.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.055 -0.72 . . . . 74.510000000000005 109.055 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -110.06 123.45 49.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.248 0.546 . . . . 64.319999999999993 110.76 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.9 mt -109.33 124.53 51.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 75.109999999999999 109.841 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.4 106.97 48.79 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.862 -0.792 . . . . 75.040000000000006 108.862 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.59 151.33 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.386 2.058 . . . . 74.400000000000006 111.837 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.54 ' HA ' ' CD ' ' A' ' 141' ' ' ARG . 78.3 ttt180 -52.92 -52.21 58.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.845 -0.616 . . . . 75.209999999999994 111.543 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.92 28.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.147 -0.781 . . . . 61.439999999999998 111.147 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.554 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 20.6 mtp180 -76.06 -24.48 55.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.164 0.482 . . . . 74.310000000000002 110.308 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.63 64.28 2.52 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.903 -0.665 . . . . 75.25 111.787 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.4 m -154.37 167.94 28.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 74.5 110.115 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -86.16 98.22 10.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.399 -0.364 . . . . 73.310000000000002 110.243 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.68 81.97 67.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.176 -0.466 . . . . 73.230000000000004 110.61 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 93.2 Cg_endo -87.63 37.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.738 2.292 . . . . 74.140000000000001 112.259 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -87.38 134.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 75.030000000000001 110.533 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 24.1 mmmt -111.13 -57.77 2.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.577 -0.738 . . . . 72.329999999999998 110.658 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.466 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 95.2 t -121.19 138.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 74.049999999999997 110.945 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.29 138.34 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.885 -0.598 . . . . 72.310000000000002 109.651 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.44 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.0 mt-10 -118.04 135.11 54.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.317 -0.402 . . . . 74.319999999999993 111.152 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -117.02 129.87 56.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 73.319999999999993 110.142 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 97' ' ' TRP . . . -128.49 143.97 51.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.328 -0.397 . . . . 72.129999999999995 110.652 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 149.97 49.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.368 -0.378 . . . . 62.009999999999998 110.34 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.3 t -150.09 150.92 32.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.186 0.517 . . . . 72.310000000000002 111.625 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.17 -30.85 12.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.337 -0.847 . . . . 73.519999999999996 109.837 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 3.4 p-10 -105.73 -12.17 16.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 64.409999999999997 112.126 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.8 t30 71.22 5.14 5.35 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.617 0.722 . . . . 75.120000000000005 110.758 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.569 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 98.7 t -100.82 -58.32 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.93 -0.577 . . . . 73.219999999999999 110.103 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -102.43 118.96 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 70.530000000000001 110.127 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 94.5 m95 -95.86 124.42 39.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 74.409999999999997 111.154 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 m -90.44 122.63 67.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.143 -0.48 . . . . 72.310000000000002 110.109 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.54 110.2 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.42 2.08 . . . . 64.450000000000003 111.507 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.619 HD11 HG21 ' A' ' 116' ' ' VAL . 13.7 pt -80.81 -19.49 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.577 -0.283 . . . . 73.450000000000003 110.983 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 136.92 2.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.302 -0.951 . . . . 70.510000000000005 113.558 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.3 ttm180 -102.72 125.6 49.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.436 -0.579 . . . . 75.409999999999997 109.436 169.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.552 ' HE2' HG12 ' A' ' 116' ' ' VAL . 77.8 m-85 -138.56 -176.23 4.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.269 -0.572 . . . . 75.140000000000001 111.289 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -99.15 147.54 18.47 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.855 -0.611 . . . . 65.140000000000001 112.248 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 40.8 t80 -96.47 148.29 22.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 73.230000000000004 110.119 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.418 ' HB ' HD22 ' A' ' 112' ' ' LEU . 26.5 m -133.38 117.83 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.893 -0.41 . . . . 74.329999999999998 109.893 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 77' ' ' ARG . 20.2 t30 -77.21 106.44 8.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.408 0.623 . . . . 72.540000000000006 110.533 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -144.47 177.66 8.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.256 -0.883 . . . . 74.030000000000001 110.222 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -97.86 8.67 44.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.31 -0.404 . . . . 64.099999999999994 110.801 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.73 158.05 30.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 74.420000000000002 109.848 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.47 142.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 73.299999999999997 111.539 -175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD22 ' HB ' ' A' ' 106' ' ' THR . 63.1 mt -92.26 121.85 34.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.569 -0.742 . . . . 71.109999999999999 111.0 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.82 109.8 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 71.530000000000001 111.29 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.412 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 95.5 m-85 -104.55 110.11 22.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 75.219999999999999 110.649 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -86.5 100.51 12.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.789 -0.641 . . . . 73.219999999999999 109.709 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.619 HG21 HD11 ' A' ' 100' ' ' ILE . 26.7 m -106.06 179.4 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.95 -0.568 . . . . 73.450000000000003 111.412 -174.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.62 139.19 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 75.5 110.468 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.685 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 23.9 m -80.67 121.43 25.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.297 -0.411 . . . . 72.530000000000001 110.861 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -155.14 149.94 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 110.326 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.776 ' HG3' HD11 ' A' ' 150' ' ' ILE . 2.7 ttpm? -89.78 132.53 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.097 -0.334 . . . . 74.519999999999996 110.097 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.08 166.09 33.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.522 -0.308 . . . . 65.239999999999995 111.091 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' A' ' 123' ' ' TYR . 24.9 ttm180 -111.27 -33.53 6.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.171 0.51 . . . . 73.400000000000006 110.2 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.463 ' CE1' ' HD2' ' A' ' 122' ' ' ARG . 70.7 m-85 -105.21 145.16 31.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.914 -0.585 . . . . 73.540000000000006 110.213 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.419 HG23 ' HB ' ' A' ' 59' ' ' ILE . 10.5 tt -136.31 129.34 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.079 -0.509 . . . . 72.120000000000005 110.065 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 125' ' ' ARG . 13.5 ttp180 -113.4 121.19 43.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 72.319999999999993 110.659 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 48.0 tp -91.55 113.72 26.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.202 -0.666 . . . . 74.409999999999997 109.202 172.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -109.99 119.94 40.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.997 0.427 . . . . 74.239999999999995 110.934 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.9 mm -100.77 96.28 5.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.058 -0.719 . . . . 72.25 109.058 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.855 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 89.5 Cg_endo -75.68 -179.85 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 75.340000000000003 112.786 -176.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -110.01 -9.05 14.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.166 0.984 . . . . 72.140000000000001 108.398 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.44 -46.14 91.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.659 -1.61 . . . . 75.310000000000002 112.11 -173.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.466 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -82.01 6.82 65.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.716 -0.754 . . . . 74.340000000000003 113.713 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.94 25.41 9.69 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.169 -1.015 . . . . 71.219999999999999 112.071 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -78.78 -175.92 4.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 74.120000000000005 111.133 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.425 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.1 m -139.24 174.5 10.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.998 -0.546 . . . . 73.230000000000004 109.628 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.403 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 1.2 p -79.96 -0.73 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.952 0.406 . . . . 74.239999999999995 112.035 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.68 124.09 62.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.799 -0.445 . . . . 65.140000000000001 109.799 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.47 142.99 30.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.659 -0.246 . . . . 73.140000000000001 110.655 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.7 109.48 5.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 74.25 111.118 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 28.8 mt -127.49 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 65.040000000000006 109.102 178.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.54 ' CD ' ' HA ' ' A' ' 75' ' ' ARG . 1.5 tpt180 -74.44 -68.82 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.606 -0.516 . . . . 74.519999999999996 109.606 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.469 ' HA ' HD11 ' A' ' 33' ' ' LEU . 17.7 pt-20 -148.87 160.99 42.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.208 0.527 . . . . 71.420000000000002 110.734 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.34 121.75 44.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.382 -0.826 . . . . 75.019999999999996 108.958 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.601 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.4 t70 -117.1 162.33 18.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.869 -0.419 . . . . 71.310000000000002 109.869 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 5' ' ' ILE . 95.3 t -127.89 124.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 75.420000000000002 110.296 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . 48.3 tttm -101.45 101.61 12.25 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.264 -0.643 . . . . 75.450000000000003 109.264 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.09 -161.64 10.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.727 -0.749 . . . . 75.099999999999994 112.089 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -118.05 133.64 55.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.652 0.263 . . . . 75.219999999999999 110.554 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 5' ' ' ILE . 38.4 mm -71.54 124.46 28.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.081 -0.509 . . . . 75.329999999999998 111.419 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.784 HG22 ' H ' ' A' ' 152' ' ' LEU . 29.0 mt -118.01 134.3 62.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.162 0.506 . . . . 72.310000000000002 110.109 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -102.2 4.68 39.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.279 0.561 . . . . 63.520000000000003 110.169 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.784 ' H ' HG22 ' A' ' 150' ' ' ILE . 97.0 mt -105.74 106.03 16.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 73.519999999999996 111.999 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.906 ' HB3' HD22 ' A' ' 64' ' ' ASN . 12.7 pt-20 -124.47 -24.19 4.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.955 0.883 . . . . 71.0 108.835 169.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -137.99 122.65 18.64 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.992 -1.458 . . . . 74.219999999999999 108.967 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -79.49 169.0 18.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.031 -0.531 . . . . 74.530000000000001 110.227 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -69.49 118.71 12.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.712 -0.477 . . . . 72.439999999999998 109.712 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -83.82 -8.03 59.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.85 -0.614 . . . . 73.329999999999998 110.845 -172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.78 115.51 27.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.894 -0.409 . . . . 75.140000000000001 109.894 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.443 . . . . 74.129999999999995 110.621 -178.808 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.967 0.413 . . . . 74.019999999999996 110.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.12 94.97 0.87 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.436 -0.887 . . . . 61.229999999999997 113.113 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 t -147.28 139.16 24.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.203 -0.665 . . . . 74.239999999999995 109.203 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p -117.91 161.0 20.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.439 -0.346 . . . . 74.329999999999998 110.992 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.494 HD11 HD13 ' A' ' 149' ' ' ILE . 37.6 mm -66.65 131.91 32.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.134 -0.485 . . . . 73.109999999999999 110.327 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -64.78 111.73 2.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.376 -0.375 . . . . 75.439999999999998 110.829 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 36.0 mtmm -87.52 16.25 5.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 75.030000000000001 110.567 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -65.48 -16.36 63.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.493 -0.776 . . . . 64.209999999999994 112.16 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.1 23.25 4.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.497 -0.859 . . . . 72.319999999999993 112.874 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.411 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 33.3 m0 -84.35 156.79 21.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.992 0.396 . . . . 74.319999999999993 110.853 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 22.2 pt-20 -135.4 159.54 41.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.81 0.338 . . . . 71.209999999999994 110.768 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.54 130.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.972 -0.558 . . . . 64.319999999999993 109.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.5 -36.86 9.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.166 0.508 . . . . 74.230000000000004 110.78 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.3 t -144.94 139.36 27.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 75.219999999999999 110.66 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -151.1 134.84 16.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 74.540000000000006 109.526 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -85.37 -38.9 18.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 71.439999999999998 111.278 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -149.13 152.51 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.993 0.425 . . . . 75.230000000000004 110.959 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.535 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.0 pt20 -163.91 139.53 6.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.425 -0.807 . . . . 71.439999999999998 108.919 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.9 tp10 -93.74 98.06 10.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.133 0.492 . . . . 74.400000000000006 111.065 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.48 -12.01 18.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.864 -0.607 . . . . 73.540000000000006 110.95 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -101.04 -47.77 4.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.02 -0.536 . . . . 75.239999999999995 110.955 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.84 -58.02 6.02 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.909 -0.587 . . . . 73.420000000000002 112.411 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 24.1 mm-40 -70.93 -50.57 33.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.084 -0.339 . . . . 73.040000000000006 110.084 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -168.02 33.23 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.972 -0.558 . . . . 64.25 112.869 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.49 22.25 11.93 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.076 0.55 . . . . 72.219999999999999 111.934 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.29 18.31 78.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.934 -0.65 . . . . 71.319999999999993 112.013 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -113.16 150.45 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.732 -0.469 . . . . 74.299999999999997 109.732 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 2.96 72.73 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.611 -0.595 . . . . 65.450000000000003 111.611 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 82.0 mt -82.13 157.44 24.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.584 -0.308 . . . . 64.319999999999993 110.272 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.83 -28.74 68.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.773 0.321 . . . . 72.420000000000002 110.973 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' HE3' HD11 ' A' ' 29' ' ' LEU . 21.3 pttp -69.41 -23.02 63.65 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.742 0.306 . . . . 75.420000000000002 111.044 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.79 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.7 m -66.99 -24.24 66.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.015 0.436 . . . . 71.409999999999997 110.408 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.0 tp -65.92 -25.54 67.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 73.230000000000004 110.371 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.635 HG22 HG22 ' A' ' 59' ' ' ILE . 2.5 pp -119.48 13.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.207 0.527 . . . . 74.140000000000001 110.336 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.79 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.2 t70 -65.27 -42.25 93.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.287 -0.869 . . . . 74.109999999999999 110.174 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.9 55.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.824 -0.703 . . . . 65.219999999999999 111.682 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -117.12 124.44 49.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.368 -0.416 . . . . 73.140000000000001 109.986 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -72.65 -15.13 61.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.285 -0.416 . . . . 72.109999999999999 111.755 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.31 -24.33 50.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 75.439999999999998 110.718 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -100.23 160.16 14.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.4 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.69 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 48.3 p90 -156.15 165.0 37.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.848 -0.427 . . . . 75.299999999999997 109.848 174.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.529 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 39.2 t90 -98.12 129.27 44.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.379 -0.6 . . . . 74.5 109.379 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 49.4 t-80 -131.13 137.07 48.87 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.231 -0.655 . . . . 72.200000000000003 109.231 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.12 144.63 54.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.556 -0.535 . . . . 73.409999999999997 109.556 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 50' ' ' SER . 64.8 tttp -60.4 126.09 26.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.358 . . . . 71.310000000000002 110.339 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -124.52 -32.14 3.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 74.099999999999994 110.064 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.45 108.99 13.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 61.130000000000003 109.383 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.41 -12.33 54.61 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.712 -0.676 . . . . 70.319999999999993 111.635 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 144.34 5.82 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.93 -0.652 . . . . 75.510000000000005 111.547 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 11.0 p -86.63 167.64 14.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.941 0.4 . . . . 74.129999999999995 111.505 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -100.54 146.9 32.83 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 75.239999999999995 109.715 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.96 141.54 44.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.691 2.261 . . . . 71.349999999999994 112.63 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.59 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.5 mt -75.85 164.63 59.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 75.420000000000002 110.569 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 88.1 Cg_endo -83.69 161.75 71.04 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 123.766 -1.348 . . . . 71.219999999999999 113.239 1.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -100.06 111.46 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 73.5 109.923 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -104.42 125.69 50.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.082 -0.34 . . . . 70.310000000000002 110.082 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 48.3 mt -119.44 121.36 66.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.134 -0.321 . . . . 74.209999999999994 110.134 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -112.31 117.85 56.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.334 -0.394 . . . . 74.439999999999998 110.616 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.635 HG22 HG22 ' A' ' 34' ' ' ILE . 4.7 mp -117.05 140.62 38.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.19 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 19.8 t70 -103.04 134.2 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.594 -0.275 . . . . 74.239999999999995 110.264 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.515 ' HE2' HD13 ' A' ' 67' ' ' ILE . 64.8 mtm -96.64 3.92 52.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 75.310000000000002 111.092 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.7 mmtp 70.89 -30.06 0.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.617 0.969 . . . . 73.219999999999999 113.617 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -133.71 172.44 12.76 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.236 -0.29 . . . . 74.239999999999995 111.051 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.08 129.82 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 73.209999999999994 110.399 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.455 ' CD1' HG23 ' A' ' 5' ' ' ILE . 69.6 mt -139.07 139.91 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.018 0.437 . . . . 72.120000000000005 110.333 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -83.31 105.08 13.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.927 -0.768 . . . . 73.299999999999997 108.927 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.71 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.8 mm -72.93 106.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.235 -0.283 . . . . 74.299999999999997 110.235 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.03 -43.9 6.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.052 0.453 . . . . 70.150000000000006 110.843 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.6 tt0 -145.42 140.88 27.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.991 -0.549 . . . . 75.439999999999998 110.787 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.21 130.73 61.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.531 -0.544 . . . . 64.409999999999997 109.531 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -113.47 129.76 56.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.957 0.408 . . . . 73.519999999999996 110.521 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 70.4 mt -117.14 120.49 38.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.213 -0.449 . . . . 75.430000000000007 109.92 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.73 103.56 15.07 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.023 -0.732 . . . . 74.219999999999999 109.023 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 15.3 Cg_exo -67.37 167.65 19.95 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.038 2.492 . . . . 74.109999999999999 112.645 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' HD2' ' CB ' ' A' ' 139' ' ' ALA . 77.4 ttt180 -61.05 -28.65 69.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.73 -0.668 . . . . 64.209999999999994 110.933 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.26 145.19 5.11 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.98 -0.848 . . . . 32.530000000000001 110.98 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -61.18 -23.18 65.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.941 0.37 . . . . 74.319999999999993 111.472 -176.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.52 59.3 0.46 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.662 -0.78 . . . . 64.329999999999998 112.137 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.5 p -160.88 162.98 32.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.017 -0.364 . . . . 73.420000000000002 110.017 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.41 120.22 18.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.837 0.351 . . . . 74.530000000000001 111.112 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -151.89 89.13 4.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.864 -0.607 . . . . 74.239999999999995 110.49 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.93 29.77 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.145 2.563 . . . . 72.430000000000007 114.171 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG22 ' HB3' ' A' ' 105' ' ' PHE . 73.2 mt -79.0 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.568 -0.53 . . . . 62.109999999999999 109.568 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -114.84 -46.03 2.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 111.453 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.697 HG11 ' HE ' ' A' ' 102' ' ' ARG . 62.0 t -127.13 138.35 55.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.469 -0.332 . . . . 75.530000000000001 110.898 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.6 m -132.22 137.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.186 -0.461 . . . . 72.549999999999997 110.52 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 40.2 mt-10 -116.6 140.45 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.402 -0.363 . . . . 74.510000000000005 110.907 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -120.4 132.67 55.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 73.219999999999999 110.669 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.51 147.71 50.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 74.239999999999995 110.267 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.32 150.03 52.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 71.030000000000001 110.495 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.5 t -150.26 150.7 31.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 71.030000000000001 110.878 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.629 ' HG3' ' HA ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -101.31 -31.35 11.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.957 0.408 . . . . 74.299999999999997 110.129 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 8.9 p-10 -105.22 -4.33 21.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 71.239999999999995 111.518 -174.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 24.5 t-20 76.31 -16.16 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.797 0.685 . . . . 71.310000000000002 111.337 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 95.2 t -89.32 -58.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.97 0.414 . . . . 72.540000000000006 110.627 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.89 111.48 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.466 . . . . 71.209999999999994 110.454 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -96.6 132.39 42.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.993 0.425 . . . . 74.400000000000006 110.921 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.3 m -105.09 124.76 35.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 75.310000000000002 110.505 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.72 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.468 2.112 . . . . 74.299999999999997 111.572 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.492 HD13 HG22 ' A' ' 116' ' ' VAL . 21.6 pt -93.1 -6.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.332 -0.395 . . . . 63.200000000000003 111.059 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.61 147.82 4.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.538 -0.839 . . . . 72.430000000000007 113.044 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.697 ' HE ' HG11 ' A' ' 85' ' ' VAL . 77.9 ttt180 -113.06 119.65 38.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.214 -0.661 . . . . 74.25 109.214 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.573 ' HE2' HG13 ' A' ' 116' ' ' VAL . 84.5 m-85 -130.36 177.17 7.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.82 0.343 . . . . 74.540000000000006 110.911 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.8 149.81 19.41 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.043 -0.599 . . . . 72.25 111.774 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.414 ' HB3' HG22 ' A' ' 83' ' ' ILE . 51.6 t80 -105.06 121.62 44.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.985 0.421 . . . . 75.400000000000006 110.081 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.465 ' O ' HD11 ' A' ' 112' ' ' LEU . 24.2 m -113.35 107.69 16.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.972 -0.558 . . . . 70.5 109.962 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -68.83 94.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.38 0.61 . . . . 74.0 110.072 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -113.93 -166.17 1.07 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.087 -0.96 . . . . 75.329999999999998 109.55 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.97 -14.22 20.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.973 0.416 . . . . 61.310000000000002 110.697 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.21 169.42 8.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 74.420000000000002 110.653 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -75.52 137.52 40.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 75.200000000000003 110.948 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 106' ' ' THR . 34.8 mt -87.46 111.29 21.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.622 -0.717 . . . . 70.120000000000005 110.533 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.82 108.93 19.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.933 0.397 . . . . 72.510000000000005 110.47 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.33 113.48 25.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 72.420000000000002 110.799 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -80.2 92.05 5.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.248 -0.649 . . . . 75.219999999999999 109.248 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.573 HG13 ' HE2' ' A' ' 103' ' ' PHE . 27.3 m -96.67 177.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 62.020000000000003 111.669 -172.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.77 118.74 13.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 70.200000000000003 109.662 177.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 14.4 m -75.6 118.75 18.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.001 -0.545 . . . . 74.409999999999997 110.847 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -147.76 153.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.466 . . . . 72.299999999999997 110.731 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.551 ' HG2' HD11 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -81.8 125.81 31.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 64.150000000000006 109.698 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.629 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . . . -152.41 175.42 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 72.200000000000003 111.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -128.51 -32.82 2.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.844 -0.616 . . . . 74.519999999999996 109.927 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -106.35 146.38 30.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.626 . . . . 73.420000000000002 109.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.55 135.21 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 110.267 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -121.49 124.06 43.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.93 0.395 . . . . 71.430000000000007 110.93 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.21 116.9 31.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 75.439999999999998 109.091 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.0 m -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.19 0.519 . . . . 75.329999999999998 110.966 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.9 mm -106.52 95.68 12.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 71.219999999999999 109.196 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.584 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 57.0 Cg_endo -71.87 173.96 11.93 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.354 2.036 . . . . 75.129999999999995 112.552 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.486 ' HA ' HD11 ' A' ' 53' ' ' LEU . 16.7 t70 -91.01 -6.1 54.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.146 0.974 . . . . 64.430000000000007 108.893 175.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.28 143.35 26.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.695 -1.139 . . . . 74.510000000000005 110.532 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.21 -11.52 58.54 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.721 -0.752 . . . . 73.409999999999997 112.315 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.94 12.12 14.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.876 -0.678 . . . . 64.049999999999997 112.733 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -67.78 124.84 24.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 73.0 110.936 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -95.35 178.15 5.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.03 -0.532 . . . . 73.310000000000002 110.02 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.8 p -79.08 1.57 23.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 74.209999999999994 112.127 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.12 101.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.871 -0.418 . . . . 53.200000000000003 109.871 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -119.87 130.52 54.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.269 -0.423 . . . . 75.540000000000006 110.114 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.547 ' CB ' ' HD2' ' A' ' 75' ' ' ARG . . . -147.07 111.92 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.159 0.505 . . . . 74.430000000000007 111.486 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.94 132.86 56.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.394 -0.595 . . . . 74.519999999999996 109.394 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.69 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmt180 -61.39 -63.79 1.16 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.669 0.271 . . . . 75.099999999999994 110.417 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.6 155.51 30.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.471 0.653 . . . . 64.129999999999995 111.346 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -106.51 123.92 48.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.849 -1.069 . . . . 74.450000000000003 108.313 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.8 152.07 37.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.554 -0.535 . . . . 70.319999999999993 109.554 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.03 130.96 74.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.928 0.394 . . . . 71.409999999999997 111.603 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 39.0 mttp -101.97 107.06 18.08 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.944 -0.761 . . . . 74.329999999999998 108.944 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.11 177.76 31.36 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.238 -0.982 . . . . 63.43 112.143 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.8 m -106.85 127.31 53.3 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.241 -0.281 . . . . 75.109999999999999 110.241 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.607 ' HB ' HD23 ' A' ' 152' ' ' LEU . 35.8 mm -69.81 130.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.96 -0.564 . . . . 74.120000000000005 110.526 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.551 HD11 ' HG2' ' A' ' 120' ' ' LYS . 16.3 mt -119.67 150.36 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.596 -0.52 . . . . 74.420000000000002 109.596 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 65.6 30.38 10.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.745 0.784 . . . . 74.420000000000002 109.559 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.607 HD23 ' HB ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -78.95 84.28 4.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.004 -0.998 . . . . 75.0 112.516 -174.304 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -104.5 155.33 18.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.984 -0.747 . . . . 71.019999999999996 108.984 170.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -108.23 37.73 2.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.121 0.486 . . . . 74.040000000000006 112.123 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -113.03 -41.63 3.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.988 -0.745 . . . . 73.030000000000001 108.988 166.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 37.3 m170 63.64 74.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.905 -1.043 . . . . 71.239999999999995 111.435 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -69.38 -24.57 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.181 -0.918 . . . . 74.129999999999995 109.04 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -86.98 109.63 19.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.58 -0.737 . . . . 72.510000000000005 109.248 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.4 p80 . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.262 -0.427 . . . . 72.209999999999994 110.144 -176.541 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.161 -0.681 . . . . 74.310000000000002 109.161 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.48 -156.5 21.61 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.639 -0.985 . . . . 71.319999999999993 110.639 -171.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 146' ' ' LYS . 12.0 m -69.63 -46.22 66.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.037 0.446 . . . . 73.25 110.04 176.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 p -80.02 147.19 31.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 70.430000000000007 110.403 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 HG22 HD11 ' A' ' 65' ' ' ILE . 37.7 mm -83.5 138.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 110.284 -0.265 . . . . 74.140000000000001 110.284 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -85.21 130.9 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 61.439999999999998 109.755 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -108.97 13.66 24.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 75.430000000000007 110.725 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -71.25 -10.0 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.627 -0.715 . . . . 71.420000000000002 111.192 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.88 9.11 21.37 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 52.43 112.163 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -89.39 159.34 17.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.701 0.286 . . . . 74.129999999999995 110.541 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.482 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 9.2 pt-20 -142.42 161.88 36.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.857 0.36 . . . . 70.239999999999995 110.147 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.0 117.89 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 73.140000000000001 110.185 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.53 -43.88 18.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 73.319999999999993 110.681 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -148.85 141.7 24.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 110.204 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -141.93 142.69 33.03 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.018 -0.734 . . . . 73.310000000000002 109.018 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -85.53 -29.32 24.3 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.83 -0.348 . . . . 75.430000000000007 110.996 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 t -154.49 149.29 26.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 70.140000000000001 111.0 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -168.06 140.28 3.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.904 -0.776 . . . . 61.450000000000003 108.904 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -98.27 116.92 31.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.015 0.436 . . . . 73.230000000000004 110.573 -176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.11 -16.37 12.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.01 -0.541 . . . . 75.140000000000001 111.251 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 m -113.4 -40.0 3.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.368 -0.378 . . . . 71.129999999999995 111.169 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -63.07 -53.19 42.1 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.083 -0.508 . . . . 43.520000000000003 112.835 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.9 -47.6 18.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 72.230000000000004 110.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.14 -175.5 54.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.992 -0.623 . . . . 72.420000000000002 112.813 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.1 24.09 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.997 0.519 . . . . 73.239999999999995 111.857 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.52 18.72 72.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 71.349999999999994 111.805 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -112.89 144.87 41.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.564 -0.318 . . . . 73.329999999999998 110.274 -175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.87 -1.75 38.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.015 -0.612 . . . . 43.219999999999999 111.706 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 62.5 mt -80.46 156.77 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 73.519999999999996 110.641 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.93 -31.05 71.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.484 -0.326 . . . . 73.430000000000007 111.252 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -76.09 -16.44 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.479 -0.328 . . . . 72.310000000000002 111.751 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 60.8 m -71.38 -23.65 61.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 74.430000000000007 109.831 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 35.4 tp -72.82 -8.99 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.579 -0.737 . . . . 73.310000000000002 110.701 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -130.56 25.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 73.420000000000002 110.406 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.17 -46.94 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.514 -0.312 . . . . 74.409999999999997 111.627 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.32 6.99 25.13 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.485 -0.864 . . . . 73.409999999999997 112.167 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' HB2' ' A' ' 39' ' ' GLU . 32.8 t70 -117.48 120.84 39.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.912 -0.403 . . . . 75.549999999999997 109.912 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 p -72.99 -8.79 57.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.507 0.558 . . . . 73.510000000000005 112.507 -173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 47.4 mt-10 -85.21 -26.79 26.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 73.439999999999998 110.292 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -96.84 137.29 36.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.978 -0.556 . . . . 74.430000000000007 109.879 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 23.2 p90 -139.17 175.69 9.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.832 0.348 . . . . 63.030000000000001 110.908 -174.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 45.9 t90 -105.44 134.31 48.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 74.200000000000003 109.597 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -132.37 143.81 50.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.211 -0.663 . . . . 74.0 109.211 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.03 148.57 49.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.545 -0.298 . . . . 74.310000000000002 110.236 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 50' ' ' SER . 78.2 tttt -66.4 116.36 7.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.093 -0.503 . . . . 74.549999999999997 110.018 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -123.13 -27.2 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.887 -0.325 . . . . 74.230000000000004 111.264 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -78.57 107.54 11.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.034 0.445 . . . . 71.549999999999997 110.032 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.14 2.19 51.43 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 52.240000000000002 111.976 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.17 146.15 8.86 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.831 -0.7 . . . . 63.450000000000003 111.937 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.581 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 12.1 p -89.63 151.87 21.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 64.340000000000003 110.889 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.07 158.92 69.36 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.952 -0.567 . . . . 72.319999999999993 110.978 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.29 153.01 61.8 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.766 2.311 . . . . 63.409999999999997 112.924 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.52 158.04 41.2 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 72.430000000000007 110.132 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.03 167.56 64.85 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.567 -1.43 . . . . 70.409999999999997 112.767 2.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.638 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 26.4 m-85 -101.67 108.98 20.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.075 -0.512 . . . . 73.329999999999998 110.275 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.22 126.62 53.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 73.340000000000003 110.436 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.544 HD11 HD21 ' A' ' 126' ' ' LEU . 55.4 mt -120.31 117.75 54.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 62.229999999999997 109.78 176.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.82 114.55 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.268 -0.423 . . . . 63.439999999999998 110.592 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.4 134.91 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.089 -0.505 . . . . 74.049999999999997 110.091 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -99.17 120.22 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.181 -0.463 . . . . 65.340000000000003 109.755 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.6 mtm -86.84 -5.68 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.596 . . . . 70.5 110.9 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.9 mmtt 68.45 5.96 5.1 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.312 0.856 . . . . 72.540000000000006 113.312 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.35 174.22 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.706 0.289 . . . . 64.239999999999995 111.122 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.8 121.7 27.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 72.040000000000006 110.198 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 5' ' ' ILE . 61.6 mt -132.33 134.52 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 120.995 0.426 . . . . 74.010000000000005 110.517 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.534 ' HB2' HD12 ' A' ' 150' ' ' ILE . 55.9 tp60 -84.28 105.13 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.608 -0.724 . . . . 75.349999999999994 109.296 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.2 mm -74.35 117.27 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 73.219999999999999 110.427 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.53 -47.99 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.282 -0.417 . . . . 75.430000000000007 110.995 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.578 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 6.1 tt0 -141.79 152.77 44.03 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.84 -0.344 . . . . 64.310000000000002 110.605 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.38 123.07 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.772 -0.649 . . . . 63.119999999999997 109.517 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -103.75 122.71 45.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.968 -0.56 . . . . 74.530000000000001 110.642 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 114' ' ' TYR . 55.2 mt -113.58 123.39 49.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 74.209999999999994 110.337 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.9 tp -102.25 101.16 17.85 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.381 -0.6 . . . . 74.450000000000003 109.381 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 3.1 Cg_exo -75.11 166.85 28.21 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 123.214 2.609 . . . . 74.019999999999996 112.905 -175.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.434 ' HD3' ' HB2' ' A' ' 79' ' ' SER . 70.3 ttt180 -94.0 56.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 74.5 109.646 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -67.55 169.23 37.71 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.278 -0.873 . . . . 74.409999999999997 113.457 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 39.85 64.33 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.258 1.023 . . . . 74.450000000000003 111.99 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.99 -43.99 0.27 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.205 -0.907 . . . . 43.039999999999999 111.662 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.434 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 35.7 t -111.76 157.48 20.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.094 -0.336 . . . . 62.130000000000003 110.094 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -85.74 -42.04 14.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 74.349999999999994 110.42 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.421 ' C ' ' H ' ' A' ' 83' ' ' ILE . 6.6 m-20 56.17 84.47 0.21 Allowed Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 123.741 0.651 . . . . 74.540000000000006 112.338 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.572 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 5.2 Cg_exo -75.39 36.96 0.47 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.299 2.666 . . . . 75.219999999999999 111.936 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 81' ' ' ASN . 35.8 mt -96.65 125.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.651 . . . . 73.299999999999997 109.553 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.89 -54.0 2.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 74.420000000000002 110.765 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.19 137.3 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.243 -0.435 . . . . 75.409999999999997 110.562 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.42 134.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 74.030000000000001 110.261 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.7 mt-10 -116.63 132.51 56.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.022 -0.536 . . . . 72.549999999999997 110.596 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -112.08 129.74 56.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.673 -0.694 . . . . 74.25 109.944 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.28 153.62 42.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.702 -0.227 . . . . 75.219999999999999 110.435 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.82 43.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.377 -0.374 . . . . 71.510000000000005 110.369 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 146.35 27.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 71.340000000000003 110.607 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.86 -42.26 34.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.89 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.06 9.52 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.004 0.372 . . . . 74.230000000000004 112.004 -173.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.6 t30 64.96 30.06 12.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.784 0.802 . . . . 74.420000000000002 110.261 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.78 -52.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.434 -0.803 . . . . 73.340000000000003 109.456 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -103.04 107.13 17.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.25 -0.648 . . . . 61.409999999999997 109.25 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -94.36 130.65 40.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.154 0.502 . . . . 72.109999999999999 111.116 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 m -122.29 122.63 27.41 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.803 -0.635 . . . . 74.420000000000002 110.36 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.81 128.9 27.05 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.515 2.144 . . . . 72.430000000000007 111.129 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.56 -10.94 8.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.985 -0.286 . . . . 75.340000000000003 110.8 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 153.21 7.53 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.095 -1.05 . . . . 54.420000000000002 113.599 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.2 ttt180 -130.77 115.05 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.832 -0.803 . . . . 74.430000000000007 108.832 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.43 -177.82 4.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.689 0.281 . . . . 73.439999999999998 110.828 -174.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.96 14.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.957 -0.639 . . . . 65.519999999999996 112.024 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.409 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 49.8 t80 -93.27 114.6 27.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 73.120000000000005 110.069 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -99.17 106.98 19.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.237 -0.438 . . . . 74.439999999999998 110.025 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -68.17 111.7 4.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.147 0.499 . . . . 74.230000000000004 110.638 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.27 -176.26 5.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.399 -0.819 . . . . 71.409999999999997 108.922 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.74 -10.48 19.91 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.617 -0.433 . . . . 75.540000000000006 110.545 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.48 20.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 61.100000000000001 110.389 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.1 133.0 45.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 62.420000000000002 111.588 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.3 mt -89.65 122.84 33.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.266 -0.879 . . . . 73.530000000000001 110.213 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.578 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 33.0 mt-10 -98.05 108.36 21.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.266 -0.425 . . . . 75.340000000000003 110.591 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.468 ' CE2' HD11 ' A' ' 72' ' ' LEU . 91.2 m-85 -101.85 104.57 15.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.116 -0.493 . . . . 71.120000000000005 110.993 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.64 93.32 2.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.672 -0.694 . . . . 75.25 110.055 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.14 178.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.854 -0.612 . . . . 62.100000000000001 111.913 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.684 ' HB3' ' HZ3' ' A' ' 117' ' ' LYS . 5.3 ttpm? -75.4 112.8 12.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.205 -0.907 . . . . 74.120000000000005 110.094 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 20.0 p -56.72 120.53 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.857 -0.611 . . . . 74.420000000000002 111.222 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.8 tt -160.57 148.9 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.454 -0.339 . . . . 74.519999999999996 110.238 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.508 ' HZ3' HD21 ' A' ' 152' ' ' LEU . 39.6 ttpt -89.86 135.76 33.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 75.140000000000001 110.169 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.86 175.15 13.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.557 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -121.74 -34.49 3.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 74.109999999999999 110.02 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -108.92 145.4 35.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.238 -0.653 . . . . 75.430000000000007 109.238 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.6 tt -131.71 139.23 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.986 -0.375 . . . . 75.120000000000005 109.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 60.7 ttp180 -124.31 118.2 26.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.966 0.412 . . . . 75.329999999999998 111.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.544 HD21 HD11 ' A' ' 57' ' ' ILE . 43.4 tp -85.61 114.58 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.903 -0.777 . . . . 64.329999999999998 108.903 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -112.1 117.66 33.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.299 0.571 . . . . 65.310000000000002 111.347 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.638 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.1 mm -100.2 98.15 7.27 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.456 -0.793 . . . . 75.409999999999997 108.948 172.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.03 168.86 20.69 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.457 2.105 . . . . 54.439999999999998 112.305 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 7.73 45.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 65.329999999999998 109.881 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.48 138.26 48.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 70.540000000000006 110.157 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.05 -10.84 24.79 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.988 -0.625 . . . . 53.149999999999999 111.699 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 109.1 18.88 8.88 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.051 -0.595 . . . . 72.409999999999997 112.386 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -76.73 135.64 39.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 74.319999999999993 110.759 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 45.9 m -106.88 -173.94 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 74.530000000000001 110.281 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 14.4 p -84.55 2.3 41.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 71.409999999999997 112.131 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.572 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 48.7 t -105.57 124.53 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.452 -0.34 . . . . 62.219999999999999 110.386 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.21 140.93 29.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.22 -0.445 . . . . 75.310000000000002 110.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.6 113.68 4.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.939 0.4 . . . . 74.349999999999994 111.06 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 19.3 mt -126.18 132.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.073 -0.714 . . . . 75.540000000000006 109.073 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.66 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 97.4 mtt180 -65.58 -61.83 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 73.219999999999999 110.481 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.74 138.92 23.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.24 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.02 116.41 29.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.323 -0.621 . . . . 74.010000000000005 109.323 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -114.62 150.57 34.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.993 0.425 . . . . 70.140000000000001 110.149 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.37 124.03 72.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.183 -0.673 . . . . 61.509999999999998 109.183 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.457 ' HG2' HG23 ' A' ' 3' ' ' THR . 0.6 OUTLIER -105.33 102.87 12.33 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.366 0.603 . . . . 74.430000000000007 109.86 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.87 -156.9 7.34 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.405 -0.816 . . . . 75.140000000000001 111.574 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.1 m -119.1 131.85 55.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.705 0.288 . . . . 62.030000000000001 110.936 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.483 HD12 HG23 ' A' ' 5' ' ' ILE . 37.5 mm -74.56 123.01 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.097 -0.501 . . . . 75.25 110.29 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 66' ' ' GLN . 51.1 mt -115.9 133.32 62.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.683 -0.488 . . . . 74.230000000000004 109.683 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.02 95.0 4.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.314 0.578 . . . . 72.420000000000002 111.343 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.508 HD21 ' HZ3' ' A' ' 120' ' ' LYS . 2.1 pp -134.36 105.15 6.45 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.783 -0.821 . . . . 73.049999999999997 108.783 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -114.61 14.1 17.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.714 -0.676 . . . . 71.129999999999995 111.066 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -93.96 7.71 44.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.163 -0.471 . . . . 74.530000000000001 110.223 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.1 100.93 0.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.876 -0.787 . . . . 65.450000000000003 108.876 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -87.75 129.21 35.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.597 -0.729 . . . . 64.319999999999993 112.636 -164.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -102.24 166.74 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.791 -0.818 . . . . 72.329999999999998 108.791 168.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -84.77 113.72 21.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.939 0.4 . . . . 72.510000000000005 110.536 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.045 -0.525 . . . . 75.510000000000005 110.442 -179.797 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HA ' ' OG1' ' A' ' 4' ' ' THR . 24.0 ptp . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 109.878 -0.416 . . . . 64.409999999999997 109.878 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.85 -66.11 4.0 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.747 -0.74 . . . . 54.329999999999998 111.783 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 m -74.37 -24.26 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.325 0.583 . . . . 73.329999999999998 109.822 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.787 HG21 ' HG2' ' A' ' 146' ' ' LYS . 46.3 p -79.1 154.52 29.31 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.824 -0.625 . . . . 62.32 109.978 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.555 HG23 HD11 ' A' ' 149' ' ' ILE . 38.9 mm -74.78 138.71 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 111.189 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 122.82 17.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.312 -0.625 . . . . 62.329999999999998 109.312 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -101.64 6.45 42.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.679 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -72.54 84.45 1.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 71.430000000000007 110.239 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.81 -9.76 2.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.635 -0.711 . . . . 73.219999999999999 112.38 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -70.49 155.81 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 73.319999999999993 110.461 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.5 pt-20 -138.96 155.87 47.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.079 0.466 . . . . 75.219999999999999 110.015 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.55 113.48 31.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.821 -0.627 . . . . 74.140000000000001 110.005 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.55 HD13 ' HB2' ' A' ' 60' ' ' ASP . 93.2 mt -79.67 -36.46 37.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.83 -0.623 . . . . 74.299999999999997 110.591 -177.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.3 t -147.91 141.24 25.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 72.329999999999998 110.721 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.466 ' HE2' ' HG2' ' A' ' 18' ' ' GLN . 35.4 p90 -155.72 136.11 13.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.765 -0.652 . . . . 75.329999999999998 109.633 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -85.25 -44.91 12.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.204 -0.453 . . . . 62.420000000000002 111.786 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -134.34 147.51 50.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.022 0.439 . . . . 72.530000000000001 111.001 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.466 ' HG2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -161.57 148.47 14.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.732 -0.667 . . . . 74.230000000000004 109.407 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.67 112.22 20.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.897 -0.409 . . . . 63.420000000000002 109.897 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.65 1.31 17.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.652 0.612 . . . . 71.430000000000007 112.652 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -143.83 -29.79 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.384 -0.526 . . . . 63.310000000000002 112.331 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -51.55 57.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.93 -0.652 . . . . 64.200000000000003 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' HG3' ' HE1' ' A' ' 41' ' ' PHE . 17.2 mm-40 -83.98 -37.82 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 71.140000000000001 110.337 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.41 153.14 9.07 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.893 -0.67 . . . . 73.200000000000003 111.739 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.44 99.42 0.41 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 71.030000000000001 111.093 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.59 -0.73 55.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.916 -0.659 . . . . 71.120000000000005 112.184 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -120.14 122.94 42.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.112 -0.329 . . . . 74.219999999999999 110.112 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.0 2.49 20.34 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.298 -0.721 . . . . 64.219999999999999 111.298 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.497 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.7 mt -74.67 150.74 39.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.532 -0.334 . . . . 73.340000000000003 110.74 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.99 -23.21 67.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.09 0.471 . . . . 71.420000000000002 111.214 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 -17.28 57.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 74.230000000000004 111.341 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.621 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 63.4 m -73.55 -17.61 61.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.176 0.512 . . . . 72.209999999999994 110.046 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -71.97 -14.36 61.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.37 -0.832 . . . . 74.109999999999999 110.7 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -130.66 21.59 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 74.420000000000002 109.911 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.621 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 18.1 t70 -72.39 -45.68 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.646 -0.707 . . . . 74.439999999999998 111.167 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.68 -1.47 21.71 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.478 -0.868 . . . . 61.32 112.655 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -131.16 118.36 20.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.126 -0.324 . . . . 70.230000000000004 110.126 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 p -72.22 2.07 6.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.953 -0.567 . . . . 70.049999999999997 111.683 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.24 -35.78 80.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.631 -0.877 . . . . 75.129999999999995 108.631 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.1 p -95.42 165.73 12.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.834 -1.076 . . . . 70.049999999999997 110.141 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 32.6 p90 -155.63 167.84 29.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.491 -0.322 . . . . 74.409999999999997 110.674 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.54 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.9 t90 -101.22 133.23 46.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.268 -0.642 . . . . 72.439999999999998 109.268 172.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.62 144.19 49.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.332 -0.618 . . . . 75.209999999999994 109.332 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.16 146.93 52.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.282 -0.417 . . . . 74.549999999999997 110.435 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 50' ' ' SER . 82.8 tttt -63.12 116.61 5.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.978 -0.556 . . . . 72.209999999999994 110.197 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -120.4 -27.93 5.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.523 -0.471 . . . . 75.299999999999997 110.663 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.88 110.72 11.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 73.530000000000001 110.2 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 10.11 59.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.804 -0.712 . . . . 54.350000000000001 112.06 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.08 154.6 16.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.841 -0.695 . . . . 74.010000000000005 112.156 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 52.0 m -102.86 159.61 15.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 55.020000000000003 111.286 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.75 156.6 52.75 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.846 -0.615 . . . . 73.450000000000003 110.35 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.68 153.56 43.53 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.534 2.156 . . . . 74.420000000000002 113.194 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' A' ' 130' ' ' ASP . 11.9 mt -92.16 159.79 36.76 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 75.120000000000005 110.118 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.795 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 77.5 Cg_endo -80.52 162.45 82.71 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.578 -1.426 . . . . 74.319999999999993 112.875 -1.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 28.6 m-85 -93.98 132.31 38.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 73.019999999999996 111.199 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.552 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 3.4 t70 -111.49 125.45 53.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 75.409999999999997 110.219 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.421 HG21 HD12 ' A' ' 59' ' ' ILE . 52.5 mt -131.43 111.26 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.21 -0.45 . . . . 73.129999999999995 109.909 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.37 122.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.062 -0.517 . . . . 74.129999999999995 110.562 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 57' ' ' ILE . 4.9 mp -116.25 136.13 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.638 -0.255 . . . . 75.140000000000001 110.694 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HB2' HD13 ' A' ' 13' ' ' LEU . 57.3 t0 -99.12 119.73 38.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.721 -0.844 . . . . 75.140000000000001 108.721 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.6 mtm -85.6 -5.62 59.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.356 -0.384 . . . . 73.099999999999994 111.111 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 66.27 12.02 8.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.806 -0.634 . . . . 74.310000000000002 112.026 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 153' ' ' GLU . 27.8 pt20 -165.88 147.56 7.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 63.420000000000002 109.746 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.7 128.43 35.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.899 -0.592 . . . . 73.239999999999995 110.042 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' CD1' HG22 ' A' ' 5' ' ' ILE . 71.7 mt -132.38 139.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.18 -0.464 . . . . 74.530000000000001 110.258 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' A' ' 118' ' ' SER . 55.8 tp60 -83.37 102.95 12.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.869 -0.789 . . . . 70.319999999999993 108.869 176.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -72.28 129.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.376 . . . . 74.349999999999994 110.833 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.89 -32.85 3.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 72.409999999999997 111.079 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -163.29 147.68 11.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.881 -0.599 . . . . 74.129999999999995 111.177 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.2 t -119.84 133.87 65.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.162 -0.472 . . . . 74.510000000000005 109.871 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.678 ' HG3' ' HD2' ' A' ' 146' ' ' LYS . 26.0 mt-10 -110.76 127.61 55.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.126 0.489 . . . . 73.219999999999999 110.602 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.96 121.3 43.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.664 -0.698 . . . . 63.329999999999998 109.622 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.7 tp -111.13 95.88 27.42 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.325 -0.398 . . . . 72.150000000000006 109.963 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.619 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 65.0 Cg_endo -76.68 174.73 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.458 2.105 . . . . 71.430000000000007 111.657 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.514 ' HD3' ' HB3' ' A' ' 139' ' ' ALA . 65.8 mtp180 -68.98 -26.99 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.598 -0.89 . . . . 74.219999999999999 108.598 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 88.48 -168.67 36.68 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.042 -0.981 . . . . 75.030000000000001 113.881 168.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -60.51 115.41 3.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.653 -0.774 . . . . 74.150000000000006 109.438 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.47 5.59 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.151 -0.78 . . . . 73.340000000000003 111.151 -172.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 75' ' ' ARG . 79.0 p -117.6 158.23 24.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.035 -0.357 . . . . 74.049999999999997 110.035 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -76.32 108.65 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.05 0.452 . . . . 65.400000000000006 109.832 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.778 ' HB3' HD21 ' A' ' 107' ' ' ASN . 21.2 t-20 -138.1 91.61 12.93 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.1 -0.5 . . . . 74.120000000000005 110.319 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.03 27.4 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.181 2.588 . . . . 74.319999999999993 112.659 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.68 121.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.496 . . . . 73.129999999999995 110.457 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -105.89 -37.24 6.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.623 -0.717 . . . . 75.010000000000005 111.197 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG22 ' HA3' ' A' ' 132' ' ' GLY . 91.1 t -134.53 138.48 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.569 0.223 . . . . 72.200000000000003 111.097 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 m -132.13 139.73 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 73.230000000000004 110.418 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.56 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 67.9 mt-10 -121.06 134.53 55.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.394 -0.366 . . . . 74.310000000000002 110.791 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -116.22 131.03 57.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 73.040000000000006 110.8 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.75 153.33 49.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.173 -0.467 . . . . 73.310000000000002 110.369 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.16 155.53 46.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.243 -0.435 . . . . 75.319999999999993 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.4 t -150.02 147.33 27.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.063 0.459 . . . . 74.120000000000005 110.781 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.17 -33.74 16.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 74.319999999999993 110.841 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -122.97 -2.69 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.893 0.331 . . . . 75.140000000000001 111.893 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 63.85 34.62 11.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.657 0.741 . . . . 72.150000000000006 109.587 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.2 t -110.39 -54.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.859 -0.609 . . . . 75.329999999999998 109.366 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.65 135.15 54.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.669 -0.863 . . . . 72.340000000000003 108.669 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -105.83 119.22 38.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.364 0.602 . . . . 75.010000000000005 110.687 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.2 m -95.29 125.03 51.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.233 -0.894 . . . . 72.340000000000003 110.875 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.0 111.98 3.3 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.627 2.218 . . . . 72.129999999999995 111.76 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.591 HD13 HG22 ' A' ' 116' ' ' VAL . 21.2 pt -86.24 -18.87 8.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 73.430000000000007 110.948 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.88 139.96 2.78 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.288 -0.958 . . . . 72.450000000000003 113.074 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.56 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 30.2 ttt180 -119.59 126.55 51.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.401 -0.592 . . . . 72.409999999999997 109.401 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.36 -175.91 4.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 74.430000000000007 110.84 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.96 143.97 16.42 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.839 -0.696 . . . . 55.149999999999999 111.788 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.529 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 33.4 t80 -91.19 136.38 33.13 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.744 -0.465 . . . . 74.219999999999999 109.744 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.515 ' HB ' HD22 ' A' ' 112' ' ' LEU . 27.1 m -112.78 123.22 49.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.519 -0.31 . . . . 74.140000000000001 110.763 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.778 HD21 ' HB3' ' A' ' 81' ' ' ASN . 24.9 t-20 -67.05 93.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.035 0.445 . . . . 72.219999999999999 109.852 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.419 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 12.0 pt20 -144.54 169.27 18.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.895 -0.593 . . . . 75.439999999999998 109.417 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -104.9 18.59 22.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.538 0.685 . . . . 71.329999999999998 110.196 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.54 153.57 31.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.446 -0.797 . . . . 53.229999999999997 109.74 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.54 124.47 22.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.067 0.461 . . . . 70.430000000000007 111.262 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.515 HD22 ' HB ' ' A' ' 106' ' ' THR . 75.0 mt -80.74 117.79 21.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 74.420000000000002 110.439 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -95.86 119.81 35.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.266 -0.424 . . . . 73.530000000000001 110.392 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.57 105.17 13.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 109.905 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -82.59 90.77 6.84 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.282 -0.636 . . . . 73.340000000000003 109.282 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.591 HG22 HD13 ' A' ' 100' ' ' ILE . 30.5 m -86.86 179.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.323 -0.853 . . . . 74.25 110.581 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.542 ' HG2' ' HA ' ' A' ' 100' ' ' ILE . 47.8 pttt -81.44 148.2 29.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.078 0.466 . . . . 72.329999999999998 110.226 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 37.4 p -79.01 127.62 32.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.747 -0.66 . . . . 73.120000000000005 111.511 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.8 tt -161.49 150.57 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.635 -0.711 . . . . 71.319999999999993 109.388 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.497 ' HG3' HD11 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -79.38 140.69 37.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.157 -0.683 . . . . 73.329999999999998 109.157 177.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.75 144.19 17.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.569 0.223 . . . . 65.420000000000002 110.848 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.76 -22.61 13.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.804 -0.813 . . . . 75.25 108.804 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -115.65 145.42 42.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.846 . . . . 75.319999999999993 109.673 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.0 tt -136.34 141.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.957 -0.386 . . . . 74.400000000000006 109.957 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.552 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 59.9 ttp180 -126.78 125.71 42.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.033 0.444 . . . . 75.219999999999999 111.435 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 57' ' ' ILE . 57.9 tp -95.62 124.32 39.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.554 -0.748 . . . . 71.409999999999997 109.045 172.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 76.4 m -119.47 123.16 43.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.991 0.424 . . . . 72.209999999999994 110.663 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.0 mm -105.56 94.01 7.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.354 -0.61 . . . . 73.040000000000006 109.354 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.795 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 68.0 Cg_endo -87.76 136.94 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.033 2.489 . . . . 75.010000000000005 113.006 -175.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HB2' HD11 ' A' ' 53' ' ' LEU . 25.3 t0 -81.48 66.36 7.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.433 -0.951 . . . . 74.310000000000002 108.433 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -124.93 -12.54 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.835 -1.075 . . . . 74.340000000000003 111.703 -173.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.472 ' HA3' HG22 ' A' ' 85' ' ' VAL . . . -139.83 22.62 2.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.659 -1.258 . . . . 63.119999999999997 114.001 -173.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.8 26.06 7.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.162 -1.018 . . . . 55.450000000000003 112.611 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -82.11 178.45 8.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.887 0.375 . . . . 75.439999999999998 110.827 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 m -146.79 178.96 7.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.882 -0.414 . . . . 64.549999999999997 109.882 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 p -84.68 16.08 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 73.319999999999993 111.667 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.8 127.92 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.52 . . . . 72.040000000000006 109.879 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.95 143.45 30.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.313 -0.403 . . . . 75.120000000000005 110.18 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.514 ' HB3' ' HD3' ' A' ' 75' ' ' ARG . . . -149.16 106.09 3.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.836 0.35 . . . . 73.219999999999999 111.33 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.619 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 9.3 mt -126.23 140.5 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.73 -0.841 . . . . 70.209999999999994 108.73 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.502 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 69.6 mtt180 -75.91 -63.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.025 0.44 . . . . 72.329999999999998 110.159 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.97 133.52 22.02 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.666 -0.697 . . . . 73.0 110.863 -170.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 143' ' ' LEU . 9.2 tt -107.47 120.63 42.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 72.530000000000001 109.418 177.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.88 124.26 44.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 74.430000000000007 110.562 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.21 142.07 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 74.25 109.867 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.787 ' HG2' HG21 ' A' ' 4' ' ' THR . 26.6 mtpt -119.16 124.27 46.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.438 . . . . 73.319999999999993 109.816 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.56 -166.83 32.44 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.649 -0.786 . . . . 64.140000000000001 112.152 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.8 m -107.3 130.15 54.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.573 0.225 . . . . 62.039999999999999 110.592 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.555 HD11 HG23 ' A' ' 5' ' ' ILE . 40.7 mm -72.0 125.05 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.411 . . . . 75.239999999999995 110.938 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.648 HG21 ' H ' ' A' ' 152' ' ' LEU . 44.6 mt -110.48 150.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.169 -0.678 . . . . 70.439999999999998 109.169 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -116.32 13.37 15.56 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.6 . . . . 73.010000000000005 111.03 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.648 ' H ' HG21 ' A' ' 150' ' ' ILE . 84.7 mt -85.65 64.19 8.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.681 -0.69 . . . . 73.420000000000002 110.486 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 33.3 mm-40 -80.34 14.26 2.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.542 -0.754 . . . . 74.219999999999999 111.43 -176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 39.7 m80 60.58 38.7 18.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 74.530000000000001 109.708 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -71.99 94.65 1.5 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.611 0.72 . . . . 75.200000000000003 111.985 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.38 98.32 6.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.471 -0.786 . . . . 75.239999999999995 108.911 174.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.9 t60 61.33 38.53 16.24 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.857 0.837 . . . . 75.209999999999994 108.866 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -102.31 121.3 42.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.007 -0.997 . . . . 72.519999999999996 110.298 -173.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.437 -0.347 . . . . 74.319999999999993 110.829 -179.393 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 111.637 0.236 . . . . 72.25 111.637 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.28 -85.2 0.64 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.857 -0.687 . . . . 73.0 112.426 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.5 m -78.82 -24.55 44.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.546 0.689 . . . . 75.519999999999996 109.652 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.458 HG21 ' HG3' ' A' ' 146' ' ' LYS . 22.6 p -83.81 153.52 24.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.466 -0.788 . . . . 72.409999999999997 110.304 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG23 HD12 ' A' ' 65' ' ' ILE . 44.1 mm -63.79 147.76 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 73.040000000000006 111.213 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -72.95 112.79 9.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.575 -0.528 . . . . 72.219999999999999 109.575 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -89.56 -8.54 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.433 . . . . 74.540000000000006 111.057 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -73.17 97.67 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.742 0.782 . . . . 75.010000000000005 109.31 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.12 -11.91 4.14 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.627 -1.17 . . . . 65.129999999999995 111.25 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.515 ' HE3' HG23 ' A' ' 59' ' ' ILE . 30.6 m0 -74.98 161.29 29.61 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.58 -0.526 . . . . 71.120000000000005 109.58 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.482 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 8.9 pt-20 -138.57 158.69 43.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.34 -0.544 . . . . 74.049999999999997 110.585 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.97 119.54 45.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 64.129999999999995 109.709 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.58 -39.0 28.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.014 0.435 . . . . 75.010000000000005 110.448 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.6 t -157.04 141.1 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 74.349999999999994 109.703 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 18' ' ' GLN . 51.7 p90 -136.02 146.2 46.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.002 -0.545 . . . . 75.519999999999996 109.532 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -86.27 -40.98 14.98 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.797 -0.361 . . . . 74.430000000000007 110.737 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 5.9 t -147.81 148.17 30.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.153 0.501 . . . . 75.209999999999994 111.111 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.54 HE22 ' HB3' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.87 145.1 1.85 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.249 -0.887 . . . . 64.510000000000005 108.947 172.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 9.5 tp10 -105.44 102.31 11.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.198 -0.456 . . . . 63.119999999999997 110.67 -173.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HB3' HE22 ' A' ' 18' ' ' GLN . . . -100.43 -30.14 12.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 72.120000000000005 110.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -83.21 -33.69 26.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 71.239999999999995 110.556 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . -84.43 -48.39 5.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.771 -0.728 . . . . 74.439999999999998 113.129 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HG3' ' HA3' ' A' ' 28' ' ' GLY . 23.8 mm-40 -74.81 -29.76 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.656 0.228 . . . . 72.430000000000007 111.601 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.49 -148.35 17.91 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.436 -0.888 . . . . 41.409999999999997 113.574 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.97 6.41 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.598 0.592 . . . . 70.25 112.598 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.34 17.66 80.14 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.564 -0.744 . . . . 63.350000000000001 113.428 172.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -128.19 145.9 50.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.005 -0.278 . . . . 75.030000000000001 110.274 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.445 ' HA3' ' HG3' ' A' ' 23' ' ' GLU . . . 78.86 -4.52 60.98 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.403 -0.427 . . . . 71.019999999999996 112.757 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.9 mt -73.79 144.69 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.004 -0.369 . . . . 75.120000000000005 110.004 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.47 -22.83 64.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.573 0.701 . . . . 63.140000000000001 110.064 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.657 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 13.9 ptmt -74.97 -23.44 58.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.999 -1.0 . . . . 73.439999999999998 111.335 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 79.1 m -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.949 0.404 . . . . 74.340000000000003 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -67.15 -15.02 63.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.617 -0.72 . . . . 74.209999999999994 110.581 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.45 HG22 HG12 ' A' ' 59' ' ' ILE . 27.5 pt -133.69 26.5 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 75.120000000000005 110.827 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.29 -46.63 19.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.052 0.453 . . . . 72.310000000000002 111.305 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.12 6.03 7.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.53 -0.843 . . . . 75.209999999999994 112.672 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.632 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 7.4 t70 -125.35 127.29 46.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.185 0.492 . . . . 63.200000000000003 110.518 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 p -76.34 -5.55 47.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.956 0.724 . . . . 73.439999999999998 112.956 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.632 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 7.9 pt-20 -91.42 -21.34 21.01 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.111 -0.636 . . . . 73.219999999999999 110.46 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -90.94 136.76 32.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.258 -0.645 . . . . 75.010000000000005 109.258 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.711 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 51.2 p90 -137.76 170.73 15.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.438 0.637 . . . . 75.530000000000001 112.412 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.457 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 30.3 t90 -106.43 139.81 40.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.629 -1.169 . . . . 75.420000000000002 109.375 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -135.52 139.18 43.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.323 -0.621 . . . . 72.129999999999995 109.323 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 146.33 53.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.433 . . . . 62.439999999999998 110.113 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 35.1 ttpt -65.61 131.13 45.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.381 -0.372 . . . . 74.530000000000001 110.164 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.423 ' NE1' ' HG2' ' A' ' 19' ' ' GLU . 64.5 p-90 -130.32 -33.89 1.66 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 73.430000000000007 111.517 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 7.6 tt0 -67.71 -41.64 83.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 75.310000000000002 110.767 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.85 26.17 25.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.532 -0.842 . . . . 71.349999999999994 111.448 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.27 165.47 40.35 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.1 -0.8 . . . . 73.299999999999997 111.1 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.558 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 38.3 m -100.82 145.72 28.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 117.189 0.495 . . . . 70.140000000000001 110.452 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 18.3 m-20 -79.11 161.37 68.43 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 110.621 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 60.1 Cg_endo -73.37 132.78 18.19 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.405 2.07 . . . . 72.430000000000007 112.734 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.11 158.27 88.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.822 -0.626 . . . . 72.25 110.198 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.704 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.7 Cg_exo -76.3 159.98 95.96 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.002 -1.249 . . . . 74.420000000000002 112.692 0.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.714 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.0 m-85 -95.74 101.75 13.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 74.219999999999999 110.13 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.516 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 7.2 m-20 -98.71 117.96 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.059 -0.518 . . . . 75.120000000000005 110.51 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 52.7 mt -111.71 116.79 53.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.266 -0.425 . . . . 75.230000000000004 109.922 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.78 115.44 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.515 HG23 ' HE3' ' A' ' 10' ' ' TRP . 5.0 mp -111.08 136.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 74.450000000000003 110.576 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -104.06 119.54 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.401 -0.592 . . . . 62.420000000000002 109.401 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 73.430000000000007 110.895 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 31.2 mmtp 72.0 -11.67 0.75 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.514 0.726 . . . . 70.450000000000003 112.643 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -145.13 170.5 16.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.617 0.246 . . . . 70.25 110.58 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.434 HD21 ' HA ' ' A' ' 64' ' ' ASN . 2.2 m120 -85.95 124.36 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 64.319999999999993 110.74 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.559 HD12 HG23 ' A' ' 5' ' ' ILE . 78.1 mt -130.17 136.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 72.230000000000004 110.065 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.564 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.9 tp60 -80.02 100.71 8.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.099 -0.704 . . . . 71.25 109.099 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.722 ' O ' ' HA ' ' A' ' 118' ' ' SER . 31.7 mm -69.36 118.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.909 -0.404 . . . . 71.430000000000007 109.909 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.6 -39.38 5.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.233 0.539 . . . . 72.109999999999999 110.914 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.684 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 51.3 tt0 -159.24 148.68 18.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.611 -0.722 . . . . 75.310000000000002 110.563 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.16 115.85 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.369 . . . . 72.010000000000005 110.817 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.578 ' OE2' ' HA ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -97.79 128.1 44.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.707 -0.679 . . . . 75.299999999999997 110.689 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.527 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 45.9 mt -109.34 118.17 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.463 -0.569 . . . . 65.099999999999994 109.463 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -103.74 99.07 14.58 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.588 -0.523 . . . . 73.129999999999995 109.588 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 5.4 Cg_exo -78.48 172.17 15.67 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.869 2.379 . . . . 74.239999999999995 111.795 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HD3' ' OG ' ' A' ' 79' ' ' SER . 71.5 ttt180 -77.59 -28.74 51.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.245 0.545 . . . . 72.420000000000002 109.647 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 93.83 -125.1 8.11 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.569 -0.742 . . . . 74.430000000000007 113.083 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -102.11 140.89 35.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.982 0.42 . . . . 75.400000000000006 110.002 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.48 -21.44 8.61 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.27 -0.732 . . . . 73.299999999999997 111.27 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.433 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 67.9 m -123.27 171.57 9.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.858 -0.423 . . . . 73.439999999999998 109.858 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -102.48 105.81 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.593 -0.276 . . . . 74.010000000000005 110.526 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -121.58 84.12 42.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.478 -0.328 . . . . 74.540000000000006 111.122 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.487 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 2.3 Cg_endo -82.95 32.12 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.35 2.7 . . . . 73.109999999999999 111.73 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.43 118.86 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.818 -0.628 . . . . 74.25 110.186 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -100.57 -50.12 3.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.675 . . . . 74.299999999999997 110.904 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.434 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 60.9 t -127.36 141.68 45.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.042 -0.526 . . . . 71.129999999999995 110.599 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.36 129.82 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.151 -0.477 . . . . 71.140000000000001 109.743 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.6 mt-10 -109.79 125.41 52.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.132 -0.486 . . . . 71.409999999999997 110.493 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -107.68 129.66 55.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.081 -0.509 . . . . 74.299999999999997 110.426 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.58 145.33 49.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.279 -0.418 . . . . 63.409999999999997 110.76 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.02 48.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.027 -0.533 . . . . 75.129999999999995 109.846 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t -149.86 154.62 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.345 0.593 . . . . 72.329999999999998 111.344 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -102.64 -32.79 9.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.432 -0.804 . . . . 71.310000000000002 109.985 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 26.8 t0 -106.81 -12.32 15.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 74.409999999999997 111.252 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.498 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 15.8 t-20 76.25 -21.5 0.31 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.413 0.625 . . . . 75.209999999999994 111.114 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' H ' ' C ' ' A' ' 93' ' ' ASP . 78.3 t -75.72 -50.96 21.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.684 -0.689 . . . . 74.150000000000006 110.319 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.1 113.41 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.225 -0.898 . . . . 63.310000000000002 109.913 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -94.08 142.19 27.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.014 -0.539 . . . . 73.530000000000001 110.946 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.4 m -115.1 124.55 30.09 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.786 -0.643 . . . . 73.230000000000004 109.967 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.52 116.17 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.567 2.178 . . . . 74.349999999999994 112.143 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.527 HD11 HG22 ' A' ' 116' ' ' VAL . 15.7 pt -86.78 -13.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.395 -0.366 . . . . 74.049999999999997 110.571 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.69 130.76 1.15 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.333 -0.937 . . . . 43.420000000000002 113.177 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 38.4 ttt180 -106.71 114.56 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.713 -0.847 . . . . 73.530000000000001 108.713 171.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.55 ' HE2' HG13 ' A' ' 116' ' ' VAL . 96.4 m-85 -125.79 172.3 9.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.404 -0.362 . . . . 74.0 110.682 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.53 151.3 22.41 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.027 -0.829 . . . . 53.409999999999997 111.027 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -100.86 131.96 46.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.96 -0.385 . . . . 65.150000000000006 109.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.506 ' HB ' HD23 ' A' ' 112' ' ' LEU . 21.1 m -105.8 124.74 50.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 110.433 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -70.69 94.87 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.095 0.474 . . . . 73.310000000000002 110.312 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.401 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 11.9 pt20 -146.09 176.84 9.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.988 -0.745 . . . . 71.219999999999999 108.988 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.46 -7.81 17.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.033 0.444 . . . . 73.200000000000003 110.983 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.72 159.26 16.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 71.519999999999996 110.47 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.27 130.0 41.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 73.129999999999995 111.616 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.506 HD23 ' HB ' ' A' ' 106' ' ' THR . 36.0 mt -87.28 116.38 25.33 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 74.510000000000005 110.33 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.578 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 40.9 mt-10 -83.16 121.14 26.68 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.283 0.364 . . . . 62.219999999999999 110.846 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.484 ' HE2' HD11 ' A' ' 72' ' ' LEU . 49.9 m-85 -122.29 104.96 9.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 74.120000000000005 110.711 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.36 97.0 5.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.592 -0.731 . . . . 74.109999999999999 109.414 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.55 HG13 ' HE2' ' A' ' 103' ' ' PHE . 27.1 m -98.13 -178.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.443 -0.798 . . . . 75.420000000000002 111.792 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.447 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 45.8 tttp -61.04 125.69 24.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 71.450000000000003 111.088 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.722 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 9.6 p -73.05 120.02 18.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 75.239999999999995 110.029 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.413 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 10.6 tt -150.9 141.01 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.972 0.415 . . . . 74.420000000000002 111.406 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -82.9 115.02 21.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.277 -0.638 . . . . 74.010000000000005 109.277 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -142.8 175.0 10.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.292 . . . . 75.230000000000004 110.983 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -121.04 -32.5 3.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.6 . . . . 74.430000000000007 110.015 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.97 145.98 33.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 73.310000000000002 110.298 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.448 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -134.17 136.68 53.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.134 -0.484 . . . . 65.25 109.953 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.516 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.1 ttp180 -123.86 122.2 37.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.993 0.425 . . . . 74.019999999999996 111.095 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.4 tp -93.79 111.45 23.15 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.974 -0.75 . . . . 75.219999999999999 108.974 172.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 61.0 m -105.91 120.59 42.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.071 0.462 . . . . 75.019999999999996 111.061 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.714 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -98.31 96.23 3.5 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.566 -0.901 . . . . 75.450000000000003 108.566 171.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.704 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -68.71 171.72 12.79 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.68 2.254 . . . . 70.349999999999994 113.057 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.34 -2.43 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.251 1.024 . . . . 74.019999999999996 108.407 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -72.45 -31.84 65.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.138 -1.392 . . . . 74.040000000000006 112.439 -170.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.434 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -94.2 0.11 66.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.187 -1.006 . . . . 74.299999999999997 113.621 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.88 20.71 11.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.108 -1.044 . . . . 74.239999999999995 111.668 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -72.55 142.6 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.45 . . . . 72.340000000000003 111.031 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.487 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 17.4 m -100.06 172.24 7.32 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.924 -0.58 . . . . 60.310000000000002 109.867 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 16.2 p -83.19 22.05 1.03 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 62.509999999999998 112.128 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.23 129.42 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.506 -0.553 . . . . 65.219999999999999 109.506 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.17 135.11 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.507 -0.315 . . . . 71.109999999999999 110.939 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -134.47 106.04 6.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 75.519999999999996 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 29.9 mt -124.07 133.64 68.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.426 -0.583 . . . . 72.109999999999999 109.426 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.711 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 72.3 mtt180 -66.03 -71.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.274 0.359 . . . . 74.409999999999997 110.27 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.7 153.73 44.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.431 0.634 . . . . 73.230000000000004 111.705 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 tt -106.68 111.31 23.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.541 -1.281 . . . . 73.140000000000001 107.541 168.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -112.11 123.34 50.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.766 -0.457 . . . . 71.120000000000005 109.766 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.05 128.35 52.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.916 0.389 . . . . 64.209999999999994 111.978 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.684 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 54.1 mtpt -94.51 130.6 40.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.377 -0.601 . . . . 63.039999999999999 109.377 171.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.15 -167.35 35.42 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.186 -1.007 . . . . 44.299999999999997 112.265 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.2 m -123.06 129.49 51.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.479 0.18 . . . . 75.329999999999998 110.548 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.53 HD11 HG21 ' A' ' 5' ' ' ILE . 41.6 mm -69.36 116.36 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.163 -0.471 . . . . 73.450000000000003 109.981 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 66' ' ' GLN . 62.0 mt -101.02 141.22 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.974 0.416 . . . . 72.099999999999994 109.97 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -118.98 133.73 55.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.058 -0.519 . . . . 74.519999999999996 110.495 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.97 79.98 1.07 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.767 0.794 . . . . 71.129999999999995 109.503 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.4 131.85 38.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 71.030000000000001 110.105 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -56.99 116.21 3.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.711 -0.477 . . . . 75.329999999999998 109.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -50.17 134.29 22.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.096 -0.502 . . . . 75.420000000000002 111.319 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -60.15 137.79 58.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.474 -0.785 . . . . 74.140000000000001 112.498 -172.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -142.17 165.13 28.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.026 -0.988 . . . . 74.510000000000005 108.591 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -57.02 113.75 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.258 0.348 . . . . 74.409999999999997 110.208 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 4.5 t60 . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 116.313 -0.403 . . . . 64.140000000000001 110.332 -176.656 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.799 -0.445 . . . . 72.519999999999996 109.799 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.11 90.83 1.21 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.78 -0.724 . . . . 34.520000000000003 112.425 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.7 m -66.97 100.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.034 -0.358 . . . . 70.25 110.034 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.613 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 35.3 p -133.18 161.71 33.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 75.420000000000002 110.446 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.8 HG21 HD13 ' A' ' 149' ' ' ILE . 47.5 mm -88.65 134.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.837 0.351 . . . . 71.129999999999995 111.317 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -66.64 118.35 10.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.12 -0.491 . . . . 64.340000000000003 110.07 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -98.47 19.61 14.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.505 . . . . 72.319999999999993 111.217 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.5 m -58.7 -42.18 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.498 0.555 . . . . 73.109999999999999 112.498 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.13 8.05 62.69 Favored Glycine 0 C--O 1.235 0.186 0 C-N-CA 120.541 -0.838 . . . . 41.009999999999998 112.946 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -75.39 138.38 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.29 . . . . 74.409999999999997 110.236 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.4 pt-20 -130.3 152.91 49.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.074 -0.343 . . . . 71.409999999999997 110.074 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.28 115.23 32.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.907 -0.588 . . . . 74.109999999999999 109.829 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.462 HD13 ' HE2' ' A' ' 123' ' ' TYR . 84.8 mt -77.24 -48.97 16.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 74.340000000000003 110.062 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 t -143.26 142.99 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.562 -0.745 . . . . 74.030000000000001 110.138 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.571 -0.74 . . . . 75.340000000000003 109.257 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.2 m -77.12 -40.91 44.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.055 0.455 . . . . 72.310000000000002 110.37 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -150.98 150.34 30.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.219 -0.446 . . . . 72.129999999999995 110.864 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.19 140.51 7.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.502 -0.925 . . . . 72.349999999999994 108.502 173.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -86.12 95.94 9.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.423 0.63 . . . . 71.120000000000005 110.632 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.83 2.58 20.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.259 -0.882 . . . . 74.430000000000007 110.786 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 m -112.56 -43.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.887 -0.597 . . . . 72.430000000000007 110.629 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -76.31 -30.78 56.39 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.012 -0.54 . . . . 64.430000000000007 113.372 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.15 6.44 9.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.18 0.49 . . . . 61.340000000000003 111.368 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.95 -140.31 19.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.879 -0.677 . . . . 70.140000000000001 113.205 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.76 150.8 34.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.7 0.286 . . . . 74.349999999999994 110.495 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.17 -10.21 67.0 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.01 -0.615 . . . . 75.099999999999994 112.382 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -142.02 140.28 32.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.004 -0.369 . . . . 74.049999999999997 110.004 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.5 83.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.014 -0.612 . . . . 74.239999999999995 111.971 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.75 154.33 21.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.58 0.229 . . . . 74.430000000000007 110.488 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.96 -22.54 65.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.878 0.371 . . . . 72.530000000000001 111.448 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -77.83 -22.69 49.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.504 -0.317 . . . . 74.319999999999993 111.315 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 40.3 m -68.56 -24.33 64.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 74.530000000000001 109.911 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.564 HD11 ' HA ' ' A' ' 142' ' ' GLU . 24.9 tp -65.12 -24.49 67.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.39 -0.823 . . . . 71.540000000000006 110.776 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.557 HG22 HG12 ' A' ' 59' ' ' ILE . 35.9 pt -120.86 14.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.379 . . . . 74.209999999999994 111.16 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.86 -33.03 73.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.05 0.452 . . . . 74.420000000000002 110.197 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.0 36.29 6.41 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.708 -0.678 . . . . 51.439999999999998 112.023 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -139.05 128.93 24.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.988 -0.375 . . . . 63.109999999999999 109.988 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.519 HG22 ' CD2' ' A' ' 73' ' ' LEU . 2.5 p -70.36 -11.72 61.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.626 0.602 . . . . 72.340000000000003 112.626 -174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -89.06 -27.11 21.02 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.84 0.352 . . . . 64.219999999999999 111.049 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.2 p -87.78 146.1 25.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.739 -0.384 . . . . 74.439999999999998 109.974 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.649 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 42.6 p90 -146.5 166.09 27.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.217 0.532 . . . . 75.019999999999996 111.772 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -108.24 139.89 42.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.948 -1.023 . . . . 74.420000000000002 109.547 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -133.01 147.11 52.26 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.234 -0.654 . . . . 72.219999999999999 109.234 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.11 145.92 41.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.992 -0.373 . . . . 73.430000000000007 109.992 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 51' ' ' ASP . 37.7 ttpt -66.15 118.14 9.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 75.400000000000006 110.355 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -118.96 -30.9 4.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.425 -0.352 . . . . 75.420000000000002 110.896 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -78.72 107.67 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 74.510000000000005 110.249 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.12 -0.6 47.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.891 -0.671 . . . . 75.299999999999997 111.684 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 143.0 7.46 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.795 -0.717 . . . . 71.329999999999998 112.144 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.544 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -95.98 151.79 19.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.822 0.344 . . . . 72.340000000000003 111.053 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 30.5 m-20 -82.39 150.32 63.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.921 -0.582 . . . . 54.43 110.661 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.81 145.02 44.97 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.746 2.297 . . . . 72.549999999999997 112.269 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.506 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.8 mt -70.6 162.13 72.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 73.109999999999999 110.529 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 95.2 Cg_endo -83.15 170.02 56.16 Favored 'Cis proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.487 -1.464 . . . . 73.299999999999997 112.831 1.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.4 m-85 -108.17 111.02 22.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.406 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -110.79 130.95 55.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 74.329999999999998 110.622 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 57.4 mt -121.72 114.41 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.479 -0.563 . . . . 73.519999999999996 109.479 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -102.36 115.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.139 -0.482 . . . . 72.140000000000001 110.921 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 34' ' ' ILE . 4.9 mp -110.1 133.35 55.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.122 -0.49 . . . . 74.120000000000005 110.535 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -97.79 113.74 25.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.675 . . . . 73.420000000000002 109.179 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.2 mtm -81.98 -5.36 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 65.230000000000004 110.82 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 32.5 mmtp 73.41 -35.63 0.32 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.74 0.816 . . . . 74.129999999999995 112.965 174.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -123.9 166.73 15.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.005 0.431 . . . . 74.329999999999998 110.975 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.58 123.19 25.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.625 -0.716 . . . . 75.319999999999993 110.139 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.562 HD12 HG23 ' A' ' 5' ' ' ILE . 66.6 mt -131.68 136.87 56.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 110.614 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HB2' HD13 ' A' ' 150' ' ' ILE . 52.7 tp60 -86.48 108.56 18.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.858 -0.793 . . . . 74.109999999999999 108.858 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.665 ' O ' ' HA ' ' A' ' 118' ' ' SER . 28.1 mm -75.33 130.56 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.441 -0.207 . . . . 73.530000000000001 110.441 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -42.27 2.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.075 0.464 . . . . 73.420000000000002 111.331 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.8 tt0 -153.39 145.84 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 73.510000000000005 110.296 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -110.39 134.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.02 -0.363 . . . . 75.219999999999999 110.02 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -113.02 126.96 56.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.139 0.495 . . . . 70.420000000000002 110.899 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.617 HD13 ' HE2' ' A' ' 114' ' ' TYR . 61.3 mt -110.71 123.38 49.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.725 -0.67 . . . . 74.200000000000003 109.499 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.519 ' CD2' HG22 ' A' ' 38' ' ' THR . 22.4 tp -103.93 104.76 44.97 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.905 -0.405 . . . . 73.400000000000006 109.905 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.8 -178.22 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.815 2.343 . . . . 74.519999999999996 111.955 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -98.46 -59.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 74.349999999999994 110.574 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.56 -52.19 3.09 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.119 -0.563 . . . . 64.040000000000006 112.81 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -88.89 109.28 20.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.752 0.311 . . . . 74.230000000000004 111.162 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 61.83 4.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.911 -0.586 . . . . 71.200000000000003 112.684 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -160.91 139.8 10.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.252 0.548 . . . . 72.420000000000002 111.525 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -100.45 123.29 44.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.117 -0.947 . . . . 72.319999999999993 108.733 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.612 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 41.1 t-20 -146.65 96.88 4.35 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.21 0.528 . . . . 72.129999999999995 110.756 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 9.3 Cg_endo -91.22 21.64 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.912 3.075 . . . . 72.140000000000001 112.796 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.06 122.92 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 75.239999999999995 110.169 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -100.08 -50.24 4.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 73.400000000000006 110.855 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 60.2 t -126.97 138.41 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 73.25 110.928 -173.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.91 137.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.069 -0.514 . . . . 72.129999999999995 110.128 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.13 135.53 54.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.039 0.447 . . . . 64.549999999999997 110.662 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.11 129.76 55.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.938 -0.574 . . . . 74.140000000000001 110.118 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.9 143.44 50.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 64.439999999999998 110.671 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.59 151.35 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 110.254 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 t -146.26 152.88 39.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 62.299999999999997 110.949 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -29.41 9.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.716 -0.674 . . . . 74.519999999999996 110.89 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -111.19 -0.03 16.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 74.109999999999999 111.11 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.1 t30 68.7 21.09 7.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.92 0.866 . . . . 75.219999999999999 109.614 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.76 -59.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.434 -0.803 . . . . 73.030000000000001 110.275 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -89.12 110.86 21.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 74.109999999999999 109.769 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -99.12 107.59 20.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.937 0.398 . . . . 75.519999999999996 110.312 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.8 m -88.46 123.89 67.25 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.967 -0.561 . . . . 73.120000000000005 110.378 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.13 107.33 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.243 1.962 . . . . 63.219999999999999 111.012 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 13.8 pt -80.21 -11.84 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.059 -0.519 . . . . 72.340000000000003 110.641 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.21 128.56 1.0 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.453 -0.88 . . . . 61.140000000000001 112.862 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -100.62 123.58 45.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.92 -0.771 . . . . 75.239999999999995 108.92 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.52 -177.73 4.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.741 0.305 . . . . 75.409999999999997 110.482 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -96.72 175.26 31.24 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.753 -0.737 . . . . 62.020000000000003 111.264 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -131.7 141.96 49.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.135 0.467 . . . . 75.420000000000002 110.095 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 m -136.69 119.42 16.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.931 -0.577 . . . . 74.099999999999994 110.058 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 63.9 t30 -69.62 95.93 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.725 -0.472 . . . . 71.219999999999999 109.725 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -125.8 -167.98 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 72.040000000000006 110.843 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.09 -33.47 14.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.916 -0.584 . . . . 55.310000000000002 111.186 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.87 168.62 10.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.887 -0.597 . . . . 63.310000000000002 111.56 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.8 144.81 47.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.091 0.472 . . . . 74.030000000000001 111.146 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.6 mt -101.18 104.54 15.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.637 -0.711 . . . . 72.010000000000005 110.01 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.29 115.82 24.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.476 . . . . 73.010000000000005 110.688 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.617 ' HE2' HD13 ' A' ' 72' ' ' LEU . 42.1 m-85 -113.34 108.17 16.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.117 0.484 . . . . 74.140000000000001 110.534 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -72.86 112.78 9.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.477 -0.783 . . . . 74.319999999999993 109.495 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.559 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -112.06 178.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.086 -0.507 . . . . 73.430000000000007 111.653 -172.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.73 128.19 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 73.349999999999994 110.481 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.8 p -77.02 106.44 8.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 110.175 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.85 146.73 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.915 -0.584 . . . . 74.129999999999995 110.487 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -88.29 131.44 34.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 110.506 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.96 176.65 11.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 63.439999999999998 110.339 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -125.38 -30.66 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 73.209999999999994 110.158 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.462 ' HE2' HD13 ' A' ' 13' ' ' LEU . 93.5 m-85 -106.78 146.02 31.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.056 -0.52 . . . . 74.129999999999995 110.14 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.0 tt -135.99 135.66 50.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.934 0.397 . . . . 74.140000000000001 110.157 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 33.6 ttp180 -122.88 120.06 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.34 -0.391 . . . . 74.230000000000004 110.679 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.421 HD23 HD13 ' A' ' 57' ' ' ILE . 41.3 tp -84.48 113.73 21.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.769 -0.826 . . . . 74.510000000000005 108.769 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.5 m -107.77 116.92 32.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.349 0.595 . . . . 62.219999999999999 111.278 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.722 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.9 mm -100.59 91.34 1.77 Allowed Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.002 -1.11 . . . . 74.439999999999998 108.002 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 174.45 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.243 1.962 . . . . 53.210000000000001 112.521 -173.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.34 36.91 0.89 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.613 -0.884 . . . . 62.210000000000001 108.613 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -113.52 146.37 39.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.571 -1.195 . . . . 72.140000000000001 110.752 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.98 9.9 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.144 -0.55 . . . . 71.549999999999997 113.522 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 116.37 25.28 3.52 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.285 -0.959 . . . . 44.039999999999999 112.263 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.93 145.0 56.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 71.209999999999994 110.383 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.464 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 15.4 m -118.74 176.87 5.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.068 -0.515 . . . . 70.519999999999996 110.541 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.544 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 34.1 p -78.16 10.14 3.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.243 -0.435 . . . . 73.150000000000006 111.879 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.407 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 44.8 t -109.4 119.29 58.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.654 -0.499 . . . . 73.409999999999997 109.654 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -139.59 135.74 33.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.612 -0.267 . . . . 72.530000000000001 110.535 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.87 107.55 3.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 75.540000000000006 110.887 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.9 mt -133.43 136.97 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.478 -0.564 . . . . 71.409999999999997 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 36.3 mmt180 -63.77 -72.4 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.849 0.357 . . . . 75.239999999999995 110.071 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.564 ' HA ' HD11 ' A' ' 33' ' ' LEU . 12.8 pt-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.917 -0.713 . . . . 74.340000000000003 111.812 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.39 130.56 56.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.715 -1.13 . . . . 74.420000000000002 108.147 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.613 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -128.16 164.4 22.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.696 -0.483 . . . . 71.319999999999993 109.696 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -133.28 128.02 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 71.099999999999994 110.277 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 50.7 mttm -93.13 134.66 35.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.172 -0.677 . . . . 73.200000000000003 109.172 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.39 8.56 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.87 -0.681 . . . . 72.439999999999998 111.453 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -136.31 133.61 37.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.484 0.183 . . . . 74.409999999999997 110.562 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.8 HD13 HG21 ' A' ' 5' ' ' ILE . 31.2 mm -73.55 115.83 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.525 -0.546 . . . . 75.430000000000007 109.525 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.415 HD13 ' HB2' ' A' ' 66' ' ' GLN . 56.1 mt -95.66 138.23 21.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.709 -0.478 . . . . 74.239999999999995 109.709 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.99 142.7 34.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.632 0.729 . . . . 75.140000000000001 110.952 -177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.09 148.84 42.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.075 -0.966 . . . . 72.439999999999998 108.903 177.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.54 94.75 1.33 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.839 0.828 . . . . 73.140000000000001 110.932 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -109.12 18.36 20.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.239 -1.346 . . . . 70.150000000000006 109.292 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -63.27 -41.05 98.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 72.409999999999997 110.296 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -139.52 -20.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 61.439999999999998 111.301 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -91.88 130.47 37.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.919 0.39 . . . . 71.340000000000003 110.622 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -146.13 131.49 18.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 74.549999999999997 110.035 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.824 -0.625 . . . . 73.219999999999999 110.672 178.237 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.788 0.328 . . . . 73.439999999999998 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.27 79.1 1.52 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 73.530000000000001 111.345 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.0 t -89.79 11.65 19.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.182 0.515 . . . . 74.329999999999998 111.23 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 p -78.51 160.8 27.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.931 -0.577 . . . . 71.120000000000005 110.35 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.502 HG22 ' CD1' ' A' ' 65' ' ' ILE . 44.5 mm -82.74 130.53 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.786 0.327 . . . . 73.549999999999997 110.85 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.3 t -65.6 125.05 23.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 110.171 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -96.83 21.8 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 74.439999999999998 110.586 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 t -54.73 -46.04 74.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.576 -0.738 . . . . 74.430000000000007 112.069 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.29 18.29 36.12 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.239 -0.981 . . . . 61.409999999999997 113.643 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -77.41 144.07 38.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.063 0.432 . . . . 74.150000000000006 110.669 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.531 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 23.5 pt-20 -139.85 162.7 34.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.432 . . . . 71.099999999999994 110.666 176.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.33 127.48 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.869 -0.605 . . . . 74.349999999999994 110.133 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 mt -90.99 -45.82 8.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.245 0.545 . . . . 75.040000000000006 110.096 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 m -137.0 140.43 42.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 75.209999999999994 110.283 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -149.55 142.42 24.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 72.030000000000001 110.071 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 m -81.8 -51.95 7.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 71.230000000000004 111.256 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -142.17 151.51 42.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.409 . . . . 74.400000000000006 110.8 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.519 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 9.6 pt20 -163.34 137.11 5.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.448 -0.796 . . . . 74.430000000000007 108.972 174.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.603 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.8 tp10 -89.48 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.208 0.528 . . . . 73.439999999999998 110.875 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.68 -8.59 22.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.53 -0.759 . . . . 70.219999999999999 111.097 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -106.52 -52.64 2.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 74.030000000000001 110.81 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -65.15 -54.93 24.4 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 116.074 -0.512 . . . . 65.340000000000003 112.55 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 59.9 mm-40 -76.66 -38.65 54.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.823 0.344 . . . . 73.239999999999995 110.556 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.44 -165.79 13.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.869 -0.682 . . . . 73.409999999999997 112.333 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.08 133.69 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.685 0.279 . . . . 63.439999999999998 110.538 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.59 2.87 78.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.907 -0.663 . . . . 64.340000000000003 112.832 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -153.35 139.18 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.078 -0.342 . . . . 63.140000000000001 110.078 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.6 -1.98 79.68 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.606 -0.598 . . . . 73.540000000000006 111.606 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 60.4 mt -84.32 155.84 22.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.192 -0.299 . . . . 73.109999999999999 110.192 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.81 -28.34 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.21 0.529 . . . . 71.25 111.098 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -79.58 -14.28 58.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.549 . . . . 75.420000000000002 111.545 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 71.1 m -73.11 -19.29 61.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.063 0.459 . . . . 74.140000000000001 109.822 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.5 tp -68.62 -13.05 62.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.482 -0.781 . . . . 73.299999999999997 110.7 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.625 HG22 HD13 ' A' ' 59' ' ' ILE . 34.6 pt -137.59 21.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.803 -0.635 . . . . 74.200000000000003 110.306 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.681 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 12.3 t70 -67.76 -41.58 83.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 73.420000000000002 110.793 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.26 -2.26 11.47 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.869 -0.892 . . . . 61.200000000000003 110.869 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -125.04 115.08 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 75.239999999999995 109.951 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -75.93 2.61 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.929 -0.578 . . . . 73.040000000000006 112.482 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.34 -27.62 21.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.955 0.407 . . . . 65.299999999999997 110.049 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -89.07 137.42 32.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.017 -0.735 . . . . 73.140000000000001 109.017 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.647 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 41.8 p90 -130.11 173.2 10.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.057 0.456 . . . . 70.109999999999999 111.431 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.58 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.7 t90 -107.4 128.6 54.62 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 71.209999999999994 108.793 172.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -129.67 132.9 46.81 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.467 -0.568 . . . . 72.430000000000007 109.467 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.69 136.25 58.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.974 -0.75 . . . . 61.240000000000002 108.974 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.3 132.96 55.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.174 0.296 . . . . 75.129999999999995 110.385 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -124.09 -22.1 4.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 111.149 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -69.47 108.18 3.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.197 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.96 11.91 72.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 73.319999999999993 112.055 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.16 176.14 18.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 72.319999999999993 111.972 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -123.76 149.28 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.925 0.393 . . . . 73.120000000000005 110.856 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 2.6 t70 -75.66 142.93 74.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.974 -0.557 . . . . 75.299999999999997 109.712 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 30.8 Cg_endo -63.59 146.1 92.3 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.566 2.177 . . . . 73.140000000000001 113.193 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.559 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 9.7 mt -77.58 163.53 63.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.661 -0.7 . . . . 74.400000000000006 110.034 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.692 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.8 Cg_endo -81.28 163.95 77.96 Favored 'Cis proline' 0 N--CA 1.461 -0.401 0 C-N-CA 124.101 -1.208 . . . . 65.329999999999998 112.92 1.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.3 m-85 -99.28 122.86 43.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.82 -0.627 . . . . 71.519999999999996 110.318 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 9.9 t0 -110.22 126.67 54.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.695 . . . . 75.530000000000001 109.817 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.7 mt -130.25 108.92 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.769 0.319 . . . . 73.310000000000002 110.372 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.84 118.46 47.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.023 -0.535 . . . . 71.519999999999996 110.566 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.625 HD13 HG22 ' A' ' 34' ' ' ILE . 82.8 mt -117.35 134.08 62.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.122 -0.49 . . . . 73.109999999999999 111.124 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -100.66 122.7 43.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.521 -0.548 . . . . 75.5 109.521 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.413 ' SD ' HD13 ' A' ' 65' ' ' ILE . 71.3 mtm -88.21 -6.21 57.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 64.209999999999994 110.766 -177.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.531 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.5 mmtt 67.26 11.53 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.752 -0.658 . . . . 70.450000000000003 112.197 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -163.46 159.84 22.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.228 -0.286 . . . . 74.219999999999999 110.228 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 58.7 m-80 -81.5 130.45 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.615 -0.513 . . . . 74.030000000000001 109.615 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.502 ' CD1' HG22 ' A' ' 5' ' ' ILE . 65.4 mt -135.55 136.01 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.078 0.466 . . . . 72.439999999999998 110.422 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -82.34 99.91 9.65 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 73.409999999999997 108.635 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 118' ' ' SER . 34.5 mm -69.79 113.55 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.091 -0.504 . . . . 75.349999999999994 110.174 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 -32.6 7.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.896 0.379 . . . . 65.140000000000001 111.161 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.673 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 7.0 tt0 -154.2 147.42 24.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.283 -0.417 . . . . 73.049999999999997 110.78 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.87 134.15 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.111 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.782 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 44.3 mt-10 -115.56 138.63 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.162 0.506 . . . . 74.329999999999998 110.927 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.408 HD12 ' HE2' ' A' ' 114' ' ' TYR . 92.7 mt -124.28 118.71 27.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.739 -0.664 . . . . 75.420000000000002 109.755 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -103.33 99.75 15.9 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 109.094 -0.706 . . . . 75.340000000000003 109.094 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.62 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 55.5 Cg_endo -69.88 -170.55 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.526 . . . . 75.109999999999999 112.656 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -67.35 -29.82 69.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.761 -0.376 . . . . 75.510000000000005 110.716 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.48 -73.47 2.64 Favored Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 120.823 -0.703 . . . . 53.0 112.366 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -132.04 -176.38 4.05 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.381 0.61 . . . . 75.129999999999995 110.845 -176.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.48 -52.98 1.16 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.052 -0.976 . . . . 53.509999999999998 112.336 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.1 m -143.27 160.88 39.67 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.102 -0.333 . . . . 53.229999999999997 110.102 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.58 140.79 48.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.585 -0.524 . . . . 65.019999999999996 109.585 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -127.45 92.2 43.93 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.026 -0.534 . . . . 72.349999999999994 109.732 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.49 46.07 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.945 3.096 . . . . 74.319999999999993 113.906 -170.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.4 111.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.171 -0.677 . . . . 75.150000000000006 109.171 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.02 -48.05 8.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 72.329999999999998 110.91 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.689 HG11 ' HE ' ' A' ' 102' ' ' ARG . 12.0 t -130.95 143.15 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 74.510000000000005 110.713 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.88 142.01 45.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.144 -0.48 . . . . 74.400000000000006 110.238 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -112.68 130.18 56.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.983 -0.553 . . . . 75.25 110.497 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.81 129.1 55.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 73.519999999999996 110.312 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.33 148.55 52.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.316 -0.402 . . . . 65.109999999999999 110.476 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.36 153.63 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.42 -0.354 . . . . 71.25 110.479 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 t -145.39 142.38 29.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 70.450000000000003 110.136 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.689 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -77.32 -45.66 25.46 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.925 -0.58 . . . . 73.230000000000004 111.279 -176.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.61 23.85 5.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.372 -0.376 . . . . 71.519999999999996 111.048 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.1 t30 65.63 29.55 10.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.93 0.871 . . . . 73.510000000000005 110.089 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.17 -64.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.34 -0.845 . . . . 71.519999999999996 109.741 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -96.41 105.1 17.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 64.200000000000003 110.792 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -89.33 114.63 26.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.291 -0.413 . . . . 71.319999999999993 110.148 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 60.8 m -117.38 130.4 24.68 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.955 -0.566 . . . . 72.319999999999993 110.87 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 8.1 Cg_exo -70.88 106.99 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.865 2.376 . . . . 61.520000000000003 111.336 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.583 HD13 HG22 ' A' ' 116' ' ' VAL . 11.8 pt -76.04 -11.1 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.777 -0.647 . . . . 72.430000000000007 111.057 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.77 149.0 5.8 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.339 -0.934 . . . . 65.310000000000002 113.101 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.689 ' HE ' HG11 ' A' ' 85' ' ' VAL . 78.1 ttt180 -124.21 118.4 26.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.705 -0.85 . . . . 75.439999999999998 108.705 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' HE2' HG11 ' A' ' 116' ' ' VAL . 96.0 m-85 -133.32 163.17 29.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.897 0.38 . . . . 73.430000000000007 111.364 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.65 141.4 25.5 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.663 -0.699 . . . . 75.310000000000002 111.595 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.62 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 48.0 t80 -100.54 138.38 37.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.954 0.407 . . . . 71.109999999999999 110.368 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.487 ' O ' HD13 ' A' ' 112' ' ' LEU . 32.6 m -131.3 112.73 13.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 73.219999999999999 110.184 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.66 103.07 2.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.291 0.567 . . . . 74.519999999999996 110.942 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -130.83 -174.34 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.317 -0.856 . . . . 73.109999999999999 109.425 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -90.56 -15.38 30.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.78 0.324 . . . . 72.430000000000007 110.98 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 150.77 22.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.344 -0.389 . . . . 64.530000000000001 110.839 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.06 127.51 32.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.115 0.483 . . . . 74.019999999999996 111.125 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -79.63 105.34 10.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.657 -0.701 . . . . 72.340000000000003 110.349 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.782 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 42.6 mt-10 -88.64 111.71 22.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.181 0.515 . . . . 74.329999999999998 111.187 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . 0.408 ' HE2' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -108.57 111.46 23.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.652 -0.703 . . . . 73.140000000000001 110.35 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -74.25 102.59 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.686 . . . . 72.319999999999993 109.636 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.583 HG22 HD13 ' A' ' 100' ' ' ILE . 31.5 m -102.08 -179.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 73.420000000000002 111.583 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -72.28 125.21 26.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.562 -0.745 . . . . 74.340000000000003 110.07 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.739 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 32.5 p -70.2 127.18 31.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.951 -0.568 . . . . 74.439999999999998 111.295 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.89 148.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.29 -0.414 . . . . 72.299999999999997 110.329 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.522 ' HG2' HD11 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -85.52 116.28 23.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 71.430000000000007 109.526 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . . . -141.81 156.43 45.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.959 -0.564 . . . . 73.439999999999998 110.828 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.92 -26.99 8.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.505 0.669 . . . . 74.239999999999995 109.388 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -111.4 145.4 38.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.459 -0.792 . . . . 75.0 109.319 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.5 tt -133.08 139.63 49.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.693 -0.484 . . . . 73.120000000000005 109.693 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.6 ttp180 -125.02 123.43 39.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.055 0.455 . . . . 74.329999999999998 111.126 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.428 HD22 HD11 ' A' ' 57' ' ' ILE . 41.3 tp -91.02 115.55 28.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.411 -0.813 . . . . 74.329999999999998 108.92 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.7 m -109.63 116.17 31.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.949 0.404 . . . . 55.43 110.865 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.647 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 40.2 mm -100.75 97.54 6.91 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.784 -0.821 . . . . 71.430000000000007 108.784 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.692 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 52.2 Cg_endo -69.96 170.28 17.19 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.432 2.088 . . . . 74.129999999999995 112.611 -176.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.98 -16.42 26.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.974 0.893 . . . . 74.340000000000003 108.754 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.55 148.03 22.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.285 -1.325 . . . . 71.409999999999997 110.895 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.97 -12.96 49.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.949 -0.86 . . . . 52.329999999999998 110.949 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.76 24.83 7.53 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.093 -0.575 . . . . 72.299999999999997 111.689 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -75.61 127.58 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 74.430000000000007 110.748 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.2 m -95.88 164.43 12.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 109.996 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 17.4 p -68.98 -6.18 26.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.26 0.467 . . . . 72.439999999999998 112.26 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 42.3 t -85.04 95.58 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.828 -0.434 . . . . 74.310000000000002 109.828 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.61 121.95 36.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.106 -0.497 . . . . 65.049999999999997 110.503 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.25 108.75 6.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 74.409999999999997 111.097 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 21.0 mt -121.96 132.65 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.592 -0.892 . . . . 71.420000000000002 108.592 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 77.1 mtt-85 -69.96 -70.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.936 -0.305 . . . . 75.230000000000004 110.613 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -148.07 141.14 24.94 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.157 -0.617 . . . . 62.109999999999999 111.322 -177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 143' ' ' LEU . 7.9 tt -100.27 132.0 45.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.154 -0.93 . . . . 74.540000000000006 109.229 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.21 155.94 41.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.961 0.41 . . . . 74.329999999999998 110.387 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.6 t -126.74 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.127 -0.488 . . . . 64.209999999999994 110.542 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.593 ' HD2' ' NE2' ' A' ' 69' ' ' GLN . 46.3 mttp -104.69 115.45 30.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.191 -0.67 . . . . 74.329999999999998 109.191 171.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.02 -169.14 24.95 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.762 -0.733 . . . . 75.439999999999998 112.096 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.1 m -113.32 130.73 56.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.425 -0.213 . . . . 70.5 110.425 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.47 HD12 HG23 ' A' ' 5' ' ' ILE . 34.3 mm -76.11 120.63 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.063 0.459 . . . . 75.510000000000005 110.966 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.522 HD11 ' HG2' ' A' ' 120' ' ' LYS . 37.0 mt -112.71 132.95 60.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.698 -0.683 . . . . 72.430000000000007 109.456 176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.549 ' N ' HD21 ' A' ' 151' ' ' ASN . 0.0 OUTLIER -140.8 78.71 1.66 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.793 0.806 . . . . 75.510000000000005 110.655 -175.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.7 mt -79.49 80.18 5.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 75.519999999999996 109.341 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.97 147.11 47.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.443 -0.799 . . . . 75.510000000000005 111.003 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -122.95 -170.78 2.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.522 -0.763 . . . . 70.219999999999999 109.045 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -79.43 92.68 5.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.13 -0.693 . . . . 74.409999999999997 109.13 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -81.14 76.25 8.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.539 -0.755 . . . . 62.539999999999999 111.172 -171.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -131.36 131.13 43.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.51 -0.768 . . . . 74.519999999999996 108.994 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -79.46 -35.85 39.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.777 0.323 . . . . 73.409999999999997 111.041 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.407 -0.36 . . . . 74.010000000000005 110.54 176.019 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.524 HG22 ' HE2' ' A' ' 146' ' ' LYS . 19.2 p . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.347 -0.612 . . . . 74.03 109.347 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 145' ' ' VAL . 40.1 mm -67.16 129.17 31.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.446 -0.343 . . . . 75.12 110.388 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.8 m -63.11 116.47 5.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.356 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -86.61 15.7 5.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 70.05 110.907 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -62.54 -35.23 78.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.774 -0.648 . . . . 73.02 111.848 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.36 15.9 38.55 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.551 -0.833 . . . . 33.45 113.106 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.412 ' HB3' HD12 ' A' ' 34' ' ' ILE . 30.2 m0 -84.06 141.99 30.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.933 0.366 . . . . 72.11 110.842 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.7 pt-20 -136.73 157.36 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.966 0.412 . . . . 54.5 110.373 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.24 122.44 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.747 -0.661 . . . . 73.13 109.94 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 60' ' ' ASP . 71.4 mt -84.75 -39.95 17.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.056 0.455 . . . . 63.45 110.572 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -154.59 142.06 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 61.1 110.091 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.509 ' CE2' ' HG2' ' A' ' 18' ' ' GLN . 32.5 p90 -139.97 145.58 38.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.691 -0.686 . . . . 74.24 109.38 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 m -88.24 -33.88 17.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.86 0.362 . . . . 71.32 111.282 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 t -148.88 151.15 34.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.908 0.385 . . . . 74.22 111.158 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.509 ' HG2' ' CE2' ' A' ' 15' ' ' PHE . 1.5 pp0? -167.81 142.71 3.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.894 -0.78 . . . . 73.01 108.894 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 9.4 tp10 -109.82 94.2 4.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.138 0.494 . . . . 53.51 110.776 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.58 8.01 41.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 62.31 111.048 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -120.01 -46.33 2.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.116 0.484 . . . . 75.32 110.26 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.455 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.209 0 CA-C-N 115.963 -0.562 . . . . 53.24 112.647 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.6 t30 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.233 -0.654 . . . . 43.12 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.05 6.6 88.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.993 -0.622 . . . . 62.54 112.175 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.8 mt -80.15 148.59 30.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 72.31 110.565 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.31 -25.71 65.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 73.33 111.191 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -76.39 -23.21 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.796 -0.362 . . . . 74.01 111.254 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 71.1 m -63.08 -27.73 69.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.03 0.443 . . . . 73.23 110.234 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.27 -30.92 70.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 70.02 110.469 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 HG12 ' A' ' 59' ' ' ILE . 46.9 pt -115.23 13.1 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 74.05 111.054 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.4 t70 -77.32 -33.02 55.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 74.0 109.226 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' OE1' ' A' ' 142' ' ' GLU . . . 84.2 55.1 2.83 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.519 -0.764 . . . . 61.12 112.623 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.51 129.62 16.51 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.815 -0.439 . . . . 74.01 109.815 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.598 HG22 HD21 ' A' ' 73' ' ' LEU . 11.1 p -70.21 -19.79 63.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.38 0.511 . . . . 70.33 112.38 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.52 -13.29 40.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.733 0.301 . . . . 73.21 110.893 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -105.36 151.72 23.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.789 -0.448 . . . . 70.42 109.789 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -151.93 162.37 41.18 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.575 -0.45 . . . . 75.0 111.04 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.6 t90 -98.79 137.59 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 74.43 109.271 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.3 t-80 -131.67 139.16 49.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.588 -0.523 . . . . 75.05 109.588 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 151.5 46.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 61.11 109.973 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -61.87 129.32 40.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.318 -0.253 . . . . 73.24 110.318 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -134.71 -32.99 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.073 -0.251 . . . . 72.42 111.068 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.455 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 34.2 tt0 -81.27 102.6 10.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.727 -0.471 . . . . 73.5 109.727 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.62 -11.64 53.72 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.921 -0.657 . . . . 72.21 111.54 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.45 149.42 7.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.733 -0.746 . . . . 74.43 112.291 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.5 m -86.16 173.44 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 65.31 111.3 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 24.1 m-20 -98.2 166.51 13.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.966 -0.561 . . . . 63.53 109.787 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 56.9 Cg_endo -71.92 122.76 8.76 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.1 1.867 . . . . 62.3 112.973 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 16.8 mt -67.96 154.49 93.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 75.42 110.139 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 86.6 Cg_endo -81.17 167.21 72.63 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.669 -1.388 . . . . 74.35 113.019 1.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.0 m-85 -104.99 119.43 38.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 64.33 110.491 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.19 125.51 54.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.911 0.386 . . . . 54.44 110.705 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.4 mt -118.62 117.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.446 . . . . 72.03 110.049 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 ' HG3' ' A' ' 125' ' ' ARG . 54.7 t -106.23 122.34 59.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.936 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.701 HG12 HG21 ' A' ' 34' ' ' ILE . 4.6 mp -112.38 139.39 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 75.22 110.609 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.521 ' HB2' HD11 ' A' ' 13' ' ' LEU . 58.0 t0 -103.26 121.19 42.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.333 -0.618 . . . . 73.14 109.333 174.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.1 mtm -88.34 -3.14 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.284 -0.416 . . . . 73.33 110.725 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 65.57 13.44 8.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.712 -0.676 . . . . 63.45 111.991 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' OE1' HD12 ' A' ' 149' ' ' ILE . 4.8 pt20 -165.35 153.8 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.359 -0.608 . . . . 61.45 109.359 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -82.7 123.81 29.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.942 -0.392 . . . . 74.53 109.942 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.4 mt -126.44 139.14 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.167 -0.47 . . . . 74.54 110.374 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -82.1 101.46 10.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.734 -0.839 . . . . 73.23 108.734 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.7 mm -70.55 134.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 61.03 110.811 -174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 -42.57 1.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.067 -0.515 . . . . 71.02 110.699 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.625 ' HG2' ' HD3' ' A' ' 146' ' ' LYS . 11.8 tt0 -147.95 138.73 23.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 72.14 111.444 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.9 143.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.028 -0.73 . . . . 70.33 109.028 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.878 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 17.8 tt0 -120.75 133.72 55.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.175 -0.306 . . . . 75.42 110.175 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 48.1 mt -117.26 121.45 41.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.311 -0.625 . . . . 61.45 109.311 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD21 HG22 ' A' ' 38' ' ' THR . 34.5 tp -102.4 101.27 18.82 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.829 -0.434 . . . . 65.11 109.829 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.6 Cg_endo . . . . . 0 N--CA 1.45 -1.062 0 C-N-CA 122.89 2.393 . . . . 52.13 111.397 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 112.289 0.477 . . . . 73.22 112.289 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.27 40.48 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.949 2.433 . . . . 74.11 112.099 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -94.55 122.1 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 71.44 109.824 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -99.89 -50.35 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 64.24 110.938 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 41.7 t -132.85 139.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 71.54 110.923 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.29 140.14 49.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.268 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 46.9 mt-10 -120.12 130.45 54.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.785 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.82 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.123 -0.49 . . . . 63.42 110.546 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.47 150.54 49.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.158 -0.474 . . . . 33.55 110.363 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CB ' ' A' ' 121' ' ' ALA . . . -138.73 155.74 47.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.367 -0.379 . . . . 74.13 110.088 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.1 t -149.3 147.42 28.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.072 0.463 . . . . 71.45 111.743 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.05 -28.21 17.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 70.35 110.601 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 11.8 p-10 -123.38 4.09 9.09 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.891 0.33 . . . . 74.13 111.891 -173.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.4 t-20 77.24 -20.83 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.522 0.729 . . . . 71.45 111.265 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.1 -54.27 8.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.024 0.44 . . . . 74.13 110.351 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -90.14 103.82 16.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.882 -0.599 . . . . 74.15 110.911 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -94.53 137.16 34.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.178 0.513 . . . . 74.33 110.573 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -122.01 125.12 26.75 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.668 -0.696 . . . . 71.15 109.938 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.7 108.63 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.608 2.205 . . . . 33.44 111.283 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 116' ' ' VAL . 18.2 pt -81.28 -13.46 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.0 -0.546 . . . . 41.31 111.163 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.46 135.18 1.85 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.326 -0.94 . . . . 61.4 112.792 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 60.8 ttt180 -111.69 121.29 44.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.486 -0.561 . . . . 72.15 109.486 172.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -140.0 165.9 26.09 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.768 -0.373 . . . . 72.44 111.01 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -81.39 147.74 27.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.002 -0.618 . . . . 50.32 111.678 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.58 123.32 40.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.932 -0.396 . . . . 74.35 109.932 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.658 ' HB ' HD21 ' A' ' 112' ' ' LEU . 10.3 m -102.13 106.78 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.246 -0.434 . . . . 55.35 110.302 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -65.69 110.29 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 71.34 110.429 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -152.38 177.98 10.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 74.24 109.752 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.9 -9.56 36.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.251 0.548 . . . . 74.05 110.356 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.51 157.65 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 61.23 110.641 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -70.26 144.47 51.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.045 0.45 . . . . 71.1 111.703 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' A' ' 106' ' ' THR . 20.4 mt -99.55 113.85 26.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.525 -0.761 . . . . 70.13 110.146 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 50.4 mt-10 -85.15 115.78 23.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.848 0.356 . . . . 72.43 110.593 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.55 105.36 14.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.779 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -75.86 118.55 18.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.959 -0.756 . . . . 70.14 108.959 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 100' ' ' ILE . 29.4 m -120.67 -172.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.324 0.491 . . . . 71.41 112.324 -171.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -66.53 125.89 27.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.16 -0.927 . . . . 73.52 110.719 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.7 m -74.87 108.06 7.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.035 0.445 . . . . 75.25 110.217 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.74 152.2 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.964 -0.562 . . . . 74.41 109.943 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.6 ' HG3' HD12 ' A' ' 150' ' ' ILE . 1.1 ttmp? -73.36 138.91 45.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.554 -0.536 . . . . 75.03 109.554 175.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . . . -156.27 134.43 11.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.51 -0.313 . . . . 71.34 110.88 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -95.57 -29.82 14.14 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.799 -0.815 . . . . 74.21 108.799 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.9 145.08 41.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.1 -0.954 . . . . 75.11 109.499 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.71 137.18 51.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.657 -0.497 . . . . 74.45 109.657 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.924 ' HG3' HG22 ' A' ' 58' ' ' VAL . 4.4 ttm180 -122.13 130.21 53.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 75.1 111.159 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.2 tp -97.48 118.16 33.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 74.53 109.016 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.6 m -109.97 122.83 48.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.5 . . . . 74.51 111.1 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.1 mm -101.46 94.0 3.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 75.13 108.714 173.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 59.0 Cg_endo -71.48 151.67 59.41 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.86 2.373 . . . . 60.24 113.308 -173.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 12.6 p-10 -89.72 4.79 48.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.589 0.709 . . . . 71.11 109.535 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.16 -34.39 15.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.075 -0.966 . . . . 72.21 111.39 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.18 -3.45 76.0 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.616 -0.802 . . . . 54.12 113.529 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.07 8.18 45.26 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.488 -0.863 . . . . 42.21 111.335 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -69.05 133.73 48.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.309 -0.446 . . . . 74.3 111.608 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 m -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.965 -0.561 . . . . 73.05 109.728 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 38.5 p -84.4 16.27 3.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.971 0.415 . . . . 73.24 111.36 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.83 119.48 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.546 -0.538 . . . . 75.34 109.546 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -144.27 130.91 20.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.59 -0.277 . . . . 73.4 110.613 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -136.64 105.61 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.051 0.453 . . . . 52.15 110.884 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.63 133.14 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.838 -0.43 . . . . 72.21 109.838 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.27 -62.54 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.223 0.327 . . . . 75.12 110.724 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 36' ' ' GLY . 15.1 pt-20 -154.13 161.32 41.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.457 0.646 . . . . 72.32 111.59 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -119.43 135.94 54.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.832 -1.076 . . . . 75.42 108.19 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.463 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.8 t70 -129.23 161.6 29.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.016 -0.364 . . . . 73.42 110.016 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' ILE . 45.4 t -135.35 133.56 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.403 . . . . 73.32 110.267 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.878 ' HE3' ' HB2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -108.86 125.6 52.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.848 -0.797 . . . . 74.45 108.848 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.21 -168.25 30.96 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.407 -0.902 . . . . 42.01 112.449 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.7 m -112.35 132.29 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.465 -0.198 . . . . 74.31 110.465 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 63' ' ' GLN . 40.3 mm -73.36 123.58 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 70.23 110.757 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.6 HD12 ' HG3' ' A' ' 120' ' ' LYS . 48.0 mt . . . . . 0 C--N 1.326 -0.451 0 N-CA-C 109.558 -0.534 . . . . 71.23 109.558 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.831 0.348 . . . . 71.14 110.539 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 149' ' ' ILE . 30.0 mm -94.69 132.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.249 -0.432 . . . . 52.1 110.467 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -70.77 123.43 21.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.592 -0.522 . . . . 74.03 109.592 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -98.59 16.41 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 62.03 111.468 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -77.44 -5.15 48.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.911 0.386 . . . . 72.01 111.497 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.89 -0.09 24.28 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.652 -0.785 . . . . 34.42 112.357 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -82.86 153.9 24.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.645 0.26 . . . . 73.44 110.654 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.02 155.4 48.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.93 0.395 . . . . 74.41 110.663 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.33 119.7 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.516 -0.766 . . . . 75.01 109.948 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 60' ' ' ASP . 84.9 mt -84.18 -42.04 16.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.942 -0.572 . . . . 74.41 110.53 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.8 t -149.21 143.73 26.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 71.31 110.131 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -148.88 149.52 31.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 70.3 109.687 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 m -92.57 -44.3 8.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.844 0.313 . . . . 74.22 111.844 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -138.49 149.48 45.45 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.73 -0.388 . . . . 63.35 111.137 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -161.93 142.86 10.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.799 -0.637 . . . . 75.32 109.441 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 tp10 -115.84 93.6 4.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.295 -0.412 . . . . 75.32 110.541 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.91 -14.31 26.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 40.31 111.204 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -98.81 -51.84 3.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.406 -0.361 . . . . 75.21 111.308 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 121.065 -0.588 . . . . 73.04 113.38 -175.827 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 110.446 -0.205 . . . . 65.32 110.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.7 -7.78 63.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.242 -0.504 . . . . 75.24 112.638 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.8 mt -73.67 142.95 46.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.741 0.305 . . . . 75.23 110.768 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.41 -27.21 68.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 50.11 111.309 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -19.35 61.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 75.13 110.562 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 1.079 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 69.5 m -72.84 -18.42 61.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 73.22 111.032 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 126' ' ' LEU . 32.6 tp -64.88 -24.32 67.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.546 0.689 . . . . 72.3 109.925 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.401 HG21 HG12 ' A' ' 59' ' ' ILE . 35.8 pt -122.6 19.65 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.339 -0.846 . . . . 70.13 109.775 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 1.079 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 22.0 t70 -64.68 -41.57 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.325 -0.852 . . . . 65.4 111.458 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 38.19 5.25 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.471 -0.871 . . . . 71.41 112.077 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -151.28 128.8 11.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.194 -0.298 . . . . 63.04 110.194 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.4 p -75.58 -2.9 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.142 0.423 . . . . 62.22 112.142 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.37 -22.34 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.109 -0.236 . . . . 74.42 110.95 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p -88.55 165.69 14.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.875 -0.417 . . . . 63.34 109.875 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 31.8 p90 -164.97 165.82 19.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.421 . . . . 74.22 111.442 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 36.3 t90 -106.4 141.92 36.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.198 -0.91 . . . . 72.12 109.018 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.4 t-80 -139.62 143.21 37.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.509 -0.552 . . . . 61.35 109.509 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 136.65 50.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.583 -0.525 . . . . 62.33 109.583 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.687 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 3.5 ttpm? -62.87 122.04 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.578 0.228 . . . . 71.42 110.396 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -117.34 -29.13 5.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.524 -0.307 . . . . 75.14 110.686 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.9 110.98 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 73.24 110.251 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.31 -5.95 65.62 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.898 -0.668 . . . . 51.23 111.982 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.84 143.17 5.51 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 45.23 112.459 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.612 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 19.0 m -93.71 144.7 25.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.813 0.34 . . . . 72.01 110.761 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.9 m-20 -76.76 148.02 78.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.083 -0.508 . . . . 51.3 109.965 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 9.6 Cg_exo -72.39 144.25 40.57 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.695 2.263 . . . . 73.24 112.81 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 161.88 77.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 61.25 110.342 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.1 Cg_exo -79.77 168.96 71.96 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.082 -1.216 . . . . 74.32 112.577 -1.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.754 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 25.2 m-85 -107.92 128.74 54.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.688 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.8 133.14 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 64.41 110.172 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 51.0 mt -132.17 111.43 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.868 -0.419 . . . . 65.35 109.868 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 ' HH2' ' A' ' 97' ' ' TRP . 57.8 t -106.42 121.38 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 74.44 111.096 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 34' ' ' ILE . 5.1 mp -116.1 136.19 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.33 . . . . 73.12 110.837 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.0 t0 -96.45 117.5 31.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.149 -0.685 . . . . 73.45 109.149 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.75 -3.28 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.517 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.1 mmtp 73.05 -13.9 0.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.625 0.77 . . . . 73.3 112.401 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -147.53 177.14 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.9 0.381 . . . . 72.34 110.953 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 121.51 30.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.609 . . . . 51.42 110.209 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 5' ' ' ILE . 67.7 mt -129.18 134.81 63.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.891 0.377 . . . . 75.24 110.259 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -81.77 105.76 13.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.194 -0.669 . . . . 61.22 109.194 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 118' ' ' SER . 10.2 mm -80.18 117.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.231 -0.285 . . . . 62.44 110.231 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.19 -41.92 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 61.43 110.665 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -144.59 138.84 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.004 -0.544 . . . . 71.04 110.865 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -110.2 133.94 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.387 -0.598 . . . . 72.42 109.387 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 52.8 mt-10 -114.42 127.93 56.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.033 0.444 . . . . 62.24 110.834 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.0 mt -109.35 125.95 52.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.876 -0.602 . . . . 73.05 109.709 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -112.27 96.44 35.23 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.164 -0.68 . . . . 65.04 109.164 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 56.6 Cg_endo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.443 2.095 . . . . 72.52 111.589 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.457 HD21 HD12 ' A' ' 83' ' ' ILE . 21.8 t-20 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 64.31 110.823 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 71.6 Cg_endo -92.55 19.47 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.127 2.551 . . . . 41.54 112.813 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.457 HD12 HD21 ' A' ' 81' ' ' ASN . 58.7 mt -79.59 129.89 36.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 53.14 109.772 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.93 -38.05 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.856 -0.611 . . . . 73.11 110.419 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.97 137.96 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 75.31 111.206 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.38 141.66 45.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.142 -0.481 . . . . 72.24 110.507 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -118.32 132.79 56.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 63.21 109.937 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.71 133.34 55.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.441 -0.345 . . . . 75.35 110.466 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.98 146.76 50.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.788 0.328 . . . . 74.23 111.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.39 146.41 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 75.41 110.162 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.4 t -140.17 157.46 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.226 0.536 . . . . 62.33 111.516 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.8 mt-10 -116.14 -32.23 5.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 74.33 110.668 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -114.82 5.13 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 74.31 112.161 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 71.92 -1.91 2.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.119 0.568 . . . . 62.53 111.752 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 -51.69 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 52.0 110.195 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -89.94 112.72 24.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.796 -0.638 . . . . 72.52 110.538 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.428 ' HH2' HG13 ' A' ' 58' ' ' VAL . 97.9 m95 -104.81 108.04 19.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.07 -0.514 . . . . 73.3 109.935 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 80.7 m -89.28 120.05 69.73 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.287 -0.415 . . . . 71.02 110.314 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 42.2 Cg_endo -66.82 110.9 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.396 2.064 . . . . 74.43 110.83 174.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -86.38 -10.12 11.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.124 -0.489 . . . . 70.23 110.81 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.91 128.7 0.98 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.083 -1.056 . . . . 64.54 113.322 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.27 117.2 33.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.387 -0.968 . . . . 64.25 108.387 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.58 175.28 9.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.124 0.488 . . . . 74.41 111.47 -171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.79 15.79 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.35 -0.841 . . . . 71.45 111.745 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.589 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 51.4 t80 -97.01 148.01 23.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 73.04 110.106 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -142.71 112.06 6.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.398 -0.364 . . . . 72.03 110.444 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -72.54 114.42 10.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.071 0.462 . . . . 74.22 110.556 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 74' ' ' PRO . 13.2 pt20 -154.07 179.8 8.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.622 -0.717 . . . . 73.44 109.43 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.88 -5.39 51.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 75.04 110.283 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.97 36.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 44.32 110.208 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.65 140.33 58.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.045 0.45 . . . . 72.43 110.886 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 32.8 mt -94.81 104.75 16.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.719 -0.673 . . . . 71.4 110.248 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -79.97 109.04 14.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.004 0.431 . . . . 73.32 110.752 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.12 104.59 14.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.069 -0.514 . . . . 64.25 110.404 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -70.86 106.75 3.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.994 -0.743 . . . . 75.45 108.994 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 27.4 m -106.08 174.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.903 0.382 . . . . 71.44 111.445 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HD3' ' HB ' ' A' ' 119' ' ' ILE . 7.5 tmtm? -64.04 122.51 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 75.14 110.086 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 25.1 m -66.53 114.82 5.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.93 -0.577 . . . . 72.23 109.92 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.444 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 12.8 tt -144.19 145.07 22.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.861 0.363 . . . . 70.5 110.958 -174.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.536 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -94.29 115.21 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.97 -0.752 . . . . 54.3 108.97 175.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.522 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.3 175.22 10.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 34.14 111.303 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -118.39 -34.19 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 72.31 110.362 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -107.52 146.21 32.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.932 -0.577 . . . . 75.1 110.25 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.16 137.91 53.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.945 -0.571 . . . . 72.22 109.827 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 28.3 ttp180 -123.52 122.54 38.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.499 -0.319 . . . . 72.31 110.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 37.2 tp -84.69 113.03 21.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.515 -0.92 . . . . 54.04 108.515 169.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 22.8 m -103.48 118.37 36.58 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.574 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.754 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.3 mm -102.51 96.76 7.78 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.712 -0.847 . . . . 71.33 108.712 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 72.8 Cg_endo -76.44 175.98 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.391 2.061 . . . . 64.34 112.595 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.95 13.25 29.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.729 0.776 . . . . 71.13 109.141 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.93 144.76 25.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.677 -1.147 . . . . 71.31 111.093 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.96 57.86 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.992 -0.623 . . . . 70.4 113.38 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 115.97 22.55 4.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.274 -0.965 . . . . 74.25 112.655 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -68.15 155.01 40.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 72.42 110.821 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.402 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 50.7 m -129.39 -176.89 4.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.02 110.197 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 40.3 p -85.23 22.58 1.44 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 72.41 111.605 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.1 123.55 68.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.574 -0.528 . . . . 71.34 109.574 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.14 138.88 30.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.469 -0.332 . . . . 71.23 110.216 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.75 105.24 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 73.14 111.026 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 42.3 mt -129.45 132.57 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.437 -0.579 . . . . 42.14 109.437 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.579 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 31.6 mmt180 -67.36 -67.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.465 -0.568 . . . . 74.23 109.465 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.45 152.81 47.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 73.35 111.494 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -112.76 116.09 29.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.456 -1.312 . . . . 63.11 107.456 166.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.83 161.39 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.753 -0.462 . . . . 65.44 109.753 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -131.51 125.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.282 -0.417 . . . . 63.24 110.262 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -102.31 105.06 15.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.417 0.627 . . . . 74.23 109.354 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.5 -148.93 4.86 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.181 -0.918 . . . . 63.22 111.524 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.8 m -132.71 129.25 38.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.809 0.337 . . . . 72.23 110.878 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 5' ' ' ILE . 31.6 mm -71.71 119.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.616 . . . . 73.21 110.567 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.536 HD12 ' HG2' ' A' ' 120' ' ' LYS . 46.2 mt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 72.01 109.757 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.904 0.383 . . . . 71.43 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 65' ' ' ILE . 21.2 mm -72.08 137.2 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.969 -0.56 . . . . 74.12 111.337 -172.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -70.87 111.21 6.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.941 -0.572 . . . . 72.35 110.538 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -87.04 3.46 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.72 -0.673 . . . . 51.33 111.803 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -66.88 -26.59 66.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.942 0.401 . . . . 64.34 110.779 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.84 -5.6 68.27 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.557 -0.83 . . . . 75.51 112.082 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -81.81 158.43 24.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.606 0.241 . . . . 71.25 110.643 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 pt-20 -142.37 158.26 43.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.913 0.387 . . . . 63.13 110.199 173.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.22 125.78 45.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 70.45 109.62 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 87.7 mt -94.75 -41.12 9.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.321 -0.399 . . . . 74.3 110.715 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.0 t -142.48 140.92 32.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 73.41 110.613 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.43 136.32 19.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.829 -0.623 . . . . 75.34 109.655 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -87.84 -33.4 18.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 74.51 111.156 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -146.6 146.61 30.49 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.93 0.395 . . . . 74.34 110.955 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -162.01 140.47 9.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 72.45 108.839 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.8 tp10 -109.78 81.84 1.5 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.336 0.589 . . . . 72.13 111.331 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.43 -4.26 53.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.449 -0.796 . . . . 72.15 110.467 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -100.27 -53.54 3.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.74 -0.664 . . . . 65.05 111.092 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 121.3 -0.476 . . . . 75.4 112.412 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.675 -0.491 . . . . 72.24 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 5.87 88.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 62.31 112.832 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.2 mt -77.57 139.38 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.384 -0.228 . . . . 53.15 110.384 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.14 -21.27 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.03 111.529 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -22.28 46.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 73.44 110.901 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.882 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 86.3 m -69.63 -18.29 63.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.058 -0.519 . . . . 61.52 110.642 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.92 -27.46 69.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 75.52 110.176 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 59' ' ' ILE . 34.2 pt -120.32 18.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 64.21 110.208 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.882 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -63.92 -45.75 87.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 73.55 110.222 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.08 24.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.631 -0.795 . . . . 60.21 112.708 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.49 131.73 54.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 74.41 111.134 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.7 p -71.55 -10.26 59.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.713 -0.676 . . . . 73.23 111.079 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.91 -21.67 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.33 111.058 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 17.1 p -89.76 169.77 11.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.091 -0.337 . . . . 74.35 110.091 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.2 p90 -163.62 157.9 19.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 74.12 111.284 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.499 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 34.8 t90 -103.83 142.41 34.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.283 -0.871 . . . . 74.5 108.98 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' GLU . 38.4 t-80 -138.72 144.53 39.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.532 -0.544 . . . . 74.2 109.532 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 144.39 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.027 -0.36 . . . . 45.12 110.027 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HE3' ' O ' ' A' ' 49' ' ' GLY . 29.2 ttpt -72.61 126.47 29.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.487 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -125.15 -24.84 3.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.39 -0.368 . . . . 74.43 110.772 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -71.19 112.56 7.43 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.087 0.47 . . . . 75.24 110.461 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.16 12.99 56.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.957 -0.639 . . . . 73.52 111.763 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.523 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . 107.97 143.02 10.48 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.091 -0.804 . . . . 74.13 111.091 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.4 m -85.78 166.79 15.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.71 0.29 . . . . 75.33 110.72 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 22.7 m-20 -91.13 148.9 38.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.421 -0.354 . . . . 72.12 110.518 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 12.0 Cg_exo -71.23 151.48 60.68 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.053 2.502 . . . . 71.35 112.531 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 15.5 mt -93.85 159.65 34.13 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.634 -0.712 . . . . 70.21 110.391 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.3 Cg_endo -81.73 161.54 79.41 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 123.481 -1.466 . . . . 73.04 112.845 2.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.807 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.1 m-85 -91.13 123.1 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.566 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.744 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 0.7 OUTLIER -109.49 123.36 49.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.447 -0.797 . . . . 74.31 110.361 -178.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 126' ' ' LEU . 61.8 mt -127.77 110.76 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.812 -0.44 . . . . 72.54 109.812 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG13 ' CH2' ' A' ' 97' ' ' TRP . 59.5 t -104.81 122.11 57.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.873 -0.603 . . . . 72.34 110.69 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 34' ' ' ILE . 57.5 mt -119.77 136.31 57.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.02 -0.537 . . . . 71.33 110.591 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.7 t0 -101.73 123.8 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 72.04 110.339 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 67' ' ' ILE . 68.5 mtm -90.52 -3.1 57.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 61.14 110.783 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 71.79 0.2 3.42 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.365 0.666 . . . . 75.44 112.688 173.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -163.81 170.95 16.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.431 -0.211 . . . . 71.34 110.431 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ALA . 43.6 m-20 -79.47 127.16 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 52.31 110.206 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.446 ' CD1' HG21 ' A' ' 5' ' ' ILE . 75.0 mt -133.42 135.46 56.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.753 -0.462 . . . . 74.21 109.753 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 150' ' ' ILE . 51.5 tp60 -80.11 104.09 10.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.009 -0.737 . . . . 64.01 109.009 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.6 mm -74.41 108.12 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.637 -0.256 . . . . 71.11 110.564 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.26 -50.79 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 73.34 110.895 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -142.23 140.08 32.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.025 0.441 . . . . 75.22 111.09 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.0 129.09 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 75.53 109.445 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -111.47 129.43 56.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.068 0.461 . . . . 62.42 110.971 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 114' ' ' TYR . 54.3 mt -116.77 129.36 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.804 -0.634 . . . . 73.23 110.241 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.4 tp -106.92 104.94 53.88 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.285 -0.416 . . . . 51.55 110.231 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.649 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.51 2.806 . . . . 73.03 111.477 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.596 HD21 ' HE2' ' A' ' 105' ' ' PHE . 64.5 t30 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.52 -0.548 . . . . 62.14 109.52 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.51 40.91 1.02 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.191 2.594 . . . . 71.25 113.636 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mt -83.48 130.73 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.879 -0.415 . . . . 60.13 109.879 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -109.99 -56.18 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.87 -0.605 . . . . 61.31 110.578 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 ' HA3' ' A' ' 132' ' ' GLY . 92.6 t -118.83 137.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.549 . . . . 61.14 110.622 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -127.4 134.56 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.615 . . . . 62.23 110.273 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 45.4 mt-10 -115.91 125.87 53.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.223 0.535 . . . . 75.1 110.614 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -104.87 129.45 53.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.807 -0.633 . . . . 72.04 109.967 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.33 151.21 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 72.32 110.779 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.01 150.25 51.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.901 -0.591 . . . . 73.35 109.86 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -149.63 161.11 42.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.101 0.477 . . . . 51.14 111.047 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 32.7 mt-10 -120.29 -7.14 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.0 -0.546 . . . . 72.43 110.603 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -122.14 -9.81 8.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.641 -0.254 . . . . 71.25 111.036 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.58 6.46 5.02 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.907 0.755 . . . . 72.34 110.331 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.4 t -113.84 -50.71 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.686 -0.688 . . . . 62.44 110.301 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -98.4 104.78 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.734 -0.666 . . . . 70.32 109.863 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CH2' HG13 ' A' ' 58' ' ' VAL . 99.0 m95 -91.71 131.14 37.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.053 -0.521 . . . . 72.4 110.529 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 m -110.67 122.82 37.21 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 116.006 -0.543 . . . . 62.5 109.91 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 125.71 15.94 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.427 2.085 . . . . 72.41 111.723 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 HG21 ' A' ' 116' ' ' VAL . 28.7 pt -100.4 -17.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 64.1 110.57 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.65 133.23 1.82 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.891 -1.147 . . . . 65.42 113.025 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 9.9 ttt180 -114.99 114.96 26.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.86 -0.793 . . . . 74.51 108.86 172.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.403 ' HE2' HG12 ' A' ' 116' ' ' VAL . 56.9 m-85 -138.69 -174.25 3.78 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.402 -0.519 . . . . 64.12 111.124 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.61 146.04 16.33 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.944 -0.646 . . . . 51.11 112.043 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.596 ' HE2' HD21 ' A' ' 81' ' ' ASN . 42.8 t80 -99.1 148.69 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 74.41 110.057 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -139.61 127.49 22.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.298 -0.41 . . . . 72.33 110.193 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -80.87 100.3 8.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.185 0.517 . . . . 74.11 110.187 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -140.73 172.98 11.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.716 -0.675 . . . . 72.42 109.996 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.98 -3.92 58.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 75.33 110.603 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.42 34.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.935 -0.575 . . . . 63.21 110.452 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 131.17 45.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.124 0.488 . . . . 54.43 110.708 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.37 114.29 21.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.641 -0.709 . . . . 74.41 110.637 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.41 108.56 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 74.23 110.711 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 72' ' ' LEU . 96.1 m-85 -100.89 104.33 15.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 54.13 110.523 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -74.3 99.78 3.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.611 -0.722 . . . . 73.14 109.28 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 100' ' ' ILE . 26.9 m -100.47 175.22 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 63.22 111.814 -173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.89 113.15 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 72.11 109.295 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.771 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 49.7 m -68.98 118.01 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 64.24 111.258 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -146.7 150.41 14.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 72.33 110.028 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.0 ttpp -83.88 133.12 34.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.904 -0.406 . . . . 70.33 109.904 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -154.64 171.82 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.416 -0.357 . . . . 73.14 110.433 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -114.61 -35.01 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.372 0.606 . . . . 72.33 109.82 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -108.08 145.01 34.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.754 . . . . 71.21 109.902 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -128.87 139.33 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.39 -0.596 . . . . 51.11 109.39 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.744 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 31.5 ttp180 -127.29 124.56 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.103 0.477 . . . . 74.32 111.804 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 57' ' ' ILE . 41.2 tp -87.4 112.34 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.704 -0.851 . . . . 70.51 108.704 171.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -107.59 117.09 33.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.952 0.406 . . . . 71.13 110.81 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.807 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -101.27 95.25 4.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.596 -0.89 . . . . 65.01 108.596 172.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.683 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -74.36 172.87 15.23 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.384 2.056 . . . . 63.13 112.529 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.26 25.9 4.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.889 0.852 . . . . 41.3 109.133 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -113.57 142.83 45.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.432 -1.258 . . . . 44.33 110.096 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' HG23 ' A' ' 85' ' ' VAL . . . 100.29 -18.11 55.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.83 -0.7 . . . . 75.42 113.044 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 112.95 17.09 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.33 -0.938 . . . . 62.24 112.248 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.7 127.73 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 53.23 110.663 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.3 m -93.84 -179.73 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.29 -0.414 . . . . 72.42 110.069 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 2.0 p -81.3 31.49 0.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.07 0.462 . . . . 61.44 111.954 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.28 130.77 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.626 -0.509 . . . . 72.14 109.626 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.28 31.11 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.974 -0.38 . . . . 74.23 109.974 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.6 105.93 4.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.138 0.494 . . . . 60.13 111.521 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.3 mt -129.89 132.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.415 -0.587 . . . . 65.33 109.415 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.649 ' HD3' ' O ' ' A' ' 74' ' ' PRO . 58.6 mtp180 -72.54 -52.16 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.321 -0.152 . . . . 71.2 110.914 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.39 160.46 34.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.723 -0.791 . . . . 61.14 112.097 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -118.91 127.92 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.691 -1.14 . . . . 73.53 108.602 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.19 145.68 47.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.871 -0.418 . . . . 72.44 109.871 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.39 124.39 72.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.047 0.451 . . . . 65.0 110.21 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -103.31 103.67 13.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.814 -0.63 . . . . 74.34 109.341 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.54 -168.23 15.25 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.721 -0.752 . . . . 42.23 112.166 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.5 m -118.2 134.08 55.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.59 0.233 . . . . 62.5 110.708 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.406 HD11 HD12 ' A' ' 5' ' ' ILE . 38.0 mm -71.67 133.04 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 63.13 111.326 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 120' ' ' LYS . 56.6 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.616 -0.72 . . . . 74.04 109.132 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.912 0.387 . . . . 35.02 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CD1' ' A' ' 65' ' ' ILE . 39.0 mm -88.59 136.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.912 -0.585 . . . . 65.42 110.24 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 m -69.37 120.35 15.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.98 0.419 . . . . 61.24 110.007 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -88.15 5.96 38.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 64.44 111.016 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 88.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.887 -0.597 . . . . 74.35 110.406 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.67 -13.66 3.67 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.513 -0.767 . . . . 64.11 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -69.5 142.26 53.76 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.725 -0.472 . . . . 75.04 109.725 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 21.8 pt-20 -127.89 158.76 36.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.186 0.517 . . . . 61.4 111.109 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 114.67 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 60.3 110.023 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 60' ' ' ASP . 81.7 mt -81.35 -48.74 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.036 -0.529 . . . . 73.45 110.229 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -147.19 142.16 26.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 52.24 110.371 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.18 146.88 34.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.686 -0.688 . . . . 75.34 109.196 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -86.0 -37.49 18.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.858 0.361 . . . . 72.42 111.176 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -153.89 149.8 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.014 0.435 . . . . 72.12 111.109 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 24.8 pt20 -159.01 146.4 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.069 -1.086 . . . . 75.23 108.069 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -99.31 94.73 6.62 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 75.4 110.407 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.74 -0.83 23.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.665 -0.698 . . . . 74.05 110.853 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 m -114.26 -37.94 4.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.139 -0.482 . . . . 54.12 110.94 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-N 116.012 -0.54 . . . . 64.24 112.891 -178.806 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.4 t30 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.247 -0.649 . . . . 74.3 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.33 -1.16 76.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.975 -0.631 . . . . 63.2 111.808 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 63.8 mt -77.08 150.31 35.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.273 -0.269 . . . . 54.51 110.273 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.47 -29.95 69.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 51.3 110.108 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -67.62 -22.69 65.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 63.33 111.374 177.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.8 m -68.86 -25.2 64.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.971 0.415 . . . . 72.13 110.293 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.22 -27.87 69.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.694 -0.684 . . . . 61.32 110.361 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 59' ' ' ILE . 31.3 pt -119.31 14.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 73.25 110.434 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.825 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.0 t70 -65.15 -40.7 94.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 71.41 110.548 -176.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.6 25.76 13.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 43.44 111.882 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -131.8 122.35 25.64 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.652 -0.499 . . . . 74.23 109.652 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 p -75.07 -7.79 54.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.906 -0.588 . . . . 75.54 111.791 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -85.65 -24.2 27.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 72.44 110.38 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.0 p -96.95 155.8 16.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.292 -0.413 . . . . 63.23 110.454 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.717 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 40.9 p90 -149.07 168.91 21.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.855 0.36 . . . . 72.33 111.153 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.6 t90 -104.85 138.4 41.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 72.02 109.083 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -133.88 136.96 44.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.411 -0.588 . . . . 74.34 109.411 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.43 58.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.672 -0.492 . . . . 73.1 109.672 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 50' ' ' SER . 53.6 tttm -64.87 120.17 12.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 72.22 110.369 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -111.19 -30.91 7.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.844 -0.617 . . . . 74.52 110.845 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.11 129.21 37.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.996 -0.372 . . . . 72.03 109.996 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.06 -12.27 62.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.946 -0.645 . . . . 53.3 111.974 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.23 140.96 5.9 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.599 -0.601 . . . . 33.41 111.599 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 9.8 p -81.94 145.79 30.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.662 0.268 . . . . 70.25 110.812 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.72 156.02 90.35 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.096 -0.502 . . . . 74.12 110.339 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.32 148.79 49.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.526 2.151 . . . . 74.13 113.01 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -82.46 158.69 65.77 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 61.42 109.866 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.91 159.31 91.24 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.497 -1.46 . . . . 62.25 112.678 0.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.8 m-85 -91.3 117.89 30.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.092 -0.503 . . . . 74.35 110.196 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.692 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.2 t70 -108.16 126.7 53.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.528 -0.76 . . . . 65.02 110.572 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 57.9 mt -130.64 114.96 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 74.51 110.242 175.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.13 115.82 49.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.948 -0.569 . . . . 72.21 110.984 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 34' ' ' ILE . 49.4 mm -112.16 142.79 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.493 . . . . 73.24 110.822 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HB2' HD11 ' A' ' 13' ' ' LEU . 59.0 t0 -108.77 121.6 45.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.912 -0.585 . . . . 54.43 109.508 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 68.3 mtm -85.15 -9.65 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 55.21 111.155 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 71.6 mmtt 68.33 16.04 9.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.148 -0.478 . . . . 73.2 112.215 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 61' ' ' MET . 8.3 pt20 -169.17 159.51 9.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.61 0.243 . . . . 75.32 110.936 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -85.78 126.0 33.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.481 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.512 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.8 mt -135.95 140.45 44.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.064 -0.517 . . . . 70.13 110.304 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.0 tp60 -82.86 101.81 11.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.188 -0.671 . . . . 75.43 109.188 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.5 mm -66.8 122.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.551 -0.295 . . . . 70.25 110.328 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.46 -33.09 4.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.738 0.304 . . . . 54.43 111.429 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.687 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 10.3 tt0 -159.41 145.41 16.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.571 -0.286 . . . . 63.33 110.384 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -114.18 137.24 48.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.49 -0.559 . . . . 75.42 109.49 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 16.7 tt0 -112.9 132.6 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.832 -0.347 . . . . 74.11 110.185 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.462 HD12 ' CE2' ' A' ' 114' ' ' TYR . 44.5 mt -120.4 116.82 26.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.384 . . . . 75.3 110.146 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.4 tp -101.91 103.91 32.26 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.348 -0.612 . . . . 75.21 109.348 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 15.3 Cg_exo . . . . . 0 CA--C 1.53 0.282 0 C-N-CA 123.438 2.759 . . . . 62.03 112.835 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 61.3 t30 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 121.167 0.508 . . . . 54.12 110.255 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 81' ' ' ASN . 4.1 Cg_exo -74.47 60.5 5.01 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.164 2.576 . . . . 64.41 113.474 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -92.17 125.54 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.825 -0.435 . . . . 64.4 109.825 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -93.4 -53.05 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.027 -0.533 . . . . 73.12 110.003 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.73 137.45 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 65.42 110.836 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 m -121.68 135.22 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.73 . . . . 63.21 109.542 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 54.6 mt-10 -119.05 125.48 49.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.03 0.443 . . . . 74.32 110.646 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB2' HG13 ' A' ' 100' ' ' ILE . 47.4 m-85 -104.81 131.08 52.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 64.32 110.424 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.57 149.81 49.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.224 -0.444 . . . . 74.25 110.145 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.83 48.49 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.48 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 t -149.86 152.49 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.949 0.404 . . . . 63.3 110.199 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.673 ' HB3' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.23 7.32 10.22 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.418 0.628 . . . . 75.33 109.804 175.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.4 -15.06 7.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.342 -0.845 . . . . 73.33 109.904 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.45 7.22 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.355 -0.839 . . . . 64.43 110.103 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.69 -59.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.477 -0.783 . . . . 62.24 110.512 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -88.78 104.05 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 74.35 110.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.8 m95 -91.96 116.05 28.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.901 0.381 . . . . 74.24 110.608 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.5 m -94.83 125.08 52.51 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.972 -0.558 . . . . 74.15 110.444 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 111.47 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.665 2.243 . . . . 72.41 111.51 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 116' ' ' VAL . 20.1 pt -89.93 -9.88 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.321 -0.4 . . . . 60.13 111.404 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.35 128.7 0.98 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.259 -1.448 . . . . 42.41 114.287 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 7.5 ttm180 -98.75 126.17 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.84 -0.8 . . . . 71.24 108.84 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.7 m-85 -141.82 169.24 17.96 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.26 -0.576 . . . . 72.3 111.394 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.32 139.26 15.94 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.649 . . . . 62.32 111.765 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -95.33 148.23 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.109 0.48 . . . . 72.11 110.701 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 112' ' ' LEU . 85.6 m -132.3 114.25 14.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.0 -0.546 . . . . 64.4 110.062 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -75.48 97.4 3.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.44 . . . . 62.04 110.102 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 12.6 pt20 -136.27 -179.97 5.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.88 -0.6 . . . . 73.13 110.423 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.46 9.82 42.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 64.14 110.247 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.66 151.14 39.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.692 -0.686 . . . . 55.42 109.973 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -75.95 128.17 34.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.161 0.505 . . . . 70.11 111.605 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 106' ' ' THR . 26.7 mt -82.75 117.88 22.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.485 -0.78 . . . . 75.4 110.388 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.687 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 43.4 mt-10 -92.87 111.76 23.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.923 0.392 . . . . 64.34 110.811 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CE2' HD12 ' A' ' 72' ' ' LEU . 85.0 m-85 -105.15 107.41 18.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.071 0.462 . . . . 75.55 110.516 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -76.96 95.07 4.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.587 -0.733 . . . . 52.23 109.36 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.424 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.3 m -97.58 179.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.512 -0.767 . . . . 54.43 111.817 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -65.75 134.94 54.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.739 . . . . 65.04 110.816 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 45.9 p -79.1 123.32 27.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.805 -0.634 . . . . 71.33 110.366 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.3 tt -157.84 148.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 65.4 110.757 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.37 122.76 28.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.693 -0.484 . . . . 75.33 109.693 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . . . -144.72 175.39 10.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.351 -0.386 . . . . 74.22 111.002 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -127.79 -32.51 2.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.377 0.608 . . . . 73.33 109.631 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.51 145.6 31.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.59 -0.732 . . . . 64.11 109.424 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 59' ' ' ILE . 11.4 tt -131.47 135.16 59.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.015 0.436 . . . . 72.24 109.872 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.692 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 54.5 ttp180 -121.76 118.48 29.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.045 0.45 . . . . 72.01 111.04 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 57.5 tp -87.43 119.71 27.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 74.34 109.063 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 45.5 m -116.42 120.51 39.04 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.933 0.397 . . . . 54.11 111.123 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.0 mm -98.76 95.96 3.54 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.311 -0.996 . . . . 72.41 108.311 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.99 163.33 39.63 Favored 'Trans proline' 0 CA--C 1.52 -0.179 0 C-N-CA 123.056 2.504 . . . . 51.45 113.575 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.57 71.49 0.79 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.559 -0.904 . . . . 72.32 108.559 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -149.42 -39.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.027 -0.988 . . . . 61.43 110.901 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.57 -6.18 83.66 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.384 -0.912 . . . . 54.02 113.705 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.78 26.94 7.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.974 -1.107 . . . . 64.32 111.917 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -72.69 137.02 45.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.601 0.239 . . . . 64.12 110.447 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -94.68 173.0 7.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.252 -0.431 . . . . 63.14 110.171 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 p -81.33 10.89 4.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.422 0.527 . . . . 71.23 112.422 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 94.8 t -109.07 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.417 . . . . 71.52 110.089 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.55 125.02 48.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.911 -0.586 . . . . 53.53 110.055 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -142.57 109.08 5.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.281 0.562 . . . . 73.34 111.558 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.93 132.67 69.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.144 -0.687 . . . . 72.13 109.144 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 94.1 mtt180 -67.16 -62.48 1.41 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.082 0.468 . . . . 64.14 110.212 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.48 148.75 34.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 73.02 111.614 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.42 126.74 54.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.405 -1.332 . . . . 73.44 107.405 170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.73 157.95 29.84 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.729 -0.471 . . . . 75.01 109.729 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.12 124.19 63.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.199 0.523 . . . . 51.23 110.471 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 80.2 mttt -102.18 112.17 24.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.441 -0.799 . . . . 73.5 108.862 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.99 -175.01 32.56 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.3 -0.952 . . . . 71.3 112.685 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 m -104.94 127.91 52.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.589 0.233 . . . . 74.31 110.795 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.431 HD11 HD12 ' A' ' 5' ' ' ILE . 36.0 mm -65.99 128.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.254 -0.43 . . . . 65.41 110.722 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 66' ' ' GLN . 60.4 mt . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.3 111.272 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.966 -0.383 . . . . 74.33 109.966 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 65' ' ' ILE . 44.4 mm -81.76 148.24 5.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.62 -0.264 . . . . 75.53 110.559 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -66.24 107.08 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.903 0.382 . . . . 74.03 110.301 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 144' ' ' ASP . 37.8 mtmt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.147 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -71.06 -10.26 59.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.026 -0.534 . . . . 44.34 111.624 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.28 9.32 38.84 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.859 -0.686 . . . . 65.25 111.967 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB2' HD12 ' A' ' 34' ' ' ILE . 30.4 m0 -90.9 161.94 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.014 -0.365 . . . . 73.01 110.014 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.4 pt-20 -141.37 159.81 41.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 72.41 110.731 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.02 116.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.608 -0.724 . . . . 61.34 110.132 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 60' ' ' ASP . 59.4 mt -80.84 -43.62 19.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.921 -0.581 . . . . 72.21 110.711 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 t -142.45 140.71 32.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 64.3 110.371 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.02 146.14 29.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.471 -0.786 . . . . 72.33 109.13 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -85.51 -33.95 21.67 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.723 -0.391 . . . . 73.21 110.952 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -155.6 152.34 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.05 0.452 . . . . 75.0 110.885 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -163.19 145.99 10.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.153 -1.054 . . . . 72.22 108.153 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.52 98.21 10.36 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.44 0.638 . . . . 71.35 110.189 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 8.4 29.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.874 . . . . 73.12 111.425 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 m -136.52 -43.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.908 -0.317 . . . . 64.21 111.346 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 121.078 -0.582 . . . . 73.22 112.769 -179.549 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.0 t30 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.916 -0.401 . . . . 73.31 109.916 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.16 3.49 72.74 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.846 -0.901 . . . . 73.33 110.846 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 51.3 mt -84.42 159.15 20.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.177 -0.512 . . . . 74.11 110.299 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.39 -28.83 68.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 73.13 110.909 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -75.45 -20.8 58.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 74.21 111.37 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 64.5 m -69.76 -23.76 63.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 72.05 110.532 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.73 -21.2 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.698 -0.683 . . . . 74.43 110.543 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 59' ' ' ILE . 30.4 pt -127.65 24.12 2.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 54.23 110.41 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.658 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.7 t70 -75.22 -38.8 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.117 -0.492 . . . . 55.43 111.533 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 40.68 3.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.265 -0.734 . . . . 62.41 111.265 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 8.9 t0 -153.64 126.21 8.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.728 -0.471 . . . . 71.34 109.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -73.23 -14.38 61.32 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.871 0.693 . . . . 63.25 112.871 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -93.53 -13.06 28.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 74.13 110.638 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 41.2 p -97.22 137.1 36.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.204 -0.665 . . . . 73.14 109.204 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.978 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 4.0 p90 -145.07 171.57 14.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.959 0.409 . . . . 75.33 111.111 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.52 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 41.5 t90 -105.19 125.46 51.0 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 70.22 109.256 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -124.47 137.49 54.43 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.425 -0.954 . . . . 74.0 108.425 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 144.88 56.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.625 -0.509 . . . . 32.41 109.625 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -65.59 112.58 3.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.838 0.351 . . . . 60.31 110.324 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -103.08 -25.08 13.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.364 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.51 121.64 15.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 74.44 110.318 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.89 -3.62 83.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.924 -0.655 . . . . 65.22 113.002 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.26 148.5 8.55 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.727 -0.749 . . . . 62.42 111.884 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 24.9 p -82.86 148.61 27.62 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.986 0.422 . . . . 74.1 111.338 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.79 158.98 86.8 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.637 . . . . 73.15 110.642 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.43 136.75 29.32 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.181 1.921 . . . . 60.1 112.413 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 16.5 mt -77.99 161.5 70.77 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 75.04 110.157 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.879 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 3.6 Cg_exo -81.9 162.23 78.16 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 124.115 -1.202 . . . . 44.22 112.585 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.9 m-85 -97.21 133.6 41.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 73.44 109.742 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 22.1 t70 -131.68 117.63 18.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.676 0.274 . . . . 73.53 110.518 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.45 119.39 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.819 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -107.01 119.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.389 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.525 ' HB ' HG23 ' A' ' 124' ' ' ILE . 75.2 mt -118.06 139.82 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.407 -0.36 . . . . 62.23 111.232 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 13' ' ' LEU . 54.8 t0 -108.27 121.85 45.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.052 -0.522 . . . . 73.44 109.629 176.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.5 mtm -86.01 -8.29 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 64.25 111.068 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.478 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 73.3 -11.93 0.86 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.244 0.618 . . . . 64.11 112.591 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -144.14 167.26 22.82 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.132 -0.321 . . . . 75.52 110.132 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.29 128.78 34.97 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.816 0.341 . . . . 73.32 110.092 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.537 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.7 mt -135.19 137.98 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.451 -0.34 . . . . 74.44 110.283 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -82.31 103.28 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.233 -0.654 . . . . 74.44 109.233 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 118' ' ' SER . 26.5 mm -70.11 125.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.469 -0.332 . . . . 70.34 110.119 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.34 -48.54 2.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 70.21 110.813 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.435 ' NE2' ' HE2' ' A' ' 146' ' ' LYS . 23.7 tt0 -147.59 146.42 29.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 72.35 109.977 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.15 131.96 70.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.16 -0.473 . . . . 61.54 110.049 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -109.84 135.66 50.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.074 0.464 . . . . 70.41 111.048 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 57.1 mt -114.28 118.27 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 tp -103.37 99.75 16.02 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.413 -0.358 . . . . 73.43 110.345 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 12.3 Cg_exo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.734 2.289 . . . . 74.25 111.067 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 . . . . . 0 C--O 1.231 0.102 0 N-CA-C 109.51 -0.552 . . . . 72.11 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 27.3 Cg_endo -92.81 62.08 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.406 2.737 . . . . 65.04 113.689 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' HB1' ' A' ' 138' ' ' ALA . 54.1 mt -96.64 131.8 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.136 -0.69 . . . . 71.44 109.136 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -108.67 -46.98 3.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.765 0.316 . . . . 55.35 111.079 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.465 HG11 ' HE ' ' A' ' 102' ' ' ARG . 47.2 t -124.33 139.06 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.565 -0.289 . . . . 70.42 110.971 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.03 144.71 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 64.11 110.668 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 34.2 mt-10 -120.1 135.99 54.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 70.2 111.207 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -118.2 130.52 56.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.947 -0.569 . . . . 72.51 110.618 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -136.37 148.91 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.474 -0.33 . . . . 63.15 110.628 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.58 148.28 51.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.35 -0.386 . . . . 72.43 110.382 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -150.3 161.24 42.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 73.44 111.268 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.36 -20.56 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 63.13 110.773 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -118.1 -5.09 10.96 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.311 0.486 . . . . 74.31 112.311 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.0 t30 69.85 12.47 7.94 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.595 0.712 . . . . 62.53 110.382 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.7 -53.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 70.03 109.773 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.61 98.99 10.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 61.24 109.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 125' ' ' ARG . 98.2 m95 -88.69 123.46 33.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 71.44 110.899 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 121.91 57.2 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.073 -0.512 . . . . 62.02 110.009 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 109.38 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.396 2.064 . . . . 75.11 111.942 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.622 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -80.62 -12.65 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 62.21 110.205 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.1 145.94 4.37 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.625 -0.798 . . . . 24.35 113.02 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HE ' HG11 ' A' ' 85' ' ' VAL . 70.9 ttt180 -115.91 120.54 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.818 -0.808 . . . . 70.45 108.818 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.41 ' HE2' HG12 ' A' ' 116' ' ' VAL . 89.4 m-85 -133.22 178.94 6.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.099 0.476 . . . . 75.35 111.151 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.39 143.89 16.99 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.71 -0.677 . . . . 64.31 111.791 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -94.75 125.61 39.52 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.786 -0.45 . . . . 74.03 109.786 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.533 ' HB ' HD21 ' A' ' 112' ' ' LEU . 19.7 m -113.76 104.35 12.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.188 -0.46 . . . . 73.43 109.94 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.45 92.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.008 0.432 . . . . 73.35 110.024 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -121.02 -173.59 2.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.778 -0.646 . . . . 64.45 110.816 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.16 -18.91 27.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.819 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.3 -175.09 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 74.44 111.014 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.27 147.99 26.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.979 0.419 . . . . 70.2 110.442 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 106' ' ' THR . 21.2 mt -98.33 104.24 16.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.022 -0.535 . . . . 75.15 110.145 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -81.32 116.09 21.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 71.25 110.571 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.42 105.48 14.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.826 0.346 . . . . 75.24 110.848 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -73.03 102.33 3.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.896 -0.779 . . . . 71.23 108.896 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -107.71 175.93 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.206 0.527 . . . . 64.32 112.122 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.609 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 52.8 tttp -59.61 116.85 4.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.237 -0.892 . . . . 75.34 110.434 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.3 m -70.94 115.8 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 70.4 110.373 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.5 tt -156.54 147.93 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.286 -0.415 . . . . 63.43 110.229 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.732 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.4 ttpt -83.62 133.96 34.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.0 -0.37 . . . . 73.24 110.0 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.98 169.63 21.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.309 -0.405 . . . . 71.1 110.565 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -117.22 -32.97 4.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.199 0.523 . . . . 74.32 109.835 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.84 145.39 32.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.653 . . . . 71.03 109.646 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.0 tt -133.29 137.8 52.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.482 -0.562 . . . . 72.4 109.482 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 23.9 ttp180 -125.71 128.56 47.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.899 0.38 . . . . 71.44 111.099 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.9 tp -104.31 115.34 30.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.55 -0.75 . . . . 71.51 109.642 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 41.4 m -107.17 123.72 48.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.111 0.481 . . . . 62.35 110.746 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.629 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.4 mm -105.97 92.46 6.46 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.44 -0.8 . . . . 74.23 108.973 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.879 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.3 Cg_endo -69.61 -178.62 2.37 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.816 2.344 . . . . 75.35 113.303 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 36.8 t70 -129.24 65.06 1.47 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.618 -1.253 . . . . 73.12 107.618 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.7 -46.58 2.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.094 -0.957 . . . . 75.13 112.506 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.13 36.65 4.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.183 -1.008 . . . . 73.24 113.754 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.66 18.5 32.42 Favored Glycine 0 CA--C 1.51 -0.258 0 C-N-CA 120.241 -0.98 . . . . 75.3 112.187 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.91 166.69 10.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 71.42 111.361 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.0 m -129.9 167.54 18.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.164 -0.471 . . . . 71.41 110.181 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 32.2 p -84.89 -24.42 28.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.111 0.481 . . . . 45.43 110.32 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 57.8 t -82.3 122.35 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 75.44 109.761 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 83' ' ' ILE . . . -141.86 139.66 32.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.261 -0.427 . . . . 72.22 110.431 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.54 105.05 4.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.272 0.558 . . . . 72.43 111.253 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.06 132.48 71.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.737 -0.838 . . . . 73.14 108.737 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.978 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.7 mtm180 -69.98 -65.02 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.886 -0.326 . . . . 74.24 110.331 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -139.58 146.58 40.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.606 0.717 . . . . 75.2 112.331 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -108.2 121.95 45.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.514 -1.291 . . . . 65.21 107.514 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 m-20 -122.8 154.75 37.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.919 0.39 . . . . 73.34 110.794 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.49 129.94 56.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 54.14 110.438 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.435 ' HE2' ' NE2' ' A' ' 69' ' ' GLN . 44.5 mttm -96.02 129.08 43.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.069 -0.715 . . . . 73.44 109.069 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.53 -176.68 39.01 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.203 -0.999 . . . . 45.5 112.457 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.8 m -108.4 133.49 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.86 -0.422 . . . . 74.24 109.86 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.24 125.02 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.075 0.464 . . . . 71.55 110.575 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.732 HD12 ' HG3' ' A' ' 120' ' ' LYS . 60.8 mt . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 115.884 -0.598 . . . . 71.23 110.464 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.626 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 39.9 p . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.744 0.307 . . . . 72.1 110.306 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 149' ' ' ILE . 43.4 mm -86.05 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.347 -0.388 . . . . 74.0 111.152 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -67.38 118.81 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 73.04 109.76 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -97.2 9.86 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 75.44 110.726 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 m -65.5 -27.34 68.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.832 -0.622 . . . . 72.24 111.681 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.5 20.35 34.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 75.4 112.731 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.472 ' HB2' HD12 ' A' ' 34' ' ' ILE . 36.1 m0 -94.17 150.55 20.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.821 -0.437 . . . . 71.1 109.821 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.7 pt-20 -133.61 156.59 47.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 71.22 110.279 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 116.14 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.736 -0.665 . . . . 65.01 109.76 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 60' ' ' ASP . 80.6 mt -78.76 -42.79 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 74.25 110.494 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 m -152.34 133.9 14.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.1 -0.5 . . . . 42.05 110.329 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -131.52 137.52 48.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 74.4 109.736 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.1 m -78.58 -33.42 47.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.809 0.338 . . . . 75.45 110.807 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 t -157.53 145.8 19.19 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.794 0.33 . . . . 72.25 110.979 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.27 137.67 5.2 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.963 -0.754 . . . . 74.01 108.963 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.74 133.56 33.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.136 0.493 . . . . 73.2 110.23 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.32 -27.91 0.94 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.842 -0.617 . . . . 62.1 110.852 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -101.97 -31.24 10.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.278 -0.419 . . . . 72.34 111.09 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.535 0 C-N-CA 120.959 -0.639 . . . . 45.02 111.509 177.358 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.7 t30 . . . . . 0 CA--C 1.518 -0.268 0 N-CA-C 110.334 -0.247 . . . . 74.24 110.334 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.49 82.12 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 116.146 -0.479 . . . . 71.34 112.539 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 73.4 mt -72.26 147.01 46.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 73.41 110.391 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.2 -22.68 64.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.403 -0.362 . . . . 75.12 111.14 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -79.11 -22.46 45.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 75.54 110.946 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 66.7 m -65.38 -26.25 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 41.14 110.102 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 142' ' ' GLU . 22.7 tp -61.84 -26.14 67.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.343 -0.844 . . . . 70.22 110.543 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 59' ' ' ILE . 28.3 pt -116.16 12.52 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.396 . . . . 74.21 110.755 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 38.8 t70 -77.72 -29.53 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.116 0.484 . . . . 75.4 110.105 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.93 31.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.888 -0.672 . . . . 73.33 113.268 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.546 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 14.5 t0 -115.8 128.46 55.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.345 -0.613 . . . . 73.0 109.345 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' NH2' ' A' ' 141' ' ' ARG . 10.5 p -77.37 -5.65 50.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.916 0.71 . . . . 75.31 112.916 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.8 pt-20 -103.02 -5.34 23.48 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.324 -0.55 . . . . 75.51 111.013 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 9.3 p -105.73 161.78 14.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.837 -0.431 . . . . 73.22 109.837 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.643 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 48.1 p90 -157.33 162.32 39.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.99 0.424 . . . . 74.34 111.095 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 35.4 t90 -92.72 134.17 35.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.877 -0.786 . . . . 73.33 108.877 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -132.24 138.01 47.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.04 -0.726 . . . . 62.35 109.04 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.99 138.94 58.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.706 -0.479 . . . . 74.34 109.706 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 50' ' ' SER . 31.1 ttpt -67.54 120.1 13.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.61 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -111.51 -22.92 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.167 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -71.89 107.42 4.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 70.13 110.169 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.94 -0.99 56.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.721 -0.752 . . . . 43.12 112.258 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.16 133.63 5.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.819 -0.705 . . . . 52.45 112.215 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.8 m -72.69 143.71 47.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.82 0.343 . . . . 71.04 110.375 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 10.5 m-20 -74.01 151.68 88.45 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.235 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 3.0 Cg_exo -76.65 144.99 25.59 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.684 2.256 . . . . 71.04 111.599 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 130' ' ' ASP . 15.1 mt -75.31 158.18 84.03 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.18 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.9 Cg_endo -83.49 167.14 63.69 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.696 -1.377 . . . . 74.13 113.536 2.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.8 m-85 -106.85 122.26 46.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 72.24 109.983 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.84 125.19 51.19 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.095 0.474 . . . . 73.44 110.524 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 62.8 mt -115.07 112.65 40.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.054 -0.521 . . . . 75.0 110.151 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.97 117.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.153 -0.476 . . . . 64.03 110.743 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 34' ' ' ILE . 66.3 mt -117.87 137.05 53.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.255 -0.43 . . . . 72.21 110.723 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 13' ' ' LEU . 56.9 t0 -103.59 120.63 41.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.682 -0.488 . . . . 70.24 109.682 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.426 ' SD ' HD12 ' A' ' 65' ' ' ILE . 65.2 mtm -84.66 -7.43 59.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.814 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.8 mmtt 65.9 13.64 9.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.769 -0.65 . . . . 74.32 112.183 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.411 ' OE1' HD12 ' A' ' 149' ' ' ILE . 6.0 pt20 -164.57 164.93 21.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 74.15 110.542 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.98 122.79 31.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.399 . . . . 45.21 110.366 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD13 HG21 ' A' ' 5' ' ' ILE . 74.0 mt -130.65 137.82 55.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.292 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.497 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.0 tp60 -83.29 102.93 12.3 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.063 -0.717 . . . . 75.35 109.063 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.3 mm -74.14 125.79 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.665 0.269 . . . . 74.25 110.525 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.62 -39.71 2.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.161 0.505 . . . . 40.34 110.831 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 26.7 tt0 -148.89 142.93 25.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.092 -0.504 . . . . 50.01 110.821 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.07 136.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.519 -0.549 . . . . 72.11 109.519 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 39.9 mt-10 -118.73 133.57 55.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.147 0.499 . . . . 71.32 111.247 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 72.2 mt -114.53 126.79 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.549 -0.75 . . . . 54.53 109.162 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 141' ' ' ARG . 24.3 tp -106.24 97.14 15.06 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.727 -0.472 . . . . 71.23 109.727 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 6.3 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 123.088 2.526 . . . . 72.44 111.073 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.799 0.666 . . . . 71.54 112.799 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 72.6 Cg_endo -75.82 25.71 0.41 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.861 2.374 . . . . 71.23 112.671 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.49 120.75 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.616 -0.513 . . . . 64.12 109.616 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.52 -50.82 3.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.111 0.482 . . . . 71.0 110.749 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 102' ' ' ARG . 57.4 t -120.41 137.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 54.25 110.583 -175.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.36 129.71 65.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.556 -0.747 . . . . 71.01 109.688 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 97.2 mt-10 -112.65 125.75 54.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 61.02 110.128 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -102.84 129.75 49.62 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.679 -0.691 . . . . 74.1 110.269 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 125' ' ' ARG . . . -125.32 151.07 46.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.144 -0.48 . . . . 61.22 110.428 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.21 39.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 51.25 109.96 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 t -148.87 151.15 34.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.198 0.523 . . . . 72.41 110.762 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 -32.87 10.48 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.794 -0.639 . . . . 71.23 110.61 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -109.69 -5.59 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.429 -0.351 . . . . 74.22 110.878 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 78.19 -9.61 1.48 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.991 0.917 . . . . 73.24 111.083 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.8 t -90.91 -49.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.107 0.48 . . . . 74.34 110.819 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.43 102.77 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.105 -0.498 . . . . 54.33 109.85 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.98 118.07 30.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 73.53 111.044 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 m -99.46 120.82 56.82 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.469 -0.787 . . . . 75.14 110.51 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.96 112.53 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.359 2.039 . . . . 50.41 111.111 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 14.1 pt -87.33 -9.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.466 -0.334 . . . . 61.44 111.025 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.63 137.35 2.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.763 -1.208 . . . . 51.43 113.848 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.576 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 16.2 ttt180 -107.02 114.57 28.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.045 -0.724 . . . . 70.02 109.045 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.599 ' HE2' HG12 ' A' ' 116' ' ' VAL . 92.2 m-85 -125.98 169.92 12.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.84 0.352 . . . . 74.32 111.128 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -91.59 139.77 14.9 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.467 -0.653 . . . . 65.45 111.467 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -93.37 125.48 38.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 64.3 110.483 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 112' ' ' LEU . 90.2 m -103.08 115.23 30.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 54.21 110.579 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -72.59 102.56 3.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 72.52 110.534 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -143.91 -176.92 5.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 74.02 110.446 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.5 -7.97 22.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.05 0.453 . . . . 73.13 110.033 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.2 170.27 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.861 -0.608 . . . . 60.24 111.042 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.63 143.45 38.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.124 0.487 . . . . 54.21 111.613 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 106' ' ' THR . 46.4 mt -103.28 106.77 17.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 75.31 110.285 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 43.0 mt-10 -87.12 112.78 22.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.807 0.337 . . . . 75.42 110.735 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.23 106.66 17.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.155 -0.475 . . . . 62.03 110.55 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -72.13 102.61 3.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.061 -0.718 . . . . 61.12 109.061 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.599 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.1 m -103.18 179.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 64.43 112.159 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 6.5 tmtm? -66.04 124.19 21.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 72.42 110.421 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 21.2 p -70.49 127.37 32.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 75.31 110.68 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -163.45 150.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.42 -0.355 . . . . 63.05 110.481 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.698 ' HG3' HD12 ' A' ' 150' ' ' ILE . 5.9 ttpm? -85.69 128.07 34.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.285 -0.635 . . . . 62.33 109.285 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.19 160.82 43.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.861 0.362 . . . . 43.03 111.239 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -117.42 -26.12 6.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.67 -0.695 . . . . 70.45 109.642 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.16 146.45 42.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 74.42 109.859 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -131.1 143.25 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.628 -0.508 . . . . 61.43 109.628 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.5 ttp180 -131.38 124.75 30.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 73.43 111.227 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 57' ' ' ILE . 37.6 tp -90.16 113.0 24.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.553 -0.749 . . . . 65.42 109.401 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.6 m -107.18 115.83 30.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.19 0.519 . . . . 74.12 111.179 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 31.7 mm -105.06 98.05 14.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.104 -0.702 . . . . 70.12 109.104 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.7 Cg_endo -71.09 170.45 18.1 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.361 2.041 . . . . 75.31 112.39 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HA ' HD13 ' A' ' 53' ' ' LEU . 34.7 t70 -91.21 -4.09 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.109 0.957 . . . . 70.31 109.099 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.21 140.96 31.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 75.42 110.677 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.78 -13.28 35.1 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.633 -0.794 . . . . 73.13 111.93 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 110.68 18.29 8.56 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.712 . . . . 63.31 112.335 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.56 150.4 43.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 71.44 110.854 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 48.9 m -127.75 -176.76 3.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.972 -0.558 . . . . 71.32 110.388 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 39.0 p -84.53 -2.4 57.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.028 0.442 . . . . 64.44 111.649 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -93.7 96.28 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.149 0.499 . . . . 52.41 110.038 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.45 129.54 50.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.847 -0.615 . . . . 65.02 110.159 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -150.07 110.64 4.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 64.44 110.791 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.5 mt -128.67 133.0 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 64.22 109.301 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.643 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.1 mtp180 -61.76 -61.16 2.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.952 0.406 . . . . 74.41 110.268 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HA ' HD12 ' A' ' 33' ' ' LEU . 15.3 pt-20 -154.82 158.79 39.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.503 0.668 . . . . 70.51 111.338 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -115.15 134.6 55.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.657 -1.238 . . . . 62.44 107.657 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.626 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.1 t70 -131.09 167.16 19.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.721 -0.391 . . . . 71.24 110.014 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.7 t -138.6 128.43 32.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.73 0.3 . . . . 73.34 110.847 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.5 mttp -97.97 125.27 42.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.391 -0.596 . . . . 72.11 109.391 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.62 -158.71 14.99 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.798 -0.715 . . . . 60.32 111.404 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.0 m -131.1 130.23 42.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.849 0.324 . . . . 62.33 110.583 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 5' ' ' ILE . 34.7 mm -68.41 116.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 63.13 109.902 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 120' ' ' LYS . 42.6 mt . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 121.239 0.543 . . . . 71.03 110.17 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 12.8 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.602 -0.888 . . . . 51.13 108.602 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 145' ' ' VAL . 36.5 mm -65.7 129.1 29.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.978 0.418 . . . . 72.44 110.752 -173.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 m -67.19 111.69 4.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.947 -0.569 . . . . 61.0 109.807 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 9.1 mtmp? -85.06 20.37 1.91 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.432 -0.804 . . . . 73.03 111.467 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -59.13 -42.48 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.899 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.13 7.68 52.46 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 63.23 113.053 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.488 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.3 m0 -73.08 154.29 40.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.706 0.288 . . . . 70.1 110.457 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 24.5 pt-20 -148.87 161.27 42.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.262 0.553 . . . . 64.12 111.183 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.89 120.11 47.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.88 . . . . 71.33 110.066 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 60' ' ' ASP . 86.3 mt -85.75 -47.72 9.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.001 -0.545 . . . . 75.55 110.758 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 t -138.76 142.3 38.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.01 -0.541 . . . . 72.42 109.934 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -146.91 148.92 32.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.072 -0.513 . . . . 73.13 109.651 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.5 m -86.16 -42.02 14.21 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.852 0.358 . . . . 64.35 110.973 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -150.9 153.47 35.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.325 -0.398 . . . . 62.35 110.746 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.28 146.0 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.286 -0.635 . . . . 70.32 109.286 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -102.57 110.81 22.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.932 0.396 . . . . 63.13 110.417 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.65 13.11 11.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.049 -0.523 . . . . 63.24 111.187 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 m -134.21 -49.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.513 -0.312 . . . . 64.3 111.393 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.905 -0.664 . . . . 73.03 112.201 179.632 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.659 -0.497 . . . . 74.01 109.659 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.79 -8.43 70.83 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.274 -0.73 . . . . 62.0 111.274 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 43.2 mt -72.47 153.58 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.14 -0.53 . . . . 75.52 110.07 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.22 -28.99 69.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 71.12 110.787 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.97 -24.82 60.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 70.24 110.993 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.847 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 77.4 m -67.33 -21.56 65.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.386 -0.37 . . . . 63.3 110.404 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 51.3 tp -64.93 -14.41 59.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.837 -0.62 . . . . 63.2 110.687 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 10' ' ' TRP . 27.8 pt -131.58 14.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.531 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.847 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.9 t70 -65.85 -33.67 76.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.291 -0.413 . . . . 73.33 111.279 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HZ1' ' A' ' 7' ' ' LYS . . . 99.84 5.49 55.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.53 -0.843 . . . . 72.03 113.408 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.67 140.22 50.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.0 0.4 . . . . 62.45 109.93 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 26.6 p -80.66 -7.39 59.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.895 0.332 . . . . 71.31 111.895 -174.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.69 -8.16 44.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.593 -0.276 . . . . 73.21 110.303 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.6 p -107.49 138.52 43.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 74.42 110.018 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.864 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 10.9 p90 -141.09 169.85 16.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.45 -0.341 . . . . 63.21 110.567 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.0 t90 -104.65 133.04 50.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.826 -0.805 . . . . 72.11 108.826 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.074 -0.713 . . . . 75.44 109.074 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 145.21 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.31 -0.626 . . . . 64.44 109.31 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -55.85 125.24 20.48 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.339 0.399 . . . . 71.54 109.995 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -124.78 -30.22 3.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.844 -0.342 . . . . 63.12 110.79 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -77.65 107.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.785 -0.45 . . . . 70.35 109.785 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.94 11.55 52.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.636 -0.792 . . . . 65.01 111.899 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.27 20.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.955 -0.64 . . . . 53.32 111.893 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.0 m -127.7 165.76 19.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 72.24 110.896 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' HE1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -89.21 152.79 48.35 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.13 109.375 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 38.5 Cg_endo -68.09 139.07 45.51 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.158 1.905 . . . . 72.34 113.222 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.44 158.02 87.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 73.54 109.951 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 83.4 Cg_endo -82.4 161.8 76.61 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.525 -1.448 . . . . 73.05 113.061 0.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HE1' ' HB3' ' A' ' 51' ' ' ASP . 25.8 m-85 -97.79 129.02 44.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.62 . . . . 72.31 109.598 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.1 t0 -127.33 118.44 24.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.748 0.308 . . . . 72.21 110.309 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.444 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 56.9 mt -116.55 122.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 74.4 111.339 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.1 t -105.45 118.19 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.83 -0.623 . . . . 63.32 110.514 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 124' ' ' ILE . 71.1 mt -115.56 139.07 43.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 75.12 111.049 -175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.512 ' HB2' HD11 ' A' ' 13' ' ' LEU . 63.8 t0 -105.63 122.13 45.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.169 -0.468 . . . . 63.43 110.001 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.2 mtm -88.45 -5.31 58.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 72.53 110.672 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 67.11 8.51 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.902 0.704 . . . . 54.44 112.902 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -168.2 174.8 6.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.589 0.233 . . . . 71.33 110.642 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 52.3 m-80 -83.06 122.04 27.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.214 -0.448 . . . . 44.45 110.243 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 5' ' ' ILE . 68.2 mt -131.11 133.3 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.063 0.458 . . . . 74.3 110.022 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.7 tp60 -79.79 106.47 11.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.573 -0.739 . . . . 75.14 109.168 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 118' ' ' SER . 15.9 mm -76.79 102.92 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.136 -0.32 . . . . 41.21 110.136 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.3 -39.62 8.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 32.44 110.281 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -152.14 142.29 22.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.686 . . . . 41.32 110.207 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -114.28 134.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.91 -0.404 . . . . 64.23 109.91 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 49.5 mt-10 -110.75 129.72 55.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.988 0.423 . . . . 70.24 110.999 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 mt -109.78 120.82 43.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.418 -0.586 . . . . 75.41 109.418 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -102.99 103.62 34.96 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.912 -0.586 . . . . 73.12 109.751 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 8.4 Cg_exo . . . . . 0 N--CA 1.464 -0.234 0 C-N-CA 122.947 2.432 . . . . 61.43 111.339 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.939 0.399 . . . . 61.14 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 18.6 Cg_endo -93.37 23.63 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.527 2.818 . . . . 73.44 112.979 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.66 125.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 75.53 110.075 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -107.28 -46.21 3.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 74.0 111.145 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG11 ' HE ' ' A' ' 102' ' ' ARG . 34.2 t -129.34 139.87 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.572 -0.285 . . . . 74.12 110.82 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.11 144.99 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.343 -0.389 . . . . 74.4 110.15 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.5 mt-10 -119.06 131.13 55.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.93 0.395 . . . . 74.0 110.595 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.89 136.03 51.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.113 -0.494 . . . . 75.53 110.772 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.24 152.52 49.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.507 -0.315 . . . . 53.41 110.851 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.23 51.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.327 -0.397 . . . . 75.41 110.264 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -149.95 153.81 37.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.196 0.522 . . . . 63.01 111.076 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 52.3 mt-10 -97.54 -24.82 15.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 65.44 110.937 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.82 -1.4 8.4 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.859 -0.336 . . . . 61.42 111.489 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.17 1.81 3.8 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.205 0.526 . . . . 74.24 111.396 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -96.8 -58.45 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.477 0.656 . . . . 71.21 110.068 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.79 106.39 18.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.096 -0.956 . . . . 62.02 109.824 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -97.31 125.15 41.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.157 0.503 . . . . 70.43 111.409 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 95.4 m -109.02 123.78 35.97 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.73 -0.668 . . . . 71.31 110.135 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 29.8 Cg_endo -64.31 120.76 8.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.412 2.075 . . . . 75.24 111.578 176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 HG21 ' A' ' 116' ' ' VAL . 15.1 pt -86.41 -16.03 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.152 -0.477 . . . . 63.4 110.65 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.56 143.84 3.85 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.492 -0.861 . . . . 64.04 112.899 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.578 ' HE ' HG11 ' A' ' 85' ' ' VAL . 73.7 ttt180 -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.216 -0.661 . . . . 64.53 109.216 173.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HE2' HG12 ' A' ' 116' ' ' VAL . 97.1 m-85 -137.56 174.11 10.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 71.03 111.449 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.32 138.56 14.26 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.756 -0.656 . . . . 71.33 112.21 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -93.17 148.45 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 74.11 110.09 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' HD11 ' A' ' 112' ' ' LEU . 33.7 m -144.83 110.14 5.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.072 -0.513 . . . . 74.14 109.908 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -70.03 97.09 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.326 0.584 . . . . 75.52 109.931 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.573 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 11.1 pt20 -130.8 -179.69 5.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.449 -0.796 . . . . 74.53 110.713 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.74 -24.41 41.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.557 . . . . 74.34 110.949 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.39 151.87 20.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 71.32 110.988 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.12 129.98 41.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 45.32 110.542 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -80.56 104.9 11.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.703 . . . . 54.33 110.501 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -85.26 108.73 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.104 0.478 . . . . 73.34 110.51 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -101.34 106.82 18.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.834 -0.621 . . . . 74.35 110.679 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -72.3 104.92 3.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 74.33 109.623 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.571 HG21 HD12 ' A' ' 100' ' ' ILE . 31.6 m -111.13 -176.54 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.068 0.461 . . . . 74.14 111.776 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.91 117.07 7.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.475 -0.784 . . . . 52.14 110.109 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 22.0 m -70.39 113.68 7.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 35.12 110.718 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.12 144.94 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 73.24 110.464 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.593 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -86.26 126.03 34.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 72.11 109.42 175.566 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -151.43 166.72 30.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.636 -0.256 . . . . 53.11 111.029 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -107.16 -30.48 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.362 0.601 . . . . 72.05 109.867 173.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -109.21 145.41 35.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.752 -0.658 . . . . 73.23 110.481 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.0 tt -133.21 138.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 73.34 109.432 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.487 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 13.0 ttp180 -127.83 130.77 49.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 74.05 111.249 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.14 114.89 29.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.381 -0.827 . . . . 74.53 109.601 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.7 m -109.11 125.23 51.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.202 0.525 . . . . 73.53 111.104 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 38.6 mm -103.96 95.96 8.63 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.056 -0.72 . . . . 73.14 109.056 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.7 Cg_endo -75.92 157.38 38.95 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.821 2.347 . . . . 73.41 113.087 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.23 63.52 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 54.43 108.58 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.27 122.53 2.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 50.53 110.227 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.85 -1.9 21.39 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.834 -0.698 . . . . 52.32 112.314 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.17 21.5 7.67 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.905 -0.664 . . . . 54.15 112.691 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -79.31 146.19 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 73.41 111.737 -175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.6 m -113.47 174.43 5.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.486 -0.779 . . . . 71.12 109.608 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 18.8 p -79.16 -14.36 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 53.44 111.716 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 48.1 t -84.38 104.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.969 0.414 . . . . 74.11 110.219 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.26 130.84 55.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.24 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.84 105.16 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.102 0.477 . . . . 71.53 111.289 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.34 133.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.803 -0.814 . . . . 73.13 108.803 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.864 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 71.1 mtm180 -74.25 -57.63 3.82 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.517 -0.473 . . . . 64.45 111.278 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.13 148.43 28.27 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.551 -0.86 . . . . 42.44 112.239 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 72' ' ' LEU . 7.8 tt -105.85 120.93 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.551 -1.204 . . . . 71.11 108.31 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.6 t70 -117.81 162.03 18.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.361 -0.607 . . . . 64.33 109.361 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 5' ' ' ILE . 59.9 t -126.08 123.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.197 0.522 . . . . 73.12 110.422 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 4' ' ' THR . 47.0 mttt -99.67 76.03 1.96 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.558 0.694 . . . . 63.41 109.389 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -124.05 -146.19 6.91 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.911 -1.04 . . . . 54.34 111.785 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.4 m -135.86 134.0 38.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.803 0.335 . . . . 54.31 110.704 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 40.4 mm -72.0 130.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 70.45 110.94 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' A' ' 66' ' ' GLN . 20.5 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.069 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 108.604 -0.887 . . . . 72.01 108.604 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 HD13 ' A' ' 65' ' ' ILE . 47.3 mm -60.81 128.49 22.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.701 0.286 . . . . 73.34 111.13 -173.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -67.5 119.43 12.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.105 0.478 . . . . 75.34 109.841 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -95.44 4.33 53.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.731 -0.668 . . . . 72.12 110.647 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -73.43 93.4 1.96 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.736 . . . . 74.43 109.442 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.34 -16.2 4.39 Favored Glycine 0 C--N 1.316 -0.583 0 CA-C-N 115.28 -0.873 . . . . 72.1 111.476 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -68.92 150.64 47.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.752 -0.462 . . . . 73.04 109.752 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.3 pt-20 -132.37 157.71 43.81 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.319 0.581 . . . . 74.24 110.924 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.74 110.04 25.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 54.33 109.645 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 HG12 ' A' ' 58' ' ' VAL . 81.6 mt -72.43 -48.95 37.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.801 -0.636 . . . . 75.34 110.612 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -149.94 142.85 24.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.666 -0.697 . . . . 62.23 110.527 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 38.2 p90 -138.77 148.54 43.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 74.21 109.837 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m -88.26 -37.91 15.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.739 0.304 . . . . 53.13 111.029 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 145.88 31.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.148 0.499 . . . . 61.34 110.859 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -154.94 151.75 28.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 50.41 108.781 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -124.56 92.35 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.153 0.501 . . . . 73.01 111.064 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.59 -18.74 21.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.736 -0.666 . . . . 70.13 111.239 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 m -91.72 -40.37 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 61.33 110.863 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.639 0 C-N-CA 120.898 -0.668 . . . . 72.22 112.934 -178.884 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.129 -0.323 . . . . 65.12 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 -5.95 66.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.378 -0.439 . . . . 25.34 112.119 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 77.1 mt -75.15 148.45 39.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.566 -0.317 . . . . 73.25 110.321 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.74 63.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.402 -0.363 . . . . 74.31 111.264 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.75 -25.68 44.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.506 -0.315 . . . . 61.41 110.888 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.844 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.9 m -64.84 -25.79 68.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 70.51 110.455 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 143' ' ' LEU . 34.4 tp -64.24 -22.22 66.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 74.42 110.827 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 59' ' ' ILE . 40.1 pt -125.79 15.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 74.43 110.363 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.844 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 4.6 t70 -75.38 -37.3 60.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 52.4 110.528 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.92 23.93 7.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.472 -0.871 . . . . 63.11 112.299 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.3 109.58 7.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.273 -0.64 . . . . 73.1 109.273 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.7 p -68.7 -21.16 64.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.214 -0.448 . . . . 62.0 111.923 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HA ' HH21 ' A' ' 141' ' ' ARG . 61.4 mm-40 -72.56 -26.88 61.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.925 -0.31 . . . . 61.23 110.422 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -89.3 152.09 21.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.755 -0.831 . . . . 72.11 108.755 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.707 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 47.2 p90 -148.93 174.96 11.7 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.307 -0.557 . . . . 72.4 111.333 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' HD11 ' A' ' 57' ' ' ILE . 39.0 t90 -107.82 135.67 48.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.559 -0.746 . . . . 64.35 109.046 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.442 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 48.5 t-80 -135.14 145.01 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.687 -0.486 . . . . 72.13 109.687 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.53 146.6 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.952 -0.567 . . . . 55.01 109.944 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -60.29 133.6 56.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.401 . . . . 74.43 110.787 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -139.7 -26.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 73.3 111.553 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -62.42 -42.02 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 64.25 110.255 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.77 32.09 6.21 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 75.11 111.91 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.37 148.41 13.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 63.43 111.83 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -81.94 156.63 24.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.2 0.524 . . . . 61.41 111.114 -178.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -91.39 162.36 32.14 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 75.44 110.587 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.35 139.18 31.46 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.736 2.291 . . . . 63.12 112.791 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.03 159.88 69.81 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 62.4 110.157 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.773 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.4 Cg_endo -79.66 161.28 86.78 Favored 'Cis proline' 0 C--N 1.343 0.273 0 C-N-CA 123.622 -1.408 . . . . 62.41 112.975 0.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -95.75 108.81 21.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.112 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -108.72 116.91 32.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.955 0.407 . . . . 74.35 110.634 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 126' ' ' LEU . 60.9 mt -109.81 108.61 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.96 -0.564 . . . . 73.13 109.636 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 125' ' ' ARG . 48.1 t -97.94 116.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.512 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 34' ' ' ILE . 68.5 mt -115.52 137.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.726 -0.67 . . . . 73.02 110.615 -175.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -101.84 122.21 43.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 61.15 109.697 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.4 mtm -87.33 -8.5 56.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 64.23 110.611 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.2 mmtt 67.97 7.55 5.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.719 . . . . 72.24 112.26 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 5.7 pt20 -161.26 163.03 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.43 -0.211 . . . . 63.11 110.43 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.413 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 43.9 m-80 -83.97 126.17 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.85 -0.426 . . . . 74.02 109.85 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 5' ' ' ILE . 61.3 mt -132.01 136.88 55.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.033 0.444 . . . . 72.34 110.701 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -84.38 101.74 12.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.826 -0.805 . . . . 74.23 108.826 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.2 mm -71.56 127.33 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.327 -0.397 . . . . 62.1 110.306 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.26 -46.1 2.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 72.32 110.875 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -144.51 144.91 31.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.687 0.28 . . . . 75.11 110.847 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.89 132.27 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.232 -0.655 . . . . 73.52 109.232 173.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.716 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 26.8 tt0 -115.08 127.97 55.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.933 0.397 . . . . 74.31 110.367 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 114' ' ' TYR . 57.2 mt -115.72 117.75 31.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.954 -0.566 . . . . 72.03 110.16 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.6 tp -110.08 100.16 42.5 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.404 -0.362 . . . . 73.34 110.439 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 105' ' ' PHE . 29.5 Cg_endo . . . . . 0 N--CA 1.452 -0.957 0 C-N-CA 122.84 2.36 . . . . 54.3 110.465 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.102 0.477 . . . . 63.4 111.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 1.1 Cg_endo -82.55 59.53 6.92 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.283 2.655 . . . . 71.23 113.225 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.4 mt -98.41 119.37 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.078 0.466 . . . . 54.25 109.821 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 25.7 mmmt -97.52 -56.41 2.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.716 -0.675 . . . . 64.25 111.4 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -121.89 139.65 48.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.319 -0.4 . . . . 65.3 110.347 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.61 133.41 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.888 0.375 . . . . 62.35 110.02 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 20.7 tt0 -121.5 128.72 52.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.911 -0.586 . . . . 71.03 110.095 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -112.07 129.38 56.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.071 -0.513 . . . . 63.14 109.961 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.76 151.72 41.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.464 -0.334 . . . . 74.44 110.273 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.34 149.49 45.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.175 -0.466 . . . . 61.25 110.185 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -147.12 148.0 31.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.271 -0.422 . . . . 53.04 110.232 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -87.04 -32.55 19.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.714 0.292 . . . . 62.32 110.992 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -132.63 16.11 4.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.573 -0.285 . . . . 61.51 111.632 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.2 t30 59.49 58.5 2.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.727 0.775 . . . . 70.1 110.308 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.26 -71.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.162 -0.926 . . . . 73.43 108.917 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -90.46 118.67 30.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.781 -0.645 . . . . 65.25 109.666 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.97 107.78 19.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.083 0.468 . . . . 75.43 110.744 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.8 m -93.84 125.99 51.11 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.802 -0.635 . . . . 63.41 110.212 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.66 104.01 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.543 2.162 . . . . 71.45 111.662 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.0 -23.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.105 -0.498 . . . . 64.33 110.901 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -169.69 128.33 1.64 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.209 -0.996 . . . . 22.45 113.004 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 2.4 tmt_? -124.29 115.0 20.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 74.14 108.649 171.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -141.4 -177.11 4.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.91 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.31 143.76 16.81 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.804 -0.634 . . . . 74.14 111.754 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.453 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 53.3 t80 -96.68 120.97 37.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 62.41 110.772 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.636 ' HB ' HD21 ' A' ' 112' ' ' LEU . 23.0 m -97.75 109.64 22.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 71.04 110.145 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.38 98.57 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 74.33 110.468 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -139.55 174.36 10.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 60.04 109.737 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.31 5.34 50.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.192 0.52 . . . . 70.1 110.707 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.65 152.63 24.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.596 -0.729 . . . . 62.4 109.672 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -73.93 124.96 27.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.03 0.443 . . . . 61.25 111.316 -175.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 106' ' ' THR . 35.9 mt -77.49 124.35 27.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.729 . . . . 74.32 110.594 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -95.11 109.55 21.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 73.01 110.681 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 91.8 m-85 -102.47 109.57 21.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.508 . . . . 74.5 110.474 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -81.13 90.19 6.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.602 . . . . 71.4 109.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 101' ' ' GLY . 26.8 m -87.62 -177.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.211 -0.904 . . . . 71.25 111.45 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -72.87 128.74 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.585 -0.734 . . . . 73.15 110.863 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 4.5 m -68.53 114.68 7.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.201 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 tt -153.53 148.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 74.43 110.532 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.53 126.26 35.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.767 -0.457 . . . . 73.34 109.767 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.61 165.22 29.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.442 -0.344 . . . . 53.44 110.831 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 37.1 ttt180 -115.39 -26.35 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.519 0.676 . . . . 73.14 109.744 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -116.07 146.33 42.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 74.14 109.653 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -132.83 140.48 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.962 -0.384 . . . . 74.22 109.962 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.813 ' HG3' HG22 ' A' ' 58' ' ' VAL . 5.6 ttm180 -126.38 132.09 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.816 0.341 . . . . 72.3 111.166 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 57' ' ' ILE . 56.2 tp -98.2 118.18 34.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.088 -0.708 . . . . 52.22 109.088 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 95.5 m -115.38 125.05 52.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.158 0.504 . . . . 73.41 111.321 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 39.7 mm -105.1 90.21 3.55 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.431 -0.951 . . . . 73.41 108.431 171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.773 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 83.6 Cg_endo -86.87 150.49 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.734 2.29 . . . . 61.42 113.138 -174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -81.77 61.52 5.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.893 0.854 . . . . 64.54 108.782 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -104.32 -42.67 5.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.877 -1.056 . . . . 75.54 112.23 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.61 29.67 4.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.82 -1.181 . . . . 75.22 113.992 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.23 25.18 9.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.181 -1.009 . . . . 74.34 112.963 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.3 131.32 43.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 63.25 111.358 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 m -93.65 174.68 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 74.35 110.188 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 3.3 p -85.88 19.07 2.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.007 0.432 . . . . 63.05 111.926 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t -125.92 124.36 66.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.843 -0.429 . . . . 61.24 109.843 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.79 135.94 26.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.538 -0.301 . . . . 65.24 110.417 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -137.12 105.99 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 64.44 111.514 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.6 mt -122.31 133.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.114 -0.699 . . . . 74.42 109.114 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.707 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 67.5 mtp180 -82.59 -45.84 14.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.092 0.473 . . . . 71.3 110.305 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.89 129.37 13.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.757 -0.656 . . . . 74.41 110.953 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 8.9 tt -109.56 118.36 36.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.625 -0.88 . . . . 74.11 108.625 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 149.98 42.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.007 0.432 . . . . 63.03 110.86 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.25 135.03 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.983 -0.553 . . . . 75.23 110.341 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -111.66 120.33 41.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.004 -0.739 . . . . 73.12 109.004 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.35 -159.9 16.2 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 62.22 111.847 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.0 m -120.84 130.82 54.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.588 0.232 . . . . 71.23 110.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 5' ' ' ILE . 33.6 mm -74.78 127.54 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 61.5 110.143 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.8 mt . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 109.747 -0.464 . . . . 44.02 109.747 179.116 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.628 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 71.4 p . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 120.989 0.423 . . . . 74.41 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 HD11 ' A' ' 149' ' ' ILE . 48.0 mm -88.36 136.48 23.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.698 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -64.26 109.41 1.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 71.45 109.958 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.51 -1.01 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 75.14 111.51 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -70.24 91.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.415 0.626 . . . . 52.04 109.835 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.75 -17.99 2.8 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.279 -0.873 . . . . 75.34 111.735 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -68.02 155.49 39.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 74.33 109.698 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -140.08 153.17 46.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.338 -0.545 . . . . 72.21 111.145 175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.31 107.97 19.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.283 -0.871 . . . . 64.42 109.478 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 58' ' ' VAL . 83.5 mt -73.61 -47.12 42.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.725 -0.67 . . . . 72.11 110.437 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -143.28 139.38 30.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 51.42 110.167 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.62 140.17 36.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.465 -0.568 . . . . 74.42 109.465 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -84.61 -28.67 26.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.848 0.356 . . . . 75.33 110.991 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 t -162.19 149.7 14.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.877 0.37 . . . . 63.11 110.887 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -165.85 137.5 3.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.53 -0.759 . . . . 75.41 109.107 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 9.8 tp10 -105.17 95.0 5.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.011 0.434 . . . . 53.41 111.434 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -92.58 -31.48 15.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.25 110.572 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -79.66 -42.21 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 73.13 110.867 -173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.642 0 C-N-CA 120.947 -0.644 . . . . 62.44 112.7 -177.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 CA--C 1.515 -0.383 0 N-CA-C 110.017 -0.364 . . . . 71.42 110.017 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.38 -8.04 79.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.088 -0.577 . . . . 74.51 112.759 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.6 mt -73.27 144.65 46.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.322 -0.251 . . . . 71.15 110.322 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.7 -23.63 66.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.02 0.438 . . . . 65.34 110.923 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -75.4 -23.87 57.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 65.35 110.988 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 57.8 m -67.15 -25.38 66.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 53.21 110.417 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.37 -26.75 66.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.724 . . . . 74.32 110.522 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 59' ' ' ILE . 31.9 pt -121.27 12.19 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 73.41 110.723 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t70 -71.08 -36.66 72.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 72.32 109.719 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.94 52.97 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.499 -0.858 . . . . 52.33 113.42 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.629 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 8.3 t0 -149.3 135.16 18.82 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.842 -0.429 . . . . 64.21 109.842 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.6 p -81.55 10.77 5.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.604 -0.725 . . . . 75.42 112.64 -172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 13.0 pt-20 -118.45 -7.7 10.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.525 -0.47 . . . . 73.41 111.315 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p -96.71 166.9 11.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.504 -0.554 . . . . 74.32 109.504 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.521 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 50.6 p90 -161.82 165.28 28.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.269 0.557 . . . . 72.01 112.25 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 32.1 t90 -109.65 139.41 44.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.763 -1.108 . . . . 75.22 108.966 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.68 142.4 43.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.06 151.81 45.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.316 -0.402 . . . . 71.11 110.221 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -62.51 125.76 25.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.039 -0.356 . . . . 65.34 110.039 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 68.7 p-90 -126.22 -34.02 2.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 72.44 110.616 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -75.61 108.6 8.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.622 -0.511 . . . . 72.24 109.622 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.43 -20.54 46.4 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.769 -0.729 . . . . 45.11 111.462 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.6 167.8 11.34 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.677 -0.773 . . . . 53.53 112.001 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 54.8 m -115.03 149.77 36.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 60.45 110.503 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.56 152.5 66.99 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 73.42 110.076 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.02 142.8 35.16 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.216 1.944 . . . . 72.1 112.738 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.14 156.69 87.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 71.44 110.002 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.59 170.24 65.41 Favored 'Cis proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.627 -1.406 . . . . 70.22 113.437 2.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -110.37 129.94 55.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.035 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 15.8 m-20 -118.43 130.05 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.882 0.372 . . . . 75.11 110.505 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 126' ' ' LEU . 60.6 mt -121.25 108.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 53.41 109.681 173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 13' ' ' LEU . 40.8 t -95.93 119.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.907 -0.588 . . . . 62.33 110.23 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 34' ' ' ILE . 61.3 mt -119.28 133.03 67.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.279 -0.419 . . . . 74.3 110.94 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.7 t0 -100.05 120.88 40.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 74.12 109.633 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE1' HD11 ' A' ' 67' ' ' ILE . 70.5 mtm -86.78 -4.88 59.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 60.13 111.01 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.51 0.07 3.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.181 0.808 . . . . 75.33 113.181 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -159.94 173.75 15.44 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.298 -0.251 . . . . 75.24 110.734 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -82.67 122.75 28.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 71.42 109.906 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 5' ' ' ILE . 64.9 mt -132.59 135.31 57.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 75.23 110.322 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.517 HE21 ' HB3' ' A' ' 118' ' ' SER . 57.2 tp60 -83.16 104.31 13.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.046 -0.724 . . . . 64.32 109.046 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.1 mm -73.6 121.75 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.414 -0.357 . . . . 64.33 110.288 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.2 -36.33 4.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.053 0.454 . . . . 73.33 110.748 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 31.1 tt0 -153.44 143.25 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.884 -0.598 . . . . 72.21 110.813 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -114.7 138.43 44.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.355 -0.609 . . . . 74.03 109.355 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.4 mt-10 -117.31 133.62 55.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 73.53 111.3 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.34 122.78 45.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.793 -0.639 . . . . 74.21 109.687 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 tp -106.25 106.48 57.36 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.239 -0.437 . . . . 65.04 110.043 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 C-N-CA 122.724 2.283 . . . . 55.24 111.127 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.346 -0.613 . . . . 71.41 109.346 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.817 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 2.8 Cg_exo -77.89 31.05 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.369 2.713 . . . . 71.14 112.24 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' PHE . 30.8 mt -95.1 112.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 75.11 109.4 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -100.56 -44.76 5.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.005 -0.543 . . . . 55.33 110.643 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG11 ' HE ' ' A' ' 102' ' ' ARG . 58.6 t -127.32 138.39 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 73.12 110.865 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 m -128.5 140.74 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 71.35 110.364 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -118.12 129.17 55.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.145 -0.48 . . . . 71.04 110.654 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -112.04 130.18 55.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 74.54 110.234 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.05 148.46 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.803 0.335 . . . . 50.22 111.031 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 148.39 52.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 71.31 109.979 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 154.94 38.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.118 0.485 . . . . 63.55 111.458 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 45.1 mt-10 -105.62 -9.64 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.279 -0.637 . . . . 73.22 109.279 170.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.55 -36.17 8.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 45.33 111.606 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.32 15.15 3.58 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.574 1.178 . . . . 73.41 108.031 -167.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -122.28 -62.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.019 -1.446 . . . . 75.45 109.485 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -89.49 104.85 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.886 -0.597 . . . . 64.44 109.435 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -93.86 117.6 30.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 71.01 111.309 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.6 m -94.18 125.29 53.05 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.641 . . . . 71.12 110.256 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.29 113.92 3.84 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.403 2.069 . . . . 74.14 111.943 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 116' ' ' VAL . 20.9 pt -83.87 -12.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 55.45 110.75 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.07 146.54 4.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.25 -0.976 . . . . 74.24 113.035 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HE ' HG11 ' A' ' 85' ' ' VAL . 69.3 ttt180 -125.99 118.56 25.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.801 -0.815 . . . . 72.11 108.801 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -136.82 -176.14 4.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.019 0.438 . . . . 73.31 111.051 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.48 148.54 18.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.569 -0.742 . . . . 61.51 112.134 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 42.6 t80 -95.81 119.91 35.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 74.32 110.276 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.439 ' HB ' HD21 ' A' ' 112' ' ' LEU . 20.1 m -103.54 110.18 22.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.228 -0.442 . . . . 42.1 110.749 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -64.39 100.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 73.3 110.572 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -139.94 -179.34 5.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 70.2 110.375 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.53 -11.06 35.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.99 0.424 . . . . 72.11 110.975 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.166 -0.47 . . . . 74.35 111.009 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 130.67 43.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.49 . . . . 64.34 110.916 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 106' ' ' THR . 58.8 mt -83.32 109.46 17.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 54.13 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.26 112.46 21.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 74.11 110.94 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.0 104.13 14.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 63.44 110.016 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.431 ' CE1' ' NE2' ' A' ' 69' ' ' GLN . 37.9 m-85 -77.57 91.25 3.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.356 -0.838 . . . . 72.01 109.355 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 100' ' ' ILE . 31.2 m -96.28 -178.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 72.01 112.392 -170.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -65.73 126.49 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.136 -0.938 . . . . 63.33 110.649 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 63.9 m -71.49 123.99 23.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.074 -0.512 . . . . 53.23 110.45 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.059 -0.518 . . . . 62.12 110.286 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.555 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -93.83 113.61 25.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.178 -0.675 . . . . 71.44 109.178 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.06 173.61 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.676 0.274 . . . . 74.33 111.041 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -115.93 -32.36 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.32 0.581 . . . . 71.51 110.512 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.35 145.75 31.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.97 -0.559 . . . . 63.04 110.203 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.7 tt -135.13 138.02 49.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.021 -0.536 . . . . 55.01 109.69 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.3 ttp180 -124.7 125.9 44.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.017 0.437 . . . . 60.11 111.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' ILE . 47.0 tp -93.28 112.79 24.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.491 -0.777 . . . . 54.51 108.979 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.3 m -111.81 123.09 49.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.39 0.614 . . . . 71.15 111.151 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.98 100.49 11.53 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.649 -0.871 . . . . 71.1 108.649 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.6 164.88 24.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.718 2.279 . . . . 74.52 112.98 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.69 14.71 24.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.153 0.977 . . . . 73.33 108.855 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -125.08 134.58 52.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.905 -1.043 . . . . 74.11 110.389 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.78 -9.92 14.21 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.941 -0.647 . . . . 41.14 112.445 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.72 23.54 6.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.773 -0.727 . . . . 70.3 112.147 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -79.96 144.79 33.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.771 0.32 . . . . 64.43 110.789 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 24.5 m -117.47 177.28 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.169 -0.469 . . . . 24.13 110.458 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 32.4 p -79.13 -3.12 43.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 45.52 111.814 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.817 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 87.4 t -95.23 121.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.373 -0.376 . . . . 75.41 110.081 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.32 128.65 17.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 73.23 110.428 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.96 106.22 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.411 . . . . 53.31 110.674 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.51 132.95 67.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.001 -0.74 . . . . 62.22 109.001 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 92.9 mtt180 -70.98 -59.41 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.724 -0.39 . . . . 63.41 110.884 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.1 157.63 40.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.759 0.79 . . . . 73.01 112.097 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.85 133.28 56.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.454 -1.248 . . . . 62.13 107.736 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.628 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -130.77 170.3 14.55 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.579 -0.448 . . . . 72.12 109.844 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.1 t -141.38 128.11 20.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.937 -0.394 . . . . 62.1 109.937 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.2 mttm -97.91 124.41 42.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.433 -0.951 . . . . 75.3 108.433 172.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.64 -167.13 26.85 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.282 -0.961 . . . . 24.13 112.052 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 m -119.17 126.76 52.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.767 0.317 . . . . 74.44 110.501 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 5' ' ' ILE . 41.4 mm -70.66 127.15 32.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.036 -0.529 . . . . 73.22 110.005 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 120' ' ' LYS . 47.4 mt . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.373 . . . . 65.33 110.212 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.644 0.259 . . . . 75.22 110.474 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.609 HG21 HD13 ' A' ' 65' ' ' ILE . 51.1 mm -86.2 132.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.538 -0.301 . . . . 61.23 110.578 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -72.81 120.23 18.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.627 . . . . 61.41 109.306 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -82.24 29.49 0.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 63.02 111.017 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -79.01 95.96 5.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.661 -0.699 . . . . 64.43 110.222 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.86 -9.02 9.16 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 71.42 112.265 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.462 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.2 m0 -69.67 134.34 48.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.983 -0.377 . . . . 74.1 109.983 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' OE2' ' HE2' ' A' ' 62' ' ' LYS . 13.5 pt-20 -132.41 160.92 34.96 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.764 -0.374 . . . . 72.12 110.567 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -95.71 125.39 48.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.224 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 60' ' ' ASP . 77.7 mt -90.5 -44.54 9.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.132 0.492 . . . . 75.1 110.303 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -142.2 137.22 30.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.752 -0.658 . . . . 72.34 110.316 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.57 144.33 34.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.411 . . . . 61.42 110.138 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.8 m -80.15 -51.31 9.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 71.22 110.858 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.4 t -142.7 150.17 39.79 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.98 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -164.94 142.82 6.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.471 -0.937 . . . . 74.23 108.471 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 9.1 tp10 -103.27 107.94 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.7 -0.4 . . . . 72.42 111.029 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -114.34 -5.88 12.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 72.42 111.332 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -111.74 -40.03 4.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.401 -0.363 . . . . 73.14 110.837 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 121.002 -0.618 . . . . 60.41 112.038 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.577 HD21 ' N ' ' A' ' 27' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.885 0.374 . . . . 73.41 110.055 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.19 -10.8 60.09 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.481 -0.648 . . . . 70.21 111.481 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 89.7 mt -74.49 147.11 42.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.617 -0.291 . . . . 74.45 110.273 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.64 -24.06 64.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.044 0.449 . . . . 43.44 110.995 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -72.56 -26.91 61.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.755 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.3 m -70.57 -17.78 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 71.51 110.867 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.14 -20.58 66.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.544 0.687 . . . . 71.15 110.067 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 10' ' ' TRP . 40.2 pt -131.24 18.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.759 -0.655 . . . . 73.22 110.267 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 1.008 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -71.57 -30.44 65.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.026 -0.534 . . . . 54.21 110.651 -172.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.53 33.97 5.44 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.842 -0.694 . . . . 73.15 112.33 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 39' ' ' GLU . 8.8 t0 -153.32 124.4 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.695 -0.484 . . . . 73.33 109.695 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 p -77.53 -3.45 40.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.298 0.481 . . . . 20.12 112.298 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 16.9 mm-40 -83.34 -24.02 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.751 0.31 . . . . 61.51 110.208 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.4 p -93.93 165.06 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.958 -0.386 . . . . 72.14 109.958 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 52.8 p90 -163.92 172.01 14.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.296 . . . . 65.14 110.91 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 42.8 t90 -112.28 134.02 54.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.554 -0.748 . . . . 70.23 109.292 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.6 137.01 45.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.118 -0.697 . . . . 75.13 109.118 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 144.65 56.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.957 -0.386 . . . . 32.44 109.957 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.43 137.14 57.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.913 -0.585 . . . . 54.32 110.11 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -138.35 -13.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 75.51 110.9 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -67.59 101.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.127 0.489 . . . . 73.52 110.65 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.82 90.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.896 -0.669 . . . . 75.41 112.256 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.99 177.21 14.82 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.818 -0.706 . . . . 60.3 111.599 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 t -125.0 175.12 7.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.093 0.473 . . . . 72.44 110.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 17.0 m-20 -97.97 146.49 31.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 72.12 110.116 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.31 145.85 61.1 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.764 2.31 . . . . 74.32 112.835 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 21.0 mt -80.61 159.51 69.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.697 -0.683 . . . . 72.03 109.968 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.4 Cg_endo -78.42 158.61 92.91 Favored 'Cis proline' 0 C--N 1.344 0.307 0 C-N-CA 123.631 -1.404 . . . . 72.41 113.125 1.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.711 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.0 m-30 -91.08 129.93 37.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 74.23 109.974 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 11.8 t70 -121.07 124.96 46.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.202 -0.454 . . . . 62.42 109.955 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.39 117.15 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.92 0.391 . . . . 72.42 110.4 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.35 116.68 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 61.33 110.842 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.4 mp -107.82 136.69 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.517 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.499 ' HB2' HD11 ' A' ' 13' ' ' LEU . 39.8 t0 -104.47 122.75 46.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 61.42 109.791 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -90.12 -4.34 57.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 71.4 110.881 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HE2' ' OE2' ' A' ' 11' ' ' GLU . 33.4 mmtp 71.74 -6.99 1.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.456 0.702 . . . . 72.32 112.601 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -152.77 168.18 26.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.189 -0.3 . . . . 73.03 110.189 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.551 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 47.2 m-80 -85.58 125.43 33.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 71.01 110.344 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.609 HD13 HG21 ' A' ' 5' ' ' ILE . 62.0 mt -130.34 136.75 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.973 -0.558 . . . . 55.21 109.881 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.5 tp60 -83.19 100.53 10.63 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.901 -0.777 . . . . 74.31 108.901 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.735 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -66.89 130.92 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.378 -0.374 . . . . 73.53 110.318 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.71 -46.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.934 0.397 . . . . 73.42 110.943 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 19.3 tt0 -138.79 149.42 44.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.631 -0.507 . . . . 65.14 109.631 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.89 127.57 73.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.82 -0.437 . . . . 72.14 109.82 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 1.9 mp0 -108.66 131.79 54.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.333 0.587 . . . . 72.35 111.048 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 60.1 mt -111.66 119.27 38.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 174.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 27.0 tp -102.32 96.45 7.17 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.256 -0.646 . . . . 62.13 109.256 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.1 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 C-N-CA 123.259 2.64 . . . . 61.35 112.154 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 138' ' ' ALA . 65.4 t30 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 121.194 0.521 . . . . 71.0 111.543 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 4.4 Cg_exo -75.79 55.6 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.343 2.696 . . . . 71.12 113.672 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.7 mt -99.51 115.61 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.089 -0.708 . . . . 71.24 109.089 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -100.44 -48.36 4.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.829 0.347 . . . . 73.54 110.832 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.16 139.82 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.1 110.466 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 105' ' ' PHE . 5.1 m -130.08 143.32 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.984 0.421 . . . . 63.45 110.885 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 38.1 mt-10 -125.31 130.5 52.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.071 -0.513 . . . . 71.13 110.849 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -113.22 132.48 55.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.484 . . . . 73.22 110.554 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.14 154.69 50.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.393 -0.367 . . . . 34.41 110.503 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.29 156.78 47.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 61.42 109.921 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 t -149.65 143.82 25.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 45.12 110.555 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -93.37 -41.75 9.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.004 -0.544 . . . . 74.25 110.781 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -109.2 3.56 21.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.833 -0.621 . . . . 64.51 110.992 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 23.7 t-20 75.53 -9.64 1.38 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.559 0.744 . . . . 70.43 111.055 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.08 -42.98 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 62.03 110.815 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.68 106.76 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 31.13 110.043 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.4 m95 -99.58 120.41 39.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 73.32 110.572 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.3 m -113.36 126.14 28.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.265 -0.425 . . . . 64.33 110.586 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.75 113.7 2.86 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.445 2.097 . . . . 61.43 111.126 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 116' ' ' VAL . 12.8 pt -82.17 -11.52 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.771 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.92 142.97 3.54 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.496 -0.859 . . . . 51.33 112.546 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.514 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 34.3 ttt180 -119.0 125.13 48.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.433 -0.58 . . . . 71.32 109.433 175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -140.28 -176.17 4.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.048 0.451 . . . . 71.22 110.718 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.81 155.55 20.08 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.435 -0.666 . . . . 53.33 111.435 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.491 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 52.1 t80 -103.27 135.33 45.12 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.898 0.38 . . . . 74.22 110.189 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.457 ' O ' HD11 ' A' ' 112' ' ' LEU . 34.3 m -116.04 116.55 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.483 -0.562 . . . . 72.0 109.483 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.68 93.6 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.273 0.559 . . . . 73.24 110.282 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -131.54 177.15 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.325 -0.852 . . . . 72.42 108.867 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.28 -8.74 35.08 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.49 -0.484 . . . . 73.13 110.252 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.62 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.808 -0.633 . . . . 54.33 110.223 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.31 128.48 35.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.11 0.481 . . . . 75.31 111.773 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 41.6 mt -84.96 125.68 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.06 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -98.0 115.32 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.969 0.414 . . . . 52.24 110.789 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.83 107.27 17.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.154 -0.475 . . . . 64.43 110.257 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.06 92.1 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.746 -0.661 . . . . 74.31 109.49 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 100' ' ' ILE . 28.9 m -98.56 176.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.796 . . . . 61.51 111.937 -171.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.89 134.23 52.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.379 -0.828 . . . . 61.31 110.594 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.735 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 19.2 m -77.28 117.72 19.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.071 -0.513 . . . . 74.1 110.7 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.62 143.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.982 -0.554 . . . . 75.33 110.802 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.551 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.522 -0.547 . . . . 74.03 109.522 173.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.58 159.72 44.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.211 -0.45 . . . . 61.33 110.944 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.433 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 39.9 ttt180 -107.53 -27.47 10.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.45 0.643 . . . . 72.53 109.728 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 94' ' ' ASN . 71.8 m-85 -114.17 146.26 40.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.691 -0.686 . . . . 74.24 110.071 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.503 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.3 tt -133.62 140.3 46.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.452 -0.573 . . . . 70.04 109.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 49.6 ttp180 -127.97 124.54 37.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 72.45 111.394 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.3 tp -95.24 120.28 35.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.315 -0.857 . . . . 45.54 109.428 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -114.84 122.23 45.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 70.04 110.804 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.6 mm -102.24 97.19 8.13 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.87 -0.789 . . . . 72.14 108.87 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -73.48 -173.48 1.33 Allowed 'Trans proline' 0 CA--C 1.522 -0.123 0 C-N-CA 122.938 2.425 . . . . 74.43 113.058 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 16.2 t0 -129.26 75.36 1.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 65.52 108.4 166.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.53 -50.94 2.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.273 -0.876 . . . . 71.31 112.094 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.4 28.77 7.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.24 -0.981 . . . . 74.52 113.916 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 106.55 26.06 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.858 -1.163 . . . . 64.11 113.007 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 6.5 m-20 -70.81 132.12 44.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.725 0.298 . . . . 62.52 110.281 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 m -109.54 179.37 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.5 -0.318 . . . . 73.24 111.045 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 p -90.02 16.05 9.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.368 0.604 . . . . 65.21 111.544 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.471 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 78.2 t -110.43 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.014 -0.539 . . . . 72.13 109.65 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . . . -135.38 130.97 35.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.498 -0.319 . . . . 73.11 110.566 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.3 106.11 5.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.085 0.469 . . . . 71.45 110.879 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.8 mt -129.46 135.79 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.817 -0.629 . . . . 72.24 109.432 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 57.5 mtt180 -66.95 -71.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 75.42 110.096 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -145.42 162.42 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.544 0.688 . . . . 75.12 111.98 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.88 124.7 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.507 -1.224 . . . . 75.32 108.18 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -126.35 162.17 26.14 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.637 -0.505 . . . . 72.32 109.637 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.1 t -136.03 134.93 50.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.876 0.37 . . . . 71.41 111.382 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 65.0 mttp -95.76 131.86 41.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.22 -169.65 37.96 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.194 -1.003 . . . . 74.35 112.474 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.2 m -118.81 132.86 56.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.35 -0.241 . . . . 64.21 110.35 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.82 121.37 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 71.1 110.11 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 66' ' ' GLN . 73.5 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 120.979 0.418 . . . . 61.11 110.457 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 109.298 -0.63 . . . . 61.22 109.298 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 149' ' ' ILE . 39.7 mm -71.43 136.45 25.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 71.34 111.067 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.1 m -73.15 109.08 6.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 72.54 109.826 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -85.94 26.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 74.2 111.383 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -6.09 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 43.21 111.463 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.2 2.87 10.59 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.608 -0.806 . . . . 74.32 112.399 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -81.46 134.9 35.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.427 -0.212 . . . . 73.45 110.427 -175.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.3 155.72 45.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.734 -0.386 . . . . 72.53 110.497 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.6 t -90.05 108.27 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.825 -0.625 . . . . 75.3 109.981 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.6 mt -74.77 -49.24 21.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.017 -0.538 . . . . 75.44 110.477 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -143.42 134.18 25.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.726 . . . . 73.4 110.015 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 54.3 p90 -135.33 148.91 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.706 -0.479 . . . . 73.12 109.706 175.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.2 m -86.62 -44.61 11.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.388 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -143.8 144.37 31.76 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.187 0.517 . . . . 50.32 111.077 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -149.92 148.29 28.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 175.042 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 8.5 tp10 -119.4 89.1 3.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.354 0.597 . . . . 50.05 110.963 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . . . -100.38 -21.77 15.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.546 -0.752 . . . . 74.44 110.088 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -83.71 -44.46 14.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.673 -0.694 . . . . 64.4 110.93 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.731 0 C-N-CA 120.911 -0.661 . . . . 72.52 112.35 178.398 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.513 -0.449 0 N-CA-C 109.78 -0.452 . . . . 75.51 109.78 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.31 3.06 90.25 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.709 -0.556 . . . . 74.34 111.709 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 80.6 mt -84.31 144.49 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.273 -0.269 . . . . 72.12 110.273 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.95 -24.51 66.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 74.52 110.409 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 19.4 ptpt -72.74 -25.26 61.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 74.41 111.037 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.855 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 61.2 m -71.58 -18.67 62.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 75.42 110.387 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.23 -15.04 61.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.818 -0.628 . . . . 62.12 110.273 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.23 22.24 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.824 -0.625 . . . . 71.25 109.593 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.855 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 13.6 t70 -72.54 -58.7 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 64.43 110.402 -175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.57 39.25 0.79 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.023 -0.608 . . . . 74.41 112.203 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -148.16 122.58 9.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.866 0.365 . . . . 64.23 110.265 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -74.9 7.14 3.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.101 0.778 . . . . 61.42 113.101 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -106.7 -19.72 13.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.035 -0.266 . . . . 75.44 111.051 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -88.65 168.93 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.03 -0.359 . . . . 72.24 110.03 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 56.2 p90 -161.6 163.62 29.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.036 0.446 . . . . 73.33 111.586 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 32.5 t90 -107.02 143.02 35.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.294 -0.866 . . . . 72.34 109.072 172.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 51.3 t-80 -138.96 145.72 40.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.126 -0.694 . . . . 61.52 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.1 149.73 39.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.118 -0.327 . . . . 64.4 110.118 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 50' ' ' SER . 63.1 tttm -61.06 119.37 8.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.428 -0.351 . . . . 73.31 110.619 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.465 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 69.8 p-90 -118.29 -27.13 6.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 70.35 110.307 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.32 127.25 32.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.729 -0.471 . . . . 75.45 109.729 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.22 89.97 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.725 -0.75 . . . . 65.44 111.828 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.57 148.5 9.0 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.491 -0.643 . . . . 74.42 111.491 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 20.6 m -78.85 150.19 32.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.117 -0.327 . . . . 44.2 110.117 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 2.0 t70 -80.42 145.48 59.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.021 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 20.3 Cg_endo -62.25 129.98 28.84 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.632 2.221 . . . . 71.13 113.327 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.2 158.69 66.5 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 74.24 110.125 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 1.0 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.3 Cg_exo -76.5 161.58 93.48 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 124.284 -1.132 . . . . 75.25 113.295 0.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.1 m-85 -96.11 138.46 33.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 71.41 109.579 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' A' ' 125' ' ' ARG . 6.2 t70 -132.67 123.69 26.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.221 -0.288 . . . . 62.22 110.221 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.39 124.18 66.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.695 0.283 . . . . 72.21 110.624 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 ' HG3' ' A' ' 125' ' ' ARG . 45.5 t -113.23 120.16 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.34 -0.391 . . . . 63.22 111.096 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.8 mp -112.99 139.36 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 75.52 110.103 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.643 ' HB2' HD11 ' A' ' 13' ' ' LEU . 51.0 t0 -106.0 126.81 52.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.625 -0.509 . . . . 72.44 109.625 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.446 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.0 mtm -90.62 -6.97 53.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 74.23 110.664 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 31.5 mmtp 68.48 5.27 4.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.602 0.761 . . . . 74.31 112.415 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 27.4 pt20 -157.94 174.16 15.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.492 -0.188 . . . . 61.32 110.492 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -88.6 124.11 33.73 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.679 -0.489 . . . . 25.42 109.679 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.446 HD12 ' SD ' ' A' ' 61' ' ' MET . 70.9 mt -132.84 133.7 58.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.012 0.435 . . . . 72.02 110.256 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.6 tp60 -82.76 105.41 13.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.684 -0.858 . . . . 61.11 108.684 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.1 mm -75.44 124.74 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.82 0.343 . . . . 74.01 110.483 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.81 -43.88 2.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.03 -0.532 . . . . 70.13 110.784 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -148.47 140.3 23.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.242 -0.436 . . . . 71.43 111.039 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.31 139.45 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.297 -0.631 . . . . 62.04 109.297 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 42.0 mt-10 -123.29 131.37 53.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.104 0.478 . . . . 74.1 111.101 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 65.2 mt -113.36 124.72 53.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 74.0 109.893 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -103.58 104.14 40.22 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.651 -0.5 . . . . 64.04 109.651 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 11.9 Cg_exo . . . . . 0 N--CA 1.465 -0.2 0 C-N-CA 122.811 2.341 . . . . 74.1 112.129 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' ND2' ' A' ' 107' ' ' ASN . 2.7 m120 . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 112.227 0.454 . . . . 55.12 112.227 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 85.1 Cg_endo -85.89 30.52 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.813 2.342 . . . . 74.43 112.306 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -77.76 127.85 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 63.32 109.795 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -98.96 -55.2 2.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 75.11 111.126 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 48.0 t -128.82 138.03 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 40.54 110.739 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.59 133.59 68.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.169 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.2 mt-10 -115.02 126.67 55.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.982 0.42 . . . . 63.52 110.975 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -107.56 134.06 51.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.773 -0.649 . . . . 63.43 110.248 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.66 151.54 51.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.33 -0.395 . . . . 72.32 110.398 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.084 -0.339 . . . . 72.53 110.084 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -147.58 145.35 28.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.031 0.443 . . . . 62.52 111.5 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -81.52 -43.25 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.8 -0.636 . . . . 72.33 109.842 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 1.0 OUTLIER -109.72 -1.97 17.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.268 -0.878 . . . . 70.31 112.394 -170.247 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.3 t-20 76.27 -7.96 1.73 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.972 0.509 . . . . 73.23 111.079 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -94.69 -51.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.231 0.539 . . . . 42.24 109.804 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -92.64 105.71 17.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.43 -0.805 . . . . 73.14 110.328 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 96.6 m95 -97.63 121.75 39.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.853 0.359 . . . . 73.35 111.504 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 35.5 m -97.36 128.95 33.13 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 61.21 110.046 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 6.0 Cg_exo -75.22 108.69 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.463 2.109 . . . . 73.4 110.315 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 19.8 pt -82.37 -19.1 10.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.377 -0.374 . . . . 63.55 111.206 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.19 131.06 1.41 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.037 -1.078 . . . . 31.32 113.002 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 61.4 ttt180 -112.91 115.21 28.08 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.917 -0.401 . . . . 70.32 109.917 172.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -137.4 176.99 8.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.723 0.297 . . . . 72.23 110.853 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -95.61 157.59 21.85 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.902 -0.666 . . . . 74.34 112.057 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -94.14 148.29 22.33 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.719 -0.475 . . . . 71.42 109.719 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.678 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.4 m -131.21 115.93 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.501 -0.318 . . . . 55.35 110.644 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 81' ' ' ASN . 48.7 t-20 -69.67 96.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.165 0.507 . . . . 73.14 110.09 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -136.94 174.01 11.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.704 . . . . 71.43 109.284 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.55 -8.38 44.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.232 0.539 . . . . 73.35 110.752 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.42 158.78 16.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 63.53 110.618 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.18 138.21 58.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.269 -0.423 . . . . 73.22 110.945 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.678 HD21 ' HB ' ' A' ' 106' ' ' THR . 39.7 mt -90.95 110.76 22.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 75.42 110.461 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.43 120.19 26.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.198 0.523 . . . . 64.05 110.271 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.29 107.5 17.27 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.394 -0.821 . . . . 70.24 110.007 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -80.02 98.66 7.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 30.8 m -100.78 -178.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.911 -0.586 . . . . 54.14 111.801 -171.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.03 129.59 40.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 73.11 110.776 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.8 m -75.65 106.81 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 62.04 110.033 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.18 148.3 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.374 -0.375 . . . . 74.35 110.244 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HG3' HD12 ' A' ' 150' ' ' ILE . 4.5 ttpm? -84.82 135.84 33.93 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.891 -0.411 . . . . 63.32 109.891 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.22 40.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.571 -0.286 . . . . 64.53 110.982 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 41.0 ttt180 -108.73 -33.3 7.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 72.12 109.462 171.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -109.3 145.51 35.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.655 -0.702 . . . . 74.34 109.891 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.1 tt -130.8 139.1 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.407 -0.59 . . . . 75.02 109.407 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.952 ' HG3' HG22 ' A' ' 58' ' ' VAL . 1.6 ttm180 -125.12 139.44 53.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.915 0.388 . . . . 65.51 111.021 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 tp -115.11 120.51 40.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.671 -0.695 . . . . 62.24 109.458 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 42.1 m -115.55 128.55 56.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.883 0.373 . . . . 74.14 110.798 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 35.1 mm -108.35 88.77 5.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.171 -0.677 . . . . 54.54 109.171 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 1.0 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.8 Cg_endo -87.95 131.42 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.957 2.438 . . . . 72.21 113.708 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 20.3 t0 -80.1 65.0 5.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.044 0.926 . . . . 75.11 109.246 172.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.09 -19.14 11.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.687 -1.142 . . . . 41.43 110.02 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -131.49 29.04 3.5 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.611 -0.804 . . . . 25.3 112.792 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.69 24.91 16.59 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 120.506 -0.854 . . . . 74.04 113.321 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 3.2 m-20 -70.25 130.85 43.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.968 0.413 . . . . 74.0 111.193 -176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.3 m -92.49 157.26 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 70.22 110.363 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 10.0 p -67.89 -20.98 65.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.032 0.444 . . . . 73.21 111.908 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 t -80.47 93.57 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.205 0.526 . . . . 72.31 110.679 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -114.39 136.05 53.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.076 -0.511 . . . . 53.1 110.313 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -152.02 108.36 3.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.229 -0.441 . . . . 61.3 110.86 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.61 136.22 60.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 75.34 108.823 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 66.7 mtt180 -74.62 -53.52 9.2 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.852 -0.339 . . . . 65.44 111.32 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.28 135.56 15.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 75.21 111.07 -173.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 143' ' ' LEU . 9.3 tt -112.75 121.14 43.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.371 -0.603 . . . . 53.51 109.371 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.7 158.26 35.25 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.922 0.391 . . . . 61.31 110.55 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.56 136.54 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.379 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -101.7 125.42 48.35 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.207 -0.664 . . . . 73.01 109.207 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.1 -168.32 30.96 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.395 -0.907 . . . . 73.23 112.549 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.6 m -115.7 131.25 56.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.582 0.229 . . . . 74.41 110.948 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 5' ' ' ILE . 37.7 mm -76.95 118.07 22.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 60.43 110.374 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 120' ' ' LYS . 39.7 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.229 0.538 . . . . 70.54 110.607 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.932 0.396 . . . . 73.51 111.099 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.676 HG21 HD13 ' A' ' 65' ' ' ILE . 47.8 mm -85.29 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 62.41 110.115 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -66.92 118.72 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.381 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -92.2 25.79 2.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.095 0.474 . . . . 51.12 110.621 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -52.93 61.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.4 -0.818 . . . . 75.21 112.23 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.44 6.53 68.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.532 -0.842 . . . . 74.21 113.304 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -70.54 134.15 47.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.799 0.299 . . . . 72.24 110.403 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 6.8 pt-20 -130.71 161.83 30.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.983 0.421 . . . . 64.43 110.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.92 113.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.791 -0.64 . . . . 73.21 110.118 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 60' ' ' ASP . 79.4 mt -83.36 -47.89 10.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.996 -0.547 . . . . 75.31 110.478 -178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -137.36 140.41 41.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.815 -0.629 . . . . 64.42 110.164 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -150.37 148.52 28.9 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.588 -0.523 . . . . 73.1 109.588 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -90.73 -36.49 14.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 72.1 111.065 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -155.22 154.46 32.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 64.52 111.243 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 10.1 pt20 -165.63 135.81 3.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.192 -0.913 . . . . 71.52 108.81 174.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.98 94.79 10.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.33 0.586 . . . . 73.22 110.546 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.49 -3.18 34.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.654 -0.703 . . . . 73.12 111.49 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -111.39 -51.58 2.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.823 0.344 . . . . 75.23 110.131 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 121.146 -0.549 . . . . 73.31 112.14 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 C--O 1.224 -0.288 0 CA-C-O 120.636 0.255 . . . . 62.14 110.447 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.86 -5.26 83.05 Favored Glycine 0 C--N 1.322 -0.234 0 C-N-CA 120.601 -0.809 . . . . 73.23 112.438 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.49 HD12 ' HE3' ' A' ' 31' ' ' LYS . 82.2 mt -73.95 150.99 40.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.142 -0.318 . . . . 75.11 110.142 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.94 -22.25 66.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 62.11 110.953 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HE3' HD12 ' A' ' 29' ' ' LEU . 16.8 pttp -75.08 -24.17 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 62.13 110.816 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.945 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.0 m -76.51 -10.71 59.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.941 -0.572 . . . . 63.11 111.087 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.77 -15.3 62.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.616 0.722 . . . . 75.15 109.417 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 59' ' ' ILE . 28.4 pt -132.01 21.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 51.41 109.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.945 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 1.7 t70 -68.22 -48.54 64.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 61.33 109.931 -174.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 142' ' ' GLU . . . 117.74 31.12 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.809 -0.71 . . . . 74.5 114.077 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.589 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 9.7 t70 -153.27 153.95 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.981 0.89 . . . . 74.14 111.336 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -72.53 -18.36 61.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.272 0.471 . . . . 74.02 112.272 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.589 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.7 pt-20 -98.12 3.43 49.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.404 -0.518 . . . . 63.24 111.189 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -102.27 157.05 17.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.915 -0.772 . . . . 72.33 108.915 168.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 51.2 p90 -166.98 158.07 12.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 65.12 111.2 -175.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.7 t90 -102.35 134.91 44.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.402 -0.817 . . . . 72.03 109.051 172.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -134.78 136.16 42.37 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.469 -0.567 . . . . 73.21 109.469 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.18 139.79 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.945 -0.391 . . . . 54.12 109.945 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 36.9 ttpt -62.56 118.84 8.14 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.717 -0.475 . . . . 75.15 109.717 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -112.36 -29.38 7.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.594 -0.275 . . . . 75.41 110.622 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -74.25 125.47 28.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.978 0.418 . . . . 63.5 110.17 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.05 -3.09 84.46 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 73.25 112.145 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.85 132.61 7.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.874 -0.679 . . . . 41.25 111.9 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 49.7 m -78.91 149.57 32.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 74.24 111.341 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.13 157.69 89.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 72.23 110.326 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.0 146.56 41.82 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.326 2.018 . . . . 71.32 112.123 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.49 156.95 88.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.833 -0.621 . . . . 73.53 109.707 173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.806 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 84.0 Cg_endo -82.78 156.46 76.07 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.779 -1.342 . . . . 73.21 113.62 0.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.21 117.89 30.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.539 -0.755 . . . . 63.12 109.234 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 18.5 t70 -117.42 125.62 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.305 -0.258 . . . . 61.31 110.305 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 61.4 mt -122.83 115.58 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.831 0.348 . . . . 63.24 110.94 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.14 116.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.957 -0.565 . . . . 75.24 110.306 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 34' ' ' ILE . 81.8 mt -115.96 136.75 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.236 -0.438 . . . . 73.31 110.844 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 13' ' ' LEU . 53.5 t0 -101.54 120.28 40.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.47 -0.567 . . . . 64.41 109.47 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm -85.97 -5.94 59.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 65.1 110.819 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.488 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 73.2 mmtt 67.6 7.34 5.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.809 -0.632 . . . . 74.1 112.159 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -163.93 155.96 16.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.707 0.289 . . . . 71.31 110.459 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.54 128.74 36.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.601 . . . . 72.31 109.838 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.676 HD13 HG21 ' A' ' 5' ' ' ILE . 58.5 mt -133.46 135.88 55.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.857 0.36 . . . . 73.43 110.165 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.51 102.68 10.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.875 -0.787 . . . . 73.33 108.875 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 118' ' ' SER . 21.4 mm -72.93 118.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.285 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.12 -41.97 3.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.351 -0.386 . . . . 74.41 110.843 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -148.64 144.22 27.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.301 -0.409 . . . . 62.0 110.277 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.02 129.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.961 -0.385 . . . . 65.34 109.961 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -105.89 131.17 53.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.935 0.398 . . . . 74.51 110.468 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 38.4 mt -112.6 118.57 35.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.848 -0.615 . . . . 63.32 109.449 174.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.509 ' HG ' ' HD2' ' A' ' 141' ' ' ARG . 24.2 tp -102.36 101.52 20.1 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 115.82 -0.627 . . . . 75.22 109.328 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 17.0 Cg_exo . . . . . 0 N--CA 1.462 -0.324 0 C-N-CA 122.5 2.133 . . . . 64.33 111.111 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 49.9 t-20 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.311 0.577 . . . . 73.05 110.133 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 89.6 Cg_endo -90.88 28.14 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.305 2.67 . . . . 74.02 113.731 -177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 80.1 mt -82.51 117.46 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 75.33 110.512 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -92.05 -57.53 2.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.618 -0.719 . . . . 64.34 110.902 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.66 138.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.574 . . . . 61.44 111.09 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.41 138.67 54.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.157 -0.474 . . . . 60.23 110.146 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 89.9 mt-10 -119.81 127.68 53.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 73.32 110.617 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB2' HG13 ' A' ' 100' ' ' ILE . 53.5 m-85 -106.3 132.85 51.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.761 -0.654 . . . . 60.02 109.978 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.7 150.31 52.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.588 -0.278 . . . . 74.15 110.408 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.36 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.766 0.317 . . . . 72.34 111.169 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 t -150.53 149.11 29.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.303 -0.628 . . . . 65.51 109.303 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.699 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -90.65 -33.88 15.65 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 122.163 -0.335 . . . . 64.02 111.755 -177.006 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.6 20.22 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.602 -0.439 . . . . 73.01 111.222 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 65.79 47.4 2.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.426 0.632 . . . . 61.04 110.518 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.54 -74.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.042 -0.526 . . . . 62.5 109.894 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -83.29 105.82 14.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.327 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -91.06 108.32 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.274 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.0 m -94.56 123.67 57.52 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.874 -0.603 . . . . 64.52 110.181 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.48 102.55 0.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.412 2.075 . . . . 51.21 111.27 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 22.4 pt -75.79 -15.64 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 53.13 111.112 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.6 136.57 2.28 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.809 -1.186 . . . . 72.42 113.509 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 40.3 ttt180 -119.67 114.62 22.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.514 -0.921 . . . . 64.15 108.514 169.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -135.87 179.62 6.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 73.54 110.755 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.49 135.17 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.32 112.12 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -94.29 148.08 22.57 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.792 -0.448 . . . . 72.23 109.792 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' HD11 ' A' ' 112' ' ' LEU . 47.0 m -142.11 120.36 12.26 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.71 -0.478 . . . . 71.12 109.71 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 12.0 t30 -77.09 91.66 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.51 0.671 . . . . 75.34 110.935 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -118.26 -171.89 2.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.002 -0.999 . . . . 74.44 109.217 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -95.83 -26.05 15.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.935 0.397 . . . . 71.15 110.63 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.79 155.32 21.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 35.12 110.624 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.86 141.15 51.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 74.25 111.013 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 106' ' ' THR . 16.0 mt -98.2 106.45 18.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 71.34 110.083 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -80.3 116.7 20.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.885 0.374 . . . . 72.44 110.569 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.92 112.62 25.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.667 -0.697 . . . . 72.54 110.578 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -77.22 93.25 3.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.377 -0.601 . . . . 74.53 109.377 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.5 m -96.79 177.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 75.33 111.495 -173.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -67.59 132.87 48.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.321 -0.854 . . . . 74.14 110.459 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 41.8 m -74.92 122.25 23.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 75.33 110.51 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.5 tt -152.84 143.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.896 -0.593 . . . . 73.45 110.538 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -88.89 112.61 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.168 -0.678 . . . . 73.21 109.168 174.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.95 161.96 36.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.449 -0.341 . . . . 62.35 111.082 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.699 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 34.7 ttt180 -109.89 -31.85 7.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 61.41 110.159 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.05 145.92 30.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.705 -0.679 . . . . 73.34 109.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.416 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.7 tt -129.56 140.05 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.546 -0.539 . . . . 71.23 109.546 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 57.5 ttp180 -130.29 127.02 38.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 73.32 111.127 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.18 115.94 31.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.646 -0.707 . . . . 72.01 109.236 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 34.7 m -112.04 120.52 42.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.031 0.444 . . . . 74.13 110.91 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.7 96.06 8.4 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.175 -0.676 . . . . 73.35 109.175 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.806 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 98.0 Cg_endo -79.73 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.513 2.142 . . . . 73.2 112.617 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -123.69 67.73 1.02 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.912 0.863 . . . . 53.22 108.867 170.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.8 18.07 3.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.66 -1.154 . . . . 73.11 110.1 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.84 2.1 0.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.168 -1.015 . . . . 61.05 113.729 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.75 27.64 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.32 -0.943 . . . . 41.24 112.045 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.04 156.52 17.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.965 0.412 . . . . 73.34 110.958 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 22.4 m -123.43 -179.41 4.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.068 -0.515 . . . . 75.51 110.199 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 6.6 p -85.06 5.0 31.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.219 0.533 . . . . 74.21 111.993 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 46.6 t -103.05 128.56 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.661 -0.496 . . . . 60.21 109.661 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.48 131.92 19.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.7 -0.227 . . . . 70.4 110.653 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.36 105.34 4.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 63.02 111.145 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.95 133.31 67.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.363 -0.606 . . . . 65.44 109.363 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 66.9 mtt180 -64.76 -71.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.345 0.593 . . . . 73.33 109.89 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' GLY . 61.5 mm-40 -140.09 144.51 36.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 64.25 111.7 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -107.48 119.61 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.825 -1.176 . . . . 73.3 107.825 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.7 141.77 51.7 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.936 0.398 . . . . 72.32 110.557 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.11 133.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.678 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -107.49 105.24 15.05 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.75 -0.833 . . . . 63.33 108.75 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.03 -150.05 5.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.68 . . . . 73.34 111.966 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 m -132.83 133.85 43.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.503 0.192 . . . . 74.25 110.589 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.58 130.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 75.54 110.988 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.576 HD12 ' HG2' ' A' ' 120' ' ' LYS . 34.3 mt . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.796 -0.638 . . . . 72.04 109.749 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.981 0.42 . . . . 70.41 110.317 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 HD11 ' A' ' 149' ' ' ILE . 42.1 mm -70.9 137.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.781 -0.645 . . . . 63.23 111.83 -174.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -69.08 108.16 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.564 . . . . 73.22 110.174 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -87.01 10.34 16.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 74.1 111.168 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -72.06 -7.5 49.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 53.11 111.654 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -120.19 4.59 12.44 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.263 -0.97 . . . . 60.53 113.076 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.53 ' HB2' HD12 ' A' ' 34' ' ' ILE . 34.8 m0 -80.3 156.81 26.61 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.635 0.255 . . . . 74.23 110.601 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.581 ' CD ' ' HE3' ' A' ' 62' ' ' LYS . 3.2 pm0 -141.89 153.02 44.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.143 0.497 . . . . 71.51 111.046 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.99 128.64 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.322 -0.399 . . . . 54.14 110.186 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 58' ' ' VAL . 57.4 mt -89.42 -49.81 6.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.243 0.544 . . . . 61.14 110.097 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.2 p -150.7 143.84 24.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.681 -0.69 . . . . 74.24 110.587 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.77 147.7 41.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.501 -0.772 . . . . 74.24 109.087 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -85.47 -33.31 21.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.903 0.382 . . . . 74.21 110.81 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -156.27 155.02 31.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.871 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -168.03 143.05 3.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.602 -0.888 . . . . 64.53 108.602 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -94.18 115.42 27.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.083 0.468 . . . . 64.23 110.124 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.36 3.74 6.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 53.12 110.899 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.6 m -121.74 -42.13 2.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.155 -0.475 . . . . 70.4 110.923 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 C-N-CA 120.809 -0.71 . . . . 53.11 112.395 179.083 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 109.407 -0.59 . . . . 74.35 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.16 -7.88 58.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.015 -0.612 . . . . 74.43 111.944 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 90.1 mt -75.79 151.87 37.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 71.42 110.472 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.1 -25.27 65.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.009 0.433 . . . . 52.33 110.765 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.85 -20.47 61.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.672 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 60.4 m -73.01 -18.0 61.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.042 0.449 . . . . 54.52 110.742 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 tp -66.93 -17.5 64.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.737 -0.665 . . . . 70.05 110.219 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 10' ' ' TRP . 29.7 pt -128.39 22.39 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 72.45 110.45 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 26.5 t70 -70.49 -40.74 73.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 75.24 112.161 -171.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.32 23.08 9.87 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.651 -0.785 . . . . 32.11 112.061 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -138.18 128.83 26.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.49 -0.559 . . . . 72.31 109.49 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 p -76.83 0.56 20.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.029 0.751 . . . . 73.14 113.029 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.11 -7.44 15.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.572 -0.451 . . . . 62.22 111.57 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 p -92.42 149.2 21.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.081 -0.711 . . . . 73.53 109.081 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 49.7 p90 -153.05 166.72 31.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.946 0.403 . . . . 74.4 111.468 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 44.8 t90 -108.03 138.9 43.48 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.189 -0.914 . . . . 73.2 109.385 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -136.31 142.62 43.9 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.036 -0.727 . . . . 63.45 109.036 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.61 56.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.636 -0.505 . . . . 71.35 109.636 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HZ2' ' A' ' 45' ' ' LYS . 2.2 ttpm? -64.17 115.22 4.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.135 -0.32 . . . . 63.22 110.135 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -109.24 -28.94 8.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.311 -0.404 . . . . 75.21 110.805 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -76.54 113.78 14.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 73.42 110.236 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.87 -8.51 54.32 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.229 -0.748 . . . . 61.14 111.229 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.53 161.2 11.01 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.545 -0.622 . . . . 74.24 111.545 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 4.6 p -98.34 148.39 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.738 0.304 . . . . 73.52 110.51 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 21.2 m-20 -84.57 149.12 53.71 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.682 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 22.4 Cg_exo -66.24 128.79 20.15 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.872 2.382 . . . . 73.45 112.822 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.9 mt -73.09 162.33 75.05 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.391 -0.822 . . . . 74.11 110.207 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 92.4 Cg_endo -78.33 163.56 86.65 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.843 -1.315 . . . . 52.52 113.249 1.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.5 m-85 -100.19 112.89 25.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 73.31 110.649 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.78 131.62 44.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.421 -0.354 . . . . 73.43 110.254 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.414 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 60.6 mt -124.76 108.51 20.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.579 -0.526 . . . . 72.12 109.579 172.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG12 HD12 ' A' ' 13' ' ' LEU . 49.5 t -102.25 114.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.951 -0.568 . . . . 74.14 110.388 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.05 139.6 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.87 -0.604 . . . . 72.22 109.898 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HB3' ' OE1' ' A' ' 11' ' ' GLU . 19.5 t0 -102.66 138.52 39.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.693 -0.484 . . . . 64.24 109.693 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.479 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.6 mtm -91.83 -3.15 56.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 72.44 110.07 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HE3' ' CD ' ' A' ' 11' ' ' GLU . 24.0 mmtp 67.6 4.09 3.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.482 -0.781 . . . . 72.34 112.467 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -165.3 172.12 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.602 0.239 . . . . 73.13 110.754 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.41 127.18 31.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.259 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.667 HD13 HG21 ' A' ' 5' ' ' ILE . 74.6 mt -136.68 135.16 48.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.143 0.497 . . . . 71.11 110.363 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -82.82 109.39 16.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.009 -0.738 . . . . 74.22 109.009 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 118' ' ' SER . 27.4 mm -79.33 129.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.92 -0.312 . . . . 73.43 110.325 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.59 -39.28 2.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 63.23 110.968 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 29.4 tt0 -150.96 143.94 24.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.996 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.06 131.68 67.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.243 -0.435 . . . . 70.53 109.836 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.8 mt-10 -110.07 135.85 50.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.908 0.385 . . . . 72.34 110.677 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.42 HD12 ' HE2' ' A' ' 114' ' ' TYR . 69.2 mt -119.01 120.3 36.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.733 -0.667 . . . . 65.22 109.557 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 31.2 tp -104.25 104.02 41.91 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 116.052 -0.522 . . . . 75.52 109.907 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.7 Cg_exo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 123.222 2.615 . . . . 64.31 112.267 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 120.99 0.424 . . . . 61.22 111.423 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.616 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 75.4 Cg_endo -77.99 59.9 7.11 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.07 2.514 . . . . 63.33 113.755 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mt -99.0 119.36 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.041 -0.726 . . . . 74.41 109.041 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -102.64 -49.64 3.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.342 -0.39 . . . . 72.2 111.822 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.66 138.0 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.51 -0.314 . . . . 74.01 111.133 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.82 129.2 63.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.276 -0.42 . . . . 63.44 110.268 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.9 mt-10 -111.87 132.97 54.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.041 -0.527 . . . . 74.03 110.302 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.62 129.42 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.868 -0.605 . . . . 72.11 110.023 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -132.15 141.79 49.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.831 0.348 . . . . 72.22 110.943 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.03 46.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.062 -0.517 . . . . 70.15 110.387 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -149.96 158.89 44.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.845 0.355 . . . . 74.21 111.267 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.3 mt-10 -106.64 -25.08 11.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 61.13 110.985 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 19.1 p30 -114.42 0.68 14.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.48 -0.327 . . . . 54.15 111.647 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 61.9 t30 74.42 0.7 3.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.555 0.534 . . . . 74.32 110.516 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.9 -54.47 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 64.12 110.669 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -88.12 96.59 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.681 . . . . 53.33 110.278 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 99.4 m95 -90.38 121.11 32.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 73.11 110.743 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.0 m -98.47 121.81 55.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.711 -0.677 . . . . 70.34 109.814 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.42 113.61 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.288 1.992 . . . . 71.21 111.423 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 116' ' ' VAL . 21.9 pt -88.78 -15.71 8.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 65.11 110.631 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.41 150.62 7.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.318 -0.944 . . . . 50.14 113.181 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 31.9 ttt180 -129.02 114.69 16.72 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.135 -1.061 . . . . 73.01 108.135 173.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.585 ' HE2' HG12 ' A' ' 116' ' ' VAL . 98.0 m-85 -127.28 171.98 11.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 73.24 111.657 -170.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.09 131.05 10.44 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.481 -0.782 . . . . 33.4 111.198 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.46 136.87 34.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.994 0.426 . . . . 73.14 110.265 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.58 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.0 m -118.52 111.1 18.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.845 -0.616 . . . . 61.52 109.861 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.45 104.24 3.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.989 0.424 . . . . 72.32 110.567 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.7 -176.79 5.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 71.43 109.91 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -103.13 0.66 32.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 75.03 110.687 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.06 163.15 12.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 75.3 110.631 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.27 35.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 62.45 111.329 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.58 HD21 ' HB ' ' A' ' 106' ' ' THR . 33.3 mt -89.07 113.97 25.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.791 -0.64 . . . . 73.45 110.626 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 30.6 mt-10 -92.18 113.83 26.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 74.31 110.243 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.42 ' HE2' HD12 ' A' ' 72' ' ' LEU . 79.8 m-85 -106.48 101.87 11.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.95 -0.568 . . . . 71.5 109.931 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.456 ' CE2' ' NE2' ' A' ' 69' ' ' GLN . 28.6 m-85 -73.2 106.42 5.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.536 -0.756 . . . . 75.22 108.967 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 100' ' ' ILE . 28.3 m -107.88 178.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.25 0.548 . . . . 52.34 111.995 -170.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.2 134.48 52.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 74.25 110.295 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 16.7 m -82.77 130.13 35.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 70.22 110.979 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.0 tt -160.65 147.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.925 -0.579 . . . . 73.13 110.123 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.02 121.15 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.424 -0.584 . . . . 75.31 109.424 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.0 176.95 9.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.424 -0.353 . . . . 61.14 110.787 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.512 ' HG2' ' OD1' ' A' ' 60' ' ' ASP . 22.8 ttt180 -119.74 -34.86 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 73.41 110.341 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -105.36 146.07 29.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 75.31 109.932 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.06 133.55 60.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.035 0.445 . . . . 70.3 110.105 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 125' ' ' ARG . 12.4 ttp180 -124.37 129.09 50.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.401 . . . . 70.12 111.198 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.57 119.0 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.525 -0.761 . . . . 72.23 109.212 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 60.0 m -112.82 126.97 56.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.999 0.428 . . . . 70.44 110.938 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.7 mm -104.08 89.83 2.69 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.261 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 88.4 Cg_endo -81.34 134.0 8.81 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.808 2.339 . . . . 74.13 113.507 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.71 65.8 7.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.822 0.82 . . . . 75.53 108.999 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.63 -13.61 2.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.185 -0.916 . . . . 64.24 111.253 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -127.02 15.62 6.49 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.148 -1.025 . . . . 75.11 113.441 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.69 18.69 13.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.495 -0.86 . . . . 64.15 112.66 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -72.87 126.87 30.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.076 0.465 . . . . 74.32 110.927 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.616 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 19.8 m -99.69 171.96 7.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.032 -0.531 . . . . 73.41 110.232 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 3.1 p -82.31 6.9 15.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.087 0.403 . . . . 72.23 112.087 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 60.6 t -106.73 102.29 13.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.563 -0.532 . . . . 72.42 109.563 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -127.69 124.86 38.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.035 -0.53 . . . . 65.21 110.18 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.13 107.06 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 54.24 111.179 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.9 132.76 70.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.112 -0.699 . . . . 74.13 109.112 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 75.2 mtt180 -63.85 -71.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.118 0.485 . . . . 74.33 110.062 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -140.01 155.03 47.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.581 0.705 . . . . 62.22 112.439 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 72' ' ' LEU . 9.1 tt -115.54 119.98 37.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.232 -1.349 . . . . 61.04 107.84 169.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.24 151.85 36.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.941 -0.392 . . . . 74.23 109.941 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.42 131.39 73.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.678 -0.409 . . . . 63.32 110.741 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 45.1 mttp -98.16 127.21 43.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.122 -0.696 . . . . 74.44 109.122 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.29 -146.06 5.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.685 -0.769 . . . . 65.43 111.811 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.4 m -139.89 130.34 25.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.459 -0.2 . . . . 72.52 110.459 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 5' ' ' ILE . 28.6 mm -72.27 120.9 21.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.466 . . . . 72.11 110.079 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 74.22 110.024 -179.36 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.607 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 7.0 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 120.717 0.294 . . . . 71.42 110.919 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 65' ' ' ILE . 42.8 mm -71.64 136.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.064 -0.516 . . . . 51.12 110.706 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -67.28 115.79 7.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.302 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.99 3.26 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 74.1 111.213 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p -69.03 98.09 0.94 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.61 0.719 . . . . 61.33 110.62 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.64 -14.72 6.06 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.012 -0.995 . . . . 44.44 112.11 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -66.45 145.88 55.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.3 -0.259 . . . . 72.32 110.3 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.3 pt-20 -132.45 159.41 39.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.998 0.428 . . . . 54.41 110.664 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -100.72 112.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.527 -0.761 . . . . 65.52 109.578 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.0 mt -72.57 -46.7 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.527 . . . . 73.31 110.512 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -152.05 142.44 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.844 -0.616 . . . . 73.54 110.717 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.86 149.45 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.936 -0.575 . . . . 74.4 109.829 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.5 m -82.16 -49.81 9.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.354 . . . . 71.51 111.173 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.5 t -146.39 157.21 43.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 75.32 110.783 -173.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -163.31 144.6 9.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.845 -0.798 . . . . 64.41 108.845 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -96.78 101.21 12.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 74.12 110.001 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.16 5.3 34.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 43.45 111.928 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -136.99 -45.48 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.706 -0.398 . . . . 64.41 111.176 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 121.116 -0.564 . . . . 65.31 113.077 -177.05 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t30 . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.7 -0.482 . . . . 74.02 109.7 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.04 6.02 46.16 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.921 -0.871 . . . . 52.11 110.921 -173.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 66.8 mt -80.32 154.88 27.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.198 -0.501 . . . . 74.42 110.697 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -69.23 -26.97 65.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.042 -0.526 . . . . 61.24 110.875 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 75.34 110.787 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.4 m -70.47 -22.59 62.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 62.41 110.32 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 142' ' ' GLU . 25.4 tp -64.0 -19.45 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.554 -0.748 . . . . 52.13 110.824 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 59' ' ' ILE . 35.9 pt -131.46 18.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 51.2 110.436 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -68.77 -38.47 80.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 61.41 110.909 -173.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.47 19.77 13.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 71.44 111.98 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.4 121.16 25.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.699 0.285 . . . . 72.2 110.246 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 p -70.72 -20.26 62.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.333 -0.394 . . . . 55.21 111.624 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -74.27 -27.13 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.658 -0.246 . . . . 71.23 111.314 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.5 p -89.81 160.67 16.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.839 -0.43 . . . . 61.25 109.839 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 46.3 p90 -156.18 171.04 20.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 64.42 111.043 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.558 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 49.9 t90 -106.78 134.86 49.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.616 -0.72 . . . . 74.43 109.474 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -133.06 142.39 48.74 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.129 -0.693 . . . . 74.32 109.129 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.53 143.67 49.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.797 -0.446 . . . . 63.51 109.797 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.9 126.01 25.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.256 0.348 . . . . 75.24 110.231 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -128.02 -25.44 3.03 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.789 -0.364 . . . . 75.01 111.235 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.49 107.43 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.976 0.417 . . . . 71.34 110.542 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.74 80.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.933 -0.651 . . . . 45.2 112.391 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.18 171.68 12.86 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.967 -0.635 . . . . 73.51 111.581 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 136' ' ' THR . 40.9 m -116.4 175.42 5.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.729 0.3 . . . . 71.21 111.104 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.581 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 7.2 m-20 -97.99 166.3 13.72 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.133 -0.485 . . . . 74.55 110.845 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 39.4 Cg_endo -67.88 134.49 32.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.633 2.222 . . . . 54.1 113.207 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.69 154.39 61.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.557 -0.747 . . . . 64.4 109.51 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -76.05 165.54 85.19 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 123.608 -1.413 . . . . 65.14 112.928 1.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.532 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.2 m-85 -99.54 115.4 29.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.872 -0.604 . . . . 73.31 110.101 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -106.11 129.14 54.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 74.53 110.847 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.405 HD12 HD23 ' A' ' 126' ' ' LEU . 63.6 mt -121.7 108.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.959 -0.564 . . . . 70.14 109.596 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.91 114.13 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 116.047 -0.524 . . . . 74.42 110.459 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 34' ' ' ILE . 71.1 mt -115.29 137.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.861 -0.609 . . . . 71.34 110.929 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -106.29 121.81 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.847 -0.615 . . . . 74.11 109.877 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.97 -5.85 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 64.32 111.043 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 66.61 11.38 8.1 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.148 0.795 . . . . 73.04 113.148 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -165.5 172.86 11.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.252 -0.277 . . . . 71.54 110.252 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -85.24 128.65 34.76 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.056 -0.52 . . . . 74.01 109.654 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.572 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.6 mt -134.28 134.39 55.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.949 0.404 . . . . 72.05 110.17 176.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.2 tp60 -80.8 101.61 9.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.536 -0.756 . . . . 75.52 109.001 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 118' ' ' SER . 23.8 mm -71.18 123.59 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 72.02 110.344 -176.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.47 -46.28 2.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 74.51 110.201 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' A' ' 146' ' ' LYS . 34.3 tt0 -137.9 141.58 40.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.764 -0.653 . . . . 74.21 110.42 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -108.93 128.28 64.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.055 -0.72 . . . . 71.32 109.055 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -110.06 123.45 49.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.248 0.546 . . . . 54.23 110.76 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.9 mt -109.33 124.53 51.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 73.04 109.841 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.4 106.97 48.79 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.862 -0.792 . . . . 51.34 108.862 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.461 -0.431 0 C-N-CA 122.386 2.058 . . . . 74.13 111.837 177.874 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.832 0.348 . . . . 73.23 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 93.2 Cg_endo -87.63 37.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.738 2.292 . . . . 74.14 112.259 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -87.38 134.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 75.03 110.533 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 24.1 mmmt -111.13 -57.77 2.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.577 -0.738 . . . . 65.02 110.658 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.48 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 95.2 t -121.19 138.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 63.02 110.945 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.29 138.34 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.885 -0.598 . . . . 71.43 109.651 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.0 mt-10 -118.04 135.11 54.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.317 -0.402 . . . . 74.32 111.152 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -117.02 129.87 56.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 64.33 110.142 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -128.49 143.97 51.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.328 -0.397 . . . . 72.13 110.652 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 149.97 49.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.368 -0.378 . . . . 62.01 110.34 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.3 t -150.09 150.92 32.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.186 0.517 . . . . 72.31 111.625 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.17 -30.85 12.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.337 -0.847 . . . . 73.52 109.837 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 3.4 p-10 -105.73 -12.17 16.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 53.14 112.126 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.8 t30 71.22 5.14 5.35 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.617 0.722 . . . . 70.14 110.758 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.572 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 98.7 t -100.82 -58.32 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.93 -0.577 . . . . 71.33 110.103 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -102.43 118.96 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 70.53 110.127 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.518 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 94.5 m95 -95.86 124.42 39.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.154 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 m -90.44 122.63 67.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.143 -0.48 . . . . 51.43 110.109 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.54 110.2 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.42 2.08 . . . . 64.45 111.507 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 HG21 ' A' ' 116' ' ' VAL . 13.7 pt -80.81 -19.49 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.577 -0.283 . . . . 73.45 110.983 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 136.92 2.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.302 -0.951 . . . . 70.51 113.558 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.3 ttm180 -102.72 125.6 49.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.436 -0.579 . . . . 64.12 109.436 169.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.556 ' HE2' HG12 ' A' ' 116' ' ' VAL . 77.8 m-85 -138.56 -176.23 4.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.269 -0.572 . . . . 75.14 111.289 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -99.15 147.54 18.47 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.855 -0.611 . . . . 54.14 112.248 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.425 ' HA ' ' HH ' ' A' ' 114' ' ' TYR . 40.8 t80 -96.47 148.29 22.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 73.23 110.119 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.423 ' HB ' HD21 ' A' ' 112' ' ' LEU . 26.5 m -133.38 117.83 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.893 -0.41 . . . . 74.12 109.893 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -77.21 106.44 8.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.408 0.623 . . . . 72.54 110.533 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -144.47 177.66 8.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.256 -0.883 . . . . 65.11 110.222 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -97.86 8.67 44.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.31 -0.404 . . . . 52.15 110.801 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.73 158.05 30.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 74.42 109.848 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.47 142.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 73.3 111.539 -175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 106' ' ' THR . 63.1 mt -92.26 121.85 34.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.569 -0.742 . . . . 54.41 111.0 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.82 109.8 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 71.53 111.29 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.425 ' HH ' ' HA ' ' A' ' 105' ' ' PHE . 95.5 m-85 -104.55 110.11 22.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 73.42 110.649 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -86.5 100.51 12.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.789 -0.641 . . . . 73.22 109.709 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 100' ' ' ILE . 26.7 m -106.06 179.4 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.95 -0.568 . . . . 73.45 111.412 -174.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.62 139.19 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 75.5 110.468 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 23.9 m -80.67 121.43 25.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.297 -0.411 . . . . 70.42 110.861 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -155.14 149.94 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 74.2 110.326 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.763 ' HG3' HD12 ' A' ' 150' ' ' ILE . 2.7 ttpm? -89.78 132.53 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.097 -0.334 . . . . 74.4 110.097 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.08 166.09 33.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.522 -0.308 . . . . 65.24 111.091 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.479 ' HD2' ' CE1' ' A' ' 123' ' ' TYR . 24.9 ttm180 -111.27 -33.53 6.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.171 0.51 . . . . 72.24 110.2 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CE1' ' HD2' ' A' ' 122' ' ' ARG . 70.7 m-85 -105.21 145.16 31.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.914 -0.585 . . . . 72.5 110.213 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 59' ' ' ILE . 10.5 tt -136.31 129.34 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.079 -0.509 . . . . 60.2 110.065 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -113.4 121.19 43.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 72.32 110.659 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 57' ' ' ILE . 48.0 tp -91.55 113.72 26.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.202 -0.666 . . . . 52.04 109.202 172.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -109.99 119.94 40.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.997 0.427 . . . . 72.32 110.934 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.9 mm -100.77 96.28 5.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.058 -0.719 . . . . 71.42 109.058 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 89.5 Cg_endo -75.68 -179.85 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 75.34 112.786 -176.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -110.01 -9.05 14.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.166 0.984 . . . . 54.24 108.398 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.44 -46.14 91.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.659 -1.61 . . . . 75.31 112.11 -173.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -82.01 6.82 65.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.716 -0.754 . . . . 43.43 113.713 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.94 25.41 9.69 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.169 -1.015 . . . . 64.04 112.071 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -78.78 -175.92 4.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 71.51 111.133 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.448 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.1 m -139.24 174.5 10.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.998 -0.546 . . . . 72.22 109.628 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 1.2 p -79.96 -0.73 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.952 0.406 . . . . 63.3 112.035 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.68 124.09 62.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.799 -0.445 . . . . 63.0 109.799 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.47 142.99 30.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.659 -0.246 . . . . 72.14 110.655 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.7 109.48 5.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 74.25 111.118 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 28.8 mt -127.49 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 65.04 109.102 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 1.5 tpt180 -74.44 -68.82 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.606 -0.516 . . . . 74.52 109.606 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 33' ' ' LEU . 17.7 pt-20 -148.87 160.99 42.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.208 0.527 . . . . 71.42 110.734 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.34 121.75 44.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.382 -0.826 . . . . 75.02 108.958 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.607 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.4 t70 -117.1 162.33 18.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.869 -0.419 . . . . 71.31 109.869 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' ILE . 95.3 t -127.89 124.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 74.1 110.296 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . 48.3 tttm -101.45 101.61 12.25 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.264 -0.643 . . . . 75.15 109.264 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.09 -161.64 10.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.727 -0.749 . . . . 75.1 112.089 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -118.05 133.64 55.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.652 0.263 . . . . 73.2 110.554 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.54 HD11 HG23 ' A' ' 5' ' ' ILE . 38.4 mm -71.54 124.46 28.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.081 -0.509 . . . . 75.33 111.419 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.763 HD12 ' HG3' ' A' ' 120' ' ' LYS . 29.0 mt . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.162 0.506 . . . . 72.04 110.109 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 120.734 0.302 . . . . 71.31 110.992 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.5 HD12 HD11 ' A' ' 149' ' ' ILE . 37.6 mm -66.65 131.91 32.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.134 -0.485 . . . . 54.55 110.327 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -64.78 111.73 2.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.376 -0.375 . . . . 72.11 110.829 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 36.0 mtmm -87.52 16.25 5.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 75.03 110.567 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -65.48 -16.36 63.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.493 -0.776 . . . . 60.41 112.16 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.1 23.25 4.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.497 -0.859 . . . . 72.32 112.874 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 33.3 m0 -84.35 156.79 21.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.992 0.396 . . . . 65.23 110.853 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 22.2 pt-20 -135.4 159.54 41.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.81 0.338 . . . . 64.23 110.768 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.54 130.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.972 -0.558 . . . . 53.41 109.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.5 -36.86 9.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.166 0.508 . . . . 72.12 110.78 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.3 t -144.94 139.36 27.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 75.22 110.66 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -151.1 134.84 16.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 70.4 109.526 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -85.37 -38.9 18.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 54.42 111.278 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -149.13 152.51 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.993 0.425 . . . . 74.21 110.959 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.0 pt20 -163.91 139.53 6.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.425 -0.807 . . . . 71.44 108.919 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.9 tp10 -93.74 98.06 10.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.133 0.492 . . . . 74.4 111.065 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.48 -12.01 18.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.864 -0.607 . . . . 62.31 110.95 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -101.04 -47.77 4.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.02 -0.536 . . . . 64.51 110.955 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.909 -0.587 . . . . 73.42 112.411 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.2 t30 . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 109.732 -0.469 . . . . 74.3 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 2.96 72.73 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.611 -0.595 . . . . 65.45 111.611 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 82.0 mt -82.13 157.44 24.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.584 -0.308 . . . . 64.32 110.272 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.83 -28.74 68.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.773 0.321 . . . . 62.33 110.973 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.3 pttp -69.41 -23.02 63.65 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.742 0.306 . . . . 75.15 111.044 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.812 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.7 m -66.99 -24.24 66.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.015 0.436 . . . . 71.41 110.408 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.0 tp -65.92 -25.54 67.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 73.23 110.371 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 59' ' ' ILE . 2.5 pp -119.48 13.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.207 0.527 . . . . 74.14 110.336 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.2 t70 -65.27 -42.25 93.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.287 -0.869 . . . . 74.11 110.174 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.9 55.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.824 -0.703 . . . . 65.22 111.682 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -117.12 124.44 49.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.368 -0.416 . . . . 53.35 109.986 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -72.65 -15.13 61.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.285 -0.416 . . . . 72.11 111.755 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.31 -24.33 50.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 75.44 110.718 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -100.23 160.16 14.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.4 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.717 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 48.3 p90 -156.15 165.0 37.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.848 -0.427 . . . . 75.03 109.848 174.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.524 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 39.2 t90 -98.12 129.27 44.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.379 -0.6 . . . . 73.11 109.379 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 49.4 t-80 -131.13 137.07 48.87 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.231 -0.655 . . . . 71.51 109.231 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.12 144.63 54.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 50' ' ' SER . 64.8 tttp -60.4 126.09 26.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.358 . . . . 63.12 110.339 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -124.52 -32.14 3.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 63.03 110.064 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.45 108.99 13.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 61.13 109.383 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.41 -12.33 54.61 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.712 -0.676 . . . . 70.32 111.635 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 144.34 5.82 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.93 -0.652 . . . . 75.51 111.547 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 11.0 p -86.63 167.64 14.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.941 0.4 . . . . 74.13 111.505 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -100.54 146.9 32.83 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 61.24 109.715 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.96 141.54 44.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.691 2.261 . . . . 71.35 112.63 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.5 mt -75.85 164.63 59.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 65.3 110.569 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.1 Cg_endo -83.69 161.75 71.04 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 123.766 -1.348 . . . . 71.22 113.239 1.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -100.06 111.46 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 73.5 109.923 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -104.42 125.69 50.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.082 -0.34 . . . . 53.34 110.082 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.403 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 48.3 mt -119.44 121.36 66.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.134 -0.321 . . . . 71.34 110.134 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -112.31 117.85 56.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.334 -0.394 . . . . 71.4 110.616 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 34' ' ' ILE . 4.7 mp -117.05 140.62 38.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 71.54 110.19 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 19.8 t70 -103.04 134.2 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.594 -0.275 . . . . 54.53 110.264 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.509 ' HE1' HD11 ' A' ' 67' ' ' ILE . 64.8 mtm -96.64 3.92 52.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 74.34 111.092 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 70.89 -30.06 0.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.617 0.969 . . . . 72.43 113.617 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -133.71 172.44 12.76 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.236 -0.29 . . . . 74.24 111.051 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -82.08 129.82 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 73.12 110.399 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 5' ' ' ILE . 69.6 mt -139.07 139.91 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.018 0.437 . . . . 71.31 110.333 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -83.31 105.08 13.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.927 -0.768 . . . . 73.3 108.927 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.8 mm -72.93 106.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.235 -0.283 . . . . 71.3 110.235 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.03 -43.9 6.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.052 0.453 . . . . 70.15 110.843 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.6 tt0 -145.42 140.88 27.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.991 -0.549 . . . . 63.2 110.787 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.21 130.73 61.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.531 -0.544 . . . . 54.32 109.531 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -113.47 129.76 56.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.957 0.408 . . . . 73.52 110.521 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.472 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 70.4 mt -117.14 120.49 38.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.213 -0.449 . . . . 62.32 109.92 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.73 103.56 15.07 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.023 -0.732 . . . . 65.33 109.023 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 15.3 Cg_exo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 123.038 2.492 . . . . 74.11 112.645 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.908 0.385 . . . . 70.24 110.49 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.93 29.77 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.145 2.563 . . . . 71.14 114.171 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 105' ' ' PHE . 73.2 mt -79.0 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.568 -0.53 . . . . 51.41 109.568 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -114.84 -46.03 2.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 53.52 111.453 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.734 HG11 ' HE ' ' A' ' 102' ' ' ARG . 62.0 t -127.13 138.35 55.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.469 -0.332 . . . . 75.53 110.898 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 128' ' ' ILE . 7.6 m -132.22 137.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.186 -0.461 . . . . 72.55 110.52 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 40.2 mt-10 -116.6 140.45 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.402 -0.363 . . . . 64.25 110.907 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -120.4 132.67 55.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 73.22 110.669 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.51 147.71 50.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 31.14 110.267 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.32 150.03 52.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 70.03 110.495 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.5 t -150.26 150.7 31.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 71.03 110.878 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -101.31 -31.35 11.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.957 0.408 . . . . 63.11 110.129 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 8.9 p-10 -105.22 -4.33 21.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 53.13 111.518 -174.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 24.5 t-20 76.31 -16.16 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.797 0.685 . . . . 71.31 111.337 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 95.2 t -89.32 -58.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.97 0.414 . . . . 61.55 110.627 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -91.89 111.48 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.466 . . . . 71.21 110.454 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -96.6 132.39 42.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.993 0.425 . . . . 74.4 110.921 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.3 m -105.09 124.76 35.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 75.31 110.505 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.72 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.468 2.112 . . . . 74.3 111.572 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 116' ' ' VAL . 21.6 pt -93.1 -6.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.332 -0.395 . . . . 62.5 111.059 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.61 147.82 4.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.538 -0.839 . . . . 65.54 113.044 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.734 ' HE ' HG11 ' A' ' 85' ' ' VAL . 77.9 ttt180 -113.06 119.65 38.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.214 -0.661 . . . . 73.12 109.214 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.584 ' HE2' HG12 ' A' ' 116' ' ' VAL . 84.5 m-85 -130.36 177.17 7.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.82 0.343 . . . . 74.54 110.911 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.8 149.81 19.41 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.043 -0.599 . . . . 72.25 111.774 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.418 ' HB3' HG22 ' A' ' 83' ' ' ILE . 51.6 t80 -105.06 121.62 44.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.985 0.421 . . . . 75.4 110.081 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.474 ' O ' HD11 ' A' ' 112' ' ' LEU . 24.2 m -113.35 107.69 16.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.972 -0.558 . . . . 62.4 109.962 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -68.83 94.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.38 0.61 . . . . 74.0 110.072 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -113.93 -166.17 1.07 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.087 -0.96 . . . . 75.33 109.55 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.97 -14.22 20.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.973 0.416 . . . . 61.31 110.697 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.21 169.42 8.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 62.24 110.653 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -75.52 137.52 40.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 75.2 110.948 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 106' ' ' THR . 34.8 mt -87.46 111.29 21.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.622 -0.717 . . . . 70.12 110.533 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.82 108.93 19.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.933 0.397 . . . . 72.51 110.47 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.33 113.48 25.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 72.42 110.799 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -80.2 92.05 5.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.248 -0.649 . . . . 75.22 109.248 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.584 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.3 m -96.67 177.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 54.24 111.669 -172.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.77 118.74 13.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 70.11 109.662 177.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 14.4 m -75.6 118.75 18.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.001 -0.545 . . . . 73.11 110.847 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -147.76 153.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.466 . . . . 72.3 110.731 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -81.8 125.81 31.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 64.15 109.698 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . . . -152.41 175.42 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 72.2 111.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -128.51 -32.82 2.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.844 -0.616 . . . . 70.34 109.927 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -106.35 146.38 30.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.626 . . . . 73.42 109.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.55 135.21 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 65.42 110.267 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -121.49 124.06 43.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.93 0.395 . . . . 64.25 110.93 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.21 116.9 31.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 75.44 109.091 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.0 m -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.19 0.519 . . . . 75.33 110.966 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.9 mm -106.52 95.68 12.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 65.52 109.196 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.646 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 57.0 Cg_endo -71.87 173.96 11.93 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.354 2.036 . . . . 75.13 112.552 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.488 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.7 t70 -91.01 -6.1 54.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.146 0.974 . . . . 64.43 108.893 175.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.28 143.35 26.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.695 -1.139 . . . . 74.51 110.532 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.21 -11.52 58.54 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.721 -0.752 . . . . 71.34 112.315 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.94 12.12 14.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.876 -0.678 . . . . 62.35 112.733 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -67.78 124.84 24.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 73.0 110.936 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -95.35 178.15 5.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.03 -0.532 . . . . 73.31 110.02 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.8 p -79.08 1.57 23.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 72.41 112.127 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.12 101.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.871 -0.418 . . . . 52.43 109.871 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -119.87 130.52 54.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.269 -0.423 . . . . 61.14 110.114 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -147.07 111.92 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.159 0.505 . . . . 74.43 111.486 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.94 132.86 56.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.394 -0.595 . . . . 74.52 109.394 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmt180 -61.39 -63.79 1.16 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.669 0.271 . . . . 71.03 110.417 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.6 155.51 30.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.471 0.653 . . . . 64.13 111.346 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -106.51 123.92 48.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.849 -1.069 . . . . 74.45 108.313 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.8 152.07 37.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.554 -0.535 . . . . 70.32 109.554 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.03 130.96 74.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.928 0.394 . . . . 71.41 111.603 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 39.0 mttp -101.97 107.06 18.08 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.944 -0.761 . . . . 74.33 108.944 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.11 177.76 31.36 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.238 -0.982 . . . . 63.43 112.143 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.8 m -106.85 127.31 53.3 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.241 -0.281 . . . . 75.11 110.241 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.5 HD11 HD12 ' A' ' 5' ' ' ILE . 35.8 mm -69.81 130.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.96 -0.564 . . . . 72.21 110.526 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 120' ' ' LYS . 16.3 mt . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 109.596 -0.52 . . . . 74.42 109.596 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.769 0.318 . . . . 62.24 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.543 HG21 HD13 ' A' ' 65' ' ' ILE . 37.7 mm -83.5 138.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 110.284 -0.265 . . . . 73.45 110.284 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -85.21 130.9 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 61.43 109.755 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -108.97 13.66 24.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 75.43 110.725 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -71.25 -10.0 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.627 -0.715 . . . . 71.42 111.192 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.88 9.11 21.37 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 52.43 112.163 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -89.39 159.34 17.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.701 0.286 . . . . 74.13 110.541 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 9.2 pt-20 -142.42 161.88 36.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.857 0.36 . . . . 70.24 110.147 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.0 117.89 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 72.34 110.185 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.53 -43.88 18.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.681 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -148.85 141.7 24.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.204 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -141.93 142.69 33.03 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.018 -0.734 . . . . 63.51 109.018 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -85.53 -29.32 24.3 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.83 -0.348 . . . . 73.23 110.996 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 t -154.49 149.29 26.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 70.14 111.0 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -168.06 140.28 3.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.904 -0.776 . . . . 61.45 108.904 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.9 tp10 -98.27 116.92 31.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.015 0.436 . . . . 73.23 110.573 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.11 -16.37 12.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.01 -0.541 . . . . 72.35 111.251 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 m -113.4 -40.0 3.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.368 -0.378 . . . . 53.13 111.169 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.43 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.256 0 CA-C-N 116.083 -0.508 . . . . 33.24 112.835 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.274 -0.269 . . . . 73.33 110.274 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.87 -1.75 38.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.015 -0.612 . . . . 43.22 111.706 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 62.5 mt -80.46 156.77 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 73.52 110.641 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.93 -31.05 71.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.484 -0.326 . . . . 64.05 111.252 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -76.09 -16.44 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.479 -0.328 . . . . 63.42 111.751 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 60.8 m -71.38 -23.65 61.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 74.43 109.831 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 35.4 tp -72.82 -8.99 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.701 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -130.56 25.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 71.45 110.406 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.17 -46.94 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.514 -0.312 . . . . 74.41 111.627 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.32 6.99 25.13 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.485 -0.864 . . . . 73.41 112.167 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 39' ' ' GLU . 32.8 t70 -117.48 120.84 39.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.912 -0.403 . . . . 75.55 109.912 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 p -72.99 -8.79 57.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.507 0.558 . . . . 73.51 112.507 -173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 47.4 mt-10 -85.21 -26.79 26.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 62.2 110.292 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -96.84 137.29 36.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.978 -0.556 . . . . 60.11 109.879 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 23.2 p90 -139.17 175.69 9.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.832 0.348 . . . . 53.31 110.908 -174.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.628 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 45.9 t90 -105.44 134.31 48.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 74.2 109.597 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -132.37 143.81 50.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.211 -0.663 . . . . 74.0 109.211 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.03 148.57 49.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.545 -0.298 . . . . 62.21 110.236 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 78.2 tttt -66.4 116.36 7.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.093 -0.503 . . . . 73.52 110.018 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -123.13 -27.2 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.887 -0.325 . . . . 74.23 111.264 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -78.57 107.54 11.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.034 0.445 . . . . 71.54 110.032 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.14 2.19 51.43 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 45.12 111.976 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.17 146.15 8.86 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.831 -0.7 . . . . 33.41 111.937 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 12.1 p -89.63 151.87 21.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 64.34 110.889 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.07 158.92 69.36 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.952 -0.567 . . . . 65.33 110.978 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.29 153.01 61.8 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.766 2.311 . . . . 63.41 112.924 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.52 158.04 41.2 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 72.43 110.132 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.03 167.56 64.85 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.567 -1.43 . . . . 64.32 112.767 2.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 26.4 m-85 -101.67 108.98 20.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.075 -0.512 . . . . 73.33 110.275 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.22 126.62 53.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 73.34 110.436 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 HD23 ' A' ' 126' ' ' LEU . 55.4 mt -120.31 117.75 54.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 41.3 109.78 176.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.82 114.55 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.268 -0.423 . . . . 63.44 110.592 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.4 134.91 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.089 -0.505 . . . . 74.05 110.091 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -99.17 120.22 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.181 -0.463 . . . . 65.34 109.755 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.6 mtm -86.84 -5.68 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.596 . . . . 70.5 110.9 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.9 mmtt 68.45 5.96 5.1 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.312 0.856 . . . . 72.24 113.312 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.35 174.22 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.706 0.289 . . . . 61.4 111.122 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.8 121.7 27.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 54.02 110.198 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.543 HD13 HG21 ' A' ' 5' ' ' ILE . 61.6 mt -132.33 134.52 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 120.995 0.426 . . . . 74.01 110.517 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.9 tp60 -84.28 105.13 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.608 -0.724 . . . . 64.41 109.296 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.2 mm -74.35 117.27 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 73.22 110.427 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.53 -47.99 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.282 -0.417 . . . . 75.43 110.995 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.586 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 6.1 tt0 -141.79 152.77 44.03 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.84 -0.344 . . . . 64.31 110.605 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.38 123.07 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.772 -0.649 . . . . 50.42 109.517 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' OE1' ' HB2' ' A' ' 146' ' ' LYS . 51.3 mp0 -103.75 122.71 45.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.968 -0.56 . . . . 50.53 110.642 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.46 HD12 ' CE2' ' A' ' 114' ' ' TYR . 55.2 mt -113.58 123.39 49.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 74.21 110.337 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 73' ' ' LEU . 19.9 tp -102.25 101.16 17.85 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.381 -0.6 . . . . 74.14 109.381 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.464 -0.227 0 C-N-CA 123.214 2.609 . . . . 74.02 112.905 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 112.338 0.496 . . . . 74.22 112.338 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 5.2 Cg_exo -75.39 36.96 0.47 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.299 2.666 . . . . 44.13 111.936 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.65 125.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.651 . . . . 62.01 109.553 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.89 -54.0 2.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 74.42 110.765 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.19 137.3 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.243 -0.435 . . . . 75.05 110.562 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.42 134.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.261 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.7 mt-10 -116.63 132.51 56.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.022 -0.536 . . . . 72.55 110.596 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -112.08 129.74 56.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.673 -0.694 . . . . 64.44 109.944 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.28 153.62 42.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.702 -0.227 . . . . 54.2 110.435 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.82 43.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.377 -0.374 . . . . 71.51 110.369 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 146.35 27.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 71.34 110.607 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.86 -42.26 34.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.89 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.06 9.52 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.004 0.372 . . . . 74.23 112.004 -173.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.6 t30 64.96 30.06 12.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.784 0.802 . . . . 74.42 110.261 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.78 -52.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.434 -0.803 . . . . 73.34 109.456 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -103.04 107.13 17.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.25 -0.648 . . . . 54.3 109.25 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -94.36 130.65 40.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.154 0.502 . . . . 72.11 111.116 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 m -122.29 122.63 27.41 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.803 -0.635 . . . . 74.42 110.36 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.81 128.9 27.05 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.515 2.144 . . . . 70.2 111.129 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.56 -10.94 8.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.985 -0.286 . . . . 75.34 110.8 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 153.21 7.53 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.095 -1.05 . . . . 51.44 113.599 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.2 ttt180 -130.77 115.05 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.832 -0.803 . . . . 74.35 108.832 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.43 -177.82 4.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.689 0.281 . . . . 41.15 110.828 -174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.96 14.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.957 -0.639 . . . . 64.24 112.024 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 49.8 t80 -93.27 114.6 27.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 73.12 110.069 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -99.17 106.98 19.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.237 -0.438 . . . . 62.12 110.025 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -68.17 111.7 4.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.147 0.499 . . . . 74.23 110.638 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.27 -176.26 5.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.399 -0.819 . . . . 71.41 108.922 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.74 -10.48 19.91 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.617 -0.433 . . . . 75.54 110.545 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.48 20.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 61.1 110.389 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.1 133.0 45.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 55.22 111.588 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.3 mt -89.65 122.84 33.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.266 -0.879 . . . . 73.53 110.213 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 33.0 mt-10 -98.05 108.36 21.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.591 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 72' ' ' LEU . 91.2 m-85 -101.85 104.57 15.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.116 -0.493 . . . . 63.44 110.993 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.64 93.32 2.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.672 -0.694 . . . . 75.25 110.055 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.14 178.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.854 -0.612 . . . . 54.43 111.913 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 117' ' ' LYS . 5.3 ttpm? -75.4 112.8 12.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.205 -0.907 . . . . 72.21 110.094 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 20.0 p -56.72 120.53 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.857 -0.611 . . . . 51.33 111.222 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.8 tt -160.57 148.9 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.454 -0.339 . . . . 71.14 110.238 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HG3' HD12 ' A' ' 150' ' ' ILE . 39.6 ttpt -89.86 135.76 33.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 75.14 110.169 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.86 175.15 13.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.557 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -121.74 -34.49 3.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 74.04 110.02 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -108.92 145.4 35.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.238 -0.653 . . . . 64.53 109.238 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.6 tt -131.71 139.23 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.986 -0.375 . . . . 75.12 109.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 60.7 ttp180 -124.31 118.2 26.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.966 0.412 . . . . 72.44 111.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 57' ' ' ILE . 43.4 tp -85.61 114.58 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.903 -0.777 . . . . 61.24 108.903 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -112.1 117.66 33.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.299 0.571 . . . . 65.31 111.347 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.1 mm -100.2 98.15 7.27 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.456 -0.793 . . . . 75.41 108.948 172.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.03 168.86 20.69 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.457 2.105 . . . . 54.44 112.305 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 7.73 45.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 40.32 109.881 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.48 138.26 48.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 70.54 110.157 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.05 -10.84 24.79 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.988 -0.625 . . . . 44.44 111.699 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 109.1 18.88 8.88 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.051 -0.595 . . . . 72.41 112.386 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -76.73 135.64 39.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 74.32 110.759 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 45.9 m -106.88 -173.94 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 62.4 110.281 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 14.4 p -84.55 2.3 41.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 65.04 112.131 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 48.7 t -105.57 124.53 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.452 -0.34 . . . . 51.44 110.386 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.21 140.93 29.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.22 -0.445 . . . . 75.31 110.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.6 113.68 4.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.939 0.4 . . . . 74.35 111.06 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 19.3 mt -126.18 132.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.073 -0.714 . . . . 75.54 109.073 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.691 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 97.4 mtt180 -65.58 -61.83 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 73.22 110.481 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.74 138.92 23.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.24 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.02 116.41 29.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -114.62 150.57 34.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.993 0.425 . . . . 70.14 110.149 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.37 124.03 72.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.183 -0.673 . . . . 54.4 109.183 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -105.33 102.87 12.33 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.366 0.603 . . . . 74.43 109.86 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.87 -156.9 7.34 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.405 -0.816 . . . . 75.14 111.574 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.1 m -119.1 131.85 55.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.705 0.288 . . . . 60.34 110.936 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.506 HD11 HG23 ' A' ' 5' ' ' ILE . 37.5 mm -74.56 123.01 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.29 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 66' ' ' GLN . 51.1 mt . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.683 -0.488 . . . . 64.04 109.683 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.809 HG22 ' HG2' ' A' ' 146' ' ' LYS . 46.3 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.978 -0.379 . . . . 62.32 109.978 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 149' ' ' ILE . 38.9 mm -74.78 138.71 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.189 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 122.82 17.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.312 -0.625 . . . . 62.33 109.312 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -101.64 6.45 42.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.679 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -72.54 84.45 1.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 71.43 110.239 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.81 -9.76 2.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.635 -0.711 . . . . 73.21 112.38 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -70.49 155.81 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 73.32 110.461 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.5 pt-20 -138.96 155.87 47.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.079 0.466 . . . . 75.22 110.015 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.55 113.48 31.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.821 -0.627 . . . . 70.4 110.005 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.2 mt -79.67 -36.46 37.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.83 -0.623 . . . . 74.3 110.591 -177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.3 t -147.91 141.24 25.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 60.42 110.721 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.475 ' HE2' ' HG2' ' A' ' 18' ' ' GLN . 35.4 p90 -155.72 136.11 13.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.765 -0.652 . . . . 74.3 109.633 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -85.25 -44.91 12.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.204 -0.453 . . . . 62.42 111.786 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -134.34 147.51 50.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.022 0.439 . . . . 72.53 111.001 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -161.57 148.47 14.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.732 -0.667 . . . . 73.54 109.407 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.67 112.22 20.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.897 -0.409 . . . . 63.42 109.897 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.65 1.31 17.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.652 0.612 . . . . 71.12 112.652 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -143.83 -29.79 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.384 -0.526 . . . . 63.31 112.331 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.218 0 C-N-CA 120.93 -0.652 . . . . 64.2 112.866 -179.291 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.3 t30 . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.112 -0.329 . . . . 74.22 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.0 2.49 20.34 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.298 -0.721 . . . . 64.22 111.298 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.7 mt -74.67 150.74 39.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.532 -0.334 . . . . 73.32 110.74 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.99 -23.21 67.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.09 0.471 . . . . 71.24 111.214 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 -17.28 57.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 64.54 111.341 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 63.4 m -73.55 -17.61 61.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.176 0.512 . . . . 72.21 110.046 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -71.97 -14.36 61.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.37 -0.832 . . . . 52.55 110.7 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -130.66 21.59 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 61.4 109.911 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 18.1 t70 -72.39 -45.68 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.646 -0.707 . . . . 74.44 111.167 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.68 -1.47 21.71 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.478 -0.868 . . . . 61.32 112.655 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -131.16 118.36 20.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.126 -0.324 . . . . 70.23 110.126 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 p -72.22 2.07 6.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.953 -0.567 . . . . 63.11 111.683 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.24 -35.78 80.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.631 -0.877 . . . . 44.4 108.631 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.1 p -95.42 165.73 12.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.834 -1.076 . . . . 64.54 110.141 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.536 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 32.6 p90 -155.63 167.84 29.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.491 -0.322 . . . . 73.43 110.674 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.9 t90 -101.22 133.23 46.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.268 -0.642 . . . . 70.11 109.268 172.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.62 144.19 49.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.332 -0.618 . . . . 75.21 109.332 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.16 146.93 52.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.282 -0.417 . . . . 74.55 110.435 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' SER . 82.8 tttt -63.12 116.61 5.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.978 -0.556 . . . . 72.21 110.197 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -120.4 -27.93 5.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.523 -0.471 . . . . 75.3 110.663 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.88 110.72 11.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 72.45 110.2 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 10.11 59.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.804 -0.712 . . . . 54.35 112.06 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.08 154.6 16.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.841 -0.695 . . . . 63.1 112.156 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 52.0 m -102.86 159.61 15.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 55.02 111.286 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.75 156.6 52.75 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.846 -0.615 . . . . 73.45 110.35 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.68 153.56 43.53 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.534 2.156 . . . . 65.5 113.194 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 130' ' ' ASP . 11.9 mt -92.16 159.79 36.76 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 75.12 110.118 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 77.5 Cg_endo -80.52 162.45 82.71 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.578 -1.426 . . . . 71.03 112.875 -1.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 28.6 m-85 -93.98 132.31 38.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.199 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 3.4 t70 -111.49 125.45 53.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 75.41 110.219 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 126' ' ' LEU . 52.5 mt -131.43 111.26 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.21 -0.45 . . . . 71.21 109.909 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.37 122.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.062 -0.517 . . . . 71.22 110.562 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 57' ' ' ILE . 4.9 mp -116.25 136.13 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.638 -0.255 . . . . 75.14 110.694 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.3 t0 -99.12 119.73 38.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.721 -0.844 . . . . 75.14 108.721 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.6 mtm -85.6 -5.62 59.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.356 -0.384 . . . . 73.1 111.111 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.508 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 66.27 12.02 8.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.806 -0.634 . . . . 74.31 112.026 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -165.88 147.56 7.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 63.42 109.746 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.7 128.43 35.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.899 -0.592 . . . . 73.23 110.042 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.7 mt -132.38 139.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.258 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.37 102.95 12.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.869 -0.789 . . . . 70.32 108.869 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -72.28 129.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.376 . . . . 60.13 110.833 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.89 -32.85 3.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 31.43 111.079 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -163.29 147.68 11.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.881 -0.599 . . . . 54.11 111.177 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.2 t -119.84 133.87 65.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.162 -0.472 . . . . 73.53 109.871 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.694 ' HG3' ' HD2' ' A' ' 146' ' ' LYS . 26.0 mt-10 -110.76 127.61 55.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.126 0.489 . . . . 73.22 110.602 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.96 121.3 43.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.664 -0.698 . . . . 42.03 109.622 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.7 tp -111.13 95.88 27.42 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.325 -0.398 . . . . 72.15 109.963 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 65.0 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 C-N-CA 122.458 2.105 . . . . 71.43 111.657 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.1 t30 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.884 0.374 . . . . 74.12 110.319 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.03 27.4 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.181 2.588 . . . . 71.43 112.659 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.68 121.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.496 . . . . 73.13 110.457 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -105.89 -37.24 6.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.623 -0.717 . . . . 75.01 111.197 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 132' ' ' GLY . 91.1 t -134.53 138.48 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.569 0.223 . . . . 72.2 111.097 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 m -132.13 139.73 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 73.23 110.418 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 67.9 mt-10 -121.06 134.53 55.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.394 -0.366 . . . . 74.31 110.791 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -116.22 131.03 57.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 73.04 110.8 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.75 153.33 49.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.369 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.16 155.53 46.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.4 t -150.02 147.33 27.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.063 0.459 . . . . 74.04 110.781 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.17 -33.74 16.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 61.54 110.841 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -122.97 -2.69 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.893 0.331 . . . . 75.14 111.893 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 63.85 34.62 11.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.657 0.741 . . . . 61.43 109.587 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.2 t -110.39 -54.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.859 -0.609 . . . . 75.33 109.366 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.65 135.15 54.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -105.83 119.22 38.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.364 0.602 . . . . 73.34 110.687 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.2 m -95.29 125.03 51.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.233 -0.894 . . . . 54.24 110.875 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.0 111.98 3.3 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.627 2.218 . . . . 40.33 111.76 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 116' ' ' VAL . 21.2 pt -86.24 -18.87 8.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 73.43 110.948 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.88 139.96 2.78 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.288 -0.958 . . . . 72.45 113.074 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 30.2 ttt180 -119.59 126.55 51.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.36 -175.91 4.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 74.43 110.84 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.96 143.97 16.42 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.839 -0.696 . . . . 41.31 111.788 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.54 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 33.4 t80 -91.19 136.38 33.13 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.744 -0.465 . . . . 74.22 109.744 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 112' ' ' LEU . 27.1 m -112.78 123.22 49.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.519 -0.31 . . . . 73.5 110.763 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -67.05 93.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.035 0.445 . . . . 61.11 109.852 172.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -144.54 169.27 18.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.895 -0.593 . . . . 73.51 109.417 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -104.9 18.59 22.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.538 0.685 . . . . 71.33 110.196 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.54 153.57 31.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.446 -0.797 . . . . 53.13 109.74 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.54 124.47 22.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.067 0.461 . . . . 70.43 111.262 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 106' ' ' THR . 75.0 mt -80.74 117.79 21.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 74.42 110.439 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -95.86 119.81 35.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.266 -0.424 . . . . 73.53 110.392 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.57 105.17 13.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.232 -0.44 . . . . 74.31 109.905 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -82.59 90.77 6.84 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.282 -0.636 . . . . 73.34 109.282 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 100' ' ' ILE . 30.5 m -86.86 179.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.323 -0.853 . . . . 64.23 110.581 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 100' ' ' ILE . 47.8 pttt -81.44 148.2 29.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.078 0.466 . . . . 72.25 110.226 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 37.4 p -79.01 127.62 32.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.747 -0.66 . . . . 62.23 111.511 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.8 tt -161.49 150.57 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.635 -0.711 . . . . 61.21 109.388 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HB3' ' HZ2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -79.38 140.69 37.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.157 -0.683 . . . . 73.33 109.157 177.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.75 144.19 17.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.569 0.223 . . . . 51.13 110.848 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.76 -22.61 13.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.804 -0.813 . . . . 64.31 108.804 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -115.65 145.42 42.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.846 . . . . 75.32 109.673 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.0 tt -136.34 141.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.957 -0.386 . . . . 73.14 109.957 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 59.9 ttp180 -126.78 125.71 42.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.033 0.444 . . . . 75.22 111.435 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 57' ' ' ILE . 57.9 tp -95.62 124.32 39.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.554 -0.748 . . . . 62.2 109.045 172.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 76.4 m -119.47 123.16 43.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.991 0.424 . . . . 72.21 110.663 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.0 mm -105.56 94.01 7.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.354 -0.61 . . . . 72.14 109.354 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 68.0 Cg_endo -87.76 136.94 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.033 2.489 . . . . 75.01 113.006 -175.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 25.3 t0 -81.48 66.36 7.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.433 -0.951 . . . . 73.43 108.433 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -124.93 -12.54 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.835 -1.075 . . . . 74.34 111.703 -173.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 85' ' ' VAL . . . -139.83 22.62 2.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.659 -1.258 . . . . 63.12 114.001 -173.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.8 26.06 7.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.162 -1.018 . . . . 51.33 112.611 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -82.11 178.45 8.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.887 0.375 . . . . 75.44 110.827 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 m -146.79 178.96 7.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.882 -0.414 . . . . 64.55 109.882 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 p -84.68 16.08 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 34.42 111.667 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.8 127.92 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.52 . . . . 65.34 109.879 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.95 143.45 30.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.313 -0.403 . . . . 75.12 110.18 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.16 106.09 3.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.836 0.35 . . . . 73.22 111.33 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 9.3 mt -126.23 140.5 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.73 -0.841 . . . . 62.24 108.73 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 69.6 mtt180 -75.91 -63.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.025 0.44 . . . . 71.44 110.159 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.97 133.52 22.02 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.666 -0.697 . . . . 73.0 110.863 -170.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.47 120.63 42.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 72.32 109.418 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.88 124.26 44.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 72.25 110.562 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.21 142.07 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 65.34 109.867 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.809 ' HG2' HG22 ' A' ' 4' ' ' THR . 26.6 mtpt -119.16 124.27 46.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.438 . . . . 73.32 109.816 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.56 -166.83 32.44 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.649 -0.786 . . . . 64.14 112.152 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.8 m -107.3 130.15 54.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.573 0.225 . . . . 54.42 110.592 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 5' ' ' ILE . 40.7 mm -72.0 125.05 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.411 . . . . 72.5 110.938 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' A' ' 120' ' ' LYS . 44.6 mt . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 109.169 -0.678 . . . . 70.44 109.169 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 146' ' ' LYS . 22.6 p . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 110.304 -0.258 . . . . 72.41 110.304 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 65' ' ' ILE . 44.1 mm -63.79 147.76 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 73.04 111.213 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -72.95 112.79 9.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.575 -0.528 . . . . 72.22 109.575 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -89.56 -8.54 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.433 . . . . 74.54 111.057 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -73.17 97.67 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.742 0.782 . . . . 75.01 109.31 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.12 -11.91 4.14 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.627 -1.17 . . . . 43.01 111.25 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.519 ' HE3' HG21 ' A' ' 59' ' ' ILE . 30.6 m0 -74.98 161.29 29.61 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.58 -0.526 . . . . 65.33 109.58 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.507 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 8.9 pt-20 -138.57 158.69 43.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.34 -0.544 . . . . 70.13 110.585 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.97 119.54 45.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 64.13 109.709 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.58 -39.0 28.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.014 0.435 . . . . 73.52 110.448 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.6 t -157.04 141.1 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 74.35 109.703 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 18' ' ' GLN . 51.7 p90 -136.02 146.2 46.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.002 -0.545 . . . . 75.44 109.532 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -86.27 -40.98 14.98 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.797 -0.361 . . . . 74.43 110.737 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 5.9 t -147.81 148.17 30.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.153 0.501 . . . . 75.21 111.111 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -171.87 145.1 1.85 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.249 -0.887 . . . . 64.51 108.947 172.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 9.5 tp10 -105.44 102.31 11.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.198 -0.456 . . . . 63.12 110.67 -173.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.43 -30.14 12.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 65.2 110.492 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -83.21 -33.69 26.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 55.21 110.556 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 120.771 -0.728 . . . . 74.44 113.129 -178.83 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 t30 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.274 -0.269 . . . . 75.03 110.274 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.86 -4.52 60.98 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.403 -0.427 . . . . 71.02 112.757 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.698 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.9 mt -73.79 144.69 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.004 -0.369 . . . . 62.02 110.004 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.47 -22.83 64.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.573 0.701 . . . . 53.25 110.064 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.688 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 13.9 ptmt -74.97 -23.44 58.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.999 -1.0 . . . . 73.44 111.335 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 79.1 m -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.949 0.404 . . . . 62.44 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -67.15 -15.02 63.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.617 -0.72 . . . . 74.12 110.581 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.456 HG21 HG12 ' A' ' 59' ' ' ILE . 27.5 pt -133.69 26.5 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 71.32 110.827 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.29 -46.63 19.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.052 0.453 . . . . 72.31 111.305 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.12 6.03 7.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.53 -0.843 . . . . 75.21 112.672 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 7.4 t70 -125.35 127.29 46.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.185 0.492 . . . . 62.51 110.518 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 p -76.34 -5.55 47.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.956 0.724 . . . . 73.44 112.956 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.64 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 7.9 pt-20 -91.42 -21.34 21.01 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.111 -0.636 . . . . 64.43 110.46 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -90.94 136.76 32.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.258 -0.645 . . . . 72.1 109.258 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.741 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 51.2 p90 -137.76 170.73 15.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.438 0.637 . . . . 71.44 112.412 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 30.3 t90 -106.43 139.81 40.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.629 -1.169 . . . . 75.42 109.375 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -135.52 139.18 43.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.323 -0.621 . . . . 72.13 109.323 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 146.33 53.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.433 . . . . 62.44 110.113 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 35.1 ttpt -65.61 131.13 45.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.381 -0.372 . . . . 74.53 110.164 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.433 ' NE1' ' HG2' ' A' ' 19' ' ' GLU . 64.5 p-90 -130.32 -33.89 1.66 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 73.43 111.517 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.71 -41.64 83.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 74.23 110.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.85 26.17 25.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.532 -0.842 . . . . 71.35 111.448 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.27 165.47 40.35 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.1 -0.8 . . . . 73.3 111.1 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.586 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 38.3 m -100.82 145.72 28.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 117.189 0.495 . . . . 64.52 110.452 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 18.3 m-20 -79.11 161.37 68.43 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.621 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 60.1 Cg_endo -73.37 132.78 18.19 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.405 2.07 . . . . 63.4 112.734 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.11 158.27 88.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.822 -0.626 . . . . 60.21 110.198 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.716 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.7 Cg_exo -76.3 159.98 95.96 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.002 -1.249 . . . . 55.42 112.692 0.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.0 m-85 -95.74 101.75 13.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 72.32 110.13 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 7.2 m-20 -98.71 117.96 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.059 -0.518 . . . . 75.12 110.51 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 52.7 mt -111.71 116.79 53.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.266 -0.425 . . . . 75.23 109.922 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.78 115.44 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG21 ' HE3' ' A' ' 10' ' ' TRP . 5.0 mp -111.08 136.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 72.52 110.576 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -104.06 119.54 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.401 -0.592 . . . . 62.22 109.401 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 73.43 110.895 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 31.2 mmtp 72.0 -11.67 0.75 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.514 0.726 . . . . 51.01 112.643 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -145.13 170.5 16.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.617 0.246 . . . . 70.25 110.58 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -85.95 124.36 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 64.32 110.74 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 5' ' ' ILE . 78.1 mt -130.17 136.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 64.3 110.065 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.574 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.9 tp60 -80.02 100.71 8.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.099 -0.704 . . . . 65.2 109.099 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 118' ' ' SER . 31.7 mm -69.36 118.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.909 -0.404 . . . . 51.25 109.909 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.6 -39.38 5.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.233 0.539 . . . . 62.53 110.914 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 51.3 tt0 -159.24 148.68 18.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.611 -0.722 . . . . 50.12 110.563 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.16 115.85 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.369 . . . . 42.2 110.817 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.579 ' OE2' ' HA ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -97.79 128.1 44.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.707 -0.679 . . . . 71.34 110.689 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 45.9 mt -109.34 118.17 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.463 -0.569 . . . . 54.13 109.463 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -103.74 99.07 14.58 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.588 -0.523 . . . . 64.23 109.588 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 5.4 Cg_exo . . . . . 0 N--CA 1.456 -0.704 0 C-N-CA 122.869 2.379 . . . . 64.35 111.795 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.698 0.285 . . . . 65.22 111.122 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 2.3 Cg_endo -82.95 32.12 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.35 2.7 . . . . 73.11 111.73 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.43 118.86 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.818 -0.628 . . . . 74.25 110.186 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -100.57 -50.12 3.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.675 . . . . 74.3 110.904 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 60.9 t -127.36 141.68 45.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.042 -0.526 . . . . 71.13 110.599 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.36 129.82 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.151 -0.477 . . . . 71.14 109.743 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.6 mt-10 -109.79 125.41 52.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.132 -0.486 . . . . 53.42 110.493 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -107.68 129.66 55.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.081 -0.509 . . . . 74.3 110.426 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.58 145.33 49.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.279 -0.418 . . . . 63.41 110.76 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.02 48.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.027 -0.533 . . . . 61.25 109.846 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t -149.86 154.62 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.345 0.593 . . . . 71.32 111.344 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 41.5 mt-10 -102.64 -32.79 9.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.432 -0.804 . . . . 71.31 109.985 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 26.8 t0 -106.81 -12.32 15.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 74.41 111.252 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 15.8 t-20 76.25 -21.5 0.31 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.413 0.625 . . . . 75.21 111.114 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ASP . 78.3 t -75.72 -50.96 21.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.684 -0.689 . . . . 54.31 110.319 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.1 113.41 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.225 -0.898 . . . . 63.31 109.913 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -94.08 142.19 27.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.014 -0.539 . . . . 73.52 110.946 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.4 m -115.1 124.55 30.09 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.786 -0.643 . . . . 73.23 109.967 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.52 116.17 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.567 2.178 . . . . 74.35 112.143 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 116' ' ' VAL . 15.7 pt -86.78 -13.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.395 -0.366 . . . . 74.05 110.571 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.69 130.76 1.15 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.333 -0.937 . . . . 43.42 113.177 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 38.4 ttt180 -106.71 114.56 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.713 -0.847 . . . . 71.31 108.713 171.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.568 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.4 m-85 -125.79 172.3 9.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.404 -0.362 . . . . 74.0 110.682 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.53 151.3 22.41 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.027 -0.829 . . . . 53.41 111.027 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -100.86 131.96 46.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.96 -0.385 . . . . 65.15 109.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.536 ' HB ' HD21 ' A' ' 112' ' ' LEU . 21.1 m -105.8 124.74 50.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 65.43 110.433 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.69 94.87 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.095 0.474 . . . . 73.31 110.312 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -146.09 176.84 9.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.988 -0.745 . . . . 71.14 108.988 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.46 -7.81 17.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.033 0.444 . . . . 73.2 110.983 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.72 159.26 16.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 44.5 110.47 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.27 130.0 41.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 72.24 111.616 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 106' ' ' THR . 36.0 mt -87.28 116.38 25.33 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 74.51 110.33 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.579 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 40.9 mt-10 -83.16 121.14 26.68 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.283 0.364 . . . . 62.22 110.846 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 72' ' ' LEU . 49.9 m-85 -122.29 104.96 9.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 73.43 110.711 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.36 97.0 5.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.592 -0.731 . . . . 74.11 109.414 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.568 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.1 m -98.13 -178.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.443 -0.798 . . . . 75.42 111.792 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 45.8 tttp -61.04 125.69 24.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 71.45 111.088 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 9.6 p -73.05 120.02 18.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 75.24 110.029 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.431 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 10.6 tt -150.9 141.01 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.972 0.415 . . . . 74.42 111.406 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -82.9 115.02 21.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.277 -0.638 . . . . 74.01 109.277 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -142.8 175.0 10.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.292 . . . . 75.23 110.983 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -121.04 -32.5 3.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.6 . . . . 74.43 110.015 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.97 145.98 33.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 73.31 110.298 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -134.17 136.68 53.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.134 -0.484 . . . . 65.25 109.953 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.522 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.1 ttp180 -123.86 122.2 37.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.993 0.425 . . . . 74.02 111.095 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 HD12 ' A' ' 57' ' ' ILE . 40.4 tp -93.79 111.45 23.15 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.974 -0.75 . . . . 75.22 108.974 172.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 61.0 m -105.91 120.59 42.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.071 0.462 . . . . 73.21 111.061 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.732 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -98.31 96.23 3.5 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.566 -0.901 . . . . 74.0 108.566 171.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.716 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -68.71 171.72 12.79 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.68 2.254 . . . . 54.33 113.057 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.34 -2.43 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.251 1.024 . . . . 65.25 108.407 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' H ' ' HB2' ' A' ' 129' ' ' PRO . 7.0 m-20 -72.45 -31.84 65.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.138 -1.392 . . . . 74.04 112.439 -170.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -94.2 0.11 66.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.187 -1.006 . . . . 64.21 113.621 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.88 20.71 11.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.108 -1.044 . . . . 73.35 111.668 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -72.55 142.6 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.45 . . . . 72.34 111.031 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 17.4 m -100.06 172.24 7.32 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.924 -0.58 . . . . 54.51 109.867 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 16.2 p -83.19 22.05 1.03 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 55.32 112.128 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.23 129.42 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.506 -0.553 . . . . 65.21 109.506 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.17 135.11 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.507 -0.315 . . . . 65.05 110.939 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -134.47 106.04 6.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 63.11 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 29.9 mt -124.07 133.64 68.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.426 -0.583 . . . . 42.22 109.426 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.741 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 72.3 mtt180 -66.03 -71.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.274 0.359 . . . . 70.11 110.27 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.7 153.73 44.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.431 0.634 . . . . 73.23 111.705 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 tt -106.68 111.31 23.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.541 -1.281 . . . . 73.14 107.541 168.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -112.11 123.34 50.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.766 -0.457 . . . . 71.12 109.766 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.05 128.35 52.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.916 0.389 . . . . 61.34 111.978 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.704 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 54.1 mtpt -94.51 130.6 40.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.377 -0.601 . . . . 60.13 109.377 171.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.15 -167.35 35.42 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.186 -1.007 . . . . 44.3 112.265 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.2 m -123.06 129.49 51.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.479 0.18 . . . . 75.33 110.548 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 41.6 mm -69.36 116.36 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.163 -0.471 . . . . 73.45 109.981 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 66' ' ' GLN . 62.0 mt . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 120.974 0.416 . . . . 62.42 109.97 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.624 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 35.3 p . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.68 0.276 . . . . 53.3 110.446 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 HD11 ' A' ' 149' ' ' ILE . 47.5 mm -88.65 134.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.837 0.351 . . . . 71.13 111.317 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -66.64 118.35 10.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.12 -0.491 . . . . 63.1 110.07 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -98.47 19.61 14.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.505 . . . . 72.32 111.217 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.5 m -58.7 -42.18 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.498 0.555 . . . . 72.05 112.498 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.13 8.05 62.69 Favored Glycine 0 C--O 1.235 0.186 0 C-N-CA 120.541 -0.838 . . . . 41.01 112.946 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -75.39 138.38 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.29 . . . . 74.41 110.236 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.4 pt-20 -130.3 152.91 49.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.074 -0.343 . . . . 71.41 110.074 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.28 115.23 32.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.907 -0.588 . . . . 54.21 109.829 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.459 HD11 ' HE2' ' A' ' 123' ' ' TYR . 84.8 mt -77.24 -48.97 16.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 72.22 110.062 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 t -143.26 142.99 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.562 -0.745 . . . . 74.03 110.138 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.571 -0.74 . . . . 75.34 109.257 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.2 m -77.12 -40.91 44.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.055 0.455 . . . . 72.31 110.37 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -150.98 150.34 30.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.219 -0.446 . . . . 72.13 110.864 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.19 140.51 7.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.502 -0.925 . . . . 72.35 108.502 173.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.3 tp10 -86.12 95.94 9.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.423 0.63 . . . . 71.12 110.632 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.83 2.58 20.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.259 -0.882 . . . . 74.43 110.786 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 m -112.56 -43.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.887 -0.597 . . . . 72.43 110.629 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.472 0 CA-C-N 116.012 -0.54 . . . . 64.43 113.372 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 110.004 -0.369 . . . . 74.05 110.004 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.5 83.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.014 -0.612 . . . . 65.05 111.971 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.75 154.33 21.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.58 0.229 . . . . 74.43 110.488 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.96 -22.54 65.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.878 0.371 . . . . 72.53 111.448 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -77.83 -22.69 49.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.504 -0.317 . . . . 74.11 111.315 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 40.3 m -68.56 -24.33 64.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 74.53 109.911 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 142' ' ' GLU . 24.9 tp -65.12 -24.49 67.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.39 -0.823 . . . . 64.3 110.776 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HG21 HG12 ' A' ' 59' ' ' ILE . 35.9 pt -120.86 14.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.379 . . . . 73.11 111.16 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.86 -33.03 73.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.05 0.452 . . . . 74.42 110.197 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.0 36.29 6.41 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.708 -0.678 . . . . 51.44 112.023 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -139.05 128.93 24.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.988 -0.375 . . . . 61.42 109.988 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 73' ' ' LEU . 2.5 p -70.36 -11.72 61.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.626 0.602 . . . . 72.34 112.626 -174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -89.06 -27.11 21.02 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.84 0.352 . . . . 64.22 111.049 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.2 p -87.78 146.1 25.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.739 -0.384 . . . . 74.44 109.974 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.676 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 42.6 p90 -146.5 166.09 27.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.217 0.532 . . . . 75.02 111.772 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -108.24 139.89 42.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.948 -1.023 . . . . 74.14 109.547 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -133.01 147.11 52.26 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.234 -0.654 . . . . 72.22 109.234 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . . . -75.11 145.92 41.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.992 -0.373 . . . . 73.43 109.992 175.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HE2' ' OD2' ' A' ' 51' ' ' ASP . 37.7 ttpt -66.15 118.14 9.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 75.4 110.355 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -118.96 -30.9 4.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.425 -0.352 . . . . 75.42 110.896 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -78.72 107.67 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 73.4 110.249 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.12 -0.6 47.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.891 -0.671 . . . . 75.3 111.684 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 143.0 7.46 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.795 -0.717 . . . . 53.54 112.144 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -95.98 151.79 19.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.822 0.344 . . . . 60.42 111.053 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.479 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 30.5 m-20 -82.39 150.32 63.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.921 -0.582 . . . . 54.43 110.661 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.81 145.02 44.97 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.746 2.297 . . . . 34.4 112.269 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.8 mt -70.6 162.13 72.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 54.52 110.529 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 95.2 Cg_endo -83.15 170.02 56.16 Favored 'Cis proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.487 -1.464 . . . . 64.31 112.831 1.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.4 m-85 -108.17 111.02 22.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 73.41 110.406 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -110.79 130.95 55.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 74.33 110.622 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 126' ' ' LEU . 57.4 mt -121.72 114.41 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.479 -0.563 . . . . 71.44 109.479 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -102.36 115.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.921 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 HG21 ' A' ' 34' ' ' ILE . 4.9 mp -110.1 133.35 55.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.535 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -97.79 113.74 25.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.675 . . . . 73.42 109.179 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.2 mtm -81.98 -5.36 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 64.45 110.82 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 32.5 mmtp 73.41 -35.63 0.32 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.74 0.816 . . . . 74.13 112.965 174.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -123.9 166.73 15.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.005 0.431 . . . . 73.33 110.975 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.58 123.19 25.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.625 -0.716 . . . . 75.32 110.139 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.575 HD13 HG21 ' A' ' 5' ' ' ILE . 66.6 mt -131.68 136.87 56.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.05 0.452 . . . . 64.23 110.614 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.7 tp60 -86.48 108.56 18.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.858 -0.793 . . . . 65.45 108.858 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 118' ' ' SER . 28.1 mm -75.33 130.56 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.441 -0.207 . . . . 73.53 110.441 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -42.27 2.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.075 0.464 . . . . 73.42 111.331 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.8 tt0 -153.39 145.84 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 73.51 110.296 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -110.39 134.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.02 -0.363 . . . . 61.0 110.02 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -113.02 126.96 56.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.139 0.495 . . . . 70.42 110.899 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.625 HD12 ' HE2' ' A' ' 114' ' ' TYR . 61.3 mt -110.71 123.38 49.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.725 -0.67 . . . . 72.13 109.499 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.53 ' CD2' HG22 ' A' ' 38' ' ' THR . 22.4 tp -103.93 104.76 44.97 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.905 -0.405 . . . . 71.11 109.905 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 C-N-CA 122.815 2.343 . . . . 74.52 111.955 178.062 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 41.1 t-20 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.21 0.528 . . . . 72.13 110.756 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 9.3 Cg_endo -91.22 21.64 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.912 3.075 . . . . 72.01 112.796 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.06 122.92 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 62.34 110.169 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -100.08 -50.24 4.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 73.4 110.855 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 60.2 t -126.97 138.41 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 51.32 110.928 -173.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.91 137.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.069 -0.514 . . . . 64.01 110.128 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.13 135.53 54.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.039 0.447 . . . . 64.55 110.662 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.11 129.76 55.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.938 -0.574 . . . . 74.14 110.118 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.9 143.44 50.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 50.41 110.671 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.59 151.35 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.254 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 t -146.26 152.88 39.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 34.43 110.949 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -29.41 9.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.716 -0.674 . . . . 71.3 110.89 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -111.19 -0.03 16.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 74.11 111.11 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.1 t30 68.7 21.09 7.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.92 0.866 . . . . 75.22 109.614 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.76 -59.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.434 -0.803 . . . . 72.32 110.275 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -89.12 110.86 21.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 51.02 109.769 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -99.12 107.59 20.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.937 0.398 . . . . 75.52 110.312 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.8 m -88.46 123.89 67.25 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.967 -0.561 . . . . 72.42 110.378 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.13 107.33 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.243 1.962 . . . . 54.22 111.012 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 13.8 pt -80.21 -11.84 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.059 -0.519 . . . . 53.55 110.641 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.21 128.56 1.0 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.453 -0.88 . . . . 43.42 112.862 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -100.62 123.58 45.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.92 -0.771 . . . . 75.13 108.92 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.52 -177.73 4.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.741 0.305 . . . . 60.21 110.482 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -96.72 175.26 31.24 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.753 -0.737 . . . . 62.02 111.264 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -131.7 141.96 49.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.135 0.467 . . . . 75.42 110.095 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 m -136.69 119.42 16.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.931 -0.577 . . . . 73.44 110.058 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 63.9 t30 -69.62 95.93 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.725 -0.472 . . . . 71.22 109.725 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -125.8 -167.98 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 62.04 110.843 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.09 -33.47 14.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.916 -0.584 . . . . 54.42 111.186 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.87 168.62 10.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.887 -0.597 . . . . 44.04 111.56 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.8 144.81 47.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.091 0.472 . . . . 74.03 111.146 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.6 mt -101.18 104.54 15.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.637 -0.711 . . . . 72.01 110.01 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.29 115.82 24.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.476 . . . . 73.01 110.688 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.625 ' HE2' HD12 ' A' ' 72' ' ' LEU . 42.1 m-85 -113.34 108.17 16.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.117 0.484 . . . . 74.14 110.534 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -72.86 112.78 9.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.477 -0.783 . . . . 74.32 109.495 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -112.06 178.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.086 -0.507 . . . . 72.13 111.653 -172.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.73 128.19 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 71.03 110.481 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.8 p -77.02 106.44 8.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.151 -0.477 . . . . 44.03 110.175 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.85 146.73 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.915 -0.584 . . . . 74.13 110.487 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -88.29 131.44 34.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.845 0.355 . . . . 74.4 110.506 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.96 176.65 11.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 51.23 110.339 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -125.38 -30.66 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 64.23 110.158 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.459 ' HE2' HD11 ' A' ' 13' ' ' LEU . 93.5 m-85 -106.78 146.02 31.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.056 -0.52 . . . . 74.13 110.14 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.0 tt -135.99 135.66 50.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.934 0.397 . . . . 74.14 110.157 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 33.6 ttp180 -122.88 120.06 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.34 -0.391 . . . . 74.12 110.679 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -84.48 113.73 21.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.769 -0.826 . . . . 70.15 108.769 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.5 m -107.77 116.92 32.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.349 0.595 . . . . 62.22 111.278 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.9 mm -100.59 91.34 1.77 Allowed Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.002 -1.11 . . . . 51.15 108.002 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 61.1 Cg_endo -72.8 174.45 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.243 1.962 . . . . 53.21 112.521 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.34 36.91 0.89 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.613 -0.884 . . . . 62.21 108.613 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -113.52 146.37 39.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.571 -1.195 . . . . 72.14 110.752 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.98 9.9 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.144 -0.55 . . . . 71.55 113.522 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 116.37 25.28 3.52 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.285 -0.959 . . . . 41.53 112.263 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.93 145.0 56.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 71.21 110.383 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 15.4 m -118.74 176.87 5.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.068 -0.515 . . . . 70.52 110.541 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 34.1 p -78.16 10.14 3.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.243 -0.435 . . . . 71.11 111.879 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 44.8 t -109.4 119.29 58.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.654 -0.499 . . . . 73.41 109.654 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . . . -139.59 135.74 33.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.612 -0.267 . . . . 72.53 110.535 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.87 107.55 3.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 74.51 110.887 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.9 mt -133.43 136.97 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.478 -0.564 . . . . 71.04 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 36.3 mmt180 -63.77 -72.4 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.849 0.357 . . . . 72.33 110.071 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 33' ' ' LEU . 12.8 pt-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.917 -0.713 . . . . 74.34 111.812 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.39 130.56 56.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.715 -1.13 . . . . 72.14 108.147 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.624 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -128.16 164.4 22.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.696 -0.483 . . . . 71.32 109.696 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -133.28 128.02 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 71.1 110.277 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 50.7 mttm -93.13 134.66 35.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.172 -0.677 . . . . 73.2 109.172 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.39 8.56 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.87 -0.681 . . . . 72.44 111.453 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -136.31 133.61 37.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.484 0.183 . . . . 72.2 110.562 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.821 HD11 HG23 ' A' ' 5' ' ' ILE . 31.2 mm -73.55 115.83 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 66' ' ' GLN . 56.1 mt . . . . . 0 C--N 1.315 -0.904 0 N-CA-C 109.709 -0.478 . . . . 54.33 109.709 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.808 0.337 . . . . 71.12 110.35 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 149' ' ' ILE . 44.5 mm -82.74 130.53 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.786 0.327 . . . . 72.03 110.85 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.3 t -65.6 125.05 23.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.171 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -96.83 21.8 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 42.31 110.586 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 t -54.73 -46.04 74.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.576 -0.738 . . . . 60.24 112.069 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.29 18.29 36.12 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.239 -0.981 . . . . 43.43 113.643 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.4 ' HB3' HD12 ' A' ' 34' ' ' ILE . 25.9 m0 -77.41 144.07 38.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.063 0.432 . . . . 74.13 110.669 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.557 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 23.5 pt-20 -139.85 162.7 34.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.432 . . . . 71.1 110.666 176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.33 127.48 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.869 -0.605 . . . . 74.35 110.133 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 mt -90.99 -45.82 8.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.245 0.545 . . . . 75.04 110.096 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 m -137.0 140.43 42.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 75.21 110.283 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -149.55 142.42 24.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 72.03 110.071 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 m -81.8 -51.95 7.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 71.23 111.256 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -142.17 151.51 42.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.409 . . . . 72.53 110.8 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.538 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 9.6 pt20 -163.34 137.11 5.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.448 -0.796 . . . . 60.34 108.972 174.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.8 tp10 -89.48 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.208 0.528 . . . . 73.44 110.875 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.68 -8.59 22.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.53 -0.759 . . . . 70.22 111.097 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -106.52 -52.64 2.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 54.13 110.81 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.657 0 CA-C-N 116.074 -0.512 . . . . 65.34 112.55 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 t30 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.078 -0.342 . . . . 63.14 110.078 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.6 -1.98 79.68 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.606 -0.598 . . . . 71.43 111.606 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 60.4 mt -84.32 155.84 22.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.192 -0.299 . . . . 64.13 110.192 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.81 -28.34 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.21 0.529 . . . . 71.25 111.098 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -79.58 -14.28 58.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.549 . . . . 71.12 111.545 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 71.1 m -73.11 -19.29 61.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.063 0.459 . . . . 74.14 109.822 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 39.5 tp -68.62 -13.05 62.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.482 -0.781 . . . . 72.5 110.7 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 59' ' ' ILE . 34.6 pt -137.59 21.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.803 -0.635 . . . . 61.4 110.306 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 12.3 t70 -67.76 -41.58 83.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 73.42 110.793 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.26 -2.26 11.47 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.869 -0.892 . . . . 53.05 110.869 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -125.04 115.08 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 75.24 109.951 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -75.93 2.61 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.482 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.34 -27.62 21.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.955 0.407 . . . . 65.3 110.049 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -89.07 137.42 32.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.017 -0.735 . . . . 64.22 109.017 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.655 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 41.8 p90 -130.11 173.2 10.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.057 0.456 . . . . 64.41 111.431 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.574 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.7 t90 -107.4 128.6 54.62 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 71.21 108.793 172.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -129.67 132.9 46.81 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.467 -0.568 . . . . 72.43 109.467 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.69 136.25 58.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.974 -0.75 . . . . 61.24 108.974 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.3 132.96 55.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.174 0.296 . . . . 73.02 110.385 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -124.09 -22.1 4.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.149 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -69.47 108.18 3.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.868 0.366 . . . . 75.14 110.197 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.96 11.91 72.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 73.32 112.055 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.16 176.14 18.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 72.32 111.972 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -123.76 149.28 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.925 0.393 . . . . 51.35 110.856 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 2.6 t70 -75.66 142.93 74.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.974 -0.557 . . . . 75.3 109.712 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 30.8 Cg_endo -63.59 146.1 92.3 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.566 2.177 . . . . 71.24 113.193 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 9.7 mt -77.58 163.53 63.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.661 -0.7 . . . . 72.22 110.034 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.8 Cg_endo -81.28 163.95 77.96 Favored 'Cis proline' 0 N--CA 1.461 -0.401 0 C-N-CA 124.101 -1.208 . . . . 65.33 112.92 1.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.3 m-85 -99.28 122.86 43.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.82 -0.627 . . . . 71.52 110.318 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 9.9 t0 -110.22 126.67 54.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.695 . . . . 75.53 109.817 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.7 mt -130.25 108.92 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.769 0.319 . . . . 64.24 110.372 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.84 118.46 47.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.023 -0.535 . . . . 71.52 110.566 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 34' ' ' ILE . 82.8 mt -117.35 134.08 62.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.122 -0.49 . . . . 72.43 111.124 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -100.66 122.7 43.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.521 -0.548 . . . . 75.5 109.521 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.422 ' SD ' HD12 ' A' ' 65' ' ' ILE . 71.3 mtm -88.21 -6.21 57.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 64.21 110.766 -177.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.557 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.5 mmtt 67.26 11.53 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.752 -0.658 . . . . 32.31 112.197 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -163.46 159.84 22.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.228 -0.286 . . . . 74.22 110.228 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 58.7 m-80 -81.5 130.45 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.615 -0.513 . . . . 70.42 109.615 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.489 ' CD1' HG21 ' A' ' 5' ' ' ILE . 65.4 mt -135.55 136.01 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.078 0.466 . . . . 72.44 110.422 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -82.34 99.91 9.65 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 64.23 108.635 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.752 ' O ' ' HA ' ' A' ' 118' ' ' SER . 34.5 mm -69.79 113.55 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.174 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 -32.6 7.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.896 0.379 . . . . 65.14 111.161 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.683 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 7.0 tt0 -154.2 147.42 24.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.283 -0.417 . . . . 64.33 110.78 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.87 134.15 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.111 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 44.3 mt-10 -115.56 138.63 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.162 0.506 . . . . 65.15 110.927 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 114' ' ' TYR . 92.7 mt -124.28 118.71 27.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.739 -0.664 . . . . 75.34 109.755 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -103.33 99.75 15.9 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 109.094 -0.706 . . . . 75.34 109.094 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.61 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 55.5 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.526 . . . . 75.11 112.656 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 19.2 t30 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.182 0.515 . . . . 72.35 109.732 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.49 46.07 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.945 3.096 . . . . 72.05 113.906 -170.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.4 111.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.171 -0.677 . . . . 63.13 109.171 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.02 -48.05 8.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 72.33 110.91 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.713 HG11 ' HE ' ' A' ' 102' ' ' ARG . 12.0 t -130.95 143.15 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 74.51 110.713 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.88 142.01 45.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.144 -0.48 . . . . 65.25 110.238 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -112.68 130.18 56.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.983 -0.553 . . . . 75.25 110.497 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.81 129.1 55.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 73.32 110.312 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.33 148.55 52.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.316 -0.402 . . . . 63.02 110.476 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.36 153.63 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.42 -0.354 . . . . 70.11 110.479 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 t -145.39 142.38 29.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 70.45 110.136 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -77.32 -45.66 25.46 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.925 -0.58 . . . . 73.23 111.279 -176.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.61 23.85 5.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.372 -0.376 . . . . 71.52 111.048 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.1 t30 65.63 29.55 10.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.93 0.871 . . . . 73.51 110.089 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.17 -64.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.34 -0.845 . . . . 71.52 109.741 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -96.41 105.1 17.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 64.2 110.792 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -89.33 114.63 26.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.291 -0.413 . . . . 70.44 110.148 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 60.8 m -117.38 130.4 24.68 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.955 -0.566 . . . . 64.23 110.87 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 8.1 Cg_exo -70.88 106.99 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.865 2.376 . . . . 61.52 111.336 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 116' ' ' VAL . 11.8 pt -76.04 -11.1 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.777 -0.647 . . . . 71.21 111.057 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.77 149.0 5.8 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.339 -0.934 . . . . 65.04 113.101 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.713 ' HE ' HG11 ' A' ' 85' ' ' VAL . 78.1 ttt180 -124.21 118.4 26.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.705 -0.85 . . . . 75.44 108.705 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.0 m-85 -133.32 163.17 29.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.897 0.38 . . . . 72.53 111.364 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.65 141.4 25.5 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.663 -0.699 . . . . 35.23 111.595 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.61 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 48.0 t80 -100.54 138.38 37.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.954 0.407 . . . . 61.24 110.368 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 112' ' ' LEU . 32.6 m -131.3 112.73 13.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.184 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.66 103.07 2.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.291 0.567 . . . . 74.5 110.942 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -130.83 -174.34 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.317 -0.856 . . . . 73.11 109.425 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -90.56 -15.38 30.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.78 0.324 . . . . 72.43 110.98 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 150.77 22.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.344 -0.389 . . . . 60.25 110.839 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.06 127.51 32.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.115 0.483 . . . . 62.43 111.125 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -79.63 105.34 10.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.657 -0.701 . . . . 72.34 110.349 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 42.6 mt-10 -88.64 111.71 22.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.181 0.515 . . . . 74.33 111.187 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -108.57 111.46 23.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.652 -0.703 . . . . 73.14 110.35 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -74.25 102.59 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.686 . . . . 72.23 109.636 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 100' ' ' ILE . 31.5 m -102.08 -179.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 71.14 111.583 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -72.28 125.21 26.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.562 -0.745 . . . . 71.12 110.07 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 32.5 p -70.2 127.18 31.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.951 -0.568 . . . . 74.11 111.295 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.89 148.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.29 -0.414 . . . . 70.51 110.329 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -85.52 116.28 23.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . . . -141.81 156.43 45.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.959 -0.564 . . . . 73.44 110.828 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.92 -26.99 8.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.505 0.669 . . . . 73.31 109.388 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -111.4 145.4 38.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.459 -0.792 . . . . 74.04 109.319 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -133.08 139.63 49.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.693 -0.484 . . . . 73.12 109.693 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.6 ttp180 -125.02 123.43 39.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.055 0.455 . . . . 65.54 111.126 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -91.02 115.55 28.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.411 -0.813 . . . . 74.33 108.92 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.7 m -109.63 116.17 31.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.949 0.404 . . . . 55.43 110.865 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 40.2 mm -100.75 97.54 6.91 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.784 -0.821 . . . . 71.43 108.784 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.738 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 52.2 Cg_endo -69.96 170.28 17.19 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.432 2.088 . . . . 72.53 112.611 -176.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.98 -16.42 26.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.974 0.893 . . . . 74.34 108.754 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.55 148.03 22.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.285 -1.325 . . . . 71.41 110.895 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.97 -12.96 49.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.949 -0.86 . . . . 52.33 110.949 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.76 24.83 7.53 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.093 -0.575 . . . . 72.3 111.689 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -75.61 127.58 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 74.43 110.748 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.2 m -95.88 164.43 12.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.19 -0.459 . . . . 64.4 109.996 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 17.4 p -68.98 -6.18 26.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.26 0.467 . . . . 72.44 112.26 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 42.3 t -85.04 95.58 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.61 121.95 36.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.106 -0.497 . . . . 64.24 110.503 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.25 108.75 6.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 64.51 111.097 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 21.0 mt -121.96 132.65 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.655 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 77.1 mtt-85 -69.96 -70.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.936 -0.305 . . . . 75.23 110.613 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 26.9 tt0 -148.07 141.14 24.94 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.157 -0.617 . . . . 62.04 111.322 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 143' ' ' LEU . 7.9 tt -100.27 132.0 45.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.154 -0.93 . . . . 62.2 109.229 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.21 155.94 41.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.961 0.41 . . . . 74.33 110.387 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.6 t -126.74 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.127 -0.488 . . . . 63.02 110.542 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HD2' ' NE2' ' A' ' 69' ' ' GLN . 46.3 mttp -104.69 115.45 30.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.191 -0.67 . . . . 74.04 109.191 171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.02 -169.14 24.95 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.762 -0.733 . . . . 75.44 112.096 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.1 m -113.32 130.73 56.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.425 -0.213 . . . . 63.5 110.425 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 5' ' ' ILE . 34.3 mm -76.11 120.63 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.063 0.459 . . . . 75.51 110.966 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 120' ' ' LYS . 37.0 mt . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.698 -0.683 . . . . 62.4 109.456 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.702 -0.481 . . . . 75.4 109.702 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.07 -124.98 7.57 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.855 -0.898 . . . . 71.23 110.855 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -74.29 -29.83 61.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 73.41 110.505 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.524 HG22 ' HE2' ' A' ' 146' ' ' LYS . 19.2 p -76.41 130.03 37.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.347 -0.612 . . . . 74.03 109.347 174.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 145' ' ' VAL . 40.1 mm -67.16 129.17 31.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.446 -0.343 . . . . 75.12 110.388 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.8 m -63.11 116.47 5.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.356 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -86.61 15.7 5.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 70.05 110.907 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -62.54 -35.23 78.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.774 -0.648 . . . . 73.02 111.848 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.36 15.9 38.55 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.551 -0.833 . . . . 33.45 113.106 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.412 ' HB3' HD12 ' A' ' 34' ' ' ILE . 30.2 m0 -84.06 141.99 30.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.933 0.366 . . . . 72.11 110.842 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.7 pt-20 -136.73 157.36 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.966 0.412 . . . . 54.5 110.373 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.24 122.44 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.747 -0.661 . . . . 73.13 109.94 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 60' ' ' ASP . 71.4 mt -84.75 -39.95 17.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.056 0.455 . . . . 63.45 110.572 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -154.59 142.06 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 61.1 110.091 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.509 ' CE2' ' HG2' ' A' ' 18' ' ' GLN . 32.5 p90 -139.97 145.58 38.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.691 -0.686 . . . . 74.24 109.38 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 m -88.24 -33.88 17.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.86 0.362 . . . . 71.32 111.282 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 t -148.88 151.15 34.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.908 0.385 . . . . 74.22 111.158 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.509 ' HG2' ' CE2' ' A' ' 15' ' ' PHE . 1.5 pp0? -167.81 142.71 3.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.894 -0.78 . . . . 73.01 108.894 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 9.4 tp10 -109.82 94.2 4.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.138 0.494 . . . . 53.51 110.776 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.58 8.01 41.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 62.31 111.048 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -120.01 -46.33 2.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.116 0.484 . . . . 75.32 110.26 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . -69.16 -29.2 72.21 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.963 -0.562 . . . . 53.24 112.647 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.43 16.04 18.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 74.42 110.303 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 -100.67 2.63 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.703 -0.681 . . . . 62.24 111.773 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.2 128.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.105 -0.331 . . . . 73.5 110.105 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.78 5.4 62.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.853 -0.689 . . . . 55.13 112.031 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -140.24 150.89 44.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.233 -0.654 . . . . 43.12 109.233 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.05 6.6 88.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.993 -0.622 . . . . 62.54 112.175 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.8 mt -80.15 148.59 30.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 72.31 110.565 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.31 -25.71 65.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 73.33 111.191 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -76.39 -23.21 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.796 -0.362 . . . . 74.01 111.254 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 71.1 m -63.08 -27.73 69.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.03 0.443 . . . . 73.23 110.234 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.27 -30.92 70.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 70.02 110.469 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 HG12 ' A' ' 59' ' ' ILE . 46.9 pt -115.23 13.1 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 74.05 111.054 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.4 t70 -77.32 -33.02 55.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 74.0 109.226 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' OE1' ' A' ' 142' ' ' GLU . . . 84.2 55.1 2.83 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.519 -0.764 . . . . 61.12 112.623 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.51 129.62 16.51 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.815 -0.439 . . . . 74.01 109.815 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.598 HG22 HD21 ' A' ' 73' ' ' LEU . 11.1 p -70.21 -19.79 63.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.38 0.511 . . . . 70.33 112.38 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.52 -13.29 40.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.733 0.301 . . . . 73.21 110.893 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -105.36 151.72 23.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.789 -0.448 . . . . 70.42 109.789 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -151.93 162.37 41.18 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.575 -0.45 . . . . 75.0 111.04 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.6 t90 -98.79 137.59 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 74.43 109.271 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.3 t-80 -131.67 139.16 49.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.588 -0.523 . . . . 75.05 109.588 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 151.5 46.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 61.11 109.973 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -61.87 129.32 40.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.318 -0.253 . . . . 73.24 110.318 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -134.71 -32.99 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.073 -0.251 . . . . 72.42 111.068 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.455 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 34.2 tt0 -81.27 102.6 10.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.727 -0.471 . . . . 73.5 109.727 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.62 -11.64 53.72 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.921 -0.657 . . . . 72.21 111.54 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.45 149.42 7.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.733 -0.746 . . . . 74.43 112.291 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.5 m -86.16 173.44 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 65.31 111.3 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 24.1 m-20 -98.2 166.51 13.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.966 -0.561 . . . . 63.53 109.787 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 56.9 Cg_endo -71.92 122.76 8.76 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.1 1.867 . . . . 62.3 112.973 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 16.8 mt -67.96 154.49 93.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 75.42 110.139 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 86.6 Cg_endo -81.17 167.21 72.63 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.669 -1.388 . . . . 74.35 113.019 1.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.0 m-85 -104.99 119.43 38.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 64.33 110.491 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.19 125.51 54.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.911 0.386 . . . . 54.44 110.705 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.4 mt -118.62 117.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.446 . . . . 72.03 110.049 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 ' HG3' ' A' ' 125' ' ' ARG . 54.7 t -106.23 122.34 59.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.936 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.701 HG12 HG21 ' A' ' 34' ' ' ILE . 4.6 mp -112.38 139.39 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 75.22 110.609 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.521 ' HB2' HD11 ' A' ' 13' ' ' LEU . 58.0 t0 -103.26 121.19 42.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.333 -0.618 . . . . 73.14 109.333 174.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.1 mtm -88.34 -3.14 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.284 -0.416 . . . . 73.33 110.725 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 65.57 13.44 8.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.712 -0.676 . . . . 63.45 111.991 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' OE1' HD12 ' A' ' 149' ' ' ILE . 4.8 pt20 -165.35 153.8 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.359 -0.608 . . . . 61.45 109.359 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -82.7 123.81 29.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.942 -0.392 . . . . 74.53 109.942 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.4 mt -126.44 139.14 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.167 -0.47 . . . . 74.54 110.374 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -82.1 101.46 10.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.734 -0.839 . . . . 73.23 108.734 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.7 mm -70.55 134.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 61.03 110.811 -174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 -42.57 1.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.067 -0.515 . . . . 71.02 110.699 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.625 ' HG2' ' HD3' ' A' ' 146' ' ' LYS . 11.8 tt0 -147.95 138.73 23.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 72.14 111.444 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.9 143.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.028 -0.73 . . . . 70.33 109.028 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.878 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 17.8 tt0 -120.75 133.72 55.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.175 -0.306 . . . . 75.42 110.175 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 48.1 mt -117.26 121.45 41.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.311 -0.625 . . . . 61.45 109.311 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD21 HG22 ' A' ' 38' ' ' THR . 34.5 tp -102.4 101.27 18.82 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.829 -0.434 . . . . 65.11 109.829 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.6 Cg_endo -80.8 -177.75 3.95 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.89 2.393 . . . . 52.13 111.397 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -96.09 -66.0 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.222 -0.444 . . . . 74.12 109.839 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.91 -60.06 2.17 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.089 -0.577 . . . . 65.31 112.148 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -60.46 98.22 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.89 -0.655 . . . . 72.23 111.143 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.63 15.37 81.61 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.029 -0.605 . . . . 24.25 112.653 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -119.63 143.43 47.7 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.816 -0.226 . . . . 72.53 110.625 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -83.56 -56.45 3.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.418 -0.356 . . . . 61.44 110.33 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 54.17 80.63 0.29 Allowed Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.595 -0.73 . . . . 73.22 112.289 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.27 40.48 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.949 2.433 . . . . 74.11 112.099 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -94.55 122.1 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 71.44 109.824 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -99.89 -50.35 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 64.24 110.938 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 41.7 t -132.85 139.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 71.54 110.923 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.29 140.14 49.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.268 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 46.9 mt-10 -120.12 130.45 54.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.785 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.82 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.123 -0.49 . . . . 63.42 110.546 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.47 150.54 49.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.158 -0.474 . . . . 33.55 110.363 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CB ' ' A' ' 121' ' ' ALA . . . -138.73 155.74 47.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.367 -0.379 . . . . 74.13 110.088 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.1 t -149.3 147.42 28.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.072 0.463 . . . . 71.45 111.743 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.05 -28.21 17.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 70.35 110.601 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 11.8 p-10 -123.38 4.09 9.09 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.891 0.33 . . . . 74.13 111.891 -173.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.4 t-20 77.24 -20.83 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.522 0.729 . . . . 71.45 111.265 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.1 -54.27 8.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.024 0.44 . . . . 74.13 110.351 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -90.14 103.82 16.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.882 -0.599 . . . . 74.15 110.911 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -94.53 137.16 34.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.178 0.513 . . . . 74.33 110.573 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -122.01 125.12 26.75 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.668 -0.696 . . . . 71.15 109.938 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.7 108.63 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.608 2.205 . . . . 33.44 111.283 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 116' ' ' VAL . 18.2 pt -81.28 -13.46 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.0 -0.546 . . . . 41.31 111.163 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.46 135.18 1.85 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.326 -0.94 . . . . 61.4 112.792 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 60.8 ttt180 -111.69 121.29 44.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.486 -0.561 . . . . 72.15 109.486 172.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -140.0 165.9 26.09 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.768 -0.373 . . . . 72.44 111.01 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -81.39 147.74 27.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.002 -0.618 . . . . 50.32 111.678 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.58 123.32 40.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.932 -0.396 . . . . 74.35 109.932 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.658 ' HB ' HD21 ' A' ' 112' ' ' LEU . 10.3 m -102.13 106.78 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.246 -0.434 . . . . 55.35 110.302 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -65.69 110.29 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 71.34 110.429 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -152.38 177.98 10.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 74.24 109.752 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.9 -9.56 36.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.251 0.548 . . . . 74.05 110.356 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.51 157.65 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 61.23 110.641 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -70.26 144.47 51.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.045 0.45 . . . . 71.1 111.703 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' A' ' 106' ' ' THR . 20.4 mt -99.55 113.85 26.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.525 -0.761 . . . . 70.13 110.146 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 50.4 mt-10 -85.15 115.78 23.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.848 0.356 . . . . 72.43 110.593 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.55 105.36 14.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.779 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -75.86 118.55 18.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.959 -0.756 . . . . 70.14 108.959 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 100' ' ' ILE . 29.4 m -120.67 -172.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.324 0.491 . . . . 71.41 112.324 -171.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -66.53 125.89 27.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.16 -0.927 . . . . 73.52 110.719 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.7 m -74.87 108.06 7.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.035 0.445 . . . . 75.25 110.217 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.74 152.2 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.964 -0.562 . . . . 74.41 109.943 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.6 ' HG3' HD12 ' A' ' 150' ' ' ILE . 1.1 ttmp? -73.36 138.91 45.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.554 -0.536 . . . . 75.03 109.554 175.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . . . -156.27 134.43 11.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.51 -0.313 . . . . 71.34 110.88 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -95.57 -29.82 14.14 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.799 -0.815 . . . . 74.21 108.799 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.9 145.08 41.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.1 -0.954 . . . . 75.11 109.499 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.71 137.18 51.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.657 -0.497 . . . . 74.45 109.657 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.924 ' HG3' HG22 ' A' ' 58' ' ' VAL . 4.4 ttm180 -122.13 130.21 53.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 75.1 111.159 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.2 tp -97.48 118.16 33.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 74.53 109.016 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.6 m -109.97 122.83 48.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.5 . . . . 74.51 111.1 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.1 mm -101.46 94.0 3.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 75.13 108.714 173.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 59.0 Cg_endo -71.48 151.67 59.41 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.86 2.373 . . . . 60.24 113.308 -173.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 12.6 p-10 -89.72 4.79 48.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.589 0.709 . . . . 71.11 109.535 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.16 -34.39 15.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.075 -0.966 . . . . 72.21 111.39 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.18 -3.45 76.0 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.616 -0.802 . . . . 54.12 113.529 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.07 8.18 45.26 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.488 -0.863 . . . . 42.21 111.335 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -69.05 133.73 48.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.309 -0.446 . . . . 74.3 111.608 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 m -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.965 -0.561 . . . . 73.05 109.728 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 38.5 p -84.4 16.27 3.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.971 0.415 . . . . 73.24 111.36 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.83 119.48 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.546 -0.538 . . . . 75.34 109.546 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -144.27 130.91 20.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.59 -0.277 . . . . 73.4 110.613 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -136.64 105.61 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.051 0.453 . . . . 52.15 110.884 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.63 133.14 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.838 -0.43 . . . . 72.21 109.838 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.27 -62.54 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.223 0.327 . . . . 75.12 110.724 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 36' ' ' GLY . 15.1 pt-20 -154.13 161.32 41.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.457 0.646 . . . . 72.32 111.59 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -119.43 135.94 54.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.832 -1.076 . . . . 75.42 108.19 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.463 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.8 t70 -129.23 161.6 29.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.016 -0.364 . . . . 73.42 110.016 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' ILE . 45.4 t -135.35 133.56 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.403 . . . . 73.32 110.267 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.878 ' HE3' ' HB2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -108.86 125.6 52.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.848 -0.797 . . . . 74.45 108.848 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.21 -168.25 30.96 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.407 -0.902 . . . . 42.01 112.449 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.7 m -112.35 132.29 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.465 -0.198 . . . . 74.31 110.465 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 63' ' ' GLN . 40.3 mm -73.36 123.58 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 70.23 110.757 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.6 HD12 ' HG3' ' A' ' 120' ' ' LYS . 48.0 mt -107.26 144.94 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.558 -0.534 . . . . 71.23 109.558 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -120.28 134.93 55.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.042 0.448 . . . . 64.23 111.257 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.88 11.61 27.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.639 0.733 . . . . 73.22 109.262 173.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.98 102.69 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.069 -0.969 . . . . 71.44 111.38 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -103.58 98.4 8.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.465 -0.939 . . . . 71.13 108.465 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -62.18 -32.75 73.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.711 0.634 . . . . 71.34 112.711 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -86.17 7.97 22.88 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.018 -0.273 . . . . 74.51 111.524 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -140.62 16.22 2.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.902 0.382 . . . . 75.21 110.802 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -149.95 74.43 1.21 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 74.23 109.774 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.598 -0.728 . . . . 75.11 109.712 -179.531 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.649 -0.5 . . . . 73.41 109.649 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.42 -139.61 9.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 44.42 112.641 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.421 HG23 ' HE3' ' A' ' 146' ' ' LYS . 4.2 t -134.53 -26.75 1.39 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.517 0.192 . . . . 74.31 111.517 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.29 149.7 40.57 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.739 -0.384 . . . . 71.14 110.539 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 149' ' ' ILE . 30.0 mm -94.69 132.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.249 -0.432 . . . . 52.1 110.467 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -70.77 123.43 21.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.592 -0.522 . . . . 74.03 109.592 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -98.59 16.41 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 62.03 111.468 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -77.44 -5.15 48.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.911 0.386 . . . . 72.01 111.497 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.89 -0.09 24.28 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.652 -0.785 . . . . 34.42 112.357 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -82.86 153.9 24.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.645 0.26 . . . . 73.44 110.654 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.02 155.4 48.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.93 0.395 . . . . 74.41 110.663 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.33 119.7 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.516 -0.766 . . . . 75.01 109.948 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD21 ' HE1' ' A' ' 158' ' ' HIS . 84.9 mt -84.18 -42.04 16.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.942 -0.572 . . . . 74.41 110.53 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.8 t -149.21 143.73 26.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 71.31 110.131 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -148.88 149.52 31.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 70.3 109.687 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 m -92.57 -44.3 8.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.844 0.313 . . . . 74.22 111.844 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -138.49 149.48 45.45 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.73 -0.388 . . . . 63.35 111.137 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -161.93 142.86 10.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.799 -0.637 . . . . 75.32 109.441 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 tp10 -115.84 93.6 4.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.295 -0.412 . . . . 75.32 110.541 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.91 -14.31 26.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 40.31 111.204 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -98.81 -51.84 3.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.406 -0.361 . . . . 75.21 111.308 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.01 -30.76 67.42 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.065 -0.588 . . . . 73.04 113.38 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -95.03 -25.59 16.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.966 0.383 . . . . 72.52 111.847 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.28 178.11 18.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.318 -0.944 . . . . 72.44 113.048 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 115.26 11.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.946 0.403 . . . . 54.03 110.876 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.77 -5.94 69.82 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.79 -0.719 . . . . 65.31 112.095 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -117.42 128.19 54.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.446 -0.205 . . . . 65.32 110.446 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.7 -7.78 63.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.242 -0.504 . . . . 75.24 112.638 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.8 mt -73.67 142.95 46.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.741 0.305 . . . . 75.23 110.768 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.41 -27.21 68.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 50.11 111.309 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -19.35 61.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 75.13 110.562 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 1.079 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 69.5 m -72.84 -18.42 61.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 73.22 111.032 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 126' ' ' LEU . 32.6 tp -64.88 -24.32 67.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.546 0.689 . . . . 72.3 109.925 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.401 HG21 HG12 ' A' ' 59' ' ' ILE . 35.8 pt -122.6 19.65 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.339 -0.846 . . . . 70.13 109.775 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 1.079 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 22.0 t70 -64.68 -41.57 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.325 -0.852 . . . . 65.4 111.458 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 38.19 5.25 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.471 -0.871 . . . . 71.41 112.077 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -151.28 128.8 11.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.194 -0.298 . . . . 63.04 110.194 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.4 p -75.58 -2.9 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.142 0.423 . . . . 62.22 112.142 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.37 -22.34 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.109 -0.236 . . . . 74.42 110.95 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p -88.55 165.69 14.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.875 -0.417 . . . . 63.34 109.875 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 31.8 p90 -164.97 165.82 19.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.421 . . . . 74.22 111.442 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 36.3 t90 -106.4 141.92 36.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.198 -0.91 . . . . 72.12 109.018 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.4 t-80 -139.62 143.21 37.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.509 -0.552 . . . . 61.35 109.509 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 136.65 50.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.583 -0.525 . . . . 62.33 109.583 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.687 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 3.5 ttpm? -62.87 122.04 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.578 0.228 . . . . 71.42 110.396 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -117.34 -29.13 5.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.524 -0.307 . . . . 75.14 110.686 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.9 110.98 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 73.24 110.251 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.31 -5.95 65.62 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.898 -0.668 . . . . 51.23 111.982 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.84 143.17 5.51 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 45.23 112.459 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.612 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 19.0 m -93.71 144.7 25.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.813 0.34 . . . . 72.01 110.761 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.9 m-20 -76.76 148.02 78.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.083 -0.508 . . . . 51.3 109.965 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 9.6 Cg_exo -72.39 144.25 40.57 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.695 2.263 . . . . 73.24 112.81 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 161.88 77.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 61.25 110.342 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.1 Cg_exo -79.77 168.96 71.96 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.082 -1.216 . . . . 74.32 112.577 -1.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.754 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 25.2 m-85 -107.92 128.74 54.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.688 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.8 133.14 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 64.41 110.172 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 51.0 mt -132.17 111.43 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.868 -0.419 . . . . 65.35 109.868 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 ' HH2' ' A' ' 97' ' ' TRP . 57.8 t -106.42 121.38 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 74.44 111.096 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 34' ' ' ILE . 5.1 mp -116.1 136.19 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.33 . . . . 73.12 110.837 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.0 t0 -96.45 117.5 31.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.149 -0.685 . . . . 73.45 109.149 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.75 -3.28 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.517 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.1 mmtp 73.05 -13.9 0.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.625 0.77 . . . . 73.3 112.401 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -147.53 177.14 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.9 0.381 . . . . 72.34 110.953 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 121.51 30.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.609 . . . . 51.42 110.209 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 5' ' ' ILE . 67.7 mt -129.18 134.81 63.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.891 0.377 . . . . 75.24 110.259 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -81.77 105.76 13.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.194 -0.669 . . . . 61.22 109.194 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 118' ' ' SER . 10.2 mm -80.18 117.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.231 -0.285 . . . . 62.44 110.231 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.19 -41.92 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 61.43 110.665 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -144.59 138.84 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.004 -0.544 . . . . 71.04 110.865 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -110.2 133.94 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.387 -0.598 . . . . 72.42 109.387 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 52.8 mt-10 -114.42 127.93 56.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.033 0.444 . . . . 62.24 110.834 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.0 mt -109.35 125.95 52.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.876 -0.602 . . . . 73.05 109.709 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -112.27 96.44 35.23 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.164 -0.68 . . . . 65.04 109.164 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 56.6 Cg_endo -73.19 173.33 13.87 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.443 2.095 . . . . 72.52 111.589 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HB3' ' OG ' ' A' ' 79' ' ' SER . 1.3 mtm180 -63.65 -42.35 98.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.577 -0.449 . . . . 63.24 110.412 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.36 -86.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.981 -0.554 . . . . 50.1 113.002 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 77' ' ' ARG . 48.7 mtm-85 -76.47 117.92 18.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.872 0.367 . . . . 75.35 111.041 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.94 52.42 5.79 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.89 -0.595 . . . . 60.51 112.416 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 75' ' ' ARG . 22.1 m -153.73 150.73 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 73.13 111.434 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -109.32 103.9 12.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 72.55 109.261 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.457 HD21 HD12 ' A' ' 83' ' ' ILE . 21.8 t-20 -108.67 105.64 57.31 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.995 -0.548 . . . . 64.31 110.823 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 71.6 Cg_endo -92.55 19.47 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.127 2.551 . . . . 41.54 112.813 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.457 HD12 HD21 ' A' ' 81' ' ' ASN . 58.7 mt -79.59 129.89 36.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 53.14 109.772 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.93 -38.05 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.856 -0.611 . . . . 73.11 110.419 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.97 137.96 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 75.31 111.206 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.38 141.66 45.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.142 -0.481 . . . . 72.24 110.507 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -118.32 132.79 56.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 63.21 109.937 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.71 133.34 55.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.441 -0.345 . . . . 75.35 110.466 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.98 146.76 50.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.788 0.328 . . . . 74.23 111.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.39 146.41 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 75.41 110.162 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.4 t -140.17 157.46 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.226 0.536 . . . . 62.33 111.516 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.8 mt-10 -116.14 -32.23 5.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 74.33 110.668 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -114.82 5.13 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 74.31 112.161 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 71.92 -1.91 2.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.119 0.568 . . . . 62.53 111.752 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 -51.69 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 52.0 110.195 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -89.94 112.72 24.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.796 -0.638 . . . . 72.52 110.538 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.428 ' HH2' HG13 ' A' ' 58' ' ' VAL . 97.9 m95 -104.81 108.04 19.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.07 -0.514 . . . . 73.3 109.935 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 80.7 m -89.28 120.05 69.73 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.287 -0.415 . . . . 71.02 110.314 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 42.2 Cg_endo -66.82 110.9 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.396 2.064 . . . . 74.43 110.83 174.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -86.38 -10.12 11.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.124 -0.489 . . . . 70.23 110.81 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.91 128.7 0.98 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.083 -1.056 . . . . 64.54 113.322 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.27 117.2 33.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.387 -0.968 . . . . 64.25 108.387 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.58 175.28 9.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.124 0.488 . . . . 74.41 111.47 -171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.79 15.79 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.35 -0.841 . . . . 71.45 111.745 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.589 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 51.4 t80 -97.01 148.01 23.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 73.04 110.106 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -142.71 112.06 6.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.398 -0.364 . . . . 72.03 110.444 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -72.54 114.42 10.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.071 0.462 . . . . 74.22 110.556 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 74' ' ' PRO . 13.2 pt20 -154.07 179.8 8.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.622 -0.717 . . . . 73.44 109.43 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.88 -5.39 51.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 75.04 110.283 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.97 36.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 44.32 110.208 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.65 140.33 58.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.045 0.45 . . . . 72.43 110.886 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 32.8 mt -94.81 104.75 16.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.719 -0.673 . . . . 71.4 110.248 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -79.97 109.04 14.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.004 0.431 . . . . 73.32 110.752 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.12 104.59 14.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.069 -0.514 . . . . 64.25 110.404 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -70.86 106.75 3.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.994 -0.743 . . . . 75.45 108.994 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 27.4 m -106.08 174.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.903 0.382 . . . . 71.44 111.445 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HD3' ' HB ' ' A' ' 119' ' ' ILE . 7.5 tmtm? -64.04 122.51 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 75.14 110.086 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 25.1 m -66.53 114.82 5.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.93 -0.577 . . . . 72.23 109.92 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.444 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 12.8 tt -144.19 145.07 22.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.861 0.363 . . . . 70.5 110.958 -174.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.536 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -94.29 115.21 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.97 -0.752 . . . . 54.3 108.97 175.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.522 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.3 175.22 10.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 34.14 111.303 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -118.39 -34.19 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 72.31 110.362 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -107.52 146.21 32.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.932 -0.577 . . . . 75.1 110.25 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.16 137.91 53.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.945 -0.571 . . . . 72.22 109.827 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 28.3 ttp180 -123.52 122.54 38.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.499 -0.319 . . . . 72.31 110.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 37.2 tp -84.69 113.03 21.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.515 -0.92 . . . . 54.04 108.515 169.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 22.8 m -103.48 118.37 36.58 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.574 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.754 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.3 mm -102.51 96.76 7.78 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.712 -0.847 . . . . 71.33 108.712 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 72.8 Cg_endo -76.44 175.98 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.391 2.061 . . . . 64.34 112.595 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.95 13.25 29.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.729 0.776 . . . . 71.13 109.141 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.93 144.76 25.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.677 -1.147 . . . . 71.31 111.093 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.96 57.86 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.992 -0.623 . . . . 70.4 113.38 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 115.97 22.55 4.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.274 -0.965 . . . . 74.25 112.655 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -68.15 155.01 40.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 72.42 110.821 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.402 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 50.7 m -129.39 -176.89 4.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.02 110.197 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 40.3 p -85.23 22.58 1.44 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 72.41 111.605 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.1 123.55 68.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.574 -0.528 . . . . 71.34 109.574 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.14 138.88 30.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.469 -0.332 . . . . 71.23 110.216 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.75 105.24 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 73.14 111.026 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 42.3 mt -129.45 132.57 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.437 -0.579 . . . . 42.14 109.437 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.579 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 31.6 mmt180 -67.36 -67.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.465 -0.568 . . . . 74.23 109.465 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.45 152.81 47.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 73.35 111.494 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -112.76 116.09 29.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.456 -1.312 . . . . 63.11 107.456 166.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.83 161.39 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.753 -0.462 . . . . 65.44 109.753 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -131.51 125.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.282 -0.417 . . . . 63.24 110.262 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.421 ' HE3' HG23 ' A' ' 3' ' ' THR . 47.0 mttp -102.31 105.06 15.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.417 0.627 . . . . 74.23 109.354 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.5 -148.93 4.86 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.181 -0.918 . . . . 63.22 111.524 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.8 m -132.71 129.25 38.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.809 0.337 . . . . 72.23 110.878 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 5' ' ' ILE . 31.6 mm -71.71 119.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.616 . . . . 73.21 110.567 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.536 HD12 ' HG2' ' A' ' 120' ' ' LYS . 46.2 mt -106.61 134.49 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 72.01 109.757 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -117.64 143.85 45.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.909 -0.587 . . . . 75.24 109.964 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.69 -167.09 1.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.313 -0.625 . . . . 64.43 109.313 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 154' ' ' HIS . 29.7 mm-40 -78.3 -163.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.929 0.395 . . . . 52.33 111.636 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.44 ' H ' ' HB3' ' A' ' 153' ' ' GLU . 20.8 p80 -49.4 139.99 10.98 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.508 -0.769 . . . . 74.21 112.417 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -134.4 146.68 50.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.824 -0.625 . . . . 72.13 110.102 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -85.67 173.56 10.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 64.34 111.019 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -51.28 160.29 0.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.516 -0.765 . . . . 74.1 112.784 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.451 ' HE1' HD21 ' A' ' 13' ' ' LEU . 46.8 t60 -55.97 119.25 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 64.03 111.049 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 65.41 110.009 177.865 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.229 -0.286 . . . . 75.01 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.72 -162.94 36.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.819 -0.705 . . . . 62.43 112.154 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.677 HG23 ' HG2' ' A' ' 146' ' ' LYS . 13.0 t -109.51 10.31 25.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.264 0.554 . . . . 52.23 110.403 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 127.61 33.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.713 -0.676 . . . . 71.43 110.177 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 65' ' ' ILE . 21.2 mm -72.08 137.2 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.969 -0.56 . . . . 74.12 111.337 -172.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -70.87 111.21 6.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.941 -0.572 . . . . 72.35 110.538 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -87.04 3.46 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.72 -0.673 . . . . 51.33 111.803 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -66.88 -26.59 66.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.942 0.401 . . . . 64.34 110.779 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.84 -5.6 68.27 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.557 -0.83 . . . . 75.51 112.082 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -81.81 158.43 24.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.606 0.241 . . . . 71.25 110.643 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 pt-20 -142.37 158.26 43.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.913 0.387 . . . . 63.13 110.199 173.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.22 125.78 45.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 70.45 109.62 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 87.7 mt -94.75 -41.12 9.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.321 -0.399 . . . . 74.3 110.715 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.0 t -142.48 140.92 32.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 73.41 110.613 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.43 136.32 19.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.829 -0.623 . . . . 75.34 109.655 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -87.84 -33.4 18.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 74.51 111.156 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -146.6 146.61 30.49 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.93 0.395 . . . . 74.34 110.955 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -162.01 140.47 9.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 72.45 108.839 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.8 tp10 -109.78 81.84 1.5 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.336 0.589 . . . . 72.13 111.331 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.43 -4.26 53.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.449 -0.796 . . . . 72.15 110.467 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -100.27 -53.54 3.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.74 -0.664 . . . . 65.05 111.092 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -73.02 -34.85 58.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.3 -0.476 . . . . 75.4 112.412 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.44 -57.83 2.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.989 0.423 . . . . 74.44 110.327 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.88 171.98 12.51 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.678 -0.772 . . . . 73.23 111.944 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.21 119.92 11.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.939 0.4 . . . . 71.11 110.946 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.89 -10.35 57.15 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.047 -0.597 . . . . 71.41 112.266 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -121.02 138.33 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.675 -0.491 . . . . 72.24 109.675 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 5.87 88.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 62.31 112.832 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.2 mt -77.57 139.38 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.384 -0.228 . . . . 53.15 110.384 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.14 -21.27 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.03 111.529 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -22.28 46.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 73.44 110.901 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.882 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 86.3 m -69.63 -18.29 63.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.058 -0.519 . . . . 61.52 110.642 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.92 -27.46 69.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 75.52 110.176 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 59' ' ' ILE . 34.2 pt -120.32 18.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 64.21 110.208 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.882 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -63.92 -45.75 87.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 73.55 110.222 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.08 24.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.631 -0.795 . . . . 60.21 112.708 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.49 131.73 54.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 74.41 111.134 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.7 p -71.55 -10.26 59.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.713 -0.676 . . . . 73.23 111.079 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.91 -21.67 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.33 111.058 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 17.1 p -89.76 169.77 11.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.091 -0.337 . . . . 74.35 110.091 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.2 p90 -163.62 157.9 19.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 74.12 111.284 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.499 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 34.8 t90 -103.83 142.41 34.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.283 -0.871 . . . . 74.5 108.98 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' GLU . 38.4 t-80 -138.72 144.53 39.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.532 -0.544 . . . . 74.2 109.532 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 144.39 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.027 -0.36 . . . . 45.12 110.027 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HE3' ' O ' ' A' ' 49' ' ' GLY . 29.2 ttpt -72.61 126.47 29.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.487 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -125.15 -24.84 3.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.39 -0.368 . . . . 74.43 110.772 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -71.19 112.56 7.43 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.087 0.47 . . . . 75.24 110.461 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.16 12.99 56.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.957 -0.639 . . . . 73.52 111.763 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.523 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . 107.97 143.02 10.48 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.091 -0.804 . . . . 74.13 111.091 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.4 m -85.78 166.79 15.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.71 0.29 . . . . 75.33 110.72 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 22.7 m-20 -91.13 148.9 38.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.421 -0.354 . . . . 72.12 110.518 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 12.0 Cg_exo -71.23 151.48 60.68 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.053 2.502 . . . . 71.35 112.531 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 15.5 mt -93.85 159.65 34.13 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.634 -0.712 . . . . 70.21 110.391 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.3 Cg_endo -81.73 161.54 79.41 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 123.481 -1.466 . . . . 73.04 112.845 2.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.807 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.1 m-85 -91.13 123.1 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.566 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.744 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 0.7 OUTLIER -109.49 123.36 49.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.447 -0.797 . . . . 74.31 110.361 -178.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 126' ' ' LEU . 61.8 mt -127.77 110.76 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.812 -0.44 . . . . 72.54 109.812 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG13 ' CH2' ' A' ' 97' ' ' TRP . 59.5 t -104.81 122.11 57.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.873 -0.603 . . . . 72.34 110.69 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 34' ' ' ILE . 57.5 mt -119.77 136.31 57.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.02 -0.537 . . . . 71.33 110.591 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.7 t0 -101.73 123.8 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 72.04 110.339 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 67' ' ' ILE . 68.5 mtm -90.52 -3.1 57.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 61.14 110.783 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 71.79 0.2 3.42 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.365 0.666 . . . . 75.44 112.688 173.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -163.81 170.95 16.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.431 -0.211 . . . . 71.34 110.431 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ALA . 43.6 m-20 -79.47 127.16 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 52.31 110.206 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.446 ' CD1' HG21 ' A' ' 5' ' ' ILE . 75.0 mt -133.42 135.46 56.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.753 -0.462 . . . . 74.21 109.753 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 150' ' ' ILE . 51.5 tp60 -80.11 104.09 10.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.009 -0.737 . . . . 64.01 109.009 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.6 mm -74.41 108.12 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.637 -0.256 . . . . 71.11 110.564 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.26 -50.79 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 73.34 110.895 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -142.23 140.08 32.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.025 0.441 . . . . 75.22 111.09 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.0 129.09 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 75.53 109.445 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -111.47 129.43 56.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.068 0.461 . . . . 62.42 110.971 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 114' ' ' TYR . 54.3 mt -116.77 129.36 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.804 -0.634 . . . . 73.23 110.241 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.4 tp -106.92 104.94 53.88 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.285 -0.416 . . . . 51.55 110.231 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.649 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 Cg_exo -75.81 176.98 9.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.51 2.806 . . . . 73.03 111.477 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.791 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 48.1 mtp180 -71.96 -23.18 61.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.533 0.206 . . . . 72.24 111.413 -176.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.574 ' HA2' ' C ' ' A' ' 108' ' ' GLN . . . 88.9 -60.72 3.83 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.704 -0.76 . . . . 61.12 112.758 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -75.69 167.34 22.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.15 0.5 . . . . 74.32 111.147 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.59 69.57 0.93 Allowed Glycine 0 C--N 1.321 -0.289 0 CA-C-N 114.928 -1.033 . . . . 51.12 113.019 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -100.06 167.16 10.65 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.25 -0.648 . . . . 75.45 109.25 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -68.31 101.34 1.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.963 0.411 . . . . 53.3 110.266 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.596 HD21 ' HE2' ' A' ' 105' ' ' PHE . 64.5 t30 -144.31 72.97 16.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.734 -0.666 . . . . 62.14 109.52 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.51 40.91 1.02 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.191 2.594 . . . . 71.25 113.636 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mt -83.48 130.73 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.879 -0.415 . . . . 60.13 109.879 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -109.99 -56.18 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.87 -0.605 . . . . 61.31 110.578 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 ' HA3' ' A' ' 132' ' ' GLY . 92.6 t -118.83 137.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.549 . . . . 61.14 110.622 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -127.4 134.56 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.615 . . . . 62.23 110.273 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 45.4 mt-10 -115.91 125.87 53.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.223 0.535 . . . . 75.1 110.614 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -104.87 129.45 53.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.807 -0.633 . . . . 72.04 109.967 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.33 151.21 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 72.32 110.779 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.01 150.25 51.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.901 -0.591 . . . . 73.35 109.86 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -149.63 161.11 42.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.101 0.477 . . . . 51.14 111.047 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 32.7 mt-10 -120.29 -7.14 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.0 -0.546 . . . . 72.43 110.603 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -122.14 -9.81 8.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.641 -0.254 . . . . 71.25 111.036 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.8 t30 73.58 6.46 5.02 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.907 0.755 . . . . 72.34 110.331 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.4 t -113.84 -50.71 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.686 -0.688 . . . . 62.44 110.301 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -98.4 104.78 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.734 -0.666 . . . . 70.32 109.863 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CH2' HG13 ' A' ' 58' ' ' VAL . 99.0 m95 -91.71 131.14 37.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.053 -0.521 . . . . 72.4 110.529 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 m -110.67 122.82 37.21 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 116.006 -0.543 . . . . 62.5 109.91 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 125.71 15.94 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.427 2.085 . . . . 72.41 111.723 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 HG21 ' A' ' 116' ' ' VAL . 28.7 pt -100.4 -17.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 64.1 110.57 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.65 133.23 1.82 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.891 -1.147 . . . . 65.42 113.025 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 9.9 ttt180 -114.99 114.96 26.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.86 -0.793 . . . . 74.51 108.86 172.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.403 ' HE2' HG12 ' A' ' 116' ' ' VAL . 56.9 m-85 -138.69 -174.25 3.78 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.402 -0.519 . . . . 64.12 111.124 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.61 146.04 16.33 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.944 -0.646 . . . . 51.11 112.043 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.596 ' HE2' HD21 ' A' ' 81' ' ' ASN . 42.8 t80 -99.1 148.69 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 74.41 110.057 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -139.61 127.49 22.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.298 -0.41 . . . . 72.33 110.193 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -80.87 100.3 8.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.185 0.517 . . . . 74.11 110.187 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.574 ' C ' ' HA2' ' A' ' 76' ' ' GLY . 11.9 pt20 -140.73 172.98 11.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.716 -0.675 . . . . 72.42 109.996 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.98 -3.92 58.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 75.33 110.603 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.42 34.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.935 -0.575 . . . . 63.21 110.452 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 131.17 45.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.124 0.488 . . . . 54.43 110.708 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.37 114.29 21.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.641 -0.709 . . . . 74.41 110.637 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.41 108.56 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 74.23 110.711 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 72' ' ' LEU . 96.1 m-85 -100.89 104.33 15.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 54.13 110.523 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -74.3 99.78 3.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.611 -0.722 . . . . 73.14 109.28 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 100' ' ' ILE . 26.9 m -100.47 175.22 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 63.22 111.814 -173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.89 113.15 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 72.11 109.295 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.771 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 49.7 m -68.98 118.01 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 64.24 111.258 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -146.7 150.41 14.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 72.33 110.028 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.0 ttpp -83.88 133.12 34.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.904 -0.406 . . . . 70.33 109.904 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -154.64 171.82 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.416 -0.357 . . . . 73.14 110.433 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -114.61 -35.01 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.372 0.606 . . . . 72.33 109.82 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -108.08 145.01 34.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.754 . . . . 71.21 109.902 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -128.87 139.33 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.39 -0.596 . . . . 51.11 109.39 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.744 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 31.5 ttp180 -127.29 124.56 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.103 0.477 . . . . 74.32 111.804 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 57' ' ' ILE . 41.2 tp -87.4 112.34 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.704 -0.851 . . . . 70.51 108.704 171.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -107.59 117.09 33.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.952 0.406 . . . . 71.13 110.81 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.807 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -101.27 95.25 4.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.596 -0.89 . . . . 65.01 108.596 172.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.683 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -74.36 172.87 15.23 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.384 2.056 . . . . 63.13 112.529 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.26 25.9 4.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.889 0.852 . . . . 41.3 109.133 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -113.57 142.83 45.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.432 -1.258 . . . . 44.33 110.096 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' HG23 ' A' ' 85' ' ' VAL . . . 100.29 -18.11 55.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.83 -0.7 . . . . 75.42 113.044 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 112.95 17.09 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.33 -0.938 . . . . 62.24 112.248 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.7 127.73 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 53.23 110.663 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.3 m -93.84 -179.73 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.29 -0.414 . . . . 72.42 110.069 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 2.0 p -81.3 31.49 0.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.07 0.462 . . . . 61.44 111.954 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.28 130.77 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.626 -0.509 . . . . 72.14 109.626 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.28 31.11 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.974 -0.38 . . . . 74.23 109.974 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.791 ' HB1' ' HD2' ' A' ' 75' ' ' ARG . . . -144.6 105.93 4.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.138 0.494 . . . . 60.13 111.521 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.3 mt -129.89 132.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.415 -0.587 . . . . 65.33 109.415 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.649 ' HD3' ' O ' ' A' ' 74' ' ' PRO . 58.6 mtp180 -72.54 -52.16 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.321 -0.152 . . . . 71.2 110.914 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.39 160.46 34.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.723 -0.791 . . . . 61.14 112.097 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -118.91 127.92 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.691 -1.14 . . . . 73.53 108.602 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.19 145.68 47.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.871 -0.418 . . . . 72.44 109.871 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.39 124.39 72.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.047 0.451 . . . . 65.0 110.21 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.677 ' HG2' HG23 ' A' ' 3' ' ' THR . 16.1 ttmt -103.31 103.67 13.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.814 -0.63 . . . . 74.34 109.341 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.54 -168.23 15.25 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.721 -0.752 . . . . 42.23 112.166 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.5 m -118.2 134.08 55.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.59 0.233 . . . . 62.5 110.708 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.474 HG22 ' HG ' ' A' ' 152' ' ' LEU . 38.0 mm -71.67 133.04 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 63.13 111.326 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 120' ' ' LYS . 56.6 mt -126.15 150.24 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.616 -0.72 . . . . 74.04 109.132 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.7 m120 61.21 53.15 3.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.57 -0.9 . . . . 61.01 108.57 -171.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.7 mp -66.81 141.47 57.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 72.21 111.38 -171.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 65.63 22.12 11.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.09 -0.959 . . . . 73.23 111.821 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -81.88 -17.52 46.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.921 -0.77 . . . . 73.23 108.921 170.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -74.28 141.5 45.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.969 -1.014 . . . . 75.13 111.021 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -130.08 137.66 50.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.117 -0.697 . . . . 73.14 109.117 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -77.72 -25.85 49.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 73.15 111.521 -170.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -75.73 98.88 4.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.987 0.422 . . . . 63.34 110.395 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.213 179.07 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.911 0.386 . . . . 71.0 110.437 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.39 -88.5 0.42 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.844 -0.694 . . . . 63.54 112.217 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t 46.32 27.89 0.64 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.954 0.902 . . . . 75.01 112.168 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -69.15 136.39 52.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.047 -0.979 . . . . 35.02 110.726 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CD1' ' A' ' 65' ' ' ILE . 39.0 mm -88.59 136.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.912 -0.585 . . . . 65.42 110.24 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 m -69.37 120.35 15.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.98 0.419 . . . . 61.24 110.007 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -88.15 5.96 38.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 64.44 111.016 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 88.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.887 -0.597 . . . . 74.35 110.406 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.67 -13.66 3.67 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.513 -0.767 . . . . 64.11 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -69.5 142.26 53.76 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.725 -0.472 . . . . 75.04 109.725 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 21.8 pt-20 -127.89 158.76 36.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.186 0.517 . . . . 61.4 111.109 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 114.67 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 60.3 110.023 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 60' ' ' ASP . 81.7 mt -81.35 -48.74 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.036 -0.529 . . . . 73.45 110.229 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -147.19 142.16 26.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 52.24 110.371 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.18 146.88 34.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.686 -0.688 . . . . 75.34 109.196 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -86.0 -37.49 18.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.858 0.361 . . . . 72.42 111.176 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -153.89 149.8 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.014 0.435 . . . . 72.12 111.109 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 24.8 pt20 -159.01 146.4 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.069 -1.086 . . . . 75.23 108.069 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -99.31 94.73 6.62 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 75.4 110.407 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.74 -0.83 23.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.665 -0.698 . . . . 74.05 110.853 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 m -114.26 -37.94 4.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.139 -0.482 . . . . 54.12 110.94 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.41 55.9 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.012 -0.54 . . . . 64.24 112.891 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -113.22 14.87 19.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 53.43 110.898 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.57 -176.82 51.31 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.912 -0.586 . . . . 74.42 112.949 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.74 139.29 30.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.024 -0.361 . . . . 74.11 110.024 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.552 ' H ' HD11 ' A' ' 29' ' ' LEU . . . 102.24 -2.71 50.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.99 -0.624 . . . . 61.45 111.586 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -154.1 131.97 11.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.247 -0.649 . . . . 74.3 109.247 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.33 -1.16 76.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.975 -0.631 . . . . 63.2 111.808 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 63.8 mt -77.08 150.31 35.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.273 -0.269 . . . . 54.51 110.273 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.47 -29.95 69.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 51.3 110.108 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -67.62 -22.69 65.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 63.33 111.374 177.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.8 m -68.86 -25.2 64.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.971 0.415 . . . . 72.13 110.293 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.22 -27.87 69.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.694 -0.684 . . . . 61.32 110.361 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 59' ' ' ILE . 31.3 pt -119.31 14.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 73.25 110.434 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.825 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.0 t70 -65.15 -40.7 94.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 71.41 110.548 -176.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.6 25.76 13.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 43.44 111.882 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -131.8 122.35 25.64 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.652 -0.499 . . . . 74.23 109.652 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 p -75.07 -7.79 54.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.906 -0.588 . . . . 75.54 111.791 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -85.65 -24.2 27.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 72.44 110.38 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.0 p -96.95 155.8 16.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.292 -0.413 . . . . 63.23 110.454 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.717 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 40.9 p90 -149.07 168.91 21.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.855 0.36 . . . . 72.33 111.153 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.6 t90 -104.85 138.4 41.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 72.02 109.083 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -133.88 136.96 44.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.411 -0.588 . . . . 74.34 109.411 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.43 58.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.672 -0.492 . . . . 73.1 109.672 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 50' ' ' SER . 53.6 tttm -64.87 120.17 12.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 72.22 110.369 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -111.19 -30.91 7.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.844 -0.617 . . . . 74.52 110.845 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -73.11 129.21 37.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.996 -0.372 . . . . 72.03 109.996 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.06 -12.27 62.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.946 -0.645 . . . . 53.3 111.974 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.23 140.96 5.9 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.599 -0.601 . . . . 33.41 111.599 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 9.8 p -81.94 145.79 30.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.662 0.268 . . . . 70.25 110.812 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.72 156.02 90.35 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.096 -0.502 . . . . 74.12 110.339 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.32 148.79 49.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.526 2.151 . . . . 74.13 113.01 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -82.46 158.69 65.77 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 61.42 109.866 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.91 159.31 91.24 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.497 -1.46 . . . . 62.25 112.678 0.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.8 m-85 -91.3 117.89 30.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.092 -0.503 . . . . 74.35 110.196 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.692 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.2 t70 -108.16 126.7 53.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.528 -0.76 . . . . 65.02 110.572 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 57.9 mt -130.64 114.96 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 74.51 110.242 175.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.13 115.82 49.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.948 -0.569 . . . . 72.21 110.984 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 34' ' ' ILE . 49.4 mm -112.16 142.79 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.493 . . . . 73.24 110.822 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HB2' HD11 ' A' ' 13' ' ' LEU . 59.0 t0 -108.77 121.6 45.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.912 -0.585 . . . . 54.43 109.508 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 68.3 mtm -85.15 -9.65 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 55.21 111.155 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 71.6 mmtt 68.33 16.04 9.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.148 -0.478 . . . . 73.2 112.215 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.648 ' HB2' HD11 ' A' ' 152' ' ' LEU . 8.3 pt20 -169.17 159.51 9.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.61 0.243 . . . . 75.32 110.936 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -85.78 126.0 33.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.481 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.512 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.8 mt -135.95 140.45 44.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.064 -0.517 . . . . 70.13 110.304 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.0 tp60 -82.86 101.81 11.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.188 -0.671 . . . . 75.43 109.188 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.5 mm -66.8 122.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.551 -0.295 . . . . 70.25 110.328 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.46 -33.09 4.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.738 0.304 . . . . 54.43 111.429 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.687 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 10.3 tt0 -159.41 145.41 16.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.571 -0.286 . . . . 63.33 110.384 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -114.18 137.24 48.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.49 -0.559 . . . . 75.42 109.49 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 16.7 tt0 -112.9 132.6 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.832 -0.347 . . . . 74.11 110.185 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.462 HD12 ' CE2' ' A' ' 114' ' ' TYR . 44.5 mt -120.4 116.82 26.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.384 . . . . 75.3 110.146 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.4 tp -101.91 103.91 32.26 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.348 -0.612 . . . . 75.21 109.348 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 15.3 Cg_exo -68.47 171.27 13.28 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.438 2.759 . . . . 62.03 112.835 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.514 ' HD2' ' CB ' ' A' ' 139' ' ' ALA . 35.2 ttt180 -60.64 -45.81 92.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.068 -0.515 . . . . 75.22 110.96 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.41 172.25 12.47 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.868 -0.682 . . . . 70.44 111.802 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -70.18 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.006 0.373 . . . . 75.11 112.006 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.5 45.74 3.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 73.41 112.12 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.9 t -172.45 158.28 4.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.856 -0.794 . . . . 75.34 108.856 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.57 -69.56 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.195 -0.298 . . . . 73.14 110.195 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 61.3 t30 52.75 60.2 13.03 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 123.985 0.803 . . . . 54.12 110.255 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 81' ' ' ASN . 4.1 Cg_exo -74.47 60.5 5.01 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.164 2.576 . . . . 64.41 113.474 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -92.17 125.54 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.825 -0.435 . . . . 64.4 109.825 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -93.4 -53.05 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.027 -0.533 . . . . 73.12 110.003 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.73 137.45 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 65.42 110.836 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 m -121.68 135.22 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.73 . . . . 63.21 109.542 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 54.6 mt-10 -119.05 125.48 49.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.03 0.443 . . . . 74.32 110.646 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB2' HG13 ' A' ' 100' ' ' ILE . 47.4 m-85 -104.81 131.08 52.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 64.32 110.424 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.57 149.81 49.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.224 -0.444 . . . . 74.25 110.145 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.83 48.49 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.48 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 t -149.86 152.49 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.949 0.404 . . . . 63.3 110.199 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.673 ' HB3' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.23 7.32 10.22 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.418 0.628 . . . . 75.33 109.804 175.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.4 -15.06 7.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.342 -0.845 . . . . 73.33 109.904 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.45 7.22 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.355 -0.839 . . . . 64.43 110.103 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.69 -59.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.477 -0.783 . . . . 62.24 110.512 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -88.78 104.05 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 74.35 110.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.8 m95 -91.96 116.05 28.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.901 0.381 . . . . 74.24 110.608 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.5 m -94.83 125.08 52.51 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.972 -0.558 . . . . 74.15 110.444 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 111.47 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.665 2.243 . . . . 72.41 111.51 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 116' ' ' VAL . 20.1 pt -89.93 -9.88 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.321 -0.4 . . . . 60.13 111.404 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.35 128.7 0.98 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.259 -1.448 . . . . 42.41 114.287 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 7.5 ttm180 -98.75 126.17 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.84 -0.8 . . . . 71.24 108.84 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.7 m-85 -141.82 169.24 17.96 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.26 -0.576 . . . . 72.3 111.394 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.32 139.26 15.94 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.649 . . . . 62.32 111.765 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -95.33 148.23 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.109 0.48 . . . . 72.11 110.701 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 112' ' ' LEU . 85.6 m -132.3 114.25 14.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.0 -0.546 . . . . 64.4 110.062 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -75.48 97.4 3.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.44 . . . . 62.04 110.102 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 12.6 pt20 -136.27 -179.97 5.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.88 -0.6 . . . . 73.13 110.423 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.46 9.82 42.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 64.14 110.247 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.66 151.14 39.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.692 -0.686 . . . . 55.42 109.973 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -75.95 128.17 34.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.161 0.505 . . . . 70.11 111.605 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 106' ' ' THR . 26.7 mt -82.75 117.88 22.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.485 -0.78 . . . . 75.4 110.388 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.687 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 43.4 mt-10 -92.87 111.76 23.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.923 0.392 . . . . 64.34 110.811 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CE2' HD12 ' A' ' 72' ' ' LEU . 85.0 m-85 -105.15 107.41 18.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.071 0.462 . . . . 75.55 110.516 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -76.96 95.07 4.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.587 -0.733 . . . . 52.23 109.36 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.424 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.3 m -97.58 179.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.512 -0.767 . . . . 54.43 111.817 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -65.75 134.94 54.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.739 . . . . 65.04 110.816 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 45.9 p -79.1 123.32 27.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.805 -0.634 . . . . 71.33 110.366 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.3 tt -157.84 148.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 65.4 110.757 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.37 122.76 28.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.693 -0.484 . . . . 75.33 109.693 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . . . -144.72 175.39 10.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.351 -0.386 . . . . 74.22 111.002 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -127.79 -32.51 2.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.377 0.608 . . . . 73.33 109.631 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.51 145.6 31.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.59 -0.732 . . . . 64.11 109.424 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 59' ' ' ILE . 11.4 tt -131.47 135.16 59.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.015 0.436 . . . . 72.24 109.872 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.692 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 54.5 ttp180 -121.76 118.48 29.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.045 0.45 . . . . 72.01 111.04 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 57.5 tp -87.43 119.71 27.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 74.34 109.063 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 45.5 m -116.42 120.51 39.04 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.933 0.397 . . . . 54.11 111.123 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.0 mm -98.76 95.96 3.54 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.311 -0.996 . . . . 72.41 108.311 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.99 163.33 39.63 Favored 'Trans proline' 0 CA--C 1.52 -0.179 0 C-N-CA 123.056 2.504 . . . . 51.45 113.575 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.57 71.49 0.79 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.559 -0.904 . . . . 72.32 108.559 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -149.42 -39.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.027 -0.988 . . . . 61.43 110.901 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.57 -6.18 83.66 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.384 -0.912 . . . . 54.02 113.705 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.78 26.94 7.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.974 -1.107 . . . . 64.32 111.917 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -72.69 137.02 45.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.601 0.239 . . . . 64.12 110.447 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -94.68 173.0 7.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.252 -0.431 . . . . 63.14 110.171 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 p -81.33 10.89 4.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.422 0.527 . . . . 71.23 112.422 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 94.8 t -109.07 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.417 . . . . 71.52 110.089 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.55 125.02 48.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.911 -0.586 . . . . 53.53 110.055 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 75' ' ' ARG . . . -142.57 109.08 5.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.281 0.562 . . . . 73.34 111.558 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.93 132.67 69.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.144 -0.687 . . . . 72.13 109.144 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 94.1 mtt180 -67.16 -62.48 1.41 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.082 0.468 . . . . 64.14 110.212 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.48 148.75 34.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 73.02 111.614 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.42 126.74 54.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.405 -1.332 . . . . 73.44 107.405 170.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.73 157.95 29.84 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.729 -0.471 . . . . 75.01 109.729 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.12 124.19 63.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.199 0.523 . . . . 51.23 110.471 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 80.2 mttt -102.18 112.17 24.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.441 -0.799 . . . . 73.5 108.862 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.99 -175.01 32.56 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.3 -0.952 . . . . 71.3 112.685 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 m -104.94 127.91 52.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.589 0.233 . . . . 74.31 110.795 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.667 HG23 HD12 ' A' ' 152' ' ' LEU . 36.0 mm -65.99 128.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.254 -0.43 . . . . 65.41 110.722 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 66' ' ' GLN . 60.4 mt -120.69 140.94 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.3 111.272 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.62 21.15 12.36 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.656 -0.702 . . . . 75.35 112.128 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.667 HD12 HG23 ' A' ' 149' ' ' ILE . 86.7 mt -121.72 131.77 54.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.118 0.485 . . . . 62.01 110.47 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 155' ' ' HIS . 11.0 mt-10 -130.97 -174.67 3.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 65.41 109.602 -174.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -84.75 -2.33 57.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 72.55 109.104 168.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.406 ' H ' ' HB2' ' A' ' 153' ' ' GLU . 11.5 m170 -95.38 -170.57 2.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.956 -1.02 . . . . 65.0 108.61 170.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' HIS . 7.7 p80 -133.88 71.11 1.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.46 0.647 . . . . 73.44 112.011 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -89.51 -19.97 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 54.15 110.265 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -134.0 30.92 3.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 72.14 110.461 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 19.8 m-70 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.16 -0.927 . . . . 74.43 109.486 176.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.944 0.402 . . . . 73.35 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.33 -95.43 0.56 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.044 -1.223 . . . . 51.34 110.044 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.8 m -97.64 -22.39 16.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.618 -1.253 . . . . 73.23 107.618 166.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -84.77 160.55 20.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.467 -1.242 . . . . 74.33 109.966 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 65' ' ' ILE . 44.4 mm -81.76 148.24 5.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.62 -0.264 . . . . 75.53 110.559 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -66.24 107.08 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.903 0.382 . . . . 74.03 110.301 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 144' ' ' ASP . 37.8 mtmt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.147 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -71.06 -10.26 59.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.026 -0.534 . . . . 44.34 111.624 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.28 9.32 38.84 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.859 -0.686 . . . . 65.25 111.967 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB2' HD12 ' A' ' 34' ' ' ILE . 30.4 m0 -90.9 161.94 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.014 -0.365 . . . . 73.01 110.014 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.4 pt-20 -141.37 159.81 41.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 72.41 110.731 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.02 116.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.608 -0.724 . . . . 61.34 110.132 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 60' ' ' ASP . 59.4 mt -80.84 -43.62 19.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.921 -0.581 . . . . 72.21 110.711 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 t -142.45 140.71 32.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 64.3 110.371 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.02 146.14 29.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.471 -0.786 . . . . 72.33 109.13 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -85.51 -33.95 21.67 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.723 -0.391 . . . . 73.21 110.952 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -155.6 152.34 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.05 0.452 . . . . 75.0 110.885 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -163.19 145.99 10.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.153 -1.054 . . . . 72.22 108.153 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 7.4 tp10 -95.52 98.21 10.36 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.44 0.638 . . . . 71.35 110.189 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 8.4 29.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.874 . . . . 73.12 111.425 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 m -136.52 -43.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.908 -0.317 . . . . 64.21 111.346 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.32 -31.49 71.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.078 -0.582 . . . . 73.22 112.769 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 62.1 mm-40 -93.03 6.57 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 75.45 110.835 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.4 -116.62 5.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.845 -0.693 . . . . 30.14 111.612 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.49 138.07 15.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.711 -0.477 . . . . 50.41 109.711 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 3.37 90.36 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.674 -0.774 . . . . 62.03 112.939 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -147.81 149.63 32.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.401 . . . . 73.31 109.916 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.16 3.49 72.74 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.846 -0.901 . . . . 73.33 110.846 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 51.3 mt -84.42 159.15 20.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.177 -0.512 . . . . 74.11 110.299 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.39 -28.83 68.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 73.13 110.909 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -75.45 -20.8 58.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 74.21 111.37 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 64.5 m -69.76 -23.76 63.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 72.05 110.532 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.73 -21.2 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.698 -0.683 . . . . 74.43 110.543 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 59' ' ' ILE . 30.4 pt -127.65 24.12 2.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 54.23 110.41 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.658 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.7 t70 -75.22 -38.8 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.117 -0.492 . . . . 55.43 111.533 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 40.68 3.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.265 -0.734 . . . . 62.41 111.265 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 8.9 t0 -153.64 126.21 8.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.728 -0.471 . . . . 71.34 109.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -73.23 -14.38 61.32 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.871 0.693 . . . . 63.25 112.871 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -93.53 -13.06 28.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 74.13 110.638 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 41.2 p -97.22 137.1 36.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.204 -0.665 . . . . 73.14 109.204 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.978 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 4.0 p90 -145.07 171.57 14.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.959 0.409 . . . . 75.33 111.111 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.52 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 41.5 t90 -105.19 125.46 51.0 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 70.22 109.256 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -124.47 137.49 54.43 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.425 -0.954 . . . . 74.0 108.425 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 144.88 56.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.625 -0.509 . . . . 32.41 109.625 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -65.59 112.58 3.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.838 0.351 . . . . 60.31 110.324 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -103.08 -25.08 13.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.364 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.51 121.64 15.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 74.44 110.318 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.89 -3.62 83.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.924 -0.655 . . . . 65.22 113.002 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.26 148.5 8.55 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.727 -0.749 . . . . 62.42 111.884 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 24.9 p -82.86 148.61 27.62 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.986 0.422 . . . . 74.1 111.338 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.79 158.98 86.8 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.637 . . . . 73.15 110.642 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.43 136.75 29.32 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.181 1.921 . . . . 60.1 112.413 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 16.5 mt -77.99 161.5 70.77 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 75.04 110.157 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.879 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 3.6 Cg_exo -81.9 162.23 78.16 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 124.115 -1.202 . . . . 44.22 112.585 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.9 m-85 -97.21 133.6 41.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 73.44 109.742 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 22.1 t70 -131.68 117.63 18.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.676 0.274 . . . . 73.53 110.518 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.45 119.39 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.819 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -107.01 119.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.389 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' HB ' HG23 ' A' ' 124' ' ' ILE . 75.2 mt -118.06 139.82 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.407 -0.36 . . . . 62.23 111.232 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 13' ' ' LEU . 54.8 t0 -108.27 121.85 45.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.052 -0.522 . . . . 73.44 109.629 176.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.5 mtm -86.01 -8.29 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 64.25 111.068 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.478 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 73.3 -11.93 0.86 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.244 0.618 . . . . 64.11 112.591 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -144.14 167.26 22.82 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.132 -0.321 . . . . 75.52 110.132 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.29 128.78 34.97 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.816 0.341 . . . . 73.32 110.092 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.537 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.7 mt -135.19 137.98 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.451 -0.34 . . . . 74.44 110.283 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -82.31 103.28 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.233 -0.654 . . . . 74.44 109.233 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 118' ' ' SER . 26.5 mm -70.11 125.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.469 -0.332 . . . . 70.34 110.119 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.34 -48.54 2.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 70.21 110.813 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.435 ' NE2' ' HE2' ' A' ' 146' ' ' LYS . 23.7 tt0 -147.59 146.42 29.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 72.35 109.977 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.15 131.96 70.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.16 -0.473 . . . . 61.54 110.049 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -109.84 135.66 50.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.074 0.464 . . . . 70.41 111.048 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 57.1 mt -114.28 118.27 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 tp -103.37 99.75 16.02 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.413 -0.358 . . . . 73.43 110.345 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 12.3 Cg_exo -69.62 171.72 13.81 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.734 2.289 . . . . 74.25 111.067 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -77.6 -23.52 49.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.697 -0.401 . . . . 74.21 110.577 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 109' ' ' ASP . . . 135.14 170.6 12.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.018 -0.611 . . . . 70.42 111.797 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 108' ' ' GLN . 75.3 mtp180 -77.6 -18.15 57.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 72.1 110.067 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 29.02 5.99 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.675 -0.693 . . . . 64.2 111.86 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -145.25 144.04 30.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.6 -0.518 . . . . 71.24 109.6 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -74.57 122.46 23.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 74.21 110.543 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -164.63 84.86 1.16 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 72.11 109.51 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 27.3 Cg_endo -92.81 62.08 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.406 2.737 . . . . 65.04 113.689 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' HB1' ' A' ' 138' ' ' ALA . 54.1 mt -96.64 131.8 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.136 -0.69 . . . . 71.44 109.136 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -108.67 -46.98 3.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.765 0.316 . . . . 55.35 111.079 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.465 HG11 ' HE ' ' A' ' 102' ' ' ARG . 47.2 t -124.33 139.06 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.565 -0.289 . . . . 70.42 110.971 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.03 144.71 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 64.11 110.668 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 34.2 mt-10 -120.1 135.99 54.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 70.2 111.207 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -118.2 130.52 56.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.947 -0.569 . . . . 72.51 110.618 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -136.37 148.91 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.474 -0.33 . . . . 63.15 110.628 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.58 148.28 51.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.35 -0.386 . . . . 72.43 110.382 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -150.3 161.24 42.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 73.44 111.268 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.36 -20.56 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 63.13 110.773 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -118.1 -5.09 10.96 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.311 0.486 . . . . 74.31 112.311 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.0 t30 69.85 12.47 7.94 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.595 0.712 . . . . 62.53 110.382 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.7 -53.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 70.03 109.773 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -95.61 98.99 10.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 61.24 109.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 125' ' ' ARG . 98.2 m95 -88.69 123.46 33.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 71.44 110.899 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 121.91 57.2 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.073 -0.512 . . . . 62.02 110.009 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 109.38 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.396 2.064 . . . . 75.11 111.942 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.622 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -80.62 -12.65 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 62.21 110.205 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.1 145.94 4.37 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.625 -0.798 . . . . 24.35 113.02 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HE ' HG11 ' A' ' 85' ' ' VAL . 70.9 ttt180 -115.91 120.54 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.818 -0.808 . . . . 70.45 108.818 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' HE2' HG12 ' A' ' 116' ' ' VAL . 89.4 m-85 -133.22 178.94 6.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.099 0.476 . . . . 75.35 111.151 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.39 143.89 16.99 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.71 -0.677 . . . . 64.31 111.791 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -94.75 125.61 39.52 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.786 -0.45 . . . . 74.03 109.786 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.533 ' HB ' HD21 ' A' ' 112' ' ' LEU . 19.7 m -113.76 104.35 12.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.188 -0.46 . . . . 73.43 109.94 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.45 92.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.008 0.432 . . . . 73.35 110.024 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.459 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 20.7 pt20 -121.02 -173.59 2.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.778 -0.646 . . . . 64.45 110.816 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.437 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 32.1 t70 -88.16 -18.91 27.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.819 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.3 -175.09 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 74.44 111.014 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.27 147.99 26.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.979 0.419 . . . . 70.2 110.442 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 106' ' ' THR . 21.2 mt -98.33 104.24 16.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.022 -0.535 . . . . 75.15 110.145 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -81.32 116.09 21.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 71.25 110.571 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.42 105.48 14.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.826 0.346 . . . . 75.24 110.848 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -73.03 102.33 3.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.896 -0.779 . . . . 71.23 108.896 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -107.71 175.93 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.206 0.527 . . . . 64.32 112.122 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.609 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 52.8 tttp -59.61 116.85 4.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.237 -0.892 . . . . 75.34 110.434 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.3 m -70.94 115.8 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 70.4 110.373 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.5 tt -156.54 147.93 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.286 -0.415 . . . . 63.43 110.229 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.732 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.4 ttpt -83.62 133.96 34.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.0 -0.37 . . . . 73.24 110.0 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.98 169.63 21.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.309 -0.405 . . . . 71.1 110.565 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -117.22 -32.97 4.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.199 0.523 . . . . 74.32 109.835 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.84 145.39 32.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.653 . . . . 71.03 109.646 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.0 tt -133.29 137.8 52.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.482 -0.562 . . . . 72.4 109.482 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 23.9 ttp180 -125.71 128.56 47.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.899 0.38 . . . . 71.44 111.099 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.9 tp -104.31 115.34 30.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.55 -0.75 . . . . 71.51 109.642 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 41.4 m -107.17 123.72 48.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.111 0.481 . . . . 62.35 110.746 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.629 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.4 mm -105.97 92.46 6.46 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.44 -0.8 . . . . 74.23 108.973 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.879 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.3 Cg_endo -69.61 -178.62 2.37 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.816 2.344 . . . . 75.35 113.303 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 36.8 t70 -129.24 65.06 1.47 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.618 -1.253 . . . . 73.12 107.618 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.7 -46.58 2.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.094 -0.957 . . . . 75.13 112.506 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.13 36.65 4.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.183 -1.008 . . . . 73.24 113.754 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.66 18.5 32.42 Favored Glycine 0 CA--C 1.51 -0.258 0 C-N-CA 120.241 -0.98 . . . . 75.3 112.187 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.91 166.69 10.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 71.42 111.361 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.0 m -129.9 167.54 18.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.164 -0.471 . . . . 71.41 110.181 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 32.2 p -84.89 -24.42 28.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.111 0.481 . . . . 45.43 110.32 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 57.8 t -82.3 122.35 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 75.44 109.761 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 83' ' ' ILE . . . -141.86 139.66 32.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.261 -0.427 . . . . 72.22 110.431 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.54 105.05 4.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.272 0.558 . . . . 72.43 111.253 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.06 132.48 71.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.737 -0.838 . . . . 73.14 108.737 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.978 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.7 mtm180 -69.98 -65.02 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.886 -0.326 . . . . 74.24 110.331 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -139.58 146.58 40.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.606 0.717 . . . . 75.2 112.331 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -108.2 121.95 45.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.514 -1.291 . . . . 65.21 107.514 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 m-20 -122.8 154.75 37.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.919 0.39 . . . . 73.34 110.794 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.49 129.94 56.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 54.14 110.438 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.435 ' HE2' ' NE2' ' A' ' 69' ' ' GLN . 44.5 mttm -96.02 129.08 43.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.069 -0.715 . . . . 73.44 109.069 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.53 -176.68 39.01 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.203 -0.999 . . . . 45.5 112.457 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.8 m -108.4 133.49 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.86 -0.422 . . . . 74.24 109.86 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.24 125.02 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.075 0.464 . . . . 71.55 110.575 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.732 HD12 ' HG3' ' A' ' 120' ' ' LYS . 60.8 mt -115.87 135.07 57.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.884 -0.598 . . . . 71.23 110.464 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -114.82 111.41 21.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.498 -0.774 . . . . 72.34 109.599 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.82 158.34 36.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.836 -0.62 . . . . 72.4 110.628 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -63.36 148.94 47.02 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.972 -0.558 . . . . 71.22 110.991 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -127.17 84.83 2.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.64 0.733 . . . . 70.01 110.262 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 45.7 m80 -101.54 -178.96 3.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.51 -0.768 . . . . 63.52 109.903 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.0 m170 73.66 116.44 0.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.141 0.901 . . . . 74.32 110.794 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -81.15 131.72 35.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.212 -0.662 . . . . 74.31 109.212 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 159' ' ' HIS . 58.5 t60 -127.73 76.49 1.68 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.975 -0.29 . . . . 73.42 111.168 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 158' ' ' HIS . 8.8 t-80 . . . . . 0 C--O 1.235 0.326 0 CA-C-N 115.553 -0.749 . . . . 61.42 109.485 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.716 0.294 . . . . 74.12 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 4' ' ' THR . . . 69.28 -139.02 31.57 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.753 -0.736 . . . . 72.23 111.471 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m 72.87 -13.81 0.64 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.869 0.468 . . . . 61.1 111.729 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.626 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 39.9 p -73.37 147.85 43.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.333 -0.394 . . . . 72.1 110.306 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 149' ' ' ILE . 43.4 mm -86.05 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.347 -0.388 . . . . 74.0 111.152 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -67.38 118.81 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 73.04 109.76 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -97.2 9.86 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 75.44 110.726 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 m -65.5 -27.34 68.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.832 -0.622 . . . . 72.24 111.681 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.5 20.35 34.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 75.4 112.731 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.472 ' HB2' HD12 ' A' ' 34' ' ' ILE . 36.1 m0 -94.17 150.55 20.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.821 -0.437 . . . . 71.1 109.821 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.7 pt-20 -133.61 156.59 47.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 71.22 110.279 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 116.14 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.736 -0.665 . . . . 65.01 109.76 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 60' ' ' ASP . 80.6 mt -78.76 -42.79 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 74.25 110.494 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 m -152.34 133.9 14.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.1 -0.5 . . . . 42.05 110.329 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -131.52 137.52 48.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 74.4 109.736 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.1 m -78.58 -33.42 47.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.809 0.338 . . . . 75.45 110.807 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 t -157.53 145.8 19.19 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.794 0.33 . . . . 72.25 110.979 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.27 137.67 5.2 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.963 -0.754 . . . . 74.01 108.963 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.74 133.56 33.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.136 0.493 . . . . 73.2 110.23 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.32 -27.91 0.94 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.842 -0.617 . . . . 62.1 110.852 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -101.97 -31.24 10.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.278 -0.419 . . . . 72.34 111.09 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -33.37 72.19 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.959 -0.639 . . . . 45.02 111.509 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.87 -48.9 7.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 72.2 110.011 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.55 -58.75 0.48 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.49 -0.862 . . . . 55.04 113.582 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.35 91.26 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.416 0.895 . . . . 75.45 113.416 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.2 18.09 64.55 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.151 0.82 . . . . 74.43 115.151 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -125.47 146.34 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 117.405 0.603 . . . . 74.24 110.334 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.49 82.12 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 116.146 -0.479 . . . . 71.34 112.539 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 73.4 mt -72.26 147.01 46.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 73.41 110.391 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.2 -22.68 64.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.403 -0.362 . . . . 75.12 111.14 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -79.11 -22.46 45.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 75.54 110.946 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 66.7 m -65.38 -26.25 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 41.14 110.102 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 142' ' ' GLU . 22.7 tp -61.84 -26.14 67.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.343 -0.844 . . . . 70.22 110.543 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 59' ' ' ILE . 28.3 pt -116.16 12.52 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.396 . . . . 74.21 110.755 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 38.8 t70 -77.72 -29.53 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.116 0.484 . . . . 75.4 110.105 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.93 31.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.888 -0.672 . . . . 73.33 113.268 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.546 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 14.5 t0 -115.8 128.46 55.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.345 -0.613 . . . . 73.0 109.345 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' NH2' ' A' ' 141' ' ' ARG . 10.5 p -77.37 -5.65 50.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.916 0.71 . . . . 75.31 112.916 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.8 pt-20 -103.02 -5.34 23.48 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.324 -0.55 . . . . 75.51 111.013 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 9.3 p -105.73 161.78 14.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.837 -0.431 . . . . 73.22 109.837 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.643 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 48.1 p90 -157.33 162.32 39.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.99 0.424 . . . . 74.34 111.095 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 35.4 t90 -92.72 134.17 35.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.877 -0.786 . . . . 73.33 108.877 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -132.24 138.01 47.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.04 -0.726 . . . . 62.35 109.04 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.99 138.94 58.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.706 -0.479 . . . . 74.34 109.706 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 50' ' ' SER . 31.1 ttpt -67.54 120.1 13.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.61 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -111.51 -22.92 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.167 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -71.89 107.42 4.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 70.13 110.169 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.94 -0.99 56.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.721 -0.752 . . . . 43.12 112.258 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.16 133.63 5.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.819 -0.705 . . . . 52.45 112.215 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.8 m -72.69 143.71 47.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.82 0.343 . . . . 71.04 110.375 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 10.5 m-20 -74.01 151.68 88.45 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.235 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 3.0 Cg_exo -76.65 144.99 25.59 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.684 2.256 . . . . 71.04 111.599 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 130' ' ' ASP . 15.1 mt -75.31 158.18 84.03 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.18 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.9 Cg_endo -83.49 167.14 63.69 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.696 -1.377 . . . . 74.13 113.536 2.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.8 m-85 -106.85 122.26 46.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 72.24 109.983 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.84 125.19 51.19 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.095 0.474 . . . . 73.44 110.524 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 62.8 mt -115.07 112.65 40.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.054 -0.521 . . . . 75.0 110.151 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.97 117.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.153 -0.476 . . . . 64.03 110.743 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 34' ' ' ILE . 66.3 mt -117.87 137.05 53.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.255 -0.43 . . . . 72.21 110.723 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 13' ' ' LEU . 56.9 t0 -103.59 120.63 41.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.682 -0.488 . . . . 70.24 109.682 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.426 ' SD ' HD12 ' A' ' 65' ' ' ILE . 65.2 mtm -84.66 -7.43 59.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.814 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.8 mmtt 65.9 13.64 9.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.769 -0.65 . . . . 74.32 112.183 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.411 ' OE1' HD12 ' A' ' 149' ' ' ILE . 6.0 pt20 -164.57 164.93 21.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 74.15 110.542 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.98 122.79 31.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.399 . . . . 45.21 110.366 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD13 HG21 ' A' ' 5' ' ' ILE . 74.0 mt -130.65 137.82 55.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.292 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.497 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.0 tp60 -83.29 102.93 12.3 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.063 -0.717 . . . . 75.35 109.063 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.3 mm -74.14 125.79 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.665 0.269 . . . . 74.25 110.525 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.62 -39.71 2.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.161 0.505 . . . . 40.34 110.831 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 26.7 tt0 -148.89 142.93 25.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.092 -0.504 . . . . 50.01 110.821 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.07 136.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.519 -0.549 . . . . 72.11 109.519 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 39.9 mt-10 -118.73 133.57 55.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.147 0.499 . . . . 71.32 111.247 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 72.2 mt -114.53 126.79 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.549 -0.75 . . . . 54.53 109.162 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 141' ' ' ARG . 24.3 tp -106.24 97.14 15.06 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.727 -0.472 . . . . 71.23 109.727 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 6.3 Cg_exo -72.91 153.49 52.91 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.088 2.526 . . . . 72.44 111.073 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.687 ' HA ' ' HD2' ' A' ' 141' ' ' ARG . 12.3 ptm180 -69.06 -48.78 61.9 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.03 -0.268 . . . . 72.1 111.337 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.59 2.22 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.234 -0.508 . . . . 55.32 112.659 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.82 107.68 0.64 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.317 0.647 . . . . 72.31 111.138 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.19 81.4 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.264 -0.493 . . . . 74.22 111.953 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -129.18 123.95 33.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.6 0.238 . . . . 71.43 111.116 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -88.1 -39.49 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.566 -0.531 . . . . 75.3 109.566 171.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 46.13 84.42 0.19 Allowed Pre-proline 0 N--CA 1.467 0.416 0 O-C-N 124.283 0.989 . . . . 71.54 112.799 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 72.6 Cg_endo -75.82 25.71 0.41 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.861 2.374 . . . . 71.23 112.671 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.49 120.75 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.616 -0.513 . . . . 64.12 109.616 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.52 -50.82 3.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.111 0.482 . . . . 71.0 110.749 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 102' ' ' ARG . 57.4 t -120.41 137.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 54.25 110.583 -175.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.36 129.71 65.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.556 -0.747 . . . . 71.01 109.688 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 97.2 mt-10 -112.65 125.75 54.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 61.02 110.128 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -102.84 129.75 49.62 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.679 -0.691 . . . . 74.1 110.269 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 125' ' ' ARG . . . -125.32 151.07 46.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.144 -0.48 . . . . 61.22 110.428 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.21 39.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 51.25 109.96 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 t -148.87 151.15 34.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.198 0.523 . . . . 72.41 110.762 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 -32.87 10.48 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.794 -0.639 . . . . 71.23 110.61 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -109.69 -5.59 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.429 -0.351 . . . . 74.22 110.878 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 78.19 -9.61 1.48 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.991 0.917 . . . . 73.24 111.083 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.8 t -90.91 -49.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.107 0.48 . . . . 74.34 110.819 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -93.43 102.77 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.105 -0.498 . . . . 54.33 109.85 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.98 118.07 30.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 73.53 111.044 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 m -99.46 120.82 56.82 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.469 -0.787 . . . . 75.14 110.51 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.96 112.53 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.359 2.039 . . . . 50.41 111.111 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 14.1 pt -87.33 -9.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.466 -0.334 . . . . 61.44 111.025 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.63 137.35 2.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.763 -1.208 . . . . 51.43 113.848 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.576 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 16.2 ttt180 -107.02 114.57 28.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.045 -0.724 . . . . 70.02 109.045 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.599 ' HE2' HG12 ' A' ' 116' ' ' VAL . 92.2 m-85 -125.98 169.92 12.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.84 0.352 . . . . 74.32 111.128 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -91.59 139.77 14.9 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.467 -0.653 . . . . 65.45 111.467 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -93.37 125.48 38.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 64.3 110.483 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 112' ' ' LEU . 90.2 m -103.08 115.23 30.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 54.21 110.579 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -72.59 102.56 3.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 72.52 110.534 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -143.91 -176.92 5.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 74.02 110.446 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.5 -7.97 22.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.05 0.453 . . . . 73.13 110.033 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.2 170.27 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.861 -0.608 . . . . 60.24 111.042 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.63 143.45 38.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.124 0.487 . . . . 54.21 111.613 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 106' ' ' THR . 46.4 mt -103.28 106.77 17.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 75.31 110.285 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 43.0 mt-10 -87.12 112.78 22.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.807 0.337 . . . . 75.42 110.735 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.23 106.66 17.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.155 -0.475 . . . . 62.03 110.55 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -72.13 102.61 3.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.061 -0.718 . . . . 61.12 109.061 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.599 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.1 m -103.18 179.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 64.43 112.159 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 6.5 tmtm? -66.04 124.19 21.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 72.42 110.421 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 21.2 p -70.49 127.37 32.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 75.31 110.68 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -163.45 150.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.42 -0.355 . . . . 63.05 110.481 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.698 ' HG3' HD12 ' A' ' 150' ' ' ILE . 5.9 ttpm? -85.69 128.07 34.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.285 -0.635 . . . . 62.33 109.285 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.19 160.82 43.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.861 0.362 . . . . 43.03 111.239 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -117.42 -26.12 6.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.67 -0.695 . . . . 70.45 109.642 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.16 146.45 42.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 74.42 109.859 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -131.1 143.25 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.628 -0.508 . . . . 61.43 109.628 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.5 ttp180 -131.38 124.75 30.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 73.43 111.227 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 57' ' ' ILE . 37.6 tp -90.16 113.0 24.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.553 -0.749 . . . . 65.42 109.401 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.6 m -107.18 115.83 30.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.19 0.519 . . . . 74.12 111.179 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 31.7 mm -105.06 98.05 14.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.104 -0.702 . . . . 70.12 109.104 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.7 Cg_endo -71.09 170.45 18.1 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.361 2.041 . . . . 75.31 112.39 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HA ' HD13 ' A' ' 53' ' ' LEU . 34.7 t70 -91.21 -4.09 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.109 0.957 . . . . 70.31 109.099 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.21 140.96 31.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 75.42 110.677 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.78 -13.28 35.1 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.633 -0.794 . . . . 73.13 111.93 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 110.68 18.29 8.56 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.712 . . . . 63.31 112.335 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.56 150.4 43.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 71.44 110.854 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 48.9 m -127.75 -176.76 3.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.972 -0.558 . . . . 71.32 110.388 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 39.0 p -84.53 -2.4 57.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.028 0.442 . . . . 64.44 111.649 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -93.7 96.28 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.149 0.499 . . . . 52.41 110.038 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.45 129.54 50.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.847 -0.615 . . . . 65.02 110.159 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -150.07 110.64 4.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 64.44 110.791 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.5 mt -128.67 133.0 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 64.22 109.301 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.687 ' HD2' ' HA ' ' A' ' 75' ' ' ARG . 74.1 mtp180 -61.76 -61.16 2.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.952 0.406 . . . . 74.41 110.268 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HA ' HD12 ' A' ' 33' ' ' LEU . 15.3 pt-20 -154.82 158.79 39.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.503 0.668 . . . . 70.51 111.338 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -115.15 134.6 55.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.657 -1.238 . . . . 62.44 107.657 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.626 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.1 t70 -131.09 167.16 19.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.721 -0.391 . . . . 71.24 110.014 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.7 t -138.6 128.43 32.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.73 0.3 . . . . 73.34 110.847 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.5 mttp -97.97 125.27 42.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.391 -0.596 . . . . 72.11 109.391 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.62 -158.71 14.99 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.798 -0.715 . . . . 60.32 111.404 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.0 m -131.1 130.23 42.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.849 0.324 . . . . 62.33 110.583 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 5' ' ' ILE . 34.7 mm -68.41 116.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 63.13 109.902 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 120' ' ' LYS . 42.6 mt -98.06 130.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.239 0.543 . . . . 71.03 110.17 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.83 111.97 20.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.648 0.737 . . . . 75.32 111.703 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.02 130.28 56.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.493 -0.776 . . . . 74.24 109.397 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 138.77 37.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.981 0.419 . . . . 60.03 109.998 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -107.46 43.06 1.22 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.388 0.613 . . . . 71.53 109.905 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -88.9 146.62 24.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 74.14 110.435 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -152.81 122.87 7.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.256 -0.646 . . . . 65.12 109.256 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -150.33 146.65 26.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.149 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -66.05 129.5 40.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.452 -0.34 . . . . 61.42 110.811 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.108 -0.497 . . . . 71.44 109.713 177.544 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.228 -0.286 . . . . 70.11 110.228 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.69 -128.58 3.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 72.33 111.49 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.9 t -163.82 132.87 3.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 73.01 111.007 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 12.8 p -98.81 137.63 37.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.602 -0.888 . . . . 51.13 108.602 170.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 145' ' ' VAL . 36.5 mm -65.7 129.1 29.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.978 0.418 . . . . 72.44 110.752 -173.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 m -67.19 111.69 4.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.947 -0.569 . . . . 61.0 109.807 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 9.1 mtmp? -85.06 20.37 1.91 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.432 -0.804 . . . . 73.03 111.467 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -59.13 -42.48 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.899 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.13 7.68 52.46 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 63.23 113.053 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.488 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.3 m0 -73.08 154.29 40.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.706 0.288 . . . . 70.1 110.457 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 24.5 pt-20 -148.87 161.27 42.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.262 0.553 . . . . 64.12 111.183 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.89 120.11 47.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.88 . . . . 71.33 110.066 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 60' ' ' ASP . 86.3 mt -85.75 -47.72 9.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.001 -0.545 . . . . 75.55 110.758 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 t -138.76 142.3 38.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.01 -0.541 . . . . 72.42 109.934 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -146.91 148.92 32.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.072 -0.513 . . . . 73.13 109.651 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.5 m -86.16 -42.02 14.21 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.852 0.358 . . . . 64.35 110.973 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -150.9 153.47 35.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.325 -0.398 . . . . 62.35 110.746 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.28 146.0 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.286 -0.635 . . . . 70.32 109.286 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 10.0 tp10 -102.57 110.81 22.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.932 0.396 . . . . 63.13 110.417 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.65 13.11 11.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.049 -0.523 . . . . 63.24 111.187 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 m -134.21 -49.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.513 -0.312 . . . . 64.3 111.393 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -46.19 79.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.905 -0.664 . . . . 73.03 112.201 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HG2' ' HE1' ' A' ' 46' ' ' TRP . 6.4 mm-40 -91.26 0.64 57.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.069 0.461 . . . . 75.32 110.033 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 -174.6 42.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.694 -0.685 . . . . 73.44 112.035 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.06 135.01 42.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.89 -0.411 . . . . 64.22 109.89 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.82 -1.55 58.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.645 -0.788 . . . . 73.22 111.512 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -153.36 138.53 17.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.659 -0.497 . . . . 74.01 109.659 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.79 -8.43 70.83 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.274 -0.73 . . . . 62.0 111.274 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 43.2 mt -72.47 153.58 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.14 -0.53 . . . . 75.52 110.07 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.22 -28.99 69.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 71.12 110.787 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.97 -24.82 60.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 70.24 110.993 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.847 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 77.4 m -67.33 -21.56 65.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.386 -0.37 . . . . 63.3 110.404 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 51.3 tp -64.93 -14.41 59.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.837 -0.62 . . . . 63.2 110.687 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 10' ' ' TRP . 27.8 pt -131.58 14.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.531 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.847 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.9 t70 -65.85 -33.67 76.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.291 -0.413 . . . . 73.33 111.279 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HZ1' ' A' ' 7' ' ' LYS . . . 99.84 5.49 55.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.53 -0.843 . . . . 72.03 113.408 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.67 140.22 50.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.0 0.4 . . . . 62.45 109.93 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 26.6 p -80.66 -7.39 59.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.895 0.332 . . . . 71.31 111.895 -174.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.69 -8.16 44.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.593 -0.276 . . . . 73.21 110.303 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.6 p -107.49 138.52 43.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 74.42 110.018 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.864 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 10.9 p90 -141.09 169.85 16.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.45 -0.341 . . . . 63.21 110.567 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.0 t90 -104.65 133.04 50.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.826 -0.805 . . . . 72.11 108.826 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.074 -0.713 . . . . 75.44 109.074 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 145.21 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.31 -0.626 . . . . 64.44 109.31 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -55.85 125.24 20.48 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.339 0.399 . . . . 71.54 109.995 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.533 ' HE1' ' HG2' ' A' ' 23' ' ' GLU . 68.2 p-90 -124.78 -30.22 3.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.844 -0.342 . . . . 63.12 110.79 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -77.65 107.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.785 -0.45 . . . . 70.35 109.785 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.94 11.55 52.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.636 -0.792 . . . . 65.01 111.899 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.27 20.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.955 -0.64 . . . . 53.32 111.893 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.0 m -127.7 165.76 19.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 72.24 110.896 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' HE1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -89.21 152.79 48.35 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.13 109.375 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 38.5 Cg_endo -68.09 139.07 45.51 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.158 1.905 . . . . 72.34 113.222 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.44 158.02 87.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 73.54 109.951 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 83.4 Cg_endo -82.4 161.8 76.61 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.525 -1.448 . . . . 73.05 113.061 0.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HE1' ' HB3' ' A' ' 51' ' ' ASP . 25.8 m-85 -97.79 129.02 44.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.62 . . . . 72.31 109.598 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.1 t0 -127.33 118.44 24.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.748 0.308 . . . . 72.21 110.309 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.444 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 56.9 mt -116.55 122.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 74.4 111.339 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.1 t -105.45 118.19 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.83 -0.623 . . . . 63.32 110.514 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 124' ' ' ILE . 71.1 mt -115.56 139.07 43.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 75.12 111.049 -175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.512 ' HB2' HD11 ' A' ' 13' ' ' LEU . 63.8 t0 -105.63 122.13 45.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.169 -0.468 . . . . 63.43 110.001 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.2 mtm -88.45 -5.31 58.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 72.53 110.672 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 67.11 8.51 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.902 0.704 . . . . 54.44 112.902 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -168.2 174.8 6.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.589 0.233 . . . . 71.33 110.642 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 52.3 m-80 -83.06 122.04 27.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.214 -0.448 . . . . 44.45 110.243 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 5' ' ' ILE . 68.2 mt -131.11 133.3 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.063 0.458 . . . . 74.3 110.022 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.7 tp60 -79.79 106.47 11.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.573 -0.739 . . . . 75.14 109.168 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 118' ' ' SER . 15.9 mm -76.79 102.92 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.136 -0.32 . . . . 41.21 110.136 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.3 -39.62 8.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 32.44 110.281 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -152.14 142.29 22.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.686 . . . . 41.32 110.207 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -114.28 134.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.91 -0.404 . . . . 64.23 109.91 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 49.5 mt-10 -110.75 129.72 55.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.988 0.423 . . . . 70.24 110.999 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 mt -109.78 120.82 43.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.418 -0.586 . . . . 75.41 109.418 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -102.99 103.62 34.96 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.912 -0.586 . . . . 73.12 109.751 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 8.4 Cg_exo -70.91 -168.92 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.947 2.432 . . . . 61.43 111.339 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.612 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 33.6 mtp180 -86.56 0.85 53.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.369 . . . . 61.23 110.879 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 109' ' ' ASP . . . 96.97 -123.69 7.86 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.592 -0.813 . . . . 73.22 111.985 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -121.66 128.56 52.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 61.14 109.77 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.02 57.18 1.09 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.783 -0.722 . . . . 74.54 111.919 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.378 -0.23 . . . . 73.03 110.378 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -74.91 90.77 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.781 -0.451 . . . . 72.34 109.781 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -133.09 92.59 24.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.181 -0.463 . . . . 61.14 110.315 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 18.6 Cg_endo -93.37 23.63 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.527 2.818 . . . . 73.44 112.979 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.66 125.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 75.53 110.075 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -107.28 -46.21 3.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 74.0 111.145 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG11 ' HE ' ' A' ' 102' ' ' ARG . 34.2 t -129.34 139.87 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.572 -0.285 . . . . 74.12 110.82 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.11 144.99 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.343 -0.389 . . . . 74.4 110.15 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.5 mt-10 -119.06 131.13 55.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.93 0.395 . . . . 74.0 110.595 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.89 136.03 51.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.113 -0.494 . . . . 75.53 110.772 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.24 152.52 49.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.507 -0.315 . . . . 53.41 110.851 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.23 51.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.327 -0.397 . . . . 75.41 110.264 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -149.95 153.81 37.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.196 0.522 . . . . 63.01 111.076 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 52.3 mt-10 -97.54 -24.82 15.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 65.44 110.937 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.82 -1.4 8.4 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.859 -0.336 . . . . 61.42 111.489 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.17 1.81 3.8 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.205 0.526 . . . . 74.24 111.396 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -96.8 -58.45 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.477 0.656 . . . . 71.21 110.068 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.79 106.39 18.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.096 -0.956 . . . . 62.02 109.824 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -97.31 125.15 41.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.157 0.503 . . . . 70.43 111.409 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 95.4 m -109.02 123.78 35.97 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.73 -0.668 . . . . 71.31 110.135 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 29.8 Cg_endo -64.31 120.76 8.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.412 2.075 . . . . 75.24 111.578 176.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 HG21 ' A' ' 116' ' ' VAL . 15.1 pt -86.41 -16.03 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.152 -0.477 . . . . 63.4 110.65 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.56 143.84 3.85 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.492 -0.861 . . . . 64.04 112.899 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.578 ' HE ' HG11 ' A' ' 85' ' ' VAL . 73.7 ttt180 -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.216 -0.661 . . . . 64.53 109.216 173.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HE2' HG12 ' A' ' 116' ' ' VAL . 97.1 m-85 -137.56 174.11 10.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 71.03 111.449 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.32 138.56 14.26 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.756 -0.656 . . . . 71.33 112.21 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -93.17 148.45 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 74.11 110.09 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' HD11 ' A' ' 112' ' ' LEU . 33.7 m -144.83 110.14 5.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.072 -0.513 . . . . 74.14 109.908 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -70.03 97.09 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.326 0.584 . . . . 75.52 109.931 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.573 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 11.1 pt20 -130.8 -179.69 5.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.449 -0.796 . . . . 74.53 110.713 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 5.2 p-10 -79.74 -24.41 41.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.557 . . . . 74.34 110.949 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.39 151.87 20.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 71.32 110.988 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.12 129.98 41.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 45.32 110.542 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -80.56 104.9 11.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.703 . . . . 54.33 110.501 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -85.26 108.73 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.104 0.478 . . . . 73.34 110.51 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -101.34 106.82 18.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.834 -0.621 . . . . 74.35 110.679 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -72.3 104.92 3.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 74.33 109.623 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.571 HG21 HD12 ' A' ' 100' ' ' ILE . 31.6 m -111.13 -176.54 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.068 0.461 . . . . 74.14 111.776 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.91 117.07 7.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.475 -0.784 . . . . 52.14 110.109 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 22.0 m -70.39 113.68 7.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 35.12 110.718 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.12 144.94 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 73.24 110.464 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.593 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -86.26 126.03 34.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 72.11 109.42 175.566 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -151.43 166.72 30.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.636 -0.256 . . . . 53.11 111.029 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -107.16 -30.48 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.362 0.601 . . . . 72.05 109.867 173.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -109.21 145.41 35.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.752 -0.658 . . . . 73.23 110.481 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.0 tt -133.21 138.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 73.34 109.432 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.487 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 13.0 ttp180 -127.83 130.77 49.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 74.05 111.249 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.14 114.89 29.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.381 -0.827 . . . . 74.53 109.601 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.7 m -109.11 125.23 51.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.202 0.525 . . . . 73.53 111.104 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 38.6 mm -103.96 95.96 8.63 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.056 -0.72 . . . . 73.14 109.056 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.7 Cg_endo -75.92 157.38 38.95 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.821 2.347 . . . . 73.41 113.087 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.23 63.52 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 54.43 108.58 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.27 122.53 2.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 50.53 110.227 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.85 -1.9 21.39 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.834 -0.698 . . . . 52.32 112.314 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.17 21.5 7.67 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.905 -0.664 . . . . 54.15 112.691 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -79.31 146.19 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 73.41 111.737 -175.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.6 m -113.47 174.43 5.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.486 -0.779 . . . . 71.12 109.608 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 18.8 p -79.16 -14.36 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 53.44 111.716 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 48.1 t -84.38 104.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.969 0.414 . . . . 74.11 110.219 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.26 130.84 55.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.24 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 75' ' ' ARG . . . -141.84 105.16 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.102 0.477 . . . . 71.53 111.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.34 133.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.803 -0.814 . . . . 73.13 108.803 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.864 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 71.1 mtm180 -74.25 -57.63 3.82 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.517 -0.473 . . . . 64.45 111.278 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.13 148.43 28.27 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.551 -0.86 . . . . 42.44 112.239 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 72' ' ' LEU . 7.8 tt -105.85 120.93 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.551 -1.204 . . . . 71.11 108.31 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.6 t70 -117.81 162.03 18.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.361 -0.607 . . . . 64.33 109.361 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 5' ' ' ILE . 59.9 t -126.08 123.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.197 0.522 . . . . 73.12 110.422 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 4' ' ' THR . 47.0 mttt -99.67 76.03 1.96 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.558 0.694 . . . . 63.41 109.389 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -124.05 -146.19 6.91 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.911 -1.04 . . . . 54.34 111.785 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.4 m -135.86 134.0 38.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.803 0.335 . . . . 54.31 110.704 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 40.4 mm -72.0 130.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 70.45 110.94 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.484 HG22 ' HG ' ' A' ' 152' ' ' LEU . 20.5 mt -126.64 139.2 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.069 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.31 100.93 8.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.619 0.723 . . . . 72.23 110.656 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 150' ' ' ILE . 92.8 mt -117.36 26.67 9.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.717 -0.674 . . . . 73.52 110.084 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.05 92.63 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 62.5 109.676 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -94.12 -7.18 43.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.19 -0.914 . . . . 64.34 110.205 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -141.29 163.48 32.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 74.42 109.967 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.54 146.57 27.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.978 0.418 . . . . 75.41 110.543 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -77.88 100.88 6.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 61.32 110.208 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -85.2 157.28 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 62.04 110.951 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.3 p80 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.134 -0.484 . . . . 71.32 110.116 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.22 -0.289 . . . . 64.14 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.44 144.92 43.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.853 -0.689 . . . . 64.24 112.544 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.2 m -82.41 112.9 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.46 0.648 . . . . 75.32 111.512 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -84.88 132.0 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 72.01 108.604 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 HD13 ' A' ' 65' ' ' ILE . 47.3 mm -60.81 128.49 22.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.701 0.286 . . . . 73.34 111.13 -173.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -67.5 119.43 12.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.105 0.478 . . . . 75.34 109.841 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -95.44 4.33 53.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.731 -0.668 . . . . 72.12 110.647 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -73.43 93.4 1.96 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.736 . . . . 74.43 109.442 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.34 -16.2 4.39 Favored Glycine 0 C--N 1.316 -0.583 0 CA-C-N 115.28 -0.873 . . . . 72.1 111.476 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -68.92 150.64 47.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.752 -0.462 . . . . 73.04 109.752 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.3 pt-20 -132.37 157.71 43.81 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.319 0.581 . . . . 74.24 110.924 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.74 110.04 25.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 54.33 109.645 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 HG12 ' A' ' 58' ' ' VAL . 81.6 mt -72.43 -48.95 37.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.801 -0.636 . . . . 75.34 110.612 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -149.94 142.85 24.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.666 -0.697 . . . . 62.23 110.527 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 38.2 p90 -138.77 148.54 43.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 74.21 109.837 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m -88.26 -37.91 15.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.739 0.304 . . . . 53.13 111.029 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 145.88 31.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.148 0.499 . . . . 61.34 110.859 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -154.94 151.75 28.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 50.41 108.781 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -124.56 92.35 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.153 0.501 . . . . 73.01 111.064 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.59 -18.74 21.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.736 -0.666 . . . . 70.13 111.239 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 m -91.72 -40.37 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 61.33 110.863 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.23 -45.17 9.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.898 -0.668 . . . . 72.22 112.934 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -82.9 -14.0 55.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 74.03 111.303 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 162.23 29.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.829 -0.701 . . . . 52.24 112.433 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.2 122.52 16.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.71 0.29 . . . . 70.22 110.926 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.64 -1.54 61.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.815 -0.707 . . . . 55.31 112.455 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -133.81 151.85 51.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.129 -0.323 . . . . 65.12 110.129 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 -5.95 66.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.378 -0.439 . . . . 25.34 112.119 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 77.1 mt -75.15 148.45 39.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.566 -0.317 . . . . 73.25 110.321 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.74 63.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.402 -0.363 . . . . 74.31 111.264 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.75 -25.68 44.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.506 -0.315 . . . . 61.41 110.888 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.844 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.9 m -64.84 -25.79 68.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 70.51 110.455 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 143' ' ' LEU . 34.4 tp -64.24 -22.22 66.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 74.42 110.827 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 59' ' ' ILE . 40.1 pt -125.79 15.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 74.43 110.363 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.844 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 4.6 t70 -75.38 -37.3 60.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 52.4 110.528 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.92 23.93 7.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.472 -0.871 . . . . 63.11 112.299 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.3 109.58 7.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.273 -0.64 . . . . 73.1 109.273 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.7 p -68.7 -21.16 64.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.214 -0.448 . . . . 62.0 111.923 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HA ' HH21 ' A' ' 141' ' ' ARG . 61.4 mm-40 -72.56 -26.88 61.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.925 -0.31 . . . . 61.23 110.422 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -89.3 152.09 21.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.755 -0.831 . . . . 72.11 108.755 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.707 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 47.2 p90 -148.93 174.96 11.7 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.307 -0.557 . . . . 72.4 111.333 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' HD11 ' A' ' 57' ' ' ILE . 39.0 t90 -107.82 135.67 48.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.559 -0.746 . . . . 64.35 109.046 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.442 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 48.5 t-80 -135.14 145.01 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.687 -0.486 . . . . 72.13 109.687 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.53 146.6 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.952 -0.567 . . . . 55.01 109.944 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -60.29 133.6 56.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.401 . . . . 74.43 110.787 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -139.7 -26.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 73.3 111.553 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 16.2 tp60 -62.42 -42.02 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 64.25 110.255 -176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.77 32.09 6.21 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 75.11 111.91 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.37 148.41 13.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 63.43 111.83 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -81.94 156.63 24.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.2 0.524 . . . . 61.41 111.114 -178.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -91.39 162.36 32.14 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 75.44 110.587 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.35 139.18 31.46 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.736 2.291 . . . . 63.12 112.791 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.03 159.88 69.81 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 62.4 110.157 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.773 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.4 Cg_endo -79.66 161.28 86.78 Favored 'Cis proline' 0 C--N 1.343 0.273 0 C-N-CA 123.622 -1.408 . . . . 62.41 112.975 0.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -95.75 108.81 21.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.112 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -108.72 116.91 32.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.955 0.407 . . . . 74.35 110.634 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 126' ' ' LEU . 60.9 mt -109.81 108.61 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.96 -0.564 . . . . 73.13 109.636 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 125' ' ' ARG . 48.1 t -97.94 116.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.512 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 34' ' ' ILE . 68.5 mt -115.52 137.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.726 -0.67 . . . . 73.02 110.615 -175.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -101.84 122.21 43.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 61.15 109.697 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.4 mtm -87.33 -8.5 56.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 64.23 110.611 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.2 mmtt 67.97 7.55 5.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.719 . . . . 72.24 112.26 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 5.7 pt20 -161.26 163.03 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.43 -0.211 . . . . 63.11 110.43 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.413 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 43.9 m-80 -83.97 126.17 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.85 -0.426 . . . . 74.02 109.85 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 5' ' ' ILE . 61.3 mt -132.01 136.88 55.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.033 0.444 . . . . 72.34 110.701 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -84.38 101.74 12.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.826 -0.805 . . . . 74.23 108.826 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.2 mm -71.56 127.33 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.327 -0.397 . . . . 62.1 110.306 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.26 -46.1 2.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 72.32 110.875 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -144.51 144.91 31.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.687 0.28 . . . . 75.11 110.847 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.89 132.27 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.232 -0.655 . . . . 73.52 109.232 173.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.716 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 26.8 tt0 -115.08 127.97 55.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.933 0.397 . . . . 74.31 110.367 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 114' ' ' TYR . 57.2 mt -115.72 117.75 31.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.954 -0.566 . . . . 72.03 110.16 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.6 tp -110.08 100.16 42.5 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.404 -0.362 . . . . 73.34 110.439 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -86.81 -175.59 1.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.84 2.36 . . . . 54.3 110.465 174.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' HD2' ' A' ' 141' ' ' ARG . 20.6 ptt180 -90.29 -29.94 17.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.956 -0.698 . . . . 74.25 110.055 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' HA2' ' OD1' ' A' ' 107' ' ' ASN . . . 68.65 -91.28 0.26 Allowed Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.936 -0.574 . . . . 62.25 114.04 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -76.29 128.73 35.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.356 0.598 . . . . 73.11 110.783 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.97 17.99 33.34 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.511 -0.768 . . . . 51.4 111.917 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 p -159.03 140.87 13.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.451 -0.203 . . . . 51.43 110.451 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -66.93 -50.79 61.26 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.219 -0.193 . . . . 72.42 110.573 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 t30 45.02 78.12 0.41 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.975 0.797 . . . . 63.4 111.487 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 1.1 Cg_endo -82.55 59.53 6.92 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.283 2.655 . . . . 71.23 113.225 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.4 mt -98.41 119.37 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.078 0.466 . . . . 54.25 109.821 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 25.7 mmmt -97.52 -56.41 2.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.716 -0.675 . . . . 64.25 111.4 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -121.89 139.65 48.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.319 -0.4 . . . . 65.3 110.347 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.61 133.41 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.888 0.375 . . . . 62.35 110.02 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 20.7 tt0 -121.5 128.72 52.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.911 -0.586 . . . . 71.03 110.095 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -112.07 129.38 56.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.071 -0.513 . . . . 63.14 109.961 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.76 151.72 41.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.464 -0.334 . . . . 74.44 110.273 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.34 149.49 45.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.175 -0.466 . . . . 61.25 110.185 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -147.12 148.0 31.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.271 -0.422 . . . . 53.04 110.232 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -87.04 -32.55 19.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.714 0.292 . . . . 62.32 110.992 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -132.63 16.11 4.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.573 -0.285 . . . . 61.51 111.632 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.2 t30 59.49 58.5 2.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.727 0.775 . . . . 70.1 110.308 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.26 -71.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.162 -0.926 . . . . 73.43 108.917 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -90.46 118.67 30.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.781 -0.645 . . . . 65.25 109.666 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.97 107.78 19.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.083 0.468 . . . . 75.43 110.744 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.8 m -93.84 125.99 51.11 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.802 -0.635 . . . . 63.41 110.212 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.66 104.01 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.543 2.162 . . . . 71.45 111.662 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.0 -23.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.105 -0.498 . . . . 64.33 110.901 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -169.69 128.33 1.64 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.209 -0.996 . . . . 22.45 113.004 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 2.4 tmt_? -124.29 115.0 20.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 74.14 108.649 171.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -141.4 -177.11 4.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.91 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.31 143.76 16.81 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.804 -0.634 . . . . 74.14 111.754 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.453 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 53.3 t80 -96.68 120.97 37.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 62.41 110.772 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.636 ' HB ' HD21 ' A' ' 112' ' ' LEU . 23.0 m -97.75 109.64 22.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 71.04 110.145 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.489 ' OD1' ' HA2' ' A' ' 76' ' ' GLY . 61.5 t30 -70.38 98.57 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 74.33 110.468 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -139.55 174.36 10.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 60.04 109.737 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.31 5.34 50.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.192 0.52 . . . . 70.1 110.707 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.65 152.63 24.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.596 -0.729 . . . . 62.4 109.672 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -73.93 124.96 27.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.03 0.443 . . . . 61.25 111.316 -175.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 106' ' ' THR . 35.9 mt -77.49 124.35 27.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.729 . . . . 74.32 110.594 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -95.11 109.55 21.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 73.01 110.681 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 91.8 m-85 -102.47 109.57 21.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.508 . . . . 74.5 110.474 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -81.13 90.19 6.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.602 . . . . 71.4 109.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 101' ' ' GLY . 26.8 m -87.62 -177.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.211 -0.904 . . . . 71.25 111.45 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -72.87 128.74 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.585 -0.734 . . . . 73.15 110.863 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 4.5 m -68.53 114.68 7.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.201 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 tt -153.53 148.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 74.43 110.532 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.53 126.26 35.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.767 -0.457 . . . . 73.34 109.767 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.61 165.22 29.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.442 -0.344 . . . . 53.44 110.831 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 37.1 ttt180 -115.39 -26.35 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.519 0.676 . . . . 73.14 109.744 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -116.07 146.33 42.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 74.14 109.653 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -132.83 140.48 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.962 -0.384 . . . . 74.22 109.962 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.813 ' HG3' HG22 ' A' ' 58' ' ' VAL . 5.6 ttm180 -126.38 132.09 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.816 0.341 . . . . 72.3 111.166 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 57' ' ' ILE . 56.2 tp -98.2 118.18 34.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.088 -0.708 . . . . 52.22 109.088 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 95.5 m -115.38 125.05 52.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.158 0.504 . . . . 73.41 111.321 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 39.7 mm -105.1 90.21 3.55 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.431 -0.951 . . . . 73.41 108.431 171.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.773 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 83.6 Cg_endo -86.87 150.49 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.734 2.29 . . . . 61.42 113.138 -174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -81.77 61.52 5.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.893 0.854 . . . . 64.54 108.782 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -104.32 -42.67 5.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.877 -1.056 . . . . 75.54 112.23 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.61 29.67 4.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.82 -1.181 . . . . 75.22 113.992 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.23 25.18 9.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.181 -1.009 . . . . 74.34 112.963 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.3 131.32 43.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 63.25 111.358 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 m -93.65 174.68 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 74.35 110.188 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 3.3 p -85.88 19.07 2.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.007 0.432 . . . . 63.05 111.926 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t -125.92 124.36 66.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.843 -0.429 . . . . 61.24 109.843 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.79 135.94 26.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.538 -0.301 . . . . 65.24 110.417 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -137.12 105.99 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 64.44 111.514 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.6 mt -122.31 133.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.114 -0.699 . . . . 74.42 109.114 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.707 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 67.5 mtp180 -82.59 -45.84 14.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.092 0.473 . . . . 71.3 110.305 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.89 129.37 13.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.757 -0.656 . . . . 74.41 110.953 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 8.9 tt -109.56 118.36 36.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.625 -0.88 . . . . 74.11 108.625 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 149.98 42.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.007 0.432 . . . . 63.03 110.86 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.25 135.03 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.983 -0.553 . . . . 75.23 110.341 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -111.66 120.33 41.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.004 -0.739 . . . . 73.12 109.004 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.35 -159.9 16.2 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 62.22 111.847 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.0 m -120.84 130.82 54.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.588 0.232 . . . . 71.23 110.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 5' ' ' ILE . 33.6 mm -74.78 127.54 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 61.5 110.143 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.07 149.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.747 -0.464 . . . . 44.02 109.747 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.77 60.06 2.32 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.273 0.558 . . . . 73.23 109.622 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.23 128.42 36.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.969 -1.014 . . . . 64.22 110.962 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 153' ' ' GLU . 1.3 pp20? -72.11 145.02 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.274 -0.421 . . . . 72.15 110.492 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 12.0 m170 61.92 34.52 16.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.88 -0.6 . . . . 73.53 110.186 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -54.76 114.02 1.55 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.054 -0.521 . . . . 65.41 111.225 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -56.34 138.39 50.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 71.31 110.651 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -151.89 113.9 4.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.966 0.412 . . . . 75.05 110.412 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -127.17 179.06 5.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.002 -0.544 . . . . 75.11 110.207 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.503 -0.317 . . . . 72.22 110.791 -179.857 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.766 0.317 . . . . 61.43 110.354 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.14 -101.91 2.72 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.764 -0.731 . . . . 32.1 112.708 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -81.82 -11.01 59.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.35 110.824 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.628 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 71.4 p -70.98 156.3 39.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.502 -0.772 . . . . 74.41 110.907 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 HD11 ' A' ' 149' ' ' ILE . 48.0 mm -88.36 136.48 23.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.698 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -64.26 109.41 1.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 71.45 109.958 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.51 -1.01 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 75.14 111.51 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -70.24 91.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.415 0.626 . . . . 52.04 109.835 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.75 -17.99 2.8 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.279 -0.873 . . . . 75.34 111.735 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -68.02 155.49 39.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 74.33 109.698 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -140.08 153.17 46.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.338 -0.545 . . . . 72.21 111.145 175.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.31 107.97 19.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.283 -0.871 . . . . 64.42 109.478 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 58' ' ' VAL . 83.5 mt -73.61 -47.12 42.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.725 -0.67 . . . . 72.11 110.437 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -143.28 139.38 30.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 51.42 110.167 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.62 140.17 36.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.465 -0.568 . . . . 74.42 109.465 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -84.61 -28.67 26.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.848 0.356 . . . . 75.33 110.991 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 t -162.19 149.7 14.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.877 0.37 . . . . 63.11 110.887 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -165.85 137.5 3.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.53 -0.759 . . . . 75.41 109.107 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 9.8 tp10 -105.17 95.0 5.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.011 0.434 . . . . 53.41 111.434 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -92.58 -31.48 15.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.25 110.572 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -79.66 -42.21 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 73.13 110.867 -173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.38 -47.54 22.01 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.947 -0.644 . . . . 62.44 112.7 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.41 -39.32 59.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.828 0.314 . . . . 70.14 111.166 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.37 -122.77 5.49 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.921 -1.133 . . . . 52.2 113.879 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.89 97.73 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.381 0.512 . . . . 55.32 112.381 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.8 9.34 86.97 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.95 -0.643 . . . . 43.13 113.209 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -112.66 141.47 46.4 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.017 -0.364 . . . . 71.42 110.017 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.38 -8.04 79.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.088 -0.577 . . . . 74.51 112.759 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.6 mt -73.27 144.65 46.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.322 -0.251 . . . . 71.15 110.322 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.7 -23.63 66.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.02 0.438 . . . . 65.34 110.923 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -75.4 -23.87 57.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 65.35 110.988 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 57.8 m -67.15 -25.38 66.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 53.21 110.417 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.37 -26.75 66.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.724 . . . . 74.32 110.522 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 59' ' ' ILE . 31.9 pt -121.27 12.19 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 73.41 110.723 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t70 -71.08 -36.66 72.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 72.32 109.719 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.94 52.97 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.499 -0.858 . . . . 52.33 113.42 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.629 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 8.3 t0 -149.3 135.16 18.82 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.842 -0.429 . . . . 64.21 109.842 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.6 p -81.55 10.77 5.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.604 -0.725 . . . . 75.42 112.64 -172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 13.0 pt-20 -118.45 -7.7 10.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.525 -0.47 . . . . 73.41 111.315 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p -96.71 166.9 11.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.504 -0.554 . . . . 74.32 109.504 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.521 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 50.6 p90 -161.82 165.28 28.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.269 0.557 . . . . 72.01 112.25 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 32.1 t90 -109.65 139.41 44.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.763 -1.108 . . . . 75.22 108.966 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.68 142.4 43.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.06 151.81 45.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.316 -0.402 . . . . 71.11 110.221 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -62.51 125.76 25.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.039 -0.356 . . . . 65.34 110.039 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 68.7 p-90 -126.22 -34.02 2.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 72.44 110.616 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -75.61 108.6 8.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.622 -0.511 . . . . 72.24 109.622 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.43 -20.54 46.4 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.769 -0.729 . . . . 45.11 111.462 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.6 167.8 11.34 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.677 -0.773 . . . . 53.53 112.001 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 54.8 m -115.03 149.77 36.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 60.45 110.503 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.56 152.5 66.99 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 73.42 110.076 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.02 142.8 35.16 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.216 1.944 . . . . 72.1 112.738 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.14 156.69 87.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 71.44 110.002 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.59 170.24 65.41 Favored 'Cis proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.627 -1.406 . . . . 70.22 113.437 2.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -110.37 129.94 55.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.035 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 15.8 m-20 -118.43 130.05 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.882 0.372 . . . . 75.11 110.505 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 126' ' ' LEU . 60.6 mt -121.25 108.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 53.41 109.681 173.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 13' ' ' LEU . 40.8 t -95.93 119.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.907 -0.588 . . . . 62.33 110.23 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 34' ' ' ILE . 61.3 mt -119.28 133.03 67.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.279 -0.419 . . . . 74.3 110.94 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.7 t0 -100.05 120.88 40.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 74.12 109.633 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE1' HD11 ' A' ' 67' ' ' ILE . 70.5 mtm -86.78 -4.88 59.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 60.13 111.01 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.51 0.07 3.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.181 0.808 . . . . 75.33 113.181 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -159.94 173.75 15.44 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.298 -0.251 . . . . 75.24 110.734 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -82.67 122.75 28.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 71.42 109.906 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 5' ' ' ILE . 64.9 mt -132.59 135.31 57.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 75.23 110.322 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.517 HE21 ' HB3' ' A' ' 118' ' ' SER . 57.2 tp60 -83.16 104.31 13.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.046 -0.724 . . . . 64.32 109.046 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.1 mm -73.6 121.75 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.414 -0.357 . . . . 64.33 110.288 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.2 -36.33 4.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.053 0.454 . . . . 73.33 110.748 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 31.1 tt0 -153.44 143.25 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.884 -0.598 . . . . 72.21 110.813 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -114.7 138.43 44.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.355 -0.609 . . . . 74.03 109.355 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.4 mt-10 -117.31 133.62 55.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 73.53 111.3 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.34 122.78 45.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.793 -0.639 . . . . 74.21 109.687 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 tp -106.25 106.48 57.36 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.239 -0.437 . . . . 65.04 110.043 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.95 177.92 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.724 2.283 . . . . 55.24 111.127 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -87.56 -5.98 58.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.637 -0.425 . . . . 64.14 110.847 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.78 168.51 11.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.677 -0.773 . . . . 43.0 112.17 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -89.66 133.6 34.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.626 -0.509 . . . . 63.11 109.626 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.21 10.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.758 -0.734 . . . . 24.35 111.597 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.5 m -69.48 160.96 30.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.119 -0.326 . . . . 54.24 110.119 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -80.43 98.38 7.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.222 0.534 . . . . 74.43 110.631 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -115.4 88.86 19.98 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.443 -0.799 . . . . 71.41 109.346 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.817 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 2.8 Cg_exo -77.89 31.05 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.369 2.713 . . . . 71.14 112.24 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' PHE . 30.8 mt -95.1 112.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 75.11 109.4 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -100.56 -44.76 5.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.005 -0.543 . . . . 55.33 110.643 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG11 ' HE ' ' A' ' 102' ' ' ARG . 58.6 t -127.32 138.39 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 73.12 110.865 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 m -128.5 140.74 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 71.35 110.364 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -118.12 129.17 55.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.145 -0.48 . . . . 71.04 110.654 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -112.04 130.18 55.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 74.54 110.234 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.05 148.46 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.803 0.335 . . . . 50.22 111.031 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 148.39 52.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 71.31 109.979 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 154.94 38.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.118 0.485 . . . . 63.55 111.458 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 45.1 mt-10 -105.62 -9.64 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.279 -0.637 . . . . 73.22 109.279 170.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.55 -36.17 8.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 45.33 111.606 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.32 15.15 3.58 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.574 1.178 . . . . 73.41 108.031 -167.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -122.28 -62.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.019 -1.446 . . . . 75.45 109.485 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -89.49 104.85 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.886 -0.597 . . . . 64.44 109.435 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -93.86 117.6 30.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 71.01 111.309 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.6 m -94.18 125.29 53.05 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.641 . . . . 71.12 110.256 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.29 113.92 3.84 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.403 2.069 . . . . 74.14 111.943 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 116' ' ' VAL . 20.9 pt -83.87 -12.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 55.45 110.75 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.07 146.54 4.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.25 -0.976 . . . . 74.24 113.035 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HE ' HG11 ' A' ' 85' ' ' VAL . 69.3 ttt180 -125.99 118.56 25.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.801 -0.815 . . . . 72.11 108.801 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -136.82 -176.14 4.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.019 0.438 . . . . 73.31 111.051 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.48 148.54 18.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.569 -0.742 . . . . 61.51 112.134 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 42.6 t80 -95.81 119.91 35.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 74.32 110.276 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.439 ' HB ' HD21 ' A' ' 112' ' ' LEU . 20.1 m -103.54 110.18 22.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.228 -0.442 . . . . 42.1 110.749 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.39 100.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 73.3 110.572 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -139.94 -179.34 5.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 70.2 110.375 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.53 -11.06 35.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.99 0.424 . . . . 72.11 110.975 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.166 -0.47 . . . . 74.35 111.009 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 130.67 43.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.49 . . . . 64.34 110.916 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 106' ' ' THR . 58.8 mt -83.32 109.46 17.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 54.13 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.26 112.46 21.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 74.11 110.94 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.0 104.13 14.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 63.44 110.016 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.431 ' CE1' ' NE2' ' A' ' 69' ' ' GLN . 37.9 m-85 -77.57 91.25 3.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.356 -0.838 . . . . 72.01 109.355 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 100' ' ' ILE . 31.2 m -96.28 -178.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 72.01 112.392 -170.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -65.73 126.49 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.136 -0.938 . . . . 63.33 110.649 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 63.9 m -71.49 123.99 23.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.074 -0.512 . . . . 53.23 110.45 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.059 -0.518 . . . . 62.12 110.286 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.555 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -93.83 113.61 25.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.178 -0.675 . . . . 71.44 109.178 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.06 173.61 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.676 0.274 . . . . 74.33 111.041 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -115.93 -32.36 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.32 0.581 . . . . 71.51 110.512 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.35 145.75 31.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.97 -0.559 . . . . 63.04 110.203 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.7 tt -135.13 138.02 49.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.021 -0.536 . . . . 55.01 109.69 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.3 ttp180 -124.7 125.9 44.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.017 0.437 . . . . 60.11 111.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' ILE . 47.0 tp -93.28 112.79 24.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.491 -0.777 . . . . 54.51 108.979 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.3 m -111.81 123.09 49.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.39 0.614 . . . . 71.15 111.151 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.98 100.49 11.53 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.649 -0.871 . . . . 71.1 108.649 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.6 164.88 24.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.718 2.279 . . . . 74.52 112.98 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.69 14.71 24.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.153 0.977 . . . . 73.33 108.855 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -125.08 134.58 52.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.905 -1.043 . . . . 74.11 110.389 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.78 -9.92 14.21 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.941 -0.647 . . . . 41.14 112.445 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.72 23.54 6.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.773 -0.727 . . . . 70.3 112.147 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -79.96 144.79 33.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.771 0.32 . . . . 64.43 110.789 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 24.5 m -117.47 177.28 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.169 -0.469 . . . . 24.13 110.458 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 32.4 p -79.13 -3.12 43.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 45.52 111.814 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.817 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 87.4 t -95.23 121.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.373 -0.376 . . . . 75.41 110.081 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.32 128.65 17.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 73.23 110.428 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.96 106.22 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.411 . . . . 53.31 110.674 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.51 132.95 67.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.001 -0.74 . . . . 62.22 109.001 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 92.9 mtt180 -70.98 -59.41 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.724 -0.39 . . . . 63.41 110.884 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.1 157.63 40.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.759 0.79 . . . . 73.01 112.097 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.85 133.28 56.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.454 -1.248 . . . . 62.13 107.736 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.628 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -130.77 170.3 14.55 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.579 -0.448 . . . . 72.12 109.844 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.1 t -141.38 128.11 20.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.937 -0.394 . . . . 62.1 109.937 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.2 mttm -97.91 124.41 42.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.433 -0.951 . . . . 75.3 108.433 172.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.64 -167.13 26.85 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.282 -0.961 . . . . 24.13 112.052 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 m -119.17 126.76 52.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.767 0.317 . . . . 74.44 110.501 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 5' ' ' ILE . 41.4 mm -70.66 127.15 32.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.036 -0.529 . . . . 73.22 110.005 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 120' ' ' LYS . 47.4 mt -119.62 139.43 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.373 . . . . 65.33 110.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.22 113.17 17.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.154 0.502 . . . . 74.15 110.242 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.47 86.73 3.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.454 0.645 . . . . 45.22 110.01 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.63 26.89 3.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.439 -0.801 . . . . 74.1 111.09 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -78.12 -6.23 54.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 74.35 109.568 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -80.78 115.86 20.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.418 -0.81 . . . . 71.55 109.744 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -117.77 124.08 47.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 75.35 110.036 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -127.77 79.18 1.88 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.604 0.716 . . . . 74.23 111.006 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -140.83 134.25 29.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.114 -0.948 . . . . 73.41 109.33 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 116.407 -0.36 . . . . 52.42 110.866 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.031 0.443 . . . . 74.13 110.307 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.06 -168.98 30.76 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.606 -0.598 . . . . 62.2 111.606 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.9 m -75.12 -43.62 51.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.948 0.404 . . . . 72.44 110.682 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -92.19 151.88 20.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.474 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.609 HG21 HD13 ' A' ' 65' ' ' ILE . 51.1 mm -86.2 132.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.538 -0.301 . . . . 61.23 110.578 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -72.81 120.23 18.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.627 . . . . 61.41 109.306 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -82.24 29.49 0.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 63.02 111.017 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -79.01 95.96 5.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.661 -0.699 . . . . 64.43 110.222 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.86 -9.02 9.16 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 71.42 112.265 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.462 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.2 m0 -69.67 134.34 48.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.983 -0.377 . . . . 74.1 109.983 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' OE2' ' HE2' ' A' ' 62' ' ' LYS . 13.5 pt-20 -132.41 160.92 34.96 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.764 -0.374 . . . . 72.12 110.567 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -95.71 125.39 48.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.224 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 60' ' ' ASP . 77.7 mt -90.5 -44.54 9.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.132 0.492 . . . . 75.1 110.303 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -142.2 137.22 30.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.752 -0.658 . . . . 72.34 110.316 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.57 144.33 34.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.411 . . . . 61.42 110.138 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.8 m -80.15 -51.31 9.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 71.22 110.858 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.4 t -142.7 150.17 39.79 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.98 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -164.94 142.82 6.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.471 -0.937 . . . . 74.23 108.471 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.672 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 9.1 tp10 -103.27 107.94 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.7 -0.4 . . . . 72.42 111.029 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -114.34 -5.88 12.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 72.42 111.332 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -111.74 -40.03 4.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.401 -0.363 . . . . 73.14 110.837 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -74.65 -45.3 23.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.002 -0.618 . . . . 60.41 112.038 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.672 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 41.3 mm-40 -84.51 -52.61 6.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.591 -0.522 . . . . 51.01 109.591 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.11 -170.78 23.39 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.773 -0.727 . . . . 62.2 112.305 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.48 120.27 28.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.845 0.355 . . . . 73.43 110.271 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -11.02 58.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.11 -0.567 . . . . 44.54 112.416 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.564 ' HB2' ' CE1' ' A' ' 41' ' ' PHE . 21.8 p-10 -134.67 127.96 32.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.885 0.374 . . . . 73.41 110.055 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.19 -10.8 60.09 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.481 -0.648 . . . . 70.21 111.481 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 89.7 mt -74.49 147.11 42.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.617 -0.291 . . . . 74.45 110.273 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.64 -24.06 64.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.044 0.449 . . . . 43.44 110.995 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -72.56 -26.91 61.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.755 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.3 m -70.57 -17.78 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 71.51 110.867 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.14 -20.58 66.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.544 0.687 . . . . 71.15 110.067 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 10' ' ' TRP . 40.2 pt -131.24 18.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.759 -0.655 . . . . 73.22 110.267 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 1.008 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -71.57 -30.44 65.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.026 -0.534 . . . . 54.21 110.651 -172.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.53 33.97 5.44 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.842 -0.694 . . . . 73.15 112.33 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 39' ' ' GLU . 8.8 t0 -153.32 124.4 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.695 -0.484 . . . . 73.33 109.695 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 p -77.53 -3.45 40.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.298 0.481 . . . . 20.12 112.298 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 16.9 mm-40 -83.34 -24.02 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.751 0.31 . . . . 61.51 110.208 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.4 p -93.93 165.06 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.958 -0.386 . . . . 72.14 109.958 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 52.8 p90 -163.92 172.01 14.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.296 . . . . 65.14 110.91 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 42.8 t90 -112.28 134.02 54.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.554 -0.748 . . . . 70.23 109.292 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.6 137.01 45.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.118 -0.697 . . . . 75.13 109.118 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 144.65 56.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.957 -0.386 . . . . 32.44 109.957 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.43 137.14 57.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.913 -0.585 . . . . 54.32 110.11 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -138.35 -13.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 75.51 110.9 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -67.59 101.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.127 0.489 . . . . 73.52 110.65 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.82 90.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.896 -0.669 . . . . 75.41 112.256 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.99 177.21 14.82 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.818 -0.706 . . . . 60.3 111.599 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 t -125.0 175.12 7.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.093 0.473 . . . . 72.44 110.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 17.0 m-20 -97.97 146.49 31.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 72.12 110.116 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.31 145.85 61.1 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.764 2.31 . . . . 74.32 112.835 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 21.0 mt -80.61 159.51 69.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.697 -0.683 . . . . 72.03 109.968 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.4 Cg_endo -78.42 158.61 92.91 Favored 'Cis proline' 0 C--N 1.344 0.307 0 C-N-CA 123.631 -1.404 . . . . 72.41 113.125 1.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.711 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.0 m-30 -91.08 129.93 37.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 74.23 109.974 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 11.8 t70 -121.07 124.96 46.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.202 -0.454 . . . . 62.42 109.955 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.39 117.15 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.92 0.391 . . . . 72.42 110.4 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.35 116.68 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 61.33 110.842 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.4 mp -107.82 136.69 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.517 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.499 ' HB2' HD11 ' A' ' 13' ' ' LEU . 39.8 t0 -104.47 122.75 46.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 61.42 109.791 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -90.12 -4.34 57.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 71.4 110.881 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HE2' ' OE2' ' A' ' 11' ' ' GLU . 33.4 mmtp 71.74 -6.99 1.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.456 0.702 . . . . 72.32 112.601 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -152.77 168.18 26.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.189 -0.3 . . . . 73.03 110.189 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.551 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 47.2 m-80 -85.58 125.43 33.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 71.01 110.344 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.609 HD13 HG21 ' A' ' 5' ' ' ILE . 62.0 mt -130.34 136.75 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.973 -0.558 . . . . 55.21 109.881 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.5 tp60 -83.19 100.53 10.63 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.901 -0.777 . . . . 74.31 108.901 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.735 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -66.89 130.92 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.378 -0.374 . . . . 73.53 110.318 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.71 -46.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.934 0.397 . . . . 73.42 110.943 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 19.3 tt0 -138.79 149.42 44.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.631 -0.507 . . . . 65.14 109.631 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.89 127.57 73.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.82 -0.437 . . . . 72.14 109.82 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 1.9 mp0 -108.66 131.79 54.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.333 0.587 . . . . 72.35 111.048 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 60.1 mt -111.66 119.27 38.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 174.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 27.0 tp -102.32 96.45 7.17 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.256 -0.646 . . . . 62.13 109.256 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.1 Cg_endo -83.81 -169.73 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.259 2.64 . . . . 61.35 112.154 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -99.28 -53.23 3.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 72.33 109.957 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.89 -178.23 7.61 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.907 -0.588 . . . . 53.11 112.759 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.29 -87.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.102 0.779 . . . . 63.33 113.102 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.45 48.53 3.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.123 -0.56 . . . . 62.33 112.276 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 p -168.06 148.45 4.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.527 -0.546 . . . . 53.0 109.527 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -86.56 -54.78 4.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.986 -0.376 . . . . 54.21 109.986 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 138' ' ' ALA . 65.4 t30 48.17 75.3 0.68 Allowed Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.868 0.73 . . . . 71.0 111.543 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 4.4 Cg_exo -75.79 55.6 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.343 2.696 . . . . 71.12 113.672 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.7 mt -99.51 115.61 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.089 -0.708 . . . . 71.24 109.089 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -100.44 -48.36 4.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.829 0.347 . . . . 73.54 110.832 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.16 139.82 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.1 110.466 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 105' ' ' PHE . 5.1 m -130.08 143.32 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.984 0.421 . . . . 63.45 110.885 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 38.1 mt-10 -125.31 130.5 52.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.071 -0.513 . . . . 71.13 110.849 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -113.22 132.48 55.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.484 . . . . 73.22 110.554 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.14 154.69 50.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.393 -0.367 . . . . 34.41 110.503 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.29 156.78 47.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 61.42 109.921 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 t -149.65 143.82 25.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 45.12 110.555 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -93.37 -41.75 9.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.004 -0.544 . . . . 74.25 110.781 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -109.2 3.56 21.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.833 -0.621 . . . . 64.51 110.992 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 23.7 t-20 75.53 -9.64 1.38 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.559 0.744 . . . . 70.43 111.055 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.08 -42.98 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 62.03 110.815 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.68 106.76 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 31.13 110.043 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.4 m95 -99.58 120.41 39.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 73.32 110.572 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.3 m -113.36 126.14 28.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.265 -0.425 . . . . 64.33 110.586 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.75 113.7 2.86 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.445 2.097 . . . . 61.43 111.126 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 116' ' ' VAL . 12.8 pt -82.17 -11.52 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.771 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.92 142.97 3.54 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.496 -0.859 . . . . 51.33 112.546 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.514 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 34.3 ttt180 -119.0 125.13 48.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.433 -0.58 . . . . 71.32 109.433 175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -140.28 -176.17 4.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.048 0.451 . . . . 71.22 110.718 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.81 155.55 20.08 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.435 -0.666 . . . . 53.33 111.435 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.491 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 52.1 t80 -103.27 135.33 45.12 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.898 0.38 . . . . 74.22 110.189 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.457 ' O ' HD11 ' A' ' 112' ' ' LEU . 34.3 m -116.04 116.55 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.483 -0.562 . . . . 72.0 109.483 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.68 93.6 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.273 0.559 . . . . 73.24 110.282 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -131.54 177.15 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.325 -0.852 . . . . 72.42 108.867 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.28 -8.74 35.08 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.49 -0.484 . . . . 73.13 110.252 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.62 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.808 -0.633 . . . . 54.33 110.223 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.31 128.48 35.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.11 0.481 . . . . 75.31 111.773 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 41.6 mt -84.96 125.68 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.06 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -98.0 115.32 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.969 0.414 . . . . 52.24 110.789 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.83 107.27 17.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.154 -0.475 . . . . 64.43 110.257 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.06 92.1 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.746 -0.661 . . . . 74.31 109.49 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 100' ' ' ILE . 28.9 m -98.56 176.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.796 . . . . 61.51 111.937 -171.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.89 134.23 52.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.379 -0.828 . . . . 61.31 110.594 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.735 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 19.2 m -77.28 117.72 19.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.071 -0.513 . . . . 74.1 110.7 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.62 143.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.982 -0.554 . . . . 75.33 110.802 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.551 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.522 -0.547 . . . . 74.03 109.522 173.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.58 159.72 44.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.211 -0.45 . . . . 61.33 110.944 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.433 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 39.9 ttt180 -107.53 -27.47 10.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.45 0.643 . . . . 72.53 109.728 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 94' ' ' ASN . 71.8 m-85 -114.17 146.26 40.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.691 -0.686 . . . . 74.24 110.071 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.503 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.3 tt -133.62 140.3 46.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.452 -0.573 . . . . 70.04 109.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 49.6 ttp180 -127.97 124.54 37.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 72.45 111.394 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.3 tp -95.24 120.28 35.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.315 -0.857 . . . . 45.54 109.428 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -114.84 122.23 45.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 70.04 110.804 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.6 mm -102.24 97.19 8.13 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.87 -0.789 . . . . 72.14 108.87 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -73.48 -173.48 1.33 Allowed 'Trans proline' 0 CA--C 1.522 -0.123 0 C-N-CA 122.938 2.425 . . . . 74.43 113.058 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 16.2 t0 -129.26 75.36 1.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 65.52 108.4 166.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.53 -50.94 2.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.273 -0.876 . . . . 71.31 112.094 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.4 28.77 7.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.24 -0.981 . . . . 74.52 113.916 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 106.55 26.06 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.858 -1.163 . . . . 64.11 113.007 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 6.5 m-20 -70.81 132.12 44.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.725 0.298 . . . . 62.52 110.281 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 m -109.54 179.37 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.5 -0.318 . . . . 73.24 111.045 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 p -90.02 16.05 9.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.368 0.604 . . . . 65.21 111.544 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.471 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 78.2 t -110.43 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.014 -0.539 . . . . 72.13 109.65 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . . . -135.38 130.97 35.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.498 -0.319 . . . . 73.11 110.566 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.3 106.11 5.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.085 0.469 . . . . 71.45 110.879 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.8 mt -129.46 135.79 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.817 -0.629 . . . . 72.24 109.432 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 57.5 mtt180 -66.95 -71.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 75.42 110.096 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -145.42 162.42 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.544 0.688 . . . . 75.12 111.98 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.88 124.7 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.507 -1.224 . . . . 75.32 108.18 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -126.35 162.17 26.14 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.637 -0.505 . . . . 72.32 109.637 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.1 t -136.03 134.93 50.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.876 0.37 . . . . 71.41 111.382 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 65.0 mttp -95.76 131.86 41.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.22 -169.65 37.96 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.194 -1.003 . . . . 74.35 112.474 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.2 m -118.81 132.86 56.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.35 -0.241 . . . . 64.21 110.35 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.82 121.37 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 71.1 110.11 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 66' ' ' GLN . 73.5 mt -106.01 140.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.979 0.418 . . . . 61.11 110.457 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -123.07 136.85 54.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.04 -0.527 . . . . 61.33 110.182 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.66 12.89 27.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.256 0.55 . . . . 73.14 109.928 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.97 -177.65 6.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.403 -0.817 . . . . 54.54 110.688 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -68.35 145.27 54.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.137 0.494 . . . . 74.41 111.786 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -121.46 107.24 12.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 71.12 109.838 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -110.16 -28.22 8.76 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.844 -0.428 . . . . 74.51 109.844 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -69.89 93.74 0.78 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 74.03 109.992 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -158.94 86.49 0.84 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 64.32 110.288 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.687 -0.688 . . . . 72.23 109.721 176.258 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.871 -0.418 . . . . 62.54 109.871 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.42 140.11 12.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.771 -0.728 . . . . 73.24 112.249 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 m -81.95 -24.65 35.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.157 0.503 . . . . 70.13 109.807 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -77.4 136.75 38.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.298 -0.63 . . . . 61.22 109.298 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 149' ' ' ILE . 39.7 mm -71.43 136.45 25.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 71.34 111.067 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.1 m -73.15 109.08 6.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 72.54 109.826 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -85.94 26.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 74.2 111.383 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -6.09 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 43.21 111.463 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.2 2.87 10.59 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.608 -0.806 . . . . 74.32 112.399 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -81.46 134.9 35.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.427 -0.212 . . . . 73.45 110.427 -175.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.3 155.72 45.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.734 -0.386 . . . . 72.53 110.497 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.6 t -90.05 108.27 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.825 -0.625 . . . . 75.3 109.981 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.6 mt -74.77 -49.24 21.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.017 -0.538 . . . . 75.44 110.477 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -143.42 134.18 25.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.726 . . . . 73.4 110.015 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 54.3 p90 -135.33 148.91 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.706 -0.479 . . . . 73.12 109.706 175.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.2 m -86.62 -44.61 11.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.388 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -143.8 144.37 31.76 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.187 0.517 . . . . 50.32 111.077 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -149.92 148.29 28.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 175.042 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 8.5 tp10 -119.4 89.1 3.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.354 0.597 . . . . 50.05 110.963 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . . . -100.38 -21.77 15.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.546 -0.752 . . . . 74.44 110.088 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -83.71 -44.46 14.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.673 -0.694 . . . . 64.4 110.93 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -37.23 40.05 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.911 -0.661 . . . . 72.52 112.35 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HG2' ' HG3' ' A' ' 19' ' ' GLU . 28.6 mm-40 -79.98 -28.49 39.53 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.645 0.239 . . . . 70.43 111.645 -177.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.19 -83.33 0.36 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.414 -0.898 . . . . 64.44 112.585 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.77 141.84 8.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.537 0.208 . . . . 65.45 111.001 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.51 -3.38 17.47 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 116.168 -0.469 . . . . 70.54 113.564 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.78 -0.452 . . . . 75.51 109.78 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.31 3.06 90.25 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.709 -0.556 . . . . 74.34 111.709 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 80.6 mt -84.31 144.49 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.273 -0.269 . . . . 72.12 110.273 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.95 -24.51 66.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 74.52 110.409 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 19.4 ptpt -72.74 -25.26 61.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 74.41 111.037 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.855 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 61.2 m -71.58 -18.67 62.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 75.42 110.387 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.23 -15.04 61.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.818 -0.628 . . . . 62.12 110.273 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.23 22.24 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.824 -0.625 . . . . 71.25 109.593 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.855 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 13.6 t70 -72.54 -58.7 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 64.43 110.402 -175.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.57 39.25 0.79 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.023 -0.608 . . . . 74.41 112.203 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -148.16 122.58 9.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.866 0.365 . . . . 64.23 110.265 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -74.9 7.14 3.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.101 0.778 . . . . 61.42 113.101 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -106.7 -19.72 13.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.035 -0.266 . . . . 75.44 111.051 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -88.65 168.93 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.03 -0.359 . . . . 72.24 110.03 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.438 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 56.2 p90 -161.6 163.62 29.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.036 0.446 . . . . 73.33 111.586 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 32.5 t90 -107.02 143.02 35.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.294 -0.866 . . . . 72.34 109.072 172.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 51.3 t-80 -138.96 145.72 40.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.126 -0.694 . . . . 61.52 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.1 149.73 39.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.118 -0.327 . . . . 64.4 110.118 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 50' ' ' SER . 63.1 tttm -61.06 119.37 8.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.428 -0.351 . . . . 73.31 110.619 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.465 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 69.8 p-90 -118.29 -27.13 6.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 70.35 110.307 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.32 127.25 32.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.729 -0.471 . . . . 75.45 109.729 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.22 89.97 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.725 -0.75 . . . . 65.44 111.828 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.57 148.5 9.0 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.491 -0.643 . . . . 74.42 111.491 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 20.6 m -78.85 150.19 32.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.117 -0.327 . . . . 44.2 110.117 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 2.0 t70 -80.42 145.48 59.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.021 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 20.3 Cg_endo -62.25 129.98 28.84 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.632 2.221 . . . . 71.13 113.327 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.2 158.69 66.5 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 74.24 110.125 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.0 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.3 Cg_exo -76.5 161.58 93.48 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 124.284 -1.132 . . . . 75.25 113.295 0.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.1 m-85 -96.11 138.46 33.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 71.41 109.579 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' A' ' 125' ' ' ARG . 6.2 t70 -132.67 123.69 26.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.221 -0.288 . . . . 62.22 110.221 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.39 124.18 66.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.695 0.283 . . . . 72.21 110.624 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 ' HG3' ' A' ' 125' ' ' ARG . 45.5 t -113.23 120.16 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.34 -0.391 . . . . 63.22 111.096 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.8 mp -112.99 139.36 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 75.52 110.103 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.643 ' HB2' HD11 ' A' ' 13' ' ' LEU . 51.0 t0 -106.0 126.81 52.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.625 -0.509 . . . . 72.44 109.625 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.446 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.0 mtm -90.62 -6.97 53.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 74.23 110.664 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 31.5 mmtp 68.48 5.27 4.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.602 0.761 . . . . 74.31 112.415 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 27.4 pt20 -157.94 174.16 15.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.492 -0.188 . . . . 61.32 110.492 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -88.6 124.11 33.73 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.679 -0.489 . . . . 25.42 109.679 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.446 HD12 ' SD ' ' A' ' 61' ' ' MET . 70.9 mt -132.84 133.7 58.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.012 0.435 . . . . 72.02 110.256 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.6 tp60 -82.76 105.41 13.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.684 -0.858 . . . . 61.11 108.684 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.1 mm -75.44 124.74 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.82 0.343 . . . . 74.01 110.483 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.81 -43.88 2.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.03 -0.532 . . . . 70.13 110.784 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -148.47 140.3 23.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.242 -0.436 . . . . 71.43 111.039 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.31 139.45 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.297 -0.631 . . . . 62.04 109.297 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 42.0 mt-10 -123.29 131.37 53.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.104 0.478 . . . . 74.1 111.101 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 65.2 mt -113.36 124.72 53.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 74.0 109.893 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -103.58 104.14 40.22 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.651 -0.5 . . . . 64.04 109.651 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 11.9 Cg_exo -69.27 -172.42 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.811 2.341 . . . . 74.1 112.129 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -79.26 -24.56 42.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.164 -0.68 . . . . 71.14 109.164 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 91.02 -149.76 20.11 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.553 -0.749 . . . . 65.11 113.42 172.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 126.41 30.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.397 0.618 . . . . 70.05 109.98 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.16 38.19 4.13 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 110.594 -1.002 . . . . 72.42 110.594 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.6 t -144.95 151.3 38.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.301 -0.45 . . . . 73.51 110.222 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -77.34 -65.7 0.92 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.337 -0.616 . . . . 74.34 109.337 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' ND2' ' A' ' 107' ' ' ASN . 2.7 m120 48.24 67.72 4.22 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.925 -0.58 . . . . 55.12 112.227 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 85.1 Cg_endo -85.89 30.52 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.813 2.342 . . . . 74.43 112.306 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -77.76 127.85 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 63.32 109.795 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -98.96 -55.2 2.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 75.11 111.126 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 48.0 t -128.82 138.03 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 40.54 110.739 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.59 133.59 68.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.169 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.2 mt-10 -115.02 126.67 55.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.982 0.42 . . . . 63.52 110.975 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -107.56 134.06 51.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.773 -0.649 . . . . 63.43 110.248 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.66 151.54 51.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.33 -0.395 . . . . 72.32 110.398 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.084 -0.339 . . . . 72.53 110.084 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -147.58 145.35 28.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.031 0.443 . . . . 62.52 111.5 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -81.52 -43.25 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.8 -0.636 . . . . 72.33 109.842 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 1.0 OUTLIER -109.72 -1.97 17.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.268 -0.878 . . . . 70.31 112.394 -170.247 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.3 t-20 76.27 -7.96 1.73 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.972 0.509 . . . . 73.23 111.079 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -94.69 -51.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.231 0.539 . . . . 42.24 109.804 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -92.64 105.71 17.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.43 -0.805 . . . . 73.14 110.328 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 96.6 m95 -97.63 121.75 39.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.853 0.359 . . . . 73.35 111.504 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 35.5 m -97.36 128.95 33.13 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 61.21 110.046 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 6.0 Cg_exo -75.22 108.69 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.463 2.109 . . . . 73.4 110.315 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 19.8 pt -82.37 -19.1 10.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.377 -0.374 . . . . 63.55 111.206 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.19 131.06 1.41 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.037 -1.078 . . . . 31.32 113.002 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 61.4 ttt180 -112.91 115.21 28.08 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.917 -0.401 . . . . 70.32 109.917 172.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -137.4 176.99 8.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.723 0.297 . . . . 72.23 110.853 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -95.61 157.59 21.85 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.902 -0.666 . . . . 74.34 112.057 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -94.14 148.29 22.33 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.719 -0.475 . . . . 71.42 109.719 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.678 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.4 m -131.21 115.93 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.501 -0.318 . . . . 55.35 110.644 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 81' ' ' ASN . 48.7 t-20 -69.67 96.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.165 0.507 . . . . 73.14 110.09 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.424 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 12.4 pt20 -136.94 174.01 11.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.704 . . . . 71.43 109.284 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.55 -8.38 44.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.232 0.539 . . . . 73.35 110.752 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.42 158.78 16.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 63.53 110.618 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.18 138.21 58.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.269 -0.423 . . . . 73.22 110.945 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.678 HD21 ' HB ' ' A' ' 106' ' ' THR . 39.7 mt -90.95 110.76 22.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 75.42 110.461 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.43 120.19 26.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.198 0.523 . . . . 64.05 110.271 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.29 107.5 17.27 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.394 -0.821 . . . . 70.24 110.007 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -80.02 98.66 7.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 30.8 m -100.78 -178.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.911 -0.586 . . . . 54.14 111.801 -171.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.03 129.59 40.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 73.11 110.776 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.8 m -75.65 106.81 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 62.04 110.033 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.18 148.3 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.374 -0.375 . . . . 74.35 110.244 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HG3' HD12 ' A' ' 150' ' ' ILE . 4.5 ttpm? -84.82 135.84 33.93 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.891 -0.411 . . . . 63.32 109.891 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.22 40.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.571 -0.286 . . . . 64.53 110.982 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 41.0 ttt180 -108.73 -33.3 7.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 72.12 109.462 171.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -109.3 145.51 35.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.655 -0.702 . . . . 74.34 109.891 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.1 tt -130.8 139.1 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.407 -0.59 . . . . 75.02 109.407 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.952 ' HG3' HG22 ' A' ' 58' ' ' VAL . 1.6 ttm180 -125.12 139.44 53.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.915 0.388 . . . . 65.51 111.021 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 tp -115.11 120.51 40.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.671 -0.695 . . . . 62.24 109.458 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 42.1 m -115.55 128.55 56.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.883 0.373 . . . . 74.14 110.798 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 35.1 mm -108.35 88.77 5.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.171 -0.677 . . . . 54.54 109.171 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 1.0 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.8 Cg_endo -87.95 131.42 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.957 2.438 . . . . 72.21 113.708 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 20.3 t0 -80.1 65.0 5.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.044 0.926 . . . . 75.11 109.246 172.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.09 -19.14 11.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.687 -1.142 . . . . 41.43 110.02 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -131.49 29.04 3.5 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.611 -0.804 . . . . 25.3 112.792 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.69 24.91 16.59 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 120.506 -0.854 . . . . 74.04 113.321 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 3.2 m-20 -70.25 130.85 43.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.968 0.413 . . . . 74.0 111.193 -176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.3 m -92.49 157.26 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 70.22 110.363 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 10.0 p -67.89 -20.98 65.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.032 0.444 . . . . 73.21 111.908 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 t -80.47 93.57 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.205 0.526 . . . . 72.31 110.679 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -114.39 136.05 53.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.076 -0.511 . . . . 53.1 110.313 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -152.02 108.36 3.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.229 -0.441 . . . . 61.3 110.86 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.61 136.22 60.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 75.34 108.823 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 66.7 mtt180 -74.62 -53.52 9.2 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.852 -0.339 . . . . 65.44 111.32 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.28 135.56 15.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 75.21 111.07 -173.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 143' ' ' LEU . 9.3 tt -112.75 121.14 43.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.371 -0.603 . . . . 53.51 109.371 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.7 158.26 35.25 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.922 0.391 . . . . 61.31 110.55 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.56 136.54 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.379 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -101.7 125.42 48.35 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.207 -0.664 . . . . 73.01 109.207 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.1 -168.32 30.96 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.395 -0.907 . . . . 73.23 112.549 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.6 m -115.7 131.25 56.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.582 0.229 . . . . 74.41 110.948 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 5' ' ' ILE . 37.7 mm -76.95 118.07 22.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 60.43 110.374 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 120' ' ' LYS . 39.7 mt -109.29 132.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.229 0.538 . . . . 70.54 110.607 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -117.76 101.29 8.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.841 -0.618 . . . . 65.12 110.323 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.91 92.78 8.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.286 -0.415 . . . . 75.44 109.911 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -70.9 105.66 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.508 0.67 . . . . 72.03 111.391 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -143.02 -173.18 3.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.871 -1.059 . . . . 75.13 108.284 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -83.48 73.11 10.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.611 0.719 . . . . 72.24 110.445 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.92 124.47 12.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.554 -1.203 . . . . 70.33 108.792 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -65.63 97.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.57 0.544 . . . . 64.33 110.149 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -120.94 151.77 39.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 62.4 110.693 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 72.1 110.464 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.626 0.25 . . . . 43.12 110.527 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.24 143.28 10.05 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.491 -0.862 . . . . 74.24 112.282 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.8 t -92.59 -15.71 26.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 73.04 110.684 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 p -95.41 161.16 14.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.969 -0.56 . . . . 73.51 111.099 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.676 HG21 HD13 ' A' ' 65' ' ' ILE . 47.8 mm -85.29 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 62.41 110.115 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -66.92 118.72 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.381 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -92.2 25.79 2.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.095 0.474 . . . . 51.12 110.621 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -52.93 61.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.4 -0.818 . . . . 75.21 112.23 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.44 6.53 68.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.532 -0.842 . . . . 74.21 113.304 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -70.54 134.15 47.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.799 0.299 . . . . 72.24 110.403 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 6.8 pt-20 -130.71 161.83 30.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.983 0.421 . . . . 64.43 110.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.92 113.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.791 -0.64 . . . . 73.21 110.118 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 60' ' ' ASP . 79.4 mt -83.36 -47.89 10.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.996 -0.547 . . . . 75.31 110.478 -178.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -137.36 140.41 41.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.815 -0.629 . . . . 64.42 110.164 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -150.37 148.52 28.9 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.588 -0.523 . . . . 73.1 109.588 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -90.73 -36.49 14.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 72.1 111.065 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -155.22 154.46 32.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 64.52 111.243 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 10.1 pt20 -165.63 135.81 3.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.192 -0.913 . . . . 71.52 108.81 174.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.494 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 9.0 tp10 -88.98 94.79 10.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.33 0.586 . . . . 73.22 110.546 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.49 -3.18 34.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.654 -0.703 . . . . 73.12 111.49 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -111.39 -51.58 2.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.823 0.344 . . . . 75.23 110.131 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.41 92.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.146 -0.549 . . . . 73.31 112.14 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 61.2 mm-40 -96.79 -58.43 2.04 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.888 -0.412 . . . . 64.22 109.888 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.16 -177.24 16.6 Favored Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.449 -0.881 . . . . 63.44 112.998 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.15 117.38 10.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 75.13 110.355 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.72 -5.95 54.48 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.888 -0.672 . . . . 74.14 112.343 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -137.6 128.52 27.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.636 0.255 . . . . 62.14 110.447 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.86 -5.26 83.05 Favored Glycine 0 C--N 1.322 -0.234 0 C-N-CA 120.601 -0.809 . . . . 73.23 112.438 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.49 HD12 ' HE3' ' A' ' 31' ' ' LYS . 82.2 mt -73.95 150.99 40.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.142 -0.318 . . . . 75.11 110.142 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.94 -22.25 66.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 62.11 110.953 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HE3' HD12 ' A' ' 29' ' ' LEU . 16.8 pttp -75.08 -24.17 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 62.13 110.816 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.945 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.0 m -76.51 -10.71 59.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.941 -0.572 . . . . 63.11 111.087 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.77 -15.3 62.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.616 0.722 . . . . 75.15 109.417 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 59' ' ' ILE . 28.4 pt -132.01 21.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 51.41 109.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.945 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 1.7 t70 -68.22 -48.54 64.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 61.33 109.931 -174.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 142' ' ' GLU . . . 117.74 31.12 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.809 -0.71 . . . . 74.5 114.077 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.589 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 9.7 t70 -153.27 153.95 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.981 0.89 . . . . 74.14 111.336 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -72.53 -18.36 61.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.272 0.471 . . . . 74.02 112.272 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.589 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.7 pt-20 -98.12 3.43 49.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.404 -0.518 . . . . 63.24 111.189 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -102.27 157.05 17.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.915 -0.772 . . . . 72.33 108.915 168.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 51.2 p90 -166.98 158.07 12.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 65.12 111.2 -175.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.7 t90 -102.35 134.91 44.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.402 -0.817 . . . . 72.03 109.051 172.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -134.78 136.16 42.37 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.469 -0.567 . . . . 73.21 109.469 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.18 139.79 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.945 -0.391 . . . . 54.12 109.945 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 36.9 ttpt -62.56 118.84 8.14 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.717 -0.475 . . . . 75.15 109.717 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -112.36 -29.38 7.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.594 -0.275 . . . . 75.41 110.622 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -74.25 125.47 28.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.978 0.418 . . . . 63.5 110.17 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.05 -3.09 84.46 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 73.25 112.145 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.85 132.61 7.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.874 -0.679 . . . . 41.25 111.9 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 49.7 m -78.91 149.57 32.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 74.24 111.341 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.13 157.69 89.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 72.23 110.326 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.0 146.56 41.82 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.326 2.018 . . . . 71.32 112.123 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.49 156.95 88.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.833 -0.621 . . . . 73.53 109.707 173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.806 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 84.0 Cg_endo -82.78 156.46 76.07 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.779 -1.342 . . . . 73.21 113.62 0.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.21 117.89 30.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.539 -0.755 . . . . 63.12 109.234 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 18.5 t70 -117.42 125.62 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.305 -0.258 . . . . 61.31 110.305 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 61.4 mt -122.83 115.58 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.831 0.348 . . . . 63.24 110.94 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.14 116.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.957 -0.565 . . . . 75.24 110.306 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 34' ' ' ILE . 81.8 mt -115.96 136.75 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.236 -0.438 . . . . 73.31 110.844 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 13' ' ' LEU . 53.5 t0 -101.54 120.28 40.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.47 -0.567 . . . . 64.41 109.47 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm -85.97 -5.94 59.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 65.1 110.819 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.488 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 73.2 mmtt 67.6 7.34 5.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.809 -0.632 . . . . 74.1 112.159 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.798 ' HA ' HD21 ' A' ' 152' ' ' LEU . 24.1 pt20 -163.93 155.96 16.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.707 0.289 . . . . 71.31 110.459 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.541 ' ND2' ' HB3' ' A' ' 152' ' ' LEU . 79.5 m-20 -74.54 128.74 36.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.601 . . . . 72.31 109.838 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.676 HD13 HG21 ' A' ' 5' ' ' ILE . 58.5 mt -133.46 135.88 55.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.857 0.36 . . . . 73.43 110.165 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.51 102.68 10.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.875 -0.787 . . . . 73.33 108.875 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 118' ' ' SER . 21.4 mm -72.93 118.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.285 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.12 -41.97 3.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.351 -0.386 . . . . 74.41 110.843 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -148.64 144.22 27.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.301 -0.409 . . . . 62.0 110.277 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.02 129.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.961 -0.385 . . . . 65.34 109.961 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -105.89 131.17 53.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.935 0.398 . . . . 74.51 110.468 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 38.4 mt -112.6 118.57 35.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.848 -0.615 . . . . 63.32 109.449 174.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.509 ' HG ' ' HD2' ' A' ' 141' ' ' ARG . 24.2 tp -102.36 101.52 20.1 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 115.82 -0.627 . . . . 75.22 109.328 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 17.0 Cg_exo -65.25 166.59 18.64 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.5 2.133 . . . . 64.33 111.111 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.832 ' HA ' ' HG3' ' A' ' 141' ' ' ARG . 76.8 ttt180 -72.01 -13.69 61.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 64.51 111.13 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.95 -174.53 27.8 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.713 -0.756 . . . . 51.33 111.449 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -89.49 139.28 30.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.962 0.411 . . . . 72.31 110.04 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.71 -35.19 2.36 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.285 -1.126 . . . . 54.21 110.285 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.5 m -113.13 111.83 22.78 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.064 -0.717 . . . . 65.54 109.064 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -60.51 131.46 50.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.403 0.62 . . . . 75.24 110.952 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 49.9 t-20 -124.88 102.7 31.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.597 -0.729 . . . . 73.05 110.133 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 89.6 Cg_endo -90.88 28.14 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.305 2.67 . . . . 74.02 113.731 -177.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 80.1 mt -82.51 117.46 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 75.33 110.512 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -92.05 -57.53 2.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.618 -0.719 . . . . 64.34 110.902 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.66 138.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.574 . . . . 61.44 111.09 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.41 138.67 54.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.157 -0.474 . . . . 60.23 110.146 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 89.9 mt-10 -119.81 127.68 53.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 73.32 110.617 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB2' HG13 ' A' ' 100' ' ' ILE . 53.5 m-85 -106.3 132.85 51.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.761 -0.654 . . . . 60.02 109.978 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.7 150.31 52.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.588 -0.278 . . . . 74.15 110.408 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.36 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.766 0.317 . . . . 72.34 111.169 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 t -150.53 149.11 29.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.303 -0.628 . . . . 65.51 109.303 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.699 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -90.65 -33.88 15.65 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 122.163 -0.335 . . . . 64.02 111.755 -177.006 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.6 20.22 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.602 -0.439 . . . . 73.01 111.222 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 65.79 47.4 2.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.426 0.632 . . . . 61.04 110.518 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.54 -74.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.042 -0.526 . . . . 62.5 109.894 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -83.29 105.82 14.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.327 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -91.06 108.32 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.274 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.0 m -94.56 123.67 57.52 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.874 -0.603 . . . . 64.52 110.181 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.48 102.55 0.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.412 2.075 . . . . 51.21 111.27 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 22.4 pt -75.79 -15.64 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 53.13 111.112 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.6 136.57 2.28 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.809 -1.186 . . . . 72.42 113.509 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 40.3 ttt180 -119.67 114.62 22.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.514 -0.921 . . . . 64.15 108.514 169.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -135.87 179.62 6.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 73.54 110.755 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.49 135.17 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.32 112.12 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -94.29 148.08 22.57 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.792 -0.448 . . . . 72.23 109.792 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' HD11 ' A' ' 112' ' ' LEU . 47.0 m -142.11 120.36 12.26 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.71 -0.478 . . . . 71.12 109.71 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 12.0 t30 -77.09 91.66 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.51 0.671 . . . . 75.34 110.935 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -118.26 -171.89 2.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.002 -0.999 . . . . 74.44 109.217 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -95.83 -26.05 15.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.935 0.397 . . . . 71.15 110.63 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.79 155.32 21.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 35.12 110.624 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.86 141.15 51.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 74.25 111.013 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 106' ' ' THR . 16.0 mt -98.2 106.45 18.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 71.34 110.083 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -80.3 116.7 20.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.885 0.374 . . . . 72.44 110.569 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.92 112.62 25.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.667 -0.697 . . . . 72.54 110.578 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -77.22 93.25 3.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.377 -0.601 . . . . 74.53 109.377 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.5 m -96.79 177.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 75.33 111.495 -173.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -67.59 132.87 48.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.321 -0.854 . . . . 74.14 110.459 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 41.8 m -74.92 122.25 23.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 75.33 110.51 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.5 tt -152.84 143.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.896 -0.593 . . . . 73.45 110.538 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -88.89 112.61 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.168 -0.678 . . . . 73.21 109.168 174.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.95 161.96 36.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.449 -0.341 . . . . 62.35 111.082 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.699 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 34.7 ttt180 -109.89 -31.85 7.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 61.41 110.159 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.05 145.92 30.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.705 -0.679 . . . . 73.34 109.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.416 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.7 tt -129.56 140.05 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.546 -0.539 . . . . 71.23 109.546 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 57.5 ttp180 -130.29 127.02 38.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 73.32 111.127 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.18 115.94 31.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.646 -0.707 . . . . 72.01 109.236 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 34.7 m -112.04 120.52 42.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.031 0.444 . . . . 74.13 110.91 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.7 96.06 8.4 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.175 -0.676 . . . . 73.35 109.175 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.806 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 98.0 Cg_endo -79.73 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.513 2.142 . . . . 73.2 112.617 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -123.69 67.73 1.02 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.912 0.863 . . . . 53.22 108.867 170.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.8 18.07 3.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.66 -1.154 . . . . 73.11 110.1 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.84 2.1 0.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.168 -1.015 . . . . 61.05 113.729 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.75 27.64 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.32 -0.943 . . . . 41.24 112.045 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.04 156.52 17.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.965 0.412 . . . . 73.34 110.958 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 22.4 m -123.43 -179.41 4.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.068 -0.515 . . . . 75.51 110.199 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 6.6 p -85.06 5.0 31.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.219 0.533 . . . . 74.21 111.993 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 46.6 t -103.05 128.56 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.661 -0.496 . . . . 60.21 109.661 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.48 131.92 19.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.7 -0.227 . . . . 70.4 110.653 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.36 105.34 4.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 63.02 111.145 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.95 133.31 67.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.363 -0.606 . . . . 65.44 109.363 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.832 ' HG3' ' HA ' ' A' ' 75' ' ' ARG . 66.9 mtt180 -64.76 -71.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.345 0.593 . . . . 73.33 109.89 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' GLY . 61.5 mm-40 -140.09 144.51 36.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 64.25 111.7 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -107.48 119.61 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.825 -1.176 . . . . 73.3 107.825 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.7 141.77 51.7 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.936 0.398 . . . . 72.32 110.557 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.11 133.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.678 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -107.49 105.24 15.05 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.75 -0.833 . . . . 63.33 108.75 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.03 -150.05 5.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.68 . . . . 73.34 111.966 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 m -132.83 133.85 43.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.503 0.192 . . . . 74.25 110.589 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.58 130.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 75.54 110.988 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.576 HD12 ' HG2' ' A' ' 120' ' ' LYS . 34.3 mt -123.9 150.83 28.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.796 -0.638 . . . . 72.04 109.749 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.7 168.39 18.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.34 0.59 . . . . 62.43 111.008 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.798 HD21 ' HA ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -154.41 156.13 36.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.011 -0.995 . . . . 73.42 109.87 175.393 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.81 11.32 25.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.128 -0.487 . . . . 70.32 111.174 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -91.11 94.07 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 72.43 109.439 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -111.41 127.57 55.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.009 0.433 . . . . 71.23 111.125 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -112.44 107.1 15.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.831 -0.622 . . . . 75.13 109.995 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -105.67 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.169 -0.468 . . . . 53.12 111.357 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -121.8 100.6 7.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.65 -0.704 . . . . 73.11 109.603 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.3 m170 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.525 -0.307 . . . . 73.54 110.582 -178.288 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.79 0.329 . . . . 54.24 110.353 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.98 157.27 16.81 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.618 -0.593 . . . . 52.14 111.618 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -77.86 -29.36 50.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.875 0.369 . . . . 64.41 110.325 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -102.37 135.61 43.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.126 -0.488 . . . . 70.41 110.317 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 HD11 ' A' ' 149' ' ' ILE . 42.1 mm -70.9 137.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.781 -0.645 . . . . 63.23 111.83 -174.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -69.08 108.16 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.564 . . . . 73.22 110.174 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -87.01 10.34 16.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 74.1 111.168 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -72.06 -7.5 49.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 53.11 111.654 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -120.19 4.59 12.44 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.263 -0.97 . . . . 60.53 113.076 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.53 ' HB2' HD12 ' A' ' 34' ' ' ILE . 34.8 m0 -80.3 156.81 26.61 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.635 0.255 . . . . 74.23 110.601 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.581 ' CD ' ' HE3' ' A' ' 62' ' ' LYS . 3.2 pm0 -141.89 153.02 44.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.143 0.497 . . . . 71.51 111.046 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.99 128.64 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.322 -0.399 . . . . 54.14 110.186 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 58' ' ' VAL . 57.4 mt -89.42 -49.81 6.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.243 0.544 . . . . 61.14 110.097 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.2 p -150.7 143.84 24.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.681 -0.69 . . . . 74.24 110.587 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.77 147.7 41.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.501 -0.772 . . . . 74.24 109.087 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -85.47 -33.31 21.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.903 0.382 . . . . 74.21 110.81 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -156.27 155.02 31.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.871 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -168.03 143.05 3.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.602 -0.888 . . . . 64.53 108.602 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.9 tp10 -94.18 115.42 27.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.083 0.468 . . . . 64.23 110.124 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.36 3.74 6.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 53.12 110.899 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.6 m -121.74 -42.13 2.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.155 -0.475 . . . . 70.4 110.923 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.49 -47.78 15.43 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.809 -0.71 . . . . 53.11 112.395 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -90.95 -2.72 57.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 60.24 111.237 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.27 -165.26 31.31 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.859 -0.686 . . . . 74.41 112.332 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.25 126.08 50.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.962 0.41 . . . . 73.14 110.566 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.53 55.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.827 -0.701 . . . . 72.21 111.728 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -135.57 123.97 23.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.407 -0.59 . . . . 74.35 109.407 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.16 -7.88 58.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.015 -0.612 . . . . 74.43 111.944 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 90.1 mt -75.79 151.87 37.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 71.42 110.472 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.1 -25.27 65.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.009 0.433 . . . . 52.33 110.765 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.85 -20.47 61.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.672 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 60.4 m -73.01 -18.0 61.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.042 0.449 . . . . 54.52 110.742 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 tp -66.93 -17.5 64.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.737 -0.665 . . . . 70.05 110.219 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 10' ' ' TRP . 29.7 pt -128.39 22.39 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 72.45 110.45 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 26.5 t70 -70.49 -40.74 73.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 75.24 112.161 -171.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.32 23.08 9.87 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.651 -0.785 . . . . 32.11 112.061 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -138.18 128.83 26.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.49 -0.559 . . . . 72.31 109.49 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 p -76.83 0.56 20.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.029 0.751 . . . . 73.14 113.029 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.11 -7.44 15.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.572 -0.451 . . . . 62.22 111.57 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 p -92.42 149.2 21.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.081 -0.711 . . . . 73.53 109.081 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 49.7 p90 -153.05 166.72 31.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.946 0.403 . . . . 74.4 111.468 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 44.8 t90 -108.03 138.9 43.48 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.189 -0.914 . . . . 73.2 109.385 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -136.31 142.62 43.9 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.036 -0.727 . . . . 63.45 109.036 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.61 56.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.636 -0.505 . . . . 71.35 109.636 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HZ2' ' A' ' 45' ' ' LYS . 2.2 ttpm? -64.17 115.22 4.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.135 -0.32 . . . . 63.22 110.135 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -109.24 -28.94 8.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.311 -0.404 . . . . 75.21 110.805 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -76.54 113.78 14.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 73.42 110.236 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.87 -8.51 54.32 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.229 -0.748 . . . . 61.14 111.229 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.53 161.2 11.01 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.545 -0.622 . . . . 74.24 111.545 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 4.6 p -98.34 148.39 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.738 0.304 . . . . 73.52 110.51 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 21.2 m-20 -84.57 149.12 53.71 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.682 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 22.4 Cg_exo -66.24 128.79 20.15 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.872 2.382 . . . . 73.45 112.822 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.9 mt -73.09 162.33 75.05 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.391 -0.822 . . . . 74.11 110.207 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 92.4 Cg_endo -78.33 163.56 86.65 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.843 -1.315 . . . . 52.52 113.249 1.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.5 m-85 -100.19 112.89 25.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 73.31 110.649 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.78 131.62 44.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.421 -0.354 . . . . 73.43 110.254 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.414 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 60.6 mt -124.76 108.51 20.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.579 -0.526 . . . . 72.12 109.579 172.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG12 HD12 ' A' ' 13' ' ' LEU . 49.5 t -102.25 114.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.951 -0.568 . . . . 74.14 110.388 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.05 139.6 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.87 -0.604 . . . . 72.22 109.898 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HB3' ' OE1' ' A' ' 11' ' ' GLU . 19.5 t0 -102.66 138.52 39.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.693 -0.484 . . . . 64.24 109.693 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.479 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.6 mtm -91.83 -3.15 56.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 72.44 110.07 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HE3' ' CD ' ' A' ' 11' ' ' GLU . 24.0 mmtp 67.6 4.09 3.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.482 -0.781 . . . . 72.34 112.467 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -165.3 172.12 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.602 0.239 . . . . 73.13 110.754 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.41 127.18 31.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.259 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.667 HD13 HG21 ' A' ' 5' ' ' ILE . 74.6 mt -136.68 135.16 48.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.143 0.497 . . . . 71.11 110.363 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -82.82 109.39 16.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.009 -0.738 . . . . 74.22 109.009 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 118' ' ' SER . 27.4 mm -79.33 129.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.92 -0.312 . . . . 73.43 110.325 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.59 -39.28 2.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 63.23 110.968 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 29.4 tt0 -150.96 143.94 24.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.996 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.06 131.68 67.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.243 -0.435 . . . . 70.53 109.836 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.8 mt-10 -110.07 135.85 50.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.908 0.385 . . . . 72.34 110.677 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.42 HD12 ' HE2' ' A' ' 114' ' ' TYR . 69.2 mt -119.01 120.3 36.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.733 -0.667 . . . . 65.22 109.557 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 31.2 tp -104.25 104.02 41.91 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 116.052 -0.522 . . . . 75.52 109.907 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.7 Cg_exo -76.33 178.17 7.86 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.222 2.615 . . . . 64.31 112.267 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -115.38 27.34 9.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.483 -0.326 . . . . 74.43 110.767 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.79 99.79 0.06 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.914 -0.585 . . . . 32.54 114.355 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 16.3 mmm180 -105.21 -83.97 0.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.82 -1.178 . . . . 75.42 107.82 170.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 77' ' ' ARG . . . -123.42 25.52 6.26 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 108.881 -1.688 . . . . 75.33 108.881 167.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.62 150.69 37.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.926 -1.137 . . . . 74.13 111.469 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.94 -47.69 10.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.224 -0.658 . . . . 71.45 109.224 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 t30 43.59 73.86 0.88 Allowed Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 124.238 0.961 . . . . 61.22 111.423 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.616 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 75.4 Cg_endo -77.99 59.9 7.11 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.07 2.514 . . . . 63.33 113.755 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mt -99.0 119.36 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.041 -0.726 . . . . 74.41 109.041 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -102.64 -49.64 3.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.342 -0.39 . . . . 72.2 111.822 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.66 138.0 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.51 -0.314 . . . . 74.01 111.133 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.82 129.2 63.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.276 -0.42 . . . . 63.44 110.268 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.9 mt-10 -111.87 132.97 54.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.041 -0.527 . . . . 74.03 110.302 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.62 129.42 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.868 -0.605 . . . . 72.11 110.023 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -132.15 141.79 49.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.831 0.348 . . . . 72.22 110.943 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.03 46.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.062 -0.517 . . . . 70.15 110.387 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -149.96 158.89 44.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.845 0.355 . . . . 74.21 111.267 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.3 mt-10 -106.64 -25.08 11.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 61.13 110.985 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 19.1 p30 -114.42 0.68 14.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.48 -0.327 . . . . 54.15 111.647 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 61.9 t30 74.42 0.7 3.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.555 0.534 . . . . 74.32 110.516 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.9 -54.47 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 64.12 110.669 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -88.12 96.59 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.681 . . . . 53.33 110.278 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 99.4 m95 -90.38 121.11 32.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 73.11 110.743 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.0 m -98.47 121.81 55.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.711 -0.677 . . . . 70.34 109.814 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.42 113.61 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.288 1.992 . . . . 71.21 111.423 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 116' ' ' VAL . 21.9 pt -88.78 -15.71 8.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 65.11 110.631 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.41 150.62 7.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.318 -0.944 . . . . 50.14 113.181 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 31.9 ttt180 -129.02 114.69 16.72 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.135 -1.061 . . . . 73.01 108.135 173.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.585 ' HE2' HG12 ' A' ' 116' ' ' VAL . 98.0 m-85 -127.28 171.98 11.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 73.24 111.657 -170.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.09 131.05 10.44 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.481 -0.782 . . . . 33.4 111.198 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.46 136.87 34.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.994 0.426 . . . . 73.14 110.265 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.58 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.0 m -118.52 111.1 18.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.845 -0.616 . . . . 61.52 109.861 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.45 104.24 3.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.989 0.424 . . . . 72.32 110.567 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.7 -176.79 5.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 71.43 109.91 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -103.13 0.66 32.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 75.03 110.687 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.06 163.15 12.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 75.3 110.631 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.27 35.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 62.45 111.329 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.58 HD21 ' HB ' ' A' ' 106' ' ' THR . 33.3 mt -89.07 113.97 25.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.791 -0.64 . . . . 73.45 110.626 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 30.6 mt-10 -92.18 113.83 26.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 74.31 110.243 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.42 ' HE2' HD12 ' A' ' 72' ' ' LEU . 79.8 m-85 -106.48 101.87 11.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.95 -0.568 . . . . 71.5 109.931 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.456 ' CE2' ' NE2' ' A' ' 69' ' ' GLN . 28.6 m-85 -73.2 106.42 5.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.536 -0.756 . . . . 75.22 108.967 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 100' ' ' ILE . 28.3 m -107.88 178.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.25 0.548 . . . . 52.34 111.995 -170.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.2 134.48 52.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 74.25 110.295 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 16.7 m -82.77 130.13 35.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 70.22 110.979 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.0 tt -160.65 147.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.925 -0.579 . . . . 73.13 110.123 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.02 121.15 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.424 -0.584 . . . . 75.31 109.424 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.0 176.95 9.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.424 -0.353 . . . . 61.14 110.787 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.512 ' HG2' ' OD1' ' A' ' 60' ' ' ASP . 22.8 ttt180 -119.74 -34.86 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 73.41 110.341 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -105.36 146.07 29.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 75.31 109.932 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.06 133.55 60.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.035 0.445 . . . . 70.3 110.105 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 125' ' ' ARG . 12.4 ttp180 -124.37 129.09 50.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.401 . . . . 70.12 111.198 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.57 119.0 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.525 -0.761 . . . . 72.23 109.212 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 60.0 m -112.82 126.97 56.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.999 0.428 . . . . 70.44 110.938 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.7 mm -104.08 89.83 2.69 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.261 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 88.4 Cg_endo -81.34 134.0 8.81 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.808 2.339 . . . . 74.13 113.507 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.71 65.8 7.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.822 0.82 . . . . 75.53 108.999 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.63 -13.61 2.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.185 -0.916 . . . . 64.24 111.253 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -127.02 15.62 6.49 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.148 -1.025 . . . . 75.11 113.441 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.69 18.69 13.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.495 -0.86 . . . . 64.15 112.66 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -72.87 126.87 30.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.076 0.465 . . . . 74.32 110.927 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.616 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 19.8 m -99.69 171.96 7.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.032 -0.531 . . . . 73.41 110.232 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 3.1 p -82.31 6.9 15.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.087 0.403 . . . . 72.23 112.087 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 60.6 t -106.73 102.29 13.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.563 -0.532 . . . . 72.42 109.563 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -127.69 124.86 38.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.035 -0.53 . . . . 65.21 110.18 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.13 107.06 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 54.24 111.179 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.9 132.76 70.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.112 -0.699 . . . . 74.13 109.112 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 75.2 mtt180 -63.85 -71.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.118 0.485 . . . . 74.33 110.062 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -140.01 155.03 47.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.581 0.705 . . . . 62.22 112.439 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 72' ' ' LEU . 9.1 tt -115.54 119.98 37.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.232 -1.349 . . . . 61.04 107.84 169.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.24 151.85 36.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.941 -0.392 . . . . 74.23 109.941 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.42 131.39 73.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.678 -0.409 . . . . 63.32 110.741 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 45.1 mttp -98.16 127.21 43.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.122 -0.696 . . . . 74.44 109.122 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.29 -146.06 5.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.685 -0.769 . . . . 65.43 111.811 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.4 m -139.89 130.34 25.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.459 -0.2 . . . . 72.52 110.459 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 5' ' ' ILE . 28.6 mm -72.27 120.9 21.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.466 . . . . 72.11 110.079 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.4 mt -106.44 150.17 9.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 74.22 110.024 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -116.35 141.6 47.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.296 -1.001 . . . . 65.53 108.296 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.26 129.23 39.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.189 0.519 . . . . 54.32 111.398 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -78.17 -6.19 54.05 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.743 0.782 . . . . 52.21 110.375 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -101.77 86.5 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.843 -1.071 . . . . 65.1 110.092 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -144.39 100.24 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.979 0.419 . . . . 73.52 111.197 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -153.59 91.23 1.46 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 70.23 109.469 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.53 140.24 57.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.193 -0.458 . . . . 73.23 109.815 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -99.97 -19.69 16.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.092 -0.504 . . . . 74.1 110.417 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.4 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.835 -0.62 . . . . 73.54 110.213 177.985 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 109.385 -0.598 . . . . 32.13 109.385 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.56 -18.58 4.82 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.401 -0.904 . . . . 74.1 113.313 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.413 HG21 ' HE2' ' A' ' 146' ' ' LYS . 11.3 t -80.04 -11.83 59.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.013 0.435 . . . . 72.02 110.866 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.607 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 7.0 p -74.69 161.21 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.516 . . . . 71.42 110.919 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 65' ' ' ILE . 42.8 mm -71.64 136.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.064 -0.516 . . . . 51.12 110.706 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -67.28 115.79 7.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.302 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.99 3.26 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 74.1 111.213 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p -69.03 98.09 0.94 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.61 0.719 . . . . 61.33 110.62 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.64 -14.72 6.06 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.012 -0.995 . . . . 44.44 112.11 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -66.45 145.88 55.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.3 -0.259 . . . . 72.32 110.3 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.3 pt-20 -132.45 159.41 39.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.998 0.428 . . . . 54.41 110.664 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -100.72 112.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.527 -0.761 . . . . 65.52 109.578 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.0 mt -72.57 -46.7 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.527 . . . . 73.31 110.512 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -152.05 142.44 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.844 -0.616 . . . . 73.54 110.717 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.86 149.45 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.936 -0.575 . . . . 74.4 109.829 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.5 m -82.16 -49.81 9.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.354 . . . . 71.51 111.173 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.5 t -146.39 157.21 43.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 75.32 110.783 -173.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -163.31 144.6 9.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.845 -0.798 . . . . 64.41 108.845 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.6 tp10 -96.78 101.21 12.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 74.12 110.001 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.16 5.3 34.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 43.45 111.928 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -136.99 -45.48 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.706 -0.398 . . . . 64.41 111.176 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -41.45 99.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.116 -0.564 . . . . 65.31 113.077 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 51.3 mm-40 -86.51 -49.45 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.878 0.37 . . . . 75.53 110.868 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.08 163.37 28.04 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.43 -0.89 . . . . 74.54 111.845 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.85 2.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.998 0.428 . . . . 74.3 110.228 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 29' ' ' LEU . . . 101.52 3.99 52.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.61 -0.805 . . . . 53.35 112.487 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -125.99 134.07 51.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.7 -0.482 . . . . 74.02 109.7 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.04 6.02 46.16 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.921 -0.871 . . . . 52.11 110.921 -173.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 66.8 mt -80.32 154.88 27.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.198 -0.501 . . . . 74.42 110.697 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -69.23 -26.97 65.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.042 -0.526 . . . . 61.24 110.875 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 75.34 110.787 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.4 m -70.47 -22.59 62.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 62.41 110.32 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 142' ' ' GLU . 25.4 tp -64.0 -19.45 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.554 -0.748 . . . . 52.13 110.824 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 59' ' ' ILE . 35.9 pt -131.46 18.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 51.2 110.436 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -68.77 -38.47 80.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 61.41 110.909 -173.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.47 19.77 13.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 71.44 111.98 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.4 121.16 25.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.699 0.285 . . . . 72.2 110.246 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 p -70.72 -20.26 62.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.333 -0.394 . . . . 55.21 111.624 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -74.27 -27.13 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.658 -0.246 . . . . 71.23 111.314 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.5 p -89.81 160.67 16.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.839 -0.43 . . . . 61.25 109.839 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 46.3 p90 -156.18 171.04 20.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 64.42 111.043 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.558 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 49.9 t90 -106.78 134.86 49.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.616 -0.72 . . . . 74.43 109.474 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -133.06 142.39 48.74 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.129 -0.693 . . . . 74.32 109.129 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.53 143.67 49.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.797 -0.446 . . . . 63.51 109.797 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.9 126.01 25.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.256 0.348 . . . . 75.24 110.231 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -128.02 -25.44 3.03 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.789 -0.364 . . . . 75.01 111.235 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.49 107.43 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.976 0.417 . . . . 71.34 110.542 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.74 80.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.933 -0.651 . . . . 45.2 112.391 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.18 171.68 12.86 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.967 -0.635 . . . . 73.51 111.581 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 136' ' ' THR . 40.9 m -116.4 175.42 5.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.729 0.3 . . . . 71.21 111.104 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.581 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 7.2 m-20 -97.99 166.3 13.72 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.133 -0.485 . . . . 74.55 110.845 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 39.4 Cg_endo -67.88 134.49 32.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.633 2.222 . . . . 54.1 113.207 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.69 154.39 61.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.557 -0.747 . . . . 64.4 109.51 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -76.05 165.54 85.19 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 123.608 -1.413 . . . . 65.14 112.928 1.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.532 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.2 m-85 -99.54 115.4 29.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.872 -0.604 . . . . 73.31 110.101 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -106.11 129.14 54.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 74.53 110.847 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.405 HD12 HD23 ' A' ' 126' ' ' LEU . 63.6 mt -121.7 108.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.959 -0.564 . . . . 70.14 109.596 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.91 114.13 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 116.047 -0.524 . . . . 74.42 110.459 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 34' ' ' ILE . 71.1 mt -115.29 137.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.861 -0.609 . . . . 71.34 110.929 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -106.29 121.81 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.847 -0.615 . . . . 74.11 109.877 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.97 -5.85 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 64.32 111.043 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 66.61 11.38 8.1 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.148 0.795 . . . . 73.04 113.148 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -165.5 172.86 11.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.252 -0.277 . . . . 71.54 110.252 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' A' ' 153' ' ' GLU . 19.0 m120 -85.24 128.65 34.76 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.056 -0.52 . . . . 74.01 109.654 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.572 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.6 mt -134.28 134.39 55.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.949 0.404 . . . . 72.05 110.17 176.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.2 tp60 -80.8 101.61 9.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.536 -0.756 . . . . 75.52 109.001 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 118' ' ' SER . 23.8 mm -71.18 123.59 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 72.02 110.344 -176.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.47 -46.28 2.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 74.51 110.201 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' A' ' 146' ' ' LYS . 34.3 tt0 -137.9 141.58 40.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.764 -0.653 . . . . 74.21 110.42 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -108.93 128.28 64.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.055 -0.72 . . . . 71.32 109.055 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -110.06 123.45 49.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.248 0.546 . . . . 54.23 110.76 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.9 mt -109.33 124.53 51.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 73.04 109.841 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.4 106.97 48.79 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.862 -0.792 . . . . 51.34 108.862 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.59 151.33 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.386 2.058 . . . . 74.13 111.837 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.556 ' HA ' ' CD ' ' A' ' 141' ' ' ARG . 78.3 ttt180 -52.92 -52.21 58.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.845 -0.616 . . . . 74.42 111.543 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.92 28.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.147 -0.781 . . . . 42.11 111.147 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.408 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 20.6 mtp180 -76.06 -24.48 55.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.164 0.482 . . . . 74.31 110.308 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.63 64.28 2.52 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.903 -0.665 . . . . 75.25 111.787 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.4 m -154.37 167.94 28.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 63.1 110.115 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -86.16 98.22 10.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.399 -0.364 . . . . 73.31 110.243 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.68 81.97 67.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.176 -0.466 . . . . 73.23 110.61 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 93.2 Cg_endo -87.63 37.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.738 2.292 . . . . 74.14 112.259 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -87.38 134.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 75.03 110.533 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 24.1 mmmt -111.13 -57.77 2.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.577 -0.738 . . . . 65.02 110.658 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.48 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 95.2 t -121.19 138.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 63.02 110.945 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.29 138.34 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.885 -0.598 . . . . 71.43 109.651 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.0 mt-10 -118.04 135.11 54.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.317 -0.402 . . . . 74.32 111.152 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -117.02 129.87 56.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 64.33 110.142 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -128.49 143.97 51.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.328 -0.397 . . . . 72.13 110.652 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 149.97 49.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.368 -0.378 . . . . 62.01 110.34 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.3 t -150.09 150.92 32.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.186 0.517 . . . . 72.31 111.625 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.17 -30.85 12.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.337 -0.847 . . . . 73.52 109.837 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 3.4 p-10 -105.73 -12.17 16.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 53.14 112.126 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.8 t30 71.22 5.14 5.35 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.617 0.722 . . . . 70.14 110.758 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.572 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 98.7 t -100.82 -58.32 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.93 -0.577 . . . . 71.33 110.103 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -102.43 118.96 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 70.53 110.127 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.518 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 94.5 m95 -95.86 124.42 39.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.154 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 m -90.44 122.63 67.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.143 -0.48 . . . . 51.43 110.109 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.54 110.2 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.42 2.08 . . . . 64.45 111.507 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 HG21 ' A' ' 116' ' ' VAL . 13.7 pt -80.81 -19.49 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.577 -0.283 . . . . 73.45 110.983 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 136.92 2.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.302 -0.951 . . . . 70.51 113.558 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.3 ttm180 -102.72 125.6 49.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.436 -0.579 . . . . 64.12 109.436 169.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.556 ' HE2' HG12 ' A' ' 116' ' ' VAL . 77.8 m-85 -138.56 -176.23 4.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.269 -0.572 . . . . 75.14 111.289 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -99.15 147.54 18.47 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.855 -0.611 . . . . 54.14 112.248 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.425 ' HA ' ' HH ' ' A' ' 114' ' ' TYR . 40.8 t80 -96.47 148.29 22.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 73.23 110.119 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.423 ' HB ' HD21 ' A' ' 112' ' ' LEU . 26.5 m -133.38 117.83 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.893 -0.41 . . . . 74.12 109.893 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.408 ' OD1' ' HA ' ' A' ' 77' ' ' ARG . 26.8 t-20 -77.21 106.44 8.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.408 0.623 . . . . 72.54 110.533 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -144.47 177.66 8.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.256 -0.883 . . . . 65.11 110.222 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -97.86 8.67 44.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.31 -0.404 . . . . 52.15 110.801 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.73 158.05 30.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 74.42 109.848 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.47 142.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 73.3 111.539 -175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 106' ' ' THR . 63.1 mt -92.26 121.85 34.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.569 -0.742 . . . . 54.41 111.0 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.82 109.8 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 71.53 111.29 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.425 ' HH ' ' HA ' ' A' ' 105' ' ' PHE . 95.5 m-85 -104.55 110.11 22.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 73.42 110.649 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -86.5 100.51 12.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.789 -0.641 . . . . 73.22 109.709 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 100' ' ' ILE . 26.7 m -106.06 179.4 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.95 -0.568 . . . . 73.45 111.412 -174.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.62 139.19 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 75.5 110.468 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 23.9 m -80.67 121.43 25.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.297 -0.411 . . . . 70.42 110.861 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -155.14 149.94 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 74.2 110.326 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.763 ' HG3' HD12 ' A' ' 150' ' ' ILE . 2.7 ttpm? -89.78 132.53 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.097 -0.334 . . . . 74.4 110.097 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.08 166.09 33.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.522 -0.308 . . . . 65.24 111.091 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.479 ' HD2' ' CE1' ' A' ' 123' ' ' TYR . 24.9 ttm180 -111.27 -33.53 6.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.171 0.51 . . . . 72.24 110.2 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CE1' ' HD2' ' A' ' 122' ' ' ARG . 70.7 m-85 -105.21 145.16 31.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.914 -0.585 . . . . 72.5 110.213 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 59' ' ' ILE . 10.5 tt -136.31 129.34 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.079 -0.509 . . . . 60.2 110.065 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -113.4 121.19 43.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 72.32 110.659 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 57' ' ' ILE . 48.0 tp -91.55 113.72 26.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.202 -0.666 . . . . 52.04 109.202 172.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -109.99 119.94 40.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.997 0.427 . . . . 72.32 110.934 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.9 mm -100.77 96.28 5.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.058 -0.719 . . . . 71.42 109.058 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 89.5 Cg_endo -75.68 -179.85 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 75.34 112.786 -176.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -110.01 -9.05 14.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.166 0.984 . . . . 54.24 108.398 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.44 -46.14 91.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.659 -1.61 . . . . 75.31 112.11 -173.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -82.01 6.82 65.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.716 -0.754 . . . . 43.43 113.713 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.94 25.41 9.69 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.169 -1.015 . . . . 64.04 112.071 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -78.78 -175.92 4.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 71.51 111.133 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.448 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.1 m -139.24 174.5 10.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.998 -0.546 . . . . 72.22 109.628 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 1.2 p -79.96 -0.73 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.952 0.406 . . . . 63.3 112.035 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.68 124.09 62.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.799 -0.445 . . . . 63.0 109.799 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.47 142.99 30.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.659 -0.246 . . . . 72.14 110.655 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.7 109.48 5.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 74.25 111.118 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 28.8 mt -127.49 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 65.04 109.102 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.556 ' CD ' ' HA ' ' A' ' 75' ' ' ARG . 1.5 tpt180 -74.44 -68.82 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.606 -0.516 . . . . 74.52 109.606 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 33' ' ' LEU . 17.7 pt-20 -148.87 160.99 42.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.208 0.527 . . . . 71.42 110.734 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.34 121.75 44.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.382 -0.826 . . . . 75.02 108.958 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.607 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.4 t70 -117.1 162.33 18.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.869 -0.419 . . . . 71.31 109.869 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' ILE . 95.3 t -127.89 124.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 74.1 110.296 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . 48.3 tttm -101.45 101.61 12.25 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.264 -0.643 . . . . 75.15 109.264 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.09 -161.64 10.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.727 -0.749 . . . . 75.1 112.089 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -118.05 133.64 55.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.652 0.263 . . . . 73.2 110.554 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.54 HD11 HG23 ' A' ' 5' ' ' ILE . 38.4 mm -71.54 124.46 28.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.081 -0.509 . . . . 75.33 111.419 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.85 HG22 ' H ' ' A' ' 152' ' ' LEU . 29.0 mt -118.01 134.3 62.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.162 0.506 . . . . 72.04 110.109 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -102.2 4.68 39.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.279 0.561 . . . . 62.32 110.169 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.85 ' H ' HG22 ' A' ' 150' ' ' ILE . 97.0 mt -105.74 106.03 16.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 63.5 111.999 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.508 ' HB3' ' OD1' ' A' ' 64' ' ' ASN . 12.7 pt-20 -124.47 -24.19 4.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.955 0.883 . . . . 71.0 108.835 169.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -137.99 122.65 18.64 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.992 -1.458 . . . . 71.21 108.967 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -79.49 169.0 18.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.031 -0.531 . . . . 73.24 110.227 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -69.49 118.71 12.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.712 -0.477 . . . . 72.44 109.712 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -83.82 -8.03 59.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.85 -0.614 . . . . 73.33 110.845 -172.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.78 115.51 27.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.894 -0.409 . . . . 75.14 109.894 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.443 . . . . 72.34 110.621 -178.808 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.967 0.413 . . . . 74.02 110.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.12 94.97 0.87 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.436 -0.887 . . . . 61.23 113.113 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 t -147.28 139.16 24.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.203 -0.665 . . . . 74.24 109.203 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p -117.91 161.0 20.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.439 -0.346 . . . . 71.31 110.992 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.5 HD12 HD11 ' A' ' 149' ' ' ILE . 37.6 mm -66.65 131.91 32.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.134 -0.485 . . . . 54.55 110.327 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -64.78 111.73 2.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.376 -0.375 . . . . 72.11 110.829 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 36.0 mtmm -87.52 16.25 5.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 75.03 110.567 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -65.48 -16.36 63.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.493 -0.776 . . . . 60.41 112.16 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.1 23.25 4.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.497 -0.859 . . . . 72.32 112.874 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 33.3 m0 -84.35 156.79 21.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.992 0.396 . . . . 65.23 110.853 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 22.2 pt-20 -135.4 159.54 41.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.81 0.338 . . . . 64.23 110.768 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.54 130.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.972 -0.558 . . . . 53.41 109.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.5 -36.86 9.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.166 0.508 . . . . 72.12 110.78 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.3 t -144.94 139.36 27.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 75.22 110.66 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -151.1 134.84 16.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 70.4 109.526 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -85.37 -38.9 18.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 54.42 111.278 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -149.13 152.51 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.993 0.425 . . . . 74.21 110.959 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.0 pt20 -163.91 139.53 6.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.425 -0.807 . . . . 71.44 108.919 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.9 tp10 -93.74 98.06 10.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.133 0.492 . . . . 74.4 111.065 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.48 -12.01 18.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.864 -0.607 . . . . 62.31 110.95 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -101.04 -47.77 4.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.02 -0.536 . . . . 64.51 110.955 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -70.84 -58.02 6.02 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.909 -0.587 . . . . 73.42 112.411 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.596 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 24.1 mm-40 -70.93 -50.57 33.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.084 -0.339 . . . . 73.04 110.084 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -168.02 33.23 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.972 -0.558 . . . . 64.25 112.869 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.49 22.25 11.93 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.076 0.55 . . . . 63.24 111.934 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.29 18.31 78.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.934 -0.65 . . . . 71.32 112.013 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -113.16 150.45 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.732 -0.469 . . . . 74.3 109.732 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 2.96 72.73 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.611 -0.595 . . . . 65.45 111.611 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 82.0 mt -82.13 157.44 24.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.584 -0.308 . . . . 64.32 110.272 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.83 -28.74 68.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.773 0.321 . . . . 62.33 110.973 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.3 pttp -69.41 -23.02 63.65 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.742 0.306 . . . . 75.15 111.044 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.812 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.7 m -66.99 -24.24 66.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.015 0.436 . . . . 71.41 110.408 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.0 tp -65.92 -25.54 67.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 73.23 110.371 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 59' ' ' ILE . 2.5 pp -119.48 13.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.207 0.527 . . . . 74.14 110.336 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.2 t70 -65.27 -42.25 93.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.287 -0.869 . . . . 74.11 110.174 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.9 55.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.824 -0.703 . . . . 65.22 111.682 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -117.12 124.44 49.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.368 -0.416 . . . . 53.35 109.986 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -72.65 -15.13 61.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.285 -0.416 . . . . 72.11 111.755 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.31 -24.33 50.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 75.44 110.718 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -100.23 160.16 14.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.4 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.717 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 48.3 p90 -156.15 165.0 37.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.848 -0.427 . . . . 75.03 109.848 174.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.524 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 39.2 t90 -98.12 129.27 44.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.379 -0.6 . . . . 73.11 109.379 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 49.4 t-80 -131.13 137.07 48.87 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.231 -0.655 . . . . 71.51 109.231 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.12 144.63 54.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 50' ' ' SER . 64.8 tttp -60.4 126.09 26.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.358 . . . . 63.12 110.339 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -124.52 -32.14 3.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 63.03 110.064 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.45 108.99 13.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 61.13 109.383 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.41 -12.33 54.61 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.712 -0.676 . . . . 70.32 111.635 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 144.34 5.82 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.93 -0.652 . . . . 75.51 111.547 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 11.0 p -86.63 167.64 14.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.941 0.4 . . . . 74.13 111.505 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -100.54 146.9 32.83 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 61.24 109.715 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.96 141.54 44.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.691 2.261 . . . . 71.35 112.63 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.5 mt -75.85 164.63 59.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 65.3 110.569 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.1 Cg_endo -83.69 161.75 71.04 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 123.766 -1.348 . . . . 71.22 113.239 1.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -100.06 111.46 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 73.5 109.923 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -104.42 125.69 50.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.082 -0.34 . . . . 53.34 110.082 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.403 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 48.3 mt -119.44 121.36 66.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.134 -0.321 . . . . 71.34 110.134 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -112.31 117.85 56.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.334 -0.394 . . . . 71.4 110.616 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 34' ' ' ILE . 4.7 mp -117.05 140.62 38.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 71.54 110.19 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 19.8 t70 -103.04 134.2 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.594 -0.275 . . . . 54.53 110.264 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.509 ' HE1' HD11 ' A' ' 67' ' ' ILE . 64.8 mtm -96.64 3.92 52.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 74.34 111.092 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 70.89 -30.06 0.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.617 0.969 . . . . 72.43 113.617 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -133.71 172.44 12.76 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.236 -0.29 . . . . 74.24 111.051 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -82.08 129.82 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 73.12 110.399 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 5' ' ' ILE . 69.6 mt -139.07 139.91 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.018 0.437 . . . . 71.31 110.333 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -83.31 105.08 13.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.927 -0.768 . . . . 73.3 108.927 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.8 mm -72.93 106.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.235 -0.283 . . . . 71.3 110.235 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.03 -43.9 6.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.052 0.453 . . . . 70.15 110.843 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.6 tt0 -145.42 140.88 27.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.991 -0.549 . . . . 63.2 110.787 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.21 130.73 61.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.531 -0.544 . . . . 54.32 109.531 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -113.47 129.76 56.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.957 0.408 . . . . 73.52 110.521 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.472 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 70.4 mt -117.14 120.49 38.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.213 -0.449 . . . . 62.32 109.92 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.73 103.56 15.07 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.023 -0.732 . . . . 65.33 109.023 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 15.3 Cg_exo -67.37 167.65 19.95 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.038 2.492 . . . . 74.11 112.645 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.578 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 77.4 ttt180 -61.05 -28.65 69.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.73 -0.668 . . . . 64.21 110.933 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.26 145.19 5.11 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.98 -0.848 . . . . 24.23 110.98 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -61.18 -23.18 65.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.941 0.37 . . . . 74.32 111.472 -176.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.52 59.3 0.46 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.662 -0.78 . . . . 52.43 112.137 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.5 p -160.88 162.98 32.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.017 -0.364 . . . . 73.42 110.017 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.41 120.22 18.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.837 0.351 . . . . 74.53 111.112 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -151.89 89.13 4.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.864 -0.607 . . . . 70.24 110.49 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.93 29.77 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.145 2.563 . . . . 71.14 114.171 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 105' ' ' PHE . 73.2 mt -79.0 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.568 -0.53 . . . . 51.41 109.568 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -114.84 -46.03 2.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 53.52 111.453 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.734 HG11 ' HE ' ' A' ' 102' ' ' ARG . 62.0 t -127.13 138.35 55.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.469 -0.332 . . . . 75.53 110.898 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 128' ' ' ILE . 7.6 m -132.22 137.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.186 -0.461 . . . . 72.55 110.52 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 40.2 mt-10 -116.6 140.45 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.402 -0.363 . . . . 64.25 110.907 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -120.4 132.67 55.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 73.22 110.669 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.51 147.71 50.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 31.14 110.267 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.32 150.03 52.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 70.03 110.495 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.5 t -150.26 150.7 31.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 71.03 110.878 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -101.31 -31.35 11.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.957 0.408 . . . . 63.11 110.129 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 8.9 p-10 -105.22 -4.33 21.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 53.13 111.518 -174.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 24.5 t-20 76.31 -16.16 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.797 0.685 . . . . 71.31 111.337 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 95.2 t -89.32 -58.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.97 0.414 . . . . 61.55 110.627 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -91.89 111.48 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.466 . . . . 71.21 110.454 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -96.6 132.39 42.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.993 0.425 . . . . 74.4 110.921 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.3 m -105.09 124.76 35.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 75.31 110.505 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.72 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.468 2.112 . . . . 74.3 111.572 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 116' ' ' VAL . 21.6 pt -93.1 -6.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.332 -0.395 . . . . 62.5 111.059 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.61 147.82 4.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.538 -0.839 . . . . 65.54 113.044 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.734 ' HE ' HG11 ' A' ' 85' ' ' VAL . 77.9 ttt180 -113.06 119.65 38.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.214 -0.661 . . . . 73.12 109.214 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.584 ' HE2' HG12 ' A' ' 116' ' ' VAL . 84.5 m-85 -130.36 177.17 7.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.82 0.343 . . . . 74.54 110.911 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.8 149.81 19.41 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.043 -0.599 . . . . 72.25 111.774 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.418 ' HB3' HG22 ' A' ' 83' ' ' ILE . 51.6 t80 -105.06 121.62 44.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.985 0.421 . . . . 75.4 110.081 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.474 ' O ' HD11 ' A' ' 112' ' ' LEU . 24.2 m -113.35 107.69 16.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.972 -0.558 . . . . 62.4 109.962 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -68.83 94.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.38 0.61 . . . . 74.0 110.072 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -113.93 -166.17 1.07 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.087 -0.96 . . . . 75.33 109.55 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.97 -14.22 20.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.973 0.416 . . . . 61.31 110.697 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.21 169.42 8.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 62.24 110.653 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -75.52 137.52 40.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 75.2 110.948 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 106' ' ' THR . 34.8 mt -87.46 111.29 21.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.622 -0.717 . . . . 70.12 110.533 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.82 108.93 19.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.933 0.397 . . . . 72.51 110.47 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.33 113.48 25.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 72.42 110.799 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -80.2 92.05 5.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.248 -0.649 . . . . 75.22 109.248 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.584 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.3 m -96.67 177.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 54.24 111.669 -172.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.77 118.74 13.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 70.11 109.662 177.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 14.4 m -75.6 118.75 18.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.001 -0.545 . . . . 73.11 110.847 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -147.76 153.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.466 . . . . 72.3 110.731 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -81.8 125.81 31.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 64.15 109.698 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . . . -152.41 175.42 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 72.2 111.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -128.51 -32.82 2.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.844 -0.616 . . . . 70.34 109.927 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -106.35 146.38 30.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.626 . . . . 73.42 109.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.55 135.21 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 65.42 110.267 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -121.49 124.06 43.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.93 0.395 . . . . 64.25 110.93 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.21 116.9 31.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 75.44 109.091 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.0 m -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.19 0.519 . . . . 75.33 110.966 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.9 mm -106.52 95.68 12.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 65.52 109.196 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.646 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 57.0 Cg_endo -71.87 173.96 11.93 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.354 2.036 . . . . 75.13 112.552 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.488 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.7 t70 -91.01 -6.1 54.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.146 0.974 . . . . 64.43 108.893 175.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.28 143.35 26.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.695 -1.139 . . . . 74.51 110.532 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.21 -11.52 58.54 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.721 -0.752 . . . . 71.34 112.315 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.94 12.12 14.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.876 -0.678 . . . . 62.35 112.733 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -67.78 124.84 24.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 73.0 110.936 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -95.35 178.15 5.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.03 -0.532 . . . . 73.31 110.02 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.8 p -79.08 1.57 23.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 72.41 112.127 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.12 101.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.871 -0.418 . . . . 52.43 109.871 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -119.87 130.52 54.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.269 -0.423 . . . . 61.14 110.114 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 75' ' ' ARG . . . -147.07 111.92 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.159 0.505 . . . . 74.43 111.486 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.94 132.86 56.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.394 -0.595 . . . . 74.52 109.394 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmt180 -61.39 -63.79 1.16 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.669 0.271 . . . . 71.03 110.417 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.6 155.51 30.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.471 0.653 . . . . 64.13 111.346 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -106.51 123.92 48.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.849 -1.069 . . . . 74.45 108.313 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.8 152.07 37.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.554 -0.535 . . . . 70.32 109.554 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.03 130.96 74.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.928 0.394 . . . . 71.41 111.603 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 39.0 mttp -101.97 107.06 18.08 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.944 -0.761 . . . . 74.33 108.944 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.11 177.76 31.36 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.238 -0.982 . . . . 63.43 112.143 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.8 m -106.85 127.31 53.3 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.241 -0.281 . . . . 75.11 110.241 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.611 ' HB ' HD23 ' A' ' 152' ' ' LEU . 35.8 mm -69.81 130.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.96 -0.564 . . . . 72.21 110.526 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 120' ' ' LYS . 16.3 mt -119.67 150.36 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.596 -0.52 . . . . 74.42 109.596 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 60.4 t30 65.6 30.38 10.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.745 0.784 . . . . 72.21 109.559 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.611 HD23 ' HB ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -78.95 84.28 4.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.004 -0.998 . . . . 75.0 112.516 -174.304 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -104.5 155.33 18.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.984 -0.747 . . . . 71.02 108.984 170.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -108.23 37.73 2.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.121 0.486 . . . . 74.04 112.123 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -113.03 -41.63 3.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.988 -0.745 . . . . 73.03 108.988 166.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 37.3 m170 63.64 74.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.905 -1.043 . . . . 70.13 111.435 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -69.38 -24.57 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.181 -0.918 . . . . 62.02 109.04 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -86.98 109.63 19.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.58 -0.737 . . . . 71.32 109.248 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.262 -0.427 . . . . 72.21 110.144 -176.541 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.161 -0.681 . . . . 73.12 109.161 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.48 -156.5 21.61 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.639 -0.985 . . . . 71.32 110.639 -171.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 146' ' ' LYS . 12.0 m -69.63 -46.22 66.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.037 0.446 . . . . 73.25 110.04 176.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 p -80.02 147.19 31.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 62.24 110.403 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.543 HG21 HD13 ' A' ' 65' ' ' ILE . 37.7 mm -83.5 138.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 110.284 -0.265 . . . . 73.45 110.284 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -85.21 130.9 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 61.43 109.755 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -108.97 13.66 24.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 75.43 110.725 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -71.25 -10.0 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.627 -0.715 . . . . 71.42 111.192 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.88 9.11 21.37 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 52.43 112.163 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -89.39 159.34 17.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.701 0.286 . . . . 74.13 110.541 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 9.2 pt-20 -142.42 161.88 36.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.857 0.36 . . . . 70.24 110.147 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.0 117.89 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 72.34 110.185 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.53 -43.88 18.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.681 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -148.85 141.7 24.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.204 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -141.93 142.69 33.03 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.018 -0.734 . . . . 63.51 109.018 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -85.53 -29.32 24.3 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.83 -0.348 . . . . 73.23 110.996 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 t -154.49 149.29 26.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 70.14 111.0 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -168.06 140.28 3.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.904 -0.776 . . . . 61.45 108.904 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.9 tp10 -98.27 116.92 31.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.015 0.436 . . . . 73.23 110.573 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.11 -16.37 12.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.01 -0.541 . . . . 72.35 111.251 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 m -113.4 -40.0 3.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.368 -0.378 . . . . 53.13 111.169 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -63.07 -53.19 42.1 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.083 -0.508 . . . . 33.24 112.835 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.9 -47.6 18.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 54.12 110.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.14 -175.5 54.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.992 -0.623 . . . . 72.42 112.813 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.1 24.09 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.997 0.519 . . . . 73.24 111.857 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.52 18.72 72.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 71.23 111.805 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -112.89 144.87 41.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.564 -0.318 . . . . 73.33 110.274 -175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.87 -1.75 38.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.015 -0.612 . . . . 43.22 111.706 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 62.5 mt -80.46 156.77 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 73.52 110.641 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.93 -31.05 71.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.484 -0.326 . . . . 64.05 111.252 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -76.09 -16.44 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.479 -0.328 . . . . 63.42 111.751 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 60.8 m -71.38 -23.65 61.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 74.43 109.831 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 35.4 tp -72.82 -8.99 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.701 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -130.56 25.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 71.45 110.406 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.17 -46.94 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.514 -0.312 . . . . 74.41 111.627 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.32 6.99 25.13 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.485 -0.864 . . . . 73.41 112.167 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 39' ' ' GLU . 32.8 t70 -117.48 120.84 39.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.912 -0.403 . . . . 75.55 109.912 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 p -72.99 -8.79 57.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.507 0.558 . . . . 73.51 112.507 -173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 47.4 mt-10 -85.21 -26.79 26.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 62.2 110.292 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -96.84 137.29 36.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.978 -0.556 . . . . 60.11 109.879 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 23.2 p90 -139.17 175.69 9.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.832 0.348 . . . . 53.31 110.908 -174.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.628 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 45.9 t90 -105.44 134.31 48.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 74.2 109.597 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -132.37 143.81 50.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.211 -0.663 . . . . 74.0 109.211 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.03 148.57 49.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.545 -0.298 . . . . 62.21 110.236 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 78.2 tttt -66.4 116.36 7.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.093 -0.503 . . . . 73.52 110.018 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -123.13 -27.2 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.887 -0.325 . . . . 74.23 111.264 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -78.57 107.54 11.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.034 0.445 . . . . 71.54 110.032 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.14 2.19 51.43 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 45.12 111.976 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.17 146.15 8.86 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.831 -0.7 . . . . 33.41 111.937 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 12.1 p -89.63 151.87 21.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 64.34 110.889 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.07 158.92 69.36 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.952 -0.567 . . . . 65.33 110.978 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.29 153.01 61.8 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.766 2.311 . . . . 63.41 112.924 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.52 158.04 41.2 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 72.43 110.132 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.03 167.56 64.85 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.567 -1.43 . . . . 64.32 112.767 2.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 26.4 m-85 -101.67 108.98 20.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.075 -0.512 . . . . 73.33 110.275 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.22 126.62 53.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 73.34 110.436 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 HD23 ' A' ' 126' ' ' LEU . 55.4 mt -120.31 117.75 54.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 41.3 109.78 176.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.82 114.55 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.268 -0.423 . . . . 63.44 110.592 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.4 134.91 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.089 -0.505 . . . . 74.05 110.091 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -99.17 120.22 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.181 -0.463 . . . . 65.34 109.755 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.6 mtm -86.84 -5.68 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.596 . . . . 70.5 110.9 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.9 mmtt 68.45 5.96 5.1 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.312 0.856 . . . . 72.24 113.312 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.35 174.22 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.706 0.289 . . . . 61.4 111.122 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.8 121.7 27.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 54.02 110.198 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.543 HD13 HG21 ' A' ' 5' ' ' ILE . 61.6 mt -132.33 134.52 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 120.995 0.426 . . . . 74.01 110.517 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.9 tp60 -84.28 105.13 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.608 -0.724 . . . . 64.41 109.296 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.2 mm -74.35 117.27 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 73.22 110.427 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.53 -47.99 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.282 -0.417 . . . . 75.43 110.995 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.586 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 6.1 tt0 -141.79 152.77 44.03 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.84 -0.344 . . . . 64.31 110.605 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.38 123.07 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.772 -0.649 . . . . 50.42 109.517 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' OE1' ' HB2' ' A' ' 146' ' ' LYS . 51.3 mp0 -103.75 122.71 45.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.968 -0.56 . . . . 50.53 110.642 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.46 HD12 ' CE2' ' A' ' 114' ' ' TYR . 55.2 mt -113.58 123.39 49.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 74.21 110.337 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 73' ' ' LEU . 19.9 tp -102.25 101.16 17.85 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.381 -0.6 . . . . 74.14 109.381 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 3.1 Cg_exo -75.11 166.85 28.21 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 123.214 2.609 . . . . 74.02 112.905 -175.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 79' ' ' SER . 70.3 ttt180 -94.0 56.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 74.32 109.646 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -67.55 169.23 37.71 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.278 -0.873 . . . . 51.43 113.457 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 39.85 64.33 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.258 1.023 . . . . 74.45 111.99 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.99 -43.99 0.27 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.205 -0.907 . . . . 22.02 111.662 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 35.7 t -111.76 157.48 20.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.094 -0.336 . . . . 51.1 110.094 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -85.74 -42.04 14.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 71.11 110.42 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 56.17 84.47 0.21 Allowed Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 123.741 0.651 . . . . 74.22 112.338 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 5.2 Cg_exo -75.39 36.96 0.47 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.299 2.666 . . . . 44.13 111.936 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.65 125.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.651 . . . . 62.01 109.553 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.89 -54.0 2.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 74.42 110.765 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.19 137.3 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.243 -0.435 . . . . 75.05 110.562 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.42 134.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.261 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.7 mt-10 -116.63 132.51 56.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.022 -0.536 . . . . 72.55 110.596 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -112.08 129.74 56.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.673 -0.694 . . . . 64.44 109.944 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.28 153.62 42.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.702 -0.227 . . . . 54.2 110.435 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.82 43.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.377 -0.374 . . . . 71.51 110.369 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 146.35 27.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 71.34 110.607 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.86 -42.26 34.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.89 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.06 9.52 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.004 0.372 . . . . 74.23 112.004 -173.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.6 t30 64.96 30.06 12.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.784 0.802 . . . . 74.42 110.261 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.78 -52.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.434 -0.803 . . . . 73.34 109.456 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -103.04 107.13 17.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.25 -0.648 . . . . 54.3 109.25 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -94.36 130.65 40.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.154 0.502 . . . . 72.11 111.116 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 m -122.29 122.63 27.41 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.803 -0.635 . . . . 74.42 110.36 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.81 128.9 27.05 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.515 2.144 . . . . 70.2 111.129 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.56 -10.94 8.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.985 -0.286 . . . . 75.34 110.8 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 153.21 7.53 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.095 -1.05 . . . . 51.44 113.599 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.2 ttt180 -130.77 115.05 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.832 -0.803 . . . . 74.35 108.832 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.43 -177.82 4.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.689 0.281 . . . . 41.15 110.828 -174.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.96 14.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.957 -0.639 . . . . 64.24 112.024 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 49.8 t80 -93.27 114.6 27.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 73.12 110.069 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -99.17 106.98 19.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.237 -0.438 . . . . 62.12 110.025 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -68.17 111.7 4.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.147 0.499 . . . . 74.23 110.638 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.27 -176.26 5.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.399 -0.819 . . . . 71.41 108.922 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.74 -10.48 19.91 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.617 -0.433 . . . . 75.54 110.545 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.48 20.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 61.1 110.389 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.1 133.0 45.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 55.22 111.588 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.3 mt -89.65 122.84 33.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.266 -0.879 . . . . 73.53 110.213 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 33.0 mt-10 -98.05 108.36 21.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.591 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 72' ' ' LEU . 91.2 m-85 -101.85 104.57 15.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.116 -0.493 . . . . 63.44 110.993 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.64 93.32 2.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.672 -0.694 . . . . 75.25 110.055 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.14 178.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.854 -0.612 . . . . 54.43 111.913 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 117' ' ' LYS . 5.3 ttpm? -75.4 112.8 12.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.205 -0.907 . . . . 72.21 110.094 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 20.0 p -56.72 120.53 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.857 -0.611 . . . . 51.33 111.222 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.8 tt -160.57 148.9 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.454 -0.339 . . . . 71.14 110.238 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HG3' HD12 ' A' ' 150' ' ' ILE . 39.6 ttpt -89.86 135.76 33.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 75.14 110.169 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.86 175.15 13.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.557 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -121.74 -34.49 3.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 74.04 110.02 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -108.92 145.4 35.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.238 -0.653 . . . . 64.53 109.238 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.6 tt -131.71 139.23 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.986 -0.375 . . . . 75.12 109.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 60.7 ttp180 -124.31 118.2 26.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.966 0.412 . . . . 72.44 111.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 57' ' ' ILE . 43.4 tp -85.61 114.58 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.903 -0.777 . . . . 61.24 108.903 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -112.1 117.66 33.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.299 0.571 . . . . 65.31 111.347 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.1 mm -100.2 98.15 7.27 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.456 -0.793 . . . . 75.41 108.948 172.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.03 168.86 20.69 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.457 2.105 . . . . 54.44 112.305 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 7.73 45.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 40.32 109.881 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.48 138.26 48.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 70.54 110.157 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.05 -10.84 24.79 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.988 -0.625 . . . . 44.44 111.699 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 109.1 18.88 8.88 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.051 -0.595 . . . . 72.41 112.386 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -76.73 135.64 39.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 74.32 110.759 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 45.9 m -106.88 -173.94 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 62.4 110.281 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 14.4 p -84.55 2.3 41.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 65.04 112.131 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 48.7 t -105.57 124.53 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.452 -0.34 . . . . 51.44 110.386 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.21 140.93 29.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.22 -0.445 . . . . 75.31 110.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.6 113.68 4.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.939 0.4 . . . . 74.35 111.06 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 19.3 mt -126.18 132.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.073 -0.714 . . . . 75.54 109.073 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.691 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 97.4 mtt180 -65.58 -61.83 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 73.22 110.481 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.74 138.92 23.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.24 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.02 116.41 29.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -114.62 150.57 34.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.993 0.425 . . . . 70.14 110.149 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.37 124.03 72.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.183 -0.673 . . . . 54.4 109.183 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 3' ' ' THR . 0.6 OUTLIER -105.33 102.87 12.33 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.366 0.603 . . . . 74.43 109.86 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.87 -156.9 7.34 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.405 -0.816 . . . . 75.14 111.574 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.1 m -119.1 131.85 55.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.705 0.288 . . . . 60.34 110.936 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.506 HD11 HG23 ' A' ' 5' ' ' ILE . 37.5 mm -74.56 123.01 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.29 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 66' ' ' GLN . 51.1 mt -115.9 133.32 62.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.683 -0.488 . . . . 64.04 109.683 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -121.02 95.0 4.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.314 0.578 . . . . 61.1 111.343 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.414 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.1 pp -134.36 105.15 6.45 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.783 -0.821 . . . . 73.05 108.783 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -114.61 14.1 17.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.714 -0.676 . . . . 71.13 111.066 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -93.96 7.71 44.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.163 -0.471 . . . . 64.33 110.223 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.1 100.93 0.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.876 -0.787 . . . . 65.45 108.876 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -87.75 129.21 35.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.597 -0.729 . . . . 64.32 112.636 -164.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -102.24 166.74 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.791 -0.818 . . . . 55.15 108.791 168.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -84.77 113.72 21.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.939 0.4 . . . . 72.51 110.536 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.045 -0.525 . . . . 75.51 110.442 -179.797 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HA ' ' OG1' ' A' ' 4' ' ' THR . 24.0 ptp . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 109.878 -0.416 . . . . 53.53 109.878 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.85 -66.11 4.0 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.747 -0.74 . . . . 54.33 111.783 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 m -74.37 -24.26 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.325 0.583 . . . . 73.33 109.822 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.809 HG22 ' HG2' ' A' ' 146' ' ' LYS . 46.3 p -79.1 154.52 29.31 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.824 -0.625 . . . . 62.32 109.978 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 149' ' ' ILE . 38.9 mm -74.78 138.71 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.189 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 122.82 17.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.312 -0.625 . . . . 62.33 109.312 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -101.64 6.45 42.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.679 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -72.54 84.45 1.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 71.43 110.239 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.81 -9.76 2.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.635 -0.711 . . . . 73.21 112.38 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -70.49 155.81 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 73.32 110.461 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.5 pt-20 -138.96 155.87 47.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.079 0.466 . . . . 75.22 110.015 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.55 113.48 31.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.821 -0.627 . . . . 70.4 110.005 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.2 mt -79.67 -36.46 37.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.83 -0.623 . . . . 74.3 110.591 -177.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.3 t -147.91 141.24 25.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 60.42 110.721 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.475 ' HE2' ' HG2' ' A' ' 18' ' ' GLN . 35.4 p90 -155.72 136.11 13.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.765 -0.652 . . . . 74.3 109.633 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -85.25 -44.91 12.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.204 -0.453 . . . . 62.42 111.786 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -134.34 147.51 50.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.022 0.439 . . . . 72.53 111.001 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -161.57 148.47 14.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.732 -0.667 . . . . 73.54 109.407 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.67 112.22 20.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.897 -0.409 . . . . 63.42 109.897 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.65 1.31 17.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.652 0.612 . . . . 71.12 112.652 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -143.83 -29.79 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.384 -0.526 . . . . 63.31 112.331 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -51.55 57.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.93 -0.652 . . . . 64.2 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG3' ' HE1' ' A' ' 41' ' ' PHE . 17.2 mm-40 -83.98 -37.82 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 64.13 110.337 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.41 153.14 9.07 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.893 -0.67 . . . . 41.35 111.739 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.44 99.42 0.41 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 34.31 111.093 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.59 -0.73 55.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.916 -0.659 . . . . 30.21 112.184 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -120.14 122.94 42.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.112 -0.329 . . . . 74.22 110.112 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.0 2.49 20.34 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.298 -0.721 . . . . 64.22 111.298 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.7 mt -74.67 150.74 39.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.532 -0.334 . . . . 73.32 110.74 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.99 -23.21 67.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.09 0.471 . . . . 71.24 111.214 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 -17.28 57.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 64.54 111.341 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 63.4 m -73.55 -17.61 61.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.176 0.512 . . . . 72.21 110.046 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -71.97 -14.36 61.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.37 -0.832 . . . . 52.55 110.7 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -130.66 21.59 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 61.4 109.911 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 18.1 t70 -72.39 -45.68 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.646 -0.707 . . . . 74.44 111.167 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.68 -1.47 21.71 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.478 -0.868 . . . . 61.32 112.655 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -131.16 118.36 20.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.126 -0.324 . . . . 70.23 110.126 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 p -72.22 2.07 6.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.953 -0.567 . . . . 63.11 111.683 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.24 -35.78 80.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.631 -0.877 . . . . 44.4 108.631 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.1 p -95.42 165.73 12.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.834 -1.076 . . . . 64.54 110.141 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.536 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 32.6 p90 -155.63 167.84 29.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.491 -0.322 . . . . 73.43 110.674 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.9 t90 -101.22 133.23 46.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.268 -0.642 . . . . 70.11 109.268 172.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.62 144.19 49.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.332 -0.618 . . . . 75.21 109.332 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.16 146.93 52.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.282 -0.417 . . . . 74.55 110.435 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' SER . 82.8 tttt -63.12 116.61 5.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.978 -0.556 . . . . 72.21 110.197 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -120.4 -27.93 5.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.523 -0.471 . . . . 75.3 110.663 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.88 110.72 11.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 72.45 110.2 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 10.11 59.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.804 -0.712 . . . . 54.35 112.06 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.08 154.6 16.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.841 -0.695 . . . . 63.1 112.156 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 52.0 m -102.86 159.61 15.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 55.02 111.286 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.75 156.6 52.75 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.846 -0.615 . . . . 73.45 110.35 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.68 153.56 43.53 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.534 2.156 . . . . 65.5 113.194 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 130' ' ' ASP . 11.9 mt -92.16 159.79 36.76 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 75.12 110.118 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 77.5 Cg_endo -80.52 162.45 82.71 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.578 -1.426 . . . . 71.03 112.875 -1.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 28.6 m-85 -93.98 132.31 38.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.199 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 3.4 t70 -111.49 125.45 53.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 75.41 110.219 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 126' ' ' LEU . 52.5 mt -131.43 111.26 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.21 -0.45 . . . . 71.21 109.909 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.37 122.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.062 -0.517 . . . . 71.22 110.562 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 57' ' ' ILE . 4.9 mp -116.25 136.13 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.638 -0.255 . . . . 75.14 110.694 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.3 t0 -99.12 119.73 38.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.721 -0.844 . . . . 75.14 108.721 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.6 mtm -85.6 -5.62 59.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.356 -0.384 . . . . 73.1 111.111 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.508 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 66.27 12.02 8.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.806 -0.634 . . . . 74.31 112.026 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 153' ' ' GLU . 27.8 pt20 -165.88 147.56 7.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 63.42 109.746 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.7 128.43 35.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.899 -0.592 . . . . 73.23 110.042 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.7 mt -132.38 139.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.258 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.37 102.95 12.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.869 -0.789 . . . . 70.32 108.869 176.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -72.28 129.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.376 . . . . 60.13 110.833 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.89 -32.85 3.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 31.43 111.079 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -163.29 147.68 11.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.881 -0.599 . . . . 54.11 111.177 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.2 t -119.84 133.87 65.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.162 -0.472 . . . . 73.53 109.871 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.694 ' HG3' ' HD2' ' A' ' 146' ' ' LYS . 26.0 mt-10 -110.76 127.61 55.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.126 0.489 . . . . 73.22 110.602 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.96 121.3 43.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.664 -0.698 . . . . 42.03 109.622 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.7 tp -111.13 95.88 27.42 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.325 -0.398 . . . . 72.15 109.963 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 65.0 Cg_endo -76.68 174.73 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.458 2.105 . . . . 71.43 111.657 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.555 ' HD3' ' HB1' ' A' ' 139' ' ' ALA . 65.8 mtp180 -68.98 -26.99 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 88.48 -168.67 36.68 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.042 -0.981 . . . . 65.42 113.881 168.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.46 ' HA ' HD22 ' A' ' 107' ' ' ASN . 46.8 ttp85 -60.51 115.41 3.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.653 -0.774 . . . . 55.43 109.438 177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.47 5.59 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.151 -0.78 . . . . 52.42 111.151 -172.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 75' ' ' ARG . 79.0 p -117.6 158.23 24.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.035 -0.357 . . . . 74.05 110.035 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -76.32 108.65 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.05 0.452 . . . . 61.42 109.832 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -138.1 91.61 12.93 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.1 -0.5 . . . . 74.12 110.319 -178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.03 27.4 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.181 2.588 . . . . 71.43 112.659 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.68 121.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.496 . . . . 73.13 110.457 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -105.89 -37.24 6.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.623 -0.717 . . . . 75.01 111.197 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 132' ' ' GLY . 91.1 t -134.53 138.48 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.569 0.223 . . . . 72.2 111.097 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 m -132.13 139.73 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 73.23 110.418 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 67.9 mt-10 -121.06 134.53 55.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.394 -0.366 . . . . 74.31 110.791 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -116.22 131.03 57.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 73.04 110.8 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.75 153.33 49.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.369 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.16 155.53 46.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.4 t -150.02 147.33 27.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.063 0.459 . . . . 74.04 110.781 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.17 -33.74 16.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 61.54 110.841 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -122.97 -2.69 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.893 0.331 . . . . 75.14 111.893 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 63.85 34.62 11.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.657 0.741 . . . . 61.43 109.587 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.2 t -110.39 -54.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.859 -0.609 . . . . 75.33 109.366 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.65 135.15 54.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -105.83 119.22 38.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.364 0.602 . . . . 73.34 110.687 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.2 m -95.29 125.03 51.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.233 -0.894 . . . . 54.24 110.875 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.0 111.98 3.3 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.627 2.218 . . . . 40.33 111.76 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 116' ' ' VAL . 21.2 pt -86.24 -18.87 8.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 73.43 110.948 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.88 139.96 2.78 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.288 -0.958 . . . . 72.45 113.074 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 30.2 ttt180 -119.59 126.55 51.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.36 -175.91 4.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 74.43 110.84 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.96 143.97 16.42 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.839 -0.696 . . . . 41.31 111.788 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.54 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 33.4 t80 -91.19 136.38 33.13 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.744 -0.465 . . . . 74.22 109.744 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 112' ' ' LEU . 27.1 m -112.78 123.22 49.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.519 -0.31 . . . . 73.5 110.763 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.46 HD22 ' HA ' ' A' ' 77' ' ' ARG . 5.5 t30 -67.05 93.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.035 0.445 . . . . 61.11 109.852 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.438 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 12.0 pt20 -144.54 169.27 18.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.895 -0.593 . . . . 73.51 109.417 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -104.9 18.59 22.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.538 0.685 . . . . 71.33 110.196 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.54 153.57 31.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.446 -0.797 . . . . 53.13 109.74 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.54 124.47 22.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.067 0.461 . . . . 70.43 111.262 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 106' ' ' THR . 75.0 mt -80.74 117.79 21.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 74.42 110.439 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -95.86 119.81 35.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.266 -0.424 . . . . 73.53 110.392 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.57 105.17 13.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.232 -0.44 . . . . 74.31 109.905 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -82.59 90.77 6.84 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.282 -0.636 . . . . 73.34 109.282 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 100' ' ' ILE . 30.5 m -86.86 179.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.323 -0.853 . . . . 64.23 110.581 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 100' ' ' ILE . 47.8 pttt -81.44 148.2 29.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.078 0.466 . . . . 72.25 110.226 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 37.4 p -79.01 127.62 32.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.747 -0.66 . . . . 62.23 111.511 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.8 tt -161.49 150.57 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.635 -0.711 . . . . 61.21 109.388 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HB3' ' HZ2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -79.38 140.69 37.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.157 -0.683 . . . . 73.33 109.157 177.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.75 144.19 17.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.569 0.223 . . . . 51.13 110.848 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.76 -22.61 13.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.804 -0.813 . . . . 64.31 108.804 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -115.65 145.42 42.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.846 . . . . 75.32 109.673 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.0 tt -136.34 141.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.957 -0.386 . . . . 73.14 109.957 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 59.9 ttp180 -126.78 125.71 42.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.033 0.444 . . . . 75.22 111.435 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 57' ' ' ILE . 57.9 tp -95.62 124.32 39.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.554 -0.748 . . . . 62.2 109.045 172.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 76.4 m -119.47 123.16 43.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.991 0.424 . . . . 72.21 110.663 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.0 mm -105.56 94.01 7.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.354 -0.61 . . . . 72.14 109.354 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 68.0 Cg_endo -87.76 136.94 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.033 2.489 . . . . 75.01 113.006 -175.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 25.3 t0 -81.48 66.36 7.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.433 -0.951 . . . . 73.43 108.433 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -124.93 -12.54 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.835 -1.075 . . . . 74.34 111.703 -173.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 85' ' ' VAL . . . -139.83 22.62 2.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.659 -1.258 . . . . 63.12 114.001 -173.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.8 26.06 7.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.162 -1.018 . . . . 51.33 112.611 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -82.11 178.45 8.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.887 0.375 . . . . 75.44 110.827 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 m -146.79 178.96 7.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.882 -0.414 . . . . 64.55 109.882 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 p -84.68 16.08 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 34.42 111.667 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.8 127.92 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.52 . . . . 65.34 109.879 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.95 143.45 30.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.313 -0.403 . . . . 75.12 110.18 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.555 ' HB1' ' HD3' ' A' ' 75' ' ' ARG . . . -149.16 106.09 3.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.836 0.35 . . . . 73.22 111.33 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 9.3 mt -126.23 140.5 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.73 -0.841 . . . . 62.24 108.73 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 69.6 mtt180 -75.91 -63.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.025 0.44 . . . . 71.44 110.159 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.97 133.52 22.02 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.666 -0.697 . . . . 73.0 110.863 -170.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.47 120.63 42.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 72.32 109.418 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.88 124.26 44.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 72.25 110.562 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.21 142.07 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 65.34 109.867 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.809 ' HG2' HG22 ' A' ' 4' ' ' THR . 26.6 mtpt -119.16 124.27 46.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.438 . . . . 73.32 109.816 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.56 -166.83 32.44 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.649 -0.786 . . . . 64.14 112.152 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.8 m -107.3 130.15 54.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.573 0.225 . . . . 54.42 110.592 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 5' ' ' ILE . 40.7 mm -72.0 125.05 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.411 . . . . 72.5 110.938 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.732 HG22 ' H ' ' A' ' 152' ' ' LEU . 44.6 mt -110.48 150.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.169 -0.678 . . . . 70.44 109.169 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -116.32 13.37 15.56 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.6 . . . . 73.01 111.03 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.732 ' H ' HG22 ' A' ' 150' ' ' ILE . 84.7 mt -85.65 64.19 8.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.681 -0.69 . . . . 73.42 110.486 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 33.3 mm-40 -80.34 14.26 2.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.542 -0.754 . . . . 71.15 111.43 -176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 39.7 m80 60.58 38.7 18.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 74.53 109.708 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -71.99 94.65 1.5 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.611 0.72 . . . . 75.2 111.985 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.38 98.32 6.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.471 -0.786 . . . . 74.31 108.911 174.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.9 t60 61.33 38.53 16.24 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.857 0.837 . . . . 75.21 108.866 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -102.31 121.3 42.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.007 -0.997 . . . . 72.52 110.298 -173.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.437 -0.347 . . . . 71.25 110.829 -179.393 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 111.637 0.236 . . . . 64.52 111.637 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.28 -85.2 0.64 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.857 -0.687 . . . . 73.0 112.426 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.5 m -78.82 -24.55 44.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.546 0.689 . . . . 75.52 109.652 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 146' ' ' LYS . 22.6 p -83.81 153.52 24.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.466 -0.788 . . . . 72.41 110.304 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 65' ' ' ILE . 44.1 mm -63.79 147.76 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 73.04 111.213 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -72.95 112.79 9.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.575 -0.528 . . . . 72.22 109.575 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -89.56 -8.54 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.433 . . . . 74.54 111.057 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -73.17 97.67 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.742 0.782 . . . . 75.01 109.31 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.12 -11.91 4.14 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.627 -1.17 . . . . 43.01 111.25 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.519 ' HE3' HG21 ' A' ' 59' ' ' ILE . 30.6 m0 -74.98 161.29 29.61 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.58 -0.526 . . . . 65.33 109.58 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.507 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 8.9 pt-20 -138.57 158.69 43.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.34 -0.544 . . . . 70.13 110.585 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.97 119.54 45.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 64.13 109.709 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.58 -39.0 28.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.014 0.435 . . . . 73.52 110.448 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.6 t -157.04 141.1 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 74.35 109.703 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 18' ' ' GLN . 51.7 p90 -136.02 146.2 46.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.002 -0.545 . . . . 75.44 109.532 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -86.27 -40.98 14.98 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.797 -0.361 . . . . 74.43 110.737 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 5.9 t -147.81 148.17 30.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.153 0.501 . . . . 75.21 111.111 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' HG2' ' CD1' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -171.87 145.1 1.85 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.249 -0.887 . . . . 64.51 108.947 172.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 9.5 tp10 -105.44 102.31 11.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.198 -0.456 . . . . 63.12 110.67 -173.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.43 -30.14 12.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 65.2 110.492 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -83.21 -33.69 26.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 55.21 110.556 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.43 -48.39 5.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.771 -0.728 . . . . 74.44 113.129 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HG3' ' HA3' ' A' ' 28' ' ' GLY . 23.8 mm-40 -74.81 -29.76 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.656 0.228 . . . . 70.55 111.601 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.49 -148.35 17.91 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.436 -0.888 . . . . 41.41 113.574 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.97 6.41 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.598 0.592 . . . . 70.25 112.598 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.34 17.66 80.14 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.564 -0.744 . . . . 63.35 113.428 172.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -128.19 145.9 50.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.005 -0.278 . . . . 75.03 110.274 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.471 ' HA3' ' HG3' ' A' ' 23' ' ' GLU . . . 78.86 -4.52 60.98 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.403 -0.427 . . . . 71.02 112.757 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.698 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.9 mt -73.79 144.69 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.004 -0.369 . . . . 62.02 110.004 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.47 -22.83 64.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.573 0.701 . . . . 53.25 110.064 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.688 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 13.9 ptmt -74.97 -23.44 58.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.999 -1.0 . . . . 73.44 111.335 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 79.1 m -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.949 0.404 . . . . 62.44 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -67.15 -15.02 63.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.617 -0.72 . . . . 74.12 110.581 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG21 HG12 ' A' ' 59' ' ' ILE . 27.5 pt -133.69 26.5 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 71.32 110.827 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.29 -46.63 19.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.052 0.453 . . . . 72.31 111.305 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.12 6.03 7.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.53 -0.843 . . . . 75.21 112.672 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 7.4 t70 -125.35 127.29 46.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.185 0.492 . . . . 62.51 110.518 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 p -76.34 -5.55 47.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.956 0.724 . . . . 73.44 112.956 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.64 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 7.9 pt-20 -91.42 -21.34 21.01 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.111 -0.636 . . . . 64.43 110.46 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -90.94 136.76 32.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.258 -0.645 . . . . 72.1 109.258 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.741 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 51.2 p90 -137.76 170.73 15.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.438 0.637 . . . . 71.44 112.412 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 30.3 t90 -106.43 139.81 40.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.629 -1.169 . . . . 75.42 109.375 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -135.52 139.18 43.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.323 -0.621 . . . . 72.13 109.323 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 146.33 53.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.433 . . . . 62.44 110.113 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 35.1 ttpt -65.61 131.13 45.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.381 -0.372 . . . . 74.53 110.164 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.433 ' NE1' ' HG2' ' A' ' 19' ' ' GLU . 64.5 p-90 -130.32 -33.89 1.66 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 73.43 111.517 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -67.71 -41.64 83.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 74.23 110.767 -175.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.85 26.17 25.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.532 -0.842 . . . . 71.35 111.448 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.27 165.47 40.35 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.1 -0.8 . . . . 73.3 111.1 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.586 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 38.3 m -100.82 145.72 28.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 117.189 0.495 . . . . 64.52 110.452 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 18.3 m-20 -79.11 161.37 68.43 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.621 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 60.1 Cg_endo -73.37 132.78 18.19 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.405 2.07 . . . . 63.4 112.734 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.11 158.27 88.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.822 -0.626 . . . . 60.21 110.198 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.716 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.7 Cg_exo -76.3 159.98 95.96 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.002 -1.249 . . . . 55.42 112.692 0.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.0 m-85 -95.74 101.75 13.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 72.32 110.13 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 7.2 m-20 -98.71 117.96 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.059 -0.518 . . . . 75.12 110.51 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 52.7 mt -111.71 116.79 53.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.266 -0.425 . . . . 75.23 109.922 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.78 115.44 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG21 ' HE3' ' A' ' 10' ' ' TRP . 5.0 mp -111.08 136.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 72.52 110.576 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -104.06 119.54 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.401 -0.592 . . . . 62.22 109.401 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 73.43 110.895 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 31.2 mmtp 72.0 -11.67 0.75 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.514 0.726 . . . . 51.01 112.643 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -145.13 170.5 16.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.617 0.246 . . . . 70.25 110.58 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 64' ' ' ASN . 2.2 m120 -85.95 124.36 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 64.32 110.74 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 5' ' ' ILE . 78.1 mt -130.17 136.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 64.3 110.065 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.574 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.9 tp60 -80.02 100.71 8.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.099 -0.704 . . . . 65.2 109.099 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 118' ' ' SER . 31.7 mm -69.36 118.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.909 -0.404 . . . . 51.25 109.909 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.6 -39.38 5.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.233 0.539 . . . . 62.53 110.914 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 51.3 tt0 -159.24 148.68 18.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.611 -0.722 . . . . 50.12 110.563 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.16 115.85 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.369 . . . . 42.2 110.817 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.579 ' OE2' ' HA ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -97.79 128.1 44.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.707 -0.679 . . . . 71.34 110.689 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.531 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 45.9 mt -109.34 118.17 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.463 -0.569 . . . . 54.13 109.463 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -103.74 99.07 14.58 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.588 -0.523 . . . . 64.23 109.588 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 5.4 Cg_exo -78.48 172.17 15.67 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.869 2.379 . . . . 64.35 111.795 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HD3' ' OG ' ' A' ' 79' ' ' SER . 71.5 ttt180 -77.59 -28.74 51.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.245 0.545 . . . . 72.42 109.647 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 93.83 -125.1 8.11 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.569 -0.742 . . . . 74.43 113.083 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -102.11 140.89 35.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.982 0.42 . . . . 63.13 110.002 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.48 -21.44 8.61 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.27 -0.732 . . . . 60.15 111.27 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 67.9 m -123.27 171.57 9.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.858 -0.423 . . . . 73.44 109.858 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -102.48 105.81 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.593 -0.276 . . . . 51.14 110.526 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -121.58 84.12 42.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.478 -0.328 . . . . 65.22 111.122 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 2.3 Cg_endo -82.95 32.12 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.35 2.7 . . . . 73.11 111.73 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.43 118.86 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.818 -0.628 . . . . 74.25 110.186 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -100.57 -50.12 3.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.675 . . . . 74.3 110.904 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 60.9 t -127.36 141.68 45.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.042 -0.526 . . . . 71.13 110.599 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.36 129.82 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.151 -0.477 . . . . 71.14 109.743 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.6 mt-10 -109.79 125.41 52.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.132 -0.486 . . . . 53.42 110.493 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -107.68 129.66 55.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.081 -0.509 . . . . 74.3 110.426 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.58 145.33 49.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.279 -0.418 . . . . 63.41 110.76 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.02 48.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.027 -0.533 . . . . 61.25 109.846 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t -149.86 154.62 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.345 0.593 . . . . 71.32 111.344 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 41.5 mt-10 -102.64 -32.79 9.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.432 -0.804 . . . . 71.31 109.985 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 26.8 t0 -106.81 -12.32 15.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 74.41 111.252 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 15.8 t-20 76.25 -21.5 0.31 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.413 0.625 . . . . 75.21 111.114 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ASP . 78.3 t -75.72 -50.96 21.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.684 -0.689 . . . . 54.31 110.319 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.1 113.41 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.225 -0.898 . . . . 63.31 109.913 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -94.08 142.19 27.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.014 -0.539 . . . . 73.52 110.946 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.4 m -115.1 124.55 30.09 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.786 -0.643 . . . . 73.23 109.967 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.52 116.17 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.567 2.178 . . . . 74.35 112.143 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 116' ' ' VAL . 15.7 pt -86.78 -13.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.395 -0.366 . . . . 74.05 110.571 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.69 130.76 1.15 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.333 -0.937 . . . . 43.42 113.177 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 38.4 ttt180 -106.71 114.56 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.713 -0.847 . . . . 71.31 108.713 171.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.4 m-85 -125.79 172.3 9.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.404 -0.362 . . . . 74.0 110.682 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.53 151.3 22.41 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.027 -0.829 . . . . 53.41 111.027 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -100.86 131.96 46.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.96 -0.385 . . . . 65.15 109.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.536 ' HB ' HD21 ' A' ' 112' ' ' LEU . 21.1 m -105.8 124.74 50.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 65.43 110.433 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -70.69 94.87 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.095 0.474 . . . . 73.31 110.312 177.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.412 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 11.9 pt20 -146.09 176.84 9.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.988 -0.745 . . . . 71.14 108.988 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.46 -7.81 17.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.033 0.444 . . . . 73.2 110.983 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.72 159.26 16.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 44.5 110.47 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.27 130.0 41.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 72.24 111.616 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 106' ' ' THR . 36.0 mt -87.28 116.38 25.33 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 74.51 110.33 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.579 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 40.9 mt-10 -83.16 121.14 26.68 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.283 0.364 . . . . 62.22 110.846 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 72' ' ' LEU . 49.9 m-85 -122.29 104.96 9.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 73.43 110.711 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.36 97.0 5.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.592 -0.731 . . . . 74.11 109.414 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.568 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.1 m -98.13 -178.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.443 -0.798 . . . . 75.42 111.792 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 45.8 tttp -61.04 125.69 24.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 71.45 111.088 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 9.6 p -73.05 120.02 18.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 75.24 110.029 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.431 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 10.6 tt -150.9 141.01 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.972 0.415 . . . . 74.42 111.406 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -82.9 115.02 21.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.277 -0.638 . . . . 74.01 109.277 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -142.8 175.0 10.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.292 . . . . 75.23 110.983 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -121.04 -32.5 3.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.6 . . . . 74.43 110.015 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.97 145.98 33.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 73.31 110.298 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -134.17 136.68 53.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.134 -0.484 . . . . 65.25 109.953 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.522 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.1 ttp180 -123.86 122.2 37.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.993 0.425 . . . . 74.02 111.095 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 HD12 ' A' ' 57' ' ' ILE . 40.4 tp -93.79 111.45 23.15 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.974 -0.75 . . . . 75.22 108.974 172.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 61.0 m -105.91 120.59 42.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.071 0.462 . . . . 73.21 111.061 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.732 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -98.31 96.23 3.5 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.566 -0.901 . . . . 74.0 108.566 171.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.716 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -68.71 171.72 12.79 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.68 2.254 . . . . 54.33 113.057 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.34 -2.43 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.251 1.024 . . . . 65.25 108.407 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' H ' ' HB2' ' A' ' 129' ' ' PRO . 7.0 m-20 -72.45 -31.84 65.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.138 -1.392 . . . . 74.04 112.439 -170.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -94.2 0.11 66.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.187 -1.006 . . . . 64.21 113.621 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.88 20.71 11.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.108 -1.044 . . . . 73.35 111.668 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -72.55 142.6 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.45 . . . . 72.34 111.031 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 17.4 m -100.06 172.24 7.32 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.924 -0.58 . . . . 54.51 109.867 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 16.2 p -83.19 22.05 1.03 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 55.32 112.128 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.23 129.42 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.506 -0.553 . . . . 65.21 109.506 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.17 135.11 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.507 -0.315 . . . . 65.05 110.939 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -134.47 106.04 6.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 63.11 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 29.9 mt -124.07 133.64 68.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.426 -0.583 . . . . 42.22 109.426 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.741 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 72.3 mtt180 -66.03 -71.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.274 0.359 . . . . 70.11 110.27 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.7 153.73 44.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.431 0.634 . . . . 73.23 111.705 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 tt -106.68 111.31 23.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.541 -1.281 . . . . 73.14 107.541 168.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -112.11 123.34 50.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.766 -0.457 . . . . 71.12 109.766 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.05 128.35 52.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.916 0.389 . . . . 61.34 111.978 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.704 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 54.1 mtpt -94.51 130.6 40.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.377 -0.601 . . . . 60.13 109.377 171.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.15 -167.35 35.42 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.186 -1.007 . . . . 44.3 112.265 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.2 m -123.06 129.49 51.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.479 0.18 . . . . 75.33 110.548 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 41.6 mm -69.36 116.36 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.163 -0.471 . . . . 73.45 109.981 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 66' ' ' GLN . 62.0 mt -101.02 141.22 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.974 0.416 . . . . 62.42 109.97 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -118.98 133.73 55.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.058 -0.519 . . . . 71.15 110.495 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.97 79.98 1.07 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.767 0.794 . . . . 71.13 109.503 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.4 131.85 38.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 61.14 110.105 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -56.99 116.21 3.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.711 -0.477 . . . . 75.33 109.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -50.17 134.29 22.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.096 -0.502 . . . . 63.32 111.319 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -60.15 137.79 58.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.474 -0.785 . . . . 74.14 112.498 -172.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -142.17 165.13 28.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.026 -0.988 . . . . 74.51 108.591 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -57.02 113.75 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.258 0.348 . . . . 74.41 110.208 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 4.5 t60 . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 116.313 -0.403 . . . . 64.01 110.332 -176.656 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.799 -0.445 . . . . 62.32 109.799 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.11 90.83 1.21 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.78 -0.724 . . . . 34.52 112.425 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.7 m -66.97 100.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.034 -0.358 . . . . 70.25 110.034 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.624 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 35.3 p -133.18 161.71 33.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 53.3 110.446 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 HD11 ' A' ' 149' ' ' ILE . 47.5 mm -88.65 134.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.837 0.351 . . . . 71.13 111.317 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -66.64 118.35 10.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.12 -0.491 . . . . 63.1 110.07 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -98.47 19.61 14.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.505 . . . . 72.32 111.217 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.5 m -58.7 -42.18 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.498 0.555 . . . . 72.05 112.498 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.13 8.05 62.69 Favored Glycine 0 C--O 1.235 0.186 0 C-N-CA 120.541 -0.838 . . . . 41.01 112.946 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -75.39 138.38 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.29 . . . . 74.41 110.236 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.4 pt-20 -130.3 152.91 49.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.074 -0.343 . . . . 71.41 110.074 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.28 115.23 32.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.907 -0.588 . . . . 54.21 109.829 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.459 HD11 ' HE2' ' A' ' 123' ' ' TYR . 84.8 mt -77.24 -48.97 16.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 72.22 110.062 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 t -143.26 142.99 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.562 -0.745 . . . . 74.03 110.138 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.571 -0.74 . . . . 75.34 109.257 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.2 m -77.12 -40.91 44.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.055 0.455 . . . . 72.31 110.37 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -150.98 150.34 30.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.219 -0.446 . . . . 72.13 110.864 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.19 140.51 7.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.502 -0.925 . . . . 72.35 108.502 173.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.3 tp10 -86.12 95.94 9.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.423 0.63 . . . . 71.12 110.632 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.83 2.58 20.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.259 -0.882 . . . . 74.43 110.786 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 m -112.56 -43.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.887 -0.597 . . . . 72.43 110.629 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -76.31 -30.78 56.39 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.012 -0.54 . . . . 64.43 113.372 -176.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.15 6.44 9.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.18 0.49 . . . . 61.34 111.368 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.95 -140.31 19.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.879 -0.677 . . . . 70.14 113.205 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.76 150.8 34.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.7 0.286 . . . . 63.5 110.495 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.17 -10.21 67.0 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.01 -0.615 . . . . 75.1 112.382 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -142.02 140.28 32.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.004 -0.369 . . . . 74.05 110.004 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.5 83.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.014 -0.612 . . . . 65.05 111.971 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.75 154.33 21.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.58 0.229 . . . . 74.43 110.488 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.96 -22.54 65.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.878 0.371 . . . . 72.53 111.448 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -77.83 -22.69 49.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.504 -0.317 . . . . 74.11 111.315 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 40.3 m -68.56 -24.33 64.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 74.53 109.911 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 142' ' ' GLU . 24.9 tp -65.12 -24.49 67.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.39 -0.823 . . . . 64.3 110.776 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HG21 HG12 ' A' ' 59' ' ' ILE . 35.9 pt -120.86 14.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.379 . . . . 73.11 111.16 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.86 -33.03 73.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.05 0.452 . . . . 74.42 110.197 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.0 36.29 6.41 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.708 -0.678 . . . . 51.44 112.023 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -139.05 128.93 24.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.988 -0.375 . . . . 61.42 109.988 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 73' ' ' LEU . 2.5 p -70.36 -11.72 61.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.626 0.602 . . . . 72.34 112.626 -174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -89.06 -27.11 21.02 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.84 0.352 . . . . 64.22 111.049 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.2 p -87.78 146.1 25.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.739 -0.384 . . . . 74.44 109.974 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.676 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 42.6 p90 -146.5 166.09 27.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.217 0.532 . . . . 75.02 111.772 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -108.24 139.89 42.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.948 -1.023 . . . . 74.14 109.547 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -133.01 147.11 52.26 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.234 -0.654 . . . . 72.22 109.234 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . . . -75.11 145.92 41.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.992 -0.373 . . . . 73.43 109.992 175.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HE2' ' OD2' ' A' ' 51' ' ' ASP . 37.7 ttpt -66.15 118.14 9.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 75.4 110.355 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -118.96 -30.9 4.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.425 -0.352 . . . . 75.42 110.896 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -78.72 107.67 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 73.4 110.249 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.12 -0.6 47.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.891 -0.671 . . . . 75.3 111.684 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 143.0 7.46 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.795 -0.717 . . . . 53.54 112.144 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -95.98 151.79 19.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.822 0.344 . . . . 60.42 111.053 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.479 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 30.5 m-20 -82.39 150.32 63.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.921 -0.582 . . . . 54.43 110.661 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.81 145.02 44.97 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.746 2.297 . . . . 34.4 112.269 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.8 mt -70.6 162.13 72.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 54.52 110.529 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 95.2 Cg_endo -83.15 170.02 56.16 Favored 'Cis proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.487 -1.464 . . . . 64.31 112.831 1.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.4 m-85 -108.17 111.02 22.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 73.41 110.406 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -110.79 130.95 55.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 74.33 110.622 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 126' ' ' LEU . 57.4 mt -121.72 114.41 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.479 -0.563 . . . . 71.44 109.479 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -102.36 115.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.921 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 HG21 ' A' ' 34' ' ' ILE . 4.9 mp -110.1 133.35 55.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.535 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -97.79 113.74 25.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.675 . . . . 73.42 109.179 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.2 mtm -81.98 -5.36 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 64.45 110.82 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 32.5 mmtp 73.41 -35.63 0.32 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.74 0.816 . . . . 74.13 112.965 174.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -123.9 166.73 15.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.005 0.431 . . . . 73.33 110.975 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.58 123.19 25.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.625 -0.716 . . . . 75.32 110.139 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.575 HD13 HG21 ' A' ' 5' ' ' ILE . 66.6 mt -131.68 136.87 56.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.05 0.452 . . . . 64.23 110.614 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.7 tp60 -86.48 108.56 18.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.858 -0.793 . . . . 65.45 108.858 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 118' ' ' SER . 28.1 mm -75.33 130.56 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.441 -0.207 . . . . 73.53 110.441 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -42.27 2.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.075 0.464 . . . . 73.42 111.331 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.8 tt0 -153.39 145.84 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 73.51 110.296 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -110.39 134.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.02 -0.363 . . . . 61.0 110.02 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -113.02 126.96 56.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.139 0.495 . . . . 70.42 110.899 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.625 HD12 ' HE2' ' A' ' 114' ' ' TYR . 61.3 mt -110.71 123.38 49.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.725 -0.67 . . . . 72.13 109.499 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.53 ' CD2' HG22 ' A' ' 38' ' ' THR . 22.4 tp -103.93 104.76 44.97 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.905 -0.405 . . . . 71.11 109.905 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.8 -178.22 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.815 2.343 . . . . 74.52 111.955 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -98.46 -59.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 74.35 110.574 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.56 -52.19 3.09 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.119 -0.563 . . . . 64.04 112.81 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -88.89 109.28 20.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.752 0.311 . . . . 74.23 111.162 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 61.83 4.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.911 -0.586 . . . . 71.2 112.684 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -160.91 139.8 10.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.252 0.548 . . . . 72.31 111.525 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -100.45 123.29 44.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.117 -0.947 . . . . 72.32 108.733 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 41.1 t-20 -146.65 96.88 4.35 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.21 0.528 . . . . 72.13 110.756 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 9.3 Cg_endo -91.22 21.64 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.912 3.075 . . . . 72.01 112.796 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.06 122.92 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 62.34 110.169 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -100.08 -50.24 4.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 73.4 110.855 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 60.2 t -126.97 138.41 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 51.32 110.928 -173.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.91 137.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.069 -0.514 . . . . 64.01 110.128 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.13 135.53 54.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.039 0.447 . . . . 64.55 110.662 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.11 129.76 55.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.938 -0.574 . . . . 74.14 110.118 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.9 143.44 50.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 50.41 110.671 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.59 151.35 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.254 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 t -146.26 152.88 39.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 34.43 110.949 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -29.41 9.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.716 -0.674 . . . . 71.3 110.89 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -111.19 -0.03 16.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 74.11 111.11 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.1 t30 68.7 21.09 7.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.92 0.866 . . . . 75.22 109.614 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.76 -59.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.434 -0.803 . . . . 72.32 110.275 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -89.12 110.86 21.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 51.02 109.769 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -99.12 107.59 20.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.937 0.398 . . . . 75.52 110.312 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.8 m -88.46 123.89 67.25 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.967 -0.561 . . . . 72.42 110.378 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.13 107.33 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.243 1.962 . . . . 54.22 111.012 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 13.8 pt -80.21 -11.84 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.059 -0.519 . . . . 53.55 110.641 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.21 128.56 1.0 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.453 -0.88 . . . . 43.42 112.862 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -100.62 123.58 45.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.92 -0.771 . . . . 75.13 108.92 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.52 -177.73 4.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.741 0.305 . . . . 60.21 110.482 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -96.72 175.26 31.24 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.753 -0.737 . . . . 62.02 111.264 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -131.7 141.96 49.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.135 0.467 . . . . 75.42 110.095 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 m -136.69 119.42 16.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.931 -0.577 . . . . 73.44 110.058 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 63.9 t30 -69.62 95.93 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.725 -0.472 . . . . 71.22 109.725 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -125.8 -167.98 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 62.04 110.843 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.09 -33.47 14.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.916 -0.584 . . . . 54.42 111.186 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.87 168.62 10.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.887 -0.597 . . . . 44.04 111.56 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.8 144.81 47.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.091 0.472 . . . . 74.03 111.146 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.6 mt -101.18 104.54 15.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.637 -0.711 . . . . 72.01 110.01 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.29 115.82 24.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.476 . . . . 73.01 110.688 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.625 ' HE2' HD12 ' A' ' 72' ' ' LEU . 42.1 m-85 -113.34 108.17 16.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.117 0.484 . . . . 74.14 110.534 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -72.86 112.78 9.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.477 -0.783 . . . . 74.32 109.495 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -112.06 178.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.086 -0.507 . . . . 72.13 111.653 -172.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.73 128.19 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 71.03 110.481 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.8 p -77.02 106.44 8.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.151 -0.477 . . . . 44.03 110.175 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.85 146.73 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.915 -0.584 . . . . 74.13 110.487 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -88.29 131.44 34.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.845 0.355 . . . . 74.4 110.506 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.96 176.65 11.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 51.23 110.339 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -125.38 -30.66 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 64.23 110.158 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.459 ' HE2' HD11 ' A' ' 13' ' ' LEU . 93.5 m-85 -106.78 146.02 31.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.056 -0.52 . . . . 74.13 110.14 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.0 tt -135.99 135.66 50.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.934 0.397 . . . . 74.14 110.157 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 33.6 ttp180 -122.88 120.06 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.34 -0.391 . . . . 74.12 110.679 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -84.48 113.73 21.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.769 -0.826 . . . . 70.15 108.769 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.5 m -107.77 116.92 32.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.349 0.595 . . . . 62.22 111.278 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.9 mm -100.59 91.34 1.77 Allowed Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.002 -1.11 . . . . 51.15 108.002 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 61.1 Cg_endo -72.8 174.45 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.243 1.962 . . . . 53.21 112.521 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.34 36.91 0.89 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.613 -0.884 . . . . 62.21 108.613 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -113.52 146.37 39.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.571 -1.195 . . . . 72.14 110.752 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.98 9.9 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.144 -0.55 . . . . 71.55 113.522 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 116.37 25.28 3.52 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.285 -0.959 . . . . 41.53 112.263 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.93 145.0 56.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 71.21 110.383 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 15.4 m -118.74 176.87 5.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.068 -0.515 . . . . 70.52 110.541 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 34.1 p -78.16 10.14 3.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.243 -0.435 . . . . 71.11 111.879 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 44.8 t -109.4 119.29 58.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.654 -0.499 . . . . 73.41 109.654 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . . . -139.59 135.74 33.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.612 -0.267 . . . . 72.53 110.535 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.87 107.55 3.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 74.51 110.887 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.9 mt -133.43 136.97 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.478 -0.564 . . . . 71.04 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 36.3 mmt180 -63.77 -72.4 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.849 0.357 . . . . 72.33 110.071 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 33' ' ' LEU . 12.8 pt-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.917 -0.713 . . . . 74.34 111.812 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.39 130.56 56.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.715 -1.13 . . . . 72.14 108.147 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.624 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -128.16 164.4 22.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.696 -0.483 . . . . 71.32 109.696 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -133.28 128.02 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 71.1 110.277 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 50.7 mttm -93.13 134.66 35.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.172 -0.677 . . . . 73.2 109.172 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.39 8.56 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.87 -0.681 . . . . 72.44 111.453 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -136.31 133.61 37.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.484 0.183 . . . . 72.2 110.562 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.821 HD11 HG23 ' A' ' 5' ' ' ILE . 31.2 mm -73.55 115.83 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 66' ' ' GLN . 56.1 mt -95.66 138.23 21.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.709 -0.478 . . . . 54.33 109.709 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -79.99 142.7 34.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.632 0.729 . . . . 75.14 110.952 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.09 148.84 42.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.075 -0.966 . . . . 61.14 108.903 177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.54 94.75 1.33 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.839 0.828 . . . . 73.14 110.932 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -109.12 18.36 20.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.239 -1.346 . . . . 70.15 109.292 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -63.27 -41.05 98.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 72.41 110.296 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -139.52 -20.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 61.44 111.301 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -91.88 130.47 37.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.919 0.39 . . . . 63.43 110.622 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -146.13 131.49 18.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 63.33 110.035 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.824 -0.625 . . . . 73.22 110.672 178.237 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.788 0.328 . . . . 73.44 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.27 79.1 1.52 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 73.53 111.345 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.0 t -89.79 11.65 19.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.182 0.515 . . . . 65.42 111.23 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 p -78.51 160.8 27.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.931 -0.577 . . . . 71.12 110.35 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 149' ' ' ILE . 44.5 mm -82.74 130.53 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.786 0.327 . . . . 72.03 110.85 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.3 t -65.6 125.05 23.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.171 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -96.83 21.8 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 42.31 110.586 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 t -54.73 -46.04 74.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.576 -0.738 . . . . 60.24 112.069 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.29 18.29 36.12 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.239 -0.981 . . . . 43.43 113.643 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.4 ' HB3' HD12 ' A' ' 34' ' ' ILE . 25.9 m0 -77.41 144.07 38.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.063 0.432 . . . . 74.13 110.669 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.557 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 23.5 pt-20 -139.85 162.7 34.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.432 . . . . 71.1 110.666 176.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.33 127.48 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.869 -0.605 . . . . 74.35 110.133 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 mt -90.99 -45.82 8.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.245 0.545 . . . . 75.04 110.096 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 m -137.0 140.43 42.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 75.21 110.283 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -149.55 142.42 24.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 72.03 110.071 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 m -81.8 -51.95 7.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 71.23 111.256 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -142.17 151.51 42.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.409 . . . . 72.53 110.8 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.538 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 9.6 pt20 -163.34 137.11 5.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.448 -0.796 . . . . 60.34 108.972 174.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.651 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.8 tp10 -89.48 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.208 0.528 . . . . 73.44 110.875 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.68 -8.59 22.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.53 -0.759 . . . . 70.22 111.097 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -106.52 -52.64 2.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 54.13 110.81 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -65.15 -54.93 24.4 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 116.074 -0.512 . . . . 65.34 112.55 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 59.9 mm-40 -76.66 -38.65 54.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.823 0.344 . . . . 73.24 110.556 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.44 -165.79 13.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.869 -0.682 . . . . 73.41 112.333 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.08 133.69 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.685 0.279 . . . . 53.45 110.538 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.59 2.87 78.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.907 -0.663 . . . . 64.34 112.832 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -153.35 139.18 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.078 -0.342 . . . . 63.14 110.078 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.6 -1.98 79.68 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.606 -0.598 . . . . 71.43 111.606 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 60.4 mt -84.32 155.84 22.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.192 -0.299 . . . . 64.13 110.192 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.81 -28.34 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.21 0.529 . . . . 71.25 111.098 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -79.58 -14.28 58.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.549 . . . . 71.12 111.545 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 71.1 m -73.11 -19.29 61.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.063 0.459 . . . . 74.14 109.822 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 39.5 tp -68.62 -13.05 62.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.482 -0.781 . . . . 72.5 110.7 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 59' ' ' ILE . 34.6 pt -137.59 21.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.803 -0.635 . . . . 61.4 110.306 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 12.3 t70 -67.76 -41.58 83.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 73.42 110.793 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.26 -2.26 11.47 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.869 -0.892 . . . . 53.05 110.869 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -125.04 115.08 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 75.24 109.951 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -75.93 2.61 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.482 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.34 -27.62 21.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.955 0.407 . . . . 65.3 110.049 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -89.07 137.42 32.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.017 -0.735 . . . . 64.22 109.017 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.655 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 41.8 p90 -130.11 173.2 10.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.057 0.456 . . . . 64.41 111.431 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.574 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.7 t90 -107.4 128.6 54.62 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 71.21 108.793 172.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -129.67 132.9 46.81 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.467 -0.568 . . . . 72.43 109.467 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.69 136.25 58.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.974 -0.75 . . . . 61.24 108.974 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.3 132.96 55.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.174 0.296 . . . . 73.02 110.385 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -124.09 -22.1 4.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.149 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -69.47 108.18 3.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.868 0.366 . . . . 75.14 110.197 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.96 11.91 72.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 73.32 112.055 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.16 176.14 18.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 72.32 111.972 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -123.76 149.28 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.925 0.393 . . . . 51.35 110.856 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 2.6 t70 -75.66 142.93 74.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.974 -0.557 . . . . 75.3 109.712 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 30.8 Cg_endo -63.59 146.1 92.3 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.566 2.177 . . . . 71.24 113.193 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 9.7 mt -77.58 163.53 63.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.661 -0.7 . . . . 72.22 110.034 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.8 Cg_endo -81.28 163.95 77.96 Favored 'Cis proline' 0 N--CA 1.461 -0.401 0 C-N-CA 124.101 -1.208 . . . . 65.33 112.92 1.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.3 m-85 -99.28 122.86 43.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.82 -0.627 . . . . 71.52 110.318 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 9.9 t0 -110.22 126.67 54.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.695 . . . . 75.53 109.817 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.7 mt -130.25 108.92 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.769 0.319 . . . . 64.24 110.372 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.84 118.46 47.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.023 -0.535 . . . . 71.52 110.566 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 34' ' ' ILE . 82.8 mt -117.35 134.08 62.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.122 -0.49 . . . . 72.43 111.124 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -100.66 122.7 43.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.521 -0.548 . . . . 75.5 109.521 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.422 ' SD ' HD12 ' A' ' 65' ' ' ILE . 71.3 mtm -88.21 -6.21 57.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 64.21 110.766 -177.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.557 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.5 mmtt 67.26 11.53 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.752 -0.658 . . . . 32.31 112.197 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -163.46 159.84 22.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.228 -0.286 . . . . 74.22 110.228 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 58.7 m-80 -81.5 130.45 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.615 -0.513 . . . . 70.42 109.615 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.489 ' CD1' HG21 ' A' ' 5' ' ' ILE . 65.4 mt -135.55 136.01 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.078 0.466 . . . . 72.44 110.422 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -82.34 99.91 9.65 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 64.23 108.635 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.752 ' O ' ' HA ' ' A' ' 118' ' ' SER . 34.5 mm -69.79 113.55 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.174 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 -32.6 7.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.896 0.379 . . . . 65.14 111.161 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.683 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 7.0 tt0 -154.2 147.42 24.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.283 -0.417 . . . . 64.33 110.78 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.87 134.15 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.111 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 44.3 mt-10 -115.56 138.63 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.162 0.506 . . . . 65.15 110.927 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 114' ' ' TYR . 92.7 mt -124.28 118.71 27.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.739 -0.664 . . . . 75.34 109.755 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -103.33 99.75 15.9 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 109.094 -0.706 . . . . 75.34 109.094 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.61 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 55.5 Cg_endo -69.88 -170.55 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.526 . . . . 75.11 112.656 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 75' ' ' ARG . 1.6 ptp180 -67.35 -29.82 69.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.761 -0.376 . . . . 75.4 110.716 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.48 -73.47 2.64 Favored Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 120.823 -0.703 . . . . 53.0 112.366 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 77' ' ' ARG . 14.3 ptt180 -132.04 -176.38 4.05 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.381 0.61 . . . . 73.21 110.845 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.48 -52.98 1.16 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.052 -0.976 . . . . 31.23 112.336 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.1 m -143.27 160.88 39.67 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.102 -0.333 . . . . 44.42 110.102 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.58 140.79 48.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.585 -0.524 . . . . 65.02 109.585 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 19.2 t30 -127.45 92.2 43.93 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.026 -0.534 . . . . 72.35 109.732 -176.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.49 46.07 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.945 3.096 . . . . 72.05 113.906 -170.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.4 111.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.171 -0.677 . . . . 63.13 109.171 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.02 -48.05 8.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 72.33 110.91 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.713 HG11 ' HE ' ' A' ' 102' ' ' ARG . 12.0 t -130.95 143.15 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 74.51 110.713 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.88 142.01 45.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.144 -0.48 . . . . 65.25 110.238 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -112.68 130.18 56.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.983 -0.553 . . . . 75.25 110.497 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.81 129.1 55.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 73.32 110.312 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.33 148.55 52.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.316 -0.402 . . . . 63.02 110.476 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.36 153.63 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.42 -0.354 . . . . 70.11 110.479 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 t -145.39 142.38 29.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 70.45 110.136 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -77.32 -45.66 25.46 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.925 -0.58 . . . . 73.23 111.279 -176.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.61 23.85 5.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.372 -0.376 . . . . 71.52 111.048 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.1 t30 65.63 29.55 10.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.93 0.871 . . . . 73.51 110.089 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.17 -64.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.34 -0.845 . . . . 71.52 109.741 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -96.41 105.1 17.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 64.2 110.792 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -89.33 114.63 26.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.291 -0.413 . . . . 70.44 110.148 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 60.8 m -117.38 130.4 24.68 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.955 -0.566 . . . . 64.23 110.87 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 8.1 Cg_exo -70.88 106.99 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.865 2.376 . . . . 61.52 111.336 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 116' ' ' VAL . 11.8 pt -76.04 -11.1 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.777 -0.647 . . . . 71.21 111.057 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.77 149.0 5.8 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.339 -0.934 . . . . 65.04 113.101 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.713 ' HE ' HG11 ' A' ' 85' ' ' VAL . 78.1 ttt180 -124.21 118.4 26.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.705 -0.85 . . . . 75.44 108.705 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.0 m-85 -133.32 163.17 29.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.897 0.38 . . . . 72.53 111.364 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.65 141.4 25.5 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.663 -0.699 . . . . 35.23 111.595 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.61 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 48.0 t80 -100.54 138.38 37.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.954 0.407 . . . . 61.24 110.368 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 112' ' ' LEU . 32.6 m -131.3 112.73 13.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.184 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.66 103.07 2.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.291 0.567 . . . . 74.5 110.942 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -130.83 -174.34 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.317 -0.856 . . . . 73.11 109.425 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -90.56 -15.38 30.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.78 0.324 . . . . 72.43 110.98 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 150.77 22.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.344 -0.389 . . . . 60.25 110.839 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.06 127.51 32.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.115 0.483 . . . . 62.43 111.125 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -79.63 105.34 10.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.657 -0.701 . . . . 72.34 110.349 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 42.6 mt-10 -88.64 111.71 22.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.181 0.515 . . . . 74.33 111.187 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -108.57 111.46 23.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.652 -0.703 . . . . 73.14 110.35 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -74.25 102.59 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.686 . . . . 72.23 109.636 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 100' ' ' ILE . 31.5 m -102.08 -179.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 71.14 111.583 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -72.28 125.21 26.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.562 -0.745 . . . . 71.12 110.07 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 32.5 p -70.2 127.18 31.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.951 -0.568 . . . . 74.11 111.295 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.89 148.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.29 -0.414 . . . . 70.51 110.329 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -85.52 116.28 23.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . . . -141.81 156.43 45.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.959 -0.564 . . . . 73.44 110.828 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.92 -26.99 8.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.505 0.669 . . . . 73.31 109.388 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -111.4 145.4 38.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.459 -0.792 . . . . 74.04 109.319 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -133.08 139.63 49.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.693 -0.484 . . . . 73.12 109.693 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.6 ttp180 -125.02 123.43 39.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.055 0.455 . . . . 65.54 111.126 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -91.02 115.55 28.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.411 -0.813 . . . . 74.33 108.92 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.7 m -109.63 116.17 31.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.949 0.404 . . . . 55.43 110.865 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 40.2 mm -100.75 97.54 6.91 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.784 -0.821 . . . . 71.43 108.784 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.738 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 52.2 Cg_endo -69.96 170.28 17.19 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.432 2.088 . . . . 72.53 112.611 -176.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.98 -16.42 26.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.974 0.893 . . . . 74.34 108.754 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.55 148.03 22.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.285 -1.325 . . . . 71.41 110.895 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.97 -12.96 49.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.949 -0.86 . . . . 52.33 110.949 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.76 24.83 7.53 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.093 -0.575 . . . . 72.3 111.689 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -75.61 127.58 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 74.43 110.748 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.2 m -95.88 164.43 12.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.19 -0.459 . . . . 64.4 109.996 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 17.4 p -68.98 -6.18 26.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.26 0.467 . . . . 72.44 112.26 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 42.3 t -85.04 95.58 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.61 121.95 36.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.106 -0.497 . . . . 64.24 110.503 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.25 108.75 6.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 64.51 111.097 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 21.0 mt -121.96 132.65 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.655 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 77.1 mtt-85 -69.96 -70.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.936 -0.305 . . . . 75.23 110.613 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 26.9 tt0 -148.07 141.14 24.94 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.157 -0.617 . . . . 62.04 111.322 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 143' ' ' LEU . 7.9 tt -100.27 132.0 45.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.154 -0.93 . . . . 62.2 109.229 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.21 155.94 41.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.961 0.41 . . . . 74.33 110.387 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.6 t -126.74 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.127 -0.488 . . . . 63.02 110.542 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HD2' ' NE2' ' A' ' 69' ' ' GLN . 46.3 mttp -104.69 115.45 30.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.191 -0.67 . . . . 74.04 109.191 171.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.02 -169.14 24.95 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.762 -0.733 . . . . 75.44 112.096 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.1 m -113.32 130.73 56.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.425 -0.213 . . . . 63.5 110.425 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 5' ' ' ILE . 34.3 mm -76.11 120.63 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.063 0.459 . . . . 75.51 110.966 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 120' ' ' LYS . 37.0 mt -112.71 132.95 60.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.698 -0.683 . . . . 62.4 109.456 176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -140.8 78.71 1.66 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.793 0.806 . . . . 75.51 110.655 -175.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.7 mt -79.49 80.18 5.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 75.52 109.341 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.97 147.11 47.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.443 -0.799 . . . . 75.51 111.003 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -122.95 -170.78 2.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.522 -0.763 . . . . 70.22 109.045 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -79.43 92.68 5.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.13 -0.693 . . . . 74.41 109.13 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -81.14 76.25 8.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.539 -0.755 . . . . 62.54 111.172 -171.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -131.36 131.13 43.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.51 -0.768 . . . . 54.51 108.994 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -79.46 -35.85 39.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.777 0.323 . . . . 73.41 111.041 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.407 -0.36 . . . . 74.01 110.54 176.019 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.524 HG22 ' HE2' ' A' ' 146' ' ' LYS . 19.2 p . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.347 -0.612 . . . . 74.03 109.347 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 145' ' ' VAL . 40.1 mm -67.16 129.17 31.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.446 -0.343 . . . . 75.12 110.388 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.8 m -63.11 116.47 5.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.356 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -86.61 15.7 5.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 70.05 110.907 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -62.54 -35.23 78.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.774 -0.648 . . . . 73.02 111.848 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.36 15.9 38.55 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.551 -0.833 . . . . 33.45 113.106 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.412 ' HB3' HD12 ' A' ' 34' ' ' ILE . 30.2 m0 -84.06 141.99 30.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.933 0.366 . . . . 72.11 110.842 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.7 pt-20 -136.73 157.36 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.966 0.412 . . . . 54.5 110.373 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.24 122.44 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.747 -0.661 . . . . 73.13 109.94 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 60' ' ' ASP . 71.4 mt -84.75 -39.95 17.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.056 0.455 . . . . 63.45 110.572 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -154.59 142.06 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 61.1 110.091 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.509 ' CE2' ' HG2' ' A' ' 18' ' ' GLN . 32.5 p90 -139.97 145.58 38.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.691 -0.686 . . . . 74.24 109.38 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 m -88.24 -33.88 17.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.86 0.362 . . . . 71.32 111.282 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 t -148.88 151.15 34.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.908 0.385 . . . . 74.22 111.158 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.509 ' HG2' ' CE2' ' A' ' 15' ' ' PHE . 1.5 pp0? -167.81 142.71 3.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.894 -0.78 . . . . 73.01 108.894 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 9.4 tp10 -109.82 94.2 4.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.138 0.494 . . . . 53.51 110.776 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.58 8.01 41.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 62.31 111.048 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -120.01 -46.33 2.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.116 0.484 . . . . 75.32 110.26 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.453 -0.209 0 CA-C-N 115.963 -0.562 . . . . 53.24 112.647 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.6 t30 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.233 -0.654 . . . . 43.12 109.233 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.05 6.6 88.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.993 -0.622 . . . . 62.54 112.175 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.8 mt -80.15 148.59 30.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 72.31 110.565 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.31 -25.71 65.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 73.33 111.191 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -76.39 -23.21 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.796 -0.362 . . . . 74.01 111.254 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 71.1 m -63.08 -27.73 69.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.03 0.443 . . . . 73.23 110.234 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.27 -30.92 70.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 70.02 110.469 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 HG12 ' A' ' 59' ' ' ILE . 46.9 pt -115.23 13.1 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 74.05 111.054 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.4 t70 -77.32 -33.02 55.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 74.0 109.226 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' OE1' ' A' ' 142' ' ' GLU . . . 84.2 55.1 2.83 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.519 -0.764 . . . . 61.12 112.623 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.51 129.62 16.51 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.815 -0.439 . . . . 74.01 109.815 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.598 HG22 HD21 ' A' ' 73' ' ' LEU . 11.1 p -70.21 -19.79 63.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.38 0.511 . . . . 70.33 112.38 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.52 -13.29 40.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.733 0.301 . . . . 73.21 110.893 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -105.36 151.72 23.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.789 -0.448 . . . . 70.42 109.789 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -151.93 162.37 41.18 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.575 -0.45 . . . . 75.0 111.04 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.6 t90 -98.79 137.59 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 74.43 109.271 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.3 t-80 -131.67 139.16 49.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.588 -0.523 . . . . 75.05 109.588 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 151.5 46.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 61.11 109.973 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -61.87 129.32 40.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.318 -0.253 . . . . 73.24 110.318 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -134.71 -32.99 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.073 -0.251 . . . . 72.42 111.068 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -81.27 102.6 10.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.727 -0.471 . . . . 73.5 109.727 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.62 -11.64 53.72 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.921 -0.657 . . . . 72.21 111.54 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.45 149.42 7.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.733 -0.746 . . . . 74.43 112.291 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.5 m -86.16 173.44 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 65.31 111.3 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 24.1 m-20 -98.2 166.51 13.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.966 -0.561 . . . . 63.53 109.787 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 56.9 Cg_endo -71.92 122.76 8.76 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.1 1.867 . . . . 62.3 112.973 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 16.8 mt -67.96 154.49 93.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 75.42 110.139 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 86.6 Cg_endo -81.17 167.21 72.63 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.669 -1.388 . . . . 74.35 113.019 1.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.0 m-85 -104.99 119.43 38.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 64.33 110.491 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.19 125.51 54.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.911 0.386 . . . . 54.44 110.705 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.4 mt -118.62 117.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.446 . . . . 72.03 110.049 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 ' HG3' ' A' ' 125' ' ' ARG . 54.7 t -106.23 122.34 59.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.936 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.701 HG12 HG21 ' A' ' 34' ' ' ILE . 4.6 mp -112.38 139.39 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 75.22 110.609 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.521 ' HB2' HD11 ' A' ' 13' ' ' LEU . 58.0 t0 -103.26 121.19 42.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.333 -0.618 . . . . 73.14 109.333 174.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.1 mtm -88.34 -3.14 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.284 -0.416 . . . . 73.33 110.725 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 65.57 13.44 8.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.712 -0.676 . . . . 63.45 111.991 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' OE1' HD12 ' A' ' 149' ' ' ILE . 4.8 pt20 -165.35 153.8 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.359 -0.608 . . . . 61.45 109.359 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -82.7 123.81 29.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.942 -0.392 . . . . 74.53 109.942 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.4 mt -126.44 139.14 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.167 -0.47 . . . . 74.54 110.374 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -82.1 101.46 10.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.734 -0.839 . . . . 73.23 108.734 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.7 mm -70.55 134.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 61.03 110.811 -174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 -42.57 1.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.067 -0.515 . . . . 71.02 110.699 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.625 ' HG2' ' HD3' ' A' ' 146' ' ' LYS . 11.8 tt0 -147.95 138.73 23.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 72.14 111.444 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.9 143.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.028 -0.73 . . . . 70.33 109.028 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.878 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 17.8 tt0 -120.75 133.72 55.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.175 -0.306 . . . . 75.42 110.175 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 48.1 mt -117.26 121.45 41.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.311 -0.625 . . . . 61.45 109.311 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD21 HG22 ' A' ' 38' ' ' THR . 34.5 tp -102.4 101.27 18.82 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.829 -0.434 . . . . 65.11 109.829 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.6 Cg_endo . . . . . 0 N--CA 1.45 -1.062 0 C-N-CA 122.89 2.393 . . . . 52.13 111.397 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.464 0.259 0 N-CA-C 112.289 0.477 . . . . 73.22 112.289 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.27 40.48 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.949 2.433 . . . . 74.11 112.099 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -94.55 122.1 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 71.44 109.824 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -99.89 -50.35 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 64.24 110.938 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 41.7 t -132.85 139.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 71.54 110.923 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.29 140.14 49.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.268 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 46.9 mt-10 -120.12 130.45 54.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.785 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.82 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.123 -0.49 . . . . 63.42 110.546 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.47 150.54 49.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.158 -0.474 . . . . 33.55 110.363 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CB ' ' A' ' 121' ' ' ALA . . . -138.73 155.74 47.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.367 -0.379 . . . . 74.13 110.088 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.1 t -149.3 147.42 28.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.072 0.463 . . . . 71.45 111.743 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.05 -28.21 17.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 70.35 110.601 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 11.8 p-10 -123.38 4.09 9.09 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.891 0.33 . . . . 74.13 111.891 -173.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.4 t-20 77.24 -20.83 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.522 0.729 . . . . 71.45 111.265 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.1 -54.27 8.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.024 0.44 . . . . 74.13 110.351 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -90.14 103.82 16.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.882 -0.599 . . . . 74.15 110.911 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -94.53 137.16 34.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.178 0.513 . . . . 74.33 110.573 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -122.01 125.12 26.75 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.668 -0.696 . . . . 71.15 109.938 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.7 108.63 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.608 2.205 . . . . 33.44 111.283 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 116' ' ' VAL . 18.2 pt -81.28 -13.46 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.0 -0.546 . . . . 41.31 111.163 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.46 135.18 1.85 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.326 -0.94 . . . . 61.4 112.792 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 60.8 ttt180 -111.69 121.29 44.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.486 -0.561 . . . . 72.15 109.486 172.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -140.0 165.9 26.09 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.768 -0.373 . . . . 72.44 111.01 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -81.39 147.74 27.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.002 -0.618 . . . . 50.32 111.678 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.58 123.32 40.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.932 -0.396 . . . . 74.35 109.932 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.658 ' HB ' HD21 ' A' ' 112' ' ' LEU . 10.3 m -102.13 106.78 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.246 -0.434 . . . . 55.35 110.302 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -65.69 110.29 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 71.34 110.429 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -152.38 177.98 10.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 74.24 109.752 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.9 -9.56 36.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.251 0.548 . . . . 74.05 110.356 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.51 157.65 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 61.23 110.641 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -70.26 144.47 51.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.045 0.45 . . . . 71.1 111.703 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' A' ' 106' ' ' THR . 20.4 mt -99.55 113.85 26.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.525 -0.761 . . . . 70.13 110.146 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 50.4 mt-10 -85.15 115.78 23.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.848 0.356 . . . . 72.43 110.593 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.55 105.36 14.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.779 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -75.86 118.55 18.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.959 -0.756 . . . . 70.14 108.959 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 100' ' ' ILE . 29.4 m -120.67 -172.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.324 0.491 . . . . 71.41 112.324 -171.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -66.53 125.89 27.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.16 -0.927 . . . . 73.52 110.719 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.7 m -74.87 108.06 7.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.035 0.445 . . . . 75.25 110.217 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.74 152.2 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.964 -0.562 . . . . 74.41 109.943 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.6 ' HG3' HD12 ' A' ' 150' ' ' ILE . 1.1 ttmp? -73.36 138.91 45.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.554 -0.536 . . . . 75.03 109.554 175.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . . . -156.27 134.43 11.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.51 -0.313 . . . . 71.34 110.88 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -95.57 -29.82 14.14 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.799 -0.815 . . . . 74.21 108.799 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.9 145.08 41.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.1 -0.954 . . . . 75.11 109.499 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.71 137.18 51.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.657 -0.497 . . . . 74.45 109.657 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.924 ' HG3' HG22 ' A' ' 58' ' ' VAL . 4.4 ttm180 -122.13 130.21 53.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 75.1 111.159 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.2 tp -97.48 118.16 33.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 74.53 109.016 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.6 m -109.97 122.83 48.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.5 . . . . 74.51 111.1 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.1 mm -101.46 94.0 3.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 75.13 108.714 173.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 59.0 Cg_endo -71.48 151.67 59.41 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.86 2.373 . . . . 60.24 113.308 -173.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 12.6 p-10 -89.72 4.79 48.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.589 0.709 . . . . 71.11 109.535 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.16 -34.39 15.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.075 -0.966 . . . . 72.21 111.39 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.18 -3.45 76.0 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.616 -0.802 . . . . 54.12 113.529 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.07 8.18 45.26 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.488 -0.863 . . . . 42.21 111.335 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -69.05 133.73 48.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.309 -0.446 . . . . 74.3 111.608 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 m -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.965 -0.561 . . . . 73.05 109.728 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 38.5 p -84.4 16.27 3.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.971 0.415 . . . . 73.24 111.36 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.83 119.48 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.546 -0.538 . . . . 75.34 109.546 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -144.27 130.91 20.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.59 -0.277 . . . . 73.4 110.613 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -136.64 105.61 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.051 0.453 . . . . 52.15 110.884 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.63 133.14 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.838 -0.43 . . . . 72.21 109.838 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.27 -62.54 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.223 0.327 . . . . 75.12 110.724 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 36' ' ' GLY . 15.1 pt-20 -154.13 161.32 41.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.457 0.646 . . . . 72.32 111.59 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -119.43 135.94 54.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.832 -1.076 . . . . 75.42 108.19 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.463 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.8 t70 -129.23 161.6 29.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.016 -0.364 . . . . 73.42 110.016 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' ILE . 45.4 t -135.35 133.56 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.403 . . . . 73.32 110.267 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.878 ' HE3' ' HB2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -108.86 125.6 52.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.848 -0.797 . . . . 74.45 108.848 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.21 -168.25 30.96 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.407 -0.902 . . . . 42.01 112.449 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.7 m -112.35 132.29 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.465 -0.198 . . . . 74.31 110.465 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 63' ' ' GLN . 40.3 mm -73.36 123.58 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 70.23 110.757 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.6 HD12 ' HG3' ' A' ' 120' ' ' LYS . 48.0 mt . . . . . 0 C--N 1.326 -0.451 0 N-CA-C 109.558 -0.534 . . . . 71.23 109.558 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.237 0.406 0 CA-C-O 120.831 0.348 . . . . 71.14 110.539 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 149' ' ' ILE . 30.0 mm -94.69 132.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.249 -0.432 . . . . 52.1 110.467 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -70.77 123.43 21.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.592 -0.522 . . . . 74.03 109.592 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -98.59 16.41 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 62.03 111.468 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -77.44 -5.15 48.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.911 0.386 . . . . 72.01 111.497 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.89 -0.09 24.28 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.652 -0.785 . . . . 34.42 112.357 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -82.86 153.9 24.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.645 0.26 . . . . 73.44 110.654 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.02 155.4 48.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.93 0.395 . . . . 74.41 110.663 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.33 119.7 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.516 -0.766 . . . . 75.01 109.948 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 60' ' ' ASP . 84.9 mt -84.18 -42.04 16.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.942 -0.572 . . . . 74.41 110.53 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.8 t -149.21 143.73 26.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 71.31 110.131 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -148.88 149.52 31.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 70.3 109.687 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 m -92.57 -44.3 8.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.844 0.313 . . . . 74.22 111.844 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -138.49 149.48 45.45 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.73 -0.388 . . . . 63.35 111.137 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -161.93 142.86 10.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.799 -0.637 . . . . 75.32 109.441 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 tp10 -115.84 93.6 4.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.295 -0.412 . . . . 75.32 110.541 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.91 -14.31 26.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 40.31 111.204 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -98.81 -51.84 3.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.406 -0.361 . . . . 75.21 111.308 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.499 0 C-N-CA 121.065 -0.588 . . . . 73.04 113.38 -175.827 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 CA--C 1.518 -0.287 0 N-CA-C 110.446 -0.205 . . . . 65.32 110.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.7 -7.78 63.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.242 -0.504 . . . . 75.24 112.638 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.8 mt -73.67 142.95 46.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.741 0.305 . . . . 75.23 110.768 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.41 -27.21 68.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 50.11 111.309 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -19.35 61.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 75.13 110.562 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 1.079 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 69.5 m -72.84 -18.42 61.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 73.22 111.032 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 126' ' ' LEU . 32.6 tp -64.88 -24.32 67.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.546 0.689 . . . . 72.3 109.925 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.401 HG21 HG12 ' A' ' 59' ' ' ILE . 35.8 pt -122.6 19.65 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.339 -0.846 . . . . 70.13 109.775 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 1.079 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 22.0 t70 -64.68 -41.57 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.325 -0.852 . . . . 65.4 111.458 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 38.19 5.25 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.471 -0.871 . . . . 71.41 112.077 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -151.28 128.8 11.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.194 -0.298 . . . . 63.04 110.194 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.4 p -75.58 -2.9 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.142 0.423 . . . . 62.22 112.142 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.37 -22.34 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.109 -0.236 . . . . 74.42 110.95 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p -88.55 165.69 14.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.875 -0.417 . . . . 63.34 109.875 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 31.8 p90 -164.97 165.82 19.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.421 . . . . 74.22 111.442 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 36.3 t90 -106.4 141.92 36.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.198 -0.91 . . . . 72.12 109.018 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.4 t-80 -139.62 143.21 37.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.509 -0.552 . . . . 61.35 109.509 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 136.65 50.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.583 -0.525 . . . . 62.33 109.583 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.687 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 3.5 ttpm? -62.87 122.04 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.578 0.228 . . . . 71.42 110.396 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -117.34 -29.13 5.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.524 -0.307 . . . . 75.14 110.686 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.9 110.98 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 73.24 110.251 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.31 -5.95 65.62 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.898 -0.668 . . . . 51.23 111.982 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.84 143.17 5.51 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 45.23 112.459 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.612 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 19.0 m -93.71 144.7 25.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.813 0.34 . . . . 72.01 110.761 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.9 m-20 -76.76 148.02 78.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.083 -0.508 . . . . 51.3 109.965 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 9.6 Cg_exo -72.39 144.25 40.57 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.695 2.263 . . . . 73.24 112.81 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 161.88 77.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 61.25 110.342 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.1 Cg_exo -79.77 168.96 71.96 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.082 -1.216 . . . . 74.32 112.577 -1.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.754 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 25.2 m-85 -107.92 128.74 54.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.688 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.8 133.14 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 64.41 110.172 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 51.0 mt -132.17 111.43 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.868 -0.419 . . . . 65.35 109.868 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 ' HH2' ' A' ' 97' ' ' TRP . 57.8 t -106.42 121.38 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 74.44 111.096 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 34' ' ' ILE . 5.1 mp -116.1 136.19 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.33 . . . . 73.12 110.837 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.0 t0 -96.45 117.5 31.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.149 -0.685 . . . . 73.45 109.149 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.75 -3.28 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.517 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.1 mmtp 73.05 -13.9 0.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.625 0.77 . . . . 73.3 112.401 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -147.53 177.14 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.9 0.381 . . . . 72.34 110.953 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 121.51 30.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.609 . . . . 51.42 110.209 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 5' ' ' ILE . 67.7 mt -129.18 134.81 63.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.891 0.377 . . . . 75.24 110.259 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -81.77 105.76 13.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.194 -0.669 . . . . 61.22 109.194 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 118' ' ' SER . 10.2 mm -80.18 117.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.231 -0.285 . . . . 62.44 110.231 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.19 -41.92 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 61.43 110.665 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -144.59 138.84 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.004 -0.544 . . . . 71.04 110.865 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -110.2 133.94 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.387 -0.598 . . . . 72.42 109.387 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 52.8 mt-10 -114.42 127.93 56.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.033 0.444 . . . . 62.24 110.834 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.0 mt -109.35 125.95 52.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.876 -0.602 . . . . 73.05 109.709 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -112.27 96.44 35.23 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.164 -0.68 . . . . 65.04 109.164 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 56.6 Cg_endo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.443 2.095 . . . . 72.52 111.589 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.457 HD21 HD12 ' A' ' 83' ' ' ILE . 21.8 t-20 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 120.758 0.313 . . . . 64.31 110.823 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 71.6 Cg_endo -92.55 19.47 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.127 2.551 . . . . 41.54 112.813 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.457 HD12 HD21 ' A' ' 81' ' ' ASN . 58.7 mt -79.59 129.89 36.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 53.14 109.772 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.93 -38.05 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.856 -0.611 . . . . 73.11 110.419 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.97 137.96 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 75.31 111.206 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.38 141.66 45.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.142 -0.481 . . . . 72.24 110.507 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -118.32 132.79 56.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 63.21 109.937 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.71 133.34 55.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.441 -0.345 . . . . 75.35 110.466 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.98 146.76 50.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.788 0.328 . . . . 74.23 111.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.39 146.41 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 75.41 110.162 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.4 t -140.17 157.46 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.226 0.536 . . . . 62.33 111.516 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.8 mt-10 -116.14 -32.23 5.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 74.33 110.668 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -114.82 5.13 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 74.31 112.161 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 71.92 -1.91 2.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.119 0.568 . . . . 62.53 111.752 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 -51.69 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 52.0 110.195 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -89.94 112.72 24.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.796 -0.638 . . . . 72.52 110.538 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.428 ' HH2' HG13 ' A' ' 58' ' ' VAL . 97.9 m95 -104.81 108.04 19.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.07 -0.514 . . . . 73.3 109.935 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 80.7 m -89.28 120.05 69.73 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.287 -0.415 . . . . 71.02 110.314 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 42.2 Cg_endo -66.82 110.9 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.396 2.064 . . . . 74.43 110.83 174.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -86.38 -10.12 11.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.124 -0.489 . . . . 70.23 110.81 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.91 128.7 0.98 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.083 -1.056 . . . . 64.54 113.322 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.27 117.2 33.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.387 -0.968 . . . . 64.25 108.387 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.58 175.28 9.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.124 0.488 . . . . 74.41 111.47 -171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.79 15.79 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.35 -0.841 . . . . 71.45 111.745 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.589 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 51.4 t80 -97.01 148.01 23.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 73.04 110.106 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -142.71 112.06 6.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.398 -0.364 . . . . 72.03 110.444 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -72.54 114.42 10.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.071 0.462 . . . . 74.22 110.556 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 74' ' ' PRO . 13.2 pt20 -154.07 179.8 8.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.622 -0.717 . . . . 73.44 109.43 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.88 -5.39 51.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 75.04 110.283 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.97 36.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 44.32 110.208 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.65 140.33 58.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.045 0.45 . . . . 72.43 110.886 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 32.8 mt -94.81 104.75 16.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.719 -0.673 . . . . 71.4 110.248 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -79.97 109.04 14.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.004 0.431 . . . . 73.32 110.752 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.12 104.59 14.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.069 -0.514 . . . . 64.25 110.404 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -70.86 106.75 3.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.994 -0.743 . . . . 75.45 108.994 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 27.4 m -106.08 174.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.903 0.382 . . . . 71.44 111.445 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HD3' ' HB ' ' A' ' 119' ' ' ILE . 7.5 tmtm? -64.04 122.51 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 75.14 110.086 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 25.1 m -66.53 114.82 5.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.93 -0.577 . . . . 72.23 109.92 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.444 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 12.8 tt -144.19 145.07 22.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.861 0.363 . . . . 70.5 110.958 -174.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.536 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -94.29 115.21 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.97 -0.752 . . . . 54.3 108.97 175.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.522 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.3 175.22 10.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 34.14 111.303 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -118.39 -34.19 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 72.31 110.362 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -107.52 146.21 32.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.932 -0.577 . . . . 75.1 110.25 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.16 137.91 53.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.945 -0.571 . . . . 72.22 109.827 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 28.3 ttp180 -123.52 122.54 38.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.499 -0.319 . . . . 72.31 110.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 37.2 tp -84.69 113.03 21.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.515 -0.92 . . . . 54.04 108.515 169.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 22.8 m -103.48 118.37 36.58 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.574 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.754 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.3 mm -102.51 96.76 7.78 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.712 -0.847 . . . . 71.33 108.712 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 72.8 Cg_endo -76.44 175.98 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.391 2.061 . . . . 64.34 112.595 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.95 13.25 29.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.729 0.776 . . . . 71.13 109.141 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.93 144.76 25.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.677 -1.147 . . . . 71.31 111.093 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.96 57.86 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.992 -0.623 . . . . 70.4 113.38 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 115.97 22.55 4.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.274 -0.965 . . . . 74.25 112.655 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -68.15 155.01 40.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 72.42 110.821 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.402 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 50.7 m -129.39 -176.89 4.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.02 110.197 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 40.3 p -85.23 22.58 1.44 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 72.41 111.605 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.1 123.55 68.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.574 -0.528 . . . . 71.34 109.574 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.14 138.88 30.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.469 -0.332 . . . . 71.23 110.216 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.75 105.24 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 73.14 111.026 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 42.3 mt -129.45 132.57 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.437 -0.579 . . . . 42.14 109.437 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.579 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 31.6 mmt180 -67.36 -67.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.465 -0.568 . . . . 74.23 109.465 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.45 152.81 47.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 73.35 111.494 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -112.76 116.09 29.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.456 -1.312 . . . . 63.11 107.456 166.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.83 161.39 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.753 -0.462 . . . . 65.44 109.753 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -131.51 125.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.282 -0.417 . . . . 63.24 110.262 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 47.0 mttp -102.31 105.06 15.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.417 0.627 . . . . 74.23 109.354 174.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.5 -148.93 4.86 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.181 -0.918 . . . . 63.22 111.524 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.8 m -132.71 129.25 38.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.809 0.337 . . . . 72.23 110.878 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 5' ' ' ILE . 31.6 mm -71.71 119.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.616 . . . . 73.21 110.567 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.536 HD12 ' HG2' ' A' ' 120' ' ' LYS . 46.2 mt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 72.01 109.757 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.904 0.383 . . . . 71.43 110.177 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 65' ' ' ILE . 21.2 mm -72.08 137.2 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.969 -0.56 . . . . 74.12 111.337 -172.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -70.87 111.21 6.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.941 -0.572 . . . . 72.35 110.538 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -87.04 3.46 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.72 -0.673 . . . . 51.33 111.803 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -66.88 -26.59 66.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.942 0.401 . . . . 64.34 110.779 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.84 -5.6 68.27 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.557 -0.83 . . . . 75.51 112.082 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -81.81 158.43 24.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.606 0.241 . . . . 71.25 110.643 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 pt-20 -142.37 158.26 43.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.913 0.387 . . . . 63.13 110.199 173.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.22 125.78 45.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 70.45 109.62 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 87.7 mt -94.75 -41.12 9.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.321 -0.399 . . . . 74.3 110.715 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.0 t -142.48 140.92 32.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 73.41 110.613 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.43 136.32 19.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.829 -0.623 . . . . 75.34 109.655 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -87.84 -33.4 18.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 74.51 111.156 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -146.6 146.61 30.49 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.93 0.395 . . . . 74.34 110.955 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -162.01 140.47 9.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 72.45 108.839 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.8 tp10 -109.78 81.84 1.5 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.336 0.589 . . . . 72.13 111.331 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.43 -4.26 53.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.449 -0.796 . . . . 72.15 110.467 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -100.27 -53.54 3.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.74 -0.664 . . . . 65.05 111.092 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.457 0 C-N-CA 121.3 -0.476 . . . . 75.4 112.412 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 CA--C 1.519 -0.232 0 N-CA-C 109.675 -0.491 . . . . 72.24 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 5.87 88.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 62.31 112.832 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.2 mt -77.57 139.38 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.384 -0.228 . . . . 53.15 110.384 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.14 -21.27 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.03 111.529 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -22.28 46.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 73.44 110.901 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.882 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 86.3 m -69.63 -18.29 63.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.058 -0.519 . . . . 61.52 110.642 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.92 -27.46 69.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 75.52 110.176 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 59' ' ' ILE . 34.2 pt -120.32 18.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 64.21 110.208 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.882 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -63.92 -45.75 87.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 73.55 110.222 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.08 24.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.631 -0.795 . . . . 60.21 112.708 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.49 131.73 54.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 74.41 111.134 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.7 p -71.55 -10.26 59.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.713 -0.676 . . . . 73.23 111.079 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.91 -21.67 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.33 111.058 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 17.1 p -89.76 169.77 11.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.091 -0.337 . . . . 74.35 110.091 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.2 p90 -163.62 157.9 19.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 74.12 111.284 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.499 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 34.8 t90 -103.83 142.41 34.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.283 -0.871 . . . . 74.5 108.98 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' GLU . 38.4 t-80 -138.72 144.53 39.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.532 -0.544 . . . . 74.2 109.532 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 144.39 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.027 -0.36 . . . . 45.12 110.027 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HE3' ' O ' ' A' ' 49' ' ' GLY . 29.2 ttpt -72.61 126.47 29.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.487 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -125.15 -24.84 3.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.39 -0.368 . . . . 74.43 110.772 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -71.19 112.56 7.43 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.087 0.47 . . . . 75.24 110.461 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.16 12.99 56.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.957 -0.639 . . . . 73.52 111.763 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.523 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . 107.97 143.02 10.48 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.091 -0.804 . . . . 74.13 111.091 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.4 m -85.78 166.79 15.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.71 0.29 . . . . 75.33 110.72 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 22.7 m-20 -91.13 148.9 38.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.421 -0.354 . . . . 72.12 110.518 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 12.0 Cg_exo -71.23 151.48 60.68 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.053 2.502 . . . . 71.35 112.531 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 15.5 mt -93.85 159.65 34.13 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.634 -0.712 . . . . 70.21 110.391 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.3 Cg_endo -81.73 161.54 79.41 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 123.481 -1.466 . . . . 73.04 112.845 2.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.807 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.1 m-85 -91.13 123.1 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.566 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.744 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 0.7 OUTLIER -109.49 123.36 49.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.447 -0.797 . . . . 74.31 110.361 -178.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 126' ' ' LEU . 61.8 mt -127.77 110.76 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.812 -0.44 . . . . 72.54 109.812 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG13 ' CH2' ' A' ' 97' ' ' TRP . 59.5 t -104.81 122.11 57.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.873 -0.603 . . . . 72.34 110.69 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 34' ' ' ILE . 57.5 mt -119.77 136.31 57.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.02 -0.537 . . . . 71.33 110.591 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.7 t0 -101.73 123.8 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 72.04 110.339 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 67' ' ' ILE . 68.5 mtm -90.52 -3.1 57.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 61.14 110.783 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 71.79 0.2 3.42 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.365 0.666 . . . . 75.44 112.688 173.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -163.81 170.95 16.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.431 -0.211 . . . . 71.34 110.431 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ALA . 1.9 m120 -79.47 127.16 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 52.31 110.206 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.446 ' CD1' HG21 ' A' ' 5' ' ' ILE . 75.0 mt -133.42 135.46 56.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.753 -0.462 . . . . 74.21 109.753 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 150' ' ' ILE . 51.5 tp60 -80.11 104.09 10.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.009 -0.737 . . . . 64.01 109.009 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.6 mm -74.41 108.12 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.637 -0.256 . . . . 71.11 110.564 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.26 -50.79 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 73.34 110.895 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -142.23 140.08 32.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.025 0.441 . . . . 75.22 111.09 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.0 129.09 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 75.53 109.445 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -111.47 129.43 56.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.068 0.461 . . . . 62.42 110.971 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 114' ' ' TYR . 54.3 mt -116.77 129.36 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.804 -0.634 . . . . 73.23 110.241 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.4 tp -106.92 104.94 53.88 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.285 -0.416 . . . . 51.55 110.231 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.649 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 Cg_exo . . . . . 0 C--N 1.345 0.365 0 C-N-CA 123.51 2.806 . . . . 73.03 111.477 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.596 HD21 ' HE2' ' A' ' 105' ' ' PHE . 64.5 t30 . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 109.52 -0.548 . . . . 62.14 109.52 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.51 40.91 1.02 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.191 2.594 . . . . 71.25 113.636 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mt -83.48 130.73 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.879 -0.415 . . . . 60.13 109.879 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -109.99 -56.18 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.87 -0.605 . . . . 61.31 110.578 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 ' HA3' ' A' ' 132' ' ' GLY . 92.6 t -118.83 137.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.549 . . . . 61.14 110.622 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -127.4 134.56 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.615 . . . . 62.23 110.273 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 45.4 mt-10 -115.91 125.87 53.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.223 0.535 . . . . 75.1 110.614 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -104.87 129.45 53.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.807 -0.633 . . . . 72.04 109.967 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.33 151.21 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 72.32 110.779 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.01 150.25 51.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.901 -0.591 . . . . 73.35 109.86 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -149.63 161.11 42.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.101 0.477 . . . . 51.14 111.047 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 32.7 mt-10 -120.29 -7.14 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.0 -0.546 . . . . 72.43 110.603 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -122.14 -9.81 8.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.641 -0.254 . . . . 71.25 111.036 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 73.58 6.46 5.02 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.907 0.755 . . . . 72.34 110.331 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.4 t -113.84 -50.71 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.686 -0.688 . . . . 62.44 110.301 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -98.4 104.78 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.734 -0.666 . . . . 70.32 109.863 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CH2' HG13 ' A' ' 58' ' ' VAL . 99.0 m95 -91.71 131.14 37.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.053 -0.521 . . . . 72.4 110.529 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 m -110.67 122.82 37.21 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 116.006 -0.543 . . . . 62.5 109.91 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 125.71 15.94 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.427 2.085 . . . . 72.41 111.723 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 HG21 ' A' ' 116' ' ' VAL . 28.7 pt -100.4 -17.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 64.1 110.57 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.65 133.23 1.82 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.891 -1.147 . . . . 65.42 113.025 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 9.9 ttt180 -114.99 114.96 26.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.86 -0.793 . . . . 74.51 108.86 172.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.403 ' HE2' HG12 ' A' ' 116' ' ' VAL . 56.9 m-85 -138.69 -174.25 3.78 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.402 -0.519 . . . . 64.12 111.124 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.61 146.04 16.33 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.944 -0.646 . . . . 51.11 112.043 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.596 ' HE2' HD21 ' A' ' 81' ' ' ASN . 42.8 t80 -99.1 148.69 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 74.41 110.057 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -139.61 127.49 22.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.298 -0.41 . . . . 72.33 110.193 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -80.87 100.3 8.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.185 0.517 . . . . 74.11 110.187 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -140.73 172.98 11.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.716 -0.675 . . . . 72.42 109.996 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.98 -3.92 58.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 75.33 110.603 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.42 34.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.935 -0.575 . . . . 63.21 110.452 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 131.17 45.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.124 0.488 . . . . 54.43 110.708 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.37 114.29 21.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.641 -0.709 . . . . 74.41 110.637 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.41 108.56 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 74.23 110.711 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 72' ' ' LEU . 96.1 m-85 -100.89 104.33 15.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 54.13 110.523 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -74.3 99.78 3.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.611 -0.722 . . . . 73.14 109.28 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 100' ' ' ILE . 26.9 m -100.47 175.22 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 63.22 111.814 -173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.89 113.15 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 72.11 109.295 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.771 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 49.7 m -68.98 118.01 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 64.24 111.258 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -146.7 150.41 14.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 72.33 110.028 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.0 ttpp -83.88 133.12 34.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.904 -0.406 . . . . 70.33 109.904 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -154.64 171.82 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.416 -0.357 . . . . 73.14 110.433 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -114.61 -35.01 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.372 0.606 . . . . 72.33 109.82 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -108.08 145.01 34.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.754 . . . . 71.21 109.902 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -128.87 139.33 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.39 -0.596 . . . . 51.11 109.39 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.744 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 31.5 ttp180 -127.29 124.56 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.103 0.477 . . . . 74.32 111.804 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 57' ' ' ILE . 41.2 tp -87.4 112.34 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.704 -0.851 . . . . 70.51 108.704 171.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -107.59 117.09 33.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.952 0.406 . . . . 71.13 110.81 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.807 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -101.27 95.25 4.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.596 -0.89 . . . . 65.01 108.596 172.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.683 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -74.36 172.87 15.23 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.384 2.056 . . . . 63.13 112.529 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.26 25.9 4.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.889 0.852 . . . . 41.3 109.133 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -113.57 142.83 45.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.432 -1.258 . . . . 44.33 110.096 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' HG23 ' A' ' 85' ' ' VAL . . . 100.29 -18.11 55.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.83 -0.7 . . . . 75.42 113.044 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 112.95 17.09 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.33 -0.938 . . . . 62.24 112.248 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.7 127.73 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 53.23 110.663 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.3 m -93.84 -179.73 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.29 -0.414 . . . . 72.42 110.069 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 2.0 p -81.3 31.49 0.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.07 0.462 . . . . 61.44 111.954 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.28 130.77 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.626 -0.509 . . . . 72.14 109.626 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.28 31.11 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.974 -0.38 . . . . 74.23 109.974 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.6 105.93 4.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.138 0.494 . . . . 60.13 111.521 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.3 mt -129.89 132.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.415 -0.587 . . . . 65.33 109.415 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.649 ' HD3' ' O ' ' A' ' 74' ' ' PRO . 58.6 mtp180 -72.54 -52.16 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.321 -0.152 . . . . 71.2 110.914 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.39 160.46 34.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.723 -0.791 . . . . 61.14 112.097 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -118.91 127.92 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.691 -1.14 . . . . 73.53 108.602 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.19 145.68 47.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.871 -0.418 . . . . 72.44 109.871 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.39 124.39 72.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.047 0.451 . . . . 65.0 110.21 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 16.1 ttmt -103.31 103.67 13.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.814 -0.63 . . . . 74.34 109.341 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.54 -168.23 15.25 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.721 -0.752 . . . . 42.23 112.166 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.5 m -118.2 134.08 55.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.59 0.233 . . . . 62.5 110.708 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.406 HD11 HD12 ' A' ' 5' ' ' ILE . 38.0 mm -71.67 133.04 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 63.13 111.326 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 120' ' ' LYS . 56.6 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.616 -0.72 . . . . 74.04 109.132 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 120.912 0.387 . . . . 35.02 110.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CD1' ' A' ' 65' ' ' ILE . 39.0 mm -88.59 136.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.912 -0.585 . . . . 65.42 110.24 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 m -69.37 120.35 15.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.98 0.419 . . . . 61.24 110.007 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -88.15 5.96 38.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 64.44 111.016 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 88.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.887 -0.597 . . . . 74.35 110.406 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.67 -13.66 3.67 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.513 -0.767 . . . . 64.11 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -69.5 142.26 53.76 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.725 -0.472 . . . . 75.04 109.725 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 21.8 pt-20 -127.89 158.76 36.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.186 0.517 . . . . 61.4 111.109 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 114.67 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 60.3 110.023 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 60' ' ' ASP . 81.7 mt -81.35 -48.74 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.036 -0.529 . . . . 73.45 110.229 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -147.19 142.16 26.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 52.24 110.371 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.18 146.88 34.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.686 -0.688 . . . . 75.34 109.196 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -86.0 -37.49 18.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.858 0.361 . . . . 72.42 111.176 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -153.89 149.8 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.014 0.435 . . . . 72.12 111.109 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 24.8 pt20 -159.01 146.4 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.069 -1.086 . . . . 75.23 108.069 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -99.31 94.73 6.62 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 75.4 110.407 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.74 -0.83 23.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.665 -0.698 . . . . 74.05 110.853 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 m -114.26 -37.94 4.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.139 -0.482 . . . . 54.12 110.94 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 CA-C-N 116.012 -0.54 . . . . 64.24 112.891 -178.806 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.4 t30 . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 109.247 -0.649 . . . . 74.3 109.247 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.33 -1.16 76.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.975 -0.631 . . . . 63.2 111.808 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 63.8 mt -77.08 150.31 35.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.273 -0.269 . . . . 54.51 110.273 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.47 -29.95 69.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 51.3 110.108 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -67.62 -22.69 65.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 63.33 111.374 177.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.8 m -68.86 -25.2 64.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.971 0.415 . . . . 72.13 110.293 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.22 -27.87 69.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.694 -0.684 . . . . 61.32 110.361 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 59' ' ' ILE . 31.3 pt -119.31 14.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 73.25 110.434 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.825 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.0 t70 -65.15 -40.7 94.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 71.41 110.548 -176.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.6 25.76 13.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 43.44 111.882 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -131.8 122.35 25.64 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.652 -0.499 . . . . 74.23 109.652 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 p -75.07 -7.79 54.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.906 -0.588 . . . . 75.54 111.791 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -85.65 -24.2 27.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 72.44 110.38 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.0 p -96.95 155.8 16.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.292 -0.413 . . . . 63.23 110.454 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.717 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 40.9 p90 -149.07 168.91 21.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.855 0.36 . . . . 72.33 111.153 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.6 t90 -104.85 138.4 41.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 72.02 109.083 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -133.88 136.96 44.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.411 -0.588 . . . . 74.34 109.411 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.43 58.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.672 -0.492 . . . . 73.1 109.672 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 50' ' ' SER . 53.6 tttm -64.87 120.17 12.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 72.22 110.369 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -111.19 -30.91 7.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.844 -0.617 . . . . 74.52 110.845 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -73.11 129.21 37.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.996 -0.372 . . . . 72.03 109.996 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.06 -12.27 62.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.946 -0.645 . . . . 53.3 111.974 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.23 140.96 5.9 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.599 -0.601 . . . . 33.41 111.599 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 9.8 p -81.94 145.79 30.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.662 0.268 . . . . 70.25 110.812 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.72 156.02 90.35 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.096 -0.502 . . . . 74.12 110.339 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.32 148.79 49.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.526 2.151 . . . . 74.13 113.01 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -82.46 158.69 65.77 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 61.42 109.866 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.91 159.31 91.24 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.497 -1.46 . . . . 62.25 112.678 0.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.8 m-85 -91.3 117.89 30.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.092 -0.503 . . . . 74.35 110.196 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.692 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.2 t70 -108.16 126.7 53.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.528 -0.76 . . . . 65.02 110.572 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 57.9 mt -130.64 114.96 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 74.51 110.242 175.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.13 115.82 49.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.948 -0.569 . . . . 72.21 110.984 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 34' ' ' ILE . 49.4 mm -112.16 142.79 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.493 . . . . 73.24 110.822 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HB2' HD11 ' A' ' 13' ' ' LEU . 59.0 t0 -108.77 121.6 45.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.912 -0.585 . . . . 54.43 109.508 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 68.3 mtm -85.15 -9.65 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 55.21 111.155 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 71.6 mmtt 68.33 16.04 9.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.148 -0.478 . . . . 73.2 112.215 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.514 ' HG2' ' O ' ' A' ' 61' ' ' MET . 8.3 pt20 -169.17 159.51 9.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.61 0.243 . . . . 75.32 110.936 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.78 126.0 33.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.481 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.512 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.8 mt -135.95 140.45 44.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.064 -0.517 . . . . 70.13 110.304 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.0 tp60 -82.86 101.81 11.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.188 -0.671 . . . . 75.43 109.188 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.5 mm -66.8 122.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.551 -0.295 . . . . 70.25 110.328 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.46 -33.09 4.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.738 0.304 . . . . 54.43 111.429 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.687 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 10.3 tt0 -159.41 145.41 16.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.571 -0.286 . . . . 63.33 110.384 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -114.18 137.24 48.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.49 -0.559 . . . . 75.42 109.49 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 16.7 tt0 -112.9 132.6 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.832 -0.347 . . . . 74.11 110.185 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.462 HD12 ' CE2' ' A' ' 114' ' ' TYR . 44.5 mt -120.4 116.82 26.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.384 . . . . 75.3 110.146 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.4 tp -101.91 103.91 32.26 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.348 -0.612 . . . . 75.21 109.348 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 15.3 Cg_exo . . . . . 0 CA--C 1.53 0.282 0 C-N-CA 123.438 2.759 . . . . 62.03 112.835 -176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 61.3 t30 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 121.167 0.508 . . . . 54.12 110.255 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 81' ' ' ASN . 4.1 Cg_exo -74.47 60.5 5.01 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.164 2.576 . . . . 64.41 113.474 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -92.17 125.54 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.825 -0.435 . . . . 64.4 109.825 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -93.4 -53.05 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.027 -0.533 . . . . 73.12 110.003 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.73 137.45 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 65.42 110.836 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 m -121.68 135.22 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.73 . . . . 63.21 109.542 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 54.6 mt-10 -119.05 125.48 49.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.03 0.443 . . . . 74.32 110.646 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB2' HG13 ' A' ' 100' ' ' ILE . 47.4 m-85 -104.81 131.08 52.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 64.32 110.424 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.57 149.81 49.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.224 -0.444 . . . . 74.25 110.145 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.83 48.49 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.48 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 t -149.86 152.49 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.949 0.404 . . . . 63.3 110.199 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.673 ' HB3' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.23 7.32 10.22 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.418 0.628 . . . . 75.33 109.804 175.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.4 -15.06 7.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.342 -0.845 . . . . 73.33 109.904 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.45 7.22 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.355 -0.839 . . . . 64.43 110.103 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.69 -59.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.477 -0.783 . . . . 62.24 110.512 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -88.78 104.05 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 74.35 110.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.8 m95 -91.96 116.05 28.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.901 0.381 . . . . 74.24 110.608 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.5 m -94.83 125.08 52.51 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.972 -0.558 . . . . 74.15 110.444 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 111.47 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.665 2.243 . . . . 72.41 111.51 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 116' ' ' VAL . 20.1 pt -89.93 -9.88 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.321 -0.4 . . . . 60.13 111.404 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.35 128.7 0.98 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.259 -1.448 . . . . 42.41 114.287 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 7.5 ttm180 -98.75 126.17 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.84 -0.8 . . . . 71.24 108.84 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.7 m-85 -141.82 169.24 17.96 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.26 -0.576 . . . . 72.3 111.394 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.32 139.26 15.94 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.649 . . . . 62.32 111.765 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -95.33 148.23 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.109 0.48 . . . . 72.11 110.701 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 112' ' ' LEU . 85.6 m -132.3 114.25 14.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.0 -0.546 . . . . 64.4 110.062 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -75.48 97.4 3.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.44 . . . . 62.04 110.102 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 12.6 pt20 -136.27 -179.97 5.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.88 -0.6 . . . . 73.13 110.423 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.46 9.82 42.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 64.14 110.247 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.66 151.14 39.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.692 -0.686 . . . . 55.42 109.973 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -75.95 128.17 34.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.161 0.505 . . . . 70.11 111.605 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 106' ' ' THR . 26.7 mt -82.75 117.88 22.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.485 -0.78 . . . . 75.4 110.388 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.687 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 43.4 mt-10 -92.87 111.76 23.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.923 0.392 . . . . 64.34 110.811 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CE2' HD12 ' A' ' 72' ' ' LEU . 85.0 m-85 -105.15 107.41 18.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.071 0.462 . . . . 75.55 110.516 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -76.96 95.07 4.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.587 -0.733 . . . . 52.23 109.36 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.424 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.3 m -97.58 179.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.512 -0.767 . . . . 54.43 111.817 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -65.75 134.94 54.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.739 . . . . 65.04 110.816 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 45.9 p -79.1 123.32 27.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.805 -0.634 . . . . 71.33 110.366 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.3 tt -157.84 148.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 65.4 110.757 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.37 122.76 28.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.693 -0.484 . . . . 75.33 109.693 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . . . -144.72 175.39 10.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.351 -0.386 . . . . 74.22 111.002 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -127.79 -32.51 2.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.377 0.608 . . . . 73.33 109.631 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.51 145.6 31.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.59 -0.732 . . . . 64.11 109.424 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 59' ' ' ILE . 11.4 tt -131.47 135.16 59.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.015 0.436 . . . . 72.24 109.872 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.692 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 54.5 ttp180 -121.76 118.48 29.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.045 0.45 . . . . 72.01 111.04 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 57.5 tp -87.43 119.71 27.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 74.34 109.063 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 45.5 m -116.42 120.51 39.04 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.933 0.397 . . . . 54.11 111.123 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.0 mm -98.76 95.96 3.54 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.311 -0.996 . . . . 72.41 108.311 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.99 163.33 39.63 Favored 'Trans proline' 0 CA--C 1.52 -0.179 0 C-N-CA 123.056 2.504 . . . . 51.45 113.575 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.57 71.49 0.79 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.559 -0.904 . . . . 72.32 108.559 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -149.42 -39.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.027 -0.988 . . . . 61.43 110.901 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.57 -6.18 83.66 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.384 -0.912 . . . . 54.02 113.705 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.78 26.94 7.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.974 -1.107 . . . . 64.32 111.917 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -72.69 137.02 45.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.601 0.239 . . . . 64.12 110.447 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -94.68 173.0 7.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.252 -0.431 . . . . 63.14 110.171 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 p -81.33 10.89 4.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.422 0.527 . . . . 71.23 112.422 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 94.8 t -109.07 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.417 . . . . 71.52 110.089 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.55 125.02 48.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.911 -0.586 . . . . 53.53 110.055 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -142.57 109.08 5.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.281 0.562 . . . . 73.34 111.558 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.93 132.67 69.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.144 -0.687 . . . . 72.13 109.144 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 94.1 mtt180 -67.16 -62.48 1.41 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.082 0.468 . . . . 64.14 110.212 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.48 148.75 34.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 73.02 111.614 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.42 126.74 54.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.405 -1.332 . . . . 73.44 107.405 170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.73 157.95 29.84 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.729 -0.471 . . . . 75.01 109.729 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.12 124.19 63.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.199 0.523 . . . . 51.23 110.471 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 80.2 mttt -102.18 112.17 24.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.441 -0.799 . . . . 73.5 108.862 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.99 -175.01 32.56 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.3 -0.952 . . . . 71.3 112.685 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 m -104.94 127.91 52.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.589 0.233 . . . . 74.31 110.795 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.431 HD11 HD12 ' A' ' 5' ' ' ILE . 36.0 mm -65.99 128.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.254 -0.43 . . . . 65.41 110.722 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 66' ' ' GLN . 60.4 mt . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.3 111.272 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p . . . . . 0 N--CA 1.45 -0.472 0 N-CA-C 109.966 -0.383 . . . . 74.33 109.966 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 65' ' ' ILE . 44.4 mm -81.76 148.24 5.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.62 -0.264 . . . . 75.53 110.559 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -66.24 107.08 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.903 0.382 . . . . 74.03 110.301 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 144' ' ' ASP . 37.8 mtmt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.147 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -71.06 -10.26 59.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.026 -0.534 . . . . 44.34 111.624 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.28 9.32 38.84 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.859 -0.686 . . . . 65.25 111.967 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB2' HD12 ' A' ' 34' ' ' ILE . 30.4 m0 -90.9 161.94 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.014 -0.365 . . . . 73.01 110.014 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.4 pt-20 -141.37 159.81 41.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 72.41 110.731 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.02 116.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.608 -0.724 . . . . 61.34 110.132 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 60' ' ' ASP . 59.4 mt -80.84 -43.62 19.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.921 -0.581 . . . . 72.21 110.711 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 t -142.45 140.71 32.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 64.3 110.371 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.02 146.14 29.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.471 -0.786 . . . . 72.33 109.13 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -85.51 -33.95 21.67 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.723 -0.391 . . . . 73.21 110.952 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -155.6 152.34 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.05 0.452 . . . . 75.0 110.885 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -163.19 145.99 10.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.153 -1.054 . . . . 72.22 108.153 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.52 98.21 10.36 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.44 0.638 . . . . 71.35 110.189 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 8.4 29.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.874 . . . . 73.12 111.425 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 m -136.52 -43.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.908 -0.317 . . . . 64.21 111.346 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 121.078 -0.582 . . . . 73.22 112.769 -179.549 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.0 t30 . . . . . 0 CA--C 1.52 -0.179 0 N-CA-C 109.916 -0.401 . . . . 73.31 109.916 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.16 3.49 72.74 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.846 -0.901 . . . . 73.33 110.846 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 51.3 mt -84.42 159.15 20.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.177 -0.512 . . . . 74.11 110.299 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.39 -28.83 68.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 73.13 110.909 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -75.45 -20.8 58.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 74.21 111.37 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 64.5 m -69.76 -23.76 63.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 72.05 110.532 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.73 -21.2 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.698 -0.683 . . . . 74.43 110.543 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 59' ' ' ILE . 30.4 pt -127.65 24.12 2.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 54.23 110.41 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.658 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.7 t70 -75.22 -38.8 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.117 -0.492 . . . . 55.43 111.533 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 40.68 3.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.265 -0.734 . . . . 62.41 111.265 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 8.9 t0 -153.64 126.21 8.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.728 -0.471 . . . . 71.34 109.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -73.23 -14.38 61.32 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.871 0.693 . . . . 63.25 112.871 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -93.53 -13.06 28.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 74.13 110.638 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 41.2 p -97.22 137.1 36.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.204 -0.665 . . . . 73.14 109.204 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.978 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 4.0 p90 -145.07 171.57 14.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.959 0.409 . . . . 75.33 111.111 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.52 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 41.5 t90 -105.19 125.46 51.0 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 70.22 109.256 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -124.47 137.49 54.43 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.425 -0.954 . . . . 74.0 108.425 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 144.88 56.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.625 -0.509 . . . . 32.41 109.625 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -65.59 112.58 3.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.838 0.351 . . . . 60.31 110.324 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -103.08 -25.08 13.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.364 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.51 121.64 15.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 74.44 110.318 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.89 -3.62 83.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.924 -0.655 . . . . 65.22 113.002 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.26 148.5 8.55 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.727 -0.749 . . . . 62.42 111.884 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 24.9 p -82.86 148.61 27.62 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.986 0.422 . . . . 74.1 111.338 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.79 158.98 86.8 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.637 . . . . 73.15 110.642 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.43 136.75 29.32 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.181 1.921 . . . . 60.1 112.413 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 16.5 mt -77.99 161.5 70.77 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 75.04 110.157 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.879 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 3.6 Cg_exo -81.9 162.23 78.16 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 124.115 -1.202 . . . . 44.22 112.585 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.9 m-85 -97.21 133.6 41.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 73.44 109.742 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 22.1 t70 -131.68 117.63 18.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.676 0.274 . . . . 73.53 110.518 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.45 119.39 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.819 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -107.01 119.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.389 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.525 ' HB ' HG23 ' A' ' 124' ' ' ILE . 75.2 mt -118.06 139.82 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.407 -0.36 . . . . 62.23 111.232 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 13' ' ' LEU . 54.8 t0 -108.27 121.85 45.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.052 -0.522 . . . . 73.44 109.629 176.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.5 mtm -86.01 -8.29 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 64.25 111.068 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.478 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 73.3 -11.93 0.86 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.244 0.618 . . . . 64.11 112.591 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -144.14 167.26 22.82 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.132 -0.321 . . . . 75.52 110.132 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.29 128.78 34.97 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.816 0.341 . . . . 73.32 110.092 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.537 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.7 mt -135.19 137.98 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.451 -0.34 . . . . 74.44 110.283 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -82.31 103.28 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.233 -0.654 . . . . 74.44 109.233 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 118' ' ' SER . 26.5 mm -70.11 125.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.469 -0.332 . . . . 70.34 110.119 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.34 -48.54 2.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 70.21 110.813 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.435 ' NE2' ' HE2' ' A' ' 146' ' ' LYS . 23.7 tt0 -147.59 146.42 29.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 72.35 109.977 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.15 131.96 70.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.16 -0.473 . . . . 61.54 110.049 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -109.84 135.66 50.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.074 0.464 . . . . 70.41 111.048 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 57.1 mt -114.28 118.27 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 tp -103.37 99.75 16.02 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.413 -0.358 . . . . 73.43 110.345 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 12.3 Cg_exo . . . . . 0 N--CA 1.463 -0.316 0 C-N-CA 122.734 2.289 . . . . 74.25 111.067 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 . . . . . 0 C--O 1.231 0.102 0 N-CA-C 109.51 -0.552 . . . . 72.11 109.51 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 27.3 Cg_endo -92.81 62.08 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.406 2.737 . . . . 65.04 113.689 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' HB1' ' A' ' 138' ' ' ALA . 54.1 mt -96.64 131.8 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.136 -0.69 . . . . 71.44 109.136 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -108.67 -46.98 3.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.765 0.316 . . . . 55.35 111.079 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.465 HG11 ' HE ' ' A' ' 102' ' ' ARG . 47.2 t -124.33 139.06 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.565 -0.289 . . . . 70.42 110.971 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.03 144.71 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 64.11 110.668 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 34.2 mt-10 -120.1 135.99 54.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 70.2 111.207 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -118.2 130.52 56.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.947 -0.569 . . . . 72.51 110.618 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -136.37 148.91 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.474 -0.33 . . . . 63.15 110.628 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.58 148.28 51.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.35 -0.386 . . . . 72.43 110.382 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -150.3 161.24 42.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 73.44 111.268 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.36 -20.56 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 63.13 110.773 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -118.1 -5.09 10.96 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.311 0.486 . . . . 74.31 112.311 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.0 t30 69.85 12.47 7.94 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.595 0.712 . . . . 62.53 110.382 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.7 -53.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 70.03 109.773 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -95.61 98.99 10.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 61.24 109.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 125' ' ' ARG . 98.2 m95 -88.69 123.46 33.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 71.44 110.899 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 121.91 57.2 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.073 -0.512 . . . . 62.02 110.009 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 109.38 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.396 2.064 . . . . 75.11 111.942 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.622 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -80.62 -12.65 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 62.21 110.205 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.1 145.94 4.37 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.625 -0.798 . . . . 24.35 113.02 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HE ' HG11 ' A' ' 85' ' ' VAL . 70.9 ttt180 -115.91 120.54 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.818 -0.808 . . . . 70.45 108.818 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.41 ' HE2' HG12 ' A' ' 116' ' ' VAL . 89.4 m-85 -133.22 178.94 6.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.099 0.476 . . . . 75.35 111.151 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.39 143.89 16.99 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.71 -0.677 . . . . 64.31 111.791 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -94.75 125.61 39.52 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.786 -0.45 . . . . 74.03 109.786 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.533 ' HB ' HD21 ' A' ' 112' ' ' LEU . 19.7 m -113.76 104.35 12.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.188 -0.46 . . . . 73.43 109.94 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.45 92.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.008 0.432 . . . . 73.35 110.024 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -121.02 -173.59 2.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.778 -0.646 . . . . 64.45 110.816 -176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -88.16 -18.91 27.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.819 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.3 -175.09 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 74.44 111.014 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.27 147.99 26.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.979 0.419 . . . . 70.2 110.442 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 106' ' ' THR . 21.2 mt -98.33 104.24 16.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.022 -0.535 . . . . 75.15 110.145 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -81.32 116.09 21.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 71.25 110.571 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.42 105.48 14.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.826 0.346 . . . . 75.24 110.848 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -73.03 102.33 3.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.896 -0.779 . . . . 71.23 108.896 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -107.71 175.93 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.206 0.527 . . . . 64.32 112.122 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.609 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 52.8 tttp -59.61 116.85 4.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.237 -0.892 . . . . 75.34 110.434 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.3 m -70.94 115.8 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 70.4 110.373 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.5 tt -156.54 147.93 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.286 -0.415 . . . . 63.43 110.229 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.732 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.4 ttpt -83.62 133.96 34.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.0 -0.37 . . . . 73.24 110.0 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.98 169.63 21.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.309 -0.405 . . . . 71.1 110.565 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -117.22 -32.97 4.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.199 0.523 . . . . 74.32 109.835 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.84 145.39 32.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.653 . . . . 71.03 109.646 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.0 tt -133.29 137.8 52.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.482 -0.562 . . . . 72.4 109.482 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 23.9 ttp180 -125.71 128.56 47.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.899 0.38 . . . . 71.44 111.099 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.9 tp -104.31 115.34 30.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.55 -0.75 . . . . 71.51 109.642 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 41.4 m -107.17 123.72 48.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.111 0.481 . . . . 62.35 110.746 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.629 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.4 mm -105.97 92.46 6.46 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.44 -0.8 . . . . 74.23 108.973 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.879 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.3 Cg_endo -69.61 -178.62 2.37 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.816 2.344 . . . . 75.35 113.303 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 36.8 t70 -129.24 65.06 1.47 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.618 -1.253 . . . . 73.12 107.618 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.7 -46.58 2.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.094 -0.957 . . . . 75.13 112.506 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.13 36.65 4.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.183 -1.008 . . . . 73.24 113.754 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.66 18.5 32.42 Favored Glycine 0 CA--C 1.51 -0.258 0 C-N-CA 120.241 -0.98 . . . . 75.3 112.187 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.91 166.69 10.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 71.42 111.361 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.0 m -129.9 167.54 18.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.164 -0.471 . . . . 71.41 110.181 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 32.2 p -84.89 -24.42 28.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.111 0.481 . . . . 45.43 110.32 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 57.8 t -82.3 122.35 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 75.44 109.761 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 83' ' ' ILE . . . -141.86 139.66 32.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.261 -0.427 . . . . 72.22 110.431 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.54 105.05 4.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.272 0.558 . . . . 72.43 111.253 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.06 132.48 71.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.737 -0.838 . . . . 73.14 108.737 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.978 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.7 mtm180 -69.98 -65.02 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.886 -0.326 . . . . 74.24 110.331 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -139.58 146.58 40.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.606 0.717 . . . . 75.2 112.331 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -108.2 121.95 45.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.514 -1.291 . . . . 65.21 107.514 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 m-20 -122.8 154.75 37.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.919 0.39 . . . . 73.34 110.794 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.49 129.94 56.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 54.14 110.438 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.435 ' HE2' ' NE2' ' A' ' 69' ' ' GLN . 44.5 mttm -96.02 129.08 43.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.069 -0.715 . . . . 73.44 109.069 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.53 -176.68 39.01 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.203 -0.999 . . . . 45.5 112.457 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.8 m -108.4 133.49 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.86 -0.422 . . . . 74.24 109.86 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.24 125.02 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.075 0.464 . . . . 71.55 110.575 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.732 HD12 ' HG3' ' A' ' 120' ' ' LYS . 60.8 mt . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 115.884 -0.598 . . . . 71.23 110.464 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.626 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 39.9 p . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 120.744 0.307 . . . . 72.1 110.306 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 149' ' ' ILE . 43.4 mm -86.05 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.347 -0.388 . . . . 74.0 111.152 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -67.38 118.81 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 73.04 109.76 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -97.2 9.86 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 75.44 110.726 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 m -65.5 -27.34 68.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.832 -0.622 . . . . 72.24 111.681 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.5 20.35 34.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 75.4 112.731 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.472 ' HB2' HD12 ' A' ' 34' ' ' ILE . 36.1 m0 -94.17 150.55 20.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.821 -0.437 . . . . 71.1 109.821 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.7 pt-20 -133.61 156.59 47.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 71.22 110.279 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 116.14 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.736 -0.665 . . . . 65.01 109.76 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 60' ' ' ASP . 80.6 mt -78.76 -42.79 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 74.25 110.494 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 m -152.34 133.9 14.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.1 -0.5 . . . . 42.05 110.329 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -131.52 137.52 48.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 74.4 109.736 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.1 m -78.58 -33.42 47.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.809 0.338 . . . . 75.45 110.807 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 t -157.53 145.8 19.19 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.794 0.33 . . . . 72.25 110.979 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.27 137.67 5.2 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.963 -0.754 . . . . 74.01 108.963 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.74 133.56 33.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.136 0.493 . . . . 73.2 110.23 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.32 -27.91 0.94 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.842 -0.617 . . . . 62.1 110.852 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -101.97 -31.24 10.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.278 -0.419 . . . . 72.34 111.09 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.535 0 C-N-CA 120.959 -0.639 . . . . 45.02 111.509 177.358 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.7 t30 . . . . . 0 CA--C 1.518 -0.268 0 N-CA-C 110.334 -0.247 . . . . 74.24 110.334 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.49 82.12 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 116.146 -0.479 . . . . 71.34 112.539 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 73.4 mt -72.26 147.01 46.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 73.41 110.391 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.2 -22.68 64.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.403 -0.362 . . . . 75.12 111.14 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -79.11 -22.46 45.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 75.54 110.946 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 66.7 m -65.38 -26.25 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 41.14 110.102 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 142' ' ' GLU . 22.7 tp -61.84 -26.14 67.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.343 -0.844 . . . . 70.22 110.543 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 59' ' ' ILE . 28.3 pt -116.16 12.52 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.396 . . . . 74.21 110.755 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 38.8 t70 -77.72 -29.53 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.116 0.484 . . . . 75.4 110.105 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.93 31.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.888 -0.672 . . . . 73.33 113.268 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.546 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 14.5 t0 -115.8 128.46 55.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.345 -0.613 . . . . 73.0 109.345 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' NH2' ' A' ' 141' ' ' ARG . 10.5 p -77.37 -5.65 50.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.916 0.71 . . . . 75.31 112.916 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.8 pt-20 -103.02 -5.34 23.48 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.324 -0.55 . . . . 75.51 111.013 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 9.3 p -105.73 161.78 14.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.837 -0.431 . . . . 73.22 109.837 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.643 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 48.1 p90 -157.33 162.32 39.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.99 0.424 . . . . 74.34 111.095 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 35.4 t90 -92.72 134.17 35.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.877 -0.786 . . . . 73.33 108.877 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -132.24 138.01 47.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.04 -0.726 . . . . 62.35 109.04 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.99 138.94 58.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.706 -0.479 . . . . 74.34 109.706 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 50' ' ' SER . 31.1 ttpt -67.54 120.1 13.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.61 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -111.51 -22.92 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.167 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -71.89 107.42 4.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 70.13 110.169 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.94 -0.99 56.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.721 -0.752 . . . . 43.12 112.258 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.16 133.63 5.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.819 -0.705 . . . . 52.45 112.215 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.8 m -72.69 143.71 47.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.82 0.343 . . . . 71.04 110.375 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 10.5 m-20 -74.01 151.68 88.45 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.235 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 3.0 Cg_exo -76.65 144.99 25.59 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.684 2.256 . . . . 71.04 111.599 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 130' ' ' ASP . 15.1 mt -75.31 158.18 84.03 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.18 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.9 Cg_endo -83.49 167.14 63.69 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.696 -1.377 . . . . 74.13 113.536 2.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.8 m-85 -106.85 122.26 46.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 72.24 109.983 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.84 125.19 51.19 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.095 0.474 . . . . 73.44 110.524 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 62.8 mt -115.07 112.65 40.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.054 -0.521 . . . . 75.0 110.151 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.97 117.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.153 -0.476 . . . . 64.03 110.743 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 34' ' ' ILE . 66.3 mt -117.87 137.05 53.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.255 -0.43 . . . . 72.21 110.723 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 13' ' ' LEU . 56.9 t0 -103.59 120.63 41.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.682 -0.488 . . . . 70.24 109.682 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.426 ' SD ' HD12 ' A' ' 65' ' ' ILE . 65.2 mtm -84.66 -7.43 59.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.814 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.8 mmtt 65.9 13.64 9.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.769 -0.65 . . . . 74.32 112.183 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.411 ' OE1' HD12 ' A' ' 149' ' ' ILE . 6.0 pt20 -164.57 164.93 21.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 74.15 110.542 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.98 122.79 31.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.399 . . . . 45.21 110.366 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.54 HD13 HG21 ' A' ' 5' ' ' ILE . 74.0 mt -130.65 137.82 55.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.292 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.497 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.0 tp60 -83.29 102.93 12.3 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.063 -0.717 . . . . 75.35 109.063 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.3 mm -74.14 125.79 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.665 0.269 . . . . 74.25 110.525 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.62 -39.71 2.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.161 0.505 . . . . 40.34 110.831 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 26.7 tt0 -148.89 142.93 25.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.092 -0.504 . . . . 50.01 110.821 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.07 136.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.519 -0.549 . . . . 72.11 109.519 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 39.9 mt-10 -118.73 133.57 55.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.147 0.499 . . . . 71.32 111.247 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 72.2 mt -114.53 126.79 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.549 -0.75 . . . . 54.53 109.162 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 141' ' ' ARG . 24.3 tp -106.24 97.14 15.06 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.727 -0.472 . . . . 71.23 109.727 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 6.3 Cg_exo . . . . . 0 N--CA 1.461 -0.409 0 C-N-CA 123.088 2.526 . . . . 72.44 111.073 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.799 0.666 . . . . 71.54 112.799 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 72.6 Cg_endo -75.82 25.71 0.41 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.861 2.374 . . . . 71.23 112.671 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.49 120.75 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.616 -0.513 . . . . 64.12 109.616 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.52 -50.82 3.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.111 0.482 . . . . 71.0 110.749 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 102' ' ' ARG . 57.4 t -120.41 137.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 54.25 110.583 -175.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.36 129.71 65.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.556 -0.747 . . . . 71.01 109.688 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 97.2 mt-10 -112.65 125.75 54.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 61.02 110.128 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -102.84 129.75 49.62 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.679 -0.691 . . . . 74.1 110.269 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 125' ' ' ARG . . . -125.32 151.07 46.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.144 -0.48 . . . . 61.22 110.428 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.21 39.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 51.25 109.96 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 t -148.87 151.15 34.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.198 0.523 . . . . 72.41 110.762 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 -32.87 10.48 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.794 -0.639 . . . . 71.23 110.61 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -109.69 -5.59 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.429 -0.351 . . . . 74.22 110.878 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 78.19 -9.61 1.48 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.991 0.917 . . . . 73.24 111.083 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.8 t -90.91 -49.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.107 0.48 . . . . 74.34 110.819 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -93.43 102.77 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.105 -0.498 . . . . 54.33 109.85 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.98 118.07 30.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 73.53 111.044 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 m -99.46 120.82 56.82 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.469 -0.787 . . . . 75.14 110.51 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.96 112.53 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.359 2.039 . . . . 50.41 111.111 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 14.1 pt -87.33 -9.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.466 -0.334 . . . . 61.44 111.025 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.63 137.35 2.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.763 -1.208 . . . . 51.43 113.848 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.576 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 16.2 ttt180 -107.02 114.57 28.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.045 -0.724 . . . . 70.02 109.045 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.599 ' HE2' HG12 ' A' ' 116' ' ' VAL . 92.2 m-85 -125.98 169.92 12.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.84 0.352 . . . . 74.32 111.128 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -91.59 139.77 14.9 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.467 -0.653 . . . . 65.45 111.467 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -93.37 125.48 38.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 64.3 110.483 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 112' ' ' LEU . 90.2 m -103.08 115.23 30.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 54.21 110.579 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -72.59 102.56 3.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 72.52 110.534 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -143.91 -176.92 5.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 74.02 110.446 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.5 -7.97 22.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.05 0.453 . . . . 73.13 110.033 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.2 170.27 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.861 -0.608 . . . . 60.24 111.042 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.63 143.45 38.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.124 0.487 . . . . 54.21 111.613 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 106' ' ' THR . 46.4 mt -103.28 106.77 17.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 75.31 110.285 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 43.0 mt-10 -87.12 112.78 22.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.807 0.337 . . . . 75.42 110.735 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.23 106.66 17.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.155 -0.475 . . . . 62.03 110.55 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -72.13 102.61 3.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.061 -0.718 . . . . 61.12 109.061 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.599 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.1 m -103.18 179.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 64.43 112.159 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 6.5 tmtm? -66.04 124.19 21.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 72.42 110.421 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 21.2 p -70.49 127.37 32.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 75.31 110.68 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -163.45 150.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.42 -0.355 . . . . 63.05 110.481 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.698 ' HG3' HD12 ' A' ' 150' ' ' ILE . 5.9 ttpm? -85.69 128.07 34.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.285 -0.635 . . . . 62.33 109.285 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.19 160.82 43.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.861 0.362 . . . . 43.03 111.239 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -117.42 -26.12 6.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.67 -0.695 . . . . 70.45 109.642 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.16 146.45 42.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 74.42 109.859 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -131.1 143.25 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.628 -0.508 . . . . 61.43 109.628 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.5 ttp180 -131.38 124.75 30.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 73.43 111.227 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 57' ' ' ILE . 37.6 tp -90.16 113.0 24.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.553 -0.749 . . . . 65.42 109.401 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.6 m -107.18 115.83 30.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.19 0.519 . . . . 74.12 111.179 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 31.7 mm -105.06 98.05 14.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.104 -0.702 . . . . 70.12 109.104 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.7 Cg_endo -71.09 170.45 18.1 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.361 2.041 . . . . 75.31 112.39 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HA ' HD13 ' A' ' 53' ' ' LEU . 34.7 t70 -91.21 -4.09 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.109 0.957 . . . . 70.31 109.099 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.21 140.96 31.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 75.42 110.677 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.78 -13.28 35.1 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.633 -0.794 . . . . 73.13 111.93 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 110.68 18.29 8.56 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.712 . . . . 63.31 112.335 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.56 150.4 43.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 71.44 110.854 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 48.9 m -127.75 -176.76 3.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.972 -0.558 . . . . 71.32 110.388 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 39.0 p -84.53 -2.4 57.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.028 0.442 . . . . 64.44 111.649 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -93.7 96.28 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.149 0.499 . . . . 52.41 110.038 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.45 129.54 50.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.847 -0.615 . . . . 65.02 110.159 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -150.07 110.64 4.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 64.44 110.791 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.5 mt -128.67 133.0 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 64.22 109.301 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.643 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.1 mtp180 -61.76 -61.16 2.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.952 0.406 . . . . 74.41 110.268 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HA ' HD12 ' A' ' 33' ' ' LEU . 15.3 pt-20 -154.82 158.79 39.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.503 0.668 . . . . 70.51 111.338 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -115.15 134.6 55.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.657 -1.238 . . . . 62.44 107.657 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.626 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.1 t70 -131.09 167.16 19.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.721 -0.391 . . . . 71.24 110.014 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.7 t -138.6 128.43 32.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.73 0.3 . . . . 73.34 110.847 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.5 mttp -97.97 125.27 42.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.391 -0.596 . . . . 72.11 109.391 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.62 -158.71 14.99 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.798 -0.715 . . . . 60.32 111.404 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.0 m -131.1 130.23 42.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.849 0.324 . . . . 62.33 110.583 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 5' ' ' ILE . 34.7 mm -68.41 116.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 63.13 109.902 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 120' ' ' LYS . 42.6 mt . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 121.239 0.543 . . . . 71.03 110.17 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 12.8 p . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.602 -0.888 . . . . 51.13 108.602 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 145' ' ' VAL . 36.5 mm -65.7 129.1 29.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.978 0.418 . . . . 72.44 110.752 -173.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 m -67.19 111.69 4.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.947 -0.569 . . . . 61.0 109.807 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 9.1 mtmp? -85.06 20.37 1.91 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.432 -0.804 . . . . 73.03 111.467 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -59.13 -42.48 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.899 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.13 7.68 52.46 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 63.23 113.053 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.488 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.3 m0 -73.08 154.29 40.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.706 0.288 . . . . 70.1 110.457 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 24.5 pt-20 -148.87 161.27 42.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.262 0.553 . . . . 64.12 111.183 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.89 120.11 47.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.88 . . . . 71.33 110.066 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 60' ' ' ASP . 86.3 mt -85.75 -47.72 9.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.001 -0.545 . . . . 75.55 110.758 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 t -138.76 142.3 38.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.01 -0.541 . . . . 72.42 109.934 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -146.91 148.92 32.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.072 -0.513 . . . . 73.13 109.651 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.5 m -86.16 -42.02 14.21 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.852 0.358 . . . . 64.35 110.973 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -150.9 153.47 35.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.325 -0.398 . . . . 62.35 110.746 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.28 146.0 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.286 -0.635 . . . . 70.32 109.286 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -102.57 110.81 22.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.932 0.396 . . . . 63.13 110.417 -176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.65 13.11 11.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.049 -0.523 . . . . 63.24 111.187 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 m -134.21 -49.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.513 -0.312 . . . . 64.3 111.393 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.905 -0.664 . . . . 73.03 112.201 179.632 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 . . . . . 0 N--CA 1.454 -0.275 0 N-CA-C 109.659 -0.497 . . . . 74.01 109.659 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.79 -8.43 70.83 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.274 -0.73 . . . . 62.0 111.274 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 43.2 mt -72.47 153.58 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.14 -0.53 . . . . 75.52 110.07 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.22 -28.99 69.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 71.12 110.787 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.97 -24.82 60.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 70.24 110.993 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.847 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 77.4 m -67.33 -21.56 65.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.386 -0.37 . . . . 63.3 110.404 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 51.3 tp -64.93 -14.41 59.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.837 -0.62 . . . . 63.2 110.687 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 10' ' ' TRP . 27.8 pt -131.58 14.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.531 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.847 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.9 t70 -65.85 -33.67 76.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.291 -0.413 . . . . 73.33 111.279 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HZ1' ' A' ' 7' ' ' LYS . . . 99.84 5.49 55.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.53 -0.843 . . . . 72.03 113.408 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.67 140.22 50.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.0 0.4 . . . . 62.45 109.93 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 26.6 p -80.66 -7.39 59.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.895 0.332 . . . . 71.31 111.895 -174.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.69 -8.16 44.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.593 -0.276 . . . . 73.21 110.303 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.6 p -107.49 138.52 43.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 74.42 110.018 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.864 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 10.9 p90 -141.09 169.85 16.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.45 -0.341 . . . . 63.21 110.567 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.0 t90 -104.65 133.04 50.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.826 -0.805 . . . . 72.11 108.826 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.074 -0.713 . . . . 75.44 109.074 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 145.21 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.31 -0.626 . . . . 64.44 109.31 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -55.85 125.24 20.48 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.339 0.399 . . . . 71.54 109.995 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -124.78 -30.22 3.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.844 -0.342 . . . . 63.12 110.79 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -77.65 107.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.785 -0.45 . . . . 70.35 109.785 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.94 11.55 52.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.636 -0.792 . . . . 65.01 111.899 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.27 20.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.955 -0.64 . . . . 53.32 111.893 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.0 m -127.7 165.76 19.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 72.24 110.896 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' HE1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -89.21 152.79 48.35 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.13 109.375 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 38.5 Cg_endo -68.09 139.07 45.51 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.158 1.905 . . . . 72.34 113.222 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.44 158.02 87.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 73.54 109.951 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 83.4 Cg_endo -82.4 161.8 76.61 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.525 -1.448 . . . . 73.05 113.061 0.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HE1' ' HB3' ' A' ' 51' ' ' ASP . 25.8 m-85 -97.79 129.02 44.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.62 . . . . 72.31 109.598 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.1 t0 -127.33 118.44 24.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.748 0.308 . . . . 72.21 110.309 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.444 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 56.9 mt -116.55 122.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 74.4 111.339 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.1 t -105.45 118.19 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.83 -0.623 . . . . 63.32 110.514 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 124' ' ' ILE . 71.1 mt -115.56 139.07 43.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 75.12 111.049 -175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.512 ' HB2' HD11 ' A' ' 13' ' ' LEU . 63.8 t0 -105.63 122.13 45.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.169 -0.468 . . . . 63.43 110.001 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.2 mtm -88.45 -5.31 58.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 72.53 110.672 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 67.11 8.51 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.902 0.704 . . . . 54.44 112.902 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -168.2 174.8 6.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.589 0.233 . . . . 71.33 110.642 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.593 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 52.3 m-80 -83.06 122.04 27.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.214 -0.448 . . . . 44.45 110.243 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 5' ' ' ILE . 68.2 mt -131.11 133.3 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.063 0.458 . . . . 74.3 110.022 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.7 tp60 -79.79 106.47 11.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.573 -0.739 . . . . 75.14 109.168 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 118' ' ' SER . 15.9 mm -76.79 102.92 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.136 -0.32 . . . . 41.21 110.136 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.3 -39.62 8.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 32.44 110.281 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -152.14 142.29 22.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.686 . . . . 41.32 110.207 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -114.28 134.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.91 -0.404 . . . . 64.23 109.91 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 49.5 mt-10 -110.75 129.72 55.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.988 0.423 . . . . 70.24 110.999 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 mt -109.78 120.82 43.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.418 -0.586 . . . . 75.41 109.418 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -102.99 103.62 34.96 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.912 -0.586 . . . . 73.12 109.751 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 8.4 Cg_exo . . . . . 0 N--CA 1.464 -0.234 0 C-N-CA 122.947 2.432 . . . . 61.43 111.339 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.939 0.399 . . . . 61.14 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 18.6 Cg_endo -93.37 23.63 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.527 2.818 . . . . 73.44 112.979 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.66 125.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 75.53 110.075 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -107.28 -46.21 3.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 74.0 111.145 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG11 ' HE ' ' A' ' 102' ' ' ARG . 34.2 t -129.34 139.87 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.572 -0.285 . . . . 74.12 110.82 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.11 144.99 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.343 -0.389 . . . . 74.4 110.15 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.5 mt-10 -119.06 131.13 55.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.93 0.395 . . . . 74.0 110.595 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.89 136.03 51.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.113 -0.494 . . . . 75.53 110.772 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.24 152.52 49.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.507 -0.315 . . . . 53.41 110.851 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.23 51.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.327 -0.397 . . . . 75.41 110.264 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -149.95 153.81 37.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.196 0.522 . . . . 63.01 111.076 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 52.3 mt-10 -97.54 -24.82 15.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 65.44 110.937 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.82 -1.4 8.4 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.859 -0.336 . . . . 61.42 111.489 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.17 1.81 3.8 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.205 0.526 . . . . 74.24 111.396 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -96.8 -58.45 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.477 0.656 . . . . 71.21 110.068 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.79 106.39 18.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.096 -0.956 . . . . 62.02 109.824 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -97.31 125.15 41.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.157 0.503 . . . . 70.43 111.409 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 95.4 m -109.02 123.78 35.97 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.73 -0.668 . . . . 71.31 110.135 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 29.8 Cg_endo -64.31 120.76 8.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.412 2.075 . . . . 75.24 111.578 176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 HG21 ' A' ' 116' ' ' VAL . 15.1 pt -86.41 -16.03 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.152 -0.477 . . . . 63.4 110.65 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.56 143.84 3.85 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.492 -0.861 . . . . 64.04 112.899 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.578 ' HE ' HG11 ' A' ' 85' ' ' VAL . 73.7 ttt180 -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.216 -0.661 . . . . 64.53 109.216 173.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HE2' HG12 ' A' ' 116' ' ' VAL . 97.1 m-85 -137.56 174.11 10.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 71.03 111.449 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.32 138.56 14.26 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.756 -0.656 . . . . 71.33 112.21 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -93.17 148.45 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 74.11 110.09 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' HD11 ' A' ' 112' ' ' LEU . 33.7 m -144.83 110.14 5.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.072 -0.513 . . . . 74.14 109.908 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -70.03 97.09 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.326 0.584 . . . . 75.52 109.931 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.573 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 11.1 pt20 -130.8 -179.69 5.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.449 -0.796 . . . . 74.53 110.713 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.74 -24.41 41.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.557 . . . . 74.34 110.949 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.39 151.87 20.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 71.32 110.988 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.12 129.98 41.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 45.32 110.542 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -80.56 104.9 11.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.703 . . . . 54.33 110.501 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -85.26 108.73 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.104 0.478 . . . . 73.34 110.51 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -101.34 106.82 18.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.834 -0.621 . . . . 74.35 110.679 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -72.3 104.92 3.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 74.33 109.623 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.571 HG21 HD12 ' A' ' 100' ' ' ILE . 31.6 m -111.13 -176.54 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.068 0.461 . . . . 74.14 111.776 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.91 117.07 7.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.475 -0.784 . . . . 52.14 110.109 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 22.0 m -70.39 113.68 7.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 35.12 110.718 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.12 144.94 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 73.24 110.464 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.593 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -86.26 126.03 34.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 72.11 109.42 175.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -151.43 166.72 30.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.636 -0.256 . . . . 53.11 111.029 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -107.16 -30.48 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.362 0.601 . . . . 72.05 109.867 173.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -109.21 145.41 35.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.752 -0.658 . . . . 73.23 110.481 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.0 tt -133.21 138.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 73.34 109.432 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.487 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 13.0 ttp180 -127.83 130.77 49.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 74.05 111.249 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.14 114.89 29.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.381 -0.827 . . . . 74.53 109.601 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.7 m -109.11 125.23 51.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.202 0.525 . . . . 73.53 111.104 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 38.6 mm -103.96 95.96 8.63 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.056 -0.72 . . . . 73.14 109.056 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.7 Cg_endo -75.92 157.38 38.95 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.821 2.347 . . . . 73.41 113.087 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.23 63.52 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 54.43 108.58 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.27 122.53 2.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 50.53 110.227 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.85 -1.9 21.39 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.834 -0.698 . . . . 52.32 112.314 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.17 21.5 7.67 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.905 -0.664 . . . . 54.15 112.691 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -79.31 146.19 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 73.41 111.737 -175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.6 m -113.47 174.43 5.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.486 -0.779 . . . . 71.12 109.608 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 18.8 p -79.16 -14.36 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 53.44 111.716 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 48.1 t -84.38 104.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.969 0.414 . . . . 74.11 110.219 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.26 130.84 55.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.24 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.84 105.16 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.102 0.477 . . . . 71.53 111.289 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.34 133.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.803 -0.814 . . . . 73.13 108.803 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.864 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 71.1 mtm180 -74.25 -57.63 3.82 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.517 -0.473 . . . . 64.45 111.278 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.13 148.43 28.27 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.551 -0.86 . . . . 42.44 112.239 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 72' ' ' LEU . 7.8 tt -105.85 120.93 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.551 -1.204 . . . . 71.11 108.31 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.6 t70 -117.81 162.03 18.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.361 -0.607 . . . . 64.33 109.361 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 5' ' ' ILE . 59.9 t -126.08 123.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.197 0.522 . . . . 73.12 110.422 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 4' ' ' THR . 47.0 mttt -99.67 76.03 1.96 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.558 0.694 . . . . 63.41 109.389 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -124.05 -146.19 6.91 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.911 -1.04 . . . . 54.34 111.785 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.4 m -135.86 134.0 38.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.803 0.335 . . . . 54.31 110.704 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 40.4 mm -72.0 130.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 70.45 110.94 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.421 HD11 ' HB2' ' A' ' 66' ' ' GLN . 20.5 mt . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.069 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.446 -0.665 0 N-CA-C 108.604 -0.887 . . . . 72.01 108.604 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 HD13 ' A' ' 65' ' ' ILE . 47.3 mm -60.81 128.49 22.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.701 0.286 . . . . 73.34 111.13 -173.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -67.5 119.43 12.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.105 0.478 . . . . 75.34 109.841 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -95.44 4.33 53.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.731 -0.668 . . . . 72.12 110.647 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -73.43 93.4 1.96 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.736 . . . . 74.43 109.442 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.34 -16.2 4.39 Favored Glycine 0 C--N 1.316 -0.583 0 CA-C-N 115.28 -0.873 . . . . 72.1 111.476 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -68.92 150.64 47.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.752 -0.462 . . . . 73.04 109.752 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.3 pt-20 -132.37 157.71 43.81 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.319 0.581 . . . . 74.24 110.924 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.74 110.04 25.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 54.33 109.645 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 HG12 ' A' ' 58' ' ' VAL . 81.6 mt -72.43 -48.95 37.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.801 -0.636 . . . . 75.34 110.612 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -149.94 142.85 24.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.666 -0.697 . . . . 62.23 110.527 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 38.2 p90 -138.77 148.54 43.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 74.21 109.837 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m -88.26 -37.91 15.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.739 0.304 . . . . 53.13 111.029 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 145.88 31.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.148 0.499 . . . . 61.34 110.859 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -154.94 151.75 28.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 50.41 108.781 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -124.56 92.35 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.153 0.501 . . . . 73.01 111.064 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.59 -18.74 21.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.736 -0.666 . . . . 70.13 111.239 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 m -91.72 -40.37 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 61.33 110.863 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . . . . . . 0 N--CA 1.446 -0.639 0 C-N-CA 120.898 -0.668 . . . . 72.22 112.934 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 . . . . . 0 N--CA 1.455 -0.213 0 N-CA-C 110.129 -0.323 . . . . 65.12 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 -5.95 66.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.378 -0.439 . . . . 25.34 112.119 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 77.1 mt -75.15 148.45 39.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.566 -0.317 . . . . 73.25 110.321 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.74 63.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.402 -0.363 . . . . 74.31 111.264 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.75 -25.68 44.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.506 -0.315 . . . . 61.41 110.888 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.844 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.9 m -64.84 -25.79 68.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 70.51 110.455 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 143' ' ' LEU . 34.4 tp -64.24 -22.22 66.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 74.42 110.827 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 59' ' ' ILE . 40.1 pt -125.79 15.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 74.43 110.363 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.844 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 4.6 t70 -75.38 -37.3 60.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 52.4 110.528 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.92 23.93 7.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.472 -0.871 . . . . 63.11 112.299 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.3 109.58 7.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.273 -0.64 . . . . 73.1 109.273 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.7 p -68.7 -21.16 64.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.214 -0.448 . . . . 62.0 111.923 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HA ' HH21 ' A' ' 141' ' ' ARG . 61.4 mm-40 -72.56 -26.88 61.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.925 -0.31 . . . . 61.23 110.422 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -89.3 152.09 21.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.755 -0.831 . . . . 72.11 108.755 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.707 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 47.2 p90 -148.93 174.96 11.7 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.307 -0.557 . . . . 72.4 111.333 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' HD11 ' A' ' 57' ' ' ILE . 39.0 t90 -107.82 135.67 48.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.559 -0.746 . . . . 64.35 109.046 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.442 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 48.5 t-80 -135.14 145.01 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.687 -0.486 . . . . 72.13 109.687 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.53 146.6 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.952 -0.567 . . . . 55.01 109.944 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -60.29 133.6 56.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.401 . . . . 74.43 110.787 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -139.7 -26.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 73.3 111.553 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.401 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 4.7 tp-100 -62.42 -42.02 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 64.25 110.255 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.77 32.09 6.21 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 75.11 111.91 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.37 148.41 13.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 63.43 111.83 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -81.94 156.63 24.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.2 0.524 . . . . 61.41 111.114 -178.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -91.39 162.36 32.14 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 75.44 110.587 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.35 139.18 31.46 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.736 2.291 . . . . 63.12 112.791 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.03 159.88 69.81 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 62.4 110.157 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.773 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.4 Cg_endo -79.66 161.28 86.78 Favored 'Cis proline' 0 C--N 1.343 0.273 0 C-N-CA 123.622 -1.408 . . . . 62.41 112.975 0.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -95.75 108.81 21.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.112 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -108.72 116.91 32.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.955 0.407 . . . . 74.35 110.634 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 126' ' ' LEU . 60.9 mt -109.81 108.61 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.96 -0.564 . . . . 73.13 109.636 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 125' ' ' ARG . 48.1 t -97.94 116.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.512 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 34' ' ' ILE . 68.5 mt -115.52 137.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.726 -0.67 . . . . 73.02 110.615 -175.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -101.84 122.21 43.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 61.15 109.697 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.4 mtm -87.33 -8.5 56.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 64.23 110.611 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.2 mmtt 67.97 7.55 5.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.719 . . . . 72.24 112.26 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 5.7 pt20 -161.26 163.03 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.43 -0.211 . . . . 63.11 110.43 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.413 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 43.9 m-80 -83.97 126.17 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.85 -0.426 . . . . 74.02 109.85 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 5' ' ' ILE . 61.3 mt -132.01 136.88 55.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.033 0.444 . . . . 72.34 110.701 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -84.38 101.74 12.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.826 -0.805 . . . . 74.23 108.826 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.2 mm -71.56 127.33 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.327 -0.397 . . . . 62.1 110.306 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.26 -46.1 2.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 72.32 110.875 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -144.51 144.91 31.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.687 0.28 . . . . 75.11 110.847 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.89 132.27 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.232 -0.655 . . . . 73.52 109.232 173.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.716 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 26.8 tt0 -115.08 127.97 55.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.933 0.397 . . . . 74.31 110.367 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 114' ' ' TYR . 57.2 mt -115.72 117.75 31.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.954 -0.566 . . . . 72.03 110.16 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.6 tp -110.08 100.16 42.5 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.404 -0.362 . . . . 73.34 110.439 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 105' ' ' PHE . 29.5 Cg_endo . . . . . 0 N--CA 1.452 -0.957 0 C-N-CA 122.84 2.36 . . . . 54.3 110.465 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 t30 . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 121.102 0.477 . . . . 63.4 111.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 1.1 Cg_endo -82.55 59.53 6.92 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.283 2.655 . . . . 71.23 113.225 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.4 mt -98.41 119.37 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.078 0.466 . . . . 54.25 109.821 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 25.7 mmmt -97.52 -56.41 2.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.716 -0.675 . . . . 64.25 111.4 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -121.89 139.65 48.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.319 -0.4 . . . . 65.3 110.347 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.61 133.41 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.888 0.375 . . . . 62.35 110.02 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 20.7 tt0 -121.5 128.72 52.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.911 -0.586 . . . . 71.03 110.095 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -112.07 129.38 56.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.071 -0.513 . . . . 63.14 109.961 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.76 151.72 41.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.464 -0.334 . . . . 74.44 110.273 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.34 149.49 45.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.175 -0.466 . . . . 61.25 110.185 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -147.12 148.0 31.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.271 -0.422 . . . . 53.04 110.232 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -87.04 -32.55 19.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.714 0.292 . . . . 62.32 110.992 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -132.63 16.11 4.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.573 -0.285 . . . . 61.51 111.632 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.2 t30 59.49 58.5 2.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.727 0.775 . . . . 70.1 110.308 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.26 -71.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.162 -0.926 . . . . 73.43 108.917 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -90.46 118.67 30.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.781 -0.645 . . . . 65.25 109.666 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.97 107.78 19.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.083 0.468 . . . . 75.43 110.744 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.8 m -93.84 125.99 51.11 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.802 -0.635 . . . . 63.41 110.212 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.66 104.01 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.543 2.162 . . . . 71.45 111.662 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.0 -23.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.105 -0.498 . . . . 64.33 110.901 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -169.69 128.33 1.64 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.209 -0.996 . . . . 22.45 113.004 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 2.4 tmt_? -124.29 115.0 20.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 74.14 108.649 171.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -141.4 -177.11 4.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.91 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.31 143.76 16.81 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.804 -0.634 . . . . 74.14 111.754 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.453 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 53.3 t80 -96.68 120.97 37.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 62.41 110.772 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.636 ' HB ' HD21 ' A' ' 112' ' ' LEU . 23.0 m -97.75 109.64 22.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 71.04 110.145 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -70.38 98.57 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 74.33 110.468 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -139.55 174.36 10.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 60.04 109.737 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.31 5.34 50.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.192 0.52 . . . . 70.1 110.707 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.65 152.63 24.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.596 -0.729 . . . . 62.4 109.672 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -73.93 124.96 27.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.03 0.443 . . . . 61.25 111.316 -175.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 106' ' ' THR . 35.9 mt -77.49 124.35 27.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.729 . . . . 74.32 110.594 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -95.11 109.55 21.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 73.01 110.681 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 91.8 m-85 -102.47 109.57 21.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.508 . . . . 74.5 110.474 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -81.13 90.19 6.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.602 . . . . 71.4 109.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 101' ' ' GLY . 26.8 m -87.62 -177.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.211 -0.904 . . . . 71.25 111.45 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -72.87 128.74 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.585 -0.734 . . . . 73.15 110.863 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 4.5 m -68.53 114.68 7.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.201 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 tt -153.53 148.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 74.43 110.532 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.53 126.26 35.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.767 -0.457 . . . . 73.34 109.767 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.61 165.22 29.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.442 -0.344 . . . . 53.44 110.831 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 37.1 ttt180 -115.39 -26.35 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.519 0.676 . . . . 73.14 109.744 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -116.07 146.33 42.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 74.14 109.653 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -132.83 140.48 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.962 -0.384 . . . . 74.22 109.962 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.813 ' HG3' HG22 ' A' ' 58' ' ' VAL . 5.6 ttm180 -126.38 132.09 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.816 0.341 . . . . 72.3 111.166 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 57' ' ' ILE . 56.2 tp -98.2 118.18 34.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.088 -0.708 . . . . 52.22 109.088 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 95.5 m -115.38 125.05 52.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.158 0.504 . . . . 73.41 111.321 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 39.7 mm -105.1 90.21 3.55 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.431 -0.951 . . . . 73.41 108.431 171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.773 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 83.6 Cg_endo -86.87 150.49 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.734 2.29 . . . . 61.42 113.138 -174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -81.77 61.52 5.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.893 0.854 . . . . 64.54 108.782 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -104.32 -42.67 5.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.877 -1.056 . . . . 75.54 112.23 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.61 29.67 4.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.82 -1.181 . . . . 75.22 113.992 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.23 25.18 9.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.181 -1.009 . . . . 74.34 112.963 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.3 131.32 43.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 63.25 111.358 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 m -93.65 174.68 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 74.35 110.188 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 3.3 p -85.88 19.07 2.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.007 0.432 . . . . 63.05 111.926 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t -125.92 124.36 66.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.843 -0.429 . . . . 61.24 109.843 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.79 135.94 26.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.538 -0.301 . . . . 65.24 110.417 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -137.12 105.99 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 64.44 111.514 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.6 mt -122.31 133.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.114 -0.699 . . . . 74.42 109.114 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.707 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 67.5 mtp180 -82.59 -45.84 14.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.092 0.473 . . . . 71.3 110.305 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.89 129.37 13.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.757 -0.656 . . . . 74.41 110.953 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.43 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 8.9 tt -109.56 118.36 36.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.625 -0.88 . . . . 74.11 108.625 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 149.98 42.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.007 0.432 . . . . 63.03 110.86 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.25 135.03 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.983 -0.553 . . . . 75.23 110.341 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -111.66 120.33 41.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.004 -0.739 . . . . 73.12 109.004 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.35 -159.9 16.2 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 62.22 111.847 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.0 m -120.84 130.82 54.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.588 0.232 . . . . 71.23 110.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 5' ' ' ILE . 33.6 mm -74.78 127.54 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 61.5 110.143 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.8 mt . . . . . 0 C--N 1.322 -0.615 0 N-CA-C 109.747 -0.464 . . . . 44.02 109.747 179.116 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.628 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 71.4 p . . . . . 0 N--CA 1.449 -0.518 0 CA-C-O 120.989 0.423 . . . . 74.41 110.907 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 HD11 ' A' ' 149' ' ' ILE . 48.0 mm -88.36 136.48 23.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.698 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -64.26 109.41 1.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 71.45 109.958 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.51 -1.01 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 75.14 111.51 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -70.24 91.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.415 0.626 . . . . 52.04 109.835 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.75 -17.99 2.8 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.279 -0.873 . . . . 75.34 111.735 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -68.02 155.49 39.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 74.33 109.698 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -140.08 153.17 46.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.338 -0.545 . . . . 72.21 111.145 175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.31 107.97 19.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.283 -0.871 . . . . 64.42 109.478 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 58' ' ' VAL . 83.5 mt -73.61 -47.12 42.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.725 -0.67 . . . . 72.11 110.437 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -143.28 139.38 30.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 51.42 110.167 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.62 140.17 36.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.465 -0.568 . . . . 74.42 109.465 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -84.61 -28.67 26.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.848 0.356 . . . . 75.33 110.991 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 t -162.19 149.7 14.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.877 0.37 . . . . 63.11 110.887 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -165.85 137.5 3.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.53 -0.759 . . . . 75.41 109.107 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 9.8 tp10 -105.17 95.0 5.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.011 0.434 . . . . 53.41 111.434 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -92.58 -31.48 15.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.25 110.572 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -79.66 -42.21 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 73.13 110.867 -173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.642 0 C-N-CA 120.947 -0.644 . . . . 62.44 112.7 -177.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 CA--C 1.515 -0.383 0 N-CA-C 110.017 -0.364 . . . . 71.42 110.017 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.38 -8.04 79.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.088 -0.577 . . . . 74.51 112.759 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.6 mt -73.27 144.65 46.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.322 -0.251 . . . . 71.15 110.322 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.7 -23.63 66.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.02 0.438 . . . . 65.34 110.923 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -75.4 -23.87 57.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 65.35 110.988 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 57.8 m -67.15 -25.38 66.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 53.21 110.417 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.37 -26.75 66.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.724 . . . . 74.32 110.522 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 59' ' ' ILE . 31.9 pt -121.27 12.19 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 73.41 110.723 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t70 -71.08 -36.66 72.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 72.32 109.719 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.94 52.97 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.499 -0.858 . . . . 52.33 113.42 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.629 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 8.3 t0 -149.3 135.16 18.82 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.842 -0.429 . . . . 64.21 109.842 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.6 p -81.55 10.77 5.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.604 -0.725 . . . . 75.42 112.64 -172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 13.0 pt-20 -118.45 -7.7 10.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.525 -0.47 . . . . 73.41 111.315 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p -96.71 166.9 11.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.504 -0.554 . . . . 74.32 109.504 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.521 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 50.6 p90 -161.82 165.28 28.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.269 0.557 . . . . 72.01 112.25 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 32.1 t90 -109.65 139.41 44.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.763 -1.108 . . . . 75.22 108.966 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.68 142.4 43.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.06 151.81 45.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.316 -0.402 . . . . 71.11 110.221 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -62.51 125.76 25.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.039 -0.356 . . . . 65.34 110.039 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 68.7 p-90 -126.22 -34.02 2.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 72.44 110.616 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -75.61 108.6 8.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.622 -0.511 . . . . 72.24 109.622 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.43 -20.54 46.4 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.769 -0.729 . . . . 45.11 111.462 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.6 167.8 11.34 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.677 -0.773 . . . . 53.53 112.001 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 54.8 m -115.03 149.77 36.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 60.45 110.503 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.56 152.5 66.99 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 73.42 110.076 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.02 142.8 35.16 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.216 1.944 . . . . 72.1 112.738 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.14 156.69 87.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 71.44 110.002 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.59 170.24 65.41 Favored 'Cis proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.627 -1.406 . . . . 70.22 113.437 2.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -110.37 129.94 55.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.035 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 15.8 m-20 -118.43 130.05 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.882 0.372 . . . . 75.11 110.505 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 126' ' ' LEU . 60.6 mt -121.25 108.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 53.41 109.681 173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 13' ' ' LEU . 40.8 t -95.93 119.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.907 -0.588 . . . . 62.33 110.23 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 34' ' ' ILE . 61.3 mt -119.28 133.03 67.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.279 -0.419 . . . . 74.3 110.94 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.7 t0 -100.05 120.88 40.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 74.12 109.633 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE1' HD11 ' A' ' 67' ' ' ILE . 70.5 mtm -86.78 -4.88 59.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 60.13 111.01 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.51 0.07 3.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.181 0.808 . . . . 75.33 113.181 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -159.94 173.75 15.44 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.298 -0.251 . . . . 75.24 110.734 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -82.67 122.75 28.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 71.42 109.906 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 5' ' ' ILE . 64.9 mt -132.59 135.31 57.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 75.23 110.322 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.517 HE21 ' HB3' ' A' ' 118' ' ' SER . 57.2 tp60 -83.16 104.31 13.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.046 -0.724 . . . . 64.32 109.046 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.1 mm -73.6 121.75 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.414 -0.357 . . . . 64.33 110.288 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.2 -36.33 4.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.053 0.454 . . . . 73.33 110.748 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.486 HE22 ' HE2' ' A' ' 146' ' ' LYS . 20.6 tt0 -153.44 143.25 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.884 -0.598 . . . . 72.21 110.813 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -114.7 138.43 44.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.355 -0.609 . . . . 74.03 109.355 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.4 mt-10 -117.31 133.62 55.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 73.53 111.3 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.34 122.78 45.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.793 -0.639 . . . . 74.21 109.687 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 tp -106.25 106.48 57.36 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.239 -0.437 . . . . 65.04 110.043 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 N--CA 1.461 -0.413 0 C-N-CA 122.724 2.283 . . . . 55.24 111.127 176.656 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m120 . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.346 -0.613 . . . . 71.41 109.346 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.817 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 2.8 Cg_exo -77.89 31.05 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.369 2.713 . . . . 71.14 112.24 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' PHE . 30.8 mt -95.1 112.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 75.11 109.4 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -100.56 -44.76 5.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.005 -0.543 . . . . 55.33 110.643 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG11 ' HE ' ' A' ' 102' ' ' ARG . 58.6 t -127.32 138.39 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 73.12 110.865 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 m -128.5 140.74 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 71.35 110.364 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -118.12 129.17 55.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.145 -0.48 . . . . 71.04 110.654 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -112.04 130.18 55.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 74.54 110.234 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.05 148.46 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.803 0.335 . . . . 50.22 111.031 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 148.39 52.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 71.31 109.979 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 154.94 38.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.118 0.485 . . . . 63.55 111.458 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 45.1 mt-10 -105.62 -9.64 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.279 -0.637 . . . . 73.22 109.279 170.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.55 -36.17 8.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 45.33 111.606 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.32 15.15 3.58 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.574 1.178 . . . . 73.41 108.031 -167.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -122.28 -62.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.019 -1.446 . . . . 75.45 109.485 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -89.49 104.85 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.886 -0.597 . . . . 64.44 109.435 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -93.86 117.6 30.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 71.01 111.309 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.6 m -94.18 125.29 53.05 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.641 . . . . 71.12 110.256 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.29 113.92 3.84 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.403 2.069 . . . . 74.14 111.943 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 116' ' ' VAL . 20.9 pt -83.87 -12.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 55.45 110.75 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.07 146.54 4.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.25 -0.976 . . . . 74.24 113.035 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HE ' HG11 ' A' ' 85' ' ' VAL . 69.3 ttt180 -125.99 118.56 25.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.801 -0.815 . . . . 72.11 108.801 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -136.82 -176.14 4.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.019 0.438 . . . . 73.31 111.051 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.48 148.54 18.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.569 -0.742 . . . . 61.51 112.134 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 42.6 t80 -95.81 119.91 35.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 74.32 110.276 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.439 ' HB ' HD21 ' A' ' 112' ' ' LEU . 20.1 m -103.54 110.18 22.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.228 -0.442 . . . . 42.1 110.749 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.39 100.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 73.3 110.572 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -139.94 -179.34 5.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 70.2 110.375 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.53 -11.06 35.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.99 0.424 . . . . 72.11 110.975 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.166 -0.47 . . . . 74.35 111.009 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 130.67 43.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.49 . . . . 64.34 110.916 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 106' ' ' THR . 58.8 mt -83.32 109.46 17.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 54.13 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.26 112.46 21.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 74.11 110.94 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.0 104.13 14.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 63.44 110.016 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -77.57 91.25 3.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.356 -0.838 . . . . 72.01 109.355 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 100' ' ' ILE . 31.2 m -96.28 -178.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 72.01 112.392 -170.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -65.73 126.49 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.136 -0.938 . . . . 63.33 110.649 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 63.9 m -71.49 123.99 23.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.074 -0.512 . . . . 53.23 110.45 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.059 -0.518 . . . . 62.12 110.286 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.555 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -93.83 113.61 25.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.178 -0.675 . . . . 71.44 109.178 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.06 173.61 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.676 0.274 . . . . 74.33 111.041 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -115.93 -32.36 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.32 0.581 . . . . 71.51 110.512 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.35 145.75 31.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.97 -0.559 . . . . 63.04 110.203 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.7 tt -135.13 138.02 49.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.021 -0.536 . . . . 55.01 109.69 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.3 ttp180 -124.7 125.9 44.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.017 0.437 . . . . 60.11 111.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' ILE . 47.0 tp -93.28 112.79 24.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.491 -0.777 . . . . 54.51 108.979 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.3 m -111.81 123.09 49.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.39 0.614 . . . . 71.15 111.151 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.98 100.49 11.53 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.649 -0.871 . . . . 71.1 108.649 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.6 164.88 24.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.718 2.279 . . . . 74.52 112.98 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.69 14.71 24.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.153 0.977 . . . . 73.33 108.855 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -125.08 134.58 52.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.905 -1.043 . . . . 74.11 110.389 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.78 -9.92 14.21 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.941 -0.647 . . . . 41.14 112.445 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.72 23.54 6.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.773 -0.727 . . . . 70.3 112.147 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -79.96 144.79 33.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.771 0.32 . . . . 64.43 110.789 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 24.5 m -117.47 177.28 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.169 -0.469 . . . . 24.13 110.458 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 32.4 p -79.13 -3.12 43.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 45.52 111.814 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.817 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 87.4 t -95.23 121.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.373 -0.376 . . . . 75.41 110.081 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.32 128.65 17.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 73.23 110.428 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.96 106.22 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.411 . . . . 53.31 110.674 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.51 132.95 67.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.001 -0.74 . . . . 62.22 109.001 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 92.9 mtt180 -70.98 -59.41 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.724 -0.39 . . . . 63.41 110.884 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.1 157.63 40.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.759 0.79 . . . . 73.01 112.097 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.85 133.28 56.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.454 -1.248 . . . . 62.13 107.736 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.628 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -130.77 170.3 14.55 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.579 -0.448 . . . . 72.12 109.844 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.1 t -141.38 128.11 20.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.937 -0.394 . . . . 62.1 109.937 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.486 ' HE2' HE22 ' A' ' 69' ' ' GLN . 48.2 mttm -97.91 124.41 42.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.433 -0.951 . . . . 75.3 108.433 172.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.64 -167.13 26.85 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.282 -0.961 . . . . 24.13 112.052 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 m -119.17 126.76 52.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.767 0.317 . . . . 74.44 110.501 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 5' ' ' ILE . 41.4 mm -70.66 127.15 32.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.036 -0.529 . . . . 73.22 110.005 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 120' ' ' LYS . 47.4 mt . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.373 . . . . 65.33 110.212 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.644 0.259 . . . . 75.22 110.474 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.609 HG21 HD13 ' A' ' 65' ' ' ILE . 51.1 mm -86.2 132.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.538 -0.301 . . . . 61.23 110.578 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -72.81 120.23 18.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.627 . . . . 61.41 109.306 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -82.24 29.49 0.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 63.02 111.017 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -79.01 95.96 5.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.661 -0.699 . . . . 64.43 110.222 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.86 -9.02 9.16 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 71.42 112.265 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.462 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.2 m0 -69.67 134.34 48.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.983 -0.377 . . . . 74.1 109.983 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' OE2' ' HE2' ' A' ' 62' ' ' LYS . 13.5 pt-20 -132.41 160.92 34.96 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.764 -0.374 . . . . 72.12 110.567 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -95.71 125.39 48.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.224 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 60' ' ' ASP . 77.7 mt -90.5 -44.54 9.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.132 0.492 . . . . 75.1 110.303 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -142.2 137.22 30.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.752 -0.658 . . . . 72.34 110.316 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.57 144.33 34.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.411 . . . . 61.42 110.138 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.8 m -80.15 -51.31 9.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 71.22 110.858 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.4 t -142.7 150.17 39.79 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.98 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -164.94 142.82 6.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.471 -0.937 . . . . 74.23 108.471 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 9.1 tp10 -103.27 107.94 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.7 -0.4 . . . . 72.42 111.029 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -114.34 -5.88 12.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 72.42 111.332 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -111.74 -40.03 4.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.401 -0.363 . . . . 73.14 110.837 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 121.002 -0.618 . . . . 60.41 112.038 177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.564 ' HB2' ' CE1' ' A' ' 41' ' ' PHE . 21.8 p-10 . . . . . 0 N--CA 1.454 -0.258 0 CA-C-O 120.885 0.374 . . . . 73.41 110.055 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.19 -10.8 60.09 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.481 -0.648 . . . . 70.21 111.481 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 89.7 mt -74.49 147.11 42.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.617 -0.291 . . . . 74.45 110.273 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.64 -24.06 64.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.044 0.449 . . . . 43.44 110.995 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -72.56 -26.91 61.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.755 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.3 m -70.57 -17.78 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 71.51 110.867 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.14 -20.58 66.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.544 0.687 . . . . 71.15 110.067 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 10' ' ' TRP . 40.2 pt -131.24 18.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.759 -0.655 . . . . 73.22 110.267 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 1.008 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -71.57 -30.44 65.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.026 -0.534 . . . . 54.21 110.651 -172.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.53 33.97 5.44 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.842 -0.694 . . . . 73.15 112.33 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 39' ' ' GLU . 8.8 t0 -153.32 124.4 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.695 -0.484 . . . . 73.33 109.695 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 p -77.53 -3.45 40.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.298 0.481 . . . . 20.12 112.298 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 16.9 mm-40 -83.34 -24.02 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.751 0.31 . . . . 61.51 110.208 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.4 p -93.93 165.06 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.958 -0.386 . . . . 72.14 109.958 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 52.8 p90 -163.92 172.01 14.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.296 . . . . 65.14 110.91 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 42.8 t90 -112.28 134.02 54.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.554 -0.748 . . . . 70.23 109.292 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.6 137.01 45.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.118 -0.697 . . . . 75.13 109.118 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 144.65 56.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.957 -0.386 . . . . 32.44 109.957 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.43 137.14 57.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.913 -0.585 . . . . 54.32 110.11 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -138.35 -13.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 75.51 110.9 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.59 101.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.127 0.489 . . . . 73.52 110.65 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.82 90.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.896 -0.669 . . . . 75.41 112.256 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.99 177.21 14.82 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.818 -0.706 . . . . 60.3 111.599 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 t -125.0 175.12 7.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.093 0.473 . . . . 72.44 110.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 17.0 m-20 -97.97 146.49 31.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 72.12 110.116 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.31 145.85 61.1 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.764 2.31 . . . . 74.32 112.835 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 21.0 mt -80.61 159.51 69.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.697 -0.683 . . . . 72.03 109.968 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.4 Cg_endo -78.42 158.61 92.91 Favored 'Cis proline' 0 C--N 1.344 0.307 0 C-N-CA 123.631 -1.404 . . . . 72.41 113.125 1.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.711 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.0 m-30 -91.08 129.93 37.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 74.23 109.974 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 11.8 t70 -121.07 124.96 46.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.202 -0.454 . . . . 62.42 109.955 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.39 117.15 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.92 0.391 . . . . 72.42 110.4 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.35 116.68 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 61.33 110.842 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.4 mp -107.82 136.69 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.517 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.499 ' HB2' HD11 ' A' ' 13' ' ' LEU . 39.8 t0 -104.47 122.75 46.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 61.42 109.791 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -90.12 -4.34 57.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 71.4 110.881 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HE2' ' OE2' ' A' ' 11' ' ' GLU . 33.4 mmtp 71.74 -6.99 1.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.456 0.702 . . . . 72.32 112.601 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -152.77 168.18 26.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.189 -0.3 . . . . 73.03 110.189 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.551 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 47.2 m-80 -85.58 125.43 33.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 71.01 110.344 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.609 HD13 HG21 ' A' ' 5' ' ' ILE . 62.0 mt -130.34 136.75 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.973 -0.558 . . . . 55.21 109.881 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.5 tp60 -83.19 100.53 10.63 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.901 -0.777 . . . . 74.31 108.901 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.735 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -66.89 130.92 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.378 -0.374 . . . . 73.53 110.318 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.71 -46.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.934 0.397 . . . . 73.42 110.943 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 19.3 tt0 -138.79 149.42 44.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.631 -0.507 . . . . 65.14 109.631 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.89 127.57 73.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.82 -0.437 . . . . 72.14 109.82 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 1.9 mp0 -108.66 131.79 54.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.333 0.587 . . . . 72.35 111.048 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 60.1 mt -111.66 119.27 38.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 174.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 27.0 tp -102.32 96.45 7.17 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.256 -0.646 . . . . 62.13 109.256 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.1 Cg_endo . . . . . 0 N--CA 1.454 -0.802 0 C-N-CA 123.259 2.64 . . . . 61.35 112.154 -176.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 138' ' ' ALA . 65.4 t30 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 121.194 0.521 . . . . 71.0 111.543 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 4.4 Cg_exo -75.79 55.6 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.343 2.696 . . . . 71.12 113.672 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.7 mt -99.51 115.61 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.089 -0.708 . . . . 71.24 109.089 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -100.44 -48.36 4.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.829 0.347 . . . . 73.54 110.832 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.16 139.82 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.1 110.466 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 105' ' ' PHE . 5.1 m -130.08 143.32 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.984 0.421 . . . . 63.45 110.885 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 38.1 mt-10 -125.31 130.5 52.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.071 -0.513 . . . . 71.13 110.849 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -113.22 132.48 55.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.484 . . . . 73.22 110.554 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.14 154.69 50.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.393 -0.367 . . . . 34.41 110.503 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.29 156.78 47.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 61.42 109.921 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 t -149.65 143.82 25.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 45.12 110.555 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -93.37 -41.75 9.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.004 -0.544 . . . . 74.25 110.781 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -109.2 3.56 21.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.833 -0.621 . . . . 64.51 110.992 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 23.7 t-20 75.53 -9.64 1.38 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.559 0.744 . . . . 70.43 111.055 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.08 -42.98 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 62.03 110.815 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.68 106.76 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 31.13 110.043 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.4 m95 -99.58 120.41 39.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 73.32 110.572 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.3 m -113.36 126.14 28.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.265 -0.425 . . . . 64.33 110.586 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.75 113.7 2.86 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.445 2.097 . . . . 61.43 111.126 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 116' ' ' VAL . 12.8 pt -82.17 -11.52 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.771 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.92 142.97 3.54 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.496 -0.859 . . . . 51.33 112.546 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.514 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 34.3 ttt180 -119.0 125.13 48.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.433 -0.58 . . . . 71.32 109.433 175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -140.28 -176.17 4.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.048 0.451 . . . . 71.22 110.718 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.81 155.55 20.08 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.435 -0.666 . . . . 53.33 111.435 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.491 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 52.1 t80 -103.27 135.33 45.12 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.898 0.38 . . . . 74.22 110.189 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.457 ' O ' HD11 ' A' ' 112' ' ' LEU . 34.3 m -116.04 116.55 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.483 -0.562 . . . . 72.0 109.483 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.68 93.6 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.273 0.559 . . . . 73.24 110.282 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -131.54 177.15 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.325 -0.852 . . . . 72.42 108.867 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.28 -8.74 35.08 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.49 -0.484 . . . . 73.13 110.252 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.62 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.808 -0.633 . . . . 54.33 110.223 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.31 128.48 35.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.11 0.481 . . . . 75.31 111.773 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 41.6 mt -84.96 125.68 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.06 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -98.0 115.32 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.969 0.414 . . . . 52.24 110.789 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.83 107.27 17.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.154 -0.475 . . . . 64.43 110.257 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.06 92.1 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.746 -0.661 . . . . 74.31 109.49 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 100' ' ' ILE . 28.9 m -98.56 176.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.796 . . . . 61.51 111.937 -171.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.89 134.23 52.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.379 -0.828 . . . . 61.31 110.594 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.735 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 19.2 m -77.28 117.72 19.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.071 -0.513 . . . . 74.1 110.7 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.62 143.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.982 -0.554 . . . . 75.33 110.802 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.551 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.522 -0.547 . . . . 74.03 109.522 173.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.58 159.72 44.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.211 -0.45 . . . . 61.33 110.944 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.433 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 39.9 ttt180 -107.53 -27.47 10.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.45 0.643 . . . . 72.53 109.728 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 94' ' ' ASN . 71.8 m-85 -114.17 146.26 40.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.691 -0.686 . . . . 74.24 110.071 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.503 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.3 tt -133.62 140.3 46.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.452 -0.573 . . . . 70.04 109.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 49.6 ttp180 -127.97 124.54 37.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 72.45 111.394 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.3 tp -95.24 120.28 35.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.315 -0.857 . . . . 45.54 109.428 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -114.84 122.23 45.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 70.04 110.804 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.6 mm -102.24 97.19 8.13 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.87 -0.789 . . . . 72.14 108.87 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -73.48 -173.48 1.33 Allowed 'Trans proline' 0 CA--C 1.522 -0.123 0 C-N-CA 122.938 2.425 . . . . 74.43 113.058 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 16.2 t0 -129.26 75.36 1.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 65.52 108.4 166.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.53 -50.94 2.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.273 -0.876 . . . . 71.31 112.094 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.4 28.77 7.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.24 -0.981 . . . . 74.52 113.916 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 106.55 26.06 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.858 -1.163 . . . . 64.11 113.007 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 6.5 m-20 -70.81 132.12 44.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.725 0.298 . . . . 62.52 110.281 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 m -109.54 179.37 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.5 -0.318 . . . . 73.24 111.045 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 p -90.02 16.05 9.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.368 0.604 . . . . 65.21 111.544 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.471 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 78.2 t -110.43 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.014 -0.539 . . . . 72.13 109.65 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . . . -135.38 130.97 35.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.498 -0.319 . . . . 73.11 110.566 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.3 106.11 5.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.085 0.469 . . . . 71.45 110.879 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.8 mt -129.46 135.79 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.817 -0.629 . . . . 72.24 109.432 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 57.5 mtt180 -66.95 -71.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 75.42 110.096 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -145.42 162.42 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.544 0.688 . . . . 75.12 111.98 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.88 124.7 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.507 -1.224 . . . . 75.32 108.18 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -126.35 162.17 26.14 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.637 -0.505 . . . . 72.32 109.637 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.1 t -136.03 134.93 50.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.876 0.37 . . . . 71.41 111.382 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 65.0 mttp -95.76 131.86 41.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.22 -169.65 37.96 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.194 -1.003 . . . . 74.35 112.474 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.2 m -118.81 132.86 56.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.35 -0.241 . . . . 64.21 110.35 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.82 121.37 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 71.1 110.11 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 66' ' ' GLN . 73.5 mt . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 120.979 0.418 . . . . 61.11 110.457 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 109.298 -0.63 . . . . 61.22 109.298 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 149' ' ' ILE . 39.7 mm -71.43 136.45 25.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 71.34 111.067 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.1 m -73.15 109.08 6.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 72.54 109.826 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -85.94 26.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 74.2 111.383 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -6.09 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 43.21 111.463 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.2 2.87 10.59 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.608 -0.806 . . . . 74.32 112.399 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -81.46 134.9 35.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.427 -0.212 . . . . 73.45 110.427 -175.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.3 155.72 45.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.734 -0.386 . . . . 72.53 110.497 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.6 t -90.05 108.27 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.825 -0.625 . . . . 75.3 109.981 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.6 mt -74.77 -49.24 21.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.017 -0.538 . . . . 75.44 110.477 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -143.42 134.18 25.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.726 . . . . 73.4 110.015 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 54.3 p90 -135.33 148.91 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.706 -0.479 . . . . 73.12 109.706 175.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.2 m -86.62 -44.61 11.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.388 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -143.8 144.37 31.76 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.187 0.517 . . . . 50.32 111.077 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -149.92 148.29 28.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 175.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.465 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 8.5 tp10 -119.4 89.1 3.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.354 0.597 . . . . 50.05 110.963 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . . . -100.38 -21.77 15.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.546 -0.752 . . . . 74.44 110.088 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -83.71 -44.46 14.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.673 -0.694 . . . . 64.4 110.93 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.731 0 C-N-CA 120.911 -0.661 . . . . 72.52 112.35 178.398 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 CA--C 1.513 -0.449 0 N-CA-C 109.78 -0.452 . . . . 75.51 109.78 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.31 3.06 90.25 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.709 -0.556 . . . . 74.34 111.709 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 80.6 mt -84.31 144.49 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.273 -0.269 . . . . 72.12 110.273 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.95 -24.51 66.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 74.52 110.409 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 19.4 ptpt -72.74 -25.26 61.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 74.41 111.037 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.855 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 61.2 m -71.58 -18.67 62.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 75.42 110.387 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.23 -15.04 61.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.818 -0.628 . . . . 62.12 110.273 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.23 22.24 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.824 -0.625 . . . . 71.25 109.593 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.855 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 13.6 t70 -72.54 -58.7 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 64.43 110.402 -175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.57 39.25 0.79 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.023 -0.608 . . . . 74.41 112.203 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -148.16 122.58 9.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.866 0.365 . . . . 64.23 110.265 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -74.9 7.14 3.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.101 0.778 . . . . 61.42 113.101 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -106.7 -19.72 13.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.035 -0.266 . . . . 75.44 111.051 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -88.65 168.93 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.03 -0.359 . . . . 72.24 110.03 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.438 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 56.2 p90 -161.6 163.62 29.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.036 0.446 . . . . 73.33 111.586 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 32.5 t90 -107.02 143.02 35.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.294 -0.866 . . . . 72.34 109.072 172.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 51.3 t-80 -138.96 145.72 40.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.126 -0.694 . . . . 61.52 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.1 149.73 39.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.118 -0.327 . . . . 64.4 110.118 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 50' ' ' SER . 63.1 tttm -61.06 119.37 8.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.428 -0.351 . . . . 73.31 110.619 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.465 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 69.8 p-90 -118.29 -27.13 6.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 70.35 110.307 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.32 127.25 32.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.729 -0.471 . . . . 75.45 109.729 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.22 89.97 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.725 -0.75 . . . . 65.44 111.828 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.57 148.5 9.0 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.491 -0.643 . . . . 74.42 111.491 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 20.6 m -78.85 150.19 32.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.117 -0.327 . . . . 44.2 110.117 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 2.0 t70 -80.42 145.48 59.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.021 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 20.3 Cg_endo -62.25 129.98 28.84 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.632 2.221 . . . . 71.13 113.327 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.2 158.69 66.5 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 74.24 110.125 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 1.0 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.3 Cg_exo -76.5 161.58 93.48 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 124.284 -1.132 . . . . 75.25 113.295 0.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.1 m-85 -96.11 138.46 33.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 71.41 109.579 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' A' ' 125' ' ' ARG . 6.2 t70 -132.67 123.69 26.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.221 -0.288 . . . . 62.22 110.221 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.39 124.18 66.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.695 0.283 . . . . 72.21 110.624 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 ' HG3' ' A' ' 125' ' ' ARG . 45.5 t -113.23 120.16 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.34 -0.391 . . . . 63.22 111.096 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.8 mp -112.99 139.36 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 75.52 110.103 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.643 ' HB2' HD11 ' A' ' 13' ' ' LEU . 51.0 t0 -106.0 126.81 52.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.625 -0.509 . . . . 72.44 109.625 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.446 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.0 mtm -90.62 -6.97 53.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 74.23 110.664 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 31.5 mmtp 68.48 5.27 4.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.602 0.761 . . . . 74.31 112.415 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 27.4 pt20 -157.94 174.16 15.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.492 -0.188 . . . . 61.32 110.492 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -88.6 124.11 33.73 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.679 -0.489 . . . . 25.42 109.679 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.446 HD12 ' SD ' ' A' ' 61' ' ' MET . 70.9 mt -132.84 133.7 58.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.012 0.435 . . . . 72.02 110.256 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.6 tp60 -82.76 105.41 13.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.684 -0.858 . . . . 61.11 108.684 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.1 mm -75.44 124.74 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.82 0.343 . . . . 74.01 110.483 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.81 -43.88 2.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.03 -0.532 . . . . 70.13 110.784 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -148.47 140.3 23.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.242 -0.436 . . . . 71.43 111.039 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.31 139.45 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.297 -0.631 . . . . 62.04 109.297 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 42.0 mt-10 -123.29 131.37 53.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.104 0.478 . . . . 74.1 111.101 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 65.2 mt -113.36 124.72 53.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 74.0 109.893 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -103.58 104.14 40.22 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.651 -0.5 . . . . 64.04 109.651 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 11.9 Cg_exo . . . . . 0 N--CA 1.465 -0.2 0 C-N-CA 122.811 2.341 . . . . 74.1 112.129 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' ND2' ' A' ' 107' ' ' ASN . 2.7 m120 . . . . . 0 N--CA 1.466 0.33 0 N-CA-C 112.227 0.454 . . . . 55.12 112.227 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 85.1 Cg_endo -85.89 30.52 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.813 2.342 . . . . 74.43 112.306 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -77.76 127.85 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 63.32 109.795 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -98.96 -55.2 2.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 75.11 111.126 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 48.0 t -128.82 138.03 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 40.54 110.739 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.59 133.59 68.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.169 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.2 mt-10 -115.02 126.67 55.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.982 0.42 . . . . 63.52 110.975 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -107.56 134.06 51.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.773 -0.649 . . . . 63.43 110.248 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.66 151.54 51.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.33 -0.395 . . . . 72.32 110.398 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.084 -0.339 . . . . 72.53 110.084 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -147.58 145.35 28.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.031 0.443 . . . . 62.52 111.5 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -81.52 -43.25 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.8 -0.636 . . . . 72.33 109.842 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 1.0 OUTLIER -109.72 -1.97 17.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.268 -0.878 . . . . 70.31 112.394 -170.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.3 t-20 76.27 -7.96 1.73 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.972 0.509 . . . . 73.23 111.079 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -94.69 -51.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.231 0.539 . . . . 42.24 109.804 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -92.64 105.71 17.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.43 -0.805 . . . . 73.14 110.328 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 96.6 m95 -97.63 121.75 39.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.853 0.359 . . . . 73.35 111.504 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 35.5 m -97.36 128.95 33.13 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 61.21 110.046 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 6.0 Cg_exo -75.22 108.69 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.463 2.109 . . . . 73.4 110.315 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 19.8 pt -82.37 -19.1 10.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.377 -0.374 . . . . 63.55 111.206 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.19 131.06 1.41 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.037 -1.078 . . . . 31.32 113.002 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 61.4 ttt180 -112.91 115.21 28.08 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.917 -0.401 . . . . 70.32 109.917 172.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -137.4 176.99 8.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.723 0.297 . . . . 72.23 110.853 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -95.61 157.59 21.85 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.902 -0.666 . . . . 74.34 112.057 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -94.14 148.29 22.33 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.719 -0.475 . . . . 71.42 109.719 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.678 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.4 m -131.21 115.93 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.501 -0.318 . . . . 55.35 110.644 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 81' ' ' ASN . 48.7 t-20 -69.67 96.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.165 0.507 . . . . 73.14 110.09 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -136.94 174.01 11.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.704 . . . . 71.43 109.284 176.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.55 -8.38 44.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.232 0.539 . . . . 73.35 110.752 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.42 158.78 16.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 63.53 110.618 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.18 138.21 58.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.269 -0.423 . . . . 73.22 110.945 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.678 HD21 ' HB ' ' A' ' 106' ' ' THR . 39.7 mt -90.95 110.76 22.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 75.42 110.461 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.43 120.19 26.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.198 0.523 . . . . 64.05 110.271 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.29 107.5 17.27 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.394 -0.821 . . . . 70.24 110.007 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -80.02 98.66 7.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 30.8 m -100.78 -178.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.911 -0.586 . . . . 54.14 111.801 -171.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.03 129.59 40.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 73.11 110.776 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.8 m -75.65 106.81 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 62.04 110.033 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.18 148.3 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.374 -0.375 . . . . 74.35 110.244 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HG3' HD12 ' A' ' 150' ' ' ILE . 4.5 ttpm? -84.82 135.84 33.93 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.891 -0.411 . . . . 63.32 109.891 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.22 40.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.571 -0.286 . . . . 64.53 110.982 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 41.0 ttt180 -108.73 -33.3 7.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 72.12 109.462 171.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -109.3 145.51 35.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.655 -0.702 . . . . 74.34 109.891 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.1 tt -130.8 139.1 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.407 -0.59 . . . . 75.02 109.407 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.952 ' HG3' HG22 ' A' ' 58' ' ' VAL . 1.6 ttm180 -125.12 139.44 53.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.915 0.388 . . . . 65.51 111.021 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 tp -115.11 120.51 40.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.671 -0.695 . . . . 62.24 109.458 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 42.1 m -115.55 128.55 56.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.883 0.373 . . . . 74.14 110.798 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 35.1 mm -108.35 88.77 5.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.171 -0.677 . . . . 54.54 109.171 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 1.0 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.8 Cg_endo -87.95 131.42 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.957 2.438 . . . . 72.21 113.708 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 20.3 t0 -80.1 65.0 5.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.044 0.926 . . . . 75.11 109.246 172.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.09 -19.14 11.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.687 -1.142 . . . . 41.43 110.02 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -131.49 29.04 3.5 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.611 -0.804 . . . . 25.3 112.792 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.69 24.91 16.59 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 120.506 -0.854 . . . . 74.04 113.321 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 3.2 m-20 -70.25 130.85 43.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.968 0.413 . . . . 74.0 111.193 -176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.3 m -92.49 157.26 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 70.22 110.363 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 10.0 p -67.89 -20.98 65.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.032 0.444 . . . . 73.21 111.908 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 t -80.47 93.57 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.205 0.526 . . . . 72.31 110.679 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -114.39 136.05 53.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.076 -0.511 . . . . 53.1 110.313 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -152.02 108.36 3.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.229 -0.441 . . . . 61.3 110.86 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.61 136.22 60.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 75.34 108.823 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 66.7 mtt180 -74.62 -53.52 9.2 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.852 -0.339 . . . . 65.44 111.32 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.28 135.56 15.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 75.21 111.07 -173.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 143' ' ' LEU . 9.3 tt -112.75 121.14 43.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.371 -0.603 . . . . 53.51 109.371 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.7 158.26 35.25 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.922 0.391 . . . . 61.31 110.55 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.56 136.54 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.379 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -101.7 125.42 48.35 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.207 -0.664 . . . . 73.01 109.207 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.1 -168.32 30.96 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.395 -0.907 . . . . 73.23 112.549 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.6 m -115.7 131.25 56.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.582 0.229 . . . . 74.41 110.948 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 5' ' ' ILE . 37.7 mm -76.95 118.07 22.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 60.43 110.374 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 120' ' ' LYS . 39.7 mt . . . . . 0 C--N 1.321 -0.671 0 CA-C-O 121.229 0.538 . . . . 70.54 110.607 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.932 0.396 . . . . 73.51 111.099 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.676 HG21 HD13 ' A' ' 65' ' ' ILE . 47.8 mm -85.29 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 62.41 110.115 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -66.92 118.72 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.381 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -92.2 25.79 2.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.095 0.474 . . . . 51.12 110.621 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -52.93 61.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.4 -0.818 . . . . 75.21 112.23 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.44 6.53 68.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.532 -0.842 . . . . 74.21 113.304 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -70.54 134.15 47.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.799 0.299 . . . . 72.24 110.403 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 6.8 pt-20 -130.71 161.83 30.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.983 0.421 . . . . 64.43 110.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.92 113.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.791 -0.64 . . . . 73.21 110.118 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 60' ' ' ASP . 79.4 mt -83.36 -47.89 10.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.996 -0.547 . . . . 75.31 110.478 -178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -137.36 140.41 41.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.815 -0.629 . . . . 64.42 110.164 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -150.37 148.52 28.9 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.588 -0.523 . . . . 73.1 109.588 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -90.73 -36.49 14.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 72.1 111.065 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -155.22 154.46 32.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 64.52 111.243 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 10.1 pt20 -165.63 135.81 3.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.192 -0.913 . . . . 71.52 108.81 174.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -88.98 94.79 10.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.33 0.586 . . . . 73.22 110.546 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.49 -3.18 34.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.654 -0.703 . . . . 73.12 111.49 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -111.39 -51.58 2.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.823 0.344 . . . . 75.23 110.131 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.434 0 C-N-CA 121.146 -0.549 . . . . 73.31 112.14 -179.777 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 . . . . . 0 C--O 1.224 -0.288 0 CA-C-O 120.636 0.255 . . . . 62.14 110.447 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.86 -5.26 83.05 Favored Glycine 0 C--N 1.322 -0.234 0 C-N-CA 120.601 -0.809 . . . . 73.23 112.438 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.49 HD12 ' HE3' ' A' ' 31' ' ' LYS . 82.2 mt -73.95 150.99 40.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.142 -0.318 . . . . 75.11 110.142 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.94 -22.25 66.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 62.11 110.953 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HE3' HD12 ' A' ' 29' ' ' LEU . 16.8 pttp -75.08 -24.17 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 62.13 110.816 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.945 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.0 m -76.51 -10.71 59.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.941 -0.572 . . . . 63.11 111.087 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.77 -15.3 62.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.616 0.722 . . . . 75.15 109.417 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 59' ' ' ILE . 28.4 pt -132.01 21.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 51.41 109.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.945 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 1.7 t70 -68.22 -48.54 64.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 61.33 109.931 -174.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 142' ' ' GLU . . . 117.74 31.12 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.809 -0.71 . . . . 74.5 114.077 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.589 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 9.7 t70 -153.27 153.95 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.981 0.89 . . . . 74.14 111.336 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -72.53 -18.36 61.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.272 0.471 . . . . 74.02 112.272 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.589 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.7 pt-20 -98.12 3.43 49.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.404 -0.518 . . . . 63.24 111.189 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -102.27 157.05 17.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.915 -0.772 . . . . 72.33 108.915 168.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 51.2 p90 -166.98 158.07 12.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 65.12 111.2 -175.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.7 t90 -102.35 134.91 44.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.402 -0.817 . . . . 72.03 109.051 172.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -134.78 136.16 42.37 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.469 -0.567 . . . . 73.21 109.469 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.18 139.79 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.945 -0.391 . . . . 54.12 109.945 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 36.9 ttpt -62.56 118.84 8.14 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.717 -0.475 . . . . 75.15 109.717 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -112.36 -29.38 7.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.594 -0.275 . . . . 75.41 110.622 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -74.25 125.47 28.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.978 0.418 . . . . 63.5 110.17 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.05 -3.09 84.46 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 73.25 112.145 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.85 132.61 7.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.874 -0.679 . . . . 41.25 111.9 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 49.7 m -78.91 149.57 32.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 74.24 111.341 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.13 157.69 89.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 72.23 110.326 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.0 146.56 41.82 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.326 2.018 . . . . 71.32 112.123 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.49 156.95 88.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.833 -0.621 . . . . 73.53 109.707 173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.806 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 84.0 Cg_endo -82.78 156.46 76.07 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.779 -1.342 . . . . 73.21 113.62 0.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.21 117.89 30.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.539 -0.755 . . . . 63.12 109.234 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 18.5 t70 -117.42 125.62 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.305 -0.258 . . . . 61.31 110.305 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 61.4 mt -122.83 115.58 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.831 0.348 . . . . 63.24 110.94 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.14 116.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.957 -0.565 . . . . 75.24 110.306 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 34' ' ' ILE . 81.8 mt -115.96 136.75 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.236 -0.438 . . . . 73.31 110.844 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 13' ' ' LEU . 53.5 t0 -101.54 120.28 40.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.47 -0.567 . . . . 64.41 109.47 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm -85.97 -5.94 59.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 65.1 110.819 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.488 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 73.2 mmtt 67.6 7.34 5.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.809 -0.632 . . . . 74.1 112.159 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -163.93 155.96 16.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.707 0.289 . . . . 71.31 110.459 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -74.54 128.74 36.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.601 . . . . 72.31 109.838 177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.676 HD13 HG21 ' A' ' 5' ' ' ILE . 58.5 mt -133.46 135.88 55.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.857 0.36 . . . . 73.43 110.165 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.484 HE21 ' HB3' ' A' ' 118' ' ' SER . 58.5 tp60 -81.51 102.68 10.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.875 -0.787 . . . . 73.33 108.875 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 118' ' ' SER . 21.4 mm -72.93 118.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.285 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.12 -41.97 3.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.351 -0.386 . . . . 74.41 110.843 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -148.64 144.22 27.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.301 -0.409 . . . . 62.0 110.277 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.02 129.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.961 -0.385 . . . . 65.34 109.961 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -105.89 131.17 53.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.935 0.398 . . . . 74.51 110.468 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 38.4 mt -112.6 118.57 35.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.848 -0.615 . . . . 63.32 109.449 174.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.509 ' HG ' ' HD2' ' A' ' 141' ' ' ARG . 24.2 tp -102.36 101.52 20.1 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 115.82 -0.627 . . . . 75.22 109.328 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 17.0 Cg_exo . . . . . 0 N--CA 1.462 -0.324 0 C-N-CA 122.5 2.133 . . . . 64.33 111.111 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 49.9 t-20 . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 121.311 0.577 . . . . 73.05 110.133 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 89.6 Cg_endo -90.88 28.14 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.305 2.67 . . . . 74.02 113.731 -177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 80.1 mt -82.51 117.46 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 75.33 110.512 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -92.05 -57.53 2.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.618 -0.719 . . . . 64.34 110.902 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.66 138.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.574 . . . . 61.44 111.09 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.41 138.67 54.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.157 -0.474 . . . . 60.23 110.146 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 89.9 mt-10 -119.81 127.68 53.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 73.32 110.617 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB2' HG13 ' A' ' 100' ' ' ILE . 53.5 m-85 -106.3 132.85 51.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.761 -0.654 . . . . 60.02 109.978 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.7 150.31 52.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.588 -0.278 . . . . 74.15 110.408 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.36 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.766 0.317 . . . . 72.34 111.169 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 t -150.53 149.11 29.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.303 -0.628 . . . . 65.51 109.303 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.699 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -90.65 -33.88 15.65 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 122.163 -0.335 . . . . 64.02 111.755 -177.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.6 20.22 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.602 -0.439 . . . . 73.01 111.222 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 65.79 47.4 2.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.426 0.632 . . . . 61.04 110.518 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.54 -74.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.042 -0.526 . . . . 62.5 109.894 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -83.29 105.82 14.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.327 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -91.06 108.32 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.274 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.0 m -94.56 123.67 57.52 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.874 -0.603 . . . . 64.52 110.181 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.48 102.55 0.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.412 2.075 . . . . 51.21 111.27 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 22.4 pt -75.79 -15.64 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 53.13 111.112 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.6 136.57 2.28 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.809 -1.186 . . . . 72.42 113.509 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 40.3 ttt180 -119.67 114.62 22.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.514 -0.921 . . . . 64.15 108.514 169.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -135.87 179.62 6.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 73.54 110.755 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.49 135.17 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.32 112.12 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -94.29 148.08 22.57 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.792 -0.448 . . . . 72.23 109.792 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' HD11 ' A' ' 112' ' ' LEU . 47.0 m -142.11 120.36 12.26 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.71 -0.478 . . . . 71.12 109.71 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 12.0 t30 -77.09 91.66 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.51 0.671 . . . . 75.34 110.935 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -118.26 -171.89 2.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.002 -0.999 . . . . 74.44 109.217 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -95.83 -26.05 15.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.935 0.397 . . . . 71.15 110.63 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.79 155.32 21.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 35.12 110.624 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.86 141.15 51.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 74.25 111.013 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 106' ' ' THR . 16.0 mt -98.2 106.45 18.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 71.34 110.083 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -80.3 116.7 20.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.885 0.374 . . . . 72.44 110.569 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.92 112.62 25.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.667 -0.697 . . . . 72.54 110.578 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -77.22 93.25 3.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.377 -0.601 . . . . 74.53 109.377 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.5 m -96.79 177.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 75.33 111.495 -173.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -67.59 132.87 48.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.321 -0.854 . . . . 74.14 110.459 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 41.8 m -74.92 122.25 23.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 75.33 110.51 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.5 tt -152.84 143.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.896 -0.593 . . . . 73.45 110.538 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -88.89 112.61 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.168 -0.678 . . . . 73.21 109.168 174.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.95 161.96 36.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.449 -0.341 . . . . 62.35 111.082 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.699 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 34.7 ttt180 -109.89 -31.85 7.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 61.41 110.159 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.05 145.92 30.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.705 -0.679 . . . . 73.34 109.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.416 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.7 tt -129.56 140.05 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.546 -0.539 . . . . 71.23 109.546 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 57.5 ttp180 -130.29 127.02 38.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 73.32 111.127 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.18 115.94 31.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.646 -0.707 . . . . 72.01 109.236 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 34.7 m -112.04 120.52 42.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.031 0.444 . . . . 74.13 110.91 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.7 96.06 8.4 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.175 -0.676 . . . . 73.35 109.175 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.806 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 98.0 Cg_endo -79.73 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.513 2.142 . . . . 73.2 112.617 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -123.69 67.73 1.02 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.912 0.863 . . . . 53.22 108.867 170.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.8 18.07 3.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.66 -1.154 . . . . 73.11 110.1 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.84 2.1 0.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.168 -1.015 . . . . 61.05 113.729 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.75 27.64 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.32 -0.943 . . . . 41.24 112.045 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.04 156.52 17.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.965 0.412 . . . . 73.34 110.958 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 22.4 m -123.43 -179.41 4.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.068 -0.515 . . . . 75.51 110.199 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 6.6 p -85.06 5.0 31.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.219 0.533 . . . . 74.21 111.993 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 46.6 t -103.05 128.56 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.661 -0.496 . . . . 60.21 109.661 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.48 131.92 19.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.7 -0.227 . . . . 70.4 110.653 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.36 105.34 4.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 63.02 111.145 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.95 133.31 67.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.363 -0.606 . . . . 65.44 109.363 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 66.9 mtt180 -64.76 -71.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.345 0.593 . . . . 73.33 109.89 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' GLY . 61.5 mm-40 -140.09 144.51 36.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 64.25 111.7 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -107.48 119.61 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.825 -1.176 . . . . 73.3 107.825 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.7 141.77 51.7 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.936 0.398 . . . . 72.32 110.557 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.11 133.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.678 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -107.49 105.24 15.05 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.75 -0.833 . . . . 63.33 108.75 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.03 -150.05 5.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.68 . . . . 73.34 111.966 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 m -132.83 133.85 43.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.503 0.192 . . . . 74.25 110.589 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.58 130.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 75.54 110.988 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.576 HD12 ' HG2' ' A' ' 120' ' ' LYS . 34.3 mt . . . . . 0 C--N 1.323 -0.587 0 CA-C-N 115.796 -0.638 . . . . 72.04 109.749 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 120.981 0.42 . . . . 70.41 110.317 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 HD11 ' A' ' 149' ' ' ILE . 42.1 mm -70.9 137.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.781 -0.645 . . . . 63.23 111.83 -174.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -69.08 108.16 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.564 . . . . 73.22 110.174 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -87.01 10.34 16.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 74.1 111.168 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -72.06 -7.5 49.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 53.11 111.654 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -120.19 4.59 12.44 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.263 -0.97 . . . . 60.53 113.076 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.53 ' HB2' HD12 ' A' ' 34' ' ' ILE . 34.8 m0 -80.3 156.81 26.61 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.635 0.255 . . . . 74.23 110.601 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.581 ' CD ' ' HE3' ' A' ' 62' ' ' LYS . 3.2 pm0 -141.89 153.02 44.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.143 0.497 . . . . 71.51 111.046 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.99 128.64 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.322 -0.399 . . . . 54.14 110.186 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 58' ' ' VAL . 57.4 mt -89.42 -49.81 6.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.243 0.544 . . . . 61.14 110.097 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.2 p -150.7 143.84 24.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.681 -0.69 . . . . 74.24 110.587 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.77 147.7 41.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.501 -0.772 . . . . 74.24 109.087 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -85.47 -33.31 21.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.903 0.382 . . . . 74.21 110.81 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -156.27 155.02 31.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.871 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -168.03 143.05 3.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.602 -0.888 . . . . 64.53 108.602 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -94.18 115.42 27.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.083 0.468 . . . . 64.23 110.124 -178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.36 3.74 6.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 53.12 110.899 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.6 m -121.74 -42.13 2.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.155 -0.475 . . . . 70.4 110.923 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.46 0 C-N-CA 120.809 -0.71 . . . . 53.11 112.395 179.083 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 . . . . . 0 CA--C 1.519 -0.231 0 N-CA-C 109.407 -0.59 . . . . 74.35 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.16 -7.88 58.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.015 -0.612 . . . . 74.43 111.944 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 90.1 mt -75.79 151.87 37.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 71.42 110.472 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.1 -25.27 65.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.009 0.433 . . . . 52.33 110.765 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.85 -20.47 61.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.672 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 60.4 m -73.01 -18.0 61.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.042 0.449 . . . . 54.52 110.742 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 tp -66.93 -17.5 64.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.737 -0.665 . . . . 70.05 110.219 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 10' ' ' TRP . 29.7 pt -128.39 22.39 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 72.45 110.45 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 26.5 t70 -70.49 -40.74 73.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 75.24 112.161 -171.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.32 23.08 9.87 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.651 -0.785 . . . . 32.11 112.061 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -138.18 128.83 26.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.49 -0.559 . . . . 72.31 109.49 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 p -76.83 0.56 20.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.029 0.751 . . . . 73.14 113.029 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.11 -7.44 15.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.572 -0.451 . . . . 62.22 111.57 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 p -92.42 149.2 21.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.081 -0.711 . . . . 73.53 109.081 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 49.7 p90 -153.05 166.72 31.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.946 0.403 . . . . 74.4 111.468 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 44.8 t90 -108.03 138.9 43.48 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.189 -0.914 . . . . 73.2 109.385 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -136.31 142.62 43.9 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.036 -0.727 . . . . 63.45 109.036 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.61 56.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.636 -0.505 . . . . 71.35 109.636 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HZ2' ' A' ' 45' ' ' LYS . 2.2 ttpm? -64.17 115.22 4.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.135 -0.32 . . . . 63.22 110.135 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -109.24 -28.94 8.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.311 -0.404 . . . . 75.21 110.805 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -76.54 113.78 14.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 73.42 110.236 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.87 -8.51 54.32 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.229 -0.748 . . . . 61.14 111.229 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.53 161.2 11.01 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.545 -0.622 . . . . 74.24 111.545 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 4.6 p -98.34 148.39 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.738 0.304 . . . . 73.52 110.51 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 21.2 m-20 -84.57 149.12 53.71 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.682 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 22.4 Cg_exo -66.24 128.79 20.15 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.872 2.382 . . . . 73.45 112.822 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.9 mt -73.09 162.33 75.05 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.391 -0.822 . . . . 74.11 110.207 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 92.4 Cg_endo -78.33 163.56 86.65 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.843 -1.315 . . . . 52.52 113.249 1.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.5 m-85 -100.19 112.89 25.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 73.31 110.649 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.78 131.62 44.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.421 -0.354 . . . . 73.43 110.254 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.414 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 60.6 mt -124.76 108.51 20.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.579 -0.526 . . . . 72.12 109.579 172.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.467 HG12 HD12 ' A' ' 13' ' ' LEU . 49.5 t -102.25 114.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.951 -0.568 . . . . 74.14 110.388 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.05 139.6 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.87 -0.604 . . . . 72.22 109.898 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HB3' ' OE1' ' A' ' 11' ' ' GLU . 19.5 t0 -102.66 138.52 39.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.693 -0.484 . . . . 64.24 109.693 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.479 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.6 mtm -91.83 -3.15 56.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 72.44 110.07 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HE3' ' CD ' ' A' ' 11' ' ' GLU . 24.0 mmtp 67.6 4.09 3.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.482 -0.781 . . . . 72.34 112.467 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -165.3 172.12 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.602 0.239 . . . . 73.13 110.754 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.41 127.18 31.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.259 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.667 HD13 HG21 ' A' ' 5' ' ' ILE . 74.6 mt -136.68 135.16 48.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.143 0.497 . . . . 71.11 110.363 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -82.82 109.39 16.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.009 -0.738 . . . . 74.22 109.009 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 118' ' ' SER . 27.4 mm -79.33 129.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.92 -0.312 . . . . 73.43 110.325 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.59 -39.28 2.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 63.23 110.968 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 15.8 tt0 -150.96 143.94 24.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.996 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.06 131.68 67.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.243 -0.435 . . . . 70.53 109.836 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.8 mt-10 -110.07 135.85 50.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.908 0.385 . . . . 72.34 110.677 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.42 HD12 ' HE2' ' A' ' 114' ' ' TYR . 69.2 mt -119.01 120.3 36.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.733 -0.667 . . . . 65.22 109.557 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 31.2 tp -104.25 104.02 41.91 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 116.052 -0.522 . . . . 75.52 109.907 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.7 Cg_exo . . . . . 0 CA--C 1.53 0.304 0 C-N-CA 123.222 2.615 . . . . 64.31 112.267 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 t30 . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 120.99 0.424 . . . . 61.22 111.423 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.616 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 75.4 Cg_endo -77.99 59.9 7.11 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.07 2.514 . . . . 63.33 113.755 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mt -99.0 119.36 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.041 -0.726 . . . . 74.41 109.041 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -102.64 -49.64 3.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.342 -0.39 . . . . 72.2 111.822 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.66 138.0 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.51 -0.314 . . . . 74.01 111.133 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.82 129.2 63.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.276 -0.42 . . . . 63.44 110.268 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.9 mt-10 -111.87 132.97 54.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.041 -0.527 . . . . 74.03 110.302 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.62 129.42 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.868 -0.605 . . . . 72.11 110.023 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -132.15 141.79 49.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.831 0.348 . . . . 72.22 110.943 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.03 46.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.062 -0.517 . . . . 70.15 110.387 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -149.96 158.89 44.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.845 0.355 . . . . 74.21 111.267 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.3 mt-10 -106.64 -25.08 11.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 61.13 110.985 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 19.1 p30 -114.42 0.68 14.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.48 -0.327 . . . . 54.15 111.647 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 5.8 t-20 74.42 0.7 3.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.555 0.534 . . . . 74.32 110.516 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.9 -54.47 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 64.12 110.669 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -88.12 96.59 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.681 . . . . 53.33 110.278 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 99.4 m95 -90.38 121.11 32.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 73.11 110.743 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.0 m -98.47 121.81 55.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.711 -0.677 . . . . 70.34 109.814 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.42 113.61 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.288 1.992 . . . . 71.21 111.423 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 116' ' ' VAL . 21.9 pt -88.78 -15.71 8.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 65.11 110.631 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.41 150.62 7.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.318 -0.944 . . . . 50.14 113.181 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 31.9 ttt180 -129.02 114.69 16.72 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.135 -1.061 . . . . 73.01 108.135 173.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.585 ' HE2' HG12 ' A' ' 116' ' ' VAL . 98.0 m-85 -127.28 171.98 11.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 73.24 111.657 -170.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.09 131.05 10.44 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.481 -0.782 . . . . 33.4 111.198 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.46 136.87 34.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.994 0.426 . . . . 73.14 110.265 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.58 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.0 m -118.52 111.1 18.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.845 -0.616 . . . . 61.52 109.861 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.45 104.24 3.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.989 0.424 . . . . 72.32 110.567 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.7 -176.79 5.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 71.43 109.91 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -103.13 0.66 32.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 75.03 110.687 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.06 163.15 12.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 75.3 110.631 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.27 35.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 62.45 111.329 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.58 HD21 ' HB ' ' A' ' 106' ' ' THR . 33.3 mt -89.07 113.97 25.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.791 -0.64 . . . . 73.45 110.626 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 30.6 mt-10 -92.18 113.83 26.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 74.31 110.243 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.42 ' HE2' HD12 ' A' ' 72' ' ' LEU . 79.8 m-85 -106.48 101.87 11.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.95 -0.568 . . . . 71.5 109.931 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.2 106.42 5.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.536 -0.756 . . . . 75.22 108.967 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 100' ' ' ILE . 28.3 m -107.88 178.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.25 0.548 . . . . 52.34 111.995 -170.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.2 134.48 52.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 74.25 110.295 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 16.7 m -82.77 130.13 35.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 70.22 110.979 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.0 tt -160.65 147.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.925 -0.579 . . . . 73.13 110.123 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.02 121.15 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.424 -0.584 . . . . 75.31 109.424 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.0 176.95 9.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.424 -0.353 . . . . 61.14 110.787 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.512 ' HG2' ' OD1' ' A' ' 60' ' ' ASP . 22.8 ttt180 -119.74 -34.86 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 73.41 110.341 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -105.36 146.07 29.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 75.31 109.932 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.06 133.55 60.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.035 0.445 . . . . 70.3 110.105 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 125' ' ' ARG . 12.4 ttp180 -124.37 129.09 50.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.401 . . . . 70.12 111.198 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.57 119.0 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.525 -0.761 . . . . 72.23 109.212 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 60.0 m -112.82 126.97 56.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.999 0.428 . . . . 70.44 110.938 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.7 mm -104.08 89.83 2.69 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.261 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 88.4 Cg_endo -81.34 134.0 8.81 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.808 2.339 . . . . 74.13 113.507 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.71 65.8 7.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.822 0.82 . . . . 75.53 108.999 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.63 -13.61 2.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.185 -0.916 . . . . 64.24 111.253 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -127.02 15.62 6.49 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.148 -1.025 . . . . 75.11 113.441 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.69 18.69 13.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.495 -0.86 . . . . 64.15 112.66 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -72.87 126.87 30.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.076 0.465 . . . . 74.32 110.927 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.616 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 19.8 m -99.69 171.96 7.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.032 -0.531 . . . . 73.41 110.232 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 3.1 p -82.31 6.9 15.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.087 0.403 . . . . 72.23 112.087 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 60.6 t -106.73 102.29 13.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.563 -0.532 . . . . 72.42 109.563 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -127.69 124.86 38.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.035 -0.53 . . . . 65.21 110.18 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.13 107.06 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 54.24 111.179 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.9 132.76 70.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.112 -0.699 . . . . 74.13 109.112 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 75.2 mtt180 -63.85 -71.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.118 0.485 . . . . 74.33 110.062 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -140.01 155.03 47.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.581 0.705 . . . . 62.22 112.439 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 72' ' ' LEU . 9.1 tt -115.54 119.98 37.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.232 -1.349 . . . . 61.04 107.84 169.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.24 151.85 36.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.941 -0.392 . . . . 74.23 109.941 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.42 131.39 73.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.678 -0.409 . . . . 63.32 110.741 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 45.1 mttp -98.16 127.21 43.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.122 -0.696 . . . . 74.44 109.122 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.29 -146.06 5.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.685 -0.769 . . . . 65.43 111.811 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.4 m -139.89 130.34 25.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.459 -0.2 . . . . 72.52 110.459 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 5' ' ' ILE . 28.6 mm -72.27 120.9 21.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.466 . . . . 72.11 110.079 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 74.22 110.024 -179.36 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.607 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 7.0 p . . . . . 0 C--O 1.237 0.409 0 CA-C-O 120.717 0.294 . . . . 71.42 110.919 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 65' ' ' ILE . 42.8 mm -71.64 136.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.064 -0.516 . . . . 51.12 110.706 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -67.28 115.79 7.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.302 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.99 3.26 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 74.1 111.213 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p -69.03 98.09 0.94 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.61 0.719 . . . . 61.33 110.62 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.64 -14.72 6.06 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.012 -0.995 . . . . 44.44 112.11 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -66.45 145.88 55.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.3 -0.259 . . . . 72.32 110.3 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.3 pt-20 -132.45 159.41 39.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.998 0.428 . . . . 54.41 110.664 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -100.72 112.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.527 -0.761 . . . . 65.52 109.578 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.0 mt -72.57 -46.7 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.527 . . . . 73.31 110.512 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -152.05 142.44 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.844 -0.616 . . . . 73.54 110.717 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.86 149.45 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.936 -0.575 . . . . 74.4 109.829 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.5 m -82.16 -49.81 9.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.354 . . . . 71.51 111.173 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.5 t -146.39 157.21 43.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 75.32 110.783 -173.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -163.31 144.6 9.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.845 -0.798 . . . . 64.41 108.845 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -96.78 101.21 12.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 74.12 110.001 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.16 5.3 34.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 43.45 111.928 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -136.99 -45.48 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.706 -0.398 . . . . 64.41 111.176 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 121.116 -0.564 . . . . 65.31 113.077 -177.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t30 . . . . . 0 CA--C 1.521 -0.153 0 N-CA-C 109.7 -0.482 . . . . 74.02 109.7 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.04 6.02 46.16 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.921 -0.871 . . . . 52.11 110.921 -173.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 66.8 mt -80.32 154.88 27.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.198 -0.501 . . . . 74.42 110.697 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -69.23 -26.97 65.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.042 -0.526 . . . . 61.24 110.875 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 75.34 110.787 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.4 m -70.47 -22.59 62.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 62.41 110.32 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 142' ' ' GLU . 25.4 tp -64.0 -19.45 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.554 -0.748 . . . . 52.13 110.824 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 59' ' ' ILE . 35.9 pt -131.46 18.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 51.2 110.436 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -68.77 -38.47 80.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 61.41 110.909 -173.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.47 19.77 13.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 71.44 111.98 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.4 121.16 25.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.699 0.285 . . . . 72.2 110.246 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 p -70.72 -20.26 62.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.333 -0.394 . . . . 55.21 111.624 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -74.27 -27.13 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.658 -0.246 . . . . 71.23 111.314 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.5 p -89.81 160.67 16.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.839 -0.43 . . . . 61.25 109.839 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 46.3 p90 -156.18 171.04 20.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 64.42 111.043 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.558 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 49.9 t90 -106.78 134.86 49.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.616 -0.72 . . . . 74.43 109.474 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -133.06 142.39 48.74 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.129 -0.693 . . . . 74.32 109.129 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.53 143.67 49.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.797 -0.446 . . . . 63.51 109.797 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.9 126.01 25.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.256 0.348 . . . . 75.24 110.231 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -128.02 -25.44 3.03 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.789 -0.364 . . . . 75.01 111.235 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.49 107.43 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.976 0.417 . . . . 71.34 110.542 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.74 80.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.933 -0.651 . . . . 45.2 112.391 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.18 171.68 12.86 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.967 -0.635 . . . . 73.51 111.581 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 136' ' ' THR . 40.9 m -116.4 175.42 5.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.729 0.3 . . . . 71.21 111.104 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.581 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 7.2 m-20 -97.99 166.3 13.72 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.133 -0.485 . . . . 74.55 110.845 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 39.4 Cg_endo -67.88 134.49 32.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.633 2.222 . . . . 54.1 113.207 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.69 154.39 61.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.557 -0.747 . . . . 64.4 109.51 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -76.05 165.54 85.19 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 123.608 -1.413 . . . . 65.14 112.928 1.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.532 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.2 m-85 -99.54 115.4 29.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.872 -0.604 . . . . 73.31 110.101 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -106.11 129.14 54.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 74.53 110.847 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.405 HD12 HD23 ' A' ' 126' ' ' LEU . 63.6 mt -121.7 108.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.959 -0.564 . . . . 70.14 109.596 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.91 114.13 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 116.047 -0.524 . . . . 74.42 110.459 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 34' ' ' ILE . 71.1 mt -115.29 137.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.861 -0.609 . . . . 71.34 110.929 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -106.29 121.81 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.847 -0.615 . . . . 74.11 109.877 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.97 -5.85 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 64.32 111.043 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 66.61 11.38 8.1 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.148 0.795 . . . . 73.04 113.148 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -165.5 172.86 11.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.252 -0.277 . . . . 71.54 110.252 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -85.24 128.65 34.76 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.056 -0.52 . . . . 74.01 109.654 179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.572 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.6 mt -134.28 134.39 55.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.949 0.404 . . . . 72.05 110.17 176.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.2 tp60 -80.8 101.61 9.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.536 -0.756 . . . . 75.52 109.001 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 118' ' ' SER . 23.8 mm -71.18 123.59 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 72.02 110.344 -176.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.47 -46.28 2.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 74.51 110.201 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' A' ' 146' ' ' LYS . 34.3 tt0 -137.9 141.58 40.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.764 -0.653 . . . . 74.21 110.42 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -108.93 128.28 64.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.055 -0.72 . . . . 71.32 109.055 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -110.06 123.45 49.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.248 0.546 . . . . 54.23 110.76 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.9 mt -109.33 124.53 51.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 73.04 109.841 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.4 106.97 48.79 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.862 -0.792 . . . . 51.34 108.862 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.461 -0.431 0 C-N-CA 122.386 2.058 . . . . 74.13 111.837 177.874 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 . . . . . 0 CA--C 1.529 0.149 0 CA-C-O 120.832 0.348 . . . . 73.23 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 93.2 Cg_endo -87.63 37.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.738 2.292 . . . . 74.14 112.259 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -87.38 134.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 75.03 110.533 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 24.1 mmmt -111.13 -57.77 2.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.577 -0.738 . . . . 65.02 110.658 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.48 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 95.2 t -121.19 138.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 63.02 110.945 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.29 138.34 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.885 -0.598 . . . . 71.43 109.651 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.0 mt-10 -118.04 135.11 54.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.317 -0.402 . . . . 74.32 111.152 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -117.02 129.87 56.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 64.33 110.142 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -128.49 143.97 51.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.328 -0.397 . . . . 72.13 110.652 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 149.97 49.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.368 -0.378 . . . . 62.01 110.34 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.3 t -150.09 150.92 32.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.186 0.517 . . . . 72.31 111.625 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.17 -30.85 12.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.337 -0.847 . . . . 73.52 109.837 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 3.4 p-10 -105.73 -12.17 16.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 53.14 112.126 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.8 t30 71.22 5.14 5.35 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.617 0.722 . . . . 70.14 110.758 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.572 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 98.7 t -100.82 -58.32 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.93 -0.577 . . . . 71.33 110.103 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -102.43 118.96 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 70.53 110.127 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.518 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 94.5 m95 -95.86 124.42 39.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.154 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 m -90.44 122.63 67.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.143 -0.48 . . . . 51.43 110.109 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.54 110.2 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.42 2.08 . . . . 64.45 111.507 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 HG21 ' A' ' 116' ' ' VAL . 13.7 pt -80.81 -19.49 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.577 -0.283 . . . . 73.45 110.983 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 136.92 2.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.302 -0.951 . . . . 70.51 113.558 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.3 ttm180 -102.72 125.6 49.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.436 -0.579 . . . . 64.12 109.436 169.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.556 ' HE2' HG12 ' A' ' 116' ' ' VAL . 77.8 m-85 -138.56 -176.23 4.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.269 -0.572 . . . . 75.14 111.289 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -99.15 147.54 18.47 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.855 -0.611 . . . . 54.14 112.248 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.425 ' HA ' ' HH ' ' A' ' 114' ' ' TYR . 40.8 t80 -96.47 148.29 22.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 73.23 110.119 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.423 ' HB ' HD21 ' A' ' 112' ' ' LEU . 26.5 m -133.38 117.83 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.893 -0.41 . . . . 74.12 109.893 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -77.21 106.44 8.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.408 0.623 . . . . 72.54 110.533 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -144.47 177.66 8.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.256 -0.883 . . . . 65.11 110.222 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -97.86 8.67 44.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.31 -0.404 . . . . 52.15 110.801 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.73 158.05 30.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 74.42 109.848 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.47 142.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 73.3 111.539 -175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 106' ' ' THR . 63.1 mt -92.26 121.85 34.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.569 -0.742 . . . . 54.41 111.0 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.82 109.8 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 71.53 111.29 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.425 ' HH ' ' HA ' ' A' ' 105' ' ' PHE . 95.5 m-85 -104.55 110.11 22.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 73.42 110.649 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -86.5 100.51 12.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.789 -0.641 . . . . 73.22 109.709 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 100' ' ' ILE . 26.7 m -106.06 179.4 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.95 -0.568 . . . . 73.45 111.412 -174.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.62 139.19 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 75.5 110.468 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 23.9 m -80.67 121.43 25.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.297 -0.411 . . . . 70.42 110.861 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -155.14 149.94 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 74.2 110.326 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.763 ' HG3' HD12 ' A' ' 150' ' ' ILE . 2.7 ttpm? -89.78 132.53 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.097 -0.334 . . . . 74.4 110.097 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.08 166.09 33.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.522 -0.308 . . . . 65.24 111.091 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.479 ' HD2' ' CE1' ' A' ' 123' ' ' TYR . 24.9 ttm180 -111.27 -33.53 6.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.171 0.51 . . . . 72.24 110.2 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CE1' ' HD2' ' A' ' 122' ' ' ARG . 70.7 m-85 -105.21 145.16 31.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.914 -0.585 . . . . 72.5 110.213 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 59' ' ' ILE . 10.5 tt -136.31 129.34 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.079 -0.509 . . . . 60.2 110.065 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -113.4 121.19 43.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 72.32 110.659 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 57' ' ' ILE . 48.0 tp -91.55 113.72 26.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.202 -0.666 . . . . 52.04 109.202 172.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -109.99 119.94 40.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.997 0.427 . . . . 72.32 110.934 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.9 mm -100.77 96.28 5.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.058 -0.719 . . . . 71.42 109.058 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 89.5 Cg_endo -75.68 -179.85 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 75.34 112.786 -176.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -110.01 -9.05 14.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.166 0.984 . . . . 54.24 108.398 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.44 -46.14 91.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.659 -1.61 . . . . 75.31 112.11 -173.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -82.01 6.82 65.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.716 -0.754 . . . . 43.43 113.713 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.94 25.41 9.69 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.169 -1.015 . . . . 64.04 112.071 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -78.78 -175.92 4.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 71.51 111.133 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.448 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.1 m -139.24 174.5 10.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.998 -0.546 . . . . 72.22 109.628 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 1.2 p -79.96 -0.73 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.952 0.406 . . . . 63.3 112.035 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.68 124.09 62.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.799 -0.445 . . . . 63.0 109.799 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.47 142.99 30.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.659 -0.246 . . . . 72.14 110.655 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.7 109.48 5.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 74.25 111.118 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 28.8 mt -127.49 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 65.04 109.102 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 1.5 tpt180 -74.44 -68.82 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.606 -0.516 . . . . 74.52 109.606 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 33' ' ' LEU . 17.7 pt-20 -148.87 160.99 42.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.208 0.527 . . . . 71.42 110.734 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.34 121.75 44.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.382 -0.826 . . . . 75.02 108.958 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.607 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.4 t70 -117.1 162.33 18.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.869 -0.419 . . . . 71.31 109.869 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' ILE . 95.3 t -127.89 124.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 74.1 110.296 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . 48.3 tttm -101.45 101.61 12.25 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.264 -0.643 . . . . 75.15 109.264 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.09 -161.64 10.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.727 -0.749 . . . . 75.1 112.089 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -118.05 133.64 55.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.652 0.263 . . . . 73.2 110.554 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.54 HD11 HG23 ' A' ' 5' ' ' ILE . 38.4 mm -71.54 124.46 28.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.081 -0.509 . . . . 75.33 111.419 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.763 HD12 ' HG3' ' A' ' 120' ' ' LYS . 29.0 mt . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 121.162 0.506 . . . . 72.04 110.109 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 120.734 0.302 . . . . 71.31 110.992 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.5 HD12 HD11 ' A' ' 149' ' ' ILE . 37.6 mm -66.65 131.91 32.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.134 -0.485 . . . . 54.55 110.327 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -64.78 111.73 2.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.376 -0.375 . . . . 72.11 110.829 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 36.0 mtmm -87.52 16.25 5.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 75.03 110.567 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -65.48 -16.36 63.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.493 -0.776 . . . . 60.41 112.16 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.1 23.25 4.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.497 -0.859 . . . . 72.32 112.874 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 33.3 m0 -84.35 156.79 21.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.992 0.396 . . . . 65.23 110.853 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 22.2 pt-20 -135.4 159.54 41.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.81 0.338 . . . . 64.23 110.768 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.54 130.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.972 -0.558 . . . . 53.41 109.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.5 -36.86 9.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.166 0.508 . . . . 72.12 110.78 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.3 t -144.94 139.36 27.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 75.22 110.66 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -151.1 134.84 16.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 70.4 109.526 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -85.37 -38.9 18.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 54.42 111.278 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -149.13 152.51 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.993 0.425 . . . . 74.21 110.959 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.0 pt20 -163.91 139.53 6.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.425 -0.807 . . . . 71.44 108.919 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.9 tp10 -93.74 98.06 10.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.133 0.492 . . . . 74.4 111.065 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.48 -12.01 18.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.864 -0.607 . . . . 62.31 110.95 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -101.04 -47.77 4.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.02 -0.536 . . . . 64.51 110.955 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.448 -0.53 0 CA-C-N 115.909 -0.587 . . . . 73.42 112.411 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.2 t30 . . . . . 0 N--CA 1.456 -0.15 0 N-CA-C 109.732 -0.469 . . . . 74.3 109.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 2.96 72.73 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.611 -0.595 . . . . 65.45 111.611 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 82.0 mt -82.13 157.44 24.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.584 -0.308 . . . . 64.32 110.272 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.83 -28.74 68.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.773 0.321 . . . . 62.33 110.973 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.3 pttp -69.41 -23.02 63.65 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.742 0.306 . . . . 75.15 111.044 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.812 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.7 m -66.99 -24.24 66.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.015 0.436 . . . . 71.41 110.408 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.0 tp -65.92 -25.54 67.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 73.23 110.371 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 59' ' ' ILE . 2.5 pp -119.48 13.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.207 0.527 . . . . 74.14 110.336 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.2 t70 -65.27 -42.25 93.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.287 -0.869 . . . . 74.11 110.174 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.9 55.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.824 -0.703 . . . . 65.22 111.682 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -117.12 124.44 49.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.368 -0.416 . . . . 53.35 109.986 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -72.65 -15.13 61.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.285 -0.416 . . . . 72.11 111.755 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.31 -24.33 50.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 75.44 110.718 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -100.23 160.16 14.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.4 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.717 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 48.3 p90 -156.15 165.0 37.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.848 -0.427 . . . . 75.03 109.848 174.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.524 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 39.2 t90 -98.12 129.27 44.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.379 -0.6 . . . . 73.11 109.379 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 49.4 t-80 -131.13 137.07 48.87 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.231 -0.655 . . . . 71.51 109.231 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.12 144.63 54.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 50' ' ' SER . 64.8 tttp -60.4 126.09 26.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.358 . . . . 63.12 110.339 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -124.52 -32.14 3.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 63.03 110.064 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.45 108.99 13.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 61.13 109.383 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.41 -12.33 54.61 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.712 -0.676 . . . . 70.32 111.635 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 144.34 5.82 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.93 -0.652 . . . . 75.51 111.547 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 11.0 p -86.63 167.64 14.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.941 0.4 . . . . 74.13 111.505 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -100.54 146.9 32.83 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 61.24 109.715 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.96 141.54 44.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.691 2.261 . . . . 71.35 112.63 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.5 mt -75.85 164.63 59.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 65.3 110.569 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.1 Cg_endo -83.69 161.75 71.04 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 123.766 -1.348 . . . . 71.22 113.239 1.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -100.06 111.46 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 73.5 109.923 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -104.42 125.69 50.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.082 -0.34 . . . . 53.34 110.082 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.403 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 48.3 mt -119.44 121.36 66.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.134 -0.321 . . . . 71.34 110.134 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -112.31 117.85 56.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.334 -0.394 . . . . 71.4 110.616 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 34' ' ' ILE . 4.7 mp -117.05 140.62 38.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 71.54 110.19 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 19.8 t70 -103.04 134.2 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.594 -0.275 . . . . 54.53 110.264 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.509 ' HE1' HD11 ' A' ' 67' ' ' ILE . 64.8 mtm -96.64 3.92 52.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 74.34 111.092 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 70.89 -30.06 0.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.617 0.969 . . . . 72.43 113.617 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -133.71 172.44 12.76 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.236 -0.29 . . . . 74.24 111.051 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.08 129.82 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 73.12 110.399 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 5' ' ' ILE . 69.6 mt -139.07 139.91 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.018 0.437 . . . . 71.31 110.333 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -83.31 105.08 13.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.927 -0.768 . . . . 73.3 108.927 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.8 mm -72.93 106.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.235 -0.283 . . . . 71.3 110.235 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.03 -43.9 6.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.052 0.453 . . . . 70.15 110.843 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.6 tt0 -145.42 140.88 27.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.991 -0.549 . . . . 63.2 110.787 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.21 130.73 61.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.531 -0.544 . . . . 54.32 109.531 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -113.47 129.76 56.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.957 0.408 . . . . 73.52 110.521 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.472 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 70.4 mt -117.14 120.49 38.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.213 -0.449 . . . . 62.32 109.92 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.73 103.56 15.07 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.023 -0.732 . . . . 65.33 109.023 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 15.3 Cg_exo . . . . . 0 C--N 1.344 0.308 0 C-N-CA 123.038 2.492 . . . . 74.11 112.645 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 . . . . . 0 C--O 1.234 0.271 0 CA-C-O 120.908 0.385 . . . . 70.24 110.49 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.93 29.77 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.145 2.563 . . . . 71.14 114.171 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 105' ' ' PHE . 73.2 mt -79.0 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.568 -0.53 . . . . 51.41 109.568 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -114.84 -46.03 2.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 53.52 111.453 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.734 HG11 ' HE ' ' A' ' 102' ' ' ARG . 62.0 t -127.13 138.35 55.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.469 -0.332 . . . . 75.53 110.898 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 128' ' ' ILE . 7.6 m -132.22 137.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.186 -0.461 . . . . 72.55 110.52 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 40.2 mt-10 -116.6 140.45 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.402 -0.363 . . . . 64.25 110.907 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -120.4 132.67 55.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 73.22 110.669 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.51 147.71 50.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 31.14 110.267 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.32 150.03 52.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 70.03 110.495 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.5 t -150.26 150.7 31.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 71.03 110.878 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -101.31 -31.35 11.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.957 0.408 . . . . 63.11 110.129 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 8.9 p-10 -105.22 -4.33 21.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 53.13 111.518 -174.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 24.5 t-20 76.31 -16.16 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.797 0.685 . . . . 71.31 111.337 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 95.2 t -89.32 -58.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.97 0.414 . . . . 61.55 110.627 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.89 111.48 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.466 . . . . 71.21 110.454 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -96.6 132.39 42.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.993 0.425 . . . . 74.4 110.921 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.3 m -105.09 124.76 35.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 75.31 110.505 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.72 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.468 2.112 . . . . 74.3 111.572 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 116' ' ' VAL . 21.6 pt -93.1 -6.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.332 -0.395 . . . . 62.5 111.059 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.61 147.82 4.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.538 -0.839 . . . . 65.54 113.044 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.734 ' HE ' HG11 ' A' ' 85' ' ' VAL . 77.9 ttt180 -113.06 119.65 38.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.214 -0.661 . . . . 73.12 109.214 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.584 ' HE2' HG12 ' A' ' 116' ' ' VAL . 84.5 m-85 -130.36 177.17 7.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.82 0.343 . . . . 74.54 110.911 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.8 149.81 19.41 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.043 -0.599 . . . . 72.25 111.774 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.418 ' HB3' HG22 ' A' ' 83' ' ' ILE . 51.6 t80 -105.06 121.62 44.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.985 0.421 . . . . 75.4 110.081 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.474 ' O ' HD11 ' A' ' 112' ' ' LEU . 24.2 m -113.35 107.69 16.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.972 -0.558 . . . . 62.4 109.962 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -68.83 94.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.38 0.61 . . . . 74.0 110.072 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -113.93 -166.17 1.07 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.087 -0.96 . . . . 75.33 109.55 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.97 -14.22 20.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.973 0.416 . . . . 61.31 110.697 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.21 169.42 8.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 62.24 110.653 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -75.52 137.52 40.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 75.2 110.948 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 106' ' ' THR . 34.8 mt -87.46 111.29 21.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.622 -0.717 . . . . 70.12 110.533 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.82 108.93 19.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.933 0.397 . . . . 72.51 110.47 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.33 113.48 25.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 72.42 110.799 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -80.2 92.05 5.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.248 -0.649 . . . . 75.22 109.248 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.584 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.3 m -96.67 177.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 54.24 111.669 -172.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.77 118.74 13.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 70.11 109.662 177.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 14.4 m -75.6 118.75 18.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.001 -0.545 . . . . 73.11 110.847 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -147.76 153.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.466 . . . . 72.3 110.731 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -81.8 125.81 31.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 64.15 109.698 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . . . -152.41 175.42 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 72.2 111.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -128.51 -32.82 2.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.844 -0.616 . . . . 70.34 109.927 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -106.35 146.38 30.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.626 . . . . 73.42 109.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.55 135.21 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 65.42 110.267 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -121.49 124.06 43.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.93 0.395 . . . . 64.25 110.93 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.21 116.9 31.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 75.44 109.091 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.0 m -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.19 0.519 . . . . 75.33 110.966 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.9 mm -106.52 95.68 12.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 65.52 109.196 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.646 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 57.0 Cg_endo -71.87 173.96 11.93 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.354 2.036 . . . . 75.13 112.552 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.488 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.7 t70 -91.01 -6.1 54.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.146 0.974 . . . . 64.43 108.893 175.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.28 143.35 26.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.695 -1.139 . . . . 74.51 110.532 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.21 -11.52 58.54 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.721 -0.752 . . . . 71.34 112.315 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.94 12.12 14.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.876 -0.678 . . . . 62.35 112.733 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -67.78 124.84 24.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 73.0 110.936 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -95.35 178.15 5.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.03 -0.532 . . . . 73.31 110.02 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.8 p -79.08 1.57 23.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 72.41 112.127 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.12 101.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.871 -0.418 . . . . 52.43 109.871 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -119.87 130.52 54.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.269 -0.423 . . . . 61.14 110.114 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -147.07 111.92 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.159 0.505 . . . . 74.43 111.486 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.94 132.86 56.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.394 -0.595 . . . . 74.52 109.394 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmt180 -61.39 -63.79 1.16 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.669 0.271 . . . . 71.03 110.417 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.6 155.51 30.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.471 0.653 . . . . 64.13 111.346 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -106.51 123.92 48.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.849 -1.069 . . . . 74.45 108.313 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.8 152.07 37.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.554 -0.535 . . . . 70.32 109.554 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.03 130.96 74.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.928 0.394 . . . . 71.41 111.603 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 39.0 mttp -101.97 107.06 18.08 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.944 -0.761 . . . . 74.33 108.944 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.11 177.76 31.36 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.238 -0.982 . . . . 63.43 112.143 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.8 m -106.85 127.31 53.3 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.241 -0.281 . . . . 75.11 110.241 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.5 HD11 HD12 ' A' ' 5' ' ' ILE . 35.8 mm -69.81 130.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.96 -0.564 . . . . 72.21 110.526 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 120' ' ' LYS . 16.3 mt . . . . . 0 C--N 1.324 -0.538 0 N-CA-C 109.596 -0.52 . . . . 74.42 109.596 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.236 0.358 0 CA-C-O 120.769 0.318 . . . . 62.24 110.403 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.543 HG21 HD13 ' A' ' 65' ' ' ILE . 37.7 mm -83.5 138.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 110.284 -0.265 . . . . 73.45 110.284 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -85.21 130.9 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 61.43 109.755 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -108.97 13.66 24.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 75.43 110.725 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -71.25 -10.0 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.627 -0.715 . . . . 71.42 111.192 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.88 9.11 21.37 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 52.43 112.163 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -89.39 159.34 17.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.701 0.286 . . . . 74.13 110.541 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 9.2 pt-20 -142.42 161.88 36.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.857 0.36 . . . . 70.24 110.147 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.0 117.89 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 72.34 110.185 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.53 -43.88 18.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.681 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -148.85 141.7 24.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.204 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -141.93 142.69 33.03 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.018 -0.734 . . . . 63.51 109.018 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -85.53 -29.32 24.3 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.83 -0.348 . . . . 73.23 110.996 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 t -154.49 149.29 26.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 70.14 111.0 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -168.06 140.28 3.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.904 -0.776 . . . . 61.45 108.904 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.9 tp10 -98.27 116.92 31.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.015 0.436 . . . . 73.23 110.573 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.11 -16.37 12.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.01 -0.541 . . . . 72.35 111.251 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 m -113.4 -40.0 3.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.368 -0.378 . . . . 53.13 111.169 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.43 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.452 -0.256 0 CA-C-N 116.083 -0.508 . . . . 33.24 112.835 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.274 -0.269 . . . . 73.33 110.274 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.87 -1.75 38.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.015 -0.612 . . . . 43.22 111.706 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 62.5 mt -80.46 156.77 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 73.52 110.641 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.93 -31.05 71.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.484 -0.326 . . . . 64.05 111.252 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -76.09 -16.44 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.479 -0.328 . . . . 63.42 111.751 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 60.8 m -71.38 -23.65 61.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 74.43 109.831 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 35.4 tp -72.82 -8.99 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.701 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -130.56 25.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 71.45 110.406 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.17 -46.94 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.514 -0.312 . . . . 74.41 111.627 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.32 6.99 25.13 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.485 -0.864 . . . . 73.41 112.167 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 39' ' ' GLU . 32.8 t70 -117.48 120.84 39.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.912 -0.403 . . . . 75.55 109.912 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 p -72.99 -8.79 57.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.507 0.558 . . . . 73.51 112.507 -173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 47.4 mt-10 -85.21 -26.79 26.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 62.2 110.292 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -96.84 137.29 36.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.978 -0.556 . . . . 60.11 109.879 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 23.2 p90 -139.17 175.69 9.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.832 0.348 . . . . 53.31 110.908 -174.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.628 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 45.9 t90 -105.44 134.31 48.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 74.2 109.597 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -132.37 143.81 50.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.211 -0.663 . . . . 74.0 109.211 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.03 148.57 49.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.545 -0.298 . . . . 62.21 110.236 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 78.2 tttt -66.4 116.36 7.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.093 -0.503 . . . . 73.52 110.018 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -123.13 -27.2 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.887 -0.325 . . . . 74.23 111.264 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -78.57 107.54 11.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.034 0.445 . . . . 71.54 110.032 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.14 2.19 51.43 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 45.12 111.976 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.17 146.15 8.86 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.831 -0.7 . . . . 33.41 111.937 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 12.1 p -89.63 151.87 21.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 64.34 110.889 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.07 158.92 69.36 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.952 -0.567 . . . . 65.33 110.978 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.29 153.01 61.8 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.766 2.311 . . . . 63.41 112.924 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.52 158.04 41.2 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 72.43 110.132 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.03 167.56 64.85 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.567 -1.43 . . . . 64.32 112.767 2.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 26.4 m-85 -101.67 108.98 20.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.075 -0.512 . . . . 73.33 110.275 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.22 126.62 53.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 73.34 110.436 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 HD23 ' A' ' 126' ' ' LEU . 55.4 mt -120.31 117.75 54.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 41.3 109.78 176.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.82 114.55 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.268 -0.423 . . . . 63.44 110.592 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.4 134.91 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.089 -0.505 . . . . 74.05 110.091 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -99.17 120.22 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.181 -0.463 . . . . 65.34 109.755 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.6 mtm -86.84 -5.68 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.596 . . . . 70.5 110.9 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.9 mmtt 68.45 5.96 5.1 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.312 0.856 . . . . 72.24 113.312 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.35 174.22 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.706 0.289 . . . . 61.4 111.122 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.8 121.7 27.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 54.02 110.198 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.543 HD13 HG21 ' A' ' 5' ' ' ILE . 61.6 mt -132.33 134.52 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 120.995 0.426 . . . . 74.01 110.517 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.9 tp60 -84.28 105.13 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.608 -0.724 . . . . 64.41 109.296 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.2 mm -74.35 117.27 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 73.22 110.427 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.53 -47.99 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.282 -0.417 . . . . 75.43 110.995 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.586 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 6.1 tt0 -141.79 152.77 44.03 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.84 -0.344 . . . . 64.31 110.605 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.38 123.07 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.772 -0.649 . . . . 50.42 109.517 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.41 ' OE1' ' HB2' ' A' ' 146' ' ' LYS . 51.3 mp0 -103.75 122.71 45.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.968 -0.56 . . . . 50.53 110.642 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.46 HD12 ' CE2' ' A' ' 114' ' ' TYR . 55.2 mt -113.58 123.39 49.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 74.21 110.337 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 73' ' ' LEU . 19.9 tp -102.25 101.16 17.85 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.381 -0.6 . . . . 74.14 109.381 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 3.1 Cg_exo . . . . . 0 N--CA 1.464 -0.227 0 C-N-CA 123.214 2.609 . . . . 74.02 112.905 -175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 112.338 0.496 . . . . 74.22 112.338 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 5.2 Cg_exo -75.39 36.96 0.47 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.299 2.666 . . . . 44.13 111.936 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.65 125.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.651 . . . . 62.01 109.553 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.89 -54.0 2.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 74.42 110.765 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.19 137.3 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.243 -0.435 . . . . 75.05 110.562 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.42 134.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.261 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.7 mt-10 -116.63 132.51 56.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.022 -0.536 . . . . 72.55 110.596 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -112.08 129.74 56.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.673 -0.694 . . . . 64.44 109.944 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.28 153.62 42.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.702 -0.227 . . . . 54.2 110.435 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.82 43.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.377 -0.374 . . . . 71.51 110.369 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 146.35 27.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 71.34 110.607 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.86 -42.26 34.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.89 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.06 9.52 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.004 0.372 . . . . 74.23 112.004 -173.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.6 t30 64.96 30.06 12.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.784 0.802 . . . . 74.42 110.261 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.78 -52.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.434 -0.803 . . . . 73.34 109.456 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -103.04 107.13 17.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.25 -0.648 . . . . 54.3 109.25 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -94.36 130.65 40.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.154 0.502 . . . . 72.11 111.116 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 m -122.29 122.63 27.41 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.803 -0.635 . . . . 74.42 110.36 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.81 128.9 27.05 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.515 2.144 . . . . 70.2 111.129 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.56 -10.94 8.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.985 -0.286 . . . . 75.34 110.8 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 153.21 7.53 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.095 -1.05 . . . . 51.44 113.599 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.2 ttt180 -130.77 115.05 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.832 -0.803 . . . . 74.35 108.832 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.43 -177.82 4.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.689 0.281 . . . . 41.15 110.828 -174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.96 14.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.957 -0.639 . . . . 64.24 112.024 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 49.8 t80 -93.27 114.6 27.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 73.12 110.069 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -99.17 106.98 19.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.237 -0.438 . . . . 62.12 110.025 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -68.17 111.7 4.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.147 0.499 . . . . 74.23 110.638 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.27 -176.26 5.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.399 -0.819 . . . . 71.41 108.922 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.74 -10.48 19.91 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.617 -0.433 . . . . 75.54 110.545 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.48 20.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 61.1 110.389 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.1 133.0 45.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 55.22 111.588 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.3 mt -89.65 122.84 33.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.266 -0.879 . . . . 73.53 110.213 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 33.0 mt-10 -98.05 108.36 21.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.591 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 72' ' ' LEU . 91.2 m-85 -101.85 104.57 15.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.116 -0.493 . . . . 63.44 110.993 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.64 93.32 2.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.672 -0.694 . . . . 75.25 110.055 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.14 178.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.854 -0.612 . . . . 54.43 111.913 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 117' ' ' LYS . 5.3 ttpm? -75.4 112.8 12.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.205 -0.907 . . . . 72.21 110.094 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 20.0 p -56.72 120.53 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.857 -0.611 . . . . 51.33 111.222 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.8 tt -160.57 148.9 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.454 -0.339 . . . . 71.14 110.238 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HG3' HD12 ' A' ' 150' ' ' ILE . 39.6 ttpt -89.86 135.76 33.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 75.14 110.169 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.86 175.15 13.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.557 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -121.74 -34.49 3.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 74.04 110.02 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -108.92 145.4 35.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.238 -0.653 . . . . 64.53 109.238 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.6 tt -131.71 139.23 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.986 -0.375 . . . . 75.12 109.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 60.7 ttp180 -124.31 118.2 26.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.966 0.412 . . . . 72.44 111.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 57' ' ' ILE . 43.4 tp -85.61 114.58 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.903 -0.777 . . . . 61.24 108.903 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -112.1 117.66 33.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.299 0.571 . . . . 65.31 111.347 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.1 mm -100.2 98.15 7.27 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.456 -0.793 . . . . 75.41 108.948 172.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.03 168.86 20.69 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.457 2.105 . . . . 54.44 112.305 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 7.73 45.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 40.32 109.881 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.48 138.26 48.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 70.54 110.157 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.05 -10.84 24.79 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.988 -0.625 . . . . 44.44 111.699 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 109.1 18.88 8.88 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.051 -0.595 . . . . 72.41 112.386 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -76.73 135.64 39.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 74.32 110.759 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 45.9 m -106.88 -173.94 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 62.4 110.281 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 14.4 p -84.55 2.3 41.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 65.04 112.131 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 48.7 t -105.57 124.53 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.452 -0.34 . . . . 51.44 110.386 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.21 140.93 29.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.22 -0.445 . . . . 75.31 110.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.6 113.68 4.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.939 0.4 . . . . 74.35 111.06 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 19.3 mt -126.18 132.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.073 -0.714 . . . . 75.54 109.073 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.691 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 97.4 mtt180 -65.58 -61.83 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 73.22 110.481 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.74 138.92 23.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.24 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.02 116.41 29.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -114.62 150.57 34.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.993 0.425 . . . . 70.14 110.149 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.37 124.03 72.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.183 -0.673 . . . . 54.4 109.183 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.41 ' HB2' ' OE1' ' A' ' 71' ' ' GLU . 0.6 OUTLIER -105.33 102.87 12.33 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.366 0.603 . . . . 74.43 109.86 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.87 -156.9 7.34 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.405 -0.816 . . . . 75.14 111.574 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.1 m -119.1 131.85 55.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.705 0.288 . . . . 60.34 110.936 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.506 HD11 HG23 ' A' ' 5' ' ' ILE . 37.5 mm -74.56 123.01 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.29 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 66' ' ' GLN . 51.1 mt . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 109.683 -0.488 . . . . 64.04 109.683 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.809 HG22 ' HG2' ' A' ' 146' ' ' LYS . 46.3 p . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.978 -0.379 . . . . 62.32 109.978 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 149' ' ' ILE . 38.9 mm -74.78 138.71 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.189 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 122.82 17.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.312 -0.625 . . . . 62.33 109.312 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -101.64 6.45 42.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.679 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -72.54 84.45 1.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 71.43 110.239 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.81 -9.76 2.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.635 -0.711 . . . . 73.21 112.38 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -70.49 155.81 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 73.32 110.461 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.5 pt-20 -138.96 155.87 47.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.079 0.466 . . . . 75.22 110.015 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.55 113.48 31.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.821 -0.627 . . . . 70.4 110.005 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.2 mt -79.67 -36.46 37.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.83 -0.623 . . . . 74.3 110.591 -177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.3 t -147.91 141.24 25.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 60.42 110.721 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.475 ' HE2' ' HG2' ' A' ' 18' ' ' GLN . 35.4 p90 -155.72 136.11 13.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.765 -0.652 . . . . 74.3 109.633 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -85.25 -44.91 12.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.204 -0.453 . . . . 62.42 111.786 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -134.34 147.51 50.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.022 0.439 . . . . 72.53 111.001 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -161.57 148.47 14.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.732 -0.667 . . . . 73.54 109.407 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.67 112.22 20.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.897 -0.409 . . . . 63.42 109.897 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.65 1.31 17.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.652 0.612 . . . . 71.12 112.652 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -143.83 -29.79 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.384 -0.526 . . . . 63.31 112.331 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.218 0 C-N-CA 120.93 -0.652 . . . . 64.2 112.866 -179.291 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.3 t30 . . . . . 0 CA--C 1.522 -0.117 0 N-CA-C 110.112 -0.329 . . . . 74.22 110.112 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.0 2.49 20.34 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.298 -0.721 . . . . 64.22 111.298 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.7 mt -74.67 150.74 39.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.532 -0.334 . . . . 73.32 110.74 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.99 -23.21 67.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.09 0.471 . . . . 71.24 111.214 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 -17.28 57.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 64.54 111.341 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 63.4 m -73.55 -17.61 61.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.176 0.512 . . . . 72.21 110.046 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -71.97 -14.36 61.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.37 -0.832 . . . . 52.55 110.7 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -130.66 21.59 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 61.4 109.911 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 18.1 t70 -72.39 -45.68 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.646 -0.707 . . . . 74.44 111.167 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.68 -1.47 21.71 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.478 -0.868 . . . . 61.32 112.655 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -131.16 118.36 20.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.126 -0.324 . . . . 70.23 110.126 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 p -72.22 2.07 6.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.953 -0.567 . . . . 63.11 111.683 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.24 -35.78 80.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.631 -0.877 . . . . 44.4 108.631 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.1 p -95.42 165.73 12.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.834 -1.076 . . . . 64.54 110.141 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.536 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 32.6 p90 -155.63 167.84 29.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.491 -0.322 . . . . 73.43 110.674 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.9 t90 -101.22 133.23 46.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.268 -0.642 . . . . 70.11 109.268 172.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.62 144.19 49.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.332 -0.618 . . . . 75.21 109.332 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.16 146.93 52.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.282 -0.417 . . . . 74.55 110.435 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' SER . 82.8 tttt -63.12 116.61 5.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.978 -0.556 . . . . 72.21 110.197 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -120.4 -27.93 5.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.523 -0.471 . . . . 75.3 110.663 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.88 110.72 11.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 72.45 110.2 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 10.11 59.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.804 -0.712 . . . . 54.35 112.06 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.08 154.6 16.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.841 -0.695 . . . . 63.1 112.156 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 52.0 m -102.86 159.61 15.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 55.02 111.286 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.75 156.6 52.75 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.846 -0.615 . . . . 73.45 110.35 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.68 153.56 43.53 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.534 2.156 . . . . 65.5 113.194 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 130' ' ' ASP . 11.9 mt -92.16 159.79 36.76 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 75.12 110.118 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 77.5 Cg_endo -80.52 162.45 82.71 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.578 -1.426 . . . . 71.03 112.875 -1.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 28.6 m-85 -93.98 132.31 38.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.199 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 3.4 t70 -111.49 125.45 53.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 75.41 110.219 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 126' ' ' LEU . 52.5 mt -131.43 111.26 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.21 -0.45 . . . . 71.21 109.909 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.37 122.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.062 -0.517 . . . . 71.22 110.562 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 57' ' ' ILE . 4.9 mp -116.25 136.13 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.638 -0.255 . . . . 75.14 110.694 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.3 t0 -99.12 119.73 38.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.721 -0.844 . . . . 75.14 108.721 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.6 mtm -85.6 -5.62 59.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.356 -0.384 . . . . 73.1 111.111 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.508 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 66.27 12.02 8.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.806 -0.634 . . . . 74.31 112.026 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -165.88 147.56 7.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 63.42 109.746 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.7 128.43 35.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.899 -0.592 . . . . 73.23 110.042 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.7 mt -132.38 139.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.258 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.482 HE21 ' HB2' ' A' ' 118' ' ' SER . 55.8 tp60 -83.37 102.95 12.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.869 -0.789 . . . . 70.32 108.869 176.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -72.28 129.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.376 . . . . 60.13 110.833 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.89 -32.85 3.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 31.43 111.079 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -163.29 147.68 11.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.881 -0.599 . . . . 54.11 111.177 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.2 t -119.84 133.87 65.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.162 -0.472 . . . . 73.53 109.871 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.694 ' HG3' ' HD2' ' A' ' 146' ' ' LYS . 26.0 mt-10 -110.76 127.61 55.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.126 0.489 . . . . 73.22 110.602 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.96 121.3 43.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.664 -0.698 . . . . 42.03 109.622 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.7 tp -111.13 95.88 27.42 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.325 -0.398 . . . . 72.15 109.963 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 65.0 Cg_endo . . . . . 0 N--CA 1.46 -0.493 0 C-N-CA 122.458 2.105 . . . . 71.43 111.657 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.834 ' HB3' HD22 ' A' ' 107' ' ' ASN . 21.2 t-20 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.884 0.374 . . . . 74.12 110.319 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.03 27.4 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.181 2.588 . . . . 71.43 112.659 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.68 121.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.496 . . . . 73.13 110.457 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -105.89 -37.24 6.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.623 -0.717 . . . . 75.01 111.197 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 132' ' ' GLY . 91.1 t -134.53 138.48 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.569 0.223 . . . . 72.2 111.097 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 m -132.13 139.73 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 73.23 110.418 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 67.9 mt-10 -121.06 134.53 55.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.394 -0.366 . . . . 74.31 110.791 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -116.22 131.03 57.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 73.04 110.8 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.75 153.33 49.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.369 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.16 155.53 46.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.4 t -150.02 147.33 27.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.063 0.459 . . . . 74.04 110.781 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.17 -33.74 16.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 61.54 110.841 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -122.97 -2.69 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.893 0.331 . . . . 75.14 111.893 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 63.85 34.62 11.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.657 0.741 . . . . 61.43 109.587 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.2 t -110.39 -54.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.859 -0.609 . . . . 75.33 109.366 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.65 135.15 54.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -105.83 119.22 38.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.364 0.602 . . . . 73.34 110.687 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.2 m -95.29 125.03 51.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.233 -0.894 . . . . 54.24 110.875 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.0 111.98 3.3 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.627 2.218 . . . . 40.33 111.76 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 116' ' ' VAL . 21.2 pt -86.24 -18.87 8.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 73.43 110.948 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.88 139.96 2.78 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.288 -0.958 . . . . 72.45 113.074 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 30.2 ttt180 -119.59 126.55 51.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.36 -175.91 4.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 74.43 110.84 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.96 143.97 16.42 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.839 -0.696 . . . . 41.31 111.788 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.54 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 33.4 t80 -91.19 136.38 33.13 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.744 -0.465 . . . . 74.22 109.744 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 112' ' ' LEU . 27.1 m -112.78 123.22 49.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.519 -0.31 . . . . 73.5 110.763 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.834 HD22 ' HB3' ' A' ' 81' ' ' ASN . 24.9 t-20 -67.05 93.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.035 0.445 . . . . 61.11 109.852 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -144.54 169.27 18.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.895 -0.593 . . . . 73.51 109.417 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -104.9 18.59 22.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.538 0.685 . . . . 71.33 110.196 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.54 153.57 31.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.446 -0.797 . . . . 53.13 109.74 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.54 124.47 22.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.067 0.461 . . . . 70.43 111.262 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 106' ' ' THR . 75.0 mt -80.74 117.79 21.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 74.42 110.439 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -95.86 119.81 35.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.266 -0.424 . . . . 73.53 110.392 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.57 105.17 13.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.232 -0.44 . . . . 74.31 109.905 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -82.59 90.77 6.84 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.282 -0.636 . . . . 73.34 109.282 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 100' ' ' ILE . 30.5 m -86.86 179.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.323 -0.853 . . . . 64.23 110.581 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 100' ' ' ILE . 47.8 pttt -81.44 148.2 29.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.078 0.466 . . . . 72.25 110.226 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 37.4 p -79.01 127.62 32.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.747 -0.66 . . . . 62.23 111.511 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.8 tt -161.49 150.57 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.635 -0.711 . . . . 61.21 109.388 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HB3' ' HZ2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -79.38 140.69 37.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.157 -0.683 . . . . 73.33 109.157 177.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.75 144.19 17.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.569 0.223 . . . . 51.13 110.848 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.76 -22.61 13.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.804 -0.813 . . . . 64.31 108.804 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -115.65 145.42 42.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.846 . . . . 75.32 109.673 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.0 tt -136.34 141.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.957 -0.386 . . . . 73.14 109.957 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 59.9 ttp180 -126.78 125.71 42.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.033 0.444 . . . . 75.22 111.435 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 57' ' ' ILE . 57.9 tp -95.62 124.32 39.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.554 -0.748 . . . . 62.2 109.045 172.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 76.4 m -119.47 123.16 43.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.991 0.424 . . . . 72.21 110.663 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.0 mm -105.56 94.01 7.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.354 -0.61 . . . . 72.14 109.354 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 68.0 Cg_endo -87.76 136.94 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.033 2.489 . . . . 75.01 113.006 -175.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 25.3 t0 -81.48 66.36 7.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.433 -0.951 . . . . 73.43 108.433 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -124.93 -12.54 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.835 -1.075 . . . . 74.34 111.703 -173.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 85' ' ' VAL . . . -139.83 22.62 2.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.659 -1.258 . . . . 63.12 114.001 -173.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.8 26.06 7.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.162 -1.018 . . . . 51.33 112.611 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -82.11 178.45 8.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.887 0.375 . . . . 75.44 110.827 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 m -146.79 178.96 7.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.882 -0.414 . . . . 64.55 109.882 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 p -84.68 16.08 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 34.42 111.667 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.8 127.92 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.52 . . . . 65.34 109.879 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.95 143.45 30.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.313 -0.403 . . . . 75.12 110.18 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.16 106.09 3.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.836 0.35 . . . . 73.22 111.33 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 9.3 mt -126.23 140.5 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.73 -0.841 . . . . 62.24 108.73 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 69.6 mtt180 -75.91 -63.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.025 0.44 . . . . 71.44 110.159 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.97 133.52 22.02 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.666 -0.697 . . . . 73.0 110.863 -170.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.47 120.63 42.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 72.32 109.418 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.88 124.26 44.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 72.25 110.562 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.21 142.07 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 65.34 109.867 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.809 ' HG2' HG22 ' A' ' 4' ' ' THR . 26.6 mtpt -119.16 124.27 46.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.438 . . . . 73.32 109.816 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.56 -166.83 32.44 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.649 -0.786 . . . . 64.14 112.152 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.8 m -107.3 130.15 54.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.573 0.225 . . . . 54.42 110.592 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 5' ' ' ILE . 40.7 mm -72.0 125.05 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.411 . . . . 72.5 110.938 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' A' ' 120' ' ' LYS . 44.6 mt . . . . . 0 C--N 1.319 -0.747 0 N-CA-C 109.169 -0.678 . . . . 70.44 109.169 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 146' ' ' LYS . 22.6 p . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 110.304 -0.258 . . . . 72.41 110.304 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 65' ' ' ILE . 44.1 mm -63.79 147.76 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 73.04 111.213 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -72.95 112.79 9.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.575 -0.528 . . . . 72.22 109.575 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -89.56 -8.54 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.433 . . . . 74.54 111.057 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -73.17 97.67 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.742 0.782 . . . . 75.01 109.31 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.12 -11.91 4.14 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.627 -1.17 . . . . 43.01 111.25 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.519 ' HE3' HG21 ' A' ' 59' ' ' ILE . 30.6 m0 -74.98 161.29 29.61 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.58 -0.526 . . . . 65.33 109.58 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.507 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 8.9 pt-20 -138.57 158.69 43.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.34 -0.544 . . . . 70.13 110.585 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.97 119.54 45.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 64.13 109.709 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.58 -39.0 28.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.014 0.435 . . . . 73.52 110.448 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.6 t -157.04 141.1 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 74.35 109.703 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 18' ' ' GLN . 51.7 p90 -136.02 146.2 46.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.002 -0.545 . . . . 75.44 109.532 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -86.27 -40.98 14.98 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.797 -0.361 . . . . 74.43 110.737 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 5.9 t -147.81 148.17 30.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.153 0.501 . . . . 75.21 111.111 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.87 145.1 1.85 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.249 -0.887 . . . . 64.51 108.947 172.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 9.5 tp10 -105.44 102.31 11.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.198 -0.456 . . . . 63.12 110.67 -173.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB2' HE22 ' A' ' 18' ' ' GLN . . . -100.43 -30.14 12.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 65.2 110.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -83.21 -33.69 26.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 55.21 110.556 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 120.771 -0.728 . . . . 74.44 113.129 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 t30 . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 110.274 -0.269 . . . . 75.03 110.274 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.86 -4.52 60.98 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.403 -0.427 . . . . 71.02 112.757 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.698 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.9 mt -73.79 144.69 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.004 -0.369 . . . . 62.02 110.004 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.47 -22.83 64.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.573 0.701 . . . . 53.25 110.064 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.688 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 13.9 ptmt -74.97 -23.44 58.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.999 -1.0 . . . . 73.44 111.335 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 79.1 m -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.949 0.404 . . . . 62.44 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -67.15 -15.02 63.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.617 -0.72 . . . . 74.12 110.581 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.456 HG21 HG12 ' A' ' 59' ' ' ILE . 27.5 pt -133.69 26.5 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 71.32 110.827 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.29 -46.63 19.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.052 0.453 . . . . 72.31 111.305 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.12 6.03 7.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.53 -0.843 . . . . 75.21 112.672 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 7.4 t70 -125.35 127.29 46.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.185 0.492 . . . . 62.51 110.518 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 p -76.34 -5.55 47.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.956 0.724 . . . . 73.44 112.956 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.64 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 7.9 pt-20 -91.42 -21.34 21.01 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.111 -0.636 . . . . 64.43 110.46 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -90.94 136.76 32.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.258 -0.645 . . . . 72.1 109.258 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.741 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 51.2 p90 -137.76 170.73 15.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.438 0.637 . . . . 71.44 112.412 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 30.3 t90 -106.43 139.81 40.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.629 -1.169 . . . . 75.42 109.375 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -135.52 139.18 43.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.323 -0.621 . . . . 72.13 109.323 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 146.33 53.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.433 . . . . 62.44 110.113 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 35.1 ttpt -65.61 131.13 45.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.381 -0.372 . . . . 74.53 110.164 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.433 ' NE1' ' HG2' ' A' ' 19' ' ' GLU . 64.5 p-90 -130.32 -33.89 1.66 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 73.43 111.517 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.414 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 7.6 tt0 -67.71 -41.64 83.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 74.23 110.767 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.85 26.17 25.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.532 -0.842 . . . . 71.35 111.448 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.27 165.47 40.35 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.1 -0.8 . . . . 73.3 111.1 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.586 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 38.3 m -100.82 145.72 28.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 117.189 0.495 . . . . 64.52 110.452 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 18.3 m-20 -79.11 161.37 68.43 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.621 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 60.1 Cg_endo -73.37 132.78 18.19 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.405 2.07 . . . . 63.4 112.734 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.11 158.27 88.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.822 -0.626 . . . . 60.21 110.198 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.716 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.7 Cg_exo -76.3 159.98 95.96 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.002 -1.249 . . . . 55.42 112.692 0.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.0 m-85 -95.74 101.75 13.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 72.32 110.13 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 7.2 m-20 -98.71 117.96 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.059 -0.518 . . . . 75.12 110.51 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 52.7 mt -111.71 116.79 53.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.266 -0.425 . . . . 75.23 109.922 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.78 115.44 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.519 HG21 ' HE3' ' A' ' 10' ' ' TRP . 5.0 mp -111.08 136.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 72.52 110.576 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -104.06 119.54 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.401 -0.592 . . . . 62.22 109.401 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 73.43 110.895 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 31.2 mmtp 72.0 -11.67 0.75 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.514 0.726 . . . . 51.01 112.643 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -145.13 170.5 16.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.617 0.246 . . . . 70.25 110.58 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 64' ' ' ASN . 2.2 m120 -85.95 124.36 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 64.32 110.74 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 5' ' ' ILE . 78.1 mt -130.17 136.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 64.3 110.065 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.574 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.9 tp60 -80.02 100.71 8.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.099 -0.704 . . . . 65.2 109.099 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 118' ' ' SER . 31.7 mm -69.36 118.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.909 -0.404 . . . . 51.25 109.909 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.6 -39.38 5.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.233 0.539 . . . . 62.53 110.914 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 51.3 tt0 -159.24 148.68 18.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.611 -0.722 . . . . 50.12 110.563 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.16 115.85 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.369 . . . . 42.2 110.817 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.579 ' OE2' ' HA ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -97.79 128.1 44.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.707 -0.679 . . . . 71.34 110.689 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.531 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 45.9 mt -109.34 118.17 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.463 -0.569 . . . . 54.13 109.463 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -103.74 99.07 14.58 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.588 -0.523 . . . . 64.23 109.588 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 5.4 Cg_exo . . . . . 0 N--CA 1.456 -0.704 0 C-N-CA 122.869 2.379 . . . . 64.35 111.795 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.446 ' HB2' HD22 ' A' ' 107' ' ' ASN . 5.5 m-20 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.698 0.285 . . . . 65.22 111.122 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 2.3 Cg_endo -82.95 32.12 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.35 2.7 . . . . 73.11 111.73 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.43 118.86 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.818 -0.628 . . . . 74.25 110.186 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -100.57 -50.12 3.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.675 . . . . 74.3 110.904 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 60.9 t -127.36 141.68 45.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.042 -0.526 . . . . 71.13 110.599 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.36 129.82 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.151 -0.477 . . . . 71.14 109.743 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.6 mt-10 -109.79 125.41 52.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.132 -0.486 . . . . 53.42 110.493 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -107.68 129.66 55.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.081 -0.509 . . . . 74.3 110.426 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.58 145.33 49.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.279 -0.418 . . . . 63.41 110.76 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.02 48.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.027 -0.533 . . . . 61.25 109.846 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t -149.86 154.62 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.345 0.593 . . . . 71.32 111.344 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 41.5 mt-10 -102.64 -32.79 9.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.432 -0.804 . . . . 71.31 109.985 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 26.8 t0 -106.81 -12.32 15.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 74.41 111.252 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 15.8 t-20 76.25 -21.5 0.31 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.413 0.625 . . . . 75.21 111.114 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ASP . 78.3 t -75.72 -50.96 21.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.684 -0.689 . . . . 54.31 110.319 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.1 113.41 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.225 -0.898 . . . . 63.31 109.913 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -94.08 142.19 27.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.014 -0.539 . . . . 73.52 110.946 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.4 m -115.1 124.55 30.09 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.786 -0.643 . . . . 73.23 109.967 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.52 116.17 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.567 2.178 . . . . 74.35 112.143 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 116' ' ' VAL . 15.7 pt -86.78 -13.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.395 -0.366 . . . . 74.05 110.571 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.69 130.76 1.15 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.333 -0.937 . . . . 43.42 113.177 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 38.4 ttt180 -106.71 114.56 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.713 -0.847 . . . . 71.31 108.713 171.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.568 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.4 m-85 -125.79 172.3 9.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.404 -0.362 . . . . 74.0 110.682 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.53 151.3 22.41 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.027 -0.829 . . . . 53.41 111.027 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -100.86 131.96 46.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.96 -0.385 . . . . 65.15 109.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.536 ' HB ' HD21 ' A' ' 112' ' ' LEU . 21.1 m -105.8 124.74 50.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 65.43 110.433 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.446 HD22 ' HB2' ' A' ' 81' ' ' ASN . 26.6 t-20 -70.69 94.87 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.095 0.474 . . . . 73.31 110.312 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -146.09 176.84 9.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.988 -0.745 . . . . 71.14 108.988 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.46 -7.81 17.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.033 0.444 . . . . 73.2 110.983 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.72 159.26 16.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 44.5 110.47 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.27 130.0 41.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 72.24 111.616 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 106' ' ' THR . 36.0 mt -87.28 116.38 25.33 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 74.51 110.33 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.579 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 40.9 mt-10 -83.16 121.14 26.68 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.283 0.364 . . . . 62.22 110.846 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 72' ' ' LEU . 49.9 m-85 -122.29 104.96 9.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 73.43 110.711 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.36 97.0 5.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.592 -0.731 . . . . 74.11 109.414 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.568 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.1 m -98.13 -178.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.443 -0.798 . . . . 75.42 111.792 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 45.8 tttp -61.04 125.69 24.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 71.45 111.088 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 9.6 p -73.05 120.02 18.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 75.24 110.029 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.431 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 10.6 tt -150.9 141.01 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.972 0.415 . . . . 74.42 111.406 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -82.9 115.02 21.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.277 -0.638 . . . . 74.01 109.277 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -142.8 175.0 10.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.292 . . . . 75.23 110.983 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -121.04 -32.5 3.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.6 . . . . 74.43 110.015 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.97 145.98 33.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 73.31 110.298 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -134.17 136.68 53.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.134 -0.484 . . . . 65.25 109.953 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.522 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.1 ttp180 -123.86 122.2 37.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.993 0.425 . . . . 74.02 111.095 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 HD12 ' A' ' 57' ' ' ILE . 40.4 tp -93.79 111.45 23.15 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.974 -0.75 . . . . 75.22 108.974 172.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 61.0 m -105.91 120.59 42.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.071 0.462 . . . . 73.21 111.061 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.732 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -98.31 96.23 3.5 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.566 -0.901 . . . . 74.0 108.566 171.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.716 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -68.71 171.72 12.79 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.68 2.254 . . . . 54.33 113.057 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.34 -2.43 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.251 1.024 . . . . 65.25 108.407 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.448 ' H ' ' HB2' ' A' ' 129' ' ' PRO . 7.0 m-20 -72.45 -31.84 65.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.138 -1.392 . . . . 74.04 112.439 -170.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -94.2 0.11 66.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.187 -1.006 . . . . 64.21 113.621 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.88 20.71 11.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.108 -1.044 . . . . 73.35 111.668 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -72.55 142.6 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.45 . . . . 72.34 111.031 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 17.4 m -100.06 172.24 7.32 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.924 -0.58 . . . . 54.51 109.867 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 16.2 p -83.19 22.05 1.03 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 55.32 112.128 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.23 129.42 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.506 -0.553 . . . . 65.21 109.506 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.17 135.11 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.507 -0.315 . . . . 65.05 110.939 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -134.47 106.04 6.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 63.11 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 29.9 mt -124.07 133.64 68.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.426 -0.583 . . . . 42.22 109.426 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.741 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 72.3 mtt180 -66.03 -71.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.274 0.359 . . . . 70.11 110.27 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.7 153.73 44.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.431 0.634 . . . . 73.23 111.705 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 tt -106.68 111.31 23.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.541 -1.281 . . . . 73.14 107.541 168.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -112.11 123.34 50.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.766 -0.457 . . . . 71.12 109.766 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.05 128.35 52.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.916 0.389 . . . . 61.34 111.978 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.704 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 54.1 mtpt -94.51 130.6 40.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.377 -0.601 . . . . 60.13 109.377 171.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.15 -167.35 35.42 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.186 -1.007 . . . . 44.3 112.265 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.2 m -123.06 129.49 51.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.479 0.18 . . . . 75.33 110.548 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 41.6 mm -69.36 116.36 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.163 -0.471 . . . . 73.45 109.981 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 66' ' ' GLN . 62.0 mt . . . . . 0 C--N 1.32 -0.683 0 CA-C-O 120.974 0.416 . . . . 62.42 109.97 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.624 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 35.3 p . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 120.68 0.276 . . . . 53.3 110.446 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 HD11 ' A' ' 149' ' ' ILE . 47.5 mm -88.65 134.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.837 0.351 . . . . 71.13 111.317 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -66.64 118.35 10.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.12 -0.491 . . . . 63.1 110.07 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -98.47 19.61 14.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.505 . . . . 72.32 111.217 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.5 m -58.7 -42.18 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.498 0.555 . . . . 72.05 112.498 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.13 8.05 62.69 Favored Glycine 0 C--O 1.235 0.186 0 C-N-CA 120.541 -0.838 . . . . 41.01 112.946 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -75.39 138.38 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.29 . . . . 74.41 110.236 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.4 pt-20 -130.3 152.91 49.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.074 -0.343 . . . . 71.41 110.074 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.28 115.23 32.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.907 -0.588 . . . . 54.21 109.829 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.459 HD11 ' HE2' ' A' ' 123' ' ' TYR . 84.8 mt -77.24 -48.97 16.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 72.22 110.062 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 t -143.26 142.99 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.562 -0.745 . . . . 74.03 110.138 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.571 -0.74 . . . . 75.34 109.257 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.2 m -77.12 -40.91 44.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.055 0.455 . . . . 72.31 110.37 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -150.98 150.34 30.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.219 -0.446 . . . . 72.13 110.864 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.19 140.51 7.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.502 -0.925 . . . . 72.35 108.502 173.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.3 tp10 -86.12 95.94 9.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.423 0.63 . . . . 71.12 110.632 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.83 2.58 20.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.259 -0.882 . . . . 74.43 110.786 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 m -112.56 -43.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.887 -0.597 . . . . 72.43 110.629 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.449 -0.472 0 CA-C-N 116.012 -0.54 . . . . 64.43 113.372 -176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.6 t30 . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 110.004 -0.369 . . . . 74.05 110.004 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.5 83.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.014 -0.612 . . . . 65.05 111.971 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.75 154.33 21.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.58 0.229 . . . . 74.43 110.488 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.96 -22.54 65.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.878 0.371 . . . . 72.53 111.448 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -77.83 -22.69 49.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.504 -0.317 . . . . 74.11 111.315 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 40.3 m -68.56 -24.33 64.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 74.53 109.911 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 142' ' ' GLU . 24.9 tp -65.12 -24.49 67.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.39 -0.823 . . . . 64.3 110.776 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HG21 HG12 ' A' ' 59' ' ' ILE . 35.9 pt -120.86 14.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.379 . . . . 73.11 111.16 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.86 -33.03 73.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.05 0.452 . . . . 74.42 110.197 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.0 36.29 6.41 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.708 -0.678 . . . . 51.44 112.023 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -139.05 128.93 24.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.988 -0.375 . . . . 61.42 109.988 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 73' ' ' LEU . 2.5 p -70.36 -11.72 61.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.626 0.602 . . . . 72.34 112.626 -174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -89.06 -27.11 21.02 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.84 0.352 . . . . 64.22 111.049 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.2 p -87.78 146.1 25.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.739 -0.384 . . . . 74.44 109.974 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.676 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 42.6 p90 -146.5 166.09 27.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.217 0.532 . . . . 75.02 111.772 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -108.24 139.89 42.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.948 -1.023 . . . . 74.14 109.547 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -133.01 147.11 52.26 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.234 -0.654 . . . . 72.22 109.234 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . . . -75.11 145.92 41.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.992 -0.373 . . . . 73.43 109.992 175.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HE2' ' OD2' ' A' ' 51' ' ' ASP . 37.7 ttpt -66.15 118.14 9.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 75.4 110.355 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -118.96 -30.9 4.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.425 -0.352 . . . . 75.42 110.896 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -78.72 107.67 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 73.4 110.249 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.12 -0.6 47.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.891 -0.671 . . . . 75.3 111.684 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 143.0 7.46 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.795 -0.717 . . . . 53.54 112.144 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -95.98 151.79 19.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.822 0.344 . . . . 60.42 111.053 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.479 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 30.5 m-20 -82.39 150.32 63.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.921 -0.582 . . . . 54.43 110.661 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.81 145.02 44.97 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.746 2.297 . . . . 34.4 112.269 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.8 mt -70.6 162.13 72.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 54.52 110.529 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 95.2 Cg_endo -83.15 170.02 56.16 Favored 'Cis proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.487 -1.464 . . . . 64.31 112.831 1.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.4 m-85 -108.17 111.02 22.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 73.41 110.406 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -110.79 130.95 55.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 74.33 110.622 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 126' ' ' LEU . 57.4 mt -121.72 114.41 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.479 -0.563 . . . . 71.44 109.479 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -102.36 115.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.921 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 HG21 ' A' ' 34' ' ' ILE . 4.9 mp -110.1 133.35 55.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.535 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -97.79 113.74 25.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.675 . . . . 73.42 109.179 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.2 mtm -81.98 -5.36 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 64.45 110.82 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 32.5 mmtp 73.41 -35.63 0.32 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.74 0.816 . . . . 74.13 112.965 174.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -123.9 166.73 15.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.005 0.431 . . . . 73.33 110.975 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.58 123.19 25.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.625 -0.716 . . . . 75.32 110.139 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.575 HD13 HG21 ' A' ' 5' ' ' ILE . 66.6 mt -131.68 136.87 56.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.05 0.452 . . . . 64.23 110.614 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.7 tp60 -86.48 108.56 18.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.858 -0.793 . . . . 65.45 108.858 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 118' ' ' SER . 28.1 mm -75.33 130.56 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.441 -0.207 . . . . 73.53 110.441 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -42.27 2.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.075 0.464 . . . . 73.42 111.331 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.8 tt0 -153.39 145.84 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 73.51 110.296 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -110.39 134.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.02 -0.363 . . . . 61.0 110.02 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -113.02 126.96 56.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.139 0.495 . . . . 70.42 110.899 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.625 HD12 ' HE2' ' A' ' 114' ' ' TYR . 61.3 mt -110.71 123.38 49.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.725 -0.67 . . . . 72.13 109.499 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.53 ' CD2' HG22 ' A' ' 38' ' ' THR . 22.4 tp -103.93 104.76 44.97 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.905 -0.405 . . . . 71.11 109.905 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo . . . . . 0 N--CA 1.457 -0.627 0 C-N-CA 122.815 2.343 . . . . 74.52 111.955 178.062 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 41.1 t-20 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 121.21 0.528 . . . . 72.13 110.756 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 9.3 Cg_endo -91.22 21.64 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.912 3.075 . . . . 72.01 112.796 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.06 122.92 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 62.34 110.169 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -100.08 -50.24 4.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 73.4 110.855 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 60.2 t -126.97 138.41 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 51.32 110.928 -173.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.91 137.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.069 -0.514 . . . . 64.01 110.128 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.13 135.53 54.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.039 0.447 . . . . 64.55 110.662 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.11 129.76 55.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.938 -0.574 . . . . 74.14 110.118 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.9 143.44 50.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 50.41 110.671 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.59 151.35 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.254 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 t -146.26 152.88 39.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 34.43 110.949 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -29.41 9.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.716 -0.674 . . . . 71.3 110.89 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -111.19 -0.03 16.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 74.11 111.11 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.1 t30 68.7 21.09 7.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.92 0.866 . . . . 75.22 109.614 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.76 -59.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.434 -0.803 . . . . 72.32 110.275 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -89.12 110.86 21.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 51.02 109.769 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -99.12 107.59 20.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.937 0.398 . . . . 75.52 110.312 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.8 m -88.46 123.89 67.25 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.967 -0.561 . . . . 72.42 110.378 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.13 107.33 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.243 1.962 . . . . 54.22 111.012 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 13.8 pt -80.21 -11.84 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.059 -0.519 . . . . 53.55 110.641 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.21 128.56 1.0 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.453 -0.88 . . . . 43.42 112.862 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -100.62 123.58 45.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.92 -0.771 . . . . 75.13 108.92 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.52 -177.73 4.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.741 0.305 . . . . 60.21 110.482 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -96.72 175.26 31.24 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.753 -0.737 . . . . 62.02 111.264 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -131.7 141.96 49.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.135 0.467 . . . . 75.42 110.095 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 m -136.69 119.42 16.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.931 -0.577 . . . . 73.44 110.058 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 63.9 t30 -69.62 95.93 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.725 -0.472 . . . . 71.22 109.725 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -125.8 -167.98 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 62.04 110.843 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.09 -33.47 14.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.916 -0.584 . . . . 54.42 111.186 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.87 168.62 10.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.887 -0.597 . . . . 44.04 111.56 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.8 144.81 47.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.091 0.472 . . . . 74.03 111.146 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.6 mt -101.18 104.54 15.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.637 -0.711 . . . . 72.01 110.01 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.29 115.82 24.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.476 . . . . 73.01 110.688 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.625 ' HE2' HD12 ' A' ' 72' ' ' LEU . 42.1 m-85 -113.34 108.17 16.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.117 0.484 . . . . 74.14 110.534 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -72.86 112.78 9.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.477 -0.783 . . . . 74.32 109.495 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -112.06 178.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.086 -0.507 . . . . 72.13 111.653 -172.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.73 128.19 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 71.03 110.481 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.8 p -77.02 106.44 8.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.151 -0.477 . . . . 44.03 110.175 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.85 146.73 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.915 -0.584 . . . . 74.13 110.487 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -88.29 131.44 34.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.845 0.355 . . . . 74.4 110.506 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.96 176.65 11.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 51.23 110.339 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -125.38 -30.66 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 64.23 110.158 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.459 ' HE2' HD11 ' A' ' 13' ' ' LEU . 93.5 m-85 -106.78 146.02 31.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.056 -0.52 . . . . 74.13 110.14 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.0 tt -135.99 135.66 50.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.934 0.397 . . . . 74.14 110.157 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 33.6 ttp180 -122.88 120.06 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.34 -0.391 . . . . 74.12 110.679 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -84.48 113.73 21.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.769 -0.826 . . . . 70.15 108.769 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.5 m -107.77 116.92 32.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.349 0.595 . . . . 62.22 111.278 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.9 mm -100.59 91.34 1.77 Allowed Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.002 -1.11 . . . . 51.15 108.002 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 61.1 Cg_endo -72.8 174.45 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.243 1.962 . . . . 53.21 112.521 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.34 36.91 0.89 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.613 -0.884 . . . . 62.21 108.613 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -113.52 146.37 39.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.571 -1.195 . . . . 72.14 110.752 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.98 9.9 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.144 -0.55 . . . . 71.55 113.522 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 116.37 25.28 3.52 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.285 -0.959 . . . . 41.53 112.263 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.93 145.0 56.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 71.21 110.383 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 15.4 m -118.74 176.87 5.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.068 -0.515 . . . . 70.52 110.541 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 34.1 p -78.16 10.14 3.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.243 -0.435 . . . . 71.11 111.879 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 44.8 t -109.4 119.29 58.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.654 -0.499 . . . . 73.41 109.654 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . . . -139.59 135.74 33.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.612 -0.267 . . . . 72.53 110.535 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.87 107.55 3.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 74.51 110.887 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.9 mt -133.43 136.97 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.478 -0.564 . . . . 71.04 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 36.3 mmt180 -63.77 -72.4 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.849 0.357 . . . . 72.33 110.071 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 33' ' ' LEU . 12.8 pt-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.917 -0.713 . . . . 74.34 111.812 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.39 130.56 56.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.715 -1.13 . . . . 72.14 108.147 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.624 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -128.16 164.4 22.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.696 -0.483 . . . . 71.32 109.696 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -133.28 128.02 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 71.1 110.277 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 50.7 mttm -93.13 134.66 35.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.172 -0.677 . . . . 73.2 109.172 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.39 8.56 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.87 -0.681 . . . . 72.44 111.453 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -136.31 133.61 37.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.484 0.183 . . . . 72.2 110.562 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.821 HD11 HG23 ' A' ' 5' ' ' ILE . 31.2 mm -73.55 115.83 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 66' ' ' GLN . 56.1 mt . . . . . 0 C--N 1.315 -0.904 0 N-CA-C 109.709 -0.478 . . . . 54.33 109.709 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 p . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.808 0.337 . . . . 71.12 110.35 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 149' ' ' ILE . 44.5 mm -82.74 130.53 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.786 0.327 . . . . 72.03 110.85 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.3 t -65.6 125.05 23.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.171 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -96.83 21.8 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 42.31 110.586 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 t -54.73 -46.04 74.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.576 -0.738 . . . . 60.24 112.069 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.29 18.29 36.12 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.239 -0.981 . . . . 43.43 113.643 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.4 ' HB3' HD12 ' A' ' 34' ' ' ILE . 25.9 m0 -77.41 144.07 38.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.063 0.432 . . . . 74.13 110.669 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.557 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 23.5 pt-20 -139.85 162.7 34.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.432 . . . . 71.1 110.666 176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.33 127.48 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.869 -0.605 . . . . 74.35 110.133 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 mt -90.99 -45.82 8.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.245 0.545 . . . . 75.04 110.096 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 m -137.0 140.43 42.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 75.21 110.283 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -149.55 142.42 24.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 72.03 110.071 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 m -81.8 -51.95 7.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 71.23 111.256 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -142.17 151.51 42.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.409 . . . . 72.53 110.8 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.538 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 9.6 pt20 -163.34 137.11 5.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.448 -0.796 . . . . 60.34 108.972 174.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.8 tp10 -89.48 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.208 0.528 . . . . 73.44 110.875 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.68 -8.59 22.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.53 -0.759 . . . . 70.22 111.097 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -106.52 -52.64 2.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 54.13 110.81 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . . . . . . 0 N--CA 1.446 -0.657 0 CA-C-N 116.074 -0.512 . . . . 65.34 112.55 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 t30 . . . . . 0 N--CA 1.456 -0.128 0 N-CA-C 110.078 -0.342 . . . . 63.14 110.078 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.6 -1.98 79.68 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.606 -0.598 . . . . 71.43 111.606 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 60.4 mt -84.32 155.84 22.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.192 -0.299 . . . . 64.13 110.192 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.81 -28.34 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.21 0.529 . . . . 71.25 111.098 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -79.58 -14.28 58.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.549 . . . . 71.12 111.545 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 71.1 m -73.11 -19.29 61.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.063 0.459 . . . . 74.14 109.822 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 39.5 tp -68.62 -13.05 62.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.482 -0.781 . . . . 72.5 110.7 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 59' ' ' ILE . 34.6 pt -137.59 21.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.803 -0.635 . . . . 61.4 110.306 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 12.3 t70 -67.76 -41.58 83.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 73.42 110.793 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.26 -2.26 11.47 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.869 -0.892 . . . . 53.05 110.869 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -125.04 115.08 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 75.24 109.951 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -75.93 2.61 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.482 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.34 -27.62 21.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.955 0.407 . . . . 65.3 110.049 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -89.07 137.42 32.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.017 -0.735 . . . . 64.22 109.017 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.655 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 41.8 p90 -130.11 173.2 10.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.057 0.456 . . . . 64.41 111.431 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.574 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.7 t90 -107.4 128.6 54.62 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 71.21 108.793 172.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -129.67 132.9 46.81 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.467 -0.568 . . . . 72.43 109.467 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.69 136.25 58.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.974 -0.75 . . . . 61.24 108.974 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.3 132.96 55.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.174 0.296 . . . . 73.02 110.385 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -124.09 -22.1 4.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.149 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -69.47 108.18 3.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.868 0.366 . . . . 75.14 110.197 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.96 11.91 72.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 73.32 112.055 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.16 176.14 18.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 72.32 111.972 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -123.76 149.28 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.925 0.393 . . . . 51.35 110.856 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 2.6 t70 -75.66 142.93 74.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.974 -0.557 . . . . 75.3 109.712 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 30.8 Cg_endo -63.59 146.1 92.3 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.566 2.177 . . . . 71.24 113.193 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 9.7 mt -77.58 163.53 63.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.661 -0.7 . . . . 72.22 110.034 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.8 Cg_endo -81.28 163.95 77.96 Favored 'Cis proline' 0 N--CA 1.461 -0.401 0 C-N-CA 124.101 -1.208 . . . . 65.33 112.92 1.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.3 m-85 -99.28 122.86 43.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.82 -0.627 . . . . 71.52 110.318 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 9.9 t0 -110.22 126.67 54.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.695 . . . . 75.53 109.817 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.7 mt -130.25 108.92 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.769 0.319 . . . . 64.24 110.372 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.84 118.46 47.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.023 -0.535 . . . . 71.52 110.566 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 34' ' ' ILE . 82.8 mt -117.35 134.08 62.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.122 -0.49 . . . . 72.43 111.124 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -100.66 122.7 43.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.521 -0.548 . . . . 75.5 109.521 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.422 ' SD ' HD12 ' A' ' 65' ' ' ILE . 71.3 mtm -88.21 -6.21 57.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 64.21 110.766 -177.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.557 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.5 mmtt 67.26 11.53 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.752 -0.658 . . . . 32.31 112.197 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -163.46 159.84 22.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.228 -0.286 . . . . 74.22 110.228 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 58.7 m-80 -81.5 130.45 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.615 -0.513 . . . . 70.42 109.615 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.489 ' CD1' HG21 ' A' ' 5' ' ' ILE . 65.4 mt -135.55 136.01 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.078 0.466 . . . . 72.44 110.422 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -82.34 99.91 9.65 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 64.23 108.635 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.752 ' O ' ' HA ' ' A' ' 118' ' ' SER . 34.5 mm -69.79 113.55 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.174 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 -32.6 7.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.896 0.379 . . . . 65.14 111.161 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.683 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 7.0 tt0 -154.2 147.42 24.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.283 -0.417 . . . . 64.33 110.78 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.87 134.15 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.111 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 44.3 mt-10 -115.56 138.63 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.162 0.506 . . . . 65.15 110.927 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 114' ' ' TYR . 92.7 mt -124.28 118.71 27.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.739 -0.664 . . . . 75.34 109.755 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -103.33 99.75 15.9 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 109.094 -0.706 . . . . 75.34 109.094 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.61 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 55.5 Cg_endo . . . . . 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.526 . . . . 75.11 112.656 -177.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 19.2 t30 . . . . . 0 C--O 1.234 0.244 0 CA-C-O 121.182 0.515 . . . . 72.35 109.732 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.49 46.07 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.945 3.096 . . . . 72.05 113.906 -170.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.4 111.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.171 -0.677 . . . . 63.13 109.171 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.02 -48.05 8.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 72.33 110.91 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.713 HG11 ' HE ' ' A' ' 102' ' ' ARG . 12.0 t -130.95 143.15 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 74.51 110.713 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.88 142.01 45.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.144 -0.48 . . . . 65.25 110.238 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -112.68 130.18 56.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.983 -0.553 . . . . 75.25 110.497 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.81 129.1 55.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 73.32 110.312 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.33 148.55 52.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.316 -0.402 . . . . 63.02 110.476 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.36 153.63 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.42 -0.354 . . . . 70.11 110.479 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 t -145.39 142.38 29.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 70.45 110.136 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -77.32 -45.66 25.46 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.925 -0.58 . . . . 73.23 111.279 -176.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.61 23.85 5.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.372 -0.376 . . . . 71.52 111.048 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.1 t30 65.63 29.55 10.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.93 0.871 . . . . 73.51 110.089 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.17 -64.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.34 -0.845 . . . . 71.52 109.741 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -96.41 105.1 17.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 64.2 110.792 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -89.33 114.63 26.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.291 -0.413 . . . . 70.44 110.148 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 60.8 m -117.38 130.4 24.68 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.955 -0.566 . . . . 64.23 110.87 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 8.1 Cg_exo -70.88 106.99 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.865 2.376 . . . . 61.52 111.336 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 116' ' ' VAL . 11.8 pt -76.04 -11.1 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.777 -0.647 . . . . 71.21 111.057 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.77 149.0 5.8 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.339 -0.934 . . . . 65.04 113.101 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.713 ' HE ' HG11 ' A' ' 85' ' ' VAL . 78.1 ttt180 -124.21 118.4 26.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.705 -0.85 . . . . 75.44 108.705 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.0 m-85 -133.32 163.17 29.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.897 0.38 . . . . 72.53 111.364 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.65 141.4 25.5 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.663 -0.699 . . . . 35.23 111.595 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.61 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 48.0 t80 -100.54 138.38 37.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.954 0.407 . . . . 61.24 110.368 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 112' ' ' LEU . 32.6 m -131.3 112.73 13.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.184 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.66 103.07 2.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.291 0.567 . . . . 74.5 110.942 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -130.83 -174.34 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.317 -0.856 . . . . 73.11 109.425 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -90.56 -15.38 30.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.78 0.324 . . . . 72.43 110.98 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 150.77 22.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.344 -0.389 . . . . 60.25 110.839 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.06 127.51 32.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.115 0.483 . . . . 62.43 111.125 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -79.63 105.34 10.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.657 -0.701 . . . . 72.34 110.349 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 42.6 mt-10 -88.64 111.71 22.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.181 0.515 . . . . 74.33 111.187 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -108.57 111.46 23.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.652 -0.703 . . . . 73.14 110.35 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -74.25 102.59 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.686 . . . . 72.23 109.636 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 100' ' ' ILE . 31.5 m -102.08 -179.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 71.14 111.583 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -72.28 125.21 26.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.562 -0.745 . . . . 71.12 110.07 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 32.5 p -70.2 127.18 31.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.951 -0.568 . . . . 74.11 111.295 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.89 148.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.29 -0.414 . . . . 70.51 110.329 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -85.52 116.28 23.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . . . -141.81 156.43 45.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.959 -0.564 . . . . 73.44 110.828 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.92 -26.99 8.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.505 0.669 . . . . 73.31 109.388 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -111.4 145.4 38.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.459 -0.792 . . . . 74.04 109.319 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -133.08 139.63 49.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.693 -0.484 . . . . 73.12 109.693 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.6 ttp180 -125.02 123.43 39.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.055 0.455 . . . . 65.54 111.126 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -91.02 115.55 28.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.411 -0.813 . . . . 74.33 108.92 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.7 m -109.63 116.17 31.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.949 0.404 . . . . 55.43 110.865 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 40.2 mm -100.75 97.54 6.91 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.784 -0.821 . . . . 71.43 108.784 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.738 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 52.2 Cg_endo -69.96 170.28 17.19 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.432 2.088 . . . . 72.53 112.611 -176.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.98 -16.42 26.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.974 0.893 . . . . 74.34 108.754 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.55 148.03 22.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.285 -1.325 . . . . 71.41 110.895 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.97 -12.96 49.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.949 -0.86 . . . . 52.33 110.949 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.76 24.83 7.53 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.093 -0.575 . . . . 72.3 111.689 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -75.61 127.58 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 74.43 110.748 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.2 m -95.88 164.43 12.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.19 -0.459 . . . . 64.4 109.996 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 17.4 p -68.98 -6.18 26.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.26 0.467 . . . . 72.44 112.26 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 42.3 t -85.04 95.58 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.61 121.95 36.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.106 -0.497 . . . . 64.24 110.503 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.25 108.75 6.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 64.51 111.097 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 21.0 mt -121.96 132.65 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.655 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 77.1 mtt-85 -69.96 -70.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.936 -0.305 . . . . 75.23 110.613 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 26.9 tt0 -148.07 141.14 24.94 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.157 -0.617 . . . . 62.04 111.322 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 143' ' ' LEU . 7.9 tt -100.27 132.0 45.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.154 -0.93 . . . . 62.2 109.229 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.21 155.94 41.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.961 0.41 . . . . 74.33 110.387 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.6 t -126.74 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.127 -0.488 . . . . 63.02 110.542 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HD2' ' NE2' ' A' ' 69' ' ' GLN . 46.3 mttp -104.69 115.45 30.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.191 -0.67 . . . . 74.04 109.191 171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.02 -169.14 24.95 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.762 -0.733 . . . . 75.44 112.096 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.1 m -113.32 130.73 56.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.425 -0.213 . . . . 63.5 110.425 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 5' ' ' ILE . 34.3 mm -76.11 120.63 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.063 0.459 . . . . 75.51 110.966 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 120' ' ' LYS . 37.0 mt . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.698 -0.683 . . . . 62.4 109.456 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.702 -0.481 . . . . 75.4 109.702 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.07 -124.98 7.57 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.855 -0.898 . . . . 71.23 110.855 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.4 m -74.29 -29.83 61.82 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.165 0.507 . . . . 73.41 110.505 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.524 HG22 ' HE2' ' A' ' 146' ' ' LYS . 19.2 p -76.41 130.03 37.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.347 -0.612 . . . . 74.03 109.347 174.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 145' ' ' VAL . 40.1 mm -67.16 129.17 31.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.446 -0.343 . . . . 75.12 110.388 -176.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.8 m -63.11 116.47 5.4 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 54.3 110.356 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -86.61 15.7 5.36 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.111 -0.495 . . . . 70.05 110.907 -175.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -62.54 -35.23 78.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.774 -0.648 . . . . 73.02 111.848 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.36 15.9 38.55 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.551 -0.833 . . . . 33.45 113.106 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.412 ' HB3' HD12 ' A' ' 34' ' ' ILE . 30.2 m0 -84.06 141.99 30.75 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.933 0.366 . . . . 72.11 110.842 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.486 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.7 pt-20 -136.73 157.36 46.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.966 0.412 . . . . 54.5 110.373 176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -94.24 122.44 45.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.747 -0.661 . . . . 73.13 109.94 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 60' ' ' ASP . 71.4 mt -84.75 -39.95 17.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.056 0.455 . . . . 63.45 110.572 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.6 t -154.59 142.06 19.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.82 -0.627 . . . . 61.1 110.091 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.509 ' CE2' ' HG2' ' A' ' 18' ' ' GLN . 32.5 p90 -139.97 145.58 38.05 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.691 -0.686 . . . . 74.24 109.38 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.1 m -88.24 -33.88 17.94 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.86 0.362 . . . . 71.32 111.282 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.9 t -148.88 151.15 34.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.908 0.385 . . . . 74.22 111.158 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.509 ' HG2' ' CE2' ' A' ' 15' ' ' PHE . 1.5 pp0? -167.81 142.71 3.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.894 -0.78 . . . . 73.01 108.894 176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 9.4 tp10 -109.82 94.2 4.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.138 0.494 . . . . 53.51 110.776 -174.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -101.58 8.01 41.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.793 -0.64 . . . . 62.31 111.048 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.2 t -120.01 -46.33 2.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.116 0.484 . . . . 75.32 110.26 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.436 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -69.16 -29.2 72.21 Favored Glycine 0 N--CA 1.453 -0.209 0 CA-C-N 115.963 -0.562 . . . . 53.24 112.647 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -95.43 16.04 18.01 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.126 0.488 . . . . 74.42 110.303 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.02 -100.67 2.63 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.703 -0.681 . . . . 62.24 111.773 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.2 128.15 1.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.105 -0.331 . . . . 73.5 110.105 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.78 5.4 62.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.853 -0.689 . . . . 55.13 112.031 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -140.24 150.89 44.66 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.233 -0.654 . . . . 43.12 109.233 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.05 6.6 88.1 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.993 -0.622 . . . . 62.54 112.175 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.8 mt -80.15 148.59 30.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.668 0.27 . . . . 72.31 110.565 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.31 -25.71 65.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.301 -0.408 . . . . 73.33 111.191 -177.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.5 pttt -76.39 -23.21 54.07 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.796 -0.362 . . . . 74.01 111.254 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 71.1 m -63.08 -27.73 69.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.03 0.443 . . . . 73.23 110.234 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.27 -30.92 70.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.559 -0.746 . . . . 70.02 110.469 177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.701 HG21 HG12 ' A' ' 59' ' ' ILE . 46.9 pt -115.23 13.1 7.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 74.05 111.054 -179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.4 t70 -77.32 -33.02 55.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 74.0 109.226 178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' OE1' ' A' ' 142' ' ' GLU . . . 84.2 55.1 2.83 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.519 -0.764 . . . . 61.12 112.623 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -146.51 129.62 16.51 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.815 -0.439 . . . . 74.01 109.815 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.598 HG22 HD21 ' A' ' 73' ' ' LEU . 11.1 p -70.21 -19.79 63.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.38 0.511 . . . . 70.33 112.38 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -88.52 -13.29 40.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.733 0.301 . . . . 73.21 110.893 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -105.36 151.72 23.83 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.789 -0.448 . . . . 70.42 109.789 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -151.93 162.37 41.18 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.575 -0.45 . . . . 75.0 111.04 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.6 t90 -98.79 137.59 37.15 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.523 -0.762 . . . . 74.43 109.271 174.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.3 t-80 -131.67 139.16 49.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.588 -0.523 . . . . 75.05 109.588 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 151.5 46.91 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.161 -0.472 . . . . 61.11 109.973 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.2 tptp -61.87 129.32 40.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.318 -0.253 . . . . 73.24 110.318 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -134.71 -32.99 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 121.073 -0.251 . . . . 72.42 111.068 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -81.27 102.6 10.49 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.727 -0.471 . . . . 73.5 109.727 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.62 -11.64 53.72 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.921 -0.657 . . . . 72.21 111.54 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 126.45 149.42 7.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.733 -0.746 . . . . 74.43 112.291 176.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.5 m -86.16 173.44 9.82 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.03 0.443 . . . . 65.31 111.3 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.585 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 24.1 m-20 -98.2 166.51 13.24 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.966 -0.561 . . . . 63.53 109.787 178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 56.9 Cg_endo -71.92 122.76 8.76 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.1 1.867 . . . . 62.3 112.973 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.811 ' HB3' ' HB3' ' A' ' 130' ' ' ASP . 16.8 mt -67.96 154.49 93.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 75.42 110.139 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.511 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 86.6 Cg_endo -81.17 167.21 72.63 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.669 -1.388 . . . . 74.35 113.019 1.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.0 m-85 -104.99 119.43 38.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 64.33 110.491 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -113.19 125.51 54.42 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.911 0.386 . . . . 54.44 110.705 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 58.4 mt -118.62 117.84 55.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.22 -0.446 . . . . 72.03 110.049 176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.924 HG22 ' HG3' ' A' ' 125' ' ' ARG . 54.7 t -106.23 122.34 59.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.936 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.701 HG12 HG21 ' A' ' 34' ' ' ILE . 4.6 mp -112.38 139.39 37.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.08 -0.509 . . . . 75.22 110.609 -178.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.521 ' HB2' HD11 ' A' ' 13' ' ' LEU . 58.0 t0 -103.26 121.19 42.2 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.333 -0.618 . . . . 73.14 109.333 174.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.1 mtm -88.34 -3.14 58.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.284 -0.416 . . . . 73.33 110.725 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 65.57 13.44 8.89 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.712 -0.676 . . . . 63.45 111.991 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' OE1' HD12 ' A' ' 149' ' ' ILE . 4.8 pt20 -165.35 153.8 11.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.359 -0.608 . . . . 61.45 109.359 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -82.7 123.81 29.63 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.942 -0.392 . . . . 74.53 109.942 178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 85.4 mt -126.44 139.14 52.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.167 -0.47 . . . . 74.54 110.374 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -82.1 101.46 10.41 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.734 -0.839 . . . . 73.23 108.734 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.627 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.7 mm -70.55 134.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.086 -0.506 . . . . 61.03 110.811 -174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.72 -42.57 1.6 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.067 -0.515 . . . . 71.02 110.699 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.625 ' HG2' ' HD3' ' A' ' 146' ' ' LYS . 11.8 tt0 -147.95 138.73 23.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 72.14 111.444 -177.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.9 143.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.028 -0.73 . . . . 70.33 109.028 176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.878 ' HB2' ' HE3' ' A' ' 146' ' ' LYS . 17.8 tt0 -120.75 133.72 55.32 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.175 -0.306 . . . . 75.42 110.175 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 48.1 mt -117.26 121.45 41.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.311 -0.625 . . . . 61.45 109.311 177.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD21 HG22 ' A' ' 38' ' ' THR . 34.5 tp -102.4 101.27 18.82 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.829 -0.434 . . . . 65.11 109.829 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.6 Cg_endo -80.8 -177.75 3.95 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.89 2.393 . . . . 52.13 111.397 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -96.09 -66.0 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.222 -0.444 . . . . 74.12 109.839 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 73.91 -60.06 2.17 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 121.089 -0.577 . . . . 65.31 112.148 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -60.46 98.22 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.89 -0.655 . . . . 72.23 111.143 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.63 15.37 81.61 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 121.029 -0.605 . . . . 24.25 112.653 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.3 m -119.63 143.43 47.7 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.816 -0.226 . . . . 72.53 110.625 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -83.56 -56.45 3.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.418 -0.356 . . . . 61.44 110.33 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 54.17 80.63 0.29 Allowed Pre-proline 0 N--CA 1.464 0.259 0 CA-C-N 115.595 -0.73 . . . . 73.22 112.289 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.27 40.48 0.83 Allowed 'Trans proline' 0 CA--C 1.532 0.425 0 C-N-CA 122.949 2.433 . . . . 74.11 112.099 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -94.55 122.1 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.012 -0.54 . . . . 71.44 109.824 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -99.89 -50.35 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.559 -0.746 . . . . 64.24 110.938 -176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.437 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 41.7 t -132.85 139.3 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 71.54 110.923 -174.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -125.29 140.14 49.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.259 -0.428 . . . . 74.23 110.268 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.484 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 46.9 mt-10 -120.12 130.45 54.63 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.785 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.82 131.54 54.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.123 -0.49 . . . . 63.42 110.546 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.47 150.54 49.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.158 -0.474 . . . . 33.55 110.363 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.482 ' HB1' ' CB ' ' A' ' 121' ' ' ALA . . . -138.73 155.74 47.98 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.367 -0.379 . . . . 74.13 110.088 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 34.1 t -149.3 147.42 28.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.072 0.463 . . . . 71.45 111.743 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.05 -28.21 17.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.401 -0.818 . . . . 70.35 110.601 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 11.8 p-10 -123.38 4.09 9.09 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.891 0.33 . . . . 74.13 111.891 -173.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.4 t-20 77.24 -20.83 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.522 0.729 . . . . 71.45 111.265 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.1 t -86.1 -54.27 8.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.024 0.44 . . . . 74.13 110.351 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -90.14 103.82 16.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.882 -0.599 . . . . 74.15 110.911 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -94.53 137.16 34.0 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.178 0.513 . . . . 74.33 110.573 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 30.8 m -122.01 125.12 26.75 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 115.668 -0.696 . . . . 71.15 109.938 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.7 108.63 1.09 Allowed 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.608 2.205 . . . . 33.44 111.283 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 116' ' ' VAL . 18.2 pt -81.28 -13.46 12.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.0 -0.546 . . . . 41.31 111.163 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 169.46 135.18 1.85 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.326 -0.94 . . . . 61.4 112.792 176.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.484 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 60.8 ttt180 -111.69 121.29 44.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.486 -0.561 . . . . 72.15 109.486 172.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -140.0 165.9 26.09 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.768 -0.373 . . . . 72.44 111.01 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -81.39 147.74 27.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 121.002 -0.618 . . . . 50.32 111.678 176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -96.58 123.32 40.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.932 -0.396 . . . . 74.35 109.932 -177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.658 ' HB ' HD21 ' A' ' 112' ' ' LEU . 10.3 m -102.13 106.78 17.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.246 -0.434 . . . . 55.35 110.302 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -65.69 110.29 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.068 0.461 . . . . 71.34 110.429 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -152.38 177.98 10.02 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.698 -0.683 . . . . 74.24 109.752 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -93.9 -9.56 36.76 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.251 0.548 . . . . 74.05 110.356 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.51 157.65 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.751 -0.659 . . . . 61.23 110.641 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.55 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -70.26 144.47 51.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.045 0.45 . . . . 71.1 111.703 -176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.658 HD21 ' HB ' ' A' ' 106' ' ' THR . 20.4 mt -99.55 113.85 26.51 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.525 -0.761 . . . . 70.13 110.146 177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.422 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 50.4 mt-10 -85.15 115.78 23.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.848 0.356 . . . . 72.43 110.593 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -110.55 105.36 14.27 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.234 -0.439 . . . . 64.21 110.779 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -75.86 118.55 18.77 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.959 -0.756 . . . . 70.14 108.959 174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.548 HG21 HD12 ' A' ' 100' ' ' ILE . 29.4 m -120.67 -172.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.324 0.491 . . . . 71.41 112.324 -171.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -66.53 125.89 27.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.16 -0.927 . . . . 73.52 110.719 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.7 m -74.87 108.06 7.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.035 0.445 . . . . 75.25 110.217 177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 11.8 tt -151.74 152.2 11.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.964 -0.562 . . . . 74.41 109.943 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.6 ' HG3' HD12 ' A' ' 150' ' ' ILE . 1.1 ttmp? -73.36 138.91 45.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.554 -0.536 . . . . 75.03 109.554 175.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . . . -156.27 134.43 11.34 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.51 -0.313 . . . . 71.34 110.88 175.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -95.57 -29.82 14.14 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.799 -0.815 . . . . 74.21 108.799 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -112.9 145.08 41.35 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.1 -0.954 . . . . 75.11 109.499 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.8 tt -134.71 137.18 51.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.657 -0.497 . . . . 74.45 109.657 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.924 ' HG3' HG22 ' A' ' 58' ' ' VAL . 4.4 ttm180 -122.13 130.21 53.03 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.867 0.365 . . . . 75.1 111.159 -177.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.2 tp -97.48 118.16 33.35 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.016 -0.735 . . . . 74.53 109.016 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 88.6 m -109.97 122.83 48.48 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.149 0.5 . . . . 74.51 111.1 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.1 mm -101.46 94.0 3.8 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.714 -0.847 . . . . 75.13 108.714 173.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.511 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 59.0 Cg_endo -71.48 151.67 59.41 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.86 2.373 . . . . 60.24 113.308 -173.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.811 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 12.6 p-10 -89.72 4.79 48.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.589 0.709 . . . . 71.11 109.535 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -91.16 -34.39 15.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.075 -0.966 . . . . 72.21 111.39 -174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -76.18 -3.45 76.0 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.616 -0.802 . . . . 54.12 113.529 -173.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.07 8.18 45.26 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.488 -0.863 . . . . 42.21 111.335 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -69.05 133.73 48.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.309 -0.446 . . . . 74.3 111.608 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 m -86.29 175.29 8.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.965 -0.561 . . . . 73.05 109.728 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 38.5 p -84.4 16.27 3.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.971 0.415 . . . . 73.24 111.36 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -114.83 119.48 61.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.546 -0.538 . . . . 75.34 109.546 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -144.27 130.91 20.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.59 -0.277 . . . . 73.4 110.613 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.451 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -136.64 105.61 5.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.051 0.453 . . . . 52.15 110.884 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.1 mt -122.63 133.14 69.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.838 -0.43 . . . . 72.21 109.838 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.27 -62.54 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.223 0.327 . . . . 75.12 110.724 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' HA2' ' A' ' 36' ' ' GLY . 15.1 pt-20 -154.13 161.32 41.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.457 0.646 . . . . 72.32 111.59 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -119.43 135.94 54.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.832 -1.076 . . . . 75.42 108.19 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.463 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.8 t70 -129.23 161.6 29.8 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.016 -0.364 . . . . 73.42 110.016 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' ILE . 45.4 t -135.35 133.56 52.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.947 0.403 . . . . 73.32 110.267 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.878 ' HE3' ' HB2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -108.86 125.6 52.16 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.848 -0.797 . . . . 74.45 108.848 176.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.21 -168.25 30.96 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.407 -0.902 . . . . 42.01 112.449 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.7 m -112.35 132.29 55.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.465 -0.198 . . . . 74.31 110.465 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.427 HD12 ' OE1' ' A' ' 63' ' ' GLN . 40.3 mm -73.36 123.58 28.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 70.23 110.757 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.6 HD12 ' HG3' ' A' ' 120' ' ' LYS . 48.0 mt -107.26 144.94 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.558 -0.534 . . . . 71.23 109.558 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -120.28 134.93 55.16 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.042 0.448 . . . . 64.23 111.257 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.88 11.61 27.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.639 0.733 . . . . 73.22 109.262 173.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -107.98 102.69 11.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.069 -0.969 . . . . 71.44 111.38 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -103.58 98.4 8.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.465 -0.939 . . . . 71.13 108.465 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -62.18 -32.75 73.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.711 0.634 . . . . 71.34 112.711 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -86.17 7.97 22.88 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.018 -0.273 . . . . 74.51 111.524 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -140.62 16.22 2.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.902 0.382 . . . . 75.21 110.802 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.8 t60 -149.95 74.43 1.21 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 74.23 109.774 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.598 -0.728 . . . . 75.11 109.712 -179.531 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 109.649 -0.5 . . . . 73.41 109.649 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.42 -139.61 9.57 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 44.42 112.641 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.421 HG23 ' HE3' ' A' ' 146' ' ' LYS . 4.2 t -134.53 -26.75 1.39 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 111.517 0.192 . . . . 74.31 111.517 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.29 149.7 40.57 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.739 -0.384 . . . . 71.14 110.539 176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 149' ' ' ILE . 30.0 mm -94.69 132.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.249 -0.432 . . . . 52.1 110.467 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -70.77 123.43 21.93 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.592 -0.522 . . . . 74.03 109.592 175.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -98.59 16.41 22.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.406 -0.361 . . . . 62.03 111.468 -173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.6 m -77.44 -5.15 48.82 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.911 0.386 . . . . 72.01 111.497 -175.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.89 -0.09 24.28 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.652 -0.785 . . . . 34.42 112.357 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 27.1 m0 -82.86 153.9 24.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.645 0.26 . . . . 73.44 110.654 -175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.02 155.4 48.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.93 0.395 . . . . 74.41 110.663 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -92.33 119.7 40.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.516 -0.766 . . . . 75.01 109.948 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD21 ' HE1' ' A' ' 158' ' ' HIS . 84.9 mt -84.18 -42.04 16.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.942 -0.572 . . . . 74.41 110.53 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.8 t -149.21 143.73 26.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 71.31 110.131 -178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -148.88 149.52 31.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 70.3 109.687 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 59.6 m -92.57 -44.3 8.68 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 111.844 0.313 . . . . 74.22 111.844 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -138.49 149.48 45.45 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.73 -0.388 . . . . 63.35 111.137 -175.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -161.93 142.86 10.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.799 -0.637 . . . . 75.32 109.441 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 10.1 tp10 -115.84 93.6 4.33 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.295 -0.412 . . . . 75.32 110.541 -176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.91 -14.31 26.17 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.939 -0.573 . . . . 40.31 111.204 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.1 m -98.81 -51.84 3.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.406 -0.361 . . . . 75.21 111.308 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -71.01 -30.76 67.42 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.065 -0.588 . . . . 73.04 113.38 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -95.03 -25.59 16.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.966 0.383 . . . . 72.52 111.847 -176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.28 178.11 18.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.318 -0.944 . . . . 72.44 113.048 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.11 115.26 11.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.946 0.403 . . . . 54.03 110.876 -177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.77 -5.94 69.82 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.79 -0.719 . . . . 65.31 112.095 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -117.42 128.19 54.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.446 -0.205 . . . . 65.32 110.446 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.7 -7.78 63.43 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 121.242 -0.504 . . . . 75.24 112.638 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.8 mt -73.67 142.95 46.42 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.741 0.305 . . . . 75.23 110.768 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.565 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.41 -27.21 68.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.322 -0.399 . . . . 50.11 111.309 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -19.35 61.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.022 0.439 . . . . 75.13 110.562 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 1.079 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 69.5 m -72.84 -18.42 61.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.953 -0.567 . . . . 73.22 111.032 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 126' ' ' LEU . 32.6 tp -64.88 -24.32 67.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.546 0.689 . . . . 72.3 109.925 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.401 HG21 HG12 ' A' ' 59' ' ' ILE . 35.8 pt -122.6 19.65 5.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.339 -0.846 . . . . 70.13 109.775 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 1.079 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 22.0 t70 -64.68 -41.57 95.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.325 -0.852 . . . . 65.4 111.458 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.9 38.19 5.25 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.471 -0.871 . . . . 71.41 112.077 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -151.28 128.8 11.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.194 -0.298 . . . . 63.04 110.194 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.4 p -75.58 -2.9 31.34 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.142 0.423 . . . . 62.22 112.142 -172.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -98.37 -22.34 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.109 -0.236 . . . . 74.42 110.95 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.7 p -88.55 165.69 14.67 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.875 -0.417 . . . . 63.34 109.875 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.579 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 31.8 p90 -164.97 165.82 19.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.985 0.421 . . . . 74.22 111.442 -177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 36.3 t90 -106.4 141.92 36.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.198 -0.91 . . . . 72.12 109.018 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 48.4 t-80 -139.62 143.21 37.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.509 -0.552 . . . . 61.35 109.509 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.26 136.65 50.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.583 -0.525 . . . . 62.33 109.583 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.687 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 3.5 ttpm? -62.87 122.04 14.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.578 0.228 . . . . 71.42 110.396 -177.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 69.5 p-90 -117.34 -29.13 5.94 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.524 -0.307 . . . . 75.14 110.686 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.9 110.98 9.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 73.24 110.251 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.31 -5.95 65.62 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.898 -0.668 . . . . 51.23 111.982 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.84 143.17 5.51 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.867 -0.682 . . . . 45.23 112.459 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.612 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 19.0 m -93.71 144.7 25.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.813 0.34 . . . . 72.01 110.761 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.9 m-20 -76.76 148.02 78.75 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.083 -0.508 . . . . 51.3 109.965 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 9.6 Cg_exo -72.39 144.25 40.57 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.695 2.263 . . . . 73.24 112.81 -177.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.7 mt -73.35 161.88 77.0 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.972 -0.558 . . . . 61.25 110.342 174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.592 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.1 Cg_exo -79.77 168.96 71.96 Favored 'Cis proline' 0 C--N 1.346 0.413 0 C-N-CA 124.082 -1.216 . . . . 74.32 112.577 -1.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.754 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 25.2 m-85 -107.92 128.74 54.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.688 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -111.8 133.14 54.21 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.27 -0.423 . . . . 64.41 110.172 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 51.0 mt -132.17 111.43 18.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.868 -0.419 . . . . 65.35 109.868 173.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.428 HG13 ' HH2' ' A' ' 97' ' ' TRP . 57.8 t -106.42 121.38 58.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.342 -0.39 . . . . 74.44 111.096 -175.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.401 HG12 HG21 ' A' ' 34' ' ' ILE . 5.1 mp -116.1 136.19 53.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.475 -0.33 . . . . 73.12 110.837 -178.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.449 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.0 t0 -96.45 117.5 31.02 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 109.149 -0.685 . . . . 73.45 109.149 172.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.1 mtm -83.75 -3.28 57.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.517 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 34.1 mmtp 73.05 -13.9 0.65 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.625 0.77 . . . . 73.3 112.401 173.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -147.53 177.14 9.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.9 0.381 . . . . 72.34 110.953 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.44 121.51 30.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.861 -0.609 . . . . 51.42 110.209 178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.489 HD13 HG21 ' A' ' 5' ' ' ILE . 67.7 mt -129.18 134.81 63.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.891 0.377 . . . . 75.24 110.259 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -81.77 105.76 13.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.194 -0.669 . . . . 61.22 109.194 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 118' ' ' SER . 10.2 mm -80.18 117.41 26.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.231 -0.285 . . . . 62.44 110.231 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.19 -41.92 3.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.132 0.492 . . . . 61.43 110.665 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -144.59 138.84 27.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.004 -0.544 . . . . 71.04 110.865 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.6 t -110.2 133.94 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.387 -0.598 . . . . 72.42 109.387 176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 52.8 mt-10 -114.42 127.93 56.09 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.033 0.444 . . . . 62.24 110.834 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 40.0 mt -109.35 125.95 52.89 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.876 -0.602 . . . . 73.05 109.709 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -112.27 96.44 35.23 Favored Pre-proline 0 C--N 1.312 -1.033 0 N-CA-C 109.164 -0.68 . . . . 65.04 109.164 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 56.6 Cg_endo -73.19 173.33 13.87 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.443 2.095 . . . . 72.52 111.589 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HB3' ' OG ' ' A' ' 79' ' ' SER . 1.3 mtm180 -63.65 -42.35 98.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.577 -0.449 . . . . 63.24 110.412 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.36 -86.51 0.33 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.981 -0.554 . . . . 50.1 113.002 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 77' ' ' ARG . 48.7 mtm-85 -76.47 117.92 18.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.872 0.367 . . . . 75.35 111.041 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.94 52.42 5.79 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.89 -0.595 . . . . 60.51 112.416 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.452 ' OG ' ' HB3' ' A' ' 75' ' ' ARG . 22.1 m -153.73 150.73 28.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.8 0.333 . . . . 73.13 111.434 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -109.32 103.9 12.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.646 0.736 . . . . 72.55 109.261 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.457 HD21 HD12 ' A' ' 83' ' ' ILE . 21.8 t-20 -108.67 105.64 57.31 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.995 -0.548 . . . . 64.31 110.823 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 71.6 Cg_endo -92.55 19.47 0.91 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.127 2.551 . . . . 41.54 112.813 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.457 HD12 HD21 ' A' ' 81' ' ' ASN . 58.7 mt -79.59 129.89 36.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.772 -0.455 . . . . 53.14 109.772 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -112.93 -38.05 4.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.856 -0.611 . . . . 73.11 110.419 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.3 t -132.97 137.96 52.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 75.31 111.206 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.38 141.66 45.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.142 -0.481 . . . . 72.24 110.507 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 0.1 OUTLIER -118.32 132.79 56.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 63.21 109.937 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -113.71 133.34 55.4 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.441 -0.345 . . . . 75.35 110.466 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.98 146.76 50.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.788 0.328 . . . . 74.23 111.08 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.39 146.41 51.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 75.41 110.162 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 23.4 t -140.17 157.46 45.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.226 0.536 . . . . 62.33 111.516 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.522 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.8 mt-10 -116.14 -32.23 5.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.667 -0.697 . . . . 74.33 110.668 176.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -114.82 5.13 15.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.997 -0.547 . . . . 74.31 112.161 -172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 23.0 m120 71.92 -1.91 2.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.119 0.568 . . . . 62.53 111.752 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 -51.69 7.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.01 0.433 . . . . 52.0 110.195 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -89.94 112.72 24.2 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.796 -0.638 . . . . 72.52 110.538 -177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.428 ' HH2' HG13 ' A' ' 58' ' ' VAL . 97.9 m95 -104.81 108.04 19.32 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.07 -0.514 . . . . 73.3 109.935 176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.4 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 80.7 m -89.28 120.05 69.73 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 116.287 -0.415 . . . . 71.02 110.314 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 42.2 Cg_endo -66.82 110.9 2.02 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.396 2.064 . . . . 74.43 110.83 174.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.61 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -86.38 -10.12 11.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.124 -0.489 . . . . 70.23 110.81 -177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.91 128.7 0.98 Allowed Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 120.083 -1.056 . . . . 64.54 113.322 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.27 117.2 33.48 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.387 -0.968 . . . . 64.25 108.387 173.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -134.58 175.28 9.68 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.124 0.488 . . . . 74.41 111.47 -171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -89.61 140.79 15.79 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.35 -0.841 . . . . 71.45 111.745 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.589 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 51.4 t80 -97.01 148.01 23.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 73.04 110.106 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.4 m -142.71 112.06 6.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.398 -0.364 . . . . 72.03 110.444 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -72.54 114.42 10.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.071 0.462 . . . . 74.22 110.556 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 74' ' ' PRO . 13.2 pt20 -154.07 179.8 8.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.622 -0.717 . . . . 73.44 109.43 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.88 -5.39 51.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.147 0.499 . . . . 75.04 110.283 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.36 138.97 36.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.71 -0.677 . . . . 44.32 110.208 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.65 140.33 58.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.045 0.45 . . . . 72.43 110.886 -178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 32.8 mt -94.81 104.75 16.66 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.719 -0.673 . . . . 71.4 110.248 -178.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.8 mp0 -79.97 109.04 14.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.004 0.431 . . . . 73.32 110.752 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.12 104.59 14.54 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.069 -0.514 . . . . 64.25 110.404 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -70.86 106.75 3.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.994 -0.743 . . . . 75.45 108.994 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 27.4 m -106.08 174.84 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.903 0.382 . . . . 71.44 111.445 -174.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.444 ' HD3' ' HB ' ' A' ' 119' ' ' ILE . 7.5 tmtm? -64.04 122.51 16.72 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 75.14 110.086 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 25.1 m -66.53 114.82 5.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.93 -0.577 . . . . 72.23 109.92 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.444 ' HB ' ' HD3' ' A' ' 117' ' ' LYS . 12.8 tt -144.19 145.07 22.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.861 0.363 . . . . 70.5 110.958 -174.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.536 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -94.29 115.21 27.41 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.97 -0.752 . . . . 54.3 108.97 175.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.522 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.3 175.22 10.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.795 0.331 . . . . 34.14 111.303 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -118.39 -34.19 4.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.904 -0.589 . . . . 72.31 110.362 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -107.52 146.21 32.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.932 -0.577 . . . . 75.1 110.25 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.1 tt -132.16 137.91 53.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.945 -0.571 . . . . 72.22 109.827 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.519 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 28.3 ttp180 -123.52 122.54 38.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.499 -0.319 . . . . 72.31 110.697 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 37.2 tp -84.69 113.03 21.0 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.515 -0.92 . . . . 54.04 108.515 169.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 22.8 m -103.48 118.37 36.58 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.204 -0.453 . . . . 74.32 110.574 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.754 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.3 mm -102.51 96.76 7.78 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.712 -0.847 . . . . 71.33 108.712 172.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.592 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 72.8 Cg_endo -76.44 175.98 10.66 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.391 2.061 . . . . 64.34 112.595 -174.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.95 13.25 29.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.729 0.776 . . . . 71.13 109.141 175.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.93 144.76 25.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.677 -1.147 . . . . 71.31 111.093 -175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.96 57.86 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.992 -0.623 . . . . 70.4 113.38 171.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 115.97 22.55 4.56 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.274 -0.965 . . . . 74.25 112.655 -178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -68.15 155.01 40.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.966 0.412 . . . . 72.42 110.821 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.402 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 50.7 m -129.39 -176.89 4.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.073 -0.512 . . . . 64.02 110.197 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 40.3 p -85.23 22.58 1.44 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.1 0.476 . . . . 72.41 111.605 -175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.1 123.55 68.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.574 -0.528 . . . . 71.34 109.574 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.14 138.88 30.11 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.469 -0.332 . . . . 71.23 110.216 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.75 105.24 3.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.871 0.367 . . . . 73.14 111.026 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 42.3 mt -129.45 132.57 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.437 -0.579 . . . . 42.14 109.437 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.579 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 31.6 mmt180 -67.36 -67.29 0.47 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.465 -0.568 . . . . 74.23 109.465 177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -139.45 152.81 47.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 73.35 111.494 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 tt -112.76 116.09 29.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.456 -1.312 . . . . 63.11 107.456 166.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -115.83 161.39 18.83 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.753 -0.462 . . . . 65.44 109.753 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -131.51 125.77 56.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.282 -0.417 . . . . 63.24 110.262 -176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.421 ' HE3' HG23 ' A' ' 3' ' ' THR . 47.0 mttp -102.31 105.06 15.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.417 0.627 . . . . 74.23 109.354 174.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -149.5 -148.93 4.86 Favored Glycine 0 N--CA 1.439 -1.113 0 CA-C-N 115.181 -0.918 . . . . 63.22 111.524 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.8 m -132.71 129.25 38.49 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.809 0.337 . . . . 72.23 110.878 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 5' ' ' ILE . 31.6 mm -71.71 119.91 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.616 . . . . 73.21 110.567 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.536 HD12 ' HG2' ' A' ' 120' ' ' LYS . 46.2 mt -106.61 134.49 48.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 72.01 109.757 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -117.64 143.85 45.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.909 -0.587 . . . . 75.24 109.964 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 155' ' ' HIS . 3.7 mp -130.69 -167.09 1.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.313 -0.625 . . . . 64.43 109.313 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 154' ' ' HIS . 29.7 mm-40 -78.3 -163.51 0.45 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.929 0.395 . . . . 52.33 111.636 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.44 ' H ' ' HB3' ' A' ' 153' ' ' GLU . 20.8 p80 -49.4 139.99 10.98 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.508 -0.769 . . . . 74.21 112.417 -176.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.592 ' CE1' ' HB2' ' A' ' 152' ' ' LEU . 39.2 m80 -134.4 146.68 50.09 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.824 -0.625 . . . . 72.13 110.102 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -85.67 173.56 10.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.334 -0.394 . . . . 64.34 111.019 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -51.28 160.29 0.56 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.516 -0.765 . . . . 74.1 112.784 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.451 ' HE1' HD21 ' A' ' 13' ' ' LEU . 46.8 t60 -55.97 119.25 5.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.662 -0.699 . . . . 64.03 111.049 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.773 -0.648 . . . . 65.41 110.009 177.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.229 -0.286 . . . . 75.01 110.229 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.72 -162.94 36.33 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.819 -0.705 . . . . 62.43 112.154 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.677 HG23 ' HG2' ' A' ' 146' ' ' LYS . 13.0 t -109.51 10.31 25.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.264 0.554 . . . . 52.23 110.403 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.19 127.61 33.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.713 -0.676 . . . . 71.43 110.177 174.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.446 HG21 ' CD1' ' A' ' 65' ' ' ILE . 21.2 mm -72.08 137.2 24.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.969 -0.56 . . . . 74.12 111.337 -172.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.8 m -70.87 111.21 6.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.941 -0.572 . . . . 72.35 110.538 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -87.04 3.46 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.72 -0.673 . . . . 51.33 111.803 -173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -66.88 -26.59 66.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.942 0.401 . . . . 64.34 110.779 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -90.84 -5.6 68.27 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.557 -0.83 . . . . 75.51 112.082 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 28.7 m0 -81.81 158.43 24.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.606 0.241 . . . . 71.25 110.643 -176.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.415 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.9 pt-20 -142.37 158.26 43.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.913 0.387 . . . . 63.13 110.199 173.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.22 125.78 45.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.675 -0.693 . . . . 70.45 109.62 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 60' ' ' ASP . 87.7 mt -94.75 -41.12 9.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.321 -0.399 . . . . 74.3 110.715 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.0 t -142.48 140.92 32.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 73.41 110.613 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.43 136.32 19.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.829 -0.623 . . . . 75.34 109.655 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.4 m -87.84 -33.4 18.6 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 74.51 111.156 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -146.6 146.61 30.49 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 120.93 0.395 . . . . 74.34 110.955 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -162.01 140.47 9.18 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.839 -0.8 . . . . 72.45 108.839 174.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.8 tp10 -109.78 81.84 1.5 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.336 0.589 . . . . 72.13 111.331 -172.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.43 -4.26 53.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.449 -0.796 . . . . 72.15 110.467 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -100.27 -53.54 3.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.74 -0.664 . . . . 65.05 111.092 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -73.02 -34.85 58.24 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.3 -0.476 . . . . 75.4 112.412 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -88.44 -57.83 2.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.989 0.423 . . . . 74.44 110.327 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 135.88 171.98 12.51 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.678 -0.772 . . . . 73.23 111.944 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.21 119.92 11.78 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.939 0.4 . . . . 71.11 110.946 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.89 -10.35 57.15 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.047 -0.597 . . . . 71.41 112.266 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -121.02 138.33 54.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.675 -0.491 . . . . 72.24 109.675 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.12 5.87 88.96 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.794 -0.717 . . . . 62.31 112.832 176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 82.2 mt -77.57 139.38 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.384 -0.228 . . . . 53.15 110.384 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.14 -21.27 66.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 75.03 111.529 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.92 -22.28 46.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.935 0.397 . . . . 73.44 110.901 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.882 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 86.3 m -69.63 -18.29 63.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.058 -0.519 . . . . 61.52 110.642 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.92 -27.46 69.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.838 -0.619 . . . . 75.52 110.176 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 59' ' ' ILE . 34.2 pt -120.32 18.35 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 64.21 110.208 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.882 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -63.92 -45.75 87.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.507 -0.77 . . . . 73.55 110.222 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.53 7.08 24.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.631 -0.795 . . . . 60.21 112.708 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.49 131.73 54.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.108 0.48 . . . . 74.41 111.134 178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 51.7 p -71.55 -10.26 59.49 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.713 -0.676 . . . . 73.23 111.079 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -85.91 -21.67 27.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 62.33 111.058 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 17.1 p -89.76 169.77 11.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 110.091 -0.337 . . . . 74.35 110.091 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.522 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 46.2 p90 -163.62 157.9 19.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 74.12 111.284 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.499 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 34.8 t90 -103.83 142.41 34.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.283 -0.871 . . . . 74.5 108.98 173.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 19' ' ' GLU . 38.4 t-80 -138.72 144.53 39.55 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.532 -0.544 . . . . 74.2 109.532 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.23 144.39 46.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.027 -0.36 . . . . 45.12 110.027 175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HE3' ' O ' ' A' ' 49' ' ' GLY . 29.2 ttpt -72.61 126.47 29.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.487 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -125.15 -24.84 3.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.39 -0.368 . . . . 74.43 110.772 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -71.19 112.56 7.43 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.087 0.47 . . . . 75.24 110.461 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.16 12.99 56.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.957 -0.639 . . . . 73.52 111.763 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.523 ' O ' ' HE3' ' A' ' 45' ' ' LYS . . . 107.97 143.02 10.48 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.091 -0.804 . . . . 74.13 111.091 -177.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.4 m -85.78 166.79 15.79 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.71 0.29 . . . . 75.33 110.72 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 22.7 m-20 -91.13 148.9 38.91 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.421 -0.354 . . . . 72.12 110.518 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 12.0 Cg_exo -71.23 151.48 60.68 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 123.053 2.502 . . . . 71.35 112.531 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 15.5 mt -93.85 159.65 34.13 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.634 -0.712 . . . . 70.21 110.391 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.683 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.3 Cg_endo -81.73 161.54 79.41 Favored 'Cis proline' 0 C--N 1.344 0.305 0 C-N-CA 123.481 -1.466 . . . . 73.04 112.845 2.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.807 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.1 m-85 -91.13 123.1 34.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.566 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.744 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 0.7 OUTLIER -109.49 123.36 49.26 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.447 -0.797 . . . . 74.31 110.361 -178.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.594 HD12 HD23 ' A' ' 126' ' ' LEU . 61.8 mt -127.77 110.76 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 109.812 -0.44 . . . . 72.54 109.812 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG13 ' CH2' ' A' ' 97' ' ' TRP . 59.5 t -104.81 122.11 57.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.873 -0.603 . . . . 72.34 110.69 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 34' ' ' ILE . 57.5 mt -119.77 136.31 57.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.02 -0.537 . . . . 71.33 110.591 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.571 ' HB2' HD11 ' A' ' 13' ' ' LEU . 37.7 t0 -101.73 123.8 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.31 -0.404 . . . . 72.04 110.339 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.441 ' HE1' HD11 ' A' ' 67' ' ' ILE . 68.5 mtm -90.52 -3.1 57.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 61.14 110.783 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 71.79 0.2 3.42 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.365 0.666 . . . . 75.44 112.688 173.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -163.81 170.95 16.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.431 -0.211 . . . . 71.34 110.431 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 121' ' ' ALA . 1.9 m120 -79.47 127.16 31.78 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.871 0.367 . . . . 52.31 110.206 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.446 ' CD1' HG21 ' A' ' 5' ' ' ILE . 75.0 mt -133.42 135.46 56.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 109.753 -0.462 . . . . 74.21 109.753 176.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.45 ' HB2' HD11 ' A' ' 150' ' ' ILE . 51.5 tp60 -80.11 104.09 10.43 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.009 -0.737 . . . . 64.01 109.009 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.6 mm -74.41 108.12 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.637 -0.256 . . . . 71.11 110.564 -176.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.26 -50.79 4.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.89 0.376 . . . . 73.34 110.895 179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -142.23 140.08 32.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.025 0.441 . . . . 75.22 111.09 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.0 129.09 61.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 75.53 109.445 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -111.47 129.43 56.04 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.068 0.461 . . . . 62.42 110.971 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 114' ' ' TYR . 54.3 mt -116.77 129.36 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.804 -0.634 . . . . 73.23 110.241 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.4 tp -106.92 104.94 53.88 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.285 -0.416 . . . . 51.55 110.231 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.649 ' O ' ' HD3' ' A' ' 141' ' ' ARG . 2.9 Cg_exo -75.81 176.98 9.3 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.51 2.806 . . . . 73.03 111.477 178.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.791 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 48.1 mtp180 -71.96 -23.18 61.4 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.533 0.206 . . . . 72.24 111.413 -176.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.574 ' HA2' ' C ' ' A' ' 108' ' ' GLN . . . 88.9 -60.72 3.83 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.704 -0.76 . . . . 61.12 112.758 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -75.69 167.34 22.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.15 0.5 . . . . 74.32 111.147 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.59 69.57 0.93 Allowed Glycine 0 C--N 1.321 -0.289 0 CA-C-N 114.928 -1.033 . . . . 51.12 113.019 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.9 t -100.06 167.16 10.65 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.25 -0.648 . . . . 75.45 109.25 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -68.31 101.34 1.19 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.963 0.411 . . . . 53.3 110.266 175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.596 HD21 ' HE2' ' A' ' 105' ' ' PHE . 64.5 t30 -144.31 72.97 16.06 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.734 -0.666 . . . . 62.14 109.52 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.51 40.91 1.02 Allowed 'Trans proline' 0 CA--C 1.53 0.31 0 C-N-CA 123.191 2.594 . . . . 71.25 113.636 -174.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.1 mt -83.48 130.73 35.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.879 -0.415 . . . . 60.13 109.879 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -109.99 -56.18 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.87 -0.605 . . . . 61.31 110.578 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG23 ' HA3' ' A' ' 132' ' ' GLY . 92.6 t -118.83 137.7 51.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.549 . . . . 61.14 110.622 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -127.4 134.56 65.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.615 . . . . 62.23 110.273 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 45.4 mt-10 -115.91 125.87 53.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.223 0.535 . . . . 75.1 110.614 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -104.87 129.45 53.21 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.807 -0.633 . . . . 72.04 109.967 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.33 151.21 50.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.347 -0.388 . . . . 72.32 110.779 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -134.01 150.25 51.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.901 -0.591 . . . . 73.35 109.86 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.1 t -149.63 161.11 42.83 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.101 0.477 . . . . 51.14 111.047 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.802 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 32.7 mt-10 -120.29 -7.14 9.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.0 -0.546 . . . . 72.43 110.603 177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.4 p-10 -122.14 -9.81 8.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.641 -0.254 . . . . 71.25 111.036 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 73.58 6.46 5.02 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.907 0.755 . . . . 72.34 110.331 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.4 t -113.84 -50.71 5.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.686 -0.688 . . . . 62.44 110.301 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -98.4 104.78 16.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.734 -0.666 . . . . 70.32 109.863 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.46 ' CH2' HG13 ' A' ' 58' ' ' VAL . 99.0 m95 -91.71 131.14 37.31 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.053 -0.521 . . . . 72.4 110.529 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.9 m -110.67 122.82 37.21 Favored Pre-proline 0 N--CA 1.444 -0.744 0 CA-C-N 116.006 -0.543 . . . . 62.5 109.91 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 125.71 15.94 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.427 2.085 . . . . 72.41 111.723 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.462 HD12 HG21 ' A' ' 116' ' ' VAL . 28.7 pt -100.4 -17.64 6.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.274 -0.421 . . . . 64.1 110.57 177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 177.65 133.23 1.82 Allowed Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 119.891 -1.147 . . . . 65.42 113.025 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.407 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 9.9 ttt180 -114.99 114.96 26.12 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.86 -0.793 . . . . 74.51 108.86 172.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.403 ' HE2' HG12 ' A' ' 116' ' ' VAL . 56.9 m-85 -138.69 -174.25 3.78 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.402 -0.519 . . . . 64.12 111.124 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.61 146.04 16.33 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.944 -0.646 . . . . 51.11 112.043 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.596 ' HE2' HD21 ' A' ' 81' ' ' ASN . 42.8 t80 -99.1 148.69 23.79 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.994 0.426 . . . . 74.41 110.057 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.0 m -139.61 127.49 22.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.298 -0.41 . . . . 72.33 110.193 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -80.87 100.3 8.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.185 0.517 . . . . 74.11 110.187 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.574 ' C ' ' HA2' ' A' ' 76' ' ' GLY . 11.9 pt20 -140.73 172.98 11.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.716 -0.675 . . . . 72.42 109.996 -177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.98 -3.92 58.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 75.33 110.603 -176.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.86 142.42 34.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.935 -0.575 . . . . 63.21 110.452 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.94 131.17 45.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.124 0.488 . . . . 54.43 110.708 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 51.2 mt -84.37 114.29 21.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.641 -0.709 . . . . 74.41 110.637 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -89.41 108.56 19.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.014 0.435 . . . . 74.23 110.711 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.457 ' CE2' HD12 ' A' ' 72' ' ' LEU . 96.1 m-85 -100.89 104.33 15.54 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.143 -0.481 . . . . 54.13 110.523 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -74.3 99.78 3.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.611 -0.722 . . . . 73.14 109.28 177.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.462 HG21 HD12 ' A' ' 100' ' ' ILE . 26.9 m -100.47 175.22 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.226 0.536 . . . . 63.22 111.814 -173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 4.7 ttpm? -70.89 113.15 7.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.134 -0.939 . . . . 72.11 109.295 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.771 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 49.7 m -68.98 118.01 11.36 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 64.24 111.258 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -146.7 150.41 14.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.501 -0.772 . . . . 72.33 110.028 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.475 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.0 ttpp -83.88 133.12 34.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.904 -0.406 . . . . 70.33 109.904 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -154.64 171.82 18.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.416 -0.357 . . . . 73.14 110.433 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 29.5 ttt180 -114.61 -35.01 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.372 0.606 . . . . 72.33 109.82 173.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -108.08 145.01 34.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.754 . . . . 71.21 109.902 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.7 tt -128.87 139.33 52.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.39 -0.596 . . . . 51.11 109.39 177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.744 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 31.5 ttp180 -127.29 124.56 39.07 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.103 0.477 . . . . 74.32 111.804 -176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.594 HD23 HD12 ' A' ' 57' ' ' ILE . 41.2 tp -87.4 112.34 22.04 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.704 -0.851 . . . . 70.51 108.704 171.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 32.5 m -107.59 117.09 33.19 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.952 0.406 . . . . 71.13 110.81 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.807 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -101.27 95.25 4.7 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 108.596 -0.89 . . . . 65.01 108.596 172.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.683 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -74.36 172.87 15.23 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.384 2.056 . . . . 63.13 112.529 -174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -95.26 25.9 4.08 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.889 0.852 . . . . 41.3 109.133 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -113.57 142.83 45.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.432 -1.258 . . . . 44.33 110.096 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.457 ' HA3' HG23 ' A' ' 85' ' ' VAL . . . 100.29 -18.11 55.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.83 -0.7 . . . . 75.42 113.044 176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 112.95 17.09 8.05 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.33 -0.938 . . . . 62.24 112.248 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -64.7 127.73 32.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 53.23 110.663 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.3 m -93.84 -179.73 5.08 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.29 -0.414 . . . . 72.42 110.069 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 2.0 p -81.3 31.49 0.33 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.07 0.462 . . . . 61.44 111.954 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.9 t -137.28 130.77 44.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.626 -0.509 . . . . 72.14 109.626 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.28 31.11 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.974 -0.38 . . . . 74.23 109.974 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.791 ' HB1' ' HD2' ' A' ' 75' ' ' ARG . . . -144.6 105.93 4.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.138 0.494 . . . . 60.13 111.521 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.3 mt -129.89 132.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.415 -0.587 . . . . 65.33 109.415 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.649 ' HD3' ' O ' ' A' ' 74' ' ' PRO . 58.6 mtp180 -72.54 -52.16 16.79 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.321 -0.152 . . . . 71.2 110.914 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -159.39 160.46 34.94 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.723 -0.791 . . . . 61.14 112.097 174.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -118.91 127.92 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.691 -1.14 . . . . 73.53 108.602 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.19 145.68 47.97 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.871 -0.418 . . . . 72.44 109.871 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.8 t -116.39 124.39 72.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.047 0.451 . . . . 65.0 110.21 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.677 ' HG2' HG23 ' A' ' 3' ' ' THR . 16.1 ttmt -103.31 103.67 13.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.814 -0.63 . . . . 74.34 109.341 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -150.54 -168.23 15.25 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.721 -0.752 . . . . 42.23 112.166 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.5 m -118.2 134.08 55.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.59 0.233 . . . . 62.5 110.708 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.474 HG22 ' HG ' ' A' ' 152' ' ' LEU . 38.0 mm -71.67 133.04 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.284 0.564 . . . . 63.13 111.326 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 120' ' ' LYS . 56.6 mt -126.15 150.24 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.616 -0.72 . . . . 74.04 109.132 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 61.21 53.15 3.64 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.57 -0.9 . . . . 61.01 108.57 -171.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 152' ' ' LEU . 4.7 mp -66.81 141.47 57.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.852 -1.067 . . . . 72.21 111.38 -171.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 65.63 22.12 11.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.09 -0.959 . . . . 73.23 111.821 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -81.88 -17.52 46.98 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.921 -0.77 . . . . 73.23 108.921 170.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -74.28 141.5 45.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.969 -1.014 . . . . 75.13 111.021 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -130.08 137.66 50.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.117 -0.697 . . . . 73.14 109.117 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -77.72 -25.85 49.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.377 -0.374 . . . . 73.15 111.521 -170.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -75.73 98.88 4.21 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.987 0.422 . . . . 63.34 110.395 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.213 179.07 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 120.911 0.386 . . . . 71.0 110.437 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.39 -88.5 0.42 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.844 -0.694 . . . . 63.54 112.217 -177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.9 t 46.32 27.89 0.64 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.954 0.902 . . . . 75.01 112.168 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 p -69.15 136.39 52.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.047 -0.979 . . . . 35.02 110.726 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CD1' ' A' ' 65' ' ' ILE . 39.0 mm -88.59 136.36 23.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.912 -0.585 . . . . 65.42 110.24 -178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.8 m -69.37 120.35 15.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.98 0.419 . . . . 61.24 110.007 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -88.15 5.96 38.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 64.44 111.016 -174.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.1 m -72.7 88.86 1.31 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.887 -0.597 . . . . 74.35 110.406 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.67 -13.66 3.67 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.513 -0.767 . . . . 64.11 111.632 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.6 m0 -69.5 142.26 53.76 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.725 -0.472 . . . . 75.04 109.725 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 21.8 pt-20 -127.89 158.76 36.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.186 0.517 . . . . 61.4 111.109 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 114.67 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.312 -0.858 . . . . 60.3 110.023 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 60' ' ' ASP . 81.7 mt -81.35 -48.74 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.036 -0.529 . . . . 73.45 110.229 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -147.19 142.16 26.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.867 -0.606 . . . . 52.24 110.371 -178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -143.18 146.88 34.1 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.686 -0.688 . . . . 75.34 109.196 176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.3 m -86.0 -37.49 18.91 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.858 0.361 . . . . 72.42 111.176 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.7 t -153.89 149.8 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.014 0.435 . . . . 72.12 111.109 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' LYS . 24.8 pt20 -159.01 146.4 17.47 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.069 -1.086 . . . . 75.23 108.069 173.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -99.31 94.73 6.62 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.146 0.498 . . . . 75.4 110.407 -176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.74 -0.83 23.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.665 -0.698 . . . . 74.05 110.853 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.8 m -114.26 -37.94 4.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.139 -0.482 . . . . 54.12 110.94 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.62 -49.41 55.9 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 116.012 -0.54 . . . . 64.24 112.891 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -113.22 14.87 19.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.973 0.416 . . . . 53.43 110.898 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.57 -176.82 51.31 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.912 -0.586 . . . . 74.42 112.949 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -92.74 139.29 30.7 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.024 -0.361 . . . . 74.11 110.024 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.552 ' H ' HD11 ' A' ' 29' ' ' LEU . . . 102.24 -2.71 50.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.99 -0.624 . . . . 61.45 111.586 -176.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -154.1 131.97 11.61 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.247 -0.649 . . . . 74.3 109.247 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.33 -1.16 76.1 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.975 -0.631 . . . . 63.2 111.808 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.627 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 63.8 mt -77.08 150.31 35.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.273 -0.269 . . . . 54.51 110.273 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.47 -29.95 69.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 51.3 110.108 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -67.62 -22.69 65.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.826 -0.625 . . . . 63.33 111.374 177.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.825 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.8 m -68.86 -25.2 64.51 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.971 0.415 . . . . 72.13 110.293 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.22 -27.87 69.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.694 -0.684 . . . . 61.32 110.361 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.534 HD13 HD12 ' A' ' 59' ' ' ILE . 31.3 pt -119.31 14.78 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.894 -0.594 . . . . 73.25 110.434 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.825 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.0 t70 -65.15 -40.7 94.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 71.41 110.548 -176.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.6 25.76 13.04 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.763 -0.732 . . . . 43.44 111.882 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -131.8 122.35 25.64 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.652 -0.499 . . . . 74.23 109.652 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.4 p -75.07 -7.79 54.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.906 -0.588 . . . . 75.54 111.791 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -85.65 -24.2 27.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.335 -0.393 . . . . 72.44 110.38 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.0 p -96.95 155.8 16.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.292 -0.413 . . . . 63.23 110.454 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.717 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 40.9 p90 -149.07 168.91 21.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.855 0.36 . . . . 72.33 111.153 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.452 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.6 t90 -104.85 138.4 41.17 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.574 -0.739 . . . . 72.02 109.083 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -133.88 136.96 44.68 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.411 -0.588 . . . . 74.34 109.411 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.43 58.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.672 -0.492 . . . . 73.1 109.672 174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 50' ' ' SER . 53.6 tttm -64.87 120.17 12.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.032 0.444 . . . . 72.22 110.369 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -111.19 -30.91 7.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.844 -0.617 . . . . 74.52 110.845 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -73.11 129.21 37.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.996 -0.372 . . . . 72.03 109.996 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 87.06 -12.27 62.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.946 -0.645 . . . . 53.3 111.974 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 122.23 140.96 5.9 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 111.599 -0.601 . . . . 33.41 111.599 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 9.8 p -81.94 145.79 30.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.662 0.268 . . . . 70.25 110.812 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.72 156.02 90.35 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.096 -0.502 . . . . 74.12 110.339 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.32 148.79 49.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.526 2.151 . . . . 74.13 113.01 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -82.46 158.69 65.77 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.629 -0.714 . . . . 61.42 109.866 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.91 159.31 91.24 Favored 'Cis proline' 0 C--N 1.344 0.314 0 C-N-CA 123.497 -1.46 . . . . 62.25 112.678 0.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.671 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.8 m-85 -91.3 117.89 30.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.092 -0.503 . . . . 74.35 110.196 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.692 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.2 t70 -108.16 126.7 53.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.528 -0.76 . . . . 65.02 110.572 -176.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 126' ' ' LEU . 57.9 mt -130.64 114.96 29.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.989 0.423 . . . . 74.51 110.242 175.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.6 t -108.13 115.82 49.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.948 -0.569 . . . . 72.21 110.984 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.534 HD12 HD13 ' A' ' 34' ' ' ILE . 49.4 mm -112.16 142.79 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.114 -0.493 . . . . 73.24 110.822 -178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' HB2' HD11 ' A' ' 13' ' ' LEU . 59.0 t0 -108.77 121.6 45.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.912 -0.585 . . . . 54.43 109.508 175.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 68.3 mtm -85.15 -9.65 57.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 55.21 111.155 -177.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 71.6 mmtt 68.33 16.04 9.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.148 -0.478 . . . . 73.2 112.215 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.648 ' HB2' HD11 ' A' ' 152' ' ' LEU . 8.3 pt20 -169.17 159.51 9.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.61 0.243 . . . . 75.32 110.936 -175.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -85.78 126.0 33.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.465 . . . . 73.43 110.481 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.512 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.8 mt -135.95 140.45 44.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.064 -0.517 . . . . 70.13 110.304 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.652 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.0 tp60 -82.86 101.81 11.23 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.188 -0.671 . . . . 75.43 109.188 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.5 mm -66.8 122.09 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.551 -0.295 . . . . 70.25 110.328 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.46 -33.09 4.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.738 0.304 . . . . 54.43 111.429 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.687 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 10.3 tt0 -159.41 145.41 16.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.571 -0.286 . . . . 63.33 110.384 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -114.18 137.24 48.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.49 -0.559 . . . . 75.42 109.49 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 16.7 tt0 -112.9 132.6 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.832 -0.347 . . . . 74.11 110.185 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.462 HD12 ' CE2' ' A' ' 114' ' ' TYR . 44.5 mt -120.4 116.82 26.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.384 . . . . 75.3 110.146 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.4 tp -101.91 103.91 32.26 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.348 -0.612 . . . . 75.21 109.348 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.517 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 15.3 Cg_exo -68.47 171.27 13.28 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 123.438 2.759 . . . . 62.03 112.835 -176.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.514 ' HD2' ' CB ' ' A' ' 139' ' ' ALA . 35.2 ttt180 -60.64 -45.81 92.66 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.068 -0.515 . . . . 75.22 110.96 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.41 172.25 12.47 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.868 -0.682 . . . . 70.44 111.802 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -70.18 -14.98 62.87 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.006 0.373 . . . . 75.11 112.006 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.5 45.74 3.54 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.765 -0.731 . . . . 73.41 112.12 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.9 t -172.45 158.28 4.24 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.856 -0.794 . . . . 75.34 108.856 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -74.57 -69.56 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.195 -0.298 . . . . 73.14 110.195 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.48 ' N ' ' HD3' ' A' ' 82' ' ' PRO . 61.3 t30 52.75 60.2 13.03 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 123.985 0.803 . . . . 54.12 110.255 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 81' ' ' ASN . 4.1 Cg_exo -74.47 60.5 5.01 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.164 2.576 . . . . 64.41 113.474 -174.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.1 mt -92.17 125.54 44.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.825 -0.435 . . . . 64.4 109.825 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -93.4 -53.05 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.027 -0.533 . . . . 73.12 110.003 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.3 t -125.73 137.45 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.541 -0.754 . . . . 65.42 110.836 -174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.6 m -121.68 135.22 62.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.593 -0.73 . . . . 63.21 109.542 174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 54.6 mt-10 -119.05 125.48 49.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.03 0.443 . . . . 74.32 110.646 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.403 ' HB2' HG13 ' A' ' 100' ' ' ILE . 47.4 m-85 -104.81 131.08 52.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.827 -0.624 . . . . 64.32 110.424 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.57 149.81 49.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.224 -0.444 . . . . 74.25 110.145 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.4 149.83 48.49 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.48 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 t -149.86 152.49 35.18 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.949 0.404 . . . . 63.3 110.199 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.673 ' HB3' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -121.23 7.32 10.22 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.418 0.628 . . . . 75.33 109.804 175.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -122.4 -15.06 7.72 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.342 -0.845 . . . . 73.33 109.904 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 66.2 t30 71.45 7.22 5.98 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.355 -0.839 . . . . 64.43 110.103 -177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 92.7 t -113.69 -59.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.477 -0.783 . . . . 62.24 110.512 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -88.78 104.05 16.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.054 -0.521 . . . . 74.35 110.258 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.8 m95 -91.96 116.05 28.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.901 0.381 . . . . 74.24 110.608 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 26.5 m -94.83 125.08 52.51 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.972 -0.558 . . . . 74.15 110.444 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.0 111.47 2.87 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.665 2.243 . . . . 72.41 111.51 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 116' ' ' VAL . 20.1 pt -89.93 -9.88 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.321 -0.4 . . . . 60.13 111.404 -177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.35 128.7 0.98 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 119.259 -1.448 . . . . 42.41 114.287 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.477 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 7.5 ttm180 -98.75 126.17 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.84 -0.8 . . . . 71.24 108.84 166.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.7 m-85 -141.82 169.24 17.96 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.26 -0.576 . . . . 72.3 111.394 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -87.32 139.26 15.94 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.771 -0.649 . . . . 62.32 111.765 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -95.33 148.23 22.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.109 0.48 . . . . 72.11 110.701 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.484 ' O ' HD11 ' A' ' 112' ' ' LEU . 85.6 m -132.3 114.25 14.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.0 -0.546 . . . . 64.4 110.062 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -75.48 97.4 3.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.023 0.44 . . . . 62.04 110.102 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 12.6 pt20 -136.27 -179.97 5.99 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.88 -0.6 . . . . 73.13 110.423 -177.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.46 9.82 42.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 64.14 110.247 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -120.66 151.14 39.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.692 -0.686 . . . . 55.42 109.973 178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -75.95 128.17 34.5 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.161 0.505 . . . . 70.11 111.605 -175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 106' ' ' THR . 26.7 mt -82.75 117.88 22.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.485 -0.78 . . . . 75.4 110.388 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.687 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 43.4 mt-10 -92.87 111.76 23.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.923 0.392 . . . . 64.34 110.811 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.462 ' CE2' HD12 ' A' ' 72' ' ' LEU . 85.0 m-85 -105.15 107.41 18.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.071 0.462 . . . . 75.55 110.516 -178.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -76.96 95.07 4.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.587 -0.733 . . . . 52.23 109.36 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.424 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.3 m -97.58 179.0 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.512 -0.767 . . . . 54.43 111.817 -172.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -65.75 134.94 54.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.573 -0.739 . . . . 65.04 110.816 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.725 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 45.9 p -79.1 123.32 27.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.805 -0.634 . . . . 71.33 110.366 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.3 tt -157.84 148.16 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 65.4 110.757 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -83.37 122.76 28.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.693 -0.484 . . . . 75.33 109.693 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.673 ' HA ' ' HB3' ' A' ' 92' ' ' GLU . . . -144.72 175.39 10.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.351 -0.386 . . . . 74.22 111.002 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -127.79 -32.51 2.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.377 0.608 . . . . 73.33 109.631 173.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.51 145.6 31.64 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.59 -0.732 . . . . 64.11 109.424 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 59' ' ' ILE . 11.4 tt -131.47 135.16 59.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.015 0.436 . . . . 72.24 109.872 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.692 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 54.5 ttp180 -121.76 118.48 29.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.045 0.45 . . . . 72.01 111.04 -176.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 57' ' ' ILE . 57.5 tp -87.43 119.71 27.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 74.34 109.063 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 45.5 m -116.42 120.51 39.04 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.933 0.397 . . . . 54.11 111.123 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.0 mm -98.76 95.96 3.54 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 108.311 -0.996 . . . . 72.41 108.311 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.99 163.33 39.63 Favored 'Trans proline' 0 CA--C 1.52 -0.179 0 C-N-CA 123.056 2.504 . . . . 51.45 113.575 -171.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -108.57 71.49 0.79 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.559 -0.904 . . . . 72.32 108.559 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -149.42 -39.23 0.15 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.027 -0.988 . . . . 61.43 110.901 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -85.57 -6.18 83.66 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.384 -0.912 . . . . 54.02 113.705 -175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 101.78 26.94 7.32 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.974 -1.107 . . . . 64.32 111.917 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -72.69 137.02 45.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.601 0.239 . . . . 64.12 110.447 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.2 m -94.68 173.0 7.83 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.252 -0.431 . . . . 63.14 110.171 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.7 p -81.33 10.89 4.92 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.422 0.527 . . . . 71.23 112.422 -175.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 94.8 t -109.07 98.3 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.975 0.417 . . . . 71.52 110.089 175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.55 125.02 48.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.911 -0.586 . . . . 53.53 110.055 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.514 ' CB ' ' HD2' ' A' ' 75' ' ' ARG . . . -142.57 109.08 5.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.281 0.562 . . . . 73.34 111.558 -177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.93 132.67 69.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.144 -0.687 . . . . 72.13 109.144 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 94.1 mtt180 -67.16 -62.48 1.41 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.082 0.468 . . . . 64.14 110.212 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -144.48 148.75 34.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.584 0.707 . . . . 73.02 111.614 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -110.42 126.74 54.63 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.405 -1.332 . . . . 73.44 107.405 170.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.73 157.95 29.84 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.729 -0.471 . . . . 75.01 109.729 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.12 124.19 63.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.199 0.523 . . . . 51.23 110.471 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 80.2 mttt -102.18 112.17 24.74 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.441 -0.799 . . . . 73.5 108.862 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -161.99 -175.01 32.56 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.3 -0.952 . . . . 71.3 112.685 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 m -104.94 127.91 52.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.589 0.233 . . . . 74.31 110.795 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.667 HG23 HD12 ' A' ' 152' ' ' LEU . 36.0 mm -65.99 128.52 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.254 -0.43 . . . . 65.41 110.722 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.652 HD11 ' HB2' ' A' ' 66' ' ' GLN . 60.4 mt -120.69 140.94 43.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.3 111.272 -177.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 64.62 21.15 12.36 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.656 -0.702 . . . . 75.35 112.128 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.667 HD12 HG23 ' A' ' 149' ' ' ILE . 86.7 mt -121.72 131.77 54.26 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.118 0.485 . . . . 62.01 110.47 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 155' ' ' HIS . 11.0 mt-10 -130.97 -174.67 3.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 65.41 109.602 -174.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 23.3 m80 -84.75 -2.33 57.48 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.104 -0.702 . . . . 72.55 109.104 168.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.406 ' H ' ' HB2' ' A' ' 153' ' ' GLU . 11.5 m170 -95.38 -170.57 2.2 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 114.956 -1.02 . . . . 65.0 108.61 170.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 159' ' ' HIS . 7.7 p80 -133.88 71.11 1.45 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.46 0.647 . . . . 73.44 112.011 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -89.51 -19.97 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.832 -0.622 . . . . 54.15 110.265 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 12.8 m80 -134.0 30.92 3.62 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 72.14 110.461 177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 156' ' ' HIS . 8.1 m170 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.16 -0.927 . . . . 74.43 109.486 176.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.944 0.402 . . . . 73.35 110.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 121.33 -95.43 0.56 Allowed Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.044 -1.223 . . . . 51.34 110.044 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.8 m -97.64 -22.39 16.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.618 -1.253 . . . . 73.23 107.618 166.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.6 p -84.77 160.55 20.24 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.467 -1.242 . . . . 74.33 109.966 173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.537 HG21 ' CD1' ' A' ' 65' ' ' ILE . 44.4 mm -81.76 148.24 5.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.62 -0.264 . . . . 75.53 110.559 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.9 m -66.24 107.08 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.903 0.382 . . . . 74.03 110.301 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 144' ' ' ASP . 37.8 mtmt -88.46 -4.53 58.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 74.42 111.147 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.7 m -71.06 -10.26 59.44 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.026 -0.534 . . . . 44.34 111.624 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.28 9.32 38.84 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.859 -0.686 . . . . 65.25 111.967 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.417 ' HB2' HD12 ' A' ' 34' ' ' ILE . 30.4 m0 -90.9 161.94 15.0 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.014 -0.365 . . . . 73.01 110.014 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.478 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 22.4 pt-20 -141.37 159.81 41.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 72.41 110.731 174.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.1 t -102.02 116.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.608 -0.724 . . . . 61.34 110.132 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 60' ' ' ASP . 59.4 mt -80.84 -43.62 19.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.921 -0.581 . . . . 72.21 110.711 -177.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 t -142.45 140.71 32.02 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.775 -0.648 . . . . 64.3 110.371 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -147.02 146.14 29.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.471 -0.786 . . . . 72.33 109.13 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -85.51 -33.95 21.67 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.723 -0.391 . . . . 73.21 110.952 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.5 t -155.6 152.34 28.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.05 0.452 . . . . 75.0 110.885 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -163.19 145.99 10.35 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.153 -1.054 . . . . 72.22 108.153 173.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.462 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 7.4 tp10 -95.52 98.21 10.36 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.44 0.638 . . . . 71.35 110.189 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.4 8.4 29.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.278 -0.874 . . . . 73.12 111.425 -175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 m -136.52 -43.63 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.908 -0.317 . . . . 64.21 111.346 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.32 -31.49 71.58 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.078 -0.582 . . . . 73.22 112.769 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 62.1 mm-40 -93.03 6.57 47.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.791 0.329 . . . . 75.45 110.835 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.4 -116.62 5.28 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.845 -0.693 . . . . 30.14 111.612 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.49 138.07 15.08 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.711 -0.477 . . . . 50.41 109.711 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.74 3.37 90.36 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.674 -0.774 . . . . 62.03 112.939 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -147.81 149.63 32.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.916 -0.401 . . . . 73.31 109.916 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.16 3.49 72.74 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.846 -0.901 . . . . 73.33 110.846 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.502 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 51.3 mt -84.42 159.15 20.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.177 -0.512 . . . . 74.11 110.299 -178.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.52 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -67.39 -28.83 68.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.882 0.372 . . . . 73.13 110.909 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -75.45 -20.8 58.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.411 -0.358 . . . . 74.21 111.37 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 64.5 m -69.76 -23.76 63.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.939 0.399 . . . . 72.05 110.532 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.73 -21.2 66.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.698 -0.683 . . . . 74.43 110.543 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 59' ' ' ILE . 30.4 pt -127.65 24.12 2.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 54.23 110.41 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.658 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 15.7 t70 -75.22 -38.8 60.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.117 -0.492 . . . . 55.43 111.533 -174.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.75 40.68 3.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.265 -0.734 . . . . 62.41 111.265 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.464 ' HB3' ' OG1' ' A' ' 40' ' ' THR . 8.9 t0 -153.64 126.21 8.15 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.728 -0.471 . . . . 71.34 109.728 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -73.23 -14.38 61.32 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.871 0.693 . . . . 63.25 112.871 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -93.53 -13.06 28.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 74.13 110.638 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 41.2 p -97.22 137.1 36.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.204 -0.665 . . . . 73.14 109.204 174.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.978 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 4.0 p90 -145.07 171.57 14.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.959 0.409 . . . . 75.33 111.111 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.52 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 41.5 t90 -105.19 125.46 51.0 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.481 -0.781 . . . . 70.22 109.256 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -124.47 137.49 54.43 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.425 -0.954 . . . . 74.0 108.425 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 144.88 56.13 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.625 -0.509 . . . . 32.41 109.625 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -65.59 112.58 3.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.838 0.351 . . . . 60.31 110.324 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -103.08 -25.08 13.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.364 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -66.51 121.64 15.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.075 -0.511 . . . . 74.44 110.318 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.89 -3.62 83.07 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.924 -0.655 . . . . 65.22 113.002 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 118.26 148.5 8.55 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.727 -0.749 . . . . 62.42 111.884 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.587 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 24.9 p -82.86 148.61 27.62 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.986 0.422 . . . . 74.1 111.338 -177.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.79 158.98 86.8 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.637 . . . . 73.15 110.642 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.43 136.75 29.32 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.181 1.921 . . . . 60.1 112.413 178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 130' ' ' ASP . 16.5 mt -77.99 161.5 70.77 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.946 -0.57 . . . . 75.04 110.157 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.879 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 3.6 Cg_exo -81.9 162.23 78.16 Favored 'Cis proline' 0 C--N 1.345 0.382 0 C-N-CA 124.115 -1.202 . . . . 44.22 112.585 -0.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.9 m-85 -97.21 133.6 41.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 73.44 109.742 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 22.1 t70 -131.68 117.63 18.92 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.676 0.274 . . . . 73.53 110.518 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.4 mt -113.45 119.39 60.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 74.13 110.819 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -107.01 119.54 56.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.389 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' HB ' HG23 ' A' ' 124' ' ' ILE . 75.2 mt -118.06 139.82 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.407 -0.36 . . . . 62.23 111.232 -175.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 13' ' ' LEU . 54.8 t0 -108.27 121.85 45.74 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.052 -0.522 . . . . 73.44 109.629 176.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.5 mtm -86.01 -8.29 58.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.411 -0.359 . . . . 64.25 111.068 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.478 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 73.3 -11.93 0.86 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.244 0.618 . . . . 64.11 112.591 175.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -144.14 167.26 22.82 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.132 -0.321 . . . . 75.52 110.132 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.29 128.78 34.97 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 120.816 0.341 . . . . 73.32 110.092 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.537 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.7 mt -135.19 137.98 49.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 116.451 -0.34 . . . . 74.44 110.283 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -82.31 103.28 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.233 -0.654 . . . . 74.44 109.233 176.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.68 ' O ' ' HA ' ' A' ' 118' ' ' SER . 26.5 mm -70.11 125.24 27.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.469 -0.332 . . . . 70.34 110.119 -177.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.34 -48.54 2.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.957 0.408 . . . . 70.21 110.813 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.435 ' NE2' ' HE2' ' A' ' 146' ' ' LYS . 23.7 tt0 -147.59 146.42 29.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.03 -0.532 . . . . 72.35 109.977 -178.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.3 t -119.15 131.96 70.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.16 -0.473 . . . . 61.54 110.049 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -109.84 135.66 50.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.074 0.464 . . . . 70.41 111.048 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.55 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 57.1 mt -114.28 118.27 33.46 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 173.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 tp -103.37 99.75 16.02 Favored Pre-proline 0 C--N 1.314 -0.958 0 CA-C-N 116.413 -0.358 . . . . 73.43 110.345 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 12.3 Cg_exo -69.62 171.72 13.81 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.734 2.289 . . . . 74.25 111.067 177.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -77.6 -23.52 49.88 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.697 -0.401 . . . . 74.21 110.577 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 109' ' ' ASP . . . 135.14 170.6 12.2 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.018 -0.611 . . . . 70.42 111.797 178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.459 ' HG2' ' HA ' ' A' ' 108' ' ' GLN . 75.3 mtp180 -77.6 -18.15 57.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.095 0.474 . . . . 72.1 110.067 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -88.66 29.02 5.99 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.675 -0.693 . . . . 64.2 111.86 177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.2 t -145.25 144.04 30.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 109.6 -0.518 . . . . 71.24 109.6 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -74.57 122.46 23.16 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.218 0.532 . . . . 74.21 110.543 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -164.63 84.86 1.16 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.703 -0.681 . . . . 72.11 109.51 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 27.3 Cg_endo -92.81 62.08 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.406 2.737 . . . . 65.04 113.689 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.601 HD11 ' HB1' ' A' ' 138' ' ' ALA . 54.1 mt -96.64 131.8 42.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.136 -0.69 . . . . 71.44 109.136 173.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -108.67 -46.98 3.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.765 0.316 . . . . 55.35 111.079 -175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.465 HG11 ' HE ' ' A' ' 102' ' ' ARG . 47.2 t -124.33 139.06 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.565 -0.289 . . . . 70.42 110.971 -178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -132.03 144.71 36.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.346 -0.388 . . . . 64.11 110.668 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.511 ' HB2' ' HB ' ' A' ' 127' ' ' THR . 34.2 mt-10 -120.1 135.99 54.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 70.2 111.207 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -118.2 130.52 56.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.947 -0.569 . . . . 72.51 110.618 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -136.37 148.91 48.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.474 -0.33 . . . . 63.15 110.628 178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.58 148.28 51.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.35 -0.386 . . . . 72.43 110.382 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 43.6 t -150.3 161.24 42.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.877 0.37 . . . . 73.44 111.268 -177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -105.36 -20.56 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.165 -0.47 . . . . 63.13 110.773 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 p30 -118.1 -5.09 10.96 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.311 0.486 . . . . 74.31 112.311 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.0 t30 69.85 12.47 7.94 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.595 0.712 . . . . 62.53 110.382 178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.7 -53.3 4.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.272 0.558 . . . . 70.03 109.773 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -95.61 98.99 10.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 61.24 109.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.42 ' CH2' ' HB2' ' A' ' 125' ' ' ARG . 98.2 m95 -88.69 123.46 33.15 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 71.44 110.899 -179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.6 m -97.38 121.91 57.2 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 116.073 -0.512 . . . . 62.02 110.009 175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 109.38 2.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.396 2.064 . . . . 75.11 111.942 178.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.622 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 pt -80.62 -12.65 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.076 -0.511 . . . . 62.21 110.205 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.1 145.94 4.37 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.625 -0.798 . . . . 24.35 113.02 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.465 ' HE ' HG11 ' A' ' 85' ' ' VAL . 70.9 ttt180 -115.91 120.54 39.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.818 -0.808 . . . . 70.45 108.818 171.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.41 ' HE2' HG12 ' A' ' 116' ' ' VAL . 89.4 m-85 -133.22 178.94 6.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.099 0.476 . . . . 75.35 111.151 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -97.39 143.89 16.99 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.71 -0.677 . . . . 64.31 111.791 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -94.75 125.61 39.52 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.786 -0.45 . . . . 74.03 109.786 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.533 ' HB ' HD21 ' A' ' 112' ' ' LEU . 19.7 m -113.76 104.35 12.12 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.188 -0.46 . . . . 73.43 109.94 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -67.45 92.86 0.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.008 0.432 . . . . 73.35 110.024 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.459 ' HA ' ' HG2' ' A' ' 77' ' ' ARG . 20.7 pt20 -121.02 -173.59 2.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.778 -0.646 . . . . 64.45 110.816 -176.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.437 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 32.1 t70 -88.16 -18.91 27.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.715 -0.675 . . . . 73.41 110.819 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -107.3 -175.09 2.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.073 -0.512 . . . . 74.44 111.014 -176.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -85.27 147.99 26.28 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 120.979 0.419 . . . . 70.2 110.442 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 106' ' ' THR . 21.2 mt -98.33 104.24 16.25 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.022 -0.535 . . . . 75.15 110.145 177.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -81.32 116.09 21.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 71.25 110.571 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -110.42 105.48 14.48 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.826 0.346 . . . . 75.24 110.848 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -73.03 102.33 3.48 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.896 -0.779 . . . . 71.23 108.896 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.622 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -107.71 175.93 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.206 0.527 . . . . 64.32 112.122 -172.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.609 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 52.8 tttp -59.61 116.85 4.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.237 -0.892 . . . . 75.34 110.434 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.3 m -70.94 115.8 10.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.122 -0.49 . . . . 70.4 110.373 178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.5 tt -156.54 147.93 11.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.286 -0.415 . . . . 63.43 110.229 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.732 ' HG3' HD12 ' A' ' 150' ' ' ILE . 27.4 ttpt -83.62 133.96 34.81 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.0 -0.37 . . . . 73.24 110.0 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.98 169.63 21.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.309 -0.405 . . . . 71.1 110.565 177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.8 ttt180 -117.22 -32.97 4.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.199 0.523 . . . . 74.32 109.835 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -106.84 145.39 32.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.653 . . . . 71.03 109.646 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.0 tt -133.29 137.8 52.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.482 -0.562 . . . . 72.4 109.482 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HB2' ' CH2' ' A' ' 97' ' ' TRP . 23.9 ttp180 -125.71 128.56 47.96 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.899 0.38 . . . . 71.44 111.099 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.9 tp -104.31 115.34 30.21 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.55 -0.75 . . . . 71.51 109.642 174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 41.4 m -107.17 123.72 48.68 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.111 0.481 . . . . 62.35 110.746 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.629 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.4 mm -105.97 92.46 6.46 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.44 -0.8 . . . . 74.23 108.973 174.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.879 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.3 Cg_endo -69.61 -178.62 2.37 Favored 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.816 2.344 . . . . 75.35 113.303 -177.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 36.8 t70 -129.24 65.06 1.47 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.618 -1.253 . . . . 73.12 107.618 173.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.7 -46.58 2.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.094 -0.957 . . . . 75.13 112.506 -169.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -109.13 36.65 4.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.183 -1.008 . . . . 73.24 113.754 -173.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 95.66 18.5 32.42 Favored Glycine 0 CA--C 1.51 -0.258 0 C-N-CA 120.241 -0.98 . . . . 75.3 112.187 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -65.91 166.69 10.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.86 0.362 . . . . 71.42 111.361 -176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.0 m -129.9 167.54 18.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.164 -0.471 . . . . 71.41 110.181 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.587 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 32.2 p -84.89 -24.42 28.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.111 0.481 . . . . 45.43 110.32 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 57.8 t -82.3 122.35 36.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 75.44 109.761 175.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.601 ' HB1' HD11 ' A' ' 83' ' ' ILE . . . -141.86 139.66 32.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.261 -0.427 . . . . 72.22 110.431 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.54 105.05 4.48 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.272 0.558 . . . . 72.43 111.253 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 16.4 mt -123.06 132.48 71.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.737 -0.838 . . . . 73.14 108.737 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.978 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 74.7 mtm180 -69.98 -65.02 0.78 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.886 -0.326 . . . . 74.24 110.331 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -139.58 146.58 40.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.606 0.717 . . . . 75.2 112.331 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -108.2 121.95 45.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.514 -1.291 . . . . 65.21 107.514 168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 7' ' ' LYS . 1.1 m-20 -122.8 154.75 37.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.919 0.39 . . . . 73.34 110.794 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.7 t -133.49 129.94 56.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.933 -0.576 . . . . 54.14 110.438 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.435 ' HE2' ' NE2' ' A' ' 69' ' ' GLN . 44.5 mttm -96.02 129.08 43.39 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.069 -0.715 . . . . 73.44 109.069 172.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.53 -176.68 39.01 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.203 -0.999 . . . . 45.5 112.457 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.8 m -108.4 133.49 52.51 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.86 -0.422 . . . . 74.24 109.86 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.24 125.02 34.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.075 0.464 . . . . 71.55 110.575 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.732 HD12 ' HG3' ' A' ' 120' ' ' LYS . 60.8 mt -115.87 135.07 57.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.884 -0.598 . . . . 71.23 110.464 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -114.82 111.41 21.19 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.498 -0.774 . . . . 72.34 109.599 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 87.3 mt -71.82 158.34 36.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.836 -0.62 . . . . 72.4 110.628 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.412 ' HB2' ' CD2' ' A' ' 155' ' ' HIS . 2.5 pm0 -63.36 148.94 47.02 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.972 -0.558 . . . . 71.22 110.991 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -127.17 84.83 2.3 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.64 0.733 . . . . 70.01 110.262 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.412 ' CD2' ' HB2' ' A' ' 153' ' ' GLU . 33.4 m-70 -101.54 -178.96 3.88 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.51 -0.768 . . . . 63.52 109.903 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 52.0 m170 73.66 116.44 0.05 Allowed 'General case' 0 N--CA 1.465 0.278 0 O-C-N 124.141 0.901 . . . . 74.32 110.794 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 -81.15 131.72 35.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.212 -0.662 . . . . 74.31 109.212 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 159' ' ' HIS . 58.5 t60 -127.73 76.49 1.68 Allowed 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 120.975 -0.29 . . . . 73.42 111.168 -174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 158' ' ' HIS . 8.8 t-80 . . . . . 0 C--O 1.235 0.326 0 CA-C-N 115.553 -0.749 . . . . 61.42 109.485 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.716 0.294 . . . . 74.12 110.736 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 4' ' ' THR . . . 69.28 -139.02 31.57 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.753 -0.736 . . . . 72.23 111.471 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m 72.87 -13.81 0.64 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 122.869 0.468 . . . . 61.1 111.729 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.626 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 39.9 p -73.37 147.85 43.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.333 -0.394 . . . . 72.1 110.306 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.641 HG23 HD11 ' A' ' 149' ' ' ILE . 43.4 mm -86.05 138.0 19.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.347 -0.388 . . . . 74.0 111.152 -176.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t -67.38 118.81 11.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.07 0.462 . . . . 73.04 109.76 175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.8 mtmt -97.2 9.86 41.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.686 -0.688 . . . . 75.44 110.726 -174.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.2 m -65.5 -27.34 68.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.832 -0.622 . . . . 72.24 111.681 -174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.5 20.35 34.88 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.687 -0.768 . . . . 75.4 112.731 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.472 ' HB2' HD12 ' A' ' 34' ' ' ILE . 36.1 m0 -94.17 150.55 20.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.821 -0.437 . . . . 71.1 109.821 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.7 pt-20 -133.61 156.59 47.59 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 71.22 110.279 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -94.03 116.14 34.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.736 -0.665 . . . . 65.01 109.76 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' A' ' 60' ' ' ASP . 80.6 mt -78.76 -42.79 27.09 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.907 -0.588 . . . . 74.25 110.494 -177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.9 m -152.34 133.9 14.59 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.1 -0.5 . . . . 42.05 110.329 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -131.52 137.52 48.55 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 74.4 109.736 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.1 m -78.58 -33.42 47.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.809 0.338 . . . . 75.45 110.807 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 t -157.53 145.8 19.19 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 120.794 0.33 . . . . 72.25 110.979 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -164.27 137.67 5.2 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.963 -0.754 . . . . 74.01 108.963 173.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.74 133.56 33.65 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.136 0.493 . . . . 73.2 110.23 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.32 -27.91 0.94 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.842 -0.617 . . . . 62.1 110.852 -178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.0 m -101.97 -31.24 10.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.278 -0.419 . . . . 72.34 111.09 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.5 -33.37 72.19 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.959 -0.639 . . . . 45.02 111.509 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.87 -48.9 7.14 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.037 0.446 . . . . 72.2 110.011 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.55 -58.75 0.48 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.49 -0.862 . . . . 55.04 113.582 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.35 91.26 3.5 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.416 0.895 . . . . 75.45 113.416 -170.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.2 18.09 64.55 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 115.151 0.82 . . . . 74.43 115.151 166.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -125.47 146.34 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 117.405 0.603 . . . . 74.24 110.334 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.49 82.12 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 116.146 -0.479 . . . . 71.34 112.539 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.576 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 73.4 mt -72.26 147.01 46.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.291 . . . . 73.41 110.391 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.2 -22.68 64.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.403 -0.362 . . . . 75.12 111.14 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -79.11 -22.46 45.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.833 0.349 . . . . 75.54 110.946 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 66.7 m -65.38 -26.25 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.207 0.527 . . . . 41.14 110.102 177.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 142' ' ' GLU . 22.7 tp -61.84 -26.14 67.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.343 -0.844 . . . . 70.22 110.543 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.483 HG21 HD13 ' A' ' 59' ' ' ILE . 28.3 pt -116.16 12.52 7.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.931 0.396 . . . . 74.21 110.755 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 38.8 t70 -77.72 -29.53 51.27 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.116 0.484 . . . . 75.4 110.105 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.57 29.93 31.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.888 -0.672 . . . . 73.33 113.268 173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.546 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 14.5 t0 -115.8 128.46 55.85 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.345 -0.613 . . . . 73.0 109.345 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.615 ' HB ' ' NH2' ' A' ' 141' ' ' ARG . 10.5 p -77.37 -5.65 50.43 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.916 0.71 . . . . 75.31 112.916 -172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.8 pt-20 -103.02 -5.34 23.48 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.324 -0.55 . . . . 75.51 111.013 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 37' ' ' ASP . 9.3 p -105.73 161.78 14.1 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.837 -0.431 . . . . 73.22 109.837 175.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.643 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 48.1 p90 -157.33 162.32 39.11 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.99 0.424 . . . . 74.34 111.095 176.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.47 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 35.4 t90 -92.72 134.17 35.3 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.877 -0.786 . . . . 73.33 108.877 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -132.24 138.01 47.76 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.04 -0.726 . . . . 62.35 109.04 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.99 138.94 58.43 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.706 -0.479 . . . . 74.34 109.706 175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 50' ' ' SER . 31.1 ttpt -67.54 120.1 13.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.61 -176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 57.3 p-90 -111.51 -22.92 11.02 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.205 -0.452 . . . . 54.23 110.167 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -71.89 107.42 4.64 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 70.13 110.169 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.94 -0.99 56.4 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.721 -0.752 . . . . 43.12 112.258 -178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 114.16 133.63 5.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.819 -0.705 . . . . 52.45 112.215 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 15.8 m -72.69 143.71 47.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.82 0.343 . . . . 71.04 110.375 -178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 10.5 m-20 -74.01 151.68 88.45 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.166 -0.47 . . . . 72.14 110.235 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 3.0 Cg_exo -76.65 144.99 25.59 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.684 2.256 . . . . 71.04 111.599 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 130' ' ' ASP . 15.1 mt -75.31 158.18 84.03 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.18 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.67 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.9 Cg_endo -83.49 167.14 63.69 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.696 -1.377 . . . . 74.13 113.536 2.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.401 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 24.8 m-85 -106.85 122.26 46.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.497 -0.774 . . . . 72.24 109.983 176.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -116.84 125.19 51.19 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.095 0.474 . . . . 73.44 110.524 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 62.8 mt -115.07 112.65 40.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.054 -0.521 . . . . 75.0 110.151 177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.97 117.18 45.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.153 -0.476 . . . . 64.03 110.743 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 34' ' ' ILE . 66.3 mt -117.87 137.05 53.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.255 -0.43 . . . . 72.21 110.723 -177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' HB2' HD11 ' A' ' 13' ' ' LEU . 56.9 t0 -103.59 120.63 41.27 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.682 -0.488 . . . . 70.24 109.682 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.426 ' SD ' HD12 ' A' ' 65' ' ' ILE . 65.2 mtm -84.66 -7.43 59.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.814 -177.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.8 mmtt 65.9 13.64 9.14 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.769 -0.65 . . . . 74.32 112.183 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.411 ' OE1' HD12 ' A' ' 149' ' ' ILE . 6.0 pt20 -164.57 164.93 21.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.51 0.195 . . . . 74.15 110.542 -177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -86.98 122.79 31.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.323 -0.399 . . . . 45.21 110.366 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.54 HD13 HG21 ' A' ' 5' ' ' ILE . 74.0 mt -130.65 137.82 55.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.292 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.497 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.0 tp60 -83.29 102.93 12.3 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.063 -0.717 . . . . 75.35 109.063 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 118' ' ' SER . 29.3 mm -74.14 125.79 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.665 0.269 . . . . 74.25 110.525 -176.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.62 -39.71 2.84 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.161 0.505 . . . . 40.34 110.831 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 26.7 tt0 -148.89 142.93 25.88 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.092 -0.504 . . . . 50.01 110.821 -176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.5 t -115.07 136.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.519 -0.549 . . . . 72.11 109.519 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 39.9 mt-10 -118.73 133.57 55.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.147 0.499 . . . . 71.32 111.247 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.529 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 72.2 mt -114.53 126.79 55.33 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.549 -0.75 . . . . 54.53 109.162 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 141' ' ' ARG . 24.3 tp -106.24 97.14 15.06 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 109.727 -0.472 . . . . 71.23 109.727 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 6.3 Cg_exo -72.91 153.49 52.91 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.088 2.526 . . . . 72.44 111.073 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.687 ' HA ' ' HD2' ' A' ' 141' ' ' ARG . 12.3 ptm180 -69.06 -48.78 61.9 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.03 -0.268 . . . . 72.1 111.337 -177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.1 -49.59 2.22 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.234 -0.508 . . . . 55.32 112.659 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -59.82 107.68 0.64 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 123.317 0.647 . . . . 72.31 111.138 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.02 48.19 81.4 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 121.264 -0.493 . . . . 74.22 111.953 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -129.18 123.95 33.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.6 0.238 . . . . 71.43 111.116 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -88.1 -39.49 14.54 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.566 -0.531 . . . . 75.3 109.566 171.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 46.13 84.42 0.19 Allowed Pre-proline 0 N--CA 1.467 0.416 0 O-C-N 124.283 0.989 . . . . 71.54 112.799 175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 72.6 Cg_endo -75.82 25.71 0.41 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.861 2.374 . . . . 71.23 112.671 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.3 mt -80.49 120.75 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.616 -0.513 . . . . 64.12 109.616 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.52 -50.82 3.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.111 0.482 . . . . 71.0 110.749 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG11 ' CZ ' ' A' ' 102' ' ' ARG . 57.4 t -120.41 137.13 55.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.728 -0.669 . . . . 54.25 110.583 -175.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -130.36 129.71 65.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.556 -0.747 . . . . 71.01 109.688 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 97.2 mt-10 -112.65 125.75 54.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.242 0.544 . . . . 61.02 110.128 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -102.84 129.75 49.62 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.679 -0.691 . . . . 74.1 110.269 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 125' ' ' ARG . . . -125.32 151.07 46.53 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.144 -0.48 . . . . 61.22 110.428 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.21 39.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.885 -0.598 . . . . 51.25 109.96 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 t -148.87 151.15 34.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.198 0.523 . . . . 72.41 110.762 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.82 -32.87 10.48 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.794 -0.639 . . . . 71.23 110.61 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -109.69 -5.59 15.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.429 -0.351 . . . . 74.22 110.878 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 78.19 -9.61 1.48 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.991 0.917 . . . . 73.24 111.083 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 65.8 t -90.91 -49.9 13.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.107 0.48 . . . . 74.34 110.819 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -93.43 102.77 15.01 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.105 -0.498 . . . . 54.33 109.85 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -90.98 118.07 30.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 73.53 111.044 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.7 m -99.46 120.82 56.82 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.469 -0.787 . . . . 75.14 110.51 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.96 112.53 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.359 2.039 . . . . 50.41 111.111 173.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 14.1 pt -87.33 -9.2 11.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.466 -0.334 . . . . 61.44 111.025 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 160.63 137.35 2.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 119.763 -1.208 . . . . 51.43 113.848 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.576 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 16.2 ttt180 -107.02 114.57 28.73 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.045 -0.724 . . . . 70.02 109.045 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.599 ' HE2' HG12 ' A' ' 116' ' ' VAL . 92.2 m-85 -125.98 169.92 12.22 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.84 0.352 . . . . 74.32 111.128 -174.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -91.59 139.77 14.9 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.467 -0.653 . . . . 65.45 111.467 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -93.37 125.48 38.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.87 0.367 . . . . 64.3 110.483 -176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.594 ' HB ' HD21 ' A' ' 112' ' ' LEU . 90.2 m -103.08 115.23 30.2 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 54.21 110.579 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -72.59 102.56 3.31 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 72.52 110.534 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -143.91 -176.92 5.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.192 -0.458 . . . . 74.02 110.446 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -101.5 -7.97 22.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.05 0.453 . . . . 73.13 110.033 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.2 170.27 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.861 -0.608 . . . . 60.24 111.042 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.63 143.45 38.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.124 0.487 . . . . 54.21 111.613 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.594 HD21 ' HB ' ' A' ' 106' ' ' THR . 46.4 mt -103.28 106.77 17.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.54 -0.754 . . . . 75.31 110.285 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.477 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 43.0 mt-10 -87.12 112.78 22.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.807 0.337 . . . . 75.42 110.735 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.23 106.66 17.26 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.155 -0.475 . . . . 62.03 110.55 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -72.13 102.61 3.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.061 -0.718 . . . . 61.12 109.061 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.599 HG12 ' HE2' ' A' ' 103' ' ' PHE . 29.1 m -103.18 179.19 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 64.43 112.159 -171.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.527 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 6.5 tmtm? -66.04 124.19 21.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.107 -0.951 . . . . 72.42 110.421 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 21.2 p -70.49 127.37 32.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.741 -0.663 . . . . 75.31 110.68 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.7 tt -163.45 150.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.42 -0.355 . . . . 63.05 110.481 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.698 ' HG3' HD12 ' A' ' 150' ' ' ILE . 5.9 ttpm? -85.69 128.07 34.68 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.285 -0.635 . . . . 62.33 109.285 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.19 160.82 43.03 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.861 0.362 . . . . 43.03 111.239 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -117.42 -26.12 6.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.67 -0.695 . . . . 70.45 109.642 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -116.16 146.45 42.28 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.695 -0.684 . . . . 74.42 109.859 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -131.1 143.25 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.628 -0.508 . . . . 61.43 109.628 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.572 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 59.5 ttp180 -131.38 124.75 30.99 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 73.43 111.227 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.467 HD23 HD12 ' A' ' 57' ' ' ILE . 37.6 tp -90.16 113.0 24.68 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.553 -0.749 . . . . 65.42 109.401 172.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 92.6 m -107.18 115.83 30.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.19 0.519 . . . . 74.12 111.179 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 31.7 mm -105.06 98.05 14.79 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.104 -0.702 . . . . 70.12 109.104 175.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.67 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 56.7 Cg_endo -71.09 170.45 18.1 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.361 2.041 . . . . 75.31 112.39 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.479 ' HA ' HD13 ' A' ' 53' ' ' LEU . 34.7 t70 -91.21 -4.09 56.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 122.109 0.957 . . . . 70.31 109.099 176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.21 140.96 31.73 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.581 -1.19 . . . . 75.42 110.677 -174.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 108.78 -13.28 35.1 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.633 -0.794 . . . . 73.13 111.93 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 110.68 18.29 8.56 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.712 . . . . 63.31 112.335 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -72.56 150.4 43.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.064 0.459 . . . . 71.44 110.854 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.406 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 48.9 m -127.75 -176.76 3.86 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.972 -0.558 . . . . 71.32 110.388 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 39.0 p -84.53 -2.4 57.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.028 0.442 . . . . 64.44 111.649 -175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.5 t -93.7 96.28 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.149 0.499 . . . . 52.41 110.038 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.45 129.54 50.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.847 -0.615 . . . . 65.02 110.159 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -150.07 110.64 4.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.053 0.454 . . . . 64.44 110.791 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 51.5 mt -128.67 133.0 67.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.636 -0.711 . . . . 64.22 109.301 -178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.687 ' HD2' ' HA ' ' A' ' 75' ' ' ARG . 74.1 mtp180 -61.76 -61.16 2.7 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 120.952 0.406 . . . . 74.41 110.268 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.457 ' HA ' HD12 ' A' ' 33' ' ' LEU . 15.3 pt-20 -154.82 158.79 39.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.503 0.668 . . . . 70.51 111.338 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -115.15 134.6 55.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.657 -1.238 . . . . 62.44 107.657 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.626 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.1 t70 -131.09 167.16 19.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.721 -0.391 . . . . 71.24 110.014 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 58.7 t -138.6 128.43 32.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.73 0.3 . . . . 73.34 110.847 -174.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 48.5 mttp -97.97 125.27 42.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.391 -0.596 . . . . 72.11 109.391 172.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.62 -158.71 14.99 Favored Glycine 0 N--CA 1.44 -1.037 0 C-N-CA 120.798 -0.715 . . . . 60.32 111.404 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 34.0 m -131.1 130.23 42.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.849 0.324 . . . . 62.33 110.583 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.641 HD11 HG23 ' A' ' 5' ' ' ILE . 34.7 mm -68.41 116.54 8.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.639 . . . . 63.13 109.902 176.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.698 HD12 ' HG3' ' A' ' 120' ' ' LYS . 42.6 mt -98.06 130.98 46.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.239 0.543 . . . . 71.03 110.17 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.83 111.97 20.46 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.648 0.737 . . . . 75.32 111.703 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 5.1 mp -113.02 130.28 56.2 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.493 -0.776 . . . . 74.24 109.397 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.4 138.77 37.02 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.981 0.419 . . . . 60.03 109.998 179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -107.46 43.06 1.22 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.388 0.613 . . . . 71.53 109.905 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -88.9 146.62 24.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.818 -0.628 . . . . 74.14 110.435 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -152.81 122.87 7.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.256 -0.646 . . . . 65.12 109.256 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -150.33 146.65 26.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.149 -174.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -66.05 129.5 40.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.452 -0.34 . . . . 61.42 110.811 177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.108 -0.497 . . . . 71.44 109.713 177.544 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 110.228 -0.286 . . . . 70.11 110.228 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.69 -128.58 3.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.49 -0.644 . . . . 72.33 111.49 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.9 t -163.82 132.87 3.86 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.177 0.513 . . . . 73.01 111.007 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 12.8 p -98.81 137.63 37.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.602 -0.888 . . . . 51.13 108.602 170.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 145' ' ' VAL . 36.5 mm -65.7 129.1 29.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.978 0.418 . . . . 72.44 110.752 -173.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.9 m -67.19 111.69 4.08 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.947 -0.569 . . . . 61.0 109.807 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HD2' ' HB ' ' A' ' 34' ' ' ILE . 9.1 mtmp? -85.06 20.37 1.91 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.432 -0.804 . . . . 73.03 111.467 -175.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -59.13 -42.48 90.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.899 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.13 7.68 52.46 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.786 -0.721 . . . . 63.23 113.053 -176.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.488 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.3 m0 -73.08 154.29 40.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.706 0.288 . . . . 70.1 110.457 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.561 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 24.5 pt-20 -148.87 161.27 42.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.262 0.553 . . . . 64.12 111.183 177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.89 120.11 47.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.265 -0.88 . . . . 71.33 110.066 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 60' ' ' ASP . 86.3 mt -85.75 -47.72 9.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.001 -0.545 . . . . 75.55 110.758 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.7 t -138.76 142.3 38.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.01 -0.541 . . . . 72.42 109.934 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -146.91 148.92 32.29 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.072 -0.513 . . . . 73.13 109.651 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.5 m -86.16 -42.02 14.21 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.852 0.358 . . . . 64.35 110.973 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 t -150.9 153.47 35.36 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 116.325 -0.398 . . . . 62.35 110.746 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -158.28 146.0 18.26 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.286 -0.635 . . . . 70.32 109.286 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 10.0 tp10 -102.57 110.81 22.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.932 0.396 . . . . 63.13 110.417 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.65 13.11 11.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.049 -0.523 . . . . 63.24 111.187 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.6 m -134.21 -49.42 0.79 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.513 -0.312 . . . . 64.3 111.393 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.42 -46.19 79.79 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.905 -0.664 . . . . 73.03 112.201 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' HG2' ' HE1' ' A' ' 46' ' ' TRP . 6.4 mm-40 -91.26 0.64 57.49 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.069 0.461 . . . . 75.32 110.033 177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.24 -174.6 42.1 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.694 -0.685 . . . . 73.44 112.035 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.06 135.01 42.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.89 -0.411 . . . . 64.22 109.89 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.82 -1.55 58.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.645 -0.788 . . . . 73.22 111.512 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -153.36 138.53 17.4 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.659 -0.497 . . . . 74.01 109.659 177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.79 -8.43 70.83 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 111.274 -0.73 . . . . 62.0 111.274 -176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.541 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 43.2 mt -72.47 153.58 41.3 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.14 -0.53 . . . . 75.52 110.07 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.623 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.22 -28.99 69.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.881 0.372 . . . . 71.12 110.787 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -72.97 -24.82 60.83 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.292 -0.413 . . . . 70.24 110.993 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.847 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 77.4 m -67.33 -21.56 65.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.386 -0.37 . . . . 63.3 110.404 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 51.3 tp -64.93 -14.41 59.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.837 -0.62 . . . . 63.2 110.687 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 10' ' ' TRP . 27.8 pt -131.58 14.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.271 -0.422 . . . . 73.31 110.531 177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.847 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.9 t70 -65.85 -33.67 76.38 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.291 -0.413 . . . . 73.33 111.279 -172.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HZ1' ' A' ' 7' ' ' LYS . . . 99.84 5.49 55.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.53 -0.843 . . . . 72.03 113.408 177.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.67 140.22 50.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.0 0.4 . . . . 62.45 109.93 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.464 ' O ' ' HD2' ' A' ' 141' ' ' ARG . 26.6 p -80.66 -7.39 59.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.895 0.332 . . . . 71.31 111.895 -174.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -92.69 -8.16 44.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.593 -0.276 . . . . 73.21 110.303 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.6 p -107.49 138.52 43.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.329 -0.396 . . . . 74.42 110.018 175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.864 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 10.9 p90 -141.09 169.85 16.83 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.45 -0.341 . . . . 63.21 110.567 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 37.0 t90 -104.65 133.04 50.17 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.826 -0.805 . . . . 72.11 108.826 172.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -131.82 134.78 46.16 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.074 -0.713 . . . . 75.44 109.074 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 145.21 56.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.31 -0.626 . . . . 64.44 109.31 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -55.85 125.24 20.48 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 123.339 0.399 . . . . 71.54 109.995 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.533 ' HE1' ' HG2' ' A' ' 23' ' ' GLU . 68.2 p-90 -124.78 -30.22 3.31 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.844 -0.342 . . . . 63.12 110.79 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -77.65 107.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.785 -0.45 . . . . 70.35 109.785 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.94 11.55 52.71 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.636 -0.792 . . . . 65.01 111.899 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 110.8 -179.27 20.06 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.955 -0.64 . . . . 53.32 111.893 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.0 m -127.7 165.76 19.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.817 0.342 . . . . 72.24 110.896 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' HE1' ' A' ' 55' ' ' TYR . 0.6 OUTLIER -89.21 152.79 48.35 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.375 -0.602 . . . . 74.13 109.375 -179.053 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 38.5 Cg_endo -68.09 139.07 45.51 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 122.158 1.905 . . . . 72.34 113.222 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 mt -73.44 158.02 87.12 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.376 -0.829 . . . . 73.54 109.951 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 83.4 Cg_endo -82.4 161.8 76.61 Favored 'Cis proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.525 -1.448 . . . . 73.05 113.061 0.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HE1' ' HB3' ' A' ' 51' ' ' ASP . 25.8 m-85 -97.79 129.02 44.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.837 -0.62 . . . . 72.31 109.598 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 17.1 t0 -127.33 118.44 24.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.748 0.308 . . . . 72.21 110.309 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.444 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 56.9 mt -116.55 122.06 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.923 0.392 . . . . 74.4 111.339 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.1 t -105.45 118.19 52.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.83 -0.623 . . . . 63.32 110.514 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 124' ' ' ILE . 71.1 mt -115.56 139.07 43.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.232 -0.44 . . . . 75.12 111.049 -175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.512 ' HB2' HD11 ' A' ' 13' ' ' LEU . 63.8 t0 -105.63 122.13 45.41 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.169 -0.468 . . . . 63.43 110.001 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.2 mtm -88.45 -5.31 58.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.099 -0.5 . . . . 72.53 110.672 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.561 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 67.11 8.51 6.23 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.902 0.704 . . . . 54.44 112.902 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -168.2 174.8 6.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.589 0.233 . . . . 71.33 110.642 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.593 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 52.3 m-80 -83.06 122.04 27.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.214 -0.448 . . . . 44.45 110.243 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 5' ' ' ILE . 68.2 mt -131.11 133.3 62.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.063 0.458 . . . . 74.3 110.022 176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.421 ' HB2' HD11 ' A' ' 150' ' ' ILE . 53.7 tp60 -79.79 106.47 11.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.573 -0.739 . . . . 75.14 109.168 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.691 ' O ' ' HA ' ' A' ' 118' ' ' SER . 15.9 mm -76.79 102.92 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 110.136 -0.32 . . . . 41.21 110.136 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.3 -39.62 8.73 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.183 0.516 . . . . 32.44 110.281 177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -152.14 142.29 22.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.69 -0.686 . . . . 41.32 110.207 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.8 t -114.28 134.96 55.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.91 -0.404 . . . . 64.23 109.91 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 49.5 mt-10 -110.75 129.72 55.76 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.988 0.423 . . . . 70.24 110.999 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.465 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 mt -109.78 120.82 43.67 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.418 -0.586 . . . . 75.41 109.418 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.0 tp -102.99 103.62 34.96 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.912 -0.586 . . . . 73.12 109.751 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.573 ' HG2' ' H ' ' A' ' 108' ' ' GLN . 8.4 Cg_exo -70.91 -168.92 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.947 2.432 . . . . 61.43 111.339 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.612 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 33.6 mtp180 -86.56 0.85 53.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.876 0.369 . . . . 61.23 110.879 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 109' ' ' ASP . . . 96.97 -123.69 7.86 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.592 -0.813 . . . . 73.22 111.985 177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -121.66 128.56 52.0 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.77 -0.456 . . . . 61.14 109.77 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.02 57.18 1.09 Allowed Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.783 -0.722 . . . . 74.54 111.919 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 40.7 m -148.76 144.95 27.37 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.378 -0.23 . . . . 73.03 110.378 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -74.91 90.77 2.43 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.781 -0.451 . . . . 72.34 109.781 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -133.09 92.59 24.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.181 -0.463 . . . . 61.14 110.315 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 18.6 Cg_endo -93.37 23.63 0.49 Allowed 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 123.527 2.818 . . . . 73.44 112.979 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.66 125.41 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.047 0.451 . . . . 75.53 110.075 177.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -107.28 -46.21 3.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.897 -0.592 . . . . 74.0 111.145 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG11 ' HE ' ' A' ' 102' ' ' ARG . 34.2 t -129.34 139.87 50.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.572 -0.285 . . . . 74.12 110.82 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 m -130.11 144.99 36.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.343 -0.389 . . . . 74.4 110.15 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.411 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.5 mt-10 -119.06 131.13 55.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.93 0.395 . . . . 74.0 110.595 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.89 136.03 51.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.113 -0.494 . . . . 75.53 110.772 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.24 152.52 49.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.507 -0.315 . . . . 53.41 110.851 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.23 51.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.327 -0.397 . . . . 75.41 110.264 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.8 t -149.95 153.81 37.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.196 0.522 . . . . 63.01 111.076 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 52.3 mt-10 -97.54 -24.82 15.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 65.44 110.937 178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -123.82 -1.4 8.4 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.859 -0.336 . . . . 61.42 111.489 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 61.8 t30 75.17 1.81 3.8 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.205 0.526 . . . . 74.24 111.396 175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.3 t -96.8 -58.45 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.477 0.656 . . . . 71.21 110.068 177.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.79 106.39 18.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.096 -0.956 . . . . 62.02 109.824 -175.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -97.31 125.15 41.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.157 0.503 . . . . 70.43 111.409 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 99' ' ' PRO . 95.4 m -109.02 123.78 35.97 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 115.73 -0.668 . . . . 71.31 110.135 175.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 98' ' ' THR . 29.8 Cg_endo -64.31 120.76 8.17 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.412 2.075 . . . . 75.24 111.578 176.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.571 HD12 HG21 ' A' ' 116' ' ' VAL . 15.1 pt -86.41 -16.03 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.152 -0.477 . . . . 63.4 110.65 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 164.56 143.84 3.85 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.492 -0.861 . . . . 64.04 112.899 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.578 ' HE ' HG11 ' A' ' 85' ' ' VAL . 73.7 ttt180 -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.216 -0.661 . . . . 64.53 109.216 173.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.475 ' HE2' HG12 ' A' ' 116' ' ' VAL . 97.1 m-85 -137.56 174.11 10.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.0 0.429 . . . . 71.03 111.449 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -92.32 138.56 14.26 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.756 -0.656 . . . . 71.33 112.21 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -93.17 148.45 22.01 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 74.11 110.09 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.486 ' O ' HD11 ' A' ' 112' ' ' LEU . 33.7 m -144.83 110.14 5.21 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.072 -0.513 . . . . 74.14 109.908 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -70.03 97.09 1.11 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.326 0.584 . . . . 75.52 109.931 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.573 ' H ' ' HG2' ' A' ' 74' ' ' PRO . 11.1 pt20 -130.8 -179.69 5.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.449 -0.796 . . . . 74.53 110.713 -175.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.432 ' HA ' ' HA2' ' A' ' 76' ' ' GLY . 5.2 p-10 -79.74 -24.41 41.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.557 . . . . 74.34 110.949 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -99.39 151.87 20.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.282 -0.417 . . . . 71.32 110.988 -174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.12 129.98 41.42 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 45.32 110.542 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -80.56 104.9 11.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.652 -0.703 . . . . 54.33 110.501 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -85.26 108.73 17.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.104 0.478 . . . . 73.34 110.51 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -101.34 106.82 18.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.834 -0.621 . . . . 74.35 110.679 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -72.3 104.92 3.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.727 -0.67 . . . . 74.33 109.623 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.571 HG21 HD12 ' A' ' 100' ' ' ILE . 31.6 m -111.13 -176.54 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.068 0.461 . . . . 74.14 111.776 -173.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -65.91 117.07 7.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.475 -0.784 . . . . 52.14 110.109 176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 22.0 m -70.39 113.68 7.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.117 -0.492 . . . . 35.12 110.718 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.9 tt -147.12 144.94 19.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.934 -0.575 . . . . 73.24 110.464 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.593 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -86.26 126.03 34.0 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.42 -0.585 . . . . 72.11 109.42 175.566 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -151.43 166.72 30.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.636 -0.256 . . . . 53.11 111.029 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -107.16 -30.48 8.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.362 0.601 . . . . 72.05 109.867 173.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -109.21 145.41 35.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.752 -0.658 . . . . 73.23 110.481 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.0 tt -133.21 138.75 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 73.34 109.432 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.487 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 13.0 ttp180 -127.83 130.77 49.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.09 0.471 . . . . 74.05 111.249 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.5 tp -104.14 114.89 29.45 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.381 -0.827 . . . . 74.53 109.601 175.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.7 m -109.11 125.23 51.93 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.202 0.525 . . . . 73.53 111.104 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 38.6 mm -103.96 95.96 8.63 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.056 -0.72 . . . . 73.14 109.056 174.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.7 Cg_endo -75.92 157.38 38.95 Favored 'Trans proline' 0 N--CA 1.464 -0.225 0 C-N-CA 122.821 2.347 . . . . 73.41 113.087 -174.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -93.23 63.52 3.64 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.58 -0.896 . . . . 54.43 108.58 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -162.27 122.53 2.48 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.322 -0.854 . . . . 50.53 110.227 -178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.85 -1.9 21.39 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.834 -0.698 . . . . 52.32 112.314 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 108.17 21.5 7.67 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.905 -0.664 . . . . 54.15 112.691 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -79.31 146.19 33.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 73.41 111.737 -175.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.6 m -113.47 174.43 5.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.486 -0.779 . . . . 71.12 109.608 176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 18.8 p -79.16 -14.36 59.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.911 0.386 . . . . 53.44 111.716 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.421 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 48.1 t -84.38 104.72 12.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.969 0.414 . . . . 74.11 110.219 178.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.26 130.84 55.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.028 -0.533 . . . . 75.33 110.24 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 75' ' ' ARG . . . -141.84 105.16 4.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.102 0.477 . . . . 71.53 111.289 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 22.3 mt -131.34 133.3 62.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.803 -0.814 . . . . 73.13 108.803 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.864 ' HG2' ' HB3' ' A' ' 41' ' ' PHE . 71.1 mtm180 -74.25 -57.63 3.82 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.517 -0.473 . . . . 64.45 111.278 -175.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -151.13 148.43 28.27 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.551 -0.86 . . . . 42.44 112.239 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.423 HD12 HD21 ' A' ' 72' ' ' LEU . 7.8 tt -105.85 120.93 42.99 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.551 -1.204 . . . . 71.11 108.31 172.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.461 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.6 t70 -117.81 162.03 18.75 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.361 -0.607 . . . . 64.33 109.361 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 5' ' ' ILE . 59.9 t -126.08 123.91 64.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.197 0.522 . . . . 73.12 110.422 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.437 ' HG3' HG22 ' A' ' 4' ' ' THR . 47.0 mttt -99.67 76.03 1.96 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.558 0.694 . . . . 63.41 109.389 177.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -124.05 -146.19 6.91 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 114.911 -1.04 . . . . 54.34 111.785 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.4 m -135.86 134.0 38.36 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.803 0.335 . . . . 54.31 110.704 179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 40.4 mm -72.0 130.62 35.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.983 -0.553 . . . . 70.45 110.94 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.484 HG22 ' HG ' ' A' ' 152' ' ' LEU . 20.5 mt -126.64 139.2 52.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.069 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -114.31 100.93 8.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.619 0.723 . . . . 72.23 110.656 175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.484 ' HG ' HG22 ' A' ' 150' ' ' ILE . 92.8 mt -117.36 26.67 9.59 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.717 -0.674 . . . . 73.52 110.084 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -76.05 92.63 3.2 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 62.5 109.676 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -94.12 -7.18 43.19 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.19 -0.914 . . . . 64.34 110.205 -174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 -141.29 163.48 32.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.794 -0.639 . . . . 74.42 109.967 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -84.54 146.57 27.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.978 0.418 . . . . 75.41 110.543 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -77.88 100.88 6.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.727 -0.67 . . . . 61.32 110.208 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -85.2 157.28 20.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.159 -0.473 . . . . 62.04 110.951 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 26.3 p80 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.134 -0.484 . . . . 71.32 110.116 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.22 -0.289 . . . . 64.14 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.44 144.92 43.27 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.853 -0.689 . . . . 64.24 112.544 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 53.2 m -82.41 112.9 19.78 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.46 0.648 . . . . 75.32 111.512 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.9 p -84.88 132.0 34.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.143 -0.935 . . . . 72.01 108.604 168.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 HD13 ' A' ' 65' ' ' ILE . 47.3 mm -60.81 128.49 22.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.701 0.286 . . . . 73.34 111.13 -173.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.7 t -67.5 119.43 12.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.105 0.478 . . . . 75.34 109.841 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 41.6 mtmt -95.44 4.33 53.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.731 -0.668 . . . . 72.12 110.647 -175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -73.43 93.4 1.96 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.736 . . . . 74.43 109.442 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 134.34 -16.2 4.39 Favored Glycine 0 C--N 1.316 -0.583 0 CA-C-N 115.28 -0.873 . . . . 72.1 111.476 -175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -68.92 150.64 47.52 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.752 -0.462 . . . . 73.04 109.752 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.3 pt-20 -132.37 157.71 43.81 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.319 0.581 . . . . 74.24 110.924 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -98.74 110.04 25.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 54.33 109.645 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.444 HD12 HG12 ' A' ' 58' ' ' VAL . 81.6 mt -72.43 -48.95 37.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.801 -0.636 . . . . 75.34 110.612 -176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 p -149.94 142.85 24.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.666 -0.697 . . . . 62.23 110.527 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.547 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 38.2 p90 -138.77 148.54 43.97 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.92 -0.582 . . . . 74.21 109.837 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.1 m -88.26 -37.91 15.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.739 0.304 . . . . 53.13 111.029 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.1 t -145.74 145.88 31.02 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.148 0.499 . . . . 61.34 110.859 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.547 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -154.94 151.75 28.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 50.41 108.781 176.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -124.56 92.35 3.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.153 0.501 . . . . 73.01 111.064 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -94.59 -18.74 21.11 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.736 -0.666 . . . . 70.13 111.239 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 29.2 m -91.72 -40.37 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 61.33 110.863 -174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . -79.23 -45.17 9.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.898 -0.668 . . . . 72.22 112.934 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -82.9 -14.0 55.03 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.009 0.433 . . . . 74.03 111.303 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.65 162.23 29.04 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.829 -0.701 . . . . 52.24 112.433 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.2 122.52 16.33 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.71 0.29 . . . . 70.22 110.926 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.64 -1.54 61.85 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.815 -0.707 . . . . 55.31 112.455 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -133.81 151.85 51.69 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.129 -0.323 . . . . 65.12 110.129 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.36 -5.95 66.05 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 121.378 -0.439 . . . . 25.34 112.119 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.523 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 77.1 mt -75.15 148.45 39.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.566 -0.317 . . . . 73.25 110.321 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.51 -18.74 63.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.402 -0.363 . . . . 74.31 111.264 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.75 -25.68 44.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.506 -0.315 . . . . 61.41 110.888 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.844 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.9 m -64.84 -25.79 68.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 70.51 110.455 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 143' ' ' LEU . 34.4 tp -64.24 -22.22 66.87 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.605 -0.725 . . . . 74.42 110.827 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.596 HG21 HD13 ' A' ' 59' ' ' ILE . 40.1 pt -125.79 15.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 74.43 110.363 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.844 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 4.6 t70 -75.38 -37.3 60.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 52.4 110.528 -173.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.92 23.93 7.94 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.472 -0.871 . . . . 63.11 112.299 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.3 109.58 7.83 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.273 -0.64 . . . . 73.1 109.273 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.7 p -68.7 -21.16 64.43 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.214 -0.448 . . . . 62.0 111.923 -175.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.549 ' HA ' HH21 ' A' ' 141' ' ' ARG . 61.4 mm-40 -72.56 -26.88 61.89 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.925 -0.31 . . . . 61.23 110.422 177.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.7 p -89.3 152.09 21.74 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.755 -0.831 . . . . 72.11 108.755 169.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.707 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 47.2 p90 -148.93 174.96 11.7 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.307 -0.557 . . . . 72.4 111.333 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.408 ' CZ2' HD11 ' A' ' 57' ' ' ILE . 39.0 t90 -107.82 135.67 48.83 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.559 -0.746 . . . . 64.35 109.046 174.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.442 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 48.5 t-80 -135.14 145.01 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.687 -0.486 . . . . 72.13 109.687 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.53 146.6 53.77 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.952 -0.567 . . . . 55.01 109.944 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -60.29 133.6 56.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.401 . . . . 74.43 110.787 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -139.7 -26.82 0.79 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.562 -0.29 . . . . 73.3 111.553 177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.401 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 4.7 tp-100 -62.42 -42.02 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.988 0.423 . . . . 64.25 110.255 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.77 32.09 6.21 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 75.11 111.91 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.37 148.41 13.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 63.43 111.83 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.485 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -81.94 156.63 24.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.2 0.524 . . . . 61.41 111.114 -178.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -91.39 162.36 32.14 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.917 -0.583 . . . . 75.44 110.587 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.35 139.18 31.46 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.736 2.291 . . . . 63.12 112.791 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.3 mt -80.03 159.88 69.81 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.708 -0.678 . . . . 62.4 110.157 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.773 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 96.4 Cg_endo -79.66 161.28 86.78 Favored 'Cis proline' 0 C--N 1.343 0.273 0 C-N-CA 123.622 -1.408 . . . . 62.41 112.975 0.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -95.75 108.81 21.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.112 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -108.72 116.91 32.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.955 0.407 . . . . 74.35 110.634 -179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.476 HD12 HD23 ' A' ' 126' ' ' LEU . 60.9 mt -109.81 108.61 25.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.96 -0.564 . . . . 73.13 109.636 176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.813 HG22 ' HG3' ' A' ' 125' ' ' ARG . 48.1 t -97.94 116.48 40.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 116.133 -0.485 . . . . 73.21 110.512 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 34' ' ' ILE . 68.5 mt -115.52 137.29 49.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.726 -0.67 . . . . 73.02 110.615 -175.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -101.84 122.21 43.57 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 61.15 109.697 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 65.4 mtm -87.33 -8.5 56.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.519 . . . . 64.23 110.611 -176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.2 mmtt 67.97 7.55 5.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.719 . . . . 72.24 112.26 175.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 5.7 pt20 -161.26 163.03 31.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.43 -0.211 . . . . 63.11 110.43 -176.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.413 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 43.9 m-80 -83.97 126.17 32.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.85 -0.426 . . . . 74.02 109.85 178.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.508 HD13 HG21 ' A' ' 5' ' ' ILE . 61.3 mt -132.01 136.88 55.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.033 0.444 . . . . 72.34 110.701 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -84.38 101.74 12.21 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.826 -0.805 . . . . 74.23 108.826 174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.651 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.2 mm -71.56 127.33 33.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.327 -0.397 . . . . 62.1 110.306 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.26 -46.1 2.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.735 0.302 . . . . 72.32 110.875 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -144.51 144.91 31.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.687 0.28 . . . . 75.11 110.847 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.89 132.27 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.232 -0.655 . . . . 73.52 109.232 173.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.716 ' HG2' ' HB1' ' A' ' 111' ' ' ALA . 26.8 tt0 -115.08 127.97 55.94 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.933 0.397 . . . . 74.31 110.367 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' CE2' ' A' ' 114' ' ' TYR . 57.2 mt -115.72 117.75 31.14 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.954 -0.566 . . . . 72.03 110.16 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.6 tp -110.08 100.16 42.5 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 116.404 -0.362 . . . . 73.34 110.439 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 105' ' ' PHE . 29.5 Cg_endo -86.81 -175.59 1.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.84 2.36 . . . . 54.3 110.465 174.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.512 ' HA ' ' HD2' ' A' ' 141' ' ' ARG . 20.6 ptt180 -90.29 -29.94 17.81 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 119.956 -0.698 . . . . 74.25 110.055 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' HA2' ' OD1' ' A' ' 107' ' ' ASN . . . 68.65 -91.28 0.26 Allowed Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.936 -0.574 . . . . 62.25 114.04 170.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -76.29 128.73 35.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.356 0.598 . . . . 73.11 110.783 -174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.97 17.99 33.34 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.511 -0.768 . . . . 51.4 111.917 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.6 p -159.03 140.87 13.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.451 -0.203 . . . . 51.43 110.451 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -66.93 -50.79 61.26 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.219 -0.193 . . . . 72.42 110.573 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 65.6 t30 45.02 78.12 0.41 Allowed Pre-proline 0 N--CA 1.47 0.572 0 O-C-N 123.975 0.797 . . . . 63.4 111.487 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 1.1 Cg_endo -82.55 59.53 6.92 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.283 2.655 . . . . 71.23 113.225 -173.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.4 mt -98.41 119.37 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.078 0.466 . . . . 54.25 109.821 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 25.7 mmmt -97.52 -56.41 2.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.716 -0.675 . . . . 64.25 111.4 -177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.7 t -121.89 139.65 48.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.319 -0.4 . . . . 65.3 110.347 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -125.61 133.41 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.888 0.375 . . . . 62.35 110.02 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' HB ' ' A' ' 127' ' ' THR . 20.7 tt0 -121.5 128.72 52.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.911 -0.586 . . . . 71.03 110.095 -177.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -112.07 129.38 56.24 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.071 -0.513 . . . . 63.14 109.961 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -122.76 151.72 41.33 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.464 -0.334 . . . . 74.44 110.273 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.34 149.49 45.66 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.175 -0.466 . . . . 61.25 110.185 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.6 t -147.12 148.0 31.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.271 -0.422 . . . . 53.04 110.232 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -87.04 -32.55 19.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.714 0.292 . . . . 62.32 110.992 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -132.63 16.11 4.38 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.573 -0.285 . . . . 61.51 111.632 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 43.2 t30 59.49 58.5 2.92 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.727 0.775 . . . . 70.1 110.308 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 52.7 t -136.26 -71.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.162 -0.926 . . . . 73.43 108.917 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 -90.46 118.67 30.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.781 -0.645 . . . . 65.25 109.666 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -101.97 107.78 19.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.083 0.468 . . . . 75.43 110.744 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 91.8 m -93.84 125.99 51.11 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 115.802 -0.635 . . . . 63.41 110.212 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.66 104.01 0.9 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.543 2.162 . . . . 71.45 111.662 176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 22.2 pt -74.0 -23.33 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.105 -0.498 . . . . 64.33 110.901 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -169.69 128.33 1.64 Allowed Glycine 0 N--CA 1.44 -1.064 0 C-N-CA 120.209 -0.996 . . . . 22.45 113.004 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.443 ' HB2' ' HG3' ' A' ' 87' ' ' GLU . 2.4 tmt_? -124.29 115.0 20.32 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 74.14 108.649 171.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -141.4 -177.11 4.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.078 -0.51 . . . . 73.41 110.91 -171.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -95.31 143.76 16.81 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.804 -0.634 . . . . 74.14 111.754 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.453 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 53.3 t80 -96.68 120.97 37.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.981 0.42 . . . . 62.41 110.772 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.636 ' HB ' HD21 ' A' ' 112' ' ' LEU . 23.0 m -97.75 109.64 22.36 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.089 -0.505 . . . . 71.04 110.145 176.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.489 ' OD1' ' HA2' ' A' ' 76' ' ' GLY . 61.5 t30 -70.38 98.57 1.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.949 0.404 . . . . 74.33 110.468 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -139.55 174.36 10.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.964 -0.562 . . . . 60.04 109.737 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -97.31 5.34 50.1 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.192 0.52 . . . . 70.1 110.707 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -108.65 152.63 24.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.596 -0.729 . . . . 62.4 109.672 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HB1' ' HG2' ' A' ' 71' ' ' GLU . . . -73.93 124.96 27.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.03 0.443 . . . . 61.25 111.316 -175.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 106' ' ' THR . 35.9 mt -77.49 124.35 27.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.729 . . . . 74.32 110.594 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -95.11 109.55 21.61 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.895 0.378 . . . . 73.01 110.681 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.453 ' OH ' ' HA ' ' A' ' 105' ' ' PHE . 91.8 m-85 -102.47 109.57 21.25 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.508 . . . . 74.5 110.474 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -81.13 90.19 6.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.602 . . . . 71.4 109.612 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 101' ' ' GLY . 26.8 m -87.62 -177.85 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.211 -0.904 . . . . 71.25 111.45 -174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -72.87 128.74 36.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.585 -0.734 . . . . 73.15 110.863 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 4.5 m -68.53 114.68 7.15 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.201 177.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 tt -153.53 148.6 13.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.576 -0.284 . . . . 74.43 110.532 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -88.53 126.26 35.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.767 -0.457 . . . . 73.34 109.767 177.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.61 165.22 29.32 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.442 -0.344 . . . . 53.44 110.831 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 37.1 ttt180 -115.39 -26.35 7.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.519 0.676 . . . . 73.14 109.744 176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -116.07 146.33 42.29 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.468 -0.787 . . . . 74.14 109.653 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.6 tt -132.83 140.48 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.962 -0.384 . . . . 74.22 109.962 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.813 ' HG3' HG22 ' A' ' 58' ' ' VAL . 5.6 ttm180 -126.38 132.09 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.816 0.341 . . . . 72.3 111.166 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 57' ' ' ILE . 56.2 tp -98.2 118.18 34.26 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.088 -0.708 . . . . 52.22 109.088 171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 95.5 m -115.38 125.05 52.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.158 0.504 . . . . 73.41 111.321 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 39.7 mm -105.1 90.21 3.55 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.431 -0.951 . . . . 73.41 108.431 171.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.773 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 83.6 Cg_endo -86.87 150.49 8.46 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.734 2.29 . . . . 61.42 113.138 -174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -81.77 61.52 5.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.893 0.854 . . . . 64.54 108.782 174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -104.32 -42.67 5.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.877 -1.056 . . . . 75.54 112.23 -173.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -125.61 29.67 4.66 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 119.82 -1.181 . . . . 75.22 113.992 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.23 25.18 9.03 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.181 -1.009 . . . . 74.34 112.963 177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -70.3 131.32 43.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.112 0.482 . . . . 63.25 111.358 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.6 m -93.65 174.68 7.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.783 -0.644 . . . . 74.35 110.188 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.485 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 3.3 p -85.88 19.07 2.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.007 0.432 . . . . 63.05 111.926 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.446 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t -125.92 124.36 66.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.843 -0.429 . . . . 61.24 109.843 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -143.79 135.94 26.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.538 -0.301 . . . . 65.24 110.417 -178.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.442 ' HB2' ' CD2' ' A' ' 43' ' ' HIS . . . -137.12 105.99 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.955 0.407 . . . . 64.44 111.514 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.6 mt -122.31 133.34 68.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.114 -0.699 . . . . 74.42 109.114 175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.707 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 67.5 mtp180 -82.59 -45.84 14.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.092 0.473 . . . . 71.3 110.305 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -149.89 129.37 13.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.757 -0.656 . . . . 74.41 110.953 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.43 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 8.9 tt -109.56 118.36 36.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.625 -0.88 . . . . 74.11 108.625 173.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.75 149.98 42.49 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.007 0.432 . . . . 63.03 110.86 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.25 135.03 61.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.983 -0.553 . . . . 75.23 110.341 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -111.66 120.33 41.68 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.004 -0.739 . . . . 73.12 109.004 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.35 -159.9 16.2 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.778 -0.725 . . . . 62.22 111.847 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.0 m -120.84 130.82 54.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.588 0.232 . . . . 71.23 110.582 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 5' ' ' ILE . 33.6 mm -74.78 127.54 36.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.209 -0.45 . . . . 61.5 110.143 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.07 149.32 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.747 -0.464 . . . . 44.02 109.747 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 59.77 60.06 2.32 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.273 0.558 . . . . 73.23 109.622 -172.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 76.3 mt -57.23 128.42 36.89 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.969 -1.014 . . . . 64.22 110.962 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.441 ' HG3' ' H ' ' A' ' 153' ' ' GLU . 1.3 pp20? -72.11 145.02 48.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.274 -0.421 . . . . 72.15 110.492 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 12.0 m170 61.92 34.52 16.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.88 -0.6 . . . . 73.53 110.186 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -54.76 114.02 1.55 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.054 -0.521 . . . . 65.41 111.225 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -56.34 138.39 50.96 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.528 -0.76 . . . . 71.31 110.651 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -151.89 113.9 4.46 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.966 0.412 . . . . 75.05 110.412 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -127.17 179.06 5.63 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.002 -0.544 . . . . 75.11 110.207 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.503 -0.317 . . . . 72.22 110.791 -179.857 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.766 0.317 . . . . 61.43 110.354 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.14 -101.91 2.72 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.764 -0.731 . . . . 32.1 112.708 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.9 m -81.82 -11.01 59.16 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.517 0.675 . . . . 74.35 110.824 -176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.628 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 71.4 p -70.98 156.3 39.79 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.502 -0.772 . . . . 74.41 110.907 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.524 HG23 HD11 ' A' ' 149' ' ' ILE . 48.0 mm -88.36 136.48 23.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.157 -0.474 . . . . 64.11 110.698 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -64.26 109.41 1.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 71.45 109.958 176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.0 mtmt -86.51 -1.01 57.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.338 -0.392 . . . . 75.14 111.51 -174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 m -70.24 91.32 0.72 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.415 0.626 . . . . 52.04 109.835 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.75 -17.99 2.8 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.279 -0.873 . . . . 75.34 111.735 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.8 m0 -68.02 155.49 39.39 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.698 -0.482 . . . . 74.33 109.698 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -140.08 153.17 46.67 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.338 -0.545 . . . . 72.21 111.145 175.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.9 t -91.31 107.97 19.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.283 -0.871 . . . . 64.42 109.478 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.497 HD12 HG12 ' A' ' 58' ' ' VAL . 83.5 mt -73.61 -47.12 42.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.725 -0.67 . . . . 72.11 110.437 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.0 m -143.28 139.38 30.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.774 -0.648 . . . . 51.42 110.167 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -139.62 140.17 36.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.465 -0.568 . . . . 74.42 109.465 177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.7 m -84.61 -28.67 26.36 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.848 0.356 . . . . 75.33 110.991 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 t -162.19 149.7 14.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 120.877 0.37 . . . . 63.11 110.887 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -165.85 137.5 3.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.53 -0.759 . . . . 75.41 109.107 175.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.491 ' HG2' ' CD1' ' A' ' 46' ' ' TRP . 9.8 tp10 -105.17 95.0 5.54 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.011 0.434 . . . . 53.41 111.434 -173.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -92.58 -31.48 15.17 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 64.25 110.572 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 m -79.66 -42.21 25.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.822 -0.626 . . . . 73.13 110.867 -173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.38 -47.54 22.01 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.947 -0.644 . . . . 62.44 112.7 -177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -75.41 -39.32 59.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.828 0.314 . . . . 70.14 111.166 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 118.37 -122.77 5.49 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 119.921 -1.133 . . . . 52.2 113.879 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.89 97.73 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.381 0.512 . . . . 55.32 112.381 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.8 9.34 86.97 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.95 -0.643 . . . . 43.13 113.209 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -112.66 141.47 46.4 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.017 -0.364 . . . . 71.42 110.017 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.38 -8.04 79.57 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.088 -0.577 . . . . 74.51 112.759 176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.682 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 94.6 mt -73.27 144.65 46.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.322 -0.251 . . . . 71.15 110.322 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.519 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.7 -23.63 66.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.02 0.438 . . . . 65.34 110.923 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 pttp -75.4 -23.87 57.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 65.35 110.988 -178.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.787 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 57.8 m -67.15 -25.38 66.14 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.07 -0.514 . . . . 53.21 110.417 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.37 -26.75 66.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.724 . . . . 74.32 110.522 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 59' ' ' ILE . 31.9 pt -121.27 12.19 6.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.273 -0.421 . . . . 73.41 110.723 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.787 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 7.5 t70 -71.08 -36.66 72.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.1 0.476 . . . . 72.32 109.719 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.94 52.97 1.56 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.499 -0.858 . . . . 52.33 113.42 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.629 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 8.3 t0 -149.3 135.16 18.82 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.842 -0.429 . . . . 64.21 109.842 171.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.6 p -81.55 10.77 5.38 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.604 -0.725 . . . . 75.42 112.64 -172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.629 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 13.0 pt-20 -118.45 -7.7 10.61 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.525 -0.47 . . . . 73.41 111.315 173.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.0 p -96.71 166.9 11.43 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.504 -0.554 . . . . 74.32 109.504 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.521 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 50.6 p90 -161.82 165.28 28.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.269 0.557 . . . . 72.01 112.25 -175.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.519 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 32.1 t90 -109.65 139.41 44.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.763 -1.108 . . . . 75.22 108.966 172.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -136.68 142.4 43.17 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.343 -0.614 . . . . 74.51 109.343 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.06 151.81 45.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.316 -0.402 . . . . 71.11 110.221 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.1 tptp -62.51 125.76 25.02 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.039 -0.356 . . . . 65.34 110.039 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.491 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 68.7 p-90 -126.22 -34.02 2.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.857 0.36 . . . . 72.44 110.616 179.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -75.61 108.6 8.55 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.622 -0.511 . . . . 72.24 109.622 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.43 -20.54 46.4 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.769 -0.729 . . . . 45.11 111.462 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.6 167.8 11.34 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.677 -0.773 . . . . 53.53 112.001 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.504 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 54.8 m -115.03 149.77 36.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.819 0.342 . . . . 60.45 110.503 -178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.56 152.5 66.99 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 73.42 110.076 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.02 142.8 35.16 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.216 1.944 . . . . 72.1 112.738 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.14 156.69 87.51 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 115.907 -0.588 . . . . 71.44 110.002 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.59 170.24 65.41 Favored 'Cis proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.627 -1.406 . . . . 70.22 113.437 2.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -110.37 129.94 55.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.651 -0.704 . . . . 62.13 110.035 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 15.8 m-20 -118.43 130.05 55.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.882 0.372 . . . . 75.11 110.505 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.425 HD12 HD23 ' A' ' 126' ' ' LEU . 60.6 mt -121.25 108.92 23.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.075 -0.511 . . . . 53.41 109.681 173.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.497 HG12 HD12 ' A' ' 13' ' ' LEU . 40.8 t -95.93 119.71 44.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.907 -0.588 . . . . 62.33 110.23 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 34' ' ' ILE . 61.3 mt -119.28 133.03 67.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.279 -0.419 . . . . 74.3 110.94 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.7 t0 -100.05 120.88 40.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.633 -0.506 . . . . 74.12 109.633 176.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.44 ' HE1' HD11 ' A' ' 67' ' ' ILE . 70.5 mtm -86.78 -4.88 59.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 60.13 111.01 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp 71.51 0.07 3.33 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.181 0.808 . . . . 75.33 113.181 172.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -159.94 173.75 15.44 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 122.298 -0.251 . . . . 75.24 110.734 -176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -82.67 122.75 28.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.082 -0.508 . . . . 71.42 109.906 176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.523 HD13 HG21 ' A' ' 5' ' ' ILE . 64.9 mt -132.59 135.31 57.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.055 0.455 . . . . 75.23 110.322 177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.517 HE21 ' HB3' ' A' ' 118' ' ' SER . 57.2 tp60 -83.16 104.31 13.24 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.046 -0.724 . . . . 64.32 109.046 176.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.667 ' O ' ' HA ' ' A' ' 118' ' ' SER . 24.1 mm -73.6 121.75 25.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.414 -0.357 . . . . 64.33 110.288 -177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.2 -36.33 4.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.053 0.454 . . . . 73.33 110.748 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.486 HE22 ' HE2' ' A' ' 146' ' ' LYS . 20.6 tt0 -153.44 143.25 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.884 -0.598 . . . . 72.21 110.813 -176.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -114.7 138.43 44.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.355 -0.609 . . . . 74.03 109.355 174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.4 mt-10 -117.31 133.62 55.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.949 0.404 . . . . 73.53 111.3 -178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.34 122.78 45.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.793 -0.639 . . . . 74.21 109.687 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 tp -106.25 106.48 57.36 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.239 -0.437 . . . . 65.04 110.043 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -71.95 177.92 6.5 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.724 2.283 . . . . 55.24 111.127 176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -87.56 -5.98 58.53 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.637 -0.425 . . . . 64.14 110.847 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.78 168.51 11.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.677 -0.773 . . . . 43.0 112.17 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 7.7 ttm-85 -89.66 133.6 34.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.626 -0.509 . . . . 63.11 109.626 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 112.96 -26.21 10.8 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.758 -0.734 . . . . 24.35 111.597 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.5 m -69.48 160.96 30.46 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.119 -0.326 . . . . 54.24 110.119 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -80.43 98.38 7.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.222 0.534 . . . . 74.43 110.631 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -115.4 88.86 19.98 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.443 -0.799 . . . . 71.41 109.346 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.817 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 2.8 Cg_exo -77.89 31.05 0.44 Allowed 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 123.369 2.713 . . . . 71.14 112.24 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 105' ' ' PHE . 30.8 mt -95.1 112.54 27.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 75.11 109.4 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -100.56 -44.76 5.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.005 -0.543 . . . . 55.33 110.643 -177.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG11 ' HE ' ' A' ' 102' ' ' ARG . 58.6 t -127.32 138.39 54.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.109 -0.496 . . . . 73.12 110.865 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.7 m -128.5 140.74 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 71.35 110.364 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -118.12 129.17 55.38 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.145 -0.48 . . . . 71.04 110.654 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -112.04 130.18 55.96 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.03 -0.532 . . . . 74.54 110.234 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.05 148.46 51.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.803 0.335 . . . . 50.22 111.031 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.88 148.39 52.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.998 -0.546 . . . . 71.31 109.979 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 32.4 t -150.43 154.94 38.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.118 0.485 . . . . 63.55 111.458 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 45.1 mt-10 -105.62 -9.64 17.26 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.279 -0.637 . . . . 73.22 109.279 170.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -101.55 -36.17 8.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.499 -0.773 . . . . 45.33 111.606 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 64.2 t30 74.32 15.15 3.58 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.574 1.178 . . . . 73.41 108.031 -167.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -122.28 -62.14 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 114.019 -1.446 . . . . 75.45 109.485 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.4 m-80 -89.49 104.85 17.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.886 -0.597 . . . . 64.44 109.435 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -93.86 117.6 30.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.938 0.399 . . . . 71.01 111.309 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 88.6 m -94.18 125.29 53.05 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.791 -0.641 . . . . 71.12 110.256 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.29 113.92 3.84 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.403 2.069 . . . . 74.14 111.943 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 116' ' ' VAL . 20.9 pt -83.87 -12.34 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 55.45 110.75 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.07 146.54 4.81 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.25 -0.976 . . . . 74.24 113.035 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.554 ' HE ' HG11 ' A' ' 85' ' ' VAL . 69.3 ttt180 -125.99 118.56 25.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.801 -0.815 . . . . 72.11 108.801 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -136.82 -176.14 4.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.019 0.438 . . . . 73.31 111.051 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.48 148.54 18.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.569 -0.742 . . . . 61.51 112.134 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.423 ' HB3' ' O ' ' A' ' 83' ' ' ILE . 42.6 t80 -95.81 119.91 35.13 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.146 0.498 . . . . 74.32 110.276 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.439 ' HB ' HD21 ' A' ' 112' ' ' LEU . 20.1 m -103.54 110.18 22.12 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.228 -0.442 . . . . 42.1 110.749 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -64.39 100.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.27 -0.423 . . . . 73.3 110.572 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -139.94 -179.34 5.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.258 -0.428 . . . . 70.2 110.375 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.53 -11.06 35.52 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.99 0.424 . . . . 72.11 110.975 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -106.73 158.82 16.69 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.166 -0.47 . . . . 74.35 111.009 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 130.67 43.89 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.121 -0.49 . . . . 64.34 110.916 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.439 HD21 ' HB ' ' A' ' 106' ' ' THR . 58.8 mt -83.32 109.46 17.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.68 -0.691 . . . . 54.13 110.43 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.26 112.46 21.4 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.282 -0.417 . . . . 74.11 110.94 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -102.0 104.13 14.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.047 -0.524 . . . . 63.44 110.016 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -77.57 91.25 3.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.356 -0.838 . . . . 72.01 109.355 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 100' ' ' ILE . 31.2 m -96.28 -178.78 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.94 -0.573 . . . . 72.01 112.392 -170.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -65.73 126.49 28.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.136 -0.938 . . . . 63.33 110.649 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 63.9 m -71.49 123.99 23.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.074 -0.512 . . . . 53.23 110.45 178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.7 146.0 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.059 -0.518 . . . . 62.12 110.286 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.555 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.0 OUTLIER -93.83 113.61 25.68 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.178 -0.675 . . . . 71.44 109.178 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.06 173.61 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.676 0.274 . . . . 74.33 111.041 -177.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -115.93 -32.36 5.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.32 0.581 . . . . 71.51 110.512 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -106.35 145.75 31.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.97 -0.559 . . . . 63.04 110.203 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.7 tt -135.13 138.02 49.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.021 -0.536 . . . . 55.01 109.69 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.3 ttp180 -124.7 125.9 44.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.017 0.437 . . . . 60.11 111.094 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' ILE . 47.0 tp -93.28 112.79 24.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.491 -0.777 . . . . 54.51 108.979 172.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.3 m -111.81 123.09 49.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.39 0.614 . . . . 71.15 111.151 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 38.6 mm -99.98 100.49 11.53 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 108.649 -0.871 . . . . 71.1 108.649 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.6 164.88 24.75 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.718 2.279 . . . . 74.52 112.98 -174.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -96.69 14.71 24.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 122.153 0.977 . . . . 73.33 108.855 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -125.08 134.58 52.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.905 -1.043 . . . . 74.11 110.389 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.78 -9.92 14.21 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.941 -0.647 . . . . 41.14 112.445 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 107.72 23.54 6.79 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.773 -0.727 . . . . 70.3 112.147 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -79.96 144.79 33.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.771 0.32 . . . . 64.43 110.789 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.554 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 24.5 m -117.47 177.28 4.8 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.169 -0.469 . . . . 24.13 110.458 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 32.4 p -79.13 -3.12 43.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.055 0.455 . . . . 45.52 111.814 -177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.817 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 87.4 t -95.23 121.58 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.373 -0.376 . . . . 75.41 110.081 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.32 128.65 17.84 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.322 -0.399 . . . . 73.23 110.428 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.96 106.22 5.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.295 -0.411 . . . . 53.31 110.674 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 50.7 mt -128.51 132.95 67.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.001 -0.74 . . . . 62.22 109.001 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.521 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 92.9 mtt180 -70.98 -59.41 2.8 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.724 -0.39 . . . . 63.41 110.884 -177.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -153.1 157.63 40.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.759 0.79 . . . . 73.01 112.097 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.5 tt -115.85 133.28 56.19 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.454 -1.248 . . . . 62.13 107.736 176.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.628 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -130.77 170.3 14.55 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.579 -0.448 . . . . 72.12 109.844 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.1 t -141.38 128.11 20.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.937 -0.394 . . . . 62.1 109.937 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' HE2' HE22 ' A' ' 69' ' ' GLN . 48.2 mttm -97.91 124.41 42.33 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.433 -0.951 . . . . 75.3 108.433 172.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.64 -167.13 26.85 Favored Glycine 0 N--CA 1.437 -1.244 0 C-N-CA 120.282 -0.961 . . . . 24.13 112.052 -177.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.5 m -119.17 126.76 52.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.767 0.317 . . . . 74.44 110.501 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.524 HD11 HG23 ' A' ' 5' ' ' ILE . 41.4 mm -70.66 127.15 32.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.036 -0.529 . . . . 73.22 110.005 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 120' ' ' LYS . 47.4 mt -119.62 139.43 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.373 . . . . 65.33 110.212 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -124.22 113.17 17.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.154 0.502 . . . . 74.15 110.242 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.47 86.73 3.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.454 0.645 . . . . 45.22 110.01 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -95.63 26.89 3.7 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.439 -0.801 . . . . 74.1 111.09 -174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -78.12 -6.23 54.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.352 0.596 . . . . 74.35 109.568 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -80.78 115.86 20.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.418 -0.81 . . . . 71.55 109.744 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -117.77 124.08 47.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.26 -0.427 . . . . 75.35 110.036 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -127.77 79.18 1.88 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.604 0.716 . . . . 74.23 111.006 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -140.83 134.25 29.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.114 -0.948 . . . . 73.41 109.33 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 116.407 -0.36 . . . . 52.42 110.866 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.477 0.896 0 CA-C-O 121.031 0.443 . . . . 74.13 110.307 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 151.06 -168.98 30.76 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.606 -0.598 . . . . 62.2 111.606 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.9 m -75.12 -43.62 51.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.948 0.404 . . . . 72.44 110.682 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.1 p -92.19 151.88 20.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.474 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.609 HG21 HD13 ' A' ' 65' ' ' ILE . 51.1 mm -86.2 132.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.538 -0.301 . . . . 61.23 110.578 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -72.81 120.23 18.14 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.306 -0.627 . . . . 61.41 109.306 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -82.24 29.49 0.42 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.908 -0.587 . . . . 63.02 111.017 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -79.01 95.96 5.64 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.661 -0.699 . . . . 64.43 110.222 -178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.86 -9.02 9.16 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.55 -0.75 . . . . 71.42 112.265 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.462 ' HB3' HD12 ' A' ' 34' ' ' ILE . 21.2 m0 -69.67 134.34 48.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.983 -0.377 . . . . 74.1 109.983 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' OE2' ' HE2' ' A' ' 62' ' ' LYS . 13.5 pt-20 -132.41 160.92 34.96 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.764 -0.374 . . . . 72.12 110.567 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.9 t -95.71 125.39 48.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.224 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.499 HD11 ' HB2' ' A' ' 60' ' ' ASP . 77.7 mt -90.5 -44.54 9.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.132 0.492 . . . . 75.1 110.303 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -142.2 137.22 30.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.752 -0.658 . . . . 72.34 110.316 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -141.57 144.33 34.19 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.297 -0.411 . . . . 61.42 110.138 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 45.8 m -80.15 -51.31 9.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.896 0.379 . . . . 71.22 110.858 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 8.4 t -142.7 150.17 39.79 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.269 -0.423 . . . . 64.42 110.98 -174.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -164.94 142.82 6.3 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.471 -0.937 . . . . 74.23 108.471 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.672 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 9.1 tp10 -103.27 107.94 18.96 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.7 -0.4 . . . . 72.42 111.029 -174.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -114.34 -5.88 12.93 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.878 -0.601 . . . . 72.42 111.332 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.1 m -111.74 -40.03 4.42 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.401 -0.363 . . . . 73.14 110.837 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -74.65 -45.3 23.05 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 121.002 -0.618 . . . . 60.41 112.038 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.672 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 41.3 mm-40 -84.51 -52.61 6.02 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.591 -0.522 . . . . 51.01 109.591 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 137.11 -170.78 23.39 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.773 -0.727 . . . . 62.2 112.305 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.48 120.27 28.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.845 0.355 . . . . 73.43 110.271 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.37 -11.02 58.23 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.11 -0.567 . . . . 44.54 112.416 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.564 ' HB2' ' CE1' ' A' ' 41' ' ' PHE . 21.8 p-10 -134.67 127.96 32.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.885 0.374 . . . . 73.41 110.055 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.19 -10.8 60.09 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.481 -0.648 . . . . 70.21 111.481 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.608 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 89.7 mt -74.49 147.11 42.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.617 -0.291 . . . . 74.45 110.273 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.64 -24.06 64.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.044 0.449 . . . . 43.44 110.995 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -72.56 -26.91 61.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.755 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 1.008 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.3 m -70.57 -17.78 62.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.036 -0.529 . . . . 71.51 110.867 -176.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 tp -66.14 -20.58 66.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.544 0.687 . . . . 71.15 110.067 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 10' ' ' TRP . 40.2 pt -131.24 18.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.759 -0.655 . . . . 73.22 110.267 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 1.008 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 0.9 OUTLIER -71.57 -30.44 65.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.026 -0.534 . . . . 54.21 110.651 -172.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.53 33.97 5.44 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.842 -0.694 . . . . 73.15 112.33 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 39' ' ' GLU . 8.8 t0 -153.32 124.4 7.44 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.695 -0.484 . . . . 73.33 109.695 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.6 p -77.53 -3.45 40.65 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.298 0.481 . . . . 20.12 112.298 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 37' ' ' ASP . 16.9 mm-40 -83.34 -24.02 32.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.751 0.31 . . . . 61.51 110.208 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.636 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 22.4 p -93.93 165.06 12.85 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.958 -0.386 . . . . 72.14 109.958 175.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 52.8 p90 -163.92 172.01 14.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.721 0.296 . . . . 65.14 110.91 -174.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.492 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 42.8 t90 -112.28 134.02 54.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.554 -0.748 . . . . 70.23 109.292 174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.6 137.01 45.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.118 -0.697 . . . . 75.13 109.118 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.8 144.65 56.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.957 -0.386 . . . . 32.44 109.957 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.43 137.14 57.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.913 -0.585 . . . . 54.32 110.11 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 53.0 p-90 -138.35 -13.5 1.34 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.457 -0.338 . . . . 75.51 110.9 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.59 101.02 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.127 0.489 . . . . 73.52 110.65 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.55 2.82 90.67 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.896 -0.669 . . . . 75.41 112.256 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.99 177.21 14.82 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.818 -0.706 . . . . 60.3 111.599 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.7 t -125.0 175.12 7.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.093 0.473 . . . . 72.44 110.655 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 17' ' ' THR . 17.0 m-20 -97.97 146.49 31.58 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.981 -0.554 . . . . 72.12 110.116 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -69.31 145.85 61.1 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.764 2.31 . . . . 74.32 112.835 -176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 21.0 mt -80.61 159.51 69.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.697 -0.683 . . . . 72.03 109.968 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.568 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.4 Cg_endo -78.42 158.61 92.91 Favored 'Cis proline' 0 C--N 1.344 0.307 0 C-N-CA 123.631 -1.404 . . . . 72.41 113.125 1.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.711 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.0 m-30 -91.08 129.93 37.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 74.23 109.974 176.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 11.8 t70 -121.07 124.96 46.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.202 -0.454 . . . . 62.42 109.955 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.39 117.15 42.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.92 0.391 . . . . 72.42 110.4 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.8 t -104.35 116.68 48.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.989 -0.55 . . . . 61.33 110.842 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.4 mp -107.82 136.69 42.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.517 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.499 ' HB2' HD11 ' A' ' 13' ' ' LEU . 39.8 t0 -104.47 122.75 46.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.16 -0.473 . . . . 61.42 109.791 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -90.12 -4.34 57.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.257 -0.429 . . . . 71.4 110.881 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.412 ' HE2' ' OE2' ' A' ' 11' ' ' GLU . 33.4 mmtp 71.74 -6.99 1.32 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.456 0.702 . . . . 72.32 112.601 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -152.77 168.18 26.56 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.189 -0.3 . . . . 73.03 110.189 -176.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.551 ' OD1' ' HD3' ' A' ' 120' ' ' LYS . 47.2 m-80 -85.58 125.43 33.1 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.984 0.421 . . . . 71.01 110.344 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.609 HD13 HG21 ' A' ' 5' ' ' ILE . 62.0 mt -130.34 136.75 57.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.973 -0.558 . . . . 55.21 109.881 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.464 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.5 tp60 -83.19 100.53 10.63 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.901 -0.777 . . . . 74.31 108.901 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.735 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -66.89 130.92 32.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.378 -0.374 . . . . 73.53 110.318 -176.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -123.71 -46.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.934 0.397 . . . . 73.42 110.943 178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 19.3 tt0 -138.79 149.42 44.96 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.631 -0.507 . . . . 65.14 109.631 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -123.89 127.57 73.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.82 -0.437 . . . . 72.14 109.82 175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 1.9 mp0 -108.66 131.79 54.54 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.333 0.587 . . . . 72.35 111.048 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.578 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 60.1 mt -111.66 119.27 38.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 174.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 27.0 tp -102.32 96.45 7.17 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.256 -0.646 . . . . 62.13 109.256 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.1 Cg_endo -83.81 -169.73 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 123.259 2.64 . . . . 61.35 112.154 -176.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -99.28 -53.23 3.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.84 -0.618 . . . . 72.33 109.957 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.89 -178.23 7.61 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.907 -0.588 . . . . 53.11 112.759 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.29 -87.01 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 113.102 0.779 . . . . 63.33 113.102 171.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.45 48.53 3.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.123 -0.56 . . . . 62.33 112.276 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 p -168.06 148.45 4.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.527 -0.546 . . . . 53.0 109.527 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -86.56 -54.78 4.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.986 -0.376 . . . . 54.21 109.986 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 138' ' ' ALA . 65.4 t30 48.17 75.3 0.68 Allowed Pre-proline 0 N--CA 1.468 0.451 0 O-C-N 123.868 0.73 . . . . 71.0 111.543 175.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 4.4 Cg_exo -75.79 55.6 4.41 Favored 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 123.343 2.696 . . . . 71.12 113.672 -175.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.7 mt -99.51 115.61 40.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.089 -0.708 . . . . 71.24 109.089 172.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -100.44 -48.36 4.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.829 0.347 . . . . 73.54 110.832 -175.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.16 139.82 39.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.1 110.466 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 105' ' ' PHE . 5.1 m -130.08 143.32 41.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.984 0.421 . . . . 63.45 110.885 176.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 38.1 mt-10 -125.31 130.5 52.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.071 -0.513 . . . . 71.13 110.849 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -113.22 132.48 55.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.134 -0.484 . . . . 73.22 110.554 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.14 154.69 50.37 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.393 -0.367 . . . . 34.41 110.503 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.29 156.78 47.33 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.185 -0.461 . . . . 61.42 109.921 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 21.7 t -149.65 143.82 25.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.073 0.463 . . . . 45.12 110.555 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -93.37 -41.75 9.67 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.004 -0.544 . . . . 74.25 110.781 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -109.2 3.56 21.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.833 -0.621 . . . . 64.51 110.992 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 23.7 t-20 75.53 -9.64 1.38 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.559 0.744 . . . . 70.43 111.055 177.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.5 t -93.08 -42.98 13.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.071 -0.513 . . . . 62.03 110.815 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -99.68 106.76 18.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.131 -0.486 . . . . 31.13 110.043 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.454 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 98.4 m95 -99.58 120.41 39.61 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.915 0.388 . . . . 73.32 110.572 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 49.3 m -113.36 126.14 28.62 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.265 -0.425 . . . . 64.33 110.586 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.75 113.7 2.86 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.445 2.097 . . . . 61.43 111.126 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.607 HD12 HG21 ' A' ' 116' ' ' VAL . 12.8 pt -82.17 -11.52 12.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.771 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.92 142.97 3.54 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.496 -0.859 . . . . 51.33 112.546 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.514 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 34.3 ttt180 -119.0 125.13 48.66 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.433 -0.58 . . . . 71.32 109.433 175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -140.28 -176.17 4.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.048 0.451 . . . . 71.22 110.718 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.81 155.55 20.08 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.435 -0.666 . . . . 53.33 111.435 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.491 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 52.1 t80 -103.27 135.33 45.12 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.898 0.38 . . . . 74.22 110.189 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.457 ' O ' HD11 ' A' ' 112' ' ' LEU . 34.3 m -116.04 116.55 28.09 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.483 -0.562 . . . . 72.0 109.483 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -78.68 93.6 4.93 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.273 0.559 . . . . 73.24 110.282 -176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -131.54 177.15 7.72 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.325 -0.852 . . . . 72.42 108.867 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -95.28 -8.74 35.08 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.49 -0.484 . . . . 73.13 110.252 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.08 156.62 16.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.808 -0.633 . . . . 54.33 110.223 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -73.31 128.48 35.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.11 0.481 . . . . 75.31 111.773 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 71' ' ' GLU . 41.6 mt -84.96 125.68 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 73.22 110.06 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -98.0 115.32 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.969 0.414 . . . . 52.24 110.789 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -107.83 107.27 17.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.154 -0.475 . . . . 64.43 110.257 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -82.06 92.1 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.746 -0.661 . . . . 74.31 109.49 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.607 HG21 HD12 ' A' ' 100' ' ' ILE . 28.9 m -98.56 176.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.45 -0.796 . . . . 61.51 111.937 -171.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.89 134.23 52.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.379 -0.828 . . . . 61.31 110.594 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.735 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 19.2 m -77.28 117.72 19.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.071 -0.513 . . . . 74.1 110.7 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 8.2 tt -147.62 143.21 19.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.982 -0.554 . . . . 75.33 110.802 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.551 ' HD3' ' OD1' ' A' ' 64' ' ' ASN . 0.7 OUTLIER -81.47 121.97 26.94 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.522 -0.547 . . . . 74.03 109.522 173.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.58 159.72 44.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.211 -0.45 . . . . 61.33 110.944 -178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.433 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 39.9 ttt180 -107.53 -27.47 10.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.45 0.643 . . . . 72.53 109.728 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CE2' ' HB2' ' A' ' 94' ' ' ASN . 71.8 m-85 -114.17 146.26 40.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.691 -0.686 . . . . 74.24 110.071 -176.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.503 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.3 tt -133.62 140.3 46.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.452 -0.573 . . . . 70.04 109.452 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.454 ' HB2' ' CZ3' ' A' ' 97' ' ' TRP . 49.6 ttp180 -127.97 124.54 37.51 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.221 0.534 . . . . 72.45 111.394 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.3 tp -95.24 120.28 35.19 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.315 -0.857 . . . . 45.54 109.428 174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.9 m -114.84 122.23 45.69 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.077 0.465 . . . . 70.04 110.804 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.6 mm -102.24 97.19 8.13 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 108.87 -0.789 . . . . 72.14 108.87 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 73.9 Cg_endo -73.48 -173.48 1.33 Allowed 'Trans proline' 0 CA--C 1.522 -0.123 0 C-N-CA 122.938 2.425 . . . . 74.43 113.058 -176.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.552 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 16.2 t0 -129.26 75.36 1.64 Allowed 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.4 -0.963 . . . . 65.52 108.4 166.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -109.53 -50.94 2.93 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.273 -0.876 . . . . 71.31 112.094 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -115.4 28.77 7.68 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.24 -0.981 . . . . 74.52 113.916 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 106.55 26.06 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 119.858 -1.163 . . . . 64.11 113.007 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.552 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 6.5 m-20 -70.81 132.12 44.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.725 0.298 . . . . 62.52 110.281 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.1 m -109.54 179.37 4.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.5 -0.318 . . . . 73.24 111.045 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 6.8 p -90.02 16.05 9.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.368 0.604 . . . . 65.21 111.544 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.471 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 78.2 t -110.43 114.83 48.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.014 -0.539 . . . . 72.13 109.65 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . . . -135.38 130.97 35.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.498 -0.319 . . . . 73.11 110.566 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.3 106.11 5.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.085 0.469 . . . . 71.45 110.879 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 39.8 mt -129.46 135.79 60.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.817 -0.629 . . . . 72.24 109.432 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 41' ' ' PHE . 57.5 mtt180 -66.95 -71.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.096 -0.335 . . . . 75.42 110.096 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -145.42 162.42 37.35 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.544 0.688 . . . . 75.12 111.98 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.88 124.7 48.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.507 -1.224 . . . . 75.32 108.18 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -126.35 162.17 26.14 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.637 -0.505 . . . . 72.32 109.637 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 95.1 t -136.03 134.93 50.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.876 0.37 . . . . 71.41 111.382 -173.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.592 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 65.0 mttp -95.76 131.86 41.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.453 -0.573 . . . . 75.42 109.453 170.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -176.22 -169.65 37.96 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.194 -1.003 . . . . 74.35 112.474 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 42.2 m -118.81 132.86 56.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.35 -0.241 . . . . 64.21 110.35 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.82 121.37 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.265 -0.425 . . . . 71.1 110.11 178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.464 HD11 ' HB2' ' A' ' 66' ' ' GLN . 73.5 mt -106.01 140.03 25.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.979 0.418 . . . . 61.11 110.457 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -123.07 136.85 54.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.04 -0.527 . . . . 61.33 110.182 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 86.4 mt -107.66 12.89 27.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.256 0.55 . . . . 73.14 109.928 178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.97 -177.65 6.74 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.403 -0.817 . . . . 54.54 110.688 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -68.35 145.27 54.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.137 0.494 . . . . 74.41 111.786 -174.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -121.46 107.24 12.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.642 -0.708 . . . . 71.12 109.838 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -110.16 -28.22 8.76 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.844 -0.428 . . . . 74.51 109.844 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -69.89 93.74 0.78 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 74.03 109.992 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.1 t-80 -158.94 86.49 0.84 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.711 -0.677 . . . . 64.32 110.288 -174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.687 -0.688 . . . . 72.23 109.721 176.258 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 mtm . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.871 -0.418 . . . . 62.54 109.871 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -124.42 140.11 12.35 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.771 -0.728 . . . . 73.24 112.249 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.1 m -81.95 -24.65 35.42 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.157 0.503 . . . . 70.13 109.807 176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -77.4 136.75 38.44 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.298 -0.63 . . . . 61.22 109.298 172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 149' ' ' ILE . 39.7 mm -71.43 136.45 25.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.309 -0.405 . . . . 71.34 111.067 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.1 m -73.15 109.08 6.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 72.54 109.826 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -85.94 26.85 0.94 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.922 -0.581 . . . . 74.2 111.383 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -74.77 -6.09 46.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 43.21 111.463 -178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -122.2 2.87 10.59 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.608 -0.806 . . . . 74.32 112.399 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.7 m0 -81.46 134.9 35.6 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.427 -0.212 . . . . 73.45 110.427 -175.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -130.3 155.72 45.85 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.734 -0.386 . . . . 72.53 110.497 176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.6 t -90.05 108.27 19.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.825 -0.625 . . . . 75.3 109.981 179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.6 mt -74.77 -49.24 21.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.017 -0.538 . . . . 75.44 110.477 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -143.42 134.18 25.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.602 -0.726 . . . . 73.4 110.015 -176.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.479 ' CE1' ' HG2' ' A' ' 18' ' ' GLN . 54.3 p90 -135.33 148.91 49.61 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.706 -0.479 . . . . 73.12 109.706 175.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.2 m -86.62 -44.61 11.74 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 73.32 110.388 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -143.8 144.37 31.76 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.187 0.517 . . . . 50.32 111.077 -174.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG2' ' CE1' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -149.92 148.29 28.92 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.184 -1.043 . . . . 63.44 108.184 175.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 8.5 tp10 -119.4 89.1 3.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.354 0.597 . . . . 50.05 110.963 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB2' ' CD2' ' A' ' 29' ' ' LEU . . . -100.38 -21.77 15.29 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.546 -0.752 . . . . 74.44 110.088 175.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m -83.71 -44.46 14.45 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.673 -0.694 . . . . 64.4 110.93 -171.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -37.23 40.05 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.911 -0.661 . . . . 72.52 112.35 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.508 ' HG2' ' HG3' ' A' ' 19' ' ' GLU . 28.6 mm-40 -79.98 -28.49 39.53 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.645 0.239 . . . . 70.43 111.645 -177.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 121.19 -83.33 0.36 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.414 -0.898 . . . . 64.44 112.585 176.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.77 141.84 8.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.537 0.208 . . . . 65.45 111.001 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.51 -3.38 17.47 Favored Glycine 0 C--N 1.333 0.369 0 CA-C-N 116.168 -0.469 . . . . 70.54 113.564 174.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -129.94 147.3 51.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.78 -0.452 . . . . 75.51 109.78 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.31 3.06 90.25 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.709 -0.556 . . . . 74.34 111.709 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.691 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 80.6 mt -84.31 144.49 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.273 -0.269 . . . . 72.12 110.273 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.95 -24.51 66.07 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.997 0.427 . . . . 74.52 110.409 179.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 19.4 ptpt -72.74 -25.26 61.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.996 -0.547 . . . . 74.41 111.037 178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.855 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 61.2 m -71.58 -18.67 62.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 75.42 110.387 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.23 -15.04 61.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.818 -0.628 . . . . 62.12 110.273 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -131.23 22.24 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.824 -0.625 . . . . 71.25 109.593 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.855 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 13.6 t70 -72.54 -58.7 3.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.609 -0.723 . . . . 64.43 110.402 -175.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.57 39.25 0.79 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.023 -0.608 . . . . 74.41 112.203 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -148.16 122.58 9.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.866 0.365 . . . . 64.23 110.265 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.2 p -74.9 7.14 3.38 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.101 0.778 . . . . 61.42 113.101 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -106.7 -19.72 13.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 121.035 -0.266 . . . . 75.44 111.051 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -88.65 168.93 12.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 110.03 -0.359 . . . . 72.24 110.03 178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.438 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 56.2 p90 -161.6 163.62 29.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.036 0.446 . . . . 73.33 111.586 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 32.5 t90 -107.02 143.02 35.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.294 -0.866 . . . . 72.34 109.072 172.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.405 ' CD2' ' HB2' ' A' ' 139' ' ' ALA . 51.3 t-80 -138.96 145.72 40.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.126 -0.694 . . . . 61.52 109.126 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.1 149.73 39.02 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.118 -0.327 . . . . 64.4 110.118 176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 50' ' ' SER . 63.1 tttm -61.06 119.37 8.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.428 -0.351 . . . . 73.31 110.619 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.465 ' CD1' ' HG2' ' A' ' 19' ' ' GLU . 69.8 p-90 -118.29 -27.13 6.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 70.35 110.307 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.32 127.25 32.54 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.729 -0.471 . . . . 75.45 109.729 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.85 5.22 89.97 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.725 -0.75 . . . . 65.44 111.828 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.57 148.5 9.0 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.491 -0.643 . . . . 74.42 111.491 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 20.6 m -78.85 150.19 32.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 110.117 -0.327 . . . . 44.2 110.117 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 55' ' ' TYR . 2.0 t70 -80.42 145.48 59.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.021 -176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 20.3 Cg_endo -62.25 129.98 28.84 Favored 'Trans proline' 0 CA--C 1.532 0.386 0 C-N-CA 122.632 2.221 . . . . 71.13 113.327 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.2 158.69 66.5 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 74.24 110.125 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.0 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 5.3 Cg_exo -76.5 161.58 93.48 Favored 'Cis proline' 0 C--N 1.345 0.359 0 C-N-CA 124.284 -1.132 . . . . 75.25 113.295 0.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.1 m-85 -96.11 138.46 33.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.899 -0.591 . . . . 71.41 109.579 175.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' A' ' 125' ' ' ARG . 6.2 t70 -132.67 123.69 26.81 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.221 -0.288 . . . . 62.22 110.221 -177.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 53.7 mt -125.39 124.18 66.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.695 0.283 . . . . 72.21 110.624 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.952 HG22 ' HG3' ' A' ' 125' ' ' ARG . 45.5 t -113.23 120.16 62.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.34 -0.391 . . . . 63.22 111.096 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 124' ' ' ILE . 4.8 mp -112.99 139.36 38.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.247 -0.433 . . . . 75.52 110.103 -178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.643 ' HB2' HD11 ' A' ' 13' ' ' LEU . 51.0 t0 -106.0 126.81 52.64 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.625 -0.509 . . . . 72.44 109.625 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.446 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.0 mtm -90.62 -6.97 53.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.092 -0.504 . . . . 74.23 110.664 -177.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HD3' ' OD2' ' A' ' 60' ' ' ASP . 31.5 mmtp 68.48 5.27 4.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.602 0.761 . . . . 74.31 112.415 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.462 ' O ' ' HA ' ' A' ' 122' ' ' ARG . 27.4 pt20 -157.94 174.16 15.68 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.492 -0.188 . . . . 61.32 110.492 -177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -88.6 124.11 33.73 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.679 -0.489 . . . . 25.42 109.679 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.446 HD12 ' SD ' ' A' ' 61' ' ' MET . 70.9 mt -132.84 133.7 58.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-O 121.012 0.435 . . . . 72.02 110.256 178.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.6 tp60 -82.76 105.41 13.76 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.684 -0.858 . . . . 61.11 108.684 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.1 mm -75.44 124.74 33.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.82 0.343 . . . . 74.01 110.483 -175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.81 -43.88 2.98 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.03 -0.532 . . . . 70.13 110.784 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -148.47 140.3 23.79 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.242 -0.436 . . . . 71.43 111.039 -176.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.31 139.45 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.297 -0.631 . . . . 62.04 109.297 176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 42.0 mt-10 -123.29 131.37 53.64 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.104 0.478 . . . . 74.1 111.101 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 65.2 mt -113.36 124.72 53.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 74.0 109.893 178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 tp -103.58 104.14 40.22 Favored Pre-proline 0 C--N 1.316 -0.851 0 N-CA-C 109.651 -0.5 . . . . 64.04 109.651 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 11.9 Cg_exo -69.27 -172.42 0.52 Allowed 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.811 2.341 . . . . 74.1 112.129 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -79.26 -24.56 42.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.164 -0.68 . . . . 71.14 109.164 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 91.02 -149.76 20.11 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.553 -0.749 . . . . 65.11 113.42 172.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.96 126.41 30.95 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.397 0.618 . . . . 70.05 109.98 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.16 38.19 4.13 Favored Glycine 0 C--N 1.316 -0.553 0 N-CA-C 110.594 -1.002 . . . . 72.42 110.594 -173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.6 t -144.95 151.3 38.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.301 -0.45 . . . . 73.51 110.222 -176.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -77.34 -65.7 0.92 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.337 -0.616 . . . . 74.34 109.337 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.532 ' HB2' ' ND2' ' A' ' 107' ' ' ASN . 2.7 m120 48.24 67.72 4.22 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 115.925 -0.58 . . . . 55.12 112.227 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 85.1 Cg_endo -85.89 30.52 0.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.813 2.342 . . . . 74.43 112.306 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 50.8 mt -77.76 127.85 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 63.32 109.795 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -98.96 -55.2 2.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.08 -0.509 . . . . 75.11 111.126 -175.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 48.0 t -128.82 138.03 55.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 40.54 110.739 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.1 m -126.59 133.59 68.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.237 -0.438 . . . . 74.11 110.169 177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 42.2 mt-10 -115.02 126.67 55.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.982 0.42 . . . . 63.52 110.975 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -107.56 134.06 51.12 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.773 -0.649 . . . . 63.43 110.248 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.66 151.54 51.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.33 -0.395 . . . . 72.32 110.398 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.76 149.97 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.084 -0.339 . . . . 72.53 110.084 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 37.8 t -147.58 145.35 28.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.031 0.443 . . . . 62.52 111.5 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -81.52 -43.25 19.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.8 -0.636 . . . . 72.33 109.842 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 1.0 OUTLIER -109.72 -1.97 17.67 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.268 -0.878 . . . . 70.31 112.394 -170.247 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 28.3 t-20 76.27 -7.96 1.73 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.972 0.509 . . . . 73.23 111.079 178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.5 t -94.69 -51.72 10.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.231 0.539 . . . . 42.24 109.804 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -92.64 105.71 17.81 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.43 -0.805 . . . . 73.14 110.328 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.522 ' CZ3' ' HB2' ' A' ' 125' ' ' ARG . 96.6 m95 -97.63 121.75 39.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.853 0.359 . . . . 73.35 111.504 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 35.5 m -97.36 128.95 33.13 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.028 -0.533 . . . . 61.21 110.046 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 6.0 Cg_exo -75.22 108.69 2.77 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.463 2.109 . . . . 73.4 110.315 174.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.507 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 19.8 pt -82.37 -19.1 10.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.377 -0.374 . . . . 63.55 111.206 -174.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 176.19 131.06 1.41 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.037 -1.078 . . . . 31.32 113.002 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.493 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 61.4 ttt180 -112.91 115.21 28.08 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.917 -0.401 . . . . 70.32 109.917 172.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -137.4 176.99 8.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.723 0.297 . . . . 72.23 110.853 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -95.61 157.59 21.85 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.902 -0.666 . . . . 74.34 112.057 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -94.14 148.29 22.33 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.719 -0.475 . . . . 71.42 109.719 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.678 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.4 m -131.21 115.93 16.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.501 -0.318 . . . . 55.35 110.644 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 81' ' ' ASN . 48.7 t-20 -69.67 96.63 0.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.165 0.507 . . . . 73.14 110.09 174.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.424 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 12.4 pt20 -136.94 174.01 11.08 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.652 -0.704 . . . . 71.43 109.284 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -92.55 -8.38 44.56 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.232 0.539 . . . . 73.35 110.752 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.42 158.78 16.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.957 -0.565 . . . . 63.53 110.618 -178.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.18 138.21 58.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.269 -0.423 . . . . 73.22 110.945 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.678 HD21 ' HB ' ' A' ' 106' ' ' THR . 39.7 mt -90.95 110.76 22.01 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.826 -0.625 . . . . 75.42 110.461 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.43 120.19 26.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.198 0.523 . . . . 64.05 110.271 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -110.29 107.5 17.27 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.394 -0.821 . . . . 70.24 110.007 177.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -80.02 98.66 7.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.209 -0.663 . . . . 74.31 109.209 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.507 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 30.8 m -100.78 -178.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.911 -0.586 . . . . 54.14 111.801 -171.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.03 129.59 40.31 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.301 -0.863 . . . . 73.11 110.776 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 18.8 m -75.65 106.81 7.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.038 -0.528 . . . . 62.04 110.033 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.1 tt -150.18 148.3 15.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.374 -0.375 . . . . 74.35 110.244 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.688 ' HG3' HD12 ' A' ' 150' ' ' ILE . 4.5 ttpm? -84.82 135.84 33.93 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.891 -0.411 . . . . 63.32 109.891 177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.75 163.22 40.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.571 -0.286 . . . . 64.53 110.982 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 63' ' ' GLN . 41.0 ttt180 -108.73 -33.3 7.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.362 0.601 . . . . 72.12 109.462 171.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -109.3 145.51 35.85 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.655 -0.702 . . . . 74.34 109.891 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 59' ' ' ILE . 13.1 tt -130.8 139.1 52.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.407 -0.59 . . . . 75.02 109.407 177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.952 ' HG3' HG22 ' A' ' 58' ' ' VAL . 1.6 ttm180 -125.12 139.44 53.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.915 0.388 . . . . 65.51 111.021 -176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 54.7 tp -115.11 120.51 40.05 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.671 -0.695 . . . . 62.24 109.458 174.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 42.1 m -115.55 128.55 56.06 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.883 0.373 . . . . 74.14 110.798 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 35.1 mm -108.35 88.77 5.23 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.171 -0.677 . . . . 54.54 109.171 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 1.0 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 75.8 Cg_endo -87.95 131.42 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.957 2.438 . . . . 72.21 113.708 -174.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.528 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 20.3 t0 -80.1 65.0 5.12 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.044 0.926 . . . . 75.11 109.246 172.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -113.09 -19.14 11.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.687 -1.142 . . . . 41.43 110.02 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -131.49 29.04 3.5 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.611 -0.804 . . . . 25.3 112.792 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 94.69 24.91 16.59 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 120.506 -0.854 . . . . 74.04 113.321 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.528 ' HB2' ' HA ' ' A' ' 130' ' ' ASP . 3.2 m-20 -70.25 130.85 43.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.968 0.413 . . . . 74.0 111.193 -176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.567 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.3 m -92.49 157.26 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.245 -0.434 . . . . 70.22 110.363 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 10.0 p -67.89 -20.98 65.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.032 0.444 . . . . 73.21 111.908 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.45 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 t -80.47 93.57 2.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.205 0.526 . . . . 72.31 110.679 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -114.39 136.05 53.42 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.076 -0.511 . . . . 53.1 110.313 177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 42' ' ' TRP . . . -152.02 108.36 3.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.229 -0.441 . . . . 61.3 110.86 -178.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.7 mt -122.61 136.22 60.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.823 -0.806 . . . . 75.34 108.823 178.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 66.7 mtt180 -74.62 -53.52 9.2 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.852 -0.339 . . . . 65.44 111.32 -178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.28 135.56 15.87 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.474 -0.49 . . . . 75.21 111.07 -173.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.401 ' C ' HD23 ' A' ' 143' ' ' LEU . 9.3 tt -112.75 121.14 43.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.371 -0.603 . . . . 53.51 109.371 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.7 158.26 35.25 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.922 0.391 . . . . 61.31 110.55 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 67.2 t -131.56 136.54 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.104 -0.498 . . . . 63.44 110.379 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -101.7 125.42 48.35 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.207 -0.664 . . . . 73.01 109.207 172.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -169.1 -168.32 30.96 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.395 -0.907 . . . . 73.23 112.549 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 31.6 m -115.7 131.25 56.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.582 0.229 . . . . 74.41 110.948 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.432 HD11 HG23 ' A' ' 5' ' ' ILE . 37.7 mm -76.95 118.07 22.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.086 -0.506 . . . . 60.43 110.374 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.688 HD12 ' HG3' ' A' ' 120' ' ' LYS . 39.7 mt -109.29 132.95 56.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.229 0.538 . . . . 70.54 110.607 -179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.412 HD22 ' C ' ' A' ' 150' ' ' ILE . 0.9 OUTLIER -117.76 101.29 8.2 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.841 -0.618 . . . . 65.12 110.323 177.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 95.9 mt -84.91 92.78 8.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.286 -0.415 . . . . 75.44 109.911 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -70.9 105.66 3.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.508 0.67 . . . . 72.03 111.391 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -143.02 -173.18 3.84 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.871 -1.059 . . . . 75.13 108.284 176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -83.48 73.11 10.22 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.611 0.719 . . . . 72.24 110.445 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.92 124.47 12.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.554 -1.203 . . . . 70.33 108.792 177.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -65.63 97.99 0.35 Allowed 'General case' 0 C--N 1.321 -0.646 0 O-C-N 123.57 0.544 . . . . 64.33 110.149 -176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -120.94 151.77 39.31 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.947 -0.57 . . . . 62.4 110.693 -173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 72.1 110.464 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.626 0.25 . . . . 43.12 110.527 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.24 143.28 10.05 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.491 -0.862 . . . . 74.24 112.282 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.8 t -92.59 -15.71 26.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.058 0.456 . . . . 73.04 110.684 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.3 p -95.41 161.16 14.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.969 -0.56 . . . . 73.51 111.099 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.676 HG21 HD13 ' A' ' 65' ' ' ILE . 47.8 mm -85.29 137.01 21.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 62.41 110.115 176.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.8 m -66.92 118.72 10.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.208 -0.451 . . . . 74.1 110.381 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -92.2 25.79 2.77 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.095 0.474 . . . . 51.12 110.621 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.13 -52.93 61.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.4 -0.818 . . . . 75.21 112.23 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.44 6.53 68.23 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.532 -0.842 . . . . 74.21 113.304 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -70.54 134.15 47.42 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.799 0.299 . . . . 72.24 110.403 -177.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 6.8 pt-20 -130.71 161.83 30.8 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.983 0.421 . . . . 64.43 110.532 177.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -98.92 113.84 34.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.791 -0.64 . . . . 73.21 110.118 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 60' ' ' ASP . 79.4 mt -83.36 -47.89 10.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.996 -0.547 . . . . 75.31 110.478 -178.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.3 t -137.36 140.41 41.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.815 -0.629 . . . . 64.42 110.164 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -150.37 148.52 28.9 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.588 -0.523 . . . . 73.1 109.588 179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.4 m -90.73 -36.49 14.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.931 0.396 . . . . 72.1 111.065 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -155.22 154.46 32.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.069 0.461 . . . . 64.52 111.243 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.429 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 10.1 pt20 -165.63 135.81 3.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.192 -0.913 . . . . 71.52 108.81 174.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.494 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 9.0 tp10 -88.98 94.79 10.07 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.33 0.586 . . . . 73.22 110.546 -175.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -99.49 -3.18 34.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.654 -0.703 . . . . 73.12 111.49 -176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -111.39 -51.58 2.85 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.823 0.344 . . . . 75.23 110.131 -178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.41 92.43 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.146 -0.549 . . . . 73.31 112.14 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 61.2 mm-40 -96.79 -58.43 2.04 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.888 -0.412 . . . . 64.22 109.888 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.16 -177.24 16.6 Favored Glycine 0 C--O 1.227 -0.334 0 C-N-CA 120.449 -0.881 . . . . 63.44 112.998 174.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.15 117.38 10.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.974 0.416 . . . . 75.13 110.355 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.72 -5.95 54.48 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.888 -0.672 . . . . 74.14 112.343 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -137.6 128.52 27.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.636 0.255 . . . . 62.14 110.447 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.86 -5.26 83.05 Favored Glycine 0 C--N 1.322 -0.234 0 C-N-CA 120.601 -0.809 . . . . 73.23 112.438 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.49 HD12 ' HE3' ' A' ' 31' ' ' LYS . 82.2 mt -73.95 150.99 40.47 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.142 -0.318 . . . . 75.11 110.142 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.583 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.94 -22.25 66.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.001 0.429 . . . . 62.11 110.953 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.49 ' HE3' HD12 ' A' ' 29' ' ' LEU . 16.8 pttp -75.08 -24.17 58.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.57 . . . . 62.13 110.816 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.945 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 75.0 m -76.51 -10.71 59.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.941 -0.572 . . . . 63.11 111.087 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.9 tp -70.77 -15.3 62.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.616 0.722 . . . . 75.15 109.417 174.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.46 HG21 HD13 ' A' ' 59' ' ' ILE . 28.4 pt -132.01 21.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.426 -0.806 . . . . 51.41 109.857 177.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.945 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 1.7 t70 -68.22 -48.54 64.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.843 -0.617 . . . . 61.33 109.931 -174.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' CD ' ' A' ' 142' ' ' GLU . . . 117.74 31.12 1.68 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.809 -0.71 . . . . 74.5 114.077 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.589 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 9.7 t70 -153.27 153.95 33.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.981 0.89 . . . . 74.14 111.336 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.9 p -72.53 -18.36 61.65 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.272 0.471 . . . . 74.02 112.272 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.589 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 12.7 pt-20 -98.12 3.43 49.15 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 120.404 -0.518 . . . . 63.24 111.189 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 p -102.27 157.05 17.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.915 -0.772 . . . . 72.33 108.915 168.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 51.2 p90 -166.98 158.07 12.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.984 0.421 . . . . 65.12 111.2 -175.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.583 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.7 t90 -102.35 134.91 44.89 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.402 -0.817 . . . . 72.03 109.051 172.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -134.78 136.16 42.37 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.469 -0.567 . . . . 73.21 109.469 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.18 139.79 58.7 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.945 -0.391 . . . . 54.12 109.945 175.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 36.9 ttpt -62.56 118.84 8.14 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.717 -0.475 . . . . 75.15 109.717 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -112.36 -29.38 7.55 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.594 -0.275 . . . . 75.41 110.622 -177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -74.25 125.47 28.51 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.978 0.418 . . . . 63.5 110.17 177.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.05 -3.09 84.46 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 73.25 112.145 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.85 132.61 7.08 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.874 -0.679 . . . . 41.25 111.9 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 49.7 m -78.91 149.57 32.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 74.24 111.341 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -71.13 157.69 89.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 72.23 110.326 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.0 146.56 41.82 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.326 2.018 . . . . 71.32 112.123 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.3 mt -73.49 156.95 88.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.833 -0.621 . . . . 73.53 109.707 173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.806 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 84.0 Cg_endo -82.78 156.46 76.07 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.779 -1.342 . . . . 73.21 113.62 0.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.21 117.89 30.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.539 -0.755 . . . . 63.12 109.234 174.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.456 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 18.5 t70 -117.42 125.62 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.305 -0.258 . . . . 61.31 110.305 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 61.4 mt -122.83 115.58 46.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.831 0.348 . . . . 63.24 110.94 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -104.14 116.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.957 -0.565 . . . . 75.24 110.306 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 34' ' ' ILE . 81.8 mt -115.96 136.75 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.236 -0.438 . . . . 73.31 110.844 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.67 ' HB2' HD11 ' A' ' 13' ' ' LEU . 53.5 t0 -101.54 120.28 40.07 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.47 -0.567 . . . . 64.41 109.47 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.3 mtm -85.97 -5.94 59.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.393 -0.367 . . . . 65.1 110.819 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.488 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 73.2 mmtt 67.6 7.34 5.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.809 -0.632 . . . . 74.1 112.159 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.798 ' HA ' HD21 ' A' ' 152' ' ' LEU . 24.1 pt20 -163.93 155.96 16.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.707 0.289 . . . . 71.31 110.459 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.541 ' ND2' ' HB3' ' A' ' 152' ' ' LEU . 79.5 m-20 -74.54 128.74 36.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.601 . . . . 72.31 109.838 177.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.676 HD13 HG21 ' A' ' 5' ' ' ILE . 58.5 mt -133.46 135.88 55.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 120.857 0.36 . . . . 73.43 110.165 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.484 HE21 ' HB3' ' A' ' 118' ' ' SER . 58.5 tp60 -81.51 102.68 10.73 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.875 -0.787 . . . . 73.33 108.875 175.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.703 ' O ' ' HA ' ' A' ' 118' ' ' SER . 21.4 mm -72.93 118.5 18.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.285 -177.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.12 -41.97 3.43 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.351 -0.386 . . . . 74.41 110.843 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -148.64 144.22 27.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.301 -0.409 . . . . 62.0 110.277 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.02 129.93 73.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.961 -0.385 . . . . 65.34 109.961 177.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -105.89 131.17 53.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.935 0.398 . . . . 74.51 110.468 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 38.4 mt -112.6 118.57 35.44 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.848 -0.615 . . . . 63.32 109.449 174.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.509 ' HG ' ' HD2' ' A' ' 141' ' ' ARG . 24.2 tp -102.36 101.52 20.1 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 115.82 -0.627 . . . . 75.22 109.328 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 17.0 Cg_exo -65.25 166.59 18.64 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.5 2.133 . . . . 64.33 111.111 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.832 ' HA ' ' HG3' ' A' ' 141' ' ' ARG . 76.8 ttt180 -72.01 -13.69 61.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 64.51 111.13 -175.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.95 -174.53 27.8 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.713 -0.756 . . . . 51.33 111.449 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 74.3 mtp180 -89.49 139.28 30.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 120.962 0.411 . . . . 72.31 110.04 -178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 132.71 -35.19 2.36 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.285 -1.126 . . . . 54.21 110.285 -174.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.5 m -113.13 111.83 22.78 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.064 -0.717 . . . . 65.54 109.064 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -60.51 131.46 50.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.403 0.62 . . . . 75.24 110.952 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.685 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 49.9 t-20 -124.88 102.7 31.46 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.597 -0.729 . . . . 73.05 110.133 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.66 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 89.6 Cg_endo -90.88 28.14 0.41 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.305 2.67 . . . . 74.02 113.731 -177.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 80.1 mt -82.51 117.46 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 75.33 110.512 175.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -92.05 -57.53 2.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.618 -0.719 . . . . 64.34 110.902 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 57.9 t -116.66 138.23 47.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.574 . . . . 61.44 111.09 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.41 138.67 54.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.157 -0.474 . . . . 60.23 110.146 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 89.9 mt-10 -119.81 127.68 53.0 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.035 0.445 . . . . 73.32 110.617 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB2' HG13 ' A' ' 100' ' ' ILE . 53.5 m-85 -106.3 132.85 51.85 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.761 -0.654 . . . . 60.02 109.978 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.7 150.31 52.19 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.588 -0.278 . . . . 74.15 110.408 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.18 150.36 44.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.766 0.317 . . . . 72.34 111.169 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.3 t -150.53 149.11 29.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.303 -0.628 . . . . 65.51 109.303 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.699 ' HA ' ' H ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -90.65 -33.88 15.65 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 122.163 -0.335 . . . . 64.02 111.755 -177.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -128.6 20.22 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.602 -0.439 . . . . 73.01 111.222 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 65.79 47.4 2.1 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.426 0.632 . . . . 61.04 110.518 174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 46.7 t -130.54 -74.24 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.042 -0.526 . . . . 62.5 109.894 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -83.29 105.82 14.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.475 . . . . 74.24 110.327 178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -91.06 108.32 19.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.274 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.0 m -94.56 123.67 57.52 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.874 -0.603 . . . . 64.52 110.181 177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.48 102.55 0.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.412 2.075 . . . . 51.21 111.27 174.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 22.4 pt -75.79 -15.64 15.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.933 -0.576 . . . . 53.13 111.112 -177.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.6 136.57 2.28 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.809 -1.186 . . . . 72.42 113.509 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 40.3 ttt180 -119.67 114.62 22.46 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.514 -0.921 . . . . 64.15 108.514 169.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -135.87 179.62 6.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.867 0.365 . . . . 73.54 110.755 -174.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -93.49 135.17 12.46 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.788 -0.642 . . . . 64.32 112.12 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -94.29 148.08 22.57 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.792 -0.448 . . . . 72.23 109.792 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.461 ' O ' HD11 ' A' ' 112' ' ' LEU . 47.0 m -142.11 120.36 12.26 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.71 -0.478 . . . . 71.12 109.71 176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.685 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 12.0 t30 -77.09 91.66 3.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.51 0.671 . . . . 75.34 110.935 -176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -118.26 -171.89 2.16 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.002 -0.999 . . . . 74.44 109.217 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -95.83 -26.05 15.79 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.935 0.397 . . . . 71.15 110.63 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -85.79 155.32 21.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 35.12 110.624 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -70.86 141.15 51.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.267 -0.424 . . . . 74.25 111.013 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.461 HD11 ' O ' ' A' ' 106' ' ' THR . 16.0 mt -98.2 106.45 18.73 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 71.34 110.083 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -80.3 116.7 20.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.885 0.374 . . . . 72.44 110.569 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -105.92 112.62 25.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.667 -0.697 . . . . 72.54 110.578 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -77.22 93.25 3.93 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.377 -0.601 . . . . 74.53 109.377 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.5 m -96.79 177.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.543 -0.753 . . . . 75.33 111.495 -173.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -67.59 132.87 48.37 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.321 -0.854 . . . . 74.14 110.459 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 41.8 m -74.92 122.25 23.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.872 -0.604 . . . . 75.33 110.51 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.5 tt -152.84 143.43 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.896 -0.593 . . . . 73.45 110.538 -177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.576 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -88.89 112.61 23.49 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.168 -0.678 . . . . 73.21 109.168 174.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.95 161.96 36.59 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.449 -0.341 . . . . 62.35 111.082 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.699 ' H ' ' HA ' ' A' ' 92' ' ' GLU . 34.7 ttt180 -109.89 -31.85 7.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.321 0.581 . . . . 61.41 110.159 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -106.05 145.92 30.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.705 -0.679 . . . . 73.34 109.474 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.416 HG23 ' HB ' ' A' ' 59' ' ' ILE . 14.7 tt -129.56 140.05 50.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.546 -0.539 . . . . 71.23 109.546 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.456 ' HD2' ' OD2' ' A' ' 56' ' ' ASP . 57.5 ttp180 -130.29 127.02 38.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.938 0.399 . . . . 73.32 111.127 -176.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.18 115.94 31.02 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.646 -0.707 . . . . 72.01 109.236 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 34.7 m -112.04 120.52 42.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.031 0.444 . . . . 74.13 110.91 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.7 96.06 8.4 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.175 -0.676 . . . . 73.35 109.175 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.806 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 98.0 Cg_endo -79.73 -176.8 3.43 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.513 2.142 . . . . 73.2 112.617 -176.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -123.69 67.73 1.02 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.912 0.863 . . . . 53.22 108.867 170.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -135.8 18.07 3.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.66 -1.154 . . . . 73.11 110.1 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -148.84 2.1 0.62 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.168 -1.015 . . . . 61.05 113.729 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 100.99 15.75 27.64 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.32 -0.943 . . . . 41.24 112.045 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -61.04 156.52 17.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.965 0.412 . . . . 73.34 110.958 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 22.4 m -123.43 -179.41 4.32 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.068 -0.515 . . . . 75.51 110.199 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 6.6 p -85.06 5.0 31.36 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.219 0.533 . . . . 74.21 111.993 -177.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 46.6 t -103.05 128.56 55.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.661 -0.496 . . . . 60.21 109.661 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -145.48 131.92 19.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.7 -0.227 . . . . 70.4 110.653 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -143.36 105.34 4.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.091 0.472 . . . . 63.02 111.145 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 19.0 mt -127.95 133.31 67.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.363 -0.606 . . . . 65.44 109.363 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.832 ' HG3' ' HA ' ' A' ' 75' ' ' ARG . 66.9 mtt180 -64.76 -71.78 0.17 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.345 0.593 . . . . 73.33 109.89 176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 36' ' ' GLY . 61.5 mm-40 -140.09 144.51 36.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.39 -0.823 . . . . 64.25 111.7 -172.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt -107.48 119.61 39.89 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.825 -1.176 . . . . 73.3 107.825 168.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.7 141.77 51.7 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.936 0.398 . . . . 72.32 110.557 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 41.3 t -111.11 133.49 56.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.241 -0.436 . . . . 74.22 110.678 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -107.49 105.24 15.05 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.75 -0.833 . . . . 63.33 108.75 175.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -152.03 -150.05 5.26 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.871 -0.68 . . . . 73.34 111.966 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 m -132.83 133.85 43.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.503 0.192 . . . . 74.25 110.589 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.621 HD11 HG23 ' A' ' 5' ' ' ILE . 42.4 mm -75.58 130.37 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.955 0.407 . . . . 75.54 110.988 -178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.576 HD12 ' HG2' ' A' ' 120' ' ' LYS . 34.3 mt -123.9 150.83 28.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.796 -0.638 . . . . 72.04 109.749 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.7 168.39 18.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.34 0.59 . . . . 62.43 111.008 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.798 HD21 ' HA ' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -154.41 156.13 36.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.011 -0.995 . . . . 73.42 109.87 175.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.81 11.32 25.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.128 -0.487 . . . . 70.32 111.174 -176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -91.11 94.07 9.43 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.924 -0.58 . . . . 72.43 109.439 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -111.41 127.57 55.71 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.009 0.433 . . . . 71.23 111.125 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -112.44 107.1 15.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.831 -0.622 . . . . 75.13 109.995 177.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -105.67 172.1 6.98 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.169 -0.468 . . . . 53.12 111.357 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -121.8 100.6 7.09 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.65 -0.704 . . . . 73.11 109.603 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 41.3 m170 . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.525 -0.307 . . . . 73.54 110.582 -178.288 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.8 ttm . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 120.79 0.329 . . . . 54.24 110.353 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.98 157.27 16.81 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.618 -0.593 . . . . 52.14 111.618 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.3 t -77.86 -29.36 50.35 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.875 0.369 . . . . 64.41 110.325 178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.0 p -102.37 135.61 43.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.126 -0.488 . . . . 70.41 110.317 177.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.782 HG23 HD11 ' A' ' 149' ' ' ILE . 42.1 mm -70.9 137.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.781 -0.645 . . . . 63.23 111.83 -174.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.1 m -69.08 108.16 3.46 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.958 -0.564 . . . . 73.22 110.174 175.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -87.01 10.34 16.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 74.1 111.168 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -72.06 -7.5 49.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.152 -0.476 . . . . 53.11 111.654 -174.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 62' ' ' LYS . . . -120.19 4.59 12.44 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.263 -0.97 . . . . 60.53 113.076 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.53 ' HB2' HD12 ' A' ' 34' ' ' ILE . 34.8 m0 -80.3 156.81 26.61 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 120.635 0.255 . . . . 74.23 110.601 -176.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.581 ' CD ' ' HE3' ' A' ' 62' ' ' LYS . 3.2 pm0 -141.89 153.02 44.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.143 0.497 . . . . 71.51 111.046 177.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.7 t -90.99 128.64 42.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.322 -0.399 . . . . 54.14 110.186 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.467 HD12 HG12 ' A' ' 58' ' ' VAL . 57.4 mt -89.42 -49.81 6.48 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.243 0.544 . . . . 61.14 110.097 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.2 p -150.7 143.84 24.79 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.681 -0.69 . . . . 74.24 110.587 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -139.77 147.7 41.18 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.501 -0.772 . . . . 74.24 109.087 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.7 m -85.47 -33.31 21.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.903 0.382 . . . . 74.21 110.81 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.1 t -156.27 155.02 31.62 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.871 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -168.03 143.05 3.64 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.602 -0.888 . . . . 64.53 108.602 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.9 tp10 -94.18 115.42 27.69 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.083 0.468 . . . . 64.23 110.124 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -127.36 3.74 6.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.747 -0.66 . . . . 53.12 110.899 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.6 m -121.74 -42.13 2.43 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.155 -0.475 . . . . 70.4 110.923 -177.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.49 -47.78 15.43 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.809 -0.71 . . . . 53.11 112.395 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -90.95 -2.72 57.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.972 0.415 . . . . 60.24 111.237 -179.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.27 -165.26 31.31 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.859 -0.686 . . . . 74.41 112.332 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.25 126.08 50.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.962 0.41 . . . . 73.14 110.566 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.57 -6.53 55.26 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.827 -0.701 . . . . 72.21 111.728 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -135.57 123.97 23.35 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.407 -0.59 . . . . 74.35 109.407 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.16 -7.88 58.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.015 -0.612 . . . . 74.43 111.944 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 90.1 mt -75.79 151.87 37.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.778 0.323 . . . . 71.42 110.472 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.1 -25.27 65.23 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.009 0.433 . . . . 52.33 110.765 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -72.85 -20.47 61.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.459 . . . . 74.25 111.672 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 60.4 m -73.01 -18.0 61.39 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.042 0.449 . . . . 54.52 110.742 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 19.4 tp -66.93 -17.5 64.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.737 -0.665 . . . . 70.05 110.219 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 10' ' ' TRP . 29.7 pt -128.39 22.39 2.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.761 -0.654 . . . . 72.45 110.45 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.659 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 26.5 t70 -70.49 -40.74 73.4 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.669 -0.696 . . . . 75.24 112.161 -171.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.32 23.08 9.87 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.651 -0.785 . . . . 32.11 112.061 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -138.18 128.83 26.58 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.49 -0.559 . . . . 72.31 109.49 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.8 p -76.83 0.56 20.28 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.029 0.751 . . . . 73.14 113.029 -173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -109.11 -7.44 15.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.572 -0.451 . . . . 62.22 111.57 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 p -92.42 149.2 21.54 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.081 -0.711 . . . . 73.53 109.081 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.57 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 49.7 p90 -153.05 166.72 31.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.946 0.403 . . . . 74.4 111.468 -174.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 44.8 t90 -108.03 138.9 43.48 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.189 -0.914 . . . . 73.2 109.385 173.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -136.31 142.62 43.9 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.036 -0.727 . . . . 63.45 109.036 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 141.61 56.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.636 -0.505 . . . . 71.35 109.636 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HB3' ' HZ2' ' A' ' 45' ' ' LYS . 2.2 ttpm? -64.17 115.22 4.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.135 -0.32 . . . . 63.22 110.135 -178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.2 p-90 -109.24 -28.94 8.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.311 -0.404 . . . . 75.21 110.805 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -76.54 113.78 14.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 73.42 110.236 -178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.87 -8.51 54.32 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.229 -0.748 . . . . 61.14 111.229 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.53 161.2 11.01 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.545 -0.622 . . . . 74.24 111.545 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.443 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 4.6 p -98.34 148.39 23.72 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.738 0.304 . . . . 73.52 110.51 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 21.2 m-20 -84.57 149.12 53.71 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.263 -0.426 . . . . 73.2 110.682 -176.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' ASP . 22.4 Cg_exo -66.24 128.79 20.15 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.872 2.382 . . . . 73.45 112.822 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.9 mt -73.09 162.33 75.05 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.391 -0.822 . . . . 74.11 110.207 176.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 92.4 Cg_endo -78.33 163.56 86.65 Favored 'Cis proline' 0 C--N 1.348 0.506 0 C-N-CA 123.843 -1.315 . . . . 52.52 113.249 1.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 20.5 m-85 -100.19 112.89 25.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.707 -0.679 . . . . 73.31 110.649 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -98.78 131.62 44.77 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.421 -0.354 . . . . 73.43 110.254 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.414 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 60.6 mt -124.76 108.51 20.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.579 -0.526 . . . . 72.12 109.579 172.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.467 HG12 HD12 ' A' ' 13' ' ' LEU . 49.5 t -102.25 114.5 41.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.951 -0.568 . . . . 74.14 110.388 -177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.7 mt -119.05 139.6 45.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.87 -0.604 . . . . 72.22 109.898 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.55 ' HB3' ' OE1' ' A' ' 11' ' ' GLU . 19.5 t0 -102.66 138.52 39.45 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.693 -0.484 . . . . 64.24 109.693 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.479 ' SD ' HD12 ' A' ' 65' ' ' ILE . 68.6 mtm -91.83 -3.15 56.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.867 -0.606 . . . . 72.44 110.07 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.581 ' HE3' ' CD ' ' A' ' 11' ' ' GLU . 24.0 mmtp 67.6 4.09 3.69 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.482 -0.781 . . . . 72.34 112.467 173.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -165.3 172.12 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.602 0.239 . . . . 73.13 110.754 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.41 127.18 31.82 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.213 -0.449 . . . . 71.03 110.259 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.667 HD13 HG21 ' A' ' 5' ' ' ILE . 74.6 mt -136.68 135.16 48.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.143 0.497 . . . . 71.11 110.363 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -82.82 109.39 16.92 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.009 -0.738 . . . . 74.22 109.009 176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 118' ' ' SER . 27.4 mm -79.33 129.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.92 -0.312 . . . . 73.43 110.325 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.59 -39.28 2.31 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.018 0.437 . . . . 63.23 110.968 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 15.8 tt0 -150.96 143.94 24.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.267 -0.424 . . . . 74.33 110.996 -176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.06 131.68 67.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.243 -0.435 . . . . 70.53 109.836 175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 112' ' ' LEU . 44.8 mt-10 -110.07 135.85 50.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.908 0.385 . . . . 72.34 110.677 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.42 HD12 ' HE2' ' A' ' 114' ' ' TYR . 69.2 mt -119.01 120.3 36.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.733 -0.667 . . . . 65.22 109.557 177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 141' ' ' ARG . 31.2 tp -104.25 104.02 41.91 Favored Pre-proline 0 C--N 1.314 -0.976 0 CA-C-N 116.052 -0.522 . . . . 75.52 109.907 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 2.7 Cg_exo -76.33 178.17 7.86 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.222 2.615 . . . . 64.31 112.267 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 77' ' ' ARG . 0.4 OUTLIER -115.38 27.34 9.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.483 -0.326 . . . . 74.43 110.767 -178.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.79 99.79 0.06 OUTLIER Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.914 -0.585 . . . . 32.54 114.355 -173.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 75' ' ' ARG . 16.3 mmm180 -105.21 -83.97 0.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.82 -1.178 . . . . 75.42 107.82 170.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' H ' ' HB2' ' A' ' 77' ' ' ARG . . . -123.42 25.52 6.26 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 108.881 -1.688 . . . . 75.33 108.881 167.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.62 150.69 37.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.926 -1.137 . . . . 74.13 111.469 -171.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -83.94 -47.69 10.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.224 -0.658 . . . . 71.45 109.224 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 66.4 t30 43.59 73.86 0.88 Allowed Pre-proline 0 N--CA 1.473 0.696 0 O-C-N 124.238 0.961 . . . . 61.22 111.423 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.616 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 75.4 Cg_endo -77.99 59.9 7.11 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.07 2.514 . . . . 63.33 113.755 -173.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.9 mt -99.0 119.36 46.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.041 -0.726 . . . . 74.41 109.041 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -102.64 -49.64 3.78 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.342 -0.39 . . . . 72.2 111.822 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -124.66 138.0 55.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.51 -0.314 . . . . 74.01 111.133 -174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.7 m -130.82 129.2 63.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.276 -0.42 . . . . 63.44 110.268 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.9 mt-10 -111.87 132.97 54.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.041 -0.527 . . . . 74.03 110.302 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -113.62 129.42 56.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.868 -0.605 . . . . 72.11 110.023 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -132.15 141.79 49.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.831 0.348 . . . . 72.22 110.943 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -124.03 149.03 46.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.062 -0.517 . . . . 70.15 110.387 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.7 t -149.96 158.89 44.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.845 0.355 . . . . 74.21 111.267 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.558 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 39.3 mt-10 -106.64 -25.08 11.94 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.157 -0.474 . . . . 61.13 110.985 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.4 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 19.1 p30 -114.42 0.68 14.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.48 -0.327 . . . . 54.15 111.647 -175.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 5.8 t-20 74.42 0.7 3.65 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 123.555 0.534 . . . . 74.32 110.516 178.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.3 t -109.9 -54.47 5.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.09 -0.505 . . . . 64.12 110.669 -178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -88.12 96.59 10.59 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.701 -0.681 . . . . 53.33 110.278 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.431 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 99.4 m95 -90.38 121.11 32.07 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.007 -0.542 . . . . 73.11 110.743 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 79.0 m -98.47 121.81 55.51 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.711 -0.677 . . . . 70.34 109.814 175.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.42 113.61 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.288 1.992 . . . . 71.21 111.423 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.588 HD12 HG21 ' A' ' 116' ' ' VAL . 21.9 pt -88.78 -15.71 8.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.133 -0.485 . . . . 65.11 110.631 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 171.41 150.62 7.2 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.318 -0.944 . . . . 50.14 113.181 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.479 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 31.9 ttt180 -129.02 114.69 16.72 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.135 -1.061 . . . . 73.01 108.135 173.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.585 ' HE2' HG12 ' A' ' 116' ' ' VAL . 98.0 m-85 -127.28 171.98 11.0 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.97 0.414 . . . . 73.24 111.657 -170.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.09 131.05 10.44 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.481 -0.782 . . . . 33.4 111.198 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.46 136.87 34.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.994 0.426 . . . . 73.14 110.265 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.58 ' HB ' HD21 ' A' ' 112' ' ' LEU . 18.0 m -118.52 111.1 18.18 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.845 -0.616 . . . . 61.52 109.861 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.45 104.24 3.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.989 0.424 . . . . 72.32 110.567 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -143.7 -176.79 5.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.917 -0.583 . . . . 71.43 109.91 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -103.13 0.66 32.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.913 0.387 . . . . 75.03 110.687 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -104.06 163.15 12.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.976 -0.556 . . . . 75.3 110.631 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.43 131.27 35.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.076 0.465 . . . . 62.45 111.329 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.58 HD21 ' HB ' ' A' ' 106' ' ' THR . 33.3 mt -89.07 113.97 25.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.791 -0.64 . . . . 73.45 110.626 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.4 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 30.6 mt-10 -92.18 113.83 26.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.942 0.401 . . . . 74.31 110.243 177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.42 ' HE2' HD12 ' A' ' 72' ' ' LEU . 79.8 m-85 -106.48 101.87 11.3 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.95 -0.568 . . . . 71.5 109.931 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -73.2 106.42 5.03 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.536 -0.756 . . . . 75.22 108.967 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.588 HG21 HD12 ' A' ' 100' ' ' ILE . 28.3 m -107.88 178.18 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.25 0.548 . . . . 52.34 111.995 -170.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -66.2 134.48 52.81 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.095 -0.957 . . . . 74.25 110.295 176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 16.7 m -82.77 130.13 35.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.873 -0.603 . . . . 70.22 110.979 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.0 tt -160.65 147.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.925 -0.579 . . . . 73.13 110.123 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.02 121.15 31.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.424 -0.584 . . . . 75.31 109.424 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.558 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -145.0 176.95 9.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.424 -0.353 . . . . 61.14 110.787 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.512 ' HG2' ' OD1' ' A' ' 60' ' ' ASP . 22.8 ttt180 -119.74 -34.86 3.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.991 0.424 . . . . 73.41 110.341 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -105.36 146.07 29.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.314 -0.403 . . . . 75.31 109.932 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.9 tt -132.06 133.55 60.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.035 0.445 . . . . 70.3 110.105 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 125' ' ' ARG . 12.4 ttp180 -124.37 129.09 50.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.941 0.401 . . . . 70.12 111.198 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -101.57 119.0 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.525 -0.761 . . . . 72.23 109.212 173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.434 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 60.0 m -112.82 126.97 56.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.999 0.428 . . . . 70.44 110.938 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.7 mm -104.08 89.83 2.69 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.261 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.757 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 88.4 Cg_endo -81.34 134.0 8.81 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.808 2.339 . . . . 74.13 113.507 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -81.71 65.8 7.0 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.822 0.82 . . . . 75.53 108.999 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -132.63 -13.61 2.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.185 -0.916 . . . . 64.24 111.253 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -127.02 15.62 6.49 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.148 -1.025 . . . . 75.11 113.441 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.69 18.69 13.52 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.495 -0.86 . . . . 64.15 112.66 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -72.87 126.87 30.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.076 0.465 . . . . 74.32 110.927 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.616 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 19.8 m -99.69 171.96 7.57 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.032 -0.531 . . . . 73.41 110.232 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 3.1 p -82.31 6.9 15.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.087 0.403 . . . . 72.23 112.087 -176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.401 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 60.6 t -106.73 102.29 13.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.563 -0.532 . . . . 72.42 109.563 175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -127.69 124.86 38.91 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.035 -0.53 . . . . 65.21 110.18 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -136.13 107.06 6.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.099 0.476 . . . . 54.24 111.179 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 31.2 mt -125.9 132.76 70.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.112 -0.699 . . . . 74.13 109.112 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 75.2 mtt180 -63.85 -71.28 0.18 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.118 0.485 . . . . 74.33 110.062 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -140.01 155.03 47.28 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.581 0.705 . . . . 62.22 112.439 -175.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 72' ' ' LEU . 9.1 tt -115.54 119.98 37.94 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.232 -1.349 . . . . 61.04 107.84 169.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.24 151.85 36.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.941 -0.392 . . . . 74.23 109.941 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 46.6 t -123.42 131.39 73.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 C-N-CA 120.678 -0.409 . . . . 63.32 110.741 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 45.1 mttp -98.16 127.21 43.97 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.122 -0.696 . . . . 74.44 109.122 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.29 -146.06 5.2 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.685 -0.769 . . . . 65.43 111.811 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 15.4 m -139.89 130.34 25.51 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.459 -0.2 . . . . 72.52 110.459 177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.782 HD11 HG23 ' A' ' 5' ' ' ILE . 28.6 mm -72.27 120.9 21.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.176 -0.466 . . . . 72.11 110.079 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 54.4 mt -106.44 150.17 9.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.089 0.471 . . . . 74.22 110.024 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -116.35 141.6 47.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.296 -1.001 . . . . 65.53 108.296 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 4.2 mt -67.26 129.23 39.23 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.189 0.519 . . . . 54.32 111.398 -174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 153' ' ' GLU . 0.1 OUTLIER -78.17 -6.19 54.05 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.743 0.782 . . . . 52.21 110.375 -177.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -101.77 86.5 2.93 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.843 -1.071 . . . . 65.1 110.092 178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -144.39 100.24 3.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.979 0.419 . . . . 73.52 111.197 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -153.59 91.23 1.46 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.497 -0.774 . . . . 70.23 109.469 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -66.53 140.24 57.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.193 -0.458 . . . . 73.23 109.815 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -99.97 -19.69 16.46 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.092 -0.504 . . . . 74.1 110.417 -174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 73.4 t60 . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.835 -0.62 . . . . 73.54 110.213 177.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 tpt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 109.385 -0.598 . . . . 32.13 109.385 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.56 -18.58 4.82 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.401 -0.904 . . . . 74.1 113.313 -175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.413 HG21 ' HE2' ' A' ' 146' ' ' LYS . 11.3 t -80.04 -11.83 59.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.013 0.435 . . . . 72.02 110.866 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.607 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 7.0 p -74.69 161.21 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.064 -0.516 . . . . 71.42 110.919 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 ' CD1' ' A' ' 65' ' ' ILE . 42.8 mm -71.64 136.43 25.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.064 -0.516 . . . . 51.12 110.706 -176.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 m -67.28 115.79 7.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.175 -0.466 . . . . 73.45 110.302 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -82.99 3.26 30.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.124 -0.489 . . . . 74.1 111.213 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 p -69.03 98.09 0.94 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.61 0.719 . . . . 61.33 110.62 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.64 -14.72 6.06 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.012 -0.995 . . . . 44.44 112.11 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -66.45 145.88 55.17 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.3 -0.259 . . . . 72.32 110.3 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.551 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 8.3 pt-20 -132.45 159.41 39.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.998 0.428 . . . . 54.41 110.664 176.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.1 t -100.72 112.3 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.527 -0.761 . . . . 65.52 109.578 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 81.0 mt -72.57 -46.7 53.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.206 0.527 . . . . 73.31 110.512 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.9 p -152.05 142.44 22.54 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.844 -0.616 . . . . 73.54 110.717 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -139.86 149.45 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.936 -0.575 . . . . 74.4 109.829 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.5 m -82.16 -49.81 9.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.42 -0.354 . . . . 71.51 111.173 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 14.5 t -146.39 157.21 43.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.32 -0.4 . . . . 75.32 110.783 -173.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -163.31 144.6 9.48 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.845 -0.798 . . . . 64.41 108.845 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.6 tp10 -96.78 101.21 12.77 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 74.12 110.001 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.16 5.3 34.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.73 -0.668 . . . . 43.45 111.928 -174.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 t -136.99 -45.48 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.706 -0.398 . . . . 64.41 111.176 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.56 -41.45 99.57 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.116 -0.564 . . . . 65.31 113.077 -177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 51.3 mm-40 -86.51 -49.45 7.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.878 0.37 . . . . 75.53 110.868 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.08 163.37 28.04 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.43 -0.89 . . . . 74.54 111.845 177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.39 96.85 2.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.998 0.428 . . . . 74.3 110.228 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA2' HD11 ' A' ' 29' ' ' LEU . . . 101.52 3.99 52.89 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.61 -0.805 . . . . 53.35 112.487 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -125.99 134.07 51.6 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.7 -0.482 . . . . 74.02 109.7 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.04 6.02 46.16 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 110.921 -0.871 . . . . 52.11 110.921 -173.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 66.8 mt -80.32 154.88 27.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.198 -0.501 . . . . 74.42 110.697 -177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -69.23 -26.97 65.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.042 -0.526 . . . . 61.24 110.875 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 75.34 110.787 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.821 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.4 m -70.47 -22.59 62.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 62.41 110.32 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 142' ' ' GLU . 25.4 tp -64.0 -19.45 65.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.554 -0.748 . . . . 52.13 110.824 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 59' ' ' ILE . 35.9 pt -131.46 18.52 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.95 0.405 . . . . 51.2 110.436 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.821 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t70 -68.77 -38.47 80.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.887 -0.597 . . . . 61.41 110.909 -173.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.47 19.77 13.31 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.822 -0.704 . . . . 71.44 111.98 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.4 121.16 25.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.699 0.285 . . . . 72.2 110.246 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.2 p -70.72 -20.26 62.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.333 -0.394 . . . . 55.21 111.624 -176.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -74.27 -27.13 60.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.658 -0.246 . . . . 71.23 111.314 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.5 p -89.81 160.67 16.39 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.839 -0.43 . . . . 61.25 109.839 178.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 141' ' ' ARG . 46.3 p90 -156.18 171.04 20.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 64.42 111.043 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.558 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 49.9 t90 -106.78 134.86 49.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.616 -0.72 . . . . 74.43 109.474 173.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -133.06 142.39 48.74 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.129 -0.693 . . . . 74.32 109.129 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.53 143.67 49.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.797 -0.446 . . . . 63.51 109.797 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -60.9 126.01 25.8 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.256 0.348 . . . . 75.24 110.231 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -128.02 -25.44 3.03 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.789 -0.364 . . . . 75.01 111.235 178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -69.49 107.43 3.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.976 0.417 . . . . 71.34 110.542 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.51 -6.74 80.42 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.933 -0.651 . . . . 45.2 112.391 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 132.18 171.68 12.86 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.967 -0.635 . . . . 73.51 111.581 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 136' ' ' THR . 40.9 m -116.4 175.42 5.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.729 0.3 . . . . 71.21 111.104 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.581 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 7.2 m-20 -97.99 166.3 13.72 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.133 -0.485 . . . . 74.55 110.845 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 39.4 Cg_endo -67.88 134.49 32.36 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.633 2.222 . . . . 54.1 113.207 -179.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 24.8 mt -84.69 154.39 61.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.557 -0.747 . . . . 64.4 109.51 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 74.2 Cg_endo -76.05 165.54 85.19 Favored 'Cis proline' 0 C--N 1.342 0.203 0 C-N-CA 123.608 -1.413 . . . . 65.14 112.928 1.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.532 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.2 m-85 -99.54 115.4 29.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.872 -0.604 . . . . 73.31 110.101 177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -106.11 129.14 54.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.88 0.371 . . . . 74.53 110.847 -179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.405 HD12 HD23 ' A' ' 126' ' ' LEU . 63.6 mt -121.7 108.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.959 -0.564 . . . . 70.14 109.596 174.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -94.91 114.13 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 CA-C-N 116.047 -0.524 . . . . 74.42 110.459 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.513 HD13 HG21 ' A' ' 34' ' ' ILE . 71.1 mt -115.29 137.08 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.861 -0.609 . . . . 71.34 110.929 -175.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -106.29 121.81 44.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.847 -0.615 . . . . 74.11 109.877 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 67.7 mtm -87.97 -5.85 58.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.273 -0.421 . . . . 64.32 111.043 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.551 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.4 mmtt 66.61 11.38 8.1 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.148 0.795 . . . . 73.04 113.148 173.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -165.5 172.86 11.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.252 -0.277 . . . . 71.54 110.252 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.942 HD21 ' HB3' ' A' ' 153' ' ' GLU . 39.0 m-80 -85.24 128.65 34.76 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 116.056 -0.52 . . . . 74.01 109.654 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.572 ' CD1' HG21 ' A' ' 5' ' ' ILE . 67.6 mt -134.28 134.39 55.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 120.949 0.404 . . . . 72.05 110.17 176.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.501 ' HB2' HD11 ' A' ' 150' ' ' ILE . 56.2 tp60 -80.8 101.61 9.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.536 -0.756 . . . . 75.52 109.001 176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.699 ' O ' ' HA ' ' A' ' 118' ' ' SER . 23.8 mm -71.18 123.59 25.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 72.02 110.344 -176.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.47 -46.28 2.28 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.255 0.55 . . . . 74.51 110.201 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.563 ' HB3' ' HB3' ' A' ' 146' ' ' LYS . 34.3 tt0 -137.9 141.58 40.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.764 -0.653 . . . . 74.21 110.42 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -108.93 128.28 64.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.055 -0.72 . . . . 71.32 109.055 173.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -110.06 123.45 49.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.248 0.546 . . . . 54.23 110.76 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 44.9 mt -109.33 124.53 51.1 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.755 -0.657 . . . . 73.04 109.841 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.4 106.97 48.79 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 108.862 -0.792 . . . . 51.34 108.862 176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.59 151.33 70.04 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.386 2.058 . . . . 74.13 111.837 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.556 ' HA ' ' CD ' ' A' ' 141' ' ' ARG . 78.3 ttt180 -52.92 -52.21 58.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.845 -0.616 . . . . 74.42 111.543 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.33 168.92 28.24 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.147 -0.781 . . . . 42.11 111.147 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.558 ' HA ' ' ND2' ' A' ' 107' ' ' ASN . 20.6 mtp180 -76.06 -24.48 55.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.164 0.482 . . . . 74.31 110.308 -177.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -91.63 64.28 2.52 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.903 -0.665 . . . . 75.25 111.787 177.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.4 m -154.37 167.94 28.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.115 -0.328 . . . . 63.1 110.115 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -86.16 98.22 10.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.399 -0.364 . . . . 73.31 110.243 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -126.68 81.97 67.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.176 -0.466 . . . . 73.23 110.61 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 93.2 Cg_endo -87.63 37.15 0.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.738 2.292 . . . . 74.14 112.259 174.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -87.38 134.39 27.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.048 0.451 . . . . 75.03 110.533 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' A' ' 84' ' ' LYS . 24.1 mmmt -111.13 -57.77 2.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.577 -0.738 . . . . 65.02 110.658 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.48 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 95.2 t -121.19 138.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 63.02 110.945 -175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.1 m -126.29 138.34 54.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.885 -0.598 . . . . 71.43 109.651 175.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.0 mt-10 -118.04 135.11 54.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.317 -0.402 . . . . 74.32 111.152 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -117.02 129.87 56.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.891 -0.595 . . . . 64.33 110.142 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 97' ' ' TRP . . . -128.49 143.97 51.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.328 -0.397 . . . . 72.13 110.652 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.7 149.97 49.98 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.368 -0.378 . . . . 62.01 110.34 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.3 t -150.09 150.92 32.39 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.186 0.517 . . . . 72.31 111.625 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -97.17 -30.85 12.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.337 -0.847 . . . . 73.52 109.837 174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.572 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 3.4 p-10 -105.73 -12.17 16.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.77 -0.65 . . . . 53.14 112.126 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 62.8 t30 71.22 5.14 5.35 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.617 0.722 . . . . 70.14 110.758 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.572 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 98.7 t -100.82 -58.32 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.93 -0.577 . . . . 71.33 110.103 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 -102.43 118.96 37.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.319 -0.4 . . . . 70.53 110.127 176.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.518 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 94.5 m95 -95.86 124.42 39.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.1 -0.5 . . . . 74.41 111.154 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 68.8 m -90.44 122.63 67.05 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.143 -0.48 . . . . 51.43 110.109 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.54 110.2 2.81 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.42 2.08 . . . . 64.45 111.507 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.631 HD12 HG21 ' A' ' 116' ' ' VAL . 13.7 pt -80.81 -19.49 11.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.577 -0.283 . . . . 73.45 110.983 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.57 136.92 2.09 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.302 -0.951 . . . . 70.51 113.558 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.449 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.3 ttm180 -102.72 125.6 49.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.436 -0.579 . . . . 64.12 109.436 169.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.556 ' HE2' HG12 ' A' ' 116' ' ' VAL . 77.8 m-85 -138.56 -176.23 4.4 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.269 -0.572 . . . . 75.14 111.289 177.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -99.15 147.54 18.47 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.855 -0.611 . . . . 54.14 112.248 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.425 ' HA ' ' HH ' ' A' ' 114' ' ' TYR . 40.8 t80 -96.47 148.29 22.96 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.91 0.386 . . . . 73.23 110.119 -178.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.423 ' HB ' HD21 ' A' ' 112' ' ' LEU . 26.5 m -133.38 117.83 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.893 -0.41 . . . . 74.12 109.893 177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.558 ' ND2' ' HA ' ' A' ' 77' ' ' ARG . 20.2 t30 -77.21 106.44 8.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.408 0.623 . . . . 72.54 110.533 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -144.47 177.66 8.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.256 -0.883 . . . . 65.11 110.222 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -97.86 8.67 44.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.31 -0.404 . . . . 52.15 110.801 -178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -122.73 158.05 30.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 74.42 109.848 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.47 142.16 48.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.106 0.479 . . . . 73.3 111.539 -175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 106' ' ' THR . 63.1 mt -92.26 121.85 34.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.569 -0.742 . . . . 54.41 111.0 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -87.82 109.8 20.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 71.53 111.29 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.425 ' HH ' ' HA ' ' A' ' 105' ' ' PHE . 95.5 m-85 -104.55 110.11 22.27 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 73.42 110.649 176.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -86.5 100.51 12.43 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.789 -0.641 . . . . 73.22 109.709 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.631 HG21 HD12 ' A' ' 100' ' ' ILE . 26.7 m -106.06 179.4 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.95 -0.568 . . . . 73.45 111.412 -174.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -67.62 139.19 56.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 75.5 110.468 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.699 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 23.9 m -80.67 121.43 25.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.297 -0.411 . . . . 70.42 110.861 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 13.2 tt -155.14 149.94 11.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.234 -0.439 . . . . 74.2 110.326 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.763 ' HG3' HD12 ' A' ' 150' ' ' ILE . 2.7 ttpm? -89.78 132.53 35.17 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.097 -0.334 . . . . 74.4 110.097 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.08 166.09 33.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.522 -0.308 . . . . 65.24 111.091 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.479 ' HD2' ' CE1' ' A' ' 123' ' ' TYR . 24.9 ttm180 -111.27 -33.53 6.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.171 0.51 . . . . 72.24 110.2 174.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.479 ' CE1' ' HD2' ' A' ' 122' ' ' ARG . 70.7 m-85 -105.21 145.16 31.01 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.914 -0.585 . . . . 72.5 110.213 -175.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.441 HG23 ' HB ' ' A' ' 59' ' ' ILE . 10.5 tt -136.31 129.34 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.079 -0.509 . . . . 60.2 110.065 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -113.4 121.19 43.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.064 -0.516 . . . . 72.32 110.659 -178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.405 HD23 HD12 ' A' ' 57' ' ' ILE . 48.0 tp -91.55 113.72 26.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.202 -0.666 . . . . 52.04 109.202 172.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 70.6 m -109.99 119.94 40.9 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.997 0.427 . . . . 72.32 110.934 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.9 mm -100.77 96.28 5.36 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 109.058 -0.719 . . . . 71.42 109.058 172.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 89.5 Cg_endo -75.68 -179.85 5.54 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.532 2.155 . . . . 75.34 112.786 -176.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -110.01 -9.05 14.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 122.166 0.984 . . . . 54.24 108.398 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -60.44 -46.14 91.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 113.659 -1.61 . . . . 75.31 112.11 -173.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.48 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -82.01 6.82 65.25 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.716 -0.754 . . . . 43.43 113.713 -172.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.94 25.41 9.69 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.169 -1.015 . . . . 64.04 112.071 178.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -78.78 -175.92 4.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.04 0.448 . . . . 71.51 111.133 -176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.448 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 20.1 m -139.24 174.5 10.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.998 -0.546 . . . . 72.22 109.628 178.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.41 ' HB ' ' CB ' ' A' ' 50' ' ' SER . 1.2 p -79.96 -0.73 36.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.952 0.406 . . . . 63.3 112.035 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 56.3 t -106.68 124.09 62.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.799 -0.445 . . . . 63.0 109.799 177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.47 142.99 30.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.659 -0.246 . . . . 72.14 110.655 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -142.7 109.48 5.46 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.829 0.347 . . . . 74.25 111.118 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 28.8 mt -127.49 141.11 47.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.102 -0.703 . . . . 65.04 109.102 178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.556 ' CD ' ' HA ' ' A' ' 75' ' ' ARG . 1.5 tpt180 -74.44 -68.82 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.606 -0.516 . . . . 74.52 109.606 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.48 ' HA ' HD12 ' A' ' 33' ' ' LEU . 17.7 pt-20 -148.87 160.99 42.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.208 0.527 . . . . 71.42 110.734 175.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.34 121.75 44.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.382 -0.826 . . . . 75.02 108.958 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.607 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 1.4 t70 -117.1 162.33 18.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.869 -0.419 . . . . 71.31 109.869 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' ILE . 95.3 t -127.89 124.5 63.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.123 0.487 . . . . 74.1 110.296 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 69' ' ' GLN . 48.3 tttm -101.45 101.61 12.25 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.264 -0.643 . . . . 75.15 109.264 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -153.09 -161.64 10.45 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.727 -0.749 . . . . 75.1 112.089 -177.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -118.05 133.64 55.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.652 0.263 . . . . 73.2 110.554 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.54 HD11 HG23 ' A' ' 5' ' ' ILE . 38.4 mm -71.54 124.46 28.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.081 -0.509 . . . . 75.33 111.419 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.85 HG22 ' H ' ' A' ' 152' ' ' LEU . 29.0 mt -118.01 134.3 62.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.162 0.506 . . . . 72.04 110.109 176.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -102.2 4.68 39.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.279 0.561 . . . . 62.32 110.169 179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.85 ' H ' HG22 ' A' ' 150' ' ' ILE . 97.0 mt -105.74 106.03 16.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.571 -0.74 . . . . 63.5 111.999 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.942 ' HB3' HD21 ' A' ' 64' ' ' ASN . 12.7 pt-20 -124.47 -24.19 4.28 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.955 0.883 . . . . 71.0 108.835 169.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -137.99 122.65 18.64 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.992 -1.458 . . . . 71.21 108.967 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -79.49 169.0 18.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.031 -0.531 . . . . 73.24 110.227 -175.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -69.49 118.71 12.71 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.712 -0.477 . . . . 72.44 109.712 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -83.82 -8.03 59.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.85 -0.614 . . . . 73.33 110.845 -172.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -93.78 115.51 27.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.894 -0.409 . . . . 75.14 109.894 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.1 t60 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.224 -0.443 . . . . 72.34 110.621 -178.808 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.967 0.413 . . . . 74.02 110.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -109.12 94.97 0.87 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.436 -0.887 . . . . 61.23 113.113 -173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 t -147.28 139.16 24.26 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.203 -0.665 . . . . 74.24 109.203 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.0 p -117.91 161.0 20.48 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.439 -0.346 . . . . 71.31 110.992 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.5 HD12 HD11 ' A' ' 149' ' ' ILE . 37.6 mm -66.65 131.91 32.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.134 -0.485 . . . . 54.55 110.327 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -64.78 111.73 2.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.376 -0.375 . . . . 72.11 110.829 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' CD1' ' A' ' 10' ' ' TRP . 36.0 mtmm -87.52 16.25 5.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.077 0.465 . . . . 75.03 110.567 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -65.48 -16.36 63.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.493 -0.776 . . . . 60.41 112.16 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.1 23.25 4.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.497 -0.859 . . . . 72.32 112.874 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.419 ' CD1' ' HA ' ' A' ' 7' ' ' LYS . 33.3 m0 -84.35 156.79 21.71 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.992 0.396 . . . . 65.23 110.853 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.441 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 22.2 pt-20 -135.4 159.54 41.26 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.81 0.338 . . . . 64.23 110.768 176.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.54 130.89 54.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.972 -0.558 . . . . 53.41 109.739 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.5 -36.86 9.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.166 0.508 . . . . 72.12 110.78 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.3 t -144.94 139.36 27.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 75.22 110.66 -176.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -151.1 134.84 16.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.609 -0.723 . . . . 70.4 109.526 177.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -85.37 -38.9 18.21 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.401 -0.363 . . . . 54.42 111.278 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -149.13 152.51 36.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.993 0.425 . . . . 74.21 110.959 -178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 12.0 pt20 -163.91 139.53 6.3 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.425 -0.807 . . . . 71.44 108.919 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.596 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.9 tp10 -93.74 98.06 10.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.133 0.492 . . . . 74.4 111.065 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -102.48 -12.01 18.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.864 -0.607 . . . . 62.31 110.95 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.4 m -101.04 -47.77 4.65 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.02 -0.536 . . . . 64.51 110.955 -174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -70.84 -58.02 6.02 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.909 -0.587 . . . . 73.42 112.411 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.596 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 24.1 mm-40 -70.93 -50.57 33.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.084 -0.339 . . . . 73.04 110.084 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.85 -168.02 33.23 Favored Glycine 0 C--N 1.331 0.273 0 CA-C-N 115.972 -0.558 . . . . 64.25 112.869 178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 60.49 22.25 11.93 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.076 0.55 . . . . 63.24 111.934 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.29 18.31 78.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.934 -0.65 . . . . 71.32 112.013 -178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -113.16 150.45 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.732 -0.469 . . . . 74.3 109.732 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.38 2.96 72.73 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.611 -0.595 . . . . 65.45 111.611 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 18' ' ' GLN . 82.0 mt -82.13 157.44 24.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.584 -0.308 . . . . 64.32 110.272 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.524 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.83 -28.74 68.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.773 0.321 . . . . 62.33 110.973 -178.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' HD12 ' A' ' 29' ' ' LEU . 21.3 pttp -69.41 -23.02 63.65 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-O 120.742 0.306 . . . . 75.15 111.044 178.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.812 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 59.7 m -66.99 -24.24 66.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.015 0.436 . . . . 71.41 110.408 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.0 tp -65.92 -25.54 67.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.833 -0.622 . . . . 73.23 110.371 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 59' ' ' ILE . 2.5 pp -119.48 13.54 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.207 0.527 . . . . 74.14 110.336 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 10.2 t70 -65.27 -42.25 93.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.287 -0.869 . . . . 74.11 110.174 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.9 55.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.824 -0.703 . . . . 65.22 111.682 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -117.12 124.44 49.2 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.368 -0.416 . . . . 53.35 109.986 -178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.0 p -72.65 -15.13 61.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.285 -0.416 . . . . 72.11 111.755 -177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.31 -24.33 50.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 75.44 110.718 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.5 p -100.23 160.16 14.54 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.159 -0.473 . . . . 74.21 110.4 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.717 ' HB3' ' HD3' ' A' ' 141' ' ' ARG . 48.3 p90 -156.15 165.0 37.7 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.848 -0.427 . . . . 75.03 109.848 174.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.524 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 39.2 t90 -98.12 129.27 44.93 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.379 -0.6 . . . . 73.11 109.379 175.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 138' ' ' ALA . 49.4 t-80 -131.13 137.07 48.87 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.231 -0.655 . . . . 71.51 109.231 178.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.12 144.63 54.95 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 50' ' ' SER . 64.8 tttp -60.4 126.09 26.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.853 0.358 . . . . 63.12 110.339 -178.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 62.7 p-90 -124.52 -32.14 3.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 63.03 110.064 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.45 108.99 13.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 61.13 109.383 -177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.41 -12.33 54.61 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.712 -0.676 . . . . 70.32 111.635 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 128.27 144.34 5.82 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.93 -0.652 . . . . 75.51 111.547 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 11.0 p -86.63 167.64 14.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.941 0.4 . . . . 74.13 111.505 -178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -100.54 146.9 32.83 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 61.24 109.715 175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -69.96 141.54 44.68 Favored 'Trans proline' 0 N--CA 1.464 -0.253 0 C-N-CA 122.691 2.261 . . . . 71.35 112.63 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.571 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 16.5 mt -75.85 164.63 59.19 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.924 -0.58 . . . . 65.3 110.569 177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 88.1 Cg_endo -83.69 161.75 71.04 Favored 'Cis proline' 0 C--N 1.346 0.421 0 C-N-CA 123.766 -1.348 . . . . 71.22 113.239 1.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.493 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 21.6 m-85 -100.06 111.46 23.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 73.5 109.923 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -104.42 125.69 50.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 110.082 -0.34 . . . . 53.34 110.082 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.403 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 48.3 mt -119.44 121.36 66.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.134 -0.321 . . . . 71.34 110.134 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -112.31 117.85 56.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.334 -0.394 . . . . 71.4 110.616 -177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.653 HG21 HG21 ' A' ' 34' ' ' ILE . 4.7 mp -117.05 140.62 38.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.159 -0.473 . . . . 71.54 110.19 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD2' ' HD3' ' A' ' 62' ' ' LYS . 19.8 t70 -103.04 134.2 46.88 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.594 -0.275 . . . . 54.53 110.264 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.509 ' HE1' HD11 ' A' ' 67' ' ' ILE . 64.8 mtm -96.64 3.92 52.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.898 -0.592 . . . . 74.34 111.092 -178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.441 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 34.7 mmtp 70.89 -30.06 0.2 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.617 0.969 . . . . 72.43 113.617 175.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -133.71 172.44 12.76 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.236 -0.29 . . . . 74.24 111.051 -177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.08 129.82 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 73.12 110.399 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' CD1' HG21 ' A' ' 5' ' ' ILE . 69.6 mt -139.07 139.91 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.018 0.437 . . . . 71.31 110.333 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.7 tp60 -83.31 105.08 13.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.927 -0.768 . . . . 73.3 108.927 175.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.728 ' O ' ' HA ' ' A' ' 118' ' ' SER . 32.8 mm -72.93 106.31 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 110.235 -0.283 . . . . 71.3 110.235 -177.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.03 -43.9 6.51 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.052 0.453 . . . . 70.15 110.843 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.6 tt0 -145.42 140.88 27.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.991 -0.549 . . . . 63.2 110.787 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.21 130.73 61.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.531 -0.544 . . . . 54.32 109.531 176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -113.47 129.76 56.47 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.957 0.408 . . . . 73.52 110.521 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.472 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 70.4 mt -117.14 120.49 38.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.213 -0.449 . . . . 62.32 109.92 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -96.73 103.56 15.07 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 109.023 -0.732 . . . . 65.33 109.023 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 15.3 Cg_exo -67.37 167.65 19.95 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.038 2.492 . . . . 74.11 112.645 -176.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.578 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 77.4 ttt180 -61.05 -28.65 69.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.73 -0.668 . . . . 64.21 110.933 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.26 145.19 5.11 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.98 -0.848 . . . . 24.23 110.98 -179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -61.18 -23.18 65.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.941 0.37 . . . . 74.32 111.472 -176.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -104.52 59.3 0.46 Allowed Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.662 -0.78 . . . . 52.43 112.137 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.5 p -160.88 162.98 32.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 110.017 -0.364 . . . . 73.42 110.017 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -73.41 120.22 18.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.837 0.351 . . . . 74.53 111.112 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -151.89 89.13 4.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.864 -0.607 . . . . 70.24 110.49 177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -85.93 29.77 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.145 2.563 . . . . 71.14 114.171 176.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 105' ' ' PHE . 73.2 mt -79.0 130.42 36.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.568 -0.53 . . . . 51.41 109.568 173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -114.84 -46.03 2.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.192 -0.458 . . . . 53.52 111.453 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.734 HG11 ' HE ' ' A' ' 102' ' ' ARG . 62.0 t -127.13 138.35 55.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.469 -0.332 . . . . 75.53 110.898 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 128' ' ' ILE . 7.6 m -132.22 137.59 54.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.186 -0.461 . . . . 72.55 110.52 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 40.2 mt-10 -116.6 140.45 49.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.402 -0.363 . . . . 64.25 110.907 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -120.4 132.67 55.36 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.051 -0.522 . . . . 73.22 110.669 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -134.51 147.71 50.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.224 -0.444 . . . . 31.14 110.267 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.32 150.03 52.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.456 -0.338 . . . . 70.03 110.495 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.5 t -150.26 150.7 31.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.799 0.333 . . . . 71.03 110.878 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.652 ' HG3' ' HA ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER -101.31 -31.35 11.01 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.957 0.408 . . . . 63.11 110.129 176.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.663 ' OD2' ' HB ' ' A' ' 95' ' ' VAL . 8.9 p-10 -105.22 -4.33 21.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 53.13 111.518 -174.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 24.5 t-20 76.31 -16.16 0.64 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.797 0.685 . . . . 71.31 111.337 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.663 ' HB ' ' OD2' ' A' ' 93' ' ' ASP . 95.2 t -89.32 -58.91 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.97 0.414 . . . . 61.55 110.627 -178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.89 111.48 23.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.176 -0.466 . . . . 71.21 110.454 -178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -96.6 132.39 42.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.993 0.425 . . . . 74.4 110.921 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 50.3 m -105.09 124.76 35.55 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.798 -0.637 . . . . 75.31 110.505 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.72 116.81 4.82 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.468 2.112 . . . . 74.3 111.572 176.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 116' ' ' VAL . 21.6 pt -93.1 -6.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.332 -0.395 . . . . 62.5 111.059 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 148.61 147.82 4.61 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.538 -0.839 . . . . 65.54 113.044 174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.734 ' HE ' HG11 ' A' ' 85' ' ' VAL . 77.9 ttt180 -113.06 119.65 38.58 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.214 -0.661 . . . . 73.12 109.214 173.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.584 ' HE2' HG12 ' A' ' 116' ' ' VAL . 84.5 m-85 -130.36 177.17 7.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.82 0.343 . . . . 74.54 110.911 -176.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -96.8 149.81 19.41 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.043 -0.599 . . . . 72.25 111.774 178.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.418 ' HB3' HG22 ' A' ' 83' ' ' ILE . 51.6 t80 -105.06 121.62 44.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.985 0.421 . . . . 75.4 110.081 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.474 ' O ' HD11 ' A' ' 112' ' ' LEU . 24.2 m -113.35 107.69 16.21 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.972 -0.558 . . . . 62.4 109.962 178.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -68.83 94.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.38 0.61 . . . . 74.0 110.072 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -113.93 -166.17 1.07 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.087 -0.96 . . . . 75.33 109.55 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -97.97 -14.22 20.71 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.973 0.416 . . . . 61.31 110.697 -176.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -112.21 169.42 8.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 62.24 110.653 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -75.52 137.52 40.92 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.05 0.452 . . . . 75.2 110.948 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 106' ' ' THR . 34.8 mt -87.46 111.29 21.0 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.622 -0.717 . . . . 70.12 110.533 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -88.82 108.93 19.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.933 0.397 . . . . 72.51 110.47 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.33 113.48 25.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 72.42 110.799 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -80.2 92.05 5.65 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.248 -0.649 . . . . 75.22 109.248 177.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.584 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.3 m -96.67 177.11 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.633 -0.712 . . . . 54.24 111.669 -172.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.77 118.74 13.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.334 -0.848 . . . . 70.11 109.662 177.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.728 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 14.4 m -75.6 118.75 18.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.001 -0.545 . . . . 73.11 110.847 -174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.1 tt -147.76 153.56 11.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.174 -0.466 . . . . 72.3 110.731 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.583 ' HG2' HD12 ' A' ' 150' ' ' ILE . 0.1 OUTLIER -81.8 125.81 31.1 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.698 -0.482 . . . . 64.15 109.698 178.289 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.652 ' HA ' ' HG3' ' A' ' 92' ' ' GLU . . . -152.41 175.42 12.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 72.2 111.331 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -128.51 -32.82 2.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.844 -0.616 . . . . 70.34 109.927 174.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -106.35 146.38 30.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.824 -0.626 . . . . 73.42 109.639 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 11.8 tt -130.55 135.21 60.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 120.804 0.335 . . . . 65.42 110.267 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -121.49 124.06 43.52 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.93 0.395 . . . . 64.25 110.93 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.4 tp -98.21 116.9 31.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.514 -0.766 . . . . 75.44 109.091 173.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 98.0 m -108.66 121.29 44.71 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.19 0.519 . . . . 75.33 110.966 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.493 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.9 mm -106.52 95.68 12.37 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.467 -0.788 . . . . 65.52 109.196 174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.646 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 57.0 Cg_endo -71.87 173.96 11.93 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.354 2.036 . . . . 75.13 112.552 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.488 ' HA ' HD13 ' A' ' 53' ' ' LEU . 16.7 t70 -91.01 -6.1 54.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 122.146 0.974 . . . . 64.43 108.893 175.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -92.28 143.35 26.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.695 -1.139 . . . . 74.51 110.532 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 101.21 -11.52 58.54 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.721 -0.752 . . . . 71.34 112.315 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.94 12.12 14.92 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.876 -0.678 . . . . 62.35 112.733 178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -67.78 124.84 24.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 73.0 110.936 -177.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.4 m -95.35 178.15 5.6 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.03 -0.532 . . . . 73.31 110.02 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 2.8 p -79.08 1.57 23.73 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.0 0.429 . . . . 72.41 112.127 -177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -98.12 101.02 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.871 -0.418 . . . . 52.43 109.871 176.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 43' ' ' HIS . . . -119.87 130.52 54.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.269 -0.423 . . . . 61.14 110.114 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 75' ' ' ARG . . . -147.07 111.92 5.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.159 0.505 . . . . 74.43 111.486 -177.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.4 mt -133.94 132.86 56.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.394 -0.595 . . . . 74.52 109.394 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.717 ' HD3' ' HB3' ' A' ' 41' ' ' PHE . 35.7 mmt180 -61.39 -63.79 1.16 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.669 0.271 . . . . 71.03 110.417 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -157.6 155.51 30.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.471 0.653 . . . . 64.13 111.346 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.3 tt -106.51 123.92 48.82 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.849 -1.069 . . . . 74.45 108.313 175.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.8 152.07 37.83 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.554 -0.535 . . . . 70.32 109.554 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 96.0 t -122.03 130.96 74.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 120.928 0.394 . . . . 71.41 111.603 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 39.0 mttp -101.97 107.06 18.08 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.944 -0.761 . . . . 74.33 108.944 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -154.11 177.76 31.36 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.238 -0.982 . . . . 63.43 112.143 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 26.8 m -106.85 127.31 53.3 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.241 -0.281 . . . . 75.11 110.241 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.611 ' HB ' HD23 ' A' ' 152' ' ' LEU . 35.8 mm -69.81 130.88 34.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.96 -0.564 . . . . 72.21 110.526 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 120' ' ' LYS . 16.3 mt -119.67 150.36 22.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.596 -0.52 . . . . 74.42 109.596 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 65.6 30.38 10.53 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.745 0.784 . . . . 72.21 109.559 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.611 HD23 ' HB ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -78.95 84.28 4.99 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.004 -0.998 . . . . 75.0 112.516 -174.304 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -104.5 155.33 18.9 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.984 -0.747 . . . . 71.02 108.984 170.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.7 p-80 -108.23 37.73 2.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.121 0.486 . . . . 74.04 112.123 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -113.03 -41.63 3.7 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.988 -0.745 . . . . 73.03 108.988 166.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 37.3 m170 63.64 74.66 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.905 -1.043 . . . . 70.13 111.435 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -69.38 -24.57 63.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.181 -0.918 . . . . 62.02 109.04 173.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -86.98 109.63 19.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.58 -0.737 . . . . 71.32 109.248 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 2.4 p80 . . . . . 0 C--N 1.321 -0.661 0 CA-C-N 116.262 -0.427 . . . . 72.21 110.144 -176.541 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.161 -0.681 . . . . 73.12 109.161 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.48 -156.5 21.61 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.639 -0.985 . . . . 71.32 110.639 -171.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.486 HG22 ' HG2' ' A' ' 146' ' ' LYS . 12.0 m -69.63 -46.22 66.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.037 0.446 . . . . 73.25 110.04 176.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 p -80.02 147.19 31.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.045 -0.525 . . . . 62.24 110.403 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.543 HG21 HD13 ' A' ' 65' ' ' ILE . 37.7 mm -83.5 138.07 19.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 110.284 -0.265 . . . . 73.45 110.284 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -85.21 130.9 34.51 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 61.43 109.755 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -108.97 13.66 24.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.642 -0.708 . . . . 75.43 110.725 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 m -71.25 -10.0 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.627 -0.715 . . . . 71.42 111.192 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -114.88 9.11 21.37 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 52.43 112.163 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 35.3 m0 -89.39 159.34 17.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.701 0.286 . . . . 74.13 110.541 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.525 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 9.2 pt-20 -142.42 161.88 36.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.857 0.36 . . . . 70.24 110.147 174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.0 117.89 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 72.34 110.185 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -81.53 -43.88 18.12 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.245 -0.434 . . . . 71.0 110.681 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -148.85 141.7 24.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.204 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -141.93 142.69 33.03 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.018 -0.734 . . . . 63.51 109.018 176.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -85.53 -29.32 24.3 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.83 -0.348 . . . . 73.23 110.996 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.5 t -154.49 149.29 26.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.816 0.341 . . . . 70.14 111.0 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -168.06 140.28 3.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.904 -0.776 . . . . 61.45 108.904 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 8.9 tp10 -98.27 116.92 31.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.015 0.436 . . . . 73.23 110.573 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.11 -16.37 12.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.01 -0.541 . . . . 72.35 111.251 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.7 m -113.4 -40.0 3.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.368 -0.378 . . . . 53.13 111.169 -173.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -63.07 -53.19 42.1 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 116.083 -0.508 . . . . 33.24 112.835 -178.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -77.9 -47.6 18.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.896 0.379 . . . . 54.12 110.151 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 81.14 -175.5 54.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.992 -0.623 . . . . 72.42 112.813 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 61.1 24.09 14.22 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 122.997 0.519 . . . . 73.24 111.857 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.52 18.72 72.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 71.23 111.805 -178.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -112.89 144.87 41.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.564 -0.318 . . . . 73.33 110.274 -175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.87 -1.75 38.69 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.015 -0.612 . . . . 43.22 111.706 -176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 62.5 mt -80.46 156.77 26.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 73.52 110.641 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.521 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -65.93 -31.05 71.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.484 -0.326 . . . . 64.05 111.252 -176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -76.09 -16.44 59.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.479 -0.328 . . . . 63.42 111.751 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 60.8 m -71.38 -23.65 61.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.036 0.446 . . . . 74.43 109.831 176.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' A' ' 42' ' ' TRP . 35.4 tp -72.82 -8.99 58.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.579 -0.737 . . . . 73.31 110.701 -179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.9 pt -130.56 25.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.936 -0.575 . . . . 71.45 110.406 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -82.17 -46.94 13.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.514 -0.312 . . . . 74.41 111.627 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.32 6.99 25.13 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.485 -0.864 . . . . 73.41 112.167 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' OD2' ' HB2' ' A' ' 39' ' ' GLU . 32.8 t70 -117.48 120.84 39.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.912 -0.403 . . . . 75.55 109.912 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.0 p -72.99 -8.79 57.31 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.507 0.558 . . . . 73.51 112.507 -173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' A' ' 37' ' ' ASP . 47.4 mt-10 -85.21 -26.79 26.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 62.2 110.292 177.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 66.0 p -96.84 137.29 36.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.978 -0.556 . . . . 60.11 109.879 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 23.2 p90 -139.17 175.69 9.34 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.832 0.348 . . . . 53.31 110.908 -174.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.628 ' HB2' ' HB2' ' A' ' 33' ' ' LEU . 45.9 t90 -105.44 134.31 48.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.923 -0.58 . . . . 74.2 109.597 173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -132.37 143.81 50.09 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.211 -0.663 . . . . 74.0 109.211 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.03 148.57 49.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.545 -0.298 . . . . 62.21 110.236 176.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' SER . 78.2 tttt -66.4 116.36 7.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.093 -0.503 . . . . 73.52 110.018 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -123.13 -27.2 4.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.887 -0.325 . . . . 74.23 111.264 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -78.57 107.54 11.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.034 0.445 . . . . 71.54 110.032 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 102.14 2.19 51.43 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 45.12 111.976 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.17 146.15 8.86 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.831 -0.7 . . . . 33.41 111.937 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.591 ' HB2' ' HB ' ' A' ' 136' ' ' THR . 12.1 p -89.63 151.87 21.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.878 0.371 . . . . 64.34 110.889 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -81.07 158.92 69.36 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.952 -0.567 . . . . 65.33 110.978 -177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.29 153.01 61.8 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.766 2.311 . . . . 63.41 112.924 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.52 158.04 41.2 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.818 -0.628 . . . . 72.43 110.132 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -83.03 167.56 64.85 Favored 'Cis proline' 0 C--N 1.345 0.368 0 C-N-CA 123.567 -1.43 . . . . 64.32 112.767 2.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 26.4 m-85 -101.67 108.98 20.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.075 -0.512 . . . . 73.33 110.275 178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -109.22 126.62 53.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.858 0.361 . . . . 73.34 110.436 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 HD23 ' A' ' 126' ' ' LEU . 55.4 mt -120.31 117.75 54.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.116 -0.493 . . . . 41.3 109.78 176.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.82 114.55 43.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.268 -0.423 . . . . 63.44 110.592 -177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.9 mp -109.4 134.91 49.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.089 -0.505 . . . . 74.05 110.091 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -99.17 120.22 39.15 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.181 -0.463 . . . . 65.34 109.755 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 63.6 mtm -86.84 -5.68 59.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.888 -0.596 . . . . 70.5 110.9 -177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.525 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 74.9 mmtt 68.45 5.96 5.1 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 113.312 0.856 . . . . 72.24 113.312 172.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -164.35 174.22 11.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.706 0.289 . . . . 61.4 111.122 -177.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.8 121.7 27.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.929 -0.578 . . . . 54.02 110.198 178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.543 HD13 HG21 ' A' ' 5' ' ' ILE . 61.6 mt -132.33 134.52 59.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 120.995 0.426 . . . . 74.01 110.517 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.546 ' HB2' HD11 ' A' ' 150' ' ' ILE . 55.9 tp60 -84.28 105.13 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.608 -0.724 . . . . 64.41 109.296 176.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 118' ' ' SER . 22.2 mm -74.35 117.27 18.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.438 -0.346 . . . . 73.22 110.427 -176.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.53 -47.99 3.21 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.282 -0.417 . . . . 75.43 110.995 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.586 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 6.1 tt0 -141.79 152.77 44.03 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.84 -0.344 . . . . 64.31 110.605 176.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.38 123.07 71.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.772 -0.649 . . . . 50.42 109.517 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.41 ' OE1' ' HB2' ' A' ' 146' ' ' LYS . 51.3 mp0 -103.75 122.71 45.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.968 -0.56 . . . . 50.53 110.642 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.46 HD12 ' CE2' ' A' ' 114' ' ' TYR . 55.2 mt -113.58 123.39 49.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.049 -0.523 . . . . 74.21 110.337 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 73' ' ' LEU . 19.9 tp -102.25 101.16 17.85 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 109.381 -0.6 . . . . 74.14 109.381 175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 3.1 Cg_exo -75.11 166.85 28.21 Favored 'Trans proline' 0 N--CA 1.464 -0.227 0 C-N-CA 123.214 2.609 . . . . 74.02 112.905 -175.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 79' ' ' SER . 70.3 ttt180 -94.0 56.66 2.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.403 0.621 . . . . 74.32 109.646 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -67.55 169.23 37.71 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.278 -0.873 . . . . 51.43 113.457 -177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 39.85 64.33 0.89 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.258 1.023 . . . . 74.45 111.99 -176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 165.99 -43.99 0.27 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.205 -0.907 . . . . 22.02 111.662 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 35.7 t -111.76 157.48 20.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.094 -0.336 . . . . 51.1 110.094 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -85.74 -42.04 14.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.215 -0.448 . . . . 71.11 110.42 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 56.17 84.47 0.21 Allowed Pre-proline 0 N--CA 1.465 0.276 0 O-C-N 123.741 0.651 . . . . 74.22 112.338 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 137' ' ' VAL . 5.2 Cg_exo -75.39 36.96 0.47 Allowed 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.299 2.666 . . . . 44.13 111.936 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.65 125.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.651 . . . . 62.01 109.553 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -111.89 -54.0 2.65 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.478 -0.328 . . . . 74.42 110.765 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.19 137.3 53.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.243 -0.435 . . . . 75.05 110.562 -177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.3 m -128.42 134.78 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.261 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HG2' ' HB2' ' A' ' 102' ' ' ARG . 43.7 mt-10 -116.63 132.51 56.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.022 -0.536 . . . . 72.55 110.596 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -112.08 129.74 56.12 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.673 -0.694 . . . . 64.44 109.944 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -125.28 153.62 42.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.702 -0.227 . . . . 54.2 110.435 177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.94 152.82 43.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.377 -0.374 . . . . 71.51 110.369 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.1 t -148.88 146.35 27.88 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 71.34 110.607 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -77.86 -42.26 34.1 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.89 178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.06 9.52 8.08 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.004 0.372 . . . . 74.23 112.004 -173.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.6 t30 64.96 30.06 12.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.784 0.802 . . . . 74.42 110.261 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.8 t -119.78 -52.88 3.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.434 -0.803 . . . . 73.34 109.456 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -103.04 107.13 17.81 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.25 -0.648 . . . . 54.3 109.25 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -94.36 130.65 40.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.154 0.502 . . . . 72.11 111.116 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.1 m -122.29 122.63 27.41 Favored Pre-proline 0 N--CA 1.445 -0.711 0 CA-C-N 115.803 -0.635 . . . . 74.42 110.36 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.81 128.9 27.05 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.515 2.144 . . . . 70.2 111.129 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.56 -10.94 8.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.985 -0.286 . . . . 75.34 110.8 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 165.7 153.21 7.53 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.095 -1.05 . . . . 51.44 113.599 175.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' A' ' 87' ' ' GLU . 15.2 ttt180 -130.77 115.05 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.832 -0.803 . . . . 74.35 108.832 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -135.43 -177.82 4.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.689 0.281 . . . . 41.15 110.828 -174.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -98.73 139.96 14.75 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.957 -0.639 . . . . 64.24 112.024 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.417 ' HA ' ' OH ' ' A' ' 114' ' ' TYR . 49.8 t80 -93.27 114.6 27.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.057 0.456 . . . . 73.12 110.069 -178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.1 m -99.17 106.98 19.22 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.237 -0.438 . . . . 62.12 110.025 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -68.17 111.7 4.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.147 0.499 . . . . 74.23 110.638 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -151.27 -176.26 5.5 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.399 -0.819 . . . . 71.41 108.922 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -101.74 -10.48 19.91 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.617 -0.433 . . . . 75.54 110.545 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.47 151.48 20.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.035 -0.529 . . . . 61.1 110.389 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.1 133.0 45.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.237 0.542 . . . . 55.22 111.588 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 40.3 mt -89.65 122.84 33.15 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.266 -0.879 . . . . 73.53 110.213 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.586 ' HB3' ' OE1' ' A' ' 69' ' ' GLN . 33.0 mt-10 -98.05 108.36 21.05 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.266 -0.425 . . . . 75.34 110.591 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 72' ' ' LEU . 91.2 m-85 -101.85 104.57 15.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.116 -0.493 . . . . 63.44 110.993 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.64 93.32 2.05 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.672 -0.694 . . . . 75.25 110.055 178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 28.8 m -91.14 178.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.854 -0.612 . . . . 54.43 111.913 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HZ3' ' HB3' ' A' ' 117' ' ' LYS . 5.3 ttpm? -75.4 112.8 12.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.205 -0.907 . . . . 72.21 110.094 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 20.0 p -56.72 120.53 7.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.857 -0.611 . . . . 51.33 111.222 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.8 tt -160.57 148.9 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.454 -0.339 . . . . 71.14 110.238 -177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.488 ' HG3' HD12 ' A' ' 150' ' ' ILE . 39.6 ttpt -89.86 135.76 33.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.169 -0.308 . . . . 75.14 110.169 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.86 175.15 13.22 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.557 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -121.74 -34.49 3.39 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 74.04 110.02 173.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -108.92 145.4 35.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.238 -0.653 . . . . 64.53 109.238 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 12.6 tt -131.71 139.23 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.986 -0.375 . . . . 75.12 109.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 60.7 ttp180 -124.31 118.2 26.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.966 0.412 . . . . 72.44 111.095 -177.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.559 HD23 HD12 ' A' ' 57' ' ' ILE . 43.4 tp -85.61 114.58 22.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.903 -0.777 . . . . 61.24 108.903 172.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.6 m -112.1 117.66 33.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.299 0.571 . . . . 65.31 111.347 -178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 37.1 mm -100.2 98.15 7.27 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.456 -0.793 . . . . 75.41 108.948 172.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.03 168.86 20.69 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.457 2.105 . . . . 54.44 112.305 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -96.87 7.73 45.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.326 0.584 . . . . 40.32 109.881 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -111.48 138.26 48.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.254 -0.884 . . . . 70.54 110.157 -178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.05 -10.84 24.79 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.988 -0.625 . . . . 44.44 111.699 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 109.1 18.88 8.88 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 121.051 -0.595 . . . . 72.41 112.386 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -76.73 135.64 39.04 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.776 0.322 . . . . 74.32 110.759 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.569 ' HB2' ' HB2' ' A' ' 82' ' ' PRO . 45.9 m -106.88 -173.94 2.42 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.089 -0.505 . . . . 62.4 110.281 176.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 50' ' ' SER . 14.4 p -84.55 2.3 41.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.079 0.466 . . . . 65.04 112.131 -175.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 82' ' ' PRO . 48.7 t -105.57 124.53 60.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.452 -0.34 . . . . 51.44 110.386 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.21 140.93 29.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.22 -0.445 . . . . 75.31 110.449 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.6 113.68 4.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.939 0.4 . . . . 74.35 111.06 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 19.3 mt -126.18 132.88 70.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.073 -0.714 . . . . 75.54 109.073 178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.691 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 97.4 mtt180 -65.58 -61.83 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.89 0.376 . . . . 73.22 110.481 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.74 138.92 23.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.197 -0.456 . . . . 75.14 110.24 -173.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.02 116.41 29.89 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.323 -0.621 . . . . 74.01 109.323 176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -114.62 150.57 34.88 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.993 0.425 . . . . 70.14 110.149 179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 59.9 t -119.37 124.03 72.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.183 -0.673 . . . . 54.4 109.183 176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.486 ' HG2' HG22 ' A' ' 3' ' ' THR . 0.6 OUTLIER -105.33 102.87 12.33 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.366 0.603 . . . . 74.43 109.86 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -148.87 -156.9 7.34 Favored Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.405 -0.816 . . . . 75.14 111.574 -177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.1 m -119.1 131.85 55.95 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.705 0.288 . . . . 60.34 110.936 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.506 HD11 HG23 ' A' ' 5' ' ' ILE . 37.5 mm -74.56 123.01 29.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 116.097 -0.501 . . . . 74.31 110.29 176.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 66' ' ' GLN . 51.1 mt -115.9 133.32 62.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.683 -0.488 . . . . 64.04 109.683 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -121.02 95.0 4.52 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.314 0.578 . . . . 61.1 111.343 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.414 ' O ' HD12 ' A' ' 152' ' ' LEU . 2.1 pp -134.36 105.15 6.45 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.783 -0.821 . . . . 73.05 108.783 171.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -114.61 14.1 17.57 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.714 -0.676 . . . . 71.13 111.066 -173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -93.96 7.71 44.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.163 -0.471 . . . . 64.33 110.223 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.1 100.93 0.13 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.876 -0.787 . . . . 65.45 108.876 176.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -87.75 129.21 35.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.597 -0.729 . . . . 64.32 112.636 -164.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -102.24 166.74 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.791 -0.818 . . . . 55.15 108.791 168.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -84.77 113.72 21.54 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.939 0.4 . . . . 72.51 110.536 -177.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 116.045 -0.525 . . . . 75.51 110.442 -179.797 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HA ' ' OG1' ' A' ' 4' ' ' THR . 24.0 ptp . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 109.878 -0.416 . . . . 53.53 109.878 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.85 -66.11 4.0 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.747 -0.74 . . . . 54.33 111.783 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.9 m -74.37 -24.26 59.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.325 0.583 . . . . 73.33 109.822 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.809 HG22 ' HG2' ' A' ' 146' ' ' LYS . 46.3 p -79.1 154.52 29.31 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.824 -0.625 . . . . 62.32 109.978 176.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 149' ' ' ILE . 38.9 mm -74.78 138.71 20.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.189 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 122.82 17.12 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.312 -0.625 . . . . 62.33 109.312 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -101.64 6.45 42.0 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.191 -0.459 . . . . 73.33 110.679 -175.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -72.54 84.45 1.13 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.371 0.605 . . . . 71.43 110.239 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.81 -9.76 2.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.635 -0.711 . . . . 73.21 112.38 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -70.49 155.81 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 73.32 110.461 178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 11.5 pt-20 -138.96 155.87 47.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.079 0.466 . . . . 75.22 110.015 173.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.55 113.48 31.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.821 -0.627 . . . . 70.4 110.005 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 60' ' ' ASP . 93.2 mt -79.67 -36.46 37.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.83 -0.623 . . . . 74.3 110.591 -177.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.3 t -147.91 141.24 25.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.009 -0.541 . . . . 60.42 110.721 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.475 ' HE2' ' HG2' ' A' ' 18' ' ' GLN . 35.4 p90 -155.72 136.11 13.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.765 -0.652 . . . . 74.3 109.633 175.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -85.25 -44.91 12.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.204 -0.453 . . . . 62.42 111.786 -174.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -134.34 147.51 50.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.022 0.439 . . . . 72.53 111.001 -175.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG2' ' HE2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -161.57 148.47 14.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.732 -0.667 . . . . 73.54 109.407 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.67 112.22 20.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.897 -0.409 . . . . 63.42 109.897 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.65 1.31 17.91 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.652 0.612 . . . . 71.12 112.652 -173.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.9 m -143.83 -29.79 0.5 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.384 -0.526 . . . . 63.31 112.331 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.14 -51.55 57.6 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.93 -0.652 . . . . 64.2 112.866 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG3' ' HE1' ' A' ' 41' ' ' PHE . 17.2 mm-40 -83.98 -37.82 21.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.171 0.51 . . . . 64.13 110.337 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.41 153.14 9.07 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.893 -0.67 . . . . 41.35 111.739 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.44 99.42 0.41 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 34.31 111.093 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.59 -0.73 55.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.916 -0.659 . . . . 30.21 112.184 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -120.14 122.94 42.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.112 -0.329 . . . . 74.22 110.112 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 116.0 2.49 20.34 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.298 -0.721 . . . . 64.22 111.298 -172.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 57.7 mt -74.67 150.74 39.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.532 -0.334 . . . . 73.32 110.74 -179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.534 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -64.99 -23.21 67.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.09 0.471 . . . . 71.24 111.214 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -77.82 -17.28 57.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 64.54 111.341 179.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.643 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 63.4 m -73.55 -17.61 61.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.176 0.512 . . . . 72.21 110.046 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.6 tp -71.97 -14.36 61.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.37 -0.832 . . . . 52.55 110.7 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.8 pt -130.66 21.59 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 61.4 109.911 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 18.1 t70 -72.39 -45.68 58.65 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.646 -0.707 . . . . 74.44 111.167 -173.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 115.68 -1.47 21.71 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.478 -0.868 . . . . 61.32 112.655 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -131.16 118.36 20.37 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.126 -0.324 . . . . 70.23 110.126 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.5 p -72.22 2.07 6.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.953 -0.567 . . . . 63.11 111.683 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -67.24 -35.78 80.27 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.631 -0.877 . . . . 44.4 108.631 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 21.1 p -95.42 165.73 12.22 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.834 -1.076 . . . . 64.54 110.141 177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.536 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 32.6 p90 -155.63 167.84 29.08 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.491 -0.322 . . . . 73.43 110.674 179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.534 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 33.9 t90 -101.22 133.23 46.1 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.268 -0.642 . . . . 70.11 109.268 172.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -133.62 144.19 49.1 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.332 -0.618 . . . . 75.21 109.332 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.16 146.93 52.96 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.282 -0.417 . . . . 74.55 110.435 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 50' ' ' SER . 82.8 tttt -63.12 116.61 5.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.978 -0.556 . . . . 72.21 110.197 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -120.4 -27.93 5.1 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.523 -0.471 . . . . 75.3 110.663 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -76.88 110.72 11.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.104 0.478 . . . . 72.45 110.2 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 10.11 59.38 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.804 -0.712 . . . . 54.35 112.06 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.08 154.6 16.15 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.841 -0.695 . . . . 63.1 112.156 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 45' ' ' LYS . 52.0 m -102.86 159.61 15.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.938 0.399 . . . . 55.02 111.286 -178.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -87.75 156.6 52.75 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.846 -0.615 . . . . 73.45 110.35 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -74.68 153.56 43.53 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.534 2.156 . . . . 65.5 113.194 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' A' ' 130' ' ' ASP . 11.9 mt -92.16 159.79 36.76 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.411 -0.813 . . . . 75.12 110.118 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.844 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 77.5 Cg_endo -80.52 162.45 82.71 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.578 -1.426 . . . . 71.03 112.875 -1.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 28.6 m-85 -93.98 132.31 38.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 73.02 111.199 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.569 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 3.4 t70 -111.49 125.45 53.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 75.41 110.219 178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 126' ' ' LEU . 52.5 mt -131.43 111.26 18.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.21 -0.45 . . . . 71.21 109.909 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.37 122.9 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.062 -0.517 . . . . 71.22 110.562 -175.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 57' ' ' ILE . 4.9 mp -116.25 136.13 54.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.638 -0.255 . . . . 75.14 110.694 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.52 ' HB2' HD11 ' A' ' 13' ' ' LEU . 57.3 t0 -99.12 119.73 38.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.721 -0.844 . . . . 75.14 108.721 173.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 71.6 mtm -85.6 -5.62 59.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.356 -0.384 . . . . 73.1 111.111 -174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.508 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.6 mmtt 66.27 12.02 8.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.806 -0.634 . . . . 74.31 112.026 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 153' ' ' GLU . 27.8 pt20 -165.88 147.56 7.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.84 -0.618 . . . . 63.42 109.746 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -72.7 128.43 35.53 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.899 -0.592 . . . . 73.23 110.042 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.541 ' CD1' HG21 ' A' ' 5' ' ' ILE . 71.7 mt -132.38 139.64 49.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.18 -0.464 . . . . 64.25 110.258 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.482 HE21 ' HB2' ' A' ' 118' ' ' SER . 55.8 tp60 -83.37 102.95 12.37 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.869 -0.789 . . . . 70.32 108.869 176.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' SER . 30.8 mm -72.28 129.17 35.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.372 -0.376 . . . . 60.13 110.833 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.89 -32.85 3.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.158 0.504 . . . . 31.43 111.079 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -163.29 147.68 11.0 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.881 -0.599 . . . . 54.11 111.177 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.2 t -119.84 133.87 65.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.162 -0.472 . . . . 73.53 109.871 176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.694 ' HG3' ' HD2' ' A' ' 146' ' ' LYS . 26.0 mt-10 -110.76 127.61 55.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.126 0.489 . . . . 73.22 110.602 175.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.7 mt -113.96 121.3 43.49 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.664 -0.698 . . . . 42.03 109.622 177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.7 tp -111.13 95.88 27.42 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 116.325 -0.398 . . . . 72.15 109.963 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 140' ' ' ILE . 65.0 Cg_endo -76.68 174.73 12.37 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.458 2.105 . . . . 71.43 111.657 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.555 ' HD3' ' HB1' ' A' ' 139' ' ' ALA . 65.8 mtp180 -68.98 -26.99 65.31 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.598 -0.89 . . . . 74.22 108.598 173.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 88.48 -168.67 36.68 Favored Glycine 0 N--CA 1.442 -0.913 0 CA-C-N 115.042 -0.981 . . . . 65.42 113.881 168.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.8 ttp85 -60.51 115.41 3.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.653 -0.774 . . . . 55.43 109.438 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.36 -17.47 5.59 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 111.151 -0.78 . . . . 52.42 111.151 -172.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.451 ' OG ' ' HB2' ' A' ' 75' ' ' ARG . 79.0 p -117.6 158.23 24.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.035 -0.357 . . . . 74.05 110.035 176.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -76.32 108.65 9.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.05 0.452 . . . . 61.42 109.832 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.834 ' HB3' HD22 ' A' ' 107' ' ' ASN . 21.2 t-20 -138.1 91.61 12.93 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.1 -0.5 . . . . 74.12 110.319 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -92.03 27.4 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.181 2.588 . . . . 71.43 112.659 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.8 mt -82.68 121.55 35.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.496 . . . . 73.13 110.457 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -105.89 -37.24 6.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.623 -0.717 . . . . 75.01 111.197 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.486 HG21 ' HA3' ' A' ' 132' ' ' GLY . 91.1 t -134.53 138.48 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.569 0.223 . . . . 72.2 111.097 -174.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.5 m -132.13 139.73 49.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 73.23 110.418 177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.57 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 67.9 mt-10 -121.06 134.53 55.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.394 -0.366 . . . . 74.31 110.791 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -116.22 131.03 57.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.95 -0.568 . . . . 73.04 110.8 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -130.75 153.33 49.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.369 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.16 155.53 46.92 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.243 -0.435 . . . . 75.32 110.494 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.4 t -150.02 147.33 27.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.063 0.459 . . . . 74.04 110.781 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -89.17 -33.74 16.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.902 -0.59 . . . . 61.54 110.841 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -122.97 -2.69 8.68 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.893 0.331 . . . . 75.14 111.893 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 63.85 34.62 11.66 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.657 0.741 . . . . 61.43 109.587 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.2 t -110.39 -54.51 5.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.859 -0.609 . . . . 75.33 109.366 176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -115.65 135.15 54.34 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.669 -0.863 . . . . 72.34 108.669 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -105.83 119.22 38.61 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.364 0.602 . . . . 73.34 110.687 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 53.2 m -95.29 125.03 51.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.233 -0.894 . . . . 54.24 110.875 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.0 111.98 3.3 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.627 2.218 . . . . 40.33 111.76 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 116' ' ' VAL . 21.2 pt -86.24 -18.87 8.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.117 -0.492 . . . . 73.43 110.948 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.88 139.96 2.78 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.288 -0.958 . . . . 72.45 113.074 178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 87' ' ' GLU . 30.2 ttt180 -119.59 126.55 51.46 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -141.36 -175.91 4.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.948 0.404 . . . . 74.43 110.84 -178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -100.96 143.97 16.42 Favored Glycine 0 N--CA 1.442 -0.957 0 C-N-CA 120.839 -0.696 . . . . 41.31 111.788 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.54 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 33.4 t80 -91.19 136.38 33.13 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.744 -0.465 . . . . 74.22 109.744 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.527 ' HB ' HD21 ' A' ' 112' ' ' LEU . 27.1 m -112.78 123.22 49.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.519 -0.31 . . . . 73.5 110.763 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.834 HD22 ' HB3' ' A' ' 81' ' ' ASN . 24.9 t-20 -67.05 93.73 0.3 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.035 0.445 . . . . 61.11 109.852 172.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.438 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 12.0 pt20 -144.54 169.27 18.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.895 -0.593 . . . . 73.51 109.417 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -104.9 18.59 22.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.538 0.685 . . . . 71.33 110.196 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -116.54 153.57 31.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.446 -0.797 . . . . 53.13 109.74 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.54 124.47 22.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.067 0.461 . . . . 70.43 111.262 -176.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.527 HD21 ' HB ' ' A' ' 106' ' ' THR . 75.0 mt -80.74 117.79 21.72 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.598 -0.728 . . . . 74.42 110.439 177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -95.86 119.81 35.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.266 -0.424 . . . . 73.53 110.392 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.57 105.17 13.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.232 -0.44 . . . . 74.31 109.905 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -82.59 90.77 6.84 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.282 -0.636 . . . . 73.34 109.282 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.613 HG21 HD12 ' A' ' 100' ' ' ILE . 30.5 m -86.86 179.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.323 -0.853 . . . . 64.23 110.581 -175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 100' ' ' ILE . 47.8 pttt -81.44 148.2 29.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.078 0.466 . . . . 72.25 110.226 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 37.4 p -79.01 127.62 32.21 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.747 -0.66 . . . . 62.23 111.511 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 15.8 tt -161.49 150.57 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.635 -0.711 . . . . 61.21 109.388 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.533 ' HB3' ' HZ2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -79.38 140.69 37.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.157 -0.683 . . . . 73.33 109.157 177.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.75 144.19 17.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.569 0.223 . . . . 51.13 110.848 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -103.76 -22.61 13.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.804 -0.813 . . . . 64.31 108.804 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -115.65 145.42 42.74 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.338 -0.846 . . . . 75.32 109.673 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 14.0 tt -136.34 141.7 40.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.957 -0.386 . . . . 73.14 109.957 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.569 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 59.9 ttp180 -126.78 125.71 42.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.033 0.444 . . . . 75.22 111.435 -176.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.435 HD23 HD12 ' A' ' 57' ' ' ILE . 57.9 tp -95.62 124.32 39.59 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.554 -0.748 . . . . 62.2 109.045 172.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 129' ' ' PRO . 76.4 m -119.47 123.16 43.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.991 0.424 . . . . 72.21 110.663 -179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 43.0 mm -105.56 94.01 7.95 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.354 -0.61 . . . . 72.14 109.354 175.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.844 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 68.0 Cg_endo -87.76 136.94 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.033 2.489 . . . . 75.01 113.006 -175.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 25.3 t0 -81.48 66.36 7.0 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.433 -0.951 . . . . 73.43 108.433 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -124.93 -12.54 7.02 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.835 -1.075 . . . . 74.34 111.703 -173.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 85' ' ' VAL . . . -139.83 22.62 2.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 119.659 -1.258 . . . . 63.12 114.001 -173.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.8 26.06 7.31 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.162 -1.018 . . . . 51.33 112.611 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 -82.11 178.45 8.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.887 0.375 . . . . 75.44 110.827 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.6 m -146.79 178.96 7.92 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.882 -0.414 . . . . 64.55 109.882 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 15.3 p -84.68 16.08 3.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.11 0.481 . . . . 34.42 111.667 -177.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 45.6 t -122.8 127.92 75.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.055 -0.52 . . . . 65.34 109.879 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -144.95 143.45 30.54 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.313 -0.403 . . . . 75.12 110.18 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.555 ' HB1' ' HD3' ' A' ' 75' ' ' ARG . . . -149.16 106.09 3.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.836 0.35 . . . . 73.22 111.33 -177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.628 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 9.3 mt -126.23 140.5 48.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.73 -0.841 . . . . 62.24 108.73 176.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 69.6 mtt180 -75.91 -63.17 1.37 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.025 0.44 . . . . 71.44 110.159 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -144.97 133.52 22.02 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.666 -0.697 . . . . 73.0 110.863 -170.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.47 120.63 42.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.418 -0.586 . . . . 72.32 109.418 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -120.88 124.26 44.54 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.086 0.47 . . . . 72.25 110.562 -177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.21 142.07 13.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.11 -0.495 . . . . 65.34 109.867 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.809 ' HG2' HG22 ' A' ' 4' ' ' THR . 26.6 mtpt -119.16 124.27 46.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.816 -0.438 . . . . 73.32 109.816 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -173.56 -166.83 32.44 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.649 -0.786 . . . . 64.14 112.152 -178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.8 m -107.3 130.15 54.8 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.573 0.225 . . . . 54.42 110.592 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 5' ' ' ILE . 40.7 mm -72.0 125.05 29.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.295 -0.411 . . . . 72.5 110.938 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.732 HG22 ' H ' ' A' ' 152' ' ' LEU . 44.6 mt -110.48 150.31 13.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.169 -0.678 . . . . 70.44 109.169 176.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -116.32 13.37 15.56 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.359 0.6 . . . . 73.01 111.03 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.732 ' H ' HG22 ' A' ' 150' ' ' ILE . 84.7 mt -85.65 64.19 8.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.681 -0.69 . . . . 73.42 110.486 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.489 ' OE1' ' HA ' ' A' ' 63' ' ' GLN . 33.3 mm-40 -80.34 14.26 2.05 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.542 -0.754 . . . . 71.15 111.43 -176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 39.7 m80 60.58 38.7 18.65 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.708 -0.479 . . . . 74.53 109.708 178.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -71.99 94.65 1.5 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.611 0.72 . . . . 75.2 111.985 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.38 98.32 6.0 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.471 -0.786 . . . . 74.31 108.911 174.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 51.9 t60 61.33 38.53 16.24 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.857 0.837 . . . . 75.21 108.866 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -102.31 121.3 42.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.007 -0.997 . . . . 72.52 110.298 -173.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 116.437 -0.347 . . . . 71.25 110.829 -179.393 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 111.637 0.236 . . . . 64.52 111.637 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.28 -85.2 0.64 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.857 -0.687 . . . . 73.0 112.426 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.5 m -78.82 -24.55 44.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.546 0.689 . . . . 75.52 109.652 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 146' ' ' LYS . 22.6 p -83.81 153.52 24.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.466 -0.788 . . . . 72.41 110.304 176.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.572 HG21 HD13 ' A' ' 65' ' ' ILE . 44.1 mm -63.79 147.76 12.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.303 -0.408 . . . . 73.04 111.213 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -72.95 112.79 9.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.575 -0.528 . . . . 72.22 109.575 175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -89.56 -8.54 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.008 0.433 . . . . 74.54 111.057 -174.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.4 m -73.17 97.67 2.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.742 0.782 . . . . 75.01 109.31 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.12 -11.91 4.14 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.627 -1.17 . . . . 43.01 111.25 -173.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.519 ' HE3' HG21 ' A' ' 59' ' ' ILE . 30.6 m0 -74.98 161.29 29.61 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.58 -0.526 . . . . 65.33 109.58 176.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.507 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 8.9 pt-20 -138.57 158.69 43.76 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.34 -0.544 . . . . 70.13 110.585 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.1 t -96.97 119.54 45.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.385 -0.825 . . . . 64.13 109.709 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.58 -39.0 28.39 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.014 0.435 . . . . 73.52 110.448 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 32.6 t -157.04 141.1 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.783 -0.644 . . . . 74.35 109.703 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 18' ' ' GLN . 51.7 p90 -136.02 146.2 46.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.002 -0.545 . . . . 75.44 109.532 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.5 m -86.27 -40.98 14.98 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 120.797 -0.361 . . . . 74.43 110.737 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 51' ' ' ASP . 5.9 t -147.81 148.17 30.63 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.153 0.501 . . . . 75.21 111.111 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -171.87 145.1 1.85 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.249 -0.887 . . . . 64.51 108.947 172.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 45' ' ' LYS . 9.5 tp10 -105.44 102.31 11.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.198 -0.456 . . . . 63.12 110.67 -173.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.576 ' HB2' HE22 ' A' ' 18' ' ' GLN . . . -100.43 -30.14 12.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.936 -0.574 . . . . 65.2 110.492 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.7 t -83.21 -33.69 26.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.675 . . . . 55.21 110.556 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' HA2' ' NE2' ' A' ' 47' ' ' GLN . . . -84.43 -48.39 5.06 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.771 -0.728 . . . . 74.44 113.129 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HG3' ' HA3' ' A' ' 28' ' ' GLY . 23.8 mm-40 -74.81 -29.76 61.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.656 0.228 . . . . 70.55 111.601 -175.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.49 -148.35 17.91 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.436 -0.888 . . . . 41.41 113.574 173.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.86 107.97 6.41 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.598 0.592 . . . . 70.25 112.598 -172.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.34 17.66 80.14 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.564 -0.744 . . . . 63.35 113.428 172.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -128.19 145.9 50.89 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 121.005 -0.278 . . . . 75.03 110.274 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.471 ' HA3' ' HG3' ' A' ' 23' ' ' GLU . . . 78.86 -4.52 60.98 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.403 -0.427 . . . . 71.02 112.757 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.698 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 56.9 mt -73.79 144.69 45.47 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.004 -0.369 . . . . 62.02 110.004 178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -68.47 -22.83 64.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.573 0.701 . . . . 53.25 110.064 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.688 ' HG2' ' HB3' ' A' ' 29' ' ' LEU . 13.9 ptmt -74.97 -23.44 58.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.999 -1.0 . . . . 73.44 111.335 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.698 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 79.1 m -72.97 -23.14 60.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.949 0.404 . . . . 62.44 110.484 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.0 tp -67.15 -15.02 63.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.617 -0.72 . . . . 74.12 110.581 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG21 HG12 ' A' ' 59' ' ' ILE . 27.5 pt -133.69 26.5 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.607 -0.724 . . . . 71.32 110.827 -178.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -78.29 -46.63 19.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.052 0.453 . . . . 72.31 111.305 -176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 124.12 6.03 7.13 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.53 -0.843 . . . . 75.21 112.672 -177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 39' ' ' GLU . 7.4 t70 -125.35 127.29 46.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.185 0.492 . . . . 62.51 110.518 177.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 p -76.34 -5.55 47.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.956 0.724 . . . . 73.44 112.956 -172.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.64 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 7.9 pt-20 -91.42 -21.34 21.01 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.111 -0.636 . . . . 64.43 110.46 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.4 p -90.94 136.76 32.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.258 -0.645 . . . . 72.1 109.258 177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.741 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 51.2 p90 -137.76 170.73 15.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.438 0.637 . . . . 71.44 112.412 -173.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 30.3 t90 -106.43 139.81 40.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.629 -1.169 . . . . 75.42 109.375 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -135.52 139.18 43.77 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.323 -0.621 . . . . 72.13 109.323 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.43 146.33 53.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.246 -0.433 . . . . 62.44 110.113 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 19' ' ' GLU . 35.1 ttpt -65.61 131.13 45.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.381 -0.372 . . . . 74.53 110.164 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.433 ' NE1' ' HG2' ' A' ' 19' ' ' GLU . 64.5 p-90 -130.32 -33.89 1.66 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.333 -0.394 . . . . 73.43 111.517 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.414 ' NE2' ' HA2' ' A' ' 22' ' ' GLY . 7.6 tt0 -67.71 -41.64 83.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.074 0.464 . . . . 74.23 110.767 -175.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.85 26.17 25.62 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.532 -0.842 . . . . 71.35 111.448 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.27 165.47 40.35 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 111.1 -0.8 . . . . 73.3 111.1 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.586 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 38.3 m -100.82 145.72 28.19 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 117.189 0.495 . . . . 64.52 110.452 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' HD2' ' A' ' 52' ' ' PRO . 18.3 m-20 -79.11 161.37 68.43 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.621 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 51' ' ' ASP . 60.1 Cg_endo -73.37 132.78 18.19 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.405 2.07 . . . . 63.4 112.734 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.11 158.27 88.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.822 -0.626 . . . . 60.21 110.198 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.716 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.7 Cg_exo -76.3 159.98 95.96 Favored 'Cis proline' 0 C--N 1.345 0.375 0 C-N-CA 124.002 -1.249 . . . . 55.42 112.692 0.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.732 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 19.0 m-85 -95.74 101.75 13.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.016 -0.538 . . . . 72.32 110.13 177.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.522 ' OD1' ' HD2' ' A' ' 125' ' ' ARG . 7.2 m-20 -98.71 117.96 34.35 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.059 -0.518 . . . . 75.12 110.51 -179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 52.7 mt -111.71 116.79 53.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.266 -0.425 . . . . 75.23 109.922 176.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.78 115.44 45.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.942 -176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.519 HG21 ' HE3' ' A' ' 10' ' ' TRP . 5.0 mp -111.08 136.61 46.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 72.52 110.576 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -104.06 119.54 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.401 -0.592 . . . . 62.22 109.401 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 69.6 mtm -85.13 -5.64 59.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.22 -0.445 . . . . 73.43 110.895 -177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.507 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 31.2 mmtp 72.0 -11.67 0.75 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.514 0.726 . . . . 51.01 112.643 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -145.13 170.5 16.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.617 0.246 . . . . 70.25 110.58 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 64' ' ' ASN . 2.2 m120 -85.95 124.36 32.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.132 0.491 . . . . 64.32 110.74 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.572 HD13 HG21 ' A' ' 5' ' ' ILE . 78.1 mt -130.17 136.97 57.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.559 -0.746 . . . . 64.3 110.065 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.574 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.9 tp60 -80.02 100.71 8.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.099 -0.704 . . . . 65.2 109.099 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 118' ' ' SER . 31.7 mm -69.36 118.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.909 -0.404 . . . . 51.25 109.909 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.6 -39.38 5.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.233 0.539 . . . . 62.53 110.914 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.704 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 51.3 tt0 -159.24 148.68 18.6 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.611 -0.722 . . . . 50.12 110.563 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.16 115.85 46.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.876 0.369 . . . . 42.2 110.817 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.579 ' OE2' ' HA ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -97.79 128.1 44.2 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.707 -0.679 . . . . 71.34 110.689 179.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.531 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 45.9 mt -109.34 118.17 35.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.463 -0.569 . . . . 54.13 109.463 177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.0 tp -103.74 99.07 14.58 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 109.588 -0.523 . . . . 64.23 109.588 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 72' ' ' LEU . 5.4 Cg_exo -78.48 172.17 15.67 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.869 2.379 . . . . 64.35 111.795 -179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HD3' ' OG ' ' A' ' 79' ' ' SER . 71.5 ttt180 -77.59 -28.74 51.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.245 0.545 . . . . 72.42 109.647 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 108' ' ' GLN . . . 93.83 -125.1 8.11 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.569 -0.742 . . . . 74.43 113.083 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -102.11 140.89 35.79 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.982 0.42 . . . . 63.13 110.002 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 120.48 -21.44 8.61 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.27 -0.732 . . . . 60.15 111.27 -176.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.431 ' OG ' ' HD3' ' A' ' 75' ' ' ARG . 67.9 m -123.27 171.57 9.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.858 -0.423 . . . . 73.44 109.858 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -102.48 105.81 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.593 -0.276 . . . . 51.14 110.526 -176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.446 ' HB2' HD22 ' A' ' 107' ' ' ASN . 5.5 m-20 -121.58 84.12 42.2 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.478 -0.328 . . . . 65.22 111.122 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 2.3 Cg_endo -82.95 32.12 0.52 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.35 2.7 . . . . 73.11 111.73 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.43 118.86 24.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.818 -0.628 . . . . 74.25 110.186 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -100.57 -50.12 3.99 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.716 -0.675 . . . . 74.3 110.904 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.45 ' CG2' ' HA3' ' A' ' 132' ' ' GLY . 60.9 t -127.36 141.68 45.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.042 -0.526 . . . . 71.13 110.599 -176.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 m -129.36 129.82 67.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.151 -0.477 . . . . 71.14 109.743 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' OE2' ' HD2' ' A' ' 102' ' ' ARG . 57.6 mt-10 -109.79 125.41 52.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.132 -0.486 . . . . 53.42 110.493 -177.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -107.68 129.66 55.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.081 -0.509 . . . . 74.3 110.426 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -133.58 145.33 49.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.279 -0.418 . . . . 63.41 110.76 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -129.2 153.02 48.15 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.027 -0.533 . . . . 61.25 109.846 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 29.5 t -149.86 154.62 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.345 0.593 . . . . 71.32 111.344 -177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.418 ' HG2' ' HA ' ' A' ' 121' ' ' ALA . 41.5 mt-10 -102.64 -32.79 9.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.432 -0.804 . . . . 71.31 109.985 175.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.508 ' O ' ' HB3' ' A' ' 94' ' ' ASN . 26.8 t0 -106.81 -12.32 15.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.875 -0.602 . . . . 74.41 111.252 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 15.8 t-20 76.25 -21.5 0.31 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.413 0.625 . . . . 75.21 111.114 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 93' ' ' ASP . 78.3 t -75.72 -50.96 21.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.684 -0.689 . . . . 54.31 110.319 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -111.1 113.41 25.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.225 -0.898 . . . . 63.31 109.913 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -94.08 142.19 27.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.014 -0.539 . . . . 73.52 110.946 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 65.4 m -115.1 124.55 30.09 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.786 -0.643 . . . . 73.23 109.967 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.52 116.17 4.27 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.567 2.178 . . . . 74.35 112.143 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.55 HD12 HG21 ' A' ' 116' ' ' VAL . 15.7 pt -86.78 -13.61 10.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.395 -0.366 . . . . 74.05 110.571 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.69 130.76 1.15 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.333 -0.937 . . . . 43.42 113.177 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.417 ' HD2' ' OE2' ' A' ' 87' ' ' GLU . 38.4 ttt180 -106.71 114.56 28.73 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.713 -0.847 . . . . 71.31 108.713 171.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.568 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.4 m-85 -125.79 172.3 9.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.404 -0.362 . . . . 74.0 110.682 -175.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -88.53 151.3 22.41 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.027 -0.829 . . . . 53.41 111.027 176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -100.86 131.96 46.49 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.96 -0.385 . . . . 65.15 109.96 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.536 ' HB ' HD21 ' A' ' 112' ' ' LEU . 21.1 m -105.8 124.74 50.06 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.149 -0.478 . . . . 65.43 110.433 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.446 HD22 ' HB2' ' A' ' 81' ' ' ASN . 26.6 t-20 -70.69 94.87 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.095 0.474 . . . . 73.31 110.312 177.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.412 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 11.9 pt20 -146.09 176.84 9.42 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.988 -0.745 . . . . 71.14 108.988 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.46 -7.81 17.4 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.033 0.444 . . . . 73.2 110.983 -177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -90.72 159.26 16.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.975 -0.557 . . . . 44.5 110.47 177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.27 130.0 41.39 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.091 0.472 . . . . 72.24 111.616 -177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 106' ' ' THR . 36.0 mt -87.28 116.38 25.33 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.517 -0.765 . . . . 74.51 110.33 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.579 ' HA ' ' OE2' ' A' ' 71' ' ' GLU . 40.9 mt-10 -83.16 121.14 26.68 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.283 0.364 . . . . 62.22 110.846 178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.488 ' HE2' HD12 ' A' ' 72' ' ' LEU . 49.9 m-85 -122.29 104.96 9.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 73.43 110.711 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -78.36 97.0 5.46 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.592 -0.731 . . . . 74.11 109.414 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.568 HG12 ' HE2' ' A' ' 103' ' ' PHE . 27.1 m -98.13 -178.95 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.443 -0.798 . . . . 75.42 111.792 -173.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 100' ' ' ILE . 45.8 tttp -61.04 125.69 24.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.409 -0.814 . . . . 71.45 111.088 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.744 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 9.6 p -73.05 120.02 18.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.09 -0.505 . . . . 75.24 110.029 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.431 ' HB ' ' HE3' ' A' ' 117' ' ' LYS . 10.6 tt -150.9 141.01 15.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.972 0.415 . . . . 74.42 111.406 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -82.9 115.02 21.59 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.277 -0.638 . . . . 74.01 109.277 172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 92' ' ' GLU . . . -142.8 175.0 10.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.292 . . . . 75.23 110.983 -178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -121.04 -32.5 3.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.361 0.6 . . . . 74.43 110.015 174.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -107.97 145.98 33.1 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.644 -0.707 . . . . 73.31 110.298 -176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -134.17 136.68 53.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.134 -0.484 . . . . 65.25 109.953 178.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.522 ' HD2' ' OD1' ' A' ' 56' ' ' ASP . 15.1 ttp180 -123.86 122.2 37.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.993 0.425 . . . . 74.02 111.095 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.422 HD23 HD12 ' A' ' 57' ' ' ILE . 40.4 tp -93.79 111.45 23.15 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.974 -0.75 . . . . 75.22 108.974 172.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 87' ' ' GLU . 61.0 m -105.91 120.59 42.13 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.071 0.462 . . . . 73.21 111.061 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.732 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 41.5 mm -98.31 96.23 3.5 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.566 -0.901 . . . . 74.0 108.566 171.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.716 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 42.3 Cg_endo -68.71 171.72 12.79 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.68 2.254 . . . . 54.33 113.057 -175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -105.34 -2.43 23.92 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 122.251 1.024 . . . . 65.25 108.407 170.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.448 ' H ' ' HB2' ' A' ' 129' ' ' PRO . 7.0 m-20 -72.45 -31.84 65.78 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.138 -1.392 . . . . 74.04 112.439 -170.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.45 ' HA3' ' CG2' ' A' ' 85' ' ' VAL . . . -94.2 0.11 66.05 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.187 -1.006 . . . . 64.21 113.621 -172.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 102.88 20.71 11.07 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.108 -1.044 . . . . 73.35 111.668 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -72.55 142.6 48.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.046 0.45 . . . . 72.34 111.031 -176.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.486 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 17.4 m -100.06 172.24 7.32 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.924 -0.58 . . . . 54.51 109.867 177.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.586 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 16.2 p -83.19 22.05 1.03 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 55.32 112.128 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.4 t -126.23 129.42 72.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.506 -0.553 . . . . 65.21 109.506 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -155.17 135.11 12.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.507 -0.315 . . . . 65.05 110.939 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -134.47 106.04 6.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.109 -0.496 . . . . 63.11 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.404 ' O ' ' HB2' ' A' ' 41' ' ' PHE . 29.9 mt -124.07 133.64 68.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.426 -0.583 . . . . 42.22 109.426 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.741 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 72.3 mtt180 -66.03 -71.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 O-C-N 123.274 0.359 . . . . 70.11 110.27 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -141.7 153.73 44.84 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.431 0.634 . . . . 73.23 111.705 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.0 tt -106.68 111.31 23.79 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 107.541 -1.281 . . . . 73.14 107.541 168.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -112.11 123.34 50.05 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.766 -0.457 . . . . 71.12 109.766 -172.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 48.7 t -100.05 128.35 52.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.916 0.389 . . . . 61.34 111.978 -171.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.704 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 54.1 mtpt -94.51 130.6 40.85 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.377 -0.601 . . . . 60.13 109.377 171.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.15 -167.35 35.42 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.186 -1.007 . . . . 44.3 112.265 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.2 m -123.06 129.49 51.56 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.479 0.18 . . . . 75.33 110.548 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.552 HD11 HG23 ' A' ' 5' ' ' ILE . 41.6 mm -69.36 116.36 10.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.163 -0.471 . . . . 73.45 109.981 177.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 66' ' ' GLN . 62.0 mt -101.02 141.22 18.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.974 0.416 . . . . 62.42 109.97 -178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -118.98 133.73 55.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.058 -0.519 . . . . 71.15 110.495 -176.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.97 79.98 1.07 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.767 0.794 . . . . 71.13 109.503 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.4 131.85 38.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 61.14 110.105 -178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -56.99 116.21 3.07 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.711 -0.477 . . . . 75.33 109.711 173.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -50.17 134.29 22.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.096 -0.502 . . . . 63.32 111.319 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -60.15 137.79 58.03 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.474 -0.785 . . . . 74.14 112.498 -172.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -142.17 165.13 28.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.026 -0.988 . . . . 74.51 108.591 173.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -57.02 113.75 1.83 Allowed 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.258 0.348 . . . . 74.41 110.208 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 4.5 t60 . . . . . 0 C--N 1.321 -0.631 0 CA-C-N 116.313 -0.403 . . . . 64.01 110.332 -176.656 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.799 -0.445 . . . . 62.32 109.799 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.11 90.83 1.21 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.78 -0.724 . . . . 34.52 112.425 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.7 m -66.97 100.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.034 -0.358 . . . . 70.25 110.034 174.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.624 ' HB ' ' OD1' ' A' ' 144' ' ' ASP . 35.3 p -133.18 161.71 33.71 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.32 -0.4 . . . . 53.3 110.446 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.821 HG23 HD11 ' A' ' 149' ' ' ILE . 47.5 mm -88.65 134.55 27.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 120.837 0.351 . . . . 71.13 111.317 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.8 m -66.64 118.35 10.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.12 -0.491 . . . . 63.1 110.07 174.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 16.0 mtmt -98.47 19.61 14.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.09 -0.505 . . . . 72.32 111.217 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.5 m -58.7 -42.18 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.498 0.555 . . . . 72.05 112.498 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -98.13 8.05 62.69 Favored Glycine 0 C--O 1.235 0.186 0 C-N-CA 120.541 -0.838 . . . . 41.01 112.946 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -75.39 138.38 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.708 0.29 . . . . 74.41 110.236 -178.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG2' ' HE3' ' A' ' 62' ' ' LYS . 12.4 pt-20 -130.3 152.91 49.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.074 -0.343 . . . . 71.41 110.074 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.4 t -94.28 115.23 32.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.907 -0.588 . . . . 54.21 109.829 179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.459 HD11 ' HE2' ' A' ' 123' ' ' TYR . 84.8 mt -77.24 -48.97 16.11 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 72.22 110.062 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 t -143.26 142.99 31.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.562 -0.745 . . . . 74.03 110.138 -177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.571 -0.74 . . . . 75.34 109.257 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.2 m -77.12 -40.91 44.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.055 0.455 . . . . 72.31 110.37 -178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.2 t -150.98 150.34 30.66 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.219 -0.446 . . . . 72.13 110.864 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -163.19 140.51 7.61 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.502 -0.925 . . . . 72.35 108.502 173.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 7.3 tp10 -86.12 95.94 9.72 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.423 0.63 . . . . 71.12 110.632 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.83 2.58 20.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.259 -0.882 . . . . 74.43 110.786 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 m -112.56 -43.86 3.42 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.887 -0.597 . . . . 72.43 110.629 -177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -76.31 -30.78 56.39 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 116.012 -0.54 . . . . 64.43 113.372 -176.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.15 6.44 9.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 117.18 0.49 . . . . 61.34 111.368 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.95 -140.31 19.22 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.879 -0.677 . . . . 70.14 113.205 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.76 150.8 34.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.7 0.286 . . . . 63.5 110.495 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.17 -10.21 67.0 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.01 -0.615 . . . . 75.1 112.382 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -142.02 140.28 32.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.004 -0.369 . . . . 74.05 110.004 -178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.5 83.87 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.014 -0.612 . . . . 65.05 111.971 -178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.2 mt -86.75 154.33 21.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.58 0.229 . . . . 74.43 110.488 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.96 -22.54 65.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.878 0.371 . . . . 72.53 111.448 -176.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -77.83 -22.69 49.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.504 -0.317 . . . . 74.11 111.315 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 40' ' ' THR . 40.3 m -68.56 -24.33 64.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.177 0.513 . . . . 74.53 109.911 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.57 HD12 ' HA ' ' A' ' 142' ' ' GLU . 24.9 tp -65.12 -24.49 67.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.39 -0.823 . . . . 64.3 110.776 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HG21 HG12 ' A' ' 59' ' ' ILE . 35.9 pt -120.86 14.38 6.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.379 . . . . 73.11 111.16 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.86 -33.03 73.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.05 0.452 . . . . 74.42 110.197 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.0 36.29 6.41 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.708 -0.678 . . . . 51.44 112.023 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -139.05 128.93 24.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.988 -0.375 . . . . 61.42 109.988 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.53 HG22 ' CD2' ' A' ' 73' ' ' LEU . 2.5 p -70.36 -11.72 61.1 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.626 0.602 . . . . 72.34 112.626 -174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -89.06 -27.11 21.02 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.84 0.352 . . . . 64.22 111.049 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 32' ' ' CYS . 25.2 p -87.78 146.1 25.79 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.739 -0.384 . . . . 74.44 109.974 -178.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.676 ' HB3' ' HA ' ' A' ' 141' ' ' ARG . 42.6 p90 -146.5 166.09 27.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.217 0.532 . . . . 75.02 111.772 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 34.0 t90 -108.24 139.89 42.26 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.948 -1.023 . . . . 74.14 109.547 176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -133.01 147.11 52.26 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.234 -0.654 . . . . 72.22 109.234 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . . . -75.11 145.92 41.83 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.992 -0.373 . . . . 73.43 109.992 175.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' HE2' ' OD2' ' A' ' 51' ' ' ASP . 37.7 ttpt -66.15 118.14 9.46 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.782 0.325 . . . . 75.4 110.355 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 68.7 p-90 -118.96 -30.9 4.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.425 -0.352 . . . . 75.42 110.896 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -78.72 107.67 11.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 73.4 110.249 -178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.12 -0.6 47.54 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.891 -0.671 . . . . 75.3 111.684 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 143.0 7.46 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.795 -0.717 . . . . 53.54 112.144 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.569 ' HB3' ' HB ' ' A' ' 136' ' ' THR . 49.6 m -95.98 151.79 19.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.822 0.344 . . . . 60.42 111.053 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.479 ' OD2' ' HE2' ' A' ' 45' ' ' LYS . 30.5 m-20 -82.39 150.32 63.47 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.921 -0.582 . . . . 54.43 110.661 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.81 145.02 44.97 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.746 2.297 . . . . 34.4 112.269 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.8 mt -70.6 162.13 72.8 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.069 -0.514 . . . . 54.52 110.529 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HA ' ' HB3' ' A' ' 53' ' ' LEU . 95.2 Cg_endo -83.15 170.02 56.16 Favored 'Cis proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.487 -1.464 . . . . 64.31 112.831 1.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.746 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.4 m-85 -108.17 111.02 22.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.144 -0.48 . . . . 73.41 110.406 178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -110.79 130.95 55.44 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.888 0.375 . . . . 74.33 110.622 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 126' ' ' LEU . 57.4 mt -121.72 114.41 42.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.479 -0.563 . . . . 71.44 109.479 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.5 t -102.36 115.74 44.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.139 -0.482 . . . . 72.14 110.921 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.574 HG12 HG21 ' A' ' 34' ' ' ILE . 4.9 mp -110.1 133.35 55.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.535 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -97.79 113.74 25.6 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.179 -0.675 . . . . 73.42 109.179 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 64.2 mtm -81.98 -5.36 58.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 64.45 110.82 -176.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE3' ' HG2' ' A' ' 11' ' ' GLU . 32.5 mmtp 73.41 -35.63 0.32 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.74 0.816 . . . . 74.13 112.965 174.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -123.9 166.73 15.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.005 0.431 . . . . 73.33 110.975 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -76.58 123.19 25.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.625 -0.716 . . . . 75.32 110.139 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.575 HD13 HG21 ' A' ' 5' ' ' ILE . 66.6 mt -131.68 136.87 56.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.05 0.452 . . . . 64.23 110.614 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 150' ' ' ILE . 52.7 tp60 -86.48 108.56 18.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.858 -0.793 . . . . 65.45 108.858 175.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.682 ' O ' ' HA ' ' A' ' 118' ' ' SER . 28.1 mm -75.33 130.56 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 110.441 -0.207 . . . . 73.53 110.441 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.9 -42.27 2.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.075 0.464 . . . . 73.42 111.331 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 146' ' ' LYS . 21.8 tt0 -153.39 145.84 24.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.059 -0.519 . . . . 73.51 110.296 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.7 t -110.39 134.06 53.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.02 -0.363 . . . . 61.0 110.02 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -113.02 126.96 56.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.139 0.495 . . . . 70.42 110.899 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.625 HD12 ' HE2' ' A' ' 114' ' ' TYR . 61.3 mt -110.71 123.38 49.91 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.725 -0.67 . . . . 72.13 109.499 176.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.53 ' CD2' HG22 ' A' ' 38' ' ' THR . 22.4 tp -103.93 104.76 44.97 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.905 -0.405 . . . . 71.11 109.905 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.8 -178.22 4.04 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.815 2.343 . . . . 74.52 111.955 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.9 mtp180 -98.46 -59.25 1.78 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 74.35 110.574 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.56 -52.19 3.09 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 121.119 -0.563 . . . . 64.04 112.81 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -88.89 109.28 20.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.752 0.311 . . . . 74.23 111.162 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.31 61.83 4.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.911 -0.586 . . . . 71.2 112.684 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -160.91 139.8 10.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.252 0.548 . . . . 72.31 111.525 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -100.45 123.29 44.47 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.117 -0.947 . . . . 72.32 108.733 173.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.621 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 41.1 t-20 -146.65 96.88 4.35 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 121.21 0.528 . . . . 72.13 110.756 -175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 135' ' ' SER . 9.3 Cg_endo -91.22 21.64 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.912 3.075 . . . . 72.01 112.796 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.8 mt -72.06 122.92 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.961 0.41 . . . . 62.34 110.169 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -100.08 -50.24 4.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.83 . . . . 73.4 110.855 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.498 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 60.2 t -126.97 138.41 54.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.944 -0.571 . . . . 51.32 110.928 -173.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.91 137.74 55.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.069 -0.514 . . . . 64.01 110.128 177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -120.13 135.53 54.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.039 0.447 . . . . 64.55 110.662 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.11 129.76 55.83 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.938 -0.574 . . . . 74.14 110.118 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.9 143.44 50.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.643 0.259 . . . . 50.41 110.671 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -126.59 151.35 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.254 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 t -146.26 152.88 39.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.231 0.539 . . . . 34.43 110.949 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -29.41 9.19 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.716 -0.674 . . . . 71.3 110.89 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -111.19 -0.03 16.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 74.11 111.11 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.1 t30 68.7 21.09 7.98 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.92 0.866 . . . . 75.22 109.614 -177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.5 t -117.76 -59.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.434 -0.803 . . . . 72.32 110.275 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -89.12 110.86 21.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 51.02 109.769 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -99.12 107.59 20.0 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.937 0.398 . . . . 75.52 110.312 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.8 m -88.46 123.89 67.25 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.967 -0.561 . . . . 72.42 110.378 177.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -68.13 107.33 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.243 1.962 . . . . 54.22 111.012 174.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 13.8 pt -80.21 -11.84 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.059 -0.519 . . . . 53.55 110.641 -178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 168.21 128.56 1.0 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.453 -0.88 . . . . 43.42 112.862 176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -100.62 123.58 45.02 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.92 -0.771 . . . . 75.13 108.92 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -138.52 -177.73 4.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.741 0.305 . . . . 60.21 110.482 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 85' ' ' VAL . . . -96.72 175.26 31.24 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.753 -0.737 . . . . 62.02 111.264 175.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -131.7 141.96 49.69 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.135 0.467 . . . . 75.42 110.095 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.8 m -136.69 119.42 16.13 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.931 -0.577 . . . . 73.44 110.058 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 81' ' ' ASN . 63.9 t30 -69.62 95.93 0.9 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.725 -0.472 . . . . 71.22 109.725 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -125.8 -167.98 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.288 -0.415 . . . . 62.04 110.843 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -92.09 -33.47 14.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.916 -0.584 . . . . 54.42 111.186 -176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -97.87 168.62 10.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.887 -0.597 . . . . 44.04 111.56 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.8 144.81 47.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.091 0.472 . . . . 74.03 111.146 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 42.6 mt -101.18 104.54 15.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.637 -0.711 . . . . 72.01 110.01 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -87.29 115.82 24.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.154 -0.476 . . . . 73.01 110.688 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.625 ' HE2' HD12 ' A' ' 72' ' ' LEU . 42.1 m-85 -113.34 108.17 16.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.117 0.484 . . . . 74.14 110.534 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -72.86 112.78 9.21 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.477 -0.783 . . . . 74.32 109.495 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 29.0 m -112.06 178.27 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.086 -0.507 . . . . 72.13 111.653 -172.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -61.73 128.19 35.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.512 -0.767 . . . . 71.03 110.481 178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.682 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 2.8 p -77.02 106.44 8.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.151 -0.477 . . . . 44.03 110.175 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 12.9 tt -148.85 146.73 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.915 -0.584 . . . . 74.13 110.487 -174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 26.6 tttm -88.29 131.44 34.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.845 0.355 . . . . 74.4 110.506 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.96 176.65 11.63 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.976 -0.556 . . . . 51.23 110.339 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -125.38 -30.66 3.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 64.23 110.158 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.459 ' HE2' HD11 ' A' ' 13' ' ' LEU . 93.5 m-85 -106.78 146.02 31.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.056 -0.52 . . . . 74.13 110.14 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 13.0 tt -135.99 135.66 50.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.934 0.397 . . . . 74.14 110.157 177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 33.6 ttp180 -122.88 120.06 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.34 -0.391 . . . . 74.12 110.679 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.44 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -84.48 113.73 21.42 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.769 -0.826 . . . . 70.15 108.769 171.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 94.5 m -107.77 116.92 32.82 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.349 0.595 . . . . 62.22 111.278 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.746 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 30.9 mm -100.59 91.34 1.77 Allowed Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 108.002 -1.11 . . . . 51.15 108.002 170.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 61.1 Cg_endo -72.8 174.45 11.82 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.243 1.962 . . . . 53.21 112.521 -173.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -90.34 36.91 0.89 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.613 -0.884 . . . . 62.21 108.613 175.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -113.52 146.37 39.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.571 -1.195 . . . . 72.14 110.752 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.67 -20.98 9.9 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.144 -0.55 . . . . 71.55 113.522 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 116.37 25.28 3.52 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.285 -0.959 . . . . 41.53 112.263 -177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -63.93 145.0 56.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.74 0.305 . . . . 71.21 110.383 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.476 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 15.4 m -118.74 176.87 5.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.068 -0.515 . . . . 70.52 110.541 -178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 50' ' ' SER . 34.1 p -78.16 10.14 3.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.243 -0.435 . . . . 71.11 111.879 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 44.8 t -109.4 119.29 58.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.654 -0.499 . . . . 73.41 109.654 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . . . -139.59 135.74 33.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.612 -0.267 . . . . 72.53 110.535 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.87 107.55 3.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.033 0.444 . . . . 74.51 110.887 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.9 mt -133.43 136.97 53.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.478 -0.564 . . . . 71.04 109.478 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.676 ' HA ' ' HB3' ' A' ' 41' ' ' PHE . 36.3 mmt180 -63.77 -72.4 0.14 Allowed 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.849 0.357 . . . . 72.33 110.071 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.57 ' HA ' HD12 ' A' ' 33' ' ' LEU . 12.8 pt-20 -151.39 162.43 40.94 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.917 -0.713 . . . . 74.34 111.812 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.9 tt -118.39 130.56 56.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.715 -1.13 . . . . 72.14 108.147 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.624 ' OD1' ' HB ' ' A' ' 4' ' ' THR . 2.7 t70 -128.16 164.4 22.56 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.696 -0.483 . . . . 71.32 109.696 177.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 5' ' ' ILE . 61.8 t -133.28 128.02 54.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.314 -0.403 . . . . 71.1 110.277 -175.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 69' ' ' GLN . 50.7 mttm -93.13 134.66 35.07 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.172 -0.677 . . . . 73.2 109.172 172.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 179.83 -149.39 8.56 Favored Glycine 0 N--CA 1.438 -1.214 0 C-N-CA 120.87 -0.681 . . . . 72.44 111.453 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 37.8 m -136.31 133.61 37.08 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.484 0.183 . . . . 72.2 110.562 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.821 HD11 HG23 ' A' ' 5' ' ' ILE . 31.2 mm -73.55 115.83 15.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.525 -0.546 . . . . 75.43 109.525 176.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 66' ' ' GLN . 56.1 mt -95.66 138.23 21.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.709 -0.478 . . . . 54.33 109.709 -178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.403 HD22 ' C ' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -79.99 142.7 34.78 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.632 0.729 . . . . 75.14 110.952 -177.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.09 148.84 42.61 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.075 -0.966 . . . . 61.14 108.903 177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -71.54 94.75 1.33 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.839 0.828 . . . . 73.14 110.932 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 11.9 t-160 -109.12 18.36 20.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.239 -1.346 . . . . 70.15 109.292 -175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -63.27 -41.05 98.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.456 -0.793 . . . . 72.41 110.296 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -139.52 -20.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 61.44 111.301 176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -91.88 130.47 37.64 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.919 0.39 . . . . 63.43 110.622 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -146.13 131.49 18.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.03 -0.532 . . . . 63.33 110.035 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.824 -0.625 . . . . 73.22 110.672 178.237 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.788 0.328 . . . . 73.44 110.877 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.27 79.1 1.52 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 73.53 111.345 176.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.0 t -89.79 11.65 19.47 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.182 0.515 . . . . 65.42 111.23 -175.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.1 p -78.51 160.8 27.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.931 -0.577 . . . . 71.12 110.35 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.494 HG23 HD11 ' A' ' 149' ' ' ILE . 44.5 mm -82.74 130.53 35.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.786 0.327 . . . . 72.03 110.85 -177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.3 t -65.6 125.05 23.99 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.171 177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -96.83 21.8 9.09 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 42.31 110.586 -177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.2 t -54.73 -46.04 74.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.576 -0.738 . . . . 60.24 112.069 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.29 18.29 36.12 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.239 -0.981 . . . . 43.43 113.643 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.4 ' HB3' HD12 ' A' ' 34' ' ' ILE . 25.9 m0 -77.41 144.07 38.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.063 0.432 . . . . 74.13 110.669 -178.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.557 ' HG2' ' HE2' ' A' ' 62' ' ' LYS . 23.5 pt-20 -139.85 162.7 34.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.006 0.432 . . . . 71.1 110.666 176.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t -102.33 127.48 55.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.869 -0.605 . . . . 74.35 110.133 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 mt -90.99 -45.82 8.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.245 0.545 . . . . 75.04 110.096 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.8 m -137.0 140.43 42.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.574 -0.739 . . . . 75.21 110.283 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -149.55 142.42 24.74 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.071 -0.344 . . . . 72.03 110.071 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.5 m -81.8 -51.95 7.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.995 0.426 . . . . 71.23 111.256 -178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 t -142.17 151.51 42.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.958 0.409 . . . . 72.53 110.8 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.538 ' HB2' ' HA ' ' A' ' 29' ' ' LEU . 9.6 pt20 -163.34 137.11 5.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.448 -0.796 . . . . 60.34 108.972 174.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.651 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 8.8 tp10 -89.48 97.96 11.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.208 0.528 . . . . 73.44 110.875 -174.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -100.68 -8.59 22.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.53 -0.759 . . . . 70.22 111.097 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -106.52 -52.64 2.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.276 -0.42 . . . . 54.13 110.81 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' H ' ' CD ' ' A' ' 19' ' ' GLU . . . -65.15 -54.93 24.4 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 116.074 -0.512 . . . . 65.34 112.55 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' H ' ' HG3' ' A' ' 19' ' ' GLU . 59.9 mm-40 -76.66 -38.65 54.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.823 0.344 . . . . 73.24 110.556 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 120.44 -165.79 13.78 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.869 -0.682 . . . . 73.41 112.333 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -90.08 133.69 34.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.685 0.279 . . . . 53.45 110.538 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.59 2.87 78.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.907 -0.663 . . . . 64.34 112.832 177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -153.35 139.18 18.03 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.078 -0.342 . . . . 63.14 110.078 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.6 -1.98 79.68 Favored Glycine 0 N--CA 1.452 -0.279 0 N-CA-C 111.606 -0.598 . . . . 71.43 111.606 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.539 ' HB2' ' SG ' ' A' ' 32' ' ' CYS . 60.4 mt -84.32 155.84 22.2 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.192 -0.299 . . . . 64.13 110.192 -178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 42' ' ' TRP . . . -66.81 -28.34 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.21 0.529 . . . . 71.25 111.098 -177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 pttt -79.58 -14.28 58.94 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.993 -0.549 . . . . 71.12 111.545 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.692 ' HA ' ' HB2' ' A' ' 35' ' ' ASP . 71.1 m -73.11 -19.29 61.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.063 0.459 . . . . 74.14 109.822 177.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.408 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 39.5 tp -68.62 -13.05 62.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.482 -0.781 . . . . 72.5 110.7 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 59' ' ' ILE . 34.6 pt -137.59 21.57 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.803 -0.635 . . . . 61.4 110.306 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.692 ' HB2' ' HA ' ' A' ' 32' ' ' CYS . 12.3 t70 -67.76 -41.58 83.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.96 -0.564 . . . . 73.42 110.793 -173.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 121.26 -2.26 11.47 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.869 -0.892 . . . . 53.05 110.869 -175.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -125.04 115.08 19.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.096 0.474 . . . . 75.24 109.951 -178.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -75.93 2.61 12.06 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.929 -0.578 . . . . 73.04 112.482 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.34 -27.62 21.54 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.955 0.407 . . . . 65.3 110.049 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 p -89.07 137.42 32.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.017 -0.735 . . . . 64.22 109.017 174.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.655 ' CB ' ' HA ' ' A' ' 141' ' ' ARG . 41.8 p90 -130.11 173.2 10.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.057 0.456 . . . . 64.41 111.431 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.574 ' CD1' ' HA ' ' A' ' 30' ' ' ALA . 40.7 t90 -107.4 128.6 54.62 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.24 -0.891 . . . . 71.21 108.793 172.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 40.5 t-80 -129.67 132.9 46.81 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.467 -0.568 . . . . 72.43 109.467 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.69 136.25 58.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.974 -0.75 . . . . 61.24 108.974 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -59.3 132.96 55.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.174 0.296 . . . . 73.02 110.385 -175.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -124.09 -22.1 4.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.208 -0.451 . . . . 74.4 111.149 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -69.47 108.18 3.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.868 0.366 . . . . 75.14 110.197 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.96 11.91 72.4 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 73.32 112.055 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 116.16 176.14 18.06 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 72.32 111.972 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 66.3 m -123.76 149.28 45.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.925 0.393 . . . . 51.35 110.856 -177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.409 ' CG ' ' HD2' ' A' ' 52' ' ' PRO . 2.6 t70 -75.66 142.93 74.47 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.974 -0.557 . . . . 75.3 109.712 -177.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 51' ' ' ASP . 30.8 Cg_endo -63.59 146.1 92.3 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.566 2.177 . . . . 71.24 113.193 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 9.7 mt -77.58 163.53 63.24 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.661 -0.7 . . . . 72.22 110.034 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.738 ' HB3' ' HA ' ' A' ' 129' ' ' PRO . 2.8 Cg_endo -81.28 163.95 77.96 Favored 'Cis proline' 0 N--CA 1.461 -0.401 0 C-N-CA 124.101 -1.208 . . . . 65.33 112.92 1.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 128' ' ' ILE . 22.3 m-85 -99.28 122.86 43.02 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.82 -0.627 . . . . 71.52 110.318 177.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.455 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 9.9 t0 -110.22 126.67 54.38 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.695 . . . . 75.53 109.817 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 125' ' ' ARG . 58.7 mt -130.25 108.92 16.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.769 0.319 . . . . 64.24 110.372 177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.84 118.46 47.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.023 -0.535 . . . . 71.52 110.566 -178.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 34' ' ' ILE . 82.8 mt -117.35 134.08 62.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.122 -0.49 . . . . 72.43 111.124 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -100.66 122.7 43.75 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.521 -0.548 . . . . 75.5 109.521 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.422 ' SD ' HD12 ' A' ' 65' ' ' ILE . 71.3 mtm -88.21 -6.21 57.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.424 . . . . 64.21 110.766 -177.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.557 ' HE2' ' HG2' ' A' ' 11' ' ' GLU . 72.5 mmtt 67.26 11.53 8.43 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.752 -0.658 . . . . 32.31 112.197 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -163.46 159.84 22.64 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.228 -0.286 . . . . 74.22 110.228 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 120' ' ' LYS . 58.7 m-80 -81.5 130.45 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.615 -0.513 . . . . 70.42 109.615 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.489 ' CD1' HG21 ' A' ' 5' ' ' ILE . 65.4 mt -135.55 136.01 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.078 0.466 . . . . 72.44 110.422 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -82.34 99.91 9.65 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 64.23 108.635 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.752 ' O ' ' HA ' ' A' ' 118' ' ' SER . 34.5 mm -69.79 113.55 5.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.091 -0.504 . . . . 73.55 110.174 -175.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 -32.6 7.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.896 0.379 . . . . 65.14 111.161 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.683 ' OE1' ' HB3' ' A' ' 113' ' ' GLU . 7.0 tt0 -154.2 147.42 24.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.283 -0.417 . . . . 64.33 110.78 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.7 t -117.87 134.15 62.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.111 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 113' ' ' GLU . 44.3 mt-10 -115.56 138.63 50.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.162 0.506 . . . . 65.15 110.927 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.414 HD12 ' HE2' ' A' ' 114' ' ' TYR . 92.7 mt -124.28 118.71 27.4 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.739 -0.664 . . . . 75.34 109.755 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -103.33 99.75 15.9 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 109.094 -0.706 . . . . 75.34 109.094 173.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.61 ' HB3' ' HZ ' ' A' ' 105' ' ' PHE . 55.5 Cg_endo -69.88 -170.55 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.526 . . . . 75.11 112.656 -177.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 75' ' ' ARG . 1.6 ptp180 -67.35 -29.82 69.46 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.761 -0.376 . . . . 75.4 110.716 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.48 -73.47 2.64 Favored Glycine 0 CA--C 1.502 -0.738 0 C-N-CA 120.823 -0.703 . . . . 53.0 112.366 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 77' ' ' ARG . 14.3 ptt180 -132.04 -176.38 4.05 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.381 0.61 . . . . 73.21 110.845 -176.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.48 -52.98 1.16 Allowed Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.052 -0.976 . . . . 31.23 112.336 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.1 m -143.27 160.88 39.67 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.102 -0.333 . . . . 44.42 110.102 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.58 140.79 48.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.585 -0.524 . . . . 65.02 109.585 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' A' ' 82' ' ' PRO . 19.2 t30 -127.45 92.2 43.93 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.026 -0.534 . . . . 72.35 109.732 -176.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -82.49 46.07 2.09 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.945 3.096 . . . . 72.05 113.906 -170.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.9 mt -88.4 111.11 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.171 -0.677 . . . . 63.13 109.171 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -88.02 -48.05 8.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.301 -0.409 . . . . 72.33 110.91 -175.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.713 HG11 ' HE ' ' A' ' 102' ' ' ARG . 12.0 t -130.95 143.15 41.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.213 -0.449 . . . . 74.51 110.713 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.7 m -128.88 142.01 45.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.144 -0.48 . . . . 65.25 110.238 177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -112.68 130.18 56.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.983 -0.553 . . . . 75.25 110.497 178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -108.81 129.1 55.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.074 -0.512 . . . . 73.32 110.312 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -131.33 148.55 52.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.316 -0.402 . . . . 63.02 110.476 178.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.36 153.63 47.71 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.42 -0.354 . . . . 70.11 110.479 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.3 t -145.39 142.38 29.29 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.078 -0.51 . . . . 70.45 110.136 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -77.32 -45.66 25.46 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.925 -0.58 . . . . 73.23 111.279 -176.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -130.61 23.85 5.08 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.372 -0.376 . . . . 71.52 111.048 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 59.1 t30 65.63 29.55 10.86 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.93 0.871 . . . . 73.51 110.089 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.17 -64.55 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.34 -0.845 . . . . 71.52 109.741 176.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -96.41 105.1 17.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.204 -0.453 . . . . 64.2 110.792 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -89.33 114.63 26.06 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.291 -0.413 . . . . 70.44 110.148 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.462 ' HA ' ' HD3' ' A' ' 99' ' ' PRO . 60.8 m -117.38 130.4 24.68 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.955 -0.566 . . . . 64.23 110.87 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 98' ' ' THR . 8.1 Cg_exo -70.88 106.99 1.97 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.865 2.376 . . . . 61.52 111.336 176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 116' ' ' VAL . 11.8 pt -76.04 -11.1 13.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.777 -0.647 . . . . 71.21 111.057 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 166.77 149.0 5.8 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.339 -0.934 . . . . 65.04 113.101 176.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.713 ' HE ' HG11 ' A' ' 85' ' ' VAL . 78.1 ttt180 -124.21 118.4 26.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.705 -0.85 . . . . 75.44 108.705 173.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' HE2' HG12 ' A' ' 116' ' ' VAL . 96.0 m-85 -133.32 163.17 29.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.897 0.38 . . . . 72.53 111.364 -174.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -77.65 141.4 25.5 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.663 -0.699 . . . . 35.23 111.595 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.61 ' HZ ' ' HB3' ' A' ' 74' ' ' PRO . 48.0 t80 -100.54 138.38 37.68 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.954 0.407 . . . . 61.24 110.368 -177.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.508 ' O ' HD11 ' A' ' 112' ' ' LEU . 32.6 m -131.3 112.73 13.02 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.139 -0.482 . . . . 73.22 110.184 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -71.66 103.07 2.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.291 0.567 . . . . 74.5 110.942 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -130.83 -174.34 3.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.317 -0.856 . . . . 73.11 109.425 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -90.56 -15.38 30.73 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.78 0.324 . . . . 72.43 110.98 -178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.96 150.77 22.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.344 -0.389 . . . . 60.25 110.839 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.06 127.51 32.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.115 0.483 . . . . 62.43 111.125 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.508 HD11 ' O ' ' A' ' 106' ' ' THR . 30.0 mt -79.63 105.34 10.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.657 -0.701 . . . . 72.34 110.349 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.806 ' HG2' ' HG2' ' A' ' 71' ' ' GLU . 42.6 mt-10 -88.64 111.71 22.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.181 0.515 . . . . 74.33 111.187 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . 0.414 ' HE2' HD12 ' A' ' 72' ' ' LEU . 50.5 m-85 -108.57 111.46 23.3 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.652 -0.703 . . . . 73.14 110.35 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -74.25 102.59 4.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.69 -0.686 . . . . 72.23 109.636 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.61 HG21 HD12 ' A' ' 100' ' ' ILE . 31.5 m -102.08 -179.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 71.14 111.583 -172.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 5.2 tmmm? -72.28 125.21 26.79 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.562 -0.745 . . . . 71.12 110.07 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 67' ' ' ILE . 32.5 p -70.2 127.18 31.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.951 -0.568 . . . . 74.11 111.295 -177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.6 tt -152.89 148.81 13.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.29 -0.414 . . . . 70.51 110.329 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.547 ' HG2' HD12 ' A' ' 150' ' ' ILE . 1.0 OUTLIER -85.52 116.28 23.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.526 -0.546 . . . . 71.43 109.526 175.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.707 ' HA ' ' HA ' ' A' ' 92' ' ' GLU . . . -141.81 156.43 45.55 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.959 -0.564 . . . . 73.44 110.828 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -111.92 -26.99 8.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.505 0.669 . . . . 73.31 109.388 173.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -111.4 145.4 38.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.459 -0.792 . . . . 74.04 109.319 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 59' ' ' ILE . 12.5 tt -133.08 139.63 49.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 109.693 -0.484 . . . . 73.12 109.693 179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ILE . 48.6 ttp180 -125.02 123.43 39.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.055 0.455 . . . . 65.54 111.126 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.459 HD23 HD12 ' A' ' 57' ' ' ILE . 41.3 tp -91.02 115.55 28.1 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.411 -0.813 . . . . 74.33 108.92 173.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 59.7 m -109.63 116.17 31.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.949 0.404 . . . . 55.43 110.865 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.658 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 40.2 mm -100.75 97.54 6.91 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 108.784 -0.821 . . . . 71.43 108.784 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.738 ' HA ' ' HB3' ' A' ' 54' ' ' PRO . 52.2 Cg_endo -69.96 170.28 17.19 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.432 2.088 . . . . 72.53 112.611 -176.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -91.98 -16.42 26.57 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.974 0.893 . . . . 74.34 108.754 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.55 148.03 22.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.285 -1.325 . . . . 71.41 110.895 -173.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.97 -12.96 49.57 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 110.949 -0.86 . . . . 52.33 110.949 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.76 24.83 7.53 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 121.093 -0.575 . . . . 72.3 111.689 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -75.61 127.58 33.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.752 -0.379 . . . . 74.43 110.748 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.2 m -95.88 164.43 12.74 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.19 -0.459 . . . . 64.4 109.996 177.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 17.4 p -68.98 -6.18 26.18 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.26 0.467 . . . . 72.44 112.26 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 82' ' ' PRO . 42.3 t -85.04 95.58 4.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.828 -0.434 . . . . 74.31 109.828 176.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -124.61 121.95 36.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.106 -0.497 . . . . 64.24 110.503 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -137.25 108.75 6.93 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.078 -0.51 . . . . 64.51 111.097 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.559 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 21.0 mt -121.96 132.65 70.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.592 -0.892 . . . . 71.21 108.592 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.655 ' HA ' ' CB ' ' A' ' 41' ' ' PHE . 77.1 mtt-85 -69.96 -70.74 0.27 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.936 -0.305 . . . . 75.23 110.613 -178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 33' ' ' LEU . 26.9 tt0 -148.07 141.14 24.94 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.157 -0.617 . . . . 62.04 111.322 -177.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 143' ' ' LEU . 7.9 tt -100.27 132.0 45.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.154 -0.93 . . . . 62.2 109.229 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.21 155.94 41.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.961 0.41 . . . . 74.33 110.387 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 73.6 t -126.74 135.94 62.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 116.127 -0.488 . . . . 63.02 110.542 -177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.603 ' HD2' ' NE2' ' A' ' 69' ' ' GLN . 46.3 mttp -104.69 115.45 30.34 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.191 -0.67 . . . . 74.04 109.191 171.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -162.02 -169.14 24.95 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.762 -0.733 . . . . 75.44 112.096 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.1 m -113.32 130.73 56.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.425 -0.213 . . . . 63.5 110.425 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 5' ' ' ILE . 34.3 mm -76.11 120.63 26.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.063 0.459 . . . . 75.51 110.966 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.547 HD12 ' HG2' ' A' ' 120' ' ' LYS . 37.0 mt -112.71 132.95 60.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.698 -0.683 . . . . 62.4 109.456 176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.577 ' N ' HD22 ' A' ' 151' ' ' ASN . 0.0 OUTLIER -140.8 78.71 1.66 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.793 0.806 . . . . 75.51 110.655 -175.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 75.7 mt -79.49 80.18 5.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.033 -0.985 . . . . 75.52 109.341 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -71.97 147.11 47.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.443 -0.799 . . . . 75.51 111.003 -176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -122.95 -170.78 2.17 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.522 -0.763 . . . . 70.22 109.045 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 -79.43 92.68 5.26 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.13 -0.693 . . . . 74.41 109.13 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -81.14 76.25 8.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.539 -0.755 . . . . 62.54 111.172 -171.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -131.36 131.13 43.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.51 -0.768 . . . . 54.51 108.994 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -79.46 -35.85 39.73 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.777 0.323 . . . . 73.41 111.041 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.407 -0.36 . . . . 74.01 110.54 176.019 . . . . . . . . 0 0 . 1 stop_ save_